PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bonde, S; Pedram, M; Stultz, R; Zavazava, N				Bonde, Sabrina; Pedram, Mehrdad; Stultz, Ryan; Zavazava, Nicholas			Cell fusion of bone marrow cells and somatic cell reprogramming by embryonic stem cells	FASEB JOURNAL			English	Article						cre/loxP; transdifferentiation; lacZ; beta-gal	ACUTE MYOCARDIAL-INFARCTION; IN-VIVO; PROGENITOR CELLS; EXPRESSION; TRANSPLANTATION; CARDIOMYOCYTES; HEPATOCYTES; ENGRAFTMENT; TOLERANCE; PHENOTYPE	Bone marrow transplantation is a curative treatment for many diseases, including leukemia, autoimmune diseases, and a number of immunodeficiencies. Recently, it was claimed that bone marrow cells transdifferentiate, a much desired property as bone marrow cells are abundant and therefore could be used in regenerative medicine to treat incurable chronic diseases. Using a Cre/loxP system, we studied cell fusion after bone marrow transplantation. Fused cells were chiefly Gr-1(+), a myeloid cell marker, and found predominantly in the bone marrow; in parenchymal tissues. Surprisingly, fused cells were most abundant in the kidney, Peyer's patches, and cardiac tissue. In contrast, after cell fusion with embryonic stem cells, bone marrow cells were reprogrammed into new tetraploid pluripotent stem cells that successfully differentiated into beating cardiomyocytes. Together, these data suggest that cell fusion is ubiquitous after cellular transplants and that the subsequent sharing of genetic material between the fusion partners affects cellular survival and function. Fusion between tumor cells and bone marrow cells could have consequences for tumor malignancy.-Bonde, S., Pedram, M., Stultz, R., Zavazava, N. Cell fusion of bone marrow cells and somatic cell reprogramming by embryonic stem cells. FASEB J. 24, 364-373 (2010). www.fasebj.org	[Bonde, Sabrina; Pedram, Mehrdad; Stultz, Ryan; Zavazava, Nicholas] Univ Iowa, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Stultz, Ryan] Univ Iowa, Iowa Biosci Advantage Program, Iowa City, IA 52242 USA; [Pedram, Mehrdad] Univ Tehran Med Sci, Dept Med Genet, Tehran, Iran; [Zavazava, Nicholas] Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Tehran University of Medical Sciences; University of Iowa	Zavazava, N (corresponding author), Univ Iowa, Dept Vet Affairs Med Ctr, 200 Hawkins Dr,C51-F, Iowa City, IA 52242 USA.	nicholas-zavazava@uiowa.edu	Pedram, Mehrdad/L-4072-2016	Pedram, Mehrdad/0000-0002-7348-3475	VA Merit Review award; National Institutes of Health/National Heart Lung and Blood Institute [R01 HLO73015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073015] Funding Source: NIH RePORTER	VA Merit Review award(US Department of Veterans Affairs); National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was made possible by a VA Merit Review award and by National Institutes of Health/National Heart Lung and Blood Institute grant R01 HLO73015. We thank the University of Iowa Gene Transfer Vector Core for providing the FIV vectors and Chantal Allamargot (University of Iowa Central Microscopy Research Facility) for technical assistance. We thank John Engelhardt (Department of Anatomy and Cell Biology, University of Iowa) for useful discussions.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kurtz J, 2004, BLOOD, V103, P4336, DOI 10.1182/blood-2003-08-2642; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Stein CS, 2001, MOL THER, V3, P850, DOI 10.1006/mthe.2001.0325; Strizzi Luigi, 2008, Breast Dis, V29, P91; Sykes M, 2001, IMMUNITY, V14, P417, DOI 10.1016/S1074-7613(01)00122-4; Takei S, 2005, CELL TRANSPLANT, V14, P701, DOI 10.3727/000000005783982693; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; WEKERLE T, 1999, NAT MED, V6, P464; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	35	16	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					364	373		10.1096/fj.09-137141	http://dx.doi.org/10.1096/fj.09-137141			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19762558	Green Published			2022-12-25	WOS:000274045000005
J	Roth, HM; Tessmer, I; Van Houten, B; Kisker, C				Roth, Heide M.; Tessmer, Ingrid; Van Houten, Bennett; Kisker, Caroline			Bax1 Is a Novel Endonuclease IMPLICATIONS FOR ARCHAEAL NUCLEOTIDE EXCISION REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; RESTRICTION ENZYMES; STRUCTURAL BASIS; DNA-REPLICATION; TFIIH; TRANSCRIPTION; MECHANISMS; ARGONAUTE; MUTATIONS; NUCLEASES	The helicases XPB and XPD are part of the TFIIH complex, which mediates transcription initiation as well as eukaryotic nucleotide excision repair (NER). Although there is no TFIIH complex present in archaea, most species contain both XPB and XPD and serve as a model for their eukaryotic homologs. Recently, a novel binding partner for XPB, Bax1 (binds archeal XPB), was identified in archaea. To gain insights into its role in NER, Bax1 from Thermoplasma acidophilum was characterized. We identified Bax1 as a novel Mg2+-dependent structure-specific endonuclease recognizing DNA containing a 3' overhang. Incision assays conducted with DNA substrates providing different lengths of the 3' overhang indicate that Bax1 specifically incises DNA in the single-stranded region of the 3' overhang 4-6 nucleotides to the single-stranded DNA/double-stranded DNA junction and thus is a structure-specific and not a sequence-specific endonuclease. In contrast, no incision was detected in the presence of a 5' overhang, double-stranded DNA, or DNA containing few unpaired nucleotides forming a bubble. Several Bax1 variants were generated based on multiple sequence alignments and examined with respect to their ability to perform the incision reaction. Residues Glu-124, Asp-132, Tyr-152, and Glu-155 show a dramatic reduction in incision activity, indicating a pivotal role in catalysis. Interestingly, Bax1 does not exhibit any incision activity in the presence of XPB, thus suggesting a role in NER in which the endonuclease activity is tightly regulated until the damage has been recognized and verified prior to the incision event.	[Roth, Heide M.; Tessmer, Ingrid; Kisker, Caroline] Rudolf Virchow Ctr Environm Biomed, D-97080 Wurzburg, Germany; [Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kisker, C (corresponding author), Rudolf Virchow Ctr Environm Biomed, Josef Schneider Str 2 D15, D-97080 Wurzburg, Germany.	caroline.kisker@virchow.uni-wuerzburg.de	Van Houten, Bennett/K-2284-2019; Tessmer, Ingrid/O-2810-2013; Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026; Resch, Heide Marie/0000-0001-9635-6340; Tessmer, Ingrid/0000-0002-8353-6315	Deutsche Forschungsgemeinschaft [KI-562/2-1, FZ-82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KI-562/2-1 and Forschungszentrum FZ-82 (to C.K.).	Araujo SJ, 2000, GENE DEV, V14, P349; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1111/j.1574-6976.2003.tb00626.x; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hwang JR, 1996, J BIOL CHEM, V271, P15898, DOI 10.1074/jbc.271.27.15898; Karakas E, 2007, EMBO J, V26, P613, DOI 10.1038/sj.emboj.7601497; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lovell S, 2002, NAT STRUCT BIOL, V9, P278, DOI 10.1038/nsb778; Moolenaar GF, 2002, P NATL ACAD SCI USA, V99, P1467, DOI 10.1073/pnas.032584099; Nishino T, 2006, CURR OPIN STRUC BIOL, V16, P60, DOI 10.1016/j.sbi.2006.01.009; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Ogrunc M, 1998, J BACTERIOL, V180, P5796; Richards JD, 2008, J MOL BIOL, V376, P634, DOI 10.1016/j.jmb.2007.12.019; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149	35	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32272	32278		10.1074/jbc.M109.055913	http://dx.doi.org/10.1074/jbc.M109.055913			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759013	Green Published, hybrid			2022-12-25	WOS:000272028400008
J	Oka, M; Sumita, N; Sakaguchi, M; Iwasaki, T; Bito, T; Kageshita, T; Sato, K; Fukami, Y; Nishigori, C				Oka, Masahiro; Sumita, Naoko; Sakaguchi, Masanobu; Iwasaki, Tetsushi; Bito, Toshinori; Kageshita, Toshiro; Sato, Ken-ichi; Fukami, Yasuo; Nishigori, Chikako			12-O-Tetradecanoylphorbol-13-acetate Inhibits Melanoma Growth by Inactivation of STAT3 through Protein Kinase C-activated Tyrosine Phosphatase(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN MELANOCYTES; PHOSPHOLIPASE D1; TARGETING STAT3; CELLS; SRC; PHOSPHORYLATION; 21ST-CENTURY	The growth of most melanoma cells in vitro is inhibited by the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA). In this study, the involvement of the signal transducer and activator of transcription 3 (STAT3) in the TPA-induced growth inhibition of melanoma cells was examined. The in vitro growth and DNA synthesis of five melanoma cell lines, whose STAT3 was activated (phosphorylated), was inhibited by TPA, whereas that of WM35 and WM39 cells, whose STAT3 activity was at negligible levels, was considerably slow and not affected by TPA. Blockade of STAT3 activity by small interfering RNAs suppressed the growth of WM1205Lu cells containing constitutively activated STAT3. Treatment of WM1205Lu cells with TPA decreased both the phosphorylated STAT3 and the DNA-binding activity of STAT3. Pretreatment of WM1205Lu cells with either a protein-tyrosine phosphatase inhibitor or a protein kinase C (PKC) inhibitor prevented the inhibitory effects of TPA on the level of phosphorylated STAT3. The five melanoma cell lines containing phosphorylated STAT3 commonly expressed PKC alpha, PKC delta, and PKC epsilon. Introduction of the dominant negative mutant of one of these PKC isoforms into WM1205Lu cells inhibited the TPA-induced dephosphorylation of STAT3. A Src inhibitor attenuated the STAT3 phosphorylation in WM1205Lu cells. These results indicate that constitutively activated STAT3 is positively regulated by c-Src and negatively regulated by a PKC-activated tyrosine phosphatase(s) in melanoma cells. Because TPA did not affect c-Src activity, we conclude that the growth inhibitory effect of TPA on melanoma cells is mediated through inactivation of STAT3 by a PKC-activated tyrosine phosphatase(s).	[Oka, Masahiro; Sumita, Naoko; Sakaguchi, Masanobu; Bito, Toshinori; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Div Dermatol, Dept Internal Related,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Iwasaki, Tetsushi; Fukami, Yasuo] Kobe Univ, Org Adv Sci & Technol, Res Ctr Environm Gen, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kageshita, Toshiro] Kumamoto Univ, Grad Sch Med Sci, Dept Dermatol, Kumamoto 8608556, Japan; [Sato, Ken-ichi] Kyoto Sangyo Univ, Fac Engn, Dept Biotechnol, Kita Ku, Kyoto 6038555, Japan	Kobe University; Kobe University; Kumamoto University; Kyoto Sangyo University	Oka, M (corresponding author), Kobe Univ, Grad Sch Med, Div Dermatol, Dept Internal Related,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	oka@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [19591305]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by Research Grant 19591305 (to M. O.) and the Global Center of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" (to M. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ARITA Y, 1994, INT J CANCER, V56, P229, DOI 10.1002/ijc.2910560215; BECKER D, 1990, ONCOGENE, V5, P1133; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; BROOKS G, 1990, PIGM CELL RES, V3, P98, DOI 10.1111/j.1600-0749.1990.tb00328.x; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; HALABAN R, 1986, J INVEST DERMATOL, V87, P95, DOI 10.1111/1523-1747.ep12523594; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Hsu MY, 1999, HUMAN CELL CULTURE, V1, P259; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; Kreis S, 2007, MOL CANCER RES, V5, P1331, DOI 10.1158/1541-7786.MCR-07-0317; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lacreusette A, 2007, ONCOGENE, V26, P881, DOI 10.1038/sj.onc.1209844; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Messina Jane L, 2008, Cancer Control, V15, P196; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Niu GL, 1999, CANCER RES, V59, P5059; Oka M, 2002, BIOCHEM BIOPH RES CO, V294, P1109, DOI 10.1016/S0006-291X(02)00614-9; Oka M, 2005, CANCER METAST REV, V24, P287, DOI 10.1007/s10555-005-1578-8; Oka M, 1996, J CELL PHYSIOL, V167, P406, DOI 10.1002/(SICI)1097-4652(199606)167:3<406::AID-JCP4>3.3.CO;2-A; Oka M, 2003, FEBS LETT, V554, P179, DOI 10.1016/S0014-5793(03)01158-X; OKA M, 1995, J INVEST DERMATOL, V105, P567, DOI 10.1111/1523-1747.ep12323485; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Xi SC, 2005, ONCOGENE, V24, P970, DOI 10.1038/sj.onc.1208316; Yamamoto N, 2006, J CELL SCI, V119, P4623, DOI 10.1242/jcs.03236; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	44	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30416	30423		10.1074/jbc.M109.001073	http://dx.doi.org/10.1074/jbc.M109.001073			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19755418	Green Published, hybrid			2022-12-25	WOS:000271090000044
J	Horowitz-Kraus, T; Breznitz, Z				Horowitz-Kraus, Tzipi; Breznitz, Zvia			Can the Error Detection Mechanism Benefit from Training the Working Memory? A Comparison between Dyslexics and Controls - An ERP Study	PLOS ONE			English	Article							SHORT-TERM-MEMORY; NEURAL PLASTICITY; WORD RECOGNITION; BRAIN PLASTICITY; ADULT DYSLEXICS; CRITICAL PERIOD; SYSTEM; COMPREHENSION; ACQUISITION; PERFORMANCE	Background: Based on the relationship between working memory and error detection, we investigated the capacity of adult dyslexic readers' working memory to change as a result of training, and the impact of training on the error detection mechanism. Methodology: 27 dyslexics and 34 controls, all university students, participated in the study. ERP methodology and behavioral measures were employed prior to, immediately after, and 6 months after training. The CogniFit Personal Coach Program, which consists of 24 sessions of direct training of working memory skills, was used. Findings: Both groups of readers gained from the training program but the dyslexic readers gained significantly more. In the dyslexic group, digit span increased from 9.84 +/- 63.15 to 10.79 +/- 3.03. Working memory training significantly increased the number of words per minute read correctly by 14.73%. Adult brain activity changed as a result of training, evidenced by an increase in both working memory capacity and the amplitude of the Error-related Negativity (ERN) component (24.71%). When ERN amplitudes increased, the percentage of errors on the Sternberg tests decreased. Conclusions: We suggest that by expanding the working memory capacity, larger units of information are retained in the system, enabling more effective error detection. The crucial functioning of the central-executive as a sub-component of the working memory is also discussed.			Horowitz-Kraus, T (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Fac Educ, IL-31999 Haifa, Israel.	Thorvitz@construct.haifa.ac.il						ACKERMAN PT, 1993, J LEARN DISABIL, V26, P597, DOI 10.1177/002221949302600910; [Anonymous], 2002, READING WRITING INTE, DOI DOI 10.1023/A:1013872422108; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; Bitan T, 2005, COGNITIVE BRAIN RES, V25, P90, DOI 10.1016/j.cogbrainres.2005.04.014; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; BREZNITZ Z, 2006, FLUENCY READING SYCH; Brickenkamp R., 1981, TEST D2 AUFMERK SANK; British Psychological Society, 1999, DYSL LIT PSYCH ASS; Callan DE, 2003, NEUROIMAGE, V19, P113, DOI 10.1016/S1053-8119(03)00020-X; CARRIER LM, 1995, J EXP PSYCHOL LEARN, V21, P1339, DOI 10.1037/0278-7393.21.5.1339; Chard DJ, 2002, J LEARN DISABIL-US, V35, P386, DOI 10.1177/00222194020350050101; *COGNIFIT LTD, 2008, COGNIFIT PERS COACH; COHEN RL, 1984, J LEARN DISABIL, V17, P218, DOI 10.1177/002221948401700406; Cowan Nelson, 1999, MODELS WORKING MEMOR; *CTR PSYCH TESTS, 1994, OR SIL COMPR T UNPUB; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Dorfberger S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000240; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FERMAN S, 2009, J NEUROLING IN PRESS; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harrison RV, 2005, DEV PSYCHOBIOL, V46, P252, DOI 10.1002/dev.20052; Helland T, 2004, J CLIN EXP NEUROPSYC, V26, P31, DOI 10.1076/jcen.26.1.31.23935; Helmstaedter C, 2002, ANN NEUROL, V52, P89, DOI 10.1002/ana.10260; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hochman EY, 2005, MEM COGNITION, V33, P635, DOI 10.3758/BF03195330; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Horowitz-Kraus T, 2008, CLIN NEUROPHYSIOL, V119, P2238, DOI 10.1016/j.clinph.2008.06.009; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; JORM AF, 1983, BRIT J PSYCHOL, V74, P311, DOI 10.1111/j.2044-8295.1983.tb01865.x; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; MATAL Battery, 2007, DIAGN BATT ASS LEARN; Meyer MS, 1999, ANN DYSLEXIA, V49, P283, DOI 10.1007/s11881-999-0027-8; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Palmer S., 2000, J RES READ, V23, P28, DOI DOI 10.1111/1467-9817.00100; Papanicolaou AC, 2001, J CHILD NEUROL, V16, P241; PATTERSON JV, 1991, ELECTROEN CLIN NEURO, V78, P424, DOI 10.1016/0013-4694(91)90060-H; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Raven J.C., 1960, GUIDE STANDARD PROGR; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Roodenrys S, 2001, READ WRIT, V14, P379, DOI 10.1023/A:1011123406884; Russeler J, 2003, NEUROSCI RES, V47, P233, DOI 10.1016/S0168-0102(03)00212-8; SHIRAN A, 2009, THESIS U HAIFA ISRAE; Smith-Spark JH, 2007, MEMORY, V15, P34, DOI 10.1080/09658210601043384; Smith-Spark JH, 2003, EUR J COGN PSYCHOL, V15, P567, DOI 10.1080/09541440340000024; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; Swanson HL, 2000, INTELLIGENCE, V28, P1, DOI 10.1016/S0160-2896(99)00025-2; THOMSON ME, 1978, J RES READ, V1, P7; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Wechsler D., 1997, WECHSLER ADULT INTEL; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	65	65	67	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7141	10.1371/journal.pone.0007141	http://dx.doi.org/10.1371/journal.pone.0007141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498WL	19779625	gold, Green Published, Green Submitted			2022-12-25	WOS:000270176200003
J	Lee, HG; Chen, Q; Wolfram, JA; Richardson, SL; Liner, A; Siedlak, SL; Zhu, XW; Ziats, NP; Fujioka, H; Felsher, DW; Castellani, RJ; Valencik, ML; McDonald, JA; Hoit, BD; Lesnefsky, EJ; Smith, MA				Lee, Hyoung-gon; Chen, Qun; Wolfram, Julie A.; Richardson, Sandy L.; Liner, Anna; Siedlak, Sandra L.; Zhu, Xiongwei; Ziats, Nicholas P.; Fujioka, Hisashi; Felsher, Dean W.; Castellani, Rudy J.; Valencik, Maria L.; McDonald, John A.; Hoit, Brian D.; Lesnefsky, Edward J.; Smith, Mark A.			Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure	PLOS ONE			English	Article								While considerable evidence supports the causal relationship between increases in c-Myc (Myc) and cardiomyopathy as a part of a "fetal re-expression'' pattern, the functional role of Myc in mechanisms of cardiomyopathy remains unclear. To address this, we developed a bitransgenic mouse that inducibly expresses Myc under the control of the cardiomyocyte-specific MHC promoter. In adult mice the induction of Myc expression in cardiomyocytes in the heart led to the development of severe hypertrophic cardiomyopathy followed by ventricular dysfunction and ultimately death from congestive heart failure. Mechanistically, following Myc activation, cell cycle markers and other indices of DNA replication were significantly increased suggesting that cell cycle-related events might be a primary mechanism of cardiac dysfunction. Furthermore, pathological alterations at the cellular level included alterations in mitochondrial function with dysregulation of mitochondrial biogenesis and defects in electron transport chain complexes I and III. These data are consistent with the known role of Myc in several different pathways including cell cycle activation, mitochondrial proliferation, and apoptosis, and indicate that Myc activation in cardiomyocytes is an important regulator of downstream pathological sequelae. Moreover, our findings indicate that the induction of Myc in cardiomyocytes is sufficient to cause cardiomyopathy and heart failure, and that sustained induction of Myc, leading to cell cycle re-entry in adult cardiomyocytes, represents a maladaptive response for the mature heart.			Lee, HG (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	hyoung-gon.lee@case.edu; mark.smith@case.edu	Chen, Qun/HGD-0868-2022; Zhu, Xiongwei/A-9629-2009; Smith, Mark A/A-9053-2009; Castellani, Rudy J/A-9555-2009; Lee, Hyoung-gon/A-9637-2009	Zhu, Xiongwei/0000-0003-2092-6508; 	NATIONAL INSTITUTE ON AGING [R01AG028679, P01AG015885, R21AG031364] Funding Source: NIH RePORTER; NIA NIH HHS [R21 AG031364, P01 AG015885, R01 AG028679, AG028679, AG031364, AG15885] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; BUCHWALD A, 1990, EUR HEART J, V11, P509, DOI 10.1093/oxfordjournals.eurheartj.a059743; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Dang CV, 1999, MOL CELL BIOL, V19, P1; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hayashi M, 2005, MOL VIS, V11, P201; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kai H, 1998, CIRC RES, V83, P594, DOI 10.1161/01.RES.83.6.594; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Lucas DT, 2003, AM J PHYSIOL-HEART C, V284, pH575, DOI 10.1152/ajpheart.00619.2002; Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1; MarinGarcia J, 1996, BIOCHEM MOL BIOL INT, V40, P487; Morgan EE, 2004, AM J PHYSIOL-HEART C, V287, pH2049, DOI 10.1152/ajpheart.00393.2004; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; POLLACK PS, 1994, J CELL BIOCHEM, V54, P78, DOI 10.1002/jcb.240540109; Quigley AF, 2000, J CARD FAIL, V6, P47, DOI 10.1016/S1071-9164(00)00011-7; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; REISS K, 1993, AM J PHYSIOL, V264, pH760, DOI 10.1152/ajpheart.1993.264.3.H760; ROBBINS RJ, 1992, AM J PHYSIOL, V262, pH590, DOI 10.1152/ajpheart.1992.262.2.H590; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Suzuki M, 2002, CIRCULATION, V105, P1824, DOI 10.1161/01.CIR.0000014926.32463.89; Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465; Van Coster R, 2000, ACTA NEUROL BELG, V100, P156; Xiao GS, 2001, CIRC RES, V89, P1122, DOI 10.1161/hh2401.100742; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252; Zhu XW, 2004, J NEUROCHEM, V89, P1233, DOI 10.1111/j.1471-4159.2004.02416.x	42	37	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7172	10.1371/journal.pone.0007172	http://dx.doi.org/10.1371/journal.pone.0007172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779629	Green Published, gold, Green Submitted			2022-12-25	WOS:000270176200013
J	Baumann, O; Greenlee, MW				Baumann, Oliver; Greenlee, Mark W.			Effects of Attention to Auditory Motion on Cortical Activations during Smooth Pursuit Eye Tracking	PLOS ONE			English	Article							EVENT-RELATED FMRI; SPATIAL ATTENTION; TARGET SELECTION; MOVEMENTS; SCHIZOPHRENIA; PERCEPTION; CORTEX; FIELD; TASK; HUMANS	Background: In contrast to traditional views that consider smooth pursuit as a relatively automatic process, evidence has been reported for the importance of attention for accurate pursuit performance. However, the exact role that attention might play in the maintenance of pursuit remains unclear. Methodology/Principal Findings: We analysed the neuronal activity associated with healthy subjects executing smooth pursuit eye movements (SPEM) during concurrent attentive tracking of a moving sound source, which was either in-phase or in antiphase to the executed eye movements. Assuming that attentional resources must be allocated to the moving sound source, the simultaneous execution of SPEM and auditory tracking in diverging directions should result in increased load on common attentional resources. By using an auditory stimulus as a distractor rather then a visual stimulus we guaranteed that cortical activity cannot be caused by conflicts between two simultaneous visual motion stimuli. Our results revealed that the smooth pursuit task with divided attention led to significantly higher activations bilaterally in the posterior parietal cortex and lateral and medial frontal cortex, presumably containing the parietal, frontal and supplementary eye fields respectively. Conclusions: The additional cortical activation in these areas is apparently due to the process of dividing attention between the execution of SPEM and the covert tracking of the auditory target. On the other hand, even though attention had to be divided the attentional resources did not seem to be exhausted, since the identification of the direction of the auditory target and the quality of SPEM were unaffected by the congruence between visual and auditory motion stimuli. Finally, we found that this form of task-related attention modulated not only the cortical pursuit network in general but also affected modality specific and supramodal attention regions.			Baumann, O (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	o.baumann@uq.edu.au	Baumann, Oliver/C-8296-2009; Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286; Lauwereyns, Jan/0000-0003-0551-2550; Baumann, Oliver/0000-0003-3976-5855				ACKER W, 1978, BRIT J SOC CLIN PSYC, V17, P173, DOI 10.1111/j.2044-8260.1978.tb00261.x; Baumann O, 2007, EXP BRAIN RES, V181, P237, DOI 10.1007/s00221-007-0922-3; Baumann O, 2007, CEREB CORTEX, V17, P1433, DOI 10.1093/cercor/bhl055; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; Berryhill ME, 2006, J NEUROPHYSIOL, V96, P461, DOI 10.1152/jn.00152.2006; Bon L, 1997, EXP BRAIN RES, V113, P180, DOI 10.1007/BF02454156; Boucher L, 2004, J PHYSIOL-PARIS, V98, P235, DOI 10.1016/j.jphysparis.2004.03.010; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P155, DOI 10.1001/archpsyc.56.2.155; Colonius H, 2001, PERCEPT PSYCHOPHYS, V63, P126, DOI 10.3758/BF03200508; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Driver J, 1998, PHILOS T R SOC B, V353, P1319, DOI 10.1098/rstb.1998.0286; FERRERA VP, 1995, J NEUROSCI, V15, P7472; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Hutton S, 1998, NEUROLOGY, V50, P604, DOI 10.1212/WNL.50.3.604; Hutton SB, 2005, EXP BRAIN RES, V163, P306, DOI 10.1007/s00221-004-2171-z; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kathmann N, 1999, PSYCHOPHYSIOLOGY, V36, P158, DOI 10.1017/S0048577299981167; Kimmig H, 1999, EXP BRAIN RES, V126, P443, DOI 10.1007/s002210050751; Knox PC, 2002, PROG BRAIN RES, V140, P211; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LIPTON RB, 1980, PERCEPT MOTOR SKILL, V50, P159; Muri RM, 1996, J NEUROL NEUROSUR PS, V60, P445, DOI 10.1136/jnnp.60.4.445; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Ohlendorf S, 2007, EUR J NEUROSCI, V26, P2096, DOI 10.1111/j.1460-9568.2007.05824.x; Ortuno F, 2002, NEUROIMAGE, V17, P411, DOI 10.1006/nimg.2002.1168; Pack C, 2001, J COGNITIVE NEUROSCI, V13, P102, DOI 10.1162/089892901564207; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; Posner M I, 1992, Curr Opin Neurobiol, V2, P165, DOI 10.1016/0959-4388(92)90006-7; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rosano C, 2002, CEREB CORTEX, V12, P107, DOI 10.1093/cercor/12.2.107; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Schmid A, 2001, NEUROREPORT, V12, P1409, DOI 10.1097/00001756-200105250-00023; Schulz KP, 2004, AM J PSYCHIAT, V161, P1650, DOI 10.1176/appi.ajp.161.9.1650; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHELIGA BM, 1995, EXP BRAIN RES, V105, P261; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Stuve TA, 1997, PSYCHOL MED, V27, P143, DOI 10.1017/S0033291796004230; Tanabe J, 2002, NEUROIMAGE, V17, P1315, DOI 10.1006/nimg.2002.1263; VANGELDER P, 1995, VISION RES, V35, P667, DOI 10.1016/0042-6989(94)00161-E; WYATT HJ, 1987, VISION RES, V27, P1565, DOI 10.1016/0042-6989(87)90165-9	52	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7110	10.1371/journal.pone.0007110	http://dx.doi.org/10.1371/journal.pone.0007110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498PN	19771159	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154400008
J	Ye, BC; Zhang, Y; Yu, H; Yu, WB; Liu, BH; Yin, BC; Yin, CY; Li, YY; Chu, J; Zhang, SL				Ye, Bang-Ce; Zhang, Yan; Yu, Hui; Yu, Wen-Bang; Liu, Bao-Hong; Yin, Bin-Cheng; Yin, Chun-Yun; Li, Yuan-Yuan; Chu, Ju; Zhang, Si-Liang			Time-Resolved Transcriptome Analysis of Bacillus subtilis Responding to Valine, Glutamate, and Glutamine	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; AMINO-ACIDS; EXPRESSION; SIGMA(W); OPERON; CODY; BIOSYNTHESIS; SPORULATION; CHEMOTAXIS; MUTATION	Microorganisms can restructure their transcriptional output to adapt to environmental conditions by sensing endogenous metabolite pools. In this paper, an Agilent customized microarray representing 4,106 genes was used to study temporal transcript profiles of Bacillus subtilis in response to valine, glutamate and glutamine pulses over 24 h. A total of 673, 835, and 1135 amino-acid-regulated genes were identified having significantly changed expression at one or more time points in response to valine, glutamate, and glutamine, respectively, including genes involved in cell wall, cellular import, metabolism of amino-acids and nucleotides, transcriptional regulation, flagellar motility, chemotaxis, phage proteins, sporulation, and many genes of unknown function. Different amino acid treatments were compared in terms of both the global temporal profiles and the 5-minute quick regulations, and between-experiment differential genes were identified. The highlighted genes were analyzed based on diverse sources of gene functions using a variety of computational tools, including T-profiler analysis, and hierarchical clustering. The results revealed the common and distinct modes of action of these three amino acids, and should help to elucidate the specific signaling mechanism of each amino acid as an effector.			Ye, BC (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn; yyli@scbit.org	Yu, Hui/B-3787-2018					ABRAHAM LS, 2007, NATURE REV MICROBIOL, V5, P917; ABRAHAM LS, 2008, MOL MICROBIOL, V68, P242; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; AGUSTINO MA, 2006, TRENDS MICROBIOL, V14, P22; ALEX TB, 2008, J BACTERIOL, V190, P1751; Altabe SG, 2003, J BACTERIOL, V185, P3228, DOI 10.1128/JB.185.10.3228-3231.2003; ANDREAS GL, 2006, MOL CELL, V24, P1; ANNE G, 2008, BMC SYSTEMS BIOL, V2, P20; ASWIN SNS, 2006, CURR OPIN MICROBIOL, V9, P511; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergara F, 2003, J BACTERIOL, V185, P3118, DOI 10.1128/JB.185.10.3118-3126.2003; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Cao M, 2002, J MOL BIOL, V316, P443, DOI 10.1006/jmbi.2001.5372; Debarbouille M, 1999, J BACTERIOL, V181, P2059, DOI 10.1128/JB.181.7.2059-2066.1999; DEJONG MH, 1977, ARCH MICROBIOL, V113, P153, DOI 10.1007/BF00428596; Diaz M, 2005, MICROBIOL-SGM, V151, P2583, DOI 10.1099/mic.0.27983-0; ERIC G, 2001, MOL MICROBIOL, V40, P1227; Esteban A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-201; FABIAN MC, 2008, J BACTERIOL, V190, P3557; FABIAN MC, 2006, CURR OPIN MICROBIOL, P167; Fisher SH, 2008, P NATL ACAD SCI USA, V105, P1014, DOI 10.1073/pnas.0709949105; GEORGE MS, 2006, MICROBIOL MOL BIOL R, V70, P253; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; GREGORY TS, 2007, MICROBIOLOGY, V153, P4123; HANS PF, 2004, GENOME RES, V14, P90; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; HELADIA S, 2007, FEBS LETT, V581, P3499; Huang XJ, 1998, J BACTERIOL, V180, P3765, DOI 10.1128/JB.180.15.3765-3770.1998; Ito M, 2005, J MOL BIOL, V352, P396, DOI 10.1016/j.jmb.2005.07.030; Jenkins AH, 2007, NAT CHEM BIOL, V3, P492, DOI 10.1038/nchembio.2007.13; JENNIFER MA, 2006, J BACTERIOL, V188, P5273; KATHRIN D, 1998, J BACTERIOL, V180, P6674; KAZUO K, 2001, J BACTERIOL, V183, P7365; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KYLE NE, 2005, J BACTERIOL, V187, P4042; LARISA EC, 2004, J BIOL CHEM, V279, P39340; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Matsuoka H, 2007, J BIOL CHEM, V282, P5180, DOI 10.1074/jbc.M606831200; Mirel DB, 2000, J BACTERIOL, V182, P3055, DOI 10.1128/JB.182.11.3055-3062.2000; MITSUO O, 2002, J BACTERIOL, V184, P2344; ORDAL GW, 1977, J BACTERIOL, V129, P151, DOI 10.1128/JB.129.1.151-155.1977; PIERRE B, 2005, J BACTERIOL, V187, P6019; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; ROBERT PS, 2004, MOL MICROBIOL, V53, P599; SARATH CJ, 2007, J MOL BIOL, V368, P263; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; SERGINE E, 2006, J BACTERIOL, V188, P2184; Serizawa M, 2005, BIOSCI BIOTECH BIOCH, V69, P2155, DOI 10.1271/bbb.69.2155; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; SHADIA Z, 2009, MOL SYSTEMS BIOL, V5, P245; SHASHI C, 2009, J BACTERIOL, V191, P2362; SHIGEO T, 2005, MOL MICROBIOL, V56, P1560; TAKENORI S, 2005, J BACTERIOL, V187, P4813; Terahara N, 2006, J BACTERIOL, V188, P2701, DOI 10.1128/JB.188.7.2701-2705.2006; Terahara N, 2008, P NATL ACAD SCI USA, V105, P14359, DOI 10.1073/pnas.0802106105; Tojo S, 2004, J BACTERIOL, V186, P7971, DOI 10.1128/JB.186.23.7971-7979.2004; Tseng CL, 2008, J BACTERIOL, V190, P1561, DOI 10.1128/JB.01497-07; ULRIKE M, 2002, J BACTERIOL, V184, P4288; VANDERDRIFT C, 1974, ARCH MICROBIOL, V96, P83, DOI 10.1007/BF00590165; Wang LJ, 2007, J BACTERIOL, V189, P8467, DOI 10.1128/JB.01285-07; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wray LV, 1997, J BACTERIOL, V179, P5494, DOI 10.1128/jb.179.17.5494-5501.1997; Yang YH, 2001, PROC SPIE, V4266, P141, DOI 10.1117/12.427982; Zakrzewska A, 2005, EUKARYOT CELL, V4, P703, DOI 10.1128/EC.4.4.703-715.2005; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZOLTAN P, 2002, MICROBIOLOGY, V148, P1593	72	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7073	10.1371/journal.pone.0007073	http://dx.doi.org/10.1371/journal.pone.0007073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763274	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970400010
J	Okamoto, N; Chantangsi, C; Horak, A; Leander, BS; Keeling, PJ				Okamoto, Noriko; Chantangsi, Chitchai; Horak, Ales; Leander, Brian S.; Keeling, Patrick J.			Molecular Phylogeny and Description of the Novel Katablepharid Roombia truncata gen. et sp nov., and Establishment of the Hacrobia Taxon nov	PLOS ONE			English	Article							FLAGELLATES PROTISTA; ALGAL GROUP; MARINE; PHYLUM; ULTRASTRUCTURE; DIVERSITY; PLASTIDS; ORIGIN; TREE; DINOFLAGELLATE	Background: Photosynthetic eukaryotes with a secondary plastid of red algal origin (cryptophytes, haptophytes, stramenopiles, dinoflagellates, and apicomplexans) are hypothesized to share a single origin of plastid acquisition according to Chromalveolate hypothesis. Recent phylogenomic analyses suggest that photosynthetic "chromalveolates'' form a large clade with inclusion of several non-photosynthetic protist lineages. Katablepharids are one such non-photosynthetic lineage closely related to cryptophytes. Despite their evolutionary and ecological importance, katablepharids are poorly investigated. Methodology/Principal Findings: Here, we report a newly discovered flagellate, Roombia truncata gen. et sp. nov., that is related to katablepharids, but is morphologically distinct from othermembers of the group in the following ways: ( 1) two flagella emerge from a papilla-like subapical protrusion, ( 2) conspicuous ejectisomes are aligned in multiple (5-11) rows, ( 3) each ejectisome increases in size towards the posterior end of the rows, and ( 4) upon feeding, a part of cytoplasm elastically stretch to engulf whole prey cell. Molecular phylogenies inferred from Hsp90, SSU rDNA, and LSU rDNA sequences consistently and strongly show R. truncata as the sister lineage to all other katablepharids, including lineages known only from environmental sequence surveys. A close association between katablepharids and cryptophytes was also recovered in most analyses. Katablepharids and cryptophytes are together part of a larger, more inclusive, group that also contains haptophytes, telonemids, centrohelids and perhaps biliphytes. The monophyly of this group is supported by several different molecular phylogenetic datasets and one shared lateral gene transfer; therefore, we formally establish this diverse clade as the "Hacrobia.'' Conclusions/Significance: Our discovery of R. truncata not only expands our knowledge in the less studied flagellate group, but provide a better understanding of phylogenetic relationship and evolutionary view of plastid acquisition/losses of Hacrobia. Being an ancestral to all katablepharids, and readily cultivable, R. truncata is a good candidate for multiple gene analyses that will contribute to future phylogenetic studies of Hacrobia.			Okamoto, N (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	pkeeling@interchange.ubc.ca	Horak, Ales/H-6723-2012; Okamoto, Noriko/J-6570-2012	Horak, Ales/0000-0002-3364-7383; Okamoto, Noriko/0000-0001-5493-8051; Keeling, Patrick/0000-0002-7644-0745				Auer B, 2001, FRESHWATER BIOL, V46, P959, DOI 10.1046/j.1365-2427.2001.00730.x; Barlow SB, 2002, HYDROBIOLOGIA, V473, P129, DOI 10.1023/A:1016585818665; Brandt SM, 2000, ESTUAR COAST SHELF S, V51, P91, DOI 10.1006/ecss.2000.0607; Braun EL, 2008, J PHYCOL, V44, P2, DOI 10.1111/j.1529-8817.2007.00432.x; BURKI F, 2009, EARLY EVOLU IN PRESS; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cavalier-Smith T, 2004, SYST ASSOC SPEC VOL, P75; Clay B, 1999, PROTIST, V150, P43, DOI 10.1016/S1434-4610(99)70008-8; Cleven EJ, 2001, AQUAT MICROB ECOL, V23, P147, DOI 10.3354/ame023147; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Grauvogel C, 2007, J MOL EVOL, V65, P725, DOI 10.1007/s00239-007-9053-5; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Hoppenrath M, 2006, J EUKARYOT MICROBIOL, V53, P327, DOI 10.1111/j.1550-7408.2006.00110.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Klaveness D, 2005, INT J SYST EVOL MICR, V55, P2595, DOI 10.1099/ijs.0.63652-0; KUGRENS P, 1987, J PHYCOL, V23, P511; KUGRENS P, 1994, PROTOPLASMA, V181, P164, DOI 10.1007/BF01666394; LARSEN J, 1990, J NAT HIST, V24, P801, DOI 10.1080/00222939000770571; LEE RE, 1991, J PHYCOL, V27, P725, DOI 10.1111/j.0022-3646.1991.00725.x; Lee WJ, 2000, J NAT HIST, V34, P483, DOI 10.1080/002229300299435; Matsuzaki M, 2008, MOL BIOL EVOL, V25, P1167, DOI 10.1093/molbev/msn064; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Okamoto N, 2005, SCIENCE, V310, P287, DOI 10.1126/science.1116125; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003; Okamoto N, 2006, PROTIST, V157, P401, DOI 10.1016/j.protis.2006.05.011; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shalchian-Tabrizi K, 2006, P ROY SOC B-BIOL SCI, V273, P1833, DOI 10.1098/rspb.2006.3515; Shalchian-Tabrizi K, 2007, PROTIST, V158, P173, DOI 10.1016/j.protis.2006.10.003; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SKUJA H., 1939, ACTA HORTI BOT UNIV LATVIENSIS, V11/12, P41; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Slapeta J, 2006, PROTIST, V157, P7, DOI 10.1016/j.protis.2005.11.004; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Teles-Grilo ML, 2007, EUR J PROTISTOL, V43, P163, DOI 10.1016/j.ejop.2007.02.002; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; VORS N, 1992, EUR J PROTISTOL, V28, P369, DOI 10.1016/S0932-4739(11)80001-5; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	56	82	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7080	10.1371/journal.pone.0007080	http://dx.doi.org/10.1371/journal.pone.0007080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759916	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970200010
J	Deniaud, E; Baguet, J; Chalard, R; Blanquier, B; Brinza, L; Meunier, J; Michallet, MC; Laugraud, A; Ah-Soon, C; Wierinckx, A; Castellazzi, M; Lachuer, J; Gautier, C; Marvel, J; Leverrier, Y				Deniaud, Emmanuelle; Baguet, Joel; Chalard, Roxane; Blanquier, Bariza; Brinza, Lilia; Meunier, Julien; Michallet, Marie-Cecile; Laugraud, Aurelie; Ah-Soon, Claudette; Wierinckx, Anne; Castellazzi, Marc; Lachuer, Joel; Gautier, Christian; Marvel, Jacqueline; Leverrier, Yann			Overexpression of Transcription Factor Sp1 Leads to Gene Expression Perturbations and Cell Cycle Inhibition	PLOS ONE			English	Article								Background: The ubiquitous transcription factor Sp1 regulates the expression of a vast number of genes involved in many cellular functions ranging from differentiation to proliferation and apoptosis. Sp1 expression levels show a dramatic increase during transformation and this could play a critical role for tumour development or maintenance. Although Sp1 deregulation might be beneficial for tumour cells, its overexpression induces apoptosis of untransformed cells. Here we further characterised the functional and transcriptional responses of untransformed cells following Sp1 overexpression. Methodology and Principal Findings: We made use of wild-type and DNA-binding-deficient Sp1 to demonstrate that the induction of apoptosis by Sp1 is dependent on its capacity to bind DNA. Genome-wide expression profiling identified genes involved in cancer, cell death and cell cycle as being enriched among differentially expressed genes following Sp1 overexpression. In silico search to determine the presence of Sp1 binding sites in the promoter region of modulated genes was conducted. Genes that contained Sp1 binding sites in their promoters were enriched among down-regulated genes. The endogenous sp1 gene is one of the most down-regulated suggesting a negative feedback loop induced by overexpressed Sp1. In contrast, genes containing Sp1 binding sites in their promoters were not enriched among up-regulated genes. These results suggest that the transcriptional response involves both direct Sp1-driven transcription and indirect mechanisms. Finally, we show that Sp1 overexpression led to a modified expression of G1/S transition regulatory genes such as the down-regulation of cyclin D2 and the up-regulation of cyclin G2 and cdkn2c/p18 expression. The biological significance of these modifications was confirmed by showing that the cells accumulated in the G1 phase of the cell cycle before the onset of apoptosis. Conclusion: This study shows that the binding to DNA of overexpressed Sp1 induces an inhibition of cell cycle progression that precedes apoptosis and a transcriptional response targeting genes containing Sp1 binding sites in their promoter or not suggesting both direct Sp1-driven transcription and indirect mechanisms.			Deniaud, E (corresponding author), INSERM, U851, F-69008 Lyon, France.	jacqueline.marvel@inserm.fr; yann.leverrier@inserm.fr	Wierinckx, Anne/AAF-5233-2021; LEVERRIER, Yann/M-3767-2014; meunier, julien/ABE-1435-2020; marvel, jacqueline/H-8638-2014	Wierinckx, Anne/0000-0002-0186-6645; LEVERRIER, Yann/0000-0002-4227-5446; marvel, jacqueline/0000-0001-6241-459X; lachuer, joel/0000-0002-5209-5094				Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blais A, 2002, J BIOL CHEM, V277, P31679, DOI 10.1074/jbc.M204554200; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chamboredon S, 2005, ONCOGENE, V24, P2547, DOI 10.1038/sj.onc.1208489; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Kavurma MM, 2003, J BIOL CHEM, V278, P32537, DOI 10.1074/jbc.M305650200; Kumar AP, 1999, CANCER LETT, V137, P159, DOI 10.1016/S0304-3835(98)00351-6; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Leverrier Y, 1997, ONCOGENE, V14, P425, DOI 10.1038/sj.onc.1200845; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lou Z, 2005, CANCER RES, V65, P1007; Marcais A, 2006, EUR J IMMUNOL, V36, P2745, DOI 10.1002/eji.200636259; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Martino A, 2001, J IMMUNOL, V166, P1723, DOI 10.4049/jimmunol.166.3.1723; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Parada Y, 2001, J BIOL CHEM, V276, P23572, DOI 10.1074/jbc.M101885200; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Song J, 2001, J BIOL CHEM, V276, P30429, DOI 10.1074/jbc.M103968200; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092; Zannetti A, 2000, CANCER RES, V60, P1546	44	66	68	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7035	10.1371/journal.pone.0007035	http://dx.doi.org/10.1371/journal.pone.0007035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753117	gold, Green Submitted, Green Published			2022-12-25	WOS:000269796500018
J	Martin-Subero, JI; Ammerpohl, O; Bibikova, M; Wickham-Garcia, E; Agirre, X; Alvarez, S; Bruggemann, M; Bug, S; Calasanz, MJ; Deckert, M; Dreyling, M; Du, MQ; Durig, J; Dyer, MJS; Fan, JB; Gesk, S; Hansmann, ML; Harder, L; Hartmann, S; Klapper, W; Kuppers, R; Montesinos-Rongen, M; Nagel, I; Pott, C; Richter, J; Roman-Gomez, J; Seifert, M; Stein, H; Suela, J; Trumper, L; Vater, I; Prosper, F; Haferlach, C; Cigudosa, JC; Siebert, R				Martin-Subero, Jose I.; Ammerpohl, Ole; Bibikova, Marina; Wickham-Garcia, Eliza; Agirre, Xabier; Alvarez, Sara; Brueggemann, Monika; Bug, Stefanie; Calasanz, Maria J.; Deckert, Martina; Dreyling, Martin; Du, Ming Q.; Duerig, Jan; Dyer, Martin J. S.; Fan, Jian-Bing; Gesk, Stefan; Hansmann, Martin-Leo; Harder, Lana; Hartmann, Sylvia; Klapper, Wolfram; Kueppers, Ralf; Montesinos-Rongen, Manuel; Nagel, Inga; Pott, Christiane; Richter, Julia; Roman-Gomez, Jose; Seifert, Marc; Stein, Harald; Suela, Javier; Truemper, Lorenz; Vater, Inga; Prosper, Felipe; Haferlach, Claudia; Cigudosa, Juan Cruz; Siebert, Reiner			A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms	PLOS ONE			English	Article								Background: Alterations in the DNA methylation pattern are a hallmark of leukemias and lymphomas. However, most epigenetic studies in hematologic neoplasms (HNs) have focused either on the analysis of few candidate genes or many genes and few HN entities, and comprehensive studies are required. Methodology/Principal Findings: Here, we report for the first time a microarray-based DNA methylation study of 767 genes in 367 HNs diagnosed with 16 of the most representative B-cell (n = 203), T-cell (n = 30), and myeloid (n = 134) neoplasias, as well as 37 samples from different cell types of the hematopoietic system. Using appropriate controls of B-, T-, or myeloid cellular origin, we identified a total of 220 genes hypermethylated in at least one HN entity. In general, promoter hypermethylation was more frequent in lymphoid malignancies than in myeloid malignancies, being germinal center mature B- cell lymphomas as well as B and T precursor lymphoid neoplasias those entities with highest frequency of gene-associated DNA hypermethylation. We also observed a significant correlation between the number of hypermethylated and hypomethylated genes in several mature B-cell neoplasias, but not in precursor B- and T-cell leukemias. Most of the genes becoming hypermethylated contained promoters with high CpG content, and a significant fraction of them are targets of the polycomb repressor complex. Interestingly, T-cell prolymphocytic leukemias show low levels of DNA hypermethylation and a comparatively large number of hypomethylated genes, many of them showing an increased gene expression. Conclusions/Significance: We have characterized the DNA methylation profile of a wide range of different HNs entities. As well as identifying genes showing aberrant DNA methylation in certain HN subtypes, we also detected six genes-DBC1, DIO3, FZD9, HS3ST2, MOS, and MYOD1-that were significantly hypermethylated in B-cell, T-cell, and myeloid malignancies. These might therefore play an important role in the development of different HNs.			Martin-Subero, JI (corresponding author), Univ Kiel, Inst Human Genet, Kiel, Germany.	jimartin@idibell.cat; rsiebert@medgen.uni-kiel.de	Agirre, Xabier/ABE-4110-2020; Brüggemann, Monika/M-8150-2013; Hartmann, Sylvia/AAJ-4376-2021; Klapper, Wolfram/D-2516-2010; SUELA, JAVIER/K-3968-2016; Ammerpohl, Ole/G-2691-2010; Klapper, Wolfram/S-6314-2016; Seifert, Marc/N-5602-2015; Siebert, Reiner/A-8049-2010; Calasanz, MJ/R-5813-2016; Prosper, Felipe/H-6859-2017; Deckert, Martina/P-2842-2016; Dyer, Martin/F-2691-2014	Brüggemann, Monika/0000-0001-5514-5010; Seifert, Marc/0000-0001-9453-369X; Calasanz, MJ/0000-0002-0374-3008; Prosper, Felipe/0000-0001-6115-8790; Du, Ming-Qing/0000-0002-1017-5045; Montesinos-Rongen, Manuel/0000-0003-4724-5526; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Kuppers, Ralf/0000-0002-6691-7191; Dyer, Martin/0000-0002-5033-2236	Medical Research Council [MC_U132670597] Funding Source: Medline; MRC [MC_U132670597] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Moundhri MS, 2009, J CLIN GASTROENTEROL, V43, P152, DOI 10.1097/MCG.0b013e31815853fa; Baiocchi OCG, 2008, LEUKEMIA LYMPHOMA, V49, P2031, DOI 10.1080/10428190802517799; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Bermudez-Morales VH, 2008, CANCER INVEST, V26, P1037, DOI 10.1080/07357900802112693; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boultwood J, 2007, BRIT J HAEMATOL, V138, P3, DOI 10.1111/j.1365-2141.2007.06604.x; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Dolloff NG, 2005, ONCOGENE, V24, P6848, DOI 10.1038/sj.onc.1208815; Durig J, 2007, LEUKEMIA, V21, P2153, DOI 10.1038/sj.leu.2404877; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Feng YX, 2008, CANCER LETT, V270, P250, DOI 10.1016/j.canlet.2008.05.013; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; Ford CE, 2007, BRIT J CANCER, V96, P808, DOI 10.1038/sj.bjc.6603614; Galinsky VL, 2003, BIOINFORMATICS, V19, P1832, DOI 10.1093/bioinformatics/btg260; Galinsky VL, 2003, BIOINFORMATICS, V19, P1824, DOI 10.1093/bioinformatics/btg259; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Garcia-Manero G, 2008, CURR OPIN ONCOL, V20, P705, DOI 10.1097/CCO.0b013e328313699c; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Gronbaek K, 2008, MODERN PATHOL, V21, P632, DOI 10.1038/modpathol.2008.27; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann U, 2004, ANN HEMATOL, V83, P137, DOI 10.1007/s00277-003-0798-7; Lind H, 2005, LUNG CANCER, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Lurje G, 2009, PHARMACOGENET GENOM, V19, P95, DOI 10.1097/FPC.0b013e32831a9ad1; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Muste A, 2009, CYTOKINE, V45, P8, DOI 10.1016/j.cyto.2008.10.019; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; ORIAIN C, 2009, LEUKEMIA; Pike BL, 2008, LEUKEMIA, V22, P1035, DOI 10.1038/leu.2008.18; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Raaphorst FM, 2001, J IMMUNOL, V166, P5925, DOI 10.4049/jimmunol.166.10.5925; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; Roman-Gomez J, 2007, BLOOD, V109, P3462, DOI 10.1182/blood-2006-09-047043; Rowley JD, 1999, SEMIN HEMATOL, V36, P59; San Jose-Eneriz E, 2006, BRIT J HAEMATOL, V134, P137, DOI 10.1111/j.1365-2141.2006.06131.x; Sato N, 2003, CANCER RES, V63, P4158; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Scholz C, 2005, ANN HEMATOL, V84, P236, DOI 10.1007/s00277-004-0969-1; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Swerdlow E., 2008, WHO CLASSIFICATION T; Taylor JME, 2001, LEUKEMIA, V15, P583, DOI 10.1038/sj.leu.2402080; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Vairaktaris E, 2008, J CANCER RES CLIN, V134, P821, DOI 10.1007/s00432-008-0360-z; van Galen JC, 2004, EUR J IMMUNOL, V34, P1870, DOI 10.1002/eji.200424985; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wehler TC, 2008, ONCOL REP, V19, P697; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wilczynski SP, 2005, HUM PATHOL, V36, P242, DOI 10.1016/j.humpath.2004.11.009; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441	65	102	106	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6986	10.1371/journal.pone.0006986	http://dx.doi.org/10.1371/journal.pone.0006986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750229	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696600015
J	Wang, W; Wang, W; Mei, XP; Huang, J; Wei, YY; Wang, YY; Wu, SX; Li, YQ				Wang, Wei; Wang, Wen; Mei, Xiaopeng; Huang, Jing; Wei, Yanyan; Wang, Yayun; Wu, Shengxi; Li, Yunqing			Crosstalk between Spinal Astrocytes and Neurons in Nerve Injury-Induced Neuropathic Pain	PLOS ONE			English	Article								Emerging research implicates the participation of spinal dorsal horn (SDH) neurons and astrocytes in nerve injury-induced neuropathic pain. However, the crosstalk between spinal astrocytes and neurons in neuropathic pain is not clear. Using a lumbar 5 (L5) spinal nerve ligation (SNL) pain model, we testified our hypothesis that SDH neurons and astrocytes reciprocally regulate each other to maintain the persistent neuropathic pain states. Glial fibrillary acidic protein (GFAP) was used as the astrocytic specific marker and Fos, protein of the protooncogene c-fos, was used as a marker for activated neurons. SNL induced a significant mechanical allodynia as well as activated SDH neurons indicated by the Fos expression at the early phase and activated astrocytes with the increased expression of GFAP during the late phase of pain, respectively. Intrathecal administration of c-fos antisense oligodeoxynucleotides (ASO) or astroglial toxin L-alpha-aminoadipate (L-AA) reversed the mechanical allodynia, respectively. Immunofluorescent histochemistry revealed that intrathecal administration of c-fos ASO significantly suppressed activation of not only neurons but also astrocytes induced by SNL. Meanwhile, L-AA shortened the duration of neuronal activation by SNL. Our data offers evidence that neuronal and astrocytic activations are closely related with the maintenance of neuropathic pain through a reciprocal "crosstalk''. The current study suggests that neuronal and non-neuronal elements should be taken integrally into consideration for nociceptive transmission, and that the intervention of such interaction may offer some novel pain therapeutic strategies.			Wang, W (corresponding author), Fourth Mil Med Univ, Dept Anat Histol & Embryol, KK Leung Brain Res Ctr, Xian 710032, Peoples R China.	shengxi@fmmu.edu.cn; deptanat@fmmu.edu.cn	王, 亚云/AAJ-7271-2020; 王, 亚/GXM-4793-2022	wang, yayun/0000-0002-0397-0390				Abbadie C, 2005, TRENDS IMMUNOL, V26, P529, DOI 10.1016/j.it.2005.08.001; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen T, 2003, J ANAT, V203, P579, DOI 10.1046/j.1469-7580.2003.00242.x; Chen Y, 2005, PAIN, V119, P38, DOI 10.1016/j.pain.2005.09.007; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Feng YP, 2002, NEUROSIGNALS, V11, P151, DOI 10.1159/000065056; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; HUCK S, 1984, J NEUROSCI, V4, P2650; Ikeda H, 2007, EUR J NEUROSCI, V25, P1297, DOI 10.1111/j.1460-9568.2007.05386.x; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Inoue K, 2007, J NEUROCHEM, V102, P1447, DOI 10.1111/j.1471-4159.2007.04824.x; IVANUSIC JJ, 2008, EUR J PAIN; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Li A, 2007, NEUROREPORT, V18, P495, DOI 10.1097/WNR.0b013e3280586839; Mika J, 2008, PHARMACOL REP, V60, P297; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Qin M, 2006, NEUROSCI RES, V55, P442, DOI 10.1016/j.neures.2006.04.017; Rodriguez MJ, 2004, J NEUROSCI RES, V77, P344, DOI 10.1002/jnr.20177; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Suter MR, 2007, NEURON GLIA BIOL, V3, P255, DOI 10.1017/S1740925X08000100; Svensson CI, 2005, NEUROPEPTIDES, V39, P485, DOI 10.1016/j.npep.2005.08.002; TABER KH, 2008, J NEUROPSYCHIATRY CL, V20, P129; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Terayama R, 2008, NEUROSCIENCE, V153, P1245, DOI 10.1016/j.neuroscience.2008.03.041; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Viviani B, 2003, J NEUROSCI, V23, P8692; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang H., 2003, International Journal of Fuzzy Systems, V5, P106; Wang W, 2008, ANAT REC, V291, P513, DOI 10.1002/ar.20673; Wang YY, 2006, NEUROSCIENCE, V139, P1083, DOI 10.1016/j.neuroscience.2006.01.011; Wang YY, 2003, BIOCHEM BIOPH RES CO, V309, P631, DOI 10.1016/j.bbrc.2003.08.046; Watkins LR, 2007, BRAIN BEHAV IMMUN, V21, P131, DOI 10.1016/j.bbi.2006.10.011; Watkins LR, 2001, PAIN, V93, P201, DOI 10.1016/S0304-3959(01)00359-1; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wu SX, 2002, NEUROSIGNALS, V11, P224, DOI 10.1159/000065430; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang RX, 1998, BRAIN RES, V795, P282, DOI 10.1016/S0006-8993(98)00300-X; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	81	84	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6973	10.1371/journal.pone.0006973	http://dx.doi.org/10.1371/journal.pone.0006973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759893	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696600012
J	Yakob, L; Yan, GY				Yakob, Laith; Yan, Guiyun			Modeling the Effects of Integrating Larval Habitat Source Reduction and Insecticide Treated Nets for Malaria Control	PLOS ONE			English	Article							CONTROLLING AQUATIC STAGES; ANOPHELES-GAMBIAE; BED NETS; SPATIAL-DISTRIBUTION; MOSQUITO NETS; BEHAVIOR; MORTALITY; CHILDREN; TRANSMISSION; DYNAMICS	Integrated vector management for malaria control has received a lot of recent interest. Attacking multiple points in the transmission cycle is hoped to act synergistically and improve upon current single-tool interventions based on the use of insecticide-treated bed nets (ITNs). In the present study, we theoretically examined the application of larval habitat source reduction with ITNs in reducing malaria transmission. We selected this type of environmental management to complement ITNs because of a potential secondary mode of action that both control strategies share. In addition to increasing vector mortality, ITNs reduce the rate at which female mosquitoes locate human hosts for blood feeding, thereby extending their gonotrophic cycle. Similarly, while reducing adult vector emergence and abundance, source reduction of larval habitats may prolong the cycle duration by extending delays in locating oviposition sites. We found, however, that source reduction of larval habitats only operates through this secondary mode of action when habitat density is below a critical threshold. Hence, we illustrate how this strategy becomes increasingly effective when larval habitats are limited. We also demonstrate that habitat source reduction is better suited to human populations of higher density and in the presence of insecticide resistance or when the insecticidal properties of ITNs are depleted.			Yakob, L (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA.	lyakob@uci.edu	Yakob, Laith/B-1059-2012; Yakob, Laith/AAD-4521-2019	Yakob, Laith/0000-0001-8639-4511	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050243] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; ArredondoJimenez JI, 1997, MED VET ENTOMOL, V11, P87, DOI 10.1111/j.1365-2915.1997.tb00294.x; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; GILROY AB, 1948, MALARIA CONTROL COAS; Gimnig JE, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.115; GOSONIU L, 2008, BMC PUBLIC HEALTH, V8, DOI DOI 10.1186/1471-2458-1188-1356; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Gu WD, 2008, AM J TROP MED HYG, V78, P2, DOI 10.4269/ajtmh.2008.78.2; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hii JLK, 2001, T ROY SOC TROP MED H, V95, P7, DOI 10.1016/S0035-9203(01)90315-3; Kachur SP, 1999, TROP MED INT HEALTH, V4, P728, DOI 10.1046/j.1365-3156.1999.00481.x; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2006, AM J TROP MED HYG, V74, P517, DOI 10.4269/ajtmh.2006.74.517; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lengeler C, 2004, B WORLD HEALTH ORGAN, V82, P84; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; MACDONALD G, 1968, B WORLD HEALTH ORGAN, V38, P743; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Schellenberg JA, 2002, T ROY SOC TROP MED H, V96, P368, DOI 10.1016/S0035-9203(02)90361-5; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; WHO, 2004, WHO GLOB STRAT FRAM; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	46	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6921	10.1371/journal.pone.0006921	http://dx.doi.org/10.1371/journal.pone.0006921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742312	Green Published, Green Accepted, gold			2022-12-25	WOS:000269622500006
J	Garza, RM; Tran, PN; Hampton, RY				Garza, Renee M.; Tran, Peter N.; Hampton, Randolph Y.			Geranylgeranyl Pyrophosphate Is a Potent Regulator of HRD-dependent 3-Hydroxy-3-methylglutaryl-CoA Reductase Degradation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; UBIQUITIN-MEDIATED REGULATION; RAB ESCORT PROTEIN; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; DIPHOSPHATE SYNTHASE; MEMBRANE-PROTEIN; IN-VITRO; PRENYLTRANSFERASES; INSIG	3-Hydroxy-3-methylglutaryl (HMG)-CoA reductase (HMGR), the rate-limiting enzymes of sterol synthesis, undergoes feed-back-regulated endoplasmic reticulum degradation in both mammals and yeast. The yeast Hmg2p isozyme is subject to ubiquitin-mediated endoplasmic reticulum degradation by the HRD pathway. We had previously shown that alterations in cellular levels of the 15-carbon sterol pathway intermediate farnesyl pyrophosphate (FPP) cause increased Hmg2p ubiquitination and degradation. We now present evidence that the FPP-derived, 20-carbon molecule geranylgeranyl pyrophosphate (GGPP) is a potent endogenous regulator of Hmg2p degradation. This work was launched by the unexpected observation that GGPP addition directly to living yeast cultures caused high potency and specific stimulation of Hmg2p degradation. This effect of GGPP was not recapitulated by FPP, GGOH, or related isoprenoids. GGPP-caused Hmg2p degradation met all the criteria for the previously characterized endogenous signal. The action of added GGPP did not require production of endogenous sterol molecules, indicating that it did not act by causing the build-up of an endogenous pathway signal. Manipulation of endogenous GGPP by several means showed that naturally made GGPP controls Hmg2p stability. Analysis of the action of GGPP indicated that the molecule works upstream of retrotranslocation and can directly alter the structure of Hmg2p. We propose that GGPP is the FPP-derived regulator of Hmg2p ubiquitination. Intriguingly, the sterol-dependent degradation of mammalian HMGR is similarly stimulated by the addition of GGOH to intact cells, implying that a dependence on 20-carbon geranylgeranyl signals may be a common conserved feature of HMGR regulation that may lead to highly specific therapeutic approaches for modulation of HMGR.	[Garza, Renee M.; Tran, Peter N.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [5 R01 DK051996-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 R01 DK051996-15 (to R. Y. H.). This work was also supported by a minority supplement associated with the same grant (to R. M. G.).	Bauer BE, 1996, MOL BIOL CELL, V7, P1521, DOI 10.1091/mbc.7.10.1521; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; JIANG Y, 1995, J BIOL CHEM, V270, P21793, DOI 10.1074/jbc.270.37.21793; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Miaczynska M, 2001, YEAST, V18, P697, DOI 10.1002/yea.719; Muramatsu M, 2008, APPL MICROBIOL BIOT, V80, P589, DOI 10.1007/s00253-008-1578-z; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; Ye YF, 2007, MOL BIOL CELL, V18, P3568, DOI 10.1091/mbc.e07-02-0112	28	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35368	35380		10.1074/jbc.M109.023994	http://dx.doi.org/10.1074/jbc.M109.023994			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19776008	Green Published, hybrid			2022-12-25	WOS:000272645600013
J	Eriksson, HM; Wessman, P; Ge, CR; Edwards, K; Wieslander, A				Eriksson, Hanna M.; Wessman, Per; Ge, Changrong; Edwards, Katarina; Wieslander, Ake			Massive Formation of Intracellular Membrane Vesicles in Escherichia coli by a Monotopic Membrane-bound Lipid Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS SPORULATION; OUTER-MEMBRANE; ACHOLEPLASMA-LAIDLAWII; CRYSTAL-STRUCTURE; INNER-MEMBRANE; 1,2-DIACYLGLYCEROL 3-GLUCOSYLTRANSFERASE; ENDOPLASMIC-RETICULUM; PROTEIN COMPLEXES; MOLECULAR SHAPE; ANIONIC LIPIDS	The morphology and curvature of biological bilayers are determined by the packing shapes and interactions of their participant molecules. Bacteria, except photosynthetic groups, usually lack intracellular membrane organelles. Strong overexpression in Escherichia coli of a foreign monotopic glycosyltransferase (named monoglycosyldiacylglycerol synthase), synthesizing a nonbilayer-prone glucolipid, induced massive formation of membrane vesicles in the cytoplasm. Vesicle assemblies were visualized in cytoplasmic zones by fluorescence microscopy. These have a very low buoyant density, substantially different from inner membranes, with a lipid content of >= 60% (w/w). Cryo-transmission electron microscopy revealed cells to be filled with membrane vesicles of various sizes and shapes, which when released were mostly spherical (diameter approximate to 100 nm). The protein repertoire was similar in vesicle and inner membranes and dominated by the glycosyltransferase. Membrane polar lipid composition was similar too, including the foreign glucolipid. A related glycosyltransferase and an inactive monoglycosyldiacylglycerol synthase mutant also yielded membrane vesicles, but without glucolipid synthesis, strongly indicating that vesiculation is induced by the protein itself. The high capacity for membrane vesicle formation seems inherent in the glycosyltransferase structure, and it depends on the following: (i) lateral expansion of the inner monolayer by interface binding of many molecules; (ii) membrane expansion through stimulation of phospholipid synthesis, by electrostatic binding and sequestration of anionic lipids; (iii) bilayer bending by the packing shape of excess nonbilayer-prone phospholipid or glucolipid; and (iv) potentially also the shape or penetration profile of the glycosyltransferase binding surface. These features seem to apply to several other proteins able to achieve an analogous membrane expansion.	[Eriksson, Hanna M.; Ge, Changrong; Wieslander, Ake] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Wessman, Per; Edwards, Katarina] Uppsala Univ, Dept Phys & Analyt Chem, SE-75123 Uppsala, Sweden	Stockholm University; Uppsala University	Wieslander, A (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	ake@dbb.su.se	Edwards, Katarina/AAR-7679-2021; Edwards, Katarina/A-1159-2012	Edwards, Katarina/0000-0003-0674-2219; Edwards, Katarina/0000-0003-0674-2219	Swedish Research Council; European Commission; Marie-Curie Action BIOCONTROL	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie-Curie Action BIOCONTROL(European Commission)	This work was supported in part by grants from the Swedish Research Council (to angstrom.W. and K. E.) and by the European Commission 6th Framework Programme, Marie-Curie Action BIOCONTROL (to angstrom.W.).	ALLISON DP, 1971, J BACTERIOL, V108, P1390, DOI 10.1128/JB.108.3.1390-1401.1971; Almgren M, 2000, COLLOID SURFACE A, V174, P3, DOI 10.1016/S0927-7757(00)00516-1; Arechaga I, 2000, FEBS LETT, V482, P215, DOI 10.1016/S0014-5793(00)02054-8; ARMOUR GA, 1990, FASEB J, V4, P1488, DOI 10.1096/fasebj.4.5.2407591; Balali-Mood K, 2009, BIOCHEMISTRY-US, V48, P2135, DOI 10.1021/bi8017398; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CHRISTIANSSON A, 1985, J CELL BIOL, V101, P1455, DOI 10.1083/jcb.101.4.1455; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DECOCK H, 1989, BIOCHIM BIOPHYS ACTA, V985, P313, DOI 10.1016/0005-2736(89)90418-5; Domanov YA, 2006, BIOPHYS J, V91, P4427, DOI 10.1529/biophysj.106.091702; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Eriksson HM, 2009, PROTEIN EXPRES PURIF, V66, P143, DOI 10.1016/j.pep.2009.03.008; GEORGIEV A, 2008, THESIS STOCKHOLM U S; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; JACKSON BJ, 1986, J BIOL CHEM, V261, P3464; KARLSSON OP, 1994, J BIOL CHEM, V269, P23484; Kawai C, 2009, BIOCHEMISTRY-US, V48, P8335, DOI 10.1021/bi9006463; Kim AC, 2008, J MOL BIOL, V376, P352, DOI 10.1016/j.jmb.2007.11.080; Kim JY, 2008, J MOL BIOL, V380, P51, DOI 10.1016/j.jmb.2008.03.076; Kol S, 2008, J BIOL CHEM, V283, P31269, DOI 10.1074/jbc.R800029200; Laan EVDD, 2003, J BACTERIOL, V185, P3773, DOI 10.1128/JB.185.3773.3779.2003; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; LETELLIER L, 1977, P NATL ACAD SCI USA, V74, P452, DOI 10.1073/pnas.74.2.452; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; Linde K, 2004, FEBS LETT, V575, P77, DOI 10.1016/j.febslet.2004.08.038; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nieboer M, 1996, EUR J BIOCHEM, V241, P691, DOI 10.1111/j.1432-1033.1996.00691.x; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Price CE, 2008, J BIOL CHEM, V283, P26921, DOI 10.1074/jbc.M804490200; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; SELSTAM E, 1998, LIPIDS PHOTOSYNTHESI, P209; Sener MK, 2007, P NATL ACAD SCI USA, V104, P15723, DOI 10.1073/pnas.0706861104; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Sturgis JN, 2009, BIOCHEMISTRY-US, V48, P3679, DOI 10.1021/bi900045x; SUPPLY P, 1993, J BIOL CHEM, V268, P19744; Svetina S, 2001, CELL MOL BIOL LETT, V6, P305; VANWEEGHEL RP, 1990, P NATL ACAD SCI USA, V87, P2613, DOI 10.1073/pnas.87.7.2613; VERGERES G, 1993, J CELL SCI, V106, P249; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; VONMEYENBURG K, 1984, EMBO J, V3, P1791, DOI 10.1002/j.1460-2075.1984.tb02047.x; Wan SZ, 2009, J COMPUT CHEM, V30, P1038, DOI 10.1002/jcc.21130; Weber S, 1996, VIRUS GENES, V12, P5, DOI 10.1007/BF00369995; WEIGAND RA, 1970, J BACTERIOL, V102, P240, DOI 10.1128/JB.102.1.240-249.1970; WEINER JH, 1984, J BACTERIOL, V158, P590, DOI 10.1128/JB.158.2.590-596.1984; WIESLANDER A, 1980, BIOCHEMISTRY-US, V19, P3650, DOI 10.1021/bi00557a002; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; WILKISON WO, 1986, J BIOL CHEM, V261, P9951; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	79	35	36	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33904	33914		10.1074/jbc.M109.021618	http://dx.doi.org/10.1074/jbc.M109.021618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19767390	Green Published, hybrid			2022-12-25	WOS:000272165200023
J	Li, X; Shen, Y; Ichikawa, H; Antes, T; Goldberg, GS				Li, X.; Shen, Y.; Ichikawa, H.; Antes, T.; Goldberg, G. S.			Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration	ONCOGENE			English	Article						Src; contact normalization; cell communication; anchorage independence; migration; cancer	GAP JUNCTIONAL COMMUNICATION; BREAST-CANCER; MICRORNA EXPRESSION; TRANSFORMED-CELLS; HEPATOCELLULAR-CARCINOMA; NONTRANSFORMED CELLS; IN-VIVO; V-CRK; INHIBITION; INVASION	Transformation by the Src tyrosine kinase (Src) promotes nonanchored cell growth and migration. However, non-transformed cells can force Src-transformed cells to assume a normal morphology and phenotype by a process called 'contact normalization'. It has become clear that microRNA (miRNA) can affect tumorigenesis by targeting gene products that direct cell growth and migration. However, the roles of miRNA in Src transformation or contact normalization have not yet been reported. We examined the expression of 95 miRNAs and found 9 of them significantly affected by Src. In this study, we report that miR-218 and miR-224 were most significantly induced by Src, but not affected by contact normalization. In contrast, miR-126 was most significantly suppressed by Src and was induced by contact normalization in transformed cells. Mir-126 targets Crk, a component of the focal adhesion network that participates in events required for tumor cell migration. Accordingly, we show that miR-126 expression correlates inversely with Crk levels, motility and the invasive potential of human mammary carcinoma cells. Moreover, we show that miR-224 expression promotes nonanchored growth of nontransformed cells. These data reveal novel insights into how Src regulates miRNA expression to promote hallmarks of tumor cell growth and invasion, and how nontransformed cells can affect miRNA expression in adjacent tumor cells to inhibit this process. Oncogene (2009) 28, 4272-4283; doi: 10.1038/onc.2009.278; published online 21 September 2009	[Li, X.; Shen, Y.; Goldberg, G. S.] Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA; [Li, X.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Ichikawa, H.] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Antes, T.] Syst Biosci SBI, Mountain View, CA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Cancer Center - Japan	Goldberg, GS (corresponding author), Univ Med & Dent New Jersey, Dept Mol Biol, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	gary.goldberg@umdnj.edu		Antes, Travis/0000-0002-2294-8797	United States National Institutes of Health [CA88805]; Research Foundation of UMDNJ; Marks and Holzman families; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE [R01CA088805] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Foundation of UMDNJ; Marks and Holzman families; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Xiaofeng Ye and Reuben Lotan (MD Anderson Cancer Center) for helpful suggestions and for the gifts of cells, and Min Han (UMDNJ) for technical assistance. This study was supported by a grant from the United States National Institutes of Health (CA88805), the Research Foundation of UMDNJ, and the Marks and Holzman families to GSG, and by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HI.	Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Alexander DB, 2004, CANCER RES, V64, P1347, DOI 10.1158/0008-5472.CAN-03-2558; Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BIGNAMI M, 1988, ONCOGENE, V2, P509; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Burnham MR, 1996, ONCOGENE, V12, P2467; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; DUBIK D, 1987, CANCER RES, V47, P6517; ENOMOTO T, 1984, CANCER RES, V44, P5200; ESINDUY CB, 1995, CARCINOGENESIS, V16, P915, DOI 10.1093/carcin/16.4.915; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Glick AB, 2005, SEMIN CANCER BIOL, V15, P75, DOI 10.1016/j.semcancer.2004.08.008; GOLDBERG GS, 1994, MOL CARCINOGEN, V11, P106, DOI 10.1002/mc.2940110208; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; GOLDBERG GS, 2008, ENCY CANC; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; HENNINGS H, 1990, CANCER RES, V50, P4794; Holst CR, 2003, CANCER RES, V63, P1596; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Jeffrey SS, 2008, NAT BIOTECHNOL, V26, P400, DOI 10.1038/nbt0408-400; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; LIU B, 2009, LUNG CANC IN PRESS, P126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN W, 1991, CANCER RES, V51, P5348; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; NELSON MA, 1992, P NATL ACAD SCI USA, V89, P6398, DOI 10.1073/pnas.89.14.6398; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Rubin H, 2006, BIOESSAYS, V28, P515, DOI 10.1002/bies.20403; Rubin H, 2008, ADV CANCER RES, V100, P159, DOI 10.1016/S0065-230X(08)00006-7; Rubin H, 2008, P NATL ACAD SCI USA, V105, P6215, DOI 10.1073/pnas.0800747105; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; STOKER MGP, 1966, J CELL SCI, V1, P297; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vaccariello M, 1999, J INVEST DERMATOL, V113, P384, DOI 10.1046/j.1523-1747.1999.00701.x; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Valiunas V, 2005, BIOCHEM BIOPH RES CO, V333, P174, DOI 10.1016/j.bbrc.2005.05.104; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Widschwendter M, 1997, CANCER RES, V57, P4158; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	71	38	40	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4272	4283		10.1038/onc.2009.278	http://dx.doi.org/10.1038/onc.2009.278			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19767772				2022-12-25	WOS:000272876300005
J	Aviv, V; Meivar-Levy, I; Rachmut, IH; Rubinek, T; Mor, E; Ferber, S				Aviv, Vered; Meivar-Levy, Irit; Rachmut, Itzhak H.; Rubinek, Tamar; Mor, Eytan; Ferber, Sarah			Exendin-4 Promotes Liver Cell Proliferation and Enhances the PDX-1-induced Liver to Pancreas Transdifferentiation Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; INSULIN-PRODUCING CELLS; EMBRYONIC STEM-CELLS; BETA-CELL; GENE-THERAPY; ISLET; GLP-1; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION	Over the last few years, evidence has accumulated revealing the unexpected potential of committed mammalian cells to convert to a different phenotype via a process called transdifferentiation or adult cell reprogramming. These findings may have major practical implications because this process may facilitate the generation of functional autologous tissues that can be used for replacing malfunctioning organs. An instructive role for transcription factors in diverting the developmental fate of cells in adult tissues has been demonstrated when adult human liver cells were induced to transdifferentiate to the pancreatic endocrine lineage upon ectopic expression of the pancreatic master regulator PDX-1 (pancreatic and duodenal homeobox gene 1). Since organogenesis and lineage commitment are affected also by developmental signals generated in response to environmental triggers, we have now analyzed whether the hormone GLP-1 (glucogen-like peptide-1) documented to play a role in pancreatic beta cell differentiation, maturation, and survival, can also increase the efficiency of liver to pancreas transdifferentiation. We demonstrate that the GLP-1R agonist, exendin-4, significantly improves the efficiency of PDX-1-mediated transdifferentiation. Exendin-4 affects the transdifferentiation process at two distinct steps; it increases the proliferation of liver cells predisposed to transdifferentiated in response to PDX-1 and promotes the maturation of transdifferentiated cells along the pancreatic lineage. Liver cell reprogramming toward the pancreatic beta cell lineage has been suggested as a strategy for functional replacement of the ablated insulin-producing cells in diabetics. Understanding the cellular and molecular basis of the transdifferentiation process will allow us to increase the efficiency of the reprogramming process and optimize its therapeutic merit.	[Aviv, Vered; Meivar-Levy, Irit; Rachmut, Itzhak H.; Ferber, Sarah] Chaim Sheba Med Ctr, Endocrine Inst, IL-52621 Tel Hashomer, Israel; [Aviv, Vered; Ferber, Sarah] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; [Rachmut, Itzhak H.] Bar Ilan Univ, IL-52900 Ramat Gan, Israel; [Rubinek, Tamar] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Tel Hashomer, Israel; [Mor, Eytan] Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Chaim Sheba Medical Center; Rabin Medical Center	Ferber, S (corresponding author), Chaim Sheba Med Ctr, Endocrine Inst, IL-52621 Tel Hashomer, Israel.	sferber@sheba.health.gov.il		Ferber, Sarah/0000-0003-2764-2786	Juvenile Diabetes Research Foundation [1-2006-221]; Israel Science Foundation [ISF-99-05]; EFSD-Lilly award; Legacy Heritage Fund of New York	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); EFSD-Lilly award; Legacy Heritage Fund of New York	This work was supported in part by Juvenile Diabetes Research Foundation Grant 1-2006-221, Israel Science Foundation Grant ISF-99-05, and EFSD-Lilly award 2005 (all to S. F.) and by the Legacy Heritage Fund of New York (to V. A.).	Ahren B, 2004, HORM METAB RES, V36, P842, DOI 10.1055/s-2004-826173; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bai L, 2005, J ENDOCRINOL, V186, P343, DOI 10.1677/joe.1.06078; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Chakrabarti SK, 2003, J BIOL CHEM, V278, P23617, DOI 10.1074/jbc.M303423200; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; Hardikar AA, 2002, ENDOCRINOLOGY, V143, P3505, DOI 10.1210/en.2001-211344; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Li WC, 2005, J CELL MOL MED, V9, P569, DOI 10.1111/j.1582-4934.2005.tb00489.x; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Meivar-Levy I, 2003, TRENDS ENDOCRIN MET, V14, P460, DOI 10.1016/j.tem.2003.10.006; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Meivar-Levy I, 2006, ISR MED ASSOC J, V8, P430; Samson SL, 2006, TRENDS ENDOCRIN MET, V17, P92, DOI 10.1016/j.tem.2006.02.002; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shternhall-Ron K, 2007, J AUTOIMMUN, V28, P134, DOI 10.1016/j.jaut.2007.02.010; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; VILLANUEVAPENACARRILLO ML, 1995, J ENDOCRINOL, V146, P183, DOI 10.1677/joe.0.1460183; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Yue FM, 2006, TISSUE ENG, V12, P2105, DOI 10.1089/ten.2006.12.2105; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568	31	70	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33509	33520		10.1074/jbc.M109.017608	http://dx.doi.org/10.1074/jbc.M109.017608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19755420	hybrid, Green Published			2022-12-25	WOS:000272028500057
J	Montano, X				Montano, X.			Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation	ONCOGENE			English	Article						SHP-1; trkA; phosphorylation; cell-cycle arrest; breast-cancer; p53	NERVE GROWTH-FACTOR; ACTIVATION LOOP TYROSINES; FACTOR RECEPTOR; PHOSPHATASE SHP-1; NF-Y; TRANSCRIPTIONAL REPRESSION; SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR; ADAPTER PROTEIN; DNA-DAMAGE	The nerve growth factor (NGF) receptor, trkA, the tumour suppressor p53 and the phosphatase SHP-1 are critical in cell proliferation and differentiation. SHP-1 is a trkA phosphatase that dephosphorylates trkA at tyrosines (Y) 674 and 675. p53 can induce trkA activation and tyrosine phosphorylation in the absence of NGF stimulation. In breast cancer tumours trkA expression is associated with increased patient survival. TrkA protein expression is higher in breast-cancer cell lines than in normal breast epithelia. In cell lines (but not in normal breast epithelia) trkA is functional and can be NGF-stimulated to promote cell proliferation. This study investigates the functional relationship between trkA, p53 and SHP-1 in breast-cancer, and reveals that in wildtype (wt) trkA expressing breast-cancer cells both endogenous wtp53, activated by therapeutic agents, and transfected wtp53 repress expression of SHP-1 through the proximal CCAAT sequence of the SHP-1-P1-promoter and the transcription factor NF-Y. In these cells trkA-Y674/Y675 phosphorylation is detected when SHP-1 protein levels decrease in a wtp53-dependent manner. Proliferation and cell-cycle assays, with cells expressing endogenous or transfected wt-trkA and a temperature-sensitive p53 grown at 32 degrees C (when p53 is in the wt configuration), show suppressed cell proliferation. Suppression is not detected when grown at 37 degrees C (when p53 is in the mutant configuration). A release from suppression is observed when these cells are transiently transfected with wt-SHP-1 and grown at 32 degrees C. Suppression is also detected when, as control, wt-trkA-expressing cells are transiently transfected with SHP-1-siRNA, but not when a dominant-negative (DN) mutant trkA is used to abolish wt-trkA activity. Importantly, suppression is not seen with control trkA-negative breast-cancer cells (expressing wtp53, wt-SHP-1 and undetectable trkA), transfected with Y674F/Y675F mutant-trkA. BrdU-incorporation experiments reveal lack of incorporation in cells expressing wt-trkA and wtp53, or wt-trkA and SHP-1-siRNA. However, BrdU is incorporated in the presence of Y674F/Y675F mutant trkA or DN mutant trkA. These results indicate that p53 repression of SHP-1 expression leads to trkA-Y674/Y675 phosphorylation and trkA-dependent suppression of breast-cancer cell proliferation. These data provide an explanation as to why high trkA levels are associated with favourable prognosis. Oncogene (2009) 28, 3787-3800; doi:10.1038/onc.2009.143; published online 14 September 2009	Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Mol Signalling Grp, London SW7 2AZ, England	Imperial College London	Montano, X (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Mol Signalling Grp, Sir Alexander Fleming Bldg,Imperial Coll Rd, London SW7 2AZ, England.	xmontano@ich.ucl.ac.uk			Breast Cancer Campaign grant	Breast Cancer Campaign grant	Thanks to Tessa Crompton, Sue Outram, Anna Furmanski and Ayad Eddaoudi for helping with FACS analysis; Shanie Budham-Mahadeo for helping with luciferase assays; Ralf Kirschner, KurtEngeland, Finn Werner and David Mann for ChIP and BrdU incorporation protocols; Ben Neel and David Kaplan for wt-SHP-1, Delta-SHP-1 and anti-trk203-antibodies; Alison Sparks for sheep anti-p53-antibodies; Reiner Janicke for MCF7-p53-RNAi cells; Borek Vojtesek for MCF7-p53DD Derek Huntley for bioinformatics and particularly to David Bacon for technical help with photography and graphics. This research was supported by a Breast Cancer Campaign grant awarded to XM.	BANVILLE D, 1995, GENOMICS, V27, P165, DOI 10.1006/geno.1995.1020; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Browes C, 2001, FEBS LETT, V497, P20, DOI 10.1016/S0014-5793(01)02429-2; Brown A, 2000, ONCOGENE, V19, P3032, DOI 10.1038/sj.onc.1203619; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Concin N, 2003, BREAST CANCER RES TR, V79, P37, DOI 10.1023/A:1023351717408; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Descamps S, 1998, J BIOL CHEM, V273, P16659, DOI 10.1074/jbc.273.27.16659; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Downward J, 2004, ONCOGENE, V23, P8376, DOI 10.1038/sj.onc.1208073; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Feki A, 2004, CRIT REV ONCOL HEMAT, V52, P103, DOI 10.1016/j.critrevonc.2004.07.002; Fraser SP, 2003, J CELL PHYSIOL, V195, P479, DOI 10.1002/jcp.10312; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Horvat A, 2001, J NEUROSCI, V21, P865, DOI 10.1523/JNEUROSCI.21-03-00865.2001; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; JAGJIT SG, 1998, J NEUROONCOL, V40, P19; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; MacDonald JIS, 2000, J BIOL CHEM, V275, P18225, DOI 10.1074/jbc.M001862200; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Marsh HN, 2003, J CELL BIOL, V163, P999, DOI 10.1083/jcb.200309036; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Moll UM, 2004, MOL CANCER RES, V2, P371; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Montano X, 1997, ONCOGENE, V15, P245, DOI 10.1038/sj.onc.1201215; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Olivier Magali, 2004, IARC Sci Publ, P247; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reis JS, 2006, MODERN PATHOL, V19, P307, DOI 10.1038/modpathol.3800542; Roccato E, 2005, J BIOL CHEM, V280, P3382, DOI 10.1074/jbc.M407522200; Sakamoto Y, 2001, ONCOL REP, V8, P973; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; SHAULSKY G, 1991, CELL GROWTH DIFFER, V2, P661; Spiesbach K, 2005, INT J CANCER, V114, P555, DOI 10.1002/ijc.20766; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tagliabue E, 2000, J BIOL CHEM, V275, P5388, DOI 10.1074/jbc.275.8.5388; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Vadlamudi RK, 2002, J CELL PHYSIOL, V190, P189, DOI 10.1002/JCP.10054; VAMBUTAS V, 1995, J BIOL CHEM, V270, P25629, DOI 10.1074/jbc.270.43.25629; Wasner M, 2003, GENE, V312, P225, DOI 10.1016/S0378-1119(03)00618-8; Wu CY, 2003, J CELL BIOCHEM, V90, P1026, DOI 10.1002/jcb.10727; Xie P, 2000, LEUKEMIA LYMPHOMA, V36, P595, DOI 10.3109/10428190009148408; Xu Y, 2001, GENE, V269, P141, DOI 10.1016/S0378-1119(01)00445-0; Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677	62	28	28	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2009	28	43					3787	3800		10.1038/onc.2009.143	http://dx.doi.org/10.1038/onc.2009.143			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19749791				2022-12-25	WOS:000271248400003
J	Armougom, F; Henry, M; Vialettes, B; Raccah, D; Raoult, D				Armougom, Fabrice; Henry, Mireille; Vialettes, Bernard; Raccah, Denis; Raoult, Didier			Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients	PLOS ONE			English	Article							DIVERSITY; THERAPY	Background: Studies of the bacterial communities of the gut microbiota have revealed a shift in the ratio of Firmicutes and Bacteroidetes in obese patients. Determining the variations of microbial communities in feces may be beneficial for the identification of specific profiles in patients with abnormal weights. The roles of the archaeon Methanobrevibacter smithii and Lactobacillus species have not been described in these studies. Methods and Findings: We developed an efficient and robust real-time PCR tool that includes a plasmid-based internal control and allows for quantification of the bacterial divisions Bacteroidetes, Firmicutes, and Lactobacillus as well as the methanogen M. smithii. We applied this technique to the feces of 20 obese subjects, 9 patients with anorexia nervosa, and 20 normal-weight healthy controls. Our results confirmed a reduction in the Bacteroidetes community in obese patients (p<0.01). We found a significantly higher Lactobacillus species concentration in obese patients than in lean controls (p = 0.0197) or anorexic patients (p = 0.0332). The M. smithii concentration was much higher in anorexic patients than in the lean population (p = 0.0171). Conclusions: Lactobacillus species are widely used as growth promoters in the farm industry and are now linked to obesity in humans. The study of the bacterial flora in anorexic patients revealed an increase in M. smithii. This increase might represent an adaptive use of nutrients in this population.			Armougom, F (corresponding author), Univ Mediterranee, Fac Med, IRD 3R198, URMITE UMR CNRS 6236, Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Armougom F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-576; Charrel RN, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-21; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FIEDOREK SC, 1990, J PEDIATR GASTR NUTR, V10, P473, DOI 10.1097/00005176-199005000-00010; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kanamori Y, 2004, J PEDIATR SURG, V39, P1686, DOI 10.1016/j.jpedsurg.2004.07.013; Khan M, 2007, BRIT POULTRY SCI, V48, P732, DOI 10.1080/00071660701716222; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; MILLER TL, 1986, SYST APPL MICROBIOL, V7, P223; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Raoult D, 2008, EUR J CLIN MICROBIOL, V27, P631, DOI 10.1007/s10096-008-0490-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uchida K, 2007, PEDIATR SURG INT, V23, P243, DOI 10.1007/s00383-006-1866-6; Walker A, 2006, NAT REV MICROBIOL, V4, P572, DOI 10.1038/nrmicro1483; Walker A, 2007, NAT REV MICROBIOL, V5, P572, DOI 10.1038/nrmicro1720; WEAVER GA, 1986, GUT, V27, P698, DOI 10.1136/gut.27.6.698; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	27	574	610	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7125	10.1371/journal.pone.0007125	http://dx.doi.org/10.1371/journal.pone.0007125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774074	Green Published, gold, Green Submitted			2022-12-25	WOS:000270160900010
J	Olivier, P; Fontaine, RH; Loron, G; Van Steenwinckel, J; Biran, V; Massonneau, V; Kaindl, A; Dalous, J; Charriaut-Marlangue, C; Aigrot, MS; Pansiot, J; Verney, C; Gressens, P; Baud, O				Olivier, Paul; Fontaine, Romain H.; Loron, Gauthier; Van Steenwinckel, Juliette; Biran, Valerie; Massonneau, Veronique; Kaindl, Angela; Dalous, Jeremie; Charriaut-Marlangue, Christiane; Aigrot, Marie-Stephane; Pansiot, Julien; Verney, Catherine; Gressens, Pierre; Baud, Olivier			Melatonin Promotes Oligodendroglial Maturation of Injured White Matter in Neonatal Rats	PLOS ONE			English	Article								Objective: To investigate the effects of melatonin treatment in a rat model of white matter damage (WMD) in the developing brain. Additionally, we aim to delineate the cellular mechanisms of melatonin effect on the oligodendroglial cell lineage. Methods: A unilateral ligation of the uterine artery in pregnant rat at the embryonic day 17 induces fetal hypoxia and subsequent growth restriction (GR) in neonatal pups. GR and control pups received a daily intra-peritoneal injection of melatonin from birth to post-natal day (P) 3. Results: Melatonin administration was associated with a dramatic decrease in microglial activation and astroglial reaction compared to untreated GR pups. At P14, melatonin prevented white matter myelination defects with an increased number of mature oligodendrocytes (APC-immunoreactive) in treated GR pups. Conversely, melatonin was not found to be associated with an increased density of total oligodendrocytes (Olig2-immunoreactive), suggesting that melatonin is able to promote oligodendrocyte maturation but not proliferation. These effects appear to be melatonin-receptor dependent and were reproduced in vitro. Interpretation: These data suggest that melatonin has a strong protective effect on developing damaged white matter through decreased microglial activation and oligodendroglial maturation leading to a normalization of the myelination process. Consequently, melatonin should be a considered as an effective neuroprotective candidate not only in perinatal brain damage but also in inflammatory and demyelinating diseases observed in adults.			Olivier, P (corresponding author), Hop Robert Debre, INSERM, AVENIR, R05230HS, F-75019 Paris, France.	olivier.baud@rdb.aphp.fr	Biran, Valerie/GQY-8192-2022; , CHARRIAUT-MARLANGUE/H-3249-2019; gressens, pierre/M-7557-2017	gressens, pierre/0000-0002-0909-4221; Van Steenwinckel, Juliette/0000-0003-3463-4856; Kaindl, Angela/0000-0001-9454-206X; LORON, Gauthier/0000-0001-9536-9510; Fontaine, Romain/0000-0003-4574-9165				Baud O, 2004, J NEUROSCI, V24, P1531, DOI 10.1523/JNEUROSCI.3989-03.2004; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Borlongan CV, 2000, NEUROREPORT, V11, P923, DOI 10.1097/00001756-200004070-00005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Chung SY, 2003, J PINEAL RES, V34, P95, DOI 10.1034/j.1600-079X.2003.00010.x; Floreani M, 1997, FASEB J, V11, P1309, DOI 10.1096/fasebj.11.14.9409550; Fontaine RH, 2008, P NATL ACAD SCI USA, V105, P16779, DOI 10.1073/pnas.0803004105; Haynes RL, 2005, BRAIN PATHOL, V15, P225; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Ishimura R, 2002, TOXICOL APPL PHARM, V185, P197, DOI 10.1006/taap.2002.9539; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kilic U, 2005, J PINEAL RES, V38, P67, DOI 10.1111/j.1600-079X.2004.00178.x; Lee MY, 2007, J PINEAL RES, V42, P297, DOI 10.1111/j.1600-079X.2007.00420.x; Manev H, 1996, FASEB J, V10, P1546, DOI 10.1096/fasebj.10.13.8940301; Martin V, 2002, J PINEAL RES, V33, P204, DOI 10.1034/j.1600-079X.2002.02113.x; Matuszak Z, 1997, FREE RADICAL BIO MED, V23, P367, DOI 10.1016/S0891-5849(96)00614-4; Mayo JC, 2005, J NEUROIMMUNOL, V165, P139, DOI 10.1016/j.jneuroim.2005.05.002; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mesples B, 2005, NEUROBIOL DIS, V18, P193, DOI 10.1016/j.nbd.2004.09.018; Mohan N, 1995, BIOCHEM MOL BIOL INT, V37, P1063; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; Olivier P, 2005, J NEUROPATH EXP NEUR, V64, P998, DOI 10.1097/01.jnen.0000187052.81889.57; Olivier P, 2007, NEUROBIOL DIS, V26, P253, DOI 10.1016/j.nbd.2007.01.001; Padilla-Gomes NF, 2007, ACTA PAEDIATR, V96, P1582, DOI 10.1111/j.1651-2227.2007.00496.x; Pei Z, 2003, J PINEAL RES, V34, P194, DOI 10.1034/j.1600-079X.2003.00026.x; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Riccio P, 2000, J NEUROSCI RES, V59, P513, DOI 10.1002/(SICI)1097-4547(20000215)59:4<513::AID-JNR6>3.0.CO;2-M; ROSENBLUTH J, 1980, J COMP NEUROL, V194, P639, DOI 10.1002/cne.901940310; Schober ME, 2009, AM J PHYSIOL-REG I, V296, pR681, DOI 10.1152/ajpregu.90396.2008; Sun FY, 2002, J PINEAL RES, V33, P48, DOI 10.1034/j.1600-079X.2002.01891.x; Tahraoui SL, 2001, BRAIN PATHOL, V11, P56; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.1a; Zhou JF, 2008, J PINEAL RES, V45, P157, DOI 10.1111/j.1600-079X.2008.00570.x	36	91	94	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7128	10.1371/journal.pone.0007128	http://dx.doi.org/10.1371/journal.pone.0007128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771167	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154400018
J	Hester, ME; Song, S; Miranda, CJ; Eagle, A; Schwartz, PH; Kaspar, BK				Hester, Mark E.; Song, SungWon; Miranda, Carlos J.; Eagle, Amy; Schwartz, Phillip H.; Kaspar, Brian K.			Two Factor Reprogramming of Human Neural Stem Cells into Pluripotency	PLOS ONE			English	Article							PROGENITOR CELLS; SOMATIC-CELLS; SELF-RENEWAL; FIBROBLASTS; GENERATION; MOUSE; EXPRESSION; INDUCTION; CIRCUITRY; SURVIVAL	Background: Reprogramming human somatic cells to pluripotency represents a valuable resource for the development of vitro based models for human disease and holds tremendous potential for deriving patient-specific pluripotent stem cells. Recently, mouse neural stem cells (NSCs) have been shown capable of reprogramming into a pluripotent state by forced expression of Oct3/4 and Klf4; however it has been unknown whether this same strategy could apply to human NSCs, which would result in more relevant pluripotent stem cells for modeling human disease. Methodology and Principal Findings: Here, we show that OCT3/4 and KLF4 are indeed sufficient to induce pluripotency from human NSCs within a two week time frame and are molecularly indistinguishable from human ES cells. Furthermore, human NSC-derived pluripotent stem cells can differentiate into all three germ lineages both in vitro and in vivo. Conclusions/Significance: We propose that human NSCs represent an attractive source of cells for producing human iPS cells since they only require two factors, obviating the need for c-MYC, for induction into pluripotency. Thus, in vitro human disease models could be generated from iPS cells derived from human NSCs.			Hester, ME (corresponding author), Nationwide Childrens Res Inst, Res Inst, Columbus, OH 44408 USA.	Brian.Kaspar@pediatrics.ohio-state.edu	Hester, Mark/AAY-8611-2020; Kaspar, Brian/E-3349-2011; Miranda, Carlos/B-7885-2008	Miranda, Carlos/0000-0001-8208-7100	NINDS NIH HHS [R01 NS064492, 1R01NS064492-01A1, R01 NS064492-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064492] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BANITO A, 2009, GENES DEV; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Darr H, 2006, REGEN MED, V1, P317, DOI 10.2217/17460751.1.3.317; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; HONG H, 2009, NATURE; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; KAWAMURA T, 2009, NATURE; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; LI H, 2009, NATURE; Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARION RM, 2009, NATURE; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; UTIKAL J, 2009, NATURE; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	53	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7044	10.1371/journal.pone.0007044	http://dx.doi.org/10.1371/journal.pone.0007044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763260	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970400004
J	Masia, L; Casadio, M; Sandini, G; Morasso, P				Masia, Lorenzo; Casadio, Maura; Sandini, Giulio; Morasso, Pietro			Eye-Hand Coordination during Dynamic Visuomotor Rotations	PLOS ONE			English	Article							SENSORIMOTOR ADAPTATION; INTERNAL-MODEL; TRANSFORMATIONS; DIRECTION; POSITION; REPRESENTATIONS; LOCALIZATION; MECHANISMS; VISION; MUSCLE	Background: for many technology-driven visuomotor tasks such as tele-surgery, human operators face situations in which the frames of reference for vision and action are misaligned and need to be compensated in order to perform the tasks with the necessary precision. The cognitive mechanisms for the selection of appropriate frames of reference are still not fully understood. This study investigated the effect of changing visual and kinesthetic frames of reference during wrist pointing, simulating activities typical for tele-operations. Methods: using a robotic manipulandum, subjects had to perform center-out pointing movements to visual targets presented on a computer screen, by coordinating wrist flexion/extension with abduction/adduction. We compared movements in which the frames of reference were aligned (unperturbed condition) with movements performed under different combinations of visual/kinesthetic dynamic perturbations. The visual frame of reference was centered to the computer screen, while the kinesthetic frame was centered around the wrist joint. Both frames changed their orientation dynamically (angular velocity = 36 degrees/s) with respect to the head-centered frame of reference (the eyes). Perturbations were either unimodal (visual or kinesthetic), or bimodal (visual+kinesthetic). As expected, pointing performance was best in the unperturbed condition. The spatial pointing error dramatically worsened during both unimodal and most bimodal conditions. However, in the bimodal condition, in which both disturbances were in phase, adaptation was very fast and kinematic performance indicators approached the values of the unperturbed condition. Conclusions: this result suggests that subjects learned to exploit an "affordance" made available by the invariant phase relation between the visual and kinesthetic frames. It seems that after detecting such invariance, subjects used the kinesthetic input as an informative signal rather than a disturbance, in order to compensate the visual rotation without going through the lengthy process of building an internal adaptation model. Practical implications are discussed as regards the design of advanced, high-performance man-machine interfaces.			Masia, L (corresponding author), Italian Inst Technol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	lorenzo.masia@iit.it	MASIA, LORENZO/D-9385-2014; Casadio, Maura/AAH-2861-2022; Casadio, Maura/AFM-0496-2022	Sandini, Giulio/0000-0003-3324-985X				Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; Abeele S, 2001, EXP BRAIN RES, V139, P248, DOI 10.1007/s002210100768; ANDERSON R, 1980, TECHNIQUE USE SURG T; Baugh LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005484; BERNOTAT R, 1970, ERGONOMICS, V13, P353; Bock O, 2008, HUM MOVEMENT SCI, V27, P383, DOI 10.1016/j.humov.2008.01.001; BREEDVELD P, 2002, MINIM INVASIV THER, V10, P155; BRIAN P, 2004, P IEEE INT C ROB AUT; Brown LE, 2003, J NEUROPHYSIOL, V90, P3105, DOI 10.1152/jn.00013.2003; Congedo M, 2006, PRESENCE-TELEOP VIRT, V15, P353, DOI 10.1162/pres.15.3.353; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; CUNNINGHAM HA, 1990, BIOL CYBERN, V64, P117, DOI 10.1007/BF02331340; Cuschieri A, 1992, OPERATIVE MANUAL END; DIZIO P, 1993, J NEUROPHYSIOL, V70, P1578, DOI 10.1152/jn.1993.70.4.1578; ELLIS SR, 1993, SID 93 DIGEST, P487; GHILARDI MF, 1995, J NEUROPHYSIOL, V73, P2535, DOI 10.1152/jn.1995.73.6.2535; Girgenrath M, 2008, EXP BRAIN RES, V184, P561, DOI 10.1007/s00221-007-1124-8; Groen J, 1998, PRESENCE-TELEOP VIRT, V7, P429, DOI 10.1162/105474698565839; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KIM WS, 1987, IEEE T SYST MAN CYB, V17, P61, DOI 10.1109/TSMC.1987.289333; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; KOHLER, 1964, FORMATION TRANSFORMA; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; LACKNER JR, 1979, AVIAT SPACE ENVIR MD, V50, P346; Pennel I, 2003, J MOTOR BEHAV, V35, P274, DOI 10.1080/00222890309602140; Pennel I, 2002, ERGONOMICS, V45, P1047, DOI 10.1080/00140130210166906; PICK HL, 1969, J EXP PSYCHOL, V80, P125, DOI 10.1037/h0027111; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Soechting J F, 1991, Exerc Sport Sci Rev, V19, P389; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Stratton G.M., 1897, PSYCHOL REV, V4, P341, DOI [DOI 10.1037/H0075482, 10.1037/h0075482]; Tendick F., 1993, PRESENCETELEOP VIRT, V2, P66, DOI [DOI 10.1162/PRES.1993.2.1.66, 10.1162/pres.1993.2.1.66]; VANLAER E, 1970, PERCEPT MOTOR SKILL, V30, P723, DOI 10.2466/pms.1970.30.3.723; Vindras P, 1998, J EXP PSYCHOL HUMAN, V24, P569, DOI 10.1037/0096-1523.24.2.569; WARREN DH, 1979, PERCEPTION, V8, P323, DOI 10.1068/p080323; WARREN DH, 1971, J EXP PSYCHOL, V90, P206, DOI 10.1037/h0031545; WARREN DH, 1978, J EXP PSYCHOL HUMAN, V4, P302, DOI 10.1037/0096-1523.4.2.302; Wentink M, 2002, SURG ENDOSC, V16, P1533, DOI 10.1007/s00464-001-9214-3; Wigmore V, 2002, J EXP PSYCHOL HUMAN, V28, P447, DOI 10.1037//0096-1523.28.2.447; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460	48	48	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7004	10.1371/journal.pone.0007004	http://dx.doi.org/10.1371/journal.pone.0007004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494FO	19753120	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796500003
J	Massip, L; Garand, C; Paquet, ER; Cogger, VC; O'Reilly, JN; Tworek, L; Hatherell, A; Taylor, CG; Thorin, E; Zahradka, P; Le Couteur, DG; Lebel, M				Massip, Laurent; Garand, Chantal; Paquet, Eric R.; Cogger, Victoria C.; O'Reilly, Jennifer N.; Tworek, Leslee; Hatherell, Avril; Taylor, Carla G.; Thorin, Eric; Zahradka, Peter; Le Couteur, David G.; Lebel, Michel			Vitamin C restores healthy aging in a mouse model for Werner syndrome	FASEB JOURNAL			English	Article						ascorbate; metabolism; microarrays; liver; adipocyte; inflammation	GENE-EXPRESSION PROFILES; L-ASCORBIC-ACID; INSULIN-RESISTANCE; SYNDROME PROTEIN; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASE-1; DWARF MICE; LIFE-SPAN; KAPPA-B; CELLS	Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-like DNA helicase. Mice lacking the helicase domain of the WRN homologue exhibit many phenotypic features of WS, including a prooxidant status and a shorter mean life span compared to wild-type animals. Here, we show that Wrn mutant mice also develop premature liver sinusoidal endothelial defenestration along with inflammation and metabolic syndrome. Vitamin C supplementation rescued the shorter mean life span of Wrn mutant mice and reversed several age-related abnormalities in adipose tissues and liver endothelial defenestration, genomic integrity, and inflammatory status. At the molecular level, phosphorylation of age-related stress markers like Akt kinase-specific substrates and the transcription factor NF-kappa B, as well as protein kinase C delta and Hif-1 alpha transcription factor levels, which are increased in the liver of Wrn mutants, were normalized by vitamin C. Vitamin C also increased the transcriptional regulator of lipid metabolism PPAR alpha. Finally, microarray and gene set enrichment analyses on liver tissues revealed that vitamin C decreased genes normally up-regulated in human WS fibroblasts and cancers, and it increased genes involved in tissue injury response and adipocyte dedifferentiation in obese mice. Vitamin C did not have such effect on wild-type mice. These results indicate that vitamin C supplementation could be beneficial for patients with WS.-Massip, L., Garand, C., Paquet, E. R., Cogger, V. C., O'Reilly, J. N., Tworek, L., Hatherell, A., Taylor, C. G., Thorin, E., Zahradka, P., Le Couteur, D. G., Lebel, M. Vitamin C restores healthy aging in a mouse model for Werner syndrome. FASEB J. 24, 158-172 ( 2010). www.fasebj.org	[Massip, Laurent; Garand, Chantal; Paquet, Eric R.; Lebel, Michel] Univ Laval, Ctr Rech Cancerol, Hop Hotel Dieu, Quebec City, PQ, Canada; [Cogger, Victoria C.; O'Reilly, Jennifer N.; Le Couteur, David G.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; [Cogger, Victoria C.; O'Reilly, Jennifer N.; Le Couteur, David G.] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia; [Cogger, Victoria C.; O'Reilly, Jennifer N.; Le Couteur, David G.] Concord RG Hosp, Sydney, NSW, Australia; [Tworek, Leslee; Hatherell, Avril; Taylor, Carla G.; Zahradka, Peter] Univ Manitoba, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB, Canada; [Tworek, Leslee; Hatherell, Avril; Taylor, Carla G.; Zahradka, Peter] St Boniface Gen Hosp, Res Ctr, Winnipeg, MB, Canada; [Thorin, Eric] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada	Laval University; University of Sydney; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; Universite de Montreal	Lebel, M (corresponding author), Hop HoDieu Quebec, Ctr Rech Cancerol, 9 McMahon St, Quebec City, PQ G1R 2J6, Canada.	michel.lebel@crhdq.ulaval.ca	Thorin, Eric/K-3978-2013; Research Institute, ANZAC/CAE-9030-2022	Thorin, Eric/0000-0001-5827-8935; Taylor, Carla G./0000-0003-3358-6418; Zahradka, Peter/0000-0002-7814-0658; Le Couteur, David/0000-0002-4227-5817; Garand, Chantal/0000-0003-0716-6487; Paquet, Eric/0000-0001-9194-1655	Canadian Institutes of Health Research; National Sciences and Engineering Research Council of Canada; The National Health and Medical Research Council of Australia; Aging and Alzheimers Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); The National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Aging and Alzheimers Research Foundation	We thank Dr. O. Neyret-Djossou of the functional genomic platform of the Institut de Recherche Clinique de Montreal (Montreal, QC, Canada) for the microarray services. We are also grateful to M. Sild and A. Labbe for real-time RT-PCRs ( Centre de Recherche en Cancerologie de l'Universite Laval). This work was supported in part by grants from the Canadian Institutes of Health Research and from the National Sciences and Engineering Research Council of Canada to M. L. and from The National Health and Medical Research Council of Australia and from the Aging and Alzheimers Research Foundation ( a Division of the Medical Foundation of the University of Sydney) to D. G. L. M. L. is a senior scholar of the Fonds de la Recherche en Sante du Quebec.	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881; BORGESE N, 1986, BIOCHEM J, V239, P393, DOI 10.1042/bj2390393; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cooper MP, 2000, GENE DEV, V14, P907; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Davis T, 2005, J GERONTOL A-BIOL, V60, P1386, DOI 10.1093/gerona/60.11.1386; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Honjo S, 2008, J AM GERIATR SOC, V56, P173, DOI 10.1111/j.1532-5415.2007.01484.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Huang SR, 2006, HUM MUTAT, V27, P558, DOI 10.1002/humu.20337; Ichiba T, 2003, BLOOD, V102, P763, DOI 10.1182/blood-2002-09-2748; Kashino G, 2003, FREE RADICAL BIO MED, V35, P438, DOI 10.1016/S0891-5849(03)00326-5; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kuo SM, 2004, J NUTR, V134, P2216; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661; Lebel M, 2003, AM J PATHOL, V162, P1559, DOI 10.1016/S0002-9440(10)64290-3; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Lloret A, 2008, FREE RADICAL BIO MED, V44, P495, DOI 10.1016/j.freeradbiomed.2007.10.046; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MASSIE HR, 1984, GERONTOLOGY, V30, P370, DOI 10.1159/000212659; Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011; Masternak MM, 2007, PPAR RES, V2007, DOI 10.1155/2007/28436; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLachlan JL, 2005, BBA-MOL BASIS DIS, V1741, P271, DOI 10.1016/j.bbadis.2005.03.007; Moore G, 2008, MECH AGEING DEV, V129, P201, DOI 10.1016/j.mad.2007.12.009; MORI S, 2001, INT J OBESITY, V25, P29229; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Otsuka M, 1999, J NUTR SCI VITAMINOL, V45, P163, DOI 10.3177/jnsv.45.163; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yamamoto H, 2007, CLIN CHIM ACTA, V379, P167, DOI 10.1016/j.cca.2007.01.009; Yokote K, 2008, J AM GERIATR SOC, V56, P1770, DOI 10.1111/j.1532-5415.2008.01817.x; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	69	75	75	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					158	172		10.1096/fj.09-137133	http://dx.doi.org/10.1096/fj.09-137133			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19741171	Green Accepted			2022-12-25	WOS:000273233600018
J	Bulfer, SL; Scott, EM; Couture, JF; Pillus, L; Trievel, RC				Bulfer, Stacie L.; Scott, Erin M.; Couture, Jean-Francois; Pillus, Lorraine; Trievel, Raymond C.			Crystal Structure and Functional Analysis of Homocitrate Synthase, an Essential Enzyme in Lysine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; CITRATE SYNTHASE; TERNARY COMPLEX; ACTIVE-SITE; MECHANISM; REFINEMENT; COENZYME; OXALOACETATE; PURIFICATION; PROTEINS	Homocitrate synthase (HCS) catalyzes the first and committed step in lysine biosynthesis in many fungi and certain Archaea and is a potential target for antifungal drugs. Here we report the crystal structure of the HCS apoenzyme from Schizosaccharomyces pombe and two distinct structures of the enzyme in complex with the substrate 2-oxoglutarate (2-OG). The structures reveal that HCS forms an intertwined homodimer stabilized by domain-swapping between the N- and C-terminal domains of each monomer. The N- terminal catalytic domain is composed of a TIM barrel fold in which 2-OG binds via hydrogen bonds and coordination to the active site divalent metal ion, whereas the C-terminal domain is composed of mixed alpha/beta topology. In the structures of the HCS apoenzyme and one of the 2-OG binary complexes, a lid motif from the C-terminal domain occludes the entrance to the active site of the neighboring monomer, whereas in the second 2-OG complex the lid is disordered, suggesting that it regulates substrate access to the active site through its apparent flexibility. Mutations of the active site residues involved in 2-OG binding or implicated in acid-base catalysis impair or abolish activity in vitro and in vivo. Together, these results yield new insights into the structure and catalytic mechanism of HCSs and furnish a platform for developing HCS-selective inhibitors.	[Trievel, Raymond C.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, UCSD Moores Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Trievel, RC (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu			National Institutes of Health [GM056469, GM073839, 5T32GM008353-18, T32GM007240, Y1-CO-1020 (NCI), Y1-GM-1104 (NIGMS)]; University of Michigan Biomedical Research Council; University of Michigan Rackham Graduate School; Canadian Institutes of Health; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri- Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056469, T32GM008353, R01GM073839, T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biomedical Research Council(University of Michigan System); University of Michigan Rackham Graduate School(University of Michigan System); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri- Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM056469 (to L.P.) and GM073839 (R.C.T.). This work was also supported by a University of Michigan Biomedical Research Council pilot grant (to R.C.T.).; Supported by National Institutes of Health Cellular Biotechnology Training Program 5T32GM008353-18 and by a predoctoral fellowship and a graduate student research grant from the University of Michigan Rackham Graduate School.; Supported in part by National Institutes of Health Cell, Molecular, and Genetics Training Grant T32GM007240.; Supported by a Canadian Institutes of Health Research postdoctoral fellowship.; We thank J. Woodward at the Sanger Institute for providing the genomic clone of lys4<SUP>+</SUP> and J. Aris for supplying the yeast HCS antibody. We also thank E. Townsend and C. Burbank for assistance in protein purification and preparing site-directed mutants, respectively. In addition, we acknowledge S. Anderson and R. Sanishvili for assistance in x-ray data collection, T. Huston for performing the inductively coupled plasma mass spectrometry analysis, and A. Gafni and E. Lee for use of the CD spectropolarimeter. We kindly thank T. Baker and N. Koon for furnishing the coordinates of the alpha-IPMS.AcCoA.2-OIV model and P. O'Brien and P. Del Rizzo for reading the manuscript and providing useful comments. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science under Contract DE-AC02-06CH11357. General Medicine and Cancer Institutes Collaborative Access Team was funded in whole or in part with National Institutes of Health Grants Y1-CO-1020 (NCI) and Y1-GM-1104 (NIGMS). Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri- Corridor for support of this research program (Grant 085P1000817).	Amberg DC., 2005, METHODS YEAST GENETI; Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2004, BIOCHEMISTRY-US, V43, P11790, DOI 10.1021/bi048766p; Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu ZJ, 2006, J BIOL CHEM, V281, P7526, DOI 10.1074/jbc.M506880200; GARRAD RC, 1992, J BACTERIOL, V174, P7379, DOI 10.1128/jb.174.22.7379-7384.1992; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Howard BR, 2000, BIOCHEMISTRY-US, V39, P3156, DOI 10.1021/bi992519h; JAKLITSCH WM, 1990, BIOCHEM J, V269, P247, DOI 10.1042/bj2690247; KARPUSAS M, 1990, BIOCHEMISTRY-US, V29, P2213, DOI 10.1021/bi00461a002; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Kosuge T, 1998, FEMS MICROBIOL LETT, V169, P361, DOI 10.1016/S0378-1097(98)00502-3; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian JH, 2008, BIOCHEMISTRY-US, V47, P6851, DOI 10.1021/bi800087k; Qian JH, 2006, BIOCHEMISTRY-US, V45, P12136, DOI 10.1021/bi060889h; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; TUCCI AF, 1972, ARCH BIOCHEM BIOPHYS, V153, P742, DOI 10.1016/0003-9861(72)90393-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOGEL HJ, 1960, BIOCHIM BIOPHYS ACTA, V41, P172, DOI 10.1016/0006-3002(60)90392-9; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; WIEGAND G, 1984, J MOL BIOL, V174, P205, DOI 10.1016/0022-2836(84)90373-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43	39	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35769	35780		10.1074/jbc.M109.046821	http://dx.doi.org/10.1074/jbc.M109.046821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19776021	Green Published, hybrid			2022-12-25	WOS:000272645600054
J	Davidson, RE; Chesters, CJ; Reid, JD				Davidson, Ruth E.; Chesters, Christopher J.; Reid, James D.			Metal Ion Selectivity and Substrate Inhibition in the Metal Ion Chelation Catalyzed by Human Ferrochelatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY CONSTANTS; N-METHYLPROTOPORPHYRIN; 2-SUBSTRATE ENZYMES; ZINC PROTOPORPHYRIN; HEME-BIOSYNTHESIS; BACILLUS-SUBTILIS; PRODUCT RELEASE; TERMINAL ENZYME; ACTIVE-SITE; BINDING	Protoporphyrin IX ferrochelatase (EC 4.99.1.1) catalyzes the terminal step in the heme biosynthetic pathway, the insertion of ferrous iron into protoporphyrin IX. Ferrochelatase shows specificity, in vitro, for multiple metal ion substrates and exhibits substrate inhibition in the case of zinc, copper, cobalt, and nickel. Zinc is the most biologically significant of these; when iron is depleted, zinc porphyrins are formed physiologically. Examining the k(cat)/K-m(app) ratios for zinc and iron reveals that, in vitro, zinc is the preferred substrate at all concentrations of porphyrin. This is not the observed biological specificity, where zinc porphyrins are abnormal; these data argue for the existence of a specific iron delivery mechanism in vivo. We demonstrate that zinc acts as an uncompetitive substrate inhibitor, suggesting that ferrochelatase acts via an ordered pathway. Steady-state characterization demonstrates that the apparent k(cat) depends on zinc and shows substrate inhibition. Although porphyrin substrate is not inhibitory, zinc inhibition is enhanced by increasing porphyrin concentration. This indicates that zinc inhibits by binding to an enzyme-product complex (EZnDIX) and is likely to be the second substrate in an ordered mechanism. Our analysis shows that substrate inhibition by zinc is not a mechanism that can promote specificity for iron over zinc, but is instead one that will reduce the production of all metalloporphyrins in the presence of high concentrations of zinc.	Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Chesters, Christopher J.] Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England	University of Sheffield; University of Manchester		j.reid@sheffield.ac.uk		Reid, James/0000-0003-4921-1047	Biotechnology and Biological Sciences Research Council, United Kingdom	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom.	ABBAS A, 1993, J BIOL CHEM, V268, P8541; Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Al-Karadaghi S, 1997, STRUCTURE, V5, P1501, DOI 10.1016/S0969-2126(97)00299-2; BARNSLEY EA, 1993, BIOCHEM J, V291, P323; Burden AE, 1999, BBA-PROTEIN STRUCT M, V1435, P191, DOI 10.1016/S0167-4838(99)00196-X; COOK PF, 2007, ENZYME KINETICS MECH, P175; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; CORNISHBOWDEN A, 1993, BIOCHEM J, V291, P323; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; DAILEY HA, 2003, PORPHYRIN HDB, P87; ENGEL PC, 1992, BIOCHEM J, V284, P604, DOI 10.1042/bj2840604; ENGEL PC, 1993, BIOCHEM J, V291, P324, DOI 10.1042/bj2910324; Falk JE, 1964, PORPHYRINS METALLOPO, P236; Fersht AR., 1977, ENZYME STRUCTURE MEC; Franco R, 2001, BIOCHEM J, V356, P217, DOI 10.1042/0264-6021:3560217; GOLDIN BR, 1969, BIOCHIM BIOPHYS ACTA, V171, P321, DOI 10.1016/0005-2744(69)90165-X; Hansen SH, 2006, NEW ASTRON, V11, P333, DOI 10.1016/j.newast.2005.09.001; HANSSON M, 1994, EUR J BIOCHEM, V220, P201, DOI 10.1111/j.1432-1033.1994.tb18615.x; Hoggins M, 2007, BIOCHEMISTRY-US, V46, P8121, DOI 10.1021/bi602418e; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Karlberg T, 2002, BIOCHEMISTRY-US, V41, P13499, DOI 10.1021/bi0260785; Karlberg T, 2008, J MOL BIOL, V378, P1074, DOI 10.1016/j.jmb.2008.03.040; LAMOLA AA, 1974, SCIENCE, V186, P936, DOI 10.1126/science.186.4167.936; LAMOLA AA, 1975, CLIN CHEM, V21, P93; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Lecerof D, 2000, J MOL BIOL, V297, P221, DOI 10.1006/jmbi.2000.3569; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Medlock AE, 2009, J MOL BIOL, V393, P308, DOI 10.1016/j.jmb.2009.08.042; PORRA RJ, 1967, BIOCHEM J, V104, P321, DOI 10.1042/bj1040321; Sellers VM, 2001, BIOCHEMISTRY-US, V40, P9821, DOI 10.1021/bi010012c; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi Z, 2006, BIOCHEM J, V399, P21, DOI 10.1042/BJ20060753; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; [No title captured]	36	18	18	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33795	33799		10.1074/jbc.M109.030205	http://dx.doi.org/10.1074/jbc.M109.030205			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19767646	hybrid, Green Published			2022-12-25	WOS:000272165200010
J	Martin, S; Okano, S; Kistler, C; Fernandez-Rojo, MA; Hill, MM; Parton, RG				Martin, Sally; Okano, Satomi; Kistler, Carol; Fernandez-Rojo, Manuel A.; Hill, Michelle M.; Parton, Robert G.			Spatiotemporal Regulation of Early Lipolytic Signaling in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; KINASE ANCHORING PROTEINS; LIPID DROPLETS; 3T3-L1 ADIPOCYTES; PHOSPHORYLATION; IDENTIFICATION; TRANSLOCATION; STIMULATION; INSULIN; MECHANISM	Hormone-sensitive lipase (HSL) is a key enzyme regulating the acute activation of lipolysis. HSL functionality is controlled by multiple phosphorylation events, which regulate its association with the surface of lipid droplets (LDs). We determined the progression and stability of HSL phosphorylation on individual serine residues both spatially and temporally in adipocytes using phospho-specific antibodies. Within seconds of beta-adrenergic receptor activation, HSL was phosphorylated on Ser-660, the phosphorylated form appearing in the peripheral cytosol prior to rapid translocation to, and stable association with, LDs. In contrast, phosphorylation of HSL on Ser-563 was delayed, the phosphorylated protein was predominantly detected on LDs, and mutation of the Ser-659/Ser-660 site to Ala significantly reduced subsequent phosphorylation on Ser-563. Phosphorylation of HSL on Ser-565 was observed in control cells; the phosphorylated protein was translocated to LDs with similar kinetics to total HSL, and the degree of phosphorylation was inversely related to phospho-HSLSer-563. These results describe the remarkably rapid, sequential phosphorylation of specific serine residues in HSL at spatially distinct intracellular locales, providing new insight into the complex regulation of lipolysis.	[Martin, Sally; Okano, Satomi; Kistler, Carol; Fernandez-Rojo, Manuel A.; Hill, Michelle M.; Parton, Robert G.] Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Martin, S (corresponding author), Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	s.martin@uq.edu.au	Parton, Robert G/C-5673-2009; Hill, Michelle Mei Chih/G-4417-2010; Okano, Satomi/AAX-9546-2021; Martin, Sally/A-7150-2010	Parton, Robert G/0000-0002-7494-5248; Hill, Michelle Mei Chih/0000-0003-1134-0951; Okano, Satomi/0000-0003-4913-9612; Martin, Sally/0000-0001-9294-5404	National Health and Medical Research Council of Australia; Diabetes Australia Research Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by grants from the National Health and Medical Research Council of Australia (to R. G. P. and S. M.) and the Diabetes Australia Research Trust (to S. M.).	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Bridges D, 2006, BIOCHEM BIOPH RES CO, V346, P351, DOI 10.1016/j.bbrc.2006.05.138; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; GARTON AJ, 1988, FEBS LETT, V229, P68, DOI 10.1016/0014-5793(88)80799-3; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Harmer SC, 2008, J ENDOCRINOL, V196, P149, DOI 10.1677/JOE-07-0391; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Shen WJ, 2000, BIOCHEMISTRY-US, V39, P2392, DOI 10.1021/bi992283h; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	28	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32097	32107		10.1074/jbc.M109.002675	http://dx.doi.org/10.1074/jbc.M109.002675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19755426	Green Published, hybrid			2022-12-25	WOS:000271572700064
J	An, DD; Apidianakis, Y; Boechat, AL; Baldini, RL; Goumnerov, BC; Rahme, LG				An, Dingding; Apidianakis, Yiorgos; Boechat, Ana Laura; Baldini, Regina L.; Goumnerov, Boyan C.; Rahme, Laurence G.			The Pathogenic Properties of a Novel and Conserved Gene Product, KerV, in Proteobacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PATHOGENESIS; TRANSPOSON MUTANT LIBRARY; III SECRETION; BACTERIAL; HOST; PROTEIN; DNA; METHYLGLYOXAL; REPLICATION; MECHANISMS	Identification of novel virulence factors is essential for understanding bacterial pathogenesis and designing antibacterial strategies. In this study, we uncover such a factor, termed KerV, in Proteobacteria. Experiments carried out in a variety of eukaryotic host infection models revealed that the virulence of a Pseudomonas aeruginosa kerV null mutant was compromised when it interacted with amoebae, plants, flies, and mice. Bioinformatics analyses indicated that KerV is a hypothetical methyltransferase and is well-conserved across numerous Proteobacteria, including both well-known and emerging pathogens (e.g., virulent Burkholderia, Escherichia, Shigella, Vibrio, Salmonella, Yersinia and Brucella species). Furthermore, among the 197 kerV orthologs analyzed in this study, about 89% reside in a defined genomic neighborhood, which also possesses essential DNA replication and repair genes and detoxification gene. Finally, infection of Drosophila melanogaster with null mutants demonstrated that KerV orthologs are also crucial in Vibrio cholerae and Yersinia pseudotuberculosis pathogenesis. Our findings suggested that KerV has a novel and broad significance as a virulence factor in pathogenic Proteobacteria and it might serve as a new target for antibiotic drug design.			An, DD (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.	rahme@molbio.mgh.harvard.edu	Baldini, Regina L/C-4035-2012; Apidianakis, Yiorgos/ABF-7464-2020; Borges, Ana Laura/AAQ-4158-2020	Baldini, Regina L/0000-0003-4349-6352; Apidianakis, Yiorgos/0000-0002-7465-3560; 				Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008; BOLIN I, 1982, INFECT IMMUN, V37, P506; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Cai H, 2001, BIOCHEMISTRY-US, V40, P2210, DOI 10.1021/bi0022902; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Clatworthy AE, 2009, INFECT IMMUN, V77, P1293, DOI 10.1128/IAI.01181-08; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; FINK RB, 1993, PSEUDOMONAS AERUGINO; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; KANAYA S, 1984, P NATL ACAD SCI-BIOL, V81, P3447, DOI 10.1073/pnas.81.11.3447; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Murata-Kamiya N, 2000, MUTAT RES-GEN TOX EN, V468, P173, DOI 10.1016/S1383-5718(00)00044-9; OGAWA T, 1984, P NATL ACAD SCI-BIOL, V81, P1040, DOI 10.1073/pnas.81.4.1040; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Robins E V, 1989, Crit Care Nurs Clin North Am, V1, P767; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Stevens Emily J., 1994, Journal of Burn Care and Rehabilitation, V15, P232, DOI 10.1097/00004630-199405000-00005; Taft-Benz SA, 1998, NUCLEIC ACIDS RES, V26, P4005, DOI 10.1093/nar/26.17.4005; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TANG H, 1995, INFECT IMMUN, V63, P1278, DOI 10.1128/IAI.63.4.1278-1285.1995; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Waldor MK., 1996, ENTERIC INFECT IMMUN, P37, DOI [10.1007/978-1-4899-0313-6_3, DOI 10.1007/978-1-4899-0313-6_3]; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350	48	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7167	10.1371/journal.pone.0007167	http://dx.doi.org/10.1371/journal.pone.0007167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779606	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200010
J	Suda, Y; Rodriguez, RK; Coluccio, AE; Neiman, AM				Suda, Yasuyuki; Rodriguez, Rachael K.; Coluccio, Alison E.; Neiman, Aaron M.			A Screen for Spore Wall Permeability Mutants Identifies a Secreted Protease Required for Proper Spore Wall Assembly	PLOS ONE			English	Article								The ascospores of Saccharomyces cerevisiae are surrounded by a complex wall that protects the spores from environmental stresses. The outermost layer of the spore wall is composed of a polymer that contains the cross-linked amino acid dityrosine. This dityrosine layer is important for stress resistance of the spore. This work reports that the dityrosine layer acts as a barrier blocking the diffusion of soluble proteins out of the spore wall into the cytoplasm of the ascus. Diffusion of a fluorescent protein out of the spore wall was used as an assay to screen for mutants affecting spore wall permeability. One of the genes identified in this screen, OSW3 (RRT12/YCR045c), encodes a subtilisin-family protease localized to the spore wall. Mutation of the active site serine of Osw3 results in spores with permeable walls, indicating that the catalytic activity of Osw3 is necessary for proper construction of the dityrosine layer. These results indicate that dityrosine promotes stress resistance by acting as a protective shell around the spore. OSW3 and other OSW genes identified in this screen are strong candidates to encode enzymes involved in assembly of this protective dityrosine coat.			Suda, Y (corresponding author), RIKEN Adv Sci Inst, Mol Membrane Biol Lab, Saitama, Japan.	Aaron.Neiman@sunysb.edu	Suda, Yasuyuki/AAH-5065-2020; Suda, Yasuyuki/D-3870-2017	Suda, Yasuyuki/0000-0001-8725-8001; Suda, Yasuyuki/0000-0001-8725-8001; Neiman, Aaron/0000-0002-6600-6996	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072540] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072540] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen MR, 2008, GENETICS, V179, P1179, DOI 10.1534/genetics.108.089250; BRIZA P, 1986, J BIOL CHEM, V261, P4288; BRIZA P, 1990, J BIOL CHEM, V265, P15118; BRIZA P, 1988, J BIOL CHEM, V263, P11569; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; Christodoulidou A, 1999, FEBS LETT, V460, P275, DOI 10.1016/S0014-5793(99)01334-4; Christodoulidou A, 1996, J BIOL CHEM, V271, P31420, DOI 10.1074/jbc.271.49.31420; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; Coluccio A, 2004, MICROBIOL-SGM, V150, P3189, DOI 10.1099/mic.0.27253-0; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Diamond AE, 2009, MOL BIOL CELL, V20, P134, DOI 10.1091/mbc.E08-06-0615; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hontz RD, 2009, GENETICS, V182, P105, DOI 10.1534/genetics.108.100313; Ishihara S, 2007, EUKARYOT CELL, V6, P143, DOI 10.1128/EC.00200-06; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Kalebina TS, 2003, ANTON LEEUW INT J G, V84, P179, DOI 10.1023/A:1026034123673; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KREGERVANRIJ NJW, 1978, ARCH MICROBIOL, V117, P73, DOI 10.1007/BF00689354; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Li J, 2007, GENETICS, V175, P143, DOI 10.1534/genetics.106.066381; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Melo NR, 2008, ANTIMICROB AGENTS CH, V52, P3718, DOI 10.1128/AAC.00446-08; MOEHLE CM, 1987, MOL CELL BIOL, V7, P4390, DOI 10.1128/MCB.7.12.4390; MUTHUKUMAR G, 1993, J BACTERIOL, V175, P386, DOI 10.1128/JB.175.2.386-394.1993; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; PAMMER M, 1992, YEAST, V8, P1089, DOI 10.1002/yea.320081211; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; Rose MD., 1990, METHODS YEAST GENETI; SANSEGUNDO P, 1993, J BACTERIOL, V175, P3823, DOI 10.1128/JB.175.12.3823-3837.1993; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIKORSKI RS, 1989, GENETICS, V122, P19; Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781; VANDEVEN WJM, 1991, ENZYME, V45, P257, DOI 10.1159/000468900	40	33	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7184	10.1371/journal.pone.0007184	http://dx.doi.org/10.1371/journal.pone.0007184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779569	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200017
J	Alonso-Camino, V; Sanchez-Martin, D; Compte, M; Sanz, L; Alvarez-Vallina, L				Alonso-Camino, Vanesa; Sanchez-Martin, David; Compte, Marta; Sanz, Laura; Alvarez-Vallina, Luis			Lymphocyte Display: A Novel Antibody Selection Platform Based on T Cell Activation	PLOS ONE			English	Article								Since their onset, display technologies have proven useful for the selection of antibodies against a variety of targets; however, most of the antibodies selected with the currently available platforms need to be further modified for their use in humans, and are restricted to accessible antigens. Furthermore, these platforms are not well suited for in vivo selections. We present here a novel cell based antibody display platform, which takes advantage of the functional capabilities of T lymphocytes. The display of antibodies on the surface of T lymphocytes, as a part of a chimeric-immune receptor (CIR) mediating signaling, may ideally link the antigen-antibody interaction to a demonstrable change in T cell phenotype, due to subsequent expression of the early T cell activation marker CD69. In this proof-of-concept, an in vitro selection was carried out using a human T cell line lentiviral-transduced to express a tumor-specific CIR on the surface, against a human tumor cell line expressing the carcinoembryonic antigen. Based on an effective interaction between the CIR and the tumor antigen, we demonstrated that combining CIR-mediated activation with FACS sorting of CD69(+) T cells, it is possible to isolate binders to tumor specific cell surface antigen, with an enrichment factor of at least 10(3)-fold after two rounds, resulting in a homogeneous population of T cells expressing tumor-specific CIRs.			Alonso-Camino, V (corresponding author), Hosp Univ Puerta Hierro, Mol Immunol Unit, Madrid, Spain.	lalvarezv.hpth@salud.madrid.org	Alvarez-Vallina, Luis/ABD-2431-2020; Álvarez-Vallina, Luis/A-2032-2010; Sanz, Laura/F-8542-2010; Alvarez-Vallina, Luis/A-2033-2010; Compte Grau, Marta/H-5873-2012; Sánchez-Martín, David/C-9927-2013	Alvarez-Vallina, Luis/0000-0003-3053-6757; Sanz, Laura/0000-0002-3119-3218; Sánchez-Martín, David/0000-0002-2712-4762; Compte Grau, Marta/0000-0002-7138-9266				Alemany R, 2000, NAT BIOTECHNOL, V18, P723, DOI 10.1038/77283; Alvarez-Vallina L, 2000, CANCER GENE THER, V7, P526, DOI 10.1038/sj.cgt.7700128; Alvarez-Vallina L., 2001, Current Gene Therapy, V1, P385, DOI 10.2174/1566523013348418; AlvarezVallina L, 1996, EUR J IMMUNOL, V26, P2304, DOI 10.1002/eji.1830261006; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Blanco B, 2002, CANCER GENE THER, V9, P275, DOI 10.1038/sj.cgt.7700438; Buchholz CJ, 1998, NAT BIOTECHNOL, V16, P951, DOI 10.1038/nbt1098-951; CHESTER KA, 1994, LANCET, V343, P455, DOI 10.1016/S0140-6736(94)92695-6; Compte M, 2007, CANCER GENE THER, V14, P380, DOI 10.1038/sj.cgt.7701021; Finney HM, 1998, J IMMUNOL, V161, P2791; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; HEFTA LJF, 1992, CANCER RES, V52, P5647; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Khare PD, 2003, VIROLOGY, V315, P313, DOI 10.1016/S0042-6822(03)00530-0; Paillard F, 1998, HUM GENE THER, V9, P2307, DOI 10.1089/hum.1998.9.16-2307; Pizzato M, 1999, J VIROL, V73, P8599, DOI 10.1128/JVI.73.10.8599-8611.1999; RUSSELL SJ, 1993, NUCLEIC ACIDS RES, V21, P1081, DOI 10.1093/nar/21.5.1081; Sanz L, 2004, TRENDS IMMUNOL, V25, P85, DOI 10.1016/j.it.2003.12.001; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH GP, 1985, SCIENCE, V14, P228; Taube R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003181; Urban JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni033; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wolkowicz R, 2005, J BIOL CHEM, V280, P15195, DOI 10.1074/jbc.M500254200; Zhang LL, 2006, CANCER RES, V66, P5696, DOI 10.1158/0008-5472.CAN-05-3876	26	15	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7174	10.1371/journal.pone.0007174	http://dx.doi.org/10.1371/journal.pone.0007174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777065	Green Published, Green Submitted, gold			2022-12-25	WOS:000270164600010
J	Paccagnini, D; Sieswerda, L; Rosu, V; Masala, S; Pacifico, A; Gazouli, M; Ikonomopoulos, J; Ahmed, N; Zanetti, S; Sechi, LA				Paccagnini, Daniela; Sieswerda, Lee; Rosu, Valentina; Masala, Speranza; Pacifico, Adolfo; Gazouli, Maria; Ikonomopoulos, John; Ahmed, Niyaz; Zanetti, Stefania; Sechi, Leonardo A.			Linking Chronic Infection and Autoimmune Diseases: Mycobacterium avium Subspecies paratuberculosis, SLC11A1 Polymorphisms and Type-1 Diabetes Mellitus	PLOS ONE			English	Article								Background: The etiology of type 1 diabetes mellitus (T1DM) is still unknown; numerous studies are performed to unravel the environmental factors involved in triggering the disease. SLC11A1 is a membrane transporter that is expressed in late endosomes of antigen presenting cells involved in the immunopathogenic events leading to T1DM. Mycobacterium avium subsp. paratuberculosis (MAP) has been reported to be a possible trigger in the development of T1DM. Methodology/Principal Findings: Fifty nine T1DM patients and 79 healthy controls were genotyped for 9 polymorphisms of SLC11A1 gene, and screened for the presence of MAP by PCR. Differences in genotype frequency were evaluated for both T1DM patients and controls. We found a polymorphism in the SLC11A1 gene (274C/T) associated to type 1 diabetic patients and not to controls. The presence of MAP DNA was also significantly associated with T1DM patients and not with controls. Conclusions/Significance: The 274C/T SCL11A1 polymorphism was found to be associated with T1DM as well as the presence of MAP DNA in blood. Since MAP persists within macrophages and it is also processed by dendritic cells, further studies are necessary to evaluate if mutant forms of SLC11A1 alter the processing or presentation of MAP antigens triggering thereby an autoimmune response in T1DM patients.			Paccagnini, D (corresponding author), Sez Microbiol Clin & Sperimentale, Dipartimento Sci Biomed, Sassari, Italy.	sechila@uniss.it	Ahmed, Niyaz/D-2589-2010; Gazouli, Maria/I-2572-2018; Sechi, Leonardo Antonio/Y-3109-2018; Gazouli, Maria/W-6245-2019	Ahmed, Niyaz/0000-0001-6425-7583; Gazouli, Maria/0000-0002-3295-6811; Gazouli, Maria/0000-0002-3295-6811; Masala, Speranza/0000-0003-4943-9164; sechi, leonardo antonio/0000-0003-0566-2049				Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; Alter-Koltunoff M, 2003, J BIOL CHEM, V278, P44025, DOI 10.1074/jbc.M307954200; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Blackwell JM, 1999, IMMUNOL LETT, V65, P73, DOI 10.1016/S0165-2478(98)00127-8; BLACKWELL JM, 1995, MOL MED, V1, P194, DOI 10.1007/BF03401567; Canonne-Hergaux F, 1999, P ASSOC AM PHYSICIAN, V111, P283, DOI 10.1046/j.1525-1381.1999.99236.x; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; Comabella M, 2004, MULT SCLER J, V10, P618, DOI 10.1191/1352458504ms1097oa; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Dow CT, 2006, MED HYPOTHESES, V67, P782, DOI 10.1016/j.mehy.2006.04.029; Ferreira FR, 2004, INT J LEPROSY, V72, P457, DOI 10.1489/1544-581X(2004)72&lt;457:STLMBC&gt;2.0.CO;2; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Hofmeister A, 1997, SURGERY, V122, P173, DOI 10.1016/S0039-6060(97)90006-4; Jin J, 2009, CLIN INFECT DIS, V48, P733, DOI 10.1086/597034; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Litherland SA, 2005, J IMMUNOL, V175, P4561, DOI 10.4049/jimmunol.175.7.4561; Nishino M, 2005, METABOLISM, V54, P628, DOI 10.1016/j.metabol.2004.12.006; O'Keeffe M, 2005, INT IMMUNOL, V17, P307, DOI 10.1093/intimm/dxh210; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; Polymeros D, 2006, GASTROENTEROLOGY, V131, P85, DOI 10.1053/j.gastro.2006.04.021; Rook GAW, 2004, SPRINGER SEMIN IMMUN, V25, P237, DOI 10.1007/s00281-003-0148-9; ROSU V, 2008, ANN CLIN MICROBIOL A, V22, P7; Rosu V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004386; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sechi LA, 2008, CLIN VACCINE IMMUNOL, V15, P320, DOI 10.1128/CVI.00381-07; Sechi LA, 2008, CLIN INFECT DIS, V46, P148, DOI 10.1086/524084; Sechi LA, 2006, WORLD J GASTROENTERO, V12, P7161, DOI 10.3748/wjg.v12.i44.7161; Takahashi K, 2004, TISSUE ANTIGENS, V63, P231, DOI 10.1111/j.1399-0039.2004.000172.x; Yang YS, 2000, J KOREAN MED SCI, V15, P83, DOI 10.3346/jkms.2000.15.1.83; Yen JH, 2006, IMMUNOL LETT, V102, P91, DOI 10.1016/j.imlet.2005.07.008	35	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7109	10.1371/journal.pone.0007109	http://dx.doi.org/10.1371/journal.pone.0007109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768110	gold, Green Published, Green Submitted			2022-12-25	WOS:000270154000009
J	Molina-Luna, K; Pekanovic, A; Rohrich, S; Hertler, B; Schubring-Giese, M; Rioult-Pedotti, MS; Luft, AR				Molina-Luna, Katiuska; Pekanovic, Ana; Roehrich, Sebastian; Hertler, Benjamin; Schubring-Giese, Maximilian; Rioult-Pedotti, Mengia-Seraina; Luft, Andreas R.			Dopamine in Motor Cortex Is Necessary for Skill Learning and Synaptic Plasticity	PLOS ONE			English	Article								Preliminary evidence indicates that dopamine given by mouth facilitates the learning of motor skills and improves the recovery of movement after stroke. The mechanism of these phenomena is unknown. Here, we describe a mechanism by demonstrating in rat that dopaminergic terminals and receptors in primary motor cortex (M1) enable motor skill learning and enhance M1 synaptic plasticity. Elimination of dopaminergic terminals in M1 specifically impaired motor skill acquisition, which was restored upon DA substitution. Execution of a previously acquired skill was unaffected. Reversible blockade of M1 D1 and D2 receptors temporarily impaired skill acquisition but not execution, and reduced long-term potentiation (LTP) within M1, a form of synaptic plasticity critically involved in skill learning. These findings identify a behavioral and functional role of dopaminergic signaling in M1. DA in M1 optimizes the learning of a novel motor skill.			Molina-Luna, K (corresponding author), Univ Zurich, Dept Neurol, Zurich, Switzerland.	andreas.luft@usz.ch	Rioult-Pedotti, Mengia-Seraina/AAF-1377-2021	Lauwereyns, Jan/0000-0003-0551-2550				Asanuma H, 1997, NEUROREPORT, V8, pR1; Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; DAWSON TM, 1986, J NEUROSCI, V6, P2352; DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8; DEUTCH AY, 1986, NEUROSCI LETT, V71, P257, DOI 10.1016/0304-3940(86)90630-0; Doyon J, 2008, CURR OPIN NEUROL, V21, P478, DOI 10.1097/WCO.0b013e328304b6a3; FAULL RLM, 1968, J COMP NEUROL, V132, P73, DOI 10.1002/cne.901320104; Fleming SM, 2005, BEHAV BRAIN RES, V156, P201, DOI 10.1016/j.bbr.2004.05.024; Floel A, 2005, NEUROLOGY, V65, P472, DOI 10.1212/01.wnl.0000172340.56307.5e; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; GASPAR P, 1995, EUR J NEUROSCI, V7, P1050, DOI 10.1111/j.1460-9568.1995.tb01092.x; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Harms KJ, 2008, J NEUROSCI, V28, P5686, DOI 10.1523/JNEUROSCI.0584-08.2008; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P863; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; HUNTLEY GW, 1992, MOL BRAIN RES, V15, P181, DOI 10.1016/0169-328X(92)90107-M; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ioffe M E, 2004, Neurosci Behav Physiol, V34, P5, DOI 10.1023/B:NEAB.0000003241.12053.47; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LEWIS DA, 1987, J NEUROSCI, V7, P279; LIDOW MS, 1989, P NATL ACAD SCI USA, V86, P6412, DOI 10.1073/pnas.86.16.6412; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Luft AR, 2008, STROKE, V39, P3341, DOI 10.1161/STROKEAHA.108.527531; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McDonnell MN, 2007, EXP BRAIN RES, V180, P181, DOI 10.1007/s00221-006-0849-0; MCENTEE WJ, 1987, YALE J BIOL MED, V60, P187; MIKLYAEVA EI, 1994, J NEUROSCI, V14, P7148; Molina-Luna K, 2007, J NEUROSCI METH, V161, P118, DOI 10.1016/j.jneumeth.2006.10.025; Nagai T, 2007, LEARN MEMORY, V14, P117, DOI 10.1101/lm.461407; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; PAVLIDES C, 1993, J NEUROPHYSIOL, V70, P733, DOI 10.1152/jn.1993.70.2.733; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Pleger B, 2004, CLIN NEUROPHYSIOL, V115, P2157, DOI 10.1016/j.clinph.2004.04.015; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; SAKAMOTO T, 1989, BRAIN RES, V503, P258, DOI 10.1016/0006-8993(89)91672-7; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; TEYLER TJ, 1994, HIPPOCAMPUS, V4, P623, DOI 10.1002/hipo.450040602; Ueki Y, 2006, ANN NEUROL, V59, P60, DOI 10.1002/ana.20692; Whishaw IQ, 2007, NEUROSCIENCE, V146, P86, DOI 10.1016/j.neuroscience.2007.01.034; Wolters EC, 2000, ADV RES NEURODEGENER, V8, P291	55	218	219	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7082	10.1371/journal.pone.0007082	http://dx.doi.org/10.1371/journal.pone.0007082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759902	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970200012
J	Vire, B; de Walque, S; Restouin, A; Olive, D; Van Lint, C; Collette, Y				Vire, Berengere; de Walque, Stephane; Restouin, Audrey; Olive, Daniel; Van Lint, Carine; Collette, Yves			Anti-Leukemia Activity of MS-275 Histone Deacetylase Inhibitor Implicates 4-1BBL/4-1BB Immunomodulatory Functions	PLOS ONE			English	Article								Histone deacetylase inhibitors (HDACi) have demonstrated promising therapeutic potential in clinical trials for hematological malignancies. HDACi, such as SAHA/Vorinostat, Trichostatin A, and MS-275 were found to induce apoptosis of leukemic blasts through activation of the death receptor pathway and transcriptional induction of the Tumor Necrosis Factor (TNF)-related pro-apoptotic family members, TRAIL and FasL. The impact of HDACi on TNF-related costimulatory molecules such as 4-1BB ligand (4-1BBL/TNFSF9) is however not known. Following exposure to SAHA/Vorinostat, Trichostatin A, and MS-275, transcript levels were determined by real time PCR in Jurkat, Raji and U937 cells. Treatment with HDACi up-regulated TNFSF9 gene expression in the three leukemia cell lines, yet to different extend and with distinct kinetics, which did not require de novo protein synthesis and was not associated with DNAse I hypersensitive chromatin remodeling. Transcriptional activity of TNFSF9 promoter-luciferase constructs was induced up to 12 fold by HDACi, and implication of Sp1/Sp3 transcription factors binding to functional GC-box elements was evidenced by reporter gene assays, site-directed mutagenesis, and electrophoretic mobility shift assays. Functionality of modulated target genes was assessed in allogeneic mixed leukocyte reaction experiments. MS-275- and to a lesser extent Trichostatin A- and SAHA-treated Raji cells significantly up regulated T lymphocytes proliferation which was reduced by about 50% by a 4-1BB blocking recombinant protein, while MS-275- but neither Trichostatin A- nor SAHA-treated cells up-regulated IFN gamma secretion by T lymphocytes. Our results identify 4-1BBL/4-1BB as a downstream target of HDACi, especially of MS-275 anti-leukemia action in vitro. Thus, HDACi such as MS-275 displaying dual TNF-dependent proapoptotic and costimulatory activities might be favored for inclusion in HDACi-based anti-cancer therapeutic strategies.			Vire, B (corresponding author), INSERM, Ctr Rech Cancerol Marseille, U891, F-13258 Marseille, France.	collette@marseille.inserm.fr	COLLETTE, Yves/F-2270-2013	COLLETTE, Yves/0000-0001-5359-7099				Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Bhuiyan MPI, 2006, BIOORGAN MED CHEM, V14, P3438, DOI 10.1016/j.bmc.2005.12.063; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler LM, 2000, CANCER RES, V60, P5165; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Castellano R, 2006, J BIOL CHEM, V281, P14719, DOI 10.1074/jbc.M602373200; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fallarino F, 1999, J IMMUNOL, V163, P4109; Glaser KB, 2003, MOL CANCER THER, V2, P151; Glick RD, 1999, CANCER RES, V59, P4392; Gramaglia I, 2000, EUR J IMMUNOL, V30, P392, DOI 10.1002/1521-4141(200002)30:2<392::AID-IMMU392>3.0.CO;2-H; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jaboin J, 2002, CANCER RES, V62, P6108; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Maeda T, 2000, BLOOD, V96, P3847, DOI 10.1182/blood.V96.12.3847.h8003847_3847_3856; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Mariadason JM, 2000, CANCER RES, V60, P4561; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Nakajima C, 2001, CANCER RES, V61, P3399; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Park SH, 2002, J BIOL CHEM, V277, P5168, DOI 10.1074/jbc.M106451200; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Suske G, 2000, Methods Mol Biol, V130, P175; Takahashi C, 1999, J IMMUNOL, V162, P5037; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; VanLint C, 1996, GENE EXPRESSION, V5, P245; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; Vigushin DM, 2004, CURR CANCER DRUG TAR, V4, P205, DOI 10.2174/1568009043481560; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilcox RA, 2002, CANCER RES, V62, P4413; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004	65	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7085	10.1371/journal.pone.0007085	http://dx.doi.org/10.1371/journal.pone.0007085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759901	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970200014
J	Fardin, P; Ognibene, M; Vanni, C; De Santanna, A; Varesio, L; Eva, A				Fardin, Paolo; Ognibene, Marzia; Vanni, Cristina; De Santanna, Amleto; Varesio, Luigi; Eva, Alessandra			Induction of Epithelial Mesenchimal Transition and Vasculogenesis in the Lenses of Dbl Oncogene Transgenic Mice	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; NF-KAPPA-B; RHO-GTPASES; TUMOR PROGRESSION; GENE-EXPRESSION; E-CADHERIN; METALLOTHIONEIN; TRANSCRIPTION; HYPOXIA; TARGET	Background: The Dbl family of proteins represents a large group of proto-oncogenes involved in cell growth regulation. The numerous domains that are present in many Dbl family proteins suggest that they act to integrate multiple inputs in complicated signaling networks involving the Rho GTPases. Alterations of the normal function of these proteins lead to pathological processes such as developmental disorders and neoplastic transformation. We generated transgenic mice introducing the cDNA of Dbl oncogene linked to the metallothionein promoter into the germ line of FVB mice and found that onco-Dbl expression in mouse lenses affected proliferation, migration and differentiation of lens epithelial cells. Results: We used high density oligonucleotide microarray to define the transcriptional profile induced by Dbl in the lenses of 2 days, 2 weeks, and 6 weeks old transgenic mice. We observed modulation of genes encoding proteins promoting epithelial-mesenchymal transition (EMT), such as down-regulation of epithelial cell markers and up-regulation of fibroblast markers. Genes encoding proteins involved in the positive regulation of apoptosis were markedly down regulated while anti-apoptotic genes were strongly up-regulated. Finally, several genes encoding proteins involved in the process of angiogenesis were up-regulated. These observations were validated by histological and immunohistochemical examination of the transgenic lenses where vascularization can be readily observed. Conclusion: Onco-Dbl expression in mouse lens correlated with modulation of genes involved in the regulation of EMT, apoptosis and vasculogenesis leading to disruption of the lens architecture, epithelial cell proliferation, and aberrant angiogenesis. We conclude that onco-Dbl has a potentially important, previously unreported, capacity to dramatically alter epithelial cell migration, replication, polarization and differentiation and to induce vascularization of an epithelial tissue.			Fardin, P (corresponding author), Ist Giannina Gaslini, Mol Biol Lab, I-16148 Genoa, Italy.	alessandraeva@ospedale-gaslini.ge.it	Ognibene, Marzia/AAA-7275-2020; varesio, luigi/J-8261-2016; Eva, Alessandra/J-8268-2016	Ognibene, Marzia/0000-0003-3698-9319; varesio, luigi/0000-0001-5659-2218; Eva, Alessandra/0000-0003-2949-078X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Banh A, 2006, INVEST OPHTH VIS SCI, V47, P3450, DOI 10.1167/iovs.05-1208; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CHIU ST, 2009, CARCINOGENESIS; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; EVA A, 1991, NEW BIOL, V3, P158; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Ghoul A, 2009, CANCER RES, V69, P4260, DOI 10.1158/0008-5472.CAN-08-2837; Hirsch E, 2002, MOL CELL BIOL, V22, P3140, DOI 10.1128/MCB.22.9.3140-3148.2002; Hu K, 2008, FRONT BIOSCI, V13, P5174, DOI 10.2741/3073; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kojima I, 2009, KIDNEY INT, V75, P268, DOI 10.1038/ki.2008.488; Lee EH, 2002, MOL VIS, V8, P235; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; LOW MJ, 1985, CELL, V41, P211, DOI 10.1016/0092-8674(85)90075-3; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Marcantonio JM, 2003, EXP EYE RES, V77, P339, DOI 10.1016/S0014-4835(03)00125-8; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Murphy BJ, 1999, CANCER RES, V59, P1315; Murphy BJ, 2008, MOL CANCER RES, V6, P483, DOI 10.1158/1541-7786.MCR-07-0341; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9; Perng MD, 2007, EXP CELL RES, V313, P2180, DOI 10.1016/j.yexcr.2007.04.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Przybylo JA, 2007, INT J BIOCHEM CELL B, V39, P1082, DOI 10.1016/j.biocel.2007.03.002; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Rodgers RJ, 2000, MOL CELL ENDOCRINOL, V163, P73, DOI 10.1016/S0303-7207(00)00219-7; RON D, 1989, ONCOGENE, V4, P1067; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; ROZEN R, 2000, PRIMER 3 WWW GEN USE, P365; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Waldmann J, 2008, BRIT J CANCER, V99, P1900, DOI 10.1038/sj.bjc.6604755; Wang B, 2008, BIOCHEM BIOPH RES CO, V368, P88, DOI 10.1016/j.bbrc.2008.01.036; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Westwick JK, 1998, J BIOL CHEM, V273, P16739, DOI 10.1074/jbc.273.27.16739; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Xu YF, 2009, J NEPHROL, V22, P403; Yoo HJ, 2009, EXP MOL MED, V41, P102, DOI 10.3858/emm.2009.41.2.013; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000106; Zhang HJ, 2005, CELL BIOL INT, V29, P213, DOI 10.1016/j.cellbi.2004.12.007	65	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7058	10.1371/journal.pone.0007058	http://dx.doi.org/10.1371/journal.pone.0007058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19759912	gold, Green Published, Green Submitted			2022-12-25	WOS:000269970000021
J	Yamamoto, K; Tanaka, S; Kobayashi, H; Kozima, H; Hashiya, K				Yamamoto, Kentaro; Tanaka, Saori; Kobayashi, Hiromi; Kozima, Hideki; Hashiya, Kazuhide			A Non-Humanoid Robot in the "Uncanny Valley": Experimental Analysis of the Reaction to Behavioral Contingency in 2-3 Year Old Children	PLOS ONE			English	Article							SOCIAL CONTINGENCY; INFANTS; RECOGNITION; PREFERENCE	Infants' sensitivity to social or behavioral contingency has been examined in the field of developmental psychology and behavioral sciences, mainly using a double video paradigm or a still face paradigm. These studies have shown that infants distinguish other individuals' contingent behaviors from non-contingent ones. The present experiment systematically examined if this ability extends to the detection of non-humanoids' contingent actions in a communicative context. We examined two-to three-year-olds' understanding of contingent actions produced by a non-humanoid robot. The robot either responded contingently to the actions of the participants (contingent condition) or programmatically reproduced the same sequence of actions to another participant (non-contingent condition). The results revealed that the participants exhibited different patterns of response depending on whether or not the robot responded contingently. It was also found that the participants did not respond positively to the contingent actions of the robot in the earlier periods of the experimental sessions. This might reflect the conflict between the non-humanlike appearance of the robot and its humanlike contingent actions, which presumably led the children to experience the uncanny valley effect.			Yamamoto, K (corresponding author), Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan.	yama-ken@kyudai.jp; hashiya@mindless.com	Yamamoto, Kentaro/AFO-9654-2022		Grants-in-Aid for Scientific Research [21330154] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arita A, 2005, COGNITION, V95, pB49, DOI 10.1016/j.cognition.2004.08.001; Bigelow AE, 1999, INFANT BEHAV DEV, V22, P367, DOI 10.1016/S0163-6383(99)00016-8; Cohen L. B., 1975, INFANT PERCEPTION SE, P347, DOI 10.1016/B978-0-12-178601-4.50011-6; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; ELLSWORTH CP, 1993, DEV PSYCHOL, V29, P63, DOI 10.1037/0012-1649.29.1.63; FUJITA K, 1987, PRIMATES, V28, P353, DOI 10.1007/BF02381018; GUSELLA JL, 1988, CHILD DEV, V59, P1111; Hains SMJ, 1996, INFANT BEHAV DEV, V19, P49, DOI 10.1016/S0163-6383(96)90043-0; Johnson SC, 2001, COGNITIVE DEV, V16, P637, DOI 10.1016/S0885-2014(01)00043-0; Johnson S, 1998, DEVELOPMENTAL SCI, V1, P233, DOI 10.1111/1467-7687.00036; Kozima H., 2006, MOBILE ROBOTS NEW AP, P269; Kozima H, 2009, INT J SOC ROBOT, V1, P3, DOI 10.1007/s12369-008-0009-8; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; Meltzoff A.N., 2005, PERSPECTIVES IMITATI, V2, P55; Meltzoff A. N., 2001, INTENTIONS INTENTION, P171; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; MURRAY L., 1985, SOCIAL PERCEPTION IN, P177; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; Plenderleith M, 2005, BIOL LETT-UK, V1, P411, DOI 10.1098/rsbl.2005.0355; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Sanefuji W, 2006, INFANT BEHAV DEV, V29, P584, DOI 10.1016/j.infbeh.2006.07.007; Sanefuji W, 2008, INFANT BEHAV DEV, V31, P624, DOI 10.1016/j.infbeh.2008.07.003; Stormark KM, 2004, INFANT BEHAV DEV, V27, P195, DOI 10.1016/j.infbeh.2003.09.004; Striano T, 2004, CHILD DEV, V75, P468, DOI 10.1111/j.1467-8624.2004.00687.x; Tanaka F, 2007, P NATL ACAD SCI USA, V104, P17954, DOI 10.1073/pnas.0707769104; TODA S, 1993, DEV PSYCHOL, V29, P532, DOI 10.1037/0012-1649.29.3.532; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; Whaling CS, 1997, P NATL ACAD SCI USA, V94, P12694, DOI 10.1073/pnas.94.23.12694; [No title captured]	30	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e6974	10.1371/journal.pone.0006974	http://dx.doi.org/10.1371/journal.pone.0006974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	496KE	19759818	Green Published, gold			2022-12-25	WOS:000269970000004
J	Crispi, S; Calogero, RA; Santini, M; Mellone, P; Vincenzi, B; Citro, G; Vicidomini, G; Fasano, S; Meccariello, R; Cobellis, G; Menegozzo, S; Pierantoni, R; Facciolo, F; Baldi, A; Menegozzo, M				Crispi, Stefania; Calogero, Raffaele A.; Santini, Mario; Mellone, Pasquale; Vincenzi, Bruno; Citro, Gennaro; Vicidomini, Giovanni; Fasano, Silvia; Meccariello, Rosaria; Cobellis, Gilda; Menegozzo, Simona; Pierantoni, Riccardo; Facciolo, Francesco; Baldi, Alfonso; Menegozzo, Massimo			Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target	PLOS ONE			English	Article							HUMAN-MALIGNANT MESOTHELIOMA; LEUCINE-ZIPPER KINASE; BREAST-CANCER CELLS; PROGNOSTIC-FACTORS; MICROARRAY DATA; GROWTH-FACTOR; LUNG-CANCER; CYCLIN B1; AURORA-A; OVEREXPRESSION	Background: The goal of our study was to molecularly dissect mesothelioma tumour pathways by mean of microarray technologies in order to identify new tumour biomarkers that could be used as early diagnostic markers and possibly as specific molecular therapeutic targets. Methodology: We performed Affymetrix HGU133A plus 2.0 microarray analysis, containing probes for about 39,000 human transcripts, comparing 9 human pleural mesotheliomas with 4 normal pleural specimens. Stringent statistical feature selection detected a set of differentially expressed genes that have been further evaluated to identify potential biomarkers to be used in early diagnostics. Selected genes were confirmed by RT-PCR. As reported by other mesothelioma profiling studies, most of genes are involved in G2/M transition. Our list contains several genes previously described as prognostic classifier. Furthermore, we found novel genes, never associated before to mesotheliom that could be involved in tumour progression. Notable is the identification of MMP-14, a member of matrix metalloproteinase family. In a cohort of 70 mesothelioma patients, we found by a multivariate Cox regression analysis, that the only parameter influencing overall survival was expression of MMP14. The calculated relative risk of death in MM patients with low MMP14 expression was significantly lower than patients with high MMp14 expression (P = 0.002). Conclusions: Based on the results provided, this molecule could be viewed as a new and effective therapeutic target to test for the cure of mesothelioma.			Crispi, S (corresponding author), Inst Genet & Biophys, Gene Express Core Human Mol Genet Lab, Naples, Italy.	crispi@igb.cnr.it	SANTINI, Mario/AAE-9516-2022; SANTINI, Mario/AFE-1150-2022; Baldi, Alfonso/ABG-2397-2021; SANTINI, Mario/AAE-9589-2022; Calogero, Raffaele/K-9428-2019; SANTINI, Mario/AFE-6002-2022	SANTINI, Mario/0000-0003-1162-7805; SANTINI, Mario/0000-0003-1162-7805; SANTINI, Mario/0000-0003-1162-7805; Calogero, Raffaele/0000-0002-2848-628X; SANTINI, Mario/0000-0003-1162-7805; Meccariello, Rosaria/0000-0003-2174-1118; FASANO, SILVIA/0000-0002-4716-6142; Crispi, Stefania/0000-0002-7566-1554; COBELLIS, Gilda/0000-0001-5884-9208; VICIDOMINI, Giovanni/0000-0002-1002-6090; PIERANTONI, Riccardo/0000-0001-8246-2177; Baldi, Alfonso/0000-0002-8693-3842; Vincenzi, Bruno/0000-0001-8222-9025; Facciolo, Francesco/0000-0002-7137-8946				Arrossi AV, 2008, AM J CLIN PATHOL, V130, P754, DOI 10.1309/AJCPHV33LJTVDGJJ; BALDI F, 2007, MESOTHELIOMA BENCH S, P279; Ball AR, 2002, MOL CELL BIOL, V22, P5769, DOI 10.1128/MCB.22.16.5769-5781.2002; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Chao JI, 2007, MOL CANCER THER, V6, P3039, DOI 10.1158/1535-7163.MCT-07-0281; Che G, 2006, NEOPLASMA, V53, P530; COGNETTI F, 2007, MESOTHELIOMA BENCH S, P347; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giet R, 1999, J CELL SCI, V112, P3591; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gordon GJ, 2007, J PATHOL, V211, P439, DOI 10.1002/path.2120; Gordon GJ, 2008, CANCER CHEMOTH PHARM, V61, P549, DOI 10.1007/s00280-007-0500-1; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Gordon GJ, 2002, CANCER RES, V62, P4963; Gordon GJ, 2003, J NATL CANCER I, V95, P598, DOI 10.1093/jnci/95.8.598; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; HUGHES JM, 1986, AM REV RESPIR DIS, V133, P5, DOI 10.1164/arrd.1986.133.1.5; Ishikawa K, 2008, BRIT J CANCER, V98, P1824, DOI 10.1038/sj.bjc.6604379; Jing L, 2004, AM J PATHOL, V164, P1799, DOI 10.1016/S0002-9440(10)63738-8; Kaiser LR, 1999, J THORAC CARDIOV SUR, V117, P63; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Koshikawa N, 2005, J BIOL CHEM, V280, P88, DOI 10.1074/jbc.M411824200; Lafleur MA, 2003, FEBS LETT, V553, P457, DOI 10.1016/S0014-5793(03)01094-9; Lassmann S, 2007, CLIN CANCER RES, V13, P4083, DOI 10.1158/1078-0432.CCR-06-2775; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Liu ZW, 2001, INT J CANCER, V91, P638, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1102>3.0.CO;2-Y; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; MENEGOZZO M, 2007, MESOTHELIOMA BENCH S, P25; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nymark P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-62; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sarafan-Vasseur N, 2002, ONCOGENE, V21, P2051, DOI 10.1038/sj.onc.1205257; Segawa T, 2008, BIOCHEM BIOPH RES CO, V369, P915, DOI 10.1016/j.bbrc.2008.02.114; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Spugnini EP, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-58; Spugnini EP, 2006, CLIN CANCER RES, V12, P6133, DOI 10.1158/1078-0432.CCR-06-1056; Spugnini EP, 2006, INT J BIOCHEM CELL B, V38, P2000, DOI 10.1016/j.biocel.2006.07.002; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Sugarbaker DJ, 1999, J THORAC CARDIOV SUR, V117, P54, DOI 10.1016/S0022-5223(99)70469-1; Suzuki T, 2007, CANCER SCI, V98, P644, DOI 10.1111/j.1349-7006.2007.00444.x; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Tomek S, 2003, CURR OPIN ONCOL, V15, P148, DOI 10.1097/00001622-200303000-00006; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Vihinen P, 2005, CURR CANCER DRUG TAR, V5, P203, DOI 10.2174/1568009053765799; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; VONHEYDEBRECK A, 2004, BIOCONDUCTOR PROJECT, V7; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wilde A, 2006, J CELL BIOL, V173, P829, DOI 10.1083/jcb.200605150; Wittmann BM, 2003, CANCER RES, V63, P5151; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; WU Z, 2004, P 8 C RES COMP MOL B, P98; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	78	65	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7016	10.1371/journal.pone.0007016	http://dx.doi.org/10.1371/journal.pone.0007016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753302	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796500007
J	Smith, MV; Boyd, WA; Kissling, GE; Rice, JR; Snyder, DW; Portier, CJ; Freedman, JH				Smith, Marjolein V.; Boyd, Windy A.; Kissling, Grace E.; Rice, Julie R.; Snyder, Daniel W.; Portier, Christopher J.; Freedman, Jonathan H.			A Discrete Time Model for the Analysis of Medium-Throughput C. elegans Growth Data	PLOS ONE			English	Article								Background: As part of a program to predict the toxicity of environmental agents on human health using alternative methods, several in vivo high- and medium-throughput assays are being developed that use C. elegans as a model organism. C. elegans-based toxicological assays utilize the COPAS Biosort flow sorting system that can rapidly measure size, extinction (EXT) and time-of-flight (TOF), of individual nematodes. The use of this technology requires the development of mathematical and statistical tools to properly analyze the large volumes of biological data. Methodology/Principal Findings: Findings A Markov model was developed that predicts the growth of populations of C. elegans. The model was developed using observations from a 60 h growth study in which five cohorts of 300 nematodes each were aspirated and measured every 12 h. Frequency distributions of log(EXT) measurements that were made when loading C. elegans L1 larvae into 96 well plates (t = 0 h) were used by the model to predict the frequency distributions of the same set of nematodes when measured at 12 h intervals. The model prediction coincided well with the biological observations confirming the validity of the model. The model was also applied to log(TOF) measurements following an adaptation. The adaptation accounted for variability in TOF measurements associated with potential curling or shortening of the nematodes as they passed through the flow cell of the Biosort. By providing accurate estimates of frequencies of EXT or TOF measurements following varying growth periods, the model was able to estimate growth rates. Best model fits showed that C. elegans did not grow at a constant exponential rate. Growth was best described with three different rates. Microscopic observations indicated that the points where the growth rates changed corresponded to specific developmental events: the L1/L2 molt and the start of oogenesis in young adult C. elegans. Conclusions: Quantitative analysis of COPAS Biosort measurements of C. elegans growth has been hampered by the lack of a mathematical model. In addition, extraneous matter and the inability to assign specific measurements to specific nematodes made it difficult to estimate growth rates. The present model addresses these problems through a population-based Markov model.			Smith, MV (corresponding author), SRA Int, Durham, NC USA.	freedma1@niehs.nih.gov	Portier, Christopher J/A-3160-2010	Portier, Christopher J/0000-0002-0954-0279; Boyd, Windy/0000-0003-3803-3716	Intramural NIH HHS [Z01 ES102046] Funding Source: Medline; PHS HHS [GS-00F-0003L] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES045004, ZIAES102046, ZIAES048002, Z01ES102046] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bhat U. N., 1984, ELEMENTS APPL STOCHA, V2nd; Boyd W.A., 2009, NEUROTOXICOL TERATOL; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Hall DH., 2008, C ELEGANS ATLAS; Khanna N, 1997, ARCH ENVIRON CON TOX, V32, P110, DOI 10.1007/s002449900162; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; Pulak Rock, 2006, V351, P275; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; Wood WB, 1988, NEMATODE CAENORHABDI, P1	15	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7018	10.1371/journal.pone.0007018	http://dx.doi.org/10.1371/journal.pone.0007018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753303	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796500009
J	Herrou, J; Debrie, AS; Willery, E; Renaud-Mongenie, G; Locht, C; Mooi, F; Jacob-Dubuisson, F; Antoine, R				Herrou, Julien; Debrie, Anne-Sophie; Willery, Eve; Renaud-Mongenie, Genevieve; Locht, Camille; Mooi, Frits; Jacob-Dubuisson, Francoise; Antoine, Rudy			Molecular Evolution of the Two-Component System BvgAS Involved in Virulence Regulation in Bordetella	PLOS ONE			English	Article								The whooping cough agent Bordetella pertussis is closely related to Bordetella bronchiseptica, which is responsible for chronic respiratory infections in various mammals and is occasionally found in humans, and to Bordetella parapertussis, one lineage of which causes mild whooping cough in humans and the other ovine respiratory infections. All three species produce similar sets of virulence factors that are co-regulated by the two-component system BvgAS. We characterized the molecular diversity of BvgAS in Bordetella by sequencing the two genes from a large number of diverse isolates. The response regulator BvgA is virtually invariant, indicating strong functional constraints. In contrast, the multi-domain sensor kinase BvgS has evolved into two different types. The pertussis type is found in B. pertussis and in a lineage of essentially human-associated B. bronchiseptica, while the bronchiseptica type is associated with the majority of B. bronchiseptica and both ovine and human B. parapertussis. BvgS is monomorphic in B. pertussis, suggesting optimal adaptation or a recent population bottleneck. The degree of diversity of the bronchiseptica type BvgS is markedly different between domains, indicating distinct evolutionary pressures. Thus, absolute conservation of the putative solute-binding cavities of the two periplasmic Venus Fly Trap (VFT) domains suggests that common signals are perceived in all three species, while the external surfaces of these domains vary more extensively. Co-evolution of the surfaces of the two VFT domains in each type and domain swapping experiments indicate that signal transduction in the periplasmic region may be type-specific. The two distinct evolutionary solutions for BvgS confirm that B. pertussis has emerged from a specific B. bronchiseptica lineage. The invariant regions of BvgS point to essential parts for its molecular mechanism, while the variable regions may indicate adaptations to different lifestyles. The repertoire of BvgS sequences will pave the way for functional analyses of this prototypic system.			Herrou, J (corresponding author), INSERM, U629, Lille, France.	francoise.jacob@ibl.fr	Antoine, Rudy/CAH-6653-2022; Jacob-Dubuisson, Françoise/F-1610-2018; Antoine, Rudy/L-1630-2018; Locht, Camille/L-3516-2018	Antoine, Rudy/0000-0002-7369-0626; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; Antoine, Rudy/0000-0002-7369-0626; Locht, Camille/0000-0001-7295-7336; Herrou, Julien/0000-0002-8585-8043; Debrie, Anne-Sophie/0000-0003-0570-4413				Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; ARICO B, 1987, MOL MICROBIOL, V1, P301, DOI 10.1111/j.1365-2958.1987.tb01936.x; BEIER D, 1995, J MOL BIOL, V248, P596, DOI 10.1006/jmbi.1995.0245; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bekker Martijn, 2006, Science Progress, V89, P213, DOI 10.3184/003685006783238308; Bock A, 2002, EUR J BIOCHEM, V269, P3479, DOI 10.1046/j.1432-1033.2002.03029.x; COOTE JG, 1991, J GEN MICROBIOL, V137, P2493, DOI 10.1099/00221287-137-11-2493; Coote JG, 2001, ADV MICROB PHYSIOL, V44, P141, DOI 10.1016/S0065-2911(01)44013-6; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; CULLINANE LC, 1987, NEW ZEAL VET J, V35, P175, DOI 10.1080/00480169.1987.35433; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Deora R, 2002, J BACTERIOL, V184, P6942, DOI 10.1128/JB.184.24.6942-6951.2002; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; deTejada GM, 1996, MOL MICROBIOL, V22, P895, DOI 10.1046/j.1365-2958.1996.01538.x; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; Felder CB, 1999, AAPS PHARMSCI, V1; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; GOYARD S, 1995, RES MICROBIOL, V146, P363, DOI 10.1016/0923-2508(96)80282-8; Hewlett EL, 1997, PEDIATR INFECT DIS J, V16, pS78, DOI 10.1097/00006454-199704001-00002; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781, DOI 10.1128/JCM.17.5.781-786.1983; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Lacey BW, 1960, J HYG, V31, P423; LINNEMANN CC, 1977, AM J DIS CHILD, V131, P560, DOI 10.1001/archpedi.1977.02120180074014; MANETTI R, 1994, GENE, V150, P123, DOI 10.1016/0378-1119(94)90870-2; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; MENOZZI FD, 1994, INFECT IMMUN, V62, P769, DOI 10.1128/IAI.62.3.769-778.1994; Merkel TJ, 1998, J BACTERIOL, V180, P1682, DOI 10.1128/JB.180.7.1682-1690.1998; MILLER JF, 1992, J BACTERIOL, V174, P970, DOI 10.1128/jb.174.3.970-979.1992; MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PORTER JF, 1993, FEMS MICROBIOL LETT, V110, P33, DOI 10.1111/j.1574-6968.1993.tb06291.x; PORTER JF, 1991, APPL ENVIRON MICROB, V57, P1202, DOI 10.1128/AEM.57.4.1202-1206.1991; Porter JF, 1996, FEMS MICROBIOL LETT, V135, P131, DOI 10.1111/j.1574-6968.1996.tb07977.x; PORTER JF, 1994, MICROBIOL-SGM, V140, P255, DOI 10.1099/13500872-140-2-255; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; PRUGNOLA A, 1995, MICROBIOL-UK, V141, P2529, DOI 10.1099/13500872-141-10-2529; STIBITZ S, 1986, GENE, V50, P133, DOI 10.1016/0378-1119(86)90318-5; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; Uhl MA, 1996, J BIOL CHEM, V271, P33176, DOI 10.1074/jbc.271.52.33176; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Xu OP, 2003, STRUCTURE, V11, P1569, DOI 10.1016/j.str.2003.10.016; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045	53	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6996	10.1371/journal.pone.0006996	http://dx.doi.org/10.1371/journal.pone.0006996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750014	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796300012
J	Murton, AJ; Alamdari, N; Gardiner, SM; Constantin-Teodosiu, D; Layfield, R; Bennett, T; Greenhaff, PL				Murton, Andrew J.; Alamdari, Nima; Gardiner, Sheila M.; Constantin-Teodosiu, Dumitru; Layfield, Robert; Bennett, Terence; Greenhaff, Paul L.			Effects of Endotoxaemia on Protein Metabolism in Rat Fast-Twitch Skeletal Muscle and Myocardium	PLOS ONE			English	Article								Background: It is unclear if the rat myocardium undergoes the same rapid reductions in protein content that are classically observed in fast-twitch skeletal muscle during endotoxaemia. Methodology/Principal Findings: To investigate this further, and to determine if there is any divergence in the response of skeletal muscle and myocardium in the mechanisms that are thought to be largely responsible for eliciting changes in protein content, Sprague Dawley rats were implanted with vascular catheters and administered lipopolysaccharide (LPS; 150 mu g kg(-1) h(-1)) intravenously for 2 h, 6 h or 24 h (saline administered control animals were also included), after which the extensor digitorum longus (EDL) and myocardium were removed under terminal anaesthesia. The protein-to-DNA ratio, a marker of protein content, was significantly reduced in the EDL following 24 h LPS administration (23%; P<0.05), but was no different from controls in the myocardium. At the same time point, a significant increase in MAFbx/atrogin-1 and MuRF1 mRNA (3.76+/-0.7- and 19.5+/-61.9 fold increase vs. controls, respectively; P<0.05), in addition to protein levels of alpha 1-3, 5-7 subunits of the 20S proteasome, were observed in EDL but not myocardium. In contrast, elevations in phosphorylation of p70 S6K residues Thr(421)/Ser(424), and 4E-BP1 residues Thr(37)/Thr(46) (P<0.05), consistent with an elevation in translation initiation, were seen exclusively in the myocardium of LPS-treated animals. Conclusions/Significance: In summary, these findings suggest that the myocardium does not undergo the same catabolic response as skeletal muscle during early endotoxaemia, partly due to the absence of transcriptional and signalling events in the myocardium typically associated with increased muscle proteolysis and the suppression of protein synthesis.			Murton, AJ (corresponding author), Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Ctr Integrated Syst Biol & Med, Nottingham NG7 2RD, England.	andrew.murton@nottingham.ac.uk		Layfield, Robert/0000-0003-0702-3259; Murton, Andrew/0000-0002-9474-9113; Greenhaff, Paul/0000-0003-4403-0490	BBSRC [BB/G011435/1] Funding Source: UKRI; MRC [G0401644] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011435/1] Funding Source: Medline; Medical Research Council [G0401644] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams V, 2008, EUR J CARDIOV PREV R, V15, P293, DOI 10.1097/HJR.0b013e3282f3ec43; Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; BLAIR R, 1980, PHARMACOL BIOCHEM BE, V12, P463, DOI 10.1016/0091-3057(80)90055-6; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boluyt MO, 2004, CARDIOVASC DRUG THER, V18, P257, DOI 10.1023/B:CARD.0000041245.61136.56; Constantin D, 2007, J PHYSIOL-LONDON, V583, P381, DOI 10.1113/jphysiol.2007.135459; Crossland H, 2008, J PHYSIOL-LONDON, V586, P5589, DOI 10.1113/jphysiol.2008.160150; Dehoux MJM, 2003, FEBS LETT, V544, P214, DOI 10.1016/S0014-5793(03)00505-2; Eliasson J, 2006, AM J PHYSIOL-ENDOC M, V291, pE1197, DOI 10.1152/ajpendo.00141.2006; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fischer D, 2000, BIOCHEM BIOPH RES CO, V270, P215, DOI 10.1006/bbrc.2000.2398; Frost RA, 2007, AM J PHYSIOL-ENDOC M, V292, pE501, DOI 10.1152/ajpendo.00359.2006; Gamrin L, 1996, CRIT CARE MED, V24, P575, DOI 10.1097/00003246-199604000-00005; GARCIAMARTINEZ C, 1993, MOL CELL BIOCHEM, V125, P11, DOI 10.1007/BF00926829; Gardiner SM, 2005, AM J PHYSIOL-HEART C, V288, pH2280, DOI 10.1152/ajpheart.00851.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kim SJ, 2008, J APPL PHYSIOL, V105, P1246, DOI 10.1152/japplphysiol.90668.2008; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lang CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE336, DOI 10.1152/ajpendo.00366.2001; Lang CH, 2000, AM J PHYSIOL-ENDOC M, V278, pE1133, DOI 10.1152/ajpendo.2000.278.6.E1133; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Lang CH, 2007, METABOLISM, V56, P49, DOI 10.1016/j.metabol.2006.08.025; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minnaard R, 2005, MUSCLE NERVE, V31, P339, DOI 10.1002/mus.20268; MUNRO HN, 1966, ANALYST, V91, P78, DOI 10.1039/an9669100078; Nader GA, 2002, CLIN ORTHOP RELAT R, pS178, DOI 10.1097/01.blo.0000031979.92980.2e; O'Leary MJ, 2002, SHOCK, V18, P265, DOI 10.1097/00024382-200209000-00011; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Vary TC, 1998, MOL CELL BIOCHEM, V178, P81, DOI 10.1023/A:1006826331115; Vary TC, 2002, AM J PHYSIOL-ENDOC M, V283, pE1032, DOI 10.1152/ajpendo.00171.2002; VARY TC, 1992, AM J PHYSIOL, V262, pC1513, DOI 10.1152/ajpcell.1992.262.6.C1513; WALLER J, 1995, BRIT J PHARMACOL, V116, P2487, DOI 10.1111/j.1476-5381.1995.tb15100.x; WALLER J, 1994, BRIT J PHARMACOL, V112, P1057, DOI 10.1111/j.1476-5381.1994.tb13190.x; Williams A, 1998, AM J PHYSIOL-REG I, V275, pR1983, DOI 10.1152/ajpregu.1998.275.6.R1983; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2	44	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6945	10.1371/journal.pone.0006945	http://dx.doi.org/10.1371/journal.pone.0006945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759896	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796300003
J	Granstedt, AE; Szpara, ML; Kuhn, B; Wang, SSH; Enquist, LW				Granstedt, Andrea E.; Szpara, Moriah L.; Kuhn, Bernd; Wang, Samuel S. -H.; Enquist, Lynn W.			Fluorescence-Based Monitoring of In Vivo Neural Activity Using a Circuit-Tracing Pseudorabies Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LIVING MICE; PREGANGLIONIC NEURONS; RAT; PROTEIN; INFECTION; SENSOR; CELLS; TOOLS; VITRO	The study of coordinated activity in neuronal circuits has been challenging without a method to simultaneously report activity and connectivity. Here we present the first use of pseudorabies virus (PRV), which spreads through synaptically connected neurons, to express a fluorescent calcium indicator protein and monitor neuronal activity in a living animal. Fluorescence signals were proportional to action potential number and could reliably detect single action potentials in vitro. With two-photon imaging in vivo, we observed both spontaneous and stimulated activity in neurons of infected murine peripheral autonomic submandibular ganglia (SMG). We optically recorded the SMG response in the salivary circuit to direct electrical stimulation of the presynaptic axons and to physiologically relevant sensory stimulation of the oral cavity. During a time window of 48 hours after inoculation, few spontaneous transients occurred. By 72 hours, we identified more frequent and prolonged spontaneous calcium transients, suggestive of neuronal or tissue responses to infection that influence calcium signaling. Our work establishes in vivo investigation of physiological neuronal circuit activity and subsequent effects of infection with single cell resolution.			Granstedt, AE (corresponding author), Princeton Univ, Dept Mol Biol, Inst Neurosci, Princeton, NJ 08544 USA.	lenquist@princeton.edu	Szpara, Moriah L./I-2287-2019; Kuhn, Bernd/N-1132-2014	Szpara, Moriah L./0000-0001-9859-1678; Kuhn, Bernd/0000-0002-6852-2433	NINDS NIH HHS [R01 NS045193, R37 NS033506, NS045193, NS060699, R01 NS060699] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060699, R01NS045193, R37NS033506] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Aston-Jones G, 2000, J NEUROSCI METH, V103, P51, DOI 10.1016/S0165-0270(00)00295-8; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Bartsch T, 1996, NEUROSCI LETT, V214, P143, DOI 10.1016/0304-3940(96)12910-4; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/NMETH.1292, 10.1038/nmeth.1292]; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Card J P, 2001, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0105s09; Curanovic D, 2009, CURR PROTOC CELL BIO; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diez-Garcia J, 2007, NEUROIMAGE, V34, P859, DOI 10.1016/j.neuroimage.2006.10.021; Ekstrand MI, 2008, TRENDS MOL MED, V14, P134, DOI 10.1016/j.molmed.2007.12.008; Feierbach B, 2006, PLOS PATHOG, V2, P763, DOI 10.1371/journal.ppat.0020085; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hoogland TM, 2009, P NATL ACAD SCI USA, V106, P3496, DOI 10.1073/pnas.0809269106; JANSEN ASP, 1992, BRAIN RES, V572, P253, DOI 10.1016/0006-8993(92)90479-S; Kim JS, 1999, J VIROL, V73, P9521, DOI 10.1128/JVI.73.11.9521-9531.1999; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; Loewy AD, 1998, NEUROSCI BIOBEHAV R, V22, P679, DOI 10.1016/S0149-7634(98)00006-2; Luker KE, 2006, VIROLOGY, V347, P286, DOI 10.1016/j.virol.2005.12.016; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MATSUO R, 1989, JPN J PHYSIOL, V39, P349, DOI 10.2170/jjphysiol.39.349; McCann CM, 2008, NAT NEUROSCI, V11, P807, DOI 10.1038/nn.2145; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; POMEROY SL, 1988, J CELL BIOL, V107, P1167, DOI 10.1083/jcb.107.3.1167; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1987, J NEUROSCI, V7, P1492; Rassnick S, 1998, J VIROL, V72, P9181, DOI 10.1128/JVI.72.11.9181-9191.1998; RINAMAN L, 1993, J NEUROSCI, V13, P685; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; SUZUKI T, 1981, Bulletin of Tokyo Dental College, V22, P183; SUZUKI T, 1978, J NEUROBIOL, V9, P367, DOI 10.1002/neu.480090504; Toth IE, 1999, J AUTONOM NERV SYST, V77, P45, DOI 10.1016/S0165-1838(99)00032-6; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wouterlood FG, 2002, NETWORK-COMP NEURAL, V13, P327, DOI 10.1088/0954-898X/13/3/305; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4	41	29	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6923	10.1371/journal.pone.0006923	http://dx.doi.org/10.1371/journal.pone.0006923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742327	gold, Green Submitted, Green Published			2022-12-25	WOS:000269622500008
J	Haddow, AD; Jones, CJ; Odoi, A				Haddow, Andrew D.; Jones, Carl J.; Odoi, Agricola			Assessing Risk in Focal Arboviral Infections: Are We Missing the Big or Little Picture?	PLOS ONE			English	Article								Background: Focal arboviral infections affecting a subset of the overall population present an often overlooked set of challenges in the assessment and reporting of risk and the detection of spatial patterns. Our objective was to assess the variation in risk when using different at-risk populations and geographic scales for the calculation of incidence risk and the detection of geographic hot-spots of infection. We explored these variations using a pediatric arbovirus, La Crosse virus (LACV), as our model. Methods and Findings: Descriptive and cluster analyses were performed on probable and confirmed cases of LACV infections reported to the Tennessee Department of Health from 1997 to 2006, using three at-risk populations (the total population, the population 18 years and younger, and the population 15 years and younger) and at two geographic levels (county and census tract) to assess the variation in incidence risk and to investigate evidence of clustering using both global and local spatial statistics. We determined that the most appropriate at-risk population to calculate incidence risk and to assess the evidence of clustering was the population 15 years and younger. Based on our findings, the most appropriate geographical level to conduct spatial analyses and report incidence risk is the census tract level. The incidence risk in the population 15 years and younger at the county level ranged from 0 to 226.5 per 100,000 persons (median 41.5) in those counties reporting cases (n = 14) and at the census tract level it ranged from 50.9 to 673.9 per 100,000 persons (median 126.7) in those census tracts reporting cases (n = 51). To our knowledge, this is the highest reported incidence risk for this population at the county level for Tennessee and at the census tract level nationally. Conclusion: The results of this study indicate the possibility of missing disease clusters resulting from performing incidence risk investigations of focal diseases using inappropriate at-risk populations and/or at large geographic scales. Improved disease surveillance and health planning will result through the use of well defined at-risk populations and the use of appropriate geographic scales for the analysis and reporting of diseases. The finding of a high incidence risk of LACV infections in eastern Tennessee demonstrates that the vast majority of these infections continue to be under-diagnosed and/or underreported in this region. Persistent prevention and surveillance efforts will be required to reduce exposure to infectious vectors and to detect new cases of infection in this region. Application of this study's observations in future investigations will enhance the quantification of incidence risk and the identification of high-risk groups within the population.			Haddow, AD (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	adhaddow@gmail.com	Odoi, Agricola/I-9532-2019; Haddow, Andrew/C-5902-2008; Haddow, Andrew/A-7507-2011	Odoi, Agricola/0000-0001-5050-6737; Haddow, Andrew/0000-0002-8957-2608; 				ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2003, GEODA VERSION 0 95I; BALFOUR HH, 1973, PEDIATRICS, V52, P680; Bennett RS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-25; BERNARDINELLI L, 1992, STAT MED, V11, P983, DOI 10.1002/sim.4780110802; Bithell JF, 2000, STAT MED, V19, P2203, DOI 10.1002/1097-0258(20000915/30)19:17/18<2203::AID-SIM564>3.0.CO;2-U; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; *CDCP, 2004, NAT CTR PUBL HLTH IN; Chun R W, 1983, Prog Clin Biol Res, V123, P193; CLARK CG, 1983, AM J TROP MED HYG, V32, P838, DOI 10.4269/ajtmh.1983.32.838; Erwin PC, 2002, AM J EPIDEMIOL, V155, P1060, DOI 10.1093/aje/155.11.1060; ESRI, 2006, ARCVIEW GIS VERS 9 2; GAULD LW, 1979, J MENT DEFIC RES, V23, P63; GRIMSTAD P, 1988, ARBOVIRUSES EPIDEMIO, V49, P99; GRIMSTAD PR, 1984, AM J EPIDEMIOL, V119, P913, DOI 10.1093/oxfordjournals.aje.a113814; Haddow AD, 2009, J VECTOR ECOL, V34, P70, DOI [10.1111/j.1948-7134.2009.00009.x, 10.3376/038.034.0109]; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145; HAINING R, 1998, GIS HLTH; Jones TF, 2000, CLIN INFECT DIS, V31, P1284, DOI 10.1086/317458; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; Kappus K D, 1983, Prog Clin Biol Res, V123, P31; KAPPUS KD, 1982, AM J TROP MED HYG, V31, P556, DOI 10.4269/ajtmh.1982.31.556; KSIAZEK TG, 1977, AM J TROP MED HYG, V26, P815, DOI 10.4269/ajtmh.1977.26.815; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; MONATH TPC, 1970, AM J EPIDEMIOL, V92, P40, DOI 10.1093/oxfordjournals.aje.a121178; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; MOULTON DW, 1971, AM J TROP MED HYG, V20, P474, DOI 10.4269/ajtmh.1971.20.474; Odoi Agricola, 2003, Int J Health Geogr, V2, P5, DOI 10.1186/1476-072X-2-5; Openshaw S., 1984, CATMOG 38; Ozonoff A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-52; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; Reimann CA, 2008, AM J TROP MED HYG, V79, P974, DOI 10.4269/ajtmh.2008.79.974; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; SNOW J, 1885, MODE COMMUNICATION; STAINES A, 2000, SPATIAL EPIDEMIOLOGY, P13; *STATA CORP, 2007, INT STATA VERS 10 0; THOMPSON WH, 1977, SCIENCE, V196, P530, DOI 10.1126/science.850794; Tsai T F, 1991, Infect Dis Clin North Am, V5, P73; *US CENS BUR, 2000, DEC CENS AM FACT FIN; *US CENS BUR GEOGR, 2000, CART BOUND FIL DESCR; US Census Bureau, 2008, CART BOUND FIL; Utz JT, 2003, AM J TROP MED HYG, V69, P509, DOI 10.4269/ajtmh.2003.69.509; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; WATTS DM, 1972, J MED ENTOMOL, V9, P125, DOI 10.1093/jmedent/9.2.125	46	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6954	10.1371/journal.pone.0006954	http://dx.doi.org/10.1371/journal.pone.0006954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742311	gold, Green Published			2022-12-25	WOS:000269622500017
J	Majeau, N; Fromentin, R; Savard, C; Duval, M; Tremblay, MJ; Leclerc, D				Majeau, Nathalie; Fromentin, Remi; Savard, Christian; Duval, Marie; Tremblay, Michel J.; Leclerc, Denis			Palmitoylation of Hepatitis C Virus Core Protein Is Important for Virion Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID DROPLET; INTRAMEMBRANE PROTEOLYSIS; SUBCELLULAR-LOCALIZATION; YEAST; REPLICATION; INFECTION; PARTICLES; DOMAIN; CELLS	Hepatitis C virus core protein is the viral nucleocapsid of hepatitis C virus. Interaction of core with cellular membranes like endoplasmic reticulum (ER) and lipid droplets (LD) appears to be involved in viral assembly. However, how these interactions with different cellular membranes are regulated is not well understood. In this study, we investigated how palmitoylation, a post-translational protein modification, can modulate the targeting of core to cellular membranes. We show that core is palmitoylated at cysteine 172, which is adjacent to the transmembrane domain at the C-terminal end of core. Site-specific mutagenesis of residue Cys(172) showed that palmitoylation is not involved in the maturation process carried out by the signal peptide peptidase or in the targeting of core to LD. However, palmitoylation was shown to be important for core association with smooth ER membranes and ER closely surrounding LDs. Finally, we demonstrate that mutation of residue Cys(172) in the J6/JFH1 virus genome clearly impairs virion production.	[Majeau, Nathalie; Fromentin, Remi; Savard, Christian; Duval, Marie; Tremblay, Michel J.; Leclerc, Denis] Univ Laval, Infect Dis Res Ctr, CHUL, Quebec City, PQ G1V 4G2, Canada	Laval University	Leclerc, D (corresponding author), Univ Laval, Infect Dis Res Ctr, CHUL, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	denis.leclerc@crchul.ulaval.ca	Leclerc, Denis/AAG-6112-2019; Majeau, Nathalie/AAU-1964-2021; Leclerc, Denis/P-1604-2019		Canadian Institutes of Health Research of Canada; Reseau Sida et Maladies Infectueuses of the Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research of Canada(Canadian Institutes of Health Research (CIHR)); Reseau Sida et Maladies Infectueuses of the Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research of Canada and the Reseau Sida et Maladies Infectueuses of the Fonds de la Recherche en Sante du Quebec.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Boscarino JA, 2008, J VIROL, V82, P2989, DOI 10.1128/JVI.01906-07; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Falcon V, 1999, TISSUE CELL, V31, P117, DOI 10.1054/tice.1999.0032; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hourioux C, 2007, GUT, V56, P1302, DOI 10.1136/gut.2006.108647; Hourioux C, 2007, CELL MICROBIOL, V9, P1014, DOI 10.1111/j.1462-5822.2006.00848.x; Irshad M, 2008, INT REV IMMUNOL, V27, P497, DOI 10.1080/08830180802432178; JACK EM, 1990, CARCINOGENESIS, V11, P1531, DOI 10.1093/carcin/11.9.1531; Kato T, 2003, J MED VIROL, V69, P357, DOI 10.1002/jmv.10297; Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Majeau N, 2004, J GEN VIROL, V85, P971, DOI 10.1099/vir.0.79775-0; Majeau N, 2007, BIOCHEM CELL BIOL, V85, P78, DOI 10.1139/O06-195; Matto M, 2004, J VIROL, V78, P12047, DOI 10.1128/JVI.78.21.12047-12053.2004; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Negro F, 2006, WORLD J GASTROENTERO, V12, P6756, DOI 10.3748/wjg.v12.i42.6756; Ogino T, 2004, J VIROL, V78, P11766, DOI 10.1128/JVI.78.21.11766-11777.2004; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Schmidt M, 2002, J CELL SCI, V115, P293; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; SUZUKI R, 1995, J GEN VIROL, V76, P53, DOI 10.1099/0022-1317-76-1-53; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Vzorov AN, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-94; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Yu GY, 2006, J VIROL, V80, P6013, DOI 10.1128/JVI.00053-06; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	57	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33915	33925		10.1074/jbc.M109.018549	http://dx.doi.org/10.1074/jbc.M109.018549			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19783655	Green Published, hybrid			2022-12-25	WOS:000272165200024
J	Holm, L; Moody, P; Howarth, M				Holm, Lotta; Moody, Paul; Howarth, Mark			Electrophilic Affibodies Forming Covalent Bonds to Protein Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBODY FRAGMENTS; CANCER-DETECTION; PHAGE-DISPLAY; AFFINITY; ANTIGEN; LIGAND; SITE; SENSITIVITY; COMPLEXES; MOLECULES	Antibody affinity limits sensitivity of detection in many areas of biology and medicine. High affinity usually depends on achieving the optimal combination of the natural 20 amino acids in the antibody binding site. Here, we investigate the effect on recognition of protein targets of placing an unnatural electrophile adjacent to the target binding site. We positioned a weak electrophile, acrylamide, near the binding site between an affibody, a non-immunoglobulin binding scaffold, and its protein target. The proximity between cysteine, lysine, or histidine on the target protein drove covalent bond formation to the electrophile on the affibody. Covalent bonds did not form to a non-interacting point mutant of the target, and there was minimal cross-reactivity with serum, cell lysate, or when imaging at the cell surface. Electrophilic affibodies showed more stable protein imaging at the surface of mammalian cells, and the sensitivity of protein detection in an immunoassay improved by two orders of magnitude. Thus electrophilic affibodies combined good specificity with improved detection of protein targets.	[Holm, Lotta; Moody, Paul; Howarth, Mark] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Howarth, M (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	mark.howarth@bioch.ox.ac.uk		Moody, Paul/0000-0002-0191-2912	Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Medical Research Council; Ministry of Defence through the Bionanotechnology Interdisciplinary Research Centre; Oxford University Department of Biochemistry; Worcester College, Oxford	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Defence through the Bionanotechnology Interdisciplinary Research Centre; Oxford University Department of Biochemistry; Worcester College, Oxford	This work was supported by the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Medical Research Council, and Ministry of Defence through the Bionanotechnology Interdisciplinary Research Centre, by the Oxford University Department of Biochemistry, and by Worcester College, Oxford.	AHMED AK, 1975, J BIOL CHEM, V250, P8477; ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; Allain JP, 2003, TRANSFUS CLIN BIOL, V10, P1, DOI 10.1016/S1246-7820(02)00276-8; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Chmura AJ, 2001, P NATL ACAD SCI USA, V98, P8480, DOI 10.1073/pnas.151260298; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Eklund M, 2002, PROTEINS, V48, P454, DOI 10.1002/prot.10169; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; FLEET GWJ, 1972, BIOCHEM J, V128, P499, DOI 10.1042/bj1280499; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Griffiths AD, 1998, CURR OPIN BIOTECH, V9, P102, DOI 10.1016/S0958-1669(98)80092-X; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3191, DOI 10.1073/pnas.0436100100; Houk KN, 2003, ANGEW CHEM INT EDIT, V42, P4872, DOI 10.1002/anie.200200565; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; JACKSON TM, 1986, J IMMUNOL METHODS, V87, P13, DOI 10.1016/0022-1759(86)90338-8; JI LL, 1993, J APPL PHYSIOL, V74, P788, DOI 10.1152/jappl.1993.74.2.788; Jung YW, 2009, ANAL CHEM, V81, P936, DOI 10.1021/ac8014565; Lendel C, 2004, PROTEIN SCI, V13, P2078, DOI 10.1110/ps.04728604; Levitsky K, 2005, CHEMBIOCHEM, V6, P890, DOI 10.1002/cbic.200400383; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; LoPachin RM, 2008, TOXICOL SCI, V104, P235, DOI 10.1093/toxsci/kfm301; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Nam JM, 2004, J AM CHEM SOC, V126, P5932, DOI 10.1021/ja049384+; Nishiyama Y, 2007, J BIOL CHEM, V282, P31250, DOI 10.1074/jbc.M706471200; Orlova A, 2007, CANCER BIOTHER RADIO, V22, P573, DOI 10.1089/cbr.2006.004-U; Parekh DJ, 2007, J UROLOGY, V178, P2252, DOI 10.1016/j.juro.2007.08.055; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Qiu J, 2009, CLIN LAB MED, V29, P31, DOI 10.1016/j.cll.2009.01.002; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Trisler K, 2007, J BIOL CHEM, V282, P26344, DOI 10.1074/jbc.M704675200; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; Wahlberg E, 2003, P NATL ACAD SCI USA, V100, P3185, DOI 10.1073/pnas.0436086100; Way JC, 2000, CURR OPIN CHEM BIOL, V4, P40, DOI 10.1016/S1367-5931(99)00049-6; Weisman LE, 2009, CURR OPIN MOL THER, V11, P208; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	47	24	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32906	32913		10.1074/jbc.M109.034322	http://dx.doi.org/10.1074/jbc.M109.034322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759009	Green Published, hybrid			2022-12-25	WOS:000272028400074
J	Sager, C; Terhag, J; Kott, S; Hollmann, M				Sager, Charlotte; Terhag, Jan; Kott, Sabine; Hollmann, Michael			C-terminal Domains of Transmembrane alpha-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate (AMPA) Receptor Regulatory Proteins Not Only Facilitate Trafficking but Are Major Modulators of AMPA Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-RECEPTOR; STARGAZIN; SUBUNITS; MUTATION; DESENSITIZATION; ISOFORM; PSD-95; FAMILY; BLOCK	alpha-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)type glutamate receptors are essential players in fast synaptic transmission in the vertebrate central nervous system. Their synaptic delivery and localization as well as their electrophysiological properties are regulated by transmembrane AMPA receptor regulatory proteins (TARPs). However, the exact mechanisms of how the four originally designated TARPs (gamma 2, gamma 3, gamma 4, and gamma 8) modulate AMPA receptor function remain largely unknown. Previous studies suggested the C-terminal domain (CTD) of gamma 2 to mediate increased trafficking and reduced desensitization of AMPA receptors. As it remained unclear whether these findings extend to other TARPs, we set out to investigate and compare the role of the CTDs of the four original TARPs in AMPA receptor modulation. To address this issue, we replaced the TARP CTDs with the CTD of the homologous subunit gamma 1, a voltage-dependent calcium channel subunit expressed in skeletal muscle that lacks TARP properties. We analyzed the impact of the resulting chimeras on GluR1 functional properties in Xenopus oocytes and HEK293 cells. Interestingly, the CTDs of all TARPs not only modulate the extent and kinetics of desensitization but also modulate agonist potencies of AMPA receptors. Furthermore, the CTDs are required for TARP-induced modulation of AMPA receptor gating, including conversion of antagonists to partial agonists and constitutive channel openings. Strikingly, we found a special role of the cytoplasmic tail of gamma 4, suggesting that the underlying mechanisms of modulation of AMPA receptor function are different among the TARPs. We propose that the intracellularly located CTD is the origin of TARP-specific functional modulation and not merely a facilitator of trafficking.	[Sager, Charlotte; Terhag, Jan] Ruhr Univ Bochum, Ruhr Univ Res Sch, D-44780 Bochum, Germany; [Terhag, Jan] Deutsch Forsch Gemeinschaft, D-44780 Bochum, Germany; [Sager, Charlotte; Terhag, Jan; Kott, Sabine; Hollmann, Michael] Ruhr Univ Bochum, Dept Biochem Receptor Biochem 1, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Hollmann, M (corresponding author), Ruhr Univ Bochum, Dept Biochem 1, Bldg NC,Rm 6-171,Univ Str 150, D-44780 Bochum, Germany.	Michael.Hollmann@rub.de			Deutsche Forschungsgemeinschaft [HO 1118/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 1118/11-1.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2008, J BIOL CHEM, V283, P1597, DOI 10.1074/jbc.M708141200; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Hollmann M, 1999, HANDB EXP PHARM, V141, P3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Korber C, 2007, J NEUROSCI, V27, P8442, DOI 10.1523/JNEUROSCI.0424-07.2007; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kott S, 2009, NEUROSCIENCE, V158, P78, DOI 10.1016/j.neuroscience.2007.12.047; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sager C, 2009, NEUROSCIENCE, V158, P45, DOI 10.1016/j.neuroscience.2007.12.046; Schmid SM, 2007, J NEUROSCI, V27, P12230, DOI 10.1523/JNEUROSCI.3175-07.2007; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Strutz-Seebohm N, 2006, PFLUG ARCH EUR J PHY, V452, P276, DOI 10.1007/s00424-005-0032-7; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2007, NEUROPHARMACOLOGY, V52, P87, DOI 10.1016/j.neuropharm.2006.07.012; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Villmann C, 1997, J NEUROSCI, V17, P7634, DOI 10.1523/jneurosci.17-20-07634.1997; Villmann C, 1999, EUR J NEUROSCI, V11, P1765, DOI 10.1046/j.1460-9568.1999.00594.x; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	47	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32413	32424		10.1074/jbc.M109.039891	http://dx.doi.org/10.1074/jbc.M109.039891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19773551	Green Published, hybrid			2022-12-25	WOS:000272028400024
J	Valliere-Douglass, JF; Kodama, P; Mujacic, M; Brady, LJ; Wang, W; Wallace, A; Yan, BX; Reddy, P; Treuheit, MJ; Balland, A				Valliere-Douglass, John F.; Kodama, Paul; Mujacic, Mirna; Brady, Lowell J.; Wang, Wes; Wallace, Alison; Yan, Boxu; Reddy, Pranhitha; Treuheit, Michael J.; Balland, Alain			Asparagine-linked Oligosaccharides Present on a Non-consensus Amino Acid Sequence in the C(H)1 Domain of Human Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL N-GLYCOSYLATION; VARIABLE REGION GLYCOSYLATION; X-SER/THR SEQUON; MASS-SPECTROMETRY; ENDOPLASMIC-RETICULUM; PROTEIN-C; MS MS; OLIGOSACCHARYLTRANSFERASE; PEPTIDES; IDENTIFICATION	We report that N-linked oligosaccharide structures can be present on an asparagine residue not adhering to the consensus site motif NX(S/T), where X is not proline, described in the literature. We have observed oligosaccharides on a non-consensus asparaginyl residue in the C(H)1 constant domain of IgG1 and IgG2 antibodies. The initial findings were obtained from characterization of charge variant populations evident in a recombinant human antibody of the IgG2 subclass. HPLC-MS results indicated that cation-exchange chromatography acidic variant populations were enriched in antibody with a second glycosylation site, in addition to the well documented canonical glycosylation site located in the C(H)2 domain. Subsequent tryptic and chymotryptic peptide map data indicated that the second glycosylation site was associated with the amino acid sequence TVSWN(162)SGAL in the C(H)1 domain of the antibody. This highly atypical modification is present at levels of 0.5-2.0% on most of the recombinant antibodies that have been tested and has also been observed in IgG1 antibodies derived from human donors. Site-directed mutagenesis of the C(H)1 domain sequence in a recombinant human IgG1 antibody resulted in an increase in non-consensus glycosylation to 3.15%, a greater than 4-fold increase over the level observed in the wild type, by changing the -1 and +1 amino acids relative to the asparagine residue at position 162. We believe that further understanding of the phenomenon of non-consensus glycosylation can be used to gain fundamental insights into the fidelity of the cellular glycosylation machinery.	[Valliere-Douglass, John F.; Kodama, Paul; Mujacic, Mirna; Brady, Lowell J.; Wang, Wes; Wallace, Alison; Yan, Boxu; Reddy, Pranhitha; Treuheit, Michael J.; Balland, Alain] Amgen Inc, Dept Proc & Prod Dev, Seattle, WA 98119 USA	Amgen	Balland, A (corresponding author), Amgen Inc, 1201 Amgen Ct, W Seattle, WA 98119 USA.	ballanda@amgen.com	Valliere-Douglass, John F/F-1618-2013					Angel PM, 2007, RAPID COMMUN MASS SP, V21, P674, DOI 10.1002/rcm.2874; BAUSE E, 1982, BIOCHEM J, V203, P761, DOI 10.1042/bj2030761; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; Bause E, 1995, BIOCHEM J, V312, P979, DOI 10.1042/bj3120979; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; BREUER W, 1995, EUR J BIOCHEM, V228, P689, DOI 10.1111/j.1432-1033.1995.0689m.x; Chalkley RJ, 2001, J AM SOC MASS SPECTR, V12, P1106, DOI 10.1016/S1044-0305(01)00295-1; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; GONZALEZ J, 1992, ANAL BIOCHEM, V205, P151, DOI 10.1016/0003-2697(92)90592-U; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Holland M, 2006, BBA-GEN SUBJECTS, V1760, P669, DOI 10.1016/j.bbagen.2005.11.021; HUDDLESTON MJ, 1993, ANAL CHEM, V65, P877, DOI 10.1021/ac00055a009; IMPERIALI B, 1991, BIOCHEMISTRY-US, V30, P4374, DOI 10.1021/bi00232a002; IMPERIALI B, 1994, J AM CHEM SOC, V116, P8424, DOI 10.1021/ja00097a083; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7942, DOI 10.1021/ja00046a068; IVANCIC MM, 2007, 55 ASMS C MASS SPECT; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kabat EA, 1991, SEQUENCES PROTEINS I; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Marshall R D, 1974, Biochem Soc Symp, P17; MCGINNES LW, 1994, VIROLOGY, V200, P470, DOI 10.1006/viro.1994.1210; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Michels DA, 2007, ANAL CHEM, V79, P5963, DOI 10.1021/ac0705521; Mimura Y, 2007, J IMMUNOL METHODS, V326, P116, DOI 10.1016/j.jim.2007.07.014; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Qu ZX, 1997, GLYCOBIOLOGY, V7, P803, DOI 10.1093/glycob/7.6.803; Qu ZX, 1998, J IMMUNOL METHODS, V213, P131, DOI 10.1016/S0022-1759(97)00192-0; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Ren D, 2007, J CHROMATOGR A, V1175, P63, DOI 10.1016/j.chroma.2007.10.005; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sheeley DM, 1997, ANAL BIOCHEM, V247, P102, DOI 10.1006/abio.1997.2036; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; STENFLO J, 1982, J BIOL CHEM, V257, P2180; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Toyoda T, 2002, J BIOCHEM, V131, P511, DOI 10.1093/oxfordjournals.jbchem.a003128; Toyoda T, 2000, J BIOCHEM-TOKYO, V128, P731, DOI 10.1093/oxfordjournals.jbchem.a022809; Valliere-Douglass JF, 2009, GLYCOBIOLOGY, V19, P144, DOI 10.1093/glycob/cwn116; WRIGHT A, 1991, EMBO J, V10, P2717, DOI 10.1002/j.1460-2075.1991.tb07819.x; WRIGHT A, 1993, SPRINGER SEMIN IMMUN, V15, P259	46	49	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32493	32506		10.1074/jbc.M109.014803	http://dx.doi.org/10.1074/jbc.M109.014803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19767389	hybrid, Green Published			2022-12-25	WOS:000272028400032
J	Zhu, ZQC; Gupta, KK; Slabbekoorn, AR; Paulson, BA; Folker, ES; Goodson, HV				Zhu, Zhiqing C.; Gupta, Kamlesh K.; Slabbekoorn, Aranda R.; Paulson, Benjamin A.; Folker, Eric S.; Goodson, Holly V.			Interactions between EB1 and Microtubules DRAMATIC EFFECT OF AFFINITY TAGS AND EVIDENCE FOR COOPERATIVE BEHAVIOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END-TRACKING; ALPHA-BETA-TUBULIN; HEXAHISTIDINE-TAG; STRUCTURAL BASIS; PROTEINS; DYNAMICS; BINDING; POLYMERIZATION; CLIP-170; P150(GLUED)	Plus end tracking proteins (+TIPs) are a unique group of microtubule binding proteins that dynamically track microtubule (MT) plus ends. EB1 is a highly conserved +TIP with a fundamental role in MT dynamics, but it remains poorly understood in part because reported EB1 activities have differed considerably. One reason for this inconsistency could be the variable presence of affinity tags used for EB1 purification. To address this question and establish the activity of native EB1, we have measured the MT binding and tubulin polymerization activities of untagged EB1 and EB1 fragments and compared them with those of His-tagged EB1 proteins. We found that N-terminal His tags directly influence the interaction between EB1 and MTs, significantly increasing both affinity and activity, and that small amounts of His-tagged proteins act synergistically with larger amounts of untagged proteins. Moreover, the binding ratio between EB1 and tubulin can exceed 1:1, and EB1-MT binding curves do not fit simple binding models. These observations demonstrate that EB1 binding is not limited to the MT seam, and they suggest that EB1 binds cooperatively to MTs. Finally, we found that removal of tubulin C-terminal tails significantly reduces EB1 binding, indicating that EB1-tubulin interactions are mediated in part by the same tubulin acidic tails utilized by other MAPs. These binding relationships are important for helping to elucidate the complex of proteins at the MT tip.	[Zhu, Zhiqing C.; Gupta, Kamlesh K.; Slabbekoorn, Aranda R.; Paulson, Benjamin A.; Goodson, Holly V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Folker, Eric S.] Columbia Univ, Dept Anat & Cell Biol, New York, NY 11032 USA	University of Notre Dame; Columbia University	Goodson, HV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	hgoodson@nd.edu	Goodson, Holly/AAE-6079-2022	Goodson, Holly/0000-0001-7942-8349; Folker, Eric/0000-0003-1619-7330	National Institutes of Health [R01 GM065420]; Notre Dame Grace Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame Grace Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065420 (to H. V. G.). This work was also supported by a Notre Dame Grace Fellowship (to Z. Z.).	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Amor-Mahjoub M, 2006, J CHROMATOGR B, V844, P328, DOI 10.1016/j.jchromb.2006.07.031; ANDERSEN SSL, 1994, J CELL BIOL, V127, P1289, DOI 10.1083/jcb.127.5.1289; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chant A, 2005, PROTEIN EXPRES PURIF, V39, P152, DOI 10.1016/j.pep.2004.10.017; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Goel A, 2000, BBA-GEN SUBJECTS, V1523, P13, DOI 10.1016/S0304-4165(00)00086-6; Gupta KK, 2009, J BIOL CHEM, V284, P6735, DOI 10.1074/jbc.M807675200; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lakamper S, 2006, J MUSCLE RES CELL M, V27, P161, DOI 10.1007/s10974-005-9052-3; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Paborsky LR, 1996, ANAL BIOCHEM, V234, P60, DOI 10.1006/abio.1996.0050; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; SAOUDI Y, 1995, J CELL SCI, V108, P357; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Zhu H, 2009, MOL CELLS, V27, P1, DOI 10.1007/s10059-009-0014-2; Zhukovsky EA, 2004, NATURE, V427, P413, DOI 10.1038/427413a	54	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32651	32661		10.1074/jbc.M109.013466	http://dx.doi.org/10.1074/jbc.M109.013466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778897	Green Published, hybrid			2022-12-25	WOS:000272028400048
J	Baud'huin, M; Duplomb, L; Teletchea, S; Charrier, C; Maillasson, M; Fouassier, M; Heymann, D				Baud'huin, Marc; Duplomb, Laurence; Teletchea, Stephane; Charrier, Celine; Maillasson, Mike; Fouassier, Marc; Heymann, Dominique			Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; CRYSTAL-STRUCTURE; HEMOPHILIC ARTHROPATHY; A1 DOMAIN; BONE MASS; IN-VIVO; OSTEOPROTEGERIN; DISEASE; TRAIL	Factor VIII-von Willebrand factor (FVIII.vWF) complex, a molecule involved in coagulation, can be physically associated with osteoprotegerin (OPG). OPG is an anti-osteoclastic protein and a soluble receptor for the proapoptotic protein TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), suggesting a potential role of FVIII.vWF complex in bone and cancer biology. We, thus, assessed the effects of FVIII.vWF complex on osteoclastogenesis and cell survival. We first evidenced that FVIII.vWF complex inhibited RANKL-induced osteoclastogenesis and enhanced the inhibitory effect of OPG. Interestingly, we revealed by surface plasmon resonance that FVIII.vWF complex bound to RANKL, whereas recombinant FVIII and vWF did not. By modeling, we showed that the OPG binding domain to the A1 domain of vWF was closely located and partially overlapped to its binding site to RANKL. Then, we demonstrated that FVIII.vWF complex cancelled the inhibitory activity of OPG on TRAIL-induced apoptosis and characterized interactions between these molecules. The present work evidenced a direct activity of FVIII.vWF complex on osteoclasts and on induced cell apoptosis, pointing out its potential involvement in physiological bone remodeling or in bone damages associated with severe hemophilia and cancer development.	[Heymann, Dominique] Nantes Atlantique Univ, Univ Nantes, INSERM,U957, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, F-44035 Nantes, France; [Baud'huin, Marc; Duplomb, Laurence; Teletchea, Stephane; Charrier, Celine; Heymann, Dominique] Univ Nantes, EA3822, F-44035 Nantes, France; [Maillasson, Mike] INSERM, U892, F-44035 Nantes, France; [Maillasson, Mike] IFR26 Ouest Genopole, F-44035 Nantes, France; [Fouassier, Marc] CHU Nantes, Hotel Dieu, Hematol Lab, Ctr Reg Traitement Hemophilie, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Heymann, D (corresponding author), 1 Rue Gaston Veil, F-44035 Nantes 1, France.	dominique.heymann@univ-nantes.fr	Téletchéa, Stéphane/B-1082-2009; Téletchéa, Stéphane/N-8897-2019; Baud'huin, Marc/K-8519-2015; Heymann, Dominique/AAC-6014-2019; Charrier, Céline/K-9198-2015	Téletchéa, Stéphane/0000-0002-2402-028X; Téletchéa, Stéphane/0000-0002-2402-028X; Heymann, Dominique/0000-0001-7777-0669; Duplomb, Laurence/0000-0002-5715-3759; Baud'huin, Marc/0000-0002-3357-329X	Region des Pays de la Loire; ANR 2007 INSERM Pathophysiology [R07196NS]	Region des Pays de la Loire(Region Pays de la Loire); ANR 2007 INSERM Pathophysiology(French National Research Agency (ANR))	This work was supported in part by the Region des Pays de la Loire (Program "Ciblage Moleculaire et Applications Therapeutique") and by the ANR 2007 INSERM Pathophysiology of Human Diseases Project R07196NS.	Adachi T, 2006, BIOCHEM BIOPH RES CO, V339, P1178, DOI 10.1016/j.bbrc.2005.11.126; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astermark J, 1999, BRIT J HAEMATOL, V105, P1109, DOI 10.1046/j.1365-2141.1999.01463.x; Baud'huin M, 2007, CELL MOL LIFE SCI, V64, P2334, DOI 10.1007/s00018-007-7104-0; Bilora F, 2006, CLIN APPL THROMB-HEM, V12, P193, DOI 10.1177/107602960601200207; Bolon B, 2002, CELL MOL LIFE SCI, V59, P1569, DOI 10.1007/s00018-002-8530-7; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Cheng X, 2004, J BIOL CHEM, V279, P8269, DOI 10.1074/jbc.M309690200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Degli-Esposti M, 1999, J LEUKOCYTE BIOL, V65, P535, DOI 10.1002/jlb.65.5.535; DEPALMA AF, 1956, ARCH SURG-CHICAGO, V72, P247; Dogan Mutlu, 2005, Support Cancer Ther, V3, P28, DOI 10.3816/SCT.2005.n.022; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Duplomb L, 2008, ENDOCRINOLOGY, V149, P3688, DOI 10.1210/en.2007-1719; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Franchini M, 2008, CRIT REV ONCOL HEMAT, V66, P194, DOI 10.1016/j.critrevonc.2007.12.004; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Hollestelle MJ, 2001, THROMB HAEMOSTASIS, V86, P855, DOI 10.1055/s-0037-1616143; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito S, 2002, J BIOL CHEM, V277, P6631, DOI 10.1074/jbc.M106525200; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kovacs CS, 2008, TRANSFUS APHER SCI, V38, P33, DOI 10.1016/j.transci.2007.12.003; Lafeber FPJG, 2008, HAEMOPHILIA, V14, P3, DOI 10.1111/j.1365-2516.2008.01732.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Nichols WL, 2008, HAEMOPHILIA, V14, P171, DOI 10.1111/j.1365-2516.2007.01643.x; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pawlinski R, 2008, SEMIN THROMB HEMOST, V34, P182, DOI 10.1055/s-2008-1079258; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shahbazi S, 2007, J THROMB HAEMOST, V5, P1956, DOI 10.1111/j.1538-7836.2007.02681.x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suva LJ, 2008, AM J PATHOL, V172, P430, DOI 10.2353/ajpath.2008.070417; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Valentino LA, 2007, HAEMOPHILIA, V13, P10, DOI 10.1111/j.1365-2516.2007.01534.x; van Durme CMPG, 2008, NETH J MED, V66, P286; Wallny TA, 2007, HAEMOPHILIA, V13, P79, DOI 10.1111/j.1365-2516.2006.01405.x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354	51	48	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31704	31713		10.1074/jbc.M109.030312	http://dx.doi.org/10.1074/jbc.M109.030312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758994	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000271572700025
J	Charrin, S; Yalaoui, S; Bartosch, B; Cocquerel, L; Franetich, JF; Boucheix, C; Mazier, D; Rubinstein, E; Silvie, O				Charrin, Stephanie; Yalaoui, Samir; Bartosch, Birke; Cocquerel, Laurence; Franetich, Jean-Francois; Boucheix, Claude; Mazier, Dominique; Rubinstein, Eric; Silvie, Olivier			The Ig Domain Protein CD9P-1 Down-regulates CD81 Ability to Support Plasmodium yoelii Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; RADIXIN-MOESIN PROTEINS; TETRASPANIN WEB; SCAVENGER RECEPTOR; MEMBRANE-PROTEINS; MALARIA PARASITE; LIVER STAGE; CELL ENTRY; MAJOR CD9; HOST-CELL	Invasion of hepatocytes by Plasmodium sporozoites is a prerequisite for establishment of a malaria natural infection. The molecular mechanisms underlying sporozoite invasion are largely unknown. We have previously reported that CD81 is required on hepatocytes for infection by Plasmodium falciparum and Plasmodium yoelii sporozoites. CD81 belongs to the tetraspanin superfamily of transmembrane proteins. By interacting with each other and with other transmembrane proteins, tetraspanins may play a role in the lateral organization of membrane proteins. In this study, we investigated the role of the two major molecular partners of CD81 in hepatocytic cells, CD9P-1/EWI-F and EWI-2, two transmembrane proteins belonging to a novel subfamily of immunoglobulin proteins. We show that CD9P-1 silencing increases the host cell susceptibility to P. yoelii sporozoite infection, whereas EWI-2 knock-down has no effect. Conversely, overexpression of CD9P-1 but not EWI-2 partially inhibits infection. Using CD81 and CD9P-1 chimeric molecules, we demonstrate the role of transmembrane regions in CD81-CD9P-1 interactions. Importantly, a CD9P-1 chimera that no longer associates with CD81 does not affect infection. Based on these data, we conclude that CD9P-1 acts as a negative regulator of P. yoelii infection by interacting with CD81 and regulating its function.	[Boucheix, Claude; Rubinstein, Eric] Univ Paris Sud, INSERM, U602, F-94807 Villejuif, France; [Charrin, Stephanie; Boucheix, Claude; Rubinstein, Eric] Inst Andre Lwoff, F-94807 Villejuif, France; [Yalaoui, Samir; Franetich, Jean-Francois; Mazier, Dominique; Silvie, Olivier] Univ Paris 06, INSERM, U945, F-75013 Paris, France; [Bartosch, Birke] Univ Lyon 1, F-69007 Lyon, France; INSERM, U758, IFR128, F-69007 Lyon, France; [Cocquerel, Laurence] Univ Lille Nord France, Inst Pasteur, CNRS, Inst Biol Lille,UMR8161, F-59021 Lille, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rubinstein, E (corresponding author), Hop Paul Brousse, INSERM, U602, 14 Av Paul Vaillant Couturier, F-94807 Villejuif, France.	eric.rubinstein@inserm.fr; silvie@mpiib-berlin.mpg.de	Franetich, Jean-François/GZA-9674-2022; Rubinstein, Eric/B-4650-2019; Silvie, Olivier/AAF-5437-2021; Silvie, Olivier/K-7290-2017; Cocquerel, Laurence/P-1951-2016; CHARRIN, Stephanie/B-2892-2019; Bartosch, Birke/I-7255-2018	Rubinstein, Eric/0000-0001-7623-9665; Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; Cocquerel, Laurence/0000-0002-2136-5178; Bartosch, Birke/0000-0001-6354-4660; Boucheix, Claude/0000-0003-4184-7008; Charrin, Stephanie/0000-0002-4942-3990	Association Nouvelle Recherche Biomedicale-Vaincre le Cancer; Association pour la Recherche sur le Cancer; Agence Nationale de Recherche sur le Sida et les Hepatites virales (ANRS); Agence Nationale de la Recherche (ANR); European Union FP5 [QLK2-CT-2002-00774]	Association Nouvelle Recherche Biomedicale-Vaincre le Cancer; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de Recherche sur le Sida et les Hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Union FP5(European Commission)	This work was supported in part by grants from the Association Nouvelle Recherche Biomedicale-Vaincre le Cancer, the Association pour la Recherche sur le Cancer, the Agence Nationale de Recherche sur le Sida et les Hepatites virales (ANRS), the Agence Nationale de la Recherche (ANR), and by European Union FP5 Contract Number QLK2-CT-2002-00774.	Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Charrin S, 2006, FRONT BIOSCI-LANDMRK, V11, P1987, DOI 10.2741/1940; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Mota MM, 2000, EXP PARASITOL, V96, P257, DOI 10.1006/expr.2000.4570; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Silvie O, 2007, INT J PARASITOL, V37, P173, DOI 10.1016/j.ijpara.2006.10.005; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013; Yang XH, 2006, J BIOL CHEM, V281, P12976, DOI 10.1074/jbc.M510617200	42	14	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31572	31578		10.1074/jbc.M109.057927	http://dx.doi.org/10.1074/jbc.M109.057927			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762465	Green Published, hybrid			2022-12-25	WOS:000271572700011
J	de Keyzer, J; Steel, GJ; Hale, SJ; Humphries, D; Stirling, CJ				de Keyzer, Jeanine; Steel, Gregor J.; Hale, Sarah J.; Humphries, Daniel; Stirling, Colin J.			Nucleotide Binding by Lhs1p Is Essential for Its Nucleotide Exchange Activity and for Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ENDOPLASMIC-RETICULUM; SHOCK COGNATE PROTEIN; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; CONFORMATIONAL-CHANGE; HSP110 CHAPERONES; HSP70 CHAPERONES; STRUCTURAL BASIS; ATPASE FRAGMENT; TRANSLOCATION	Protein translocation and folding in the endoplasmic reticulum of Saccharomyces cerevisiae involves two distinct Hsp70 chaperones, Lhs1p and Kar2p. Both proteins have the characteristic domain structure of the Hsp70 family consisting of a conserved N-terminal nucleotide binding domain and a C-terminal substrate binding domain. Kar2p is a canonical Hsp70 whose substrate binding activity is regulated by cochaperones that promote either ATP hydrolysis or nucleotide exchange. Lhs1p is a member of the Grp170/Lhs1p subfamily of Hsp70s and was previously shown to function as a nucleotide exchange factor (NEF) for Kar2p. Here we show that in addition to this NEF activity, Lhs1p can function as a holdase that prevents protein aggregation in vitro. Analysis of the nucleotide requirement of these functions demonstrates that nucleotide binding to Lhs1p stimulates the interaction with Kar2p and is essential for NEF activity. In contrast, Lhs1p holdase activity is nucleotide-independent and unaffected by mutations that interfere with ATP binding and NEF activity. In vivo, these mutants show severe protein translocation defects and are unable to support growth despite the presence of a second Kar2p-specific NEF, Sil1p. Thus, Lhs1p-dependent nucleotide exchange activity is vital for ER protein biogenesis in vivo.	[de Keyzer, Jeanine; Steel, Gregor J.; Hale, Sarah J.; Humphries, Daniel; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, A4040 Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk			The Wellcome Trust	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust.	Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; Craven RA, 1997, TRENDS CELL BIOL, V7, P277, DOI 10.1016/S0962-8924(97)01079-9; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; FULLERTON DM, 2004, THESIS U MANCHESTER; GAO BC, 1994, BIOCHEMISTRY-US, V33, P2048, DOI 10.1021/bi00174a010; Hamilton TG, 1996, J BIOL CHEM, V271, P30610, DOI 10.1074/jbc.271.48.30610; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Saris N, 1997, J CELL BIOL, V137, P813, DOI 10.1083/jcb.137.4.813; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521	42	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31564	31571		10.1074/jbc.M109.055160	http://dx.doi.org/10.1074/jbc.M109.055160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759005	Green Published, hybrid			2022-12-25	WOS:000271572700010
J	Heja, L; Barabas, P; Nyitrai, G; Kekesi, KA; Lasztoczi, B; Toke, O; Tarkanyi, G; Madsen, K; Schousboe, A; Dobolyi, A; Palkovits, M; Kardos, J				Heja, Laszlo; Barabas, Peter; Nyitrai, Gabriella; Kekesi, Katalin A.; Lasztoczi, Balint; Toke, Orsolya; Tarkanyi, Gabor; Madsen, Karsten; Schousboe, Arne; Dobolyi, Arpad; Palkovits, Miklos; Kardos, Julianna			Glutamate Uptake Triggers Transporter-Mediated GABA Release from Astrocytes	PLOS ONE			English	Article							NEURONAL DAMAGE; MOLECULAR REGULATION; HIPPOCAMPAL; GLU; INHIBITION; EXPRESSION; SEIZURES; EQUILIBRIUM; CONTRIBUTES; COEXISTENCE	Background: Glutamate (Glu) and c-aminobutyric acid (GABA) transporters play important roles in regulating neuronal activity. Glu is removed from the extracellular space dominantly by glial transporters. In contrast, GABA is mainly taken up by neurons. However, the glial GABA transporter subtypes share their localization with the Glu transporters and their expression is confined to the same subpopulation of astrocytes, raising the possibility of cooperation between Glu and GABA transport processes. Methodology/Principal Findings: Here we used diverse biological models both in vitro and in vivo to explore the interplay between these processes. We found that removal of Glu by astrocytic transporters triggers an elevation in the extracellular level of GABA. This coupling between excitatory and inhibitory signaling was found to be independent of Glu receptor-mediated depolarization, external presence of Ca2+ and glutamate decarboxylase activity. It was abolished in the presence of non-transportable blockers of glial Glu or GABA transporters, suggesting that the concerted action of these transporters underlies the process. Conclusions/Significance: Our results suggest that activation of Glu transporters results in GABA release through reversal of glial GABA transporters. This transporter-mediated interplay represents a direct link between inhibitory and excitatory neurotransmission and may function as a negative feedback combating intense excitation in pathological conditions such as epilepsy or ischemia.			Heja, L (corresponding author), Hungarian Acad Sci, Inst Biomol Chem, Chem Res Ctr, Dept Neurochem, Budapest, Hungary.	heja@chemres.hu	Tarkanyi, Gabor/A-7766-2009; Dobolyi, Arpad/AAE-5913-2020; Barabas, Peter/AAL-5650-2020; Kékesi, Katalin Adrienna A/H-3484-2017; Palkovits, Miklos/F-2707-2013	Barabas, Peter/0000-0002-8166-3476; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Palkovits, Miklos/0000-0003-0578-0387; Toke, Orsolya/0000-0002-1741-1573; Schousboe, Arne/0000-0001-9600-402X; Heja, Laszlo/0000-0002-0035-7005				Angulo MC, 2008, PROG NEUROBIOL, V86, P297, DOI 10.1016/j.pneurobio.2008.08.002; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Barabas P, 2002, J NEUROSCI RES, V67, P149, DOI 10.1002/jnr.10117; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Bonanno G, 2006, CURR TOP MED CHEM, V6, P979, DOI 10.2174/156802606777323746; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Derchansky M, 2004, HIPPOCAMPUS, V14, P935, DOI 10.1002/hipo.20007; Diamond JS, 1997, J NEUROSCI, V17, P4672; Doi T, 2005, MOL BRAIN RES, V142, P91, DOI 10.1016/j.molbrainres.2005.09.010; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Gutierrez R, 2006, CURR TOP MED CHEM, V6, P975, DOI 10.2174/156802606777323692; Heja L, 2006, CURR TOP MED CHEM, V6, P989, DOI 10.2174/156802606777323656; Hertz L., 1989, DISSECTION TISSUE CU, P105; Hoogland G, 2004, J NEUROSCI RES, V76, P881, DOI 10.1002/jnr.20128; JUHASZ G, 1989, J NEUROSCI METH, V29, P131, DOI 10.1016/0165-0270(89)90024-1; KARDOS J, 1991, BIOCHEM PHARMACOL, V41, P1141, DOI 10.1016/0006-2952(91)90652-L; Kekesi KA, 2000, NEUROCHEM INT, V37, P171, DOI 10.1016/S0197-0186(00)00020-6; Khan GM, 1999, EUR J PHARMACOL, V373, P153, DOI 10.1016/S0014-2999(99)00209-5; Kinney GA, 2005, J NEUROPHYSIOL, V94, P4533, DOI 10.1152/jn.00420.2005; Kinney GA, 2002, J NEUROPHYSIOL, V88, P2899, DOI 10.1152/jn.00037.2002; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Lasztoczi B, 2004, EUR J NEUROSCI, V19, P1361, DOI 10.1111/j.1460-9568.2004.03231.x; LASZTOCZI B, 2009, J NEUROPHYS IN PRESS; Lee TS, 2006, ACTA NEUROPATHOL, V111, P351, DOI 10.1007/s00401-005-0017-9; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Liu QY, 2000, J NEUROPHYSIOL, V84, P1392, DOI 10.1152/jn.2000.84.3.1392; Massieu L, 1997, J NEUROCHEM, V69, P1151; MASSIEU L, 1995, J NEUROCHEM, V64, P2262; Matthias K, 2003, J NEUROSCI, V23, P1750; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Montiel T, 2005, NEUROSCIENCE, V133, P667, DOI 10.1016/j.neuroscience.2004.11.020; Moussa CEH, 2007, J NEUROSCI RES, V85, P342, DOI 10.1002/jnr.21108; Munera A, 2001, J NEUROPHYSIOL, V86, P2571, DOI 10.1152/jn.2001.86.5.2571; Munir M, 2000, NEUROCHEM INT, V37, P147, DOI 10.1016/S0197-0186(00)00018-8; Nyitrai G, 2006, CURR TOP MED CHEM, V6, P935, DOI 10.2174/156802606777323674; Obrenovitch TP, 2000, INT J DEV NEUROSCI, V18, P281, DOI 10.1016/S0736-5748(99)00096-9; Paillart C, 2003, J NEUROSCI, V23, P4092; Plachez C, 2004, NEUROCHEM INT, V45, P1113, DOI 10.1016/j.neuint.2004.03.030; Richards DA, 1996, NEUROCHEM RES, V21, P135, DOI 10.1007/BF02529130; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Schousboe A, 2003, NEUROCHEM RES, V28, P347, DOI 10.1023/A:1022397704922; SCHOUSBOE A, 1977, NEUROCHEM RES, V2, P217, DOI 10.1007/BF00964098; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; SIHRA TS, 1987, J NEUROCHEM, V49, P261, DOI 10.1111/j.1471-4159.1987.tb03424.x; Somogyi J, 2006, CURR TOP MED CHEM, V6, P969, DOI 10.2174/156802606777323737; Soudijn W, 2000, CURR MED CHEM, V7, P1063, DOI 10.2174/0929867003374363; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Ueda Y, 2007, BRAIN RES, V1151, P55, DOI 10.1016/j.brainres.2007.03.021; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; Wu YM, 2006, J NEUROPHYSIOL, V96, P2425, DOI 10.1152/jn.00545.2006; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	56	90	93	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7153	10.1371/journal.pone.0007153	http://dx.doi.org/10.1371/journal.pone.0007153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777062	Green Published, gold, Green Submitted			2022-12-25	WOS:000270164600005
J	Cantu, D; Schaack, J; Patel, M				Cantu, David; Schaack, Jerome; Patel, Manisha			Oxidative Inactivation of Mitochondrial Aconitase Results in Iron and H2O2-Mediated Neurotoxicity in Rat Primary Mesencephalic Cultures	PLOS ONE			English	Article								Background: Mitochondrial oxidative stress is a contributing factor in the etiology of numerous neuronal disorders. However, the precise mechanism(s) by which mitochondrial reactive oxygen species (ROS) modify cellular targets to induce the death of neurons remains unknown. The goal of this study was to determine if oxidative inactivation of mitochondrial aconitase (m-aconitase) resulted in the release of redox-active iron (Fe2+) and hydrogen peroxide (H2O2) and whether this contributes to cell death. Methodology/Principal Findings: Incubation of rat primary mesencephalic cultures with the redox cycling herbicide paraquat (PQ(2+)) resulted in increased production of H2O2 and Fe2+ at times preceding cell death. To confirm the role of maconitase as a source of Fenton reagents and death, we overexpressed m-aconitase using an adenoviral construct thereby increasing the target available for inactivation by ROS. Co-labeling studies identified astrocytes as the predominant cell type expressing transduced m-aconitase although neurons were identified as the primary cell type dying. Oxidative inactivation of m-aconitase overexpressing cultures resulted in exacerbation of H2O2 production, Fe2+ accumulation and increased neuronal death. Increased cell death in m-aconitase overexpressing cultures was attenuated by addition of catalase and/or a cell permeable iron chelator suggesting that neuronal death occurred in part via astrocyte-derived H2O2. Conclusions: These results suggest a role of ROS-sensitive m-aconitase as a source of Fe2+ and H2O2 and as a contributing factor to neurotoxicity.			Cantu, D (corresponding author), Univ Colorado Denver, Neurosci Program, Anschutz Med Campus, Aurora, CO USA.	manisha.patel@ucdenver.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039587, R01NS045748] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS039587, NS045748, R01 NS045748, NS039587-S1, NS039587, R01 NS045748-05A1, P30 NS041854-05] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Baron M, 2007, BIOCHEM SOC T, V35, P1228, DOI 10.1042/BST0351228; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DEXTER DT, 1987, LANCET, V2, P1219; FLINT DH, 1993, J BIOL CHEM, V268, P22369; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Grammatopoulos TN, 2005, BRAIN RES, V1045, P64, DOI 10.1016/j.brainres.2005.03.038; Hirsch EC, 2005, PARKINSONISM RELAT D, V11, pS9, DOI 10.1016/j.parkreldis.2004.10.013; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Kaur D, 2004, AGEING RES REV, V3, P327, DOI 10.1016/j.arr.2004.01.003; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Li QY, 2001, J NEUROCHEM, V78, P746, DOI 10.1046/j.1471-4159.2001.00457.x; Lian XY, 2004, EPILEPSY RES, V60, P41, DOI 10.1016/j.eplepsyres.2004.05.003; Liang LP, 2004, J NEUROCHEM, V90, P1076, DOI 10.1111/j.1471-4159.2004.02567.x; Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029; LIANG LP, 2008, J NEUROSCI IN PRESS; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Longo VD, 2000, J NEUROCHEM, V75, P1977, DOI 10.1046/j.1471-4159.2000.0751977.x; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Mackensen GB, 2001, J NEUROSCI, V21, P4582, DOI 10.1523/JNEUROSCI.21-13-04582.2001; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Murakami K, 1997, BIOCHEM MOL BIOL INT, V41, P481; Park LCH, 2001, J NEUROSCI RES, V66, P1028, DOI 10.1002/jnr.10062; Patel M, 2003, NEUROSCIENCE, V118, P431, DOI 10.1016/S0306-4522(02)00979-X; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Pearce RKB, 1997, J NEURAL TRANSM, V104, P661, DOI 10.1007/BF01291884; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; SCHAPIRA AHV, 1993, BIOCHEM SOC T, V21, P367, DOI 10.1042/bst0210367; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Vielhaber S, 2008, EPILEPSIA, V49, P40, DOI 10.1111/j.1528-1167.2007.01280.x; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	45	107	112	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7095	10.1371/journal.pone.0007095	http://dx.doi.org/10.1371/journal.pone.0007095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763183	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970400019
J	Almberg, ES; Mech, LD; Smith, DW; Sheldon, JW; Crabtree, RL				Almberg, Emily S.; Mech, L. David; Smith, Douglas W.; Sheldon, Jennifer W.; Crabtree, Robert L.			A Serological Survey of Infectious Disease in Yellowstone National Park's Canid Community	PLOS ONE			English	Article								Background: Gray wolves (Canis lupus) were reintroduced into Yellowstone National Park (YNP) after a >70 year absence, and as part of recovery efforts, the population has been closely monitored. In 1999 and 2005, pup survival was significantly reduced, suggestive of disease outbreaks. Methodology/Principal Findings: We analyzed sympatric wolf, coyote (Canis latrans), and red fox (Vulpes vulpes) serologic data from YNP, spanning 1991-2007, to identify long-term patterns of pathogen exposure, identify associated risk factors, and examine evidence for disease-induced mortality among wolves for which there were survival data. We found high, constant exposure to canine parvovirus (wolf seroprevalence: 100%; coyote: 94%), canine adenovirus-1 ( wolf pups [0.5-0.9 yr]: 91%, adults [> 1 yr]: 96%; coyote juveniles [0.5-1.5 yrs]: 18%, adults [>= 1.6 yrs]: 83%), and canine herpesvirus ( wolf: 87%; coyote juveniles: 23%, young adults [1.6-4.9 yrs]: 51%, old adults [>= 5 yrs]: 87%) suggesting that these pathogens were enzootic within YNP wolves and coyotes. An average of 50% of wolves exhibited exposure to the protozoan parasite, Neospora caninum, although individuals' odds of exposure tended to increase with age and was temporally variable. Wolf, coyote, and fox exposure to canine distemper virus (CDV) was temporally variable, with evidence for distinct multi-host outbreaks in 1999 and 2005, and perhaps a smaller, isolated outbreak among wolves in the interior of YNP in 2002. The years of high wolf-pup mortality in 1999 and 2005 in the northern region of the park were correlated with peaks in CDV seroprevalence, suggesting that CDV contributed to the observed mortality. Conclusions/Significance: Of the pathogens we examined, none appear to jeopardize the long-term population of canids in YNP. However, CDV appears capable of causing short-term population declines. Additional information on how and where CDV is maintained and the frequency with which future epizootics might be expected might be useful for future management of the Northern Rocky Mountain wolf population.			Almberg, ES (corresponding author), Univ Minnesota, Dept Nat Resources Sci & Management, St Paul, MN 55108 USA.	almb0001@umn.edu						ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; ALMBERG E, 2009, THESIS U MINNESOTA G, P21; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; APPEL M, 1973, AM J VET RES, V34, P1459; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Bangs EE, 1998, WILDLIFE SOC B, V26, P785; Barker Ian K., 2001, P131, DOI 10.1002/9780470344880.ch6; Basso W, 2001, J PARASITOL, V87, P612, DOI 10.1645/0022-3395(2001)087[0612:FIONCF]2.0.CO;2; Bates D., 2008, LME4 LINEAR MIXED EF; Biek R, 2006, J WILDLIFE DIS, V42, P606, DOI 10.7589/0090-3558-42.3.606; BITTEGEKO SBPR, 1995, J AM ANIM HOSP ASSOC, V31, P42, DOI 10.5326/15473317-31-1-42; Bjorkman C, 1999, INT J PARASITOL, V29, P1497, DOI 10.1016/S0020-7519(99)00115-0; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; CARMICHAEL LE, 1970, J AM VET MED ASSOC, V156, P1714; Choate JR, 1998, J MAMMAL, V79, P1416; CHOQUETTE L P E, 1974, Journal of Wildlife Diseases, V10, P321; Cleaveland S., 2002, P139; Clifford DL, 2006, BIOL CONSERV, V131, P230, DOI 10.1016/j.biocon.2006.04.029; Cypher BL, 1998, J WILDLIFE DIS, V34, P259, DOI 10.7589/0090-3558-34.2.259; Deem SL, 2005, J ZOO WILDLIFE MED, V36, P192, DOI 10.1638/04-076.1; Dubey JP, 1999, INT J PARASITOL, V29, P1709, DOI 10.1016/S0020-7519(99)00142-3; Dubey JP, 2005, J PARASITOL, V91, P1217, DOI 10.1645/GE-576R.1; DUBEY JP, 1988, J AM VET MED ASSOC, V192, P1269; DUBIELZIG RR, 1979, VET PATHOL, V16, P268, DOI 10.1177/030098587901600216; Funk SM, 2001, CONSERV BIOL SER, V5, P443; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GESE EM, 1991, J WILDLIFE DIS, V27, P320, DOI 10.7589/0090-3558-27.2.320; Gese EM, 1997, J WILDLIFE DIS, V33, P47, DOI 10.7589/0090-3558-33.1.47; Gier H. T., 1968, AGR EXPT STATION B, P393; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Gondim LFP, 2004, INT J PARASITOL, V34, P159, DOI 10.1016/j.ijpara.2004.01.001; GORDON JC, 1986, AM J VET RES, V47, P1464; GORHAM JR, 1966, J AM VET MED ASSOC, V149, P610; GREEN JS, 1984, J WILDLIFE DIS, V20, P6, DOI 10.7589/0090-3558-20.1.6; Greene C, 2006, INFECT DIS DOG CAT, P41; Greene C.E., 2006, INFECT DIS DOG CAT; Grinder M, 2001, J WILDLIFE DIS, V37, P312, DOI 10.7589/0090-3558-37.2.312; GUO W, 1986, J AM VET MED ASSOC, V189, P1099; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; HEIDEJORGENSEN MP, 1992, J APPL ECOL, V29, P99, DOI 10.2307/2404353; Houston D.B., 1982, NO YELLOWSTONE ELK E; JOHNSON MR, 1994, J WILDLIFE DIS, V30, P270, DOI 10.7589/0090-3558-30.2.270; Junge RE, 2007, J ZOO WILDLIFE MED, V38, P18, DOI 10.1638/05-123.1; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Laurenson K, 1998, ANIM CONSERV, V1, P273, DOI 10.1111/j.1469-1795.1998.tb00038.x; Lindsay DS, 1999, VET PARASITOL, V82, P327, DOI 10.1016/S0304-4017(99)00054-0; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Mech LD, 2008, J WILDLIFE DIS, V44, P824, DOI 10.7589/0090-3558-44.4.824; MECH LD, 1993, J WILDLIFE DIS, V29, P330, DOI 10.7589/0090-3558-29.2.330; Munson L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002545; Murray DL, 1999, ANIM CONSERV, V2, P241, DOI 10.1111/j.1469-1795.1999.tb00070.x; Nunn CL, 2006, INFECT DIS PRIMATES; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Parrish C R, 1990, Adv Virus Res, V38, P403; Peterson RO, 1998, J MAMMAL, V79, P828, DOI 10.2307/1383091; POLLOCK RVH, 1982, J AM VET MED ASSOC, V180, P37; R Core Team, 2022, R LANG ENV STAT COMP; Rijsewijk FAM, 1999, VET MICROBIOL, V65, P1, DOI 10.1016/S0378-1135(98)00285-5; Smith Douglas W., 2007, Yellowstone Science, V15, P17; Smith Douglas W., 2009, P92, DOI 10.1002/9781444312034.ch5; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; SMITH DW, 2008, YCR200801 NAT PARK S; STEPHENSON RO, 1982, J WILDLIFE DIS, V18, P419, DOI 10.7589/0090-3558-18.4.419; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; TRAINER DO, 1968, J WILDLIFE MANAGE, V32, P981, DOI 10.2307/3799581; Vianna MCB, 2005, VET PARASITOL, V129, P253, DOI 10.1016/j.vetpar.2004.02.031; Williams Elizabeth S., 2001, P50; Woods Leslie W., 2001, P202, DOI 10.1002/9780470344880.ch9; *YELL NAT PARK DIV, 2008, YELL RES ISS; ZARNKE RL, 1987, J WILDLIFE DIS, V23, P77, DOI 10.7589/0090-3558-23.1.77	72	64	64	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7042	10.1371/journal.pone.0007042	http://dx.doi.org/10.1371/journal.pone.0007042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756151	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970000011
J	Davies, V; Vaughan, K; Damle, R; Peters, B; Sette, A				Davies, Vince; Vaughan, Kerrie; Damle, Rohini; Peters, Bjoern; Sette, Alessandro			Classification of the Universe of Immune Epitope Literature: Representation and Knowledge Gaps	PLOS ONE			English	Article							GLOBAL HEALTH; DISEASE; BURDEN	Background: A significant fraction of the more than 18 million scientific articles currently indexed in the PubMed database are related to immune responses to various agents, including infectious microbes, autoantigens, allergens, transplants, cancer antigens and others. The Immune Epitope Database (IEDB) is an online repository that catalogs immune epitope reactivity data derived from articles listed in the National Library of Medicine PubMed database. The IEDB is maintained and continually updated by monitoring PubMed for new, potentially relevant references. Methodology: Herein we detail the classification of all epitope-specific literature in over 100 different immunological domains representing Infectious Diseases and Microbes, Autoimmunity, Allergy, Transplantation and Cancer. The relative number of references in each category reflects past and present areas of research on immune reactivities. In addition to describing the overall landscape of data distribution, this particular characterization of the epitope reference data also allows for the exploration of possible correlations with global disease morbidity and mortality data. Conclusions/Significance: While in most cases diseases associated with high morbidity and mortality rates were amongst the most studied, a number of high impact diseases such as dengue, Schistosoma, HSV-2, B. pertussis and Chlamydia trachoma, were found to have very little coverage. The data analyzed in this fashion represents the first estimate of how reported immunological data corresponds to disease-related morbidity and mortality, and confirms significant discrepancies in the overall research foci versus disease burden, thus identifying important gaps to be pursued by future research. These findings may also provide a justification for redirecting a portion of research funds into some of the underfunded, critical disease areas.			Davies, V (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.	kvaughan@liai.org	Sette, Alessandro/AFO-8916-2022		PHS HHS [HHSN2662004000 0 6C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2004, TOP 10 CAUS DEATH; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Enserink M, 2009, SCIENCE, V323, P700, DOI 10.1126/science.323.5915.700; Flory JH, 2004, PHILOS PUBLIC AFF, V32, P36, DOI 10.1111/j.1467-6486.2004.00004.x; McKenna MT, 2009, ANN EPIDEMIOL, V19, P212, DOI 10.1016/j.annepidem.2008.11.005; Sathiamurthy Muthuraman, 2005, Immunome Res, V1, P2, DOI 10.1186/1745-7580-1-2; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x; Vita R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-341; Wang P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-269; 2000, W J MED, V173, P9	13	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6948	10.1371/journal.pone.0006948	http://dx.doi.org/10.1371/journal.pone.0006948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19774228	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796300005
J	Lipsitch, M; Lajous, M; O'Hagan, JJ; Cohen, T; Miller, JC; Goldstein, E; Danon, L; Wallinga, J; Riley, S; Dowell, SF; Reed, C; McCarron, M				Lipsitch, Marc; Lajous, Martin; O'Hagan, Justin J.; Cohen, Ted; Miller, Joel C.; Goldstein, Edward; Danon, Leon; Wallinga, Jacco; Riley, Steven; Dowell, Scott F.; Reed, Carrie; McCarron, Meg			Use of Cumulative Incidence of Novel Influenza A/H1N1 in Foreign Travelers to Estimate Lower Bounds on Cumulative Incidence in Mexico	PLOS ONE			English	Article								Background: An accurate estimate of the total number of cases and severity of illness of an emerging infectious disease is required both to define the burden of the epidemic and to determine the severity of disease. When a novel pathogen first appears, affected individuals with severe symptoms are more likely to be diagnosed. Accordingly, the total number of cases will be underestimated and disease severity overestimated. This problem is manifest in the current epidemic of novel influenza A/H1N1. Methods and Results: We used a simple approach to leverage measures of incident influenza A/H1N1 among a relatively small and well observed group of US, UK, Spanish and Canadian travelers who had visited Mexico to estimate the incidence among a much larger and less well surveyed population of Mexican residents. We estimate that a minimum of 113,000 to 375,000 cases of novel influenza A/H1N1 have occurred in Mexicans during the month of April, 2009. Such an estimate serves as a lower bound because it does not account for underreporting of cases in travelers or for nonrandom mixing between Mexican residents and visitors, which together could increase the estimates by more than an order of magnitude. Conclusions: We find that the number of cases in Mexican residents may exceed the number of confirmed cases by two to three orders of magnitude. While the extent of disease spread is greater than previously appreciated, our estimate suggests that severe disease is uncommon since the total number of cases is likely to be much larger than those of confirmed cases.			Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu	Wallinga, Jacco/C-4382-2018; Miller, Joel C./C-4229-2015; Danon, Leon/J-6324-2012; Danon, Leon/AFV-8758-2022	Wallinga, Jacco/0000-0003-1725-5627; Miller, Joel C./0000-0003-4426-0405; Danon, Leon/0000-0002-7076-1871; Danon, Leon/0000-0002-7076-1871; Lipsitch, Marc/0000-0003-1504-9213; Riley, Steven/0000-0001-7904-4804; Cohen, Ted/0000-0002-8091-7198	FIC NIH HHS [R01 TW008246-01, R01 TW008246] Funding Source: Medline; NIGMS NIH HHS [5U01GM076497, U01 GM076497] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076497] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Kuri-Morales P, 2006, SALUD PUBLICA MEXICO, V48, P379, DOI 10.1590/S0036-36342006000500004; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; *MEX MIN TOUR, 2006, TUR INT 2001 2005, P12; *MIN SAL MEX DIR G, 2009, B DIAR MIN SAL MEX, V14; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Surveillance group for New Influenza A/H1N1 Virus Investigation in Italy, 2009, EUROSURVEILLANCE, V14; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *YP YANK I, 2008, NAT LEIS TRAV MON	13	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6895	10.1371/journal.pone.0006895	http://dx.doi.org/10.1371/journal.pone.0006895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742302	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622500002
J	Yoo, BH; Wu, X; Li, YL; Haniff, M; Sasazuki, T; Shirasawa, S; Eskelinen, EL; Rosen, KV				Yoo, Byong Hoon; Wu, Xue; Li, Yongling; Haniff, Mehnaaz; Sasazuki, Takehiko; Shirasawa, Senji; Eskelinen, Eeva-Liisa; Rosen, Kirill V.			Oncogenic ras-induced Down-regulation of Autophagy Mediator Beclin-1 Is Required for Malignant Transformation of Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; ANOIKIS RESISTANCE; COLORECTAL-CANCER; K-RAS; PANCREATIC ADENOCARCINOMA; FAMILY PROTEINS; ACTIVATED RAS; CYCLE ARREST; IN-VIVO; GROWTH	Detachment of non-malignant epithelial cells from the extracellular matrix causes their growth arrest and, ultimately, death. By contrast, cells composing carcinomas, cancers of epithelial origin, can survive and proliferate without being attached to the extracellular matrix. These properties of tumor cells represent hallmarks of malignant transformation and are critical for cancer progression. Previously we identified several mechanisms by which ras, a major oncogene, blocks detachment-induced apoptosis of intestinal epithelial cells, but mechanisms by which Ras promotes proliferation of those cells that remain viable following detachment are unknown. We show here that detachment of non-malignant intestinal epithelial cells promotes formation of autophagosomes, vacuole-like structures that mediate autophagy (a process of cellular self-cannibalization), and that oncogenic ras prevents this autophagosome formation. We also found that ras activates a GTPase RhoA, that RhoA promotes activation of a protease calpain, and that calpain triggers degradation of Beclin-1, a critical mediator of autophagy, in these cells. The reversal of the effect of ras on Beclin-1 (achieved by expression of exogenous Beclin-1) promoted autophagosome formation following cell detachment, significantly reduced the fraction of detached cells in the S phase of the cell cycle and their rate of proliferation without affecting their viability. Furthermore, RNA interference-induced Beclin-1 down-regulation in non-malignant intestinal epithelial cells prevented detachment-dependent reduction of the fraction of these cells in the S phase of the cell cycle. Thus, ras oncogene promotes proliferation of those malignant intestinal epithelial cells that remain viable following detachment via a distinct novel mechanism that involves Ras-induced down-regulation of Beclin-1.	[Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat & Biochem, Halifax, NS B3H 4H7, Canada; [Yoo, Byong Hoon; Wu, Xue; Li, Yongling; Haniff, Mehnaaz; Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, Dept Mol Biol, Halifax, NS B3H 4H7, Canada; [Sasazuki, Takehiko] Int Med Ctr Japan, Dept Pathol, Res Inst, Tokyo 1628655, Japan; [Shirasawa, Senji] Fukuoka Univ, Sch Med, Dept Cell Biol, Fukuoka 8140180, Japan; [Eskelinen, Eeva-Liisa] Univ Helsinki, Div Biochem, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland	Dalhousie University; Dalhousie University; National Center for Global Health & Medicine - Japan; Fukuoka University; University of Helsinki	Rosen, KV (corresponding author), Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat & Biochem, Rm C-302,5849 Univ Ave, Halifax, NS B3H 4H7, Canada.	kirill.rosen@dal.ca	Eskelinen, Eeva-Liisa/AAF-3496-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Rosen, Kirill/0000-0002-4317-9907	Canadian Cancer Society Research Institute	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by a grant from the Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada).	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Benaud CM, 2001, ONCOGENE, V20, P4554, DOI 10.1038/sj.onc.1204609; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; FILMUS J, 1994, ONCOGENE, V9, P3627; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; MCCARTY KS, 1986, CANCER RES, V46, P4244; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	55	45	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5438	5449		10.1074/jbc.M109.046789	http://dx.doi.org/10.1074/jbc.M109.046789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19778902	Green Published, hybrid			2022-12-25	WOS:000275327200037
J	Trejo, HE; Lecuona, E; Grillo, D; Szleifer, I; Nekrasova, OE; Gelfand, VI; Sznajder, JI				Trejo, Humberto E.; Lecuona, Emilia; Grillo, Doris; Szleifer, Igal; Nekrasova, Oksana E.; Gelfand, Vladimir I.; Sznajder, Jacob I.			Role of kinesin light chain-2 of kinesin-1 in the traffic of Na,K-ATPase-containing vesicles in alveolar epithelial cells	FASEB JOURNAL			English	Article						intracellular traffic; molecular motors; sodium pump	MICROTUBULE-BASED MOTILITY; PROTEIN-COUPLED RECEPTOR; FAST AXONAL-TRANSPORT; PLASMA-MEMBRANE; NA+,K+-ATPASE ENDOCYTOSIS; MOLECULAR-MECHANISMS; MONOCLONAL-ANTIBODY; FLUORESCENT PROTEIN; PULMONARY-EDEMA; MOTOR PROTEINS	Recruitment of the Na,K-ATPase to the plasma membrane of alveolar epithelial cells results in increased active Na+ transport and fluid clearance in a process that requires an intact microtubule network. However, the microtubule motors involved in this process have not been identified. In the present report, we studied the role of kinesin-1, a plus-end microtubule molecular motor that has been implicated in the movement of organelles in the Na, K-ATPase traffic. We determined by confocal microscopy and biochemical assays that kinesin-1 and the Na, K-ATPase are present in the same membranous cellular compartment. Knockdown of kinesin-1 heavy chain (KHC) or the light chain-2 (KLC2), but not of the light chain-1 (KLC1), decreased the movement of Na, K-ATPase-containing vesicles when compared to sham siRNA-transfected cells (control group). Thus, a specific isoform of kinesin-1 is required for microtubule-dependent recruitment of Na, K-ATPase to the plasma membrane, which is of physiological significance-Trejo, H. E., Lecuona, E., Grillo, D., Szleifer, I., Nekrasova, O. E., Gelfand, V. I., Sznajder, J. I. Role of kinesin light chain-2 of kinesin-1 in the traffic of Na, K-ATPase-containing vesicles in alveolar epithelial cells. FASEB J. 24, 374-382 (2010). www.fasebj.org	[Trejo, Humberto E.; Lecuona, Emilia; Nekrasova, Oksana E.; Sznajder, Jacob I.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Gelfand, Vladimir I.] Northwestern Univ, Feinberg Sch Med, Dept Mol & Cell Biol, Chicago, IL 60611 USA; [Grillo, Doris; Szleifer, Igal] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University	Sznajder, JI (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, 240 E Huron,McGaw M300, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Gelfand, Vladimir I/D-2545-2013; Szleifer, Igal/B-6920-2009; Gelfand, Vladimir/M-1974-2019	Gelfand, Vladimir I/0000-0002-6361-2798; Gelfand, Vladimir/0000-0002-6361-2798; Trejo BIttar, Humberto/0000-0003-2701-6531	U.S. National Institutes of Health [HL-48129, HL-71643, GM-52111]; American Heart Association; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, R01HL048129, R37HL048129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM052111, R01GM052111] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the valuable insights and comments to this manuscript of Lynn Welch. This work was supported in part by U.S. National Institutes of Health grants HL-48129, HL-71643, and GM-52111. H. T. is a recipient of an American Heart Association Postdoctoral Fellowship grant. D. G. is a recipient of a National Science Foundation Graduate Research Fellowship.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; BERTHIAUME Y, 1988, J APPL PHYSIOL, V65, P585, DOI 10.1152/jappl.1988.65.2.585; Bertorello AM, 2003, MOL BIOL CELL, V14, P1149, DOI 10.1091/mbc.E02-06-0367; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; BROWN D, 1993, J CELL SCI, P49; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chen ZP, 2006, AM J RESP CELL MOL, V35, P127, DOI 10.1165/rcmb.2006-0044OC; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Feschenko MS, 1997, ANN NY ACAD SCI, V834, P479, DOI 10.1111/j.1749-6632.1997.tb52306.x; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi049288l; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; Junco A, 2001, BIOL REPROD, V64, P1320, DOI 10.1095/biolreprod64.5.1320; Khodjakov A, 1998, MOL BIOL CELL, V9, P333, DOI 10.1091/mbc.9.2.333; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Lecuona E, 1999, CHEST, V116, p29S, DOI 10.1378/chest.116.suppl_1.29S; LECUONA E, 2009, J CELL SCI IN PRESS; Lecuona E, 2007, J BIOENERG BIOMEMBR, V39, P391, DOI 10.1007/s10863-007-9102-1; Lecuona E, 2009, AM J RESP CELL MOL, V41, P671, DOI 10.1165/rcmb.2008-0365OC; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; McCart AE, 2003, TRAFFIC, V4, P576, DOI 10.1034/j.1600-0854.2003.00113.x; MITCHISON TJ, 1986, J CELL SCI, P121; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; Oatey PB, 1997, BIOCHEM J, V327, P637; Potokar M, 2005, BIOCHEM BIOPH RES CO, V329, P678, DOI 10.1016/j.bbrc.2005.02.030; RODIONOV VI, 1991, P NATL ACAD SCI USA, V88, P4956, DOI 10.1073/pnas.88.11.4956; Rose SD, 2003, J NEUROCHEM, V85, P287, DOI 10.1046/j.1471-4159.2003.01649.x; Saldias F, 1998, AM J PHYSIOL-LUNG C, V274, pL694, DOI 10.1152/ajplung.1998.274.5.L694; Saldias FJ, 1999, J APPL PHYSIOL, V87, P30, DOI 10.1152/jappl.1999.87.1.30; Sarkar S, 2006, TRAFFIC, V7, P1078, DOI 10.1111/j.1600-0854.2006.00447.x; Schepis A, 2007, CELL MICROBIOL, V9, P1960, DOI 10.1111/j.1462-5822.2007.00927.x; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; Skou JC, 1998, BIOSCIENCE REP, V18, P155, DOI 10.1023/A:1020196612909; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Teixeira VL, 2003, ANN NY ACAD SCI, V986, P587, DOI 10.1111/j.1749-6632.2003.tb07257.x; Tietz PS, 2006, BIOL CELL, V98, P43, DOI 10.1042/BC20040089; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Tuma MC, 1999, PIGM CELL RES, V12, P283, DOI 10.1111/j.1600-0749.1999.tb00762.x; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Wubbolts R, 1999, J CELL SCI, V112, P785; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x	63	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					374	382		10.1096/fj.09-137802	http://dx.doi.org/10.1096/fj.09-137802			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19773350	Green Published			2022-12-25	WOS:000274045000006
J	Liu, L; Shi, XJ; Bharadwaj, KG; Ikeda, S; Yamashita, H; Yagyu, H; Schaffer, JE; Yu, YH; Goldberg, IJ				Liu, Li; Shi, XiaoJing; Bharadwaj, Kalyani G.; Ikeda, Shota; Yamashita, Haruyo; Yagyu, Hiroaki; Schaffer, Jean E.; Yu, Yi-Hao; Goldberg, Ira J.			DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; DIACYLGLYCEROL ACYLTRANSFERASE; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; ACYL-COENZYME; UP-REGULATION; OBESITY RESISTANCE; CONSCIOUS DOG; MICE	Intracellular lipid accumulation in the heart is associated with cardiomyopathy, yet the precise role of triglyceride (TG) remains unclear. With exercise, wild type hearts develop physiologic hypertrophy. This was associated with greater TG stores and a marked induction of the TG-synthesizing enzyme diacylglycerol (DAG) acyltransferase 1 (DGAT1). Transgenic overexpression of DGAT1 in the heart using the cardiomyocyte-specific alpha-myosin heavy chain (MHC) promoter led to approximately a doubling of DGAT activity and TG content and reductions of similar to 35% in cardiac ceramide, 26% in DAG, and 20% in free fatty acid levels. Cardiac function assessed by echocardiography and cardiac catheterization was unaffected. These mice were then crossed with animals expressing long-chain acyl-CoA synthetase via the MHC promoter (MHC-ACS), which develop lipotoxic cardiomyopathy. MHC-DGAT1XMHC-ACS double transgenic male mice had improved heart function; fractional shortening increased by 74%, and diastolic function improved compared with MHC-ACS mice. The improvement of heart function correlated with a reduction in cardiac DAG and ceramide and reduced cardiomyocyte apoptosis but increased fatty acid oxidation. In addition, the survival of the mice was improved. Our study indicates that TG is not likely to be a toxic lipid species directly, but rather it is a feature of physiologic hypertrophy and may serve a cytoprotective role in lipid overload states. Moreover, induction of DGAT1 could be beneficial in the setting of excess heart accumulation of toxic lipids.	[Schaffer, Jean E.] Washington Univ, Sch Med, Div Cardiol, St Louis, MO 63110 USA; [Liu, Li; Shi, XiaoJing; Bharadwaj, Kalyani G.; Ikeda, Shota; Yamashita, Haruyo; Yagyu, Hiroaki; Yu, Yi-Hao; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Dept Med, Div Prevent Med & Metab, New York, NY 10032 USA	Washington University (WUSTL); Columbia University	Goldberg, IJ (corresponding author), Columbia Univ, Dept Med, 630 W 168th St,PH10-305, New York, NY 10032 USA.	ijg3@columbia.edu	Liu, Li/C-6761-2011	Ikeda, Shota/0000-0003-1358-524X; Yu, Yi-Hao/0000-0003-2696-1486	National Institutes of Health [HL45095]; NHLBI [HL73029, DK 064989]; Burroughs Wellcome Foundation [1005935]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073029, R01HL045095, R37HL045095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064989, R56DK064989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL45095 and HL73029 from the NHLBI (to I. J. G.) and DK 064989 (to J. S.). This work was also supported by Burroughs Wellcome Foundation Grant 1005935 (to J. S.).	Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Burelle Y, 2004, AM J PHYSIOL-HEART C, V287, pH1055, DOI 10.1152/ajpheart.00925.2003; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Cabrero A, 2001, DIABETES, V50, P1883, DOI 10.2337/diabetes.50.8.1883; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chandler MP, 2004, AM J PHYSIOL-HEART C, V287, pH1538, DOI 10.1152/ajpheart.00281.2004; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Flavell DM, 2006, J MOL MED, V84, P126, DOI 10.1007/s00109-005-0002-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDBERG DI, 1984, METABOLISM, V33, P964, DOI 10.1016/0026-0495(84)90252-X; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goodwin GW, 2000, AM J PHYSIOL-HEART C, V279, pH1490, DOI 10.1152/ajpheart.2000.279.4.H1490; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Gupte RS, 2007, J CARD FAIL, V13, P497, DOI 10.1016/j.cardfail.2007.04.003; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Gupte SA, 2008, CURR OPIN INVEST DR, V9, P993; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P395, DOI 10.1016/S0006-291X(02)00883-5; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096; Lopaschuk GD, 2003, CIRC RES, V93, pE33, DOI 10.1161/01.RES.0000086964.07404.A5; MARKLUND SL, 1982, CANCER RES, V42, P1955; Maulik N, 1999, CIRCULATION, V100, P369; Meegalla RL, 2002, BIOCHEM BIOPH RES CO, V298, P317, DOI 10.1016/S0006-291X(02)02466-X; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Okere IC, 2005, CLIN EXP PHARMACOL P, V32, P825, DOI 10.1111/j.1440-1681.2005.04272.x; Park TS, 2007, CURR OPIN LIPIDOL, V18, P277, DOI 10.1097/MOL.0b013e32814a57db; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Ryder JW, 1999, FASEB J, V13, P2246, DOI 10.1096/fasebj.13.15.2246; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; SEKILI S, 1993, CIRC RES, V73, P705, DOI 10.1161/01.RES.73.4.705; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; TRIANA JF, 1991, CIRC RES, V69, P731, DOI 10.1161/01.RES.69.3.731; VOLK ME, 1952, J BIOL CHEM, V195, P493; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Woo YJ, 1998, CIRCULATION, V98, pII255; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yamashita H, 2008, AM J PHYSIOL-ENDOC M, V295, pE705, DOI 10.1152/ajpendo.90338.2008; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu YH, 2002, J BIOL CHEM, V277, P50876, DOI 10.1074/jbc.M207353200	58	172	177	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36312	36323		10.1074/jbc.M109.049817	http://dx.doi.org/10.1074/jbc.M109.049817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19778901	hybrid, Green Published			2022-12-25	WOS:000272970500033
J	Mamidipudi, V; Cartwright, CA				Mamidipudi, V.; Cartwright, C. A.			A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways	ONCOGENE			English	Article						RACK1; Src; apoptosis; mitochondrial cell death; intrinsic pathway; Akt cell survival pathway	PROTEIN-KINASE-C; RECEPTOR-INTERACTING PROTEIN; TRANSCRIPTION FACTORS; INHIBITS APOPTOSIS; BCL-2 PROTEINS; CELL-MIGRATION; CANCER-CELLS; GROWTH; ACTIVATION; ADHESION	Earlier we showed that RACK1 regulates growth of human colon cells by suppressing Src activity at G(1) and mitotic checkpoints. Here, we show that RACK1 also induces apoptosis of the cells, partly by inhibiting Src. In the intrinsic pathway, RACK1 inhibits expression of anti-apoptotic Bcl-2 and Bcl-X-L, induces expression of proapoptotic Bim, targets Bim and Bax to the mitochondria, induces oligomerization of Bax (which requires Bim and inhibition of Src), depolarizes mitochondria membranes, releases cytochrome c, and activates caspases-9 and -3 and death substrates. Bax and Bim are required for RACK1-mediated mitochondrial cell death. RACK1-induced oligomerization of Bax is required for staurosporine-mediated cell death. RACK1 also induces apoptosis by blocking Src activation of the Akt cell survival pathway. This leads to activation of the transcription factor FOXO3, a potent inducer of apoptosis and G(1) arrest. Collectively, our results show that RACK1, partly by inhibiting Src, promotes mitochondrial cell death and blocks Akt-mediated cell survival. Thus, RACK1 inhibits growth and induces death of colon cells. Exploitation of these dual functions could lead to novel colon cancer therapies that mimic RACK1 function. Oncogene (2009) 28, 4421-4433; doi:10.1038/onc.2009.293; published online 21 September 2009	[Cartwright, C. A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Stanford University	Cartwright, CA (corresponding author), Stanford Univ, Dept Med, Sch Med, M211 Alway Bldg,MC 5187,300 Pasteur Dr, Stanford, CA 94305 USA.	chris.cartwright@stanford.edu			National Institutes of Health [DK43743]; Broad Medical Research Program [IBD-0068]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Jenny Cheng and Gayathri Swaminathan for many helpful discussions and critical review of the data and manuscript. This work was supported by a grant from the National Institutes of Health to CAC (DK43743). Preliminary studies were supported by a pilot grant from the Broad Medical Research Program (IBD-0068).	Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Gottlob K, 1998, J BIOL CHEM, V273, P33347, DOI 10.1074/jbc.273.50.33347; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Griffiths GJ, 2004, J BIOL CHEM, V279, P46113, DOI 10.1074/jbc.M408550200; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Inagaki K, 2006, CARDIOVASC RES, V70, P222, DOI 10.1016/j.cardiores.2006.02.015; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kang BPS, 2003, AM J PHYSIOL-RENAL, V285, pF1013, DOI 10.1152/ajprenal.00209.2003; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Liou JY, 2005, EXP CELL RES, V306, P75, DOI 10.1016/j.yexcr.2005.01.011; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; Makin G, 2003, TRENDS MOL MED, V9, P251, DOI 10.1016/S1471-4914(03)00084-4; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mamidipudi V, 2004, FEBS LETT, V567, P321, DOI 10.1016/j.febslet.2004.03.125; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; SUN Y, 2002, CANCER RES, V21, P6323; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483	54	53	57	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 17	2009	28	50					4421	4433		10.1038/onc.2009.293	http://dx.doi.org/10.1038/onc.2009.293			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DU	19767770				2022-12-25	WOS:000272876500002
J	Lee, JY; Johnson, J; Ding, ZW; Paetzel, M; Cornell, RB				Lee, Jaeyong; Johnson, Joanne; Ding, Ziwei; Paetzel, Mark; Cornell, Rosemary B.			Crystal Structure of a Mammalian CTP: Phosphocholine Cytidylyltransferase Catalytic Domain Reveals Novel Active Site Residues within a Highly Conserved Nucleotidyltransferase Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; MEMBRANE-BINDING DOMAIN; TRANSITION-STATE; CTP-GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE; TRYPTOPHAN ACTIVATION; SECONDARY-STRUCTURE; RAT-LIVER; IDENTIFICATION	CTP:phosphocholine cytidylyltransferase (CCT) is the key regulatory enzyme in the synthesis of phosphatidylcholine, the most abundant phospholipid in eukaryotic cell membranes. The CCT-catalyzed transfer of a cytidylyl group from CTP to phosphocholine to form CDP-choline is regulated by a membrane lipid-dependent mechanism imparted by its C-terminal membrane binding domain. We present the first analysis of a crystal structure of a eukaryotic CCT. Adeletion construct of rat CCT alpha spanning residues 1-236 (CCT236) lacks the regulatory domain and as a result displays constitutive activity. The 2.2-angstrom structure reveals a CCT236 homodimer in complex with the reaction product, CDP-choline. Each chain is composed of a complete catalytic domain with an intimately associated N-terminal extension, which together with the catalytic domain contributes to the dimer interface. Although the CCT236 structure reveals elements involved in binding cytidine that are conserved with other members of the cytidylyltransferase superfamily, it also features nonconserved active site residues, His-168 and Tyr-173, that make key interactions with the beta-phosphate of CDP-choline. Mutagenesis and kinetic analyses confirmed their role in phosphocholine binding and catalysis. These results demonstrate structural and mechanistic differences in a broadly conserved protein fold across the cytidylyltransferase family. Comparison of the CCT236 structure with those of other nucleotidyltransferases provides evidence for substrate-induced active site loop movements and a disorder-to-order transition of a loop element in the catalytic mechanism.	[Lee, Jaeyong; Johnson, Joanne; Ding, Ziwei; Paetzel, Mark; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca		Paetzel, Mark/0000-0002-7408-5487	Canadian Institutes of Health Research [12134]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant 12134 from the Canadian Institutes of Health Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; Fong DH, 2006, BBA-PROTEINS PROTEOM, V1764, P63, DOI 10.1016/j.bbapap.2005.10.015; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Izard T, 2002, J MOL BIOL, V315, P487, DOI 10.1006/jmbi.2001.5272; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwak BY, 2002, J BIOL CHEM, V277, P4343, DOI 10.1074/jbc.M109163200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEATHERBARROW RJ, 1985, P NATL ACAD SCI USA, V82, P7840, DOI 10.1073/pnas.82.23.7840; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Martin SF, 2000, BIOCHEMISTRY-US, V39, P3410, DOI 10.1021/bi9919798; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park YS, 1997, J BIOL CHEM, V272, P15161, DOI 10.1074/jbc.272.24.15161; PARK YS, 1993, J BIOL CHEM, V268, P16648; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Shen N, 2008, NUCLEIC ACIDS RES, V36, P1288, DOI 10.1093/nar/gkm1153; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; VERMEULEN PS, 1993, J BIOL CHEM, V268, P7458; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	63	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33535	33548		10.1074/jbc.M109.053363	http://dx.doi.org/10.1074/jbc.M109.053363			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19783652	Green Published, hybrid			2022-12-25	WOS:000272028500059
J	Brown, KK; Blaikie, FH; Smith, RAJ; Tyndall, JDA; Lue, H; Bernhagen, J; Winterbourn, CC; Hampton, MB				Brown, Kristin K.; Blaikie, Frances H.; Smith, Robin A. J.; Tyndall, Joel D. A.; Lue, Hongqi; Bernhagen, Juergen; Winterbourn, Christine C.; Hampton, Mark B.			Direct Modification of the Proinflammatory Cytokine Macrophage Migration Inhibitory Factor by Dietary Isothiocyanates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; FACTOR MIF; PHENETHYL ISOTHIOCYANATE; CANCER CELLS; CRUCIFEROUS VEGETABLES; COVALENT MODIFICATION; ENZYMATIC-ACTIVITY; HEPATOMA-CELLS; APOPTOSIS; SULFORAPHANE	Isothiocyanates are a class of phytochemicals with widely reported anti-cancer and anti-inflammatory activity. However, knowledge of their activity at a molecular level is limited. The objective of this study was to identify biological targets of phenethyl isothiocyanate (PEITC) using an affinity purification approach. An analogue of PEITC was synthesized to enable conjugation to a solid-phase resin. The pleiotropic cytokine macrophage migration inhibitory factor (MIF) was the major protein captured from cell lysates. Site-directed mutagenesis and mass spectrometry showed that PEITC covalently modified the N-terminal proline residue of MIF. This resulted in complete loss of catalytic tautomerase activity and disruption of protein conformation, as determined by impaired recognition by a monoclonal antibody directed to the region that receptors and interacting proteins bind to MIF. The conformational change was supported by in silico modeling. Monoclonal antibody binding to plasma MIF was disrupted in humans consuming watercress, a major dietary source of PEITC. The isothiocyanates have significant potential for development as MIF inhibitors, and this activity may contribute to the biological properties of these phytochemicals.	[Brown, Kristin K.; Winterbourn, Christine C.; Hampton, Mark B.] Univ Otago, Dept Pathol, Free Radical Res Grp, Christchurch 8140, New Zealand; [Tyndall, Joel D. A.] Univ Otago, Natl Sch Pharm, Dunedin 9054, New Zealand; [Blaikie, Frances H.; Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin 9054, New Zealand; Univ Aachen, RWTH, Inst Biochem & Mol Biol, D-52074 Aachen, Germany	University of Otago; University of Otago; University of Otago; RWTH Aachen University	Hampton, MB (corresponding author), POB 4345, Christchurch 8140, New Zealand.	mark.hampton@otago.ac.nz	tyndall, joel/C-2803-2008; Hampton, Mark B/A-8490-2008	tyndall, joel/0000-0003-0783-1635; Hampton, Mark B/0000-0002-7349-3729; BROWN, KRISTIN/0000-0002-4991-8870	Canterbury-West Coast Division; National Division of the Cancer Society of New Zealand; Maurice and Phyllis Paykel Trust; University of Otago Oxidative Stress Theme; German Research Council (Deutsche Forschungsgemeinschaft) [BE 1977/4-1/FOR809]	Canterbury-West Coast Division; National Division of the Cancer Society of New Zealand; Maurice and Phyllis Paykel Trust; University of Otago Oxidative Stress Theme; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the Canterbury-West Coast Division and the National Division of the Cancer Society of New Zealand. Support also came from the Maurice and Phyllis Paykel Trust, the University of Otago Oxidative Stress Theme, and German Research Council (Deutsche Forschungsgemeinschaft) Grant BE 1977/4-1/FOR809 (to J.B.).	Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Caddick S, 2000, TETRAHEDRON LETT, V41, P3513, DOI 10.1016/S0040-4039(00)00410-X; CALLAHAN JF, 1989, J MED CHEM, V32, P391, DOI 10.1021/jm00122a017; Chiao JW, 2004, CARCINOGENESIS, V25, P1403, DOI 10.1093/carcin/bgh136; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Cross JV, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-183; DEWEY TM, 1993, INORG CHEM, V32, P1729, DOI 10.1021/ic00061a032; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Drobnica J., 1977, CYANATES THEIR THIO, P1003; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hwang ES, 2006, J NUTR BIOCHEM, V17, P837, DOI 10.1016/j.jnutbio.2006.02.004; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Lee H, 2008, AM J CLIN PATHOL, V129, P772, DOI 10.1309/GFCLLRH8A68XKMJN; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Nakajima M, 2001, DRUG METAB DISPOS, V29, P1110; Palaniswamy UR, 2003, J AGR FOOD CHEM, V51, P5504, DOI 10.1021/jf034268w; Pham NA, 2004, MOL CANCER THER, V3, P1239; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; RUGGLI P, 1945, HELV CHIM ACTA, V28, P674, DOI 10.1002/hlca.660280197; Santos LL, 2008, CLIN EXP IMMUNOL, V152, P372, DOI 10.1111/j.1365-2249.2008.03639.x; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Stamps SL, 1998, BIOCHEMISTRY-US, V37, P10195, DOI 10.1021/bi9806955; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Taylor MS, 2004, J AM CHEM SOC, V126, P10558, DOI 10.1021/ja046259p; Thomson SJ, 2006, CANCER RES, V66, P6772, DOI 10.1158/0008-5472.CAN-05-3809; Tomiyasu M, 2002, CLIN CANCER RES, V8, P3755; Traka M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002568; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Xiao D, 2007, CANCER RES, V67, P2239, DOI 10.1158/0008-5472.CAN-06-3645; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Yu R, 1998, CANCER RES, V58, P402; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175	54	63	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32425	32433		10.1074/jbc.M109.047092	http://dx.doi.org/10.1074/jbc.M109.047092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776019	hybrid, Green Published			2022-12-25	WOS:000272028400025
J	Harr, MW; Rong, YP; Bootman, MD; Roderick, HL; Distelhorst, CW				Harr, Michael W.; Rong, Yiping; Bootman, Martin D.; Roderick, H. Llewelyn; Distelhorst, Clark W.			Glucocorticoid-mediated Inhibition of Lck Modulates the Pattern of T Cell Receptor-induced Calcium Signals by Down-regulating Inositol 1,4,5-Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; KAPPA-B ACTIVITY; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; GENE-EXPRESSION; LYMPHOMA-CELLS; NUCLEAR FACTOR; ACTIVATION; KINASE; TRANSCRIPTION	Glucocorticoids are potent immunosuppressive agents that block upstream signaling events required for T cell receptor (TCR) activation. However, the mechanism by which glucocorticoids inhibit downstream responses, such as inositol 1,4,5-trisphosphate (IP3)-induced calcium signals, is not completely understood. Here we demonstrate that low concentrations of dexamethasone rapidly convert transient calcium elevations to oscillations after strong TCR stimulation. Dexamethasone converted the pattern of calcium signaling by inhibiting the Src family kinase Lck, which was shown to interact with and positively regulate Type I IP3 receptor. In addition, low concentrations of dexamethasone were sufficient to inhibit calcium oscillations and interleukin-2mRNA after weak TCR stimulation. Together, these findings indicate that by inhibiting Lck and subsequently down-regulating IP3 receptors, glucocorticoids suppress immune responses by weakening the strength of the TCR signal.	[Harr, Michael W.; Distelhorst, Clark W.] Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, Cleveland, OH 44106 USA; [Rong, Yiping; Distelhorst, Clark W.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Distelhorst, Clark W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Distelhorst, Clark W.] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Bootman, Martin D.; Roderick, H. Llewelyn] Babraham Inst, Lab Mol & Cellular Signalling, Cambridge CB22 3AT, England; [Roderick, H. Llewelyn] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, 10900 Euclid Ave,WRB 3-133, Cleveland, OH 44106 USA.	cwd@case.edu	Bootman, Martin/AAB-3330-2019	Bootman, Martin/0000-0002-6447-3451; Roderick, Hywel/0000-0001-7065-3523	BBSRC [BBS/E/B/0000H110] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA042755] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/00001116, BBS/E/B/0000C116, BBS/E/B/0000H110] Funding Source: Medline; NCI NIH HHS [R01 CA042755] Funding Source: Medline; NHLBI NIH HHS [P01 HL080101] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADCOCK IM, 1995, AM J PHYSIOL-CELL PH, V268, pC331, DOI 10.1152/ajpcell.1995.268.2.C331; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bian XP, 1997, AM J PHYSIOL-CELL PH, V272, pC1241, DOI 10.1152/ajpcell.1997.272.4.C1241; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Cui J, 2004, J BIOL CHEM, V279, P16311, DOI 10.1074/jbc.M400206200; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Davis MC, 2008, J BIOL CHEM, V283, P10357, DOI 10.1074/jbc.M800269200; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; deSouza N, 2007, J CELL BIOL, V179, P923, DOI 10.1083/jcb.200708200; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; LAM M, 1993, MOL ENDOCRINOL, V7, P686, DOI 10.1210/me.7.5.686; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Lowenberg M, 2007, TRENDS MOL MED, V13, P158, DOI 10.1016/j.molmed.2007.02.001; Lowenberg M, 2006, EMBO REP, V7, P1023, DOI 10.1038/sj.embor.7400775; Mariathasan S, 1998, J IMMUNOL, V161, P6030; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PALIOGIANNI F, 1993, J CLIN INVEST, V91, P1481, DOI 10.1172/JCI116353; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; Qiu J, 1998, ENDOCRINOLOGY, V139, P5103, DOI 10.1210/en.139.12.5103; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; RUDD C, 1989, BIOCHEM CELL BIOL, V67, P581, DOI 10.1139/o89-090; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SZE PY, 1994, NEUROENDOCRINOLOGY, V59, P457, DOI 10.1159/000126692; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wagner PG, 1999, J NEUROSCI RES, V57, P643, DOI 10.1002/(SICI)1097-4547(19990901)57:5<643::AID-JNR6>3.0.CO;2-E; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	54	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31860	31871		10.1074/jbc.M109.005579	http://dx.doi.org/10.1074/jbc.M109.005579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776014	Green Published, hybrid			2022-12-25	WOS:000271572700041
J	Nickel, E; Nienhaus, K; Lu, CY; Yeh, SR; Nienhaus, GU				Nickel, Elena; Nienhaus, Karin; Lu, Changyuan; Yeh, Syun-Ru; Nienhaus, G. Ulrich			Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOGLOBIN MUTANT L29W; X-RAY CRYSTALLOGRAPHY; STRUCTURAL DYNAMICS; HEME-PROTEINS; TRYPTOPHAN 2,3-DIOXYGENASE; INFRARED-SPECTROSCOPY; ELECTRIC-FIELDS; CARBON-MONOXIDE; BINDING; TOLERANCE	Human indoleamine 2,3-dioxygenase (hIDO), a monomeric heme enzyme, catalyzes the oxidative degradation of L-Trp and other indoleamine derivatives. Using Fourier transform infrared and optical absorption spectroscopy, we have investigated the interplay between ferrous hIDO, the ligand analog CO, and the physiological substrate L-Trp. These data provide the long sought evidence for two distinct L-Trp binding sites. Upon photodissociation from the heme iron at T > 200 K, CO escapes into the solvent. Concomitantly, L-Trp exits the active site and, depending on the L-Trp concentration, migrates to a secondary binding site or into the solvent. Although L-Trp is spectroscopically silent at this site, it is still noticeable due to its pronounced effect on the CO association kinetics, which are significantly slower than those of L-Trp-free hIDO. L-Trp returns to its initial site only after CO has rebound to the heme iron.	[Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany; [Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Ctr Funct Nanostruct, D-76128 Karlsruhe, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lu, Changyuan; Yeh, Syun-Ru] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Ulm, Inst Biophys, D-89069 Ulm, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Yeshiva University; Albert Einstein College of Medicine; Ulm University	Nienhaus, GU (corresponding author), Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany.	uli@illinois.edu	Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Yeh, Syun-Ru/0000-0002-9858-386X	Deutsche Forschungsgemeinschaft (DFG) [Ni291/3]; Fonds der Chemischen Industrie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086482] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, Grant Ni291/3) and the Fonds der Chemischen Industrie (to G. U. N.).	ALBEN JO, 1982, P NATL ACAD SCI-BIOL, V79, P3744, DOI 10.1073/pnas.79.12.3744; Bourgeois D, 2003, P NATL ACAD SCI USA, V100, P8704, DOI 10.1073/pnas.1430900100; BRAUNSTEIN DP, 1993, BIOPHYS J, V65, P2447, DOI 10.1016/S0006-3495(93)81310-9; CHU K, 1995, PHYS REV LETT, V74, P2607, DOI 10.1103/PhysRevLett.74.2607; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1991, BER BUNSEN PHYS CHEM, V95, P272, DOI 10.1002/bbpc.19910950310; Guallar V, 2009, J BIOL CHEM, V284, P3106, DOI 10.1074/jbc.M806183200; HAYAISHI O, 1977, J BIOL CHEM, V252, P3548; Hummer G, 2004, P NATL ACAD SCI USA, V101, P15330, DOI 10.1073/pnas.0405295101; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; Kriegl JM, 2003, P NATL ACAD SCI USA, V100, P7069, DOI 10.1073/pnas.1231856100; Lehle H, 2005, BIOPHYS J, V88, P1978, DOI 10.1529/biophysj.104.048140; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Macchiarulo A, 2007, BBA-PROTEINS PROTEOM, V1774, P1058, DOI 10.1016/j.bbapap.2007.06.007; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; NIENHAUS GU, 1989, NATURE, V338, P665, DOI 10.1038/338665a0; Nienhaus K, 2005, BIOCHEMISTRY-US, V44, P5095, DOI 10.1021/bi047513t; Nienhaus K, 2005, J AM CHEM SOC, V127, P40, DOI 10.1021/ja0466917; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9647, DOI 10.1021/bi034788k; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9633, DOI 10.1021/bi034787s; Nienhaus K, 2008, METHOD ENZYMOL, V437, P347, DOI 10.1016/S0076-6879(07)37018-3; Nienhaus K, 2007, BIOCHEMISTRY-US, V46, P14018, DOI 10.1021/bi7016798; Ostermann A, 2000, NATURE, V404, P205, DOI 10.1038/35004622; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Park ES, 2002, J PHYS CHEM B, V106, P5800, DOI 10.1021/jp0203043; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Schmidt M, 2005, P NATL ACAD SCI USA, V102, P11704, DOI 10.1073/pnas.0504932102; Schmidt M, 2004, P NATL ACAD SCI USA, V101, P4799, DOI 10.1073/pnas.0305983101; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SONO M, 1980, J BIOL CHEM, V255, P1339; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vogel KM, 1999, J AM CHEM SOC, V121, P9915, DOI 10.1021/ja990042r; YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260	45	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31548	31554		10.1074/jbc.M109.039859	http://dx.doi.org/10.1074/jbc.M109.039859			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19767648	Green Published, hybrid			2022-12-25	WOS:000271572700008
J	Anderson, KR; Torres, CA; Solomon, K; Becker, TC; Newgard, CB; Wright, CV; Hagman, J; Sussel, L				Anderson, Keith R.; Torres, Ciara A.; Solomon, Keely; Becker, Thomas C.; Newgard, Christopher B.; Wright, Christopher V.; Hagman, James; Sussel, Lori			Cooperative Transcriptional Regulation of the Essential Pancreatic Islet Gene NeuroD1 (Beta2) by Nkx2.2 and Neurogenin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCRINE PANCREAS; CELL-DIFFERENTIATION; B-CELL; BETA2/NEUROD-DEFICIENT MICE; RNA INTERFERENCE; MATURE ISLET; IN-VIVO; EXPRESSION; ALPHA; ZEBRAFISH	Nkx2.2 and NeuroD1 are two critical regulators of pancreatic beta cell development. Nkx2.2 is a homeodomain transcription factor that is essential for islet cell type specification and mature beta cell function. NeuroD1 is a basic helix-loop-helix transcription factor that is critical for islet beta cell maturation and maintenance. Although both proteins influence beta cell development directly downstream of the endocrine progenitor factor, neurogenin3 (Ngn3), a connection between the two proteins in the regulation of beta cell fate and function has yet to be established. In this study, we demonstrate that Nkx2.2 transcriptional activity is required to facilitate the activation of NeuroD1 by Ngn3. Furthermore, Nkx2.2 is necessary to maintain high levels of NeuroD1 expression in developing mouse and zebrafish islets and in mature beta cells. Interestingly, Nkx2.2 regulates NeuroD1 through two independent promoter elements, one that is bound and activated directly by Nkx2.2 and one that appears to be regulated by Nkx2.2 through an indirect mechanism. Together, these findings suggest that Nkx2.2 coordinately activates NeuroD1 with Ngn3 within the endocrine progenitor cell and also plays a role in the maintenance of NeuroD1 expression to regulate beta cell function in the mature islet. Collectively, these findings further define the conserved regulatory networks involved in islet beta cell formation and function.	[Anderson, Keith R.; Sussel, Lori] Univ Colorado, Hlth Sci Ctr, Dept Biochem, Denver, CO 80045 USA; [Anderson, Keith R.] Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80045 USA; [Torres, Ciara A.; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Solomon, Keely; Wright, Christopher V.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27704 USA; [Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC 27704 USA; [Hagman, James] Natl Jewish Hlth Ctr, Integrated Dept Immunol, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Columbia University; Vanderbilt University; Duke University; Duke University; Duke University; National Jewish Health	Sussel, L (corresponding author), Columbia Univ, Dept Genet & Dev, 1150 St Nicholas Ave,Rm 607B, New York, NY 10032 USA.	lgs2@columbia.edu	Hagman, James/R-7013-2019	Hagman, James/0000-0002-5436-8455	National Institutes of Health [U01 DK072504, UO1DK072504, 5U01DK072473]; American Diabetes Association Regular Research Grant [1-2005-188]; Naomi Berrie Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072504, U01DK072473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Regular Research Grant(American Diabetes Association); Naomi Berrie Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 DK072504 (to L. S.), NIH supplement to UO1DK072504 (to C. T.), and NIH beta Cell Biology Consortium Grant 5U01DK072473 (a collaborative Bridging Project, to L. S. and C. B. N.). This work was also supported by American Diabetes Association Regular Research Grant, Juvenile Diabetes Research Foundation Regular Research Grant 1-2005-188 and the Naomi Berrie Diabetes Center (to L. S.).	Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Bewig B, 2000, BIOTECHNIQUES, V28, P870, DOI 10.2144/00285bm08; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Doyle MJ, 2007, DEVELOPMENT, V134, P515, DOI 10.1242/dev.02763; Doyle MJ, 2007, DIABETES, V56, P1999, DOI 10.2337/db06-1766; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fitzsimmons D, 1996, CURR OPIN IMMUNOL, V8, P166, DOI 10.1016/S0952-7915(96)80054-9; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Huang HP, 2002, MOL ENDOCRINOL, V16, P541, DOI 10.1210/me.16.3.541; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Itkin-Ansari P, 2005, DEV DYNAM, V233, P946, DOI 10.1002/dvdy.20443; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kemp DM, 2003, REV ENDOCR METAB DIS, V4, P5, DOI 10.1023/A:1021809917576; Kim WY, 2001, DEVELOPMENT, V128, P417; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; PICTET R, 1972, DEV EMBRYONIC ENDOCR, P26; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Qi YC, 2001, DEVELOPMENT, V128, P2723; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Schwitzgebel VM, 2001, MOL CELL ENDOCRINOL, V185, P99, DOI 10.1016/S0303-7207(01)00628-1; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Sussel L, 1998, DEVELOPMENT, V125, P2213; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Watada H, 2003, J BIOL CHEM, V278, P17130, DOI 10.1074/jbc.M213196200; Westerfield M, 1999, METHOD CELL BIOL, V60, P339; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	54	46	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31236	31248		10.1074/jbc.M109.048694	http://dx.doi.org/10.1074/jbc.M109.048694			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759004	hybrid, Green Published			2022-12-25	WOS:000271378400051
J	Kimura, N; Inoue, M; Okabayashi, S; Ono, F; Negishi, T				Kimura, Nobuyuki; Inoue, Makoto; Okabayashi, Sachi; Ono, Fumiko; Negishi, Takayuki			Dynein Dysfunction Induces Endocytic Pathology Accompanied by an Increase in Rab GTPases A POTENTIAL MECHANISM UNDERLYING AGE-DEPENDENT ENDOCYTIC DYSFUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAST AXONAL-TRANSPORT; SPORADIC ALZHEIMERS-DISEASE; CYNOMOLGUS MONKEY BRAINS; CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; NEURODEGENERATIVE DISEASES; DOWN-SYNDROME; CELLULAR-DISTRIBUTION; VESICLE TRANSPORT	Growing evidence suggests that endocytic dysfunction is intimately involved in early stage Alzheimer disease pathology, such as the accumulation of beta-amyloid precursor protein in enlarged early endosomes. However, it remains unclear how endocytic dysfunction is induced in an age-dependent manner. Cytoplasmic dynein, a microtubule-based motor protein, interacts with another microtubule-associated protein, dynactin. The resulting dynein-dynactin complex mediates minus end-directed vesicle transport, including endosome trafficking. We have previously shown that the interaction between dynein-dynactin complexes is clearly attenuated in aged monkey brains, suggesting that dynein-mediated transport dysfunction exists in aged brains. Our immunohistochemical analyses revealed that age-dependent endocytic pathology was accompanied by an increase in Rab GTPases in aged monkey brains. Here, we demonstrated that siRNA-induced dynein dysfunction reproduced the endocytic pathology accompanied by increased Rab GTPases seen in aged monkey brains and significantly disrupted exosome release. Moreover, it also resulted in endosomal beta-amyloid precursor protein accumulation characterized by increased beta-site cleavage. These findings suggest that dynein dysfunction may underlie age-dependent endocytic dysfunction via the up-regulation of Rab GTPases. In addition, this vicious circle may worsen endocytic dysfunction, ultimately leading to Alzheimer disease pathology.	[Kimura, Nobuyuki; Okabayashi, Sachi; Ono, Fumiko] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Lab Dis Control, Tsukuba, Ibaraki 3050843, Japan; [Inoue, Makoto] DNAVEC Res Inc, Tsukuba, Ibaraki 3058421, Japan; [Okabayashi, Sachi; Ono, Fumiko] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki 3050843, Japan; [Negishi, Takayuki] Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa 2298558, Japan	National Institute of Health Sciences - Japan; DNAVEC Corporation; Aoyama Gakuin University	Kimura, N (corresponding author), Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Lab Dis Control, 1-1 Hachimandai, Tsukuba, Ibaraki 3050843, Japan.	kimura@nibio.go.jp			Aging and Health, Ministry of Health, Labor, and Welfare, Japan	Aging and Health, Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant-in-aid from Comprehensive Research on Aging and Health, Ministry of Health, Labor, and Welfare, Japan.	Allan V, 1996, CURR BIOL, V6, P630, DOI 10.1016/S0960-9822(09)00434-5; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DeLacalle S, 1996, NEUROSCIENCE, V75, P19, DOI 10.1016/0306-4522(96)00239-4; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Holleran EA, 1998, INT REV CYTOL, V182, P69, DOI 10.1016/S0074-7696(08)62168-3; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Jouvenceau A, 2006, J PHYSIOL-PARIS, V99, P154, DOI 10.1016/j.jphysparis.2005.12.009; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kimura N, 2005, NEUROPATH APPL NEURO, V31, P170, DOI 10.1111/j.1365-2990.2004.00624.x; Kimura N, 2003, BIOCHEM BIOPH RES CO, V310, P303, DOI 10.1016/j.bbrc.2003.09.012; Kimura N, 2001, BRAIN RES, V922, P30, DOI 10.1016/S0006-8993(01)03146-8; Kimura N, 2007, J NEUROSCI RES, V85, P2909, DOI 10.1002/jnr.21408; Kokubo H, 2005, NEUROBIOL AGING, V26, P409, DOI 10.1016/j.neurobiolaging.2004.04.008; Ladner CJ, 1996, J NEUROPATH EXP NEUR, V55, P924, DOI 10.1097/00005072-199608000-00008; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; LIN SXH, 1994, J CELL BIOL, V127, P1009, DOI 10.1083/jcb.127.4.1009; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; MOOS T, 1995, BRAIN RES, V672, P14, DOI 10.1016/0006-8993(94)01329-G; Nakamura S, 1998, J MED PRIMATOL, V27, P244, DOI 10.1111/j.1600-0684.1998.tb00244.x; Niewiadomska G, 2005, ANN NY ACAD SCI, V1048, P287, DOI 10.1196/annals.1342.026; Niewiadomska G, 2003, NEUROREPORT, V14, P1701, DOI 10.1097/00001756-200309150-00009; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Norris CM, 1998, J NEUROPHYSIOL, V80, P1567, DOI 10.1152/jn.1998.80.3.1567; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Riggs B, 2007, MOL BIOL CELL, V18, P3313, DOI 10.1091/mbc.E07-02-0146; Runnegar MT, 1999, BIOCHEM J, V342, P1, DOI 10.1042/0264-6021:3420001; Russo R, 2005, FEBS LETT, V579, P6027, DOI 10.1016/j.febslet.2005.09.054; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; TAMAI Y, 1989, MICROBIOL IMMUNOL, V33, P35, DOI 10.1111/j.1348-0421.1989.tb01495.x; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Trojanowski JQ, 2003, NEUROMOL MED, V4, P1, DOI 10.1385/NMM:4:1-2:1; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; WANG R, 1991, J BIOL CHEM, V266, P16960; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Yoon SY, 2008, NEUROSCI LETT, V437, P111, DOI 10.1016/j.neulet.2008.03.083	66	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31291	31302		10.1074/jbc.M109.012625	http://dx.doi.org/10.1074/jbc.M109.012625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758999	Green Published, hybrid			2022-12-25	WOS:000271378400056
J	Lee, EF; Fedorova, A; Zobel, K; Boyle, MJ; Yang, H; Perugini, MA; Colman, PM; Huang, DCS; Deshayes, K; Fairlie, WD				Lee, Erinna F.; Fedorova, Anna; Zobel, Kerry; Boyle, Michelle J.; Yang, Hong; Perugini, Matthew A.; Colman, Peter M.; Huang, David C. S.; Deshayes, Kurt; Fairlie, W. Douglas			Novel Bcl-2 Homology-3 Domain-like Sequences Identified from Screening Randomized Peptide Libraries for Inhibitors of the Pro-survival Bcl-2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; BH3 DOMAINS; SCANNING MUTAGENESIS; FAMILY PROTEINS; BAX ACTIVATION; PHAGE DISPLAY; APOPTOSIS; BINDING; MCL-1; ANTAGONISTS	Interactions between Bcl-2 homology-3 (BH3)-only proteins and their pro-survival Bcl-2 family binding partners initiate the intrinsic apoptosis pathway. These interactions are mediated by a short helical motif, the BH3 domain, on the BH3-only protein, which inserts into a hydrophobic groove on the pro-survival molecule. To identify novel peptidic ligands that bind Mcl-1, a pro-survival protein relative of Bcl-2, both human and mouse Mcl-1 were screened against large randomized phage-displayed peptide libraries. We identified a number of 16-mer peptides with sub-micromolar affinity that were highly selective for Mcl-1, as well as being somewhat selective for the species of Mcl-1 (human or mouse) against which the library was panned. Interestingly, these sequences all strongly resembled natural BH3 domain sequences. By switching residues within the best of the human Mcl-1-binding sequences, or extending beyond the core sequence identified, we were able to alter the pro-survival protein interaction profile of this peptide such that it now bound all members tightly and was a potent killer when introduced into cells. Introduction of an amide lock constraint within this sequence also increased its helicity and binding to pro-survival proteins. These data provide new insights into the determinants of BH3 domain: pro-survival protein affinity and selectivity.	[Lee, Erinna F.; Boyle, Michelle J.; Yang, Hong; Colman, Peter M.; Huang, David C. S.; Fairlie, W. Douglas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Fedorova, Anna; Zobel, Kerry; Deshayes, Kurt] Genentech Inc, San Francisco, CA 94080 USA; [Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Roche Holding; Genentech; University of Melbourne	Deshayes, K (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	deshayes.kurt@gene.com; fairlie@wehi.edu.au	Huang, David C. S./C-7586-2013; Fairlie, Walter/M-8401-2015; Boyle, Michelle/P-7297-2019; Boyle, Michelle/D-4223-2018; Lee, Erinna/N-1523-2015	Huang, David C. S./0000-0002-3101-4873; Fairlie, Walter/0000-0002-2498-1160; Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; Lee, Erinna/0000-0003-1255-9808	National Health and Medical Research Council of Australia (NHRMC) [461221]; Leukemia and Lymphoma Society [SCOR 7015-02]; Cancer Council of Victoria [461239]; Leukemia Foundation of Australia Phillip Desbrow Post Doctoral Fellowship; Australian Cancer Research Foundation; NHMRC IRIISS [361646]; Victorian State Government	National Health and Medical Research Council of Australia (NHRMC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia Phillip Desbrow Post Doctoral Fellowship; Australian Cancer Research Foundation; NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government	This work was supported by the National Health and Medical Research Council of Australia (NHRMC, fellowships to W. D. F., P. M. C., and D. C. S. H.; Program Grant 461221 to P. M. C., and D. C. S. H.), by the Leukemia and Lymphoma Society (Grant SCOR 7015-02), by the Cancer Council of Victoria (Grant-in-aid 461239 to W. D. F. and D. C. S. H.; Fellowship to E. F. L.), by the Leukemia Foundation of Australia Phillip Desbrow Post Doctoral Fellowship (to E. F. L.), and by the Australian Cancer Research Foundation (to P. M. C.). Infrastructure support from NHMRC IRIISS Grant 361646 and the Victorian State Government (OIS grant) is gratefully acknowledged.	Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Fairlie WD, 2003, BIOCHEMISTRY-US, V42, P13193, DOI 10.1021/bi035303v; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; HERMES JD, 1989, GENE, V84, P143, DOI 10.1016/0378-1119(89)90148-0; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; HUTCHISON CA, 1986, P NATL ACAD SCI USA, V83, P710, DOI 10.1073/pnas.83.3.710; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lee EF, 2008, CELL DEATH DIFFER, V15, P1609, DOI 10.1038/cdd.2008.86; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pal G, 2003, J MOL BIOL, V332, P195, DOI 10.1016/S0022-2836(03)00898-2; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sidhu SS, 2007, METH MOL B, V352, P205; Skelton NJ, 2001, BIOCHEMISTRY-US, V40, P8487, DOI 10.1021/bi0103866; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang B, 2004, BIOORG MED CHEM LETT, V14, P1403, DOI 10.1016/j.bmcl.2003.09.101; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	41	28	29	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31315	31326		10.1074/jbc.M109.048009	http://dx.doi.org/10.1074/jbc.M109.048009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748896	Green Published, hybrid			2022-12-25	WOS:000271378400058
J	Palmieri, F; Rieder, B; Ventrella, A; Blanco, E; Do, PT; Nunes-Nesi, A; Trauth, AU; Fiermonte, G; Tjaden, J; Agrimi, G; Kirchberger, S; Paradies, E; Fernie, AR; Neuhaus, HE				Palmieri, Ferdinando; Rieder, Benjamin; Ventrella, Angela; Blanco, Emanuela; Do, Phuc Thi; Nunes-Nesi, Adriano; Trauth, A. Ulrike; Fiermonte, Giuseppe; Tjaden, Joachim; Agrimi, Gennaro; Kirchberger, Simon; Paradies, Eleonora; Fernie, Alisdair R.; Neuhaus, H. Ekkehard			Molecular Identification and Functional Characterization of Arabidopsis thaliana Mitochondrial and Chloroplastic NAD(+) Carrier Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSPORTER; BACTERIAL EXPRESSION; SACCHAROMYCES-CEREVISIAE; PHOSPHATE TRANSLOCATOR; ATP/ADP TRANSPORTERS; PLANT-MITOCHONDRIA; ORGAN DISTRIBUTION; SOLANUM-TUBEROSUM; ATP TRANSPORT; POTATO-TUBER	The Arabidopsis thaliana L. genome contains 58 membrane proteins belonging to the mitochondrial carrier family. Two mitochondrial carrier family members, here named AtNDT1 and AtNDT2, exhibit high structural similarities to the mitochondrial nicotinamide adenine dinucleotide (NAD(+)) carrier ScNDT1 from bakers' yeast. Expression of AtNDT1 or AtNDT2 restores mitochondrial NAD(+) transport activity in a yeast mutant lacking ScNDT. Localization studies with green fluorescent protein fusion proteins provided evidence that AtNDT1 resides in chloroplasts, whereas only AtNDT2 locates to mitochondria. Heterologous expression in Escherichia coli followed by purification, reconstitution in proteoliposomes, and uptake experiments revealed that both carriers exhibit a submillimolar affinity for NAD(+) and transport this compound in a counterexchange mode. Among various substrates ADP and AMP are the most efficient counter-exchange substrates for NAD(+). Atndt1- and Atndt2-promoter-GUS plants demonstrate that both genes are strongly expressed in developing tissues and in particular in highly metabolically active cells. The presence of both carriers is discussed with respect to the subcellular localization of de novo NAD(+) biosynthesis in plants and with respect to both the NAD(+)-dependent metabolic pathways and the redox balance of chloroplasts and mitochondria.	[Rieder, Benjamin; Trauth, A. Ulrike; Tjaden, Joachim; Kirchberger, Simon; Neuhaus, H. Ekkehard] Tech Univ Kaiserslautern, Fachbereich Biol, D-67663 Kaiserslautern, Germany; [Palmieri, Ferdinando; Ventrella, Angela; Blanco, Emanuela; Fiermonte, Giuseppe; Agrimi, Gennaro; Paradies, Eleonora] Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Palmieri, Ferdinando; Fiermonte, Giuseppe] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy; [Do, Phuc Thi; Nunes-Nesi, Adriano; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany	University of Kaiserslautern; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Max Planck Society	Neuhaus, HE (corresponding author), Tech Univ Kaiserslautern, Fachbereich Biol, Erwin Schrodinger Str, D-67663 Kaiserslautern, Germany.	neuhaus@rhrk.uni-kl.de	Blanco, Emanuela/ABF-8934-2020; Fiermonte, Giuseppe/D-3680-2018; Agrimi, Gennaro/D-4001-2018; Paradies, Eleonora/K-4606-2014; Nunes-Nesi, Adriano/D-6430-2013; Do, Phuc Thi/A-2318-2014	Fiermonte, Giuseppe/0000-0002-6764-9395; Agrimi, Gennaro/0000-0002-5219-4412; Paradies, Eleonora/0000-0002-1668-7148; Do, Phuc Thi/0000-0002-2893-8223; Nunes-Nesi, Adriano/0000-0002-9581-9355; BLANCO, EMANUELA/0000-0001-9541-7148	Deutsche Forschungsgemeinschaft Reinhard Koselleck; Ministero dell'Universitae della Ricerca; Center of Excellence in Genomics; Italian Human ProteomeNet [RBRN07BMCT_009]	Deutsche Forschungsgemeinschaft Reinhard Koselleck(German Research Foundation (DFG)); Ministero dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics; Italian Human ProteomeNet	This work was supported by a Deutsche Forschungsgemeinschaft Reinhard Koselleck grant (to E. N.), the Ministero dell'Universitae della Ricerca, the Center of Excellence in Genomics, and the Italian Human ProteomeNet RBRN07BMCT_009 (to F. P.).	Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; Arai Y, 2008, PLANT CELL, V20, P3227, DOI 10.1105/tpc.108.062877; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; Berkemeyer M, 1998, J BIOL CHEM, V273, P27927, DOI 10.1074/jbc.273.43.27927; Bouvier F, 2006, PLANT CELL, V18, P3088, DOI 10.1105/tpc.105.040741; Catoni E, 2003, FEBS LETT, V534, P87, DOI 10.1016/S0014-5793(02)03782-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Farre EM, 2000, PLANT PHYSIOL, V123, P681, DOI 10.1104/pp.123.2.681; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Glaser E, 1998, PLANT MOL BIOL, V38, P311, DOI 10.1023/A:1006020208140; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2007, FEBS LETT, V581, P2375, DOI 10.1016/j.febslet.2007.02.020; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Heldt H.-W., 2005, PLANT BIOCH; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kirchberger S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702484200; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KNIGHT JS, 1995, PLANT CELL, V7, P1421, DOI 10.1105/tpc.7.9.1421; LEHNINGER AL, 1994, PRINZIPIEN BIOCH; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Linka N, 2003, GENE, V306, P27, DOI 10.1016/S0378-1119(03)00429-3; Linka N, 2008, PLANT CELL, V20, P3241, DOI 10.1105/tpc.108.062042; Liu YJ, 2009, PLANT PHYSIOL, V150, P1248, DOI 10.1104/pp.109.136242; LODDENKOTTER B, 1993, P NATL ACAD SCI USA, V90, P2155, DOI 10.1073/pnas.90.6.2155; LUNN JE, 1993, BIOCHEM J, V290, P375, DOI 10.1042/bj2900375; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; NEUBURGER M, 1985, PLANT PHYSIOL, V78, P405, DOI 10.1104/pp.78.2.405; NEUBURGER M, 1983, BIOCHEM J, V216, P443, DOI 10.1042/bj2160443; Neuhaus HE, 1996, BIOCHEM J, V318, P945, DOI 10.1042/bj3180945; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Noctor G, 2006, J EXP BOT, V57, P1603, DOI 10.1093/jxb/erj202; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Ruiz-Medrano R, 2001, CURR OPIN PLANT BIOL, V4, P202, DOI 10.1016/S1369-5266(00)00162-X; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Schippers JHM, 2008, PLANT CELL, V20, P2909, DOI 10.1105/tpc.107.056341; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; SCHWARTZ JP, 1974, J BIOL CHEM, V249, P4138; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; STROTMANN H, 1969, BIOCHEM BIOPH RES CO, V35, P20, DOI 10.1016/0006-291X(69)90477-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; TOBIN A, 1980, PLANT PHYSIOL, V66, P225, DOI 10.1104/pp.66.2.225; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Trentmann O, 2007, PLOS BIOL, V5, P1938, DOI 10.1371/journal.pbio.0050231; Trentmann O, 2008, J BIOL CHEM, V283, P36486, DOI 10.1074/jbc.M806903200; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Weigel D., 2002, ARABIDOPSIS LAB MANU; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Wendt UK, 2000, PLANT J, V23, P723, DOI 10.1046/j.1365-313x.2000.00840.x; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; YONUSCHOT GR, 1970, J BIOL CHEM, V245, P4193; ZARA V, 1991, EUR J BIOCHEM, V198, P405, DOI 10.1111/j.1432-1033.1991.tb16029.x; Zhang QH, 2002, SCIENCE, V295, P1895; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	77	131	137	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31249	31259		10.1074/jbc.M109.041830	http://dx.doi.org/10.1074/jbc.M109.041830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19745225	Green Published, hybrid			2022-12-25	WOS:000271378400052
J	Brien, G; Debaud, AL; Robert, X; Oliver, L; Trescol-Biemont, MC; Cauquil, N; Geneste, O; Aghajari, N; Vallette, FM; Haser, R; Bonnefoy-Berard, N				Brien, Gaelle; Debaud, Anne-Laure; Robert, Xavier; Oliver, Lisa; Trescol-Biemont, Marie-Claude; Cauquil, Nicolas; Geneste, Olivier; Aghajari, Nushin; Vallette, Francois M.; Haser, Richard; Bonnefoy-Berard, Nathalie			C-terminal Residues Regulate Localization and Function of the Antiapoptotic Protein Bfl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BCL-W; ENDOPLASMIC-RETICULUM; INDUCE APOPTOSIS; B-CELLS; ANCHOR; FAMILY; BAX; ACTIVATION; SEQUESTERS	Unlike other antiapoptotic members of the Bcl-2 family, Bfl-1 does not contain a well defined C-terminal transmembrane domain, and whether the C-terminal tail of Bfl-1 functions as a membrane anchor is not yet clearly established. The molecular modeling study of the full-length Bfl-1 performed within this work suggests that Bfl-1 may co-exist in two distinct conformational states: one in which its C-terminal helix alpha 9 is inserted in the hydrophobic groove formed by the BH1-3 domains of Bfl-1 and one with its C terminus. Parallel analysis of the subcellular localization of Bfl-1 indicates that even if Bfl-1 may co-exist in two distinct conformational states, most of the endogenous protein is tightly associated with the mitochondria by its C terminus in both healthy and apoptotic peripheral blood lymphocytes as well as in malignant B cell lines. However, the helix alpha 9 of Bfl-1, and therefore the binding of Bfl-1 to mitochondria, is not absolutely required for the antiapoptotic activity of Bfl-1. A particular feature of Bfl-1 is the amphipathic character of its C-terminal helix alpha 9. Our data clearly indicate that this property of helix alpha 9 is required for the anchorage of Bfl-1 to the mitochondria but also regulates the antiapoptotic function Bfl-1.	[Brien, Gaelle; Debaud, Anne-Laure; Trescol-Biemont, Marie-Claude; Bonnefoy-Berard, Nathalie] INSERM, U851, F-69007 Lyon, France; [Brien, Gaelle; Debaud, Anne-Laure; Trescol-Biemont, Marie-Claude; Bonnefoy-Berard, Nathalie] Univ Lyon 1, IFR128, F-69003 Lyon, France; [Robert, Xavier; Aghajari, Nushin; Haser, Richard] Univ Lyon, Inst Biol & Chim Prot, IFR128 Biosci Lyon Gerland, Lab BioCristallog,CNRS UMR5086, F-69367 Lyon 07, France; [Oliver, Lisa; Vallette, Francois M.] Univ Nantes, Dept Rech Cancerol, F-44093 Nantes, France; [Oliver, Lisa; Vallette, Francois M.] INSERM, U601, F-44035 Nantes, France; [Cauquil, Nicolas; Geneste, Olivier] Inst Rech Servier, F-78290 Croissy Sur Seine, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Servier; Institut de Recherches Internationales Servier	Bonnefoy-Berard, N (corresponding author), INSERM, U851, 21 Tony Garnier, F-69007 Lyon, France.	nathalie.bonnefoy-berard@inserm.fr	Vallette, Francois M/K-9047-2015; Oliver, Lisa J/L-3070-2015; Aghajari, Nushin B.H./P-1906-2016; Bonnefoy, Nathalie/J-2536-2012; ROBERT, Xavier/C-3879-2015; Vallette, Francois/N-2361-2018	Vallette, Francois M/0000-0002-3296-8572; Oliver, Lisa J/0000-0002-5588-7564; Aghajari, Nushin B.H./0000-0002-2245-2679; Bonnefoy, Nathalie/0000-0003-4814-6722; ROBERT, Xavier/0000-0002-6174-8595; Mathieu, Anne-Laure/0000-0002-2893-7001	INSERM; Universite Claude Bernard Lyon I; Institut National du Cancer; Association pour la Recherche sur le Cancer and the Ligue contre le Cancer; Arthritis Foundation Courtin	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Claude Bernard Lyon I; Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer and the Ligue contre le Cancer; Arthritis Foundation Courtin	This work was supported by institutional grants from INSERM and Universite Claude Bernard Lyon I. This work was also supported by the Institut National du Cancer, the Association pour la Recherche sur le Cancer and the Ligue contre le Cancer (Comite de Savoie, du Rhone et de la Drome), and the Arthritis Foundation Courtin.	AKAO Y, 1994, CANCER RES, V54, P2468; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; D'Sa-Eipper C, 1998, ONCOGENE, V16, P3105, DOI 10.1038/sj.onc.1201851; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; DSaEipper C, 1996, CANCER RES, V56, P3879; Duriez PJ, 2000, J BIOL CHEM, V275, P18099, DOI 10.1074/jbc.M908925199; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Herold MJ, 2006, J BIOL CHEM, V281, P13663, DOI 10.1074/jbc.M600266200; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Ko JK, 2007, J CELL SCI, V120, P2912, DOI 10.1242/jcs.006197; Ko JK, 2003, FEBS LETT, V551, P29, DOI 10.1016/S0014-5793(03)00872-X; Kucharczak JF, 2005, CELL DEATH DIFFER, V12, P1225, DOI 10.1038/sj.cdd.4401684; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; LITHGOW T, 1994, CELL GROWTH DIFFER, V5, P411; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; ROUSSEL A, 1993, TRUBO FRODO BIOGRAPH; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Yang WS, 2005, J CELL BIOCHEM, V94, P1234, DOI 10.1002/jcb.20381	30	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30257	30263		10.1074/jbc.M109.040824	http://dx.doi.org/10.1074/jbc.M109.040824			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19759007	hybrid, Green Published			2022-12-25	WOS:000271090000029
J	McGarvey, PB; Huang, HZ; Mazumder, R; Zhang, J; Chen, YX; Zhang, CD; Cammer, S; Will, R; Odle, M; Sobral, B; Moore, M; Wu, CH				McGarvey, Peter B.; Huang, Hongzhan; Mazumder, Raja; Zhang, Jian; Chen, Yongxing; Zhang, Chengdong; Cammer, Stephen; Will, Rebecca; Odle, Margie; Sobral, Bruno; Moore, Margaret; Wu, Cathy H.			Systems Integration of Biodefense Omics Data for Analysis of Pathogen-Host Interactions and Identification of Potential Targets	PLOS ONE			English	Article							MODEL ORGANISM DATABASE; VACCINIA-VIRUS; INTRACELLULAR MATURE; BACILLUS-ANTHRACIS; PROTEIN INTERACTIONS; MEMBRANE-PROTEIN; ENVELOPE PROTEIN; GENE-EXPRESSION; IN-VITRO; PROTEOMICS	The NIAID (National Institute for Allergy and Infectious Diseases) Biodefense Proteomics program aims to identify targets for potential vaccines, therapeutics, and diagnostics for agents of concern in bioterrorism, including bacterial, parasitic, and viral pathogens. The program includes seven Proteomics Research Centers, generating diverse types of pathogen-host data, including mass spectrometry, microarray transcriptional profiles, protein interactions, protein structures and biological reagents. The Biodefense Resource Center (www.proteomicsresource.org) has developed a bioinformatics framework, employing a protein-centric approach to integrate and support mining and analysis of the large and heterogeneous data. Underlying this approach is a data warehouse with comprehensive protein + gene identifier and name mappings and annotations extracted from over 100 molecular databases. Value-added annotations are provided for key proteins from experimental findings using controlled vocabulary. The availability of pathogen and host omics data in an integrated framework allows global analysis of the data and comparisons across different experiments and organisms, as illustrated in several case studies presented here. (1) The identification of a hypothetical protein with differential gene and protein expressions in two host systems (mouse macrophage and human HeLa cells) infected by different bacterial (Bacillus anthracis and Salmonella typhimurium) and viral (orthopox) pathogens suggesting that this protein can be prioritized for additional analysis and functional characterization. (2) The analysis of a vaccinia-human protein interaction network supplemented with protein accumulation levels led to the identification of human Keratin, type II cytoskeletal 4 protein as a potential therapeutic target. (3) Comparison of complete genomes from pathogenic variants coupled with experimental information on complete proteomes allowed the identification and prioritization of ten potential diagnostic targets from Bacillus anthracis. The integrative analysis across data sets from multiple centers can reveal potential functional significance and hidden relationships between pathogen and host proteins, thereby providing a systems approach to basic understanding of pathogenicity and target identification.			McGarvey, PB (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA.	pbm9@georgetown.edu; wuc@georgetown.edu	Crozier, Laura B./A-4821-2010; McGarvey, Peter/AAE-9351-2019; Sobral, Bruno/GVU-7637-2022; Chen, YX/G-3937-2010	Sobral, Bruno/0000-0003-3908-577X; Wu, Cathy/0000-0001-6379-8601; McGarvey, Peter/0000-0002-8312-6017; Mazumder, Raja/0000-0001-8823-9945	NIAID NIH HHS [HHSN266200400061C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcami A, 1998, J IMMUNOL, V160, P624; Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; *AM ONL, 2003, CALL PERS LIB CPL VE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Bienkowska JR, 2003, PROTEIN ENG, V16, P897, DOI 10.1093/protein/gzg130; Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brown E, 2006, J VIROL, V80, P9455, DOI 10.1128/JVI.01149-06; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Chisholm RL, 2006, NUCLEIC ACIDS RES, V34, pD423, DOI 10.1093/nar/gkj090; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; DALLO S, 1987, VIROLOGY, V159, P423, DOI 10.1016/0042-6822(87)90481-8; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Deng Minghua, 2003, Pac Symp Biocomput, P140; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; GONG S, 1990, VIROLOGY, V178, P81, DOI 10.1016/0042-6822(90)90381-Z; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hermjakob H, 2006, PROTEOMICS, P34, DOI 10.1002/pmic.200600537; Ho Y, 2005, J MOL BIOL, V349, P1060, DOI 10.1016/j.jmb.2005.04.024; Hood Leroy, 2008, Briefings in Functional Genomics & Proteomics, V7, P239, DOI 10.1093/bfgp/eln027; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; HUANG H, 2004, DATA SCI J, V3, P163; Hutchens MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000153; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17302, DOI 10.1073/pnas.0508649102; *INF RETR LTD, 2009, NUCL ACIDS RES DAT I; Jones JM, 2008, CYTOKINE, V43, P220, DOI 10.1016/j.cyto.2008.05.016; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Leinonen R, 2004, BIOINFORMATICS, V20, P3236, DOI 10.1093/bioinformatics/bth191; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lu ZY, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P269; Manes NP, 2008, J PROTEOME RES, V7, P960, DOI 10.1021/pr070432+; Mathew JP, 2007, PLOS COMPUT BIOL, V3, P153, DOI 10.1371/journal.pcbi.0030012; Mazumder R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-279; McCoy SL, 2005, J IMMUNOL, V174, P3006, DOI 10.4049/jimmunol.174.5.3006; Ness SL, 1998, J BIOL CHEM, V273, P23904, DOI 10.1074/jbc.273.37.23904; Nichols RJ, 2008, J VIROL, V82, P10247, DOI 10.1128/JVI.01035-08; Norbeck AD, 2005, J AM SOC MASS SPECTR, V16, P1239, DOI 10.1016/j.jasms.2005.05.009; Orchard S, 2008, BRIEF BIOINFORM, V9, P166, DOI 10.1093/bib/bbm061; Orchard S, 2005, PROTEOMICS, V5, P3552, DOI 10.1002/pmic.200500626; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Rolfs A, 2008, P NATL ACAD SCI USA, V105, P4364, DOI 10.1073/pnas.0712049105; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheeley DM, 2005, J PROTEOME RES, V4, P1114, DOI 10.1021/pr050066z; Spellman PT, 2002, GENOME BIOL, V3; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Suthram S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-360; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Vermeer PD, 2007, J VIROL, V81, P9891, DOI 10.1128/JVI.00601-07; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Wienkoop S, 2008, MOL CELL PROTEOMICS, V7, P1725, DOI 10.1074/mcp.M700273-MCP200; Wu CH, 2004, COMPUT BIOL CHEM, V28, P87, DOI 10.1016/j.compbiolchem.2003.10.003; Yeung Natalie, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0813s23; Zhang C, 2008, NUCLEIC ACIDS RES, V36, pD884, DOI 10.1093/nar/gkm903	69	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7162	10.1371/journal.pone.0007162	http://dx.doi.org/10.1371/journal.pone.0007162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779614	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200009
J	Mukherjee, J; Webster, N; Llewellyn, LE				Mukherjee, Joydeep; Webster, Nicole; Llewellyn, Lyndon E.			Purification and Characterization of a Collagenolytic Enzyme from a Pathogen of the Great Barrier Reef Sponge, Rhopaloeides odorabile	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; COLLAGENASE; DISEASE; GENE; PROTEASE; CLONING; AGENT	Background: In recent years there has been a global increase in reports of disease affecting marine sponges. While disease outbreaks have the potential to seriously impact on the survival of sponge populations, the ecology of the marine environment and the health of associated invertebrates, our understanding of sponge disease is extremely limited. Methodology/Principal Findings: A collagenolytic enzyme suspected to enhance pathogenicity of bacterial strain NW4327 against the sponge Rhopaloeides odorabile was purified using combinations of size exclusion and anion exchange chromatography. After achieving a 77-fold increase in specific activity, continued purification decreased the yield to 21-fold with 7.2% recovery (specific activity 2575 collagen degrading units mg 21 protein) possibly due to removal of co-factors. SDS-PAGE of the partially pure enzyme showed two proteins weighing approximately 116 and 45 kDa with the heavier band being similar to reported molecular weights of collagenases from Clostridium and marine Vibrios. The enzyme degraded tissue fibres of several sponge genera suggesting that NW4327 could be deleterious to other sponge species. Activity towards casein and bird feather keratin indicates that the partially purified collagenase is either a non-selective protease able to digest collagen or is contaminated with non-specific proteases. Enzyme activity was highest at pH 5 (the internal pH of R. odorabile) and 30 degrees C (the average ambient seawater temperature). Activity under partially anaerobic conditions also supports the role of this enzyme in the degradation of the spongin tissue. Cultivation of NW4327 in the presence of collagen increased production of collagenase by 30%. Enhanced enzyme activity when NW4327 was cultivated in media formulated in sterile natural seawater indicates the presence of other factors that influence enzyme synthesis. Conclusions/Significance: Several aspects of the sponge disease etiology were revealed, particularly the strong correlation with the internal tissue chemistry and environmental temperature. This research provides a platform for further investigations into the virulence mechanisms of sponge pathogens.			Mukherjee, J (corresponding author), Jadavpur Univ, Sch Environm Studies, Kolkata, India.	L.Llewellyn@aims.gov.au	Webster, Nicole S/G-4980-2011; Llewellyn, Lyndon E/F-6030-2011	Webster, Nicole S/0000-0002-4753-5278; Llewellyn, Lyndon E/0000-0003-1680-1796				Bell PJL, 2003, J AM CHEM SOC, V125, P9304, DOI 10.1021/ja035496+; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCK TD, 1977, APPL ENVIRON MICROB, V33, P254, DOI 10.1128/AEM.33.2.254-256.1977; Cervino JM, 2006, MAR ECOL PROG SER, V324, P139, DOI 10.3354/meps324139; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Corriero G., 1996, THALASSIA SALENT, V22, P51; Demina NS, 1996, MICROBIOLOGY+, V65, P661; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; GAMMILL ER, 2005, DIS THREATENS CARIBB; Heinemann S, 2007, BIOMACROMOLECULES, V8, P3452, DOI 10.1021/bm700574y; Juarez ZE, 1999, INFECT IMMUN, V67, P271, DOI 10.1128/IAI.67.1.271-278.1999; Kang SI, 2005, BIOTECHNOL BIOPROC E, V10, P593, DOI 10.1007/BF02932300; Kim BJ, 1998, J MICROBIOL BIOTECHN, V8, P245; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; MATSUSHITA O, 1994, J BACTERIOL, V176, P149, DOI 10.1128/JB.176.1.149-156.1994; MERKEL JR, 1975, APPL MICROBIOL, V29, P145, DOI 10.1128/AEM.29.2.145-151.1975; MERKEL JR, 1978, BIOCHEMISTRY-US, V17, P2857, DOI 10.1021/bi00607a025; Nagano H, 2000, BIOSCI BIOTECH BIOCH, V64, P181, DOI 10.1271/bbb.64.181; Olson JB, 2006, DIS AQUAT ORGAN, V71, P163, DOI 10.3354/dao071163; Petrova DH, 2006, J BASIC MICROB, V46, P275, DOI 10.1002/jobm.200510063; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; TAKEUCHI H, 1992, BIOCHEM J, V281, P703, DOI 10.1042/bj2810703; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; WEBSTER NS, 2000, THESIS J COOK U TOWN; YOSHIHARA K, 1994, J BACTERIOL, V176, P6489, DOI 10.1128/JB.176.21.6489-6496.1994	29	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7177	10.1371/journal.pone.0007177	http://dx.doi.org/10.1371/journal.pone.0007177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777058	Green Submitted, Green Published, gold			2022-12-25	WOS:000270164600013
J	Publio, R; Oliveira, RF; Roque, AC				Publio, Rodrigo; Oliveira, Rodrigo F.; Roque, Antonio C.			A Computational Study on the Role of Gap Junctions and Rod I-h Conductance in the Enhancement of the Dynamic Range of the Retina	PLOS ONE			English	Article								Recent works suggest that one of the roles of gap junctions in sensory systems is to enhance their dynamic range by avoiding early saturation in the first processing stages. In this work, we use a minimal conductance-based model of the ON rod pathways in the vertebrate retina to study the effects of electrical synaptic coupling via gap junctions among rods and among AII amacrine cells on the dynamic range of the retina. The model is also used to study the effects of the maximum conductance of rod hyperpolarization activated current I-h on the dynamic range of the retina, allowing a study of the interrelations between this intrinsic membrane parameter with those two retina connectivity characteristics. Our results show that for realistic values of I-h conductance the dynamic range is enhanced by rod-rod coupling, and that AII-AII coupling is less relevant to dynamic range amplification in comparison with receptor coupling. Furthermore, a plot of the retina output response versus input intensity for the optimal parameter configuration is well fitted by a power law with exponent similar to 0.5. The results are consistent with predictions of more theoretical works and suggest that the earliest expression of gap junctions along the rod pathways, together with appropriate values of rod I-h conductance, has the highest impact on vertebrate retina dynamic range enhancement.			Publio, R (corresponding author), Okinawa Inst Sci & Technol, Computat Neurosci Unit, Okinawa, Japan.	publio@oist.jp	Oliveira, Rodrigo Freire/Q-7155-2018; Roque, Antonio C./C-2316-2011	Oliveira, Rodrigo Freire/0000-0003-0312-1839; Roque, Antonio C./0000-0003-1260-4840; Oliveira, Rodrigo/0000-0002-3414-3339	NIAAA NIH HHS [R01-AA16022, R01 AA016022] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016022] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Awatramani GB, 2001, J NEUROSCI, V21, P741, DOI 10.1523/JNEUROSCI.21-02-00741.2001; BAYLOR DA, 1984, J PHYSIOL-LONDON, V354, P203, DOI 10.1113/jphysiol.1984.sp015372; BEGGS JM, 2003, J NEUROSCI, V487, P441; Berntson A, 2004, VISUAL NEUROSCI, V21, P913, DOI 10.1017/S095252380421611X; BOOS R, 1993, J NEUROSCI, V13, P2874; Carnevale T.N., 2006, NEURON BOOK; Copelli M, 2005, NEUROCOMPUTING, V65, P691, DOI 10.1016/j.neucom.2004.10.099; Copelli M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.060901; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FOHLMEISTER J, 1997, J NEUROPHYSIOL, V78, P1395; Furtado LS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011907; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Jacoby RA, 2001, VISUAL NEUROSCI, V18, P703, DOI 10.1017/S0952523801185044; JONES G, 1995, J PHYSL, V487, P11167; Kamiyama Y, 1996, VISION RES, V36, P4059, DOI 10.1016/S0042-6989(96)00178-2; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kourennyi DE, 2004, J NEUROPHYSIOL, V92, P477, DOI 10.1152/jn.00606.2003; Lagnado L, 2003, CURR BIOL, V13, pR631, DOI 10.1016/S0960-9822(03)00566-9; Li W, 2004, NAT NEUROSCI, V7, P751, DOI 10.1038/nn1275; Liu XD, 2004, ANN BIOMED ENG, V32, P1428, DOI 10.1114/B:ABME.0000042230.99614.8d; MAO BQ, 2003, VISION RES, V83, P2756; Mukai S, 2002, JPN J PHARMACOL, V89, P44, DOI 10.1254/jjp.89.44; Mulloney B, 2003, J NEUROSCI, V23, P5953; Ogura T, 2003, VISION RES, V43, P2019, DOI 10.1016/S0042-6989(03)00309-2; Petrides A, 2008, J COMP NEUROL, V507, P1653, DOI 10.1002/cne.21617; Publio R, 2006, NEUROCOMPUTING, V69, P1020, DOI 10.1016/j.neucom.2005.12.037; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; RODIECK RW, 1988, COMP PRIMATE BIOL, V41, P203; SHEW WL, 2009, ARXIV09060527; Sikora MA, 2005, J NEUROSCI METH, V145, P47, DOI 10.1016/j.jneumeth.2004.11.023; SMITH RG, 1995, VISUAL NEUROSCI, V12, P851, DOI 10.1017/S095252380000941X; STERLING P, 1988, J NEUROSCI, V8, P623; Stevens SS, 1975, PSYCHOPHYSICS INTRO, pxiv; TESSIERLAVIGNE M, 1988, PROC R SOC SER B-BIO, V234, P171, DOI 10.1098/rspb.1988.0043; Usui S, 1996, VISION RES, V36, P4069, DOI 10.1016/S0042-6989(96)00179-4; Vardi N, 1996, VISION RES, V36, P3743, DOI 10.1016/0042-6989(96)00098-3; Veruki ML, 2009, J NEUROPHYSIOL, V101, P2339, DOI 10.1152/jn.00112.2009; Veruki ML, 2008, J NEUROPHYSIOL, V100, P3305, DOI 10.1152/jn.90957.2008; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; YUPING M, 2003, J NEUROPHYSIOL, V90, P3479; Zhang J, 2005, J PHYSIOL-LONDON, V564, P849, DOI 10.1113/jphysiol.2005.082859	48	39	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e6970	10.1371/journal.pone.0006970	http://dx.doi.org/10.1371/journal.pone.0006970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777063	Green Submitted, Green Published, gold			2022-12-25	WOS:000270164600002
J	Wyatt, HDM; Tsang, AR; Lobb, DA; Beattie, TL				Wyatt, Haley D. M.; Tsang, Allison R.; Lobb, Deirdre A.; Beattie, Tara L.			Human Telomerase Reverse Transcriptase (hTERT) Q169 Is Essential for Telomerase Function In Vitro and In Vivo	PLOS ONE			English	Article							REPEAT ADDITION PROCESSIVITY; ACTIVE HUMAN TELOMERASE; N-TERMINAL DOMAIN; TETRAHYMENA TELOMERASE; PRIMER SPECIFICITY; YEAST TELOMERASE; IMMORTAL CELLS; ANCHOR SITE; RNA; DNA	Background: Telomerase is a reverse transcriptase that maintains the telomeres of linear chromosomes and preserves genomic integrity. The core components are a catalytic protein subunit, the telomerase reverse transcriptase (TERT), and an RNA subunit, the telomerase RNA (TR). Telomerase is unique in its ability to catalyze processive DNA synthesis, which is facilitated by telomere-specific DNA-binding domains in TERT called anchor sites. A conserved glutamine residue in the TERT N-terminus is important for anchor site interactions in lower eukaryotes. The significance of this residue in higher eukaryotes, however, has not been investigated. Methodology/Principal Findings: To understand the significance of this residue in higher eukaryotes, we performed site-directed mutagenesis on human TERT (hTERT) Q169 to create neutral (Q169A), conservative (Q169N), and non-conservative (Q169D) mutant proteins. We show that these mutations severely compromise telomerase activity in vitro and in vivo. The functional defects are not due to abrogated interactions with hTR or telomeric ssDNA. However, substitution of hTERT Q169 dramatically impaired the ability of telomerase to incorporate nucleotides at the second position of the template. Furthermore, Q169 mutagenesis altered the relative strength of hTERT-telomeric ssDNA interactions, which identifies Q169 as a novel residue in hTERT required for optimal primer binding. Proteolysis experiments indicate that Q169 substitution alters the protease-sensitivity of the hTERT N-terminus, indicating that a conformational change in this region of hTERT is likely critical for catalytic function. Conclusions/Significance: We provide the first detailed evidence regarding the biochemical and cellular roles of an evolutionarily-conserved Gln residue in higher eukaryotes. Collectively, our results indicate that Q169 is needed to maintain the hTERT N-terminus in a conformation that is necessary for optimal enzyme-primer interactions and nucleotide incorporation. We show that Q169 is critical for the structure and function of human telomerase, thereby identifying a novel residue in hTERT that may be amenable to therapeutic intervention.			Wyatt, HDM (corresponding author), Univ Calgary, So Alberta Canc Res Inst, Calgary, AB, Canada.	tbeattie@ucalgary.ca						Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Beattie TL, 2000, MOL BIOL CELL, V11, P3329, DOI 10.1091/mbc.11.10.3329; Beattie TL, 1998, CURR BIOL, V8, P177, DOI 10.1016/S0960-9822(98)70067-3; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Finger SN, 2008, NUCLEIC ACIDS RES, V36, P1260, DOI 10.1093/nar/gkm866; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Friedman KL, 2003, MOL BIOL CELL, V14, P1, DOI 10.1091/mbc.E02-06-0327; GARCIA CK, 2007, NUCL ACIDS RES; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hardy CD, 2001, J BIOL CHEM, V276, P4863, DOI 10.1074/jbc.M005158200; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARRINGTON LA, 1991, NATURE, V353, P451, DOI 10.1038/353451a0; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Huard S, 2003, NUCLEIC ACIDS RES, V31, P4059, DOI 10.1093/nar/gkg437; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; LEE MS, 1993, MOL CELL BIOL, V13, P6586, DOI 10.1128/MCB.13.10.6586; Lue NF, 2007, NUCLEIC ACIDS RES, V35, P5213, DOI 10.1093/nar/gkm531; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; WANG SS, 1990, MOL CELL BIOL, V10, P4415, DOI 10.1128/MCB.10.8.4415; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wyatt HDM, 2007, MOL CELL BIOL, V27, P3226, DOI 10.1128/MCB.02368-06; Zaug AJ, 2008, NAT STRUCT MOL BIOL, V15, P871, DOI 10.1038/nsmb.1462; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388	49	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7176	10.1371/journal.pone.0007176	http://dx.doi.org/10.1371/journal.pone.0007176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777057	gold, Green Published, Green Submitted			2022-12-25	WOS:000270164600012
J	Battur, B; Boldbaatar, D; Umemiya-Shirafuji, R; Liao, M; Battsetseg, B; Taylor, D; Baymbaa, B; Fujisaki, K				Battur, Banzragch; Boldbaatar, Damdinsuren; Umemiya-Shirafuji, Rika; Liao, Min; Battsetseg, Badgar; Taylor, Demar; Baymbaa, Badarch; Fujisaki, Kozo			LKR/SDH Plays Important Roles throughout the Tick Life Cycle Including a Long Starvation Period	PLOS ONE			English	Article							LYSINE-KETOGLUTARATE REDUCTASE; AMINOADIPIC SEMIALDEHYDE SYNTHASE; SACCHAROPINE DEHYDROGENASE; PIPECOLIC ACID; CATABOLISM; PURIFICATION; METABOLISM; STRESS; DEGRADATION; GLUTAMATE	Background: Lysine-ketoglutarate reductase/saccharopine dehydrogenase (LKR/SDH) is a bifunctional enzyme catalyzing the first two steps of lysine catabolism in plants and mammals. However, to date, the properties of the lysine degradation pathway and biological functions of LKR/SDH have been very little described in arthropods such as ticks. Methodology/Principal Findings: We isolated and characterized the gene encoding lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) and saccharopine dehydrogenase (SDH, EC 1.5.1.9) from a tick, Haemaphysalis longicornis, cDNA library that encodes a bifunctional polypeptide bearing domains similar to the plant and mammalian LKR/SDH enzymes. Expression of LKR/SDH was detected in all developmental stages, indicating an important role throughout the tick life cycle, including a long period of starvation after detachment from the host. The LKR/SDH mRNA transcripts were more abundant in unfed and starved ticks than in fed and engorged ticks, suggesting that tick LKR/SDH are important for the starved tick. Gene silencing of LKR/SDH by RNAi indicated that the tick LKR/SDH plays an integral role in the osmotic regulation of water balance and development of eggs in ovary of engorged females. Conclusions/Significance: Transcription analysis and gene silencing of LKR/SDH indicated that tick LKR/SDH enzyme plays not only important roles in egg production, reproduction and development of the tick, but also in carbon, nitrogen and water balance, crucial physiological processes for the survival of ticks. This is the first report on the role of LKR/SDH in osmotic regulation in animals including vertebrate and arthropods.			Battur, B (corresponding author), Kagoshima Univ, Fac Agr, Dept Frontier Vet Med, Lab Emerging Infect Dis, Kagoshima 890, Japan.	tick@ms.kagoshima-u.ac.jp	Battsetseg, Badgar/AAA-5498-2021; Umemiya-Shirafuji, Rika/AFT-5139-2022; Banzragch, Battur/ABI-7875-2020	Battsetseg, Badgar/0000-0001-6731-9639; Umemiya-Shirafuji, Rika/0000-0001-7641-5526; Banzragch, Battur/0000-0002-2573-8031; Damdinsuren, Boldbaatar/0000-0002-0541-3766				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMEEN M, 1987, BIOCHEM INT, V14, P589; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Anger K, 1998, INVERTEBR REPROD DEV, V33, P159, DOI 10.1080/07924259.1998.9652629; Azevedo RA, 2001, AMINO ACIDS, V20, P261, DOI 10.1007/s007260170043; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; BLEMINGS KP, 1994, J NUTR, V124, P1215, DOI 10.1093/jn/124.8.1215; BOOTH T F, 1985, Experimental and Applied Acarology, V1, P165, DOI 10.1007/BF01270595; Cakouros D, 2008, J CELL BIOL, V182, P481, DOI 10.1083/jcb.200712169; Deleu C, 1999, PLANT CELL ENVIRON, V22, P979, DOI 10.1046/j.1365-3040.1999.00471.x; Epelbaum S, 1997, PLANT MOL BIOL, V35, P735, DOI 10.1023/A:1005808923191; FORSBERG NE, 1986, NUTR RES, V6, P191, DOI 10.1016/S0271-5317(86)80122-1; FOSTER AR, 1993, NUTR RES, V13, P1433, DOI 10.1016/S0271-5317(05)80792-4; FUENTE JL, 2007, TREPAR, V622, P1; FUJISAKI K, 1994, PARASITOL TODAY, V10, P31, DOI 10.1016/0169-4758(94)90355-7; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Galili G, 2001, CURR OPIN PLANT BIOL, V4, P261, DOI 10.1016/S1369-5266(00)00170-9; GALUN R, 1965, SCIENCE, V147, P166, DOI 10.1126/science.147.3654.166; Gaziola SA, 1997, EUR J BIOCHEM, V247, P364, DOI 10.1111/j.1432-1033.1997.00364.x; GIACOBINI E, 1980, CELL MOL BIOL, V26, P135; GoncalvesButruille M, 1996, PLANT PHYSIOL, V110, P765, DOI 10.1104/pp.110.3.765; Haond C, 1999, PHYSIOL BIOCHEM ZOOL, V72, P534, DOI 10.1086/316692; Hatta T, 2006, INT J PARASITOL, V36, P1123, DOI 10.1016/j.ijpara.2006.05.010; HIGASHINO K, 1971, ARCH BIOCHEM BIOPHYS, V142, P606, DOI 10.1016/0003-9861(71)90525-X; HOOGSTRAAL H, 1985, ADV PARASIT, V24, P135, DOI 10.1016/S0065-308X(08)60563-1; HUTZLER J, 1975, BIOCHIM BIOPHYS ACTA, V377, P42, DOI 10.1016/0005-2744(75)90284-3; KARCHI H, 1995, PLANT CELL, V7, P1963, DOI 10.1105/tpc.7.11.1963; KARCHI H, 1994, P NATL ACAD SCI USA, V91, P2577, DOI 10.1073/pnas.91.7.2577; Kemper EL, 1999, PLANT CELL, V11, P1981, DOI 10.1105/tpc.11.10.1981; Lees Kristin, 2007, Invertebrate Neuroscience, V7, P183, DOI 10.1007/s10158-007-0060-4; MARKOVITZ PJ, 1984, J BIOL CHEM, V259, P1643; MARKOVITZ PJ, 1987, J BIOL CHEM, V262, P9353; Mazur B, 1999, SCIENCE, V285, P372, DOI 10.1126/science.285.5426.372; Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5; Moulin M, 2006, PLANT PHYSIOL BIOCH, V44, P474, DOI 10.1016/j.plaphy.2006.08.005; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; NODA C, 1978, BIOCHIM BIOPHYS ACTA, V525, P307, DOI 10.1016/0005-2744(78)90225-5; Papes F, 1999, BIOCHEM J, V344, P555, DOI 10.1042/0264-6021:3440555; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; PUTNAM SM, 2007, ENTOMOLYGY INSECT PH, pCH22; RAO VV, 1992, COMP BIOCHEM PHYS B, V103, P221, DOI 10.1016/0305-0491(92)90435-T; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; SHINNO H, 1980, BIOCHIM BIOPHYS ACTA, V633, P310, DOI 10.1016/0304-4165(80)90190-7; SONENSHINE DE, 1991, BIOL TICKS, V1, P189; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; Takagi T, 2003, J NEUROSCI RES, V73, P270, DOI 10.1002/jnr.10656; Takagi T, 2001, NEUROSCI LETT, V310, P97, DOI 10.1016/S0304-3940(01)02059-6; Tang GL, 1997, PLANT CELL, V9, P1305, DOI 10.1105/tpc.9.8.1305; Umemiya R, 2007, INSECT BIOCHEM MOLEC, V37, P975, DOI 10.1016/j.ibmb.2007.05.006; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WINGGLESWORTH VB, 1967, PRINCIPLES INSECTS P; Zhu XH, 2000, BIOCHEM J, V351, P215, DOI 10.1042/0264-6021:3510215	53	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7136	10.1371/journal.pone.0007136	http://dx.doi.org/10.1371/journal.pone.0007136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774086	Green Published, Green Submitted, gold			2022-12-25	WOS:000270160900014
J	Castillo-Romero, A; Leon-Avila, G; Rangel, AP; Zarate, RC; Tovar, CG; Hernandez, JM				Castillo-Romero, Araceli; Leon-Avila, Gloria; Perez Rangel, Armando; Cortes Zarate, Rafael; Garcia Tovar, Carlos; Manuel Hernandez, Jose			Participation of Actin on Giardia lamblia Growth and Encystation	PLOS ONE			English	Article								Background: Microfilaments play a determinant role in different cell processes such as: motility, cell division, phagocytosis and intracellular transport; however, these structures are poorly understood in the parasite Giardia lamblia. Methodology and Principal Findings: By confocal microscopy using TRITC-phalloidin, we found structured actin distributed in the entire trophozoite, the label stand out at the ventral disc, median body, flagella and around the nuclei. During Giardia encystation, a sequence of morphological changes concurrent to modifications on the distribution of structured actin and in the expression of actin mRNA were observed. To elucidate whether actin participates actively on growth and encystation, cells were treated with Cytochalasin D, Latrunculin A and Jasplakinolide and analyzed by confocal and scanning electron microscopy. All drugs caused a growth reduction ( 27 to 45%) and changes on the distribution of actin. Besides, 60 to 80% of trophozoites treated with the drugs, exhibited damage at the caudal region, alterations in the flagella and wrinkles-like on the plasma membrane. The drugs also altered the cyst-yield and the morphology, scanning electron microscopy revealed diminished cytokinesis, cysts with damages in the wall and alterations in the size and on the intermembranal space. Furthermore, the drugs caused a significant reduction of the intensity of flourescence-labeled CWP1 on ESV and on cyst wall, this was coincident with a reduction of CWP1 gene expression ( 34%). Conclusions and Significance: All our results, indicated an important role of actin in the morphology, growth and encystation and indirectly suggested an actin role in gene expression.			Castillo-Romero, A (corresponding author), CINVESTAV IPN, Dept Biol Celular, Mexico City, DF, Mexico.	manolo@cell.cinvestav.mx	CASTILLO-ROMERO, ARACELI/AAB-5060-2019; Castillo-Romero, Araceli/AAR-8835-2021	CASTILLO-ROMERO, ARACELI/0000-0002-4461-7673; Castillo-Romero, Araceli/0000-0002-4461-7673				Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; Belmont LD, 1999, J CELL SCI, V112, P1325; BINGHAM AK, 1979, EXP PARASITOL, V47, P284, DOI 10.1016/0014-4894(79)90080-8; Bollen LS, 1996, J IMMUNOL METHODS, V191, P113; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; CLEM TR, 1978, J CLIN MICROBIOL, V7, P55; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Correa G, 2006, PARASITOL RES, V98, P250, DOI 10.1007/s00436-005-0065-z; CROSSLEY R, 1983, J CELL SCI, V59, P81; CROSSLEY R, 1983, J CELL SCI, V62, P419; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; FEELY DE, 1982, J PARASITOL, V68, P869, DOI 10.2307/3280996; FEELY DE, 1982, EXP PARASITOL, V53, P145, DOI 10.1016/0014-4894(82)90100-X; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; Gadelha APR, 2007, PARASITOL RES, V101, P1401, DOI 10.1007/s00436-007-0661-1; GILLIN FD, 1987, SCIENCE, V235, P1040, DOI 10.1126/science.3547646; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; GuerreroBarrera AL, 1996, MICROBIOL-SGM, V142, P1133, DOI 10.1099/13500872-142-5-1133; Hernandez Y, 2007, INT J PARASITOL, V37, P21, DOI 10.1016/j.ijpara.2006.09.008; Hernandez-Gonzalez EO, 2000, CELL MOTIL CYTOSKEL, V46, P43, DOI 10.1002/(SICI)1097-0169(200005)46:1&lt;43::AID-CM5&gt;3.0.CO;2-1; HOLBERTON DV, 1981, J CELL SCI, V47, P139; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; JimenezCardoso E, 1997, REV INVEST CLIN, V49, P123; KATELARIS PH, 1995, GUT, V37, P512, DOI 10.1136/gut.37.4.512; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Lovy-Wheeler A, 2007, CELL MOTIL CYTOSKEL, V64, P217, DOI 10.1002/cm.20181; Lujan HD, 2006, MEDICINA-BUENOS AIRE, V66, P70; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Lujan HD, 1998, PARASITOL TODAY, V14, P446, DOI 10.1016/S0169-4758(98)01333-7; Makioka A, 2001, EXP PARASITOL, V98, P145, DOI 10.1006/expr.2001.4629; Makioka A, 2001, J PARASITOL, V87, P399, DOI 10.1645/0022-3395(2001)087[0399:EOJOTG]2.0.CO;2; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; NARCISI EM, 1994, J PARASITOL, V80, P468, DOI 10.2307/3283419; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Ocampo J, 2005, TISSUE CELL, V37, P293, DOI 10.1016/j.tice.2005.03.003; Oda T, 2005, BIOPHYS J, V88, P2727, DOI 10.1529/biophysj.104.047753; Pasten-Hidalgo K, 2008, REPRODUCTION, V136, P41, DOI 10.1530/REP-07-0300; Pogliano J, 2008, CURR OPIN CELL BIOL, V20, P19, DOI 10.1016/j.ceb.2007.12.006; REINER DS, 1990, EUR J CELL BIOL, V53, P142; REINER DS, 1989, INFECT IMMUN, V57, P963, DOI 10.1128/IAI.57.3.963-968.1989; Sousa MC, 2001, CLIN DIAGN LAB IMMUN, V8, P258; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Towbin H, 1992, Biotechnology, V24, P145; VANDEKERCKHOVE J, 1985, EMBO J, V4, P2815, DOI 10.1002/j.1460-2075.1985.tb04008.x; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Witteck A, 2003, EXP CELL RES, V287, P106, DOI 10.1016/S0014-4827(03)00129-0; Wolyniak MJ, 2007, EUKARYOT CELL, V6, P1824, DOI 10.1128/EC.00188-07	53	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7156	10.1371/journal.pone.0007156	http://dx.doi.org/10.1371/journal.pone.0007156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774081	Green Published, Green Submitted, gold			2022-12-25	WOS:000270160900021
J	Granada, AE; Herzel, H				Granada, Adrian E.; Herzel, Hanspeter			How to Achieve Fast Entrainment? The Timescale to Synchronization	PLOS ONE			English	Article								Entrainment, where oscillators synchronize to an external signal, is ubiquitous in nature. The transient time leading to entrainment plays a major role in many biological processes. Our goal is to unveil the specific dynamics that leads to fast entrainment. By studying a generic model, we characterize the transient time to entrainment and show how it is governed by two basic properties of an oscillator: the radial relaxation time and the phase velocity distribution around the limit cycle. Those two basic properties are inherent in every oscillator. This concept can be applied to many biological systems to predict the average transient time to entrainment or to infer properties of the underlying oscillator from the observed transients. We found that both a sinusoidal oscillator with fast radial relaxation and a spike-like oscillator with slow radial relaxation give rise to fast entrainment. As an example, we discuss the jet-lag experiments in the mammalian circadian pacemaker.			Granada, AE (corresponding author), Humboldt Univ, Inst Theoret Biol, Berlin, Germany.	a.granada@biologie.hu-berlin.de	Granada, Adrian/AAR-3743-2020	Granada, Adrian/0000-0003-0537-9091				Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; Best JD, 1999, J NEUROSCI, V19, P828; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Cambras T, 2004, J BIOL RHYTHM, V19, P216, DOI 10.1177/0748730404264201; Campbell SR, 2004, IEEE T NEURAL NETWOR, V15, P1027, DOI 10.1109/TNN.2004.833134; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; DETINKO VN, 1976, I SOVIET PHYS J, V19, P1166; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Greenfield MD, 1997, P ROY SOC B-BIOL SCI, V264, P1355, DOI 10.1098/rspb.1997.0188; GUCKENHEIMER J, 1975, J MATH BIOL, V1, P259, DOI 10.1007/BF01273747; HERZEL H, 1995, CHAOS, V5, P30, DOI 10.1063/1.166078; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; HOPFIELD JJ, 1995, P NATL ACAD SCI USA, V92, P6655, DOI 10.1073/pnas.92.15.6655; HOPPENSTEADT FC, 1982, J MATH BIOL, V15, P339, DOI 10.1007/BF00275692; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Josic K., 2006, SCHOLARPEDIA, V1, P1361, DOI DOI 10.4249/SCHOLARPEDIA.1361; Koronovskii AA, 2004, TECH PHYS LETT+, V30, P253, DOI 10.1134/1.1707184; KUNYSZ A, 1995, AM J PHYSIOL-HEART C, V269, pH1153, DOI 10.1152/ajpheart.1995.269.3.H1153; Laje R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.258104; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Locke JCW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-22; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Millar AJ, 2004, J EXP BOT, V55, P277, DOI 10.1093/jxb/erh034; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Quintero JE, 2003, J NEUROSCI, V23, P8070; Rafnsson V, 2001, CANCER CAUSE CONTROL, V12, P95, DOI 10.1023/A:1008983416836; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SOMERS D, 1993, BIOL CYBERN, V68, P393, DOI 10.1007/BF00198772; Timme M, 2006, CHAOS, V16, DOI 10.1063/1.2150775; Vansteensel MJ, 2008, BRAIN RES REV, V58, P18, DOI 10.1016/j.brainresrev.2007.10.009; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Woafo P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036225; Xiong XH, 2007, PHYSICA A, V385, P689, DOI 10.1016/j.physa.2007.07.003; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	49	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7057	10.1371/journal.pone.0007057	http://dx.doi.org/10.1371/journal.pone.0007057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774087	Green Published, Green Submitted, gold			2022-12-25	WOS:000270160900004
J	Lee, VJ; Tok, MY; Chow, VT; Phua, KH; Ooi, EE; Tambyah, PA; Chen, MI				Lee, Vernon J.; Tok, Mei Yin; Chow, Vincent T.; Phua, Kai Hong; Ooi, Eng Eong; Tambyah, Paul A.; Chen, Mark I.			Economic Analysis of Pandemic Influenza Vaccination Strategies in Singapore	PLOS ONE			English	Article							CROSS-REACTIVE IMMUNITY; H5N1 VACCINE; UNITED-STATES; SPLIT-VIRION; IMMUNOGENICITY; IMMUNIZATION; VIRUSES; SAFETY	Background: All influenza pandemic plans advocate pandemic vaccination. However, few studies have evaluated the cost-effectiveness of different vaccination strategies. This paper compares the economic outcomes of vaccination compared with treatment with antiviral agents alone, in Singapore. Methodology: We analyzed the economic outcomes of pandemic vaccination (immediate vaccination and vaccine stockpiling) compared with treatment-only in Singapore using a decision-based model to perform cost-benefit and cost-effectiveness analyses. We also explored the annual insurance premium (willingness to pay) depending on the perceived risk of the next pandemic occurring. Principal Findings: The treatment-only strategy resulted in 690 deaths, 13,950 hospitalization days, and economic cost of USD$497 million. For immediate vaccination, at vaccine effectiveness of >55%, vaccination was cost-beneficial over treatment-only. Vaccine stockpiling is not cost-effective in most scenarios even with 100% vaccine effectiveness. The annual insurance premium was highest with immediate vaccination, and was lower with increased duration to the next pandemic. The premium was also higher with higher vaccine effectiveness, attack rates, and case-fatality rates. Stockpiling with case-fatality rates of 0.4-0.6% would be cost-beneficial if vaccine effectiveness was >80%; while at case-fatality of >5% stockpiling would be cost-beneficial even if vaccine effectiveness was 20%. High-risk sub-groups warrant higher premiums than low-risk sub-groups. Conclusions: The actual pandemic vaccine effectiveness and lead time is unknown. Vaccine strategy should be based on perception of severity. Immediate vaccination is most cost-effective, but requires vaccines to be available when required. Vaccine stockpiling as insurance against worst-case scenarios is also cost-effective. Research and development is therefore critical to develop and stockpile cheap, readily available effective vaccines.			Lee, VJ (corresponding author), Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore.	vernonljm@hotmail.com	Chen, Mark/CAG-2949-2022; Chen, Mark/AGC-5338-2022	Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Chow, Vincent/0000-0003-2634-6213; Ooi, Eng Eong/0000-0002-0520-1544				Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Balicer RD, 2005, EMERG INFECT DIS, V11, P1280; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Carter NJ, 2008, BIODRUGS, V22, P279, DOI 10.2165/00063030-200822050-00001; *CDCP, 2009, WKLY EPIDEMIOL REC, V84, P185; Chow VTK, 2008, ANN ACAD MED SINGAP, V37, P451; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; El Sahlyt HM, 2008, EXPERT REV VACCINES, V7, P241, DOI 10.1586/14760584.7.2.241; Evans D, 2009, J INFECT DIS, V200, P321, DOI 10.1086/603560; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HADDIX AC, 2002, GUIDE DECISION ANAL; *INFL TEAM ECDC, 2007, EURO SURVEILL, V12; JAMIESON DJ, 2009, LANCET IN PRESS; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Ng TP, 2002, ANN ACAD MED SINGAP, V31, P182; Palache B, 2008, VACCINE, V26, P6232, DOI 10.1016/j.vaccine.2008.07.022; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; *SING DEP STAT, KEY STAT; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705	32	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7108	10.1371/journal.pone.0007108	http://dx.doi.org/10.1371/journal.pone.0007108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771173	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154400007
J	Dawson, MR; Duda, DG; Chae, SS; Fukumura, D; Jain, RK				Dawson, Michelle R.; Duda, Dan G.; Chae, Sung-Suk; Fukumura, Dai; Jain, Rakesh K.			VEGFR1 Activity Modulates Myeloid Cell Infiltration in Growing Lung Metastases but Is Not Required for Spontaneous Metastasis Formation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; ANGIOGENESIS; TUMORS; PROGRESSION; ANTIBODY; THERAPY; TARGETS; FLT-1	The role of vascular endothelial growth factor receptor 1 (VEGFR1/Flt1) in tumor metastasis remains incompletely characterized. Recent reports suggested that blocking VEGFR1 activity or the interaction with its ligands (VEGF and PlGF) has anti-tumor effects. Moreover, several studies showed that VEGFR1 mediates tumor progression to distant metastasis. All these effects may be exerted indirectly by recruitment of bone marrow-derived cells (BMDCs), such as myeloid cells. We investigated the role of VEGFR1 activity in BMDCs during the pre-metastatic phase, i.e., prior to metastatic nodule formation in mice after surgical removal of the primary tumor. Using pharmacologic blockade or genetic deletion of the tyrosine kinase domain of VEGFR1, we demonstrate that VEGFR1 activity is not required for the infiltration of de novo myeloid BMDCs in the pre-metastatic lungs in two tumor models and in two mouse models. Moreover, in line with emerging clinical observations, we show that blockade of VEGFR1 activity neither prevents nor changes the rate of spontaneous metastasis formation after primary tumor removal. Prevention of metastasis will require further identification and exploration of cellular and molecular pathways that mediate the priming of the metastatic soil.			Dawson, MR (corresponding author), Georgia Inst Technol, Dept Chem & Biomol Engn, Atlanta, GA 30332 USA.	jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Dawson, Michelle R/Q-7217-2019; Duda, Dan G/H-8523-2014	Jain, Rakesh K/0000-0001-7571-3548; Dawson, Michelle R/0000-0002-2122-4711; Duda, Dan G/0000-0001-7065-8797	NCI NIH HHS [R01 CA096915, T32 CA073479-09, P01 CA080124-07, R01 CA085140-08, T32 CA073479-08, T32 CA073479, R01 CA115767-02, R01 CA126642, R01 CA115767-03, P01CA80124, R01 CA126642-01A1, P01 CA080124-05, R01 CA126642-02, P01 CA080124, R21-CA139168, R01 CA126642-02S1, P01 CA080124-08, R24 CA085140-05, R01 CA085140, R01 CA115767-04, R01 CA085140-07, P01 CA080124-09, T32 CA073479-11, T32 CA073479-12, R24 CA085140, R01 CA085140-09, R01CA85140, P01 CA080124-06A2, T32 CA073479-10, R01 CA115767-01A1, R01CA126642, R01 CA085140-06, R01CA96915, R01 CA115767, P01 CA080124-05S1, R21 CA139168, R01CA115767] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096915, T32CA073479, R24CA085140, R01CA126642, R01CA115767, R01CA085140, P01CA080124, R21CA139168] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duda DG, 2006, BLOOD, V107, P2774, DOI 10.1182/blood-2005-08-3210; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; KAMOUN WS, J CLIN ONCO IN PRESS; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Wolmark N, 2009, J CLIN ONCOL, V27; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831	25	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e6525	10.1371/journal.pone.0006525	http://dx.doi.org/10.1371/journal.pone.0006525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763275	gold, Green Submitted, Green Published			2022-12-25	WOS:000269970400001
J	Gonzalez, S; Flo, M; Margenat, M; Duran, R; Gonzalez-Sapienza, G; Grana, M; Parkinson, J; Maizels, RM; Salinas, G; Alvarez, B; Fernandez, C				Gonzalez, Silvia; Flo, Martin; Margenat, Mariana; Duran, Rosario; Gonzalez-Sapienza, Gualberto; Grana, Martin; Parkinson, John; Maizels, Rick M.; Salinas, Gustavo; Alvarez, Beatriz; Fernandez, Cecilia			A Family of Diverse Kunitz Inhibitors from Echinococcus granulosus Potentially Involved in Host-Parasite Cross-Talk	PLOS ONE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; TISSUE FACTOR; ALPHA-DENDROTOXIN; CRYSTAL-STRUCTURE; BOVINE TRYPSIN; SLOW-BINDING; EVOLUTIONARY; CHYMOTRYPSIN; SITE; GENOME	The cestode Echinococcus granulosus, the agent of hydatidosis/echinococcosis, is remarkably well adapted to its definitive host. However, the molecular mechanisms underlying the successful establishment of larval worms (protoscoleces) in the dog duodenum are unknown. With the aim of identifying molecules participating in the E. granulosus-dog cross-talk, we surveyed the transcriptomes of protoscoleces and protoscoleces treated with pepsin at pH 2. This analysis identified a multigene family of secreted monodomain Kunitz proteins associated mostly with pepsin/H+-treated worms, suggesting that they play a role at the onset of infection. We present the relevant molecular features of eight members of the E. granulosus Kunitz family (EgKU-1 - EgKU-8). Although diverse, the family includes three pairs of close paralogs (EgKU-1/EgKU-4; EgKU-3/EgKU-8; EgKU-6/EgKU-7), which would be the products of recent gene duplications. In addition, we describe the purification of EgKU-1 and EgKU-8 from larval worms, and provide data indicating that some members of the family (notably, EgKU-3 and EgKU-8) are secreted by protoscoleces. Detailed kinetic studies with native EgKU-1 and EgKU-8 highlighted their functional diversity. Like most monodomain Kunitz proteins, EgKU-8 behaved as a slow, tight-binding inhibitor of serine proteases, with global inhibition constants (K-I*) versus trypsins in the picomolar range. In sharp contrast, EgKU-1 did not inhibit any of the assayed peptidases. Interestingly, molecular modeling revealed structural elements associated with activity in Kunitz cation-channel blockers. We propose that this family of inhibitors has the potential to act at the E. granulosus-dog interface and interfere with host physiological processes at the initial stages of infection.			Gonzalez, S (corresponding author), Univ Republica, Catedra Inmunol, Fac Quim, Montevideo, Uruguay.	cfernan@fq.edu.uy	Grana, Martin/R-7245-2019; Durán, Rosario/GQH-8502-2022; Parkinson, John/A-4424-2008	Grana, Martin/0000-0003-1182-8236; Parkinson, John/0000-0001-9815-1189; Alvarez, Beatriz/0000-0001-6911-3132; Salinas, Gustavo/0000-0003-3350-3002; Duran, Rosario/0000-0002-8575-9651; Gonzalez-Sapienza, Gualberto/0000-0003-1824-0611				Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; ARNOUX B, 1995, J MOL BIOL, V246, P609, DOI 10.1006/jmbi.1994.0112; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; BELL G, 1987, NATURE, V328, P66, DOI 10.1038/328066a0; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BROZE GJ, 1987, BLOOD, V69, P150; CAPPELLO M, 1995, P NATL ACAD SCI USA, V92, P6152, DOI 10.1073/pnas.92.13.6152; Chand HS, 2004, J BIOL CHEM, V279, P17500, DOI 10.1074/jbc.M400802200; Chen CP, 2001, J BIOL CHEM, V276, P45079, DOI 10.1074/jbc.M106182200; Craig PS, 2006, ADV PARASIT, V61, P443, DOI 10.1016/S0065-308X(05)61011-1; Fernandez C, 2002, MOL BIOCHEM PARASIT, V122, P171, DOI 10.1016/S0166-6851(02)00098-1; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Gasparini S, 1998, J BIOL CHEM, V273, P25393, DOI 10.1074/jbc.273.39.25393; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; GRECO WR, 1979, J BIOL CHEM, V254, P2104; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; Hawdon JM, 2003, J PARASITOL, V89, P402, DOI 10.1645/0022-3395(2003)089[0402:MCOANM]2.0.CO;2; Heath D. D., 1995, P183; Heath D. D., 1986, The biology of Echinococcusand hydatid disease, P164; Helland R, 1998, EUR J BIOCHEM, V256, P317, DOI 10.1046/j.1432-1327.1998.2560317.x; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; Kamei S, 1999, THROMB RES, V94, P147, DOI 10.1016/S0049-3848(98)00205-9; Katoh E, 2000, BIOPOLYMERS, V54, P44, DOI 10.1002/(SICI)1097-0282(200007)54:1<44::AID-BIP50>3.0.CO;2-Z; Kohfeldt E, 1996, EUR J BIOCHEM, V238, P333, DOI 10.1111/j.1432-1033.1996.0333z.x; Kooyman FNJ, 2009, MOL BIOCHEM PARASIT, V163, P85, DOI 10.1016/j.molbiopara.2008.09.012; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Krowarsch D, 2005, PROTEIN PEPTIDE LETT, V12, P403, DOI 10.2174/0929866054395275; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MOSES E, 1983, J MOL BIOL, V170, P765, DOI 10.1016/S0022-2836(83)80130-2; OHLSSON K, 1973, BIOCHIM BIOPHYS ACTA, V317, P328, DOI 10.1016/0005-2795(73)90228-6; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Outzen H, 1996, COMP BIOCHEM PHYS B, V115, P33, DOI 10.1016/0305-0491(96)00081-8; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; Parkinson J, 2004, NUCLEIC ACIDS RES, V32, pD427, DOI 10.1093/nar/gkh018; Parkinson J, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-31; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Pritchard L, 1999, J MOL BIOL, V285, P1589, DOI 10.1006/jmbi.1998.2437; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SKARZYNSKI T, 1992, J MOL BIOL, V224, P671, DOI 10.1016/0022-2836(92)90552-U; SMALAS AO, 1994, PROTEINS, V20, P149, DOI 10.1002/prot.340200205; Smith LA, 1997, BIOCHEMISTRY-US, V36, P7690, DOI 10.1021/bi963105g; Smyth J.D., 1989, PHYSL BIOCH CESTODES; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson R. C. A., 1995, P1; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; VINCENT JP, 1973, EUR J BIOCHEM, V38, P365, DOI 10.1111/j.1432-1033.1973.tb03069.x; VINCENT JP, 1972, BIOCHEMISTRY-US, V11, P2967, DOI 10.1021/bi00766a007; Waritani T, 2001, VET IMMUNOL IMMUNOP, V80, P333, DOI 10.1016/S0165-2427(01)00293-8; Watanabe J, 2007, NUCLEIC ACIDS RES, V35, pD431, DOI 10.1093/nar/gkl1039; Williams J W, 1979, Methods Enzymol, V63, P437; Woodard SL, 2003, BIOTECHNOL APPL BIOC, V38, P123, DOI 10.1042/BA20030026; WU FC, 1955, J BIOL CHEM, V213, P609; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8	73	32	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7009	10.1371/journal.pone.0007009	http://dx.doi.org/10.1371/journal.pone.0007009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759914	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970200001
J	Rivas-Caicedo, A; Soldevila, G; Fortoul, TI; Castell-Rodriguez, A; Flores-Romo, L; Garcia-Zepeda, EA				Rivas-Caicedo, Ana; Soldevila, Gloria; Fortoul, Teresa I.; Castell-Rodriguez, Andres; Flores-Romo, Leopoldo; Garcia-Zepeda, Eduardo A.			Jak3 Is Involved in Dendritic Cell Maturation and CCR7-Dependent Migration	PLOS ONE			English	Article								Background: CCR7-mediated signalling is important for dendritic cell maturation and homing to the lymph nodes. We have previously demonstrated that Jak3 participates in the signalling pathway of CCR7 in T lymphocytes. Methodology and Principal Findings: Here, we used Jak3(-/-) mice to analyze the role of Jak3 in CCR7-mediated dendritic cells migration and function. First, we found no differences in the generation of DCs from Jak3(-/-) bone marrow progenitors, when compared to wild type cells. However, phenotypic analysis of the bone marrow derived DCs obtained from Jak3(-/-) mice showed reduced expression of co-stimulatory molecules compared to wild type (Jak3(+/+)). In addition, when we analyzed the migration of Jak3(-/-) and Jak3(+/+) mature DCs in response to CCL19 and CCL21 chemokines, we found that the absence of Jak3 results in impaired chemotactic responses both in vitro and in vivo. Moreover, lymphocyte proliferation and contact hypersensitivity experiments showed that DC-mediated T lymphocyte activation is reduced in the absence of Jak3. Conclusion/Significance: Altogether, our data provide strong evidence that Jak3 is important for DC maturation, migration and function, through a CCR7-mediated signalling pathway.			Rivas-Caicedo, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	garciaze@servidor.unam.mx	Fortoul, Teresa I./AAW-3936-2020	Fortoul, Teresa I./0000-0002-3507-1365; Castell-Rodriguez, Andres/0000-0003-2881-2759; Soldevila, Gloria/0000-0003-1539-2548				Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Cappello P, 2006, J IMMUNOL, V177, P6143, DOI 10.4049/jimmunol.177.9.6143; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; DELPRETE A, 2006, BLOOD; Garcia-Zepeda EA, 2007, IMMUNOLOGY, V122, P247, DOI 10.1111/j.1365-2567.2007.02634.x; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Grayson MH, 2007, J IMMUNOL, V179, P1438, DOI 10.4049/jimmunol.179.3.1438; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Idoyaga J, 2007, CANCER IMMUNOL IMMUN, V56, P1237, DOI 10.1007/s00262-006-0275-y; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kaiser A, 2005, J IMMUNOL, V175, P2349, DOI 10.4049/jimmunol.175.4.2349; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Mueller A, 2004, FEBS LETT, V570, P126, DOI 10.1016/j.febslet.2004.04.100; Nishio H, 2001, J ANAT, V198, P581, DOI 10.1046/j.1469-7580.2001.19850581.x; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Soldevila G, 2004, IMMUNOLOGY, V112, P191, DOI 10.1111/j.1365-2567.2004.01863.x; SOLDEVILA G, 2007, SIGNAL TRANSDUCTION, V7, P427, DOI DOI 10.1002/SITA.200700144; Stein JV, 2003, BLOOD, V101, P38, DOI 10.1182/blood-2002-03-0841; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Tanabe S, 1997, J IMMUNOL, V159, P905; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wong M, 2001, J BIOL CHEM, V276, P11427, DOI 10.1074/jbc.M010750200; Xu H, 2001, EUR J IMMUNOL, V31, P3085, DOI 10.1002/1521-4141(2001010)31:10<3085::AID-IMMU3085>3.0.CO;2-B; Yamaoka K, 2005, BLOOD, V106, P3227, DOI 10.1182/blood-2005-02-0769; Yao Q, 2007, IMMUNOL LETT, V110, P110, DOI 10.1016/j.imlet.2007.04.007; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	44	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7066	10.1371/journal.pone.0007066	http://dx.doi.org/10.1371/journal.pone.0007066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759904	gold, Green Published, Green Submitted			2022-12-25	WOS:000269970200004
J	Dhar, D; Venkataramana, M; Ponnuswamy, A; Das, S				Dhar, Debojyoti; Venkataramana, Musturi; Ponnuswamy, Anand; Das, Saumitra			Role of Polypyrimidine Tract Binding Protein in Mediating Internal Initiation of Translation of Interferon Regulatory Factor 2 RNA	PLOS ONE			English	Article								Background: Earlier we have reported translational control of interferon regulatory factor 2 (IRF2) by internal initiation (Dhar et al, Nucleic Acids Res, 2007). The results implied possible role of IRF2 in controlling the intricate balance of cellular gene expression under stress conditions in general. Here we have investigated the secondary structure of the Internal Ribosome Entry Site of IRF2 RNA and demonstrated the role of PTB protein in ribosome assembly to facilitate internal initiation. Methodology/Principal Findings: We have probed the putative secondary structure of the IRF2 5'UTR RNA using various enzymatic and chemical modification agents to constrain the secondary structure predicted from RNA folding algorithm Mfold. The IRES activity was found to be influenced by the interaction of trans-acting factor, polypyrimidine tract binding protein (PTB). Deletion of 25 nts from the 3'terminus of the 5'untranslated region resulted in reduced binding with PTB protein and also showed significant decrease in IRES activity compared to the wild type. We have also demonstrated putative contact points of PTB on the IRF2-5'UTR using primer extension inhibition assay. Majority of the PTB toe-prints were found to be restricted to the 3'end of the IRES. Additionally, Circular Dichroism (CD) spectra analysis suggested change in the conformation of the RNA upon PTB binding. Further, binding studies using S10 extract from HeLa cells, partially silenced for PTB gene expression, resulted in reduced binding by other trans-acting factors. Finally, we have demonstrated that addition of recombinant PTB enhances ribosome assembly on IRF2 IRES suggesting possible role of PTB in mediating internal initiation of translation of IRF2 RNA. Conclusion/Significance: It appears that PTB binding to multiple sites within IRF2 5'UTR leads to a conformational change in the RNA that facilitate binding of other trans-acting factors to mediate internal initiation of translation.			Dhar, D (corresponding author), Connexios Life Sci, Bangalore, Karnataka, India.	sdas@mcbl.iisc.ernet.in	Dhar, Debojyoti/AAP-3086-2020					Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Coldwell MJ, 2001, ONCOGENE, V20, P4095, DOI 10.1038/sj.onc.1204547; Dhar D, 2007, NUCLEIC ACIDS RES, V35, P5409, DOI 10.1093/nar/gkm524; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kolupaeva VG, 1996, RNA, V2, P1199; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Sella O, 1999, MOL CELL BIOL, V19, P5429; Vaughan PS, 1998, J BIOL CHEM, V273, P194, DOI 10.1074/jbc.273.1.194; Venkatramana M, 2003, VIRUS RES, V98, P141, DOI 10.1016/j.virusres.2003.09.004; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	21	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7049	10.1371/journal.pone.0007049	http://dx.doi.org/10.1371/journal.pone.0007049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756143	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970000016
J	Hale, CM; Sun, SX; Wirtz, D				Hale, Christopher M.; Sun, Sean X.; Wirtz, Denis			Resolving the Role of Actoymyosin Contractility in Cell Microrheology	PLOS ONE			English	Article								Einstein's original description of Brownian motion established a direct relationship between thermally-excited random forces and the transport properties of a submicron particle in a viscous liquid. Recent work based on reconstituted actin filament networks suggests that nonthermal forces driven by the motor protein myosin II can induce large non-equilibrium fluctuations that dominate the motion of particles in cytoskeletal networks. Here, using high-resolution particle tracking, we find that thermal forces, not myosin-induced fluctuating forces, drive the motion of submicron particles embedded in the cytoskeleton of living cells. These results resolve the roles of myosin II and contractile actomyosin structures in the motion of nanoparticles lodged in the cytoplasm, reveal the biphasic mechanical architecture of adherent cells-stiff contractile stress fibers interdigitating in a network at the cell cortex and a soft actin meshwork in the body of the cell, validate the method of particle tracking-microrheology, and reconcile seemingly disparate atomic force microscopy (AFM) and particle-tracking microrheology measurements of living cells.			Hale, CM (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Sun, Sean/M-7208-2019; Wirtz, Denis/A-3257-2010; Hale, Christopher/A-6633-2009; Sun, Sean X/C-6755-2009	Sun, Sean/0000-0002-9077-7088; Hale, Christopher/0000-0002-2360-7759; Sun, Sean X/0000-0002-9077-7088	NCI NIH HHS [R21 CA137686, CA137686] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA137686] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Haber C, 2000, BIOPHYS J, V79, P1530, DOI 10.1016/S0006-3495(00)76404-6; HOH JH, 1994, J CELL SCI, V107, P1105; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Kole TP, 2004, MOL BIOL CELL, V15, P3475, DOI 10.1091/mbc.E04-03-0218; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Le Goff L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018101; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lee JSH, 2006, J CELL SCI, V119, P1760, DOI 10.1242/jcs.02899; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MASON TG, 1995, PHYS REV LETT, V74, P1254; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Panorchan P, 2007, METHOD CELL BIOL, V83, P115, DOI 10.1016/S0091-679X(07)83006-8; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; RADMACHER M, 1994, BIOPHYS J, V66, P2159, DOI 10.1016/S0006-3495(94)81011-2; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Smith DA, 2001, BIOPHYS J, V80, P45, DOI 10.1016/S0006-3495(01)75994-2; Smoluchowski M., 1906, ANN PHYSIK, V326, P756, DOI DOI 10.1002/ANDP.19063261405; Suh J, 2003, P NATL ACAD SCI USA, V100, P3878, DOI 10.1073/pnas.0636277100; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Van Citters KM, 2006, BIOPHYS J, V91, P3946, DOI 10.1529/biophysj.106.091264; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Yarrow JC, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-5	44	52	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7054	10.1371/journal.pone.0007054	http://dx.doi.org/10.1371/journal.pone.0007054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756147	Green Submitted, gold, Green Published			2022-12-25	WOS:000269970000019
J	Jeffry, JA; Yu, SQ; Sikand, P; Parihar, A; Evans, MS; Premkumar, LS				Jeffry, Joseph A.; Yu, Shuang-Quan; Sikand, Parul; Parihar, Arti; Evans, M. Steven; Premkumar, Louis S.			Selective Targeting of TRPV1 Expressing Sensory Nerve Terminals in the Spinal Cord for Long Lasting Analgesia	PLOS ONE			English	Article								Chronic pain is a major clinical problem and opiates are often the only treatment, but they cause significant problems ranging from sedation to deadly respiratory depression. Resiniferatoxin (RTX), a potent agonist of Transient Receptor Potential Vanilloid 1 (TRPV1), causes a slow, sustained and irreversible activation of TRPV1 and increases the frequency of spontaneous excitatory postsynaptic currents, but causes significant depression of evoked EPSCs due to nerve terminal depolarization block. Intrathecal administration of RTX to rats in the short-term inhibits nociceptive synaptic transmission, and in the long-term causes a localized, selective ablation of TRPV1-expressing central sensory nerve terminals leading to long lasting analgesia in behavioral models. Since RTX actions are selective for central sensory nerve terminals, other efferent functions of dorsal root ganglion neurons can be preserved. Preventing nociceptive transmission at the level of the spinal cord can be a useful strategy to treat chronic, debilitating and intractable pain.			Jeffry, JA (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	lpremkumar@siumed.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065742, R01DK065742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042296] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK065742, R56 DK065742, DK065742] Funding Source: Medline; NINDS NIH HHS [NS042296, R01 NS042296] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akerman S, 2004, BRIT J PHARMACOL, V142, P1354, DOI 10.1038/sj.bjp.0705896; Apostolidis A, 2005, UROLOGY, V65, P400, DOI 10.1016/j.urology.2004.10.007; Appendino G, 1997, LIFE SCI, V60, P681, DOI 10.1016/S0024-3205(96)00567-X; Baccei ML, 2003, J PHYSIOL-LONDON, V549, P231, DOI 10.1113/jphysiol.2003.040451; Brown DC, 2005, ANESTHESIOLOGY, V103, P1052, DOI 10.1097/00000542-200511000-00020; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Constantin CE, 2008, J NEUROSCI, V28, P5072, DOI 10.1523/JNEUROSCI.4476-07.2008; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; Dinis P, 2004, BJU INT, V94, P153, DOI 10.1111/j.1464-4096.2004.04855.x; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Giannantoni A, 2004, J UROLOGY, V172, P240, DOI 10.1097/01.ju.0000132152.53532.5d; Gilchrist HD, 1996, PAIN, V67, P179, DOI 10.1016/0304-3959(96)03104-1; GOSO C, 1993, NEUROSCI LETT, V162, P197, DOI 10.1016/0304-3940(93)90594-B; Gram DX, 2007, EUR J NEUROSCI, V25, P213, DOI 10.1111/j.1460-9568.2006.05261.x; Gram DX, 2005, EUR J PHARMACOL, V509, P211, DOI 10.1016/j.ejphar.2004.12.039; GRUDT TJ, 1994, J NEUROSCI, V14, P1646, DOI 10.1523/JNEUROSCI.14-03-01646.1994; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Immke DC, 2006, SEMIN CELL DEV BIOL, V17, P582, DOI 10.1016/j.semcdb.2006.09.004; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V208, P449, DOI 10.1113/jphysiol.1970.sp009130; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kim JH, 2003, J SPINAL CORD MED, V26, P358, DOI 10.1080/10790268.2003.11753706; Kissin EY, 2005, ANESTH ANALG, V101, P1433, DOI 10.1213/01.ANE.0000180998.29890.B0; Lauria G, 2006, J PERIPHER NERV SYST, V11, P262, DOI 10.1111/j.1529-8027.2006.0097.x; Lazzeri M, 2004, EUR UROL, V45, P98, DOI 10.1016/S0302-2838(03)00418-4; Lehto SG, 2008, J PHARMACOL EXP THER, V326, P218, DOI 10.1124/jpet.107.132233; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; NAGY JI, 1981, BRAIN RES, V211, P497, DOI 10.1016/0006-8993(81)90980-X; Nakatsuka T, 2002, J NEUROSCI, V22, P1228, DOI 10.1523/JNEUROSCI.22-04-01228.2002; Petersen KL, 2002, PAIN, V98, P119, DOI 10.1016/S0304-3959(02)00029-5; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; RUSSELL LC, 1984, BRAIN RES REV, V8, P165, DOI 10.1016/0165-0173(84)90005-5; RUSSELL LC, 1986, PAIN, V25, P109, DOI 10.1016/0304-3959(86)90013-8; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; Strecker T, 2005, CARDIOVASC RES, V65, P405, DOI 10.1016/j.cardiores.2004.10.013; Szabo T, 1999, BRAIN RES, V840, P92, DOI 10.1016/S0006-8993(99)01763-1; SZALLASI A, 1990, LIFE SCI, V47, P1399, DOI 10.1016/0024-3205(90)90518-V; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Varga A, 2005, NEUROSCI LETT, V385, P137, DOI 10.1016/j.neulet.2005.05.015; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; YAKSH TL, 1979, SCIENCE, V206, P481, DOI 10.1126/science.228392; Yang K, 1998, NEUROSCI LETT, V255, P135, DOI 10.1016/S0304-3940(98)00730-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	56	76	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7021	10.1371/journal.pone.0007021	http://dx.doi.org/10.1371/journal.pone.0007021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753113	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796500011
J	Okoli, I; Coleman, JJ; Tempakakis, E; An, WF; Holson, E; Wagner, F; Conery, AL; Larkins-Ford, J; Wu, G; Stern, A; Ausubel, FM; Mylonakis, E				Okoli, Ikechukwu; Coleman, Jeffrey J.; Tempakakis, Emmanouil; An, W. Frank; Holson, Edward; Wagner, Florence; Conery, Annie L.; Larkins-Ford, Jonah; Wu, Gang; Stern, Andy; Ausubel, Frederick M.; Mylonakis, Eleftherios			Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay	PLOS ONE			English	Article							IN-VITRO INTERACTIONS; TACROLIMUS FK506; AMPHOTERICIN-B; CALCINEURIN; AGENTS; RESISTANCE; VIRULENCE; SUSCEPTIBILITY; INFECTIONS; SCREEN	Candida albicans, the most common human pathogenic fungus, can establish a persistent lethal infection in the intestine of the microscopic nematode Caenorhabditis elegans. The C. elegans-C. albicans infection model was previously adapted to screen for antifungal compounds. Modifications to this screen have been made to facilitate a high-throughput assay including co-inoculation of nematodes with C. albicans and instrumentation allowing precise dispensing of worms into assay wells, eliminating two labor-intensive steps. This high-throughput method was utilized to screen a library of 3,228 compounds represented by 1,948 bioactive compounds and 1,280 small molecules derived via diversity-oriented synthesis. Nineteen compounds were identified that conferred an increase in C. elegans survival, including most known antifungal compounds within the chemical library. In addition to seven clinically used antifungal compounds, twelve compounds were identified which are not primarily used as antifungal agents, including three immunosuppressive drugs. This assay also allowed the assessment of the relative minimal inhibitory concentration, the effective concentration in vivo, and the toxicity of the compound in a single assay.			Okoli, I (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	emylonakis@partners.org	Coleman, Jeffrey J/E-2981-2015	Stern, Andrew/0000-0002-8437-2957; Coleman, Jeffrey/0000-0001-8579-1996; Larkins-Ford, Jonah/0000-0001-9123-9508	NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline; NIAID NIH HHS [R01 AI072508, R01 AI075286, T32 AI007061] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561, P30 DK040561-14] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072508, T32AI007061, R01AI075286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; ARAI T, 1962, J ANTIBIOT, V15, P231; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; BACIGALUPO A, 1983, ACTA HAEMATOL-BASEL, V69, P409, DOI 10.1159/000206930; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BEGGS WH, 1985, J ANTIMICROB CHEMOTH, V16, P397, DOI 10.1093/jac/16.3.397; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; BUCHENAUER H, 1977, NETH J PLANT PATHOL, V83, P93, DOI 10.1007/BF03041424; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CarriloMunoz AJ, 1996, J ANTIMICROB CHEMOTH, V37, P815, DOI 10.1093/jac/37.4.815; Cho BP, 2003, CHEM RES TOXICOL, V16, P285, DOI 10.1021/tx0256679; COCKRELL RS, 1966, BIOCHEMISTRY-US, V5, P2326, DOI 10.1021/bi00871a022; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Dannaoui E, 2009, ANTIMICROB AGENTS CH, V53, P3549, DOI 10.1128/AAC.00184-09; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Della Casa V, 2002, ARZNEIMITTELFORSCH, V52, P699; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Espinel-Ingroff A, 2001, MYCOPATHOLOGIA, V150, P101, DOI 10.1023/A:1010954803886; Fox DS, 2001, MOL MICROBIOL, V39, P835, DOI 10.1046/j.1365-2958.2001.02295.x; Francois IEJA, 2005, CURR DRUG TARGETS, V6, P895, DOI 10.2174/138945005774912744; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P112, DOI 10.1128/AAC.01162-08; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; High KP, 1997, J INFECT DIS, V175, P222, DOI 10.1093/infdis/175.1.222; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; KANSAL VK, 1986, TETRAHEDRON, V42, P2389, DOI 10.1016/0040-4020(86)80002-3; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; KINASHI H, 1984, J ANTIBIOT, V37, P1333, DOI 10.7164/antibiotics.37.1333; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Kohler P, 2001, INT J PARASITOL, V31, P336, DOI 10.1016/S0020-7519(01)00131-X; Kontoyiannis DP, 2008, ANTIMICROB AGENTS CH, V52, P735, DOI 10.1128/AAC.00990-07; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; MARKING LL, 1994, PROG FISH CULT, V56, P225, DOI 10.1577/1548-8640(1994)056&lt;0225:AFSEOA&gt;2.3.CO;2; MATSUMURA F, 1971, SCIENCE, V173, P49, DOI 10.1126/science.173.3991.49; Miller LG, 2001, CLIN INFECT DIS, V32, P1110, DOI 10.1086/319613; MOLINA JMH, 1992, MYCOPATHOLOGIA, V118, P15, DOI 10.1007/BF00472565; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Nielsen TE, 2008, ANGEW CHEM INT EDIT, V47, P48, DOI 10.1002/anie.200703073; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; PARISER DM, 1994, CUTIS, V54, P43; Park CN, 2008, J MICROBIOL BIOTECHN, V18, P880; Park JI, 2005, J BIOL CHEM, V280, P2529, DOI 10.1074/jbc.M407900200; PETROU MA, 1985, J ANTIMICROB CHEMOTH, V16, P169, DOI 10.1093/jac/16.2.169; PFALLER MA, 1989, DIAGN MICR INFEC DIS, V12, P467, DOI 10.1016/0732-8893(89)90079-5; Reedy JL, 2006, ANTIMICROB AGENTS CH, V50, P1573, DOI 10.1128/AAC.50.4.1573-1577.2006; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; REX JH, 1995, ANTIMICROB AGENTS CH, V39, P40, DOI 10.1128/AAC.39.1.40; ROBA J, 1976, EUR J PHARMACOL, V37, P265, DOI 10.1016/0014-2999(76)90034-0; ROBINSON HJ, 1969, TEX REP BIOL MED, VS 27, P537; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; SchaferKorting M, 1996, MYCOSES, V39, P329, DOI 10.1111/j.1439-0507.1996.tb00149.x; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Singh N, 2004, TRANSPLANTATION, V77, P795, DOI 10.1097/01.TP.0000117252.75651.D6; Spanakis EK, 2006, CLIN INFECT DIS, V43, P1060, DOI 10.1086/507891; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P1664, DOI 10.1128/AAC.48.5.1664-1669.2004; Tampakakis E, 2008, NAT PROTOC, V3, P1925, DOI 10.1038/nprot.2008.193; Tang RJ, 2005, INFECT IMMUN, V73, P8219, DOI 10.1128/IAI.73.12.8219-8225.2005; UPADHYAY MP, 1980, BRIT J OPHTHALMOL, V64, P30, DOI 10.1136/bjo.64.1.30; Watanabe H, 2005, J ANTIBIOT, V58, P753, DOI 10.1038/ja.2005.102; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	68	88	98	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7025	10.1371/journal.pone.0007025	http://dx.doi.org/10.1371/journal.pone.0007025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750012	gold, Green Published			2022-12-25	WOS:000269796300019
J	Zhang, XQ; Rodriguez, ME; Harvill, ET				Zhang, Xuqing; Rodriguez, Maria Eugenia; Harvill, Eric T.			O Antigen Allows B. parapertussis to Evade B. pertussis Vaccine-Induced Immunity by Blocking Binding and Functions of Cross-Reactive Antibodies	PLOS ONE			English	Article							ENABLES BORDETELLA-PARAPERTUSSIS; LOWER RESPIRATORY-TRACT; GAMMA-INTERFERON; NEUTROPHIL RECRUITMENT; WHOLE-CELL; INFECTIONS; BRONCHISEPTICA; EPIDEMIOLOGY; CLEARANCE; RECEPTOR	Although the prevalence of Bordetella parapertussis varies dramatically among studies in different populations with different vaccination regimens, there is broad agreement that whooping cough vaccines, composed only of B. pertussis antigens, provide little if any protection against B. parapertussis. In C57BL/6 mice, a B. pertussis whole-cell vaccine (wP) provided modest protection against B. parapertussis, which was dependent on IFN-gamma. The wP was much more protective against an isogenic B. parapertussis strain lacking O-antigen than its wild-type counterpart. O-antigen inhibited binding of wP-induced antibodies to B. parapertussis, as well as antibody-mediated opsonophagocytosis in vitro and clearance in vivo. aP-induced antibodies also bound better in vitro to the O-antigen mutant than to wild-type B. parapertussis, but aP failed to confer protection against wild-type or O antigen-deficient B. parapertussis in mice. Interestingly, B. parapertussis-specific antibodies provided in addition to either wP or aP were sufficient to very rapidly reduce B. parapertussis numbers in mouse lungs. This study identifies a mechanism by which one pathogen escapes immunity induced by vaccination against a closely related pathogen and may explain why B. parapertussis prevalence varies substantially between populations with different vaccination strategies.			Zhang, XQ (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	harvill@psu.edu		Harvill, Eric/0000-0001-8893-2133	NIAID NIH HHS [R01 AI053075-03, R01 AI053075-05, R01 AI053075-04, R01 AI053075-01A1, R01 AI053075-02, R01 AI053075] Funding Source: Medline; NIGMS NIH HHS [R01 GM083113, R01 GM083113-01, R01 GM083113-02, GM083113, R01 GM083113-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; ARICO B, 1987, J BACTERIOL, V169, P2847, DOI 10.1128/jb.169.6.2847-2853.1987; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; CHERRY JD, 1988, PEDIATRICS, V81; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Gopinathan L, 2007, MICROBES INFECT, V9, P442, DOI 10.1016/j.micinf.2007.01.001; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; He QS, 1998, JAMA-J AM MED ASSOC, V280, P635, DOI 10.1001/jama.280.7.635; Heininger U, 1999, CLIN INFECT DIS, V28, P602, DOI 10.1086/515154; Hoppe JE, 1999, PEDIATR INFECT DIS J, V18, P375, DOI 10.1097/00006454-199904000-00016; KHELEF N, 1993, INFECT IMMUN, V61, P486, DOI 10.1128/IAI.61.2.486-490.1993; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Liese JG, 2003, ARCH DIS CHILD, V88, P684, DOI 10.1136/adc.88.8.684; Mahon BP, 1997, J EXP MED, V186, P1843, DOI 10.1084/jem.186.11.1843; MARCHITTO KS, 1987, INFECT IMMUN, V55, P497, DOI 10.1128/IAI.55.3.497-501.1987; Mastrantonio P, 1998, J CLIN MICROBIOL, V36, P999, DOI 10.1128/JCM.36.4.999-1002.1998; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mills K H, 1998, Dev Biol Stand, V95, P31; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Myc A, 1997, CLIN DIAGN LAB IMMUN, V4, P113, DOI 10.1128/CDLI.4.2.113-116.1997; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; Parent MA, 2006, INFECT IMMUN, V74, P3381, DOI 10.1128/IAI.00185-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pilione MR, 2006, INFECT IMMUN, V74, P1043, DOI 10.1128/IAI.74.2.1043-1049.2006; Pishko EJ, 2004, EUR J IMMUNOL, V34, P184, DOI 10.1002/eji.200324234; Powell KR, 2006, PEDIATRICS, V117, P965, DOI 10.1542/peds.2005-3038; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; REPP R, 1991, BLOOD, V78, P885, DOI 10.1182/blood.V78.4.885.bloodjournal784885; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; Rodriguez ME, 2001, J IMMUNOL METHODS, V252, P33, DOI 10.1016/S0022-1759(01)00329-5; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; van den Akker WMR, 1998, MICROBIOL-SGM, V144, P1527, DOI 10.1099/00221287-144-6-1527; van den Berg BM, 1999, INFECT IMMUN, V67, P1050, DOI 10.1128/IAI.67.3.1050-1055.1999; VONKOENIG CHW, 1988, J CLIN MICROBIOL, V26, P2558, DOI 10.1128/JCM.26.12.2558-2560.1988; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; Willems RJL, 1998, VACCINE, V16, P410, DOI 10.1016/S0264-410X(97)80919-X; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07; Wolfe DN, 2007, INFECT IMMUN, V75, P4416, DOI 10.1128/IAI.00412-07; Wolfe DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004280; Wolfe DN, 2005, INFECT IMMUN, V73, P6508, DOI 10.1128/IAI.73.10.6508-6513.2005; 2002, JAMA, V287, P977	52	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6989	10.1371/journal.pone.0006989	http://dx.doi.org/10.1371/journal.pone.0006989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750010	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796300011
J	Dutta, C; Rhind, N				Dutta, Chaitali; Rhind, Nicholas			The Role of Specific Checkpoint-Induced S-Phase Transcripts in Resistance to Replicative Stress	PLOS ONE			English	Article								Checkpoint activation during S phase modulates transcription. In response to replication arrest, the fission yeast Cds1 checkpoint kinase maintains the normal S-phase transcriptional program by regulating MBF, the S-phase transcription factor. We show that similar regulation occurs in response to DNA damage during S-phase. We test the relative contributions to replication-stress resistance of transcriptional regulation and the two other major checkpoint functions: cell-cycle arrest and fork stabilization. We show that, although transcriptional regulation provides only modest resistance relative to fork stabilization, it contributes significantly to cell survival. Finally, we investigate the roles of two specific transcripts: mik1 and mrc1. These results demonstrate the general importance of checkpoint regulation of G1/S transcription in response to replicative stress and elucidate the specific roles of Mik1 and Mrc1 in the checkpoint.			Dutta, C (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	nick.rhind@umassmed.edu		Rhind, Nicholas/0000-0003-1758-7736	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069957] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069957, R01 GM069957, R01 GM069957-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Baber-Furnari BA, 2000, MOL BIOL CELL, V11, P1; Baum B, 1997, EMBO J, V16, P4676, DOI 10.1093/emboj/16.15.4676; Baum B, 1998, EMBO J, V17, P5689, DOI 10.1093/emboj/17.19.5689; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Brondello JM, 1999, MOL CELL BIOL, V19, P4262; Carr AM, 1997, CURR OPIN GENET DEV, V7, P93, DOI 10.1016/S0959-437X(97)80115-3; Christensen PU, 2000, P NATL ACAD SCI USA, V97, P2579, DOI 10.1073/pnas.97.6.2579; Chu ZQ, 2007, MOL BIOL CELL, V18, P1756, DOI 10.1091/mbc.E06-10-0928; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Rhind N, 2001, MOL CELL BIOL, V21, P1499, DOI 10.1128/MCB.21.5.1499-1508.2001; RUSTICI G, 2004, NAT GENET; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Watson A, 2004, MOL BIOL CELL, V15, P851, DOI 10.1091/mbc.E03-08-0569; Willis N, 2009, MOL BIOL CELL, V20, P819, DOI 10.1091/mbc.E08-08-0798	27	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6944	10.1371/journal.pone.0006944	http://dx.doi.org/10.1371/journal.pone.0006944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750219	Green Published, Green Submitted, gold			2022-12-25	WOS:000269696600004
J	Paul-Victor, C; Turnbull, LA				Paul-Victor, Cloe; Turnbull, Lindsay A.			The Effect of Growth Conditions on the Seed Size/Number Trade-Off	PLOS ONE			English	Article								Background: If the amount of resources allocated to reproduction (K) is fixed, then an increase in seed mass (S) can only be achieved by a decrease in seed number (n = K/S). Thus, log(n) = log(K)-log(S) producing a slope of -1 when seed mass and number are plotted on log-log axes. However, in comparative studies, empirical support for a slope of -1 is limited and contentious, leading some to question the utility of this concept. Methodology/Principal Findings: First, we show that the expected slope depends on whether genotypes and species producing seeds of different mass are expected to reach the same adult size and that this in turn depends partly on the nature of growth. Second, we present experimental results using a population of recombinant inbred lines (RILs) of Arabidopsis thaliana. When these RILs are grown in large pots with plentiful nutrients, they exhibit a trade-off between seed size and number with a slope of-1.68 (+/- 0.18) on log-log axes. This occurs because of genetic correlations between seed mass and adult size so that, under the right growth conditions, lines producing lighter seeds have the genetic potential to produce larger rosettes and hence a greater total mass of seeds. We re-grew lines in small pots (10 and 40 mm diameter) in a nutrient-poor substrate so that final adult size was heavily restricted by pot size. Conclusions/Significance: Under our growth conditions, small-seeded lines were unable to produce a greater total mass of seeds. Hence a trade-off emerged between seed mass and seed number with a slope of -1.166 +/- 0.319 on log-log axes in 40-mm diameter pots (close to the expected value of -1), although the slope was 0.132 +/- 0.263 in 10 mm diameter pots, demonstrating that the nature of the trade-off is sensitive to the growth conditions.			Paul-Victor, C (corresponding author), Univ Zurich, Inst Environm Sci, Zurich, Switzerland.	lindsayt@uwinst.uzh.ch	Turnbull, Lindsay A./A-2680-2012	Paul-Victor, Cloe/0000-0001-5413-8046				Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 1998, GENETICS, V149, P749; Angert AL, 2007, J ECOL, V95, P321, DOI 10.1111/j.1365-2745.2006.01203.x; Cadotte MW, 2007, P ROY SOC B-BIOL SCI, V274, P2739, DOI 10.1098/rspb.2007.0925; Childs DZ, 2003, P ROY SOC B-BIOL SCI, V270, P1829, DOI 10.1098/rspb.2003.2399; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Freckleton RP, 2001, FUNCT ECOL, V15, P615, DOI 10.1046/j.0269-8463.2001.00558.x; Gelman A, DATA ANAL USING REGR; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; Hubbell Stephen P., 2001, V32, pi; Hunt R, 1982, PLANT GROWTH ANAL; Kiflawi M, 2006, OIKOS, V113, P168, DOI 10.1111/j.0030-1299.2001.14378.x; KLINKHAMER PGL, 1990, AM NAT, V135, P291, DOI 10.1086/285045; Koelewijn HP, 2005, J ECOL, V93, P373, DOI 10.1111/j.1365-2745.2004.00940.x; KRANNITZ PG, 1991, AM J BOT, V78, P446, DOI 10.2307/2444967; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; Lobin W, 1983, ARABID INF SERV, V20, P119; LORD J, 1995, AM NAT, V146, P349, DOI 10.1086/285804; MADDOX GD, 1983, ECOLOGY, V64, P1092, DOI 10.2307/1937819; Maloof JN, 2003, CURR OPIN GENET DEV, V13, P576, DOI 10.1016/j.gde.2003.10.003; MAZER SJ, 1987, AM NAT, V130, P891, DOI 10.1086/284754; Michaels HJ, 1988, EVOL ECOL, V2, P157, DOI 10.1007/BF02067274; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Pinheiro J, MIXED EFFECTS MODELS; R Development Core Team, 2009, R FDN STAT COMP; REDEI GP, 1962, GENETICS, V47, P443; REDEI GP, 1992, HEURISTIC GLANCE ARA, P1; Rees M, 1999, AM NAT, V154, P628, DOI 10.1086/303268; REES M, 1995, J ECOL, V83, P857, DOI 10.2307/2261422; Rees M, 2007, J ECOL, V95, P926, DOI 10.1111/j.1365-2745.2007.01277.x; Schamp BS, 2008, J ECOL, V96, P204, DOI 10.1111/j.1365-2745.2007.01328.x; Shimizu KK, 2005, PLANT PHYSIOL, V138, P578, DOI 10.1104/pp.105.061655; SILVERTOWN JW, 1983, AM NAT, V121, P448, DOI 10.1086/284074; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Somerville C, 2002, NAT REV GENET, V3, P883, DOI 10.1038/nrg927; Susko DJ, 2008, BOTANY, V86, P259, DOI 10.1139/B07-137; Turnbull LA, 2008, ECOL LETT, V11, P1037, DOI 10.1111/j.1461-0248.2008.01214.x; Turnbull LA, 2008, ECOLOGY, V89, P1352, DOI 10.1890/07-1531.1; Turnbull LA, 2006, BIOL LETT-UK, V2, P397, DOI 10.1098/rsbl.2006.0476; VENABLE DL, 1992, AM NAT, V140, P287, DOI 10.1086/285413; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; Weiner J, 1997, J ECOL, V85, P133, DOI 10.2307/2960645; Weiner J., 1988, PLANT POPULATION ECO, P59; WINN AA, 1988, ECOLOGY, V69, P1537, DOI 10.2307/1941651	48	44	46	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6917	10.1371/journal.pone.0006917	http://dx.doi.org/10.1371/journal.pone.0006917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746162	Green Submitted, Green Published, gold			2022-12-25	WOS:000269696500001
J	Tiemann, L; Reidt, JH; Esposito, L; Sander, D; Theiss, W; Poppert, H				Tiemann, Laura; Reidt, Jutta Hubertina; Esposito, Lorena; Sander, Dirk; Theiss, Wolfram; Poppert, Holger			Neuropsychological Sequelae of Carotid Angioplasty with Stent Placement: Correlation with Ischemic Lesions in Diffusion Weighted Imaging	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; CARDIOPULMONARY BYPASS; TRANSCRANIAL DOPPLER; BRAIN-LESIONS; ARTERY; ENDARTERECTOMY; EVENTS; MR; MICROEMBOLI; PERFORMANCE	Background and Purpose: Few studies investigated the neuropsychological outcome after carotid angioplasty with stent placement (CAS), yielding partially inconsistent results. The present investigation evaluated the effect of CAS in patients with high-grade stenosis and assessed the predictive value of ischemic lesion number for postinterventional cognitive deterioration. Methods: 22 patients were tested neuropsychologically before and six weeks after CAS. Cerebral ischemic changes were assessed with diffusion weighted imaging (DWI) prior to and after angioplasty. Results: Pre- to postinterventional cognitive performance improved significantly in terms of verbal memory (t=-2.30; p<0.05), whereas significant deterioration was noted regarding verbal memory span (t=2.31; p<0.05). 8 (36%) persons conformed to the criteria of cognitive improvement. 6 patients (27%) were postinterventionally classified as having deficits. Analysis yielded no statistically significant correlations between lesion quantity and cognitive change. Conclusion: Both improvement and deterioration of cognitive functioning was observed in our collective of patients, leaving the neuropsychological outcome after percutaneous transluminal angioplasty unpredictable in individual cases. The presence of acute ischemic lesions on DWI was found to be not tightly associated with cognitive dysfunction after CAS.			Tiemann, L (corresponding author), Tech Univ Munich, Neurol Klin & Poliklin, Munich, Germany.	tiemann@lrz.tu-muenchen.de		Poppert, Holger/0000-0003-2189-7681; Tiemann, Laura/0000-0002-5261-5459				Arrowsmith JE, 1998, STROKE, V29, P2357, DOI 10.1161/01.STR.29.11.2357; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Bakker FC, 2000, J NEUROL, V247, P669, DOI 10.1007/s004150070108; Barber PA, 2008, STROKE, V39, P1427, DOI 10.1161/STROKEAHA.107.502989; Barrett Kevin M, 2007, Curr Atheroscler Rep, V9, P333, DOI 10.1007/s11883-007-0041-4; Bendszus M, 1999, LANCET, V354, P1594, DOI 10.1016/S0140-6736(99)07083-X; BENKE T, 1991, ACTA NEUROL SCAND, V83, P378, DOI 10.1111/j.1600-0404.1991.tb03967.x; Crawley F, 1997, STROKE, V28, P2460, DOI 10.1161/01.STR.28.12.2460; Crawley F, 2000, STROKE, V31, P1329, DOI 10.1161/01.STR.31.6.1329; El-Koussy M, 2007, J ENDOVASC THER, V14, P293, DOI 10.1583/06-1990.1; GAUNT ME, 1994, BRIT J SURG, V81, P1435, DOI 10.1002/bjs.1800811009; Greenstein AJ, 2007, J VASC SURG, V46, P1138, DOI 10.1016/j.jvs.2007.08.026; HAMSTER W, 1984, EUR ARCH PSY CLIN N, V234, P69, DOI 10.1007/BF00432886; Hauth EAM, 2005, AM J NEURORADIOL, V26, P2336; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Heyer EJ, 2006, NEUROSURGERY, V58, P474, DOI 10.1227/01.NEU.0000197123.09972.EA; Karaarslan E, 2008, EUR J RADIOL, V65, P402, DOI 10.1016/j.ejrad.2007.04.023; Kastrup A, 2006, STROKE, V37, P2312, DOI 10.1161/01.STR.0000236492.86303.85; KELLY MP, 1980, ARCH NEUROL-CHICAGO, V37, P743, DOI 10.1001/archneur.1980.00500610023002; Kishikawa K, 2003, J NEUROL SCI, V213, P19, DOI 10.1016/S0022-510X(03)00128-X; LEHRL S, 1995, MANUAL ZUM MWT B; Lehrner J, 2005, J CLIN EXP NEUROPSYC, V27, P859, DOI 10.1080/13803390490919083; Louwerse K, 1999, ST HEAL T, V68, P311; Lovblad KO, 1997, ANN NEUROL, V42, P164; Mathias K D, 1999, Adv Surg, V32, P225; Mlekusch W, 2008, CATHETER CARDIO INTE, V71, P114, DOI 10.1002/ccd.21407; Naugle R I, 1986, Arch Clin Neuropsychol, V1, P25, DOI 10.1016/0887-6177(86)90023-5; NEWMAN SP, 2000, BRAIN CARDIAC SURG C, P22; OSWALD WD, 1978, NURNBERGER ALTERSINV; OSWALD WD, 1999, NURNBERGER ALTERSINV; Pelz DM, 2000, CAN MED ASSOC J, V162, P1451; Pinero P, 2006, AM J NEURORADIOL, V27, P1338; PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393; REITH W, 1995, NEUROLOGY, V45, P172, DOI 10.1212/WNL.45.1.172; Rosenkranz M, 2006, AM J NEURORADIOL, V27, P157; Sader Mark A, 2002, Heart Lung Circ, V11, P95, DOI 10.1046/j.1444-2892.2002.00127.x; Switzer Jeffrey A, 2007, Curr Treat Options Neurol, V9, P451, DOI 10.1007/s11940-007-0046-x; Tedesco MM, 2007, J VASC SURG, V46, P244, DOI 10.1016/j.jvs.2007.04.049; Tewes U, 1991, HDB TESTANWEISUNG; Touze E, 2008, CURR OPIN NEUROL, V21, P56, DOI 10.1097/WCO.0b013e3282f313d2; Turk AS, 2008, AM J NEURORADIOL, V29, P265, DOI 10.3174/ajnr.A0828; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783; van Heesewijk HPM, 2002, RADIOLOGY, V224, P361, DOI 10.1148/radiol.2242011302; Witt K, 2007, J NEUROL, V254, P1524, DOI 10.1007/s00415-007-0576-x; Wolf O, 2004, EUR J VASC ENDOVASC, V27, P167, DOI 10.1016/j.ejvs.2003.11.002; Xu GL, 2007, NEUROL RES, V29, P251, DOI 10.1179/016164107X159216	46	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e7001	10.1371/journal.pone.0007001	http://dx.doi.org/10.1371/journal.pone.0007001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746158	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696500011
J	Bennett, KL; Romigh, T; Eng, C				Bennett, Kristi L.; Romigh, Todd; Eng, Charis			AP-2 alpha Induces Epigenetic Silencing of Tumor Suppressive Genes and Microsatellite Instability in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article								Background: Activator protein 2 alpha (AP-2 alpha) is involved in a variety of physiological processes. Increased AP-2 alpha expression correlates with progression in various squamous cell carcinomas, and a recent publication found AP-2 alpha to be overexpressed in similar to 70% of Head and Neck Squamous Cell Carcinoma (HNSCC) patient samples. It was found to repress transcription of the tumor suppressor gene C/CAAT Enhancer Binding Protein alpha (C/EBP alpha), and its binding site correlated with upstream methylation of the C/EBP alpha promoter. Therefore, we investigated the potential for AP-2 alpha to target methylation to additional genes that would be relevant to HNSCC pathogenesis. Principal Findings: Stable downregulation of AP-2 alpha stable by shRNA in HNSCC cell lines correlated with decreased methylation of its target genes' regulatory regions. Furthermore, methylation of MLH1 in HNSCC with and without AP-2 alpha downregulation revealed a correlation with microsatellite instability (MSI). ChIP analysis was used to confirm binding of AP-2 alpha and HDAC1/2 to the targets. The effects of HDAC inhibition was assessed using Trichostatin A in a HNSCC cell line, which revealed that AP-2 alpha targets methylation through HDAC recruitment. Conclusions: These findings are significant because they suggest AP-2 alpha plays a role not only in epigenetic silencing, but also in genomic instability. This intensifies the potential level of regulation AP-2 alpha has through transcriptional regulation. Furthermore, these findings have the potential to revolutionize the field of HNSCC therapy, and more generally the field of epigenetic therapy, by targeting a single gene that is involved in the malignant transformation via disrupting DNA repair and cell cycle control.			Bennett, KL (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145				Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Bennett KL, 2009, INT J CANCER, V124, P1285, DOI 10.1002/ijc.24087; Boland CR, 1998, CANCER RES, V58, P5248; Bosher JM, 1996, ONCOGENE, V13, P1701; Choi HJ, 2008, GLYCOBIOLOGY, V18, P395, DOI 10.1093/glycob/cwn016; Damberg M, 2005, J NEURAL TRANSM, V112, P1281, DOI 10.1007/s00702-005-0325-1; Demokan S, 2006, ANN ONCOL, V17, P995, DOI 10.1093/annonc/mdl048; Dietmaier W, 1997, CANCER RES, V57, P4749; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Gille J, 2000, J INVEST DERMATOL, V115, P30, DOI 10.1046/j.1523-1747.2000.00020.x; Han CY, 2008, CANCER SCI, V99, P502, DOI 10.1111/j.1349-7006.2007.00718.x; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Jiang MS, 2000, P NATL ACAD SCI USA, V97, P12519, DOI 10.1073/pnas.220426097; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Leung SY, 1999, CANCER RES, V59, P159; Liu H, 2007, EMBO REP, V8, P394, DOI 10.1038/sj.embor.7400909; McCool KW, 2007, J BIOL CHEM, V282, P6696, DOI 10.1074/jbc.M609519200; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Orso F, 2008, FASEB J, V22, P2702, DOI 10.1096/fj.08-106492; Oyama N, 2002, ARCH DERMATOL RES, V294, P273, DOI 10.1007/s00403-002-0327-x; Provenzano MJ, 2007, EXP MOL PATHOL, V83, P277, DOI 10.1016/j.yexmp.2007.06.001; Schulte JH, 2008, CANCER LETT, V271, P56, DOI 10.1016/j.canlet.2008.05.039; Singh H, 2000, J CELL BIOCHEM, P61; Suyama Eigo, 2002, Nucleic Acids Res Suppl, P247; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Thibodeau SN, 1998, CANCER RES, V58, P1713; Uramoto H, 2004, J CELL SCI, V117, P5323, DOI 10.1242/jcs.01384; Yu YH, 2002, MOL CARCINOGEN, V34, P172, DOI 10.1002/mc.10062; Zhang GQ, 2004, ENDOCRINOLOGY, V145, P2760, DOI 10.1210/en.2003-1545	35	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6931	10.1371/journal.pone.0006931	http://dx.doi.org/10.1371/journal.pone.0006931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742317	Green Published, gold			2022-12-25	WOS:000269622500010
J	Taurin, S; Sandbo, N; Yau, DM; Sethakorn, N; Kach, J; Dulin, NO				Taurin, Sebastien; Sandbo, Nathan; Yau, Douglas M.; Sethakorn, Nan; Kach, Jacob; Dulin, Nickolai O.			Phosphorylation of Myocardin by Extracellular Signal-regulated Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; TRANSCRIPTION FACTORS; DEPENDENT TRANSCRIPTION; PHENOTYPIC MODULATION; CELL DIFFERENTIATION; NUCLEAR-LOCALIZATION; PROTEIN-KINASE; MARKER GENES; SMOOTH	The contractile phenotype of smooth muscle (SM) cells is controlled by serum response factor (SRF), which drives the expression of SM-specific genes including SM alpha-actin, SM22, and others. Myocardin is a cardiac and SM-restricted coactivator of SRF that is necessary for SM gene transcription. Growth factors inducing proliferation of SM cells inhibit SM gene transcription, in a manner dependent on the activation of extracellular signal-regulated kinases ERK1/2. In this study, we found that ERK1/2 phosphorylates mouse myocardin (isoform B) at four sites (Ser(812), Ser(859), Ser(866), and Thr(893)), all of which are located within the transactivation domain of myocardin. The single mutation of each site either to alanine or to aspartate has no effect on the ability of myocardin to activate SRF. However, the phosphomimetic mutation of all four sites to aspartate (4XD) significantly impairs activation of SRF by myocardin, whereas the phosphodeficient mutation of all four sites to alanine (4XA) has no effect. This translates to a reduced ability of the 4XD (but not of 4XA) mutant of myocardin to stimulate expression of SM alpha-actin and SM22, as assessed by corresponding promoter, mRNA, or protein assays. Furthermore, we found that phosphorylation of myocardin at these sites impairs its interaction with acetyltransferase, cAMP response element-binding protein-binding protein, which is known to promote the transcriptional activity of myocardin. In conclusion, we describe a novel mode of modulation of SM gene transcription by ERK1/2 through a direct phosphorylation of myocardin.	[Taurin, Sebastien; Sandbo, Nathan; Yau, Douglas M.; Sethakorn, Nan; Kach, Jacob; Dulin, Nickolai O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Dulin, NO (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 6076, Chicago, IL 60637 USA.	ndulin@medicine.bsd.uchicago.edu	Sethakorn, Nan/AAH-7721-2020	Sethakorn, Nan/0000-0002-7395-3182; Taurin, Sebastien/0000-0003-2167-5253	National Institutes of Health [R01 HL071755, GM085058, T32 HL07605, T32 HD07009, T32 HL07237]; American Heart Association Postdoctoral Fellowship Awards [0720151Z, 0520109Z, 0825868G]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071755, T32HL007605, K08HL093367, T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship Awards(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL071755 ( to N.O.D.), GM085058 ( to N.O.D.), T32 HL07605 ( to D.M.Y.), T32 HD07009 ( to N.S.), and T32 HL07237 ( to J.K.) and by American Heart Association Postdoctoral Fellowship Awards 0720151Z ( to S. T.), 0520109Z ( to N.S.), and 0825868G ( to D.M.Y.).	Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Oh J, 2004, MOL CELL BIOL, V24, P8519, DOI 10.1128/MCB.24.19.8519-8528.2004; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006	26	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33789	33794		10.1074/jbc.M109.048983	http://dx.doi.org/10.1074/jbc.M109.048983			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19776005	hybrid, Green Published			2022-12-25	WOS:000272165200009
J	Piette, C; Deprez, M; Roger, T; Noel, A; Foidart, JM; Munaut, C				Piette, Caroline; Deprez, Manuel; Roger, Thierry; Noel, Agnes; Foidart, Jean-Michel; Munaut, Carine			The Dexamethasone-induced Inhibition of Proliferation, Migration, and Invasion in Glioma Cell Lines Is Antagonized by Macrophage Migration Inhibitory Factor (MIF) and Can Be Enhanced by Specific MIF Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; GLUCOCORTICOID-RECEPTOR; RHEUMATOID-ARTHRITIS; HUMAN NEUROBLASTOMA; ENZYMATIC-ACTIVITY; SIGNALING PATHWAY; MALIGNANT GLIOMA; REGULATORY ROLE; BRAIN-TUMORS; MAP KINASE	Glioblastomas (GBMs) are the most frequent and malignant brain tumors in adults. Glucocorticoids (GCs) are routinely used in the treatment of GBMs for their capacity to reduce the tumor-associated edema. Few in vitro studies have suggested that GCs inhibit the migration and invasion of GBM cells through the induction of MAPK phosphatase 1 (MKP-1). Macrophage migration inhibitory factor (MIF), an endogenous GC antagonist is up-regulated in GBMs. Recently, MIF has been involved in tumor growth and migration/invasion and specific MIF inhibitors have been developed on their capacity to block its enzymatic tautomerase activity site. In this study, we characterized several glioma cell lines for their MIF production. U373 MG cells were selected for their very low endogenous levels of MIF. We showed that dexamethasone inhibits the migration and invasion of U373 MG cells, through a glucocorticoid receptor (GR)-dependent inhibition of the ERK1/2 MAPK pathway. Oppositely, we found that exogenous MIF increases U373 MG migration and invasion through the stimulation of the ERK1/2 MAP kinase pathway and that this activation is CD74 independent. Finally, we used the Hs 683 glioma cells that are resistant to GCs and produce high levels of endogenous MIF, and showed that the specific MIF inhibitor ISO-1 could restore dexamethasone sensitivity in these cells. Collectively, our results indicate an intricate pathway between MIF expression and GC resistance. They suggest that MIF inhibitors could increase the response of GBMs to corticotherapy.	[Piette, Caroline; Noel, Agnes; Foidart, Jean-Michel; Munaut, Carine] Univ Liege, CHU, GIGA R, Lab Tumor & Dev Biol, B-4000 Liege, Belgium; [Deprez, Manuel] Univ Liege, CHU, Dept Pathol, Neuropathol Lab, B-4000 Liege, Belgium; [Piette, Caroline] Univ Liege, CHR Citadelle, Dept Paediat, B-4000 Liege, Belgium; [Foidart, Jean-Michel] Univ Liege, CHR Citadelle, Dept Gynecol & Obstet, B-4000 Liege, Belgium; [Roger, Thierry] CHU Vaudois, Dept Med, CHU, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Roger, Thierry] Univ Lausanne, CH-1011 Lausanne, Switzerland	University of Liege; University of Liege; University of Liege; University of Liege; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Munaut, C (corresponding author), CHU Sart Tilman, LBTD, Tour Pathol B23 4, B-4000 Liege, Belgium.	c.munaut@ulg.ac.be	Roger, Thierry/G-2007-2012; Munaut, Carine/K-8138-2019	Roger, Thierry/0000-0002-9358-0109; Noel, Agnes/0000-0002-7670-6179; Piette, Caroline/0000-0003-1442-7681	EMBIC [LSHM-CT-2004-512040]; Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique; Swiss National Science Foundation [310000-118266]; Fonds speciaux de la Recherche; Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Fonds Social Europeen; Fonds d'Investissements de la Recherche Scientifique; Interuniversity Attraction Poles Programme-Belgian Science Policy	EMBIC; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds speciaux de la Recherche; Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Fonds Social Europeen(European Social Fund (ESF)); Fonds d'Investissements de la Recherche Scientifique; Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported in part by Framework Programme 6-NOE (FP6) Grant LSHM-CT-2004-512040 (EMBIC), the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (F.N.R.S., Belgium), Swiss National Science Foundation Grant 310000-118266, the Fonds speciaux de la Recherche, the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the Fonds Social Europeen, the Fonds d'Investissements de la Recherche Scientifique (CHU, Liege, Belgium), and the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium).	Aeberli D, 2006, FEBS LETT, V580, P974, DOI 10.1016/j.febslet.2006.01.027; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Bauman GS, 1999, J NEURO-ONCOL, V44, P223, DOI 10.1023/A:1006319417077; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Berdeli A, 2005, PEDIATR NEPHROL, V20, P1566, DOI 10.1007/s00467-005-1930-9; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brandes AA, 2003, SEMIN ONCOL, V30, P4, DOI 10.1053/j.seminoncol.2003.11.028; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Casulari LA, 2006, BRAZ J MED BIOL RES, V39, P1233; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Daun JM, 2000, AM J PHYSIOL-REG I, V279, pR1043, DOI 10.1152/ajpregu.2000.279.3.R1043; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Kapoor GS, 2003, NEUROSURGERY, V52, P1425, DOI 10.1227/01.NEU.0000065135.28143.39; Kapoor GS, 2003, CANCER BIOL THER, V2, P330, DOI 10.4161/cbt.2.4.507; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lin YM, 2008, EUR J PHARMACOL, V593, P1, DOI 10.1016/j.ejphar.2008.06.111; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Munaut C, 2002, NEUROPATH APPL NEURO, V28, P452, DOI 10.1046/j.1365-2990.2002.00416.x; Murakami N, 1998, J CELL PHYSIOL, V176, P127, DOI 10.1002/(SICI)1097-4652(199807)176:1<127::AID-JCP15>3.0.CO;2-4; Oakley Robert H., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P63; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; ORTI E, 1993, J BIOL CHEM, V268, P7779; Piette C, 2006, ACTA NEUROPATHOL, V112, P651, DOI 10.1007/s00401-006-0100-x; Pross C, 2002, J SURG RES, V102, P57, DOI 10.1006/jsre.2001.6220; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Ren Y, 2006, ONCOGENE, V25, P3501, DOI 10.1038/sj.onc.1209395; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shiratsuchi T, 2002, J CELL PHYSIOL, V193, P340, DOI 10.1002/jcp.10181; Stupp R, 2007, ANN ONCOL, V18, P69, DOI 10.1093/annonc/mdm044; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925	50	50	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32483	32492		10.1074/jbc.M109.014589	http://dx.doi.org/10.1074/jbc.M109.014589			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759012	hybrid, Green Published			2022-12-25	WOS:000272028400031
J	Pluciennik, A; Burdett, V; Lukianova, O; O'Donnell, M; Modrich, P				Pluciennik, Anna; Burdett, Vickers; Lukianova, Olga; O'Donnell, Mike; Modrich, Paul			Involvement of the beta Clamp in Methyl-directed Mismatch Repair in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-III; CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; ESCHERICHIA-COLI; SLIDING CLAMPS; GENE-PRODUCT; HELICASE-II; MUTL; COMPLEX	We have examined function of the bacterial beta replication clamp in the different steps of methyl-directed DNA mismatch repair. The mismatch-, MutS-, and MutL-dependent activation of MutH is unaffected by the presence or orientation of loaded beta clamp on either 3' or 5' heteroduplexes. Similarly, beta is not required for 3' or 5' mismatch- provoked excision when scored in the presence of gamma complex or in the presence of gamma complex and DNA polymerase III core components. However, mismatch repair does not occur in the absence of beta, an effect we attribute to a requirement for the clamp in the repair DNA synthesis step of the reaction. We have confirmed previous findings that beta clamp interacts specifically with MutS and MutL (Lopez de Saro, F. J., Marinus, M. G., Modrich, P., and O'Donnell, M. (2006) J. Biol. Chem. 281, 14340-14349) and show that the mutator phenotype conferred by amino acid substitution within the MutS N-terminal beta-interaction motif is the probable result of instability coupled with reduced activity in multiple steps of the repair reaction. In addition, we have found that the DNA polymerase III alpha catalytic subunit interacts strongly and specifically with both MutS and MutL. Because interactions of polymerase III holoenzyme components with MutS and MutL appear to be of limited import during the initiation and excision steps of mismatch correction, we suggest that their significance might lie in the control of replication fork events in response to the sensing of DNA lesions by the repair system.	[Pluciennik, Anna; Burdett, Vickers; Lukianova, Olga; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [O'Donnell, Mike; Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Duke University; Duke University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Rockefeller University	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu		Modrich, Paul/0000-0001-8708-9885; O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM23719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023719, R37GM023719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23719.	AU KG, 1992, J BIOL CHEM, V267, P12142; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; COOPER DL, 1993, J BIOL CHEM, V268, P11823; DE LV, 1994, METHOD ENZYMOL, V235, P386; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISTENSEN CS, 1995, J BACTERIOL, V177, P52, DOI 10.1128/jb.177.1.52-58.1995; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lau PJ, 2003, J BIOL CHEM, V278, P14, DOI 10.1074/jbc.C200627200; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Li F, 2008, MUTAT RES-FUND MOL M, V637, P101, DOI 10.1016/j.mrfmmm.2007.07.008; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; PUKKILA PJ, 1983, GENETICS, V104, P571; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; Viswanathan M, 2001, J BIOL CHEM, V276, P31053, DOI 10.1074/jbc.M105481200; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x	47	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32782	32791		10.1074/jbc.M109.054528	http://dx.doi.org/10.1074/jbc.M109.054528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783657	hybrid, Green Published			2022-12-25	WOS:000272028400063
J	Gutsche, M; Sobotta, MC; Wabnitz, GH; Ballikaya, S; Meyer, AJ; Samstag, Y; Dick, TP				Gutsche, Marcus; Sobotta, Mirko C.; Wabnitz, Guido H.; Ballikaya, Seda; Meyer, Andreas J.; Samstag, Yvonne; Dick, Tobias P.			Proximity-based Protein Thiol Oxidation by H2O2-scavenging Peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; GLUTATHIONE PEROXIDASES; REDOX REGULATION; MAMMALIAN-CELLS; SULFENIC ACIDS; SPECIFICITY; PEROXIREDOXIN; ACTIVATION; CHEMISTRY; MECHANISM	H2O2 acts as a signaling molecule by oxidizing critical thiol groups on redox-regulated target proteins. To explain the efficiency and selectivity of H2O2-based signaling, it has been proposed that oxidation of target proteins may be facilitated by H2O2-scavenging peroxidases. Recently, a peroxidase-based protein oxidation relay has been identified in yeast, namely the oxidation of the transcription factor Yap1 by the peroxidase Orp1. It has remained unclear whether the protein oxidase function of Orp1 is a singular adaptation or whether it may represent a more general principle. Here we show that Orp1 is in fact not restricted to oxidizing Yap1 but can also form a highly efficient redox relay with the oxidant target protein roGFP (redox-sensitive green fluorescent protein) in mammalian cells. Orp1 mediates near quantitative oxidation of roGFP2 by H2O2, and the Orp1-roGFP2 redox relay effectively converts physiological H2O2 signals into measurable fluorescent signals in living cells. Furthermore, the oxidant relay phenomenon is not restricted to Orp1 as the mammalian peroxidase Gpx4 also mediates oxidation of proximal roGFP2 in living cells. Together, these findings support the concept that certain peroxidases harbor an intrinsic and powerful capacity to act as H2O2-dependent protein thiol oxidases when they are recruited into proximity of oxidizable target proteins.	[Dick, Tobias P.] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ A160, Redox Regulat Res Grp, D-69120 Heidelberg, Germany; [Wabnitz, Guido H.; Samstag, Yvonne] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany; [Meyer, Andreas J.] Univ Heidelberg, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dick, TP (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ A160, Redox Regulat Res Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	t.dick@dkfz.de	Meyer, Andreas J/C-4734-2013	Meyer, Andreas J/0000-0001-8144-4364; Wabnitz, Guido/0000-0001-5101-9885	European Commission [MEXT 2761]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Grant MEXT 2761 (to T. P. D.).	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Gulow K, 2005, J IMMUNOL, V174, P5249, DOI 10.4049/jimmunol.174.9.5249; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Ma LH, 2007, J BIOL CHEM, V282, P31429, DOI 10.1074/jbc.M705953200; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	26	296	300	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31532	31540		10.1074/jbc.M109.059246	http://dx.doi.org/10.1074/jbc.M109.059246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19755417	Green Published, hybrid			2022-12-25	WOS:000271572700006
J	Chung, JS; Noguera-Mazon, V; Lancelin, JM; Kim, SK; Hirasawa, M; Hologne, M; Leustek, T; Knaff, DB				Chung, Jung-Sung; Noguera-Mazon, Valerie; Lancelin, Jean-Marc; Kim, Sung-Kun; Hirasawa, Masakazu; Hologne, Maggy; Leustek, Thomas; Knaff, David B.			Interaction Domain on Thioredoxin for Pseudomonas aeruginosa 5 '-Adenylylsulfate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; IRON-SULFUR CLUSTER; PROTEIN-PROTEIN INTERACTIONS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; CHLAMYDOMONAS-REINHARDTII; NMR; GLUTAREDOXINS; RECOGNITION; ASSIGNMENT	NMR spectroscopy has been used to map the interaction domain on Escherichia coli thioredoxin for the thioredoxin-dependent 5'-adenylylsulfate reductase from Pseudomonas aeruginosa (PaAPR). Seventeen thioredoxin amino acids, all clustered around Cys-32 (the more surface-exposed of the two active-site cysteines), have been located at the PaAPR binding site. The center of the binding domain is dominated by nonpolar amino acids, with a smaller number of charged and polar amino acids located on the periphery of the site. Twelve of the amino acids detected by NMR have non-polar, hydrophobic side chains, including one aromatic amino acid (Trp-31). Four of the thioredoxin amino acids at the PaAPR binding site have polar side chains (Lys-36, Asp-61, Gln-62 and Arg-73), with three of the four having charged side chains. Site-directed mutagenesis experiments have shown that replacement of Lys-36, Asp-61, and Arg-73 and of the absolutely conserved Trp-31 significantly decreases the Vmax for the PaAPR-catalyzed reduction of 5'-adenylylsulfate, with E. coli thioredoxin serving as the electron donor. The most dramatic effect was observed with the W31A variant, which showed no activity as a donor to PaAPR. Although the thiol of the active-site Cys-256 of PaAPR is the point of the initial nucleophilic attack by reduced thioredoxin, mutagenic replacement of Cys-256 by serine has no effect on thioredoxin binding to PaAPR.	[Knaff, David B.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Knaff, David B.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Noguera-Mazon, Valerie; Lancelin, Jean-Marc; Hologne, Maggy] Univ Lyon 1, Lab RMN & Spectrometrie Masse Biomol, CNRS, ESCPE,UMR Sci Analyt 5180, F-69622 Villeurbanne, France; [Leustek, Thomas] Rutgers State Univ, Dept Plant Biol & Pathol, Biotechnol Ctr Agr & Environm, New Brunswick, NJ 08901 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Rutgers State University New Brunswick	Knaff, DB (corresponding author), Texas Tech Univ, Dept Chem & Biochem, 1 Circle Dr, Lubbock, TX 79409 USA.	david.knaff@ttu.edu	Lancelin, Jean-marc/AAC-5686-2019; Kim, Sung-Kun/I-4193-2019; Kim, Sung-Kun/A-7055-2008	Kim, Sung-Kun/0000-0002-2325-245X; HOLOGNE, Maggy/0000-0002-4977-7887	United States Department of Agriculture [2006-35318-16581]; Robert A. Welch Foundation [D-0710]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Robert A. Welch Foundation(The Welch Foundation)	This work was supported by United States Department of Agriculture Grant 2006-35318-16581 (to T.L., S.-K.K., and D.B.K.) and Robert A. Welch Foundation Grant D-0710 (to D.B.K.).	Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Carroll KS, 2005, BIOCHEMISTRY-US, V44, P14647, DOI 10.1021/bi051344a; CHANDRASEKHAR K, 1991, FEBS LETT, V284, P178, DOI 10.1016/0014-5793(91)80679-W; Chartron J, 2007, BIOCHEMISTRY-US, V46, P3942, DOI 10.1021/bi700130e; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELAMOTTEGUERY F, 1991, EUR J BIOCHEM, V196, P287; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; FORMANKAY JD, 1991, BIOCHEMISTRY-US, V30, P2685, DOI 10.1021/bi00224a017; Gao Y, 2000, PLANT PHYSIOL, V123, P1087, DOI 10.1104/pp.123.3.1087; GLEASON FK, 1990, BIOCHEMISTRY-US, V29, P3701, DOI 10.1021/bi00467a016; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kim SK, 2005, BBA-BIOENERGETICS, V1710, P103, DOI 10.1016/j.bbabio.2005.09.004; Kim SK, 2004, BIOCHEMISTRY-US, V43, P13478, DOI 10.1021/bi048811t; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Krimm I, 1998, EUR J BIOCHEM, V255, P185, DOI 10.1046/j.1432-1327.1998.2550185.x; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; NAVARRO JA, 1991, BIOCHEMISTRY-US, V30, P2192, DOI 10.1021/bi00222a024; NIKKOLA M, 1993, BIOCHEMISTRY-US, V32, P5093, DOI 10.1021/bi00070a017; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; OBLONG JE, 1995, BIOCHEMISTRY-US, V34, P3319, DOI 10.1021/bi00010a022; RUSSEL M, 1990, J BACTERIOL, V172, P1923, DOI 10.1128/jb.172.4.1923-1929.1990; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088; Singha NC, 2003, J BIOL CHEM, V278, P21421, DOI 10.1074/jbc.M302310200; Wangensteen OS, 2001, BBA-PROTEIN STRUCT M, V1547, P156, DOI 10.1016/S0167-4838(01)00178-9; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	43	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31181	31189		10.1074/jbc.M109.035634	http://dx.doi.org/10.1074/jbc.M109.035634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744922	hybrid, Green Published			2022-12-25	WOS:000271378400046
J	Wada, M; Saunders, TL; Morrow, J; Milne, GL; Walker, KP; Dey, SK; Brock, TG; Opp, MR; Aronoff, DM; Smith, WL				Wada, Masayuki; Saunders, Thomas L.; Morrow, Jason; Milne, Ginger L.; Walker, Kimberly P.; Dey, Sudhansu K.; Brock, Thomas G.; Opp, Mark R.; Aronoff, David M.; Smith, William L.			Two Pathways for Cyclooxygenase-2 Protein Degradation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-E SYNTHASE-1; FATTY-ACIDS; GENE; MICE; LIPOPOLYSACCHARIDE; OXYGENATION; RECEPTOR; SLEEP; COX-2	COX-2, formally known as prostaglandin endoperoxide H synthase-2 (PGHS-2), catalyzes the committed step in prostaglandin biosynthesis. COX-2 is induced during inflammation and is overexpressed in colon cancer. In vitro, an 18-amino acid segment, residues 595-612, immediately upstream of the C-terminal endoplasmic reticulum targeting sequence is required for N-glycosylation of Asn(594), which permits COX-2 protein to enter the endoplasmic reticulum-associated protein degradation system. To determine the importance of this COX-2 degradation pathway in vivo, we engineered a del595-612 PGHS-2 (Delta 18 COX-2) knock-in mouse lacking this 18-amino acid segment. Delta 18 COX-2 knock-in mice do not exhibit the renal or reproductive abnormalities of COX-2 null mice. Delta 18 COX-2 mice do have elevated urinary prostaglandin E-2 metabolite levels and display a more pronounced and prolonged bacterial endotoxin-induced febrile response than wild type (WT) mice. Normal brain tissue, cultured resident peritoneal macrophages, and cultured skin fibroblasts from Delta 18 COX-2 mice overexpress Delta 18 COX-2 relative to WT COX-2 expression in control mice. These results indicate that COX-2 can be degraded via the endoplasmic reticulum-associated protein degradation pathway in vivo. Treatment of cultured cells from WT or Delta 18 COX-2 mice with flurbiprofen, which blocks substrate-dependent degradation, attenuates COX-2 degradation, and treatment of normal mice with ibuprofen increases the levels of COX-2 in brain tissue. Thus, substrate turnover-dependent COX-2 degradation appears to contribute to COX-2 degradation in vivo. Curiously, WT and Delta 18 COX-2 protein levels are similar in kidneys and spleens from WT and Delta 18 COX-2 mice. There must be compensatory mechanisms to maintain constant COX-2 levels in these tissues.	[Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Opp, Mark R.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.; Brock, Thomas G.; Aronoff, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Morrow, Jason; Milne, Ginger L.; Walker, Kimberly P.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Morrow, Jason; Milne, Ginger L.; Walker, Kimberly P.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Dey, Sudhansu K.] Univ Cincinnati, Coll Med, Div Reprod Sci, Perinatal Inst,Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X; Saunders, Thom/0000-0003-2015-101X; Opp, Mark/0000-0002-9831-9866; Aronoff, David/0000-0003-4587-6121	National Institutes of Health [GM 068848, HL085149, HL078727, DK48831, GM15431, HL080972, GM067189, HD012304, CA77839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012304, R01HD012304] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085149, K08HL078727, R01HL080972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848, P01GM067189, P50GM015431, P01GM015431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 068848 (to W. L. S.), HL085149 (to W. L. S.), HL078727 (to D. M. A.), DK48831 (to G. L. M.), GM15431 (to G. L. M.), HL080972 (to M. R. O.), GM067189 (to M. R. O.), HD012304 (to S. K. D.), and CA77839 (to S. K. D.).	Aronoff DM, 2007, PROG BRAIN RES, V162, P15, DOI 10.1016/S0079-6123(06)62002-5; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2001, AM J MED, V111, P304, DOI 10.1016/S0002-9343(01)00834-8; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buchanan FG, 2007, CANCER RES, V67, P9380, DOI 10.1158/0008-5472.CAN-07-0710; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Francois H, 2007, J AM SOC NEPHROL, V18, P1466, DOI 10.1681/ASN.2006040343; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; HERSCHMAN HR, 1993, J LIPID MEDIATOR, V6, P89; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Langenbach R, 1999, ANN NY ACAD SCI, V889, P52, DOI 10.1111/j.1749-6632.1999.tb08723.x; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; LILES JH, 1992, LAB ANIM, V26, P241, DOI 10.1258/002367792780745706; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P28, DOI 10.1016/j.bbi.2004.02.003; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Yang PY, 2002, ANAL BIOCHEM, V308, P168, DOI 10.1016/S0003-2697(02)00218-X; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200	35	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30742	30753		10.1074/jbc.M109.052415	http://dx.doi.org/10.1074/jbc.M109.052415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758985	Green Published, hybrid			2022-12-25	WOS:000271378400002
J	Palijan, A; Fernandes, I; Bastien, Y; Tang, LQ; Verway, M; Kourelis, M; Tavera-Mendoza, LE; Li, Z; Bourdeau, V; Mader, S; Yang, XJ; White, JH				Palijan, Ana; Fernandes, Isabelle; Bastien, Yolande; Tang, Liqun; Verway, Mark; Kourelis, Maria; Tavera-Mendoza, Luz E.; Li, Zhi; Bourdeau, Veronique; Mader, Sylvie; Yang, Xiang Jiao; White, John H.			Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TRANSCRIPTIONAL REPRESSION; HORMONE-RECEPTORS; GENE-EXPRESSION; CO-REPRESSOR; N-COR; COREPRESSOR; RECRUITMENT; HDAC6; ALPHA	Ligand-dependent corepressor LCoR was identified as a protein that interacts with the estrogen receptor alpha(ER alpha) ligand binding domain in a hormone-dependent manner. LCoR also interacts directly with histone deacetylase 3 (HDAC3) and HDAC6. Notably, HDAC6 has emerged as a marker of breast cancer prognosis. However, although HDAC3 is nuclear, HDAC6 is cytoplasmic in many cells. We found that HDAC6 is partially nuclear in estrogen-responsive MCF7 cells, colocalizes with LCoR, represses transactivation of estrogen- inducible reporter genes, and augments corepression by LCoR. In contrast, no repression was observed upon HDAC6 expression in COS7 cells, where it is exclusively cytoplasmic. LCoR binds to HDAC6 in vitro via a central domain, and repression by LCoR mutants lacking this domain was attenuated. Kinetic chromatin immunoprecipitation assays revealed hormone-dependent recruitment of LCoR to promoters of ER alpha-induced target genes in synchrony with ER alpha. HDAC6 was also recruited to these promoters, and repeat chromatin immunoprecipitation experiments confirmed the corecruitment of LCoR with ER alpha and with HDAC6. Remarkably, however, although we find evidence for corecruitment of LCoR and ER alpha on genes repressed by the receptor, LCoR and HDAC6 failed to coimmunoprecipitate, suggesting that they are part of distinct complexes on these genes. Although small interfering RNA-mediated knockdown of LCoR or HDAC6 augmented expression of an estrogen-sensitive reporter gene in MCF7 cells, unexpectedly their ablation led to reduced expression of some endogenous estrogen target genes. Taken together, these data establish that HDAC6 can function as a cofactor of LCoR but suggest that they may act in enhance expressing some target genes.	[Palijan, Ana; Fernandes, Isabelle; Bastien, Yolande; Tang, Liqun; Verway, Mark; Kourelis, Maria; Li, Zhi; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Yang, Xiang Jiao; White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Tavera-Mendoza, Luz E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Universite de Montreal; Universite de Montreal	White, JH (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G Y6, Canada.	john.white@mcgill.ca	white, john h/N-9782-2013; Palijan, Ana/AAV-3310-2021	white, john h/0000-0002-4785-2687; 	Canadian Institutes of Health [MT-11704]; Canadian Cancer Society [018362]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by Canadian Institutes of Health Research Grant MT-11704 ( to J.H.W.) and a grant from the Canadian Cancer Society (018362 to X.J.Y.).	Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Glass CK, 2000, GENE DEV, V14, P121; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Heim KC, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-57; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hsu MY, 2008, LAB INVEST, V88, P842, DOI 10.1038/labinvest.2008.55; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Kusumegi T, 2004, J BIOCHEM MOL TOXIC, V18, P1, DOI 10.1002/jbt.20004; Lemaire V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198102; Lopez-Garcia J, 2006, NUCLEIC ACIDS RES, V34, P6126, DOI 10.1093/nar/gkl875; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Verdel A, 2003, ZYGOTE, V11, P323, DOI 10.1017/S0967199403002387; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; White JH, 2004, VITAM HORM, V68, P123; White KA, 2005, J BIOL CHEM, V280, P7829, DOI 10.1074/jbc.M412707200; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	52	44	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30264	30274		10.1074/jbc.M109.045526	http://dx.doi.org/10.1074/jbc.M109.045526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19744931	Green Published, hybrid			2022-12-25	WOS:000271090000030
J	Widenmaier, SB; Ao, ZL; Kim, SJ; Warnock, G; McIntosh, CHS				Widenmaier, Scott B.; Ao, Ziliang; Kim, Su-Jin; Warnock, Garth; McIntosh, Christopher H. S.			Suppression of p38 MAPK and JNK via Akt-mediated Inhibition of Apoptosis Signal-regulating Kinase 1 Constitutes a Core Component of the beta-Cell Pro-survival Effects of Glucose-dependent Insulinotropic Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ENDOTHELIAL APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETES-MELLITUS; PROTEIN-KINASE; PROAPOPTOTIC FUNCTION; PHYSIOLOGICAL ROLES; RECEPTOR AGONISTS; TNF-ALPHA; PHOSPHORYLATION; PATHWAY	Glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-stimulated insulin secretion, insulin biosynthesis, and beta-cell proliferation and survival. In previous studies GIP was shown to promote beta-cell survival by modulating the activity of multiple signaling modules and regulating gene transcription of pro- and anti-apoptotic bcl-2 family proteins. We have now evaluated the mechanisms by which GIP regulates the dynamic interactions between cytoplasmic bcl-2 family members and the mitochondria in INS-1 cells during apoptosis induced by treatment with staurosporine (STS), an activator of the mitochondria-mediated apoptotic pathway. STS induced translocation of bad and bimEL, activation of mitochondrial bax, release of mitochondrial cytochrome c, cleavage of caspase-3, and apoptosis. Each response was significantly diminished by GIP. Using selective enzyme inhibitors, overexpression of dominant-negative Akt, and Akt siRNA, it was demonstrated that GIP promoted beta-cell survival via Akt-dependent suppression of p38 MAPK and JNK and that combined inhibition was sufficient to explain the entire pro-survival responses to GIP during STS treatment. This signaling pathway also explained the pro-survival effects of GIP on INS-1 cells exposed to two other promoters of stress: thapsigargin (endoplasmic reticulum stress) and etoposide (genotoxic stress). Importantly, we discovered that GIP suppressed p38 MAPK and JNK via Akt-mediated changes in the phosphorylation state of the apoptosis signal-regulating kinase 1 in INS-1 cells and human islets, resulting in inhibition of its activity. Inhibition of apoptosis by GIP is therefore mediated via a key pathway involving Akt-dependent inhibition of apoptosis signal-regulating kinase 1, which subsequently prevents the pro-apoptotic actions of p38 MAPK and JNK.	[McIntosh, Christopher H. S.] Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Widenmaier, Scott B.; Kim, Su-Jin; McIntosh, Christopher H. S.] Univ British Columbia, Diabet Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Ao, Ziliang; Warnock, Garth] Univ British Columbia, Dept Surg, Ike Barber Human Islet Transplantat Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca		Widenmaier, Scott/0000-0001-5684-2707	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Research Council of Canada; MSFHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MSFHR(Michael Smith Foundation for Health Research)	This work was supported by funding from the Canadian Institutes of Health Research and the Canadian Foundation for Innovation (to C. H. S. M.), the Michael Smith Foundation for Health Research (MSFHR) (to C. H. S. M. and G. W.), and scholarships from the Natural Sciences and Engineering Research Council of Canada and MSFHR (to S. B. W.).	Ahren B, 2004, HORM METAB RES, V36, P867, DOI 10.1055/s-2004-826178; Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Ding WG, 1997, DIABETES, V46, P615, DOI 10.2337/diabetes.46.4.615; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Ehses JA, 2001, J BIOL CHEM, V276, P23667, DOI 10.1074/jbc.M103023200; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Green BD, 2007, BEST PRACT RES CL EN, V21, P497, DOI 10.1016/j.beem.2007.09.003; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Grethe S, 2006, BIOCHEM BIOPH RES CO, V347, P781, DOI 10.1016/j.bbrc.2006.06.159; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hanke J, 2001, CELLS TISSUES ORGANS, V169, P113, DOI 10.1159/000047869; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim SJ, 2005, J BIOL CHEM, V280, P28692, DOI 10.1074/jbc.M504913200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Kim WH, 2005, CELL SIGNAL, V17, P1516, DOI 10.1016/j.cellsig.2005.03.020; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; McIntosh CHS, 2008, FRONT BIOSCI-LANDMRK, V13, P1753, DOI 10.2741/2797; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P9558, DOI 10.1073/pnas.95.16.9558; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Widenmaier SB, 2009, J BIOL CHEM, V284, P10764, DOI 10.1074/jbc.M809116200; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548	65	83	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30372	30382		10.1074/jbc.M109.060178	http://dx.doi.org/10.1074/jbc.M109.060178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19748889	Green Published, hybrid			2022-12-25	WOS:000271090000040
J	Raherison, C; Janson, C; Jarvis, D; Burney, P; Cazzoletti, L; de Marco, R; Neukirch, F; Leynaert, B				Raherison, Chantal; Janson, Christer; Jarvis, Deborah; Burney, Peter; Cazzoletti, Lucia; de Marco, Roberto; Neukirch, Francoise; Leynaert, Benedicte			Evolution of Asthma Severity in a Cohort of Young Adults: Is There Any Gender Difference?	PLOS ONE			English	Article								Introduction: Little is known about the distribution of asthma severity in men and women in the general population. The objective of our study was to describe asthma severity and change in severity according to gender in a cohort of adult asthmatics. Methods: Subjects with asthma were identified from random samples of the 22 to 44 year-olds from the general population, screened for asthma from 1991 to 1993 in 48 centers from 22 countries and followed-up during 1998-2002, as part of the European Community Respiratory Health Survey (ECRHS). All participants to follow-up with current asthma at baseline were eligible for the analysis. To assess change over the follow-up, asthma severity at the two surveys was defined using standardized data on respiratory symptoms, lung function and medication according to the Global Initiative for Asthma (GINA) Guidelines. Another quantitative score (Ronchetti) further considering hospitalizations was also analysed. Results: The study included 685 subjects with asthma followed-up over a mean period of 8.65 yr (min 4.3-max 11.7). At baseline, asthma severity according to GINA was distributed as intermittent: 40.7%, 31.7% as mild persistent, 14% as moderate persistent, and 13.5% as severe persistent. Using the Ronchetti score derived classification, the distribution of asthma severity was 58% mild, (intermittent and mild persistent), 25.8% moderate, and 15.4% severe. Whatever the classification, there was no significant difference in the severity distribution between men and women. There was also no gender difference in the severity distribution among incident cases which developed asthma between the two surveys. Men with moderate-to-severe asthma at baseline were more likely than women to have moderate-to-severe asthma at follow-up. Using GINA, 69.2% of men vs. 53.1% of women (p = 0.09) with moderate-to-severe asthma at baseline were still moderate-to-severe at follow-up. Using Ronchetti score, 53.3% of men vs. 36.2% of women (p = 0.03) with moderate-to-severe asthma at baseline were still moderate-to-severe at follow-up. Conclusions: There was no gender difference in asthma severity at the two surveys. However, our findings suggest that asthma severity might be less stable in women than in men.			Raherison, C (corresponding author), Univ Bordeaux 2, Dept Resp Dis Haut Leveque CHU Bordeaux, ISPED, EA 3672, F-33076 Bordeaux, France.	chantal.raherison@chu-bordeaux.fr	Jarvis, Deborah/E-6494-2011; de Marco, Roberto/A-5470-2008; Leynaert, Benedicte/N-5251-2018; Raherison, Chantal/T-3556-2019	Burney, Peter/0000-0001-8635-5678; Leynaert, Benedicte/0000-0001-5045-2492; Jarvis, Deborah/0000-0002-1753-3896	NCRR NIH HHS [#2 S07 RR05521-28] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005521] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		*AM THOR SOC, 1995, AM J RESP CRIT CARE, V152, P1122; [Anonymous], 2003, EUR RESP J, V22, P470; Baraldo S., 2003, EUR RESP MONOGR, V25, P1, DOI [10.1183/1025448x.00025001, DOI 10.1183/1025448X.00025001]; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; de Marco R, 2002, J ALLERGY CLIN IMMUN, V110, P228, DOI 10.1067/mai.2002.125600; de Marco R, 2006, J ALLERGY CLIN IMMUN, V117, P1249, DOI 10.1016/j.jaci.2006.03.019; European Community Respiratory Health Survey IISC, 2002, EUR RESP J, V20, P1071; JENKINS MA, 1994, BRIT MED J, V309, P90, DOI 10.1136/bmj.309.6947.90; Lee JH, 2006, J ASTHMA, V43, P179, DOI 10.1080/02770900600566405; Leynaert B, 1997, AM J RESP CRIT CARE, V156, P1413, DOI 10.1164/ajrccm.156.5.9701060; Liard R, 2000, EUR RESPIR J, V16, P615, DOI 10.1034/j.1399-3003.2000.16d08.x; Miller MK, 2005, J ALLERGY CLIN IMMUN, V116, P990, DOI 10.1016/j.jaci.2005.08.018; Moore WC, 2006, J ALLERGY CLIN IMMUN, V117, P487, DOI 10.1016/j.jaci.2006.01.033; National Institutes of Health, 1992, INT CONS REP DIAGN T; *NIH, 2004, GLOB STRAT ASTHM MAN; Pearce N, 2000, EUR RESPIR J, V16, P420, DOI 10.1183/9031936.00.16337700; Prescott E, 1997, THORAX, V52, P287, DOI 10.1136/thx.52.3.287; Ronchetti R, 1997, EUR RESPIR J, V10, P1248, DOI 10.1183/09031936.97.10061248; Salmeron S, 2001, LANCET, V358, P629, DOI 10.1016/S0140-6736(01)05779-8; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Trawick DR, 2001, CHEST, V119, P115, DOI 10.1378/chest.119.1.115; Varraso R, 2005, AM J RESP CRIT CARE, V171, P334, DOI 10.1164/rccm.200405-674OC; Watson L, 2003, EUR RESP MON, V8, P50; Zureik M, 2002, BMJ-BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411	26	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7146	10.1371/journal.pone.0007146	http://dx.doi.org/10.1371/journal.pone.0007146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779616	Green Submitted, gold, Green Published			2022-12-25	WOS:000270176200004
J	Koehler, JW; Bolton, M; Rollins, A; Snook, K; Deharo, E; Henson, E; Rogers, L; Martin, LN; Krogstad, DJ; James, MA; Rice, J; Davison, B; Veazey, RS; Prabhu, R; Amedee, AM; Garry, RF; Cogswell, FB				Koehler, Jeffrey W.; Bolton, Michael; Rollins, Amanda; Snook, Kirsten; Deharo, Eileen; Henson, Elizabeth; Rogers, Linda; Martin, Louis N.; Krogstad, Donald J.; James, Mark A.; Rice, Janet; Davison, Billie; Veazey, Ronald S.; Prabhu, Ramesh; Amedee, Angela M.; Garry, Robert F.; Cogswell, Frank B.			Altered Immune Responses in Rhesus Macaques Co-Infected with SIV and Plasmodium cynomolgi: An Animal Model for Coincident AIDS and Relapsing Malaria	PLOS ONE			English	Article								Background: Dual epidemics of the malaria parasite Plasmodium and HIV-1 in sub-Saharan Africa and Asia present a significant risk for co-infection in these overlapping endemic regions. Recent studies of HIV/Plasmodium falciparum co-infection have reported significant interactions of these pathogens, including more rapid CD4+ T cell loss, increased viral load, increased immunosuppression, and increased episodes of clinical malaria. Here, we describe a novel rhesus macaque model for co-infection that supports and expands upon findings in human co-infection studies and can be used to identify interactions between these two pathogens. Methodology/Principal Findings: Five rhesus macaques were infected with P. cynomolgi and, following three parasite relapses, with SIV. Compared to macaques infected with SIV alone, co-infected animals had, as a group, decreased survival time and more rapid declines in markers for SIV progression, including peripheral CD4+ T cells and CD4+/CD8+ T cell ratios. The naive CD4+ T cell pool of the co-infected animals was depleted more rapidly than animals infected with SIV alone. The co-infected animals also failed to generate proliferative responses to parasitemia by CD4+ and CD8+ T cells as well as B cells while also having a less robust anti-parasite and altered anti-SIV antibody response. Conclusions/Significance: These data suggest that infection with both SIV and Plasmodium enhances SIV-induced disease progression and impairs the anti-Plasmodium immune response. These data support findings in HIV/Plasmodium co-infection studies. This animal model can be used to further define impacts of lentivirus and Plasmodium co-infection and guide public health and therapeutic interventions.			Koehler, JW (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.	jeff.koehler@amedd.army.mil		Garry, Robert/0000-0002-5683-3250; Koehler, Jeffrey/0000-0003-3225-6599	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018229] Funding Source: NIH RePORTER; NCRR NIH HHS [RR018229, R01 RR018229] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; AMEDEE AM, 1995, J VIROL, V69, P7982, DOI 10.1128/JVI.69.12.7982-7990.1995; Amedee AM, 1996, J MED PRIMATOL, V25, P225, DOI 10.1111/j.1600-0684.1996.tb00020.x; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; CONWAY MD, 1991, J MED PRIMATOL, V20, P152; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Davison BB, 1998, AM J TROP MED HYG, V59, P189, DOI 10.4269/ajtmh.1998.59.189; Davison BB, 2000, AM J TROP MED HYG, V63, P158, DOI 10.4269/ajtmh.2000.63.158; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Dutta S, 2005, INFECT IMMUN, V73, P5936, DOI 10.1128/IAI.73.9.5936-5944.2005; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; FUJIOKA H, 1994, EXP PARASITOL, V78, P371, DOI 10.1006/expr.1994.1040; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Holterman L, 2000, J GEN VIROL, V81, P1719, DOI 10.1099/0022-1317-81-7-1719; Holterman L, 1999, J GEN VIROL, V80, P3089, DOI 10.1099/0022-1317-80-12-3089; IBIWOYE MO, 1993, J COMP PATHOL, V108, P303, DOI 10.1016/S0021-9975(08)80293-9; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Kaslow DC, 1996, IMMUNOL LETT, V51, P187, DOI 10.1016/0165-2478(96)02570-9; KAWAI S, 1993, AM J TROP MED HYG, V48, P630, DOI 10.4269/ajtmh.1993.48.630; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; KUVIN SANFORD F., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P371, DOI 10.1016/0035-9203(62)90007-X; Laufer MK, 2006, J INFECT DIS, V193, P872, DOI 10.1086/500245; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MARTIN LN, 1994, ANTIMICROB AGENTS CH, V38, P1277, DOI 10.1128/AAC.38.6.1277; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; MURPHEYCORB M, 1986, NATURE, V321, P435, DOI 10.1038/321435a0; Nishimura Y, 2007, J VIROL, V81, P893, DOI 10.1128/JVI.01635-06; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Praba-Egge AD, 2002, AM J TROP MED HYG, V67, P586, DOI 10.4269/ajtmh.2002.67.586; Rychert J, 2006, J VIROL, V80, P3721, DOI 10.1128/JVI.80.8.3721-3731.2006; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCHMIDT LH, 1986, AM J TROP MED HYG, V35, P1077, DOI 10.4269/ajtmh.1986.35.1077; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SPERBER K, 1995, CLIN THER, V17, P622, DOI 10.1016/0149-2918(95)80039-5; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Tongren JE, 2000, AM J TROP MED HYG, V62, P530, DOI 10.4269/ajtmh.2000.62.530; Trichel AM, 2002, J MED PRIMATOL, V31, P171, DOI 10.1034/j.1600-0684.2002.02003.x; Trichel AM, 1997, J MED PRIMATOL, V26, P3, DOI 10.1111/j.1600-0684.1997.tb00313.x; VASLIN B, 1994, VACCINE, V12, P1132, DOI 10.1016/0264-410X(94)90184-8; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; WATERS AP, 1993, MOL BIOL EVOL, V10, P914; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; 2007, AIDS EPIDEMIC UPDATE	49	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7139	10.1371/journal.pone.0007139	http://dx.doi.org/10.1371/journal.pone.0007139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774084	gold, Green Published, Green Submitted			2022-12-25	WOS:000270160900016
J	Wiley, JA; Richert, LE; Swain, SD; Harmsen, A; Barnard, DL; Randall, TD; Jutila, M; Douglas, T; Broomell, C; Young, M; Harmsen, A				Wiley, James A.; Richert, Laura E.; Swain, Steve D.; Harmsen, Ann; Barnard, Dale L.; Randall, Troy D.; Jutila, Mark; Douglas, Trevor; Broomell, Chris; Young, Mark; Harmsen, Allen			Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses	PLOS ONE			English	Article								Background: Destruction of the architectural and subsequently the functional integrity of the lung following pulmonary viral infections is attributable to both the extent of pathogen replication and to the host-generated inflammation associated with the recruitment of immune responses. The presence of antigenically disparate pulmonary viruses and the emergence of novel viruses assures the recurrence of lung damage with infection and resolution of each primary viral infection. Thus, there is a need to develop safe broad spectrum immunoprophylactic strategies capable of enhancing protective immune responses in the lung but which limits immune-mediated lung damage. The immunoprophylactic strategy described here utilizes a protein cage nanoparticle (PCN) to significantly accelerate clearance of diverse respiratory viruses after primary infection and also results in a host immune response that causes less lung damage. Methodology/Principal Findings: Mice pre-treated with PCN, independent of any specific viral antigens, were protected against both sub-lethal and lethal doses of two different influenza viruses, a mouse-adapted SARS-coronavirus, or mouse pneumovirus. Treatment with PCN significantly increased survival and was marked by enhanced viral clearance, accelerated induction of viral-specific antibody production, and significant decreases in morbidity and lung damage. The enhanced protection appears to be dependent upon the prior development of inducible bronchus-associated lymphoid tissue (iBALT) in the lung in response to the PCN treatment and to be mediated through CD4+ T cell and B cell dependent mechanisms. Conclusions/Significance: The immunoprophylactic strategy described utilizes an infection-independent induction of naturally occurring iBALT prior to infection by a pulmonary viral pathogen. This strategy non-specifically enhances primary immunity to respiratory viruses and is not restricted by the antigen specificities inherent in typical vaccination strategies. PCN treatment is asymptomatic in its application and importantly, ameliorates the damaging inflammation normally associated with the recruitment of immune responses into the lung.			Wiley, JA (corresponding author), Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA.	jwiley@montana.edu	Douglas, Trevor/GRS-0012-2022; Douglas, Trevor/F-2748-2011	Douglas, Trevor/0000-0002-7882-2704; 	NCRR NIH HHS [P20 RR016455, P20 RR020185, P20-RR16455, P20-RR020185] Funding Source: Medline; NHLBI NIH HHS [R01 HL069409, HL69409] Funding Source: Medline; NIAID NIH HHS [HHSN26620040009C/N01-AI-40009, N01AI40009, AI072689, AI083520, U54-AI065357, R21 AI083520, R01 AI072689, U54 AI065357] Funding Source: Medline; NIBIB NIH HHS [EB005364, R21 EB005364] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185, P20RR016455] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R21AI083520, R01AI072689, N01AI40009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB005364] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Chen HD, 2003, AM J PATHOL, V163, P1341, DOI 10.1016/S0002-9440(10)63493-1; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Flenniken ML, 2006, CHEM BIOL, V13, P161, DOI 10.1016/j.chembiol.2005.11.007; Humphreys IR, 2003, J EXP MED, V198, P1237, DOI 10.1084/jem.20030351; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Minne A, 2008, VACCINE, V26, P2360, DOI 10.1016/j.vaccine.2008.02.062; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rosenberg HF, 2008, IMMUNOL LETT, V118, P6, DOI 10.1016/j.imlet.2008.03.013; Treanor J, 2006, VACCINE, V24, P6913, DOI 10.1016/j.vaccine.2006.06.006; Wiley JA, 1999, AM J PATHOL, V154, P919, DOI 10.1016/S0002-9440(10)65339-4; Wiley JA, 2005, J IMMUNOL, V175, P3186, DOI 10.4049/jimmunol.175.5.3186; Wiley JA, 2001, AM J PATHOL, V158, P119, DOI 10.1016/S0002-9440(10)63950-8	19	85	89	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7142	10.1371/journal.pone.0007142	http://dx.doi.org/10.1371/journal.pone.0007142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774076	gold, Green Published			2022-12-25	WOS:000270160900017
J	Ganesalingam, J; Stahl, D; Wijesekera, L; Galtrey, C; Shaw, CE; Leigh, PN; Al-Chalabi, A				Ganesalingam, Jeban; Stahl, Daniel; Wijesekera, Lokesh; Galtrey, Clare; Shaw, Christopher E.; Leigh, P. Nigel; Al-Chalabi, Ammar			Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; LATERAL-SCLEROSIS; MOLECULAR SIGNATURE; CLINICAL-FEATURES; FLAIL ARM; CLASSIFICATION; DIAGNOSIS; CRITERIA; HISTORY; TRIALS	Background: Amyotrophic lateral sclerosis (ALS) is a degenerative disease predominantly affecting motor neurons and manifesting as several different phenotypes. Whether these phenotypes correspond to different underlying disease processes is unknown. We used latent cluster analysis to identify groupings of clinical variables in an objective and unbiased way to improve phenotyping for clinical and research purposes. Methods: Latent class cluster analysis was applied to a large database consisting of 1467 records of people with ALS, using discrete variables which can be readily determined at the first clinic appointment. The model was tested for clinical relevance by survival analysis of the phenotypic groupings using the Kaplan-Meier method. Results: The best model generated five distinct phenotypic classes that strongly predicted survival (p<0.0001). Eight variables were used for the latent class analysis, but a good estimate of the classification could be obtained using just two variables: site of first symptoms (bulbar or limb) and time from symptom onset to diagnosis (p<0.00001). Conclusion: The five phenotypic classes identified using latent cluster analysis can predict prognosis. They could be used to stratify patients recruited into clinical trials and generating more homogeneous disease groups for genetic, proteomic and risk factor research.			Ganesalingam, J (corresponding author), Kings Coll London, Inst Psychiat, MRC, Ctr Neurodegenerat Res,Dept Clin Neurosci, London WC2R 2LS, England.	ammar@iop.kcl.ac.uk	Leigh, Peter/AAD-5638-2019; Stahl, Daniel/B-9713-2011; Al-Chalabi, Ammar/E-5361-2010	Stahl, Daniel/0000-0001-7987-6619; Al-Chalabi, Ammar/0000-0002-4924-7712; Shaw, Christopher/0000-0003-0251-0146	MRC [G0500289, G0900688] Funding Source: UKRI; Medical Research Council [G0500289, G0900688, G0500289B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Beghi E, 2006, BBA-MOL BASIS DIS, V1762, P1150, DOI 10.1016/j.bbadis.2006.09.008; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; De Carvalho M, 2005, AMYOTROPH LATERAL SC, V6, P202, DOI 10.1080/14660820510011997; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; GILBERT ES, 1968, J AM STAT ASSOC, V63, P1399, DOI 10.2307/2285893; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Hu MTM, 1998, J NEUROL NEUROSUR PS, V65, P950, DOI 10.1136/jnnp.65.6.950; Katz JS, 1999, NEUROLOGY, V53, P1071, DOI 10.1212/WNL.53.5.1071; Lambrechts D, 2007, TRENDS NEUROSCI, V30, P536, DOI 10.1016/j.tins.2007.07.002; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; McCutcheon AL, 1987, LATENT CLASS ANAL; Miller RG, 1999, J NEUROL SCI, V169, P2, DOI 10.1016/S0022-510X(99)00209-9; MOORE DH, 1973, J AM STAT ASSOC, V68, P399, DOI 10.1080/01621459.1973.10482440; Muthen L, 2007, MUTH N MUTH N; PRINGLE CE, 1992, BRAIN, V115, P495, DOI 10.1093/brain/115.2.495; RAMASWAMY V, 1993, MARKET SCI, V12, P103, DOI 10.1287/mksc.12.1.103; Rosenfeld J, 2006, NEUROLOGY, V66, P624, DOI 10.1212/01.wnl.0000205597.62054.db; Skrondal A., 2004, GEN LATENT VARIABLE; Swash M, 2000, AMYOTROPH LATERAL SC, V1, P105; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th Ed., P659; Talman P, 2008, AMYOTROPH LATERAL SC, V18, P1; Turner MR, 2002, AMYOTROPH LATERAL SC, V3, P15, DOI 10.1080/146608202317576499; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Visser J, 2008, NEUROLOGY, V70, P723, DOI 10.1212/01.wnl.0000302187.20239.93; Wijesekera LC, 2009, NEUROLOGY, V72, P1087, DOI 10.1212/01.wnl.0000345041.83406.a2; Zoccolella S, 2005, NEUROL SCI, V26, P330, DOI 10.1007/s10072-005-0501-y; [No title captured]	30	50	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7107	10.1371/journal.pone.0007107	http://dx.doi.org/10.1371/journal.pone.0007107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771164	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000270154400006
J	Magold, AI; Cacquevel, M; Fraering, PC				Magold, Alexandra I.; Cacquevel, Matthias; Fraering, Patrick C.			Gene Expression Profiling in Cells with Enhanced gamma-Secretase Activity	PLOS ONE			English	Article								Background: Processing by gamma-secretase of many type-I membrane protein substrates triggers signaling cascades by releasing intracellular domains (ICDs) that, following nuclear translocation, modulate the transcription of different genes regulating a diverse array of cellular and biological processes. Because the list of gamma-secretase substrates is growing quickly and this enzyme is a cancer and Alzheimer's disease therapeutic target, the mapping of gamma-secretase activity susceptible gene transcription is important for sharpening our view of specific affected genes, molecular functions and biological pathways. Methodology/Principal Findings: To identify genes and molecular functions transcriptionally affected by gamma-secretase activity, the cellular transcriptomes of Chinese hamster ovary (CHO) cells with enhanced and inhibited gamma-secretase activity were analyzed and compared by cDNA microarray. The functional clustering by FatiGO of the 1,981 identified genes revealed over- and under-represented groups with multiple activities and functions. Single genes with the most pronounced transcriptional susceptibility to gamma-secretase activity were evaluated by real-time PCR. Among the 21 validated genes, the strikingly decreased transcription of PTPRG and AMN1 and increased transcription of UPP1 potentially support data on cell cycle disturbances relevant to cancer, stem cell and neurodegenerative diseases' research. The mapping of interactions of proteins encoded by the validated genes exclusively relied on evidence-based data and revealed broad effects on Wnt pathway members, including WNT3A and DVL3. Intriguingly, the transcription of TERA, a gene of unknown function, is affected by gamma-secretase activity and was significantly altered in the analyzed human Alzheimer's disease brain cortices. Conclusions/Significance: Investigating the effects of gamma-secretase activity on gene transcription has revealed several affected clusters of molecular functions and, more specifically, 21 genes that hold significant potential			Magold, AI (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	Patrick.fraering@epfl.ch		Magold, Alexandra/0000-0001-6979-9584; Fraering, Patrick/0000-0002-5841-5327	NIA NIH HHS [P30 AG028377] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG028377] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abe Y, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-27; Abramova N, 2005, DEV BIOL, V283, P269, DOI 10.1016/j.ydbio.2005.03.040; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; An L, 2009, NEUROSCI LETT, V452, P277, DOI 10.1016/j.neulet.2009.01.071; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Aoyama K, 2007, STEM CELLS, V25, P2488, DOI 10.1634/stemcells.2007-0102; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Avasarala JR, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-2; BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Brem H, 2007, MOL MED, V13, P30, DOI 10.2119/2006-00054.Brem; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Cansev M, 2008, ALZHEIMERS DEMENT, V4, pS153, DOI 10.1016/j.jalz.2007.10.005; Castensson A, 2000, GENOME RES, V10, P1219, DOI 10.1101/gr.10.8.1219; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cheung AKL, 2008, CANCER RES, V68, P8137, DOI 10.1158/0008-5472.CAN-08-0904; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Ernst Wolfgang, 2006, Biotechnology Journal, V1, P639, DOI 10.1002/biot.200600010; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Frank CF, 2007, TRANSL RES, V149, P211, DOI 10.1016/j.trsl.2006.11.006; GAEDICKE S, 2009, BR J NUTR, P1; Gatti MD, 2007, J BIOSCI BIOENG, V103, P82, DOI 10.1263/jbb.103.82; Gazit A, 1999, ONCOGENE, V18, P5959, DOI 10.1038/sj.onc.1202985; Haapasalo A, 2007, J BIOL CHEM, V282, P9063, DOI 10.1074/jbc.M611324200; He X, 2008, NAT CELL BIOL, V10, P11, DOI 10.1038/ncb0108-11; Hulette CM, 1997, ARCH PATHOL LAB MED, V121, P615; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Jin YH, 2009, BBA-MOL CELL RES, V1793, P290, DOI 10.1016/j.bbamcr.2008.10.002; Kamagata E, 2009, BIOCHEM BIOPH RES CO, V379, P691, DOI 10.1016/j.bbrc.2008.12.147; Kawachi H, 1999, MOL BRAIN RES, V72, P47, DOI 10.1016/S0169-328X(99)00204-1; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; *NCI NAT, 2009, PATHW INT DAT; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Opar A, 2008, NAT REV DRUG DISCOV, V7, P717, DOI 10.1038/nrd2676; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; PAUL T, 2002, PRINCIPLES PRACTICE, P229; Petroziello J, 2004, ONCOGENE, V23, P7734, DOI 10.1038/sj.onc.1207921; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Politi K, 2004, SEMIN CANCER BIOL, V14, P341, DOI 10.1016/j.semcancer.2004.04.013; Richter K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-75; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Russell RL, 2001, J BIOL CHEM, V276, P13302, DOI 10.1074/jbc.M008512200; Sahin F, 2005, PANCREAS, V30, P158, DOI 10.1097/01.mpa.0000151581.45156.e4; Saijoh Y, 1996, GENES CELLS, V1, P239, DOI 10.1046/j.1365-2443.1996.d01-237.x; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Schumann G, 1998, MOL BRAIN RES, V62, P56, DOI 10.1016/S0169-328X(98)00237-X; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shou JY, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1883; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Soulie C, 2004, NEUROSCI LETT, V365, P1, DOI 10.1016/j.neulet.2004.03.090; Sun XL, 2006, FASEB J, V20, P1361, DOI 10.1096/fj.05-5628com; TAKEDA M, 1990, ACTA NEUROL SCAND, V82, P238; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Tang BSF, 2005, J VIROL, V79, P6180, DOI 10.1128/JVI.79.10.6180-6193.2005; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; WATANABE SI, 1995, BIOCHEM BIOPH RES CO, V216, P265, DOI 10.1006/bbrc.1995.2619; Whitfield JF, 2004, CELL SIGNAL, V16, P763, DOI 10.1016/j.cellsig.2003.12.002; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yee JC, 2008, BIOTECHNOL BIOENG, V101, P1359, DOI 10.1002/bit.21984; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	92	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e6952	10.1371/journal.pone.0006952	http://dx.doi.org/10.1371/journal.pone.0006952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763259	gold, Green Published, Green Submitted			2022-12-25	WOS:000269970400002
J	Gustafsson, MCU; Knight, D; Palmer, CNA				Gustafsson, Mattias C. U.; Knight, Deborah; Palmer, Colin N. A.			Ligand Modulated Antagonism of PPAR gamma by Genomic and Non-Genomic Actions of PPAR delta	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; FATTY-ACID-METABOLISM; PEROXISOME-PROLIFERATOR; CROSS-TALK; NUTRITIONAL REGULATION; TRANSCRIPTION; GENE; LXR; PEROXISOME-PROLIFERATOR-ACTIVATED-RECEPTOR-(PPAR)-ALPHA; IDENTIFICATION	Background: Members of the Peroxisome Proliferator Activated Receptor, PPAR, subfamily of nuclear receptors display complex opposing and overlapping functions and a wide range of pharmacological and molecular genetic tools have been used to dissect their specific functions. Non-agonist bound PPAR delta has been shown to repress PPAR Response Element, PPRE, signalling and several lines of evidence point to the importance of PPAR delta repressive actions in both cardiovascular and cancer biology. Methodology/Principal Findings: In this report we have employed transient transfections and luciferase reporter gene technology to study the repressing effects of PPAR delta and two derivatives thereof. We demonstrate for the first time that the classical dominant negative deletion of the Activation Function 2, AF2, domain of PPAR delta show enhanced repression of PPRE signalling in the presence of a PPAR delta agonist. We propose that the mechanism for the phenomenon is increased RXR heterodimerisation and DNA binding upon ligand binding concomitant with transcriptional co-repressor binding. We also demonstrated ligand-dependent dominant negative action of a DNA non-binding derivative of PPAR delta on PPAR gamma 1 signalling. This activity was abolished upon over-expression of RXR alpha suggesting a role for PPAR/cofactor competition in the absence of DNA binding. Conclusions/Significance: These findings are important in understanding the wide spectrum of molecular interactions in which PPAR delta and PPAR gamma have opposing biological roles and suggest novel paradigms for the design of different functional classes of nuclear receptor antagonist drugs.			Gustafsson, MCU (corresponding author), Lund Univ, Dept Lab Med, Div Med Microbiol, Lund, Sweden.	Mattias.Gustafsson@med.lu.se	Gustafsson, Mattias C. U./A-7451-2010; Palmer, Colin NA/C-7053-2008	Gustafsson, Mattias C. U./0000-0003-3260-0724; Palmer, Colin NA/0000-0002-6415-6560	Medical Research Council [G0000119] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ABBOTT BD, 2008, REPROD TOXICOL; Adamson DJA, 2002, MOL PHARMACOL, V61, P7, DOI 10.1124/mol.61.1.7; AIYAR N, 1994, MOL CELL BIOCHEM, V131, P75, DOI 10.1007/BF01075727; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Araki O, 2005, P NATL ACAD SCI USA, V102, P16251, DOI 10.1073/pnas.0508556102; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; CHU RY, 1995, P NATL ACAD SCI USA, V92, P11593, DOI 10.1073/pnas.92.25.11593; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Hatae T, 2001, J BIOL CHEM, V276, P46260, DOI 10.1074/jbc.M107180200; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Krogsdam AM, 2002, BIOCHEM J, V363, P157, DOI 10.1042/0264-6021:3630157; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Matsusue K, 2006, MOL CELL ENDOCRINOL, V256, P23, DOI 10.1016/j.mce.2006.05.005; Michalik L, 2005, MOL ENDOCRINOL, V19, P2335, DOI 10.1210/me.2005-0068; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Sambrook J, 2001, MOL CLONING LAB MANU; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Seedorf U, 2007, BBA-MOL CELL BIOL L, V1771, P1125, DOI 10.1016/j.bbalip.2007.04.017; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Sprecher DL, 2007, ARTERIOSCL THROM VAS, V27, P359, DOI 10.1161/01.ATV.0000252790.70572.0c; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Takahashi S, 2007, ENDOCR J, V54, P347, DOI 10.1507/endocrj.KR-99; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190	36	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7046	10.1371/journal.pone.0007046	http://dx.doi.org/10.1371/journal.pone.0007046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756148	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970000013
J	Maaty, WS; Wiedenheft, B; Tarlykov, P; Schaff, N; Heinemann, J; Robison-Cox, J; Valenzuela, J; Dougherty, A; Blum, P; Lawrence, CM; Douglas, T; Young, MJ; Bothner, B				Maaty, Walid S.; Wiedenheft, Blake; Tarlykov, Pavel; Schaff, Nathan; Heinemann, Joshua; Robison-Cox, Jim; Valenzuela, Jacob; Dougherty, Amanda; Blum, Paul; Lawrence, C. Martin; Douglas, Trevor; Young, Mark J.; Bothner, Brian			Something Old, Something New, Something Borrowed; How the Thermoacidophilic Archaeon Sulfolobus solfataricus Responds to Oxidative Stress	PLOS ONE			English	Article							DPS-LIKE PROTEIN; DNA-BINDING PROTEIN; HYDROGEN-PEROXIDE; GENE-EXPRESSION; DESULFOVIBRIO-VULGARIS; SUPEROXIDE-DISMUTASE; PROTEOMICS ANALYSIS; MERCURY RESISTANCE; ESCHERICHIA-COLI; COG DATABASE	To avoid molecular damage of biomolecules due to oxidation, all cells have evolved constitutive and responsive systems to mitigate and repair chemical modifications. Archaea have adapted to some of the most extreme environments known to support life, including highly oxidizing conditions. However, in comparison to bacteria and eukaryotes, relatively little is known about the biology and biochemistry of archaea in response to changing conditions and repair of oxidative damage. In this study transcriptome, proteome, and chemical reactivity analyses of hydrogen peroxide (H2O2) induced oxidative stress in Sulfolobus solfataricus (P2) were conducted. Microarray analysis of mRNA expression showed that 102 transcripts were regulated by at least 1.5 fold, 30 minutes after exposure to 30 mu M H2O2. Parallel proteomic analyses using two-dimensional differential gel electrophoresis (2D-DIGE), monitored more than 800 proteins 30 and 105 minutes after exposure and found that 18 had significant changes in abundance. A recently characterized ferritin-like antioxidant protein, DPSL, was the most highly regulated species of mRNA and protein, in addition to being post-translationally modified. As expected, a number of antioxidant related mRNAs and proteins were differentially regulated. Three of these, DPSL, superoxide dismutase, and peroxiredoxin were shown to interact and likely form a novel supramolecular complex for mitigating oxidative damage. A scheme for the ability of this complex to perform multi-step reactions is presented. Despite the central role played by DPSL, cells maintained a lower level of protection after disruption of the dpsl gene, indicating a level of redundancy in the oxidative stress pathways of S. solfataricus. This work provides the first "omics'' scale assessment of the oxidative stress response for an archeal organism and together with a network analysis using data from previous studies on bacteria and eukaryotes reveals evolutionarily conserved pathways where complex and overlapping defense mechanisms protect against oxygen toxicity.			Maaty, WS (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	bbothner@chemistry.montana.edu	Douglas, Trevor/GRS-0012-2022; Lawrence, C. Martin/AAH-3420-2020; Tarlykov, Pavel/C-2587-2012; Douglas, Trevor/F-2748-2011	Douglas, Trevor/0000-0002-7882-2704; Lawrence, C. Martin/0000-0002-5398-466X; Tarlykov, Pavel/0000-0003-2075-307X; Valenzuela, Jacob/0000-0002-2320-241X	NCRR NIH HHS [P20 RR-020185, P20 RR020185] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coulter ED, 1999, BIOCHEM BIOPH RES CO, V255, P317, DOI 10.1006/bbrc.1999.0197; Dabney A, 2004, QVALUE Q VALUE ESTIM; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; deMare F, 1996, NAT STRUCT BIOL, V3, P539, DOI 10.1038/nsb0696-539; Eymann C, 2007, PROTEOMICS, V7, P3509, DOI 10.1002/pmic.200700232; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Ferrer-Navarro M, 2006, J PROTEOME RES, V5, P688, DOI 10.1021/pr050340p; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gauss GH, 2006, BIOCHEMISTRY-US, V45, P10815, DOI 10.1021/bi060782u; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GREGORY EM, 1985, ARCH BIOCHEM BIOPHYS, V238, P83, DOI 10.1016/0003-9861(85)90143-2; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Hao Q, 2006, MOL PHARMACOL, V69, P1938, DOI 10.1124/mol.105.020115; Hernandez JA, 2007, FEBS LETT, V581, P1351, DOI 10.1016/j.febslet.2007.02.053; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Iguchi T, 2009, IN VIVO, V23, P7; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Janowiak BE, 2005, J BIOL CHEM, V280, P11829, DOI 10.1074/jbc.M414326200; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kato S, 2008, ENVIRON MICROBIOL, V10, P893, DOI 10.1111/j.1462-2920.2007.01508.x; Kim SH, 2005, BIOCHEM J, V387, P271, DOI 10.1042/BJ20041053; Kurtz DM, 2006, J INORG BIOCHEM, V100, P679, DOI 10.1016/j.jinorgbio.2005.12.017; Kusch H, 2007, PROTEOMICS, V7, P686, DOI 10.1002/pmic.200600575; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Limauro D, 2006, FEBS J, V273, P721, DOI 10.1111/j.1742-4658.2006.05104.x; Limauro D, 2008, FEBS J, V275, P2067, DOI 10.1111/j.1742-4658.2008.06361.x; Liu JF, 2007, ELECTROPHORESIS, V28, P4348, DOI 10.1002/elps.200600696; Lower BH, 2004, J BACTERIOL, V186, P463, DOI 10.1128/JB.186.2.463-472.2004; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; Maaty WSA, 2006, J VIROL, V80, P7625, DOI 10.1128/JVI.00522-06; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; Mydel P, 2006, PLOS PATHOG, V2, P712, DOI 10.1371/journal.ppat.0020076; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Nissom PM, 2006, MOL BIOTECHNOL, V34, P125, DOI 10.1385/MB:34:2:125; NOBLE RW, 1970, J BIOL CHEM, V245, P2409; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pedone E, 2006, FEBS J, V273, P5407, DOI 10.1111/j.1742-4658.2006.05533.x; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rabilloud T, 2005, EXPERT REV PROTEOMIC, V2, P949, DOI 10.1586/14789450.2.6.949; RADAK Z, 1995, J APPL PHYSIOL, V79, P129, DOI 10.1152/jappl.1995.79.1.129; Ramsay B, 2006, J INORG BIOCHEM, V100, P1061, DOI 10.1016/j.jinorgbio.2005.12.001; Ray WK, 2005, J BACTERIOL, V187, P4270, DOI 10.1128/JB.187.12.4270-4275.2005; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; ROCHA ER, 1995, J BACTERIOL, V177, P3111, DOI 10.1128/jb.177.11.3111-3119.1995; Rockabrand D, 1998, J BACTERIOL, V180, P846, DOI 10.1128/JB.180.4.846-854.1998; Santos R, 2000, MOL MICROBIOL, V38, P750, DOI 10.1046/j.1365-2958.2000.02178.x; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schelert J, 2006, J BACTERIOL, V188, P7141, DOI 10.1128/JB.00558-06; Schulenberg B, 2004, ELECTROPHORESIS, V25, P2526, DOI 10.1002/elps.200406007; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Vergauwen B, 2006, J BIOL CHEM, V281, P4380, DOI 10.1074/jbc.M509517200; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004; Wiedenheft B, 2005, P NATL ACAD SCI USA, V102, P10551, DOI 10.1073/pnas.0501497102; Williamson AJK, 2008, MOL CELL PROTEOMICS, V7, P459, DOI 10.1074/mcp.M700370-MCP200; Worthington P, 2003, J BACTERIOL, V185, P482, DOI 10.1128/JB.185.2.482-488.2003; Yao F, 2005, J BACTERIOL, V187, P6354, DOI 10.1128/JB.187.18.6354-6362.2005; Zhang WW, 2006, ANTON LEEUW INT J G, V90, P41, DOI 10.1007/s10482-006-9059-9; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	101	60	60	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e6964	10.1371/journal.pone.0006964	http://dx.doi.org/10.1371/journal.pone.0006964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19759909	gold, Green Published			2022-12-25	WOS:000269970000002
J	Liu, GH; Gerace, L				Liu, Guang-Hui; Gerace, Larry			Sumoylation Regulates Nuclear Localization of Lipin-1 alpha in Neuronal Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PHOSPHATIDATE PHOSPHATASES; SUBCELLULAR-LOCALIZATION; LIPIN; PROTEIN; SUMO; PGC-1-ALPHA; EXPRESSION; PHOSPHORYLATION; LIPODYSTROPHY	Lipin-1 is a protein that has dual functions as a phosphatidic acid phosphohydrolase (PAP) and a nuclear transcriptional coactivator. It remains unknown how the nuclear localization and coactivator functions of lipin-1 are regulated. Here, we show that lipin-1 (including both the alpha and beta isoforms) is modified by sumoylation at two consensus sumoylation sites. We are unable to detect sumoylation of the related proteins lipin-2 and lipin-3. Lipin-1 is sumoylated at relatively high levels in brain, where lipin-1 alpha is the predominant form. In cultured embryonic cortical neurons and SH-SY5Y neuronal cells, ectopically expressed lipin-1 alpha is localized in both the nucleus and the cytoplasm, and the nuclear localization is abrogated by mutating the consensus sumyolation motifs. The sumoylation site mutant of lipin-1 alpha loses the capacity to coactivate the transcriptional (co-) activators PGC-1 alpha and MEF2, consistent with its nuclear exclusion. Thus, these results show that sumoylation facilitates the nuclear localization and transcriptional coactivator behavior of lipin-1 alpha that we observe in cultured neuronal cells, and suggest that lipin-1 alpha may act as a sumoylation-regulated transcriptional coactivator in brain.			Liu, GH (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ghliu@scripps.edu; lgerace@scripps.edu		Liu, Guang-Hui/0000-0001-9289-8177	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028521] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28521, R01 GM028521-27, R01 GM028521] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fukunaga K, 2006, J BIOL CHEM, V281, P9490, DOI 10.1074/jbc.M512970200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; HAYRT, 2005, MOL CELL, V18, P1; Higashida K, 2008, BIOCHEM BIOPH RES CO, V374, P587, DOI 10.1016/j.bbrc.2008.07.079; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu GH, 2006, MOL BIOL CELL, V17, P1822, DOI 10.1091/mbc.E05-10-0979; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Qu J, 2007, NUCLEIC ACIDS RES, V35, P2522, DOI 10.1093/nar/gkl1163; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SINIOSSOGLOU S, 2009, LIPINS LIPIDS NUCL E; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Takeuchi M, 2007, GENE, V399, P174, DOI 10.1016/j.gene.2007.05.009; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Wilson VG., 2005, SCI STKE SIGNAL TRAN, pE32; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	51	61	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7031	10.1371/journal.pone.0007031	http://dx.doi.org/10.1371/journal.pone.0007031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753306	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796500015
J	Florins, A; Reichert, M; Asquith, B; Bouzar, AB; Jean, G; Francois, C; Jasik, A; Burny, A; Kettmann, R; Willems, L				Florins, Arnaud; Reichert, Michal; Asquith, Becca; Bouzar, Amel-Baya; Jean, Genevieve; Francois, Carole; Jasik, Agnieszka; Burny, Arsene; Kettmann, Richard; Willems, Luc			Earlier Onset of delta-Retrovirus-Induced Leukemia after Splenectomy	PLOS ONE			English	Article								Infection by delta-retroviruses such as human T-lymphotropic virus type 1 (HTLV-1) and bovine leukemia virus (BLV) is mostly asymptomatic. Indeed, only a minority (<5%) of delta-retrovirus infected hosts will develop either lymphoproliferative or neurodegenerative diseases after long latency periods. In fact, the host immune response is believed to tightly control viral replication but this assumption has not been definitely proven in vivo. Here, we provide direct experimental evidence demonstrating that integrity of the spleen is required to control pathogenesis. In the BLV model, we show that asplenia decreases efficiency of the immune response and induces an imbalance in cell dynamics resulting in accelerated onset of leukemia. These observations enlighten a potential threat in splenectomized HTLV-1 carriers and justify a regular preventive evaluation.	[Florins, Arnaud; Bouzar, Amel-Baya; Francois, Carole; Burny, Arsene; Kettmann, Richard; Willems, Luc] Gembloux Agr Univ FUSAGx, Cellular Mol Biol, Gembloux, Belgium; [Reichert, Michal; Jasik, Agnieszka] Natl Vet Res Inst, Pulawy, Poland; [Asquith, Becca] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Jean, Genevieve] Gembloux Agr Univ FUSAGx, Zootechny Unit, Gembloux, Belgium; [Willems, Luc] Univ Liege, Interdisciplinary Cluster Appl Genoprote GIGA, Liege, Belgium	University of Liege; National Veterinary Institute - National Research Institute; Imperial College London; University of Liege; University of Liege	Florins, A (corresponding author), Gembloux Agr Univ FUSAGx, Cellular Mol Biol, Gembloux, Belgium.	florins.a@fsagx.ac.be		Asquith, Becca/0000-0002-5911-3160; Willems, Luc/0000-0002-0563-2213	Medical Research Council [G0601072] Funding Source: Medline; MRC [G0601072] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asquith B, 2006, P R SOC B, V273, P1165, DOI 10.1098/rspb.2005.3432; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; Chung CT, 1997, INT J RADIAT ONCOL, V37, P405, DOI 10.1016/S0360-3016(96)00498-1; CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; Davidson RN, 2001, CLIN MICROBIOL INFEC, V7, P657, DOI 10.1046/j.1198-743x.2001.00355.x; Debacq C, 2002, P NATL ACAD SCI USA, V99, P10048, DOI 10.1073/pnas.142100999; Debacq C, 2006, J VIROL, V80, P9710, DOI 10.1128/JVI.01022-06; DIETRICH PY, 1994, BLOOD, V84, P1209; Endo Y, 2008, SURG TODAY, V38, P1148, DOI 10.1007/s00595-008-3802-y; Florins A, 2007, FRONT BIOSCI-LANDMRK, V12, P1520, DOI 10.2741/2165; Florins A, 2006, J VIROL, V80, P11998, DOI 10.1128/JVI.01447-06; Fotiadis C, 1999, ANTICANCER RES, V19, P4235; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; HULL CC, 1988, ARCH SURG-CHICAGO, V123, P462; KALDOR JM, 1990, NEW ENGL J MED, V322, P7, DOI 10.1056/NEJM199001043220102; KOTZIN BL, 1980, SCIENCE, V208, P59, DOI 10.1126/science.6965803; LEWIS M, 2005, SPLEEN CONSEQUENCES; LOUGHRAN TP, 1987, BRIT J HAEMATOL, V67, P135, DOI 10.1111/j.1365-2141.1987.tb02316.x; Saji S, 1999, SURG TODAY, V29, P504, DOI 10.1007/BF02482344; Seabrook TJ, 2000, BLOOD, V96, P1180, DOI 10.1182/blood.V96.3.1180.015k24_1180_1183; Suzuki S, 2008, EUR J HAEMATOL, V81, P236, DOI 10.1111/j.1600-0609.2008.01097.x; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; TURA S, 1993, J CLIN ONCOL, V11, P925, DOI 10.1200/JCO.1993.11.5.925; WILLEMS L, 1993, J VIROL, V67, P4078, DOI 10.1128/JVI.67.7.4078-4085.1993	25	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6943	10.1371/journal.pone.0006943	http://dx.doi.org/10.1371/journal.pone.0006943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759828	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796300002
J	Sogaard, OS; Lohse, N; Gerstoft, J; Kronborg, G; Ostergaard, L; Pedersen, C; Pedersen, G; Sorensen, HT; Obel, N				Sogaard, Ole S.; Lohse, Nicolai; Gerstoft, Jan; Kronborg, Gitte; Ostergaard, Lars; Pedersen, Court; Pedersen, Gitte; Sorensen, Henrik Toft; Obel, Niels			Mortality after Hospitalization for Pneumonia among Individuals with HIV, 1995-2008: A Danish Cohort Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; HUMAN-IMMUNODEFICIENCY-VIRUS; BACTERIAL PNEUMONIA; ANTIRETROVIRAL THERAPY; OUTCOMES; INFECTION; MORBIDITY; SURVIVAL; DENMARK; DISEASE	Background: HIV-infected persons are at increased risk of pneumonia, even with highly active antiretroviral treatment (HAART). We examined the impact of pneumonia on mortality and identified prognostic factors for death among HIV-infected. Methodology/Principal Findings: In a nationwide, population-based cohort of individuals with HIV, we included persons hospitalized with pneumonia from the Danish National Hospital Registry and obtained mortality data from the Danish Civil Registration System. Comparing individuals with and without pneumonia, we used Poisson regression to estimate relative mortality and logistic regression to examine prognostic factors for death following pneumonia. From January 1, 1995, to July 1, 2008, we observed 699 episodes of first hospitalization for pneumonia among 4,352 HIV patients. Ninety-day mortality after pneumonia decreased from 22.4% (95% confidence interval [CI]: 16.5%-28.9%) in 1995-1996 to 8.4% (95% CI: 6.1%-11.6%) in 2000-2008. Mortality remained elevated for more than a year after hospitalization for pneumonia: adjusted mortality rate ratio 5.38 (95% CI: 4.27-6.78), 1.80 (95% CI: 1.36-2.37), and 1.62 (95% CI: 1.32-2.00) for days 0-90, 91-365, and 366+, respectively. The following variables predicted mortality within 90 days following hospitalization for pneumonia (adjusted Odds Ratios): male sex (3.77, 95% CI: 1.37-10.4), Charlson Comorbidity Index score >= 2 (3.86, 95% CI: 2.19-6.78); no current HAART (3.58, 95% CI: 1.83-6.99); history of AIDS (2.46, 95% CI: 1.40-4.32); age per 10 year increase (1.43, 95% CI: 1.11-1.85); and CD4+ cell count <= 200 (2.52, 95% CI: 1.37-4.65). Conclusions/Significance: The first hospitalization for pneumonia among HIV-infected individuals was associated with elevated risk of death up to more than a year later. Use of HAART decreased the risk, independent of current CD4+ cell count. Prognosis following pneumonia improved over calendar time.			Sogaard, OS (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark.	olesoega@rm.dk	Sorensen, Henrik Toft/Z-6181-2019; Kronborg, Gitte/E-4757-2010; Lohse, Nicolai/ABE-5884-2020; Søgaard, Ole Schmeltz/AEP-7968-2022; Ostergaard, Lars/AAA-3020-2020; Søgaard, Ole S/P-6058-2016	Sorensen, Henrik Toft/0000-0003-4299-7040; Søgaard, Ole Schmeltz/0000-0001-9107-2023; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X; Lohse, Nicolai/0000-0001-8403-8759				Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Gordin FM, 2008, AM J RESP CRIT CARE, V178, P630, DOI 10.1164/rccm.200804-617OC; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; KITAHATA MM, 2009, N ENGL J MED; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Mortensen EM, 2003, CLIN INFECT DIS, V37, P1617, DOI 10.1086/379712; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Obel N, 2008, INT J EPIDEMIOL; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; POLSKY B, 1986, ANN INTERN MED, V104, P38, DOI 10.7326/0003-4819-104-1-38; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; 1992, MORBIDITY MORTALITY, V41, P1	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7022	10.1371/journal.pone.0007022	http://dx.doi.org/10.1371/journal.pone.0007022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750011	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796300017
J	Chen, H; Contreras, X; Yamaguchi, Y; Handa, H; Peterlin, BM; Guo, S				Chen, Hui; Contreras, Xavier; Yamaguchi, Yuki; Handa, Hiroshi; Peterlin, B. Matija; Guo, Su			Repression of RNA Polymerase II Elongation In Vivo Is Critically Dependent on the C-Terminus of Spt5	PLOS ONE			English	Article							TRANSCRIPTION ELONGATION; P-TEFB; GENE-EXPRESSION; TARGET GENES; PROMOTER; PROTEIN; HSPT5; NELF; DSIF; PHOSPHORYLATION	The stalling of RNA polymerase II (RNAPII) at the promoters of many genes, including developmental regulators, stress-responsive genes, and HIVLTR, suggests transcription elongation as a critical regulatory step in addition to initiation. Spt5, the large subunit of the DRB sensitivity-inducing factor (DSIF), represses or activates RNAPII elongation in vitro. How RNAPII elongation is repressed in vivo is not well understood. Here we report that CTR1 and CTR2CT, the two repeat-containing regions constituting the C-terminus of Spt5, play a redundant role in repressing RNAPII elongation in vivo. First, mis-expression of Spt5 lacking CTR1 or CTR2CT is inconsequential, but mis-expression of Spt5 lacking the entire C-terminus (termed NSpt5) dominantly impairs embryogenesis in zebrafish. Second, NSpt5 de-represses the transcription of hsp70-4 in zebrafish embryos and HIVLTR in cultured human cells, which are repressed at the RNAPII elongation step under non-inducible conditions. Third, NSpt5 directly associates with hsp70-4 chromatin in vivo and increases the occupancy of RNAPII, positive transcription elongation factor b (P-TEFb), histone H3 Lys 4 trimethylation (H3K4Me3), and surprisingly, the negative elongation factor A (NELF-A) at the locus, indicating a direct action of NSpt5 on the elongation repressed locus. Together, these results reveal a dominant activity of NSpt5 to de-repress RNAPII elongation, and suggest that the C-terminus of Spt5 is critical for repressing RNAPII elongation in vivo.			Chen, H (corresponding author), Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA.	su.guo@ucsf.edu	contreras, xavier/ABA-3533-2020; Yamaguchi, Yuki/B-9390-2015	contreras, xavier/0000-0003-0748-6923; Yamaguchi, Yuki/0000-0002-0197-614X	NIAID NIH HHS [AI49104, R01 AI049104] Funding Source: Medline; NIGMS NIH HHS [P50 GM082250-02, P50 GM082250] Funding Source: Medline; NINDS NIH HHS [R01 NS042626, NS042626] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042626] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; Burckin T, 2005, NAT STRUCT MOL BIOL, V12, P175, DOI 10.1038/nsmb891; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Cooper KL, 2005, DEV DYNAM, V234, P651, DOI 10.1002/dvdy.20584; Cui YJ, 2003, MOL CELL BIOL, V23, P7887, DOI 10.1128/MCB.23.21.7887-7901.2003; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Guo Su, 1999, Techniques in the Behavioral and Neural Sciences, V13, P166; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jennings BH, 2004, CURR BIOL, V14, P1680, DOI 10.1016/j.cub.2004.08.066; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Krone PH, 2003, SEMIN CELL DEV BIOL, V14, P267, DOI 10.1016/j.semcdb.2003.09.018; Lavoie SB, 2001, J MOL BIOL, V312, P675, DOI 10.1006/jmbi.2001.4991; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; MALONE EA, 1993, MOL GEN GENET, V237, P449, DOI 10.1007/BF00279450; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Pei Y, 2003, J BIOL CHEM, V278, P43346, DOI 10.1074/jbc.M307319200; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Ping Yueh-Hsin, 2004, Retrovirology, V1, P46, DOI 10.1186/1742-4690-1-46; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Wu-Baer F, 1998, J MOL BIOL, V277, P179, DOI 10.1006/jmbi.1997.1601; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	56	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6918	10.1371/journal.pone.0006918	http://dx.doi.org/10.1371/journal.pone.0006918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742326	Green Submitted, gold, Green Published			2022-12-25	WOS:000269622500004
J	Zhou, L; Takayama, Y; Boucher, P; Tallquist, MD; Herz, J				Zhou, Li; Takayama, Yoshiharu; Boucher, Philippe; Tallquist, Michelle D.; Herz, Joachim			LRP1 Regulates Architecture of the Vascular Wall by Controlling PDGFR beta-Dependent Phosphatidylinositol 3-Kinase Activation	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; PHOSPHOLIPASE-C-GAMMA; PHOSPHOINOSITIDE 3-KINASE; MARFAN-SYNDROME; TGF-BETA; GROWTH-INHIBITION; MOUSE MODEL; PATHOGENESIS; CELLS; INVOLVEMENT	Background: Low density lipoprotein receptor-related protein 1 (LRP1) protects against atherosclerosis by regulating the activation of platelet-derived growth factor receptor beta (PDGFR beta) in vascular smooth muscle cells (SMCs). Activated PDGFR beta undergoes tyrosine phosphorylation and subsequently interacts with various signaling molecules, including phosphatidylinositol 3-kinase (PI3K), which binds to the phosphorylated tyrosine 739/750 residues in mice, and thus regulates actin polymerization and cell movement. Methods and Principal Findings: In this study, we found disorganized actin in the form of membrane ruffling and enhanced cell migration in LRP1-deficient (LRP1-/-) SMCs. Marfan syndrome-like phenotypes such as tortuous aortas, disrupted elastic layers and abnormally activated transforming growth factor beta (TGF beta) signaling are present in smooth muscle-specific LRP1 knockout (smLRP1-/-) mice. To investigate the role of LRP1-regulated PI3K activation by PDGFR beta in atherogenesis, we generated a strain of smLRP1-/- mice in which tyrosine 739/750 of the PDGFR beta had been mutated to phenylalanines (PDGFR beta F2/F2). Spontaneous atherosclerosis was significantly reduced in the absence of hypercholesterolemia in these mice compared to smLRP1-/- animals that express wild type PDGFR. Normal actin organization was restored and spontaneous SMC migration as well as PDGF-BB-induced chemotaxis was dramatically reduced, despite continued overactivation of TGF beta signaling, as indicated by high levels of nuclear phospho-Smad2. Conclusions and Significance: Our data suggest that LRP1 regulates actin organization and cell migration by controlling PDGFR beta-dependent activation of PI3K. TGF beta activation alone is not sufficient for the expression of the Marfan-like vascular phenotype. Thus, regulation of PI3 Kinase by PDGFR beta is essential for maintaining vascular integrity, and for the prevention of atherosclerosis as well as Marfan syndrome.			Zhou, L (corresponding author), UT SW Med Ctr, Dept Mol Genet, Dallas, TX USA.	joachim.herz@utsouthwestern.edu	Takayama, Yoshiharu/M-8826-2019; Tallquist, Michelle/AAU-5277-2021; Takayama, Yoshiharu/E-3662-2010	Takayama, Yoshiharu/0000-0003-4532-7114; Tallquist, Michelle/0000-0002-1383-144X; Takayama, Yoshiharu/0000-0003-4532-7114; Boucher, Philippe/0000-0002-3928-9812	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, P01HL020948, R01HL074257, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL63762, HL074257, R01 HL074257, P01 HL020948, R37 HL063762, R01 HL063762, HL20948] Funding Source: Medline; NINDS NIH HHS [R01 NS043408, NS43408] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akutsu K, 2007, CIRC J, V71, P1305, DOI 10.1253/circj.71.1305; Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.3.CO;2-9; ARVIDSSON AK, 1992, CELL GROWTH DIFFER, V3, P881; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; DeMali KA, 1997, J BIOL CHEM, V272, P9011; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; HooshmandRad R, 1997, EXP CELL RES, V234, P434, DOI 10.1006/excr.1997.3636; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; HUSSAIN MM, 1991, J BIOL CHEM, V266, P13936; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Nataatmadja M, 2006, CIRCULATION, V114, pI371, DOI 10.1161/CIRCULATIONAHA.105.000927; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Okkenhaug K, 2001, Sci STKE, V2001, ppe1; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Sheehan D.C., 1987, THEORY PRACTICE HIST; Singh KK, 2006, HUM MUTAT, V27, P770, DOI 10.1002/humu.20354; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tallquist MD, 2000, GENE DEV, V14, P3179, DOI 10.1101/gad.844700; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WENNSTROM S, 1994, ONCOGENE, V9, P651; WILLIAMS JK, 1994, HIGH TEMP CHEM PROCE, V3, P719; WOODS AE, 1995, HISTOPATHOLOGY COMPL; Yu Miao, 2003, Zhonghua Yi Xue Za Zhi, V83, P494; Zhou L, 2003, EXP GERONTOL, V38, P1161, DOI 10.1016/S0531-5565(03)00170-0	39	54	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6922	10.1371/journal.pone.0006922	http://dx.doi.org/10.1371/journal.pone.0006922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742316	Green Submitted, gold, Green Published			2022-12-25	WOS:000269622500007
J	Mei, ZQ; Wang, F; Qi, YT; Zhou, ZY; Hu, Q; Li, H; Wu, JW; Shi, YG				Mei, Ziqing; Wang, Feng; Qi, Yutao; Zhou, Zhiyuan; Hu, Qi; Li, Han; Wu, Jiawei; Shi, Yigong			Molecular Determinants of MecA as a Degradation Tag for the ClpCP Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASES; COMPETENCE TRANSCRIPTION FACTOR; AAA PLUS PROTEASE; BACILLUS-SUBTILIS; METHANOCALDOCOCCUS-JANNASCHII; OPERATING PRINCIPLES; REGULATORY PARTICLE; TAGGING SYSTEM; PORE LOOPS; RECOGNITION	Regulated proteolysis by ATP-dependent proteases is universal in all living cells. In Bacillus subtilis, the degradation of the competence transcription factor ComK is mediated by a ternary complex involving the adaptor protein MecA and the ATP-dependent protease ClpCP. Here we demonstrate that a C-terminal, 98-amino acid domain of MecA (residues 121-218) serves as a non-recycling, degradation tag and targets a variety of fusion proteins to the ClpCP protease for degradation. MecA(121-218) facilitates productive oligomerization of ClpC, stimulates the ATPase activity of ClpC, and allows the activated ClpC complex to stably associate with ClpP. Importantly, the ClpCP protease undergoes dynamic cycles of assembly and disassembly, which are triggered by association with MecA and the degradation of MecA, respectively.	[Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Med, Rm C331,Biomed Bldg, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Mei, Ziqing/AHD-6788-2022; Wang, Feng/AAC-6221-2022	Mei, Ziqing/0000-0001-8554-6309; Wang, Feng/0000-0002-9403-4337; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2009CB918801]; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	This work was supported by grants from the Ministry of Science and Technology (Grant 2009CB918801), Tsinghua University 985 Phase II funds, Project 30888001 supported by the National Natural Science Foundation of China, and Beijing Municipal Commissions of Education and Science and Technology.	Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Baumeister W, 1997, CURR OPIN STRUC BIOL, V7, P273, DOI 10.1016/S0959-440X(97)80036-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; DUBNAU D, 1990, J BACTERIOL, V172, P4048, DOI 10.1128/jb.172.7.4048-4055.1990; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; MSADEK T, 1994, P NATL ACAD SCI USA, V91, P5788, DOI 10.1073/pnas.91.13.5788; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; Wang F, 2009, J BIOL CHEM, V284, P34376, DOI 10.1074/jbc.M109.053033; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	39	22	23	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34366	34375		10.1074/jbc.M109.053017	http://dx.doi.org/10.1074/jbc.M109.053017			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19767395	hybrid, Green Published			2022-12-25	WOS:000272165200066
J	Gu, JJ; Wang, Z; Reeves, R; Magnuson, NS				Gu, J. J.; Wang, Z.; Reeves, R.; Magnuson, N. S.			PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis	ONCOGENE			English	Article						PIM1; phosphorylation; ASK1; kinase activity; apoptosis; cell survival	PROSTATE-CANCER CELLS; KINASE 1 ASK1; ACTIVATION; DEATH; PATHWAY; PROTEIN; STRESS; IDENTIFICATION; DISSOCIATION; THIOREDOXIN	The serine/threonine kinase, PIM1, is involved in promoting cell survival in part by phosphorylation and inhibition of proapoptotic proteins. Apoptosis signaling kinase 1 (ASK1), a mitogen-activated protein kinase kinase kinase, is involved in the so-called stress-activated pathways that contribute to apoptotic cell death. Here we show that PIM1 phosphorylates ASK1 specifically on serine residue 83 (Ser83) both in vitro and in vivo and that PIM1 binds to ASK1 in cells by co-immunoprecipitation. Using H1299 cells, our results further demonstrate that PIM1 phosphorylation of ASK1 decreases its kinase activity induced by oxidative stress. PIM1 phosphorylation of ASK1 on Ser83 inhibited ASK1-mediated c-Jun N-terminal kinase phosphorylation as well as p38 kinase phosphorylation. Under H2O2-induced stress conditions that normally lead to apoptosis, these phosphorylation events were associated with inhibition of caspase-3 activation and resulted in reduced cell death. Moreover, knockdown of PIM1 in H1299 cells decreased phosphorylation of endogenous Ser83 of ASK1 and was associated with a decrease in cell viability after H2O2 treatment. Taken together, these data reveal a novel mechanism by which PIM1 promotes cell survival that involves negative regulation of the stress-activated kinase, ASK1. Oncogene (2009) 28, 4261-4271; doi: 10.1038/onc.2009.276; published online 14 September 2009	[Gu, J. J.; Wang, Z.; Reeves, R.; Magnuson, N. S.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Magnuson, NS (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	magnuson@wsu.edu			NIH [R01-CA104470, R01-GM071760]; NATIONAL CANCER INSTITUTE [R01CA104470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071760] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants R01-CA104470 and R01-GM071760. We thank Dr Hidenori Ichijo (Tokyo Medical and Dental University) for providing us the ASK1 constructs (wild type, kinase mutant and deltaN-deleted).	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; CUYPERS HT, 1984, CELL, V37, P141; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; FRIEDMANN M, 1992, ARCH BIOCHEM BIOPHYS, V298, P594, DOI 10.1016/0003-9861(92)90454-5; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; Galvan V, 2003, J BIOL CHEM, V278, P13325, DOI 10.1074/jbc.M211398200; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; Katakami N, 2004, J BIOL CHEM, V279, P54742, DOI 10.1074/jbc.M409140200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Pircher TJ, 2000, ONCOGENE, V19, P3684, DOI 10.1038/sj.onc.1203684; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shay KP, 2005, MOL CANCER RES, V3, P170; Teh Beng-gwan, 2004, Hokkaido Journal of Medical Science, V79, P19; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang Z, 2001, J Vet Sci, V2, P167; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Yan W, 2007, BIOCHEM BIOPH RES CO, V355, P1038, DOI 10.1016/j.bbrc.2007.02.064; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zou XH, 2001, MOL CELL BIOL, V21, P4818, DOI 10.1128/MCB.21.14.4818-4828.2001	42	79	84	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4261	4271		10.1038/onc.2009.276	http://dx.doi.org/10.1038/onc.2009.276			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19749799	Green Accepted			2022-12-25	WOS:000272876300004
J	Ayon, R; Sones, W; Forrest, AS; Wiwchar, M; Valencik, ML; Sanguinetti, AR; Perrino, BA; Greenwood, IA; Leblanc, N				Ayon, Ramon; Sones, William; Forrest, Abigail S.; Wiwchar, Michael; Valencik, Maria L.; Sanguinetti, Amy R.; Perrino, Brian A.; Greenwood, Iain A.; Leblanc, Normand			Complex Phosphatase Regulation of Ca2+-activated Cl- Currents in Pulmonary Arterial Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNELS; PROTEIN PHOSPHATASE; OKADAIC ACID; CALCINEURIN; PHOSPHORYLATION; 2A; INHIBITION; PP2A; INACTIVATION; CONDUCTANCE	The present study was undertaken to determine whether the two ubiquitously expressed Ca2+-independent phosphatases PP1 and PP2A regulate Ca2+-activated Cl- currents (I-Cl(Ca)) elicited by 500 nM [Ca2+](i) in rabbit pulmonary artery (PA) myocytes dialyzed with or without 3 mm ATP. Reverse transcription-PCR experiments revealed the expression of PP1 alpha, PP1 beta/delta, PP1 gamma, PP2A alpha, PP2A beta, PP2B alpha (calcineurin (CaN) A alpha), and PP2B beta (CaN A beta) but not PP2B gamma (CaN A gamma) in rabbit PA. Western blot and immunofluorescence experiments confirmed the presence of all three PP1 isoforms and PP2A. Intracellular dialysis with a peptide inhibitor of calcineurin (CaN-AIP); the nonselective PP1/PP2A inhibitors okadaic acid (0.5, 10, or 30 nM), calyculin A (10 nM), or cantharidin (100 nM); and the selective PP1 inhibitor NIPP-1 (100 pM) potently antagonized the recovery of I-Cl(Ca) in cells dialyzed with no ATP, whereas the PP2A-selective antagonist fostriecin (30 or 150 nM) was ineffective. The combined application of okadaic acid (10 nM) and CaN-autoinhibitory peptide (50 mu M) did not potentiate the response of I-Cl(Ca) in 0 ATP produced by maximally inhibiting CaN or PP1/PP2A alone. Consistent with the non-additive effects of either classes of phosphatases, the PP1 inhibitor NIPP-1 (100 pM) antagonized the recovery of I-Cl(Ca) induced by exogenous CaN A alpha (0.5 mu M). These results demonstrate that ICl( Ca) in PA myocytes is regulated by CaN and PP1 and/or PP2A. Our data also suggest the existence of a functional link between these two classes of phosphatases.	[Leblanc, Normand] Univ Nevada, Sch Med, Dept Pharmacol, Ctr Biomed Res Excellence, Reno, NV 89557 USA; [Perrino, Brian A.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Ctr Biomed Res Excellence, Reno, NV 89557 USA; [Valencik, Maria L.] Univ Nevada, Sch Med, Dept Biochem, Ctr Biomed Res Excellence, Reno, NV 89557 USA; [Sones, William; Greenwood, Iain A.] Univ London, Div Basic Med Sci, London SW17 0RE, England	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of London	Leblanc, N (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, Ctr Biomed Res Excellence, MS 318, Reno, NV 89557 USA.	NLeblanc@Medicine.Nevada.edu	Ayon, Ramon/AAG-8431-2019	Ayon, Ramon/0000-0003-1016-8205; Leblanc, Normand/0000-0002-1090-9432; Greenwood, Iain/0000-0002-0603-0492	National Institutes of Health [5 RO1 HL 075477]; British Heart Foundation [PG/05/038]; National Institutes of Health; National Center for Research Resources [5 P20 RR15581, NCRR 5 P20 RR15581, 5 PPG HL 76611, NCRR 5 P20 RR018751]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751, P20RR015581] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075477, P01HL076611, F31HL090023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 RO1 HL 075477. This work was also supported by British Heart Foundation Grants PG/05/038 (to I. A. G.). This work was also made possible by National Institutes of Health, National Center for Research Resources, Grants NCRR 5 P20 RR15581 (to N. L.), NCRR 5 P20 RR15581 and 5 PPG HL 76611 (to M. L. V.), and NCRR 5 P20 RR018751 (to B. A. P.), supporting two Centers of Biomedical Research Excellence at the University of Nevada School of Medicine (Reno, NV).	Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; BARNES GN, 1995, J NEUROCHEM, V64, P340; BERGER HA, 1993, J BIOL CHEM, V268, P2037; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chipperfield AR, 2000, PROG BIOPHYS MOL BIO, V74, P175, DOI 10.1016/S0079-6107(00)00024-9; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Cohen PTW, 2002, J CELL SCI, V115, P241; Comerford KM, 2006, J CELL PHYSIOL, V209, P211, DOI 10.1002/jcp.20726; Greenwood IA, 2004, J BIOL CHEM, V279, P38830, DOI 10.1074/jbc.M406234200; Greenwood IA, 2001, J PHYSIOL-LONDON, V534, P395, DOI 10.1111/j.1469-7793.2001.00395.x; Groschner K, 1996, BIOCHEM J, V318, P513, DOI 10.1042/bj3180513; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Leblanc N, 2005, CAN J PHYSIOL PHARM, V83, P541, DOI 10.1139/Y05-040; Ledoux J, 2003, J PHYSIOL-LONDON, V552, P701, DOI 10.1113/jphysiol.2003.043836; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Marmorstein LY, 2002, J BIOL CHEM, V277, P30591, DOI 10.1074/jbc.M204269200; MCDANIEL NL, 1994, CAN J PHYSIOL PHARM, V72, P1380, DOI 10.1139/y94-199; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; OBARA K, 1993, AM J PHYSIOL, V264, pC296, DOI 10.1152/ajpcell.1993.264.2.C296; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; PERRINO BA, 1998, BIOCH PHARM CALMODUL, P169; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sheppeck JE, 1997, BIOORGAN MED CHEM, V5, P1739, DOI 10.1016/S0968-0896(97)00146-6; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V194, P930, DOI 10.1006/bbrc.1993.1910; Strack S, 1997, J NEUROCHEM, V68, P2119; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang YX, 1997, P NATL ACAD SCI USA, V94, P14918, DOI 10.1073/pnas.94.26.14918; WIWCHAR M, 2009, BR J PHARM IN PRESS; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760	45	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32507	32521		10.1074/jbc.M109.050401	http://dx.doi.org/10.1074/jbc.M109.050401			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19767392	Green Published, hybrid			2022-12-25	WOS:000272028400033
J	Zhang, YB; Huypens, P; Adamson, AW; Chang, JS; Henagan, TM; Boudreau, A; Lenard, NR; Burk, D; Klein, J; Perwitz, N; Shin, JH; Fasshauer, M; Kralli, A; Gettys, TW				Zhang, Yubin; Huypens, Peter; Adamson, Aaron W.; Chang, Ji Suk; Henagan, Tara M.; Boudreau, Anik; Lenard, Natalie R.; Burk, David; Klein, Johannes; Perwitz, Nina; Shin, Jeho; Fasshauer, Mathias; Kralli, Anastasia; Gettys, Thomas W.			Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA COACTIVATOR-1; FATTY-ACID OXIDATION; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOSE-TISSUE; PROTEIN-KINASE; ACTIVATION	The transcriptional co-activator PGC-1 alpha regulates functional plasticity in adipose tissue by linking sympathetic input to the transcriptional program of adaptive thermogenesis. We report here a novel truncated form of PGC-1 alpha (NT-PGC-1 alpha) produced by alternative 3' splicing that introduces an in-frame stop codon into PGC-1 alpha mRNA. The expressed protein includes the first 267 amino acids of PGC-1 alpha and 3 additional amino acids from the splicing insert. NT-PGC-1 alpha contains the transactivation and nuclear receptor interaction domains but is missing key domains involved in nuclear localization, interaction with other transcription factors, and protein degradation. Expression and subcellular localization of NT-PGC-1 alpha are dynamically regulated in the context of physiological signals that regulate full-length PGC-1 alpha, but the truncated domain structure conveys unique properties with respect to protein-protein interactions, protein stability, and recruitment to target gene promoters. Therefore, NT-PGC-1 alpha is a co-expressed, previously unrecognized form of PGC-1 alpha with functions that are both unique from and complementary to PGC-1 alpha.	[Lenard, Natalie R.; Burk, David; Shin, Jeho; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Klein, Johannes; Perwitz, Nina] Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany; [Fasshauer, Mathias] Univ Leipzig, Dept Internal Med 3, D-04103 Leipzig, Germany	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Scripps Research Institute; University of Lubeck; Leipzig University	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Lenard, Natalie/AFQ-8559-2022; Burk, David/D-2056-2009; Huypens, Peter/B-3617-2010; Chang, Ji Suk/N-1957-2017; Gettys, Thomas W/N-1964-2017	Lenard, Natalie/0000-0002-2093-4869; Huypens, Peter/0000-0001-7922-5787; Gettys, Thomas W/0000-0001-7125-7995; Henagan, Tara/0000-0001-5314-0128	National Institutes of Health [RO1 DK 074772, P20-RR021945, 5 U42 RR006042-19]; CNRU Center [1P30 DK072476, T32 DK064584, DK064951, DK074660]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945, U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074772, T32DK064584, R21DK074660, R01DK064951, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430, P20GM103528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRU Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 074772 (to T. W. G.) and P20-RR021945 (to T. W. G.), CNRU Center Grant 1P30 DK072476, and Grants T32 DK064584 (to A. W. A.), DK064951 (to A. K.), and DK074660 (to A. K.). Tissues were procured by the National Disease Research Interchange (NDRI) with support from National Institutes of Health Grant 5 U42 RR006042-19.	Adamson AW, 2006, BIOCHEM J, V399, P285, DOI 10.1042/BJ20060659; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Oberkofler H, 2002, J BIOL CHEM, V277, P16750, DOI 10.1074/jbc.M200475200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YB, 2005, FASEB J, V19, P1482, DOI 10.1096/fj.05-3851com	46	104	109	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32813	32826		10.1074/jbc.M109.037556	http://dx.doi.org/10.1074/jbc.M109.037556			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19773550	hybrid, Green Published			2022-12-25	WOS:000272028400066
J	Gao, SB; Feng, ZJ; Xu, B; Wu, Y; Yin, P; Yang, Y; Hua, X; Jin, GH				Gao, S-B; Feng, Z-J; Xu, B.; Wu, Y.; Yin, P.; Yang, Y.; Hua, X.; Jin, G-H			Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin	ONCOGENE			English	Article						lung adenocarcinoma; histone H3 lysine 27; Men1; pleiotrophin; Polycomb	ANAPLASTIC LYMPHOMA KINASE; TYROSINE-PHOSPHATASE-BETA/ZETA; EXPRESSION; CANCER; MLL; IDENTIFICATION; RECEPTOR; FIBROBLASTS; METHYLATION; P18(INK4C)	Menin upregulates transcription of cell-cycle inhibitors to suppress endocrine tumors, but it is poorly understood how menin suppresses non-endocrine tumors such as lung cancer. Here, we show that menin inhibits proliferation of human lung cancer cells and growth of lung cancer in mice. The menin-mediated tumor suppression requires repression of growth factor pleiotrophin (PTN), which binds to its cell surface receptor, anaplastic lymphoma kinase (ALK) that is activated in certain lung adenocarcinomas. Menin represses PTN transcription and PTN-induced proliferation of human lung cancer cells, and menin expression is substantially reduced in primary human lung adenocarcinomas. Notably, menin binds the PTN locus and enhances Polycomb gene Enhancer of Zeste homolog 2 (EZH2)-mediated histone H3 lysine 27 trimethylation (H3K27m3), a negative mark for gene transcription but does not affect histone H3K4 methylation that is usually upregulated by menin in endocrine cells. Together, our findings indicate that menin suppresses lung cancer partly through increasing Polycomb gene-mediated H3K27 methylation and repressing PTN transcription, unraveling a novel, epigenetically regulated PTN-ALK signaling pathway in suppressing lung cancer. Oncogene (2009) 28, 4095-4104; doi:10.1038/onc.2009.273; published online 14 September 2009	[Yang, Y.; Hua, X.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19096 USA; [Gao, S-B; Feng, Z-J; Xu, B.; Wu, Y.; Hua, X.; Jin, G-H] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen 361005, Fujian, Peoples R China; [Yin, P.] Xiamen Univ, Zhongshan Hosp, Dept Pathol, Xiamen, Peoples R China	University of Pennsylvania; Xiamen University; Xiamen University	Hua, X (corresponding author), Univ Penn, Dept Canc Biol, Room 412,BRB2-3,421 Curie Blvd, Philadelphia, PA 19096 USA.	huax@mail.med.upenn.edu; ghjin@xmu.edu.cn		Feng, Zijie/0000-0002-5633-3686	NFSC [30701003]; Natural Science Foundation of Fujian Province of China [C0710044]; National Cancer Institute Short-Term Scientist Exchange Program; National Cancer Institute [R01CA100912, R01CA113962]; NATIONAL CANCER INSTITUTE [R01CA100912, R01CA113962] Funding Source: NIH RePORTER	NFSC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Cancer Institute Short-Term Scientist Exchange Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is in partly supported by NFSC Grants (No 30701003, GH Jin), the Natural Science Foundation of Fujian Province of China (No C0710044, GH Jin), National Cancer Institute Short-Term Scientist Exchange Program (GH Jin), and National Cancer Institute Grants (R01CA100912 and R01CA113962, XH). We appreciate the valuable comments from other members of our laboratories.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Choudhuri R, 1997, CANCER RES, V57, P1814; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jager R, 2002, BRIT J CANCER, V86, P858, DOI 10.1038/sj.bjc.6600202; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jin SH, 2003, CANCER RES, V63, P4204; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schnepp RW, 2004, J BIOL CHEM, V279, P10685, DOI 10.1074/jbc.M308073200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Yan JZ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000047; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632	30	47	50	4	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2009	28	46					4095	4104		10.1038/onc.2009.273	http://dx.doi.org/10.1038/onc.2009.273			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19749796	Green Accepted			2022-12-25	WOS:000272560500005
J	Domanska, MK; Kiessling, V; Stein, A; Fasshauer, D; Tamm, LK				Domanska, Marta K.; Kiessling, Volker; Stein, Alexander; Fasshauer, Dirk; Tamm, Lukas K.			Single Vesicle Millisecond Fusion Kinetics Reveals Number of SNARE Complexes Optimal for Fast SNARE-mediated Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR SUPPORTED BILAYERS; FAST CNS SYNAPSE; TRANSMITTER RELEASE; EXOCYTOSIS; PROTEINS; SNAP-25; NEUROEXOCYTOSIS; BOTULINUM; ANATOMY; EVENTS	SNAREs mediate membrane fusion in intracellular vesicle traffic and neuronal exocytosis. Reconstitution of membrane fusion in vitro proved that SNAREs constitute the minimal fusion machinery. However, the slow fusion rates observed in these systems are incompatible with those required in neuro-transmission. Here we present a single vesicle fusion assay that records individual SNARE-mediated fusion events with millisecond time resolution. Docking and fusion of reconstituted synaptobrevin vesicles to target SNARE complex-containing planar membranes are distinguished by total internal reflection fluorescence microscopy as separate events. Docking and fusion are SNAP-25-dependent, require no Ca2+, and are efficient at room temperature. Analysis of the stochastic data with sequential and parallel multi-particle activation models reveals six to nine fast-activating steps. Of all the tested models, the kinetic model consisting of eight parallel reaction rates statistically fits the data best. This might be interpreted by fusion sites consisting of eight SNARE complexes that each activate in a single rate-limiting step in 8 ms.	[Domanska, Marta K.; Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Domanska, Marta K.; Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Stein, Alexander; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	University of Virginia; University of Virginia; Max Planck Society	Tamm, LK (corresponding author), Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA.	Lkt2e@virginia.edu	Kiessling, Volker/A-3539-2008; Fasshauer, Dirk/B-1563-2013; Stein, Alexander/I-4950-2012	Fasshauer, Dirk/0000-0002-1040-4282; Stein, Alexander/0000-0002-2696-0611	National Institutes of Health [P01 GM72694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM72694.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Crane JM, 2005, LANGMUIR, V21, P1377, DOI 10.1021/la047654w; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jahn R, 1995, COLD SPRING HARB SYM, V60, P329, DOI 10.1101/SQB.1995.060.01.037; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Wagner ML, 2001, BIOPHYS J, V81, P266, DOI 10.1016/S0006-3495(01)75697-4; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003	38	133	134	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32158	32166		10.1074/jbc.M109.047381	http://dx.doi.org/10.1074/jbc.M109.047381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759010	Green Published, hybrid			2022-12-25	WOS:000271572700070
J	Piscopo, DM; Johansen, EB; Derynck, R				Piscopo, Denise M.; Johansen, Eric B.; Derynck, Rik			Identification of the GATA Factor TRPS1 as a Repressor of the Osteocalcin Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; MESENCHYMAL STEM-CELLS; ZINC-FINGER PROTEIN; SYNDROME TYPE-I; TRANSCRIPTION FACTOR; TRICHORHINOPHALANGEAL SYNDROME; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; OSTEOCLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA	A proteomic analysis of proteins bound to the osteocalcin OSE2 sequence of the mouse osteocalcin promoter identified TRPS1 as a regulator of osteocalcin transcription. Mutations in the TRPS1 gene are responsible for human tricho-rhino-phalangeal syndrome, which is characterized by skeletal and craniofacial abnormalities. TRPS1 has been shown to bind regulatory promoter sequences containing GATA consensus binding sites and to repress transcription of genes involved in chondrocyte differentiation. Here we show that TRPS1 can directly bind the osteocalcin promoter in the presence or absence of Runx2. TRPS1 binds through a GATA binding sequence in the proximal promoter of the osteocalcin gene. The GATA binding site is conserved in mice, humans, and rats, although its location and orientation are not. Mutation of the mouse or human GATA binding sequence abrogates binding of TRPS1 to the osteocalcin promoter. We show that TRPS1 is expressed in osteosarcoma cells and upon induction of osteoblast differentiation in primary mouse bone marrow stromal cells and that TRPS1 regulates the expression of osteocalcin in both cell types. The expression of TRPS1 modulates mineralized bone matrix formation in differentiating osteoblast cells. These data suggest a role for TRPS1 in osteoblast differentiation, in addition to its previously described role in chondrogenesis.	[Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; [Johansen, Eric B.] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Johansen, Eric B.] Univ Calif San Francisco, Sandler Moore Mass Spectrometry Facil, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, 513 Parnassus Ave,Rm HSW 613, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu			National Institutes of Health [CA63101]; National Institutes of Health; Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health, NCI [P30 CA82103]; NATIONAL CANCER INSTITUTE [P30CA082103, R01CA063101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA63101 (to R. D.) and a National Institutes of Health Institutional Research Service Award (to D. P.). The UCSF Sandler-Moore Mass Spectrometry Core Facility was supported by the Sandler Family Foundation, the Gordon and Betty Moore Foundation, and National Institutes of Health, NCI, Grant P30 CA82103.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Blyth K, 2001, ONCOGENE, V20, P295, DOI 10.1038/sj.onc.1204090; BORTELL R, 1993, P NATL ACAD SCI USA, V90, P2300, DOI 10.1073/pnas.90.6.2300; Chang GTG, 2000, J NATL CANCER I, V92, P1414, DOI 10.1093/jnci/92.17.1414; Chang GTG, 2004, ENDOCR-RELAT CANCER, V11, P815, DOI 10.1677/erc.1.00853; Chang GTG, 1997, CANCER RES, V57, P4075; Chang GTG, 2002, APOPTOSIS, V7, P13, DOI 10.1023/A:1013504710343; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Fantauzzo KA, 2008, GENE EXPR PATTERNS, V8, P51, DOI 10.1016/j.modgep.2007.10.006; FELMAN AH, 1977, AM J ROENTGENOL, V129, P631, DOI 10.2214/ajr.129.4.631; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; GIEDION A, 1966, HELV PAEDIATR ACTA, V21, P475; GIEDION A, 1973, HELV PAEDIATR ACTA, V28, P249; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Itoh S, 2008, GENES CELLS, V13, P355, DOI 10.1111/j.1365-2443.2008.01170.x; JIMENEZ CR, 1998, CURRENT PROTOCOLS PR; Kaiser FJ, 2003, J BIOL CHEM, V278, P38780, DOI 10.1074/jbc.M306259200; Kaiser FJ, 2003, HUM MOL GENET, V12, P1349, DOI 10.1093/hmg/ddg145; Kaiser FJ, 2007, BIOL CHEM, V388, P381, DOI 10.1515/BC.2007.051; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kunath M, 2002, MECH DEVELOP, V119, pS117, DOI 10.1016/S0925-4773(03)00103-5; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lian JB, 2003, CONNECT TISSUE RES, V44, P141, DOI 10.1080/03008200390152232; Ludecke HJ, 2001, AM J HUM GENET, V68, P81, DOI 10.1086/316926; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; Malik TH, 2002, MOL CELL BIOL, V22, P8592, DOI 10.1128/MCB.22.24.8592-8600.2002; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; MCCABE LR, 1994, J CELL BIOCHEM, V56, P274, DOI 10.1002/jcb.240560221; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; NIIKAWA N, 1986, AM J MED GENET, V24, P759, DOI 10.1002/ajmg.1320240420; Nishioka K, 2008, BONE, V43, P64, DOI 10.1016/j.bone.2008.03.009; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pritsker M, 2004, GENOME RES, V14, P99; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Shi MJ, 1998, J IMMUNOL, V161, P6751; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; van den Bemd GJCM, 2003, BIOCHEM BIOPH RES CO, V312, P578, DOI 10.1016/j.bbrc.2003.10.154; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200	71	39	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31690	31703		10.1074/jbc.M109.052316	http://dx.doi.org/10.1074/jbc.M109.052316			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759027	Green Published, hybrid			2022-12-25	WOS:000271572700024
J	Salinas, M; Lazdunski, M; Lingueglia, E				Salinas, Miguel; Lazdunski, Michel; Lingueglia, Eric			Structural Elements for the Generation of Sustained Currents by the Acid Pain Sensor ASIC3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; GATED CATION CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; TISSUE ACIDOSIS; NEURONS; H+; PH; ION-CHANNEL-3; SITES	ASIC3 is an acid-sensing ion channel expressed in sensory neurons, where it participates in acidic and inflammatory pain. In addition to the "classical" transient current, ASIC3 generates a sustained current essential for pain perception. Using chimeras between the ASIC3 and ASIC1a channels we show that the first transmembrane domain (TM1), combined with the N-terminal domain, is the key structural element generating the low pH (< 6.5)-evoked sustained current. The TM1 domain also modulates the pH-dependent activation of the fast transient current thus contributing to a constitutive window current, another type of sustained current present near physiological pH. The C-terminal and the TM2 domains negatively regulate both types of sustained current, and the extracellular loop affects its kinetics. These data provide new information to aid understanding the mechanisms of the multifaceted pH gating of ASIC3. Together with the peak current, both components of the sustained current (window and sustained at pH < 6.5) allow ASIC3 to adapt its behavior to a wide range of extracellular pH variations by generating transient and/or sustained responses that contribute to nociceptor excitability.	[Lingueglia, Eric] UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France; UNSA, CNRS, Inst NeuroMed Mol, UMR6097, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lingueglia, E (corresponding author), UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	lingueglia@ipmc.cnrs.fr	LINGUEGLIA, Eric/F-5509-2013; SALINAS, Miguel/N-6380-2016	LINGUEGLIA, Eric/0000-0003-3902-3405; SALINAS, Miguel/0000-0002-7445-123X	CNRS; Agence Nationale de la Recherche; Association Francaise contre les Myopathies; Association pour la Recherche sur le Cancer; Institut UPSA de la Douleur	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut UPSA de la Douleur	This work was supported by the CNRS, the Agence Nationale de la Recherche, the Association Francaise contre les Myopathies, the Association pour la Recherche sur le Cancer, and the Institut UPSA de la Douleur.	Anzai N, 2002, J BIOL CHEM, V277, P16655, DOI 10.1074/jbc.M201087200; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2006, J BIOL CHEM, V281, P1796, DOI 10.1074/jbc.M509669200; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Deval E, 2003, NEUROPHARMACOLOGY, V44, P662, DOI 10.1016/S0028-3908(03)00047-9; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Ettaiche M, 2009, INVEST OPHTH VIS SCI, V50, P2417, DOI 10.1167/iovs.08-3028; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hruska-Hageman AM, 2004, J BIOL CHEM, V279, P46962, DOI 10.1074/jbc.M405874200; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; STEEN KH, 1995, NEUROSCI LETT, V199, P29, DOI 10.1016/0304-3940(95)12002-L; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; YEN YT, 2009, MOL PAIN IN PRESS; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	36	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31851	31859		10.1074/jbc.M109.043984	http://dx.doi.org/10.1074/jbc.M109.043984			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19778905	Green Published, hybrid			2022-12-25	WOS:000271572700040
J	Ah-Seng, Y; Lopez, F; Pasta, F; Lane, D; Bouet, JY				Ah-Seng, Yoan; Lopez, Frederic; Pasta, Franck; Lane, David; Bouet, Jean-Yves			Dual Role of DNA in Regulating ATP Hydrolysis by the SopA Partition Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC ACTIN HOMOLOG; PLASMID-PARTITION; F-PLASMID; P1 PLASMID; SEGREGATION; COMPLEX; BINDING; PARB; CENTROMERE; MECHANISM	In bacteria, mitotic stability of plasmids and many chromosomes depends on replicon-specific systems, which comprise a centromere, a centromere-binding protein and an ATPase. Dynamic self-assembly of the ATPase appears to enable active partition of replicon copies into cell-halves, but for Walker-box partition ATPases the molecular mechanism is unknown. ATPase activity appears to be essential for this process. DNA and centromere-binding proteins are known to stimulate the ATPase activity but molecular details of the stimulation mechanism have not been reported. We have investigated the interactions which stimulate ATP hydrolysis by the SopA partition ATPase of plasmid F. By using SopA and SopB proteins deficient in DNA binding, we have found that the intrinsic ability of SopA to hydrolyze ATP requires direct DNA binding by SopA but not by SopB. Our results show that two independent interactions of SopA act in synergy to stimulate its ATPase. SopA must interact with (i) DNA, through its ATP-dependent nonspecific DNA binding domain and (ii) SopB, which we show here to provide an arginine-finger motif. In addition, the latter interaction stimulates ATPase maximally when SopB is part of the partition complex. Hence, our data demonstrate that DNA acts on SopA in two ways, directly as nonspecific DNA and through SopB as centromeric DNA, to fully activate SopA ATP hydrolysis.	[Ah-Seng, Yoan; Pasta, Franck; Lane, David; Bouet, Jean-Yves] CNRS, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Ah-Seng, Yoan; Pasta, Franck; Bouet, Jean-Yves] Univ Toulouse 3, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Lopez, Frederic] CHU Rangueil, INSERM, Inst L Bugnard, F-31000 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bouet, JY (corresponding author), Univ Toulouse 3, CNRS, LMGM, Bat IBCG,118 Route Narbonne, F-31062 Toulouse 9, France.	jean-yves.bouet@ibcg.biotoul.fr	Abraham, Ajith/A-1416-2008; Bouet, Jean-Yves/H-8469-2019; Hassanien, Aboul ella/O-5672-2014	Abraham, Ajith/0000-0002-0169-6738; Bouet, Jean-Yves/0000-0003-1488-5455; Hassanien, Aboul ella/0000-0002-9989-6681	l'Agence Nationale de la Recherche [ANR-06-BLAN-0280-01]	l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by l'Agence Nationale de la Recherche Grant ANR-06-BLAN-0280-01.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Bouet JY, 2006, MOL MICROBIOL, V62, P1447, DOI 10.1111/j.1365-2958.2006.05454.x; Bouet JY, 2009, J BIOL CHEM, V284, P165, DOI 10.1074/jbc.M802752200; Bouet JY, 2005, MOL MICROBIOL, V55, P511, DOI 10.1111/j.1365-2958.2004.04396.x; Bouet JY, 2000, J BIOL CHEM, V275, P8213, DOI 10.1074/jbc.275.11.8213; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Davey MJ, 1997, J BIOL CHEM, V272, P15286, DOI 10.1074/jbc.272.24.15286; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; FUNNELL BE, 1993, J BIOL CHEM, V268, P3616; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; HAYAKAWA Y, 1985, J BACTERIOL, V163, P349, DOI 10.1128/JB.163.1.349-354.1985; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Libante V, 2001, J MOL BIOL, V314, P387, DOI 10.1006/jmbi.2001.5158; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MORI H, 1989, J BIOL CHEM, V264, P15535; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Ravin NV, 2003, J MOL BIOL, V329, P875, DOI 10.1016/S0022-2836(03)00525-4; Rosinski JA, 1999, J MOL EVOL, V49, P301, DOI 10.1007/PL00006552; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; WATANABE E, 1992, MOL GEN GENET, V234, P346, DOI 10.1007/BF00538693; Yates P, 1999, J MOL BIOL, V290, P627, DOI 10.1006/jmbi.1999.2909	38	49	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30067	30075		10.1074/jbc.M109.044800	http://dx.doi.org/10.1074/jbc.M109.044800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740757	Green Published, hybrid			2022-12-25	WOS:000271090000009
J	Lin, YC; Huang, JY; Kan, H; Frisbee, JC; Yu, HG				Lin, Yen-Chang; Huang, Jianying; Kan, Hong; Frisbee, Jefferson C.; Yu, Han-Gang			Rescue of a Trafficking Defective Human Pacemaker Channel via a Novel Mechanism ROLES OF Src, Fyn, AND Yes TYROSINE KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; NUCLEOTIDE-GATED CHANNELS; PROTEIN TRAFFICKING; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; MODULATION; CELLS; ACTIVATION; EXPRESSION; INCREASES	Therapeutic strategies such as using channel blockers and reducing culture temperature have been used to rescue some long QT-associated voltage-gated potassium Kv trafficking defective mutant channels. A hyperpolarization-activated cyclic nucleotide-gated HCN4 pacemaker channel mutant (D553N) has been recently found in a patient associated with cardiac arrhythmias including long QT. D553N showed the defective trafficking to the cell surface, leading to little ionic current expression (loss-of-function). We show in this report that enhanced tyrosine phosphorylation mediated by Src, Fyn, and Yes kinases was able to restore the surface expression of D553N for normal current expression. Src or Yes, but not Fyn, significantly increased the current density and surface expression of D553N. Fyn accelerated the activation kinetics of the rescued D553N. Co-expression of D553N with Yes exhibited the slowest activation kinetics of D553N. Src, Fyn, and Yes significantly enhanced the tyrosine phosphorylation of D553N. A combination of Src, Fyn, and Yes rescued the current expression and the gating of D553N comparable with those of wild-type HCN4. In conclusion, we demonstrate a novel mechanism using three endogenous Src kinases to rescue a trafficking defective HCN4 mutant channel (D553N) by enhancing the tyrosine phosphorylation of the mutant channel protein.	[Lin, Yen-Chang; Huang, Jianying; Kan, Hong; Frisbee, Jefferson C.; Yu, Han-Gang] W Virginia Univ, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA; [Lin, Yen-Chang; Huang, Jianying; Frisbee, Jefferson C.; Yu, Han-Gang] W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Kan, Hong] W Virginia Univ, Dept Cardiol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Yu, HG (corresponding author), W Virginia Univ, Dept Physiol, 1 Med Ctr Dr,Rm 3034 HSN, Morgantown, WV 26506 USA.	hyu@hsc.wvu.edu			National Institutes of Health [HL075023]; Office of Research and Graduate Programs/Health Sciences Center at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Graduate Programs/Health Sciences Center at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075023. This work was also supported by the Office of Research and Graduate Programs/Health Sciences Center at West Virginia University (to H.-G. Y.).	Arinsburg SS, 2006, J CARDIOVASC PHARM, V47, P578, DOI 10.1097/01.fjc.0000211740.47960.8b; Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Fogle KJ, 2007, J NEUROSCI, V27, P2802, DOI 10.1523/JNEUROSCI.4376-06.2007; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Huang JY, 2008, J BIOL CHEM, V283, P29912, DOI 10.1074/jbc.M804205200; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Kanda S, 2005, J CELL SCI, V118, P961, DOI 10.1242/jcs.01686; Li CH, 2008, AM J PHYSIOL-CELL PH, V294, pC355, DOI 10.1152/ajpcell.00236.2007; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Wu JY, 2000, BBA-BIOMEMBRANES, V1463, P15, DOI 10.1016/S0005-2736(99)00233-3; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Yu HG, 2004, PFLUG ARCH EUR J PHY, V447, P392, DOI 10.1007/s00424-003-1204-y; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	24	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30433	30440		10.1074/jbc.M109.039180	http://dx.doi.org/10.1074/jbc.M109.039180			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19748888	hybrid, Green Published			2022-12-25	WOS:000271090000046
J	Brody, JP				Brody, James P.			Parallel Routes of Human Carcinoma Development: Implications of the Age-Specific Incidence Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; MULTISTAGE CARCINOGENESIS; YOUNG-WOMEN; RACIAL-DIFFERENCES; COLON-CANCER; RISK; MODEL; SUSCEPTIBILITY; EPIDEMIOLOGY	Background: The multi-stage hypothesis suggests that cancers develop through a single defined series of genetic alterations. This hypothesis was first suggested over 50 years ago based upon age-specific incidence data. However, recent molecular studies of tumors indicate that multiple routes exist to the formation of cancer, not a single route. This parallel route hypothesis has not been tested with age-specific incidence data. Methodology/Principal Findings: To test the parallel route hypothesis, I formulated it in terms of a mathematical equation and then tested whether this equation was consistent with age-specific incidence data compiled by the Surveillance Epidemiology and End Results (SEER) cancer registries since 1973. I used the chi-squared goodness of fit test to measure consistency. The age-specific incidence data from most human carcinomas, including those of the colon, lung, prostate, and breast were consistent with the parallel route hypothesis. However, this hypothesis is only consistent if an immune sub-population exists, one that will never develop carcinoma. Furthermore, breast carcinoma has two distinct forms of the disease, and one of these occurs at significantly different rates in different racial groups. Conclusions/Significance: I conclude that the parallel route hypothesis is consistent with the age-specific incidence data only if carcinoma occurs in a distinct sub population, while the multi-stage hypothesis is inconsistent with this data.			Brody, JP (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197	NHGRI NIH HHS [K22 HG000047, T32 HG000047, HG-00047] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG000047, T32HG000047] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Anderson WF, 2001, J CLIN ONCOL, V19, P18, DOI 10.1200/JCO.2001.19.1.18; Anderson WF, 2002, BREAST CANCER RES TR, V76, P27, DOI 10.1023/A:1020299707510; Anderson WF, 2006, CANCER EPIDEM BIOMAR, V15, P1899, DOI 10.1158/1055-9965.EPI-06-0191; Anderson WF, 2006, JNCI-J NATL CANCER I, V98, P948, DOI 10.1093/jnci/djj295; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.3.CO;2-T; Colditz GA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1414; DEWAARD F, 1979, J NATL CANCER I, V63, P549, DOI 10.1093/jnci/63.3.549; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; FARBER E, 1984, CANCER RES, V44, P4217; Fay MP, 1997, STAT MED, V16, P791; Frank S. A., 2007, DYNAMICS CANC INCIDE; Frank SA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-163; Frank SA, 2004, CURR BIOL, V14, P242, DOI 10.1016/j.cub.2003.12.026; Frank SA, 2003, NATURE, V422, P494, DOI 10.1038/422494a; Heidenreich WF, 2002, RADIAT RES, V158, P607, DOI 10.1667/0033-7587(2002)158[0607:MMATIO]2.0.CO;2; Herrero-Jimenez P, 2000, MUTAT RES-FUND MOL M, V447, P73, DOI 10.1016/S0027-5107(99)00201-8; Herrero-Jimenez P, 1998, MUTAT RES-FUND MOL M, V400, P553, DOI 10.1016/S0027-5107(98)00067-0; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Houlston RS, 2004, ONCOGENE, V23, P6471, DOI 10.1038/sj.onc.1207951; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jatoi I, 2003, CANCER-AM CANCER SOC, V98, P894, DOI 10.1002/cncr.11604; Johnson SM, 2002, INT J CANCER, V98, P205, DOI 10.1002/ijc.10197; Jones S., 2008, SCIENCE; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Marees T, 2008, J NATL CANCER I, V100, P1771, DOI 10.1093/jnci/djn394; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; MOOLGAVKAR SH, 1992, J NATL CANCER I, V84, P610, DOI 10.1093/jnci/84.8.610; Moolgavkar SH, 2003, GENE CHROMOSOME CANC, V38, P302, DOI 10.1002/gcc.10264; MOOLGAVKAR SH, 1990, RISK ANAL, V10, P323, DOI 10.1111/j.1539-6924.1990.tb01053.x; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Olschwang S, 1997, P NATL ACAD SCI USA, V94, P12122, DOI 10.1073/pnas.94.22.12122; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Pfeiffer RM, 2008, JNCI-J NATL CANCER I, V100, P751, DOI 10.1093/jnci/djn112; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pompei F, 2002, TOXICOL IND HEALTH, V18, P365, DOI 10.1191/0748233702th164oa; *SEER PROGR, 2003, SEERST DAT INC SEER; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Walker RA, 1996, BRIT J CANCER, V74, P1796, DOI 10.1038/bjc.1996.632; Weber-Mangal S, 2003, INT J CANCER, V107, P583, DOI 10.1002/ijc.11460; Weinberg RA., 2002, NEW ENGL J MED, V347, P1593, DOI [DOI 10.1056/NEJMRA021902, 10.1056/NEJMra021902]; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiong QH, 2001, CANCER, V92, P2523, DOI 10.1002/1097-0142(20011115)92:10<2523::AID-CNCR1603>3.0.CO;2-6; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7053	10.1371/journal.pone.0007053	http://dx.doi.org/10.1371/journal.pone.0007053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774079	Green Published, gold, Green Submitted			2022-12-25	WOS:000270160900003
J	Ahmed, A; Engelberts, MFM; Boer, KR; Ahmed, N; Hartskeerl, RA				Ahmed, Ahmed; Engelberts, Mirjam F. M.; Boer, Kimberly R.; Ahmed, Niyaz; Hartskeerl, Rudy A.			Development and Validation of a Real-Time PCR for Detection of Pathogenic Leptospira Species in Clinical Materials	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; EARLY-DIAGNOSIS; IDENTIFICATION; ASSAY; SEROVAR; GROWTH; SETS	Available serological diagnostics do not allow the confirmation of clinically suspected leptospirosis at the early acute phase of illness. Several conventional and real-time PCRs for the early diagnosis of leptospirosis have been described but these have been incompletely evaluated. We developed a SYBR Green-based real-time PCR targeting secY and validated it according to international guidelines. To determine the analytical specificity, DNA from 56 Leptospira strains belonging to pathogenic, non-pathogenic and intermediate Leptospira spp. as well as 46 other micro-organisms was included in this study. All the pathogenic Leptospira gave a positive reaction. We found no cross-reaction with saprophytic Leptospira and other micro-organisms, implying a high analytical specificity. The analytical sensitivity of the PCR was one copy per reaction from cultured homologous strain M 20 and 1.2 and 1.5 copy for heterologous strains 1342 K and Sarmin, respectively. In spiked serum & blood and kidney tissue the sensitivity was 10 and 20 copies for M 20, 15 and 30 copies for 1342 K and 30 and 50 copies for Sarmin. To determine the diagnostic sensitivity (DSe) and specificity (DSp), clinical blood samples from 26 laboratory-confirmed and 107 negative patients suspected of leptospirosis were enrolled as a prospective consecutive cohort. Based on culture as the gold standard, we found a DSe and DSp of 100% and 93%, respectively. All eight PCR positive samples that had a negative culture seroconverted later on, implying a higher actual DSp. When using culture and serology as the gold standard, the DSe was lower (89%) while the DSp was higher (100%). DSe was 100% in samples collected within the first - for treatment important - 4 days after onset of the illness. Reproducibility and repeatability of the assay, determined by blind testing kidney samples from 20 confirmed positive and 20 negative rodents both appeared 100%. In conclusion we have described for the first time the development of a robust SYBR Green real-time PCR for the detection of pathogenic Leptospira combined with a detailed assessment of its clinical accuracy, thus providing a method for the early diagnosis of leptospirosis with a well-defined satisfactory performance.			Ahmed, A (corresponding author), WHO FAO OIE, Amsterdam, Netherlands.	r.hartskeerl@kit.nl	Ahmed, Niyaz/D-2589-2010	Ahmed, Niyaz/0000-0001-6425-7583				Abdulmawjood A, 2002, MOL CELL PROBE, V16, P335, DOI 10.1006/mcpr.2002.0431; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; BAL AE, 1994, J CLIN MICROBIOL, V32, P1894, DOI 10.1128/JCM.32.8.1894-1898.1994; BROWN PD, 1995, J MED MICROBIOL, V43, P110, DOI 10.1099/00222615-43-2-110; Dikken H., 1978, METHOD MICROBIOL, V11, P260; do Oliveira MAA, 2003, J MED MICROBIOL, V52, P127, DOI 10.1099/jmm.0.04923-0; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Hartskeerl R A, 2006, Indian J Med Microbiol, V24, P309; HARTSKEERL RA, 2008, LCI RICHTLIJNEN INFE, P238; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Kawabata H, 2001, MICROBIOL IMMUNOL, V45, P491, DOI 10.1111/j.1348-0421.2001.tb02649.x; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Louie M, 2000, CAN MED ASSOC J, V163, P301; Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; MERIEN F, 1995, J INFECT DIS, V172, P281, DOI 10.1093/infdis/172.1.281; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; National Center for Biotechnology Information, 2009, BAS LOC AL SEARCH TO; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851; Post JC, 2000, JAMA-J AM MED ASSOC, V283, P1544, DOI 10.1001/jama.283.12.1544; Priya CG, 2007, J POSTGRAD MED, V53, P236; Reitstetter RE, 2006, FEMS MICROBIOL LETT, V264, P31, DOI 10.1111/j.1574-6968.2006.00431.x; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Speelman P, 2008, HARRISONS PRINCIPLES, P1048; *STANDARDS, 2008, STANDARDS REP DIAGN; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377; Valverde MD, 2008, INFECT GENET EVOL, V8, P529, DOI 10.1016/j.meegid.2008.02.008; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Woo THS, 1997, J CLIN MICROBIOL, V35, P3140, DOI 10.1128/JCM.35.12.3140-3146.1997; World Health Organization, 2003, HUM LEPT GUID DIAGN; *WORLD ORG AN HLTH, 2004, OIE MAN DIAGN TESTS; Yersin C, 1999, TROP MED INT HEALTH, V4, P38, DOI 10.1046/j.1365-3156.1999.00352.x; Zhang Y, 1993, Hua Xi Yi Ke Da Xue Xue Bao, V24, P262; ZUERNER RL, 1995, J CLIN MICROBIOL, V33, P3284, DOI 10.1128/JCM.33.12.3284-3289.1995; Zuerner RL, 2000, FEMS MICROBIOL LETT, V182, P303, DOI 10.1016/S0378-1097(99)00598-4	46	171	175	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7093	10.1371/journal.pone.0007093	http://dx.doi.org/10.1371/journal.pone.0007093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763264	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970400017
J	Lee, JS; Kim, IS; Kim, JH; Cho, W; Suh, PG; Ryu, SH				Lee, Jun Sung; Kim, Il Shin; Kim, Jung Hwan; Cho, Wonhwa; Suh, Pann-Ghill; Ryu, Sung Ho			Determination of EGFR Endocytosis Kinetic by Auto-Regulatory Association of PLD1 with mu 2	PLOS ONE			English	Article								Background: Upon ligand binding, cell surface signaling receptors are internalized through a process tightly regulated by endocytic proteins and adaptor protein 2 (AP2) to orchestrate them. Although the molecular identities and roles of endocytic proteins are becoming clearer, it is still unclear what determines the receptor endocytosis kinetics which is mainly regulated by the accumulation of endocytic apparatus to the activated receptors. Methodology/Principal Findings: Here we employed the kinetic analysis of endocytosis and adaptor recruitment to show that mu 2, a subunit of AP2 interacts directly with phospholipase D (PLD)1, a receptor-associated signaling protein and this facilitates the membrane recruitment of AP2 and the endocytosis of epidermal growth factor receptor ( EGFR). We also demonstrate that the PLD1-m2 interaction requires the binding of PLD1 with phosphatidic acid, its own product. Conclusions/Significance: These results suggest that the temporal regulation of EGFR endocytosis is achieved by autoregulatory PLD1 which senses the receptor activation and triggers the translocation of AP2 near to the activated receptor.			Lee, JS (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010	Ryu, Sung Ho/0000-0003-0913-3048; Kim, Jung Hwan/0000-0001-8548-4435	NIGMS NIH HHS [R01 GM068849, GM 68849] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Cremona O, 2001, J CELL SCI, V114, P1041; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Gagescu R, 2000, Traffic, V1, P84, DOI 10.1034/j.1600-0854.2000.010112.x; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kim JH, 1999, BIOCHEMISTRY-US, V38, P3763, DOI 10.1021/bi982478+; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kirchhausen T, 2002, CELL, V109, P413, DOI 10.1016/S0092-8674(02)00751-1; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Lee TG, 1997, BBA-LIPID LIPID MET, V1347, P199, DOI 10.1016/S0005-2760(97)00083-0; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Wiedemann C, 1998, J NEUROSCI, V18, P5594	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7090	10.1371/journal.pone.0007090	http://dx.doi.org/10.1371/journal.pone.0007090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763255	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970400016
J	Wunschel, D; Webb-Robertson, BJ; Frevert, CW; Skerrett, S; Beagley, N; Willse, A; Colburn, H; Antolick, K				Wunschel, David; Webb-Robertson, Bobbie-Jo; Frevert, Charles W.; Skerrett, Shawn; Beagley, Nat; Willse, Alan; Colburn, Heather; Antolick, Kathryn			Differentiation of Gram-Negative Bacterial Aerosol Exposure Using Detected Markers in Bronchial-Alveolar Lavage Fluid	PLOS ONE			English	Article							TOF MASS-SPECTROMETRY; MALDI-TOF; INFLAMMATORY RESPONSE; IDENTIFICATION; CYTOKINES; DEFENSINS; BREATH; INHALATION; INFECTION; PROTEINS	The identification of biosignatures of aerosol exposure to pathogens has the potential to provide useful diagnostic information. In particular, markers of exposure to different types of respiratory pathogens may yield diverse sets of markers that can be used to differentiate exposure. We examine a mouse model of aerosol exposure to known Gram negative bacterial pathogens, Francisella tularensis novicida and Pseudomonas aeruginosa. Mice were subjected to either a pathogen or control exposure and bronchial alveolar lavage fluid (BALF) was collected at four and twenty four hours post exposure. Small protein and peptide markers within the BALF were detected by matrix assisted laser desorption/ionization (MALDI) mass spectrometry (MS) and analyzed using both exploratory and predictive data analysis methods; principle component analysis and degree of association. The markers detected were successfully used to accurately identify the four hour exposed samples from the control samples. This report demonstrates the potential for small protein and peptide marker profiles to identify aerosol exposure in a short post-exposure time frame.			Wunschel, D (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	David.Wunschel@pnl.gov	Colburn, Heather/ABC-5136-2021; Wunschel, David/F-3820-2010; Webb-Robertson, Bobbie-Jo/K-8230-2019	Colburn, Heather/0000-0003-0399-4728; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397	NIAID NIH HHS [U54 AI057141] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ardekani Ali M, 2002, Expert Rev Mol Diagn, V2, P312, DOI 10.1586/14737159.2.4.312; Ayabe T, 2001, GASTROENTEROLOGY, V120, pA187, DOI 10.1016/S0016-5085(08)80926-2; Beineke A, 2004, VET IMMUNOL IMMUNOP, V98, P59, DOI 10.1016/j.vetimm.2003.10.002; Devijver P, 1982, PATTERN RECOGNITION; Duenas AI, 2006, INT IMMUNOL, V18, P785, DOI 10.1093/intimm/dxl015; Evans RG, 2006, DIS MANAG HEALTH OUT, V14, P265, DOI 10.2165/00115677-200614050-00002; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Frevert CW, 1998, FASEB J, V12, pA788; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; Goodman RB, 1998, AM J PHYSIOL-LUNG C, V275, pL87, DOI 10.1152/ajplung.1998.275.1.L87; Greenfield RA, 2002, AM J MED SCI, V323, P299, DOI 10.1097/00000441-200206000-00003; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Holland RD, 1999, ANAL CHEM, V71, P3226, DOI 10.1021/ac990175v; Issaq HJ, 2003, ANAL CHEM, V75, p148A, DOI 10.1021/ac031249c; Jackman J, 2004, J HOPKINS APL TECH D, V25, P6; Jarman KH, 1999, RAPID COMMUN MASS SP, V13, P1586, DOI 10.1002/(SICI)1097-0231(19990815)13:15<1586::AID-RCM680>3.0.CO;2-2; Jarman KH, 2000, ANAL CHEM, V72, P1217, DOI 10.1021/ac990832j; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Kohn Elise C., 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P1163; Krader P, 2004, EXTREMOPHILES, V8, P259, DOI 10.1007/s00792-004-0382-7; Kyriacou DN, 2007, CHEST, V131, P489, DOI 10.1378/chest.06-1687; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Lee JS, 2005, AM J PHYSIOL-LUNG C, V289, pL731, DOI 10.1152/ajplung.00196.2005; Lembo A, 2008, J IMMUNOL, V180, P7574, DOI 10.4049/jimmunol.180.11.7574; Mandrell R, 2007, MOL CELL PROTEOMICS, V6, P58; Mellmann A, 2007, INT J MED MICROBIOL, V297, P16; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Ott RL, 2001, INTRO STAT METHODS D; Prieto D, 2003, J LIQ CHROMATOGR R T, V26, P2315, DOI 10.1081/JLC-120023249; Pusch W, 2007, PHARMACOGENOMICS, V8, P663, DOI 10.2217/14622416.8.6.663; Robroeks CMHHT, 2006, ANN ALLERG ASTHMA IM, V96, P349, DOI 10.1016/S1081-1206(10)61247-1; Sack U, 2006, CYTOM PART A, V69A, P169, DOI 10.1002/cyto.a.20231; SASMANO T, 2004, BIOL MACROPHAGES; Senior BW, 2005, INFECT IMMUN, V73, P1515, DOI 10.1128/IAI.73.3.1515-1522.2005; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Smoll J., 2003, Experimental Lung Research, V29, P108; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Visentainer JEL, 2003, EXP HEMATOL, V31, P1044, DOI 10.1016/j.exphem.2003.08.005; West TE, 2008, MICROBES INFECT, V10, P773, DOI 10.1016/j.micinf.2008.04.008; Wunschel SC, 2005, J AM SOC MASS SPECTR, V16, P456, DOI 10.1016/j.jasms.2004.12.004; Zhang H, 2001, AM J PHYSIOL-LUNG C, V280, pL947, DOI 10.1152/ajplung.2001.280.5.L947	45	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7047	10.1371/journal.pone.0007047	http://dx.doi.org/10.1371/journal.pone.0007047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756149	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970000014
J	Lazarini, F; Mouthon, MA; Gheusi, G; de Chaumont, F; Olivo-Marin, JC; Lamarque, S; Abrous, DN; Boussin, FD; Lledo, PM				Lazarini, Francoise; Mouthon, Marc-Andre; Gheusi, Gilles; de Chaumont, Fabrice; Olivo-Marin, Jean-Christophe; Lamarque, Stephanie; Abrous, Djoher Nora; Boussin, Francois D.; Lledo, Pierre-Marie			Cellular and Behavioral Effects of Cranial Irradiation of the Subventricular Zone in Adult Mice	PLOS ONE			English	Article								Background: In mammals, new neurons are added to the olfactory bulb (OB) throughout life. Most of these new neurons, granule and periglomerular cells originate from the subventricular zone (SVZ) lining the lateral ventricles and migrate via the rostral migratory stream toward the OB. Thousands of new neurons appear each day, but the function of this ongoing neurogenesis remains unclear. Methodology/Principal Findings: In this study, we irradiated adult mice to impair constitutive OB neurogenesis, and explored the functional impacts of this irradiation on the sense of smell. We found that focal irradiation of the SVZ greatly decreased the rate of production of new OB neurons, leaving other brain areas intact. This effect persisted for up to seven months after exposure to 15 Gray. Despite this robust impairment, the thresholds for detecting pure odorant molecules and short-term olfactory memory were not affected by irradiation. Similarly, the ability to distinguish between odorant molecules and the odorant-guided social behavior of irradiated mice were not affected by the decrease in the number of new neurons. Only long-term olfactory memory was found to be sensitive to SVZ irradiation. Conclusion/Significance: These findings suggest that the continuous production of adult-generated neurons is involved in consolidating or restituting long-lasting olfactory traces.			Lazarini, F (corresponding author), Inst Pasteur, Lab Percept & Memory, Paris, France.	pmlledo@pasteur.fr	Olivo-Marin, Jean-Christophe/K-4428-2015; Abrous, Nora-Djoher/N-6977-2017	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; de Chaumont, Fabrice/0000-0001-7613-7204; abrous, nora/0000-0002-8589-305X; Mouthon, Marc-Andre/0000-0003-2633-9179; Boussin, francois/0000-0003-3778-4403; Lazarini, Francoise/0000-0001-5572-6982				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chaillan FA, 1997, EUR J NEUROSCI, V9, P884, DOI 10.1111/j.1460-9568.1997.tb01439.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Granger R, 1991, Curr Opin Neurobiol, V1, P209, DOI 10.1016/0959-4388(91)90080-Q; Grubb MS, 2008, J NEUROSCI, V28, P2919, DOI 10.1523/JNEUROSCI.5550-07.2008; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Iwata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002283; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Linster C, 2002, J NEUROSCI, V22, P6842; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Mizrahi A, 2007, NAT NEUROSCI, V10, P444, DOI 10.1038/nn1875; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; NISSANT A, 2009, NAT NEUROSCI; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Petreanu L, 2002, J NEUROSCI, V22, P6106; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Scotto-Lomassese S, 2003, J NEUROSCI, V23, P9289; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Teuchert-Noodt G., 2000, Journal of Neural Transmission Supplement, V60, P315; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	145	149	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7017	10.1371/journal.pone.0007017	http://dx.doi.org/10.1371/journal.pone.0007017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753118	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796500008
J	Tidhar, A; Flashner, Y; Cohen, S; Levi, Y; Zauberman, A; Gur, D; Aftalion, M; Elhanany, E; Zvi, A; Shafferman, A; Mamroud, E				Tidhar, Avital; Flashner, Yehuda; Cohen, Sara; Levi, Yinon; Zauberman, Ayelet; Gur, David; Aftalion, Moshe; Elhanany, Eytan; Zvi, Anat; Shafferman, Avigdor; Mamroud, Emanuelle			The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague	PLOS ONE			English	Article							STATIONARY-PHASE SURVIVAL; ESCHERICHIA-COLI CHROMOSOME; REPAIR METHYLTRANSFERASE; SIGMA(S) SUBUNIT; RNA-POLYMERASE; PROTECTS MICE; 59 MINUTES; RPOS; GENE; IDENTIFICATION	Yersinia pestis is the causative agent of plague. Previously we have isolated an attenuated Y. pestis transposon insertion mutant in which the pcm gene was disrupted. In the present study, we investigated the expression and the role of pcm locus genes in Y. pestis pathogenesis using a set of isogenic surE, pcm, nlpD and rpoS mutants of the fully virulent Kimberley53 strain. We show that in Y. pestis, nlpD expression is controlled from elements residing within the upstream genes surE and pcm. The NlpD lipoprotein is the only factor encoded from the pcm locus that is essential for Y. pestis virulence. A chromosomal deletion of the nlpD gene sequence resulted in a drastic reduction in virulence to an LD50 of at least 10(7) cfu for subcutaneous and airway routes of infection. The mutant was unable to colonize mouse organs following infection. The filamented morphology of the nlpD mutant indicates that NlpD is involved in cell separation; however, deletion of nlpD did not affect in vitro growth rate. Trans-complementation experiments with the Y. pestis nlpD gene restored virulence and all other phenotypic defects. Finally, we demonstrated that subcutaneous administration of the nlpD mutant could protect animals against bubonic and primary pneumonic plague. Taken together, these results demonstrate that Y. pestis NlpD is a novel virulence factor essential for the development of bubonic and pneumonic plague. Further, the nlpD mutant is superior to the EV76 prototype live vaccine strain in immunogenicity and in conferring effective protective immunity. Thus it could serve as a basis for a very potent live vaccine against bubonic and pneumonic plague.			Tidhar, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	emmym@iibr.gov.il						BADGER JL, 1995, J BACTERIOL, V177, P5370, DOI 10.1128/jb.177.18.5370-5373.1995; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; BENGURION R, 1981, PLASMID, V5, P183, DOI 10.1016/0147-619X(81)90019-6; Ber R, 2003, APPL ENVIRON MICROB, V69, P5787, DOI 10.1128/AEM.69.10.5787-5792.2003; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bleves S, 2000, MICROBES INFECT, V2, P1451, DOI 10.1016/S1286-4579(00)01300-9; BRUBAKER R R, 1970, Infection and Immunity, V1, P446; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cunning C, 1998, J BACTERIOL, V180, P4564, DOI 10.1128/JB.180.17.4564-4570.1998; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; Flashner Y, 2004, INFECT IMMUN, V72, P908, DOI 10.1128/IAI.72.2.908-915.2004; Forman S, 2008, INFECT IMMUN, V76, P578, DOI 10.1128/IAI.00219-07; FU JC, 1991, J BIOL CHEM, V266, P14562; Grosfeld H, 2003, ADV EXP MED BIOL, V529, P423; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Hirsch M, 2005, J BACTERIOL, V187, P7204, DOI 10.1128/JB.187.21.7204-7213.2005; Hirsch M, 2005, J BACTERIOL, V187, P1568, DOI 10.1128/JB.187.5.1568-1580.2005; Hirsch M, 2002, J BACTERIOL, V184, P5077, DOI 10.1128/JB.184.18.5077-5087.2002; HOLZMAN T, 2006, MICROB CELL FACT, V5, P98; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; ICHIKAWA JK, 1994, J BACTERIOL, V176, P1630, DOI 10.1128/jb.176.6.1630-1638.1994; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; IRIARTE M, 1995, INFECT IMMUN, V63, P1840, DOI 10.1128/IAI.63.5.1840-1847.1995; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Lai XH, 2006, FEMS MICROBIOL LETT, V258, P78, DOI 10.1111/j.1574-6968.2006.00197.x; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; LANGE R, 1994, MOL MICROBIOL, V13, P733, DOI 10.1111/j.1365-2958.1994.tb00466.x; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; LEARY SEC, 1995, INFECT IMMUN, V63, P2854, DOI 10.1128/IAI.63.8.2854-2858.1995; LI C, 1994, J BACTERIOL, V176, P6015, DOI 10.1128/jb.176.19.6015-6022.1994; Li C, 1997, MICROBIOL-UK, V143, P3513, DOI 10.1099/00221287-143-11-3513; Lloyd AL, 2005, J MICROBIOL METH, V60, P291, DOI 10.1016/j.mimet.2004.10.009; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Munier-Lehmann H, 2003, BIOCHEM J, V373, P515, DOI 10.1042/BJ20030284; Navarro-Llorens JM, 2002, ARCH MICROBIOL, V179, P33, DOI 10.1007/s00203-002-0493-4; Paesold G, 1999, J BACTERIOL, V181, P1264, DOI 10.1128/JB.181.4.1264-1268.1999; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Pilgrim S, 2003, INFECT IMMUN, V71, P3473, DOI 10.1128/IAI.71.6.3473-3484.2003; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Sha J, 2008, INFECT IMMUN, V76, P1390, DOI 10.1128/IAI.01529-07; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Visick JE, 1998, FEMS MICROBIOL LETT, V167, P19, DOI 10.1111/j.1574-6968.1998.tb13202.x; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2007, ADV EXP MED BIOL, V603, P312; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	66	66	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7023	10.1371/journal.pone.0007023	http://dx.doi.org/10.1371/journal.pone.0007023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759820	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796300018
J	Davidson, CD; Ali, NF; Micsenyi, MC; Stephney, G; Renault, S; Dobrenis, K; Ory, DS; Vanier, MT; Walkley, SU				Davidson, Cristin D.; Ali, Nafeeza F.; Micsenyi, Matthew C.; Stephney, Gloria; Renault, Sophie; Dobrenis, Kostantin; Ory, Daniel S.; Vanier, Marie T.; Walkley, Steven U.			Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression	PLOS ONE			English	Article							PHARMACEUTICAL APPLICATIONS; LYSOSOMAL CHOLESTEROL; MOUSE MODELS; LIFE-SPAN; NPC1; ACCUMULATION; PROTEIN; BINDING; BRAIN; GANGLIOSIDES	Background: Niemann-Pick type C (NPC) disease is a fatal neurodegenerative disorder caused most commonly by a defect in the NPC1 protein and characterized by widespread intracellular accumulation of unesterified cholesterol and glycosphingolipids (GSLs). While current treatment therapies are limited, a few drugs tested in Npc1(-/-) mice have shown partial benefit. During a combination treatment trial using two such compounds, N-butyldeoxynojirimycin (NB-DNJ) and allopregnanolone, we noted increased lifespan for Npc1(-/-) mice receiving only 2-hydroxypropyl-beta-cyclodextrin (CD), the vehicle for allopregnanolone. This finding suggested that administration of CD alone, but with greater frequency, might provide additional benefit. Methodology/Principal Findings: Administration of CD to Npc1(-/-) mice beginning at either P7 or P21 and continuing every other day delayed clinical onset, reduced intraneuronal cholesterol and GSL storage as well as free sphingosine accumulation, reduced markers of neurodegeneration, and led to longer survival than any previous treatment regime. We reasoned that other lysosomal diseases characterized by cholesterol and GSL accumulation, including NPC disease due to NPC2 deficiency, GM1 gangliosidosis and mucopolysaccharidosis (MPS) type IIIA, might likewise benefit from CD treatment. Treated Npc2(-/-) mice showed benefits similar to NPC1 disease, however, mice with GM1 gangliosidosis or MPS IIIA failed to show reduction in storage. Conclusions/Significance: Treatment with CD delayed clinical disease onset, reduced intraneuronal storage and secondary markers of neurodegeneration, and significantly increased lifespan of both Npc1(-/-) and Npc2(-/-) mice. In contrast, CD failed to ameliorate cholesterol or glycosphingolipid storage in GM1 gangliosidosis and MPS IIIA disease. Understanding the mechanism(s) by which CD leads to reduced neuronal storage may provide important new opportunities for treatment of NPC and related neurodegenerative diseases characterized by cholesterol dyshomeostasis.			Davidson, CD (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Rose F Kennedy Ctr Res Mental Retardat & Human De, Bronx, NY 10467 USA.	walkley@aecom.yu.edu	Davidson, Cristin/F-4889-2017; Davidson, Cristin/AAA-2733-2020	Davidson, Cristin/0000-0002-5508-8113; Davidson, Cristin/0000-0002-5508-8113	NICHD NIH HHS [HD045561, R01 HD045561] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045561] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; Benarroch EE, 2008, NEUROLOGY, V71, P1368, DOI 10.1212/01.wnl.0000333215.93440.36; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; GOLDIN E, 1992, BIOCHIM BIOPHYS ACTA, V1127, P303, DOI 10.1016/0005-2760(92)90236-O; Gondre-Lewis MC, 2003, CURR BIOL, V13, P1324, DOI 10.1016/S0960-9822(03)00531-1; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Irie T, 1997, J PHARM SCI-US, V86, P147, DOI 10.1021/js960213f; Jeulin H, 2009, ANTIVIR RES, V81, P261, DOI 10.1016/j.antiviral.2008.12.006; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Lachmann RH, 2001, EXPERT OPIN INV DRUG, V10, P455, DOI 10.1517/13543784.10.3.455; Lange Y, 2002, J LIPID RES, V43, P198; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Liu YJ, 2000, HUM MOL GENET, V9, P1087, DOI 10.1093/hmg/9.7.1087; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Micsenyi MC, 2009, J NEUROPATH EXP NEUR, V68, P125, DOI 10.1097/NEN.0b013e3181942cf0; Monnaert V, 2004, J PHARMACOL EXP THER, V310, P745, DOI 10.1124/jpet.104.067512; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Patterson M. C., 2001, METABOLIC MOL BASES, VIII, P3611; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; RODRIGUEZLAFRASSE C, 1994, BBA-MOL BASIS DIS, V1226, P138, DOI 10.1016/0925-4439(94)90021-3; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Walkley SU, 2007, ACTA PAEDIATR, V96, P26, DOI 10.1111/j.1651-2227.2007.00202.x; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	49	314	327	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6951	10.1371/journal.pone.0006951	http://dx.doi.org/10.1371/journal.pone.0006951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750228	Green Published, Green Submitted, gold			2022-12-25	WOS:000269696600006
J	Quack, T; Knobloch, J; Beckmann, S; Vicogne, J; Dissous, C; Grevelding, CG				Quack, Thomas; Knobloch, Juergen; Beckmann, Svenja; Vicogne, Jerome; Dissous, Colette; Grevelding, Christoph G.			The Formin-Homology Protein SmDia Interacts with the Src Kinase SmTK and the GTPase SmRho1 in the Gonads of Schistosoma mansoni	PLOS ONE			English	Article							DIAPHANOUS-RELATED FORMIN; MALE-FEMALE INTERACTION; TYROSINE KINASE; CELL MORPHOGENESIS; RHO-GTPASES; SH3 DOMAIN; FAMILY; DYNAMICS; PROLINE; SWI/SNF	Background: Schistosomiasis (bilharzia) is a parasitic disease of worldwide significance affecting human and animals. As schistosome eggs are responsible for pathogenesis, the understanding of processes controlling gonad development might open new perspectives for intervention. The Src-like tyrosine-kinase SmTK3 of Schistosoma mansoni is expressed in the gonads, and its pharmacological inhibition reduces mitogenic activity and egg production in paired females in vitro. Since Src kinases are important signal transduction proteins it is of interest to unravel the signaling cascades SmTK3 is involved in to understand its cellular role in the gonads. Methodology and Results: Towards this end we established and screened a yeast two-hybrid (Y2H) cDNA library of adult S. mansoni with a bait construct encoding the SH3 (src homology) domain and unique site of SmTK3. Among the binding partners found was a diaphanous homolog (SmDia), which was characterized further. SmDia is a single-copy gene transcribed throughout development with a bias towards male transcription. Its deduced amino acid sequence reveals all diaphanous-characteristic functional domains. Binding studies with truncated SmDia clones identified SmTK3 interaction sites demonstrating that maximal binding efficiency depends on the N-terminal part of the FH1 (formin homology) domain and the inter-domain region of SmDia located upstream of FH1 in combination with the unique site and the SH3 domain of SmTK3, respectively. SmDia also directly interacted with the GTPase SmRho1 of S. mansoni. In situ hybridization experiments finally demonstrated that SmDia, SmRho1, and SmTK3 are transcribed in the gonads of both genders. Conclusion: These data provide first evidence for the existence of two cooperating pathways involving Rho and Src that bridge at SmDia probably organizing cytoskeletal events in the reproductive organs of a parasite, and beyond that in gonads of eukaryotes. Furthermore, the FH1 and inter domain region of SmDia have been discovered as binding sites for the SH3 and unique site domains of SmTK3, respectively.			Quack, T (corresponding author), Univ Giessen, Inst Parasitol, Giessen, Germany.	Christoph.Grevelding@vetmed.uni-giessen.de		Vicogne, Jerome/0000-0001-8360-7497; Knobloch, Jurgen/0000-0001-6868-0055; Dissous, Colette/0000-0002-5003-8205				Aspenstrom P, 2005, FEBS LETT, V579, P5253, DOI 10.1016/j.febslet.2005.08.053; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Bahia D, 2006, MEM I OSWALDO CRUZ, V101, P137, DOI 10.1590/S0074-02762006000900022; BELSCHES AP, 1997, FRONT BIOSCI, V2, P501; Botros S, 2005, INT J PARASITOL, V35, P787, DOI 10.1016/j.ijpara.2005.02.005; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Dissous C, 2007, BIOESSAYS, V29, P1281, DOI 10.1002/bies.20662; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; El-Sayed NMA, 2004, TRENDS PARASITOL, V20, P154, DOI 10.1016/j.pt.2004.02.002; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; FINKEN M, 1994, MOL BIOCHEM PARASIT, V64, P135, DOI 10.1016/0166-6851(94)90141-4; FOSTER AC, 1985, J NEUROCHEM, V45, P199, DOI 10.1111/j.1471-4159.1985.tb05493.x; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Grevelding CG, 2004, CURR BIOL, V14, pR545, DOI 10.1016/j.cub.2004.07.006; GREVELDING CG, 1995, MOL BIOCHEM PARASIT, V71, P269, DOI 10.1016/0166-6851(94)00058-U; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Haas BJ, 2007, EXP PARASITOL, V117, P225, DOI 10.1016/j.exppara.2007.06.005; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoffmann KF, 2004, PARASITOLOGY, V128, pS11, DOI 10.1017/S0031182004006213; JEFFREY R, 2004, PNAS, V101, P6237; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Kapp K, 2004, MOL BIOCHEM PARASIT, V138, P171, DOI 10.1016/j.molbiopara.2004.07.010; Kapp K, 2001, PARASITOLOGY, V122, P317, DOI 10.1017/S0031182001007430; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Knobloch J, 2006, INT J PARASITOL, V36, P1261, DOI 10.1016/j.ijpara.2006.06.004; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Krebs A, 2001, J CELL SCI, V114, P3663; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002; LoVerde PT, 2004, CAN J ZOOL, V82, P357, DOI 10.1139/Z03-217; Ludolf F, 2007, BIOCHEM BIOPH RES CO, V360, P163, DOI 10.1016/j.bbrc.2007.06.018; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Ou Y, 2004, INT REV CYTOL, V238, P119, DOI 10.1016/S0074-7696(04)38003-4; Quack T, 2006, BERL MUNCH TIERARZTL, V119, P365; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Santos TM, 2002, MOL BIOCHEM PARASIT, V125, P103, DOI 10.1016/S0166-6851(02)00218-9; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Vermeire JJ, 2003, INT J PARASITOL, V33, P721, DOI 10.1016/S0020-7519(03)00046-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Weiler MC, 1996, J MOL NEUROSCI, V7, P203, DOI 10.1007/BF02736841; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017	62	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6998	10.1371/journal.pone.0006998	http://dx.doi.org/10.1371/journal.pone.0006998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746159	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696500009
J	Bowerman, NA; Colf, LA; Garcia, KC; Kranz, DM				Bowerman, Natalie A.; Colf, Leremy A.; Garcia, K. Christopher; Kranz, David M.			Different Strategies Adopted by K-b and L-d to Generate T Cell Specificity Directed against Their Respective Bound Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; HIGH-AFFINITY; RECEPTOR RECOGNITION; ANTIGEN RECOGNITION; BINDING GROOVE; MHC COMPLEXES; CRYSTAL-STRUCTURE; SELF-PEPTIDES; REACTIVE CTL	Mouse T cell clone 2C recognizes two different major histocompatibility (MHC) ligands, the self MHC K-b and the allogeneic MHC L-d. Two distinct peptides, SIY (SIYRYYGL) and QL9 (QLSPFPFDL), act as strong and specific agonists when bound to K-b and L-d, respectively. To explore further the mechanisms involved in peptide potency and specificity, here we examined a collection of single amino acid peptide variants of SIY and QL9 for 1) T cell activity, 2) binding to their respective MHC, and 3) binding to the 2C T cell receptor (TCR) and high affinity TCR mutants. Characterization of SIY binding to MHC K-b revealed significant effects of three SIY residues that were clearly embedded within the K-b molecule. In contrast, QL9 binding to MHCLd was influenced by the majority of peptide side chains, distributed across the entire length of the peptide. Binding of the SIY-K-b complex to the TCR involved three SIY residues that were pointed toward the TCR, whereas again the majority of QL9 residues influenced binding of TCRs, and thus the QL9 residues had impacts on both L-d and TCR binding. In general, the magnitude of T cell activity mediated by a peptide variant was influenced more by peptide binding to MHC than by binding the TCR, especially for higher affinity TCRs. Findings with both systems, but QL9-L-d in particular, suggest that many single-residue substitutions, introduced into peptides to improve their binding to MHC and thus their vaccine potential, could impair T cell reactivity due to their dual impact on TCR binding.	[Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Colf, Leremy A.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Colf, Leremy A.; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	d-kranz@uiuc.edu			National Institutes of Health [GM55767, AI048540]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048540, R01AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55767 (to D. M. K.) and AI048540 (to K. C. G.). This work was also supported by a National Science Foundation predoctoral fellowship (to L. A. C.).	Allen P M, 1989, Int Immunol, V1, P141, DOI 10.1093/intimm/1.2.141; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; Bergmann CC, 1996, J VIROL, V70, P3252, DOI 10.1128/JVI.70.5.3252-3257.1996; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BLUESTONE JA, 1993, J IMMUNOL, V151, P3943; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Bowerman NA, 2009, MOL IMMUNOL, V46, P3000, DOI 10.1016/j.molimm.2009.06.012; Brock R, 1996, P NATL ACAD SCI USA, V93, P13108, DOI 10.1073/pnas.93.23.13108; Brophy SE, 2007, MOL IMMUNOL, V44, P2184, DOI 10.1016/j.molimm.2006.11.016; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gillanders WE, 1997, INT IMMUNOL, V9, P81, DOI 10.1093/intimm/9.1.81; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Hornell TMC, 2001, J IMMUNOL, V167, P4207, DOI 10.4049/jimmunol.167.8.4207; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Iero M, 2009, CANCER IMMUNOL IMMUN, V58, P1159, DOI 10.1007/s00262-008-0610-6; Johansen TE, 1997, SCAND J IMMUNOL, V46, P137, DOI 10.1046/j.1365-3083.1997.d01-102.x; Jones LL, 2008, J IMMUNOL, V181, P6255, DOI 10.4049/jimmunol.181.9.6255; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Robinson RA, 1996, J IMMUNOL, V156, P4266; ROHREN EM, 1994, J IMMUNOL, V152, P5337; SAITO Y, 1993, J BIOL CHEM, V268, P21309; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SOLHEIM JC, 1993, J IMMUNOL, V151, P5387; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; Udaka K, 1996, J IMMUNOL, V157, P670; Valmori D, 1998, J IMMUNOL, V160, P1750; VANBLEEK GM, 1991, P NATL ACAD SCI USA, V88, P11032, DOI 10.1073/pnas.88.24.11032; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	56	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32551	32561		10.1074/jbc.M109.040501	http://dx.doi.org/10.1074/jbc.M109.040501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19755422	Green Published, hybrid			2022-12-25	WOS:000272028400037
J	Niki, T; Tsutsui, S; Hirose, S; Aradono, S; Sugimoto, Y; Takeshita, K; Nishi, N; Hirashima, M				Niki, Toshiro; Tsutsui, Shoko; Hirose, Shigeru; Aradono, Sachiko; Sugimoto, Yasushi; Takeshita, Keisuke; Nishi, Nozomu; Hirashima, Mitsuomi			Galectin-9 Is a High Affinity IgE-binding Lectin with Anti-allergic Effect by Blocking IgE-Antigen Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELLS; TIM-3 LIGAND; PROTEIN; IDENTIFICATION; SUPPRESSES; RECEPTOR; EXPRESSION; ECALECTIN; INDUCTION	Galectin (Gal)-9 was first described as an eosinophil chemoattractant. With the progress in research, Gal-9 has come to be known as a versatile immunomodulator that is involved in various aspects of immune regulations, and the entire picture of the function still remains elusive. To uncover as-yet unknown activity of Gal-9, we have been examining the effect of the protein in various disease animal models. Here we show that Gal-9 attenuated asthmatic reaction in guinea pigs and suppressed passive-cutaneous anaphylaxis in mice. These results indicate the mast cell stabilizing effect of Gal-9. In vitro studies of mast cell degranulation involving RBL-2H3 cells demonstrated that Gal-9 suppressed degranulation from the cells stimulated by IgE plus antigen and that the inhibitory effect was completely abrogated in the presence of lactose, indicating lectin activity of Gal-9 is critical. We found that Gal-9 strongly and specifically bound IgE, which is a heavily glycosylated immunoglobulin, and that the interaction prevented IgE-antigen complex formation, clarifying the mode of action of the anti-degranulation effect. Gal-9 is expressed by several mast cells including mouse mast cell line MC/9. The fact that immunological stimuli of MC/9 cells augmented Gal-9 secretion from the cells implies that Gal-9 is an autocrine regulator of mast cell function to suppress excessive degranulation. Collectively, these findings shed light on a novel function of Gal-9 in mast cells and suggest a beneficial utility of Gal-9 for the treatment of allergic disorders including asthma.	[Niki, Toshiro; Tsutsui, Shoko; Hirose, Shigeru; Aradono, Sachiko; Sugimoto, Yasushi; Takeshita, Keisuke; Hirashima, Mitsuomi] GalPharma Co Ltd, Div Res, FROM Kagawa, Kagawa 7610301, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol, Miki, Kagawa 7610793, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunopathol, Miki, Kagawa 7610793, Japan	Kagawa University; Kagawa University	Niki, T (corresponding author), GalPharma Co Ltd, Div Res, FROM Kagawa, 2217-16 Hayashi Cho, Kagawa 7610301, Japan.	niki.t@galpharma.com		Nishi, Nozomu/0000-0001-7050-3226				ANDERSEN BR, 1966, J IMMUNOL, V97, P913; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Boushey HA, 2001, J ALLERGY CLIN IMMUN, V108, pS77, DOI 10.1067/mai.2001.116434; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; de Mora F, 2006, BRIT J DERMATOL, V155, P1109, DOI 10.1111/j.1365-2133.2006.07494.x; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gregory Gregory D, 2006, Methods Mol Biol, V315, P35; Hirashima M, 1999, INT ARCH ALLERGY IMM, V120, P7, DOI 10.1159/000053584; HSU DK, 1992, J BIOL CHEM, V267, P14167; KANNER BI, 1983, P NATL ACAD SCI-BIOL, V80, P5744, DOI 10.1073/pnas.80.18.5744; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; MAZUREK N, 1983, NATURE, V303, P528, DOI 10.1038/303528a0; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Niwa H, 2009, CLIN IMMUNOL, V132, P184, DOI 10.1016/j.clim.2009.04.012; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Pivniouk VI, 2003, INT IMMUNOL, V15, P1431, DOI 10.1093/intimm/dxg148; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Sato M, 2002, J BIOCHEM, V131, P255, DOI 10.1093/oxfordjournals.jbchem.a003096; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; ZUBERI RI, 1994, CELL IMMUNOL, V156, P1, DOI 10.1006/cimm.1994.1148	41	115	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32344	32352		10.1074/jbc.M109.035196	http://dx.doi.org/10.1074/jbc.M109.035196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776007	Green Published, hybrid			2022-12-25	WOS:000272028400017
J	Tang, CR; Liu, YH; Kessler, PS; Vaughan, AM; Oram, JF				Tang, Chongren; Liu, Yuhua; Kessler, Peter S.; Vaughan, Ashley M.; Oram, John F.			The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE; ABCA1-DEFICIENT MACROPHAGES; APOLIPOPROTEIN INTERACTIONS; ATHEROSCLEROTIC LESIONS; CELLULAR CHOLESTEROL; GENE-EXPRESSION; STAT3; MICE; EFFLUX; INTERLEUKIN-10	ATP-binding cassette transporter A1 (ABCA1) is a cell membrane protein that exports excess cholesterol from cells to apolipoprotein (apo) A-I, the major protein in high density lipoproteins. Genetic studies have shown that ABCA1 protects against cardiovascular disease. The interaction of apoA-I with ABCA1 promotes cholesterol removal and activates signaling molecules, such as Janus kinase 2 (JAK2), that optimize the lipid export activity of ABCA1. Here we show that the ABCA1-mediated activation of JAK2 also activates STAT3, which is independent of the lipid transport function of ABCA1. ABCA1 contains two candidate STAT3 docking sites that are required for the apoA-I/ABCA1/JAK2 activation of STAT3. The interaction of apoA-I with ABCA1-expressing macrophages suppressed the ability of lysopolysaccaride to induce the inflammatory cytokines interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha, which was reversed by silencing STAT3 or ABCA1. Thus, the apoA-I/ABCA1 pathway in macrophages functions as an anti-inflammatory receptor through activation of JAK2/STAT3. These findings implicate ABCA1 as a direct molecular link between the cardioprotective effects of cholesterol export from arterial macrophages and suppressed inflammation.	[Tang, Chongren; Liu, Yuhua; Kessler, Peter S.; Vaughan, Ashley M.; Oram, John F.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Oram, JF (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA.	joram@u.washington.edu			National Institutes of Health [RO1 HL055362, HL085437, PO1 HL092969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055362, R01HL085437, P01HL092969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL055362, HL085437, and PO1 HL092969.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Cho HJ, 2007, PHYSIOL GENOMICS, V29, P149, DOI 10.1152/physiolgenomics.00051.2006; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Matsukawa A, 2003, J IMMUNOL, V171, P6198, DOI 10.4049/jimmunol.171.11.6198; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Passarelli M, 2005, DIABETES, V54, P2198, DOI 10.2337/diabetes.54.7.2198; Potteaux S, 2004, ARTERIOSCL THROM VAS, V24, P1474, DOI 10.1161/01.ATV.0000134378.86443.cd; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Singaraja RR, 2006, CIRC RES, V99, P389, DOI 10.1161/01.RES.0000237920.70451.ad; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tang CR, 2006, J LIPID RES, V47, P107, DOI 10.1194/jlr.M500240-JLR200; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Tellier E, 2008, J CELL PHYSIOL, V214, P687, DOI 10.1002/jcp.21265; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2009, J LIPID RES, V50, P285, DOI 10.1194/jlr.M800366-JLR200; Wang Y, 2004, J LIPID RES, V45, P972, DOI 10.1194/jlr.M400011-JLR200; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	41	195	210	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32336	32343		10.1074/jbc.M109.047472	http://dx.doi.org/10.1074/jbc.M109.047472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783654	Green Published, hybrid			2022-12-25	WOS:000272028400016
J	Ruiz, CA; Rotundo, RL				Ruiz, Carlos A.; Rotundo, Richard L.			Limiting Role of Protein Disulfide Isomerase in the Expression of Collagen-tailed Acetylcholinesterase Forms in Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; MOLECULAR-FORMS; MESSENGER-RNA; FIBRILLAR COLLAGENS; THIOREDOXIN FAMILY; SURFACE EXPRESSION; NEURAL REGULATION; BINDING PROTEIN; GOLGI-APPARATUS	The expression of acetylcholinesterase (AChE) in skeletal muscle is regulated by muscle activity; however, the underlying molecular mechanisms are incompletely understood. We show here that the expression of the synaptic collagen-tailed AChE form (ColQ-AChE) in quail muscle cultures can be regulated by muscle activity post-translationally. Inhibition of thiol oxidoreductase activity decreases expression of all active AChE forms. Likewise, primary quail myotubes transfected with protein disulfide isomerase (PDI) short hairpin RNAs showed a significant decrease of both the intracellular pool of all collagen-tailed AChE forms and cell surface AChE clusters. Conversely, overexpression of PDI, endoplasmic reticulum protein 72, or calnexin in muscle cells enhanced expression of all collagen-tailed AChE forms. Overexpression of PDI had the most dramatic effect with a 100% increase in the intracellular ColQ-AChE pool and cell surface enzyme activity. Moreover, the levels of PDI are regulated by muscle activity and correlate with the levels of ColQ-AChE and AChE tetramers. Finally, we demonstrate that PDI interacts directly with AChE intracellularly. These results show that collagen-tailed AChE form levels induced by muscle activity can be regulated by molecular chaperones and suggest that newly synthesized exportable proteins may compete for chaperone assistance during the folding process.	Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA	University of Miami; University of Miami	Rotundo, RL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol & Anat R 124, 1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu			National Institutes of Health [AG005917, NS057994]; Ruth Kirschstein National Research Service Award;  [ARO 49497-LS-HIS]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG005917 and NS057994 ( to R. L. R.).; 1 Supported by Training Grant ARO 49497-LS-HIS ( to R. L. R.) and a Ruth Kirschstein National Research Service Award for individual predoctoral fellows.	Ahtikoski AM, 2001, ACTA PHYSIOL SCAND, V172, P131, DOI 10.1046/j.1365-201X.2001.00848.x; ANGLISTER L, 1978, J MOL BIOL, V125, P293, DOI 10.1016/0022-2836(78)90404-7; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; BROCKMAN SK, 1984, J NEUROSCI, V4, P131; Chang W, 1997, J BIOL CHEM, V272, P28925, DOI 10.1074/jbc.272.46.28925; CLIVE DR, 1994, EXP CELL RES, V214, P139, DOI 10.1006/excr.1994.1242; CRESNAR B, 1994, J NEUROSCI RES, V38, P294, DOI 10.1002/jnr.490380307; DELAPORTE S, 1984, DEV BIOL, V106, P450, DOI 10.1016/0012-1606(84)90244-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FAMBROUGH DM, 1982, P NATL ACAD SCI-BIOL, V79, P1078, DOI 10.1073/pnas.79.4.1078; FERNANDEZVALLE C, 1989, J BIOL CHEM, V264, P14043; FULLEKRUG J, 1994, J CELL SCI, V107, P2719; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; Han XY, 1999, J APPL PHYSIOL, V87, P90, DOI 10.1152/jappl.1999.87.1.90; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hubatsch DA, 1997, AM J PHYSIOL-CELL PH, V273, pC2002, DOI 10.1152/ajpcell.1997.273.6.C2002; Keller SH, 1996, J BIOL CHEM, V271, P22871, DOI 10.1074/jbc.271.37.22871; Keller SH, 1998, J BIOL CHEM, V273, P17064, DOI 10.1074/jbc.273.27.17064; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; KOENIG J, 1978, NATURE, V271, P75, DOI 10.1038/271075a0; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; OSBORNE CK, 1978, CANCER RES, V38, P94; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; REEDER RH, 1972, J MOL BIOL, V67, P433, DOI 10.1016/0022-2836(72)90461-5; RIEGER F, 1984, DEV BIOL, V101, P181, DOI 10.1016/0012-1606(84)90128-3; RIEGER F, 1980, DEV BIOL, V76, P358, DOI 10.1016/0012-1606(80)90385-1; Rimer M, 1999, BIOCHEM BIOPH RES CO, V260, P251, DOI 10.1006/bbrc.1999.0893; ROSENBERRY TL, 1977, BIOCHEMISTRY-US, V16, P3550, DOI 10.1021/bi00635a008; Rossi S. G., 1998, Journal of Physiology Paris, V92, P486, DOI 10.1016/S0928-4257(99)80102-8; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1980, CELL, V22, P583, DOI 10.1016/0092-8674(80)90368-2; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; Ruiz CA, 2009, J BIOL CHEM, V284, P21488, DOI 10.1074/jbc.M109.030049; RUPP K, 1994, J BIOL CHEM, V269, P2501; Satoh M, 2005, CELL STRESS CHAPERON, V10, P211, DOI 10.1379/CSC-109R.1; Simon S, 1998, EMBO J, V17, P6178, DOI 10.1093/emboj/17.21.6178; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; VALLETTE FM, 1990, J NEUROCHEM, V54, P915, DOI 10.1111/j.1471-4159.1990.tb02338.x; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; VIGNY M, 1976, FEBS LETT, V69, P277, DOI 10.1016/0014-5793(76)80703-X; VIGNY M, 1976, J NEUROCHEM, V27, P1347, DOI 10.1111/j.1471-4159.1976.tb02614.x; WADA I, 1991, J BIOL CHEM, V266, P19599; WEINBERG CB, 1979, DEV BIOL, V68, P631, DOI 10.1016/0012-1606(79)90233-1; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P1790, DOI 10.1073/pnas.71.5.1790; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P3426, DOI 10.1073/pnas.71.9.3426; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Ye JM, 1996, BIOCHEM BIOPH RES CO, V223, P153, DOI 10.1006/bbrc.1996.0861; ZYLBER EA, 1971, P NATL ACAD SCI USA, V68, P2861, DOI 10.1073/pnas.68.11.2861	60	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31753	31763		10.1074/jbc.M109.038471	http://dx.doi.org/10.1074/jbc.M109.038471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758986	hybrid, Green Published			2022-12-25	WOS:000271572700030
J	Thompson, JA; Paschall, CO; O'Donnell, M; Bloom, LB				Thompson, Jennifer A.; Paschall, Christopher O.; O'Donnell, Mike; Bloom, Linda B.			A Slow ATP-induced Conformational Change Limits the Rate of DNA Binding but Not the Rate of beta Clamp Binding by the Escherichia coli gamma Complex Clamp Loader	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III HOLOENZYME; REPLICATION-FACTOR-C; CELL NUCLEAR ANTIGEN; SLIDING CLAMP; STRUCTURAL-ANALYSIS; LOADING MACHINE; DELTA-SUBUNIT; MECHANISM; DYNAMICS; PURIFICATION	In Escherichia coli, the gamma complex clamp loader loads the beta-sliding clamp onto DNA. The beta clamp tethers DNA polymerase III to DNA and enhances the efficiency of replication by increasing the processivity of DNA synthesis. In the presence of ATP, gamma complex binds beta and DNA to form a ternary complex. Binding to primed template DNA triggers gamma complex to hydrolyze ATP and release the clamp onto DNA. Here, we investigated the kinetics of forming a ternary complex by measuring rates of gamma complex binding beta and DNA. A fluorescence intensity-based beta binding assay was developed in which the fluorescence of pyrene covalently attached to beta increases when bound by gamma complex. Using this assay, an association rate constant of 2.3 x 10(7) M-1 s(-1) for gamma complex binding beta was determined. The rate of beta binding was the same in experiments in which gamma complex was preincubated with ATP before adding beta or added directly to beta and ATP. In contrast, when gamma complex is preincubated with ATP, DNA binding is faster than when gamma complex is added to DNA and ATP at the same time. Slow DNA binding in the absence of ATP preincubation is the result of a rate-limiting ATP-induced conformational change. Our results strongly suggest that the ATP-induced conformational changes that promote beta binding and DNA binding differ. The slow ATP-induced conformational change that precedes DNA binding may provide a kinetic preference for gamma complex to bind beta before DNA during the clamp loading reaction cycle.	[Thompson, Jennifer A.; Paschall, Christopher O.; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA; [O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA	State University System of Florida; University of Florida; Rockefeller University; Howard Hughes Medical Institute	Bloom, LB (corresponding author), 1600 SW Archer Rd,JHMHC,Rm R3-234, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [R01 GM055596, R01 GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM055596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM055596 (to L. B. B.) and R01 GM38839 (to M.O.D.).	Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BURGERS PMJ, 1981, P NATL ACAD SCI-BIOL, V78, P5391, DOI 10.1073/pnas.78.9.5391; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; GRIEP MA, 1988, BIOCHEMISTRY-US, V27, P5210, DOI 10.1021/bi00414a040; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; MAKI S, 1988, J BIOL CHEM, V263, P6547; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; Millar D, 2004, BIOCHEMISTRY-US, V43, P12723, DOI 10.1021/bi048349c; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Williams CR, 2004, J BIOL CHEM, V279, P4376, DOI 10.1074/jbc.M310429200; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	47	19	19	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32147	32157		10.1074/jbc.M109.045997	http://dx.doi.org/10.1074/jbc.M109.045997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759003	Green Published, hybrid			2022-12-25	WOS:000271572700069
J	Winter, U; Chen, X; Fasshauer, D				Winter, Ulrike; Chen, Xiong; Fasshauer, Dirk			A Conserved Membrane Attachment Site in alpha-SNAP Facilitates N-Ethylmaleimide-sensitive Factor (NSF)-driven SNARE Complex Disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN; ATPASE ACTIVITY; CORE COMPLEX; BETA-SNAP; IN-VITRO; NSF; BINDING; EXOCYTOSIS; SYNTAXIN; FAMILY	The ATPase NSF (N-ethylmaleimide-sensitive factor) and its SNAP (soluble N-ethylmaleimide-sensitive factor attachment protein) cofactor constitute the ubiquitous enzymatic machinery responsible for recycling of the SNARE (SNAP receptor) membrane fusion machinery. The enzyme uses the energy of ATP hydrolysis to dissociate the constituents of the SNARE complex, which is formed during the fusion of a transport vesicle with the acceptor membrane. However, it is still unclear how NSF and the SNAP adaptor work together to take the tight SNARE bundle apart. SNAPs have been reported to attach to membranes independently from SNARE complex binding. We have investigated how efficient the disassembly of soluble and membrane-bound substrates are, comparing the two. We found that SNAPs support disassembly of membrane-bound SNARE complexes much more efficiently. Moreover, we identified a putative, conserved membrane attachment site in an extended loop within the N-terminal domain of alpha-SNAP. Mutation of two highly conserved, exposed phenylalanine residues on the extended loop prevent SNAPs from facilitating disassembly of membrane-bound SNARE complexes. This implies that the disassembly machinery is adapted to attack membrane-bound SNARE complexes, probably in their relaxed cis-configuration.	[Winter, Ulrike; Chen, Xiong; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, D-37077 Gottingen, Germany	Max Planck Society	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, Fassberg 11, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Fasshauer, Dirk/B-1563-2013	Fasshauer, Dirk/0000-0002-1040-4282	Deutsche Forschungsgemeinschaft [SFB523]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the SFB523 of the Deutsche Forschungsgemeinschaft ( to U. W.).	Bar-On D, 2008, FEBS LETT, V582, P3563, DOI 10.1016/j.febslet.2008.08.040; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Bitto E, 2008, PROTEINS, V70, P93, DOI 10.1002/prot.21468; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; GRIFF IC, 1992, J BIOL CHEM, V267, P12106; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Margittai M, 1999, FEBS LETT, V446, P40, DOI 10.1016/S0014-5793(99)00028-9; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; MORGAN A, 1994, J BIOL CHEM, V269, P29347; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; NAGY A, 1976, BRAIN RES, V109, P285, DOI 10.1016/0006-8993(76)90531-X; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steel GJ, 1997, BIOCHEM J, V325, P511, DOI 10.1042/bj3250511; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sudlow AW, 1996, FEBS LETT, V393, P185, DOI 10.1016/0014-5793(96)00880-0; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Xu JH, 2002, J NEUROSCI, V22, P53, DOI 10.1523/JNEUROSCI.22-01-00053.2002; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	57	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31817	31826		10.1074/jbc.M109.045286	http://dx.doi.org/10.1074/jbc.M109.045286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762473	Green Published, hybrid			2022-12-25	WOS:000271572700036
J	Capp, C; Wu, JH; Hsieh, TS				Capp, Christopher; Wu, Jianhong; Hsieh, Tao-shih			Drosophila RecQ4 Has a 3 '-5 ' DNA Helicase Activity That Is Essential for Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; SYNDROME GENE-PRODUCT; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; UNWINDING ACTIVITIES; GENOME STABILITY; FAMILY HELICASES; REPLICATION; PROTEIN; MAINTENANCE	Members of the RecQ family of proteins are highly conserved DNA helicases that have important functions in the maintenance of genomic stability. Deficiencies in RecQ4 have been linked to human diseases including Rothmund-Thomson, RAPADILINO, and Baller-Gerold syndromes, all of which are characterized by developmental defects, tumor propensity, and genetic instability. However, there are conflicting results shown in the literature regarding the DNA helicase activity of RecQ4. We report here the expression of Drosophila melanogaster RecQ4 with a baculoviral vector and its purification to near homogeneity. The purified protein has a DNA-dependent ATPase activity and is a 3'-5' DNA helicase dependent on hydrolysis of ATP. The presence of 5'-adenylyl-beta, gamma-imidodiphosphate (AMPPNP), a nonhydrolyzable ATP analog, promotes stable complex formation between RecQ4 and single-stranded DNA. Drosophila RecQ4 can also anneal complementary single strands; this activity was reduced in the presence of AMPPNP, possibly because of the stable protein-DNA complex formed under such conditions. A point mutation of the highly conserved lysine residue in the helicase domain, although retaining the wild type level of annealing activity, inactivated ATPase and helicase activities and eliminated stable complex formation. These results suggest that the helicase domain alone is responsible for the DNA unwinding action of the Drosophila enzyme. We generated a null recq4 mutant that is homozygous lethal, which we used to test the genetic function of the helicase-dead mutant in flies. Complementation tests showed that the helicase-dead mutant recq4 transgenes are incapable of rescuing the null mutation, demonstrating that the helicase activity has an essential biological function.	[Capp, Christopher; Wu, Jianhong; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	hsieh@biochem.duke.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Institutes of Health [GM29006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29006.	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Burks LM, 2007, GENE, V391, P26, DOI 10.1016/j.gene.2006.11.019; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Dietschy T, 2009, J CELL SCI, V122, P1258, DOI 10.1242/jcs.037747; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Larizza L, 2006, CANCER LETT, V232, P107, DOI 10.1016/j.canlet.2005.07.042; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Muftuoglu M, 2008, BIOCHEMISTRY-US, V47, P10247, DOI 10.1021/bi800807n; Ozsoy AZ, 2003, NUCLEIC ACIDS RES, V31, P1554, DOI 10.1093/nar/gkg243; Park SJ, 2006, DNA CELL BIOL, V25, P696, DOI 10.1089/dna.2006.25.696; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Seki M, 2008, CELL CYCLE, V7, P2472, DOI 10.4161/cc.7.16.6462; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154; Van Maldergem L, 2006, J MED GENET, V43, P148, DOI 10.1136/jmg.2005.031781; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	33	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30845	30852		10.1074/jbc.M109.008052	http://dx.doi.org/10.1074/jbc.M109.008052			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759018	Green Published, hybrid			2022-12-25	WOS:000271378400012
J	Hull, JJ; Lee, JM; Kajigaya, R; Matsumoto, S				Hull, J. Joe; Lee, Jae Min; Kajigaya, Ryosuke; Matsumoto, Shogo			Bombyx mori Homologs of STIM1 and Orai1 Are Essential Components of the Signal Transduction Cascade That Regulates Sex Pheromone Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS ACTIVATING NEUROPEPTIDE; OPERATED CALCIUM-ENTRY; MOTH HELICOVERPA-ZEA; CRAC CHANNEL; CA2+ ENTRY; SILKWORM; IDENTIFICATION; MECHANISMS; PROTEINS; SILKMOTH	Sex pheromone production in the pheromone gland (PG) of the silkmoth, Bombyx mori, is mediated by store-operated channels (SOCs) acting downstream of pheromone biosynthesis activating neuropeptide (PBAN) binding. Although recent studies have implicated STIM1 and Orai1 as essential components of SOCs, little is known about the molecular nature of the SOCs involved in sex pheromone production. In this study we cloned silkmoth homologs of STIM1 and Orai1 and sought to determine whether they comprise the PG SOC pathway. BmSTIM1 is expressed in multiple tissues and, in the PG, is encoded by two transcripts of differing size. BmOrai1A and BmOrai1B, which are identical except for a 37-residue N-terminal truncation in BmOrai1B, arise from alternative splicing of the bmorai1 locus and are expressed as independent transcripts in various tissues. In the PG, only BmOrai1B is actively transcribed. Fluorescent chimeras demonstrated that BmSTIM1 expression is restricted to the endoplasmic reticulum, whereas both BmOrai1A and BmOrai1B localize to the cell surface. In Ca2+-free medium, thapsigargin-mediated depletion of endoplasmic reticulum Ca2+ stores resulted in redistribution of BmSTIM1 to the plasma membrane, but only when the BmOrai1 homologs were also overexpressed. Translocation was dependent on the BmSTIM1 C terminus "CRAC activation domain." Ala mutation of Lys(380), Lys(383), Lys(384), Arg(382), and Arg(385) suggests that translocation involves electrostatic interactions. Translocation was also seen following PBAN stimulation in cells co-expressing BmSTIM1, BmOrai1B, and the PBAN receptor. In vivo RNA interference-mediated knockdown of BmSTIM1 and BmOrai1 significantly reduced sex pheromone production without affecting cell viability.	[Hull, J. Joe; Lee, Jae Min; Kajigaya, Ryosuke; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Mol Entomol Lab, Wako, Saitama 3510198, Japan	RIKEN	Hull, JJ (corresponding author), Univ Wyoming, Dept Mol Biol, Mol Biol Dept 3944, 1000 E Univ Ave, Laramie, WY 82071 USA.	jhull1@uwyo.edu; smatsu@riken.jp			RIKEN; Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology of Japan [20380040]	RIKEN; Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Bioarchitect Research Program from RIKEN and the Targeted Proteins Research Program (TPRP) and Grants-in-aid for Scientific Research (B) 20380040 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FONAGY A, 1992, J PESTIC SCI, V17, P47; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hull JJ, 2007, BIOSCI BIOTECH BIOCH, V71, P1993, DOI 10.1271/bbb.70175; Hull JJ, 2005, BIOCHEM BIOPH RES CO, V334, P69, DOI 10.1016/j.bbrc.2005.06.050; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Jurenka RA, 1996, ARCH INSECT BIOCHEM, V33, P245, DOI 10.1002/(SICI)1520-6327(1996)33:3/4&lt;245::AID-ARCH6&gt;3.0.CO;2-R; JURENKA RA, 1991, P NATL ACAD SCI USA, V88, P8621, DOI 10.1073/pnas.88.19.8621; JURENKA RA, 2003, INSECT PHEROMONE BIO, V53; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ozawa R, 1996, INSECT BIOCHEM MOLEC, V26, P259, DOI 10.1016/0965-1748(95)00088-7; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2001, J CELL SCI, V114, P2223; Rafaeli A, 1996, INSECT BIOCHEM MOLEC, V26, P797, DOI 10.1016/S0965-1748(96)00029-X; RAFAELI A, 2003, INSECT PHEROMONE BIO, P109; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang TY, 2005, BBA-GENE STRUCT EXPR, V1728, P44, DOI 10.1016/j.bbaexp.2005.01.009	46	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31200	31213		10.1074/jbc.M109.044198	http://dx.doi.org/10.1074/jbc.M109.044198			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740753	Green Published, hybrid			2022-12-25	WOS:000271378400048
J	Seung, KJ; Omatayo, DB; Keshavjee, S; Furin, JJ; Farmer, PE; Satti, H				Seung, Kwonjune J.; Omatayo, David B.; Keshavjee, Salmaan; Furin, Jennifer J.; Farmer, Paul E.; Satti, Hind			Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa	PLOS ONE			English	Article								Background: Little is known about treatment of multidrug-resistant tuberculosis (MDR-TB) in high HIV-prevalence settings such as sub-Saharan Africa. Methodology/Principal Findings: We did a retrospective analysis of early outcomes of the first cohort of patients registered in the Lesotho national MDR-TB program between July 21, 2007 and April 21, 2008. Seventy-six patients were included for analysis. Patient follow-up ended when an outcome was recorded, or on October 21, 2008 for those still on treatment. Fifty-six patients (74%) were infected with HIV; the median CD4 cell count was 184 cells/mu l (range 5-824 cells/mu l). By the end of the follow-up period, study patients had been followed for a median of 252 days (range 12-451 days). Twenty-two patients (29%) had died, and 52 patients (68%) were alive and in treatment. In patients who did not die, culture conversion was documented in 52/54 patients (96%). One patient had defaulted, and one patient had transferred out. Death occurred after a median of 66 days in treatment (range 12-374 days). Conclusions/Significance: In a region where clinicians and program managers are increasingly confronted by drug-resistant tuberculosis, this report provides sobering evidence of the difficulty of MDR-TB treatment in high HIV-prevalence settings. In Lesotho, an innovative community-based treatment model that involved social and nutritional support, twice-daily directly observed treatment and early empiric use of second-line TB drugs was successful in reducing mortality of MDR-TB patients. Further research is urgently needed to improve MDR-TB treatment outcomes in high HIV-prevalence settings.			Seung, KJ (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	kjseung@pih.org		Keshavjee, Salmaan/0000-0002-6967-3305				Alvarez GG, 2004, INT J TUBERC LUNG D, V8, P1472; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; *BUR STAT MIN HLTH, 2004, DEM HLTH SURV; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; *MIN HLTH SOC WELF, 2007, TB HIV COINF; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Murphy RA, 2008, CLIN INFECT DIS, V46, P1729, DOI 10.1086/587903; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; NUNN P, 1991, LANCET, V337, P627; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Rich ML, 2006, INT J TUBERC LUNG D, V10, P290; Saravia JC, 2005, INT J TUBERC LUNG D, V9, P421; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; SUTTMANN U, 1995, J ACQ IMMUN DEF SYND, V8, P239, DOI 10.1097/00042560-199503010-00004; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; *WHO, WHO GLOB TB DAT; *WHO IUATLD, 2008, WHOHTMTB2008394 IUAT; World Health Organization, 2009, MAN MDR TB FIELD GUI; World Health Organization, 2008, WHOHTMTB2008402; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	36	101	104	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7186	10.1371/journal.pone.0007186	http://dx.doi.org/10.1371/journal.pone.0007186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779624	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200018
J	Proverbio, AM; Mariani, S; Zani, A; Adorni, R				Proverbio, Alice Mado; Mariani, Serena; Zani, Alberto; Adorni, Roberta			How Are 'Barack Obama' and 'President Elect' Differentially Stored in the Brain? An ERP Investigation on the Processing of Proper and Common Noun Pairs	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; FIELD POTENTIALS; PEOPLES NAMES; ANOMIA; MEMORY; FACE; NETWORK; N400; PRESERVATION; IMPAIRMENT	Background: One of the most debated issues in the cognitive neuroscience of language is whether distinct semantic domains are differentially represented in the brain. Clinical studies described several anomic dissociations with no clear neuroanatomical correlate. Neuroimaging studies have shown that memory retrieval is more demanding for proper than common nouns in that the former are purely arbitrary referential expressions. In this study a semantic relatedness paradigm was devised to investigate neural processing of proper and common nouns. Methodology/Principal Findings: 780 words (arranged in pairs of Italian nouns/adjectives and the first/last names of well known persons) were presented. Half pairs were semantically related ("Woody Allen'' or "social security''), while the others were not ("Sigmund Parodi'' or "judicial cream''). All items were balanced for length, frequency, familiarity and semantic relatedness. Participants were to decide about the semantic relatedness of the two items in a pair. RTs and N400 data suggest that the task was more demanding for common nouns. The LORETA neural generators for the related-unrelated contrast (for proper names) included the left fusiform gyrus, right medial temporal gyrus, limbic and parahippocampal regions, inferior parietal and inferior frontal areas, which are thought to be involved in the conjoined processing a familiar face with the relevant episodic information. Person name was more emotional and sensory vivid than common noun semantic access. Conclusions/Significance: When memory retrieval is not required, proper name access (conspecifics knowledge) is not more demanding. The neural generators of N400 to unrelated items (unknown persons and things) did not differ as a function of lexical class, thus suggesting that proper and common nouns are not treated differently as belonging to different grammatical classes.			Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABG-8894-2020; Adorni, Roberta/GMW-9037-2022; Zani, Alberto/ABI-3498-2020	Adorni, Roberta/0000-0002-2851-8376; Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523; Lauwereyns, Jan/0000-0003-0551-2550				Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; BERTINETTO PM, 2006, CORPUS LESSICO FREQU; BRENNEN T, 1990, MEM COGNITION, V18, P339, DOI 10.3758/BF03197123; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; BURTON AM, 1992, BRIT J PSYCHOL, V83, P45, DOI 10.1111/j.2044-8295.1992.tb02424.x; Campanella S, 2001, NEUROIMAGE, V14, P873, DOI 10.1006/nimg.2001.0877; Caramazza A, 2006, COGN NEUROPSYCHOL, V23, P13, DOI 10.1080/02643290542000021; CARNEY R, 1993, COGNITIVE NEUROPSYCH, V10, P185, DOI 10.1080/02643299308253460; Cipolotti L, 1993, Memory, V1, P289, DOI 10.1080/09658219308258240; COHEN G, 1990, BRIT J PSYCHOL, V81, P287, DOI 10.1111/j.2044-8295.1990.tb02362.x; COHEN G, 1986, BRIT J DEV PSYCHOL, V4, P187, DOI 10.1111/j.2044-835X.1986.tb01010.x; COHEN L, 1994, J NEUROL NEUROSUR PS, V57, P1283, DOI 10.1136/jnnp.57.10.1283; COULSON S, 2007, METHDOS COGNITIVE LI; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DEHAENE S, 1995, NEUROREPORT, V6, P2153, DOI 10.1097/00001756-199511000-00014; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Douville K, 2005, NEUROPSYCHOLOGIA, V43, P693, DOI 10.1016/j.neuropsychologia.2004.09.005; Druzgal TJ, 2001, NEURON, V32, P947, DOI 10.1016/S0896-6273(01)00519-0; FERY P, 1995, CORTEX, V31, P191, DOI 10.1016/S0010-9452(13)80117-7; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; HARRIS DM, 1995, CORTEX, V31, P575, DOI 10.1016/S0010-9452(13)80068-8; HITTMAIRDELAZER M, 1994, NEUROPSYCHOLOGIA, V32, P465, DOI 10.1016/0028-3932(94)90091-4; Johnson BW, 2000, CLIN NEUROPHYSIOL, V111, P532, DOI 10.1016/S1388-2457(99)00270-9; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Kay J, 2002, COGN NEUROPSYCHOL, V19, P113, DOI 10.1080/02643290143000114; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; KUTAS M, 1994, PSYCHOLINGUISTICS EL, P83; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; LUCCHELLI F, 1992, CORTEX, V28, P221, DOI 10.1016/S0010-9452(13)80050-0; Lyons F, 2002, CORTEX, V38, P23, DOI 10.1016/S0010-9452(08)70636-1; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Martins IP, 2007, NEUROPSYCHOLOGIA, V45, P1744, DOI 10.1016/j.neuropsychologia.2006.12.016; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; MCKENNA P, 1978, J NEUROL NEUROSUR PS, V41, P571, DOI 10.1136/jnnp.41.6.571; MCKENNA P, 1980, J NEUROL NEUROSUR PS, V43, P781, DOI 10.1136/jnnp.43.9.781; Miceli G, 2000, COGN NEUROPSYCHOL, V17, P489, DOI 10.1080/02643290050110629; NOBRE AC, 1995, J NEUROSCI, V15, P1090; Otsuka Y, 2005, CORTEX, V41, P39, DOI 10.1016/S0010-9452(08)70176-X; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Proverbio AM, 2008, NEUROPSYCHOLOGIA, V46, P2292, DOI 10.1016/j.neuropsychologia.2008.03.024; Proverbio AM, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-27; Proverbio AM, 2004, NEUROPSYCHOLOGIA, V42, P1636, DOI 10.1016/j.neuropsychologia.2004.04.013; Proverbio AM, 2001, NEUROPSYCHOLOGIA, V39, P815, DOI 10.1016/S0028-3932(01)00003-3; Semenza C, 1993, Memory, V1, P265, DOI 10.1080/09658219308258238; SEMENZA C, 1989, NATURE, V342, P678, DOI 10.1038/342678a0; SEMENZA C, 1988, COGNITIVE NEUROPSYCH, V5, P711, DOI 10.1080/02643298808253279; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Silva-Pereyra J, 2003, CLIN NEUROPHYSIOL, V114, P2469, DOI 10.1016/S1388-2457(03)00248-7; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Tranel D, 2006, NEUROPSYCHOLOGY, V20, P1, DOI 10.1037/0894-4105.20.1.1; VALENTINE T, 1996, COGNITIVE PSYCHOL PR; Warrington E K, 1993, Memory, V1, P281, DOI 10.1080/09658219308258239	58	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7126	10.1371/journal.pone.0007126	http://dx.doi.org/10.1371/journal.pone.0007126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498RP	19774070	gold, Green Published, Green Submitted			2022-12-25	WOS:000270160900011
J	Zou, SM; Kamei, H; Modi, Z; Duan, CM				Zou, Shuming; Kamei, Hiroyasu; Modi, Zubin; Duan, Cunming			Zebrafish IGF Genes: Gene Duplication, Conservation and Divergence, and Novel Roles in Midline and Notochord Development	PLOS ONE			English	Article							GROWTH-FACTOR-I; MESSENGER-RNA EXPRESSION; TISSUE DISTRIBUTION; GENOME DUPLICATION; RED SEABREAM; FACTOR CDNA; INSULIN; TELEOST; FISH; INDUCTION	Insulin-like growth factors (IGFs) are key regulators of development, growth, and longevity. In most vertebrate species including humans, there is one IGF-1 gene and one IGF-2 gene. Here we report the identification and functional characterization of 4 distinct IGF genes (termed as igf-1a, -1b, -2a, and -2b) in zebrafish. These genes encode 4 structurally distinct and functional IGF peptides. IGF-1a and IGF-2a mRNAs were detected in multiple tissues in adult fish. IGF-1b mRNA was detected only in the gonad and IGF-2b mRNA only in the liver. Functional analysis showed that all 4 IGFs caused similar developmental defects but with different potencies. Many of these embryos had fully or partially duplicated notochords, suggesting that an excess of IGF signaling causes defects in the midline formation and an expansion of the notochord. IGF-2a, the most potent IGF, was analyzed in depth. IGF-2a expression caused defects in the midline formation and expansion of the notochord but it did not alter the anterior neural patterning. These results not only provide new insights into the functional conservation and divergence of the multiple igf genes but also reveal a novel role of IGF signaling in midline formation and notochord development in a vertebrate model.			Zou, SM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cduan@umich.edu		KAMEI, HIROYASU/0000-0001-7123-040X				Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; ADAMO ML, 1993, ADV EXP MED BIOL, V343, P1; ADASHI EY, 1992, GROWTH REGULAT, V2, P10; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Brown Y. A. R., 2009, ENDOCRINOLOGY, V150, P4366, DOI [10.1210/en.2009-0356, DOI 10.1210/EN.2009-0356]; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; CHAN SJ, 1990, P NATL ACAD SCI USA, V87, P9319, DOI 10.1073/pnas.87.23.9319; Chen MHC, 2001, GENE, V268, P67, DOI 10.1016/S0378-1119(01)00433-4; CHEW SL, 1995, ENDOCRINOLOGY, V136, P1939, DOI 10.1210/en.136.5.1939; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Du SJ, 2003, COMP BIOCHEM PHYS B, V134, P123, DOI 10.1016/S1096-4959(02)00194-X; DUAN C, 1993, J ENDOCRINOL, V139, P243, DOI 10.1677/joe.0.1390243; DUAN C, 1992, J ENDOCRINOL, V133, P211, DOI 10.1677/joe.0.1330211; Duan CM, 1997, AM ZOOL, V37, P491; DUAN CM, 1993, FISH PHYSIOL BIOCHEM, V11, P371, DOI 10.1007/BF00004587; DUAN CM, 1993, ZOOL SCI, V10, P473; DUGUAY SJ, 1995, FEBS LETT, V371, P69, DOI 10.1016/0014-5793(95)00879-E; DUGUAY SJ, 1992, MOL ENDOCRINOL, V6, P1202, DOI 10.1210/me.6.8.1202; Duguay SJ, 1996, J MOL ENDOCRINOL, V16, P123, DOI 10.1677/jme.0.0160123; Eivers E, 2004, INT J DEV BIOL, V48, P1131, DOI 10.1387/ijdb.041913ee; GUTIERREZ J, 1995, J ENDOCRINOL, V146, P35, DOI 10.1677/joe.0.1460035; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KAGAWA H, 1994, GEN COMP ENDOCR, V95, P293, DOI 10.1006/gcen.1994.1126; KAGAWA H, 1995, GEN COMP ENDOCR, V99, P307, DOI 10.1006/gcen.1995.1114; Kamei H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003091; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; KIM SW, 1991, MOL ENDOCRINOL, V5, P1964, DOI 10.1210/mend-5-12-1964; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; NAGAMATSU S, 1991, J BIOL CHEM, V266, P2397; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Papasani MR, 2006, PHYSIOL GENOMICS, V27, P79, DOI 10.1152/physiolgenomics.00012.2006; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Richard-Parpaillon L, 2002, DEV BIOL, V244, P407, DOI 10.1006/dbio.2002.0605; Rotwein P, 1991, Growth Factors, V5, P3, DOI 10.3109/08977199109000267; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Sang XP, 2008, ENDOCRINOLOGY, V149, P5035, DOI 10.1210/en.2008-0534; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; SCHLUETER PJ, 2007, CELL DEATH DIFFER, P1; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Shamblott Michael J., 1993, Molecular Marine Biology and Biotechnology, V2, P351; SHAMBLOTT MJ, 1995, P NATL ACAD SCI USA, V92, P6943, DOI 10.1073/pnas.92.15.6943; Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Toyoshima Y, 2008, ENDOCRINOLOGY, V149, P5996, DOI 10.1210/en.2008-0329; Wagner GP, 2005, J MOL EVOL, V60, P665, DOI 10.1007/s00239-004-0252-z; Wang DS, 2008, BIOCHEM BIOPH RES CO, V367, P336, DOI 10.1016/j.bbrc.2007.12.136; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Wood AW, 2005, MOL ENDOCRINOL, V19, P1024, DOI 10.1210/me.2004-0392; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhou JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003926	64	95	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7026	10.1371/journal.pone.0007026	http://dx.doi.org/10.1371/journal.pone.0007026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759899	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970200002
J	Chen, YJ; Cairns, R; Papandreou, I; Koong, A; Denko, NC				Chen, Yijun; Cairns, Rob; Papandreou, Ioanna; Koong, Albert; Denko, Nicholas C.			Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect	PLOS ONE			English	Article								Background: The unique metabolism of tumors was described many years ago by Otto Warburg, who identified tumor cells with increased glycolysis and decreased mitochondrial activity. However, "aerobic glycolysis" generates fewer ATP per glucose molecule than mitochondrial oxidative phosphorylation, so in terms of energy production, it is unclear how increasing a less efficient process provides tumors with a growth advantage. Methods/Findings: We carried out a screen for loss of genetic elements in pancreatic tumor cells that accelerated their growth as tumors, and identified mitochondrial ribosomal protein L28 (MRPL28). Knockdown of MRPL28 in these cells decreased mitochondrial activity, and increased glycolysis, but paradoxically, decreased cellular growth in vitro. Following Warburg's observations, this mutation causes decreased mitochondrial function, compensatory increase in glycolysis and accelerated growth in vivo. Likewise, knockdown of either mitochondrial ribosomal protein L12 (MRPL12) or cytochrome oxidase had a similar effect. Conversely, expression of the mitochondrial uncoupling protein 1 (UCP1) increased oxygen consumption and decreased tumor growth. Finally, treatment of tumor bearing animals with dichloroacetate (DCA) increased pyruvate consumption in the mitochondria, increased total oxygen consumption, increased tumor hypoxia and slowed tumor growth. Conclusions: We interpret these findings to show that non-oncogenic genetic changes that alter mitochondrial metabolism can regulate tumor growth through modulation of the consumption of oxygen, which appears to be a rate limiting substrate for tumor proliferation.			Chen, YJ (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	ndenko@stanford.edu	Pinheiro, Maísa/E-7424-2012; Papandreou, Ioanna/G-1703-2014; Cairns, Rob A/A-3232-2009; denko, nicholas/F-8444-2010	Cairns, Rob A/0000-0001-9540-7927; Koong, Albert/0000-0001-9824-1643	NATIONAL CANCER INSTITUTE [P01CA067166] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA67166, P01 CA067166] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Denko NC, 2008, NAT REV CANC; Evans SM, 2001, AM J CLIN ONCOL-CANC, V24, P467, DOI 10.1097/00000421-200110000-00011; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635; Liu VWS, 2001, CANCER RES, V61, P5998; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Mithani SK, 2007, CLIN CANCER RES, V13, P4331, DOI 10.1158/1078-0432.CCR-06-2613; MOORE JV, 1985, BRIT J CANCER, V51, P407, DOI 10.1038/bjc.1985.55; MUSCHEL RJ, 1995, CANCER RES, V55, P995; Nishikawa M, 2001, CANCER RES, V61, P1843; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Rosenfeld E, 2002, YEAST, V19, P1299, DOI 10.1002/yea.918; Santore MT, 2002, AM J PHYSIOL-LUNG C, V282, pL727, DOI 10.1152/ajplung.00281.2001; SECOMB TW, 1995, ACTA ONCOL, V34, P313, DOI 10.3109/02841869509093981; Secomb TW, 1998, ADV EXP MED BIOL, V454, P629; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Tuttle SW, 2007, J BIOL CHEM, V282, P36790, DOI 10.1074/jbc.M700327200; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; WARBURG O, 1956, Oncologia, V9, P75; WARBURG O, 1956, SCIENCE, V124, P269; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	49	126	135	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7033	10.1371/journal.pone.0007033	http://dx.doi.org/10.1371/journal.pone.0007033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753307	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796500017
J	Bradrick, SS; Gromeier, M				Bradrick, Shelton S.; Gromeier, Matthias			Identification of Gemin5 as a Novel 7-Methylguanosine Cap-Binding Protein	PLOS ONE			English	Article							MESSENGER-RNA; SMN COMPLEX; U-SNRNA; TRANSLATION INITIATION; STRUCTURAL BASIS; WD REPEAT; POLY(A)-SPECIFIC RIBONUCLEASE; SMALL NUCLEAR; RRM DOMAIN; IN-VITRO	Background: A unique attribute of RNA molecules synthesized by RNA polymerase II is the presence of a 7-methylguanosine (m(7)G) cap structure added co-transcriptionally to the 5' end. Through its association with trans-acting effector proteins, the m(7)G cap participates in multiple aspects of RNA metabolism including localization, translation and decay. However, at present relatively few eukaryotic proteins have been identified as factors capable of direct association with m(7)G. Methodology/Principal Findings: Employing an unbiased proteomic approach, we identified gemin5, a component of the survival of motor neuron (SMN) complex, as a factor capable of direct and specific interaction with the m(7)G cap. Gemin5 was readily purified by cap-affinity chromatography in contrast to other SMN complex proteins. Investigating the underlying basis for this observation, we found that purified gemin5 associates with m 7 G-linked sepharose in the absence of detectable eIF4E, and specifically crosslinks to radiolabeled cap structure after UV irradiation. Deletion analysis revealed that an intact set of WD repeat domains located in the N-terminal half of gemin5 are required for cap-binding. Moreover, using structural modeling and site-directed mutagenesis, we identified two proximal aromatic residues located within the WD repeat region that significantly impact m(7)G association. Conclusions/Significance: This study rigorously identifies gemin5 as a novel cap-binding protein and describes an unprecedented role for WD repeat domains in m(7)G recognition. The findings presented here will facilitate understanding of gemin5's role in the metabolism of non-coding snRNAs and perhaps other RNA pol II transcripts.			Bradrick, SS (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	shelton.bradrick@duke.edu			NATIONAL CANCER INSTITUTE [R01CA124756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK067781, K01DK082613] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA124756, CA124756] Funding Source: Medline; NIDDK NIH HHS [F32 DK067781, DK067781, K01 DK082613] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hogue CWV, 1997, TRENDS BIOCHEM SCI, V22, P314, DOI 10.1016/S0968-0004(97)01093-1; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Monecke T, 2008, J MOL BIOL, V382, P827, DOI 10.1016/j.jmb.2008.07.073; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nagata T, 2008, NUCLEIC ACIDS RES, V36, P4754, DOI 10.1093/nar/gkn458; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Penalva LOF, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-24; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Saha N, 1999, J BIOL CHEM, V274, P16553, DOI 10.1074/jbc.274.23.16553; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Simon E, 2006, TRENDS BIOCHEM SCI, V31, P241, DOI 10.1016/j.tibs.2006.03.001; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu MS, 2009, STRUCTURE, V17, P276, DOI 10.1016/j.str.2008.11.012	64	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7030	10.1371/journal.pone.0007030	http://dx.doi.org/10.1371/journal.pone.0007030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750007	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796300020
J	Wang, ZS; Li, V; Chan, GCK; Phan, T; Nudelman, AS; Xia, ZG; Storm, DR				Wang, Zhenshan; Li, Vicky; Chan, Guy C. K.; Phan, Trongha; Nudelman, Aaron S.; Xia, Zhengui; Storm, Daniel R.			Adult Type 3 Adenylyl Cyclase-Deficient Mice Are Obese	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; BROWN ADIPOSE-TISSUE; BASAL BODY DYSFUNCTION; DIET-INDUCED OBESITY; TRANSGENIC MICE; OVEREXPRESSING LEPTIN; LOCOMOTOR-ACTIVITY; PHYSICAL-ACTIVITY; GENE-EXPRESSION; ENERGY-BALANCE	Background: A recent study of obesity in Swedish men found that polymorphisms in the type 3 adenylyl cyclase (AC3) are associated with obesity, suggesting the interesting possibility that AC3 may play a role in weight control. Therefore, we examined the weight of AC3 mice over an extended period of time. Methodology/Principal Findings: We discovered that AC3(-/-) mice become obese as they age. Adult male AC3(-/-) mice are about 40% heavier than wild type male mice while female AC3(-/-) are 70% heavier. The additional weight of AC3(-/-) mice is due to increased fat mass and larger adipocytes. Before the onset of obesity, young AC3(-/-) mice exhibit reduced physical activity, increased food consumption, and leptin insensitivity. Surprisingly, the obesity of AC3(-/-) mice is not due to a loss of AC3 from white adipose and a decrease in lipolysis. Conclusions/Significance: We conclude that mice lacking AC3 exhibit obesity that is apparently caused by low locomotor activity, hyperphagia, and leptin insensitivity. The presence of AC3 in primary cilia of neurons of the hypothalamus suggests that cAMP signals generated by AC3 in the hypothalamus may play a critical role in regulation of body weight.			Wang, ZS (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NIDCD NIH HHS [R01 DC004158, DC04158] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004158] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ainsworth C, 2007, NATURE, V448, P638, DOI 10.1038/448638a; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Bray GA, 2006, J MED CHEM, V49, P4001, DOI 10.1021/jm0680124; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CHALLET E, 1995, PHYSIOL BEHAV, V58, P257, DOI 10.1016/0031-9384(95)00001-Y; Charon C, 1995, BIOCHEM J, V312, P781, DOI 10.1042/bj3120781; Chaudhry A, 1997, AM J PHYSIOL-REG I, V273, pR762, DOI 10.1152/ajpregu.1997.273.2.R762; CORBIN JD, 1970, J BIOL CHEM, V245, P4849; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; GRANNEMAN JG, 1995, ENDOCRINOLOGY, V136, P2007, DOI 10.1210/en.136.5.2007; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Havel PJ, 1996, J CLIN ENDOCR METAB, V81, P4406, DOI 10.1210/jc.81.12.4406; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Joosen AMCP, 2005, AM J CLIN NUTR, V82, P1253, DOI 10.1093/ajcn/82.6.1253; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kohno D, 2007, ENDOCRINOLOGY, V148, P2251, DOI 10.1210/en.2006-1240; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Nordman S, 2008, INT J OBESITY, V32, P407, DOI 10.1038/sj.ijo.0803742; Ogus S, 2003, ENDOCRINOLOGY, V144, P2865, DOI 10.1210/en.2002-0178; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; RohnerJeanrenaud F, 1996, NEW ENGL J MED, V334, P324, DOI 10.1056/NEJM199602013340511; Scarpace P, 2005, DIABETOLOGIA, V48, P1075, DOI 10.1007/s00125-005-1763-x; Scarpace PJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3531, DOI 10.2741/2332; Schulz S, 2000, J PHYSIOLOGY-PARIS, V94, P259, DOI 10.1016/S0928-4257(00)00212-6; Shapiro A, 2008, DIABETES, V57, P614, DOI 10.2337/db07-0863; Sheriff S, 2003, PEPTIDES, V24, P245, DOI 10.1016/S0196-9781(03)00037-8; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; van Harmelen V, 2003, INT J OBESITY, V27, P889, DOI 10.1038/sj.ijo.0802314; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; WOODS SC, 2001, INT J OBESITY, V5, pS35; Zhao AZ, 2005, CURR TOP DEV BIOL, V67, P207, DOI 10.1016/S0070-2153(05)67006-8; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885	60	95	105	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6979	10.1371/journal.pone.0006979	http://dx.doi.org/10.1371/journal.pone.0006979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750222	gold, Green Published, Green Submitted			2022-12-25	WOS:000269696600014
J	van der Most, RG; Currie, AJ; Cleaver, AL; Salmons, J; Nowak, AK; Mahendran, S; Larma, I; Prosser, A; Robinson, BWS; Smyth, MJ; Scalzo, AA; Degli-Esposti, MA; Lake, RA				van der Most, Robbert G.; Currie, Andrew J.; Cleaver, Amanda L.; Salmons, Joanne; Nowak, Anna K.; Mahendran, Sathish; Larma, Irma; Prosser, Amy; Robinson, Bruce W. S.; Smyth, Mark J.; Scalzo, Anthony A.; Degli-Esposti, Mariapia A.; Lake, Richard A.			Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth	PLOS ONE			English	Article								Background: Anti-cancer chemotherapy can be simultaneously lymphodepleting and immunostimulatory. Pre-clinical models clearly demonstrate that chemotherapy can synergize with immunotherapy, raising the question how the immune system can be mobilized to generate anti-tumor immune responses in the context of chemotherapy. Methods and Findings: We used a mouse model of malignant mesothelioma, AB1-HA, to investigate T cell-dependent tumor resolution after chemotherapy. Established AB1-HA tumors were cured by a single dose of cyclophosphamide in a CD8 T cell-and NK cell-dependent manner. This treatment was associated with an IFN-alpha/beta response and a profound negative impact on the anti-tumor and total CD8 T cell responses. Despite this negative effect, CD8 T cells were essential for curative responses. The important effector molecules used by the anti-tumor immune response included IFN-gamma and TRAIL. The importance of TRAIL was supported by experiments in nude mice where the lack of functional T cells could be compensated by agonistic anti-TRAIL-receptor (DR5) antibodies. Conclusion: The data support a model in which chemotherapy sensitizes tumor cells for T cell-, and possibly NK cell-, mediated apoptosis. A key role of tumor cell sensitization to immune attack is supported by the role of TRAIL in tumor resolution and explains the paradox of successful CD8 T cell-dependent anti-tumor responses in the absence of CD8 T cell expansion.			van der Most, RG (corresponding author), Univ Western Australia, Natl Res Ctr Asbestos Related Dis, Perth, WA 6009, Australia.	robbertvdm@gmail.com; rlake@cyllene.uwa.edu.au	Degli-Esposti, Mariapia/H-9073-2014; Flow, CMCA/C-4191-2013; Currie, Andrew/C-2778-2015; Nowak, Anna K/B-2487-2013; Smyth, Mark J/H-8709-2014; Robinson, Bruce/N-1900-2014; Degli-Esposti, Mariapia/E-9529-2013	Nowak, Anna K/0000-0002-9317-9526; Smyth, Mark J/0000-0001-7098-7240; Cleaver, Amanda/0000-0001-7545-5868; Currie, Andrew/0000-0002-5193-3404; Degli-Esposti, Mariapia/0000-0002-7808-5935; Prosser, Amy/0000-0003-3540-5203				Angulo I, 2000, BLOOD, V95, P212; AWWAD M, 1989, CANCER RES, V49, P1649; Belyanskaya LL, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-66; Brooks AD, 2005, CANCER IMMUNOL IMMUN, V54, P499, DOI 10.1007/s00262-004-0595-8; Broomfield SA, 2009, J IMMUNOL, V182, P5217, DOI 10.4049/jimmunol.0803826; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Cretney E, 2007, INT J BIOCHEM CELL B, V39, P280, DOI 10.1016/j.biocel.2006.10.005; Currie AJ, 2008, J IMMUNOL, V180, P1535, DOI 10.4049/jimmunol.180.3.1535; DUMONT FJ, 1986, EUR J IMMUNOL, V16, P735, DOI 10.1002/eji.1830160704; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fan ZS, 2006, BLOOD, V107, P1342, DOI 10.1182/blood-2005-08-3485; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; HAYNES NM, 2008, CURR OPIN IMMUNOL; Ibe S, 2001, J EXP MED, V194, P1549, DOI 10.1084/jem.194.11.1549; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jovasevic VM, 2001, J IMMUNOL, V167, P4895, DOI 10.4049/jimmunol.167.9.4895; Khodadoust MM, 1998, BLOOD, V92, P2399, DOI 10.1182/blood.V92.7.2399.2399_2399_2409; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Liu WH, 2001, AM J RESP CELL MOL, V25, P111, DOI 10.1165/ajrcmb.25.1.4472; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Marzo AL, 1999, J IMMUNOL, V162, P5838; Marzo AL, 1999, CANCER RES, V59, P1071; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mokyr MB, 2006, CANCER IMMUNOL IMMUN, V55, P459, DOI 10.1007/s00262-005-0029-2; NORTH RJ, 1990, IMMUNOLOGY, V71, P90; Nowak AK, 2003, J IMMUNOL, V170, P4905, DOI 10.4049/jimmunol.170.10.4905; Nowak AK, 2003, CANCER RES, V63, P4490; Nowak AK, 2002, CANCER RES, V62, P2353; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Pelaez B, 2001, J IMMUNOL, V166, P6608, DOI 10.4049/jimmunol.166.11.6608; POZAROWSKI P, 2004, CURR PROTOC CELL BIO, pCH18, DOI DOI 10.1002/0471143030.CB1808S21; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rad AN, 2003, CANCER RES, V63, P5143; RIVIERE Y, 1977, P NATL ACAD SCI USA, V74, P2135, DOI 10.1073/pnas.74.5.2135; Sayers TJ, 2006, CANCER IMMUNOL IMMUN, V55, P76, DOI 10.1007/s00262-005-0676-3; Schiavoni G, 2000, BLOOD, V95, P2024, DOI 10.1182/blood.V95.6.2024; Shankar S, 2005, INT J MOL MED, V16, P1125; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Smyth MJ, 1999, J IMMUNOL, V162, P6658; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Stumbles PA, 2004, J IMMUNOL, V173, P5923, DOI 10.4049/jimmunol.173.10.5923; Suzuki E, 2007, CANCER BIOL THER, V6, P880, DOI 10.4161/cbt.6.6.4090; Taieb J, 2006, J IMMUNOL, V176, P2722, DOI 10.4049/jimmunol.176.5.2722; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Takeda K, 2008, P NATL ACAD SCI USA, V105, P10895, DOI 10.1073/pnas.0802702105; TESNIERE A, 2008, CURR OPIN IMMUNOL; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; van der Most RG, 2008, CELL DEATH DIFFER, V15, P13, DOI 10.1038/sj.cdd.4402255; van der Most RG, 2006, CANCER RES, V66, P601, DOI 10.1158/0008-5472.CAN-05-2967; van der Most RG, 2009, CANCER IMMUNOL IMMUN, V58, P1219, DOI 10.1007/s00262-008-0628-9; WEILAND T, 2008, J PHARM EXP THER; Zitvogel L, 2004, ADV IMMUNOL, V84, P131, DOI 10.1016/S0065-2776(04)84004-5	61	73	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6982	10.1371/journal.pone.0006982	http://dx.doi.org/10.1371/journal.pone.0006982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746156	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696500003
J	Kremer, SB; Gross, DS				Kremer, Selena B.; Gross, David S.			SAGA and Rpd3 Chromatin Modification Complexes Dynamically Regulate Heat Shock Gene Structure and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE ACETYLTRANSFERASE COMPLEX; IN-VIVO TARGET; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; CODING REGIONS; ADA-COMPLEX; YEAST; RECRUITMENT; PROMOTER	The chromatin structure of heat shock protein (HSP)-encoding genes undergoes dramatic alterations upon transcriptional induction, including, in extreme cases, domain-wide nucleosome disassembly. Here, we use a combination of gene knockout, in situ mutagenesis, chromatin immunoprecipitation, and expression assays to investigate the role of histone modification complexes in regulating heat shock gene structure and expression in Saccharomyces cerevisiae. Two histone acetyltransferases, Gcn5 and Esa1, were found to stimulate HSP gene transcription. A detailed chromatin immunoprecipitation analysis of the Gcn5-containing SAGA complex (signified by Spt3) revealed its presence within the promoter of every heat shock factor 1-regulated gene examined. The occupancy of SAGA increased substantially upon heat shock, peaking at several HSP promoters within 30-45 s of temperature upshift. SAGA was also efficiently recruited to the coding regions of certain HSP genes (where its presence mirrored that of pol II), although not at others. Robust and rapid recruitment of repressive, Rpd3-containing histone deacetylase complexes was also seen and at all HSP genes examined. A detailed analysis of HSP82 revealed that both Rpd3(L) and Rpd3(S) complexes (signified by Sap30 and Rco1, respectively) were recruited to the gene promoter, yet only Rpd3(S) was recruited to its open reading frame. A consensus URS1 cis-element facilitated the recruitment of each Rpd3 complex to the HSP82 promoter, and this correlated with targeted deacetylation of promoter nucleosomes. Collectively, our observations reveal that SAGA and Rpd3 complexes are rapidly and synchronously recruited to heat shock factor 1-activated genes and suggest that their opposing activities modulate heat shock gene chromatin structure and fine-tune transcriptional output.	[Kremer, Selena B.; Gross, David S.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Gross, DS (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1501 Kings Highway, Shreveport, LA 71130 USA.	dgross@lsuhsc.edu			National Science Foundation [MCB-0450419, MCB-0747227]; Direct For Biological Sciences [0747227] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0450419 and MCB-0747227 (to D. S. G.).	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chou S, 1999, GENETICS, V153, P1573; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Erkina TY, 2008, MOL CELL BIOL, V28, P1207, DOI 10.1128/MCB.01069-07; Erkine AM, 1996, MOL CELL BIOL, V16, P7004; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; GROSS DS, 1993, EMBO J, V12, P3931, DOI 10.1002/j.1460-2075.1993.tb06071.x; GROSS DS, 1995, NUCLEUS, V1, P151; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; John S, 2000, GENE DEV, V14, P1196; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee D, 1998, NATURE, V393, P389, DOI 10.1038/30770; Lee DK, 1999, GENE DEV, V13, P2934, DOI 10.1101/gad.13.22.2934; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; MCDANIEL D, 1989, MOL CELL BIOL, V9, P4789, DOI 10.1128/MCB.9.11.4789; Mercier PA, 1999, J CELL SCI, V112, P2765; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; PARK HO, 1989, MOL CELL BIOL, V9, P2025, DOI 10.1128/MCB.9.5.2025; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Sakurai H, 1999, BIOCHEM BIOPH RES CO, V261, P734, DOI 10.1006/bbrc.1999.1113; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; SZENTGYORGYI C, 1995, MOL CELL BIOL, V15, P6754; SZENTGYORGYI C, 1987, J MOL BIOL, V193, P71, DOI 10.1016/0022-2836(87)90628-0; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Uffenbeck SR, 2006, BIOCHEM CELL BIOL, V84, P477, DOI 10.1139/O06-079; Venturi CB, 2000, MOL CELL BIOL, V20, P6435, DOI 10.1128/MCB.20.17.6435-6448.2000; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	86	30	30	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32914	32931		10.1074/jbc.M109.058610	http://dx.doi.org/10.1074/jbc.M109.058610			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759026	hybrid, Green Published			2022-12-25	WOS:000272028400075
J	Schultz, SJ; Zhang, MH; Champoux, JJ				Schultz, Sharon J.; Zhang, Miaohua; Champoux, James J.			Preferred Sequences within a Defined Cleavage Window Specify DNA 3 ' End-directed Cleavages by Retroviral RNases H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; DOUBLE-STRANDED DNA; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; FINGERS SUBDOMAIN; VIRAL REPLICATION; PRIMER SELECTION; DRUG-RESISTANCE	The RNase H activity of reverse transcriptase carries out three types of cleavage termed internal, RNA 5' end-directed, and DNA 3' end-directed. Given the strong association between the polymerase domain of reverse transcriptase and a DNA 3' primer terminus, we asked whether the distance from the primer terminus is paramount for positioning DNA 3' end-directed cleavages or whether preferred sequences and/or a cleavage window are important as they are for RNA 5' end-directed cleavages. Using the reverse transcriptases of human immunodeficiency virus, type 1 (HIV-1) and Moloney murine leukemia virus (M-MuLV), we determined the effects of sequence, distance, and substrate end structure on DNA 3' end-directed cleavages. Utilizing sequence-matched substrates, our analyses showed that DNA 3' end-directed cleavages share the same sequence preferences as RNA 5' end-directed cleavages, but the sites must fall in a narrow window between the 15th and 20th nucleotides from the recessed end for HIV-1 reverse transcriptase and between the 17th and 20th nucleotides for M-MuLV. Substrates with an RNA 5' end recessed by 1 (HIV-1) or 2-3 (M-MuLV) bases on a longer DNA could accommodate both types of end-directed cleavage, but further recession of the RNA 5' end excluded DNA 3' end-directed cleavages. For HIV-1 RNase H, the inclusion of the cognate dNTP enhanced DNA 3' end-directed cleavages at the 17th and 18th nucleotides. These data demonstrate that all three modes of retroviral RNase H cleavage share sequence determinants that may be useful in designing assays to identify inhibitors of retroviral RNases H.	[Schultz, Sharon J.; Zhang, Miaohua; Champoux, James J.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Champoux, JJ (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Box 357242, Seattle, WA 98195 USA.	champoux@u.washington.edu			National Institutes of Health [CA51605]; NATIONAL CANCER INSTITUTE [R01CA051605, R37CA051605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA51605.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Arts EJ, 1998, PROG NUCLEIC ACID RE, V58, P339; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Bohlayer WP, 2006, BIOCHEMISTRY-US, V45, P7628, DOI 10.1021/bi051770w; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; CHAMPOUX JJ, 1993, REVERSE TRANSCRIPTAS, P103; Das D, 2004, STRUCTURE, V12, P819, DOI 10.1016/j.str.2004.02.032; Dash C, 2008, NUCLEIC ACIDS RES, V36, P6363, DOI 10.1093/nar/gkn678; DESTEFANO JJ, 1993, BIOCHEMISTRY-US, V32, P6908, DOI 10.1021/bi00078a014; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1995, NUCLEIC ACIDS RES, V23, P3901, DOI 10.1093/nar/23.19.3901; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; DESTEFANO JJ, 1992, BIOCHIM BIOPHYS ACTA, V1131, P270, DOI 10.1016/0167-4781(92)90025-U; DeStefano JJ, 2001, J BIOL CHEM, V276, P32515, DOI 10.1074/jbc.M103958200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gao HQ, 1999, J MOL BIOL, V294, P1097, DOI 10.1006/jmbi.1999.3325; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Hang JQ, 2007, BIOCHEM BIOPH RES CO, V352, P341, DOI 10.1016/j.bbrc.2006.11.018; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kelleher CD, 2000, J BIOL CHEM, V275, P13061, DOI 10.1074/jbc.275.17.13061; Klumpp K, 2006, CURR PHARM DESIGN, V12, P1909, DOI 10.2174/138161206776873653; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lim D, 2006, J VIROL, V80, P8379, DOI 10.1128/JVI.00750-06; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Mandal D, 2006, NUCLEIC ACIDS RES, V34, P2853, DOI 10.1093/nar/gkl360; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Palaniappan C, 1996, J BIOL CHEM, V271, P2063, DOI 10.1074/jbc.271.47.29605; Paulson BA, 2007, VIROLOGY, V366, P361, DOI 10.1016/j.virol.2007.04.028; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Schultz SJ, 2000, J BIOL CHEM, V275, P32299, DOI 10.1074/jbc.M000021200; Schultz SJ, 2006, J BIOL CHEM, V281, P1943, DOI 10.1074/jbc.M510504200; Schultz SJ, 2004, J MOL BIOL, V344, P635, DOI 10.1016/j.jmb.2004.09.081; Schultz SJ, 2003, J VIROL, V77, P5275, DOI 10.1128/JVI.77.9.5275-5285.2003; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; Telesnitsky A, 1993, REVERSE TRANSCRIPTAS; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; Tramontano E, 2006, MINI-REV MED CHEM, V6, P727, DOI 10.2174/138955706777435733; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297; Wisniewski M, 2002, J BIOL CHEM, V277, P28400, DOI 10.1074/jbc.M201645200; YU H, 1992, J BIOL CHEM, V267, P10888	55	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32225	32238		10.1074/jbc.M109.043158	http://dx.doi.org/10.1074/jbc.M109.043158			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778906	Green Published, hybrid			2022-12-25	WOS:000272028400003
J	Daire, V; Giustiniani, J; Leroy-Gori, I; Quesnoit, M; Drevensek, S; Dimitrov, A; Perez, F; Pous, C				Daire, Vanessa; Giustiniani, Julien; Leroy-Gori, Ingrid; Quesnoit, Melanie; Drevensek, Stephanie; Dimitrov, Ariane; Perez, Franck; Poues, Christian			Kinesin-1 Regulates Microtubule Dynamics via a c-Jun N-terminal Kinase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END; MOTOR PROTEINS; IN-VIVO; PHOSPHORYLATION; BINDING; MOTILITY; GROWTH; INSTABILITY; ASSOCIATION; MODULATION	In the kinesin family, all the molecular motors that have been implicated in the regulation of microtubule dynamics have been shown to stimulate microtubule depolymerization. Here, we report that kinesin-1 (also known as conventional kinesin or KIF5B) stimulates microtubule elongation and rescues. We show that microtubule-associated kinesin-1 carries the c-Jun N-terminal kinase (JNK) to allow its activation and that microtubule elongation requires JNK activity throughout the microtubule life cycle. We also show that kinesin-1 and JNK promoted microtubule rescues to similar extents. Stimulation of microtubule rescues by the kinesin-1/JNK pathway could not be accounted for by the rescue factor CLIP-170. Indeed only a dual inhibition of kinesin-1/JNK and CLIP-170 completely blocked rescues and led to extensive microtubule loss. We propose that the kinesin-1/JNK signaling pathway is a major regulator of microtubule dynamics in living cells and that it is required with the rescue factor CLIP-170 to allow cells to build their interphase microtubule network.	[Poues, Christian] Univ Paris 11, Fac Pharm, JE2493, IFR141, F-92296 Chatenay Malabry, France; [Quesnoit, Melanie; Dimitrov, Ariane; Perez, Franck] CNRS, UMR 144, F-75246 Paris 05, France; [Quesnoit, Melanie; Dimitrov, Ariane; Perez, Franck] Inst Curie, Sect Rech, F-75246 Paris 05, France; [Daire, Vanessa] Univ Paris Sud, Pharm Galen & Biopharm Lab, CNRS, Fac Pharm,IFR141,UMR BioCis 8076, F-92296 Chatenay Malabry, France; [Poues, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Pous, C (corresponding author), Univ Paris 11, Fac Pharm, JE2493, IFR141, 5 Rue JB Clement, F-92296 Chatenay Malabry, France.	christian.pous@u-psud.fr	POÜS, Christian/R-5089-2018; Perez, Franck/A-1558-2014	Perez, Franck/0000-0002-9129-9401; POUS, Christian/0000-0002-2502-7854; Giustiniani, Julien/0000-0003-0373-5857	Ministere de la Recherche; Centre National de la Recherche Scientifique; Institut Curie; Ligue Nationale contre le Cancer; Institut de Recherche International Servier	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut de Recherche International Servier	This work was supported by the Grant ACI-BCMS 338 from the Ministere de la Recherche (to C. P.) by the Centre National de la Recherche Scientifique, and by the Institut Curie (to F. P.) and by a grant from the Ministere de la Recherche (to V. D.), a grant from the Ligue Nationale contre le Cancer (to J.G.), and a grant from the Institut de Recherche International Servier (to M. Q.).	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; CANO E, 1995, J CELL SCI, V108, P3599; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DHAMODHARAN R, 1995, J CELL SCI, V108, P1679; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Gupta V, 2008, TRAFFIC, V9, P1850, DOI 10.1111/j.1600-0854.2008.00811.x; HOWARD J, 1993, METHOD CELL BIOL, V39, P137, DOI 10.1016/S0091-679X(08)60167-3; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova YA, 2002, J CELL SCI, V115, P3527; KOWALSKI RJ, 1993, CELL MOTIL CYTOSKEL, V26, P282, DOI 10.1002/cm.970260403; Krebs A, 2004, J MOL BIOL, V335, P139, DOI 10.1016/j.jmb.2003.10.039; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Marceiller J, 2005, EXP CELL RES, V304, P483, DOI 10.1016/j.yexcr.2004.12.007; MARKS DL, 1994, J CELL SCI, V107, P2417; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Mouthiers A, 2005, MOL ENDOCRINOL, V19, P1135, DOI 10.1210/me.2004-0188; Muto E, 2005, J CELL BIOL, V168, P691, DOI 10.1083/jcb.200409035; Parsons SF, 1997, CELL MOTIL CYTOSKEL, V36, P1; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; RICKARD JE, 1991, J BIOL CHEM, V266, P17597; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	44	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31992	32001		10.1074/jbc.M109.007906	http://dx.doi.org/10.1074/jbc.M109.007906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759393	Green Published, hybrid			2022-12-25	WOS:000271572700055
J	Bach, C; Gilch, S; Rost, R; Greenwood, AD; Horsch, M; Hajj, GNM; Brodesser, S; Facius, A; Schadler, S; Sandhoff, K; Beckers, J; Leib-Mosch, C; Schatzl, HM; Vorberg, I				Bach, Christian; Gilch, Sabine; Rost, Romina; Greenwood, Alex D.; Horsch, Marion; Hajj, Glaucia N. M.; Brodesser, Susanne; Facius, Axel; Schaedler, Sandra; Sandhoff, Konrad; Beckers, Johannes; Leib-Moesch, Christine; Schaetzl, Hermann M.; Vorberg, Ina			Prion-induced Activation of Cholesterogenic Gene Expression by Srebp2 in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; MOLECULAR-BIOLOGY; CELLULAR PRION; SCRAPIE; IDENTIFICATION; BRAINS; LINE; DYSFUNCTION; MICROARRAY; ALZHEIMERS	Prion diseases are neurodegenerative diseases associated with the accumulation of a pathogenic isoform of the host-encoded prion protein. The cellular responses to prion infection are not well defined. By performing microarray analysis on cultured neuronal cells infected with prion strain 22L, in the group of up-regulated genes we observed predominantly genes of the cholesterol pathway. Increased transcript levels of at least nine enzymes involved in cholesterol synthesis, including the gene for the rate-limiting hydroxymethylglutaryl-CoA reductase, were detected. Up-regulation of cholesterogenic genes was attributable to a prion-dependent increase in the amount and activity of the sterol regulatory element-binding protein Srebp2, resulting in elevated levels of total and free cellular cholesterol. The up-regulation of cholesterol biosynthesis appeared to be a characteristic response of neurons to prion challenge, as cholesterogenic transcripts were also elevated in persistently infected GT-1 cells and prion-exposed primary hippocampal neurons but not in microglial cells and primary astrocytes. These results convincingly demonstrate that prion propagation not only depends on the availability of cholesterol but that neuronal cells themselves respond to prions with specific up-regulation of cholesterol biosynthesis.	[Schaetzl, Hermann M.; Vorberg, Ina] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Bach, Christian; Greenwood, Alex D.; Leib-Moesch, Christine] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, D-85764 Neuherberg, Germany; [Horsch, Marion; Schaedler, Sandra; Beckers, Johannes] German Res Ctr Environm & Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Neuherberg, Germany; [Hajj, Glaucia N. M.] Ludwig Inst Canc Res, BR-01323903 Sao Paulo, Brazil; [Brodesser, Susanne; Sandhoff, Konrad] Univ Bonn, Kekule Inst Organ Chem & Biochem, Membrane Biol & Lipid Biochem Unit, LIMES, D-53121 Bonn, Germany; [Facius, Axel] German Res Ctr Environm & Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat, D-85764 Neuherberg, Germany; [Beckers, Johannes] Tech Univ Munich, Inst Expt Genet, D-85350 Freising Weihenstephan, Germany; [Leib-Moesch, Christine] Heidelberg Univ, Med Fac Mannheim, Med Clin 3, D-68135 Mannheim, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ludwig Institute for Cancer Research; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ruprecht Karls University Heidelberg	Schatzl, HM (corresponding author), Tech Univ Munich, Inst Virol, Trogerstr 30, D-81675 Munich, Germany.	schaetzl@lrz.tum.de; vorberg@virologie.med.tum.de	Beckers, Johannes/K-7237-2012; Greenwood, Alex/GWU-8292-2022; Neurociencia, Inct/I-1011-2013; Hajj, Glaucia N M/I-8176-2015; Schatzl, Hermann/G-4958-2011	Beckers, Johannes/0000-0001-7874-3822; Hajj, Glaucia N M/0000-0003-2342-7384; Schatzl, Hermann/0000-0003-4972-8740	Deutsche Forschungsgemeinschaft [VO 1277/1-2, SFB 596]; Bayerischer Forschungsverbund FORPRION [TUM 7]; European Commission [TSEUR LSHB-CT-2005-018805]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerischer Forschungsverbund FORPRION; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Deutsche Forschungsgemeinschaft Grants VO 1277/1-2, SFB 596 (Projects A8 and B14), by Bayerischer Forschungsverbund FORPRION (TUM 7), and by the European Commission Grant TSEUR LSHB-CT-2005-018805. This study was performed within the framework of EU FP6 Network of Excellence Neuroprion.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Brown AR, 2005, BIOCHEM BIOPH RES CO, V334, P86, DOI 10.1016/j.bbrc.2005.06.060; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Budka H, 2003, BRIT MED BULL, V66, P121, DOI 10.1093/bmb/66.1.121; Burns M, 2002, ANN NY ACAD SCI, V977, P367, DOI 10.1111/j.1749-6632.2002.tb04839.x; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; DOHURA K, 1995, MICROB PATHOGENESIS, V18, P1, DOI 10.1016/S0882-4010(05)80008-7; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Greenwood AD, 2005, J MOL BIOL, V349, P487, DOI 10.1016/j.jmb.2005.03.076; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Julius C, 2008, J MOL BIOL, V375, P1222, DOI 10.1016/j.jmb.2007.11.003; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Koh CHV, 2007, J CELL PHYSIOL, V211, P63, DOI 10.1002/jcp.20912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Mange A, 2000, J VIROL, V74, P3135, DOI 10.1128/JVI.74.7.3135-3140.2000; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Mok SWF, 2006, BIOCHEM BIOPH RES CO, V348, P697, DOI 10.1016/j.bbrc.2006.07.123; MOMOI T, 1976, BIOCHIM BIOPHYS ACTA, V441, P488; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Nunziante M, 2003, CHEMBIOCHEM, V4, P1268, DOI 10.1002/cbic.200300704; Ohm TG, 2003, PHARMACOPSYCHIATRY, V36, pS120; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schatzl HM, 1997, J VIROL, V71, P8821; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Tang Y, 2009, J VIROL, V83, P9464, DOI 10.1128/JVI.00352-09; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Turley SD, 1996, J LIPID RES, V37, P1953; Turley SD, 1998, AM J PHYSIOL-ENDOC M, V274, pE1099, DOI 10.1152/ajpendo.1998.274.6.E1099; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Valenza M, 2006, PROG NEUROBIOL, V80, P165, DOI 10.1016/j.pneurobio.2006.09.005; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6	61	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31260	31269		10.1074/jbc.M109.004382	http://dx.doi.org/10.1074/jbc.M109.004382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748890	Green Published, hybrid			2022-12-25	WOS:000271378400053
J	Sahoo, SK; Kim, T; Kang, GB; Lee, JG; Eom, SH; Kim, DH				Sahoo, Sanjaya Kumar; Kim, Taeyong; Kang, Gil Bu; Lee, Jung-Gyu; Eom, Soo Hyun; Kim, Do Han			Characterization of Calumenin-SERCA2 Interaction in Mouse Cardiac Sarcoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ TRANSPORT ATPASE; HISTIDINE-RICH; CA2+-BINDING PROTEIN; RYANODINE RECEPTOR; CA2+-ATPASE SERCA; BINDING-PROTEIN; LUMINAL CALCIUM; PHOSPHOLAMBAN; ISOFORMS; CONTRACTILITY	Calumenin is a multiple EF-hand Ca2+-binding protein localized in the sarcoplasmic reticulum (SR) with C-terminal SR retention signal HDEF. Recently, we showed evidence that calumenin interacts with SERCA2 in rat cardiac SR (Sahoo, S. K., and Kim, D. H. (2008) Mol. Cells 26, 265-269). The present study was undertaken to further characterize the association of calumenin with SERCA2 in mouse heart by various gene manipulation approaches. Immunocytochemical analysis showed that calumenin and SERCA2 were partially co-localized in HL-1 cells. Knockdown (KD) of calumenin was conducted in HL-1 cells and 80% reduction of calumenin did not induce any expressional changes of other Ca2+-cycling proteins. But it enhanced Ca2+ transient amplitude and showed shortened time to reach peak and decreased time to reach 50% of baseline. Oxalate-supported Ca2+ uptake showed increased Ca2+ sensitivity of SERCA2 in calumenin KD HL-1 cells. Calumenin and SERCA2 interaction was significantly lower in the presence of thapsigargin, vanadate, or ATP, as compared with 1.3 mu M Ca2+, suggesting that the interaction is favored in the E1 state of SERCA2. A glutathione S-transferase-pulldown assay of calumenin deletion fragments and SERCA2 luminal domains suggested that regions of 132-222 amino acids of calumenin and 853-892 amino acids of SERCA2-L4 are the major binding partners. On the basis of our in vitro binding data and available information on three-dimensional structure of Ca2+-ATPases, a molecular model was proposed for the interaction between calumenin and SERCA2. Taken together, the present results suggest that calumenin is a novel regulator of SERCA2, and its expressional changes are tightly coupled with Ca2+-cycling of cardiomyocytes.	Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; Gwangju Inst Sci & Technol, Syst Biol Res Ctr, Kwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Kim, DH (corresponding author), 261 Cheomdan Gwagiro Oryong Dong, Kwangju 500712, South Korea.	dhkim@gist.ac.kr		Kim, Taeyong/0000-0002-4147-3635	Korea Ministry of Science and Technology Systems Biology Research [M1050301001-6N0301-0110]; Brain Korea 21; Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment	Korea Ministry of Science and Technology Systems Biology Research; Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment	This work was supported by Korea Ministry of Science and Technology Systems Biology Research Grant M1050301001-6N0301-0110, Brain Korea 21 Project, and the Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment Grant (2009).	Arvanitis DA, 2007, AM J PHYSIOL-HEART C, V293, pH1581, DOI 10.1152/ajpheart.00278.2007; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Asahi M, 2003, TRENDS CARDIOVAS MED, V13, P152, DOI 10.1016/S1050-1738(03)00037-9; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bluhm WF, 2000, AM J PHYSIOL-HEART C, V278, pH249, DOI 10.1152/ajpheart.2000.278.1.H249; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Daiho T, 2001, J BIOL CHEM, V276, P32771, DOI 10.1074/jbc.M101229200; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dremina ES, 2004, BIOCHEM J, V383, P361, DOI 10.1042/BJ20040187; Fan GC, 2004, AM J PHYSIOL-HEART C, V287, pH1705, DOI 10.1152/ajpheart.01211.2003; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Gregory KN, 2006, J MOL CELL CARDIOL, V40, P653, DOI 10.1016/j.yjmcc.2006.02.003; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Ihara Y, 2005, BIOCHEM BIOPH RES CO, V329, P1343, DOI 10.1016/j.bbrc.2005.02.112; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Jung DH, 2004, GENE, V327, P185, DOI 10.1016/j.gene.2003.10.014; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HG, 2001, J BIOL CHEM, V276, P39533, DOI 10.1074/jbc.M010664200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MAHANEY JE, 1995, BIOCHEMISTRY-US, V34, P4864, DOI 10.1021/bi00014a044; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Mueller B, 2004, BIOCHEMISTRY-US, V43, P12846, DOI 10.1021/bi0489457; Papp S, 2008, OPEN CARDIOVASC MED, V2, P31, DOI 10.2174/1874192400802010031; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; PICK U, 1982, J BIOL CHEM, V257, P6111; Ramesh V, 2001, J BIOCHEM MOL BIOL, V34, P573; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sahoo SK, 2008, MOL CELLS, V26, P265; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimura M, 2008, CARDIOVASC RES, V77, P362, DOI 10.1093/cvr/cvm019; Terracciano CMN, 1998, J PHYSIOL-LONDON, V512, P651, DOI 10.1111/j.1469-7793.1998.651bd.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Vangheluwe P, 2003, CELL CALCIUM, V34, P457, DOI 10.1016/S0143-4160(03)00126-X; VATIADAKI E, 2009, MOL BIOL CELL, V20, P306; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; Watanabe A, 2004, J MOL CELL CARDIOL, V37, P691, DOI 10.1016/j.yjmcc.2004.06.009; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232	53	43	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31109	31121		10.1074/jbc.M109.031989	http://dx.doi.org/10.1074/jbc.M109.031989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740751	Green Published, hybrid			2022-12-25	WOS:000271378400039
J	Jain, A; Munn, LL				Jain, Abhishek; Munn, Lance L.			Determinants of Leukocyte Margination in Rectangular Microchannels	PLOS ONE			English	Article							TOTAL ANALYSIS SYSTEMS; RED-CELL AGGREGATION; BLOOD-FLOW; WHOLE-BLOOD; SHEAR RATE; ADHESION; ERYTHROCYTES; MICROFLUIDICS; EMIGRATION; CAPILLARY	Microfabrication of polydimethylsiloxane (PDMS) devices has provided a new set of tools for studying fluid dynamics of blood at the scale of real microvessels. However, we are only starting to understand the power and limitations of this technology. To determine the applicability of PDMS microchannels for blood flow analysis, we studied white blood cell (WBC) margination in channels of various geometries and blood compositions. We found that WBCs prefer to marginate downstream of sudden expansions, and that red blood cell (RBC) aggregation facilitates the process. In contrast to tubes, WBC margination was restricted to the sidewalls in our low aspect ratio, pseudo-2D rectangular channels and consequently, margination efficiencies of more than 95% were achieved in a variety of channel geometries. In these pseudo-2D channels blood rheology and cell integrity were preserved over a range of flow rates, with the upper range limited by the shear in the vertical direction. We conclude that, with certain limitations, rectangular PDMS microfluidic channels are useful tools for quantitative studies of blood rheology.			Jain, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Steele Lab Tumor Biol, Charlestown, MA USA.	lance@steele.mgh.harvard.edu	Munn, Lance L/L-3950-2016	Munn, Lance L/0000-0003-0698-7232; Jain, Abhishek/0000-0003-2235-5139	NATIONAL CANCER INSTITUTE [R21CA126761] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA126761] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbitt KB, 2003, AM J PHYSIOL-HEART C, V285, pH229, DOI 10.1152/ajpheart.00408.2002; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Andersson H, 2003, SENSOR ACTUAT B-CHEM, V92, P315, DOI 10.1016/S0925-4005(03)00266-1; BAGGE U, 1983, INT J MICROCIRC, V2, P215; BAGGE U, 1980, MICROVASC RES, V20, P92, DOI 10.1016/0026-2862(80)90023-0; BARBEE JH, 1971, MICROVASC RES, V3, P17, DOI 10.1016/0026-2862(71)90003-3; BARBEE JH, 1971, MICROVASC RES, V3, P6, DOI 10.1016/0026-2862(71)90002-1; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BRENNER H, 1961, CHEM ENG SCI, V16, P242, DOI 10.1016/0009-2509(61)80035-3; Chen P, 2008, FRONT BIOSCI-LANDMRK, V13, P2464, DOI 10.2741/2859; Chen X, 2009, MICROSYST TECHNOL, V15, P667, DOI 10.1007/s00542-009-0783-8; COLDITZ IG, 1985, SURV SYN PATHOL RES, V4, P44; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; DEITCHER SR, 2003, CANC THROMBOSIS MECH, P21; Dittrich PS, 2006, ANAL CHEM, V78, P3887, DOI 10.1021/ac0605602; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Faivre M, 2006, BIORHEOLOGY, V43, P147; FIRRELL JC, 1989, AM J PHYSIOL, V256, pH1667, DOI 10.1152/ajpheart.1989.256.6.H1667; Goldsmith H L, 1984, Kroc Found Ser, V16, P131; GOLDSMITH H L, 1971, Biorheology, V7, P235; GOLDSMITH HL, 1971, FED PROC, V30, P1578; GOLDSMITH HL, 1984, MICROVASC RES, V27, P204, DOI 10.1016/0026-2862(84)90054-2; Higgins JM, 2007, P NATL ACAD SCI USA, V104, P20496, DOI 10.1073/pnas.0707122105; Iigo Y, 1997, AM J PHYSIOL-HEART C, V273, pH138, DOI 10.1152/ajpheart.1997.273.1.H138; Jaggi RD, 2007, MICROFLUID NANOFLUID, V3, P47, DOI 10.1007/s10404-006-0104-9; JAIN A, 2009, LAB ON A CHIP TECHNO; Kim S, 2005, AM J PHYSIOL-HEART C, V288, pH584, DOI 10.1152/ajpheart.00690.2004; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1947, DOI 10.1152/ajpheart.00764.2006; LAWRENCE MB, 1987, BLOOD, V70, P1284; LESS JR, 1991, CANCER RES, V51, P265; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; MUNN LL, 1994, BIOPHYS J, V67, P889, DOI 10.1016/S0006-3495(94)80550-8; Munn LL, 1996, BIOPHYS J, V71, P466, DOI 10.1016/S0006-3495(96)79248-2; Nash GB, 2008, CLIN HEMORHEOL MICRO, V39, P303, DOI 10.3233/CH-2008-1109; Neu B, 2008, BIOPHYS J, V95, P3059, DOI 10.1529/biophysj.108.130328; NOBIS U, 1985, MICROVASC RES, V29, P295, DOI 10.1016/0026-2862(85)90020-2; Pearson MJ, 2004, MICROCIRCULATION, V11, P295, DOI 10.1080/10739680490425994; Pearson MJ, 2000, AM J PHYSIOL-HEART C, V279, pH1460, DOI 10.1152/ajpheart.2000.279.4.H1460; PHIBBS RH, 1966, AM J PHYSIOL, V210, P919, DOI 10.1152/ajplegacy.1966.210.5.919; Rosenbluth MJ, 2008, LAB CHIP, V8, P1062, DOI 10.1039/b802931h; Schmid-Schonbein GW, 2006, ANNU REV BIOMED ENG, V8, P93, DOI 10.1146/annurev.bioeng.8.061505.095708; SCHMIDSCHONBEIN GW, 1980, MICROVASC RES, V19, P45, DOI 10.1016/0026-2862(80)90083-7; SCHMIDSCHONBEIN H, 1968, J CLIN INVEST, V47, P1447, DOI 10.1172/JCI105836; Secomb TW, 2003, P NATL ACAD SCI USA, V100, P7231, DOI 10.1073/pnas.1232173100; SEGRE G, 1962, J FLUID MECH, V14, P136, DOI 10.1017/S0022112062001111; Shah R. K., 1978, LAMINAR FLOW FORCED, P196; Shevkoplyas SS, 2006, LAB CHIP, V6, P914, DOI 10.1039/b601554a; Shevkoplyas SS, 2005, ANAL CHEM, V77, P933, DOI 10.1021/ac049037i; Shevkoplyas SS, 2003, MICROVASC RES, V65, P132, DOI 10.1016/S0026-2862(02)00034-1; Skalak R. C., 1987, HDB BIOENGINEERING; Sun CH, 2005, BIOPHYS J, V88, P1635, DOI 10.1529/biophysj.104.051151; Sun CH, 2003, BIOPHYS J, V85, P208, DOI 10.1016/S0006-3495(03)74467-1; SUN CH, 2006, INFLUENCE ERYTHROCYT, P191; TANGELDER GJ, 1988, AM J PHYSIOL, V254, pH1059, DOI 10.1152/ajpheart.1988.254.6.H1059; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; VanDelinder V, 2007, ANAL CHEM, V79, P2023, DOI 10.1021/ac061659b; VLODAVSKY I, 2007, HEPARANASE HEPARIN C, pS112; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Weibel DB, 2006, CURR OPIN CHEM BIOL, V10, P584, DOI 10.1016/j.cbpa.2006.10.016; Weigl B, 2008, LAB CHIP, V8, P1999, DOI 10.1039/b811314a; West J, 2008, ANAL CHEM, V80, P4403, DOI 10.1021/ac800680j; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WILLIAMSON J, 1961, AM J PATHOL, V39, P239	66	66	79	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7104	10.1371/journal.pone.0007104	http://dx.doi.org/10.1371/journal.pone.0007104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768109	gold, Green Published, Green Submitted			2022-12-25	WOS:000270154000008
J	Vellaichamy, A; Sreekumar, A; Strahler, JR; Rajendiran, T; Yu, JD; Varambally, S; Li, Y; Omenn, GS; Chinnaiyan, AM; Nesvizhskii, AI				Vellaichamy, Adaikkalam; Sreekumar, Arun; Strahler, John R.; Rajendiran, Theckelnaycke; Yu, Jindan; Varambally, Sooryanarayana; Li, Yong; Omenn, Gilbert S.; Chinnaiyan, Arul M.; Nesvizhskii, Alexey I.			Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases	PLOS ONE			English	Article							GENE-EXPRESSION; STATISTICAL-MODEL; IDENTIFICATION; PEPTIDES; NETWORKS; PATHWAYS; PROTEINS; LNCAP	Prostate cancer remains the most common malignancy among men in United States, and there is no remedy currently available for the advanced stage hormone-refractory cancer. This is partly due to the incomplete understanding of androgen-regulated proteins and their encoded functions. Whole-cell proteomes of androgen-starved and androgen-treated LNCaP cells were analyzed by semi-quantitative MudPIT ESI-ion trap MS/MS and quantitative iTRAQ MALDI-TOF MS/MS platforms, with identification of more than 1300 high-confidence proteins. An enrichment-based pathway mapping of the androgen-regulated proteomic data sets revealed a significant dysregulation of aminoacyl tRNA synthetases, indicating an increase in protein biosynthesis-a hallmark during prostate cancer progression. This observation is supported by immunoblot and transcript data from LNCaP cells, and prostate cancer tissue. Thus, data derived from multiple proteomics platforms and transcript data coupled with informatics analysis provides a deeper insight into the functional consequences of androgen action in prostate cancer.			Vellaichamy, A (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	asreekumar@mcg.edu; nesvi@med.umich.edu	Nesvizhskii, Alexey/A-5410-2012; Vellaichamy, Adaikkalam/GWN-0713-2022	Nesvizhskii, Alexey/0000-0002-2806-7819; Vellaichamy, Adaikkalam/0000-0002-1740-1252; Omenn, Gilbert S./0000-0002-8976-6074; Varambally, Sooryanarayana/0000-0002-2277-1127	NATIONAL CANCER INSTITUTE [R01CA126239, K99CA129565, U01CA111275, R01CA133458, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER; NCI NIH HHS [K99 CA129565-02S1, R01CA126239, K99 CA129565-01A1, K99 CA129565, R01CA133458, U01 CA111275, R01 CA126239, K99 CA129565-02, R01 CA133458, 1K99CA129565-01A1, P50 CA069568, P50 CA69568] Funding Source: Medline; NIDA NIH HHS [U54DA021519, U54 DA021519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bodnar WM, 2003, J AM SOC MASS SPECTR, V14, P971, DOI 10.1016/S1044-0305(03)00209-5; DEHM SM, 2007, ANDROGEN RECEPTOR ST, P2855; DePrimo SE, 2002, GENOME BIOL, V3; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gobinet J, 2002, MOL CELL ENDOCRINOL, V198, P15, DOI 10.1016/S0303-7207(02)00364-7; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Martin DB, 2004, CANCER RES, V64, P347, DOI 10.1158/0008-5472.CAN-03-2062; Meehan KL, 2004, PROTEOMICS, V4, P1116, DOI 10.1002/pmic.200300649; Nelson PS, 2000, ELECTROPHORESIS, V21, P1823; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Ott LW, 2007, J PROTEOME RES, V6, P2176, DOI 10.1021/pr060665l; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; TU LC, 2007, PROTEOMICS ANAL INTE, P575; Waghray A, 2001, PROTEOMICS, V1, P1327, DOI 10.1002/1615-9861(200110)1:10<1327::AID-PROT1327>3.3.CO;2-2; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wright ME, 2004, GENOME BIOL, V5; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; YOCUM AK, 2008, MOL CELL PROTEOMICS; YOUNG CYF, 1991, CANCER RES, V51, P3748; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; ZYBAILOV B, 2006, STAT ANAL MEMBRANE E, P2339	35	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7075	10.1371/journal.pone.0007075	http://dx.doi.org/10.1371/journal.pone.0007075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763266	gold, Green Submitted, Green Published			2022-12-25	WOS:000269970400011
J	Arnesano, F; Scintilla, S; Calo, V; Bonfrate, E; Ingrosso, C; Losacco, M; Pellegrino, T; Rizzarelli, E; Natile, G				Arnesano, Fabio; Scintilla, Simone; Calo, Vincenza; Bonfrate, Elena; Ingrosso, Chiara; Losacco, Maurizio; Pellegrino, Teresa; Rizzarelli, Enrico; Natile, Giovanni			Copper-Triggered Aggregation of Ubiquitin	PLOS ONE			English	Article								Neurodegenerative disorders share common features comprising aggregation of misfolded proteins, failure of the ubiquitin-proteasome system, and increased levels of metal ions in the brain. Protein aggregates within affected cells often contain ubiquitin, however no report has focused on the aggregation propensity of this protein. Recently it was shown that copper, differently from zinc, nickel, aluminum, or cadmium, compromises ubiquitin stability and binds to the N-terminus with 0.1 micromolar affinity. This paper addresses the role of copper upon ubiquitin aggregation. In water, incubation with Cu(II) leads to formation of spherical particles that can progress from dimers to larger conglomerates. These spherical oligomers are SDS-resistant and are destroyed upon Cu(II) chelation or reduction to Cu( I). In water/trifluoroethanol (80:20, v/v), a mimic of the local decrease in dielectric constant experienced in proximity to a membrane surface, ubiquitin incubation with Cu(II) causes time-dependent changes in circular dichroism and Fourier-transform infrared spectra, indicative of increasing beta-sheet content. Analysis by atomic force and transmission electron microscopy reveals, in the given order, formation of spherical particles consistent with the size of early oligomers detected by gel electrophoresis, clustering of these particles in straight and curved chains, formation of ring structures, growth of trigonal branches from the rings, coalescence of the trigonal branched structures in a network. Notably, none of these ubiquitin aggregates was positive to tests for amyloid and Cu( II) chelation or reduction produced aggregate disassembly. The early formed Cu(II)-stabilized spherical oligomers, when reconstituted in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes and in POPC planar bilayers, form annular and pore-like structures, respectively, which are common to several neurodegenerative disorders including Parkinson's, Alzheimer's, amyotrophic lateral sclerosis, and prion diseases, and have been proposed to be the primary toxic species. Susceptibility to aggregation of ubiquitin, as it emerges from the present study, may represent a potential risk factor for disease onset or progression while cells attempt to tag and process toxic substrates.			Arnesano, F (corresponding author), Univ Bari A Moro, Dipartimento Farmacochim, Bari, Italy.	arnesano@farmchim.uniba.it	Arnesano, Fabio/C-3066-2016; Pellegrino, teresa/G-6417-2010	Arnesano, Fabio/0000-0002-8399-0964; RIZZARELLI, ENRICO/0000-0001-5367-0823; Scintilla, Simone/0000-0002-8872-0920; Pellegrino, Teresa/0000-0001-5518-1134; Natile, Giovanni/0000-0002-1790-6365				Amici M, 2002, J BIOL INORG CHEM, V7, P750, DOI 10.1007/s00775-002-0352-4; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chwiej J, 2008, J TRACE ELEM MED BIO, V22, P183, DOI 10.1016/j.jtemb.2008.03.006; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DOHERTY FJ, 1989, BIOCHEM J, V263, P47, DOI 10.1042/bj2630047; Donnelly PS, 2007, CURR OPIN CHEM BIOL, V11, P128, DOI 10.1016/j.cbpa.2007.01.678; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hess S, 2007, EMBO REP, V8, P1196, DOI 10.1038/sj.embor.7401096; Ide-Ektessabi A, 2005, ANAL SCI, V21, P885, DOI 10.2116/analsci.21.885; Jackson SE, 2006, ORG BIOMOL CHEM, V4, P1845, DOI 10.1039/b600829c; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Lashuel H. A., 2005, SCI AGING KNOWLEDGE, V2005, pe28; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee JC, 2008, J AM CHEM SOC, V130, P6898, DOI 10.1021/ja711415b; Liang XY, 2007, CHEM SOC REV, V36, P968, DOI 10.1039/b617040b; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; Lowe J, 2005, METHOD ENZYMOL, V399, P86, DOI 10.1016/S0076-6879(05)99007-1; Lowe R, 2004, PROTEIN SCI, V13, P3245, DOI 10.1110/ps.04879704; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Milardi D, 2007, ANGEW CHEM INT EDIT, V46, P7993, DOI 10.1002/anie.200701987; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Morgan CJ, 2001, J MOL BIOL, V309, P339, DOI 10.1006/jmbi.2001.4661; Moriya M, 2008, AM J PHYSIOL-CELL PH, V295, pC708, DOI 10.1152/ajpcell.00029.2008; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PARAG HA, 1987, EMBO J, V6, P55, DOI 10.1002/j.1460-2075.1987.tb04718.x; Pellistri F, 2008, J BIOL CHEM, V283, P29950, DOI 10.1074/jbc.M803992200; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wand AJ, 1996, BIOCHEMISTRY-US, V35, P6116, DOI 10.1021/bi9530144; WANG AC, 1995, J BIOMOL NMR, V5, P376; Wright JA, 2008, J NEUROSCI RES, V86, P496, DOI 10.1002/jnr.21461; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	70	38	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7052	10.1371/journal.pone.0007052	http://dx.doi.org/10.1371/journal.pone.0007052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756145	Green Submitted, gold, Green Published			2022-12-25	WOS:000269970000018
J	Worth, CL; Kleinau, G; Krause, G				Worth, Catherine L.; Kleinau, Gunnar; Krause, Gerd			Comparative Sequence and Structural Analyses of G-Protein-Coupled Receptor Crystal Structures and Implications for Molecular Models	PLOS ONE			English	Article							3RD EXTRACELLULAR LOOP; CONFORMATIONAL-CHANGES; THYROTROPIN RECEPTOR; HORMONE RECEPTOR; LIGAND-BINDING; RHODOPSIN; MUTATIONS; GENE; IDENTIFICATION; ACTIVATION	Background: Up until recently the only available experimental (high resolution) structure of a G-protein-coupled receptor (GPCR) was that of bovine rhodopsin. In the past few years the determination of GPCR structures has accelerated with three new receptors, as well as squid rhodopsin, being successfully crystallized. All share a common molecular architecture of seven transmembrane helices and can therefore serve as templates for building molecular models of homologous GPCRs. However, despite the common general architecture of these structures key differences do exist between them. The choice of which experimental GPCR structure(s) to use for building a comparative model of a particular GPCR is unclear and without detailed structural and sequence analyses, could be arbitrary. The aim of this study is therefore to perform a systematic and detailed analysis of sequence-structure relationships of known GPCR structures. Methodology: We analyzed in detail conserved and unique sequence motifs and structural features in experimentally-determined GPCR structures. Deeper insight into specific and important structural features of GPCRs as well as valuable information for template selection has been gained. Using key features a workflow has been formulated for identifying the most appropriate template(s) for building homology models of GPCRs of unknown structure. This workflow was applied to a set of 14 human family A GPCRs suggesting for each the most appropriate template(s) for building a comparative molecular model. Conclusions: The available crystal structures represent only a subset of all possible structural variation in family A GPCRs. Some GPCRs have structural features that are distributed over different crystal structures or which are not present in the templates suggesting that homology models should be built using multiple templates. This study provides a systematic analysis of GPCR crystal structures and a consistent method for identifying suitable templates for GPCR homology modelling that will help to produce more reliable three-dimensional models.			Worth, CL (corresponding author), Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	gkrause@fmp-berlin.de	Niv, Masha Y/E-3148-2010; Kleinau, Gunnar/GPX-6330-2022	Worth, Catherine/0000-0002-1796-9606				Aarons EJ, 2001, VIROLOGY, V287, P382, DOI 10.1006/viro.2001.1046; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; ANGEL TE, 2009, P NATL ACAD SCI US; Attrill H, 2009, PROTEIN EXPRES PURIF, V64, P32, DOI 10.1016/j.pep.2008.10.001; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BELLOT G, 2009, J MOL BIOL; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya S, 2008, J MOL BIOL, V382, P539, DOI 10.1016/j.jmb.2008.06.084; Ceruso MA, 2002, J MOL BIOL, V318, P1237, DOI 10.1016/S0022-2836(02)00221-8; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dean B, 2002, MOL PSYCHIATR, V7, P1083, DOI 10.1038/sj.mp.4001199; Deflorian F, 2008, PROTEINS, V71, P783, DOI 10.1002/prot.21763; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEVILLE J, 2009, J MOL EVOL; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, P2085, DOI 10.1093/nar/gkl156; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; FUCHS S, 1994, HUM MOL GENET, V3, P1203, DOI 10.1093/hmg/3.7.1203; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Glatt SJ, 2006, AM J MED GENET B, V141B, P149, DOI 10.1002/ajmg.b.30273; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Hetherington SL, 2005, ARTERIOSCL THROM VAS, V25, P252, DOI 10.1161/01.ATV.0000148708.44691.27; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Karsak M, 2005, HUM MOL GENET, V14, P3389, DOI 10.1093/hmg/ddi370; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kleinau G, 2008, CELL MOL LIFE SCI, V65, P3664, DOI 10.1007/s00018-008-8450-2; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kneissl B, 2009, J MED CHEM, V52, P3166, DOI 10.1021/jm8014487; Krause G, 2000, MOL PHARMACOL, V57, P232; Lattig J, 2009, J PEPT SCI, V15, P479, DOI 10.1002/psc.1146; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson Z, 2004, BIOCHEM SOC T, V32, P1048, DOI 10.1042/BST0321048; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Liu G, 1999, NEW ENGL J MED, V341, P1731, DOI 10.1056/NEJM199912023412304; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; MCLACHLAN A, 2009, ACTA CRYSTALLOGR A, V38, P871; Mehler EL, 2002, J COMPUT AID MOL DES, V16, P841, DOI 10.1023/A:1023845015343; Meyer-Lindenberg A., 2008, MOL PSYCHIAT; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; MICHINO M, 2009, NAT REV DRUG DISCOV; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; NEUMANN S, 2009, P NATL ACAD SCI US; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Oliveira L, 2004, FEBS LETT, V564, P269, DOI 10.1016/S0014-5793(04)00320-5; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; ROBINSON GC, 1993, AM J DIS CHILD, V147, P325, DOI 10.1001/archpedi.1993.02160270087028; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; RUSSO D, 1995, ONCOGENE, V11, P1907; Russo P, 2007, J CLIN ENDOCR METAB, V92, P2382, DOI 10.1210/jc.2006-2523; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SCHEERER P, 2009, P NATL ACAD SCI US; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Smits G, 2003, NEW ENGL J MED, V349, P760, DOI 10.1056/NEJMoa030064; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200; Tarnow P, 2008, OBESITY FACTS, V1, P155, DOI 10.1159/000138251; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Van Durme J, 2006, MOL ENDOCRINOL, V20, P2247, DOI 10.1210/me.2006-0020; Vasseur C, 2003, NEW ENGL J MED, V349, P753, DOI 10.1056/NEJMoa030065; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	85	67	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7011	10.1371/journal.pone.0007011	http://dx.doi.org/10.1371/journal.pone.0007011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756152	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000269970000009
J	Bohbot, JD; Dickens, JC				Bohbot, Jonathan D.; Dickens, Joseph C.			Characterization of an Enantioselective Odorant Receptor in the Yellow Fever Mosquito Aedes aegypti	PLOS ONE			English	Article								Enantiomers differ only in the left or right handedness (chirality) of their orientations and exhibit identical chemical and physical properties. In chemical communication systems, enantiomers can be differentially active at the physiological and behavioral levels. Only recently were enantioselective odorant receptors demonstrated in mammals while their existence in insects has remained hypothetical. Using the two-microelectrode voltage clamp of Xenopus oocytes, we show that the yellow fever mosquito, Aedes aegypti, odorant receptor 8 (AaOR8) acts as a chiral selective receptor for the (R)-(-)-enantiomer of 1-octen-3-ol, which in the presence of other kairomones is an attractant used by blood-sucking insects to locate their hosts. In addition to steric constraints, chain length and degree of unsaturation play important roles in this recognition process. This is the first characterization of an enantioselective odorant receptor in insects and the results demonstrate that an OR alone, without helper proteins, can account for chiral specificity exhibited by olfactory sensory neurons (OSNs).			Bohbot, JD (corresponding author), ARS, USDA,Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci, Beltsville, MD USA.	joseph.dickens@ars.usda.gov	Dickens, Dick/AGY-7295-2022					Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BIERL BA, 1970, SCIENCE, V170, P87, DOI 10.1126/science.170.3953.87; Blackwell A, 1996, PHYSIOL ENTOMOL, V21, P15, DOI 10.1111/j.1365-3032.1996.tb00830.x; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; DICKENS JC, 1990, CHEM SENSES, V15, P311, DOI 10.1093/chemse/15.3.311; DICKENS JC, 1978, ENTOMOL EXP APPL, V24, P336, DOI 10.1007/BF02385082; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Greenwood DR, 2005, NATURE, V438, P1097, DOI 10.1038/4381097a; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; HALL DR, 1984, INSECT SCI APPL, V5, P335, DOI 10.1017/S1742758400008626; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; HANSEN K, 1984, PHYSIOL ENTOMOL, V9, P9, DOI 10.1111/j.1365-3032.1984.tb00676.x; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; IWAKI S, 1974, J AM CHEM SOC, V96, P7842, DOI 10.1021/ja00832a055; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kline DL, 2007, MED VET ENTOMOL, V21, P323, DOI 10.1111/j.1365-2915.2007.00697.x; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krzywinski J, 2001, SYST BIOL, V50, P540, DOI 10.1080/106351501750435095; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Laska M, 2007, NEUROSCIENCE, V144, P295, DOI 10.1016/j.neuroscience.2006.08.063; Laska M, 1999, AM J PHYSIOL-REG I, V277, pR1098, DOI 10.1152/ajpregu.1999.277.4.R1098; Laska M, 2001, BEHAV NEUROSCI, V115, P632, DOI 10.1037/0735-7044.115.3.632; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1996, P NATL ACAD SCI USA, V93, P12112, DOI 10.1073/pnas.93.22.12112; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Mori K, 1998, CHIRALITY, V10, P578, DOI 10.1002/(SICI)1520-636X(1998)10:7<578::AID-CHIR5>3.0.CO;2-Z; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; PIERCE AM, 1989, ENVIRON ENTOMOL, V18, P747, DOI 10.1093/ee/18.5.747; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Reisenman CE, 2004, J NEUROSCI, V24, P2602, DOI 10.1523/JNEUROSCI.5192-03.2004; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SUMIKAWA K, 1981, NATURE, V292, P862, DOI 10.1038/292862a0; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; TUMLINSON JH, 1977, SCIENCE, V197, P789, DOI 10.1126/science.197.4305.789; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; VOGT RG, 1989, J NEUROSCI, V9, P3332; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003; Zhang QH, 2004, J CHEM ECOL, V30, P1849, DOI 10.1023/B:JOEC.0000042406.76705.ab	58	73	74	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7032	10.1371/journal.pone.0007032	http://dx.doi.org/10.1371/journal.pone.0007032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753115	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796500016
J	Shenoy, A; Blelloch, R				Shenoy, Archana; Blelloch, Robert			Genomic Analysis Suggests that mRNA Destabilization by the Microprocessor Is Specialized for the Auto-Regulation of Dgcr8	PLOS ONE			English	Article							MICRORNA; EXPRESSION; DICER; DROSHA; COMPLEX; BIOGENESIS; SIRNAS; TRBP	Background: The Microprocessor, containing the RNA binding protein Dgcr8 and RNase III enzyme Drosha, is responsible for processing primary microRNAs to precursor microRNAs. The Microprocessor regulates its own levels by cleaving hairpins in the 5'UTR and coding region of the Dgcr8 mRNA, thereby destabilizing the mature transcript. Methodology/Principal Findings: To determine whether the Microprocessor has a broader role in directly regulating other coding mRNA levels, we integrated results from expression profiling and ultra high-throughput deep sequencing of small RNAs. Expression analysis of mRNAs in wild-type, Dgcr8 knockout, and Dicer knockout mouse embryonic stem (ES) cells uncovered mRNAs that were specifically upregulated in the Dgcr8 null background. A number of these transcripts had evolutionarily conserved predicted hairpin targets for the Microprocessor. However, analysis of deep sequencing data of 18 to 200nt small RNAs in mouse ES, HeLa, and HepG2 indicates that exonic sequence reads that map in a pattern consistent with Microprocessor activity are unique to Dgcr8. Conclusion/Significance: We conclude that the Microprocessor's role in directly destabilizing coding mRNAs is likely specifically targeted to Dgcr8 itself, suggesting a specialized cellular mechanism for gene auto-regulation.			Shenoy, A (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Ctr Reprod Sci, San Francisco, CA 94143 USA.	BlellochR@stemcell.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118, R01NS057221] Funding Source: NIH RePORTER; NINDS NIH HHS [K08 NS048118-02, R01 NS057221, K08 NS048118, K08 NS048118-04, R01 NS057221-03, R01 NS057221-01A1, K08 NS048118-03, K08 NS048118-05, R01 NS057221-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; KADENER S, 2009, GENOME WIDE IDENTIFI; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Maselli V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-457; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; TRABUCCHI M, 2009, NATURE; Triboulet R, 2009, RNA, V15, P1005, DOI 10.1261/rna.1591709; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908	32	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6971	10.1371/journal.pone.0006971	http://dx.doi.org/10.1371/journal.pone.0006971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759829	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696600011
J	Cannas, A; Kalunga, G; Green, C; Calvo, L; Katemangwe, P; Reither, K; Perkins, MD; Maboko, L; Hoelscher, M; Talbot, EA; Mwaba, P; Zumla, AI; Girardi, E; Huggett, JF				Cannas, Angela; Kalunga, Glendah; Green, Clare; Calvo, Ludovica; Katemangwe, Patrick; Reither, Klaus; Perkins, Mark D.; Maboko, Leonard; Hoelscher, Michael; Talbot, Elizabeth A.; Mwaba, Peter; Zumla, Alimuddin I.; Girardi, Enrico; Huggett, Jim F.		TB TrDNA Consortium	Implications of Storing Urinary DNA from Different Populations for Molecular Analyses	PLOS ONE			English	Article								Background: Molecular diagnosis using urine is established for many sexually transmitted diseases and is increasingly used to diagnose tumours and other infectious diseases. Storage of urine prior to analysis, whether due to home collection or bio-banking, is increasingly advocated yet no best practice has emerged. Here, we examined the stability of DNA in stored urine in two populations over 28 days. Methodology: Urine from 40 (20 male) healthy volunteers from two populations, Italy and Zambia, was stored at four different temperatures (RT, 4 degrees C, -20 degrees C & -80 degrees C) with and without EDTA preservative solution. Urines were extracted at days 0, 1, 3, 7 and 28 after storage. Human DNA content was measured using multi-copy (ALU J) and single copy (TLR2) targets by quantitative real-time PCR. Zambian and Italian samples contained comparable DNA quantity at time zero. Generally, two trends were observed during storage; no degradation, or rapid degradation from days 0 to 7 followed by little further degradation to 28 days. The biphasic degradation was always observed in Zambia regardless of storage conditions, but only twice in Italy. Conclusion: Site-specific differences in urine composition significantly affect the stability of DNA during storage. Assessing the quality of stored urine for molecular analysis, by using the type of strategy described here, is paramount before these samples are used for molecular prognostic monitoring, genetic analyses and disease diagnosis.			Cannas, A (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy.	clare.green@ucl.ac.uk	Hoelscher, Michael/D-3436-2012; Mwaba, Peter/V-6017-2019; ZUMLA, Alimuddin/ABA-8208-2020; Huggett, Jim/N-9316-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; Reither, Klaus/0000-0001-6195-8237; Girardi, Enrico/0000-0001-8182-5896; Huggett, Jim/0000-0002-0945-1911	Medical Research Council [G0601466] Funding Source: Medline; MRC [G0601466] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aceti A, 1999, THORAX, V54, P145, DOI 10.1136/thx.54.2.145; Bryzgunova OE, 2006, ANN NY ACAD SCI, V1075, P334, DOI 10.1196/annals.1368.045; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cairns P, 2004, ANN NY ACAD SCI, V1022, P40, DOI 10.1196/annals.1318.007; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; Chapin Kimberle C, 2006, Med Health R I, V89, P202; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Fisa R, 2008, AM J TROP MED HYG, V78, P741, DOI 10.4269/ajtmh.2008.78.741; GARRINGER LA, 2002, GEN M AM SOC MICR, V102, P129; GOPINATH K, 2008, INT J INFECT DIS; Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Huggett J. F., 2008, BMC RES NOTES, V1; Ingersoll J, 2008, J CLIN MICROBIOL, V46, P1628, DOI 10.1128/JCM.02486-07; JOHNSON DJ, 2004, VARIATION NUCL DNA C, P110; Kafwabulula M, 2002, INT J TUBERC LUNG D, V6, P732; Kanavarioti A, 2001, ASTROBIOLOGY, V1, P271, DOI 10.1089/15311070152757465; MCMILLIAN RA, 2004, GEN M AM SOC MICR, V104, P173; Mehta TK, 2006, TRANSPL P, V38, P3420, DOI 10.1016/j.transproceed.2006.10.149; Mharakurwa S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-103; Milde A, 1999, INT J LEGAL MED, V112, P209, DOI 10.1007/s004140050237; Morre SA, 1999, J CLIN MICROBIOL, V37, P976; Murdoch DR, 1996, CLIN INFECT DIS, V23, P475, DOI 10.1093/clinids/23.3.475; Nolan T, 2006, ANAL BIOCHEM, V351, P308, DOI 10.1016/j.ab.2006.01.051; Peakman TC, 2008, INT J EPIDEMIOL, V37, P2, DOI 10.1093/ije/dyn019; PRINZ M, 1993, INT J LEGAL MED, V106, P75, DOI 10.1007/BF01225044; Rebollo MJ, 2006, DIAGN MICR INFEC DIS, V56, P141, DOI 10.1016/j.diagmicrobio.2006.03.018; Sechi LA, 1997, MOL CELL PROBE, V11, P281, DOI 10.1006/mcpr.1997.0119; Swartz B., 2007, Abstracts of the General Meeting of the American Society for Microbiology, V107, P217; Torrea G, 2005, J MED MICROBIOL, V54, P39, DOI 10.1099/jmm.0.45688-0; van der Hel OL, 2002, ANAL BIOCHEM, V304, P206, DOI 10.1006/abio.2002.5634; Vu NT, 1999, FORENSIC SCI INT, V102, P23, DOI 10.1016/S0379-0738(99)00034-1	32	38	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6985	10.1371/journal.pone.0006985	http://dx.doi.org/10.1371/journal.pone.0006985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746164	Green Published, Green Submitted, gold			2022-12-25	WOS:000269696500005
J	Assuncao-Miranda, I; Amaral, FA; Bozza, FA; Fagundes, CT; Sousa, LP; Souza, DG; Pacheco, P; Barbosa-Lima, G; Gomes, RN; Bozza, PT; Da Poian, AT; Teixeira, MM; Bozza, MT				Assuncao-Miranda, Iranaia; Amaral, Flavio A.; Bozza, Fernando A.; Fagundes, Caio T.; Sousa, Lirlandia P.; Souza, Danielle G.; Pacheco, Patricia; Barbosa-Lima, Giselle; Gomes, Rachel N.; Bozza, Patricia T.; Da Poian, Andrea T.; Teixeira, Mauro M.; Bozza, Marcelo T.			Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection	FASEB JOURNAL			English	Article						MIF; cytokine; lipid droplets; inflammation; hemorrhagic fever; sepsis	FACTOR MIF; HEMORRHAGIC-FEVER; JAPANESE ENCEPHALITIS; CHEMOKINE RECEPTORS; DISEASE SEVERITY; INNATE IMMUNITY; REGULATORY ROLE; SHOCK-SYNDROME; SEPTIC SHOCK; SERUM-LEVELS	Dengue fever is an emerging viral disease transmitted by arthropods to humans in tropical countries. Dengue hemorrhagic fever (DHF) is escalating in frequency and mortality rates. Here we studied the involvement of macrophage migration inhibitory factor (MIF) in dengue virus (DENV) infection and its pathogenesis. Patients with DHF had elevated plasma concentrations of MIF. Both leukocytes from these patients and macrophages from healthy donors infected in vitro with DENV showed a substantial amount of MIF within lipid droplets. The secretion of MIF by macrophages and hepatocytes required a productive infection and occurred without an increase in gene transcription or cell death, thus indicating active secretion from preformed stocks. In vivo infection of wildtype and mif-deficient (Mif(-/-)) mice demonstrated a role of MIF in dengue pathogenesis. Clinical disease was less severe in Mif(-/-) mice, and they exhibited a significant delay in lethality, lower viremia, and lower viral load in the spleen than wild-type mice. This reduction in all parameters of severity on DENV infection in Mif(-/-) mice correlated with reduced proinflammatory cytokine concentrations. These results demonstrated the contribution of MIF to the pathogenesis of dengue and pointed to a possible beneficial role of neutralizing MIF as an adjunctive therapeutic approach to treat the severe forms of the disease.-Assuncao-Miranda, I., Amaral, F. A., Bozza, F. A., Fagundes, C. T., Sousa, L. P., Souza, D. G., Pacheco, P., Barbosa-Lima, G., Gomes, R. N., Bozza, P. T., Da Poian, A. T., Teixeira, M. M., Bozza, M. T. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 24, 218-228 (2010). www.fasebj.org	[Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil; [Assuncao-Miranda, Iranaia; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, Rio De Janeiro, Brazil; [Assuncao-Miranda, Iranaia; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, BR-21941 Rio De Janeiro, Brazil; [Amaral, Flavio A.; Fagundes, Caio T.; Souza, Danielle G.] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil; [Bozza, Fernando A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Intens Care Unit, Rio De Janeiro, Brazil; [Pacheco, Patricia; Barbosa-Lima, Giselle; Gomes, Rachel N.; Bozza, Patricia T.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Ave Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.	mmtex@icb.ufmg.br; mtbozza@gmail.com	Da Poian, Andrea T./V-1699-2019; Bozza, Patricia T./AAE-2933-2021; Fagundes, Caio/AAK-9336-2020; souza, danielle/D-3378-2014; Teixeira, Mauro M/A-4587-2008; Amaral, Flávio Almeida/C-3768-2018; Bozza, Fernando A/A-2618-2013; Amaral, Flavio/D-5489-2014; Gomes, Rachel N/I-7643-2013; Bozza, Patricia T./AAM-4537-2021	Fagundes, Caio/0000-0002-6747-5233; Teixeira, Mauro M/0000-0002-6944-3008; Amaral, Flávio Almeida/0000-0002-1695-0612; Bozza, Fernando A/0000-0003-4878-0256; Amaral, Flavio/0000-0002-1695-0612; Bozza, Patricia T./0000-0001-8349-9529; Da Poian, Andrea/0000-0002-3969-704X; Bozza, Marcelo/0000-0003-3683-7550; Miranda, Iranaia/0000-0001-5684-4788	Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq; Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Brazil); National Institute of Science and Technology in Dengue (INCT-Dengue; Brazil)	Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq; Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Science and Technology in Dengue (INCT-Dengue; Brazil)	This work was supported by Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq;Brazil), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Brazil), and National Institute of Science and Technology in Dengue (INCT-Dengue; Brazil).	Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Armstrong ME, 2008, J IMMUNOL, V180, P7125, DOI 10.4049/jimmunol.180.11.7125; Arndt U, 2002, J VIROL, V76, P9298, DOI 10.1128/JVI.76.18.9298-9306.2002; Assuncao-Miranda I, 2010, J MED VIROL, V82, P164, DOI 10.1002/jmv.21649; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Bacher M, 2002, VIROLOGY, V299, P32, DOI 10.1006/viro.2002.1464; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; BOZZA PT, 2009, BIOCHIM BIOPHYS ACTA, V1791, P40; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002; El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Frascaroli G, 2009, J IMMUNOL, V182, P477, DOI 10.4049/jimmunol.182.1.477; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Guzman MG, 2008, T ROY SOC TROP MED H, V102, P522, DOI 10.1016/j.trstmh.2008.03.001; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Kimura K, 2006, CLIN VACCINE IMMUNOL, V13, P415, DOI 10.1128/CVI.13.3.415-419.2006; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015; Leng L, 2005, CRIT CARE MED, V33, pS475, DOI 10.1097/01.CCM.0000191278.04636.D8; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Paiva CN, 2009, J LEUKOCYTE BIOL, V85, P855, DOI 10.1189/jlb.0108009; Pan American Health Organization, 2007, NUMB REP CAS DENG DE; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Sprong T, 2007, SHOCK, V27, P482, DOI 10.1097/01.shk.0000246898.65692.34; Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42, DOI 10.1055/s-0037-1612941; Suzuki T, 2000, BBA-GENE STRUCT EXPR, V1517, P100, DOI 10.1016/S0167-4781(00)00262-1; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; *WHO, 2002, 117 WHO; Zhang Wei, 2002, Hepatobiliary Pancreat Dis Int, V1, P577	62	95	96	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					218	228		10.1096/fj.09-139469	http://dx.doi.org/10.1096/fj.09-139469			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19776337				2022-12-25	WOS:000273233600023
J	Ortiz-Masia, D; Hernandez, C; Quintana, E; Velazquez, M; Cebrian, S; Riano, A; Calatayud, S; Esplugues, JV; Barrachina, MD				Ortiz-Masia, Dolores; Hernandez, Carlos; Quintana, Elsa; Velazquez, Miriam; Cebrian, Sonia; Riano, Annia; Calatayud, Sara; Esplugues, Juan V.; Barrachina, Maria D.			iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1	FASEB JOURNAL			English	Article						NSAID gastropathy; macrophage activation; mucosal restitution; inducible nitric oxide synthase	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; EPITHELIAL-CELL MIGRATION; TREFOIL PEPTIDES; SYNTHASE; HIF-1-ALPHA; INHIBITION; ARGININE; OXYGEN; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION	Trefoil (TFF) peptides are involved in gastrointestinal mucosal restitution. An hypoxia inducible factor 1 (HIF-1)-dependent induction of TFF genes has been reported in gastric epithelial cells. Nitric oxide (NO) is associated with mucosal damage and modulates HIF-1 activity. The aim of the present study was to analyze the role of iNOS-derived NO in HIF-1 alpha stabilization and TFF gene expression in damaged gastric mucosa. Aspirin caused gastric injury that peaked 6 h after dosing and returned to normality at 24 h. iNOS mRNA expression occurs in the corpus in parallel with damage. Blockade of iNOS activity did not modify gastric lesions induced by aspirin but delayed mucosal healing. Aspirin induced HIF-1 alpha stabilization and TFF2 mRNA up-regulation in the mucosa, but these effects were diminished when iNOS activity was inhibited. Results obtained using a coculture setup showed that iNOS-derived NO from activated macrophages induced HIF-1 alpha stabilization, TFF gene expression, and accelerated wound healing in cultured epithelial cells. Finally, transient silencing of endogenous HIF-1 alpha in epithelial cells significantly undermined activated macrophage-induced TFF gene expression. Evidence suggests that the iNOS-derived NO associated with NSAID-induced gastric injury is implicated in mucosal restitution via the HIF-1-mediated induction of TFF genes.-Ortiz-Masia, D., Hernandez, C., Quintana, E., Velazquez, M., Cebrian, S., Riano, A., Calatayud, S., Esplugues, J. V., Barrachina, M. D. iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1. FASEB J. 24,136-145 (2010). www.fasebj.org	[Ortiz-Masia, Dolores; Velazquez, Miriam; Calatayud, Sara; Esplugues, Juan V.; Barrachina, Maria D.] Univ Valencia, Dept Pharmacol, Fac Med, Valencia 46010, Spain; [Ortiz-Masia, Dolores; Hernandez, Carlos; Quintana, Elsa; Velazquez, Miriam; Cebrian, Sonia; Riano, Annia; Calatayud, Sara; Esplugues, Juan V.; Barrachina, Maria D.] Univ Valencia, CIBERehd, Fac Med, Valencia 46010, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia	Barrachina, MD (corresponding author), Univ Valencia, Dept Pharmacol, Fac Med, Avda Blasco Ibanez 15-17, Valencia 46010, Spain.	dolores.barrachina@uv.es	Calatayud, Sara/ABB-9665-2021; Esplugues, Juan/ABC-1488-2021; Barrachina, Maria/ABB-9683-2021; SAEZ, CARLOS HERNANDEZ/M-3029-2014; ORTIZ-MASIA, MARIA DOLORES/M-1413-2017	Calatayud, Sara/0000-0001-9675-2423; SAEZ, CARLOS HERNANDEZ/0000-0001-8536-429X; ORTIZ-MASIA, MARIA DOLORES/0000-0002-7924-9962; Barrachina, Maria Dolores/0000-0002-4332-2929; Esplugues Mota, Juan Vicente/0000-0001-8205-021X	Ministerio de Educacion y Cultura [SAF2007064201]; Ministerio de Sanidad y Consumo [CIBER CD06/04/0071, PI081325]; Generalitat Valenciana [ACOMP07-297]	Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	The present study has been funded by grants SAF2007064201 from the Ministerio de Educacion y Cultura, CIBER CD06/04/0071 and PI081325 from the Ministerio de Sanidad y Consumo, and ACOMP07-297 from the Generalitat Valenciana.	Agani FH, 2002, AM J PHYSIOL-CELL PH, V283, pC178, DOI 10.1152/ajpcell.00381.2001; Akiba Y, 1998, J CLIN GASTROENTEROL, V27, pS64, DOI 10.1097/00004836-199800001-00011; Anand RJ, 2008, AM J PHYSIOL-GASTR L, V294, pG109, DOI 10.1152/ajpgi.00331.2007; Azarschab P, 2001, FEBS LETT, V488, P206, DOI 10.1016/S0014-5793(00)02422-4; Beck KF, 1999, J EXP BIOL, V202, P645; Boer R, 2000, MOL PHARMACOL, V58, P1026, DOI 10.1124/mol.58.5.1026; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Calatayud S, 2001, MICROSC RES TECHNIQ, V53, P325, DOI 10.1002/jemt.1100; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Dudar GK, 2008, AM J PHYSIOL-GASTR L, V295, pG374, DOI 10.1152/ajpgi.90325.2008; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hayashi Y, 2005, MICROBIOL IMMUNOL, V49, P139, DOI 10.1111/j.1348-0421.2005.tb03713.x; Hernandez C, 2009, BRIT J PHARMACOL, V156, P262, DOI 10.1111/j.1476-5381.2008.00044.x; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Ito M, 2003, ALIMENT PHARM THER, V18, P90, DOI 10.1046/j.1365-2036.18.s1.10.x; Jimenez D, 2002, DIGEST DIS SCI, V47, P44, DOI 10.1023/A:1013203217788; Kato K, 1999, AM J PHYSIOL-GASTR L, V276, pG1105, DOI 10.1152/ajpgi.1999.276.5.G1105; KAUFFMAN GL, 1981, PROSTAGLANDINS, V21, P33, DOI 10.1016/0090-6980(81)90114-3; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lando D, 2003, EUR J BIOCHEM, V270, P781, DOI 10.1046/j.1432-1033.2003.03445.x; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Longman RJ, 2000, GUT, V47, P792, DOI 10.1136/gut.47.6.792; Louis NA, 2006, J CELL BIOCHEM, V99, P1616, DOI 10.1002/jcb.20947; Ma L, 2000, AM J PHYSIOL-GASTR L, V279, pG341, DOI 10.1152/ajpgi.2000.279.2.G341; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Nishida K, 1998, NITRIC OXIDE-BIOL CH, V2, P215, DOI 10.1006/niox.1998.0178; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P108, DOI 10.1016/0016-5085(95)90014-4; Quintana E, 2004, FASEB J, V18, P531, DOI 10.1096/fj.03-0596fje; Rhoads JM, 2008, J NUTR, V138, P1652, DOI 10.1093/jn/138.9.1652; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368; Souza MHLP, 2004, GUT, V53, P791, DOI 10.1136/gut.2002.012930; Takeuchi K, 1999, J PHYSIOLOGY-PARIS, V93, P423, DOI 10.1016/S0928-4257(99)00125-4; Tatemichi M, 2003, INT J EXP PATHOL, V84, P213, DOI 10.1111/j.1365-2613.2003.00357.x; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; WALLACE JL, 1993, CAN J PHYSIOL PHARM, V71, P98, DOI 10.1139/y93-014; Yasuhiro T, 1997, J PHYSIOLOGY-PARIS, V91, P131, DOI 10.1016/S0928-4257(97)89477-6; Yin JH, 2000, BIOCHEM BIOPH RES CO, V279, P30, DOI 10.1006/bbrc.2000.3896	47	19	20	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					136	145		10.1096/fj.09-137489	http://dx.doi.org/10.1096/fj.09-137489			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19741170				2022-12-25	WOS:000273233600016
J	Mahapatra, S; Mehta, H; Woo, SB; Neet, KE				Mahapatra, Sidharth; Mehta, Hrishikesh; Woo, Sang B.; Neet, Kenneth E.			Identification of Critical Residues within the Conserved and Specificity Patches of Nerve Growth Factor Leading to Survival or Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; HIGH-AFFINITY RECEPTOR; AMINO-ACID-RESIDUES; PROTEIN-KINASE; ALZHEIMERS-DISEASE; RETROGRADE TRANSPORT; TRKA RECEPTOR; NGF RECEPTOR; MOLECULAR-CLONING; CRYSTAL-STRUCTURE	Afflicted neurons in Alzheimer disease have been shown to display an imbalance in the expression of TrkA and p75NTR at the cell surface, and administration of nerve growth factor (NGF) has been considered and attempted for treatment. However, wild-type NGF causes extensive elaboration of neurites while providing survival support. This study was aimed at developing recombinant NGF muteins that did not support neuritogenesis while maintaining the survival response. Critical residues were identified at the ligand-receptor interface by point mutagenesis that played a greater importance in neuritogenesis versus survival. By combining point mutations, two survival-selective recombinant NGF muteins, i.e./7-84-103 and KKE/7-84-103, were generated. Both muteins reduced neuritogenesis in PC12 (TrkA(+)/p75(NTR+)) cells by >90%, while concurrently retaining near wild-type survival activity in MG139 (TrkA(+) only) and PCNA fibroblast (p75(NTR+)-only) cells. Additionally, survival in both naive and terminally differentiated PC12 cells was shown to be intermediate between NGF and negative controls. Dose-response curves with 7-84-103 showed that the differentiation curve was shifted by about 100-fold, whereas the EC50 for survival was only increased by 3.3-fold. Surface plasmon resonance analysis revealed a 200-fold decrease in binding of 7-84-103 to TrkA. The retention of cell survival was attributed to maintenance of signaling through the Akt survival pathway with reduced MAPK signaling for differentiation. The effect of key mutations along the NGF receptor interface are transmitted inside the cell to enable the generation of survival-selective recombinant NGF muteins that may represent novel pharmacologic lead agents for the amelioration of Alzheimer disease.	[Mahapatra, Sidharth; Mehta, Hrishikesh; Woo, Sang B.; Neet, Kenneth E.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Neet, KE (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kenneth.neet@rosalindfranklin.edu	Mahapatra, Sidharth/H-4697-2019; Mehta, Hrishikesh/K-1108-2016	Mahapatra, Sidharth/0000-0002-2483-0610; Mehta, Hrishikesh/0000-0001-9140-9765	USPHS [NS24380]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS24380 from the USPHS.	BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARKER PA, 1993, J BIOL CHEM, V268, P15150; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Bartlett SE, 1997, BRAIN RES, V761, P257, DOI 10.1016/S0006-8993(97)00329-6; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bose R, 2006, CURR OPIN STRUC BIOL, V16, P668, DOI 10.1016/j.sbi.2006.10.012; BOTHWELL MA, 1977, J BIOL CHEM, V252, P8532; COHENCORY S, 1991, J NEUROSCI, V11, P462; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; Counts SE, 2004, ANN NEUROL, V56, P520, DOI 10.1002/ana.20233; Counts SE, 2005, J NEUROPATH EXP NEUR, V64, P263, DOI 10.1093/jnen/64.4.263; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Cunningham ME, 1998, EMBO J, V17, P7282, DOI 10.1093/emboj/17.24.7282; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; DIAMOND J, 1992, J NEUROSCI, V12, P1467; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HERRUP K, 1987, J NEUROSCI, V7, P829; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IBANEZ CF, 1994, J NEUROBIOL, V25, P1349, DOI 10.1002/neu.480251104; IBANEZ CF, 1990, EMBO J, V9, P1477, DOI 10.1002/j.1460-2075.1990.tb08265.x; ILAG LL, 1994, J BIOL CHEM, V269, P19941; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; KAHLE P, 1992, J BIOL CHEM, V267, P22707; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KATZ DM, 1990, EXP NEUROL, V110, P1, DOI 10.1016/0014-4886(90)90046-U; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; KORSCHING S, 1993, J NEUROSCI, V13, P2739; KULLANDER K, 1994, J NEUROSCI RES, V39, P195, DOI 10.1002/jnr.490390210; Kullander K, 1997, J BIOL CHEM, V272, P9300; Lad SP, 2003, CNS NEUROL DISORD-DR, V2, P315, DOI 10.2174/1568007033482724; Lad SP, 2003, J NEUROSCI RES, V73, P614, DOI 10.1002/jnr.10695; Lad SP, 2003, J BIOL CHEM, V278, P24808, DOI 10.1074/jbc.M212270200; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LOEB DM, 1994, J BIOL CHEM, V269, P8901; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Mahapatra S., 2008, THESIS R FRANKLIN U; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; MUFSON EJ, 1995, NEUROREPORT, V6, P1063, DOI 10.1097/00001756-199505090-00028; Mufson Elliott J., 2000, Journal of Comparative Neurology, V427, P19, DOI 10.1002/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; NEET KE, 1987, METHOD ENZYMOL, V147, P186; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REINHOLD DS, 1989, J BIOL CHEM, V264, P3538; Salehi A, 2000, EXP NEUROL, V161, P245, DOI 10.1006/exnr.1999.7252; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; TIMM DE, 1994, BIOCHEMISTRY-US, V33, P4667, DOI 10.1021/bi00181a602; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; URFER R, 1994, EMBO J, V13, P5896, DOI 10.1002/j.1460-2075.1994.tb06935.x; Vaghefi H, 2004, J BIOL CHEM, V279, P15604, DOI 10.1074/jbc.M311500200; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WOO SB, 1995, J BIOL CHEM, V270, P6278, DOI 10.1074/jbc.270.11.6278; Woo SB, 1998, PROTEIN SCI, V7, P1006; Woo SB, 1996, J BIOL CHEM, V271, P24433, DOI 10.1074/jbc.271.40.24433; Yoon SO, 1997, J BIOL CHEM, V272, P23231, DOI 10.1074/jbc.272.37.23231; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	85	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33600	33613		10.1074/jbc.M109.058420	http://dx.doi.org/10.1074/jbc.M109.058420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19762468	Green Published, hybrid			2022-12-25	WOS:000272028500064
J	Noguchi, A; Matsumura, S; Dezawa, M; Tada, M; Yanazawa, M; Ito, A; Akioka, M; Kikuchi, S; Sato, M; Ideno, S; Noda, M; Fukunari, A; Muramatsu, S; Itokazu, Y; Sato, K; Takahashi, H; Teplow, DB; Nabeshima, Y; Kakita, A; Imahori, K; Hoshi, M				Noguchi, Akihiko; Matsumura, Satoko; Dezawa, Mari; Tada, Mari; Yanazawa, Masako; Ito, Akane; Akioka, Manami; Kikuchi, Satoru; Sato, Michio; Ideno, Shouji; Noda, Munehiro; Fukunari, Atsushi; Muramatsu, Shin-ichi; Itokazu, Yutaka; Sato, Kazuki; Takahashi, Hitoshi; Teplow, David B.; Nabeshima, Yo-ichi; Kakita, Akiyoshi; Imahori, Kazutomo; Hoshi, Minako			Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid beta-Protein (A beta) Assembly from Alzheimer Disease Brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILD COGNITIVE IMPAIRMENT; TRANSGENIC MICE; NEURON LOSS; SYNAPTIC PLASTICITY; NATURAL OLIGOMERS; COMMON MECHANISM; NEURODEGENERATION; AGGREGATION; MEMORY; PATHOLOGY	Amyloid beta-protein (A beta) assemblies are thought to play primary roles in Alzheimer disease (AD). They are considered to acquire surface tertiary structures, not present in physiologic monomers, that are responsible for exerting toxicity, probably through abnormal interactions with their target(s). Therefore, A beta assemblies having distinct surface tertiary structures should cause neurotoxicity through distinct mechanisms. Aiming to clarify the molecular basis of neuronal loss, which is a central phenotype in neurodegenerative diseases such as AD, we report here the selective immunoisolation of neurotoxic 10-15-nm spherical A beta assemblies termed native amylospheroids (native ASPDs) from AD and dementia with Lewy bodies brains, using ASPD tertiary structure-dependent antibodies. In AD patients, the amount of native ASPDs was correlated with the pathologic severity of disease. Native ASPDs are anti-pan oligomer A11 antibody-negative, high mass (> 100 kDa) assemblies that induce degeneration particularly of mature neurons, including those of human origin, in vitro. Importantly, their immuno-specificity strongly suggests that native ASPDs have a distinct surface tertiary structure from other reported assemblies such as dimers, A beta-derived diffusible ligands, and A11-positive assemblies. Only ASPD tertiary structure-dependent antibodies could block ASPD-induced neurodegeneration. ASPDs bind presynaptic target(s) on mature neurons and have a mode of toxicity different from those of other assemblies, which have been reported to exert their toxicity through binding postsynaptic targets and probably perturbing glutamatergic synaptic transmission. Thus, our findings indicate that native ASPDs with a distinct toxic surface induce neuronal loss through a different mechanism from other A beta assemblies.	[Noguchi, Akihiko; Matsumura, Satoko; Yanazawa, Masako; Ito, Akane; Akioka, Manami; Kikuchi, Satoru; Sato, Michio; Hoshi, Minako] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Dezawa, Mari; Itokazu, Yutaka; Nabeshima, Yo-ichi; Hoshi, Minako] Kyoto Univ, Kyoto 6068501, Japan; [Dezawa, Mari] Tohoku Univ, Sendai, Miyagi 9088575, Japan; [Tada, Mari; Takahashi, Hitoshi; Kakita, Akiyoshi] Niigata Univ, Niigata 9518585, Japan; [Ideno, Shouji; Noda, Munehiro; Fukunari, Atsushi] Mitsubishi Tanabe Pharma Corp, Osaka 5418505, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Sato, Kazuki] Fukuoka Womens Univ, Fukuoka 8138529, Japan; [Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Imahori, Kazutomo] Univ Tokyo, Tokyo 1138654, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyoto University; Tohoku University; Niigata University; Mitsubishi Tanabe Pharma Corporation; Jichi Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo	Hoshi, M (corresponding author), Sakyo Ku, Kyoto 6068501, Japan.	minhoshi@lmls.med.kyoto-u.ac.jp	Muramatsu, Shin-ichi/K-9420-2013; Muramatsu, Shinichi/ABC-6093-2021	Muramatsu, Shin-ichi/0000-0002-3185-7790; Muramatsu, Shinichi/0000-0002-3185-7790	National Institutes of Health [NS038328]; Health and Labour Sciences; Ministry of Health, Labor, and Welfare; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology; Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation; Mitsubishi Kagaku Institute of Life Sciences; Mitsubishi Chemical Corp.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Labour Sciences; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Mitsubishi Kagaku Institute of Life Sciences; Mitsubishi Chemical Corp.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part, by National Institutes of Health Grant NS038328 (to D. B. T.), by Health and Labour Sciences Research Grants "Research on Nanotechnical Medical" (to M. H.) and "Research on Psychiatric and Neurological Diseases and Mental Health" (to M. D.) from the Ministry of Health, Labor, and Welfare, by Special Coordination Funds for Promoting Science and Technology (to M. H.) from the Ministry of Education, Culture, Sports, Science, and Technology, and by the Program for Promotion of Fundamental Studies in Health Sciences (to M. D.) from the National Institute of Biomedical Innovation The authors declare the following conflict of interest: this work was supported in part by a grant (to M. H.) from Mitsubishi Kagaku Institute of Life Sciences, which is a nonprofit organization financially supported by Mitsubishi Chemical Corp.; this grant expires in March 2009.	Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Bouwman FH, 2007, NEUROBIOL AGING, V28, P1070, DOI 10.1016/j.neurobiolaging.2006.05.006; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; DICKSON DW, 1989, NEUROBIOL AGING, V10, P402, DOI 10.1016/0197-4580(89)90075-4; GIASSON BI, 2004, NEUROPATHOLOGY DEMEN, P353; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INCE PG, 2003, NEURODEGENERATION MO, P188; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kepe V, 2006, METHOD ENZYMOL, V412, P144, DOI 10.1016/S0076-6879(06)12010-8; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; KOSAKA K, 1990, J NEUROL, V237, P197, DOI 10.1007/BF00314594; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Kuwano R, 2006, HUM MOL GENET, V15, P2170, DOI 10.1093/hmg/ddl142; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Perez M, 2005, NEUROSCIENCE, V130, P339, DOI 10.1016/j.neuroscience.2004.09.029; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wilcock DM, 2009, J NEUROSCI, V29, P7957, DOI 10.1523/JNEUROSCI.1339-09.2009; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	65	141	150	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32895	32905		10.1074/jbc.M109.000208	http://dx.doi.org/10.1074/jbc.M109.000208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759000	Green Published, hybrid			2022-12-25	WOS:000272028400073
J	Rosenfeld, SS; van Duffelen, M; Behnke-Parks, WM; Beadle, C; Corrreia, J; Xing, J				Rosenfeld, Steven S.; van Duffelen, Marilyn; Behnke-Parks, William M.; Beadle, Christopher; Corrreia, John; Xing, Jun			The ATPase Cycle of the Mitotic Motor CENP-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN HEAD DOMAINS; CHROMOSOME ALIGNMENT; DIMERIC KINESIN; MICROTUBULE; HYDROLYSIS; PATHWAY; STRAIN; EG5; CONFORMATIONS; KINETOCHORES	We have previously shown that the mitotic motor centrosome protein E (CENP-E) is capable of walking for more than 250 steps on its microtubule track without dissociating. We have examined the kinetics of this molecular motor to see if its enzymology explains this remarkable degree of processivity. We find that like the highly processive transport motor kinesin 1, the enzymatic cycle of CENP-E is characterized by rapid ATP binding, multiple enzymatic turnovers per diffusive encounter, and gating of nucleotide binding. These features endow CENP-E with a high duty cycle, a prerequisite for processivity. However, unlike kinesin 1, neck linker docking in CENP-E is slow, occurring at a rate closer to that for Eg5, a mitotic kinesin that takes only 5-10 steps per processive run. These results suggest that like kinesin 1, features outside of the catalytic domain of CENP-E may also play a role in regulating the processive behavior of this motor.	[Behnke-Parks, William M.] Columbia Univ, Dept Biol, New York, NY 10032 USA; [Rosenfeld, Steven S.; van Duffelen, Marilyn; Beadle, Christopher] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Rosenfeld, Steven S.] Columbia Univ, Dept Cell Biol & Pathol, New York, NY 10032 USA; [Corrreia, John] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Xing, Jun] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Columbia University; Columbia University; Columbia University; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham	Rosenfeld, SS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 710 W 168th St, New York, NY 10032 USA.	sr2327@columbia.edu			National Institutes of Health, NIAMS [AR 0485675]	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant AR 0485675.	Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Garcia-Saez I, 2004, J MOL BIOL, V340, P1107, DOI 10.1016/j.jmb.2004.05.053; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Jiang W, 1997, J BIOL CHEM, V272, P7626, DOI 10.1074/jbc.272.12.7626; Jiang W, 1997, J BIOL CHEM, V272, P5616, DOI 10.1074/jbc.272.9.5616; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIU S, 1995, ANAL BIOCHEM, V224, P199, DOI 10.1006/abio.1995.1030; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Xing J, 2000, J BIOL CHEM, V275, P35413, DOI 10.1074/jbc.M004232200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yardimci H, 2008, P NATL ACAD SCI USA, V105, P6016, DOI 10.1073/pnas.0711314105; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	33	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32858	32868		10.1074/jbc.M109.041210	http://dx.doi.org/10.1074/jbc.M109.041210			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759394	Green Published, hybrid			2022-12-25	WOS:000272028400070
J	Ueno, S; Tatetsu, H; Hata, H; Iino, T; Niiro, H; Akashi, K; Tenen, DG; Mitsuya, H; Okuno, Y				Ueno, S.; Tatetsu, H.; Hata, H.; Iino, T.; Niiro, H.; Akashi, K.; Tenen, D. G.; Mitsuya, H.; Okuno, Y.			PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL	ONCOGENE			English	Article						myeloma; PU.1; TRAIL; apoptosis; p21	OVERCOMES DRUG-RESISTANCE; TRANSCRIPTION FACTOR PU.1; HEMATOPOIETIC STEM-CELLS; MULTIPLE-MYELOMA; REGULATORY ELEMENTS; DISTAL ELEMENTS; LEUKEMIA-CELLS; GENE; EXPRESSION; GROWTH	We earlier reported that PU.1 was downregulated in myeloma cell lines and myeloma cells in a subset of myeloma patients, and that conditional PU.1 expression in PU.1-negative myeloma cell lines, U266 and KMS12PE, induced growth arrest and apoptosis. To elucidate the molecular mechanisms of the growth arrest and apoptosis, we performed DNA microarray analyses to compare the difference in gene expression before and after PU.1 induction in U266 cells. Among cell cycle-related genes, cyclin A2, cyclin B1, CDK2 and CDK4 were downregulated and p21 was upregulated, although among apoptosis-related genes, tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) was found highly upregulated. When TRAIL was knocked down by small interference RNAs, apoptosis of PU-1-expressing cells was inhibited, suggesting that TRAIL has a critical role in PU.1-induced apoptosis in both U266 and KMS12PE myeloma cells. In both U266 and KMS12PE cells expressing PU.1, PU.1 directly bound to a region 30 bp downstream of the transcription start site of the TRAIL gene. Upregulation of PU.1-induced transactivation of the TRAIL promoter in reporter assays, and disruption of the PU.1-binding site in the TRAIL promoter eliminated this transactivation. Therefore, we conclude that PU.1 is capable of inducing apoptosis in certain myeloma cells by direct transactivation of TRAIL. Oncogene (2009) 28, 4116-4125; doi:10.1038/onc.2009.263; published online 14 September 2009	[Ueno, S.; Tatetsu, H.; Hata, H.; Mitsuya, H.; Okuno, Y.] Kumamoto Univ Med, Dept Hematol, Kumamoto 8608556, Japan; [Iino, T.; Niiro, H.; Akashi, K.] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; [Iino, T.; Akashi, K.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Tenen, D. G.] Harvard Univ, Sch Med, Ctr Life Sci, Boston, MA USA; [Tenen, D. G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	Kumamoto University; Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; National University of Singapore	Okuno, Y (corresponding author), Kumamoto Univ Med, Dept Hematol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	yokuno@gpo.kumamoto-u.ac.jp		Tenen, Daniel/0000-0002-6423-3888	International Myeloma Foundation Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE [R01CA041456] Funding Source: NIH RePORTER	International Myeloma Foundation Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Award in Aki's Memory from The International Myeloma Foundation Japan (YO) and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amaravadi L, 1999, DNA CELL BIOL, V18, P875, DOI 10.1089/104454999314737; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Coccia EM, 1999, ONCOGENE, V18, P2129, DOI 10.1038/sj.onc.1202536; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Gazitt Y, 1999, LEUKEMIA, V13, P1817, DOI 10.1038/sj.leu.2401501; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2003, IMMUNOL REV, V194, P164, DOI 10.1034/j.1600-065X.2003.00053.x; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mariani SM, 1997, J CELL BIOL, V137, P221, DOI 10.1083/jcb.137.1.221; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades N, 2002, BLOOD, V99, P2162, DOI 10.1182/blood.V99.6.2162; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Okuno Y, 2002, BLOOD, V100, P4420, DOI 10.1182/blood-2002-03-0788; Okuno Y, 2002, P NATL ACAD SCI USA, V99, P6246, DOI 10.1073/pnas.092027799; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Radomska HS, 2002, BLOOD, V100, P4410, DOI 10.1182/blood-2002-02-0355; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Tatetsu H, 2007, CANCER RES, V67, P5328, DOI 10.1158/0008-5472.CAN-06-4265; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	33	17	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 19	2009	28	46					4116	4125		10.1038/onc.2009.263	http://dx.doi.org/10.1038/onc.2009.263			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19749795	Green Accepted			2022-12-25	WOS:000272560500007
J	Huot, ME; Vogel, G; Richard, S				Huot, Marc-Etienne; Vogel, Gillian; Richard, Stephane			Identification of a Sam68 Ribonucleoprotein Complex Regulated by Epidermal Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; RNA-BINDING PROTEINS; CELL-CYCLE PROGRESSION; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; STRESS GRANULES; KH-DOMAIN; FUNCTIONAL INTERACTION; SIGNALING PATHWAY; HUMAN-BREAST	Sam68, Src associated in mitosis of 68 kDa, is a known RNA-binding protein and a signaling adaptor protein for tyrosine kinases. However, the proteins associated with Sam68 and the existence of a Sam68 complex, its mass, and regulation are, however, unknown. Herein we identify a large Sam68 complex with a mass > 1 MDa in HeLa cells that is composed of similar to 40 proteins using an immunoprecipitation followed by a mass spectrometry approach. Many of the proteins identified are RNA-binding proteins and are known components of a previously identified structure termed the spreading initiation center. The large Sam68 complex is a ribonucleoprotein complex, as treatment with RNases caused a shift in the molecular mass of the complex to 200-450 kDa. Moreover, treatment of HeLa cells with phorbol 12-myristate 13-acetate or epidermal growth factor induced the disassociation of Sam68 from the large complex and the appearance of Sam68 within the smaller complex. Actually, in certain cell lines such as breast cancer cell lines MCF-7 and BT-20, Sam68 exists in equilibrium between a large and a small complex. The appearance of the small Sam68 complex in cells correlates with the ability of Sam68 to promote the alternative splicing of CD44 and cell migration. Our findings show that Sam68 exists in equilibrium in transformed cells between two complexes and that extracellular signals, such as epidermal growth factor stimulation, promote alternative splicing by modulating the composition of the Sam68 complex.	Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	Richard, S (corresponding author), Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca			Fonds de la Recherche en Sante du Quebec; Cancer Research Society Inc.	Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Cancer Research Society Inc.	This work was supported by Canadian Institutes of Health Research Grant MT13377.; Supported by fellowships from the Fonds de la Recherche en Sante du Quebec and the Cancer Research Society Inc.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Denegri M, 2001, MOL BIOL CELL, V12, P3502, DOI 10.1091/mbc.12.11.3502; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; French J, 2002, HISTOCHEM J, V34, P223, DOI 10.1023/A:1021737413055; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Hong W, 2002, MOL CANCER RES, V1, P48; Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Li JL, 2002, J VIROL, V76, P8374, DOI 10.1128/JVI.76.16.8374-8382.2002; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; MAA MC, 1994, MOL CELL BIOL, V14, P5466, DOI 10.1128/MCB.14.8.5466; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Miki T, 2005, CELL STRUCT FUNCT, V30, P51, DOI 10.1247/csf.30.51; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Ning Jun-yu, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P215; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Parker F, 1996, MOL CELL BIOL, V16, P2561; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; PYPE S, 1994, J BIOL CHEM, V269, P31457; Rahmouni S, 2005, MOL CELL BIOL, V25, P2227, DOI 10.1128/MCB.25.6.2227-2241.2005; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Richard S, 2008, ONCOGENE, V27, P548, DOI 10.1038/sj.onc.1210652; Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; VOGEL LB, 1995, J BIOL CHEM, V270, P2506, DOI 10.1074/jbc.270.6.2506; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yang HP, 2002, ONCOGENE, V21, P7187, DOI 10.1038/sj.onc.1205759; ZHENG CF, 1994, BIOCHEMISTRY-US, V33, P5595, DOI 10.1021/bi00184a031	61	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31903	31913		10.1074/jbc.M109.018465	http://dx.doi.org/10.1074/jbc.M109.018465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762470	Green Published, hybrid			2022-12-25	WOS:000271572700045
J	Korn, A; Ajlani, G; Lagoutte, B; Gall, A; Setif, P				Korn, Anja; Ajlani, Ghada; Lagoutte, Bernard; Gall, Andrew; Setif, Pierre			Ferredoxin:NADP(+) Oxidoreductase Association with Phycocyanin Modulates Its Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; FLASH-ABSORPTION-SPECTROSCOPY; FERREDOXIN-NADP(+) REDUCTASE; ELECTRON-TRANSFER; PHOTOSYSTEM-I; CATALYTIC MECHANISM; NONPHOTOSYNTHETIC TISSUES; SPINACH-CHLOROPLASTS; NADP+ OXIDOREDUCTASE; THYLAKOID MEMBRANES	In photosynthetic organisms, ferredoxin:NADP(+) oxidoreductase (FNR) is known to provide NADPH for CO2 assimilation, but it also utilizes NADPH to provide reduced ferredoxin. The cyanobacterium Synechocystis sp. strain PCC6803 produces two FNR isoforms, a small one (FNRS) similar to the one found in plant plastids and a large one (FNRL) that is associated with the phycobilisome, a light-harvesting complex. Here we show that a mutant lacking FNRL exhibits a higher NADP(+)/NADPH ratio. We also purified to homogeneity a phycobilisome subcomplex comprising FNRL, named FNRL-PC. The enzymatic activities of FNRL-PC were compared with those of FNRS. During NADPH oxidation, FNRL-PC exhibits a 30% decrease in the Michaelis constant K-m(NADPH), and a 70% increase in K-m(ferredoxin), which is in agreement with its predicted lower activity of ferredoxin reduction. During NADP(+) reduction, the FNRL-PC shows a 29/43% decrease in the rate of single electron transfer from reduced ferredoxin in the presence/absence of NADP(+). The increase in K-m(ferredoxin) and the rate decrease of single reduction are attributed to steric hindrance by the phycocyanin moiety of FNRL-PC. Both isoforms are capable of catalyzing the NADP(+) reduction under multiple turnover conditions. Furthermore, we obtained evidence that, under high ionic strength conditions, electron transfer from reduced ferredoxin is rate limiting during this process. The differences that we observe might not fully explain the in vivo properties of the Synechocystis mutants expressing only one of the isoforms. Therefore, we advocate that FNR localization and/or substrates availability are essential in vivo.	[Korn, Anja; Ajlani, Ghada; Lagoutte, Bernard; Gall, Andrew; Setif, Pierre] CEA, Inst Biol & Technol Saclay, CNRS, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ajlani, G (corresponding author), CEA Saclay, IBiTecS, F-91191 Gif Sur Yvette, France.	gajlani@cea.fr; pierre.setif@cea.fr	Gall, Andrew/U-5819-2019	Gall, Andrew/0000-0002-5629-1834	Agence Nationale de la Recherche, France [ANR-07-CEXC-009]; European Commission [EU FP7-ENERGY-2007-1-RTD SOLAR-H2]	Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the Agence Nationale de la Recherche, France ( PHYCOSYN, to G. A. and ANR-07-CEXC-009, to A. G.) and the European Commission ( EU FP7-ENERGY-2007-1-RTD SOLAR-H2, to P. S.).	AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; Aliverti A, 2004, BBA-PROTEINS PROTEOM, V1696, P93, DOI 10.1016/j.bbapap.2003.09.011; Aliverti A, 2001, BIOCHEMISTRY-US, V40, P14501, DOI 10.1021/bi011224c; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Barth P, 2000, J BIOL CHEM, V275, P7030, DOI 10.1074/jbc.275.10.7030; BATIE CJ, 1984, J BIOL CHEM, V259, P1976; BATIE CJ, 1984, J BIOL CHEM, V259, P8832; BOTTIN H, 1992, BIOCHIM BIOPHYS ACTA, V1101, P48, DOI 10.1016/0167-4838(92)90465-P; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; BRUNS CM, 1995, J MOL BIOL, V247, P125, DOI 10.1006/jmbi.1994.0127; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Cassan N, 2005, J BIOL CHEM, V280, P25960, DOI 10.1074/jbc.M503742200; Corrado ME, 1996, EUR J BIOCHEM, V239, P662, DOI 10.1111/j.1432-1033.1996.0662u.x; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; ELMORJANI K, 1986, ARCH MICROBIOL, V146, P186, DOI 10.1007/BF00402349; ENGEL PC, 1971, BIOCHEM J, V125, P879, DOI 10.1042/bj1250879; FORTI G, 1968, EUR J BIOCHEM, V3, P461, DOI 10.1111/j.1432-1033.1967.tb19553.x; GANTT E, 1972, J CELL BIOL, V54, P313, DOI 10.1083/jcb.54.2.313; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; Gou P, 2006, BIOCHEMISTRY-US, V45, P14389, DOI 10.1021/bi061779d; GREEN LS, 1991, PLANT PHYSIOL, V96, P1207, DOI 10.1104/pp.96.4.1207; Gummadova JO, 2007, J EXP BOT, V58, P3971, DOI 10.1093/jxb/erm252; Hanke GT, 2004, PHOTOSYNTH RES, V81, P317, DOI 10.1023/B:PRES.0000036885.01534.b8; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; Hurley JK, 2002, BBA-BIOENERGETICS, V1554, P5, DOI 10.1016/S0005-2728(02)00188-3; Karplus PA, 2004, PHOTOSYNTH RES, V81, P303, DOI 10.1023/B:PRES.0000036884.57303.2e; Kondo K, 2005, PHOTOSYNTH RES, V84, P269, DOI 10.1007/s11120-004-7762-9; Kondo K, 2007, PLANT PHYSIOL, V144, P1200, DOI 10.1104/pp.107.099267; Kondo K, 2009, PHOTOSYNTH RES, V99, P217, DOI 10.1007/s11120-008-9399-6; Medina M, 1998, BIOCHEMISTRY-US, V37, P2715, DOI 10.1021/bi971795y; MORIGASAKI S, 1990, PLANT PHYSIOL, V93, P896, DOI 10.1104/pp.93.3.896; Nakajima M, 2002, PLANT CELL PHYSIOL, V43, P484, DOI 10.1093/pcp/pcf058; Okutani S, 2005, PLANT PHYSIOL, V139, P1451, DOI 10.1104/pp.105.070813; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Palatnik JF, 1997, PLANT PHYSIOL, V115, P1721, DOI 10.1104/pp.115.4.1721; Poncelet M, 1998, MOL MICROBIOL, V28, P813, DOI 10.1046/j.1365-2958.1998.00844.x; ROGNER M, 1990, J BIOL CHEM, V265, P6189; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P3092, DOI 10.1021/bi00127a009; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; SETIF PQY, 1994, BIOCHEMISTRY-US, V33, P8495, DOI 10.1021/bi00194a014; Shin M, 1971, METHOD ENZYMOL, V23, P440; Tejero J, 2007, ARCH BIOCHEM BIOPHYS, V459, P79, DOI 10.1016/j.abb.2006.10.023; Thomas JC, 2006, P NATL ACAD SCI USA, V103, P18368, DOI 10.1073/pnas.0607718103; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; van Thor JJ, 1999, EMBO J, V18, P4128, DOI 10.1093/emboj/18.15.4128; van Thor JJ, 2000, BBA-BIOENERGETICS, V1457, P129, DOI 10.1016/S0005-2728(00)00072-4; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; ZANETTI G, 1980, FEBS LETT, V111, P373, DOI 10.1016/0014-5793(80)80830-1	53	28	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31789	31797		10.1074/jbc.M109.024638	http://dx.doi.org/10.1074/jbc.M109.024638			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759024	Green Published, hybrid			2022-12-25	WOS:000271572700033
J	Evjenth, R; Hole, K; Karlsen, OA; Ziegler, M; Arnesen, T; Lillehaug, JR				Evjenth, Rune; Hole, Kristine; Karlsen, Odd A.; Ziegler, Mathias; Arnesen, Thomas; Lillehaug, Johan R.			Human Naa50p (Nat5/San) Displays Both Protein N-alpha- and N-epsilon-Acetyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN5 TRANSCRIPTIONAL COACTIVATOR; TERMINAL ACETYLTRANSFERASES; COMPLEX; ACETYLATION; YEAST; MECHANISM; REQUIREMENTS; TIPIN; PHASE; NATA	Protein acetylation is a widespread modification that is mediated by site-selective acetyltransferases. KATs (lysine N-epsilon-acetyltransferases), modify the side chain of specific lysines on histones and other proteins, a central process in regulating gene expression. N-alpha-terminal acetylation occurs on the ribosome where the alpha amino group of nascent polypeptides is acetylated by NATs(N-terminal acetyltransferase). In yeast, three different NAT complexes were identified NatA, NatB, and NatC. NatA is composed of two main subunits, the catalytic subunit Naa10p (Ard1p) and Naa15p (Nat1p). Naa50p (Nat5) is physically associated with NatA. In man, hNaa50p was shown to have acetyltransferase activity and to be important for chromosome segregation. In this study, we used purified recombinant hNaa50p and multiple oligopeptide substrates to identify and characterize an N-alpha-acetyltransferase activity of hNaa50p. As the preferred substrate this activity acetylates oligopeptides with N termini Met-Leu-Xxx-Pro. Furthermore, hNaa50p autoacetylates lysines 34, 37, and 140 in vitro, modulating hNaa50p substrate specificity. In addition, histone 4 was detected as a hNaa50p KAT substrate in vitro. Our findings thus provide the first experimental evidence of an enzyme having both KAT and NAT activities.	[Lillehaug, Johan R.] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Hole, Kristine; Arnesen, Thomas] Univ Bergen, Dept Surg Sci, N-5020 Bergen, Norway; [Hole, Kristine; Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Lillehaug, JR (corresponding author), Thormohlensgate 55, N-5020 Bergen, Norway.	Johan.lillehaug@mbi.uib.no	; Arnesen, Thomas/J-7139-2017	Ziegler, Mathias/0000-0001-6961-2396; Arnesen, Thomas/0000-0002-3005-147X	Norwegian Cancer Society; Meltzer Foundation; Norwegian Health Region West	Norwegian Cancer Society(Norwegian Cancer Society); Meltzer Foundation; Norwegian Health Region West	This work was supported by The Norwegian Cancer Society, The Meltzer Foundation, and the Norwegian Health Region West.	Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Dormeyer W, 2005, MOL CELL PROTEOMICS, V4, P1226, DOI 10.1074/mcp.M500047-MCP200; Evjenth Rune, 2009, BMC Proc, V3 Suppl 6, pS5, DOI 10.1186/1753-6561-3-S6-S5; Gamberi C, 1997, MOL CELL BIOL, V17, P2587, DOI 10.1128/MCB.17.5.2587; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Marmorstein R, 2004, METHOD ENZYMOL, V376, P106; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Pimenta-Marques A, 2008, DEV BIOL, V323, P197, DOI 10.1016/j.ydbio.2008.08.021; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	25	73	76	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31122	31129		10.1074/jbc.M109.001347	http://dx.doi.org/10.1074/jbc.M109.001347			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744929	Green Published, hybrid			2022-12-25	WOS:000271378400040
J	Hyry, M; Lantto, J; Myllyharju, J				Hyry, Marjo; Lantto, Juha; Myllyharju, Johanna			Missense Mutations That Cause Bruck Syndrome Affect Enzymatic Activity, Folding, and Oligomerization of Lysyl Hydroxylase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT CELLS; CROSS-LINKS; COLLAGEN; EXPRESSION; IDENTIFICATION; 2-OXOGLUTARATE; GLYCOSYLATION; RESIDUES; ISOFORM; CLONING	Bruck syndrome is a rare autosomal recessive connective tissue disorder characterized by fragile bones, joint contractures, scoliosis, and osteoporosis. The telopeptides of bone collagen I are underhydroxylated in these patients, leading to abnormal collagen cross-linking. Three point mutations in lysyl hydroxylase (LH) 2, the enzyme responsible for the hydroxylation of collagen telopeptides, have been identified in Bruck syndrome. As none of them affects the residues known to be critical for LH activity, we studied their consequences at the molecular level by analyzing the folding and catalytic properties of the corresponding mutant recombinant polypeptides. Folding and oligomerization of the R594H and G597V mutants were abnormal, and their activity was reduced by > 95% relative to the wild type. The T604I mutation did not affect the folding properties, although the mutant retained only similar to 8% activity under standard assay conditions. As the reduced activity was caused by a 10-fold increase in the Km for 2-oxoglutarate, the mutation interferes with binding of this cosubstrate. In the presence of a saturating 2-oxoglutarate concentration, the activity of the T604I mutant was similar to 30% of that of the wild type. However, the T604I mutant did not generate detectable amounts of hydroxylysine in the N-terminal telopeptide of a recombinant procollagen I chain when coexpressed in insect cells. The low activity of the mutant LH2 polypeptides is in accordance with the markedly reduced extent of collagen telopeptide hydroxylation in Bruck syndrome, with consequent changes in the cross-linking of collagen fibrils and severe abnormalities in the skeletal structures.	[Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi			Academy of Finland [1114344, 1211128]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland Grants 1114344 and 1211128 and by the Sigrid Juselius Foundation.	Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; CROSSEN R, 1998, BACULOVIRUS EXPRESSI; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Krol BJ, 1996, J INVEST DERMATOL, V106, P11, DOI 10.1111/1523-1747.ep12326956; Myllyharju J, 2005, TOP CURR CHEM, V247, P115, DOI 10.1007/b103821; Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/bst0280353; Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; Passoja K, 1998, FEBS LETT, V434, P145, DOI 10.1016/S0014-5793(98)00966-1; Pirskanen A, 1996, J BIOL CHEM, V271, P9398, DOI 10.1074/jbc.271.16.9398; PUISTOLA U, 1980, BIOCHIM BIOPHYS ACTA, V611, P40, DOI 10.1016/0005-2744(80)90040-6; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; Uzawa K, 2003, BIOCHEM BIOPH RES CO, V305, P484, DOI 10.1016/S0006-291X(03)00799-X; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Walker LC, 2005, MATRIX BIOL, V23, P515, DOI 10.1016/j.matbio.2004.11.002; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Yeowell HN, 1999, MATRIX BIOL, V18, P179, DOI 10.1016/S0945-053X(99)00013-X; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	42	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30917	30924		10.1074/jbc.M109.021238	http://dx.doi.org/10.1074/jbc.M109.021238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19762917	Green Published, hybrid			2022-12-25	WOS:000271378400020
J	Palijan, A; Fernandes, I; Verway, M; Kourelis, M; Bastien, Y; Tavera-Mendoza, LE; Sacheli, A; Bourdeau, V; Mader, S; White, JH				Palijan, Ana; Fernandes, Isabelle; Verway, Mark; Kourelis, Maria; Bastien, Yolande; Tavera-Mendoza, Luz E.; Sacheli, Aaron; Bourdeau, Veronique; Mader, Sylvie; White, John H.			Ligand-dependent Corepressor LCoR Is an Attenuator of Progesterone-regulated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL BINDING-PROTEIN; RECEPTOR-INTERACTING PROTEIN; TRANSCRIPTIONAL COREPRESSOR; PIPSQUEAK PROTEIN; STEROID-HORMONES; ESTROGEN; CTBP; RECRUITMENT; PHOSPHORYLATION; REPRESSION	Ligand-dependent corepressor LCoR interacts with the progesterone receptor (PR) and estrogen receptor ER alpha in the presence of hormone. LCoR contains tandem N-terminal PXDLS motifs that recruit C-terminal-binding protein (CtBP) corepressors as well as a C-terminal helix-turn-helix (HTH) domain. Here, we analyzed the function of these domains in coregulation of PR- and ER alpha-regulated gene expression. LCoR and CtBP1 colocalize in nuclear bodies that also contain CtBP-interacting protein CtIP and polycomb group repressor complex marker BMI1. Coexpression of CtBP1 in MCF7 or T47D breast cancer cells augmented corepression by LCoR, whereas coexpression of CtIP did not, consistent with direct interaction of LCoR with CtBP1, but not CtIP. The N-terminal region containing the PXDLS motifs is necessary and sufficient for CTBP1 recruitment and essential for full corepression. However, LCoR function was also strongly dependent on the helix-turn-helix domain, as its deletion completely abolished corepression. LCoR, CtBP, and CtIP were recruited to endogenous PR- and ER alpha-stimulated genes in a hormone-dependent manner. Similarly, LCoR was recruited to estrogen-repressed genes, whereas hormone treatment reduced CtBP1 binding. Small interfering RNA-mediated knockdown of LCoR or CtBP1 augmented expression of progesterone- and estrogen-stimulated reporter genes as well as endogenous progesterone- stimulated target genes. In contrast, their ablation had gene-specific effects on ER alpha-regulated transcription that generally led to reduced gene expression. Taken together, these results show that multiple domains contribute to LCoR function. They also reveal a role for LCoR and CtBP1 as attenuators of progesterone-regulated transcription but suggest that LCoR and CtBP1 can act to enhance transcription of some genes.	[Palijan, Ana; Fernandes, Isabelle; Verway, Mark; Kourelis, Maria; Bastien, Yolande; Sacheli, Aaron; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Tavera-Mendoza, Luz E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Bourdeau, Veronique; Mader, Sylvie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Universite de Montreal; Universite de Montreal	White, JH (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	john.white@mcgill.ca	Palijan, Ana/AAV-3310-2021; white, john h/N-9782-2013	white, john h/0000-0002-4785-2687	Canadian Institutes of Health [MT-11704]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MT-11704 (to J. H. W.).	Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2006, BBA-REV CANCER, V1765, P67, DOI 10.1016/j.bbcan.2005.09.002; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Duffy MJ, 2005, CLIN CHEM, V51, P494, DOI 10.1373/clinchem.2004.046227; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Ghosh D, 1999, HUM REPROD, V14, P505, DOI 10.1093/humrep/14.2.505; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Horne AW, 2006, REPRODUCTION, V131, P733, DOI 10.1530/rep.1.00883; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Kusumegi T, 2004, J BIOCHEM MOL TOXIC, V18, P1, DOI 10.1002/jbt.20004; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Mani-Telang P, 2007, DEV GENES EVOL, V217, P127, DOI 10.1007/s00427-006-0121-4; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Patel FA, 1999, J CLIN ENDOCR METAB, V84, P291, DOI 10.1210/jc.84.1.291; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Spector DL, 2001, J CELL SCI, V114, P2891; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; White JH, 2004, VITAM HORM, V68, P123; White KA, 2005, J BIOL CHEM, V280, P7829, DOI 10.1074/jbc.M412707200; Wong CW, 2002, P NATL ACAD SCI USA, V99, P14783, DOI 10.1073/pnas.192569699; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	54	30	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30275	30287		10.1074/jbc.M109.051201	http://dx.doi.org/10.1074/jbc.M109.051201			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19744932	hybrid, Green Published			2022-12-25	WOS:000271090000031
J	Zhuang, J; Jiang, GC; Willers, H; Xia, F				Zhuang, Jing; Jiang, Guochun; Willers, Henning; Xia, Fen			Exonuclease Function of Human Mre11 Promotes Deletional Nonhomologous End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA END; PROTEIN-KINASE; REPAIR; COMPLEX; RECOMBINATION; MECHANISMS; NUCLEASE; DISTINCT; COLLABORATE	DNAdouble-stranded breaks (DSBs) are lethal if not repaired and are highly mutagenic if misrepaired. Nonhomologous end joining (NHEJ) is one of the major DSB repair pathways and can rejoin the DSB ends either precisely or with mistakes. Recent evidence suggests the existence of two NHEJ subpathways: conservative NHEJ (C-NHEJ), which does not require microhomology and can join ends precisely; and deletional NHEJ (D-NHEJ), which utilizes microhomology to join the ends with small deletions. Little is known about how these NHEJ subpathways are regulated. Mre11 has been implicated in DNA damage response, thus we investigated whether Mre11 function also extended to NHEJ. We utilized an intrachromosomal NHEJ substrate in which DSBs are generated by the I-SceI to address this question. The cohesive ends are fully complementary and were either repaired by C-NHEJ or D-NHEJ with similar efficiency. We found that disruption of Mre11 by RNA interference in human cells led to a 10-fold decrease in the frequency of D-NHEJ compared with cells with functional Mre11. Interestingly, C-NHEJ was not affected by Mre11 status. Expression of wild type but not exonuclease-defective Mre11 mutants was able to rescue D-NHEJ in Mre11-deficient cells. Further mutational analysis suggested that additional mechanisms associated with methylation of Mre11 at the C-terminal glycine-arginine-rich domain contributed to the promotion of D-NHEJ by Mre11. This study provides new insights into the mechanisms by which Mre11 affects the accuracy of DSB end joining specifically through control of the D-NHEJ subpathway, thus illustrating the complexity of the Mre11 role in maintaining genomic stability.	[Zhuang, Jing; Jiang, Guochun; Xia, Fen] Vanderbilt Univ, Dept Radiat Oncol, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Zhuang, Jing; Jiang, Guochun; Xia, Fen] Vanderbilt Univ, Dept Canc Biol, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Willers, Henning] Massachusetts Gen Hosp, Lab Cellular & Mol Radiat Oncol, Ctr Canc, Boston, MA 02114 USA	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital	Xia, F (corresponding author), Vanderbilt Univ, Dept Radiat Oncol, Med Ctr, Nashville, TN 37232 USA.	fen.xia@vanderbilt.edu	Xia, Fen/G-3708-2013; Jiang, Guochun/H-8809-2019	Jiang, Guochun/0000-0003-1911-5089	National Institutes of Health [R01 CA118158-02]; NATIONAL CANCER INSTITUTE [R01CA118158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA118158-02 ( to F. X.).	Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bleuit JS, 2001, P NATL ACAD SCI USA, V98, P8298, DOI 10.1073/pnas.131007498; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Bressan DA, 1998, GENETICS, V150, P591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Dahm-Daphi J, 2005, ONCOGENE, V24, P1663, DOI 10.1038/sj.onc.1208396; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Modesti M, 2001, GENOME BIOL, V2; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; PFEIFFER P, 1994, MOL CELL BIOL, V14, P888, DOI 10.1128/MCB.14.2.888; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Willers H, 2006, RADIAT RES, V166, P567, DOI 10.1667/RR0524.1; Willers H, 2000, ONCOGENE, V19, P632, DOI 10.1038/sj.onc.1203142; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278	47	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30565	30573		10.1074/jbc.M109.059444	http://dx.doi.org/10.1074/jbc.M109.059444			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19744924	hybrid, Green Published			2022-12-25	WOS:000271090000059
J	Gjesing, AP; Sparso, T; Borch-Johnsen, K; Jorgensen, T; Pedersen, O; Hansen, T; Olsen, NV				Gjesing, Anette P.; Sparso, Thomas; Borch-Johnsen, Knut; Jorgensen, Torben; Pedersen, Oluf; Hansen, Torben; Olsen, Niels V.			No Consistent Effect of ADRB2 Haplotypes on Obesity, Hypertension and Quantitative Traits of Body Fatness and Blood Pressure among 6,514 Adult Danes	PLOS ONE			English	Article								Background: Evidence regarding the association of variation within ADRB2, the gene encoding the beta-adrenergic receptor 2 (ADRB2) with obesity and hypertension is exceedingly ambiguous. Despite negative reports, functional impacts of individual genetic variants have been reported. Also, functional haplotypes as well as haplotype combinations affecting expression levels in vivo of ADRB2 mRNA and protein as well as receptor sensitivity have been reported. The aim of the present study was therefore to evaluate if variations within ADRB2 as haplotypes or as haplotype combinations confer an increased prevalence of obesity and hypertension among adults. Methodology/Principal Findings: We genotyped five variants required to capture common variation in a region including the ADRB2 locus in a population-based study of 6,514 unrelated, middle-aged Danes. Phases of the genotypes were estimated in silico. The variations were then investigated for their combined association with obesity, hypertension and related quantitative traits. The present study did not find consistent evidence for an association of ADRB2 variants with either obesity or hypertension when variations were analysed in a case-control study. The same lack of impact was also seen in the quantitative trait analyses, apart from nominal differences on waist-to-hip ratio and systolic blood pressure between specific haplotype combinations. Conclusions/Significance: In a population-based sample of 6,514 Danes we found no consistent associations between five common variants which tag the ADRB2 locus and prevalence of obesity or hypertension neither when analysed as individual haplotypes nor as haplotype pairs.			Gjesing, AP (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	apri@hagedorn.dk	Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019; Gjesing, Anette/ACC-7521-2022	Pedersen, Oluf/0000-0002-3321-3972; Gjesing, Anette/0000-0003-4580-1576; Jorgensen, Torben/0000-0001-9453-2830				Bengtsson K, 2001, HYPERTENSION, V37, P1303, DOI 10.1161/01.HYP.37.5.1303; Binder A, 2006, J HYPERTENS, V24, P471, DOI 10.1097/01.hjh.0000209983.28735.33; Cerrone GE, 2007, MOL CELL PROBE, V21, P222, DOI 10.1016/j.mcp.2006.12.004; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Eriksson P, 2004, INT J OBESITY, V28, P185, DOI 10.1038/sj.ijo.0802521; Gjesing AP, 2007, DIABETIC MED, V24, P392, DOI 10.1111/j.1464-5491.2006.02031.x; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Pereira AC, 2003, HYPERTENSION, V42, P685, DOI 10.1161/01.HYP.0000085648.65419.17; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	12	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7206	10.1371/journal.pone.0007206	http://dx.doi.org/10.1371/journal.pone.0007206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779622	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200025
J	Gulliford, MC; Charlton, J; Ashworth, M; Rudd, AG; Toschke, AM				Gulliford, Martin C.; Charlton, Judith; Ashworth, Mark; Rudd, Anthony G.; Toschke, Andre Michael		eCRT Res Team	Selection of Medical Diagnostic Codes for Analysis of Electronic Patient Records. Application to Stroke in a Primary Care Database	PLOS ONE			English	Article								Background: Electronic patient records from primary care databases are increasingly used in public health and health services research but methods used to identify cases with disease are not well described. This study aimed to evaluate the relevance of different codes for the identification of acute stroke in a primary care database, and to evaluate trends in the use of different codes over time. Methods: Data were obtained from the General Practice Research Database from 1997 to 2006. All subjects had a minimum of 24 months of up-to-standard record before the first recorded stroke diagnosis. Initially, we identified stroke cases using a supplemented version of the set of codes for prevalent stroke used by the Office for National Statistics in Key health statistics from general practice 1998 (ONS codes). The ONS codes were then independently reviewed by four raters and a restricted set of 121 codes for 'acute stroke' was identified but the kappa statistic was low at 0.23. Results: Initial extraction of data using the ONS codes gave 48,239 cases of stroke from 1997 to 2006. Application of the restricted set of codes reduced this to 39,424 cases. There were 2,288 cases whose index medical codes were for 'stroke annual review' and 3,112 for 'stroke monitoring'. The frequency of stroke review and monitoring codes as index codes increased from 9 per year in 1997 to 1,612 in 2004, 1,530 in 2005 and 1,424 in 2006. The one year mortality of cases with the restricted set of codes was 29.1% but for 'stroke annual review,' 4.6% and for 'stroke monitoring codes', 5.7%. Conclusion: In the analysis of electronic patient records, different medical codes for a single condition may have varying clinical and prognostic significance; utilisation of different medical codes may change over time; researchers with differing clinical or epidemiological experience may have differing interpretations of the relevance of particular codes. There is a need for greater transparency in the selection of sets of codes for different conditions, for the reporting of sensitivity analyses using different sets of codes, as well as sharing of code sets among researchers.			Gulliford, MC (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England.	martin.gulliford@kcl.ac.uk	Toschke, Andre M/A-8848-2010; Gulliford, Martin C/I-8606-2018; Greiver, Michelle/N-8764-2015	Gulliford, Martin C/0000-0003-1898-9075; Greiver, Michelle/0000-0001-8957-0285; Delaney, Brendan/0000-0002-3518-0131; Yardley, Lucy/0000-0002-3853-883X; Ashworth, Mark/0000-0001-6514-9904; van Staa, Tjeerd/0000-0001-9363-742X; Little, Paul/0000-0003-3664-1873	National Institute for Health Research [RP-PG-0407-10184] Funding Source: researchfish; Wellcome Trust Funding Source: Medline; Department of Health [RP-PG-0407-10184] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Department of Health		Andersohn F, 2006, STROKE, V37, P1725, DOI 10.1161/01.STR.0000226642.55207.94; Becker C, 2007, HEADACHE, V47, P1374, DOI 10.1111/j.1526-4610.2007.00937.x; Cleary P, 2004, LANCET, V363, P1184, DOI 10.1016/S0140-6736(04)15946-1; Department of Health, 2009, NEW GMS CONTR QOF IM; Derby LE, 1999, BRIT J CLIN PHARMACO, V47, P565, DOI 10.1046/j.1365-2125.1999.00928.x; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Gallagher AM, 2008, J THROMB HAEMOST, V6, P1500, DOI 10.1111/j.1538-7836.2008.03059.x; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Hollowell J, 1997, Popul Trends, P36; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Mulnier HE, 2006, DIABETOLOGIA, V49, P2859, DOI 10.1007/s00125-006-0493-z; *NAT STAT, 2000, SER MB6 NAT STAT, V2; Renoux C, 2008, MATURITAS, V61, P305, DOI 10.1016/j.maturitas.2008.09.020; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; TOSCHKE AM, 2009, CEREBROVASC IN PRESS	16	54	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7168	10.1371/journal.pone.0007168	http://dx.doi.org/10.1371/journal.pone.0007168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777060	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000270164600009
J	Arribas, A; Garrido, G; Viseras, C; Soria, JM; Pla, S; Solano, JG; Garces, M; Beamud, E; Carrion, JS				Arribas, Alfonso; Garrido, Guiomar; Viseras, Cesar; Soria, Jesus M.; Pla, Sila; Solano, Jose G.; Garces, Miguel; Beamud, Elisabet; Carrion, Jose S.			A Mammalian Lost World in Southwest Europe during the Late Pliocene	PLOS ONE			English	Article							LOWER PLEISTOCENE SITE; GUADIX-BAZA BASIN; FONELAS P-1; BETIC CORDILLERA; DISPERSAL; GRANADA; ASSEMBLAGE; EVOLUTION; CARNIVORA; TAPHONOMY	Background: Over the last decades, there has been an increasing interest on the chronology, distribution and mammal taxonomy (including hominins) related with the faunal turnovers that took place around the Pliocene-Pleistocene transition [ca. 1.8 mega-annum (Ma)] in Europe. However, these turnovers are not fully understood due to: the precarious nature of the period's fossil record; the "non-coexistence'' in this record of many of the species involved; and the enormous geographical area encompassed. This palaeontological information gap can now be in part bridged with data from the Fonelas P-1 site (Granada, Spain), whose faunal composition and late Upper Pliocene date shed light on some of the problems concerning the timing and geography of the dispersals. Methodology/Principal Findings: This rich fossil site yielded 32 species of mammals, among which autochthonous species of the European Upper Villafranchian coexist with canids (Canis), ovibovines (Praeovibos) and giraffids (Mitilanotherium) from Asia. Typical African species, such as the brown hyena (Hyaena brunnea) and the bush pig (Potamochoerus) are also present. Conclusions/Significance: This assemblage is taxonomically and palaeobiogeographically unique, and suggests that fewer dispersal events than was previously thought (possibly only one close to 2.0 Ma) are responsible for the changes seen around 1.9-1.7 Ma ago in the fauna of the two continents.			Arribas, A (corresponding author), Inst Geol & Minero Espana, Dept Invest Recursos, Madrid, Spain.	a.arribas@igme.es	Viseras, Cesar/AAV-2519-2021; Beamud, Elisabet/D-9750-2014; Carrion, Jose S/A-8983-2015; Arribas, Alfonso/Z-4722-2019; Garces, Miguel/D-4386-2014; Pla Pueyo, Sila/D-7773-2016; García, José A Solano/B-4742-2016; Garrido, Guiomar/GSD-7024-2022; garces, miguel/AAC-9358-2021	Beamud, Elisabet/0000-0003-3158-2966; Carrion, Jose S/0000-0002-6949-4382; Garces, Miguel/0000-0001-7666-6392; Pla Pueyo, Sila/0000-0003-4884-4096; García, José A Solano/0000-0001-6300-2351; Garrido, Guiomar/0000-0001-6742-2177; garces, miguel/0000-0001-7666-6392; Soria, Jesus Miguel/0000-0003-4848-3366; Arribas, Alfonso/0000-0003-4777-3062				Alberdi MT, 2001, PALAEOGEOGR PALAEOCL, V165, P1, DOI 10.1016/S0031-0182(00)00151-6; Arribas A., 2001, Boletin Geologico y Minero (Madrid), V112, P3; Arribas A., 2004, Boletin Geologico y Minero (Madrid), V115, P567; Arribas A, 1998, GEOBIOS-LYON, V31, P3, DOI 10.1016/S0016-6995(98)80056-9; Arribas A, 1999, J ARCHAEOL SCI, V26, P571, DOI 10.1006/jasc.1998.0346; Arribas A, 2007, CR PALEVOL, V6, P545, DOI 10.1016/j.crpv.2007.06.002; Arzarello M, 2007, NATURWISSENSCHAFTEN, V94, P107, DOI 10.1007/s00114-006-0173-3; Ascenzi A, 1996, J HUM EVOL, V31, P409, DOI 10.1006/jhev.1996.0069; AZZAROLI A, 1983, PALAEOGEOGR PALAEOCL, V44, P117, DOI 10.1016/0031-0182(83)90008-1; Azzaroli A, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P311; Bar-Yosef O, 2001, QUATERN INT, V75, P19, DOI 10.1016/S1040-6182(00)00074-4; Bermudez De Castro J. M., 1997, Science (Washington D C), V276, P1392, DOI 10.1126/science.276.5317.1392; Blanc PL, 2002, GEODIN ACTA, V15, P303, DOI 10.1016/S0985-3111(02)01095-1; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Crusafont Pairo M., 1964, CR Acad Sci Paris, V258, P2869; DZAPARIDZE V, 1989, JB ROM GERM ZENTRALM, V36, P67; FERNANDEZ J, 1996, TERTIARY BASINS SPAI, P353; FERNANDEZ J, 1996, TERTIARY BASINS SPAI, P366; Gabunia L, 2000, J HUM EVOL, V38, P785, DOI 10.1006/jhev.1999.0383; GARRIDO G, 2006, THESIS COMPLUTENSE U; Garrido G, 2008, GEOBIOS-LYON, V41, P751, DOI 10.1016/j.geobios.2008.05.002; Geraads Denis, 2006, Transactions of the Royal Society of South Africa, V61, P97; Gue C., 1996, GRANDS MAMMIFE RES P, P1; Guerin C., 2004, GEOBIOS S1, V26, P349; Loget N, 2006, SEDIMENT GEOL, V188, P341, DOI 10.1016/j.sedgeo.2006.03.012; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; MAZZA P, 1994, REND LINCEI-SCI FIS, V5, P17; MCFADDEN PL, 1990, GEOPHYS J INT, V103, P725, DOI 10.1111/j.1365-246X.1990.tb05683.x; Mithen S, 2002, J HUM EVOL, V43, P433, DOI 10.1006/jhev.2002.0584; O'Regan H, 2006, COUR FOR SEKENBG, V256, P305; O'Regan HJ, 2008, QUATERNARY SCI REV, V27, P2136, DOI 10.1016/j.quascirev.2008.08.007; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palmqvist P, 2001, PALEOBIOLOGY, V27, P512, DOI 10.1666/0094-8373(2001)027<0512:TDOTPI>2.0.CO;2; PALOMBO M.R., 2003, GEOL ROMANA, V37, P145; Palombo MR, 2007, QUATERN INT, V160, P30, DOI 10.1016/j.quaint.2006.10.003; Raia P, 2009, PALAEOGEOGR PALAEOCL, V276, P15, DOI 10.1016/j.palaeo.2009.02.005; Sahnouni M, 1998, J ARCHAEOL SCI, V25, P1083, DOI 10.1006/jasc.1998.0278; Soria J.M., 2008, VERTEBRADOS PLIOCENO, V10, P3; Soria JM, 1998, GEOL MAG, V135, P565, DOI 10.1017/S0016756898001186; Torre D, 1992, COURIER FORSCH I SEN, V153, P51; Torre Danilo, 1996, Acta Zoologica Cracoviensia, V39, P559; Turq A., 1996, PAL O, V8, P161; Valli AMF, 2006, GEODIVERSITAS, V28, P297; VISERAS C, 1994, SEDIMENT GEOL, V88, P201, DOI 10.1016/0037-0738(94)90062-0; VISERAS C, 1992, J GEOL SOC LONDON, V149, P1021, DOI 10.1144/gsjgs.149.6.1021; Viseras C, 2006, PALAEOGEOGR PALAEOCL, V242, P139, DOI 10.1016/j.palaeo.2006.05.013	46	54	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7127	10.1371/journal.pone.0007127	http://dx.doi.org/10.1371/journal.pone.0007127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498RP	19774089	Green Published, gold			2022-12-25	WOS:000270160900012
J	Han, Y; Miller, A; Mangada, J; Liu, Y; Swistowski, A; Zhan, M; Rao, MS; Zeng, XM				Han, Yi; Miller, Aaron; Mangada, Julie; Liu, Ying; Swistowski, Andrzej; Zhan, Ming; Rao, Mahendra S.; Zeng, Xianmin			Identification by Automated Screening of a Small Molecule that Selectively Eliminates Neural Stem Cells Derived from hESCs but Not Dopamine Neurons	PLOS ONE			English	Article								Background: We have previously described fundamental differences in the biology of stem cells as compared to other dividing cell populations. We reasoned therefore that a differential screen using US Food and Drug Administration (FDA)-approved compounds may identify either selective survival factors or specific toxins and may be useful for the therapeutically-driven manufacturing of cells in vitro and possibly in vivo. Methodology/Principal Findings: In this study we report on optimized methods for feeder-free culture of hESCs and hESC-derived neural stem cells (NSCs) to facilitate automated screening. We show that we are able to measure ATP as an indicator of metabolic activity in an automated screening assay. With this optimized platform we screened a collection of FDA-approved drugs to identify compounds that have differential toxicity to hESCs and their neural derivatives. Nine compounds were identified to be specifically toxic for NSCs to a greater extent than for hESCs. Six of these initial hits were retested and verified by large-scale cell culture to determine dose-responsive NSC toxicity. One of the compounds retested, amiodarone HCL, was further tested for possible effects on postmitotic neurons, a likely target for transplant therapy. Amiodarone HCL was found to be selectively toxic to NSCs but not to differentiated neurons or glial cells. Treated and untreated NSCs and neurons were then interrogated with global gene expression analysis to explore the mechanisms of action of amiodarone HCl. The gene expression analysis suggests that activation of cell-type specific cationic channels may underlie the toxicity of the drug. Conclusions/Significance: In conclusion, we have developed a screening strategy that allows us to rapidly identify clinically approved drugs for use in a Chemistry, Manufacture and Control protocol that can be safely used to deplete unwanted contaminating precursor cells from a differentiated cell product. Our results also suggest that such a strategy is rich in the potential of identifying lineage specific reagents and provides additional evidence for the utility of stem cells in screening and discovery paradigms.			Han, Y (corresponding author), Buck Inst Aging Res, Novato, CA USA.	xzeng@buckinstitute.org			NATIONAL INSTITUTE ON AGING [ZICAG000619] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; Baumann S, 2003, ONCOGENE, V22, P1333, DOI 10.1038/sj.onc.1206126; CAI J, 2005, STEM CELLS; CALKINS H, 1992, J AM COLL CARDIOL, V19, P347, DOI 10.1016/0735-1097(92)90490-E; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Das B, 2003, PHARMACOL RES, V47, P447, DOI 10.1016/S1043-6618(02)00335-3; Deffois A, 1996, NEUROSCI LETT, V220, P117, DOI 10.1016/S0304-3940(96)13227-4; Dong H, 2006, J CELL BIOCHEM, V98, P1495, DOI 10.1002/jcb.20755; ELLERSTROM C, 2007, STEM CELLS; FLAKER GC, 1985, AM HEART J, V110, P371, DOI 10.1016/0002-8703(85)90158-9; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Fujii J, 2008, INFECT IMMUN, V76, P3679, DOI 10.1128/IAI.01581-07; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grell M, 1996, J INFLAMM, V47, P8; Hirasawa Y, 2009, CIRC J, V73, P639, DOI 10.1253/circj.CJ-08-0794; Holmes DS, 2000, J CARDIOVASC ELECTR, V11, P1152, DOI 10.1111/j.1540-8167.2000.tb01762.x; Jin W, 2007, FEBS LETT, V581, P3826, DOI 10.1016/j.febslet.2007.07.008; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Liu Y, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-20; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Papp, 1996, J Cardiovasc Pharmacol Ther, V1, P287; PATTERSON E, 1983, CIRCULATION, V68, P857, DOI 10.1161/01.CIR.68.4.857; SATO R, 1994, J PHARMACOL EXP THER, V269, P1213; Schulz TC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-478; SHELDON RS, 1989, CIRC RES, V65, P477, DOI 10.1161/01.RES.65.2.477; SWISTOWSKA AM, 2009, STEM CELLS IN PRESS; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang SP, 2008, CLIN EXP PHARMACOL P, V35, P1077, DOI 10.1111/j.1440-1681.2008.04964.x; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; XI D, 1992, J BIOL CHEM, V267, P25025; Yano T, 2008, APOPTOSIS, V13, P543, DOI 10.1007/s10495-008-0186-9; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yeih D F, 2000, Heart, V84, pE8, DOI 10.1136/heart.84.4.e8; Yin L, 2008, STEM CELLS DEV, V17, P53, DOI 10.1089/scd.2007.0063; Zeng XM, 2006, NEUROPSYCHOPHARMACOL, V31, P2708, DOI 10.1038/sj.npp.1301125; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zeng XM, 2003, STEM CELLS, V21, P647, DOI 10.1634/stemcells.21-6-647; Zhang XP, 2009, INT J CANCER, V124, P1980, DOI 10.1002/ijc.24139	44	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7155	10.1371/journal.pone.0007155	http://dx.doi.org/10.1371/journal.pone.0007155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774075	gold, Green Published, Green Submitted			2022-12-25	WOS:000270160900020
J	Kim, IM; Wolf, MJ				Kim, Il-Man; Wolf, Matthew J.			Serial Examination of an Inducible and Reversible Dilated Cardiomyopathy in Individual Adult Drosophila	PLOS ONE			English	Article								Recent work has demonstrated that Drosophila can be used as a model of dilated cardiomyopathy, defined as an enlarged cardiac chamber at end-diastole when the heart is fully relaxed and having an impaired systolic function when the heart is fully contracted. Gene mutations that cause cardiac dysfunction in adult Drosophila can result from abnormalities in cardiac development or alterations in post-developmental heart function. To clarify the contribution of transgene expression to post-developmental cardiac abnormalities, we applied strategies to examine the temporal and spacial effects of transgene expression on cardiac function. We engineered transgenic Drosophila based on the well-characterized temperature-sensitive Gal80 protein in the context of the bipartite Gal4/UAS transgenic expression system in Drosophila employing the cardiac specific driver, tinC Delta 4-Gal4. Then, we developed a strategy using optical coherence tomography to serially measure cardiac function in the individual flies over time course of several days. As a proof of concept we examined the effects of the expression of a human mutant delta-sarcoglycan associated with familial heart failure and observed a reversible, post-developmental dilated cardiomyopathy in Drosophila. Our results show that the unique imaging strategy based on the non-destructive, non-invasive properties of optical coherence tomography can be applied to serially examine cardiac function in individual adult flies. Furthermore, the induction and reversal of cardiac transgene expression can be investigated in adult flies thereby providing insight into the post-developmental effects of transgene expression.			Wolf, MJ (corresponding author), Duke Univ, Dept Med, Durham, NC 27706 USA.	wolf0008@mc.duke.edu		Wolf, Matthew/0000-0001-8004-4852; Kim, Il-man/0000-0002-9268-8337	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085072] Funding Source: NIH RePORTER; American Heart Association-American Stroke Association [0825499E] Funding Source: Medline; NHLBI NIH HHS [K08HL085072, K08 HL085072] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association-American Stroke Association(American Heart Association); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Heydemann A, 2007, TRENDS CARDIOVAS MED, V17, P55, DOI 10.1016/j.tcm.2006.12.002; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Ocorr KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000601; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Yin ZZ, 1998, DEV GENET, V22, P187	17	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7132	10.1371/journal.pone.0007132	http://dx.doi.org/10.1371/journal.pone.0007132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771157	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154400020
J	Wensman, H; Heldin, NE; Pejler, G; Hellmen, E				Wensman, Helena; Heldin, Nils-Erik; Pejler, Gunnar; Hellmen, Eva			Diverse Bone Morphogenetic Protein Expression Profiles and Smad Pathway Activation in Different Phenotypes of Experimental Canine Mammary Tumors	PLOS ONE			English	Article								Background: BMPs are currently receiving attention for their role in tumorigenesis and tumor progression. Currently, most BMP expression studies are performed on carcinomas, and not much is known about the situation in sarcomas. Methodology/Principal Findings: We have investigated the BMP expression profiles and Smad activation in clones from different spontaneous canine mammary tumors. Spindle cell tumor and osteosarcoma clones expressed high levels of BMPs, in particular BMP-2, -4 and -6. Clones from a scirrhous carcinoma expressed much lower BMP levels. The various clones formed different tumor types in nude mice but only clones that expressed high levels of BMP-6 gave bone formation. Phosphorylated Smad-1/5, located in the nucleus, was detected in tumors derived from clones expressing high levels of BMPs, indicating an active BMP signaling pathway and BMP-2 stimulation of mammary tumor cell clones in vitro resulted in activation of the Smad-1/5 pathway. In contrast BMP-2 stimulation did not induce phosphorylation of the non-Smad pathway p38 MAPK. Interestingly, an increased level of the BMP-antagonist chordin-like 1 was detected after BMP stimulation of non-bone forming clones. Conclusions/Significance: We conclude that the specific BMP expression repertoire differs substantially between different types of mammary tumors and that BMP-6 expression most probably has a biological role in bone formation of canine mammary tumors.			Wensman, H (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	helena.wensman@afb.slu.se; eva.hellmen@afb.slu.se						Akiyoshi T, 2004, VET PATHOL, V41, P154, DOI 10.1354/vp.41-2-154; Alarmo EL, 2006, GENE CHROMOSOME CANC, V45, P411, DOI 10.1002/gcc.20307; Alarmo EL, 2007, BREAST CANCER RES TR, V103, P239, DOI 10.1007/s10549-006-9362-1; Andreev K, 2006, EXP EYE RES, V83, P1162, DOI 10.1016/j.exer.2006.06.003; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BAADE RT, 2004, ONCOGENE, V23, P3024; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Du J, 2008, J CELL BIOCHEM, V103, P1584, DOI 10.1002/jcb.21547; Franzen A, 2001, BIOCHEM BIOPH RES CO, V285, P773; Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719; HELDIN NE, 1991, ENDOCRINOLOGY, V129, P2187, DOI 10.1210/endo-129-4-2187; HELLMEN E, 1995, J COMP PATHOL, V113, P327, DOI 10.1016/S0021-9975(05)80119-7; Hellmen E, 2000, BREAST CANCER RES TR, V61, P197, DOI 10.1023/A:1006410020384; Helms MW, 2005, J PATHOL, V206, P366, DOI 10.1002/path.1785; Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kraunz KS, 2005, BRIT J CANCER, V93, P949, DOI 10.1038/sj.bjc.6602790; Kugimiya F, 2005, J BIOL CHEM, V280, P35704, DOI 10.1074/jbc.M505166200; MISDORP W, 1999, ARMED FORCES I PATHO, V7; Moustakas A, 2002, GENE DEV, V16, P1867, DOI 10.1101/gad.1016802; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pouliot F, 2003, CANCER RES, V63, P277; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Sammons J, 2004, STEM CELLS DEV, V13, P273, DOI 10.1089/154732804323099208; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; Tateyama S, 2001, VET PATHOL, V38, P703, DOI 10.1354/vp.38-6-703; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wensman H, 2008, VET PATHOL, V45, P803, DOI 10.1354/vp.45-6-803; Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X; Yoshikawa H, 2004, J ORTHOP SCI, V9, P334, DOI 10.1007/s00776-004-0764-9	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7133	10.1371/journal.pone.0007133	http://dx.doi.org/10.1371/journal.pone.0007133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771160	gold, Green Submitted, Green Published			2022-12-25	WOS:000270154400021
J	Katsogiannou, M; El Boustany, C; Gackiere, F; Delcourt, P; Athias, A; Mariot, P; Dewailly, E; Jouy, N; Lamaze, C; Bidaux, G; Mauroy, B; Prevarskaya, N; Slomianny, C				Katsogiannou, Maria; El Boustany, Charbel; Gackiere, Florian; Delcourt, Philippe; Athias, Anne; Mariot, Pascal; Dewailly, Etienne; Jouy, Nathalie; Lamaze, Christophe; Bidaux, Gabriel; Mauroy, Brigitte; Prevarskaya, Natalia; Slomianny, Christian			Caveolae Contribute to the Apoptosis Resistance Induced by the alpha(1A)-Adrenoceptor in Androgen-Independent Prostate Cancer Cells	PLOS ONE			English	Article							SIGNAL-REGULATED-KINASE; PROTEIN-COUPLED RECEPTORS; LIPID RAFTS; POLY(ADP-RIBOSE) POLYMERASE; SURVIVAL/CLONAL GROWTH; CALCIUM-CHANNELS; EXPRESSION; ACTIVATION; DOMAINS; QUANTIFICATION	Background: During androgen ablation prostate cancer cells' growth and survival become independent of normal regulatory mechanisms. These androgen-independent cells acquire the remarkable ability to adapt to the surrounding microenvironment whose factors, such as neurotransmitters, influence their survival. Although findings are becoming evident about the expression of alpha(1A)-adrenoceptors in prostate cancer epithelial cells, their exact functional role in androgen-independent cells has yet to be established. Previous work has demonstrated that membrane lipid rafts associated with key signalling proteins mediate growth and survival signalling pathways in prostate cancer cells. Methodology/Principal Findings: In order to analyze the membrane topology of the alpha(1A)-adrenoceptor we explored its presence by a biochemical approach in purified detergent resistant membrane fractions of the androgen-independent prostate cancer cell line DU145. Electron microscopy observations demonstrated the colocalisation of the alpha(1A)-adrenoceptor with caveolin-1, the major protein component of caveolae. In addition, we showed that agonist stimulation of the alpha(1A)-adrenoceptor induced resistance to thapsigargin-induced apoptosis and that caveolin-1 was necessary for this process. Further, immunohistofluorescence revealed the relation between high levels of alpha(1A)-adrenoceptor and caveolin-1 expression with advanced stage prostate cancer. We also show by immunoblotting that the TG-induced apoptosis resistance described in DU145 cells is mediated by extracellular signal-regulated kinases (ERK). Conclusions/Significance: In conclusion, we propose that alpha(1A)-adrenoceptor stimulation in androgen-independent prostate cancer cells via caveolae constitutes one of the mechanisms contributing to their protection from TG-induced apoptosis.			Katsogiannou, M (corresponding author), Univ Lille 1 Sci & Technol, INSERM, U800, Villeneuve Dascq, France.	Christian.Slomianny@inserm.fr	Lamaze, Christophe/M-4912-2017; Slomianny, Christian/L-8285-2018; Bidaux, Gabriel/F-1294-2016	LAMAZE, Christophe/0000-0001-5430-2707; Bidaux, Gabriel/0000-0002-6162-3223; Mariot, Pascal/0000-0001-7226-9162; Prevarskaya, natacha/0000-0003-0316-197X				Abo K, 2000, CLIN BIOCHEM, V33, P541, DOI 10.1016/S0009-9120(00)00167-3; Andersson KE, 1997, PROSTATE, V30, P202; Anglin IE, 2002, PROSTATE CANCER P D, V5, P88, DOI 10.1038/sj.pcan.4500561; Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; BECART J, 1990, HRC-J HIGH RES CHROM, V13, P126; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Bruchas MR, 2008, EUR J PHARMACOL, V578, P349, DOI 10.1016/j.ejphar.2007.09.029; CHAPPLE CR, 1994, BRIT J UROL, V74, P585, DOI 10.1111/j.1464-410X.1994.tb09188.x; Chiang CF, 2005, PROSTATE, V64, P408, DOI 10.1002/pros.20260; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; CLERK A, 1994, J BIOL CHEM, V269, P32848; Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105; DAAKA Y, 2004, SCI STKE, pRE2; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujita T, 2001, CARDIOVASC RES, V51, P709, DOI 10.1016/S0008-6363(01)00348-0; Gackiere F, 2006, CELL CALCIUM, V39, P357, DOI 10.1016/j.ceca.2005.12.003; Gackiere F, 2008, J BIOL CHEM, V283, P10162, DOI 10.1074/jbc.M707159200; Gioeli D, 1999, CANCER RES, V59, P279; Goetz JG, 2008, CANC METASTASIS REV; Gohji K, 2001, J UROLOGY, V165, P1033, DOI 10.1016/S0022-5347(05)66597-4; HIGGINS JRA, 1989, PROSTATE, P5; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Humez S, 2006, ENDOCR-RELAT CANCER, V13, P181, DOI 10.1677/erc.1.01079; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Karam JA, 2007, PROSTATE, V67, P614, DOI 10.1002/pros.20557; Kojima Y, 2006, PROSTATE, V66, P761, DOI 10.1002/pros.20399; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Kyprianou N, 2000, CANCER RES, V60, P4550; Kyprianou N, 2000, Curr Urol Rep, V1, P89, DOI 10.1007/s11934-000-0042-0; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEPOR H, 1995, J UROLOGY, V154, P2096, DOI 10.1016/S0022-5347(01)66704-1; Li LK, 2001, CANCER RES, V61, P4386; MARSHALL I, 1995, BRIT J PHARMACOL, V115, P781, DOI 10.1111/j.1476-5381.1995.tb15001.x; McKenzie S, 2006, J CELL BIOCHEM, V97, P18, DOI 10.1002/jcb.20634; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Morris JB, 2006, J MOL CELL CARDIOL, V41, P17, DOI 10.1016/j.yjmcc.2006.03.011; Mouraviev V, 2002, J UROLOGY, V168, P1589, DOI 10.1016/S0022-5347(05)64526-0; Nasu K, 1996, BRIT J PHARMACOL, V119, P797, DOI 10.1111/j.1476-5381.1996.tb15742.x; Nasu Y, 1998, NAT MED, V4, P1062, DOI 10.1038/2048; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neidhold S, 2007, BRIT J PHARMACOL, V150, P261, DOI 10.1038/sj.bjp.0706980; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Price DT, 1999, J UROLOGY, V162, P1537, DOI 10.1016/S0022-5347(05)68354-1; RAGHAVAN D, 1988, SEMIN ONCOL, V15, P371; Raj GV, 2002, J UROLOGY, V167, P1458, DOI 10.1016/S0022-5347(05)65345-1; SCHRODER FH, 1992, PROSTATE, P129; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Taguchi K, 1998, N-S ARCH PHARMACOL, V357, P100, DOI 10.1007/PL00005143; Tahir SA, 2001, CANCER RES, V61, P3882; Takeda M, 1999, EUR UROL, V36, P31, DOI 10.1159/000052315; Taub JS, 2003, CANCER RES, V63, P2037; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Thebault S, 2003, J CLIN INVEST, V111, P1691, DOI 10.1172/JCI200316293; Thompson TC, 1999, APOPTOSIS, V4, P233, DOI 10.1023/A:1009612708099; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; van Helmond ZK, 2007, NEUROPATH APPL NEURO, V33, P317, DOI 10.1111/j.1365-2990.2006.00815.x; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Wertz IE, 2000, J BIOL CHEM, V275, P11470, DOI 10.1074/jbc.275.15.11470; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Yang G, 1998, CLIN CANCER RES, V4, P1873; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3	75	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7068	10.1371/journal.pone.0007068	http://dx.doi.org/10.1371/journal.pone.0007068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763272	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970400008
J	Sinnaeve, PR; Donahue, MP; Grass, P; Seo, D; Vonderscher, J; Chibout, SD; Kraus, WE; Sketch, M; Nelson, C; Ginsburg, GS; Goldschmidt-Clermont, PJ; Granger, CB				Sinnaeve, Peter R.; Donahue, Mark P.; Grass, Peter; Seo, David; Vonderscher, Jacky; Chibout, Salah-Dine; Kraus, William E.; Sketch, Michael, Jr.; Nelson, Charlotte; Ginsburg, Geoffrey S.; Goldschmidt-Clermont, Pascal J.; Granger, Christopher B.			Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ATHEROSCLEROTIC PLAQUES; DIFFERENTIATION; INFLAMMATION; MICROARRAY; MONOCYTES; RISK; HYPERTENSION; MACROPHAGES; LIPOPROTEIN	Systemic and local inflammation plays a prominent role in the pathogenesis of atherosclerotic coronary artery disease, but the relationship of whole blood gene expression changes with coronary disease remains unclear. We have investigated whether gene expression patterns in peripheral blood correlate with the severity of coronary disease and whether these patterns correlate with the extent of atherosclerosis in the vascular wall. Patients were selected according to their coronary artery disease index (CADi), a validated angiographical measure of the extent of coronary atherosclerosis that correlates with outcome. RNA was extracted from blood of 120 patients with at least a stenosis greater than 50% (CADi >= 23) and from 121 controls without evidence of coronary stenosis (CADi = 0). 160 individual genes were found to correlate with CADi (rho>0.2, P<0.003). Prominent differential expression was observed especially in genes involved in cell growth, apoptosis and inflammation. Using these 160 genes, a partial least squares multivariate regression model resulted in a highly predictive model (r(2) = 0.776, P<0.0001). The expression pattern of these 160 genes in aortic tissue also predicted the severity of atherosclerosis in human aortas, showing that peripheral blood gene expression associated with coronary atherosclerosis mirrors gene expression changes in atherosclerotic arteries. In conclusion, the simultaneous expression pattern of 160 genes in whole blood correlates with the severity of coronary artery disease and mirrors expression changes in the atherosclerotic vascular wall.			Sinnaeve, PR (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	peter.sinnaeve@uzleuven.be	Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291; Sinnaeve, Peter/0000-0003-4716-5892; Kraus, William E/0000-0003-1930-9684				Abedin MJ, 2003, J LEUKOCYTE BIOL, V73, P650, DOI 10.1189/jlb.0402163; Alcorta D, 2002, EXP NEPHROL, V10, P139; Arroyo-Espliguero R, 2004, EUR HEART J, V25, P401, DOI 10.1016/j.ehj.2003.12.017; Arvanitis DA, 2005, J CELL MOL MED, V9, P153, DOI 10.1111/j.1582-4934.2005.tb00345.x; Aziz Hamza, 2007, Genomic Med, V1, P105, DOI 10.1007/s11568-008-9017-x; Baldini PM, 2003, J LEUKOCYTE BIOL, V73, P502, DOI 10.1189/jlb.0702377; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Cagnin S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-13; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Donahue MP, 2006, AM HEART J, V152, P478, DOI 10.1016/j.ahj.2006.03.007; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Fritsche J, 2000, BIOCHEM BIOPH RES CO, V270, P17, DOI 10.1006/bbrc.2000.2371; Gibbons GH, 2004, CIRCULATION, V109, P47, DOI 10.1161/01.CIR.0000133440.86427.26; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Hiltunen MO, 2002, ATHEROSCLEROSIS, V165, P23, DOI 10.1016/S0021-9150(02)00187-9; Horwitz PA, 2004, CIRCULATION, V110, P3815, DOI 10.1161/01.CIR.0000150539.72783.BF; Hunt ME, 2001, AM HEART J, V141, P206, DOI 10.1067/mhj.2001.112488; Ijas P, 2007, ARTERIOSCL THROM VAS, V27, P154, DOI 10.1161/01.ATV.0000251991.64617.e7; Jarvis JN, 2004, ARTHRITIS RES THER, V6, pR15, DOI 10.1186/ar1018; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; King PH, 2000, GENE, V242, P125, DOI 10.1016/S0378-1119(99)00537-5; Kzhyshkowska J, 2004, J LEUKOCYTE BIOL, V76, P1151, DOI 10.1189/jlb.0504300; Lanzani C, 2005, J HYPERTENS, V23, P543, DOI 10.1097/01.hjh.0000160210.48479.78; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin CP, 2003, INT J CARDIOL, V89, P53, DOI 10.1016/S0167-5273(02)00428-X; Liu B, 2004, INT J BIOCHEM CELL B, V36, P766, DOI 10.1016/S1357-2725(03)00250-4; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; Mohler ER, 2008, ARTERIOSCL THROM VAS, V28, P850, DOI 10.1161/ATVBAHA.107.154534; Morikawa Shigeru, 2004, J Atheroscler Thromb, V11, P62; Nanni L, 2006, J MOL CELL CARDIOL, V41, P934, DOI 10.1016/j.yjmcc.2006.08.009; Pankow JS, 2005, AM J HYPERTENS, V18, P672, DOI 10.1016/j.amjhyper.2004.12.004; Paysant J, 1998, BRIT J HAEMATOL, V100, P45, DOI 10.1046/j.1365-2141.1998.00528.x; Pitzalis MV, 2003, J HYPERTENS, V21, P1491, DOI 10.1097/00004872-200308000-00012; Randi AM, 2003, J THROMB HAEMOST, V1, P829, DOI 10.1046/j.1538-7836.2003.00113.x; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rosamond WD, 2001, INT J EPIDEMIOL, V30, pS17, DOI 10.1093/ije/30.suppl_1.S17; Rosenson RS, 2003, AM J CARDIOL, V92, p10I, DOI 10.1016/S0002-9149(03)00504-6; Schirmer SH, 2009, J MOL CELL CARDIOL, V46, P177, DOI 10.1016/j.yjmcc.2008.10.029; SCHMIDT SB, 1985, AM J CARDIOL, V55, P1459, DOI 10.1016/0002-9149(85)90953-1; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161/hh2401.101272; Seo D, 2004, ARTERIOSCL THROM VAS, V24, P1922, DOI 10.1161/01.ATV.0000141358.65242.1f; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Sluimer JC, 2007, PHYSIOL GENOMICS, V30, P335, DOI 10.1152/physiolgenomics.00076.2007; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Tribioli C, 1996, P NATL ACAD SCI USA, V93, P695, DOI 10.1073/pnas.93.2.695; Wang J, 2004, CLIN BIOCHEM, V37, P741, DOI 10.1016/j.clinbiochem.2004.03.013; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730; You SA, 2005, CLIN CHIM ACTA, V357, P1, DOI 10.1016/j.cccn.2005.02.001; You SA, 2003, PHYSIOL GENOMICS, V13, P25, DOI 10.1152/physiolgenomics.00124.2002; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Zebrack JS, 2002, J AM COLL CARDIOL, V39, P632, DOI 10.1016/S0735-1097(01)01804-6	60	109	114	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7037	10.1371/journal.pone.0007037	http://dx.doi.org/10.1371/journal.pone.0007037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750006	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796300022
J	Mokarram, P; Kumar, K; Brim, H; Naghibalhossaini, F; Saberi-Firoozi, M; Nouraie, M; Green, R; Lee, E; Smoot, DT; Ashktorab, H				Mokarram, Pooneh; Kumar, Krishan; Brim, Hassan; Naghibalhossaini, Fakhraddin; Saberi-firoozi, Mehdi; Nouraie, Mehdi; Green, Robert; Lee, Ed; Smoot, Duane T.; Ashktorab, Hassan			Distinct High-Profile Methylated Genes in Colorectal Cancer	PLOS ONE			English	Article								Background: Mutations and promoters' methylation of a set of candidate cancer genes (CAN genes) are associated with progression of colorectal cancer (CRC). We hypothesized that these genes' promoters are inactivated through epigenetic silencing and may show a different profile in high-risk populations. We investigated the status of CAN gene methylation and CHD5 protein expression in African American CRC tissue microarrays (TMA) using immunohistochemical staining. Methodology/Principal Findings: The promoter methylation status of the CAN genes was studied by methylation-specific PCR (MSP) in 51 Iranians (a white population) and 51 African Americans (AA). Microsatellite instability (MSI) was analyzed as well. The differential frequency of methylation for each gene was tested by chi-square analysis between the two groups based on matched age and sex. CHD5 protein expression was evaluated in moderate to well differentiated and poorly differentiated carcinomas compared to matched normal tissue using TMA. In addition, the correlation between these epigenetic biomarkers and various clinicopathological factors, including, age, location, and stage of the disease were analyzed. Seventy-seven and 34% of tumors were distal in Iranian and African American patients, respectively. In both populations, the percentage of methylation was >65% for SYNE1, MMP2, APC2, GPNMB, EVL, PTPRD, and STARD8, whereas methylation was <50% for LGR6, RET, CD109, and RNF. The difference in methylation between the two populations was statistically significant for CHD5, ICAM5 and GPNMB. Thirty-one percent AA tumors showed MSI-H, compared to 28% in Iranians. Conclusions/Significance: A significantly higher methylation rate was found for GPNMB, ICAM5, and CHD5 genes in AA patients compared to Iranians. These genes might play a role in the high incidence and aggressiveness of CRC in the AA population. The hypermethylation of the CAN genes can be considered as a marker of colon carcinogenesis.			Mokarram, P (corresponding author), Iran Univ Med Sci, Dept Internal Med, Tehran, Iran.	hashktorab@howard.edu	Mokarram, Pooneh/E-1613-2012; Ashktorab, hassan/AAJ-2908-2020; Nouraie, Seyed Mehdi/O-4071-2018; Naghibalhossaini, Fakhraddin/I-1650-2018	Mokarram, Pooneh/0000-0002-9717-0473; Nouraie, Seyed Mehdi/0000-0001-7465-0581; Naghibalhossaini, Fakhraddin/0000-0003-4573-502X	NCI NIH HHS [R01 CA102681, CA102681] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Ashktorab H, 2007, DIGEST DIS SCI, V52, P1462, DOI 10.1007/s10620-006-9236-8; Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; ASHKTORAB H, 2008, DIG DIS SCI IN PRESS; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bienz M, 2004, CURR OPIN CELL BIOL, V16, P528, DOI 10.1016/j.ceb.2004.08.001; Boland CR, 1998, CANCER RES, V58, P5248; Bournier O, 2006, BIOL CELL, V98, P279, DOI 10.1042/BC20050024; BRIM H, 2008, MOL CANC IN PRESS; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Carethers J M, 1999, J Assoc Acad Minor Phys, V10, P59; Chiariotti L, 1998, GENOMICS, V47, P258, DOI 10.1006/geno.1997.5105; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Goodman JE, 2004, CARCINOGENESIS, V25, P2467, DOI 10.1093/carcin/bgh260; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; HERMAN JG, 1995, CANCER RES, V55, P4525; Hewitt SM, 2006, METHOD ENZYMOL, V410, P400, DOI 10.1016/S0076-6879(06)10020-8; Hosseini SV, 2004, ANZ J SURG, V74, P547, DOI 10.1111/j.1445-2197.2004.03064.x; Hsieh PC, 2007, ONCOGENE, V26, P4928, DOI 10.1038/sj.onc.1210304; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jurvansuu Jaana M, 2008, Recent Pat Biotechnol, V2, P47; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; KING BL, 1995, BRIT J CANCER, V72, P376, DOI 10.1038/bjc.1995.341; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Lindsberg PJ, 2002, NEUROLOGY, V58, P446, DOI 10.1212/WNL.58.3.446; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Mori Y, 2004, CANCER RES, V64, P2434, DOI 10.1158/0008-5472.CAN-03-3508; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P429, DOI 10.1158/1055-9965.EPI-04-0486; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Sweeney C, 2006, CANCER EPIDEM BIOMAR, V15, P744, DOI 10.1158/1055-9965.EPI-05-0814; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wood LD, 2007, SCIENCE; Yazdizadeh Bahareh, 2005, Asian Pac J Cancer Prev, V6, P130; Zhang QP, 2001, J CELL SCI, V114, P4485	52	104	112	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e7012	10.1371/journal.pone.0007012	http://dx.doi.org/10.1371/journal.pone.0007012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750230	Green Submitted, Green Published, gold			2022-12-25	WOS:000269696600017
J	Kou, Z; Li, YD; Yin, ZH; Guo, S; Wang, ML; Gao, XB; Li, P; Tang, LJ; Jiang, P; Luo, Z; Xin, Z; Ding, C; He, YB; Ren, ZY; Cui, P; Zhao, HF; Zhang, Z; Tang, SA; Yan, BP; Lei, FM; Li, TX				Kou, Zheng; Li, Yongdong; Yin, Zuohua; Guo, Shan; Wang, Mingli; Gao, Xuebin; Li, Peng; Tang, Lijun; Jiang, Ping; Luo, Ze; Xin, Zhi; Ding, Changqing; He, Yubang; Ren, Zuyi; Cui, Peng; Zhao, Hongfeng; Zhang, Zhong; Tang, Shuang; Yan, Baoping; Lei, Fumin; Li, Tianxian			The Survey of H5N1 Flu Virus in Wild Birds in 14 Provinces of China from 2004 to 2007	PLOS ONE			English	Article								Background: The highly pathogenic H5N1 avian influenza emerged in the year 1996 in Asia, and has spread to Europe and Africa recently. At present, effective monitoring and data analysis of H5N1 are not sufficient in Chinese mainland. Methodology/Principal Findings: During the period from April of 2004 to August of 2007, we collected 14,472 wild bird samples covering 56 species of 10 orders in 14 provinces of China and monitored the prevalence of flu virus based on RTPCR specific for H5N1 subtype. The 149 positive samples involved six orders. Anseriformes had the highest prevalence while Passeriformes had the lowest prevalence (2.70% versus 0.36%). Among the 24 positive species, mallard (Anas platyrhynchos) had the highest prevalence (4.37%). A difference of prevalence was found among 14 provinces. Qinghai had a higher prevalence than the other 13 provinces combined (3.88% versus 0.43%). The prevalence in three species in Qinghai province (Pintail (Anas acuta), Mallard (Anas platyrhynchos) and Tufted Duck (Aythya fuligula)) were obviously higher than those in other 13 provinces. The results of sequence analysis indicated that the 17 strains isolated from wild birds were distributed in five clades (2.3.1, 2.2, 2.5, 6, and 7), which suggested that genetic diversity existed among H5N1 viruses isolated from wild birds. The five isolates from Qinghai came from one clade (2.2) and had a short evolutionary distance with the isolates obtained from Qinghai in the year 2005. Conclusions/Significance: We have measured the prevalence of H5N1 virus in 56 species of wild birds in 14 provinces of China. Continuous monitoring in the field should be carried out to know whether H5N1 virus can be maintained by wild birds.			Kou, Z (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	leifm@ioz.ac.cn; litx@wh.iov.cn		KOU, Zheng/0000-0003-4758-2872				Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Lei FM, 2007, AVIAN DIS, V51, P568, DOI 10.1637/0005-2086(2007)51[568:COHIVI]2.0.CO;2; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; *MIN AGR PEOPL REP, 2009, REP H5N1 CONF CAS HU; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Peterson AT, 2008, EMERG INFECT DIS, V14, P1644, DOI 10.3201/eid1410.080169; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2007, REC LAB PROC DET AV; *WHO, 2009, CONT PROGR UN NOM SY; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhu QY, 2006, NEW ENGL J MED, V354, P2731, DOI 10.1056/NEJMc066058	30	55	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6926	10.1371/journal.pone.0006926	http://dx.doi.org/10.1371/journal.pone.0006926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742325	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622500009
J	Hamill, KJ; Langbein, L; Jones, JCR; McLean, WHI				Hamill, Kevin J.; Langbein, Lutz; Jones, Jonathan C. R.; McLean, W. H. Irwin			Identification of a Novel Family of Laminin N-terminal Alternate Splice Isoforms STRUCTURAL AND FUNCTIONAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; GAMMA-2 CHAIN; DIFFERENTIAL EXPRESSION; EXON USAGE; MOUSE; INTEGRIN; GENES; FIBRONECTIN; BINDING; PROTEIN	The laminins are a family of heterotrimeric basement membrane proteins that play roles in cellular adhesion, migration, and tissue morphogenesis. Through in silico analysis of the laminin-encoding genes, we identified a novel family of alternate splice isoforms derived from the 5'-end of the LAMA3 and LAMA5 genes. These isoforms resemble the netrins in that they contain a laminin N-terminal domain followed by a short stretch of laminin-type epidermal growth factor-like repeats. We suggest the terms LaNt (laminin N terminus) alpha 3 and LaNt alpha 5, for the predicted protein products of these mRNAs. RT-PCR confirmed the presence of these transcripts at the mRNA level. Moreover, they exhibit differential, tissue-specific, expression profiles. To confirm the existence of LaNt alpha 3 protein, we generated an antibody to a unique domain within the putative polypeptide. This antibody recognizes a protein at the predicted molecular mass of 64 kDa by immunoblotting. Furthermore, immunofluorescence analyses revealed a basement membrane staining in epithelial tissue for LaNt alpha 3 and LaNt alpha 3 localized along the substratum-associated surface of cultured keratinocytes. We have also tested the functionality LaNt alpha 3 through RNAi-mediated knockdown. Keratinocytes exhibiting specific knockdown of LaNt alpha 3 displayed impaired adhesion, stress resistance, and reduced ability to close scratch wounds in vitro.	[Hamill, Kevin J.; McLean, W. H. Irwin] Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Epithelial Genet Grp,Human Genet Unit, Dundee DD1 9SY, Scotland; [Hamill, Kevin J.; Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Langbein, Lutz] German Canc Res Ctr, Dept Genet Skin Carcinogenesis, D-69120 Heidelberg, Germany	University of Dundee; Northwestern University; Feinberg School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Hamill, KJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Epithelial Genet Grp,Human Genet Unit, Dundee DD1 9SY, Scotland.	k-hamill@northwestern.edu	Hamill, Kevin/F-8983-2012; McLean, William HI/C-6352-2009; Hamill, Kevin/ABF-9727-2020; Jones, Jonathan C R/T-9467-2017	Hamill, Kevin/0000-0002-7852-1944; Jones, Jonathan C R/0000-0002-1496-4922; McLean, William Henry Irwin/0000-0001-5539-5757	National Institutes of Health [R01 AR054184]; Dystrophic Epidermolysis Bullosa Research Association; MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dystrophic Epidermolysis Bullosa Research Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR054184 ( to J.C.R.J.), This work was also supported by grants from the Dystrophic Epidermolysis Bullosa Research Association ( to W. H. I. M.). Human tissue sections were provided by Northwestern University Skin Disease Research Center, Chicago, IL.	Airenne T, 1996, GENOMICS, V32, P54, DOI 10.1006/geno.1996.0076; Airenne T, 2000, CELL TISSUE RES, V300, P129, DOI 10.1007/s004410050054; Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Ashton GHS, 2004, J INVEST DERMATOL, V122, P78, DOI 10.1046/j.0022-202X.2003.22136.x; Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOYD CD, 1993, MATRIX, V13, P457, DOI 10.1016/S0934-8832(11)80112-5; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Ferrigno O, 1997, J BIOL CHEM, V272, P20502, DOI 10.1074/jbc.272.33.20502; Gagnoux-Palacios L, 2001, J CELL BIOL, V153, P835, DOI 10.1083/jcb.153.4.835; GagnouxPalacios L, 1996, J BIOL CHEM, V271, P18437, DOI 10.1074/jbc.271.31.18437; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Gonzales M, 1999, MOL BIOL CELL, V10, P259, DOI 10.1091/mbc.10.2.259; Hao JS, 2002, GENE, V283, P237, DOI 10.1016/S0378-1119(01)00850-2; Harlow E., 1988, ANTIBODIES LAB MANUA; Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kosmehl H, 1995, PATHOL RES PRACT, V191, P1105, DOI 10.1016/S0344-0338(11)80655-2; Langbein L, 2004, METHOD CELL BIOL, V78, P413; LANGHOFER M, 1993, J CELL SCI, V105, P753; Lee G, 2001, MOL CELLS, V12, P380; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; MATSUI C, 1995, J INVEST DERMATOL, V105, P648, DOI 10.1111/1523-1747.ep12324108; MAUCH JC, 1995, MATRIX BIOL, V14, P635, DOI 10.1016/S0945-053X(05)80027-7; McLean WHI, 2003, HUM MOL GENET, V12, P2395, DOI 10.1093/hmg/ddg234; Miosge N, 2002, ANAT EMBRYOL, V205, P355, DOI 10.1007/s00429-002-0256-7; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Nielsen PK, 2001, J BIOL CHEM, V276, P10906, DOI 10.1074/jbc.M008743200; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Nomizu M, 2001, BIOCHEMISTRY-US, V40, P15310, DOI 10.1021/bi011552c; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sakabe Noboru Jo, 2004, Genet Mol Res, V3, P532; Sandell LJ, 1996, CONNECT TISSUE RES, V35, P1, DOI 10.3109/03008209609029168; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Schor SL, 2003, CANCER RES, V63, P8827; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Stanco A, 2009, P NATL ACAD SCI USA, V106, P7595, DOI 10.1073/pnas.0811343106; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Sugawara K, 2007, J HISTOCHEM CYTOCHEM, V55, P43, DOI 10.1369/jhc.6A6920.2006; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; TIMPL R, 1993, EXPERIENTIA, V49, P417, DOI 10.1007/BF01923586; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Yuen HW, 2005, EXP CELL RES, V309, P198, DOI 10.1016/j.yexcr.2005.05.013; Yurchenco PD, 2004, CURR OPIN CELL BIOL, V16, P572, DOI 10.1016/j.ceb.2004.07.013; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	55	17	18	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35588	35596		10.1074/jbc.M109.052811	http://dx.doi.org/10.1074/jbc.M109.052811			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19773554	Green Published, hybrid			2022-12-25	WOS:000272645600036
J	Corsi, JM; Houbron, C; Billuart, P; Brunet, I; Bouvree, K; Eichmann, A; Girault, JA; Enslen, H				Corsi, Jean-Marc; Houbron, Christophe; Billuart, Pierre; Brunet, Isabelle; Bouvree, Karine; Eichmann, Anne; Girault, Jean-Antoine; Enslen, Herve			Autophosphorylation-independent and -dependent Functions of Focal Adhesion Kinase during Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CONDITIONAL KNOCKOUT; FAK EXPRESSION; CELL-SURVIVAL; PYK2; SRC; MIGRATION; MOTILITY; ACTIN; P53	Focal adhesion kinase (FAK) regulates numerous cellular functions and is critical for processes ranging from embryo development to cancer progression. Although autophosphorylation on Tyr-397 appears required for FAK functions in vitro, its role in vivo has not been established. We addressed this question using a mutant mouse (fak Delta) deleted of exon 15, which encodes Tyr-397. The resulting mutant protein FAK(Delta/Delta) is an active kinase expressed at normal levels. Our results demonstrate that the requirement for FAK autophosphorylation varies during development. FAK(Delta/Delta) embryos developed normally up to embryonic day (E) 12.5, contrasting with the lethality at E8.5 of FAK-null embryos. Thus, autophosphorylation on Tyr-397 is not required for FAK to achieve its functions until late mid-gestation. However, FAK(Delta/Delta) embryos displayed hemorrhages, edema, delayed artery formation, vascular remodeling defects, multiple organ abnormalities, and overall developmental retardation at E13.5-14.5, and died thereafter demonstrating that FAK autophosphorylation is also necessary for normal development. Fibroblasts derived from mutant embryos had a normal stellate morphology and expression of focal adhesion proteins, Src family members, p53, and Pyk2. In contrast, in FAK(Delta/Delta) fibroblasts and endothelial cells, spreading and lamellipodia formation were altered with an increased size and number of focal adhesions, enriched in FAK(Delta/Delta). FAK mutation also decreased fibroblast proliferation. These results show that the physiological functions of FAK in vivo are achieved through both autophosphorylation-independent and autophosphorylation-dependent mechanisms.	[Corsi, Jean-Marc; Girault, Jean-Antoine; Enslen, Herve] INSERM, U839, F-75005 Paris, France; [Corsi, Jean-Marc; Girault, Jean-Antoine; Enslen, Herve] Univ Paris 06, F-75005 Paris, France; [Corsi, Jean-Marc; Girault, Jean-Antoine; Enslen, Herve] Inst Fer a Moulin, F-75005 Paris, France; [Houbron, Christophe; Billuart, Pierre] Univ Paris 05, Inst Cochin, F-75014 Paris, France; [Houbron, Christophe; Billuart, Pierre] CNRS, UMR81074, F-75014 Paris, France; [Brunet, Isabelle; Bouvree, Karine; Eichmann, Anne] Coll France, INSERM, U833, F-75005 Paris, France; [Enslen, Herve] INSERM, U567, Inst Cochin, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Enslen, H (corresponding author), INSERM, U567, Inst Cochin, Bat G Roussy 5Eme Etage,27 Rue Faubourg St Jacque, F-75014 Paris, France.	herve.enslen@inserm.fr	Enslen, Hervé/AAH-4492-2021; Billuart, Pierre/K-3832-2017; Enslen, Hervé/M-3400-2017; Girault, Jean-Antoine/F-7518-2013	Enslen, Hervé/0000-0001-9741-5293; Billuart, Pierre/0000-0003-1913-1687; Enslen, Hervé/0000-0001-9741-5293; Girault, Jean-Antoine/0000-0002-7900-1705	Inserm [3746, 3138]; Association pour la Recherche sur le Cancer [ANR-05-2_42589]; Agence Nationale de la Recherche	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Inserm, by Grant 3746 (to H. E.) and Grant 3138 (to J.A.G.) from the Association pour la Recherche sur le Cancer, and by Grant ANR-05-2_42589 from Agence Nationale de la Recherche (to J.A.G.).	Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Burgaya F, 1997, J BIOL CHEM, V272, P28720, DOI 10.1074/jbc.272.45.28720; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Chatzizacharias NA, 2008, HISTOL HISTOPATHOL, V23, P629, DOI 10.14670/HH-23.629; Corsi JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-198; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; FURUTA Y, 1995, ONCOGENE, V11, P1989; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Grove M, 2007, J CELL BIOL, V176, P277, DOI 10.1083/jcb.200609021; Hakim ZS, 2007, MOL CELL BIOL, V27, P5352, DOI 10.1128/MCB.00068-07; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; ILLC D, 1995, NATURE, V377, P539; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; Vallejo-Illarramendi A, 2009, J CLIN INVEST, V119, P2218, DOI 10.1172/JCI38194; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038	38	42	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34769	34776		10.1074/jbc.M109.067280	http://dx.doi.org/10.1074/jbc.M109.067280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19776009	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000272439600032
J	di Martino, E; L'Hote, CG; Kennedy, W; Tomlinson, DC; Knowles, MA				di Martino, E.; L'Hote, C. G.; Kennedy, W.; Tomlinson, D. C.; Knowles, M. A.			Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner	ONCOGENE			English	Article						fibroblast growth factor; FGFR3; bladder; urothelium; signaling	FGFR3 MUTATIONS; DIFFERENTIAL EXPRESSION; BLADDER; ACTIVATION; DYSPLASIA; PHOSPHORYLATION; CARCINOMA; STAT1; ACHONDROPLASIA; UBIQUITYLATION	Although activating mutations of fibroblast growth factor receptor 3 (FGFR3) are frequent in bladder tumors, little information is available on their specific effects in urothelial cells or the basis for the observed mutation spectrum. We investigated the phenotypic and signaling consequences of three FGFR3 mutations (S249C, Y375C, and K652E) in immortalized normal human urothelial cells (TERT-NHUC) and mouse fibroblasts (NIH-3T3). In TERT-NHUC, all mutant forms of FGFR3 induced phosphorylation of FRS2 alpha and ERK1/2, but not AKT or SRC. PLC gamma 1 phosphorylation was only observed in TERT-NHUC expressing the common S249C and Y375C mutations, and not the rare K652E mutation. Cells expressing S249C and Y375C FGFR3 displayed an increased saturation density, related to increased proliferation and viability. This effect was significantly dependent on PLC gamma 1 signaling and undetectable in cells expressing K652E FGFR3, which failed to phosphorylate PLC gamma 1. In contrast to TERT-NHUC, expression of mutant FGFR3 in NIH-3T3 resulted in phosphorylation of Src and Akt. In addition, all forms of mutant FGFR3 were able to phosphorylate Plc gamma 1 and induce morphological transformation, cell proliferation, and anchorage-independent growth. Our results indicate that the effects of mutant FGFR3 are both cell type specific and mutation specific. Mutant FGFR3 may confer a selective advantage in the urothelium by overcoming normal contact inhibition of proliferation. Oncogene (2009) 28, 4306-4316; doi: 10.1038/onc.2009.280; published online 14 September 2009	[di Martino, E.; L'Hote, C. G.; Kennedy, W.; Tomlinson, D. C.; Knowles, M. A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital; University of Leeds	Knowles, MA (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Canc Res UK Clin Ctr, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	m.a.knowles@leeds.ac.uk		Tomlinson, Darren/0000-0003-4134-7484; di Martino, Erica/0000-0001-6703-1707; Knowles, Margaret/0000-0002-9363-8657	Cancer Research UK [C6228/A5433]	Cancer Research UK(Cancer Research UK)	We acknowledge Dr D Podolsky for donating the FGFR3 IIIb cDNA, and Dr R Agami for the pFB expression vector. This work was funded by a grant from Cancer Research UK (C6228/A5433).	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chen J, 2005, BLOOD, V106, P328, DOI 10.1182/blood-2004-09-3686; Chen L, 1999, J CLIN INVEST, V104, P1517, DOI 10.1172/JCI6690; Chesi M, 2001, BLOOD, V97, P729, DOI 10.1182/blood.V97.3.729; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Davies-Adetugbo AA, 1998, TROP MED INT HEALTH, V3, P9, DOI 10.1046/j.1365-3156.1998.00162.x; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Garcia-Espana A, 2005, CANCER RES, V65, P1150, DOI 10.1158/0008-5472.CAN-04-2074; Gibbs L, 2007, BBA-MOL CELL RES, V1773, P502, DOI 10.1016/j.bbamcr.2006.12.010; Guy M, 2001, BRIT J CANCER, V84, P520, DOI 10.1054/bjoc.2000.1635; Hafner C, 2006, CELL CYCLE, V5, P2723, DOI 10.4161/cc.5.23.3509; Harada D, 2007, BONE, V41, P273, DOI 10.1016/j.bone.2006.11.030; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; Karoui M, 2001, ONCOGENE, V20, P5059, DOI 10.1038/sj.onc.1204651; Korkolopoulou P, 2002, EUR UROL, V41, P274, DOI 10.1016/S0302-2838(02)00003-9; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Lievens PMJ, 2006, J MOL BIOL, V357, P783, DOI 10.1016/j.jmb.2006.01.058; Lievens PMJ, 2003, J BIOL CHEM, V278, P17344, DOI 10.1074/jbc.M212710200; Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Ornitz DM, 2001, GENOME BIOL, V2; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sibley K, 2001, ONCOGENE, V20, P4416, DOI 10.1038/sj.onc.1204543; Sibley K, 2001, ONCOGENE, V20, P686, DOI 10.1038/sj.onc.1204110; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tomlinson DC, 2005, CANCER RES, V65, P10441, DOI 10.1158/0008-5472.CAN-05-1718; van Oers JMM, 2006, INT J CANCER, V119, P1212, DOI 10.1002/ijc.21958; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Wallerand H, 2005, CARCINOGENESIS, V26, P177, DOI 10.1093/carcin/bgh275; Webster MK, 1997, MOL CELL BIOL, V17, P5739, DOI 10.1128/MCB.17.10.5739; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Wells A, 2003, CLIN EXP METASTAS, V20, P285, DOI 10.1023/A:1024088922957; YAMAMOTO H, 1995, BRIT J CANCER, V71, P1231, DOI 10.1038/bjc.1995.238	46	77	87	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4306	4316		10.1038/onc.2009.280	http://dx.doi.org/10.1038/onc.2009.280			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19749790	Green Accepted			2022-12-25	WOS:000272876300008
J	Sawai, H; Sugimoto, H; Kato, Y; Asano, Y; Shiro, Y; Aono, S				Sawai, Hitomi; Sugimoto, Hiroshi; Kato, Yasuo; Asano, Yasuhisa; Shiro, Yoshitsugu; Aono, Shigetoshi			X-ray Crystal Structure of Michaelis Complex of Aldoxime Dehydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE BOND SYNTHESIS; NITRILE-DEGRADING ENZYMES; MACROMOLECULAR STRUCTURES; DIFFRACTION; RESOLUTIONS; DISCOVERY; HYDRATASE; AMIDASE; PROGRAM; HEME	Aldoxime dehydratase (Oxd) catalyzes the dehydration of aldoximes (R-CH=N-OH) to their corresponding nitrile (R-C N). Oxd is a heme-containing enzyme that catalyzes the dehydration reaction as its physiological function. We have determined the first two structures of Oxd: the substrate-free OxdRE at 1.8 angstrom resolution and the n-butyraldoxime- and propionaldoxime-bound OxdREs at 1.8 and 1.6 angstrom resolutions, respectively. Unlike other heme enzymes, the organic substrate is directly bound to the heme iron in OxdRE. We determined the structure of the Michaelis complex of OxdRE by using the unique substrate binding and activity regulation properties of Oxd. The Michaelis complex was prepared by x-ray cryoradiolytic reduction of the ferric dead-end complex in which Oxd contains a Fe3+ heme form. The crystal structures reveal the mechanism of substrate recognition and the catalysis of OxdRE.	[Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Sayo Cho, Hyogo 6795148, Japan; [Kato, Yasuo; Asano, Yasuhisa] Toyama Prefectural Univ, Fac Engn, Biotechnol Res Ctr, Toyama 9390398, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	RIKEN; Toyama Prefectural University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Sugimoto, H (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo Cho, Hyogo 6795148, Japan.	sugimoto@spring8.or.jp; aono@ims.ac.jp	Sugimoto, Hiroshi/AAR-5442-2021; Shiro, Yoshitsugu Y/J-3757-2014; Sugimoto, Hiroshi/K-4041-2017; Sawai, Hitomi/AAW-5541-2021; Sawai, Hitomi/AAU-2584-2020; Aono, Shigetoshi/ABD-7618-2020; Asano, Yasuhisa/K-5898-2016	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Sugimoto, Hiroshi/0000-0002-3140-8362; Aono, Shigetoshi/0000-0002-2870-3694; Asano, Yasuhisa/0000-0003-3645-3952; Sawai, Hitomi/0000-0002-0714-8337	Japan Society for the Promotion of Science [19370059]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-aid for Scientific Research B 19370059 from the Japan Society for the Promotion of Science (to S.A.).	Asano Y, 2002, J BIOTECHNOL, V94, P65, DOI 10.1016/S0168-1656(01)00419-9; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kato Y, 2000, APPL ENVIRON MICROB, V66, P2290, DOI 10.1128/AEM.66.6.2290-2296.2000; Kato Y, 2004, J BIOSCI BIOENG, V97, P250, DOI 10.1016/S1389-1723(04)70200-5; Kato Y, 1998, ARCH MICROBIOL, V170, P85, DOI 10.1007/s002030050618; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kobayashi K, 2005, J BIOL CHEM, V280, P5486, DOI 10.1074/jbc.M410474200; Kobayashi K, 2006, CHEMBIOCHEM, V7, P2004, DOI 10.1002/cbic.200600261; Konishi K, 2006, P NATL ACAD SCI USA, V103, P564, DOI 10.1073/pnas.0505412103; Konishi K, 2004, J BIOL CHEM, V279, P47619, DOI 10.1074/jbc.M407223200; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; Oinuma KI, 2005, FEBS LETT, V579, P1394, DOI 10.1016/j.febslet.2005.01.037; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Sakai K, 2002, J APPL CRYSTALLOGR, V35, P270, DOI 10.1107/S0021889801021331; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie SX, 2003, BIOCHEMISTRY-US, V42, P12056, DOI 10.1021/bi035092u; Zhang C, 2000, J MOL BIOL, V299, P1075, DOI 10.1006/jmbi.2000.3678	29	42	42	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32089	32096		10.1074/jbc.M109.018762	http://dx.doi.org/10.1074/jbc.M109.018762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19740758	Green Published, hybrid			2022-12-25	WOS:000271572700063
J	Yamamoto, H; Fukui, K; Takahashi, H; Kitamura, S; Shiota, T; Terao, K; Uchida, M; Esaki, M; Nishikawa, S; Yoshihisa, T; Yamano, K; Endo, T				Yamamoto, Hayashi; Fukui, Kenji; Takahashi, Hisashi; Kitamura, Shingo; Shiota, Takuya; Terao, Kayoko; Uchida, Mayumi; Esaki, Masatoshi; Nishikawa, Shuh-ichi; Yoshihisa, Tohru; Yamano, Koji; Endo, Toshiya			Roles of Tom70 in Import of Presequence-containing Mitochondrial Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; RECEPTOR; TOM20; TRANSLOCATION; BINDING; RECOGNITION; PREPROTEIN; MACHINERY	Mitochondrial protein traffic requires precise recognition of the mitochondrial targeting signals by the import receptors on the mitochondrial surface including a general import receptor Tom20 and a receptor for presequence-less proteins, Tom70. Here we took a proteome-wide approach of mitochondrial protein import in vitro to find a set of presequence-containing precursor proteins for recognition by Tom70. The presequences of the Tom70-dependent precursor proteins were recognized by Tom20, whereas their mature parts exhibited Tom70-dependent import when attached to the presequence of Tom70-independent precursor proteins. The mature parts of the Tom70-dependent precursor proteins have the propensity to aggregate, and the presence of the receptor domain of Tom70 prevents their aggregate formation. Therefore Tom70 plays the role of a docking site for not only cytosolic chaperones but also aggregate-prone substrates to maintain their solubility for efficient transfer to downstream components of the mitochondrial import machineries.	[Uchida, Mayumi; Esaki, Masatoshi; Nishikawa, Shuh-ichi; Yamano, Koji; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yoshihisa, Tohru] Nagoya Univ, Res Ctr Mat Sci, Japan Sci & Technol Agcy, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp	Esaki, Masatoshi/L-6591-2017; Esaki, Masatoshi/ABS-6645-2022		Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants-in aid for scientific research from Ministry of Education, Culture, Sports, Science, and Technology, a Core Research for Evolutional Science and Technology grant from Japan Science and Technology Agency, and a grant from the Uehara Memorial Foundation.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Asai T, 2004, J BIOL CHEM, V279, P19464, DOI 10.1074/jbc.M401291200; Bohnert M, 2007, FEBS LETT, V581, P2802, DOI 10.1016/j.febslet.2007.03.004; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; ENDO T, 1995, FEBS LETT, V359, P93, DOI 10.1016/0014-5793(95)00015-2; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; LITHGOW T, 1995, TRENDS BIOCHEM SCI, V20, P98, DOI 10.1016/S0968-0004(00)88972-0; LITHGOW T, 1995, J BIOL CHEM, V270, P14267, DOI 10.1074/jbc.270.24.14267; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Muto T, 2001, J MOL BIOL, V306, P137, DOI 10.1006/jmbi.2000.4397; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	30	79	79	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31635	31646		10.1074/jbc.M109.041756	http://dx.doi.org/10.1074/jbc.M109.041756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19767391	hybrid, Green Published			2022-12-25	WOS:000271572700018
J	Brittain, JM; Piekarz, AD; Wang, YY; Kondo, T; Cummins, TR; Khanna, R				Brittain, Joel M.; Piekarz, Andrew D.; Wang, Yuying; Kondo, Takako; Cummins, Theodore R.; Khanna, Rajesh			An Atypical Role for Collapsin Response Mediator Protein 2 (CRMP-2) in Neurotransmitter Release via Interaction with Presynaptic Voltage-gated Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; GROWTH CONE COLLAPSE; CA2+ CHANNELS; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; NERVE-TERMINALS; DEVELOPMENTAL-CHANGES; EXCITATORY SYNAPSES; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS	Collapsin response mediator proteins (CRMPs) specify axon/dendrite fate and axonal growth of neurons through protein-protein interactions. Their functions in presynaptic biology remain unknown. Here, we identify the presynaptic N-type Ca2+ channel (CaV2.2) as a CRMP-2-interacting protein. CRMP-2 binds directly to CaV2.2 in two regions: the channel domain I-II intracellular loop and the distal C terminus. Both proteins co-localize within presynaptic sites in hippocampal neurons. Overexpression in hippocampal neurons of a CRMP-2 protein fused to enhanced green fluorescent protein caused a significant increase in Ca2+ channel current density, whereas lentivirus-mediated CRMP-2 knockdown abolished this effect. Interestingly, the increase in Ca2+ current density was not due to a change in channel gating. Rather, cell surface biotinylation studies showed an increased number of CaV2.2 at the cell surface in CRMP-2-overexpressing neurons. These neurons also exhibited a significant increase in vesicular release in response to a depolarizing stimulus. Depolarization of CRMP-2-enhanced green fluorescent protein-overexpressing neurons elicited a significant increase in release of glutamate compared with control neurons. Toxin block of Ca2+ entry via CaV2.2 abolished this stimulated release. Thus, the CRMP-2-Ca2+ channel interaction represents a novel mechanism for modulation of Ca2+ influx into nerve terminals and, hence, of synaptic strength.	[Brittain, Joel M.; Piekarz, Andrew D.; Wang, Yuying; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Piekarz, Andrew D.; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Kondo, Takako] Indiana Univ Sch Med, Dept Otolaryngol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), 950 W Walnut St,R2 Rm 478, Indianapolis, IN 46202 USA.	khanna5@iupui.edu	Tuluc, Petronel/C-2527-2011	Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health [NS053422]; Indiana State Department of Health Spinal Cord and Brain Injury Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422, R56NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State Department of Health Spinal Cord and Brain Injury Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS053422 (to T. R. C.). This work was also supported by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Fund (to R. K.).	Altier C, 2008, J RECEPT SIG TRANSD, V28, P71, DOI 10.1080/10799890801941947 ; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chan AW, 2007, CHANNELS, V1, DOI 10.4161/chan.3694; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Davies JN, 2008, CHANNELS, V2, P130, DOI 10.4161/chan.2.2.6214; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DONZANTI BA, 1988, LIFE SCI, V43, P913, DOI 10.1016/0024-3205(88)90267-6; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Grimm C, 2008, NEUROSCI LETT, V442, P44, DOI 10.1016/j.neulet.2008.06.066; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Henkel AW, 1996, J NEUROSCI, V16, P3960; Honnorat J, 1999, EUR J NEUROSCI, V11, P4226, DOI 10.1046/j.1460-9568.1999.00864.x; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones OT, 1997, J NEUROSCI, V17, P6152; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Khanna R, 2006, NEUROSCIENCE, V138, P1115, DOI 10.1016/j.neuroscience.2005.12.050; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Khanna R, 2007, EUR J NEUROSCI, V26, P560, DOI 10.1111/j.1460-9568.2007.05681.x; Khanna R, 2007, J BIOCHEM MOL BIOL, V40, P302; Kisilevsky Alexandra E., 2008, V184, P45; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; Leenders AGM, 2008, J NEUROSCI, V28, P11333, DOI 10.1523/JNEUROSCI.3078-08.2008; LEENDERS M, 2004, CURRENT PROTOCOLS NE; Li DJ, 2005, J NEUROSCI, V25, P1914, DOI 10.1523/JNEUROSCI.4790-04.2005; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nichols RA, 1996, NEUROSCI LETT, V211, P135, DOI 10.1016/0304-3940(96)12728-2; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Pan PY, 2005, J BIOL CHEM, V280, P25769, DOI 10.1074/jbc.M502356200; PANNEERSELVAM K, 1995, J BIOL CHEM, V270, P7975, DOI 10.1074/jbc.270.14.7975; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Prange O, 1999, J NEUROPHYSIOL, V81, P1810, DOI 10.1152/jn.1999.81.4.1810; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; Quinn CC, 2003, J NEUROSCI, V23, P2815; Reid B, 1999, J NEUROSCI, V19, P2511; Reid CA, 1998, J NEUROSCI, V18, P2849; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Reid CA, 1997, J NEUROSCI, V17, P2738; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Ryu MJ, 2008, J NEUROCHEM, V104, P1260, DOI 10.1111/j.1471-4159.2007.05100.x; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; SCHOLZ KP, 1995, J NEUROSCI, V15, P4612; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wang LH, 1997, J NEUROCHEM, V69, P2261; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P95; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yamaguchi K, 1998, BRAIN DEV-JPN, V20, P234, DOI 10.1016/S0387-7604(98)00027-8; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zufferey R, 2002, CURR TOP MICROBIOL, V261, P107	90	149	153	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31375	31390		10.1074/jbc.M109.009951	http://dx.doi.org/10.1074/jbc.M109.009951			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755421	hybrid, Green Published			2022-12-25	WOS:000271378400063
J	Fukunaka, A; Suzuki, T; Kurokawa, Y; Yamazaki, T; Fujiwara, N; Ishihara, K; Migaki, H; Okumura, K; Masuda, S; Yamaguchi-Iwai, Y; Nagao, M; Kambe, T				Fukunaka, Ayako; Suzuki, Tomoyuki; Kurokawa, Yayoi; Yamazaki, Tomohiro; Fujiwara, Naoko; Ishihara, Kaori; Migaki, Hitoshi; Okumura, Katsuzumi; Masuda, Seiji; Yamaguchi-Iwai, Yuko; Nagao, Masaya; Kambe, Taiho			Demonstration and Characterization of the Heterodimerization of ZnT5 and ZnT6 in the Early Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ZINC TRANSPORTER; DIFFUSION FACILITATOR FAMILY; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; ALKALINE-PHOSPHATASES; ENDOPLASMIC-RETICULUM; VERTEBRATE CELLS; HOMEOSTASIS; PROTEINS; TRAFFICKING	The majority of CDF/ZnT zinc transporters form homooligomers. However, ZnT5, ZnT6, and their orthologues form hetero-oligomers in the early secretory pathway where they load zinc onto zinc-requiring enzymes and maintain secretory pathway functions. The details of this hetero-oligomerization remain to be elucidated, and much more is known about homo-oligomerization that occurs in other CDF/ZnT family proteins. Here, we addressed this issue using co-immunoprecipitation experiments, mutagenesis, and chimera studies of hZnT5 and hZnT6 in chicken DT40 cells deficient in ZnT5, ZnT6, and ZnT7 proteins. We found that hZnT5 and hZnT6 combine to form heterodimers but do not form complexes larger than heterodimers. Mutagenesis of hZnT6 indicated that the sites present in transmembrane domains II and V in which many CDF/ZnT proteins have conserved hydrophilic amino acid residues are not involved in zinc binding of hZnT6, although they are required for zinc transport in other CDF/ZnT family homo-oligomers. We also found that the long N-terminal half of hZnT5 is not necessary for its functional interaction with hZnT6, whereas the cytosolic C-terminal tail of hZnT5 is important in determining hZnT6 as a partner molecule for heterodimer formation. In DT40 cells, cZnT5 variant lacking the N-terminal half was endogenously induced during periods of endoplasmic reticulum stress and so seemed to function to supply zinc to zinc-requiring enzymes under these conditions. The results outlined here provide new information about the mechanism of action through heterodimerization of CDF/ZnT proteins that function in the early secretory pathway.	[Fukunaka, Ayako; Suzuki, Tomoyuki; Kurokawa, Yayoi; Yamazaki, Tomohiro; Fujiwara, Naoko; Ishihara, Kaori; Migaki, Hitoshi; Masuda, Seiji; Yamaguchi-Iwai, Yuko; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Kyoto 6068502, Japan; [Okumura, Katsuzumi] Mie Univ, Dept Life Sci, Fac Bioresources, Tsu, Mie 5148507, Japan	Kyoto University; Mie University	Kambe, T (corresponding author), Kyoto Univ, Div Life Sci, Grad Sch Biostudies, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp		Kambe, Taiho/0000-0001-9757-063X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Kato Memorial Bioscience Foundation; Fuji Foundation for Protein Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by funds from the Kato Memorial Bioscience Foundation and Fuji Foundation for Protein Research (to T. K.).	Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Guffanti AA, 2002, MOL MICROBIOL, V45, P145, DOI 10.1046/j.1365-2958.2002.02998.x; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200	39	82	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30798	30806		10.1074/jbc.M109.026435	http://dx.doi.org/10.1074/jbc.M109.026435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759014	hybrid, Green Published			2022-12-25	WOS:000271378400007
J	Kolandaivelu, S; Huang, J; Hurley, JB; Ramamurthy, V				Kolandaivelu, Saravanan; Huang, Jing; Hurley, James B.; Ramamurthy, Visvanathan			AIPL1, a Protein Associated with Childhood Blindness, Interacts with alpha-Subunit of Rod Phosphodiesterase (PDE6) and Is Essential for Its Proper Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; CYCLIC-GMP PHOSPHODIESTERASE; PHOTORECEPTOR CGMP-PHOSPHODIESTERASE; OUTER SEGMENTS; RETINAL DEGENERATION; CATALYTIC SUBUNITS; GAMMA-SUBUNIT; BETA-SUBUNIT; MODEL; PHOTOTRANSDUCTION	Mutations in the gene coding for AIPL1 cause Leber congenital amaurosis (LCA), a severe form of childhood blindness. The severity in disease is reflected in the complete loss of vision and rapid photoreceptor degeneration in the retinas of mice deficient in AIPL1. Our previous observations suggest that rod photoreceptor degeneration in retinas lacking AIPL1 is due to the massive reduction in levels of rod cGMP phosphodiesterase (PDE6) subunits (alpha, beta, and gamma). To date, the crucial link between AIPL1 and the stability of PDE6 subunits is not known. In this study using ex vivo pulse label analysis, we demonstrate that AIPL1 is not involved in the synthesis of PDE6 subunits. However, ex vivo pulse-chase analysis clearly shows that in the absence of AIPL1, rod PDE6 subunits are rapidly degraded by proteasomes. We further demonstrate that this rapid degradation of PDE6 is due to the essential role of AIPL1 in the proper assembly of synthesized individual PDE6 subunits. In addition, using a novel monoclonal antibody generated against AIPL1, we show that the catalytic subunit (alpha) of PDE6 associates with AIPL1 in retinal extracts. Our studies establish that AIPL1 interacts with the catalytic subunit (alpha) of PDE6 and is needed for the proper assembly of functional rod PDE6 subunits.	[Ramamurthy, Visvanathan] W Virginia Univ, Dept Ophthalmol, Inst Eye, Sensory Neurosci Res Ctr, Morgantown, WV 26506 USA; [Kolandaivelu, Saravanan; Ramamurthy, Visvanathan] W Virginia Univ, Dept Biochem, Sensory Neurosci Res Ctr, Morgantown, WV 26506 USA; [Huang, Jing; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Jing; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	West Virginia University; West Virginia University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramamurthy, V (corresponding author), W Virginia Univ, Dept Ophthalmol, Inst Eye, Sensory Neurosci Res Ctr, 1 Stadium Dr,POB 9193, Morgantown, WV 26506 USA.	ramamurthyv@wvuh.com		Ramamurthy, Visvanathan/0000-0003-0289-3685	National Institutes of Health [EY017035]; NEI; COBRE [P20 RR15574]; Research to Prevent Blindness Challenge; International and West Virginia Lions Eye Foundation; Knight Templar Eye Foundation; Vision Core [P30EY1730]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001730, R01EY017035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); COBRE; Research to Prevent Blindness Challenge(Research to Prevent Blindness (RPB)); International and West Virginia Lions Eye Foundation; Knight Templar Eye Foundation; Vision Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY017035 from the NEI (to V. R.) and COBRE Grant P20 RR15574 (to the Sensory Neuroscience Research Center). This work was also supported by a Research to Prevent Blindness Challenge grant (to West Virginia University), the International and West Virginia Lions Eye Foundation (to West Virginia University) and a Knight Templar Eye Foundation grant (to S. K.), and Vision Core Grant P30EY1730 (to University of Washington).	ANANT JS, 1992, J BIOL CHEM, V267, P687; Artemyev NO, 1996, J BIOL CHEM, V271, P25382, DOI 10.1074/jbc.271.41.25382; Ausubel FM, 2003, CURRENT PROTOCOLS MO; BAEHR W, 1979, J BIOL CHEM, V254, P1669; CAMPBELL AM, 1984, LAB TECHNIQUES BIOCH, P86; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; CUNNICK J, 1992, BIOCHEM BIOPH RES CO, V184, P461, DOI 10.1016/0006-291X(92)91216-D; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dyer MA, 2004, MOL BRAIN RES, V132, P208, DOI 10.1016/j.molbrainres.2004.10.011; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; Hendrickson A, 2008, EXP EYE RES, V87, P415, DOI 10.1016/j.exer.2008.07.016; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; HURWITZ RL, 1984, CYCLIC NUCLEOTIDE PR, V17, P239; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; LEE RH, 1985, INVEST OPHTH VIS SCI, V26, P1569; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; MIKI N, 1975, J BIOL CHEM, V250, P6320; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov KG, 2003, BIOCHEMISTRY-US, V42, P3305, DOI 10.1021/bi027095x; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Piri N, 2006, EXP EYE RES, V83, P841, DOI 10.1016/j.exer.2006.04.003; QIN N, 1992, J BIOL CHEM, V267, P8458; Ramamurthy V, 2003, P NATL ACAD SCI USA, V100, P12630, DOI 10.1073/pnas.2134194100; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van der Spuy J, 2005, MOL VIS, V11, P542; van der Spuy J, 2003, INVEST OPHTH VIS SCI, V44, P5396, DOI 10.1167/iovs.03-0686; van der Spuy J, 2002, HUM MOL GENET, V11, P823, DOI 10.1093/hmg/11.7.823; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104	38	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30853	30861		10.1074/jbc.M109.036780	http://dx.doi.org/10.1074/jbc.M109.036780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758987	Green Published, hybrid			2022-12-25	WOS:000271378400013
J	Pennati, A; Gadda, G				Pennati, Andrea; Gadda, Giovanni			Involvement of Ionizable Groups in Catalysis of Human Liver Glycolate Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HYDROXYACID OXIDASE; L-LACTATE DEHYDROGENASE; ACTIVE-SITE BASE; CHOLINE OXIDASE; FLAVOCYTOCHROME B(2); SUBSTRATE-BINDING; ACID OXIDASE; (S)-MANDELATE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-PUTIDA	Glycolate oxidase is a flavin-dependent, peroxisomal enzyme that oxidizes alpha-hydroxy acids to the corresponding alpha-keto acids, with reduction of oxygen to H2O2. In plants, the enzyme participates in photorespiration. In humans, it is a potential drug target for treatment of primary hyperoxaluria, a genetic disorder where overproduction of oxalate results in the formation of kidney stones. In this study, steady-state and pre-steady-state kinetic approaches have been used to determine how pH affects the kinetic steps of the catalytic mechanism of human glycolate oxidase. The enzyme showed a Ping-Pong Bi-Bi kinetic mechanism between pH 6.0 and 10.0. Both the overall turnover of the enzyme (k(cat)) and the rate constant for anaerobic substrate reduction of the flavin were pH-independent at pH values above 7.0 and decreased slightly at lower pH, suggesting the involvement of an unprotonated group acting as a base in the chemical step of glycolate oxidation. The second-order rate constant for capture of glycolate (k(cat)/ K-glycolate) and the K-d(app) for the formation of the enzyme-substrate complex suggested the presence of a protonated group with apparent pK(a) of 8.5 participating in substrate binding. The k(cat)/K-oxygen values were an order of magnitude faster when a group with pKa of 6.8 was unprotonated. These results are discussed in the context of the available three-dimensional structure of GOX.	[Gadda, Giovanni] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Gadda, G (corresponding author), Georgia State Univ, Dept Chem, POB 4098, Atlanta, GA 30302 USA.	ggadda@gsu.edu	Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195	National Science Foundation [MCB-0545712]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Career Award MCB-0545712 (to G.G.).	Allison R D, 1979, Methods Enzymol, V63, P3; BELMOUDEN A, 1993, EUR J BIOCHEM, V214, P17, DOI 10.1111/j.1432-1033.1993.tb17891.x; BLANCHARD DE, 1946, J BIOL CHEM, V163, P137; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; DULEY J, 1974, GENETICS, V76, P93; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; FRY DW, 1979, BIOCHIM BIOPHYS ACTA, V568, P135, DOI 10.1016/0005-2744(79)90281-X; Gadda G, 2000, BIOCHEMISTRY-US, V39, P1406, DOI 10.1021/bi992255z; Gadda G, 2006, ARCH BIOCHEM BIOPHYS, V451, P182, DOI 10.1016/j.abb.2006.04.005; GAUME B, 1995, BIOCHIMIE, V77, P621, DOI 10.1016/0300-9084(96)88177-6; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Ghanem M, 2003, BIOCHEMISTRY-US, V42, P15179, DOI 10.1021/bi035435o; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Holmes RP, 1998, J NEPHROL, V11, P32; JACQ C, 1972, EUR J BIOCHEM, V25, P41, DOI 10.1111/j.1432-1033.1972.tb01664.x; KUN E, 1954, J BIOL CHEM, V210, P269; Lehoux IE, 1999, BIOCHEMISTRY-US, V38, P9948, DOI 10.1021/bi9907532; LIDE DR, 2000, CRC HDB CHEM PHYS, P8; LINDQVIST Y, 1985, P NATL ACAD SCI USA, V82, P6855, DOI 10.1073/pnas.82.20.6855; LINDQVIST Y, 1989, J MOL BIOL, V209, P151, DOI 10.1016/0022-2836(89)90178-2; LINDQVIST Y, 1979, J BIOL CHEM, V254, P7403; LUTZ S, 2009, PROTEIN ENG HDB, V1, P8; MACHEROUX P, 1992, BIOCHIM BIOPHYS ACTA, V1132, P11, DOI 10.1016/0167-4781(92)90046-3; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P1047, DOI 10.1111/j.1432-1033.1993.tb17852.x; MACHEROUX P, 1991, BIOCHEMISTRY-US, V30, P4612, DOI 10.1021/bi00232a036; MAEDAYORITA K, 1995, BIOCHIMIE, V77, P631, DOI 10.1016/0300-9084(96)88178-8; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Miller JR, 1999, J BIOL CHEM, V274, P23515, DOI 10.1074/jbc.274.33.23515; Mowat CG, 2000, BIOCHEMISTRY-US, V39, P3266, DOI 10.1021/bi9925975; MUH U, 1994, J BIOL CHEM, V269, P7989; Murray MS, 2008, BIOCHEMISTRY-US, V47, P2439, DOI 10.1021/bi701710r; NISHIMURA M, 1983, ARCH BIOCHEM BIOPHYS, V222, P397, DOI 10.1016/0003-9861(83)90536-2; POMPON D, 1985, EUR J BIOCHEM, V148, P145, DOI 10.1111/j.1432-1033.1985.tb08818.x; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Rungsrisuriyachai K, 2008, BIOCHEMISTRY-US, V47, P6762, DOI 10.1021/bi800650w; Rungsrisuriyachai K, 2009, ARCH BIOCHEM BIOPHYS, V483, P10, DOI 10.1016/j.abb.2008.12.018; SCHUMAN M, 1971, BIOCHIM BIOPHYS ACTA, V227, P500, DOI 10.1016/0005-2744(71)90003-9; SCHWAM H, 1979, BIOCHEMISTRY-US, V18, P2828, DOI 10.1021/bi00580a023; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Sobrado P, 2001, BIOCHEMISTRY-US, V40, P994, DOI 10.1021/bi002283d; Stenberg K, 1997, PROTEIN SCI, V6, P1009, DOI 10.1002/pro.5560060506; STENBERG K, 1995, EUR J BIOCHEM, V228, P408; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; TAN AK, 1993, BIOCHEMISTRY-US, V32, P2137, DOI 10.1021/bi00060a003; TOLBERT NE, 1949, J BIOL CHEM, V181, P905; Tsai CL, 2007, BIOCHEMISTRY-US, V46, P7844, DOI 10.1021/bi7005543; URBAN P, 1984, EUR J BIOCHEM, V144, P345, DOI 10.1111/j.1432-1033.1984.tb08470.x; USHIJIMA Y, 1973, ARCH BIOCHEM BIOPHYS, V155, P361, DOI 10.1016/0003-9861(73)90125-2; Vignaud C, 2007, ARCH BIOCHEM BIOPHYS, V465, P410, DOI 10.1016/j.abb.2007.06.021; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8825, DOI 10.1021/bi000350y; Williams E, 2000, BBA-GENE STRUCT EXPR, V1493, P246, DOI 10.1016/S0167-4781(00)00161-5; Xu Y, 2002, BIOCHEMISTRY-US, V41, P12313, DOI 10.1021/bi026258e	56	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31214	31222		10.1074/jbc.M109.040063	http://dx.doi.org/10.1074/jbc.M109.040063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758989	Green Published, hybrid			2022-12-25	WOS:000271378400049
J	Woo, SH; An, S; Lee, HC; Jin, HO; Seo, SK; Yoo, DH; Lee, KH; Rhee, CH; Choi, EJ; Hong, SI; Park, IC				Woo, Sang Hyeok; An, Sungkwan; Lee, Hyung-Chahn; Jin, Hyeon-Ok; Seo, Sung-Keum; Yoo, Doo-Hyun; Lee, Kee-Ho; Rhee, Chang Hun; Choi, Eui-Ju; Hong, Seok-Il; Park, In-Chul			A Truncated Form of p23 Down-regulates Telomerase Activity via Disruption of Hsp90 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CO-CHAPERONE P23; CASEIN KINASE-II; GLUCOCORTICOID-RECEPTOR; TYROSINE KINASE; IN-VITRO; HETEROPROTEIN COMPLEX; REVERSE-TRANSCRIPTASE; STRESS-PROTEIN; ATPASE CYCLE	The Hsp90-associated protein p23 modulates Hsp90 activity during the final stages of the chaperone pathway to facilitate maturation of client proteins. Previous reports indicate that p23 cleavage induced by caspases during cell death triggers destabilization of client proteins. However, the specific role of truncated p23 (Delta p23) in this process and the underlying mechanisms remain to be determined. One such client protein, hTERT, is a telomerase catalytic subunit regulated by several chaperone proteins, including Hsp90 and p23. In the present study, we examined the effects of p23 cleavage on hTERT stability and telomerase activity. Our data showed that overexpression of Delta p23 resulted in a decrease in hTERT levels, and a down-regulation in telomerase activity. Serine phosphorylation of Hsp90 was significantly reduced in cells expressing high levels of Delta p23 compared with those expressing full-length p23. Mutation analyses revealed that two serine residues (Ser-231 and Ser-263) in Hsp90 are important for activation of telomerase, and down-regulation of telomerase activity by Delta p23 was associated with inhibition of cell growth and sensitization of cells to cisplatin. Our data aid in determining the mechanism underlying the regulation of telomerase activity by the chaperone complex during caspase-dependent cell death.	[Hong, Seok-Il] Korea Inst Radiol & Med Sci, Dept Clin Pathol, Seoul 139706, South Korea; [Lee, Kee-Ho; Park, In-Chul] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Rhee, Chang Hun] Korea Inst Radiol & Med Sci, Dept Neurosurg, Seoul 139706, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea; [Woo, Sang Hyeok; Choi, Eui-Ju] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Konkuk University; Korea University	Hong, SI (corresponding author), Korea Inst Radiol & Med Sci, Dept Clin Pathol, 215-4 Gongneung Dong, Seoul 139706, South Korea.	hongsicp@kcch.re.kr; parkic@kcch.re.kr			Ministry of Sciences and Technology, Korea	Ministry of Sciences and Technology, Korea	This work was supported by the National Nuclear R & D Program of the Ministry of Sciences and Technology, Korea.	Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Bachand F, 1999, J BIOL CHEM, V274, P38027, DOI 10.1074/jbc.274.53.38027; Barati MT, 2006, J PROTEOME RES, V5, P1636, DOI 10.1021/pr0502469; Beattie TL, 1998, CURR BIOL, V8, P177, DOI 10.1016/S0960-9822(98)70067-3; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Freeman BC, 2000, GENE DEV, V14, P422; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; Keppler BR, 2006, J BIOL CHEM, V281, P19840, DOI 10.1074/jbc.M511067200; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; LEESMILLER SP, 1989, J BIOL CHEM, V264, P17275; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; MIMNAUGH EG, 1995, J BIOL CHEM, V270, P28654, DOI 10.1074/jbc.270.48.28654; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; MIYATA Y, 1995, BIOCHEMISTRY-US, V34, P8123, DOI 10.1021/bi00025a019; Mollerup J, 2005, FEBS LETT, V579, P4187, DOI 10.1016/j.febslet.2005.06.045; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; Ogiso H, 2004, BIOCHEMISTRY-US, V43, P15510, DOI 10.1021/bi048736m; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; TBARKA N, 1993, FEBS LETT, V322, P125, DOI 10.1016/0014-5793(93)81551-A; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Woo SH, 2005, J CELL BIOCHEM, V95, P120, DOI 10.1002/jcb.20329; Xu ZY, 1997, EUR J BIOCHEM, V246, P461, DOI 10.1111/j.1432-1033.1997.t01-1-00461.x; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao YG, 2001, J BIOL CHEM, V276, P32822, DOI 10.1074/jbc.M105562200	47	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30871	30880		10.1074/jbc.M109.052720	http://dx.doi.org/10.1074/jbc.M109.052720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740745	Green Published, hybrid			2022-12-25	WOS:000271378400015
J	Katsuki, M; Drummond, DR; Osei, M; Cross, RA				Katsuki, Miho; Drummond, Douglas R.; Osei, Michael; Cross, Robert A.			Mal3 Masks Catastrophe Events in Schizosaccharomyces pombe Microtubules by Inhibiting Shrinkage and Promoting Rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END-TRACKING; DYNAMIC INSTABILITY; INTERPHASE MICROTUBULES; INDIVIDUAL MICROTUBULES; IN-VITRO; EB1; PROTEINS; HOMOLOG; POLYMERIZATION; MICROSCOPY	Schizosaccharomyces pombe Mal3 is a member of the EB family of proteins, which are proposed to be core elements in a tip-tracking network that regulates microtubule dynamics in cells. How Mal3 itself influences microtubule dynamics is unclear. We tested the effects of full-length recombinant Mal3 on dynamic microtubules assembled in vitro from purified S. pombe tubulin, using dark field video microscopy to avoid fluorescent tagging and data-averaging techniques to improve spatiotemporal resolution. We find that catastrophe occurs stochastically as a fast (<2.2 s) transition from constant speed growth to constant speed shrinkage with a constant probability that is independent of the Mal3 concentration. This implies that Mal3 neither stabilizes nor destabilizes microtubule tips. Mal3 does, however, stabilize the main part of the microtubule lattice, inhibiting shrinkage and increasing the frequency of rescues, consistent with recent models in which Mal3 on the lattice forms stabilizing lateral links between neighboring protofilaments. At high concentrations, Mal3 can entirely block shrinkage and induce very rapid rescue, making catastrophes impossible to detect, which may account for the apparent suppression of catastrophe by Mal3 and other EBs in vivo. Overall, we find that Mal3 stabilizes microtubules not by preventing catastrophe at the microtubule tip but by inhibiting lattice depolymerization and enhancing rescue. We argue that this implies that Mal3 binds microtubules in different modes at the tip and on the lattice.	[Katsuki, Miho; Drummond, Douglas R.; Osei, Michael; Cross, Robert A.] Marie Curie Reaerch Inst, Mol Motors Grp, Surrey RH8 0TL, England		Cross, RA (corresponding author), The Chart, Surrey RH8 0TL, England.	r.cross@mcri.ac.uk	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832; Drummond, Douglas/0000-0003-4155-3747	Cancer Research UK [C19638/A6211]; Association for International Cancer Research [09-0221]; Medical Research Council [G0200542]; Marie Curie Cancer Care; MRC [G0200542] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Cancer Care; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Cancer Research UK (Grant C19638/A6211), the Association for International Cancer Research (Grant 09-0221), the Medical Research Council (Grant G0200542), and Marie Curie Cancer Care.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	23	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29246	29250		10.1074/jbc.C109.052159	http://dx.doi.org/10.1074/jbc.C109.052159			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19740752	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-25	WOS:000270896800003
J	Dinis-Oliveira, RJ; de Pinho, PG; Santos, L; Teixeira, H; Magalhaes, T; Santos, A; Bastos, MD; Remiao, F; Duarte, JA; Carvalho, F				Dinis-Oliveira, Ricardo Jorge; de Pinho, Paula Guedes; Santos, Liliana; Teixeira, Helena; Magalhaes, Teresa; Santos, Agostinho; Bastos, Maria de Lourdes; Remiao, Fernando; Duarte, Jose Alberto; Carvalho, Felix			Postmortem Analyses Unveil the Poor Efficacy of Decontamination, Anti-Inflammatory and Immunosuppressive Therapies in Paraquat Human Intoxications	PLOS ONE			English	Article								Background: Fatalities resulting from paraquat (PQ) self-poisonings represent a major burden of this herbicide. Specific therapeutic approaches have been followed to interrupt its toxic pathway, namely decontamination measures to prevent PQ absorption and to increase its excretion from organism, as well as the administration of anti-inflammatory and immunosuppressive drugs. Until now, none of the postmortem studies resulting from human PQ poisonings have assessed the relationship of these therapeutic measures with PQ toxicokinetics and related histopathological lesions, these being the aims of the present study. Methodology/Principal Findings: For that purpose, during 2008, we collected human fluids and tissues from five forensic autopsies following fatal PQ poisonings. PQ levels were measured by gas chromatography-ion trap mass spectrometry. Structural inflammatory lesions were evaluated by histological and immunohistochemistry analysis. The samples of cardiac blood, urine, gastric and duodenal wall, liver, lung, kidney, heart and diaphragm, showed quantifiable levels of PQ even at 6 days post-intoxication. Structural analysis showed diffused necrotic areas, intense macrophage activation and leukocyte infiltration in all analyzed tissues. By immunohistochemistry it was possible to observe a strong nuclear factor kappa-B (NF-kappa B) activation and excessive collagen deposition. Conclusions/Significance: Considering the observed PQ levels in all analyzed tissues and the expressive inflammatory reaction that ultimately leads to fibrosis, we conclude that the therapeutic protocol usually performed needs to be reviewed, in order to increase the efficacy of PQ elimination from the body as well as to diminish the inflammatory process.			Dinis-Oliveira, RJ (corresponding author), Univ Porto, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ricardinis@sapo.pt; felixdc@ff.up.pt	Dinis-Oliveira, Ricardo Jorge/D-9186-2013; Magalhães, Teresa/J-7897-2013; de Lourdes Bastos, Maria/D-8588-2013; Duarte, Jose Alberto/F-1443-2013; Remião, Fernando/D-8646-2013; de Pinho, P. Guedes/D-4847-2013; Teixeira, Helena M./AHB-9671-2022; Carvalho, Félix/D-4914-2013	Dinis-Oliveira, Ricardo Jorge/0000-0001-7430-6297; de Lourdes Bastos, Maria/0000-0001-9895-503X; Duarte, Jose Alberto/0000-0003-4756-5917; Remião, Fernando/0000-0003-1382-5119; de Pinho, P. Guedes/0000-0002-7395-5700; Teixeira, Helena M./0000-0001-7570-5521; Carvalho, Félix/0000-0003-3858-3494; Santos, Agostinho/0000-0002-1396-4234; Magalhaes, Teresa/0000-0002-8098-8076				BASELT RC, 1989, DISPOSITION TOXIC DR, P637; BEEBEEJAUN AR, 1971, CLIN TOXICOL, V4, P397, DOI 10.3109/15563657108990492; BISMUTH C, 1988, J TOXICOL CLIN EXPER, V8, P211; BISMUTH C, 1987, HUM TOXICOL, V6, P63, DOI 10.1177/096032718700600110; BISMUTH C, 1982, J TOXICOL-CLIN TOXIC, V19, P461, DOI 10.3109/15563658208992501; BISMUTH C, 1995, PARAQUAT POISONING M; CARSON D J L, 1976, Forensic Science, V7, P151, DOI 10.1016/0300-9432(76)90031-5; Castro Rui, 2005, Acta Med Port, V18, P423; COOPER JD, 1985, J THORAC CARDIOV SUR, V89, P734; de Almeida RM, 2007, J CHROMATOGR B, V853, P260, DOI 10.1016/j.jchromb.2007.03.026; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; DEBROE ME, 1986, HUM TOXICOL, V5, P11, DOI 10.1177/096032718600500103; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2006, FREE RADICAL BIO MED, V41, P1213, DOI 10.1016/j.freeradbiomed.2006.06.012; Dinis-Oliveira RJ, 2009, TOXICOLOGY, V255, P187, DOI 10.1016/j.tox.2008.10.015; Dinis-Oliveira RJ, 2006, PEDIATR EMERG CARE, V22, P537, DOI 10.1097/01.pec.0000223179.07633.8a; Fardel O., 2002, Annales Pharmaceutiques Francaises, V60, P380; Fardel O, 2001, TOXICOLOGY, V167, P37, DOI 10.1016/S0300-483X(01)00456-5; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; Hong SY, 2003, TOXICOL IND HEALTH, V19, P17, DOI 10.1191/0748233703th171oa; HOUZE P, 1990, HUM EXP TOXICOL, V9, P5, DOI 10.1177/096032719000900103; HOUZE P, 1995, PARAQUAT POISONING M, P161; IM JG, 1991, AM J ROENTGENOL, V157, P697, DOI 10.2214/ajr.157.4.1892020; KOPPEL C, 1994, J TOXICOL-CLIN TOXIC, V32, P205, DOI 10.3109/15563659409000452; Leveridge YR, 1998, VET HUM TOXICOL, V40, P42; LEWIS CPL, 1995, PARAQUAT POISONING M, P107; Lewis J H, 1999, Clin Liver Dis, V3, P433, DOI 10.1016/S1089-3261(05)70079-9; Mullick F G, 1981, Liver, V1, P209; Noguchi N, 1990, Nihon Hoigaku Zasshi, V44, P6; OKONEK S, 1983, J TOXICOL-CLIN TOXIC, V19, P807, DOI 10.3109/15563658208992514; OKONEK S, 1979, KLIN WOCHENSCHR, V57, P957, DOI 10.1007/BF01478553; PARKINSON C, 1980, HISTOPATHOLOGY, V4, P171, DOI 10.1111/j.1365-2559.1980.tb02910.x; Pontes H, 2008, TOXICOLOGY, V252, P64, DOI 10.1016/j.tox.2008.07.064; Povoa R, 1992, Arq Bras Cardiol, V59, P95; *PRES REP, DIARIO REPUBLICA A, V1, P5362; REIF RM, 1983, J FORENSIC SCI, V28, P505; ROSE MS, 1976, BIOCHEM PHARMACOL, V25, P419, DOI 10.1016/0006-2952(76)90344-0; Ruiz-Bailen M, 2001, CHEST, V119, P1956, DOI 10.1378/chest.119.6.1956; RUSSELL LA, 1981, CLIN TOXICOL, V18, P915, DOI 10.3109/15563658108990319; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; SHARP CW, 1972, TOXICOL APPL PHARM, V22, P241, DOI 10.1016/0041-008X(72)90174-3; Tabata N, 1999, FORENSIC SCI INT, V100, P117, DOI 10.1016/S0379-0738(98)00190-X; TAKEGOSHI K, 1988, LIVER, V8, P330; Teixeira H, 2004, FORENSIC SCI INT, V143, P199, DOI 10.1016/j.forsciint.2004.02.037; Van GIESON I., 1889, NEW YORK MED J, V50, P57; VANDEVYVER FL, 1985, J TOXICOL-CLIN TOXIC, V23, P117, DOI 10.3109/15563658508990622; VANDIJK A, 1975, ARCH TOXICOL, V34, P129, DOI 10.1007/BF00353313; Weigert K., 1904, Z WISS MIKROSK, V21, P1; Wesseling C, 2001, Int J Occup Environ Health, V7, P90; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; Yamashita M, 1996, VET HUM TOXICOL, V38, P34; ZIMMERMAN HJ, 1987, MED TOXICOL ADV DRUG, V2, P112, DOI 10.1007/BF03260010	52	44	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7149	10.1371/journal.pone.0007149	http://dx.doi.org/10.1371/journal.pone.0007149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779613	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200006
J	Balgi, AD; Fonseca, BD; Donohue, E; Tsang, TCF; Lajoie, P; Proud, CG; Nabi, IR; Roberge, M				Balgi, Aruna D.; Fonseca, Bruno D.; Donohue, Elizabeth; Tsang, Trevor C. F.; Lajoie, Patrick; Proud, Christopher G.; Nabi, Ivan R.; Roberge, Michel			Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling	PLOS ONE			English	Article								Background: Mammalian target of rapamycin complex 1 (mTORC1) is a protein kinase that relays nutrient availability signals to control numerous cellular functions including autophagy, a process of cellular self-eating activated by nutrient depletion. Addressing the therapeutic potential of modulating mTORC1 signaling and autophagy in human disease requires active chemicals with pharmacologically desirable properties. Methodology/Principal Findings: Using an automated cell-based assay, we screened a collection of >3,500 chemicals and identified three approved drugs (perhexiline, niclosamide, amiodarone) and one pharmacological reagent (rottlerin) capable of rapidly increasing autophagosome content. Biochemical assays showed that the four compounds stimulate autophagy and inhibit mTORC1 signaling in cells maintained in nutrient-rich conditions. The compounds did not inhibit mTORC2, which also contains mTOR as a catalytic subunit, suggesting that they do not inhibit mTOR catalytic activity but rather inhibit signaling to mTORC1. mTORC1 inhibition and autophagosome accumulation induced by perhexiline, niclosamide or rottlerin were rapidly reversed upon drug withdrawal whereas amiodarone inhibited mTORC1 essentially irreversibly. TSC2, a negative regulator of mTORC1, was required for inhibition of mTORC1 signaling by rottlerin but not for mTORC1 inhibition by perhexiline, niclosamide and amiodarone. Transient exposure of immortalized mouse embryo fibroblasts to these drugs was not toxic in nutrient-rich conditions but led to rapid cell death by apoptosis in starvation conditions, by a mechanism determined in large part by the tuberous sclerosis complex protein TSC2, an upstream regulator of mTORC1. By contrast, transient exposure to the mTORC1 inhibitor rapamycin caused essentially irreversible mTORC1 inhibition, sustained inhibition of cell growth and no selective cell killing in starvation. Conclusion/Significance: The observation that drugs already approved for human use can reversibly inhibit mTORC1 and stimulate autophagy should greatly facilitate the preclinical and clinical testing of mTORC1 inhibition for indications such as tuberous sclerosis, diabetes, cardiovascular disease and cancer.			Balgi, AD (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	michelr@interchange.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513; Proud, Christopher/0000-0003-0704-6442; Lajoie, Patrick/0000-0002-1614-176X				Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; ANAND N, 1997, APPROACHES DESIGN SY, V25, P239; Ashrafian H, 2007, CARDIOVASC DRUG REV, V25, P76, DOI 10.1111/j.1527-3466.2007.00006.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; CHEN N, 2009, BIOCH BIOPHYS ACTA; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; Curnock AP, 2001, BIOCHEM PHARMACOL, V61, P227, DOI 10.1016/S0006-2952(00)00552-9; Ding WX, 2009, METHOD ENZYMOL, V453, P397, DOI 10.1016/S0076-6879(08)04020-2; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hosoi H, 1999, CANCER RES, V59, P886; HOSOKAWA N, 2009, MOL BIOL CELL; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Inglis Sally, 2006, Eur J Cardiovasc Nurs, V5, P175, DOI 10.1016/j.ejcnurse.2006.01.001; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kodama I, 1999, AM J CARDIOL, V84, p20R; Kojima K, 2008, BIOCHEM BIOPH RES CO, V376, P434, DOI 10.1016/j.bbrc.2008.09.007; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Le Tourneau C, 2008, BRIT J CANCER, V99, P1197, DOI 10.1038/sj.bjc.6604636; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee L, 2004, EUR HEART J, V25, P634, DOI 10.1016/j.ehj.2004.02.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Merschiohann K, 2008, EXP PARASITOL, V118, P637, DOI 10.1016/j.exppara.2007.12.001; *MOSB INC, MOSB 2004 DRUG GUID; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PAMPORI NA, 1984, J HELMINTHOL, V58, P39, DOI 10.1017/S0022149X00028042; PAMPORI NA, 1984, MOL BIOCHEM PARASIT, V11, P205, DOI 10.1016/0166-6851(84)90066-5; Patrick G. L., 1995, INTRO MED CHEM; PAX RA, 1989, J PARASITOL, V75, P169, DOI 10.2307/3282962; PILCHER J, 1985, THER DRUG MONIT, V7, P54, DOI 10.1097/00007691-198503000-00009; Prick T, 2006, BIOCHEM J, V394, P153, DOI 10.1042/BJ20051243; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; SAZ HJ, 1981, ANNU REV PHYSIOL, V43, P323, DOI 10.1146/annurev.ph.43.030181.001543; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SINGH BN, 1986, BRIT J CLIN PHARMACO, V21, pS109, DOI 10.1111/j.1365-2125.1986.tb02860.x; Singh BN, 2004, J CARDIOVASC PHARM T, V9, P219, DOI 10.1177/107424840400900401; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Song KS, 2008, AUTOPHAGY, V4, P650, DOI 10.4161/auto.6057; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang LJ, 2003, BIOCHEM J, V373, P603, DOI 10.1042/BJ20030454; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; World Health Organization, WHOVBCDS8863; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhang YQ, 2007, J BIOL CHEM, V282, P37844, DOI 10.1074/jbc.M707593200	90	267	273	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7124	10.1371/journal.pone.0007124	http://dx.doi.org/10.1371/journal.pone.0007124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771169	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000270154400017
J	Alcaide, M; Rico, C; Ruiz, S; Soriguer, R; Munoz, J; Figuerola, J				Alcaide, Miguel; Rico, Ciro; Ruiz, Santiago; Soriguer, Ramon; Munoz, Joaquin; Figuerola, Jordi			Disentangling Vector-Borne Transmission Networks: A Universal DNA Barcoding Method to Identify Vertebrate Hosts from Arthropod Bloodmeals	PLOS ONE			English	Article							MOLECULAR ANALYSIS; IDENTIFICATION; MEALS	Emerging infectious diseases represent a challenge for global economies and public health. About one fourth of the last pandemics have been originated by the spread of vector-borne pathogens. In this sense, the advent of modern molecular techniques has enhanced our capabilities to understand vector-host interactions and disease ecology. However, host identification protocols have poorly profited of international DNA barcoding initiatives and/or have focused exclusively on a limited array of vector species. Therefore, ascertaining the potential afforded by DNA barcoding tools in other vector-host systems of human and veterinary importance would represent a major advance in tracking pathogen life cycles and hosts. Here, we show the applicability of a novel and efficient molecular method for the identification of the vertebrate host's DNA contained in the midgut of blood-feeding arthropods. To this end, we designed a eukaryote-universal forward primer and a vertebrate-specific reverse primer to selectively amplify 758 base pairs (bp) of the vertebrate mitochondrial Cytochrome c Oxidase Subunit I (COI) gene. Our method was validated using both extensive sequence surveys from the public domain and Polymerase Chain Reaction (PCR) experiments carried out over specimens from different Classes of vertebrates (Mammalia, Aves, Reptilia and Amphibia) and invertebrate ectoparasites (Arachnida and Insecta). The analysis of mosquito, culicoid, phlebotomie, sucking bugs, and tick bloodmeals revealed up to 40 vertebrate hosts, including 23 avian, 16 mammalian and one reptilian species. Importantly, the inspection and analysis of direct sequencing electropherograms also assisted the resolving of mixed bloodmeals. We therefore provide a universal and high-throughput diagnostic tool for the study of the ecology of haematophagous invertebrates in relation to their vertebrate hosts. Such information is crucial to support the efficient management of initiatives aimed at reducing epidemiologic risks of arthropod vector-borne pathogens, a priority for public health.			Alcaide, M (corresponding author), CSIC, Estac Biol Donana, E-41080 Seville, Spain.	malcaide@ebd.csic.es	Rico, Ciro/K-5725-2015; Soriguer, Ramon/J-1494-2014; Rico, Ciro/P-9750-2019; Alcaide, Miguel/A-1400-2012; Ruíz, Santiago/HGU-6016-2022; 赵, 鹏/B-8401-2009; Figuerola, Jordi/B-7917-2008; Munoz, Joaquin/B-9938-2009	Rico, Ciro/0000-0002-0822-336X; Soriguer, Ramon/0000-0002-9165-7766; Rico, Ciro/0000-0002-0822-336X; Figuerola, Jordi/0000-0002-4664-9011; Munoz, Joaquin/0000-0003-3623-2439; Alcaide, Miguel/0000-0001-6945-0972				Ali Oshaghi M, 2006, EXP PARASITOL, V112, P232, DOI 10.1016/j.exppara.2005.11.008; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Foley JE, 2008, VECTOR-BORNE ZOONOT, V8, P49, DOI 10.1089/vbz.2007.0175; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Kent RJ, 2004, AM J TROP MED HYG, V71, P514, DOI 10.4269/ajtmh.2004.71.514; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Rasgon JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002198; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Thomsen R, 2006, PRIMATES, V47, P397, DOI 10.1007/s10329-006-0194-8; Townzen JS, 2008, MED VET ENTOMOL, V22, P386, DOI 10.1111/j.1365-2915.2008.00760.x; Traugott M, 2008, MOL ECOL, V17, P3928, DOI 10.1111/j.1365-294X.2008.03878.x; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wheeler SS, 2009, CONDOR, V111, P1, DOI 10.1525/cond.2009.080013; Wickramasekara Samanthi, 2008, Emerg Infect Dis, V14, P1273, DOI 10.3201/eid1408.080227; Woods ME, 2009, AM J TROP MED HYG, V80, P998, DOI 10.4269/ajtmh.2009.80.998	26	110	117	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7092	10.1371/journal.pone.0007092	http://dx.doi.org/10.1371/journal.pone.0007092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768113	Green Published, gold			2022-12-25	WOS:000270154000005
J	Johnson, RI; Cagan, RL				Johnson, Ruth I.; Cagan, Ross L.			A Quantitative Method to Analyze Drosophila Pupal Eye Patterning	PLOS ONE			English	Article								Background: The Drosophila pupal eye has become a popular paradigm for understanding morphogenesis and tissue patterning. Correct rearrangement of cells between ommatidia is required to organize the ommatidial array across the eye field. This requires cell movement, cell death, changes to cell-cell adhesion, signaling and fate specification. Methodology: We describe a method to quantitatively assess mis-patterning of the Drosophila pupal eye and objectively calculate a 'mis-patterning score' characteristic of a specific genotype. This entails step-by-step scoring of specific traits observed in pupal eyes dissected 40-42 hours after puparium formation and subsequent statistical analysis of this data. Significance: This method provides an unbiased quantitative score of mis-patterning severity that can be used to compare the impact of different genetic mutations on tissue patterning.			Johnson, RI (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA.	Ross.Cagan@mssm.edu	Cagan, Ross Leigh/AAV-9528-2021	Cagan, Ross/0000-0001-5297-450X	NEI NIH HHS [NIH R01 EY1149] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brachmann CB, 2003, TRENDS GENET, V19, P91, DOI 10.1016/S0168-9525(02)00041-0; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; CAGAN RL, CURRENT TOP IN PRESS; Cordero J, 2004, MECH DEVELOP, V121, P1523, DOI 10.1016/j.mod.2004.07.004; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Johnson RI, 2008, J CELL BIOL, V180, P1191, DOI 10.1083/jcb.200706108; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; LARSON DE, 2007, MECH DEV; Monserrate JP, 2007, CELL DEATH DIFFER, V14, P209, DOI 10.1038/sj.cdd.4401947; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5	11	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7008	10.1371/journal.pone.0007008	http://dx.doi.org/10.1371/journal.pone.0007008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753121	Green Published, gold			2022-12-25	WOS:000269796500004
J	Yu, J; Huang, NF; Wilson, KD; Velotta, JB; Huang, M; Li, ZJ; Lee, A; Robbins, RC; Cooke, JP; Wu, JC				Yu, Jin; Huang, Ngan F.; Wilson, Kitchener D.; Velotta, Jeffrey B.; Huang, Mei; Li, Zongjin; Lee, Andrew; Robbins, Robert C.; Cooke, John P.; Wu, Joseph C.			nAChRs Mediate Human Embryonic Stem Cell-Derived Endothelial Cells: Proliferation, Apoptosis, and Angiogenesis	PLOS ONE			English	Article							SMOKE EXPOSURE; DIFFERENTIATION; TRANSPLANTATION; SURVIVAL; INHIBITION; GENERATION; PATHWAY	Background: Many patients with ischemic heart disease have cardiovascular risk factors such as cigarette smoking. We tested the effect of nicotine (a key component of cigarette smoking) on the therapeutic effects of human embryonic stem cell-derived endothelial cells (hESC-ECs). Methods and Results: To induce endothelial cell differentiation, undifferentiated hESCs (H9 line) underwent 4-day floating EB formation and 8-day outgrowth differentiation in EGM-2 media. After 12 days, CD31(+) cells (13.7 +/- 2.5%) were sorted by FACScan and maintained in EGM-2 media for further differentiation. After isolation, these hESC-ECs expressed endothelial specific markers such as vWF (96.3 +/- 1.4%), CD31 (97.2 +/- 2.5%), and VE-cadherin (93.7 +/- 2.8%), form vascular-like channels, and incorporated Dil-labeled acetylated low-density lipoprotein (Dil-Ac-LDL). Afterward, 5610 6 hESC-ECs treated for 24 hours with nicotine (10(-8) M) or PBS (as control) were injected into the hearts of mice undergoing LAD ligation followed by administration for two weeks of vehicle or nicotine (100 mu g/ml) in the drinking water. Surprisingly, bioluminescence imaging (BLI) showed significant improvement in the survival of transplanted hESC-ECs in the nicotine treated group at 6 weeks. Postmortem analysis confirmed increased presence of small capillaries in the infarcted zones. Finally, in vitro mechanistic analysis suggests activation of the MAPK and Akt pathways following activation of nicotinic acetylcholine receptors (nAChRs). Conclusions: This study shows for the first time that short-term systemic administrations of low dose nicotine can improve the survival of transplanted hESC-ECs, and enhance their angiogenic effects in vivo. Furthermore, activation of nAChRs has anti-apoptotic, angiogenic, and proliferative effects through MAPK and Akt signaling pathways.			Yu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Med, Xian 710032, Peoples R China.	joewu@stanford.edu	Li, Zongjin/A-1115-2014; Wilson, Kitchener/A-7146-2016; Li, Zongjin/G-3118-2010; Wu, Joseph/H-1067-2013	Li, Zongjin/0000-0002-4603-3743; Li, Zongjin/0000-0002-4603-3743; Wu, Joseph/0000-0002-6068-8041; Cooke, John/0000-0003-0033-9138; Huang, Ngan/0000-0003-2298-6790	NCI NIH HHS [R01 CA098303-04, R01 CA098303, NIH R01CA098303] Funding Source: Medline; NHLBI NIH HHS [1K12 HL087746, NIH HL091453, NIH R33 HL089027, R21 HL089027, R21 HL089027-03, K12 HL087746, K12 HL087746-04, R33 HL089027, R21 HL091453, R21 HL091453-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087746, R33HL089027, R21HL091453, R21HL089027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BURNS DM, 1991, CLIN CHEST MED, V12, P631; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Cooke JP, 2007, LIFE SCI, V80, P2347, DOI 10.1016/j.lfs.2007.01.061; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Finkelstein EI, 2001, AM J PHYSIOL-LUNG C, V281, pL732, DOI 10.1152/ajplung.2001.281.3.L732; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Heeschen C, 2003, J AM COLL CARDIOL, V41, P489, DOI 10.1016/S0735-1097(02)02818-8; Heeschen C, 2002, J CLIN INVEST, V110, P527, DOI 10.1172/JCI200214676; Heeschen C, 2006, J AM COLL CARDIOL, V48, P2553, DOI 10.1016/j.jacc.2006.07.066; Heiss C, 2008, J AM COLL CARDIOL, V51, P1760, DOI 10.1016/j.jacc.2008.01.040; JIANG J, 2007, STEM CELLS, V17, P17; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Levenberg S, 2007, BLOOD, V110, P806, DOI 10.1182/blood-2006-08-019190; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Mills CM, 1997, ARCH DERMATOL, V133, P823, DOI 10.1001/archderm.133.7.823; Moon SY, 2006, MOL THER, V13, P5, DOI 10.1016/j.ymthe.2005.09.008; Rodriguez JW, 1999, IMMUNOPHARM IMMUNOT, V21, P379, DOI 10.3109/08923979909052769; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Sugimoto A, 2007, STEM CELLS DEV, V16, P649, DOI 10.1089/scd.2007.9991; Suzuki J, 2003, J AM COLL CARDIOL, V41, P482, DOI 10.1016/S0735-1097(02)02820-6; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Villablanca AC, 1998, J APPL PHYSIOL, V84, P2089, DOI 10.1152/jappl.1998.84.6.2089; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Xie XY, 2007, CLONING STEM CELLS, V9, P549, DOI 10.1089/clo.2007.0032; Yamahara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001666; Zhu BQ, 2003, CANCER CELL, V4, P191, DOI 10.1016/S1535-6108(03)00219-8	42	47	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7040	10.1371/journal.pone.0007040	http://dx.doi.org/10.1371/journal.pone.0007040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753305	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796500020
J	Hesselson, SE; Matsson, P; Shima, JE; Fukushima, H; Yee, SW; Kobayashi, Y; Gow, JM; Ha, C; Ma, B; Poon, A; Johns, SJ; Stryke, D; Castro, RA; Tahara, H; Choi, JH; Chen, LG; Picard, N; Sjodin, E; Roelofs, MJE; Ferrin, TE; Myers, R; Kroetz, DL; Kwok, PY; Giacomini, KM				Hesselson, Stephanie E.; Matsson, Paer; Shima, James E.; Fukushima, Hisayo; Yee, Sook Wah; Kobayashi, Yuya; Gow, Jason M.; Ha, Connie; Ma, Benjamin; Poon, Annie; Johns, Susan J.; Stryke, Doug; Castro, Richard A.; Tahara, Harunobu; Choi, Ji Ha; Chen, Ligong; Picard, Nicolas; Sjodin, Elin; Roelofs, Maarke J. E.; Ferrin, Thomas E.; Myers, Richard; Kroetz, Deanna L.; Kwok, Pui-Yan; Giacomini, Kathleen M.			Genetic Variation in the Proximal Promoter of ABC and SLC Superfamilies: Liver and Kidney Specific Expression and Promoter Activity Predict Variation	PLOS ONE			English	Article								Membrane transporters play crucial roles in the cellular uptake and efflux of an array of small molecules including nutrients, environmental toxins, and many clinically used drugs. We hypothesized that common genetic variation in the proximal promoter regions of transporter genes contribute to observed variation in drug response. A total of 579 polymorphisms were identified in the proximal promoters (-250 to +50 bp) and flanking 59 sequence of 107 transporters in the ATP Binding Cassette (ABC) and Solute Carrier (SLC) superfamilies in 272 DNA samples from ethnically diverse populations. Many transporter promoters contained multiple common polymorphisms. Using a sliding window analysis, we observed that, on average, nucleotide diversity (pi) was lowest at approximately 300 bp upstream of the transcription start site, suggesting that this region may harbor important functional elements. The proximal promoters of transporters that were highly expressed in the liver had greater nucleotide diversity than those that were highly expressed in the kidney consistent with greater negative selective pressure on the promoters of kidney transporters. Twenty-one promoters were evaluated for activity using reporter assays. Greater nucleotide diversity was observed in promoters with strong activity compared to promoters with weak activity, suggesting that weak promoters are under more negative selective pressure than promoters with high activity. Collectively, these results suggest that the proximal promoter region of membrane transporters is rich in variation and that variants in these regions may play a role in interindividual variation in drug disposition and response.			Hesselson, SE (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	kathy.giacomini@ucsf.edu	Giacomini, Kathleen/AEF-2452-2022; Kwok, Pui-Yan/F-7725-2014; Chen, Ligong/F-7492-2016; Chen, Ligong/AAE-8536-2020; Picard, Nicolas/O-2410-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Chen, Ligong/0000-0002-7893-7173; Picard, Nicolas/0000-0001-8460-903X; Matsson, Par/0000-0002-9094-2581; Yee, Sook Wah/0000-0001-8121-8746	NCRR NIH HHS [UL1 RR024131] Funding Source: Medline; NIGMS NIH HHS [U19 GM061390, U01 GM061390, GM61390] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061390, U01GM061390] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Fay JC, 2000, GENETICS, V155, P1405; Gao B, 2000, J PHARMACOL EXP THER, V294, P73; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; HSU SIH, 1990, MOL CELL BIOL, V10, P3596, DOI 10.1128/MCB.10.7.3596; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura MA, 1985, NEUTRAL THEORY MOL E; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mrazek DA, 2009, AM J MED GENET B, V150B, P341, DOI 10.1002/ajmg.b.30816; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Ozawa N, 2004, PHARM RES-DORDR, V21, P2133, DOI 10.1023/B:PHAM.0000048207.11160.d0; Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90; Poonkuzhali B, 2008, DRUG METAB DISPOS, V36, P780, DOI 10.1124/dmd.107.018366; Prades C, 2002, CYTOGENET GENOME RES, V98, P160, DOI 10.1159/000069852; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROWLAND M, 1995, CLIN PHARMACOKINET, P203; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Sethupathy P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003137; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Smith AD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100114; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TAHARA H, 2009, J PHARM EXP IN PRESS; TAJIMA F, 1989, GENETICS, V123, P585; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yee SW, 2009, J PHARMACOL EXP THER, V328, P699, DOI 10.1124/jpet.108.147207	45	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6942	10.1371/journal.pone.0006942	http://dx.doi.org/10.1371/journal.pone.0006942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742321	Green Published, gold			2022-12-25	WOS:000269622500015
J	Fabian, M; Solomaha, E; Olson, JS; Maresso, AW				Fabian, Marian; Solomaha, Elena; Olson, John S.; Maresso, Anthony W.			Heme Transfer to the Bacterial Cell Envelope Occurs via a Secreted Hemophore in the Gram-positive Pathogen Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN SHP; STAPHYLOCOCCUS-AUREUS; IRON ACQUISITION; MACROMOLECULAR INTERACTIONS; HEMOGLOBIN RECEPTOR; HTSABC TRANSPORTER; CRYSTAL-STRUCTURE; AFFINITY BINDING; OUTER-MEMBRANE; NEAT DOMAINS	To initiate and sustain an infection in mammals, bacterial pathogens must acquire host iron. However, the host's compartmentalization of large amounts of iron in heme, which is bound primarily by hemoglobin in red blood cells, acts as a barrier to bacterial iron assimilation. Bacillus anthracis, the causative agent of the disease anthrax, secretes two NEAT ( near iron transporter) proteins, IsdX1 and IsdX2, which scavenge heme from host hemoglobin and promote growth under low iron conditions. The mechanism of heme transfer from these hemophores to the bacterial cell is not known. We present evidence that the heme-bound form of IsdX1 rapidly and directionally transfers heme to IsdC, a NEAT protein covalently attached to the cell wall, as well as to IsdX2. In both cases, the transfer of heme is mediated by a physical association between the donor and recipient. Unlike Staphylococcus aureus, whose NEAT proteins acquire heme from hemoglobin directly at the bacterial surface, B. anthracis secretes IsdX1 to capture heme in the extracellular milieu and relies on NEAT-NEAT interactions to deliver the bound heme to the envelope via IsdC. Understanding the mechanism of NEAT-mediated iron transport into pathogenic Gram-positive bacteria may provide an avenue for the development of therapeutics to combat infection.	[Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Fabian, Marian; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77096 USA; [Solomaha, Elena] Univ Chicago, Biophys Core Facil, Chicago, IL 60637 USA	Baylor College of Medicine; Rice University; University of Chicago	Maresso, AW (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	maresso@bcm.tmc.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [AI069697, GM035649, HL047020, GM84348]; Robert A. Welch Foundation [C0612]; Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI069697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084348, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI069697 (to A. W. M.), GM035649 and HL047020 (to J.S.O.), and GM84348 (to M. F.).; Supported by Robert A. Welch Foundation Grant C0612.; Supported by seed funds from the Baylor College of Medicine.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; ALISON G, 2002, HEME CHLOROPHYLL BIL; Andreev YN, 2002, GEMATOL TRANSFUZIOL, V47, P5; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Ascoli F, 1981, Methods Enzymol, V76, P72; Bonomo RA, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P1; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Crosa JH., 2004, IRON TRANSPORT BACTE; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; GREY MR, 2006, BIOTERRORISM SOURCEB; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Howell S, 1998, J MOL RECOGNIT, V11, P200, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<200::AID-JMR423>3.0.CO;2-7; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 1999, MOL MICROBIOL, V33, P546, DOI 10.1046/j.1365-2958.1999.01499.x; LINCOLN RE, 1965, J INFECT DIS, V115, P481, DOI 10.1093/infdis/115.5.481; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; ROSS JM, 1957, J PATHOL BACTERIOL, V73, P485, DOI 10.1002/path.1700730219; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; SMITH H, 1953, BRIT J EXP PATHOL, V34, P477; SMITH H, 1954, LANCET, V2, P474; SMITH H, 1955, BRIT J EXP PATHOL, V36, P460; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	68	59	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32138	32146		10.1074/jbc.M109.040915	http://dx.doi.org/10.1074/jbc.M109.040915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759022	Green Published, hybrid			2022-12-25	WOS:000271572700068
J	Yan, XH; Lin, ZH; Chen, F; Zhao, XG; Chen, H; Ning, YH; Chen, YG				Yan, Xiaohua; Lin, Zhenghong; Chen, Feng; Zhao, Xingang; Chen, Hua; Ning, Yuanheng; Chen, Ye-Guang			Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TRANSCRIPTIONAL REGULATION; PSEUDORECEPTOR BAMBI; NEGATIVE REGULATION; CELL-LINES; RECEPTOR; TRANSDUCTION; EXPRESSION; MEMBRANE; GENE	Transforming growth factor beta (TGF-beta) and related growth factors are essential regulators of embryogenesis and tissue homeostasis. The signaling pathways mediated by their receptors and Smad proteins are precisely modulated by various means. Xenopus BAMBI (bone morphogenic protein (BMP) and activin membrane-bound inhibitor) has been shown to function as a general negative regulator of TGF-beta/BMP/activin signaling. Here, we provide evidence that human BAMBI (hBAMBI), like its Xenopus homolog, inhibits TGF-beta- and BMP-mediated transcriptional responses as well as TGF-beta-induced R-Smad phosphorylation and cell growth arrest, whereas knockdown of endogenous BAMBI enhances the TGF-beta-induced reporter expression. Mechanistically, in addition to interfering with the complex formation between the type I and type II receptors, hBAMBI cooperates with Smad7 to inhibit TGF-beta signaling. hBAMBI forms a ternary complex with Smad7 and the TGF-beta type I receptor ALK5/T beta RI and inhibits the interaction between ALK5/T beta RI and Smad3, thus impairing Smad3 activation. These findings provide a novel insight to understand the molecular mechanism underlying the inhibitory effect of BAMBI on TGF-beta signaling.	[Yan, Xiaohua; Lin, Zhenghong; Chen, Feng; Zhao, Xingang; Chen, Hua; Ning, Yuanheng; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Yan, Xiaohua/J-4922-2015; Chen, Ye-Guang/L-6998-2019	Yan, Xiaohua/0000-0002-7528-5771; Lin, Zhenghong/0000-0002-6354-0042	National Natural Science Foundation of China [30671033, 90713045]; 973 Program [2006CB943401, 2006CB910102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30671033 and 90713045 and 973 Program Grants (2006CB943401 and 2006CB910102).	BOYD FT, 1989, J BIOL CHEM, V264, P2272; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Degen WGJ, 1996, INT J CANCER, V65, P460, DOI 10.1002/(SICI)1097-0215(19960208)65:4<460::AID-IJC12>3.3.CO;2-B; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Higashihori N, 2008, DEV DYNAM, V237, P1500, DOI 10.1002/dvdy.21529; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Khin SS, 2009, INT J CANCER, V125, P328, DOI 10.1002/ijc.24318; Lin ZH, 2008, J BIOL CHEM, V283, P33053, DOI 10.1074/jbc.M804039200; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Loveland KL, 2003, ENDOCRINOLOGY, V144, P4180, DOI 10.1210/en.2002-0124; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyazono K, 2000, J CELL SCI, V113, P1101; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Moustakas A, 2001, J CELL SCI, V114, P4359; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Park SH, 2005, J BIOCHEM MOL BIOL, V38, P9; Sasaki T, 2004, ONCOL REP, V11, P1219; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	51	110	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30097	30104		10.1074/jbc.M109.049304	http://dx.doi.org/10.1074/jbc.M109.049304			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19758997	Green Published, hybrid			2022-12-25	WOS:000271090000012
J	Li, HC; Sekine, M; Seng, S; Avraham, S; Avraham, HK				Li, Huchun; Sekine, Masayuki; Seng, Seyha; Avraham, Shalom; Avraham, Hava Karsenty			BRCA1 Interacts with Smad3 and Regulates Smad3-Mediated TGF-beta Signaling during Oxidative Stress Responses	PLOS ONE			English	Article								Background: BRCA1 is a key regulatory protein participating in cell cycle checkpoint and DNA damage repair networks. BRCA1 plays important roles in protecting numerous cellular processes in response to cell damaging signals. Transforming growth factor-beta (TGF-beta) is a potent regulator of growth, apoptosis and invasiveness of tumor cells. TFG-beta activates Smad signaling via its two cell surface receptors, the TbetaRII and ALK5/TbetaRI, leading to Smad-mediated transcriptional regulation. Methodology/Principal Findings: Here, we report an important role of BRCA1 in modulating TGF-beta signaling during oxidative stress responses. Wild-type (WT) BRCA1, but not mutated BRCA1 failed to activate TGF-beta mediated transactivation of the TGF-beta responsive reporter, p3TP-Lux. Further, WT-BRCA1, but not mutated BRCA1 increased the expression of Smad3 protein in a dose-dependent manner, while silencing of WT-BRCA1 by siRNA decreased Smad3 and Smad4 interaction induced by TGF-beta in MCF-7 breast cancer cells. BRCA1 interacted with Smad3 upon TGF-beta 1 stimulation in MCF-7 cells and this interaction was mediated via the domain of 298-436aa of BRCA1 and Smad3 domain of 207-426aa. In addition, H2O2 increased the colocalization and the interaction of Smad3 with WT-BRCA1. Interestingly, TGF-beta 1 induced Smad3 and Smad4 interaction was increased in the presence of H2O2 in cells expressing WT-BRCA1, while the TGF-beta 1 induced interaction between Smad3 and Smad4 was decreased upon H2O2 treatment in a dose-dependent manner in HCC1937 breast cancer cells, deficient for endogenous BRCA1. This interaction between Smad3 and Smad4 was increased in reconstituted HCC1937 cells expressing WT-BRCA1 (HCC1937/BRCA1). Further, loss of BRCA1 resulted in H2O2 induced nuclear export of phosphor-Smad3 protein to the cytoplasm, resulting decreased of Smad3 and Smad4 interaction induced by TGF-beta and in significant decrease in Smad3 and Smad4 transcriptional activities. Conclusions/Significance: These results strongly suggest that loss or reduction of BRCA1 alters TGF-beta growth inhibiting activity via Smad3 during oxidative stress responses.			Li, HC (corresponding author), Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA.	havraham@bidmc.harvard.edu	Sekine, Masayuki/AAB-8321-2022	Avraham, Hava/0000-0002-7545-3640	NCI NIH HHS [CA135226, R21 CA135226, R01 CA096805, CA096805] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA135226, R01CA096805] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dubrovska A, 2005, ONCOGENE, V24, P2289, DOI 10.1038/sj.onc.1208443; Gilmore PM, 2004, CANCER RES, V64, P4148, DOI 10.1158/0008-5472.CAN-03-4080; Gupta A, 1999, CARCINOGENESIS, V20, P2063, DOI 10.1093/carcin/20.11.2063; Gupta V, 2004, CURR CANCER DRUG TAR, V4, P165, DOI 10.2174/1568009043481542; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Kawabata M, 1999, ANN NY ACAD SCI, V886, P73, DOI 10.1111/j.1749-6632.1999.tb09402.x; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Li HC, 2002, J BIOL CHEM, V277, P20965, DOI 10.1074/jbc.M112231200; Lin DB, 2005, J BIOL CHEM, V280, P13682, DOI 10.1074/jbc.M407762200; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Ohta T, 2004, ONCOGENE, V23, P2079, DOI 10.1038/sj.onc.1207371; Orian A, 2001, Sci STKE, V2001, ppe1; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Sander CS, 2004, INT J DERMATOL, V43, P326, DOI 10.1111/j.1365-4632.2004.02222.x; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Starita LM, 2006, CANCER BIOL THER, V5, P137, DOI 10.4161/cbt.5.2.2479; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xiao CY, 2007, CELL, V128, P977, DOI 10.1016/j.cell.2007.01.034; Xiao Z, 2003, J BIOL CHEM, V278, P34245, DOI 10.1074/jbc.M301596200; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yakmovych I, 2001, FASEB J, V15, P553; Yang P, 2006, INVEST OPHTH VIS SCI, V47, P4598, DOI 10.1167/iovs.06-0140	41	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7091	10.1371/journal.pone.0007091	http://dx.doi.org/10.1371/journal.pone.0007091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768112	gold, Green Published, Green Submitted			2022-12-25	WOS:000270154000004
J	Orgel, JPRO; Eid, A; Antipova, O; Bella, J; Scott, JE				Orgel, Joseph P. R. O.; Eid, Aya; Antipova, Olga; Bella, Jordi; Scott, John E.			Decorin Core Protein (Decoron) Shape Complements Collagen Fibril Surface Structure and Mediates Its Binding	PLOS ONE			English	Article								Decorin is the archetypal small leucine rich repeat proteoglycan of the vertebrate extracellular matrix (ECM). With its glycosaminoglycuronan chain, it is responsible for stabilizing inter-fibrillar organization. Type I collagen is the predominant member of the fibrillar collagen family, fulfilling both organizational and structural roles in animal ECMs. In this study, interactions between decoron (the decorin core protein) and binding sites in the d and e(1) bands of the type I collagen fibril were investigated through molecular modeling of their respective X-ray diffraction structures. Previously, it was proposed that a model-based, highly curved concave decoron interacts with a single collagen molecule, which would form extensive van der Waals contacts and give rise to strong non-specific binding. However, the large well-ordered aggregate that is the collagen fibril places significant restraints on modes of ligand binding and necessitates multi-collagen molecular contacts. We present here a relatively high-resolution model of the decoron-fibril collagen complex. We find that the respective crystal structures complement each other well, although it is the monomeric form of decoron that shows the most appropriate shape complementarity with the fibril surface and favorable calculated energies of interaction. One molecule of decoron interacts with four to six collagen molecules, and the binding specificity relies on a large number of hydrogen bonds and electrostatic interactions, primarily with the collagen motifs KXGDRGE and AKGDRGE (d and e(1) bands). This work helps us to understand collagen-decorin interactions and the molecular architecture of the fibrillar ECM in health and disease.			Orgel, JPRO (corresponding author), IIT, Pritzker Inst Biomed Sci & Engn, BioCAT Ctr, Chicago, IL 60616 USA.	orgel@iit.edu	Bella, Jordi/F-3794-2018	Bella, Jordi/0000-0003-0443-4562	NCRR NIH HHS [RR08630, P41 RR008630] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Fischer E, 2002, J MOL STRUCT, V602, P303, DOI 10.1016/S0022-2860(01)00733-5; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Haverkamp RG, 2005, BIOMACROMOLECULES, V6, P1816, DOI 10.1021/bm0500392; Hooft RWW, 1996, PROTEINS, V26, P363; HULMES DJS, 1981, P NATL ACAD SCI-BIOL, V78, P3567, DOI 10.1073/pnas.78.6.3567; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kimura S, 1995, J ELECTRON MICROSC, V44, P445; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; MEEK KM, 1985, J MICROSC-OXFORD, V139, P205, DOI 10.1111/j.1365-2818.1985.tb02637.x; Nareyeck G, 2004, EUR J BIOCHEM, V271, P3389, DOI 10.1111/j.1432-1033.2004.04273.x; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PRINGLE GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1405, DOI 10.1177/38.10.1698203; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573; Scott JE, 1998, J ANAT, V192, P391, DOI 10.1046/j.1469-7580.1998.19230391.x; Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; SCOTT JE, 1984, BIOCHEM J, V218, P229, DOI 10.1042/bj2180229; Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t; SCOTT JE, 1993, DERMATAN SULPHATE PR, P165; Scott John E., 1993, Biochemical Society Transactions, V21, p123S; Scott JE, 2008, BIORHEOLOGY, V45, P209, DOI 10.3233/BIR-2008-0477; Scott JE, 2006, J PHYSIOL-LONDON, V574, P643, DOI 10.1113/jphysiol.2006.108100; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2006, J BIOMECH, V39, P1159, DOI 10.1016/j.jbiomech.2006.01.011; SCOTT PG, 1986, BIOCHEM BIOPH RES CO, V138, P1348, DOI 10.1016/S0006-291X(86)80431-4; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Scott PG, 2003, J BIOL CHEM, V278, P18353, DOI 10.1074/jbc.M211936200; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Twardowski T, 2007, CURR PHARM DESIGN, V13, P3608, DOI 10.2174/138161207782794176; VOGEL KG, 1987, BIOCHEM BIOPH RES CO, V148, P658, DOI 10.1016/0006-291X(87)90927-2; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; YU L, 1993, DERMATAN SULPHATE PR, P183	47	101	104	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7028	10.1371/journal.pone.0007028	http://dx.doi.org/10.1371/journal.pone.0007028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753304	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796500013
J	Bax, M; van Vliet, SJ; Litjens, M; Garcia-Vallejo, JJ; van Kooyk, Y				Bax, Marieke; van Vliet, Sandra J.; Litjens, Manja; Garcia-Vallejo, Juan J.; van Kooyk, Yvette			Interaction of Polysialic Acid with CCL21 Regulates the Migratory Capacity of Human Dendritic Cells	PLOS ONE			English	Article							GLYCOSYLATION; MATURATION; CHEMOKINES; RECOGNITION; ACTIVATION; INHIBITOR; ANTIGENS; IMMATURE; MEMBER	Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs). Immature DCs (iDCs) are situated in the periphery where they capture pathogen. Subsequently, they migrate as mature DCs (mDCs) to draining lymph nodes to activate T cells. CCR7 and CCL21 contribute to the migratory capacity of the DC, but it is not completely understood what molecular requirements are involved. Here we demonstrate that monocyte-derived DCs dramatically change ST8Sia IV expression during maturation, leading to the generation of polysialic acid (polySia). PolySia expression is highly upregulated after 2 days Toll-like receptor-4 (TLR4) triggering. Surprisingly, only immunogenic and not tolerogenic mDCs upregulated polySia expression. Furthermore, we show that polySia expression on DCs is required for CCL21 directed migration, whereby polySia directly captures CCL21. Corresponding to polySia, the expression level of CCR7 is maximal two days after TLR4 triggering. In contrast, although TLR agonists other than LPS induce upregulation of CCR7, they achieve only a moderate polySia expression. In situ we could detect polySia expressing APCs in the T cell zone of the lymph node and in the deep dermis. Together our results indicate that prolonged TLR4 engagement is required for the generation of polySia-expressing DCs that facilitate CCL21 capture and subsequent CCL21-directed migration.			Bax, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	y.vankooyk@vumc.nl	Garcia-Vallejo, Juan/H-4162-2012; Van Vliet, Sandra/AAO-9534-2020; Vallejo, Juan Garcia/AAA-3765-2020	Garcia-Vallejo, Juan/0000-0001-6238-7069; Van Kooyk, Yvette/0000-0001-5997-3665; van Vliet, Sandra/0000-0003-1811-2687				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bros M, 2007, BLOOD, V109, P3820, DOI 10.1182/blood-2006-07-035576; Cebo C, 2002, BBA-GEN SUBJECTS, V1572, P422, DOI 10.1016/S0304-4165(02)00323-9; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; FINNE J, 1982, J BIOL CHEM, V257, P1966; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; HUANG J, 1992, ONCOL RES, V4, P507; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yanagihara S, 1998, J IMMUNOL, V161, P3096; ZUBER C, 1992, J BIOL CHEM, V267, P9965	30	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6987	10.1371/journal.pone.0006987	http://dx.doi.org/10.1371/journal.pone.0006987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750015	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796300010
J	Hou, YB; Lin, SJ				Hou, Yubo; Lin, Senjie			Distinct Gene Number-Genome Size Relationships for Eukaryotes and Non-Eukaryotes: Gene Content Estimation for Dinoflagellate Genomes	PLOS ONE			English	Article							DNA-CONTENT; BINDING-PROTEIN; SYMBIODINIUM; ORGANIZATION; SEQUENCE; EVOLUTION; SMALLEST; TRENDS; CYCLE	The ability to predict gene content is highly desirable for characterization of not-yet sequenced genomes like those of dinoflagellates. Using data from completely sequenced and annotated genomes from phylogenetically diverse lineages, we investigated the relationship between gene content and genome size using regression analyses. Distinct relationships between log(10)-transformed protein-coding gene number (Y') versus log(10)-transformed genome size (X', genome size in kbp) were found for eukaryotes and non-eukaryotes. Eukaryotes best fit a logarithmic model, Y' = ln(-46.200+22.678X', whereas non-eukaryotes a linear model, Y' = 0.045+0.977X', both with high significance (p<0.001, R-2>.0.91). Total gene number shows similar trends in both groups to their respective protein coding regressions. The distinct correlations reflect lower and decreasing gene-coding percentages as genome size increases in eukaryotes (82%-1%) compared to higher and relatively stable percentages in prokaryotes and viruses (97%-47%). The eukaryotic regression models project that the smallest dinoflagellate genome (3 x 10(6) kbp) contains 38,188 protein-coding (40,086 total) genes and the largest (245 x 10(6) kbp) 87,688 protein-coding (92,013 total) genes, corresponding to 1.8% and 0.05% gene-coding percentages. These estimates do not likely represent extraordinarily high functional diversity of the encoded proteome but rather highly redundant genomes as evidenced by high gene copy numbers documented for various dinoflagellate species.			Hou, YB (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	zhang, yaqun/J-8478-2014; Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016					ALLEN JR, 1975, CELL, V6, P161, DOI 10.1016/0092-8674(75)90006-9; Anderson Donald M., 1992, Molecular Marine Biology and Biotechnology, V1, P89; Archibald JM, 2007, BIOESSAYS, V29, P392, DOI 10.1002/bies.20551; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bertomeu T, 2004, BIOCHEM BIOPH RES CO, V323, P1172, DOI 10.1016/j.bbrc.2004.09.008; Bhaud Y, 2000, J CELL SCI, V113, P1231; BLANK RJ, 1987, MAR BIOL, V94, P143, DOI 10.1007/BF00392906; Bouligand Y, 2001, BIOCHIMIE, V83, P187, DOI 10.1016/S0300-9084(00)01211-6; Chan YH, 2007, NUCLEIC ACIDS RES, V35, P2573, DOI 10.1093/nar/gkm165; Coats DW, 2002, J PHYCOL, V38, P417, DOI 10.1046/j.1529-8817.2002.03832.x; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Gregory T. Ryan, 2005, P427; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; HINNEBUSCH AG, 1980, BIOCHEMISTRY-US, V19, P1744, DOI 10.1021/bi00550a004; HOLMHANSEN O, 1969, SCIENCE, V163, P87, DOI 10.1126/science.163.3862.87; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; LEE DH, 1993, J BIOL CHEM, V268, P8842; Lin S., 2008, RNA DNA EDITING MOL, P280, DOI DOI 10.1002/9780470262269.CH13; Lin SJ, 2006, J PHYCOL, V42, P746, DOI 10.1111/j.1529-8817.2006.00213.x; Liu LY, 2006, J PHYCOL, V42, P96, DOI 10.1111/j.1529-8817.2006.00165.x; Loeblich A.R., 1981, Journal of Plankton Research, V3, P67, DOI 10.1093/plankt/3.1.67; Lukes J, 2009, P NATL ACAD SCI USA, V106, P9963, DOI 10.1073/pnas.0901004106; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M., 2007, ORIGINS GENOME ARCHI, P193; McEwan M, 2008, J EUKARYOT MICROBIOL, V55, P530, DOI 10.1111/j.1550-7408.2008.00357.x; Moreau H, 1998, Int Microbiol, V1, P35; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Pfiester L. A., 1987, BIOL DINOFLAGELLATES, P611; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; Rizzo P.J., 1987, Botanical Monographs (Oxford), V21, P143; RIZZO PJ, 1973, J PROTOZOOL, V20, P666, DOI 10.1111/j.1550-7408.1973.tb03595.x; ROBERTS TM, 1974, NATURE, V248, P446, DOI 10.1038/248446a0; Salois P, 1997, J PHYCOL, V33, P1063, DOI 10.1111/j.0022-3646.1997.01063.x; Santos SR, 2003, BIOL BULL-US, V204, P10, DOI 10.2307/1543491; SIGEE DC, 1983, BIOSYSTEMS, V16, P203, DOI 10.1016/0303-2647(83)90004-7; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Spector D.L., 1984, P107; STEEL RE, 1980, THESIS YALE U NEW HA; Van Dolah FM, 2009, HARMFUL ALGAE, V8, P562, DOI 10.1016/j.hal.2008.11.004; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2003, J PHYCOL, V39, P1160, DOI 10.1111/j.0022-3646.2003.03-055.x; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083	55	136	139	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6978	10.1371/journal.pone.0006978	http://dx.doi.org/10.1371/journal.pone.0006978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750009	Green Submitted, gold, Green Published			2022-12-25	WOS:000269796300008
J	Welch, M; Govindarajan, S; Ness, JE; Villalobos, A; Gurney, A; Minshull, J; Gustafsson, C				Welch, Mark; Govindarajan, Sridhar; Ness, Jon E.; Villalobos, Alan; Gurney, Austin; Minshull, Jeremy; Gustafsson, Claes			Design Parameters to Control Synthetic Gene Expression in Escherichia coli	PLOS ONE			English	Article							TRANSLATION INITIATION; CODON PAIRS; NGG CODONS; RNA; SEQUENCE; BIAS; OVEREXPRESSION; CONSTRUCTION; TERMINATION; PROTEINS	Background: Production of proteins as therapeutic agents, research reagents and molecular tools frequently depends on expression in heterologous hosts. Synthetic genes are increasingly used for protein production because sequence information is easier to obtain than the corresponding physical DNA. Protein-coding sequences are commonly re-designed to enhance expression, but there are no experimentally supported design principles. Principal Findings: To identify sequence features that affect protein expression we synthesized and expressed in E. coli two sets of 40 genes encoding two commercially valuable proteins, a DNA polymerase and a single chain antibody. Genes differing only in synonymous codon usage expressed protein at levels ranging from undetectable to 30% of cellular protein. Using partial least squares regression we tested the correlation of protein production levels with parameters that have been reported to affect expression. We found that the amount of protein produced in E. coli was strongly dependent on the codons used to encode a subset of amino acids. Favorable codons were predominantly those read by tRNAs that are most highly charged during amino acid starvation, not codons that are most abundant in highly expressed E. coli proteins. Finally we confirmed the validity of our models by designing, synthesizing and testing new genes using codon biases predicted to perform well. Conclusion: The systematic analysis of gene design parameters shown in this study has allowed us to identify codon usage within a gene as a critical determinant of achievable protein expression levels in E. coli. We propose a biochemical basis for this, as well as design algorithms to ensure high protein production from synthetic genes. Replication of this methodology should allow similar design algorithms to be empirically derived for any expression system.			Welch, M (corresponding author), DNA2 0, Menlo Pk, CA USA.	mwelch@DNA20.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Gustafsson, Claes/0000-0003-2181-3126				Bjornsson A, 1996, NUCLEIC ACIDS RES, V24, P1753, DOI 10.1093/nar/24.9.1753; BLANCO L, 1984, P NATL ACAD SCI-BIOL, V81, P5325, DOI 10.1073/pnas.81.17.5325; Bonomo J, 2005, BIOTECHNOL BIOENG, V90, P116, DOI 10.1002/bit.20436; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; CHEN GFT, 1994, GENE DEV, V8, P2641, DOI 10.1101/gad.8.21.2641; de Valdivia EIG, 2005, FEBS J, V272, P5306, DOI 10.1111/j.1742-4658.2005.04926.x; de Valdivia EIG, 2004, NUCLEIC ACIDS RES, V32, P5198, DOI 10.1093/nar/gkh857; DELTITO BJD, 1995, J BACTERIOL, V177, P7086, DOI 10.1128/jb.177.24.7086-7091.1995; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Fuglsang A, 2003, PROTEIN EXPRES PURIF, V31, P247, DOI 10.1016/S1046-5928(03)00213-4; GRAF M, 2009, SYSTEMS BIOL SYNTHET, P411, DOI DOI 10.1002/9780470437988.CH12; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Harcum SW, 2002, J BIOTECHNOL, V93, P189, DOI 10.1016/S0168-1656(01)00347-9; HENAUT A, 1996, ESCHERICHIA COLI SAL, V2, P2047; Holland JH, 1975, ADOPTION NATURAL ART, Vsecond; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; Kaberdin VR, 2003, NUCLEIC ACIDS RES, V31, P4710, DOI 10.1093/nar/gkg690; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Liao J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-16; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Newcomb J, 2007, GENOME SYNTHESIS DES; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROJIANI MV, 1990, P NATL ACAD SCI USA, V87, P1511, DOI 10.1073/pnas.87.4.1511; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Sohn YH, 2005, P NATL ACAD SCI USA, V102, P75, DOI 10.1073/pnas.0406581101; Sorensen MA, 2005, J MOL BIOL, V354, P16, DOI 10.1016/j.jmb.2005.08.076; Stenstrom CM, 2002, GENE, V288, P1, DOI 10.1016/S0378-1119(02)00501-2; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Stenstrom CM, 2001, GENE, V273, P259, DOI 10.1016/S0378-1119(01)00584-4; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Welch M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0520.focus; Wold S., 1994, PLS MULTIVARIATE LIN; Wu G, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100175; Wu G, 2007, NUCLEIC ACIDS RES, V35, pD76, DOI 10.1093/nar/gkl648	48	253	305	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7002	10.1371/journal.pone.0007002	http://dx.doi.org/10.1371/journal.pone.0007002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759823	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796300014
J	Dorsey, ER; Thompson, JP; Carrasco, M; de Roulet, J; Vitticore, P; Nicholson, S; Johnston, SC; Holloway, RG; Moses, H				Dorsey, E. Ray; Thompson, Joel P.; Carrasco, Melisa; de Roulet, Jason; Vitticore, Philip; Nicholson, Sean; Johnston, S. Claiborne; Holloway, Robert G.; Moses, Hamilton, III			Financing of US Biomedical Research and New Drug Approvals across Therapeutic Areas	PLOS ONE			English	Article							ANATOMY; BURDEN	Background: We estimated U.S. biomedical research funding across therapeutic areas, determined the association with disease burden, and evaluated new drug approvals that resulted from this investment. Methodology/Principal Findings: We calculated funding from 1995 to 2005 and totaled Food and Drug Administration approvals in eight therapeutic areas (cardiovascular, endocrine, gastrointestinal, genitourinary, HIV/AIDS, infectious disease excluding HIV, oncology, and respiratory) primarily using public data. We then calculated correlations between funding, published estimates of disease burden, and drug approvals. Financial support for biomedical research from 1995 to 2005 increased across all therapeutic areas between 43% and 369%. Industry was the principal funder of all areas except HIV/AIDS, infectious disease, and oncology, which were chiefly sponsored by the National Institutes of Health (NIH). Total (r = 0.70; P =.03) and industry funding (r = 0.69; P = .04) were correlated with projected disease burden in high income countries while NIH support (r = 0.80; P = .01) was correlated with projected disease burden globally. From 1995 to 2005 the number of new approvals was flat or declined across therapeutic areas, and over an 8-year lag period, neither total nor industry funding was correlated with future approvals. Conclusions/Significance: Across therapeutic areas, biomedical research funding increased substantially, appears aligned with disease burden in high income countries, but is not linked to new drug approvals. The translational gap between funding and new therapies is affecting all of medicine, and remedies must include changes beyond additional financial investment.			Dorsey, ER (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	ray.dorsey@ctcc.rochester.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER; NCRR NIH HHS [KL2 RR024136] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; *AM CAN SOC, 1998, AM CANC SOC ANN REP; *AM DIAB ASS, 1998, AM DIAB ASS ANN REP; *AM HEART ASS, AM HEART ASS ANN REP; *AM LUNG ASS, 1998, AM LUNG ASS ANN REP; Azoulay P, 2007, NEW ENGL J MED, V357, P2049, DOI 10.1056/NEJMsa067417; BLUM J, FDA APPROVES 19 NEW; Booth B, 2004, NAT REV DRUG DISCOV, V3, P451, DOI 10.1038/nrd1384; *BURR WELLC FUND, NEWS PUBL ANN REP; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Carande-Kulis Vilma G, 2007, J Public Health Manag Pract, V13, P227; Connelly E, 2006, INVESTMENT US HLTH R; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; *DAN FDN, DAN FDN ANN REP; Destler B, 2008, NATURE, V453, P853, DOI 10.1038/453853a; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Dorsey ER, 2006, ANN NEUROL, V60, P652, DOI 10.1002/ana.21047; Dorsey ER, 2009, MOVEMENT DISORD, V24, P731, DOI 10.1002/mds.22446; *FDN CTR, 2004, TOP 50 US FDN AW GRA; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; HALL P, 1998, INNOVATIVE MILIEU CI; JAMES S, MCDONNELL FDN ARCH G; Johnson MR, 2006, BIOL PSYCHIAT, V60, P11, DOI 10.1016/j.biopsych.2005.11.012; Johnston SC, 2007, ANN NEUROL, V62, pA6; *JUV DIAB RES FDN, 2002, JUV DIAB RES FDN ANN; *LEUK LYMPH SOC, 2002, LEUK LYMPH SOC ANN R; Martinez B., 2007, WALL STREET J, pA1; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; *MCKNIGHT BRAIN RE, 2001, MCKNIGHT BRAIN RES F; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Moses H, 2006, ANN NEUROL, V60, P647, DOI 10.1002/ana.21048; Murphy KM, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P41; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; *NAT HEART LUND BL, LEG INF NHLBI DIR PA; *NAT I DIAB DIG KI, BUDG LEG INF; *NIH, NIH NIH ALM APPR; *NIH, NIH PRIC IND; *OFF AIDS RES, OAR PUBL INF; *PHARM RES MAN AM, 2000, PHARM IND PROF 2000; *PHARM RES MAN AM, 1998, PHARM IND PROF 1998; Pharmaceutical Research and Manufacturers of America, 2002, PHARM IND PROF 2002; Pharmaceutical Research and Manufacturers of America, 2006, PHARM IND PROF 2006; Pisano G. P., 2006, SCI BUSINESS PROMISE, P1; *RES AM, WHAT DO YOU THINK IS; *RES AM, 2006, 2006 INV US HLTH RES; *THOMS CENTERWATCH, AB THOMS CENTERWATCH; *US BUR CENS, 1996, CURR IND REP PHARM P; *US FDA, CTR DRUG EV RES DRUG; *US SEC EXCH COMM, DIV CORP FIN STAND I; *US SEC EXCH COMM, SEC FIL FORMS EDGAR; *WHIT FDN, WHIT FDN ANN REP; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931; 2009, PHARM IND PROFILE 20	56	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e7015	10.1371/journal.pone.0007015	http://dx.doi.org/10.1371/journal.pone.0007015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750225	Green Published, gold			2022-12-25	WOS:000269696600018
J	Mehedint, MG; Niculescu, MD; Craciunescu, CN; Zeisel, SH				Mehedint, Mihai G.; Niculescu, Mihai D.; Craciunescu, Corneliu N.; Zeisel, Steven H.			Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene	FASEB JOURNAL			English	Article						G9a; hippocampus; REST/NRSF; progenitors	NEURAL-TUBE DEFECTS; EMBRYONIC-DEVELOPMENT ALTERS; PROGENITOR-CELL MITOSIS; LYSINE-9 METHYLATION; S-ADENOSYLMETHIONINE; AVAILABILITY ALTERS; DNA METHYLATION; PRECURSOR CELLS; H3 LYSINE-9; STEM	Maternal choline availability is essential for fetal neurogenesis. Choline deprivation ( CD) causes hypomethylation of specific CpG islands in genes controlling cell cycling in fetal hippocampus. We now report that, in C57BL/6 mice, CD during gestational days 12-17 also altered methylation of the histone H3 in E17 fetal hippocampi. In the ventricular and subventricular zones, monomethyl-lysine 9 of H3 (H3K9me1) was decreased by 25% (P<0.01), and in the pyramidal layer, dimethyl-lysine 9 of H3 (H3K9me2) was decreased by 37% (P<0.05). These changes were region specific and were not observed in whole-brain preparations. Also, the same effects of CD on H3 methylation were observed in E14 neural progenitor cells (NPCs) in culture. Changes in G9a histone methyltransferase might mediate altered H3K9me2,1. Gene expression of G9a was decreased by 80% in CD NPCs (P<0.001). In CD, H3 was hypomethylated upstream of the RE1 binding site in the calbindin 1 promoter, and 1 CpG site within the calbindin 1 promoter was hypermethylated. REST binding to RE1 (recruits G9a) was decreased by 45% (P<0.01) in CD. These changes resulted in increased expression of calbindin 1 in CD (260%; P<0.05). Thus, CD modulates histone methylation in NPCs, and this could underlie the observed changes in neurogenesis.-Mehedint, M. G., Niculescu, M. D., Craciunescu, C. N., Zeisel, S. H. Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene. FASEB J. 24, 184-195 ( 2010). www.fasebj.org	Univ N Carolina Chapel Hill, Sch Publ Hlth, Dept Nutr, Nutr Res Inst Kannapolis, Kannapolis, NC USA; Univ N Carolina Chapel Hill, Sch Med, Kannapolis, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), UNC Nutr Res Inst Kannapolis, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Ariel, Pablo/AGJ-4118-2022		National Institutes of Health [AG-09525, DK-55865, DK-56350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055865, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (AG-09525, DK-55865). Support for this work was also provided by grants from the National Institutes of Health to the Clinical Nutrition Research Unit (DK-56350). We thank Dr. Robert Bagnell, Jr., Professor and Director of the Microscopy Service Laboratory, UNC Department of Pathology, for assistance.	Albright CD, 1999, DEV BRAIN RES, V115, P123, DOI 10.1016/S0165-3806(99)00057-7; Albright CD, 2005, DEV BRAIN RES, V159, P149, DOI 10.1016/j.devbrainres.2005.07.002; Albright CD, 2003, NUTR NEUROSCI, V6, P129, DOI 10.1080/1028415031000084418; Albright CD, 1996, FASEB J, V10, P510, DOI 10.1096/fasebj.10.4.8647350; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fisher MC, 2002, FASEB J, V16, P619, DOI 10.1096/fj.01-0564fje; Fisher MC, 2001, TERATOLOGY, V64, P114, DOI 10.1002/tera.1053; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; JACOBOWITZ DM, 1998, CHEMOARCHITECTONIC A; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jensen LJ, 2007, FASEB J, V21, pA519; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 1997, NEUROREPORT, V8, P2831, DOI 10.1097/00001756-199709080-00005; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2005, MOL BRAIN RES, V134, P309, DOI 10.1016/j.molbrainres.2004.11.001; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Ozarda Ilcol Y, 2002, Arch Physiol Biochem, V110, P393; Park JJ, 1996, J NEUROBIOL, V30, P315, DOI 10.1002/(SICI)1097-4695(199607)30:3<315::AID-NEU1>3.0.CO;2-7; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Williams CL, 1998, BRAIN RES, V794, P225, DOI 10.1016/S0006-8993(98)00229-7; Wu Yuanyuan, 2008, V438, P39, DOI 10.1007/978-1-59745-133-8_5; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; ZEISEL SH, 1989, BIOCHEM J, V259, P725, DOI 10.1042/bj2590725; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhu XN, 2004, DEV BRAIN RES, V149, P121, DOI 10.1016/j.devbrainres.2004.01.004	76	111	116	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					184	195		10.1096/fj.09-140145	http://dx.doi.org/10.1096/fj.09-140145			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19752176	Green Published			2022-12-25	WOS:000273233600020
J	Jacobson, EM; Yang, HY; Menconi, F; Wang, R; Osman, R; Skrabanek, L; Li, CW; Fadlalla, M; Gandhi, A; Chaturvedi, V; Smith, EP; Schwemberger, S; Osterburg, A; Babcock, GF; Tomer, Y				Jacobson, Eric M.; Yang, Heyi; Menconi, Francesca; Wang, Rong; Osman, Roman; Skrabanek, Luce; Li, Cheuk Wun; Fadlalla, Mohammed; Gandhi, Alisha; Chaturvedi, Vijaya; Smith, Eric P.; Schwemberger, Sandy; Osterburg, Andrew; Babcock, George F.; Tomer, Yaron			Employing a Recombinant HLA-DR3 Expression System to Dissect Major Histocompatibility Complex II-Thyroglobulin Peptide Dynamism A GENETIC, BIOCHEMICAL, AND REVERSE IMMUNOLOGICAL PERSPECTIVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; B-CELL LINE; GRAVES-DISEASE; HLA-DR; CATHEPSIN-B; AUTOIMMUNE-THYROIDITIS; ANTIGEN PRESENTATION; ESCHERICHIA-COLI; BINDING EPITOPES; INVARIANT CHAIN	Previously, we have shown that statistical synergism between amino acid variants in thyroglobulin (Tg) and specific HLA-DR3 pocket sequence signatures conferred a high risk for autoimmune thyroid disease (AITD). Therefore, we hypothesized that this statistical synergism mirrors a biochemical interaction between Tg peptides and HLA-DR3, which is key to the pathoetiology of AITD. To test this hypothesis, we designed a recombinant HLA-DR3 expression system that was used to express HLA-DR molecules harboring either AITD susceptibility or resistance DR pocket sequences. Next, we biochemically generated the potential Tg peptidic repertoire available to HLA-DR3 by separately treating 20 purified human thyroglobulin samples with cathepsins B, D, or L, lysosomal proteases that are involved in antigen processing and thyroid biology. Sequences of the cathepsin-generated peptides were then determined by matrix-assisted laser desorption ionization time-of-flight-mass spectroscopy, and algorithmic means were employed to identify putative AITD-susceptible HLA-DR3 binders. From four predicted peptides, we identified two novel peptides that bound strongly and specifically to both recombinant AITD-susceptible HLA-DR3 protein and HLA-DR3 molecules expressed on stably transfected cells. Intriguingly, the HLA-DR3-binding peptides we identified had a marked preference for the AITD-susceptibility DR signatures and not to those signatures that were AITD-protective. Structural analyses demonstrated the profound influence that the pocket signatures have on the interaction of HLA-DR molecules with Tg peptides. Our study suggests that interactions between Tg and discrete HLA-DR pocket signatures contribute to the initiation of AITD.	[Li, Cheuk Wun; Fadlalla, Mohammed; Gandhi, Alisha; Chaturvedi, Vijaya; Smith, Eric P.; Tomer, Yaron] Univ Cincinnati, Coll Med, Div Endocrinol, Cincinnati, OH 45220 USA; [Tomer, Yaron] Univ Cincinnati, Coll Med, Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA; [Yang, Heyi; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Osman, Roman] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Schwemberger, Sandy; Osterburg, Andrew; Babcock, George F.] Shriners Hosp Children, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University; Cornell University	Jacobson, EM (corresponding author), Univ Cincinnati, Vontz Ctr Mol Studies, Div Endocrinol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	Eric.Jacobson@uc.edu	Tomer, Yaron/GWU-8933-2022; Wang, Rong/A-8721-2009		NIDDK [DK61659, DK067555, DK073681]; American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061659, R01DK067555, R01DK073681, T35DK060444] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61659, DK067555, and DK073681 from NIDDK (to Y.T.). This work was also supported by a grant from the American Thyroid Association (to E.M.J.).	Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; BOTTAZZO GF, 1983, LANCET, V2, P1115; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; CHIEZ RM, 1993, J EXP MED, V178, P27; CHIEZ RM, 1992, NATURE, V358, P764; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Doebele RC, 2003, J IMMUNOL, V170, P4683, DOI 10.4049/jimmunol.170.9.4683; DUNN AD, 1991, J BIOL CHEM, V266, P20198; DUNN AD, 1984, ENDOCRINOLOGY, V114, P375, DOI 10.1210/endo-114-2-375; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Flynn JC, 2004, CELL IMMUNOL, V229, P79, DOI 10.1016/j.cellimm.2004.07.002; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; Gauthier L, 1998, P NATL ACAD SCI USA, V95, P11828, DOI 10.1073/pnas.95.20.11828; Gebe JA, 2002, TISSUE ANTIGENS, V59, P78, DOI 10.1034/j.1399-0039.2002.590202.x; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; GORGA JC, 1987, J BIOL CHEM, V262, P16087; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HANAFUSA T, 1983, LANCET, V2, P1111; HITZEL C, 1995, J IMMUNOL, V154, P1048; Hodge SE, 2006, THYROID, V16, P351, DOI 10.1089/thy.2006.16.351; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Jacobson EM, 2008, J AUTOIMMUN, V30, P58, DOI 10.1016/j.jaut.2007.11.010; Jacobson EM, 2007, THYROID, V17, P949, DOI 10.1089/thy.2007.0153; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Karras E, 2005, J AUTOIMMUN, V24, P291, DOI 10.1016/j.jaut.2005.02.002; LAH TT, 1995, FEBS LETT, V363, P85; LOMBARDI G, 1991, INT IMMUNOL, V3, P769, DOI 10.1093/intimm/3.8.769; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Muixi L, 2008, J IMMUNOL, V181, P795, DOI 10.4049/jimmunol.181.1.795; POSCH PE, 1995, HUM IMMUNOL, V42, P61, DOI 10.1016/0198-8859(94)00074-Z; Raju R, 2001, J IMMUNOL, V167, P1118, DOI 10.4049/jimmunol.167.2.1118; RODRIGUEZ GM, 1992, J IMMUNOL, V149, P2894; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; SHACKELFORD DA, 1983, J IMMUNOL, V130, P289; Shuja S, 1999, THYROID, V9, P569, DOI 10.1089/thy.1999.9.569; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; STOCKEL J, 1994, J BIOL CHEM, V269, P29571; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; Tomer Y, 2001, J CLIN ENDOCR METAB, V86, P1687, DOI 10.1210/jc.86.4.1687; Wucherpfennig KW, 2003, ANN NY ACAD SCI, V1005, P119, DOI 10.1196/annals.1288.013; Wucherpfennig KW, 2001, CURR OPIN IMMUNOL, V13, P650, DOI 10.1016/S0952-7915(01)00274-6; WUCHERPFENNIG KW, 1995, P NATL ACAD SCI USA, V92, P11935, DOI 10.1073/pnas.92.25.11935	47	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34231	34243		10.1074/jbc.M109.041574	http://dx.doi.org/10.1074/jbc.M109.041574			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19776016	Green Published, hybrid			2022-12-25	WOS:000272165200055
J	Barsotti, AM; Prives, C				Barsotti, A. M.; Prives, C.			Pro-proliferative FoxM1 is a target of p53-mediated repression	ONCOGENE			English	Article						p53; FoxM1; transcriptional repression; p21; Rb; G2 arrest	M1 TRANSCRIPTION FACTOR; P53 TUMOR-SUPPRESSOR; MOUSE-LIVER REGENERATION; CELL-CYCLE PROGRESSION; WILD-TYPE P53; DNA-DAMAGE; DOWN-REGULATION; C-MYC; FUNCTIONAL DOMAINS; INDUCED SENESCENCE	The p53 tumor suppressor protein acts as a transcription factor to modulate cellular responses to a wide variety of stresses. In this study we show that p53 is required for the downregulation of FoxM1, an essential transcription factor that regulates many G2/M-specific genes and is overexpressed in a multitude of solid tumors. After DNA damage, p53 facilitates the repression of FoxM1 mRNA, which is accompanied by a decrease in FoxM1 protein levels. In cells with reduced p53 expression, FoxM1 is upregulated after DNA damage. Nutlin, a small-molecule activator of p53, suppresses FoxM1 levels in two cell lines in which DNA damage facilitates only mild repression. Mechanistically, p53-mediated inhibition of FoxM1 is partially p21 and retinoblastoma (Rb) family dependent, although in some cases p21-independent repression of FoxM1 was also observed. The importance of FoxM1 to cell fate was indicated by the observation that G2/M arrest follows FoxM1 ablation. Finally, our results indicate a potential contribution of p53-mediated repression of FoxM1 for maintenance of a stable G2 arrest. Oncogene (2009) 28, 4295-4305; doi: 10.1038/onc.2009.282; published online 14 September 2009	[Barsotti, A. M.; Prives, C.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, 816 Fairchild, New York, NY 10027 USA.	clp3@columbia.edu			National Institutes of Health [CA77742]; NATIONAL CANCER INSTITUTE [R01CA077742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ella Freulich provided expert technical assistance. Members of the Prives laboratory are thanked for their support and encouragement. This work was supported by the National Institutes of Health Grant CA77742.	Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Bhonde MR, 2006, J BIOL CHEM, V281, P8675, DOI 10.1074/jbc.M511333200; Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Clair SS, 2006, CELL CYCLE, V5, P709, DOI 10.4161/cc.5.7.2628; Das S, 2008, CELL CYCLE, V7, P154, DOI 10.4161/cc.7.2.5236; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Gridasova AA, 2005, MOL CELL BIOL, V25, P3247, DOI 10.1128/MCB.25.8.3247-3260.2005; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; KASTAN MB, 1991, CANCER RES, V51, P6304; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Krause K, 2001, BIOCHEM BIOPH RES CO, V284, P743, DOI 10.1006/bbrc.2001.5040; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Linhart C, 2005, CELL CYCLE, V4, P1788, DOI 10.4161/cc.4.12.2173; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Penzo M, 2009, J CELL PHYSIOL, V218, P215, DOI 10.1002/jcp.21596; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robinson M, 2003, CANCER BIOL THER, V2, P406, DOI 10.4161/cbt.2.4.437; Sax JK, 2003, CANCER BIOL THER, V2, P416, DOI 10.4161/cbt.2.4.477; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Spitkovsky D, 1997, CELL GROWTH DIFFER, V8, P699; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; St Clair S, 2004, MOL CELL, V16, P725; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Teh MT, 2002, CANCER RES, V62, P4773; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang LQ, 2001, J BIOL CHEM, V276, P43604, DOI 10.1074/jbc.M106570200; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Weymann A, 2009, HEPATOLOGY, V50, P207, DOI 10.1002/hep.22979; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xia LM, 2009, J CELL BIOCHEM, V106, P247, DOI 10.1002/jcb.21996; Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zeng JP, 2009, J PATHOL, V218, P419, DOI 10.1002/path.2530; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	77	109	111	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4295	4305		10.1038/onc.2009.282	http://dx.doi.org/10.1038/onc.2009.282			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19749794	Green Accepted			2022-12-25	WOS:000272876300007
J	Lee, JRE; Oestreich, AJ; Payne, JA; Gunawan, MS; Norgan, AP; Katzmann, DJ				Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Gunawan, Mia S.; Norgan, Andrew P.; Katzmann, David J.			The HECT Domain of the Ubiquitin Ligase Rsp5 Contributes to Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; WW-DOMAINS; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; SORTING COMPLEX; DIRECT BINDING; NEDD4 FAMILY; YEAST; BODIES; DETERMINANTS	Ubiquitin modification of endosomal membrane proteins is a signal for active inclusion into the Multivesicular Body (MVB) pathway, resulting in lysosomal degradation. However, the endosome represents a dynamic site of protein sorting with a majority of proteins destined for recycling, rather than MVB targeting. Substrate recognition by ubiquitin ligases is therefore highly regulated. We have investigated substrate recognition by the Nedd4 ortholog Rsp5 as a model for understanding ligase-substrate interactions. Rsp5 interacts directly with its substrate Cps1 via a novel interaction mode. Perturbation of this mode of interaction revealed a compensatory role for the Rsp5 adaptor Bsd2. These results highlight the ability of Rsp5 to interact with substrates via multiple modalities, suggesting additional mechanisms of regulating this interaction and relevant outcomes.	[Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Gunawan, Mia S.; Norgan, Andrew P.; Katzmann, David J.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Katzmann, DJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	Katzmann.David@mayo.edu		Eve, Jacqueline/0000-0002-3159-5620	National Institutes of Health [R01 GM73024]; American Heart Association [AHA0430369Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01 GM73024 from the National Institutes of Health. This work was also supported by the American Heart Association Grant AHA0430369Z (to D.J.K.).	Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kato Y, 2002, J BIOL CHEM, V277, P10173, DOI 10.1074/jbc.M110490200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shcherbik N, 2004, J BIOL CHEM, V279, P53892, DOI 10.1074/jbc.M410325200; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; SIKORSKI RS, 1989, GENETICS, V122, P19; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Watson H, 2007, MOL BIOL CELL, V18, P1781, DOI 10.1091/mbc.E06-10-0887; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7	53	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32126	32137		10.1074/jbc.M109.048629	http://dx.doi.org/10.1074/jbc.M109.048629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19744925	Green Published, hybrid			2022-12-25	WOS:000271572700067
J	Yin, WH; Park, JI; Loeser, RF				Yin, Weihong; Park, Jong-In; Loeser, Richard F.			Oxidative Stress Inhibits Insulin-like Growth Factor-I Induction of Chondrocyte Proteoglycan Synthesis through Differential Regulation of Phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOARTHRITIC ARTICULAR-CARTILAGE; RECEPTOR SUBSTRATE-1 IRS-1; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; IGF-I; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; SUPEROXIDE-DISMUTASE; ENDOTHELIAL-CELLS; BINDING-PROTEINS	The ability of insulin-like growth factor I (IGF-I) to stimulate cartilage matrix synthesis is reduced in aged and osteoarthritic cartilage. Aging and osteoarthritis are associated with an increase in reactive oxygen species, which we hypothesized would interfere with normal IGF-I signaling. We compared IGF-I signaling in normal and osteoarthritic human articular chondrocytes and investigated the effects of oxidative stress induced by tert-butylhydroperoxide (tBHP). In normal human chondrocytes, IGF-I initiated a strong and sustained phosphorylation of IRS-1 (Tyr-612) and Akt (Ser-473) and transient ERK phosphorylation. In contrast, in osteoarthritic chondrocytes, which possessed elevated basal IRS-1 (Ser-312) and ERK phosphorylation, IGF-I failed to stimulate IRS-1 (Tyr-612) or Akt phosphorylation. In normal human chondrocytes, tBHP triggered strong IRS-1 (Ser-312 and Ser-616) and ERK phosphorylation and inhibited IGF-I-induced IRS-1 (Tyr-612) and Akt phosphorylation. Lentivirus-mediated overexpression of constitutively active (CA) Akt significantly enhanced proteoglycan synthesis, whereas both dominant negative Akt and CA MEK inhibited proteoglycan synthesis. CA Akt also promoted type II collagen and Sox9 expression, whereas tBHP treatment and CA MEK inhibited aggrecan, collagen II, and Sox9 mRNA expression. In osteoarthritic chondrocytes, the antioxidants Mn(III) tetrakis(4-benzoic acid) porphyrin and N-acetylcysteine increased the ratio of Akt to ERK phosphorylation and promoted IGF-I-mediated proteoglycan synthesis. Chemical inhibition of ERK significantly enhanced IGF-I phosphorylation of Akt and alleviated tBHP inhibition of Akt phosphorylation. These results demonstrate opposing roles for phosphatidylinositol 3-kinase-Akt and MEK-ERK in cartilage matrix synthesis and suggest that elevated levels of reactive oxygen species cause chondrocyte IGF-I resistance by altering the balance of Akt to ERK activity.	[Yin, Weihong; Loeser, Richard F.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Park, Jong-In] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Wake Forest University; Wake Forest Baptist Medical Center; Medical College of Wisconsin	Loeser, RF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	rloeser@wfubmc.edu		Park, Jong-In/0000-0001-7248-4735	National Institutes of Health [AG-16697]; Ellison Medical Foundation/American Federation for Aging Research Postdoctoral Fellowship; NATIONAL INSTITUTE ON AGING [R01AG016697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation/American Federation for Aging Research Postdoctoral Fellowship(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-16697. This work was also supported by an Ellison Medical Foundation/American Federation for Aging Research Postdoctoral Fellowship.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bobick BE, 2004, J BIOL CHEM, V279, P4588, DOI 10.1074/jbc.M309805200; Boileau C, 2006, ANN RHEUM DIS, V65, P573, DOI 10.1136/ard.2005.041855; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Clancy R, 2001, OSTEOARTHR CARTILAGE, V9, P294, DOI 10.1053/joca.2000.0388; CRISTOFALO VJ, 1989, J GERONTOL, V44, P55, DOI 10.1093/geronj/44.6.55; dAvis PY, 1997, BIOCHEM J, V324, P753, DOI 10.1042/bj3240753; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Ezzat VA, 2008, DIABETES OBES METAB, V10, P198, DOI 10.1111/j.1463-1326.2007.00709.x; Fan Z, 2007, AM J PATHOL, V171, P938, DOI 10.2353/ajpath.2007.061083; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Henrotin YE, 2006, J RHEUMATOL, V33, P1668; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Loeser RF, 2003, J RHEUMATOL, V30, P1565; Loeser RF, 2002, ARTHRITIS RHEUM, V46, P2349, DOI 10.1002/art.10496; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; Martel-Pelletier J, 1998, INFLAMM RES, V47, P90, DOI 10.1007/s000110050288; Martin G, 2005, OSTEOARTHR CARTILAGE, V13, P915, DOI 10.1016/j.joca.2005.03.009; Martin JA, 1997, J ORTHOP RES, V15, P491, DOI 10.1002/jor.1100150403; Meng D, 2007, FREE RADICAL BIO MED, V42, P1651, DOI 10.1016/j.freeradbiomed.2007.01.037; Messai H, 2000, MECH AGEING DEV, V115, P21, DOI 10.1016/S0047-6374(00)00107-X; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; PASTERNACK RF, 1981, J INORG BIOCHEM, V15, P261, DOI 10.1016/S0162-0134(00)80161-0; Pelletier JP, 2003, ARTHRITIS RHEUM-US, V48, P1582, DOI 10.1002/art.11014; Phornphutkul C, 2004, J ENDOCRINOL, V183, P477, DOI 10.1677/joe.1.05873; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Regan E, 2005, ARTHRITIS RHEUM, V52, P3479, DOI 10.1002/art.21387; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Ruiz-Romero C, 2009, MOL CELL PROTEOMICS, V8, P172, DOI 10.1074/mcp.M800292-MCP200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sen M, 2004, ARTHRITIS RHEUM-US, V50, P488, DOI 10.1002/art.20005; Shah R, 2005, ARTHRITIS RHEUM-US, V52, P2799, DOI 10.1002/art.21239; Shimoaka T, 2004, J BIOL CHEM, V279, P15314, DOI 10.1074/jbc.M312525200; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; Tsuji M, 1996, FEBS LETT, V381, P222, DOI 10.1016/0014-5793(96)00118-4; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yagi R, 2005, J BIOL CHEM, V280, P30517, DOI 10.1074/jbc.M502751200; Yudoh K, 2005, ARTHRITIS RES THER, V7, pR380, DOI 10.1186/ar1499	61	123	133	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31972	31981		10.1074/jbc.M109.056838	http://dx.doi.org/10.1074/jbc.M109.056838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762915	Green Published, hybrid			2022-12-25	WOS:000271572700053
J	Mansouri, S; Choudhary, G; Sarzala, PM; Ratner, L; Hudak, KA				Mansouri, Sheila; Choudhary, Gunjan; Sarzala, Paulina M.; Ratner, Lee; Hudak, Katalin A.			Suppression of Human T-cell Leukemia Virus I Gene Expression by Pokeweed Antiviral Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; MOSAIC-VIRUS; PHYTOLACCA-AMERICANA; VIRAL-RNA; INHIBITION; TYPE-1; INFECTION; LYMPHOMA; DEPURINATION; TRANSLATION	Human T-cell leukemia virus I (HTLV-I) is a deltaretrovirus that is the causative agent of adult T-cell leukemia and the neurological disorder HTLV-I-associated myelopathy/tropical spastic paraparesis. Currently, no effective antiretroviral treatment options are available to restrict the development of diseases associated with the virus. In this work, we investigated the activity of pokeweed antiviral protein (PAP) on HTLV-I, when expressed from a proviral clone in 293T cells or in an HTLV-I immortalized cell line. PAP is a plant-derived N-glycosidase that exhibits antiviral activity against a number of viruses; however, its mode of action has not been clearly defined. Here, we describe the mechanism by which PAP inhibited production of HTLV-I. We show that PAP depurinated nucleotides within the gag open reading frame and suppressed the synthesis of viral proteins in part by decreasing the translational efficiency of HTLV-I gag/pol mRNA. Observed reduction in levels of viral mRNAs were not due to enhanced degradation; rather, decreased amounts of viral transactivator protein, Tax, led to feed-back inhibition of transcription from the viral promoter. Therefore, PAP efficiently suppressed HTLV-I gene expression at both translational and transcriptional levels, resulting in substantially diminished virus production. Significantly, no changes in viability or rates of cellular transcription or translation were observed in cells expressing PAP, indicating that this protein was not toxic. Antiviral activity, together with the absence of cytotoxicity, supports further investigation of this enzyme as a novel therapeutic agent against the progression of HTLV-I infection.	[Hudak, Katalin A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Choudhary, Gunjan; Ratner, Lee] Washington Univ, Dept Med, St Louis, MO 63110 USA	York University - Canada; Washington University (WUSTL)	Hudak, KA (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	hudak@yorku.ca		Ratner, Lee/0000-0003-2744-7294	National Institutes of Health Public Health Service Grants [CA94056, CA63417, CA10073, CA10521, CA109678]; Natural Sciences and Engineering Research Council of Canada; Premier's Research Excellence Award; NATIONAL CANCER INSTITUTE [R01CA063417, P50CA094056, R21CA109678] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Premier's Research Excellence Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grants CA94056, CA63417, CA10073, CA10521 and CA109678 (to L. R.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award (to K. A. H.).	Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Butsch M, 2000, J VIROL, V74, P11531, DOI 10.1128/JVI.74.24.11531-11537.2000; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; FOATOMASI L, 1982, ARCH VIROL, V71, P323, DOI 10.1007/BF01315062; Franchini G, 2003, ADV CANCER RES, V89, P69, DOI 10.1016/S0065-230X(03)01003-0; Gandhi R, 2008, J BIOL CHEM, V283, P32218, DOI 10.1074/jbc.M803785200; GESSAIN A, 1985, LANCET, V2, P407; GESSNER SL, 1980, J BIOL CHEM, V255, P3251; GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603; Grone M, 1996, VIROLOGY, V218, P316, DOI 10.1006/viro.1996.0200; Harris RS, 2003, NAT IMMUNOL, V4, P641, DOI 10.1038/ni0703-641; HIDAKA M, 1988, EMBO J, V7, P519, DOI 10.1002/j.1460-2075.1988.tb02840.x; HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173, DOI 10.1056/NEJM199304223281608; Hudak KA, 2000, RNA, V6, P369, DOI 10.1017/S1355838200991337; HUR Y, 1995, P NATL ACAD SCI USA, V92, P8448, DOI 10.1073/pnas.92.18.8448; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; IRVIN JD, 1975, ARCH BIOCHEM BIOPHYS, V169, P522, DOI 10.1016/0003-9861(75)90195-2; KIMATA JT, 1994, VIROLOGY, V204, P656, DOI 10.1006/viro.1994.1581; Machuca A, 2000, J ACQ IMMUN DEF SYND, V24, P189; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; Narayanan S, 2004, BIOCHEM J, V377, P233, DOI 10.1042/BJ20030797; NILSSON L, 1986, EUR J BIOCHEM, V161, P111, DOI 10.1111/j.1432-1033.1986.tb10130.x; Ohsugi T, 2007, J VIROL METHODS, V139, P93, DOI 10.1016/j.jviromet.2006.08.016; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; Ouyang DY, 2005, CELL MOL IMMUNOL, V2, P419; Picard D, 2005, J BIOL CHEM, V280, P20069, DOI 10.1074/jbc.M413452200; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; SODROSKI J, 1985, SCIENCE, V228, P1430, DOI 10.1126/science.2990028; STIRPE F, 1988, NUCLEIC ACIDS RES, V16, P1349, DOI 10.1093/nar/16.4.1349; TAJIMA K, 1990, INT J CANCER, V45, P237, DOI 10.1002/ijc.2910450206; TAKATSUKI K, 1985, CANCER RES, V45, P4644; Taylor GP, 2005, ONCOGENE, V24, P6047, DOI 10.1038/sj.onc.1208979; TAYLOR S, 1994, PLANT J, V5, P827, DOI 10.1046/j.1365-313X.1994.5060827.x; TOKUDOME S, 1989, CANCER RES, V49, P226; TOMLINSON JA, 1974, J GEN VIROL, V22, P225, DOI 10.1099/0022-1317-22-2-225; Tsukahara T, 2001, J VIROL, V75, P9553, DOI 10.1128/JVI.75.19.9553-9559.2001; Tumer NE, 1997, P NATL ACAD SCI USA, V94, P3866, DOI 10.1073/pnas.94.8.3866; Tung KWC, 2008, INT J BIOCHEM CELL B, V40, P2452, DOI 10.1016/j.biocel.2008.04.021; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Wagner E, 2002, J CELL SCI, V115, P3033; Wang P, 1999, NUCLEIC ACIDS RES, V27, P1900, DOI 10.1093/nar/27.8.1900; YAMAGUCHI K, 1993, CLIN HAEMATOL, V6, P899; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; ZARLING JM, 1990, NATURE, V347, P92, DOI 10.1038/347092a0; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	49	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31453	31462		10.1074/jbc.M109.046235	http://dx.doi.org/10.1074/jbc.M109.046235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748897	hybrid, Green Published			2022-12-25	WOS:000271378400070
J	Bhagat, M; Bhushan, C; Saha, G; Shimjo, S; Watanabe, K; Bhattacharya, J				Bhagat, Mayank; Bhushan, Chitresh; Saha, Goutam; Shimjo, Shinsuke; Watanabe, Katsumi; Bhattacharya, Joydeep			Investigating Neuromagnetic Brain Responses against Chromatic Flickering Stimuli by Wavelet Entropies	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NONLINEAR-ANALYSIS; EEG; EPILEPSY; PHOTOSENSITIVITY; MEG; LOCALIZATION; SEIZURES; SYSTEM	Background: Photosensitive epilepsy is a type of reflexive epilepsy triggered by various visual stimuli including colourful ones. Despite the ubiquitous presence of colorful displays, brain responses against different colour combinations are not properly studied. Methodology/Principal Findings: Here, we studied the photosensitivity of the human brain against three types of chromatic flickering stimuli by recording neuromagnetic brain responses (magnetoencephalogram, MEG) from nine adult controls, an unmedicated patient, a medicated patient, and two controls age-matched with patients. Dynamical complexities of MEG signals were investigated by a family of wavelet entropies. Wavelet entropy is a newly proposed measure to characterize large scale brain responses, which quantifies the degree of order/disorder associated with a multifrequency signal response. In particular, we found that as compared to the unmedicated patient, controls showed significantly larger wavelet entropy values. We also found that Renyi entropy is the most powerful feature for the participant classification. Finally, we also demonstrated the effect of combinational chromatic sensitivity on the underlying order/disorder in MEG signals. Conclusions/Significance: Our results suggest that when perturbed by potentially epileptic-triggering stimulus, healthy human brain manages to maintain a non-deterministic, possibly nonlinear state, with high degree of disorder, but an epileptic brain represents a highly ordered state which making it prone to hyper-excitation. Further, certain colour combination was found to be more threatening than other combinations.			Bhagat, M (corresponding author), Indian Inst Technol, Dept Elect Engn, Kharagpur 721302, W Bengal, India.	j.bhattacharya@gold.ac.uk	Saha, Goutam/AAH-6281-2020; Bhushan, Chitresh/AAG-3305-2020	Saha, Goutam/0000-0001-6187-1684; Bhushan, Chitresh/0000-0002-2935-2515; Watanabe, Katsumi/0000-0003-1282-9994				Abasolo D, 2005, CLIN NEUROPHYSIOL, V116, P1826, DOI 10.1016/j.clinph.2005.04.001; Anninos PA, 2000, BRAIN TOPOGR, V13, P135, DOI 10.1023/A:1026611219551; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P91, DOI 10.1016/S0167-8760(00)00135-5; Baumgartner C, 2004, CLIN NEUROPHYSIOL, V115, P1010, DOI 10.1016/j.clinph.2003.12.010; BELAIR J, 1995, CHAOS, V5, P1, DOI 10.1063/1.166069; Ben-Jacob E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051903; Bhattacharya J, 2004, INT J BIFURCAT CHAOS, V14, P2701, DOI 10.1142/S0218127404010850; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; Bhattacharya J, 2000, IEEE T BIO-MED ENG, V47, P738, DOI 10.1109/10.844222; Bracewell R, 1986, PENTAGRAM NOTATION C, V2nd, P192; COHEN D, 1983, ELECTROEN CLIN NEURO, V56, P38, DOI 10.1016/0013-4694(83)90005-6; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Doron I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258101; Drew P, 2001, EXP BRAIN RES, V136, P256, DOI 10.1007/s002210000605; Fernandez A, 2006, CLIN NEUROPHYSIOL, V117, P306, DOI 10.1016/j.clinph.2005.10.017; Harding G., 1994, PHOTOSENSITIVE EPILE; Harding GFA, 1998, NAT MED, V4, P265, DOI 10.1038/nm0398-265; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Inoue Y, 1999, EPILEPSIA, V40, P8, DOI 10.1111/j.1528-1157.1999.tb00900.x; Ishida S, 1998, EPILEPSIA, V39, P1340, DOI 10.1111/j.1528-1157.1998.tb01334.x; KAWABATA N, 1973, IEEE T BIO-MED ENG, VBM20, P444, DOI 10.1109/TBME.1973.324218; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Nagarajan L, 2003, PEDIATR NEUROL, V29, P222, DOI 10.1016/S0887-8994(03)00207-8; NEWMARK ME, 1979, PHOTOSENSITIVITY EPI; Nishifuji S, 2003, SICE 2003 ANNUAL CONFERENCE, VOLS 1-3, P2438; Parra J, 2003, BRAIN, V126, P1164, DOI 10.1093/brain/awg109; Porciatti V, 2000, NAT NEUROSCI, V3, P259, DOI 10.1038/72972; Quiroga RQ, 2001, BIOL CYBERN, V84, P291, DOI 10.1007/s004220000212; Rosso OA, 2006, J NEUROSCI METH, V153, P163, DOI 10.1016/j.jneumeth.2005.10.009; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Rosso OA, 2007, INT J PSYCHOPHYSIOL, V64, P75, DOI 10.1016/j.ijpsycho.2006.07.010; Rubboli G, 2004, EPILEPSIA, V45, P35, DOI 10.1111/j.0013-9580.2004.451002.x; Samar VJ, 1999, BRAIN LANG, V66, P7, DOI 10.1006/brln.1998.2024; Senhadji L, 2002, NEUROPHYSIOL CLIN, V32, P175, DOI 10.1016/S0987-7053(02)00304-0; Stam CJ, 1997, BIOL CYBERN, V77, P247, DOI 10.1007/s004220050385; TAKAHASHI T, 1976, ELECTROEN CLIN NEURO, V41, P124, DOI 10.1016/0013-4694(76)90040-7; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tobimatsu S, 1999, ANN NEUROL, V45, P790, DOI 10.1002/1531-8249(199906)45:6<790::AID-ANA14>3.0.CO;2-7; TRENITE DGA, 1989, PHOTOSENSITIVITY EPI; Trenite DGAKN, 2001, EPILEPSIA, V42, P692, DOI 10.1046/j.1528-1157.2001.30600.x; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Vandenhouten R, 2000, IEEE T BIO-MED ENG, V47, P729, DOI 10.1109/10.844220; Vermeulen J, 2008, CLIN NEUROPHYSIOL, V119, P842, DOI 10.1016/j.clinph.2007.11.177; Verrotti A, 2004, J CHILD NEUROL, V19, P571, DOI 10.1177/088307380401900802; Verrotti A, 2004, DEV MED CHILD NEUROL, V46, P347, DOI 10.1017/S0012162204000568; Walker AE, 1944, ARCH NEURO PSYCHIATR, V52, P117, DOI 10.1001/archneurpsyc.1944.02290320032004; Watanabe K, 2002, NEUROREPORT, V13, P2161, DOI 10.1097/00001756-200211150-00034; Wheless JW, 1999, EPILEPSIA, V40, P931, DOI 10.1111/j.1528-1157.1999.tb00800.x; Yasuda K, 2000, NEUROREPORT, V11, P203, DOI 10.1097/00001756-200001170-00040; Zifkin BG, 2000, EPILEPTIC DISORD, V2, P129	52	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7173	10.1371/journal.pone.0007173	http://dx.doi.org/10.1371/journal.pone.0007173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779630	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000270176200014
J	de Oca, RM; Shoemaker, CJ; Gucek, M; Cole, RN; Wilson, KL				de Oca, Rocio Montes; Shoemaker, Christopher J.; Gucek, Marjan; Cole, Robert N.; Wilson, Katherine L.			Barrier-to-Autointegration Factor Proteome Reveals Chromatin-Regulatory Partners	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PC4; IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOTIDE EXCISION-REPAIR; LEM-DOMAIN PROTEINS; DNA-BINDING; HISTONE H3; FACTOR BAF; NUCLEAR-ENVELOPE; S-PHASE; POLY(ADP-RIBOSE) POLYMERASE-1	Nuclear lamin filaments and associated proteins form a nucleoskeletal ("lamina'') network required for transcription, replication, chromatin organization and epigenetic regulation in metazoans. Lamina defects cause human disease ("laminopathies'') and are linked to aging. Barrier-to-autointegration factor (BAF) is a mobile and essential component of the nuclear lamina that binds directly to histones, lamins and LEM-domain proteins, including the inner nuclear membrane protein emerin, and has roles in chromatin structure, mitosis and gene regulation. To understand BAF's mechanisms of action, BAF associated proteins were affinity-purified from HeLa cell nuclear lysates using BAF-conjugated beads, and identified by tandem mass spectrometry or independently identified and quantified using the iTRAQ method. We recovered A- and B-type lamins and core histones, all known to bind BAF directly, plus four human transcription factors ( Requiem, NonO, p15, LEDGF), disease-linked proteins (e.g., Huntingtin, Treacle) and several proteins and enzymes that regulate chromatin. Association with endogenous BAF was independently validated by co-immunoprecipitation from HeLa cells for seven candidates including Requiem, poly(ADP-ribose) polymerase 1 (PARP1), retinoblastoma binding protein 4 (RBBP4), damage-specific DNA binding protein 1 (DDB1) and DDB2. Interestingly, endogenous BAF and emerin each associated with DDB2 and CUL4A in a UV- and time-dependent manner, suggesting BAF and emerin have dynamic roles in genome integrity and might help couple DNA damage responses to the nuclear lamina network. We conclude this proteome is a rich source of candidate partners for BAF and potentially also A- and B-type lamins, which may reveal how chromatin regulation and genome integrity are linked to nuclear structure.			de Oca, RM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	klwilson@jhmi.edu	Wilson, Katherine/HII-8144-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048646] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM48646, R01 GM048646] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Batta K, 2009, J MOL BIOL, V385, P788, DOI 10.1016/j.jmb.2008.11.008; Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Amours D, 2001, J CELL SCI, V114, P3771; Dai QA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-14; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; de Oca ROM, 2005, J BIOL CHEM, V280, P42252, DOI 10.1074/jbc.M509917200; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; Harris D, 2000, J BIOL CHEM, V275, P39671, DOI 10.1074/jbc.M002626200; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Ito T, 2008, BIOCHEM J, V411, P201, DOI 10.1042/BJ20071075; Jacob KN, 2006, MOL GENET METAB, V87, P289, DOI 10.1016/j.ymgme.2005.10.018; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jacque JM, 2006, NATURE, V441, P641, DOI 10.1038/nature04682; Joselin AP, 2006, J BIOL CHEM, V281, P12475, DOI 10.1074/jbc.M509859200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kishore AH, 2007, BIOCHEM J, V406, P437, DOI 10.1042/BJ20070390; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mansharamani M, 2003, J VIROL, V77, P13084, DOI 10.1128/JVI.77.24.13084-13092.2003; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, J CELL BIOL, V178, P661, DOI 10.1083/jcb.200704049; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mortusewicz O, 2008, J CELL BIOL, V183, P769, DOI 10.1083/jcb.200808097; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Mulky A, 2008, J VIROL, V82, P5860, DOI 10.1128/JVI.00076-08; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; Ramirez CL, 2007, CELL MOL LIFE SCI, V64, P155, DOI 10.1007/s00018-006-6349-3; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Ridgway P, 2000, J CELL SCI, V113, P2647; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Shumaker DK, 2001, EMBO J, V20, P1754, DOI 10.1093/emboj/20.7.1754; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Sridharan D, 2003, J CELL SCI, V116, P823, DOI 10.1242/jcs.00294; Sridharan DM, 2006, CELL BIOL INT, V30, P866, DOI 10.1016/j.cellbi.2006.06.005; Stiff T, 2008, HUM MOL GENET, V17, P3247, DOI 10.1093/hmg/ddn220; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vidakovic M, 2004, J CELL BIOCHEM, V93, P1155, DOI 10.1002/jcb.20289; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang XJ, 2002, J BIOL CHEM, V277, P43288, DOI 10.1074/jbc.M207952200; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Wong DCF, 2006, BIOTECHNOL BIOENG, V95, P350, DOI 10.1002/bit.20871; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang J, 1998, J PORPHYR PHTHALOCYA, V2, P93, DOI 10.1002/(SICI)1099-1409(199803/04)2:2<93::AID-JPP81>3.3.CO;2-O; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	97	74	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7050	10.1371/journal.pone.0007050	http://dx.doi.org/10.1371/journal.pone.0007050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19759913	gold, Green Published, Green Submitted			2022-12-25	WOS:000269970000017
J	Si, Y; Shi, H; Lee, K				Si, Yaguang; Shi, Hai; Lee, Kyongbum			Metabolic Flux Analysis of Mitochondrial Uncoupling in 3T3-L1 Adipocytes	PLOS ONE			English	Article								Background: Increasing energy expenditure at the cellular level offers an attractive option to limit adiposity and improve whole body energy balance. In vivo and in vitro observations have correlated mitochondrial uncoupling protein-1 (UCP1) expression with reduced white adipose tissue triglyceride (TG) content. The metabolic basis for this correlation remains unclear. Methodology/Principal Findings: This study tested the hypothesis that mitochondrial uncoupling requires the cell to compensate for the decreased oxidation phosphorylation efficiency by up-regulating lactate production, thus redirecting carbon flux away from TG synthesis. Metabolic flux analysis was used to characterize the effects of non-lethal, long-term mitochondrial uncoupling (up to 18 days) on the pathways of intermediary metabolism in differentiating 3T3-L1 adipocytes. Uncoupling was induced by forced expression of UCP1 and chemical (FCCP) treatment. Chemical uncoupling significantly decreased TG content by ca. 35%. A reduction in the ATP level suggested diminished oxidative phosphorylation efficiency in the uncoupled adipocytes. Flux analysis estimated significant up-regulation of glycolysis and down-regulation of fatty acid synthesis, with chemical uncoupling exerting quantitatively larger effects. Conclusions/Significance: The results of this study support our hypothesis regarding uncoupling-induced redirection of carbon flux into glycolysis and lactate production, and suggest mitochondrial proton translocation as a potential target for controlling adipocyte lipid metabolism.			Si, Y (corresponding author), Boston Univ, Sch Med, Obes Res Ctr, Boston, MA 02118 USA.	kyongbum.lee@tufts.edu	Shi, Hai/K-6254-2012	Lee, Kyongbum/0000-0002-0699-8057	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067228] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK67228-01, R21 DK067228] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baumruk F, 1999, FEBS LETT, V444, P206, DOI 10.1016/S0014-5793(99)00053-8; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; COHEN SA, 1994, J CHROMATOGR A, V661, P25, DOI 10.1016/0021-9673(93)E0821-B; CUNNINGHAM SA, 1986, EUR J BIOCHEM, V157, P415, DOI 10.1111/j.1432-1033.1986.tb09683.x; FABREGAT I, 1987, MOL CELL BIOCHEM, V74, P77; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HAUNER H, 2001, ADIPOSE TISSUE PROTO, V13, P334; Hvizdos KM, 1999, DRUGS, V58, P743, DOI 10.2165/00003495-199958040-00015; KATZ J, 1966, J BIOL CHEM, V241, P3600; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; KLAUS S, 1995, J CELL SCI, V108, P3171; Kopecky J, 2004, PHYSIOL RES, V53, pS225; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; LOOMIS ME, 1961, J LAB CLIN MED, V57, P966; MITROU P, 2008, RATES GLUCOSE UPTAKE; NICHOLLS JG, 1984, RES MOTIVATION ED ST, V1, P64; NIEMINEN AL, 1994, AM J PHYSIOL, V267, pC67, DOI 10.1152/ajpcell.1994.267.1.C67; Nolan RP, 2006, METAB ENG, V8, P30, DOI 10.1016/j.ymben.2005.08.004; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; Park J, 2007, DIABETES RES CLIN PR, V77, pS11, DOI 10.1016/j.diabres.2007.01.037; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rossmeisl M, 2000, FASEB J, V14, P1793, DOI 10.1096/fj.99-0965com; Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x; Si YG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1637, DOI 10.1152/ajpendo.00670.2006; Si YG, 2007, J LIPID RES, V48, P826, DOI 10.1194/jlr.M600343-JLR200; SNYDER JW, 1993, AM J PHYSIOL, V264, pC709, DOI 10.1152/ajpcell.1993.264.3.C709; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sun XC, 2003, J NUTR BIOCHEM, V14, P219, DOI 10.1016/S0955-2863(03)00004-4; Tejerina S, 2009, J CELL SCI, V122, P145, DOI 10.1242/jcs.027508; TERADA H, 1981, BIOCHIM BIOPHYS ACTA, V639, P225, DOI 10.1016/0304-4173(81)90011-2; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; Van Gaal LF, 1998, EXP CLIN ENDOCR DIAB, V106, P35, DOI 10.1055/s-0029-1212035; Wang T, 2003, OBES RES, V11, P880, DOI 10.1038/oby.2003.121; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	43	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e7000	10.1371/journal.pone.0007000	http://dx.doi.org/10.1371/journal.pone.0007000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746157	Green Published, Green Submitted, gold			2022-12-25	WOS:000269696500010
J	Tanaka, H; Yi, TM				Tanaka, Hiromasa; Yi, Tau-Mu			Synthetic Morphology Using Alternative Inputs	PLOS ONE			English	Article								Designing the shape and size of a cell is an interesting challenge for synthetic biology. Prolonged exposure to the mating pheromone alpha-factor induces an unusual morphology in yeast cells: multiple mating projections. The goal of this work was to reproduce the multiple projections phenotype in the absence of alpha-factor using a gain-of-function approach termed "Alternative Inputs (AIs)''. An alternative input is defined as any genetic manipulation that can activate the signaling pathway instead of the natural input. Interestingly, none of the alternative inputs were sufficient to produce multiple projections although some produced a single projection. Then, we extended our search by creating all combinations of alternative inputs and deletions that were summarized in an AIs-Deletions matrix. We found a genetic manipulation (AI-Ste5p ste2 Delta) that enhanced the formation of multiple projections. Following up this lead, we demonstrated that AI-Ste4p and AI-Ste5p were sufficient to produce multiple projections when combined. Further, we showed that overexpression of a membrane-targeted form of Ste5p alone could also induce multiple projections. Thus, we successfully re-engineered the multiple projections mating morphology using alternative inputs without alpha-factor.			Tanaka, H (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	tmy@uci.edu			NIGMS NIH HHS [R01GM75309, R01 GM075309, P50 GM076516] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075309, P50GM076516] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1991, Methods Enzymol, V194, P1; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bharucha JP, 2008, EUKARYOT CELL, V7, P1246, DOI 10.1128/EC.00024-08; Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; BUCKINGTHROM E, 1973, EXP CELL RES, V76, P99, DOI 10.1016/0014-4827(73)90424-2; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHENEVERT J, 1994, GENETICS, V136, P1287; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; Elion EA, 2001, J CELL SCI, V114, P3967; Giot L, 1997, MOL BIOL CELL, V8, P987, DOI 10.1091/mbc.8.6.987; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; Kroll ES, 1996, GENETICS, V143, P95; KURJAN J, 1985, MOL CELL BIOL, V5, P787, DOI 10.1128/MCB.5.4.787; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; MOORE SA, 1983, J BIOL CHEM, V258, P3849; Moore TI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003865; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Wang YM, 2005, J BIOL CHEM, V280, P13084, DOI 10.1074/jbc.M410461200; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yeh BJ, 2007, NAT CHEM BIOL, V3, P521, DOI 10.1038/nchembio0907-521; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6946	10.1371/journal.pone.0006946	http://dx.doi.org/10.1371/journal.pone.0006946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746161	gold, Green Published			2022-12-25	WOS:000269696500002
J	Jaramillo, M; Bellemare, MJ; Martel, C; Shio, MT; Contreras, AP; Godbout, M; Roger, M; Gaudreault, E; Gosselin, J; Bohle, DS; Olivier, M				Jaramillo, Maritza; Bellemare, Marie-Josee; Martel, Caroline; Shio, Marina Tiemi; Contreras, Ana Paulina; Godbout, Marianne; Roger, Michel; Gaudreault, Eric; Gosselin, Jean; Bohle, D. Scott; Olivier, Martin			Synthetic Plasmodium-Like Hemozoin Activates the Immune Response: A Morphology - Function Study	PLOS ONE			English	Article								Increasing evidence points to an important role for hemozoin (HZ), the malaria pigment, in the immunopathology related to this infection. However, there is no consensus as to whether HZ exerts its immunostimulatory activity in absence of other parasite or host components. Contamination of native HZ preparations and the lack of a unified protocol to produce crystals that mimic those of Plasmodium HZ (PHZ) are major technical limitants when performing functional studies with HZ. In fact, the most commonly used methods generate a heterogeneous nanocrystalline material. Thus, it is likely that such aggregates do not resemble to PHZ and differ in their inflammatory properties. To address this issue, the present study was designed to establish whether synthetic HZ (sHZ) crystals produced by different methods vary in their morphology and in their ability to activate immune responses. We report a new method of HZ synthesis (the precise aqueous acid-catalyzed method) that yields homogeneous sHZ crystals (Plasmodium-like HZ) which are very similar to PHZ in their size and physicochemical properties. Importantly, these crystals are devoid of protein and DNA contamination. Of interest, structure-function studies revealed that the size and shape of the synthetic crystals influences their ability to activate inflammatory responses (e. g. nitric oxide, chemokine and cytokine mRNA) in vitro and in vivo. In summary, our data confirm that sHZ possesses immunostimulatory properties and underline the importance of verifying by electron microscopy both the morphology and homogeneity of the synthetic crystals to ensure that they closely resemble those of the parasite. Periodic quality control experiments and unification of the method of HZ synthesis are key steps to unravel the role of HZ in malaria immunopathology.			Jaramillo, M (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Med,Ctr Study Host Res, Montreal, PQ, Canada.	martin.olivier@mcgill.ca	Jaramillo, Maritza/T-7467-2019; Shio, Marina Tiemi/E-6466-2019	Jaramillo, Maritza/0000-0002-1910-5684; Shio, Marina Tiemi/0000-0002-2494-6816				Amodu OK, 1998, T ROY SOC TROP MED H, V92, P54, DOI 10.1016/S0035-9203(98)90952-X; ASHONG JO, 1989, T ROY SOC TROP MED H, V83, P167, DOI 10.1016/0035-9203(89)90631-7; Biswas S, 2001, FEMS MICROBIOL LETT, V194, P175, DOI 10.1111/j.1574-6968.2001.tb09465.x; Bohle D. S., 1994, INORGANIC ORGANOMETA, P497; Bohle DS, 1997, J BIOL CHEM, V272, P713, DOI 10.1074/jbc.272.2.713; Bohle DS, 2002, ACTA CRYSTALLOGR D, V58, P1752, DOI 10.1107/S0907444902014294; Bose M, 1995, IMMUNOL LETT, V48, P59, DOI 10.1016/0165-2478(95)02444-1; BURGMANN H, 1995, CLIN IMMUNOL IMMUNOP, V76, P32, DOI 10.1006/clin.1995.1084; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; EDINGTON GM, 1967, BMJ-BRIT MED J, V1, P715, DOI 10.1136/bmj.1.5542.715; Egan TJ, 2008, J INORG BIOCHEM, V102, P1288, DOI 10.1016/j.jinorgbio.2007.12.004; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; GOLDIE P, 1990, AM J TROP MED HYG, V43, P584, DOI 10.4269/ajtmh.1990.43.584; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Keller CC, 2004, INFECT IMMUN, V72, P4868, DOI 10.1128/IAI.72.8.4868-4873.2004; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Martiney JA, 2000, INFECT IMMUN, V68, P2259, DOI 10.1128/IAI.68.4.2259-2267.2000; Mordmuller B, 1998, EUR CYTOKINE NETW, V9, P239; Newton CRJC, 1998, AM J TROP MED HYG, V58, P673, DOI 10.4269/ajtmh.1998.58.673; NEWTON CRJC, 1991, LANCET, V337, P573, DOI 10.1016/0140-6736(91)91638-B; Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4; NUSSLER AK, 1994, J INFECT DIS, V169, P1418, DOI 10.1093/infdis/169.6.1418; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PHU NH, 1995, T ROY SOC TROP MED H, V89, P200, DOI 10.1016/0035-9203(95)90496-4; PICHYANGKUL S, 1994, AM J TROP MED HYG, V51, P430, DOI 10.4269/ajtmh.1994.51.430; Pichyangkul S, 1997, AM J TROP MED HYG, V57, P383, DOI 10.4269/ajtmh.1997.57.383; PRADA J, 1995, EUR CYTOKINE NETW, V6, P109; RADZIOCH D, 1991, J LEUKOCYTE BIOL, V50, P263, DOI 10.1002/jlb.50.3.263; ROCKETT KA, 1994, PARASITE IMMUNOL, V16, P243, DOI 10.1111/j.1365-3024.1994.tb00346.x; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Rudin W, 1997, EUR J IMMUNOL, V27, P810, DOI 10.1002/eji.1830270403; Scorza T, 2005, INFECT IMMUN, V73, P2974, DOI 10.1128/IAI.73.5.2974-2985.2005; SHERRY BA, 1995, J INFLAMM, V45, P85; SHIO MT, 2009, PLOS PATHOG IN PRESS; Skorokhod OA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-73; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Solomonov I, 2007, J AM CHEM SOC, V129, P2615, DOI 10.1021/ja0674183; Sullivan AD, 1996, PARASITOLOGY, V112, P285, DOI 10.1017/S003118200006580X; URQUHART AD, 1994, CLIN INFECT DIS, V19, P117, DOI 10.1093/clinids/19.1.117; WEINBERG JB, 1995, BLOOD, V86, P1184; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; YAMADA KA, 1979, EXP PARASITOL, V48, P61, DOI 10.1016/0014-4894(79)90055-9	50	60	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6957	10.1371/journal.pone.0006957	http://dx.doi.org/10.1371/journal.pone.0006957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742308	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622500018
J	Lacraz, G; Giroix, MH; Kassis, N; Coulaud, J; Galinier, A; Noll, C; Cornut, M; Schmidlin, F; Paul, JL; Janel, N; Irminger, JC; Kergoat, M; Portha, B; Donath, MY; Ehses, JA; Homo-Delarche, F				Lacraz, Gregory; Giroix, Marie-Helene; Kassis, Nadim; Coulaud, Josiane; Galinier, Anne; Noll, Christophe; Cornut, Melanie; Schmidlin, Fabien; Paul, Jean-Louis; Janel, Nathalie; Irminger, Jean-Claude; Kergoat, Micheline; Portha, Bernard; Donath, Marc Y.; Ehses, Jan A.; Homo-Delarche, Francoise			Islet Endothelial Activation and Oxidative Stress Gene Expression Is Reduced by IL-1Ra Treatment in the Type 2 Diabetic GK Rat	PLOS ONE			English	Article							GOTO-KAKIZAKI RAT; INTERLEUKIN-1 RECEPTOR ANTAGONIST; NITRIC-OXIDE SYNTHASE; RENIN-ANGIOTENSIN SYSTEM; NECROSIS-FACTOR-ALPHA; BETA-CELL MASS; PANCREATIC-ISLETS; HEME OXYGENASE-1; CARDIOVASCULAR-DISEASE; NADPH OXIDASE	Background: Inflammation followed by fibrosis is a component of islet dysfunction in both rodent and human type 2 diabetes. Because islet inflammation may originate from endothelial cells, we assessed the expression of selected genes involved in endothelial cell activation in islets from a spontaneous model of type 2 diabetes, the Goto-Kakizaki (GK) rat. We also examined islet endotheliuml/oxidative stress (OS)/inflammation-related gene expression, islet vascularization and fibrosis after treatment with the interleukin-1 (IL-1) receptor antagonist (IL-1Ra). Methodology/Principal Findings: Gene expression was analyzed by quantitative RT-PCR on islets isolated from 10-week-old diabetic GK and control Wistar rats. Furthermore, GK rats were treated s.c twice daily with IL-1Ra (Kineret, Amgen, 100 mg/kg/day) or saline, from 4 weeks of age onwards (onset of diabetes). Four weeks later, islet gene analysis and pancreas immunochemistry were performed. Thirty-two genes were selected encoding molecules involved in endothelial cell activation, particularly fibrinolysis, vascular tone, OS, angiogenesis and also inflammation. All genes except those encoding angiotensinogen and epoxide hydrolase (that were decreased), and 12-lipoxygenase and vascular endothelial growth factor (that showed no change), were significantly up-regulated in GK islets. After IL-1Ra treatment of GK rats in vivo, most selected genes implied in endothelium/OS/immune cells/fibrosis were significantly down-regulated. IL-1Ra also improved islet vascularization, reduced fibrosis and ameliorated glycemia. Conclusions/Significance: GK rat islets have increased mRNA expression of markers of early islet endothelial cell activation, possibly triggered by several metabolic factors, and also some defense mechanisms. The beneficial effect of IL-1Ra on most islet endothelial/OS/immune cells/fibrosis parameters analyzed highlights a major endothelial-related role for IL-1 in GK islet alterations. Thus, metabolically-altered islet endothelium might affect the beta-cell microenvironment and contribute to progressive type 2 diabetic beta-cell dysfunction in GK rats. Counteracting islet endothelial cell inflammation might be one way to ameliorate/prevent beta-cell dysfunction in type 2 diabetes.			Lacraz, G (corresponding author), Univ Paris Diderot, CNRS, Lab Biol & Pathol Endocrine Pancreas, Funct & Adapt Biol Unit,EA 7059, Paris, France.	francoise.homo-delarche@paris7.jussieu.fr	paul, jean-louis/D-8071-2017; Portha, Bernard/AAW-3021-2021; Ehses, Jan/AAK-1635-2020	Galinier, Anne/0000-0003-2454-5681; Ehses, Jan/0000-0001-9066-7607; Janel, Nathalie/0000-0002-4746-8941				Adams B, 2007, TRENDS CARDIOVAS MED, V17, P246, DOI 10.1016/j.tcm.2007.08.005; Ahmed FN, 2006, ANN NY ACAD SCI, V1084, P481, DOI 10.1196/annals.1372.022; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Apostolakis Stavros, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P150, DOI 10.2174/187152508783955006; Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Becker T, 2007, TRANSPLANTATION, V84, P1644, DOI 10.1097/01.tp.0000290233.81395.81; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beltowski J, 2003, ATHEROSCLEROSIS, V170, P21, DOI 10.1016/S0021-9150(03)00236-3; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Bitar MS, 2005, EUR J PHARMACOL, V511, P53, DOI 10.1016/j.ejphar.2005.01.014; Borjesson A, 2007, J ENDOCRINOL, V192, P381, DOI 10.1677/joe.1.06676; Brigelius-Flohe R, 2004, ARCH BIOCHEM BIOPHYS, V423, P66, DOI 10.1016/j.abb.2003.12.008; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Calderari S, 2007, DIABETOLOGIA, V50, P1463, DOI 10.1007/s00125-007-0676-2; Calles-Escandon J, 2001, ENDOCR REV, V22, P36, DOI 10.1210/er.22.1.36; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chen P, 2007, AM J PHYSIOL-REG I, V293, pR1619, DOI 10.1152/ajpregu.00290.2007; Cheng ZJ, 2001, HYPERTENSION, V37, P433, DOI 10.1161/01.HYP.37.2.433; Clark A, 2004, DIABETOLOGIA, V47, P157, DOI 10.1007/s00125-003-1304-4; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Dammanahalli KJ, 2008, CLIN EXP PHARMACOL P, V35, P2, DOI 10.1111/j.1440-1681.2007.04830.x; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DEJANA E, 1987, BLOOD, V69, P695; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Ding H, 2007, EUR J PHARMACOL, V561, P121, DOI 10.1016/j.ejphar.2006.12.034; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Ehses Jan A., 2007, Current Immunology Reviews, V3, P216; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fadini GP, 2008, DIABETOLOGIA, V51, P1091, DOI 10.1007/s00125-008-1021-0; FORTIN LJ, 1995, CLIN BIOCHEM, V28, P155, DOI 10.1016/0009-9120(94)00073-5; Fujita H, 2007, BIOCHEM BIOPH RES CO, V363, P37, DOI 10.1016/j.bbrc.2007.08.090; Galinier A, 2006, FEBS LETT, V580, P6391, DOI 10.1016/j.febslet.2006.10.052; GIROIX MH, 1993, ENDOCRINOLOGY, V132, P815, DOI 10.1210/en.132.2.815; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Haddad JJ, 2005, MOL IMMUNOL, V42, P987, DOI 10.1016/j.molimm.2004.09.029; Hamelet J, 2007, EUR J CLIN INVEST, V37, P933, DOI 10.1111/j.1365-2362.2007.01879.x; Harris AK, 2005, DIABETES, V54, P2638, DOI 10.2337/diabetes.54.9.2638; Hayashi T, 2007, BBA-MOL BASIS DIS, V1772, P364, DOI 10.1016/j.bbadis.2006.11.011; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P891, DOI 10.1089/ars.2007.1610; HELSET E, 1993, MEDIAT INFLAMM, V2, P417, DOI 10.1155/S0962935193000596; HIBBS JB, 1992, J CLIN INVEST, V89, P867, DOI 10.1172/JCI115666; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Hodroj W, 2007, ARTERIOSCL THROM VAS, V27, P525, DOI 10.1161/01.ATV.0000254814.63768.3b; Holven KB, 2008, J NUTR, V138, P2070, DOI 10.3945/jn.108.090704; Homo-Delarche F, 2008, DIABETOLOGIA, V51, pS308; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Iglarz M, 2007, J CARDIOVASC PHARM, V50, P621, DOI 10.1097/FJC.0b013e31813c6cc3; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Jia XX, 2007, MOL PHARM, V4, P199, DOI 10.1021/mp060091s; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Kamide K, 2004, J HYPERTENS, V22, P121, DOI 10.1097/00004872-200401000-00021; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim JW, 2008, FRONT BIOSCI-LANDMRK, V13, P6022, DOI 10.2741/3133; Kimura I, 1998, IMMUNOPHARMACOLOGY, V40, P105, DOI 10.1016/S0162-3109(98)00024-1; Ko SH, 2004, BIOCHEM BIOPH RES CO, V316, P114, DOI 10.1016/j.bbrc.2004.02.023; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lacraz G, 2007, DIABETOLOGIA, V50, pS177; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006500; Lai EY, 2007, AM J PHYSIOL-ENDOC M, V292, pE1616, DOI 10.1152/ajpendo.00640.2006; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Larsen BT, 2007, TRENDS PHARMACOL SCI, V28, P32, DOI 10.1016/j.tips.2006.11.002; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Lentz SR, 2001, ARTERIOSCL THROM VAS, V21, P1385; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Linton MF, 2004, CURR OPIN PHARMACOL, V4, P116, DOI 10.1016/j.coph.2003.12.003; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; Mantovani A, 1997, IMMUNOL TODAY, V18, P231, DOI 10.1016/S0167-5699(97)81662-3; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Marculescu R, 2002, DIABETES, V51, P3582, DOI 10.2337/diabetes.51.12.3582; Masuyama T, 2004, BIOCHEM BIOPH RES CO, V314, P870, DOI 10.1016/j.bbrc.2003.12.180; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Nakamura M, 1995, DIABETES RES CLIN PR, V30, P89, DOI 10.1016/0168-8227(95)01155-2; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Oak JH, 2007, DIABETES, V56, P118, DOI 10.2337/db06-0288; OLEARCZYK JJ, 2008, CLIN SCI LOND; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; RISTIMAKI A, 1992, PROSTAG LEUKOTR ESS, V47, P93, DOI 10.1016/0952-3278(92)90143-7; Rojas A, 2006, ARCH MED RES, V37, P436, DOI 10.1016/j.arcmed.2005.11.012; Rozenberg O, 2008, FREE RADICAL BIO MED, V44, P1951, DOI 10.1016/j.freeradbiomed.2008.02.012; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sacerdoti D, 2005, CELL MOL BIOL, V51, P363, DOI 10.1170/T639; Sachidanandam K, 2007, DIABETES, V56, P2753, DOI 10.2337/db07-0426; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Sena CM, 2008, NUTR RES, V28, P113, DOI 10.1016/j.nutres.2007.12.005; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shao JQ, 2006, BIOCHEM BIOPH RES CO, V344, P1224, DOI 10.1016/j.bbrc.2006.04.011; Sharma M, 2007, EUR J PHARMACOL, V574, P49, DOI 10.1016/j.ejphar.2007.07.022; Shinohara M, 2004, EXP DIABESITY RES, V5, P253, DOI 10.1080/15438600490898609; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Svensson AM, 2005, J ENDOCRINOL, V184, P319, DOI 10.1677/joe.1.05676; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Terry CM, 1998, AM J PHYSIOL-HEART C, V274, pH883, DOI 10.1152/ajpheart.1998.274.3.H883; Tran POT, 2004, J BIOL CHEM, V279, P53988, DOI 10.1074/jbc.M404809200; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; VANMINKELEN R, 2008, ATHEROSCLEROSIS; Vink A, 2004, CURR OPIN LIPIDOL, V15, P515, DOI 10.1097/00041433-200410000-00004; Von Dobschuetz E, 2008, PANCREAS, V36, P377, DOI 10.1097/MPA.0b013e31815ceb0e; Wadt KAW, 1998, DIABETES, V47, P1602, DOI 10.2337/diabetes.47.10.1602; Wallis RH, 2004, DIABETOLOGIA, V47, P1096, DOI 10.1007/s00125-004-1416-5; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	135	53	59	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6963	10.1371/journal.pone.0006963	http://dx.doi.org/10.1371/journal.pone.0006963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742300	gold, Green Submitted, Green Published			2022-12-25	WOS:000269622500023
J	Heinick, A; Urban, K; Roth, S; Spies, D; Nunes, F; Phanstiel, O; Liebau, E; Luersen, K				Heinick, Alexander; Urban, Katja; Roth, Stefan; Spies, Danica; Nunes, Frank; Phanstiel, Otto, IV; Liebau, Eva; Lueersen, Kai			Caenorhabditis elegans P-5B-type ATPase CATP-5 operates in polyamine transport and is crucial for norspermidine-mediated suppression of RNA interference	FASEB JOURNAL			English	Article						S-adenosylmethionine decarboxylase; body size; life span; ornithine decarboxylase; spermidine	ORNITHINE-DECARBOXYLASE GENE; PROTEIN-KINASE; C-ELEGANS; CLONING; SPERMIDINE; MECHANISM; CELLS	Physiological polyamines are required in various biological processes. In the current study, we used norspermidine, a structural analog of the natural polyamine spermidine, to investigate polyamine uptake in the model organism Caenorhabditis elegans. Norspermidine was found to have two remarkable effects: it is toxic for the nematode, without affecting its food, Escherichia coli; and it hampers RNA interference. By characterizing a norspermidine-resistant C. elegans mutant strain that has been isolated in a genetic screen, we demonstrate that both effects, as well as the uptake of a fluorescent polyamine-conjugate, depend on the transporter protein CATP-5, a novel P-5B-type ATPase. To our knowledge, CATP-5 represents the first P-5-type ATPase that is associated with the plasma membrane, being expressed in the apical membrane of intestinal cells and the excretory cell. Moreover, genetic interaction studies using C. elegans polyamine synthesis mutants indicate that CATP-5 has a function redundant to polyamine synthesis and link reduced polyamine levels to retarded postembryonic development, reduced brood size, shortened life span, and small body size. We suggest that CATP-5 represents a crucial component of the pharmacologically important polyamine transport system, the molecular nature of which has not been identified so far in metazoa.-Heinick, A., Urban, K., Roth, S., Spies, D., Nunes, F., Phanstiel IV, O., Liebau, E., Luersen, K. Caenorhabditis elegans P-5B-type ATPase CATP-5 operates in polyamine transport and is crucial for norspermidine-mediated suppression of RNA interference. FASEB J. 24, 206-217 (2010). www.fasebj.org	[Heinick, Alexander; Urban, Katja; Roth, Stefan; Spies, Danica; Liebau, Eva; Lueersen, Kai] Univ Munster, Inst Anim Physiol, D-48143 Munster, Germany; [Nunes, Frank] Univ Munster, Inst Pharmacol & Toxicol, D-48143 Munster, Germany; [Phanstiel, Otto, IV] Univ Cent Florida, Coll Med, Dept Med Educ, Orlando, FL 32816 USA	University of Munster; University of Munster; State University System of Florida; University of Central Florida	Luersen, K (corresponding author), Univ Munster, Inst Anim Physiol, Hindenburgpl 55, D-48143 Munster, Germany.	kai.luersen@uni-muenster.de		Heinick, Alexander/0000-0002-3770-105X	U. S. National Institutes of Health National Center for Research Resources; National Bioresource Project, Tokyo Women's Medical University School of Medicine; Deutsche Forschungsgemeinschaft [733/6]	U. S. National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project, Tokyo Women's Medical University School of Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Some C. elegans strains were obtained from the Caenorhabditis Genetics Center at the University of Minnesota ( Minneapolis, MN, USA), which is funded by the U. S. National Institutes of Health National Center for Research Resources and by the National Bioresource Project, Tokyo Women's Medical University School of Medicine. This work was supported by Deutsche Forschungsgemeinschaft ( DFG; grant Lu 733/6) and is part of A. H.'s doctoral study at the Faculty of Biology, University of Muenster.	Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; BRENNER S, 1974, GENETICS, V77, P71; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Habtemichael N, 2002, GENE, V283, P271, DOI 10.1016/S0378-1119(01)00881-2; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KAKINUMA Y, 1995, BIOCHEM BIOPH RES CO, V216, P985, DOI 10.1006/bbrc.1995.2717; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994; KOUMOTO Y, 1990, CHEM PHARM BULL, V38, P1648; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Macrae M, 1998, BIOCHEM J, V333, P309, DOI 10.1042/bj3330309; MACRAE M, 1995, GENETICS, V140, P517; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Phanstiel O IV, 2007, AMINO ACIDS, V33, P305, DOI 10.1007/s00726-007-0527-y; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; PRAKASH NJ, 1988, ANTICANCER RES, V8, P563; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Romero-Calderon R, 2006, BIOCHEM J, V393, P583, DOI 10.1042/BJ20050981; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; Seiler N, 2003, CURR DRUG TARGETS, V4, P565, DOI 10.2174/1389450033490876; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; Tsen C, 2008, J MED CHEM, V51, P324, DOI 10.1021/jm701198s; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Wang CJ, 2003, J MED CHEM, V46, P2663, DOI 10.1021/jm030028w; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	42	29	35	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					206	217		10.1096/fj.09-135889	http://dx.doi.org/10.1096/fj.09-135889			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19762559	Green Published, Bronze			2022-12-25	WOS:000273233600022
J	Kumar, AHS; Metharom, P; Schmeckpeper, J; Weiss, S; Martin, K; Caplice, NM				Kumar, Arun H. S.; Metharom, Pat; Schmeckpeper, Jeff; Weiss, Sharon; Martin, Kenneth; Caplice, Noel M.			Bone marrow-derived CX(3)CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX(3)CR1 interaction	FASEB JOURNAL			English	Article						chemokine; neointima; vascular remodeling; myeloid; wire injury; monocytes	RECEPTOR CX(3)CR1; TARGETED DELETION; BLOOD; ATHEROSCLEROSIS; RECRUITMENT; DIFFERENTIATION; EXPRESSION; MONOCYTES; MACROPHAGES; HYPERPLASIA	Smooth muscle cells play a major role in numerous vascular diseases that contribute to remodeling, repair after injury, and arteriogenesis, and the source of these cells is thought to lie within the vessel wall and the circulating blood. Currently, the precise origin and mechanism of differentiation of extravascular smooth muscle progenitor cells (SPCs) is unclear. We show here that the CX(3)CR1 mononuclear cell population of murine bone marrow provides a source of SPCs that contributes to smooth muscle cells within the neointimal plaque after vascular injury. Moreover, CX(3)CR1-fractalkine (FKN) interaction in vivo is essential for smooth muscle cell differentiation of bone marrow-derived progenitor cells at the vessel wall level. Functional competence of bone marrow-derived CX(3)CR1 positive cells to interact with FKN is also crucial in part for neointima formation following vascular injury. Finally, in a pure preparation of bone marrow-derived CX(3)CR1 positive cells, we show that in vitro smooth muscle cell differentiation increases markedly in the presence of FKN. Our data highlight a novel functional relationship between the myeloid and vascular systems and in the context of vascular injury and repair underscores a key chemokine-receptor pathway that may regulate cell fate when smooth muscle cell differentiation is required.-Kumar, A. H. S., Metharom, P., Schmeckpeper, J., Weiss, S., Martin, K., Caplice, N. M. Bone marrow-derived CX(3)CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX(3)CR1 interaction. FASEB J. 24, 81-92 (2010). www.fasebj.org	[Kumar, Arun H. S.; Metharom, Pat; Schmeckpeper, Jeff; Weiss, Sharon; Martin, Kenneth; Caplice, Noel M.] Natl Univ Ireland Univ Coll Cork, Biosci Inst, CRVB, Cork, Ireland	University College Cork	Caplice, NM (corresponding author), Natl Univ Ireland Univ Coll Cork, Biosci Inst, CRVB, Room 2-39, Cork, Ireland.	n.caplice@ucc.ie	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219; Weiss, Sharon/0000-0002-0981-6917; Caplice, Noel/0000-0001-5445-1016	Science Foundation Ireland; Health Research Board, Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board, Ireland	We thank Barbara Rejman-Bochenek for technical assistance with the murine studies and Mary DeVoe for reviewing the manuscript. This work was supported by grants from Science Foundation Ireland and the Health Research Board, Ireland. The authors declare no conflicts of interest.	Adams LD, 2006, ARTERIOSCL THROM VAS, V26, P319, DOI 10.1161/01.ATV.0000196647.45718.d6; Agrotis A, 2004, J BIOL CHEM, V279, P42221, DOI 10.1074/jbc.M408121200; An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Arakawa E, 2000, FEBS LETT, V481, P193, DOI 10.1016/S0014-5793(00)01995-5; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barlic J, 2007, J BIOL CHEM, V282, P19167, DOI 10.1074/jbc.M701642200; Bentzon JF, 2007, CIRCULATION, V116, P2053, DOI 10.1161/CIRCULATIONAHA.107.722355; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100; Civelek M, 2002, J APPL PHYSIOL, V93, P1907, DOI 10.1152/japplphysiol.00988.2001; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Diez M, 2007, CARDIOVASC RES, V76, P517, DOI 10.1016/j.cardiores.2007.08.007; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; GALMICHE MC, 1993, BLOOD, V82, P66, DOI 10.1182/blood.V82.1.66.bloodjournal82166; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Hu YH, 2002, CIRC RES, V91, pE13, DOI 10.1161/01.RES.0000037090.34760.EE; Hu YH, 2002, CIRCULATION, V106, P1834, DOI 10.1161/01.CIR.0000031333.86845.DD; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jacobsen JCB, 2007, AM J PHYSIOL-HEART C, V293, pH229, DOI 10.1152/ajpheart.00727.2006; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; Komatsu R, 1998, CIRCULATION, V98, P224, DOI 10.1161/01.CIR.98.3.224; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Liu P, 2006, ARTERIOSCL THROM VAS, V26, P2056, DOI 10.1161/01.ATV.0000234947.47788.8c; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Metharom P, 2008, ATHEROSCLEROSIS, V198, P29, DOI 10.1016/j.atherosclerosis.2007.09.020; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; PELED A, 1991, BLOOD, V78, P304; Pugsley MK, 2000, J PHARMACOL TOX MET, V44, P333, DOI 10.1016/S1056-8719(00)00125-8; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Schach C, 2008, EXP LUNG RES, V34, P195, DOI 10.1080/01902140801925471; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tousoulis D, 1999, CARDIOVASC DRUG THER, V13, P295, DOI 10.1023/A:1007747114386; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zhou H, 2008, BIOCHEM BIOPH RES CO, V369, P213, DOI 10.1016/j.bbrc.2007.12.194; Zoll J, 2008, CARDIOVASC RES, V77, P471, DOI 10.1093/cvr/cvm034; ZON LI, 2001, HEMATOPOIESIS DEV AP	47	40	40	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					81	92		10.1096/fj.09-132225	http://dx.doi.org/10.1096/fj.09-132225			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19745110				2022-12-25	WOS:000273233600011
J	Moreau, KL; King, J				Moreau, Kate L.; King, Jonathan			Hydrophobic Core Mutations Associated with Cataract Development in Mice Destabilize Human gamma D-Crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LENS PROTEINS; AGE-RELATED-CHANGES; GREEK KEY DOMAINS; DOMINANT CATARACT; TRYPTOPHAN FLUORESCENCE; MOLECULAR CHAPERONE; BACKBONE CLEAVAGE; MASS-SPECTROMETRY; ALPHA-CRYSTALLIN; S-CRYSTALLIN	The human eye lens is composed of fiber cells packed with crystallins up to 450 mg/ml. Human gamma D-crystallin (H gamma D-Crys) is a monomeric, two-domain protein of the lens central nucleus. Both domains of this long lived protein have double Greek key beta-sheet folds with well packed hydrophobic cores. Three mutations resulting in amino acid substitutions in the gamma-crystallin buried cores (two in the N-terminal domain(N-td) and one in the C-terminal domain (C-td)) cause early onset cataract in mice, presumably an aggregated state of the mutant crystallins. It has not been possible to identify the aggregating precursor within lens tissues. To compare in vivo cataract-forming phenotypes with in vitro unfolding and aggregation of gamma-crystallins, mouse mutant substitutions were introduced into H gamma D-Crys. The mutant proteins L5S, V75D, and I90F were expressed and purified from Escherichia coli. WT H gamma D-Crys unfolds in vitro through a three-state pathway, exhibiting an intermediate with the N-td unfolded and the C-td native-like. L5S and V75D in the N-td also displayed three-state unfolding transitions, with the first transition, unfolding of the N-td, shifted to significantly lower denaturant concentrations. I90F destabilized the C-td, shifting the overall unfolding transition to lower denaturant concentrations. During thermal denaturation, the mutant proteins exhibited lowered thermal stability compared with WT. Kinetic unfolding experiments showed that the N-tds of L5S and V75D unfolded faster than WT. I90F was globally destabilized and unfolded more rapidly. These results support models of cataract formation in which generation of partially unfolded species are precursors to the aggregated cataractous states responsible for light scattering.	[Moreau, Kate L.; King, Jonathan] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	King, J (corresponding author), 77 Massachusetts Ave,68-330, Cambridge, MA 02139 USA.	jaking@mit.edu			National Institutes of Health [GM17980, EY015834]; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017980, F32GM017980, P50GM068762, R37GM017980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM17980 and EY015834 (to J.K.)	Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Baldwin E, 1996, J MOL BIOL, V259, P542, DOI 10.1006/jmbi.1996.0338; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; BOYLE D, 1994, EXP EYE RES, V58, P9, DOI 10.1006/exer.1994.1190; Burdon KP, 2004, BRIT J OPHTHALMOL, V88, P79, DOI 10.1136/bjo.88.1.79; Chen JJ, 2008, BIOCHEMISTRY-US, V47, P10705, DOI 10.1021/bi800499k; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; CHIOU SH, 1981, J BIOL CHEM, V256, P5176; CLARK AC, 1993, J BIOL CHEM, V268, P10773; Denisov VP, 2004, BIOPHYS J, V87, P3982, DOI 10.1529/biophysj.104.048454; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Evans P, 2004, J MOL BIOL, V343, P435, DOI 10.1016/j.jmb.2004.08.050; EVERETT CA, 1994, GENOMICS, V20, P429, DOI 10.1006/geno.1994.1197; FAGERHOLM P, 1982, CURR EYE RES, V1, P629, DOI 10.3109/02713688109001866; FAVOR J, 1983, MUTAT RES, V110, P367, DOI 10.1016/0027-5107(83)90153-7; FAVOR J, 1984, GENET RES, V44, P183, DOI 10.1017/S0016672300026380; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Graw J, 2002, INVEST OPHTH VIS SCI, V43, P2998; Graw J, 2002, MAMM GENOME, V13, P452, DOI 10.1007/s00335-002-3021-6; Graw JC, 2004, INVEST OPHTH VIS SCI, V45, P1202, DOI 10.1167/iovs.03-0811; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; HOENDERS HJ, 1983, J GERONTOL, V38, P278, DOI 10.1093/geronj/38.3.278; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; ISHIKAWA K, 1993, BIOCHEMISTRY-US, V32, P6171, DOI 10.1021/bi00075a009; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Marsili S, 2004, EXP EYE RES, V79, P595, DOI 10.1016/j.exer.2004.06.008; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Messina-Baas O, 2006, MOL VIS, V12, P995; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; MILLSHENRY I, 2007, THESIS MIT CAMBRIDGE; Nandrot E, 2003, J MED GENET, V40, P262, DOI 10.1136/jmg.40.4.262; *NIH PREV BLINDN A, 2008, VIS PROBL US PREV AD, P22; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Santhiya ST, 2002, J MED GENET, V39, P352, DOI 10.1136/jmg.39.5.352; SIEZEN RJ, 1988, J MOL BIOL, V199, P475, DOI 10.1016/0022-2836(88)90619-5; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Sinha D, 1998, Mol Vis, V4, P8; Sinha D, 2001, J BIOL CHEM, V276, P9308, DOI 10.1074/jbc.M010583200; Slingsby C, 1999, EYE, V13, P395, DOI 10.1038/eye.1999.113; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; TAKEMOTO L, 1991, EXP EYE RES, V53, P811, DOI 10.1016/0014-4835(91)90119-Y; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; TRUSCOTT RJW, 1977, BIOCHIM BIOPHYS ACTA, V492, P43, DOI 10.1016/0005-2795(77)90212-4; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Waldburger CD, 1996, P NATL ACAD SCI USA, V93, P2629, DOI 10.1073/pnas.93.7.2629; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	74	43	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33285	33295		10.1074/jbc.M109.031344	http://dx.doi.org/10.1074/jbc.M109.031344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19758984	Green Published, hybrid			2022-12-25	WOS:000272028500033
J	Fishman-Jacob, T; Reznichenko, L; Youdim, MBH; Mandel, SA				Fishman-Jacob, Tali; Reznichenko, Lydia; Youdim, Moussa B. H.; Mandel, Silvia A.			A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIGRA-PARS-COMPACTA; F-BOX PROTEIN; SUBSTANTIA-NIGRA; GENE-EXPRESSION; NEURODEGENERATIVE DISEASES; UBIQUITIN-PROTEASOME; INTERACTING PROTEIN; DOPAMINE NEURONS; PC12 CELLS; COMPLEX	The aim of this study was to develop a new model of sporadic Parkinson disease (PD) based on silencing of the SKP1A gene, a component of the ubiquitin-proteasome/E3 ligase complex, Skp1, Cullin 1, F-box protein, which was found to be highly decreased in the substantia nigra of sporadic PD patients. Initially, an embryonic mouse substantia nigra-derived cell line (SN4741 cells) was infected with short hairpin RNA lentiviruses encoding the murine transcript of the SKP1A gene or with scrambled vector. SKP1A silencing resulted in increased susceptibility to neuronal damages induced by the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium ion and serum starvation, in parallel with a decline in the expression of the dopaminergic markers, dopamine transporter and vesicular monoamine transporter-2. SKP1A-deficient cells presented a delay in completion of the cell cycle and the inability to arrest at the G(0)/G(1) phase when induced to differentiate. Instead, the cells progressed through S phase, developing rounded aggregates with characteristics of aggresomes including immunoreactivity for gamma-tubulin, alpha-synuclein, ubiquitin, tyrosine hydroxylase, Hsc-70 (70-kDa heat shock cognate protein), and proteasome subunit, and culminating in a lethal phenotype. Conversely, stably enforced expression of wild type SKP1A duplicated the survival index of naive SN4741 cells under proteasomal inhibition injury, suggesting a new structural role of SKP1 in dopaminergic neuronal function, besides its E3 ligase activity. These results link, for the first time, SKP1 to dopamine neuronal function and survival, suggesting an essential role in sporadic PD. In summary, this new model has reproduced to a significant extent the molecular alterations described in sporadic PD at the cellular level, implicating Skp1 as a potential modifier in sporadic PD neurodegeneration.	[Mandel, Silvia A.] Technion Israel Inst Technol, Fac Med, Dept Mol Pharmacol, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Eve Topf & Natl Parkinson Fdn Ctr Neurodegenerat, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Mandel, SA (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Mol Pharmacol, POB 9697, IL-31096 Haifa, Israel.	mandel@tx.technion.ac.il			Eve Topf and National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research	Eve Topf and National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research	This work was supported by the Eve Topf and National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; Chelli B, 2004, BIOCHEM PHARMACOL, V68, P125, DOI 10.1016/j.bcp.2004.03.008; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; Gassen M, 1998, MOVEMENT DISORD, V13, P661, DOI 10.1002/mds.870130409; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; HJELLE JJ, 1983, PHARMACOL BIOCHEM BE, V18, P155, DOI 10.1016/0091-3057(83)90164-8; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Macleod MR, 2001, BRAIN RES, V889, P308, DOI 10.1016/S0006-8993(00)03173-5; Mandel S, 2007, EXPERT OPIN DRUG DIS, V2, P1225, DOI 10.1517/17460441.2.9.1225; Mandel SA, 2007, PARKINSONISM RELAT D, V13, pS242, DOI 10.1016/S1353-8020(08)70009-9; MARDH G, 1986, BIOCHEMISTRY-US, V25, P7279, DOI 10.1021/bi00371a005; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; McNaught KSP, 2002, NEUROSCI LETT, V326, P155, DOI 10.1016/S0304-3940(02)00296-3; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Reznichenko L, 2005, J NEUROCHEM, V93, P1157, DOI 10.1111/j.1471-4159.2005.03085.x; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Sagi Y, 2007, NEUROBIOL DIS, V25, P35, DOI 10.1016/j.nbd.2006.07.020; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Spruck CH, 2002, CELL CYCLE, V1, P248, DOI 10.4161/cc.1.4.132; Staropoli JF, 2005, J MOL NEUROSCI, V27, P175, DOI 10.1385/JMN:27:2:175; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Weinreb O, 2003, FASEB J, V17, P935, DOI 10.1096/fj.02-0712fje; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou HX, 2007, INT J BIOL SCI, V3, P242	52	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32835	32845		10.1074/jbc.M109.034223	http://dx.doi.org/10.1074/jbc.M109.034223			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19748892	hybrid, Green Published			2022-12-25	WOS:000272028400068
J	Petroutsos, D; Terauchi, AM; Busch, A; Hirschmann, I; Merchant, SS; Finazzi, G; Hippler, M				Petroutsos, Dimitris; Terauchi, Aimee M.; Busch, Andreas; Hirschmann, Ingrid; Merchant, Sabeeha S.; Finazzi, Giovanni; Hippler, Michael			PGRL1 Participates in Iron-induced Remodeling of the Photosynthetic Apparatus and in Energy Metabolism in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON FLOW; CHLOROPHYLL-PROTEIN COMPLEX; ALGA RHODELLA-VIOLACEA; PHOTOSYSTEM-I; STATE TRANSITIONS; REDOX REGULATION; C3 PLANTS; DEFICIENCY; TRANSPORT; GENE	PGRL1 RNA and protein levels are increased in iron-deficient Chlamydomonas reinhardtii cells. In an RNAi strain, which accumulates lower PGRL1 levels in both iron-replete and -starved conditions, the photosynthetic electron transfer rate is decreased, respiratory capacity in iron-sufficient conditions is increased, and the efficiency of cyclic electron transfer under iron-deprivation is diminished. Pgrl1-kd cells exhibit iron deficiency symptoms at higher iron concentrations than wild-type cells, although the cells are not more depleted in cellular iron relative to wild-type cells as measured by mass spectrometry. Thiol-trapping experiments indicate iron-dependent and redox-induced conformational changes in PGRL1 that may provide a link between iron metabolism and the partitioning of photosynthetic electron transfer between linear and cyclic flow. We propose, therefore, that PGRL1 in C. reinhardtii may possess a dual function in the chloroplast; that is, iron sensing and modulation of electron transfer.	[Petroutsos, Dimitris; Busch, Andreas; Hirschmann, Ingrid; Hippler, Michael] Univ Munster, Inst Plant Biochem & Biotechnol, D-48143 Munster, Germany; [Terauchi, Aimee M.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Terauchi, Aimee M.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Finazzi, Giovanni] UPMC, CNRS, UMR 7141, Inst Biol Physicochim, F-75005 Paris, France	University of Munster; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Hippler, M (corresponding author), Univ Munster, Inst Plant Biochem & Biotechnol, Hindenburgpl 55, D-48143 Munster, Germany.	mhippler@uni-muenster.de	Petroutsos, Dimitris/AAB-1976-2021; Petroutsos, Dimitris/E-4958-2011	Petroutsos, Dimitris/0000-0002-9656-661X; Petroutsos, Dimitris/0000-0002-9656-661X; Michael, Hippler/0000-0001-9670-6101	German Science Foundation; Institutional Ruth L. Kirschstein National Research Service Award [GM070104]; UCLA graduate division; Department of Energy [DE-FD02-04ER15529]	German Science Foundation(German Research Foundation (DFG)); Institutional Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA graduate division; Department of Energy(United States Department of Energy (DOE))	This work was supported by the German Science Foundation (to M. H.), an Institutional Ruth L. Kirschstein National Research Service Award GM070104 and a Dissertation Year Fellowship from the UCLA graduate division (to A. M. T.) and by Department of Energy Grant DE-FD02-04ER15529 (to S. S. M.).	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; ARNON DI, 1959, NATURE, V184, P10; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Busch A, 2008, PLANT J, V55, P201, DOI 10.1111/j.1365-313X.2008.03490.x; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Chen JC, 2008, EUKARYOT CELL, V7, P541, DOI 10.1128/EC.00463-07; Clemens S, 2009, FRONT BIOSCI-LANDMRK, V14, P1955, DOI 10.2741/3355; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Desquilbet TE, 2003, PLANT CELL PHYSIOL, V44, P1141, DOI 10.1093/pcp/pcg139; Doan JM, 2003, FEBS LETT, V533, P59, DOI 10.1016/S0014-5793(02)03748-1; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Finazzi G, 2005, J EXP BOT, V56, P383, DOI 10.1093/jxb/erh230; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; GUIKEMA JA, 1984, PLANT PHYSIOL, V74, P90, DOI 10.1104/pp.74.1.90; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kang HJ, 2008, BIOCHEM BIOPH RES CO, V371, P63, DOI 10.1016/j.bbrc.2008.03.156; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KUCHKA MR, 1989, CELL, V58, P869, DOI 10.1016/0092-8674(89)90939-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JC, 2008, GENETICS, V179, P137, DOI 10.1534/genetics.107.083824; MAXWELL PC, 1976, BIOCHEMISTRY-US, V15, P3975, DOI 10.1021/bi00663a011; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nagamori S, 2002, J BIOCHEM, V132, P629, DOI 10.1093/oxfordjournals.jbchem.a003266; Nandha B, 2007, BBA-BIOENERGETICS, V1767, P1252, DOI 10.1016/j.bbabio.2007.07.007; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Oelze ML, 2008, BBA-GEN SUBJECTS, V1780, P1261, DOI 10.1016/j.bbagen.2008.03.015; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Steigmiller S, 2008, P NATL ACAD SCI USA, V105, P3745, DOI 10.1073/pnas.0708356105; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Taiz L., 2018, FUNDAMENTALS PLANT P; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Varsano T, 2006, J BIOL CHEM, V281, P10305, DOI 10.1074/jbc.M511057200; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9; Zumbrennen KB, 2009, MOL CELL BIOL, V29, P2219, DOI 10.1128/MCB.00004-09	62	71	73	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32770	32781		10.1074/jbc.M109.050468	http://dx.doi.org/10.1074/jbc.M109.050468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783661	Green Published, hybrid			2022-12-25	WOS:000272028400062
J	Kim, ST; Takeuchi, K; Sun, ZYJ; Touma, M; Castro, CE; Fahmy, A; Lang, MJ; Wagner, G; Reinherz, EL				Kim, Sun Taek; Takeuchi, Koh; Sun, Zhen-Yu J.; Touma, Maki; Castro, Carlos E.; Fahmy, Amr; Lang, Matthew J.; Wagner, Gerhard; Reinherz, Ellis L.			The alpha beta T Cell Receptor Is an Anisotropic Mechanosensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC SELECTION; FG LOOP; CD3-EPSILON-GAMMA HETERODIMER; ECTODOMAIN FRAGMENT; CRYSTAL-STRUCTURE; TCR; COMPLEX; ACTIVATION; THYMOCYTES; MODEL	Thymus-derived lymphocytes protect mammalian hosts against virus- or cancer-related cellular alterations through immune surveillance, eliminating diseased cells. In this process, T cell receptors (TCRs) mediate both recognition and T cell activation via their dimeric alpha beta, CD3 epsilon gamma, CD3 epsilon delta, and CD3 zeta zeta subunits using an unknown structural mechanism. Here, site-specific binding topology of anti-CD3 monoclonal antibodies (mAbs) and dynamic TCR quaternary change provide key clues. Agonist mAbs footprint to the membrane distal CD3 epsilon lobe that they approach diagonally, adjacent to the lever-like C beta FG loop that facilitates antigen (pMHC)-triggered activation. In contrast, a non-agonist mAb binds to the cleft between CD3 epsilon and CD3 gamma in a perpendicular mode and is stimulatory only subsequent to an external tangential but not a normal force (similar to 50 piconewtons) applied via optical tweezers. Specific pMHC but not irrelevant pMHC activates a T cell upon application of a similar force. These findings suggest that the TCR is an anisotropic mechanosensor, converting mechanical energy into a biochemical signal upon specific pMHC ligation during immune surveillance. Activating anti-CD3 mAbs mimic this force via their intrinsic binding mode. A common TCR quaternary change rather than conformational alterations can better facilitate structural signal initiation, given the vast array of TCRs and their specific pMHC ligands.	[Kim, Sun Taek; Touma, Maki; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Lab Immunobiol, Boston, MA 02115 USA; [Kim, Sun Taek; Touma, Maki; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Takeuchi, Koh; Sun, Zhen-Yu J.; Fahmy, Amr; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Castro, Carlos E.; Lang, Matthew J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Lang, Matthew J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Reinherz, EL (corresponding author), 77 Ave Louis Pasteur,HIM 419, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Castro, Carlos E/D-8756-2016; Takeuchi, Koh/B-4971-2010	Castro, Carlos E/0000-0001-7023-6105; Takeuchi, Koh/0000-0002-6227-4627	National Institutes of Health [AI19807, AI37581, GM47467, EB002026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019807, R01AI037581, R37AI019807, R56AI019807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI19807 (to E. L. R.) and AI37581, GM47467, and EB002026 (to G. W.).	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Fahmy A, 2002, J AM CHEM SOC, V124, P1241, DOI 10.1021/ja011240x; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Ghendler Y, 1997, EUR J IMMUNOL, V27, P2279, DOI 10.1002/eji.1830270923; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Minguet S, 2008, TRENDS BIOCHEM SCI, V33, P51, DOI 10.1016/j.tibs.2007.10.008; Mizoguchi A, 2003, INT IMMUNOL, V15, P97, DOI 10.1093/intimm/dxg006; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; Nishida T, 2004, J IMMUNOL, V172, P6634, DOI 10.4049/jimmunol.172.11.6634; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Ruggeri ZM, 2007, THROMB HAEMOSTASIS, V98, P55, DOI 10.1160/TH07-04-0279; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHINKAI Y, 1995, IMMUNITY, V2, P401; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Touma M, 2007, J IMMUNOL, V178, P3668, DOI 10.4049/jimmunol.178.6.3668; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011	46	268	273	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31028	31037		10.1074/jbc.M109.052712	http://dx.doi.org/10.1074/jbc.M109.052712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755427	Green Published, hybrid			2022-12-25	WOS:000271378400032
J	Zhou, Z; Fan, JB; Zhu, HL; Shewmaker, F; Yan, X; Chen, X; Chen, J; Xiao, GF; Guo, L; Liang, Y				Zhou, Zheng; Fan, Jun-Bao; Zhu, Hai-Li; Shewmaker, Frank; Yan, Xu; Chen, Xi; Chen, Jie; Xiao, Geng-Fu; Guo, Lin; Liang, Yi			Crowded Cell-like Environment Accelerates the Nucleation Step of Amyloidogenic Protein Misfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN PRION PROTEIN; MUSCLE CREATINE-KINASE; IN-VITRO CONVERSION; ALPHA-SYNUCLEIN; TAU-PHOSPHORYLATION; ALZHEIMERS-DISEASE; QUALITY-CONTROL; FIBRILS; AGGREGATION; FIBRILLATION	To understand the role of a crowded physiological environment in the pathogenesis of neurodegenerative diseases, we report the following. 1) The formation of fibrous aggregates of the human Tau fragment Tau-(244-441), when hyperphosphorylated by glycogen synthase kinase-3 beta, is dramatically facilitated by the addition of crowding agents. 2) Fibril formation of nonphosphorylated Tau-(244 -441) is only promoted moderately by macromolecular crowding. 3) Macromolecular crowding dramatically accelerates amyloid formation by human prion protein. A sigmoidal equation has been used to fit these kinetic data, including published data of human alpha-synuclein, yielding lag times and apparent rate constants for the growth of fibrils for these amyloidogenic proteins. These biochemical data indicate that crowded cell-like environments significantly accelerate the nucleation step of fibril formation of human Tau fragment/human prion protein/human alpha-synuclein (a significant decrease in the lag time). These results can in principle be predicted based on some known data concerning protein concentration effects on fibril formation both in vitro and in vivo. Furthermore, macromolecular crowding causes human prion protein to form short fibrils and nonfibrillar particles with lower conformational stability and higher protease resistance activity, compared with those formed in dilute solutions. Our data demonstrate that a crowded physiological environment could play an important role in the pathogenesis of neurodegenerative diseases by accelerating amyloidogenic protein misfolding and inducing human prion fibril fragmentation, which is considered to be an essential step in prion replication.	[Zhou, Zheng; Fan, Jun-Bao; Zhu, Hai-Li; Yan, Xu; Chen, Xi; Chen, Jie; Xiao, Geng-Fu; Guo, Lin; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Shewmaker, Frank] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Fan, Jun-bao/E-7155-2012; Liang, Yi/V-1396-2017; Zhou, Zheng/AAK-2669-2021	Liang, Yi/0000-0002-7349-8300; Zhou, Zheng/0000-0002-3124-6041; Fan, Junbao/0000-0002-1709-3659	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30770421, 30970599]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was authored, in part, by National Institutes of Health staff. This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301 and National Natural Science Foundation of China Grants 30770421 and 30970599.	Abraha A, 2000, J CELL SCI, V113, P3737; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn Stefan, 2004, V299, P35; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bellotti V, 1999, CELL MOL LIFE SCI, V55, P977, DOI 10.1007/s000180050348; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bokvist M, 2007, J AM CHEM SOC, V129, P14848, DOI 10.1021/ja076059o; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; MANDELKOW EM, 1993, TRENDS BIOCHEM SCI, V18, P480, DOI 10.1016/0968-0004(93)90011-B; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	78	82	83	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30148	30158		10.1074/jbc.M109.002832	http://dx.doi.org/10.1074/jbc.M109.002832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19748895	Green Published, hybrid			2022-12-25	WOS:000271090000018
J	Root, DH; Fabbricatore, AT; Barker, DJ; Ma, S; Pawlak, AP; West, MO				Root, David H.; Fabbricatore, Anthony T.; Barker, David J.; Ma, Sisi; Pawlak, Anthony P.; West, Mark O.			Evidence for Habitual and Goal-Directed Behavior Following Devaluation of Cocaine: A Multifaceted Interpretation of Relapse	PLOS ONE			English	Article							DRUG-SEEKING BEHAVIOR; DISCRIMINATIVE-STIMULUS TASK; BASOLATERAL AMYGDALA; INTRAVENOUS COCAINE; SMOKED COCAINE; ACCUMBENS CORE; ALTERNATIVE REINFORCEMENT; CONTINGENCY KNOWLEDGE; INDUCED REINSTATEMENT; ADDICTIVE BEHAVIOR	Background: Cocaine addiction is characterized as a chronically relapsing disorder. It is believed that cues present during self-administration become learned and increase the probability that relapse will occur when they are confronted during abstinence. However, the way in which relapse-inducing cues are interpreted by the user has remained elusive. Recent theories of addiction posit that relapse-inducing cues cause relapse habitually or automatically, bypassing processing information related to the consequences of relapse. Alternatively, other theories hypothesize that relapse-inducing cues produce an expectation of the drug's consequences, designated as goal-directed relapse. Discrete discriminative stimuli signaling the availability of cocaine produce robust cue-induced responding after thirty days of abstinence. However, it is not known whether cue-induced responding is a goal-directed action or habit. Methodology/Principal Findings: We tested whether cue-induced responding is a goal-directed action or habit by explicitly pairing or unpairing cocaine with LiCl-induced sickness (n = 7/group), thereby decreasing or not altering the value of cocaine, respectively. Following thirty days of abstinence, no difference in responding between groups was found when animals were reintroduced to the self-administration environment alone, indicating habitual behavior. However, upon discriminative stimulus presentations, cocaine-sickness paired animals exhibited decreased cue-induced responding relative to unpaired controls, indicating goal-directed behavior. In spite of the difference between groups revealed during abstinent testing, no differences were found between groups when animals were under the influence of cocaine. Conclusions/Significance: Unexpectedly, both habitual and goal-directed responding occurred during abstinent testing. Furthermore, habitual or goal-directed responding may have been induced by cues that differed in their correlation with the cocaine infusion. Non-discriminative stimulus cues were weak correlates of the infusion, which failed to evoke a representation of the value of cocaine and led to habitual behavior. However, the discriminative stimulus-nearly perfectly correlated with the infusion-likely evoked a representation of the value of the infusion and led to goal-directed behavior. These data indicate that abstinent cue-induced responding is multifaceted, dynamically engendering habitual or goal-directed behavior. Moreover, since goal-directed behavior terminated habitual behavior during testing, therapeutic approaches aimed at reducing the perceived value of cocaine in addicted individuals may reduce the capacity of cues to induce relapse.			Root, DH (corresponding author), Rutgers State Univ, Dept Psychol, New Brunswick, NJ 08903 USA.	markwest@rutgers.edu	Ma, Sisi/E-6367-2015; Barker, David JP/A-5671-2013		NATIONAL INSTITUTE ON DRUG ABUSE [F31DA026252, R01DA006886] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 026252, F31 DA026252-01, R01 DA006886, DA 06886, F31 DA026252] Funding Source: Medline; NIMH NIH HHS [MH0919957] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Anderson KG, 2000, BEHAV PHARMACOL, V11, P413, DOI 10.1097/00008877-200008000-00007; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; BALLEINE BW, 1995, J EXP PSYCHOL ANIM B, V21, P203, DOI 10.1037/0097-7403.21.3.203; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Berglind WJ, 2006, NEUROSCIENCE, V137, P699, DOI 10.1016/j.neuroscience.2005.08.064; Bordnick PS, 2004, BEHAV INTERVENT, V19, P1, DOI 10.1002/bin.146; Callu D, 2007, NEUROBIOL DIS, V27, P228, DOI 10.1016/j.nbd.2007.04.007; Caprioli D, 2009, BIOL PSYCHIAT, V65, P893, DOI 10.1016/j.biopsych.2008.12.009; Carelli RM, 1997, J NEUROSCI, V17, P1804; CARROLL ME, 1985, DRUG ALCOHOL DEPEN, V16, P95, DOI 10.1016/0376-8716(85)90109-7; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Donny EC, 2004, PSYCHOPHARMACOLOGY, V172, P316, DOI 10.1007/s00213-003-1655-z; Donny EC, 2003, DRUG ALCOHOL DEPEN, V69, P289, DOI 10.1016/S0376-8716(02)00327-7; Donny EC, 2006, PSYCHOPHARMACOLOGY, V186, P544, DOI 10.1007/s00213-006-0312-8; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Epstein DH, 2003, PSYCHOPHARMACOLOGY, V168, P31, DOI 10.1007/s00213-003-1470-6; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; FLEMENBAUM A, 1977, PHARMACOL BIOCHEM BE, V7, P83, DOI 10.1016/0091-3057(77)90015-6; Foltin FW, 1999, J EXP ANAL BEHAV, V72, P215, DOI 10.1901/jeab.1999.72-215; Foltin RW, 1997, EXP CLIN PSYCHOPHARM, V5, P404; Foltin RW, 2000, PSYCHOPHARMACOLOGY, V149, P24, DOI 10.1007/s002139900340; Fuchs RA, 2006, J NEUROSCI, V26, P3584, DOI 10.1523/JNEUROSCI.5146-05.2006; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Gawin F H, 1996, NIDA Res Monogr, V163, P224; Ghitza UE, 2004, J NEUROPHYSIOL, V92, P1608, DOI 10.1152/jn.00268.2004; Ghitza UE, 2003, J NEUROSCI, V23, P7239; Haney M, 1999, PSYCHOPHARMACOLOGY, V143, P102, DOI 10.1007/s002130050925; Hart CL, 2007, BEHAV PHARMACOL, V18, P71, DOI 10.1097/FBP.0b013e328014139d; Hart CL, 2000, BEHAV PHARMACOL, V11, P87, DOI 10.1097/00008877-200002000-00010; Hayes RJ, 2003, PSYCHOPHARMACOLOGY, V168, P75, DOI 10.1007/s00213-002-1328-3; Hogarth L, 2006, PSYCHOPHARMACOLOGY, V184, P553, DOI 10.1007/s00213-005-0150-0; Hogarth L, 2006, PSYCHOPHARMACOLOGY, V185, P495, DOI 10.1007/s00213-005-0287-x; Hogarth L, 2005, PSYCHOPHARMACOLOGY, V177, P428, DOI 10.1007/s00213-004-1973-9; Hogarth L, 2008, PSYCHOPHARMACOLOGY, V201, P29, DOI 10.1007/s00213-008-1244-2; Hogarth L, 2007, J EXP PSYCHOL ANIM B, V33, P484, DOI 10.1037/0097-7403.33.4.484; Hogarth L, 2006, ADDICTION, V101, P1153, DOI 10.1111/j.1360-0443.2006.01459.x; Hogarth L, 2009, EXP CLIN PSYCHOPHARM, V17, P21, DOI 10.1037/a0014957; Hollander JA, 2005, NEUROPSYCHOPHARMACOL, V30, P1464, DOI 10.1038/sj.npp.1300748; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Jaffe J.H., 1990, PHARMACOL BASIS THER, P522; Kantak KM, 2002, J NEUROSCI, V22, P1126, DOI 10.1523/JNEUROSCI.22-03-01126.2002; Kruzich PJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-14-j0002.2001; Lau-Barraco C, 2008, AM J DRUG ALCOHOL AB, V34, P211, DOI 10.1080/00952990701877136; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lynch WJ, 2006, PSYCHOPHARMACOLOGY, V185, P306, DOI 10.1007/s00213-006-0323-5; Macey DJ, 2004, PSYCHOPHARMACOLOGY, V172, P384, DOI 10.1007/s00213-003-1676-7; MARLATT GA, 1985, RELAPSE PREVENTION, P00250; MCLELLAN A T, 1985, Journal of Substance Abuse Treatment, V2, P187, DOI 10.1016/0740-5472(85)90051-0; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; MUCHA RF, 1982, BRAIN RES, V243, P91, DOI 10.1016/0006-8993(82)91123-4; NADER MA, 1992, BEHAV PHARMACOL, V3, P635; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nordquist RE, 2007, EUR NEUROPSYCHOPHARM, V17, P532, DOI 10.1016/j.euroneuro.2006.12.005; Norman AB, 2006, BRAIN RES, V1116, P143, DOI 10.1016/j.brainres.2006.07.092; OBRIEN CP, 1975, PHARMACOL REV, V27, P533; Peoples LL, 1996, J NEUROSCI, V16, P3459; Peoples LL, 1997, BRAIN RES, V757, P280, DOI 10.1016/S0006-8993(97)00299-0; Peters J, 2008, PSYCHOPHARMACOLOGY, V197, P319, DOI 10.1007/s00213-007-1034-2; PICKENS R, 1968, J PHARMACOL EXP THER, V161, P122; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Smelson DA, 2001, AM J DRUG ALCOHOL AB, V27, P391, DOI 10.1081/ADA-100103716; Smith BJ, 2001, PSYCHOPHARMACOLOGY, V156, P435, DOI 10.1007/s002130100740; Stalnaker TA, 2007, NAT NEUROSCI, V10, P949, DOI 10.1038/nn1931; SUZUKI T, 1992, JPN J PHARMACOL, V58, P435, DOI 10.1254/jjp.58.435; Tang C, 2008, J PHARMACOL EXP THER, V324, P701, DOI 10.1124/jpet.107.129734; Tang CK, 2007, EUR J NEUROSCI, V25, P1212, DOI 10.1111/j.1460-9568.2007.05353.x; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; WALLACE BC, 1989, J SUBST ABUSE TREAT, V6, P95, DOI 10.1016/0740-5472(89)90036-6; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Ward AS, 1997, BEHAV PHARMACOL, V8, P736, DOI 10.1097/00008877-199712000-00009; Ward AS, 1997, PSYCHOPHARMACOLOGY, V132, P375, DOI 10.1007/s002130050358; WILSON CL, 1981, J EXP PSYCHOL ANIM B, V7, P165, DOI 10.1037/0097-7403.7.2.165; Woolverton WL, 1997, DRUG ALCOHOL DEPEN, V49, P71, DOI 10.1016/S0376-8716(97)00145-2; Woolverton WL, 2006, PSYCHOPHARMACOLOGY, V186, P99, DOI 10.1007/s00213-006-0355-x; Woolverton WL, 2004, EUR J PHARMACOL, V486, P251, DOI 10.1016/j.ejphar.2004.01.003; WOOLVERTON WL, 1979, COMMUN PSYCHOPHARMAC, V3, P309; Woolverton WL, 1998, PSYCHOPHARMACOLOGY, V138, P102, DOI 10.1007/s002130050651; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Yun IA, 2003, NEUROSCIENCE, V121, P747, DOI 10.1016/S0306-4522(03)00531-1	90	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7170	10.1371/journal.pone.0007170	http://dx.doi.org/10.1371/journal.pone.0007170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498WL	19779607	Green Submitted, Green Published, gold			2022-12-25	WOS:000270176200012
J	Grigor'eva, EV; Shevchenko, AI; Mazurok, NA; Elisaphenko, EA; Zhelezova, AI; Shilov, AG; Dyban, PA; Dyban, AP; Noniashvili, EM; Slobodyanyuk, SY; Nesterova, TB; Brockdorff, N; Zakian, SM				Grigor'eva, Elena V.; Shevchenko, Alexander I.; Mazurok, Nina A.; Elisaphenko, Eugeny A.; Zhelezova, Antonina I.; Shilov, Alexander G.; Dyban, Pavel A.; Dyban, Andrey P.; Noniashvili, Ekaterina M.; Slobodyanyuk, Sergey Ya; Nesterova, Tatyana B.; Brockdorff, Neil; Zakian, Suren M.			FGF4 Independent Derivation of Trophoblast Stem Cells from the Common Vole	PLOS ONE			English	Article								The derivation of stable multipotent trophoblast stem (TS) cell lines from preimplantation, and early postimplantation mouse embryos has been reported previously. FGF4, and its receptor FGFR2, have been identified as embryonic signaling factors responsible for the maintenance of the undifferentiated state of multipotent TS cells. Here we report the derivation of stable TS-like cell lines from the vole M. rossiaemeridionalis, in the absence of FGF4 and heparin. Vole TS-like cells are similar to murine TS cells with respect to their morphology, transcription factor gene expression and differentiation in vitro into derivatives of the trophectoderm lineage, and with respect to their ability to invade and erode host tissues, forming haemorrhagic tumours after subcutaneous injection into nude mice. Moreover, vole TS-like cells carry an inactive paternal X chromosome, indicating that they have undergone imprinted X inactivation, which is characteristic of the trophoblast lineage. Our results indicate that an alternative signaling pathway may be responsible for the establishment and stable proliferation of vole TS-like cells.			Grigor'eva, EV (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Dept, Novosibirsk 630090, Russia.	zakian@bionet.nsc.ru	Grigor'eva, Elena V/V-5416-2018; Shevchenko, Alexander I./T-3400-2018; Zakian, Suren/J-2196-2018; Elisaphenko, Eugeny/V-5115-2018; Elisafenko, Eugeny/AAD-5901-2020	Elisafenko, Eugeny/0000-0002-3204-8178; Brockdorff, Neil/0000-0003-4838-2653; Grigor'eva, Elena/0000-0002-9162-9108; Nesterova, Tatyana/0000-0001-7740-4386; Zakian, Suren/0000-0003-2448-6511	Wellcome Trust [103768, 081385] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; CARNEY EW, 1993, MOL REPROD DEV, V34, P357, DOI 10.1002/mrd.1080340403; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Elisaphenko EA, 1998, CHROMOSOME RES, V6, P351, DOI 10.1023/A:1009284031287; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; GARDNER RL, 1973, J EMBRYOL EXP MORPH, V30, P561; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GRAVES KH, 1993, MOL REPROD DEV, V36, P424, DOI 10.1002/mrd.1080360404; Grummer R, 1999, PLACENTA, V20, P547, DOI 10.1053/plac.1999.0406; Guzman-Ayala M, 2004, P NATL ACAD SCI USA, V101, P15656, DOI 10.1073/pnas.0405429101; Haffner-Krausz R, 1999, MECH DEVELOP, V85, P167, DOI 10.1016/S0925-4773(99)00082-9; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Iwatsuki K, 2000, BIOL REPROD, V62, P1352, DOI 10.1095/biolreprod62.5.1352; Kibschull M, 2004, DEV BIOL, V273, P63, DOI 10.1016/j.ydbio.2004.04.037; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mazurok NA, 1995, HEREDITAS, V123, P47, DOI 10.1111/j.1601-5223.1995.t01-1-00047.x; MAZUROK NA, 2003, ONTOGENEZ, V34, P213; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nesterova TB, 1998, CHROMOSOME RES, V6, P41, DOI 10.1023/A:1009266324602; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; NOTARIANNI E, 1991, J REPROD FERTIL, P255; NOTARIANNI E, 1990, J REPROD FERTIL, P51; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; Romejs B., 1953, MICROSCOPICAL TECHNI, P71; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; ROSSANT J, 1977, J EMBRYOL EXP MORPH, V39, P183; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHMIDT M, 1990, P NATL ACAD SCI USA, V87, P3685, DOI 10.1073/pnas.87.10.3685; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Shevchenko AI, 2008, RUSS J GENET+, V44, P1280, DOI 10.1134/S1022795408110057; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soares MJ, 1996, PLACENTA, V17, P277, DOI 10.1016/S0143-4004(96)90051-X; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Yan JL, 2001, DEV BIOL, V235, P422, DOI 10.1006/dbio.2001.0300; ZAKIAN SM, 1991, GENET RES, V58, P105, DOI 10.1017/S0016672300029748; ZAKIAN SM, 1987, GENET RES, V50, P23, DOI 10.1017/S0016672300023296	63	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7161	10.1371/journal.pone.0007161	http://dx.doi.org/10.1371/journal.pone.0007161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777059	Green Published, gold, Green Submitted			2022-12-25	WOS:000270164600007
J	Arunajadai, SG				Arunajadai, Srikesh G.			RNA Unwinding by NS3 Helicase: A Statistical Approach	PLOS ONE			English	Article								The study of double-stranded RNA unwinding by helicases is a problem of basic scientific interest. One such example is provided by studies on the hepatitis C virus (HCV) NS3 helicase using single molecule mechanical experiments. HCV currently infects nearly 3% of the world population and NS3 is a protein essential for viral genome replication. The objective of this study is to model the RNA unwinding mechanism based on previously published data and study its characteristics and their dependence on force, ATP and NS3 protein concentration. In this work, RNA unwinding by NS3 helicase is hypothesized to occur in a series of discrete steps and the steps themselves occurring in accordance with an underlying point process. A point process driven change point model is employed to model the RNA unwinding mechanism. The results are in large agreement with findings in previous studies. A gamma distribution based renewal process was found to model well the point process that drives the unwinding mechanism. The analysis suggests that the periods of constant extension observed during NS3 activity can indeed be classified into pauses and subpauses and that each depend on the ATP concentration. The step size is independent of external factors and seems to have a median value of 11.37 base pairs. The steps themselves are composed of a number of substeps with an average of about 4 substeps per step and an average substep size of about 3.7 base pairs. An interesting finding pertains to the stepping velocity. Our analysis indicates that stepping velocity may be of two kinds- a low and a high velocity.			Arunajadai, SG (corresponding author), Columbia Univ, Dept Biostat & Anesthesiol, New York, NY 10027 USA.	sarunajadai@columbia.edu						Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Arunajadai SG, 2009, MATH BIOSCI, V220, P57, DOI 10.1016/j.mbs.2009.04.003; BOX GE, 2008, TIME SERIES ANAL FOR; BRILLINGER DR, 1978, COMP ASPECTS STUDY O, V1; Brodsky B. E., 1993, NONPARAMETRIC METHOD, V243; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chen J., 2000, PARAMETRIC STAT CHAN, DOI 10.1007/978-1-4757-3131-6; Cox D., 1980, POINT PROCESSES; Danilowicz C, 2003, P NATL ACAD SCI USA, V100, P1694, DOI 10.1073/pnas.262789199; Duda R.O., 2000, PATTERN CLASSIFICATI; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Lewis PAW, 1966, STAT ANAL SERIES EVE; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Weeks JD, 2005, BIOPHYS J, V88, P2752, DOI 10.1529/biophysj.104.047340	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e6937	10.1371/journal.pone.0006937	http://dx.doi.org/10.1371/journal.pone.0006937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771177	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154400001
J	Favier, J; Briere, JJ; Burnichon, N; Riviere, J; Vescovo, L; Benit, P; Giscos-Douriez, I; De Reynies, A; Bertherat, J; Badoual, C; Tissier, F; Amar, L; Libe, R; Plouin, PF; Jeunemaitre, X; Rustin, P; Gimenez-Roqueplo, AP				Favier, Judith; Briere, Jean-Jacques; Burnichon, Nelly; Riviere, Julie; Vescovo, Laure; Benit, Paule; Giscos-Douriez, Isabelle; De Reynies, Aurelien; Bertherat, Jerome; Badoual, Cecile; Tissier, Frederique; Amar, Laurence; Libe, Rosella; Plouin, Pierre-Francois; Jeunemaitre, Xavier; Rustin, Pierre; Gimenez-Roqueplo, Anne-Paule			The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas	PLOS ONE			English	Article								The Warburg effect describes how cancer cells down-regulate their aerobic respiration and preferentially use glycolysis to generate energy. To evaluate the link between hypoxia and Warburg effect, we studied mitochondrial electron transport, angiogenesis and glycolysis in pheochromocytomas induced by germ-line mutations in VHL, RET, NF1 and SDH genes. SDH and VHL gene mutations have been shown to lead to the activation of hypoxic response, even in normoxic conditions, a process now referred to as pseudohypoxia. We observed a decrease in electron transport protein expression and activity, associated with increased angiogenesis in SDH- and VHL-related, pseudohypoxic tumors, while stimulation of glycolysis was solely observed in VHL tumors. Moreover, microarray analyses revealed that expression of genes involved in these metabolic pathways is an efficient tool for classification of pheochromocytomas in accordance with the predisposition gene mutated. Our data suggest an unexpected association between pseudohypoxia and loss of p53, which leads to a distinct Warburg effect in VHL-related pheochromocytomas.			Favier, J (corresponding author), INSERM, U970, Paris, France.	judith.favier@inserm.fr	GIMENEZ-ROQUEPLO, Anne-Paule/T-6752-2018; Favier, Judith/M-7601-2017; de Reyniès, Aurélien/Q-8640-2017; Amar, Laurence/P-5278-2017; JEUNEMAITRE, Xavier/AAQ-4853-2021; Burnichon, Nelly/AAF-6003-2020	GIMENEZ-ROQUEPLO, Anne-Paule/0000-0002-4816-670X; Favier, Judith/0000-0001-8190-5853; de Reyniès, Aurélien/0000-0002-1328-5290; Amar, Laurence/0000-0003-3942-4276; JEUNEMAITRE, Xavier/0000-0001-5925-381X; libe, rossella/0000-0003-2881-6362; Badoual, Cecile/0000-0002-1143-3085; BERTHERAT, Jerome/0000-0003-2551-3008				Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Eisenhofer G, 2004, ENDOCR-RELAT CANCER, V11, P897, DOI 10.1677/erc.1.00838; Favier J, 2005, HORM RES, V63, P171, DOI 10.1159/000084685; Favier J, 1999, FEBS LETT, V462, P19, DOI 10.1016/S0014-5793(99)01476-3; Fredlund E, 2008, BIOCHEM BIOPH RES CO, V366, P1054, DOI 10.1016/j.bbrc.2007.12.074; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herfarth KKF, 1997, GENE CHROMOSOME CANC, V20, P24, DOI 10.1002/(SICI)1098-2264(199709)20:1<24::AID-GCC4>3.3.CO;2-V; Hervouet E, 2005, CARCINOGENESIS, V26, P531, DOI 10.1093/carcin/bgi001; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; Petri BJ, 2008, MODERN PATHOL, V21, P407, DOI 10.1038/modpathol.3801013; Pollard PJ, 2006, J CLIN ENDOCR METAB, V91, P4593, DOI 10.1210/jc.2006-0920; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; RUSTIN P, 2007, ERNST SHER RES FDN W, P62; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; VANNEDERVEEN FH, 2009, LANCET ONCOL; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1930, UEBER STOFFWECHSEL T; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yoshimoto T, 1998, J ENDOCRINOL, V159, P247, DOI 10.1677/joe.0.1590247; Zelinka T, 2008, ENDOCR-RELAT CANCER, V15, P311, DOI 10.1677/ERC-07-0217; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	42	183	183	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7094	10.1371/journal.pone.0007094	http://dx.doi.org/10.1371/journal.pone.0007094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763184	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970400018
J	Li, MD; Mangold, JE; Seneviratne, C; Chen, GB; Ma, JZ; Lou, XY; Payne, TJ				Li, Ming D.; Mangold, Jamie E.; Seneviratne, Chamindi; Chen, Guo-Bo; Ma, Jennie Z.; Lou, Xiang-Yang; Payne, Thomas J.			Association and Interaction Analyses of GABBR1 and GABBR2 with Nicotine Dependence in European- and African-American Populations	PLOS ONE			English	Article								Previous studies have demonstrated that the gamma-aminobutyric acid type B (GABA(B)) receptor plays an essential role in modulating neurotransmitter release and regulating the activity of ion channels and adenyl cyclase. However, whether the naturally occurring polymorphisms in the two GABA(B) receptor subunit genes interact with each other to alter susceptibility to nicotine dependence (ND) remains largely unknown. In this study, we genotyped 5 and 33 single nucleotide polymorphisms (SNPs) for GABA(B) receptor subunit 1 and 2 genes (GABBR1, GABBR2), respectively, in a sample of 2037 individuals from 602 nuclear families of African-American (AA) or European-American (EA) origin. We conducted association analyses to determine (1) the association of each subunit gene with ND at both the individual SNP and haplotype levels and (2) the collective effect(s) of SNPs in both GABA(B) subunits on the development of ND. Several individual SNPs and haplotypes in GABBR2 were significantly associated with ND in both ethnic samples. Two haplotypes in AAs and one haplotype in EAs showed a protective effect against ND, whilst two other haplotypes in AAs and three haplotypes in EAs showed a risk effect for developing ND. Interestingly, these significant haplotypes were confined to two regions of GABBR2 in the AA and EA samples. Additionally, we found two minor haplotypes in GABBR1 to be positively associated with Heaviness of Smoking Index (HSI) in the EA sample. Finally, we demonstrated the presence of epistasis between GABBR1 and GABBR2 for developing ND. The variants of GABBR1 and GABBR2 are significantly associated with ND, and the involvement of GABBR1 is most likely through its interaction with GABBR2, whereas GABBR2 polymorphisms directly alter susceptibility to ND. Future studies are needed with more dense SNP coverage of GABBR1 and GABBR2 to verify the epistatic effects of the two subunit genes.			Li, MD (corresponding author), Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA.	Ming_Li@virginia.edu	Payne, Thomas/R-4290-2019; Lou, Xiang-Yang/B-6291-2013; Chen, Guo-Bo/C-2435-2009	Payne, Thomas/0000-0002-9839-6255; Chen, Guo-Bo/0000-0001-5475-8237; seneviratne, Chamindi/0000-0002-3135-2979	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025095, R01DA012844] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA012844, R01DA025095, R01 DA025095, R01 DA012844] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergen AW, 1999, GENET EPIDEMIOL, V17, pS55; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Beuten J, 2005, AM J HUM GENET, V76, P859, DOI 10.1086/429839; Bierut LJ, 2004, AM J MED GENET A, V124A, P19, DOI 10.1002/ajmg.a.20329; Calver AR, 2001, J NEUROSCI, V21, P1203; Cousins M S, 2001, Nicotine Tob Res, V3, P123, DOI 10.1080/14622200110042624; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gelernter J, 2007, BIOL PSYCHIAT, V61, P119, DOI 10.1016/j.biopsych.2006.08.023; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Lange C, 2003, HUM HERED, V56, P10, DOI 10.1159/000073728; Li MD, 2008, MOL PSYCHIATR, V13, P407, DOI 10.1038/sj.mp.4002038; Li MD, 2007, MOL PSYCHIATR, V12, P462, DOI 10.1038/sj.mp.4001933; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S103; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Li MD, 2006, AM J HUM GENET, V79, P745, DOI 10.1086/508208; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Sullivan P.F., 1999, NICOTINE TOB RES S2, V1, pS69; Sun DX, 2007, NEUROPSYCHOPHARMACOL, V32, P110, DOI 10.1038/sj.npp.1301134; U.S. Department of Health and Human Services, 2000, RED TOB US REP SURG; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001	30	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7055	10.1371/journal.pone.0007055	http://dx.doi.org/10.1371/journal.pone.0007055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763258	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970400005
J	Mavrodiev, EV				Mavrodiev, Evgeny V.			Classical Morphology of Plants as an Elementary Instance of Classical Invariant Theory	PLOS ONE			English	Article								It has long been known that structural chemistry shows an intriguing correspondence with Classical Invariant Theory (CIT). Under this view, an algebraic binary form of the degree n corresponds to a chemical atom with valence n and each physical molecule or ion has an invariant-theoretic counterpart. This theory was developed using the Aronhold symbolical approach and the symbolical processes of convolution/transvection in CIT was characterized as a potential "accurate morphological method''. However, CIT has not been applied to the formal morphology of living organisms. Based on the morphological interpretation of binary form, as well as the process of convolution/transvection, the First and Second Fundamental Theorems of CIT and the Nullforms of CIT, we show how CIT can be applied to the structure of plants, especially when conceptualized as a series of plant metamers (phytomers). We also show that the weight of the covariant/invariant that describes a morphological structure is a criterion of simplicity and, therefore, we argue that this allows us to formulate a parsimonious method of formal morphology. We demonstrate that the "theory of axilar bud'' is the simplest treatment of the grass seedling/embryo. Our interpretations also represent Troll's bauplan of the angiosperms, the principle of variable proportions, morphological misfits, the basic types of stem segmentation, and Goethe's principle of metamorphosis in terms of CIT. Binary forms of different degrees might describe any repeated module of plant organisms. As bacteria, invertebrates, and higher vertebrates are all generally shared a metameric morphology, wider implications of the proposed symmetry between CIT and formal morphology of plants are apparent.			Mavrodiev, EV (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	evgeny@ufl.edu						ALEXEJEFF W, 1901, CHEMIE, V38, P741; Andrews JH, 1998, ANNU REV MICROBIOL, V52, P105, DOI 10.1146/annurev.micro.52.1.105; Arber A, 1954, MIND EYE STUDY BIOL; Arber A., 1950, NATURAL PHILOS PLANT; BARLOW P, 1989, BOT J LINN SOC, V100, P225; BARLOW PW, 1994, BIOL REV, V69, P475, DOI 10.1111/j.1469-185X.1994.tb01248.x; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Bateson W., 1894, MAT STUDY VARIATION; BEKLEMISHEV WN, 1964, PRINCIPLES COMP ANAT; Bell A., 1991, PLANT FORM ILLUSTRAT; Born M, 1932, ANGEW CHEM-GER EDIT, V45, P0006, DOI 10.1002/ange.19320450103; Bossinger G., 1992, Barley: genetics, biochemistry, molecular biology and biotechnology., P231; BROWN WALTER V., 1960, PHYTOMORPHOLOGY [DELHI], V10, P215; CELAKOVSKY LJ, 1901, BOT Z, V59, P79; CLIFFORD W, 1878, AM J MATH, V1, P126; DICKSON A, 1885, T P BOT SOC EDINBURG, V16, P130; ETTER ALFRED GORDON, 1951, ANN MISSOURI BOT GARD, V38, P293, DOI 10.2307/2394639; Forster BP, 2007, ANN BOT-LONDON, V100, P725, DOI 10.1093/aob/mcm183; GALINAT W. C., 1959, BOT MUS LEAFLETS HARVARD UNIV, V19, P1; Gaudichaud C., 1841, CR HEBD ACAD SCI, V12, P627; Goethe J.W., 1952, BOT WRITINGS; Gordan P, 1900, Z PHYS CHEM-STOCH VE, V35, P610; Grace John Hilton, 1903, ALGEBRA INVARIANTS; Griffith J. S., 1964, MATH GAZ, V48, P57; Halle F., 1978, TROPICAL TREES FORES, Vfirst; Ivanov P. P., 1944, ZH OBSHCH BIOL, V5, P61; JACQUESFELIX H, 1957, CR HEBD ACAD SCI, V245, P1260; Kaplan DR, 2001, AM J BOT, V88, P1711, DOI 10.2307/3558347; Kaplan DR, 2001, INT J PLANT SCI, V162, P465, DOI 10.1086/320135; Louarn G, 2007, ANN BOT-LONDON, V99, P425, DOI 10.1093/aob/mcl276; McCall MA, 1934, J AGRIC RES, V48, P0283; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; NAYAR BK, 1985, CURR SCI INDIA, V54, P1025; Olver P.J., 1999, CLASSICAL INVARIANT; OLVER PJ, 1989, ADV MATH, V75, P212, DOI 10.1016/0001-8708(89)90038-8; Percival J., 1921, WHEAT PLANT MONOGRAP; Priestley JH, 1935, ANN BOT-LONDON, V49, P161, DOI 10.1093/oxfordjournals.aob.a090494; RAY TS, 1987, AM J BOT, V74, P1373, DOI 10.2307/2444315; RICHENS RH, 1946, NATURE, V157, P127, DOI 10.1038/157127a0; Romer A.S., 1962, VERTEBRATE BODY; ROUVRAY DH, 1974, CHEM SOC REV, V3, P355, DOI 10.1039/cs9740300355; RUMER G, 1932, NACHR GES WIS GOT MP, P499; Rutishauser R, 2001, ANN BOT-LONDON, V88, P1173, DOI 10.1006/anbo.2001.1498; SCHUEPP O, 1969, AM J BOT, V56, P899; SMIRNOV P. A., 1953, BIULL MOSKOVSKOVO OBSHCHESTVA ISPYTATELEI PRIRODY OTDEL BIOL, V58, P71; SVETLOV P G, 1957, Arkh Anat Gistol Embriol, V34, P3; Sylvester J, 1878, AM J MATH, V1, P64, DOI [DOI 10.2307/2369436, 10.2307/2369436]; SYLVESTER JJ, 1996, KANT HILBERT SOURCE, V1, P511; TAKASO T, 1991, AM J BOT, V78, P417, DOI 10.2307/2444964; Thiele R, 2003, AM MATH MON, V110, P1, DOI 10.2307/3072340; Tillich HJ, 2007, ANN BOT-LONDON, V100, P1413, DOI 10.1093/aob/mcm238; TROLL W, 1950, GOETHES MORPHOLOGISC; TZVELEV NN, 1997, B MOSC SOC NAT BIOL, V102, P54; VELENOVSKY J, 1907, VERGLEICHENDE MORPHO, V2; Weyl H., 1949, PHILOS MATH NATURAL; WEYL H, 1949, PHILOSPOPHY MATH NAT, P266; Wormer PES, 2006, ADV QUANTUM CHEM, V51, P59, DOI 10.1016/S0065-3276(06)51002-0	57	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6969	10.1371/journal.pone.0006969	http://dx.doi.org/10.1371/journal.pone.0006969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759908	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696600010
J	Bjorkholm, B; Bok, CM; Lundin, A; Rafter, J; Hibberd, ML; Pettersson, S				Bjorkholm, Britta; Bok, Chek Mei; Lundin, Annelie; Rafter, Joseph; Hibberd, Martin Lloyd; Pettersson, Sven			Intestinal Microbiota Regulate Xenobiotic Metabolism in the Liver	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; GERM-FREE; NEUROTROPHIC FACTOR; MICROSOMAL METABOLISM; CONDITIONAL DELETION; NUCLEAR RECEPTORS; DRUG-METABOLISM; INNATE IMMUNITY; BILE-ACIDS	Background: The liver is the central organ for xenobiotic metabolism (XM) and is regulated by nuclear receptors such as CAR and PXR, which control the metabolism of drugs. Here we report that gut microbiota influences liver gene expression and alters xenobiotic metabolism in animals exposed to barbiturates. Principal findings: By comparing hepatic gene expression on microarrays from germfree (GF) and conventionally-raised mice (SPF), we identified a cluster of 112 differentially expressed target genes predominantly connected to xenobiotic metabolism and pathways inhibiting RXR function. These findings were functionally validated by exposing GF and SPF mice to pentobarbital which confirmed that xenobiotic metabolism in GF mice is significantly more efficient (shorter time of anesthesia) when compared to the SPF group. Conclusion: Our data demonstrate that gut microbiota modulates hepatic gene expression and function by altering its xenobiotic response to drugs without direct contact with the liver.			Bjorkholm, B (corresponding author), Smittskyddsinst, Swedish Inst Infect Dis Control, Solna, Sweden.	sven.pettersson@ki.se	Hibberd, Martin L/D-5050-2009; Pettersson, Sven/F-9511-2015	Hibberd, Martin/0000-0001-8587-1849				Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; EINARSSO.K, 1974, P SOC EXP BIOL MED, V145, P48; EINARSSON K, 1977, P SOC EXP BIOL MED, V154, P319; EINARSSON K, 1973, J BIOL CHEM, V248, P3623; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gachon F, 2007, ANN MED, V39, P562, DOI 10.1080/07853890701491034; Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Gray J, 2007, INT J OBESITY, V31, P359, DOI 10.1038/sj.ijo.0803390; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; GUSTAFSSON BE, 1977, J LIPID RES, V18, P717; GUSTAFSSON BE, 1975, J BIOL CHEM, V250, P8496; GUSTAFSSON BE, 1960, J EXP MED, V112, P975, DOI 10.1084/jem.112.6.975; Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Meyer UA, 2007, DRUG METAB REV, V39, P639, DOI 10.1080/03602530701498737; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Roth A, 2008, PHARMACOGENET GENOM, V18, P325, DOI 10.1097/FPC.0b013e3282f706e0; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; SNYDER DL, 1990, J GERONTOL, V45, pB52, DOI 10.1093/geronj/45.2.B52; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; TAZUME S, 1991, EXP ANIM TOKYO, V40, P517, DOI 10.1538/expanim1978.40.4_517; Vitek L, 2005, J HEPATOL, V42, P238, DOI 10.1016/j.jhep.2004.10.012; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	38	164	171	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6958	10.1371/journal.pone.0006958	http://dx.doi.org/10.1371/journal.pone.0006958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742318	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000269622500019
J	Gubern, A; Barcelo-Torns, M; Barneda, D; Lopez, JM; Masgrau, R; Picatoste, F; Chalfant, CE; Balsinde, J; Balboa, MA; Claro, E				Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Lopez, Jose M.; Masgrau, Roser; Picatoste, Fernando; Chalfant, Charles E.; Balsinde, Jesus; Balboa, Maria A.; Claro, Enrique			JNK and Ceramide Kinase Govern the Biogenesis of Lipid Droplets through Activation of Group IVA Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; C2 DOMAIN; CALCIUM; PHOSPHORYLATION; TRANSLOCATION; CERAMIDE-1-PHOSPHATE; 1-PHOSPHATE; MACROPHAGES; PROTEINS; BINDING	The biogenesis of lipid droplets (LD) induced by serum depends on group IVA phospholipase A(2) (cPLA(2)alpha). This work dissects the pathway leading to cPLA(2)alpha activation and LD biogenesis. Both processes were Ca2+-independent, as they took place after pharmacological blockade of Ca2+ transients elicited by serum or chelation with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester). The single mutation D43N in cPLA(2)alpha, which abrogates its Ca2+ binding capacity and translocation to membranes, did not affect enzyme activation and formation of LD. In contrast, the mutation S505A did not affect membrane relocation of the enzyme in response to Ca2+ but prevented its phosphorylation, activation, and the appearance of LD. Expression of specific activators of different mitogen-activated protein kinases showed that phosphorylation of cPLA(2)alpha at Ser-505 is due to JNK. This was confirmed by pharmacological inhibition and expression of a dominant-negative form of the upstream activator MEKK1. LD biogenesis was accompanied by increased synthesis of ceramide 1-phosphate. Overexpression of its synthesizing enzyme ceramide kinase increased phosphorylation of cPLA(2)alpha at Ser-505 and formation of LD, and its down-regulation blocked the phosphorylation of cPLA(2)alpha and LD biogenesis. These results demonstrate that LD biogenesis induced by serum is regulated by JNK and ceramide kinase.	[Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Lopez, Jose M.; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Lopez, Jose M.; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Chalfant, Charles E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA; [Balsinde, Jesus; Balboa, Maria A.] Consejo Super Invest Cient, Inst Mol Biol & Genet, E-47003 Valladolid, Spain; [Balsinde, Jesus; Balboa, Maria A.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-47003 Valladolid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Virginia Commonwealth University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M2,Campus UAB, E-08193 Barcelona, Spain.	enrique.claro@uab.es	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020; Claro, Enrique/D-5612-2009; Gubern, Albert/C-9902-2011; Masgrau, Roser/D-3047-2011; Balboa, María A./V-9493-2018; Balsinde, Jesús/C-7833-2018	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262; Claro, Enrique/0000-0002-7592-7906; Gubern, Albert/0000-0001-6458-1498; Masgrau, Roser/0000-0002-6722-5939; Balboa, María A./0000-0002-2130-5298; Balsinde, Jesús/0000-0002-4157-6714; Barneda, David/0000-0002-4436-4100	National Institutes of Health [HL-072925, CA-117990]; Spanish Ministry of Education and Science [SAF 2004-01698, SAF 2007-60055, SAF 2007-67154, BFU2009-07823]; Spanish Ministry of Health [PI05/1723]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-072925 and CA-117990, Grants SAF 2004-01698, SAF 2007-60055, SAF 2007-67154, and BFU2009-07823 from the Spanish Ministry of Education and Science, and Grant PI05/1723 from the Spanish Ministry of Health.	Balboa MA, 2000, BIOCHEM BIOPH RES CO, V267, P145, DOI 10.1006/bbrc.1999.1964; Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Lamour NF, 2005, MOL INTERV, V5, P358, DOI 10.1124/mi.5.6.8; Lee JG, 2008, CELL SIGNAL, V20, P105, DOI 10.1016/j.cellsig.2007.09.003; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Sheridan AM, 2001, J BIOL CHEM, V276, P29899, DOI 10.1074/jbc.M103758200; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Sun XH, 1999, J CELL BIOCHEM, V73, P458, DOI 10.1002/(SICI)1097-4644(19990615)73:4<458::AID-JCB4>3.0.CO;2-0; Wijesinghe DS, 2007, METHOD ENZYMOL, V434, P265, DOI 10.1016/S0076-6879(07)34015-9; Wijesinghe DS, 2005, J LIPID RES, V46, P2706, DOI 10.1194/jlr.M500313-JLR200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040	40	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32359	32369		10.1074/jbc.M109.061515	http://dx.doi.org/10.1074/jbc.M109.061515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778898	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000272028400019
J	Ma, L; Xu, MX; Forman, JR; Clarke, J; Oberhauser, AF				Ma, Liang; Xu, Meixiang; Forman, Julia R.; Clarke, Jane; Oberhauser, Andres F.			Naturally Occurring Mutations Alter the Stability of Polycystin-1 Polycystic Kidney Disease (PKD) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; AUTOSOMAL-DOMINANT; PATHOGENIC MUTATIONS; MECHANICAL STABILITY; MOLECULAR-GENETICS; PROTEINS; TITIN; MECHANOTRANSDUCTION; MECHANOSENSATION; REGION	Mutations in polycystin-1 (PC1) can cause autosomal dominant polycystic kidney disease, which is a leading cause of renal failure. The available evidence suggests that PC1 acts as a mechanosensor, receiving signals from the primary cilia, neighboring cells, and extracellular matrix. PC1 is a large membrane protein that has a long N-terminal extracellular region (about 3000 amino acids) with a multimodular structure including 16 Ig-like polycystic kidney disease (PKD) domains, which are targeted by many naturally occurring missense mutations. Nothing is known about the effects of these mutations on the biophysical properties of PKD domains. Here we investigate the effects of several naturally occurring mutations on the mechanical stability of the first PKD domain of human PC1 (HuPKDd1). We found that several missense mutations alter the mechanical unfolding pathways of HuPKDd1, resulting in distinct mechanical phenotypes. Moreover, we found that these mutations also alter the thermodynamic stability of a structurally homologous archaeal PKD domain. Based on these findings, we hypothesize that missense mutations may cause autosomal dominant polycystic kidney disease by altering the stability of the PC1 ectodomain, thereby perturbing its ability to sense mechanical signals.	[Ma, Liang; Xu, Meixiang; Oberhauser, Andres F.] Dept Neurosci & Cell Biol, Cambridge CB2 1EW, England; [Forman, Julia R.; Clarke, Jane] Univ Cambridge, Chem Lab, MRC Ctr Prot Engn, Cambridge CB2 1EW, England; [Oberhauser, Andres F.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	MRC Laboratory Molecular Biology; University of Cambridge; University of Texas System; University of Texas Medical Branch Galveston	Oberhauser, AF (corresponding author), Dept Neurosci & Cell Biol, Lensfield Rd, Cambridge CB2 1EW, England.	afoberha@utmb.edu			National Institutes of Health [R01DK073394]; John Sealy Memorial Endowment Fund; Polycystic Kidney Foundation [116a2r]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Sealy Memorial Endowment Fund; Polycystic Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK073394 (to A.F.O.). This work was also supported by grants from the John Sealy Memorial Endowment Fund for Biomedical Research and the Polycystic Kidney Foundation (Grant 116a2r).	Alenghat FJ, 2004, EXP CELL RES, V301, P23, DOI 10.1016/j.yexcr.2004.08.003; Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; Best RB, 2002, P NATL ACAD SCI USA, V99, P12143, DOI 10.1073/pnas.192351899; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Bullard B, 2002, J MUSCLE RES CELL M, V23, P435, DOI 10.1023/A:1023454305437; Burtey S, 2002, J MED GENET, V39, P422, DOI 10.1136/jmg.39.6.422; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; Garcia TI, 2009, PROTEINS, V75, P706, DOI 10.1002/prot.22281; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Kaletta T, 2003, NEPHRON EXP NEPHROL, V93, pE9, DOI 10.1159/000066650; Klein DCG, 2003, CHEMPHYSCHEM, V4, P1367, DOI 10.1002/cphc.200300844; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Mathura VS, 2003, BIOINFORMATICS, V19, P1381, DOI 10.1093/bioinformatics/btg164; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Pace C N, 1986, Methods Enzymol, V131, P266; Phakdeekitcharoen B, 2000, KIDNEY INT, V58, P1400, DOI 10.1046/j.1523-1755.2000.00302.x; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Randles LG, 2006, J BIOL CHEM, V281, P24216, DOI 10.1074/jbc.M603593200; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Thomas R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wilson PD, 2004, INT J BIOCHEM CELL B, V36, P1868, DOI 10.1016/j.biocel.2004.03.012; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943	45	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32942	32949		10.1074/jbc.M109.021832	http://dx.doi.org/10.1074/jbc.M109.021832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759016	Green Published, hybrid			2022-12-25	WOS:000272028400077
J	MacKenzie, DA; Tailford, LE; Hemmings, AM; Juge, N				MacKenzie, Donald A.; Tailford, Louise E.; Hemmings, Andrew M.; Juge, Nathalie			Crystal Structure of a Mucus-binding Protein Repeat Reveals an Unexpected Functional Immunoglobulin Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; CELL-SURFACE; PEPTOSTREPTOCOCCUS-MAGNUS; LACTOBACILLUS-PLANTARUM; STAPHYLOCOCCUS-AUREUS; INTESTINAL MUCUS; ADHESION PROPERTIES; PROBIOTIC STRAINS; DOMAIN; IGA	Lactobacillus reuteri mucus-binding protein (MUB) is a cell-surface protein that is involved in bacterial interaction with mucus and colonization of the digestive tract. The 353-kDa mature protein is representative of a broadly important class of adhesins that have remained relatively poorly characterized due to their large size and highly modular nature. MUB contains two different types of repeats (Mub1 and Mub2) present in six and eight copies, respectively, and shown to be responsible for the adherence to intestinal mucus. Here we report the 1.8-A resolution crystal structure of a type 2 Mub repeat (184 amino acids) comprising two structurally related domains resembling the functional repeat found in a family of immunoglobulin (Ig)-binding proteins. The N-terminal domain bears striking structural similarity to the repeat unit of Protein L (PpL) from Peptostreptococcus magnus, suggesting binding in a non-immune Fab-dependent manner. A distorted PpL-like fold is also seen in the C-terminal domain. As with PpL, Mub repeats were able to interact in vitro with a large repertoire of mammalian Igs, including secretory IgA. This hitherto undetected activity is consistent with the current model that antibody responses against commensal flora are of broad specificity and low affinity.	[Hemmings, Andrew M.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Hemmings, Andrew M.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of East Anglia; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Hemmings, AM (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.hemmings@uea.ac.uk; nathalie.juge@bbsrc.ac.uk	HEMMINGS, ANDREW MICHAEL/E-5517-2011	HEMMINGS, ANDREW MICHAEL/0000-0003-3053-3134; Juge, Nathalie/0000-0001-8515-1315	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042268] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; BBSRC [BBS/E/F/00042268] Funding Source: UKRI; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a Biotechnology and Biological Sciences Research Council core strategic grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agniswamy J, 2006, STRUCTURE, V14, P225, DOI 10.1016/j.str.2005.10.012; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Beckingham JA, 2001, BIOCHEM J, V353, P395, DOI 10.1042/0264-6021:3530395; Beckingham JA, 1999, BIOCHEM J, V340, P193, DOI 10.1042/0264-6021:3400193; BJORCK L, 1988, J IMMUNOL, V140, P1194; BJORCK L, 1984, J IMMUNOL, V133, P969; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; Bumbaca D, 2007, PROTEINS, V66, P547, DOI 10.1002/prot.21205; Collado MC, 2007, CURR MICROBIOL, V55, P260, DOI 10.1007/s00284-007-0144-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Vrese M, 2007, J NUTR, V137, p803S, DOI 10.1093/jn/137.3.803S; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enokizono J, 1997, J MOL BIOL, V270, P8, DOI 10.1006/jmbi.1997.1090; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gill H, 2008, ADV EXP MED BIOL, V606, P423, DOI 10.1007/978-0-387-74087-4_17; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GOWARD CR, 1993, TRENDS BIOCHEM SCI, V18, P136, DOI 10.1016/0968-0004(93)90021-E; Graille M, 2002, J BIOL CHEM, V277, P47500, DOI 10.1074/jbc.M206105200; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Housden NG, 2003, BIOCHEM SOC T, V31, P716, DOI 10.1042/BST0310716; KASTERN W, 1992, J BIOL CHEM, V267, P12820; Kazeeva TN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P12, DOI 10.1134/S0006297909010027; Kirjavainen PV, 1998, FEMS MICROBIOL LETT, V167, P185, DOI 10.1016/S0378-1097(98)00387-5; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; LANGONE JJ, 1982, ADV IMMUNOL, V32, P157; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Leo JC, 2009, MOL IMMUNOL, V46, P1860, DOI 10.1016/j.molimm.2009.02.024; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li XJ, 2008, J APPL MICROBIOL, V104, P1082, DOI 10.1111/j.1365-2672.2007.03636.x; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Ma YL, 2006, LETT APPL MICROBIOL, V42, P369, DOI 10.1111/j.1472-765X.2006.01844.x; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Macfarlane S, 2004, CLIN INFECT DIS, V38, P1690, DOI 10.1086/420823; MACIASRODRIGUEZ ME, 2009, J APPL MICROBIOL, DOI DOI 10.1111/I.1365-2672.2009.04368; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Miyoshi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1622, DOI 10.1271/bbb.50688; Munoz-Provencio D, 2009, ARCH MICROBIOL, V191, P153, DOI 10.1007/s00203-008-0436-9; MURPHY JP, 1994, MOL MICROBIOL, V12, P911, DOI 10.1111/j.1365-2958.1994.tb01079.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; SJODAHL J, 1977, EUR J BIOCHEM, V73, P343, DOI 10.1111/j.1432-1033.1977.tb11324.x; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sun J, 2007, LETT APPL MICROBIOL, V44, P79, DOI 10.1111/j.1472-765X.2006.02031.x; Svensson HG, 2004, BIOCHEMISTRY-US, V43, P2445, DOI 10.1021/bi034873s; Tallon R, 2007, J APPL MICROBIOL, V102, P442, DOI 10.1111/j.1365-2672.2006.03086.x; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vesterlund S, 2006, MICROBIOL-SGM, V152, P1819, DOI 10.1099/mic.0.28522-0; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WIKSTROM M, 1994, BIOCHEMISTRY-US, V33, P14011, DOI 10.1021/bi00251a008; WIKSTROM M, 1995, J MOL BIOL, V250, P128, DOI 10.1006/jmbi.1995.0364; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x	83	59	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32444	32453		10.1074/jbc.M109.040907	http://dx.doi.org/10.1074/jbc.M109.040907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19758995	hybrid, Green Published			2022-12-25	WOS:000272028400027
J	Holberger, LE; Hayes, CS				Holberger, Laura E.; Hayes, Christopher S.			Ribosomal Protein S12 and Aminoglycoside Antibiotics Modulate A-site mRNA Cleavage and Transfer-Messenger RNA Activity in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-TRANSFER-RNA; TAGGED PROTEINS; QUALITY-CONTROL; TAGGING SYSTEM; HYPER-ACCURATE; STOP CODONS; RPSL GENE; TRANSLATION; TMRNA; STREPTOMYCIN	Translational pausing in Escherichia coli can lead to mRNA cleavage within the ribosomal A-site. A-site mRNA cleavage is thought to facilitate transfer-messenger RNA (tmRNA).SmpB-mediated recycling of stalled ribosome complexes. Here, we demonstrate that the aminoglycosides paromomycin and streptomycin inhibit A-site cleavage of stop codons during inefficient translation termination. Aminoglycosides also induced stop codon read-through, suggesting that these antibiotics alleviate ribosome pausing during termination. Streptomycin did not inhibit A-site cleavage in rpsL mutants, which express streptomycin-resistant variants of ribosomal protein S12. However, rpsL strains exhibited reduced A-site mRNA cleavage compared with rpsL(+) cells. Additionally, tmRNA.SmpB-mediated SsrA peptide tagging was significantly reduced in several rpsL strains but could be fully restored in a subset of mutants when treated with streptomycin. The streptomycin-dependent rpsL(P90K) mutant also showed significantly lower levels of A-site cleavage and tmRNA.SmpB activity. Mutations in rpsD (encoding ribosomal protein S4), which suppressed streptomycin dependence, were able to partially restore A-site cleavage to rpsL(P90K) cells but failed to increase tmRNA.SmpB activity. Taken together, these results show that perturbations to A-site structure and function modulate A-site mRNA cleavage and tmRNA.SmpB activity. We propose that tmRNA.SmpB binds to streptomycin-resistant rpsL ribosomes less efficiently, leading to a partial loss of ribosome rescue function in these mutants.	[Holberger, Laura E.; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Biomol Sci, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Life Sci Technol Bldg,Rm 3105, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu	Hayes, Christopher/A-5505-2009	Holberger, Laura/0000-0002-6704-8522	National Institutes of Health [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM078634.	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; BENZER S, 1962, P NATL ACAD SCI USA, V48, P1114, DOI 10.1073/pnas.48.7.1114; BILGIN N, 1992, J MOL BIOL, V224, P1011, DOI 10.1016/0022-2836(92)90466-W; BISWAS DK, 1972, P NATL ACAD SCI USA, V69, P2141, DOI 10.1073/pnas.69.8.2141; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CHANG FN, 1972, ANTIMICROB AGENTS CH, V2, P294, DOI 10.1128/AAC.2.4.294; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Corvaisier S, 2003, J BIOL CHEM, V278, P14788, DOI 10.1074/jbc.M212830200; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Diner EJ, 2009, J MOL BIOL, V386, P300, DOI 10.1016/j.jmb.2008.12.064; DONG HJ, 1995, J MOL BIOL, V248, P551, DOI 10.1006/jmbi.1995.0242; GARVIN RT, 1974, P NATL ACAD SCI USA, V71, P3814, DOI 10.1073/pnas.71.10.3814; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hayes CS, 1998, J BIOL CHEM, V273, P17326, DOI 10.1074/jbc.273.28.17326; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Ivanova N, 2005, NUCLEIC ACIDS RES, V33, P3529, DOI 10.1093/nar/gki666; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; KARIMI R, 1994, EUR J BIOCHEM, V226, P355, DOI 10.1111/j.1432-1033.1994.tb20059.x; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kurita D, 2007, NUCLEIC ACIDS RES, V35, P7248, DOI 10.1093/nar/gkm677; Kurland C.G., 1996, ESCHERICHIA COLI SAL, P979; Luidalepp Hannes, 2005, RNA Biol, V2, P70, DOI 10.4161/rna.2.2.2020; Mikkelsen NE, 1999, P NATL ACAD SCI USA, V96, P6155, DOI 10.1073/pnas.96.11.6155; MODOLELL J, 1970, P NATL ACAD SCI USA, V67, P1148, DOI 10.1073/pnas.67.3.1148; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Nonin-Lecomte S, 2009, EMBO REP, V10, P160, DOI 10.1038/embor.2008.243; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; ORIAS E, 1966, J BACTERIOL, V91, P2210, DOI 10.1128/JB.91.6.2210-2215.1966; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Takahashi T, 2003, J BIOL CHEM, V278, P27672, DOI 10.1074/jbc.M211724200; TIMMS AR, 1995, MUTAGENESIS, V10, P463, DOI 10.1093/mutage/10.5.463; TIMMS AR, 1992, MOL GEN GENET, V232, P89, DOI 10.1007/BF00299141; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015	56	24	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32188	32200		10.1074/jbc.M109.062745	http://dx.doi.org/10.1074/jbc.M109.062745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776006	Green Published, hybrid			2022-12-25	WOS:000271572700073
J	Bernard, K; Wang, W; Narlawar, R; Schmidt, B; Kirk, KL				Bernard, Karen; Wang, Wei; Narlawar, Rajeshwar; Schmidt, Boris; Kirk, Kevin L.			Curcumin Cross-links Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Polypeptides and Potentiates CFTR Channel Activity by Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CHLORIDE CHANNEL; PLASMA-MEMBRANE; DELTA-F508 CFTR; PROTEIN; CELLS; MUTATION; DISEASE; DIMERIZATION; ULTRAVIOLET	Cystic fibrosis (CF) is caused by loss-of-function mutations in the CFTR chloride channel. Wild type and mutant CFTR channels can be activated by curcumin, a well tolerated dietary compound with some appeal as a prospective CF therapeutic. However, we show here that curcumin has the unexpected effect of cross-linking CFTR polypeptides into SDS-resistant oligomers. This effect occurred for CFTR channels in microsomes as well as in intact cells and at the same concentrations that are effective for promoting CFTR channel activity (5-50 mu M). Both mature CFTR polypeptides at the cell surface and immature CFTR protein in the endoplasmic reticulum were cross-linked by curcumin, although the latter pool was more susceptible to this modification. Curcumin cross-linked two CF mutant channels (Delta F508 and G551D) as well as a variety of deletion constructs that lack the major cytoplasmic domains. In vitro cross-linking could be prevented by high concentrations of oxidant scavengers (i.e. reduced glutathione and sodium azide) indicating a possible oxidation reaction with the CFTR polypeptide. Importantly, cyclic derivatives of curcumin that lack the reactive beta diketone moiety had no cross-linking activity. One of these cyclic derivatives stimulated the activities of wild type CFTR channels, Lambda 1198-CFTR channels, and G551D-CFTR channels in excised membrane patches. Like the parent compound, the cyclic derivative irreversibly activated CFTR channels in excised patches during prolonged exposure (> 5 min). Our results raise a note of caution about secondary biochemical effects of reactive compounds like curcumin in the treatment of CF. Cyclic curcumin derivatives may have better therapeutic potential in this regard.	[Bernard, Karen; Wang, Wei; Kirk, Kevin L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Bernard, Karen; Wang, Wei; Kirk, Kevin L.] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Narlawar, Rajeshwar; Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, D-64287 Darmstadt, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Technical University of Darmstadt	Kirk, KL (corresponding author), Univ Alabama, Dept Physiol & Biophys, 982B MCLM, Birmingham, AL 35294 USA.	klkirk@uab.edu	Schmidt, Boris/M-7886-2019; Narlawar, Rajeshwar/E-4981-2010; Schmidt, Boris/D-3293-2009	Schmidt, Boris/0000-0003-1662-2392; Schmidt, Boris/0000-0003-1662-2392	NCRR [S10 RR13795, S10 RR16849]; UAB Health Services Foundation General Endowment Fund; UAB Comprehensive Cancer Center [P30 CA13148]; National Institutes of Health [DK56796]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016849, S10RR013795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796, R56DK056796] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UAB Health Services Foundation General Endowment Fund; UAB Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Ge Li for technical assistance. We thank the UAB Mass Spectrometry Shared Facility for assistance with the MALDI-TOF analysis (supported by NCRR Shared Instrumentation Grants (S10 RR13795, S10 RR16849), UAB Health Services Foundation General Endowment Fund, and the UAB Comprehensive Cancer Center Core Support Grant (P30 CA13148).; This work was supported, in whole or in part, by National Institutes of Health Grant DK56796 (to K. L. K.).	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Arnbjerg J, 2007, J PHYS CHEM A, V111, P5756, DOI 10.1021/jp0711971; Barrondo S, 2009, NEUROPHARMACOLOGY, V56, P455, DOI 10.1016/j.neuropharm.2008.09.018; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHIGNELL CF, 1994, PHOTOCHEM PHOTOBIOL, V59, P295, DOI 10.1111/j.1751-1097.1994.tb05037.x; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; FRIZZELL RA, 1995, AM J RESP CRIT CARE, V151, pS54, DOI 10.1164/ajrccm/151.3_Pt_2.S54; Fujiwara H, 2008, DIABETES RES CLIN PR, V80, P185, DOI 10.1016/j.diabres.2007.12.004; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Grubb BR, 2006, AM J RESP CELL MOL, V34, P355, DOI 10.1165/rcmb.2005-0286OC; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hirasawa M, 2005, PHOTOSYNTH RES, V86, P325, DOI 10.1007/s11120-005-6966-y; Holy J, 2004, CELL MOTIL CYTOSKEL, V58, P253, DOI 10.1002/cm.20012; Hung WC, 2008, BIOPHYS J, V94, P4331, DOI 10.1529/biophysj.107.126888; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jung YJ, 2007, BBA-MOL CELL RES, V1773, P383, DOI 10.1016/j.bbamcr.2006.11.004; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Murthy M, 2005, EUR J PHARMACOL, V516, P118, DOI 10.1016/j.ejphar.2005.04.037; Narlawar R, 2008, CHEMMEDCHEM, V3, P165, DOI 10.1002/cmdc.200700218; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Pattison DI, 2006, EXP SUPPL, V96, P131; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Shen HR, 1996, J PHOTOCH PHOTOBIO B, V35, P213, DOI 10.1016/S1011-1344(96)07300-9; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; Stanwell C, 1996, BIOCHEM PHARMACOL, V52, P475, DOI 10.1016/0006-2952(96)00250-X; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verna LK, 1998, CELL BIOL TOXICOL, V14, P237, DOI 10.1023/A:1007474912498; Wang J, 2009, BIOCHEM PHARMACOL, V78, P178, DOI 10.1016/j.bcp.2009.03.031; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zhu XC, 2007, REDOX REP, V12, P45, DOI 10.1179/135100007X162176	51	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30754	30765		10.1074/jbc.M109.056010	http://dx.doi.org/10.1074/jbc.M109.056010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740743	Green Published, hybrid			2022-12-25	WOS:000271378400003
J	Falsone, SF; Kungl, AJ; Rek, A; Cappai, R; Zangger, K				Falsone, S. Fabio; Kungl, Andreas J.; Rek, Angelika; Cappai, Roberto; Zangger, Klaus			The Molecular Chaperone Hsp90 Modulates Intermediate Steps of Amyloid Assembly of the Parkinson-related Protein alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; LEWY BODIES; CONFORMATIONAL-CHANGES; ATP HYDROLYSIS; LIVING CELLS; AGGREGATION; OLIGOMERS; DISEASE; TOXICITY; COMPLEX	alpha-Synuclein is an intrinsically unstructured protein that binds to membranes, forms fibrils, and is involved in neurodegeneration. Weused a reconstituted in vitro system to show that the molecular chaperone Hsp90 influenced alpha-synuclein vesicle binding and amyloid fibril formation, two processes that are tightly coupled to alpha-synuclein folding. Binding of Hsp90 to monomeric alpha-synuclein occurred in the low micromolar range, involving regions of alpha-synuclein that are critical for vesicle binding and amyloidogenesis. As a consequence, both processes were affected. In the absence of ATP, the accumulation of non-amyloid alpha-synuclein oligomers prevailed over fibril formation, whereas ATP favored fibril growth. This suggests that Hsp90 modulates the assembly of alpha-synuclein in an ATP-dependent manner. We propose that Hsp90 affects these folding processes by restricting conformational fluctuations of alpha-synuclein.	[Falsone, S. Fabio; Zangger, Klaus] Graz Univ, Inst Chem, A-8010 Graz, Austria; [Kungl, Andreas J.; Rek, Angelika] Graz Univ, Inst Pharmaceut Sci, A-8010 Graz, Austria; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Graz; University of Graz; University of Melbourne	Falsone, SF (corresponding author), Graz Univ, Inst Chem, Heinrichstr 28, A-8010 Graz, Austria.	fabio.falsone@uni-graz.at	Cappai, Roberto/B-3347-2010	Cappai, Roberto/0000-0002-9505-8496; Zangger, Klaus/0000-0003-1682-1594; Falsone, Salvatore Fabio/0000-0002-3724-5824; Kungl, Andreas/0000-0003-3362-797X	Austrian Science Fund [P20020]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund number P20020 (to K.Z.).	Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Cantuti-Castelvetri I, 2005, J NEUROPATH EXP NEUR, V64, P1058, DOI 10.1097/01.jnen.0000190063.90440.69; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Gall C, 2007, PROTEIN SCI, V16, P2510, DOI 10.1110/ps.073062707; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liang J, 2008, HUM MOL GENET, V17, P3784, DOI 10.1093/hmg/ddn276; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pountney DL, 2005, NEUROTOX RES, V7, P59, DOI 10.1007/BF03033776; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	50	92	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31190	31199		10.1074/jbc.M109.057240	http://dx.doi.org/10.1074/jbc.M109.057240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759002	Green Published, hybrid			2022-12-25	WOS:000271378400047
J	Jepson, JEC; Reenan, RA				Jepson, James E. C.; Reenan, Robert A.			Adenosine-to-Inosine Genetic Recoding Is Required in the Adult Stage Nervous System for Coordinated Behavior in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLUTIONARY CONSERVATION; LOCOMOTOR-ACTIVITY; MELANOGASTER; DEAMINASE; EXPRESSION; MUTANTS; TARGETS; CELLS; SLEEP; ADAR	Adenosine deaminases acting on RNA (ADARs) catalyze the deamination of adenosine to inosine in double-stranded RNA templates, a process known as RNA editing. In Drosophila, multiple ADAR isoforms are generated from a single locus (dAdar) via post-transcriptional modifications. Collectively, these isoforms act to edit a wide range of transcripts involved in neuronal signaling, as well as the precursors of endogenous small interfering RNAs. The phenotypic consequences of a loss of dADAR activity have been well characterized and consist of profound behavioral defects manifested at the adult stage, including extreme uncoordination, seizures, and temperature-sensitive paralysis. However, the spatio-temporal requirements of adenosine to inosine editing for correct behavior are unclear. Using transgenic RNA interference, we show that network-wide editing in the nervous system is required for normal adult locomotion. Regulated restoration of editing activity demonstrates that the neuronal requirement of dADAR activity has a significant adult stage component. Furthermore we show that in relation to behavior there are no observable genetic interactions between dAdar and several loci encoding RNA interference components, suggesting that editing of neuronal transcripts is the key mode of ADAR activity for normal behavior in Drosophila.	[Jepson, James E. C.; Reenan, Robert A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Reenan, RA (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, SFH Life Sci Bldg,185 Meeting St, Providence, RI 02912 USA.	Robert_Reenan@brown.edu		jepson, james/0000-0002-3357-2801	Ellison Medical Foundation Senior Scholar award	Ellison Medical Foundation Senior Scholar award(Lawrence Ellison Foundation)	This work was supported by an Ellison Medical Foundation Senior Scholar award.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 2001, RNA EDITING, P94; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grauso M, 2002, GENETICS, V160, P1519; Hanrahan CJ, 2000, GENETICS, V155, P1149; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Ingleby L, 2009, J GEN PHYSIOL, V133, P17, DOI 10.1085/jgp.200810133; Jin YF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-98; Jones AK, 2009, J NEUROSCI, V29, P4287, DOI 10.1523/JNEUROSCI.5251-08.2009; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Maas S, 1996, J BIOL CHEM, V271, P12221, DOI 10.1074/jbc.271.21.12221; Martin JR, 1998, LEARN MEMORY, V5, P179; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Peixoto AA, 1998, GENETICS, V148, P827; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; Smith L A, 1998, J Neurogenet, V12, P227; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200	45	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31391	31400		10.1074/jbc.M109.035048	http://dx.doi.org/10.1074/jbc.M109.035048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759011	hybrid, Green Published			2022-12-25	WOS:000271378400064
J	Jha, P; Manickam, B; Matta, B; Bora, PS; Bora, NS				Jha, Purushottam; Manickam, Balasubramanian; Matta, Bharati; Bora, Puran S.; Bora, Nalini S.			Proteolytic Cleavage of Type I Collagen Generates an Autoantigen in Autoimmune Uveitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANIN-ASSOCIATED ANTIGEN; COMPLEMENT REGULATORY PROTEINS; ANTERIOR UVEITIS; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; FIBROBLASTS; EXPRESSION; INDUCTION; EAAU; SPECIFICITY	This study was initiated to induce experimental autoimmune anterior uveitis (EAAU) in Lewis rats by melanin-associated antigen (MAA; 22-kDa fragment of type I collagen alpha 2 chain) derived from rat iris and ciliary body (CB), to localize MAA within the eye, and to investigate the possible mechanism of MAA generation in vivo. The EAAU model replicates idiopathic human anterior uveitis. Lewis rats sensitized to rat MAA developed anterior uveitis, and EAAU induced by rat MAA can be adoptively transferred to naive syngenic rats by MAA-primed T cells. Animals immunized with rat MAA developed cellular immunity to the antigen. MAA was detected only in the iris and CB of the eye. Iris and CB were the major source of matrix metalloproteinase-1 (MMP-1) in the naive eye, and ocular expression of MMP-1 was up-regulated, whereas expression of tissue inhibitor of metalloproteinase 1 decreased before the onset of EAAU. These results demonstrated that EAAU can be induced by autologous MAA. Uveitogenic antigen is present only in the iris and CB of the eye, and the imbalance between MMP-1 and tissue inhibitor of metalloproteinase 1 may play a role in the generation of MAA in vivo. Collectively, the evidence presented here suggests that MAA is an autoantigen in EAAU. These observations may extend to idiopathic human anterior uveitis and facilitate the development of antigen-specific therapy.	[Jha, Purushottam; Manickam, Balasubramanian; Matta, Bharati; Bora, Puran S.; Bora, Nalini S.] Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bora, NS (corresponding author), Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, 4301 W Markham,Mail Slot 523, Little Rock, AR 72205 USA.	nbora@uams.edu		Bora, Puran/0000-0003-4781-1217	National Institutes of Health [EY016205, EY 014623]; Pat and Willard Walker Eye Research Center; Jones Eye Institute and Arkansas Master Tobacco Settlement; Arkansas Biosciences Institute, University of Arkansas for Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016205, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat and Willard Walker Eye Research Center; Jones Eye Institute and Arkansas Master Tobacco Settlement; Arkansas Biosciences Institute, University of Arkansas for Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016205 and EY 014623. This work was also supported by the Pat and Willard Walker Eye Research Center, the Jones Eye Institute and Arkansas Master Tobacco Settlement, and the Arkansas Biosciences Institute, University of Arkansas for Medical Sciences (Little Rock, AR).	Abe T, 1997, EXP EYE RES, V65, P703, DOI 10.1006/exer.1997.0379; Akiyama K, 1997, RES COMMUN MOL PATH, V95, P115; Atassi MZ, 2008, AUTOIMMUNITY, V41, P123, DOI 10.1080/08916930801929021; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Bora Nalini S, 2007, Chem Immunol Allergy, V92, P213, DOI 10.1159/000099272; Bora NS, 2004, J IMMUNOL, V172, P7086, DOI 10.4049/jimmunol.172.11.7086; Bora NS, 1997, INVEST OPHTH VIS SCI, V38, P2171; BORA NS, 1995, INVEST OPHTH VIS SCI, V36, P1056; BROEKHUYSE RM, 1991, EXP EYE RES, V52, P465, DOI 10.1016/0014-4835(91)90044-F; Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO;2-V; CHEDEKEL MR, 1992, PIGM CELL RES, V5, P240, DOI 10.1111/j.1600-0749.1992.tb00543.x; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; FLING SP, 1991, J IMMUNOL, V147, P483; Gaton DD, 1999, INVEST OPHTH VIS SCI, V40, P363; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Higashikata T, 2006, ATHEROSCLEROSIS, V185, P165, DOI 10.1016/j.atherosclerosis.2005.05.039; Jha P, 2006, INVEST OPHTH VIS SCI, V47, P1030, DOI 10.1167/iovs.05-1062; Jha P, 2007, INVEST OPHTH VIS SCI, V48, P5091, DOI 10.1167/iovs.07-0651; Jha P, 2006, J IMMUNOL, V176, P7221, DOI 10.4049/jimmunol.176.12.7221; Kielty Cay M., 1993, P103; KIM MC, 1995, CURR EYE RES, V14, P703, DOI 10.3109/02713689508998498; KIVIRIKKO KI, 1992, HYDROXYLATION PROLIN, P1; Krane SM, 1996, J BIOL CHEM, V271, P28509, DOI 10.1074/jbc.271.45.28509; Leonardi A, 2003, INVEST OPHTH VIS SCI, V44, P183, DOI 10.1167/iovs.02-0420; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MARSHALL GE, 1993, BRIT J OPHTHALMOL, V77, P515, DOI 10.1136/bjo.77.8.515; Matsuo A, 1997, AM J PATHOL, V150, P1253; Matta B, 2008, AM J PATHOL, V173, P1440, DOI 10.2353/ajpath.2008.080150; NORDLUND JJ, 1989, J INVEST DERMATOL S, V92, P53; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Searle A.G., 1968, COMP GENETICS COAT C; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; WOODS AC, 1962, UVEITIS ASS COLL DIS; Wu CT, 2005, ANN NY ACAD SCI, V1050, P134, DOI 10.1196/annals.1313.015	40	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31401	31411		10.1074/jbc.M109.033381	http://dx.doi.org/10.1074/jbc.M109.033381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755419	Green Published, hybrid			2022-12-25	WOS:000271378400065
J	Clark, JL; Lescano, AG; Konda, KA; Leon, SR; Jones, FR; Klausner, JD; Coates, TJ; Caceres, CF				Clark, Jesse L.; Lescano, Andres G.; Konda, Kelika A.; Leon, Segundo R.; Jones, Franca R.; Klausner, Jeffrey D.; Coates, Thomas J.; Caceres, Carlos F.		NIMH Int Collaborative HIV STD Pre	Syndromic Management and STI Control in Urban Peru	PLOS ONE			English	Article								Background: Syndromic management is an inexpensive and effective method for the treatment of symptomatic sexually transmitted infections (STIs), but its effectiveness as a method of STI control in at-risk populations is questionable. We sought to determine the potential utility of syndromic management as a public health strategy to control STI transmission in high-risk populations in urban Peru. Methodology: We surveyed 3,285 at-risk men and women from three Peruvian cities from 2003-05. Participants were asked about the presence of genital ulcers, discharge, or dysuria in the preceding six months. Participants reporting symptoms were asked about subsequent health-seeking and partner notification behavior. Urine and vaginal swab samples were tested for Neisseria gonorrhoeae and Chlamydia trachomatis by nucleic acid testing. Serum was tested for syphilis and Herpes Simplex Virus-Type 2 antibodies. Findings: Recent urogenital discharge or dysuria was reported by 42.1% of participants with gonorrhea or chlamydia versus 28.3% of participants without infection. Genital ulceration was reported by 6.2% of participants with, and 7.4% of participants without, recent syphilis. Many participants reporting symptoms continued sexual activity while symptomatic, and approximately half of all symptomatic participants sought treatment. The positive and negative predictive values of urogenital discharge or genital ulcer disease in detecting STIs that are common in the study population were 14.4% and 81.5% for chlamydia in women and 8.3% and 89.5% for syphilis among gay-identified men. Conclusions: In our study, STIs among high-risk men and women in urban Peru were frequently asymptomatic and symptomatic participants often remained sexually active without seeking treatment. Additional research is needed to assess the costs and benefits of targeted, laboratory-based STI screening as part of a comprehensive STI control program in developing countries.			Clark, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA.	jlclark@mednet.ucla.edu	Lescano, Andres G./M-9849-2019; Lescano, Andres G/B-8479-2008; Leon, Segundo Ramos/J-3058-2019	Lescano, Andres G./0000-0001-9779-633X; Lescano, Andres G/0000-0001-9779-633X; Leon, Segundo Ramos/0000-0002-5630-5714; Caceres, Carlos F./0000-0002-8101-0790; Clark, Jesse/0000-0001-5862-6530	FIC NIH HHS [D43 TW007393-06, D43 TW007393] Funding Source: Medline; NIMH NIH HHS [T32 MH080634, U10 MH061536, K23 MH084611, U10 MH61536] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634, U10MH061536, K23MH084611] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams EJ, 2003, SEX TRANSM DIS, V30, P379, DOI 10.1097/00007435-200305000-00002; Caceres CF, 2008, AIDS BEHAV, V12, P544, DOI 10.1007/s10461-007-9348-y; Crosby RA, 2004, SEX TRANSM DIS, V31, P421, DOI [10.1097/01.OLQ.0000130534.12309.2C, 10.1097/01.olq.0000130534.12309.2C]; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Garcia PJ, 2007, SEX TRANSM INFECT, V83, P142, DOI 10.1136/sti.2006.022657; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Hook EW, 1997, SEX TRANSM DIS, V24, P443, DOI 10.1097/00007435-199709000-00001; Irwin DE, 1999, SEX TRANSM DIS, V26, P286, DOI 10.1097/00007435-199905000-00009; Konda KA, 2005, SEX TRANSM DIS, V32, P534, DOI 10.1097/01.olq.0000175413.89733.ae; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Liu HJ, 2003, SEX TRANSM DIS, V30, P327, DOI 10.1097/00007435-200304000-00010; Liu HJ, 2002, SEX TRANSM DIS, V29, P335, DOI 10.1097/00007435-200206000-00005; *MIN SAL, 2004, GUIAS NAC AT INT SAL; RAY K, 2009, INT J INFECT DIS; Romoren M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-27; Sanchez J, 2002, SEX TRANSM DIS, V29, P559, DOI 10.1097/00007435-200210000-00001; STIGMA, 2019, GUID MAN SEX TRANSM; Tann CJ, 2006, SEX TRANSM INFECT, V82, P285, DOI 10.1136/sti.2005.014845; TSAI CH, 2008, SEX TRANSM INFECT; VIBERG N, 2009, SEX TRANSM IN PRESS; Wang QQ, 2002, INT J STD AIDS, V13, P469, DOI 10.1258/09564620260079626; Wilkinson D, 1999, B WORLD HEALTH ORGAN, V77, P22	22	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7201	10.1371/journal.pone.0007201	http://dx.doi.org/10.1371/journal.pone.0007201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779620	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200022
J	Cremieux, AC; Dumitrescu, O; Lina, G; Vallee, C; Cote, JF; Muffat-Joly, M; Lilin, T; Etienne, J; Vandenesch, F; Saleh-Mghir, A				Cremieux, Anne-Claude; Dumitrescu, Oana; Lina, Gerard; Vallee, Christian; Cote, Jean-Francois; Muffat-Joly, Martine; Lilin, Thomas; Etienne, Jerome; Vandenesch, Francois; Saleh-Mghir, Azzam			Panton-Valentine Leukocidin Enhances the Severity of Community-Associated Methicillin-Resistant Staphylococcus aureus Rabbit Osteomyelitis	PLOS ONE			English	Article								Background: Extensive spread of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in the United States, and the concomitant increase in severe invasive staphylococcal infections, including osteomyelitis, in healthy children, has led to renewed interest in Panton-Valentine leukocidin (PVL). However, the pathogenetic role of PVL in staphylococcal infections remains controversial, possibly because it depends on the site of infection. Methodology/Principal Findings: We compared the course of experimental rabbit osteomyelitis due to the PVL-positive CA-MRSA strain USA 300 (LAC) and its PVL-negative isogenic derivative (LAC Delta pvl), using a low and a high inoculum (8610 5 and 4 x 10(8) CFU). With the low inoculum, bone infection was less frequent on day 7 (D7) and day 28 (D28) with LACDpvl than with LAC (respectively 12/19 and 18/19 animals, p = 0.042). With the high inoculum of both strains, all the animals were infected on D7 and the infection persisted on D28 in almost every case. However, tibial bacterial counts and the serum CRP concentration fell significantly between D7 and D28 with LACDpvl but not with LAC. Respectively 67% and 60% of LAC-infected rabbits had bone deformation and muscle/joint involvement on D7, compared to 0% and 7% of LAC Delta pvl-infected rabbits (p = 0.001 and p = 0.005 respectively). Between D0 and D28, the anti-PVL antibody titer increased significantly only with the high inoculum of LAC. Conclusions/Significance: PVL appears to play a role in the persistence and rapid local extension of rabbit osteomyelitis, in keeping with the greater severity of human bone infections due to PVL-positive S. aureus. The possible therapeutic implications of these findings are discussed.			Cremieux, AC (corresponding author), Hop Raymond Poincare, AP HP, Dept Med Aigue, Garches, France.	anne-claude.cremieux@rpc.aphp.fr; denesch@univ-lyon1.fr	Vandenesch, Francois/C-7209-2014; Lina, Gerard J/L-9352-2014; Dumitrescu, Oana/C-6222-2013; ETIENNE, Jerome/C-5471-2014	Vandenesch, Francois/0000-0001-9412-7106; Dumitrescu, Oana/0000-0001-8193-1437; ETIENNE, Jerome/0000-0002-3348-3315; Lina, Gerard/0000-0002-9236-7998				Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Brown EL, 2009, CLIN VACCINE IMMUNOL, V16, P139, DOI 10.1128/CVI.00360-08; Chambers HF, 2009, J INFECT DIS, V199, P291, DOI 10.1086/595983; Cremieux AC, 1997, CLIN INFECT DIS, V25, P1295, DOI 10.1086/516135; Croze M, 2009, CLIN MICROBIOL INFEC, V15, P144, DOI 10.1111/j.1469-0691.2008.02650.x; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gerber JS, 2009, CLIN INFECT DIS, V49, P65, DOI 10.1086/599348; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410; Panton PN, 1932, LANCET, V1, P506; Scheman L, 1941, J AMER MED ASSOC, V117, P1525, DOI 10.1001/jama.1941.02820440033008; SZMIGIELSKI S, 1966, J PATHOL BACTERIOL, V91, P599, DOI 10.1002/path.1700910237; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Valentine FCO, 1939, LANCET, V1, P973; VOLK A, 1994, MAGN RESON IMAGING, V12, P1039, DOI 10.1016/0730-725X(94)91235-O; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; WALDVOGEL FA, 1970, NEW ENGL J MED, V282, P316, DOI 10.1056/NEJM197002052820606; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; WHALEN JL, 1988, J BONE JOINT SURG AM, V70A, P1383, DOI 10.2106/00004623-198870090-00017; 2007, MMWR MORB MORTAL WKL, V56, P325; 2001, J AM VET MED ASS, V218, P669	31	93	95	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7204	10.1371/journal.pone.0007204	http://dx.doi.org/10.1371/journal.pone.0007204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779608	Green Submitted, Green Published, gold			2022-12-25	WOS:000270176200024
J	Davis, DR; Zhang, YQ; Smith, RR; Cheng, K; Terrovitis, J; Malliaras, K; Li, TS; White, A; Makkar, R; Marban, E				Davis, Darryl R.; Zhang, Yiqiang; Smith, Rachel R.; Cheng, Ke; Terrovitis, John; Malliaras, Konstantinos; Li, Tao-Sheng; White, Anthony; Makkar, Raj; Marban, Eduardo			Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue	PLOS ONE			English	Article							STEM-CELLS; ADULT; RENEWAL	Background: At least four laboratories have shown that endogenous cardiac progenitor cells (CPCs) can be grown directly from adult heart tissue in primary culture, as cardiospheres or their progeny (cardiosphere-derived cells, CDCs). Indeed, CDCs are already being tested in a clinical trial for cardiac regeneration. Nevertheless, the validity of the cardiosphere strategy to generate CPCs has been called into question by reports based on variant methods. In those reports, cardiospheres are argued to be cardiomyogenic only because of retained cardiomyocytes, and stem cell activity has been proposed to reflect hematological contamination. We use a variety of approaches (including genetic lineage tracing) to show that neither artifact is applicable to cardiospheres and CDCs grown using established methods, and we further document the stem cell characteristics (namely, clonogenicity and multilineage potential) of CDCs. Methodology/Principal Findings: CPCs were expanded from human endomyocardial biopsies (n = 160), adult bi-transgenic MerCreMer-Z/EG mice (n = 6), adult C57BL/6 mice (n = 18), adult GFP(+) C57BL/6 transgenic mice (n = 3), Yucatan mini pigs (n = 67), adult SCID beige mice (n = 8), and adult Wistar-Kyoto rats (n = 80). Cellular yield was enhanced by collagenase digestion and process standardization; yield was reduced in altered media and in specific animal strains. Heparinization/retrograde organ perfusion did not alter the ability to generate outgrowth from myocardial sample. The initial outgrowth from myocardial samples was enriched for sub-populations of CPCs (c-Kit(+)), endothelial cells (CD31(+), CD34(+)), and mesenchymal cells (CD90(+)). Lineage tracing using MerCreMer-Z/EG transgenic mice revealed that the presence of cardiomyocytes in the cellular outgrowth is not required for the generation of CPCs. Rat CDCs are shown to be clonogenic, and cloned CDCs exhibit spontaneous multineage potential. Conclusions/Significance: This study demonstrates that direct culture and expansion of CPCs from myocardial tissue is simple, straightforward, and reproducible when appropriate techniques are used.			Davis, DR (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.	eduardo.marban@csmc.edu	White, Anthony J/I-1472-2013; Marban, Eduardo/GWC-8514-2022; Zhang, Yiqiang/D-9613-2012	White, Anthony J/0000-0002-5442-6985; Zhang, Yiqiang/0000-0003-0691-6645; Li, Tao-Sheng/0000-0002-7653-8873; Davis, Darryl/0000-0001-9642-3910	NHLBI NIH HHS [R01 HL083109] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083109] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Heart Association, 2009, HEART DIS STROK STAT; Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chimenti I, 2007, CIRC RES, V101, P1209; Davis DR, 2008, CIRC RES, V103, P1495; Galli R, 2003, CIRC RES, V92, P598, DOI 10.1161/01.RES.0000065580.02404.F4; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Johnston P, 2007, CIRC RES, V101, P1209; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ott Harald C, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS27, DOI 10.1038/ncpcardio0771; Shenje LT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001929; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216	20	219	237	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7195	10.1371/journal.pone.0007195	http://dx.doi.org/10.1371/journal.pone.0007195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779618	Green Published, gold, Green Submitted			2022-12-25	WOS:000270176200020
J	Pai, NP; Estes, M; Moodie, EEM; Reingold, AL; Tulsky, JP				Pai, Nitika Pant; Estes, Milton; Moodie, Erica E. M.; Reingold, Arthur L.; Tulsky, Jacqueline P.			The Impact of Antiretroviral Therapy in a Cohort of HIV Infected Patients Going in and out of the San Francisco County Jail	PLOS ONE			English	Article								Background: Jails are an important venue of HIV care and a place for identification, treatment and referral for care. HIV infected inmates in the San Francisco County jail are offered antiretroviral treatment ( ART), which many take only while in jail. We evaluated the effect of ART administration in a cohort of jail inmates going in and out of jail over a nine year period. Methodology/Principal Findings: In this retrospective study, we examined inmates with HIV going in and out of jail. Inmates were categorized by patterns of ART use: continuous ART - ART both in and out of jail, intermittent ART - ART only in jail; never on ART - eligible by national guidelines, but refused ART. CD4 and HIV viral load (VL) were compared over time in these groups. Over a 9 year period, 512 inmates were studied: 388 (76%) on intermittent ART, 79 (15%) on continuous ART and 45(9%) never-on ART. In a linear mixed model analysis, inmates on intermittent ART were 1.43; 95%CI (1.03, 1.99) times and those never on ART were 2.89; 95%CI (1.71, 4.87) times more likely to have higher VL than inmates on continuous ART. Furthermore, Inmates on intermittent ART and never-on ART lost 1.60; 95%CI (1.06, 2.13) and 1.97; 95%CI (0.96, 3.00) more CD4 cells per month, respectively, compared to continuously treated inmates. The continuous ART inmates gained 0.67CD4 cells/month. Conclusions/Significance: Continuous ART therapy in jail inmate's benefits CD4 cell counts and control of VL especially compared to those who never took ART. Although jail inmates on intermittent ART were more likely to lose CD4 cells and experience higher VL over time than those on continuous ART, CD4 cell loss was slower in these inmates as compared to inmates never on ART. Further studies are needed to evaluate whether or not intermittent ART provides some benefit in outcome if continuous ART is not possible or likely.			Pai, NP (corresponding author), McGill Univ, Ctr Hlth, Div Infect Dis, Div Clin Epidemiol, Montreal, PQ, Canada.	jtulsky@php.ucsf.edu		Pant Pai, Nitika/0000-0002-4672-0500	FIC NIH HHS [I-D43-TW00008-16] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000008] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Blankenship KM, 2005, J HEALTH CARE POOR U, V16, P140, DOI 10.1353/hpu.2005.0110; Burman W, 2008, JAIDS-J ACQ IMM DEF, V49, P142, DOI 10.1097/QAI.0b013e318183a9ad; ELSADR WMG, 2008, ANN INTERN MED, V149, P30; Hammett TM, 2006, AM J PUBLIC HEALTH, V96, P974, DOI 10.2105/AJPH.2005.066993; Palepu A, 2004, ANTIVIR THER, V9, P713; Pontali E, 2005, HIV CLIN TRIALS, V6, P25; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; ROUX AVA, 2005, J INFECT DIS, V191; Spaulding A, 2002, CLIN INFECT DIS, V35, P305, DOI 10.1086/341418; Spaulding A C, 1998, Med Health R I, V81, P204; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer Sandra A, 2005, Curr HIV/AIDS Rep, V2, P165, DOI 10.1007/s11904-005-0011-9; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; White MC, 2001, INT J STD AIDS, V12, P380, DOI 10.1258/0956462011923327; Wohl David A, 2006, AIDS Read, V16, P247; 2004, HIV AIDS POLICY LAW, V9, P50; 2004, HIV AIDS POLICY LAW, V9, P52	17	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7115	10.1371/journal.pone.0007115	http://dx.doi.org/10.1371/journal.pone.0007115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771176	Green Published, gold			2022-12-25	WOS:000270154400011
J	Goldstein, J; Morris, WE; Loidl, CF; Tironi-Farinatti, C; McClane, BA; Uzal, FA; Miyakawa, MEF				Goldstein, Jorge; Morris, Winston E.; Fabian Loidl, Cesar; Tironi-Farinatti, Carla; McClane, Bruce A.; Uzal, Francisco A.; Fernandez Miyakawa, Mariano E.			Clostridium perfringens Epsilon Toxin Increases the Small Intestinal Permeability in Mice and Rats	PLOS ONE			English	Article								Epsilon toxin is a potent neurotoxin produced by Clostridium perfringens types B and D, an anaerobic bacterium that causes enterotoxaemia in ruminants. In the affected animal, it causes oedema of the lungs and brain by damaging the endothelial cells, inducing physiological and morphological changes. Although it is believed to compromise the intestinal barrier, thus entering the gut vasculature, little is known about the mechanism underlying this process. This study characterizes the effects of epsilon toxin on fluid transport and bioelectrical parameters in the small intestine of mice and rats. The enteropooling and the intestinal loop tests, together with the single-pass perfusion assay and in vitro and ex vivo analysis in Ussing's chamber, were all used in combination with histological and ultrastructural analysis of mice and rat small intestine, challenged with or without C. perfringens epsilon toxin. Luminal epsilon toxin induced a time and concentration dependent intestinal fluid accumulation and fall of the transepithelial resistance. Although no evident histological changes were observed, opening of the mucosa tight junction in combination with apoptotic changes in the lamina propria were seen with transmission electron microscopy. These results indicate that C. perfringens epsilon toxin alters the intestinal permeability, predominantly by opening the mucosa tight junction, increasing its permeability to macromolecules, and inducing further degenerative changes in the lamina propria of the bowel.			Goldstein, J (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina.	mfernandez@cnia.inta.gov.ar		Fernandez Miyakawa, Mariano Enrique/0000-0001-5251-4685; Goldstein, Jorge/0000-0002-9488-0074				Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Athman R, 2002, AM J PHYSIOL-GASTR L, V282, pG634, DOI 10.1152/ajpgi.00327.2001; BALLARD ST, 1995, ANNU REV NUTR, V15, P35, DOI 10.1146/annurev.nu.15.070195.000343; BULLEN JJ, 1957, J PATHOL BACTERIOL, V73, P511, DOI 10.1002/path.1700730221; EWE K, 1988, PHARMACOLOGY, V36, P73, DOI 10.1159/000138424; Femandez-Miyakawa ME, 2008, VET MICROBIOL, V127, P379, DOI 10.1016/j.vetmic.2007.09.013; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P4282, DOI 10.1128/IAI.00562-07; Finnie JW, 2003, AUST VET J, V81, P219, DOI 10.1111/j.1751-0813.2003.tb11474.x; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; FRIZZELL RA, 1972, J GEN PHYSIOL, V59, P318, DOI 10.1085/jgp.59.3.318; GARDNER DE, 1973, J COMP PATHOL, V83, P509, DOI 10.1016/0021-9975(73)90009-1; GRINER LA, 1961, AM J VET RES, V22, P429; Kucharzik T, 2000, ALIMENT PHARM THERAP, V14, P247; LANGE S, 1994, SCAND J GASTROENTERO, V29, P38, DOI 10.3109/00365529409090435; Losada-Eaton DM, 2008, TOXICON, V51, P1207, DOI 10.1016/j.toxicon.2008.02.008; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; McClane BA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P698, DOI 10.1007/0-387-30744-3_22; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyakawa MEF, 2003, ANAEROBE, V9, P145, DOI 10.1016/S1075-9964(03)00069-6; Miyakawa MEF, 2003, VET RES COMMUN, V27, P231, DOI 10.1023/A:1023348708599; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; MORGAN KT, 1974, J COMP PATHOL, V84, P181, DOI 10.1016/0021-9975(74)90059-0; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; NAGAHAMA M, 1993, TOXICON, V31, P427, DOI 10.1016/0041-0101(93)90178-L; OHISHI I, 1983, INFECT IMMUN, V40, P691, DOI 10.1128/IAI.40.2.691-695.1983; Priestley J.V., 1992, ELECT MICROSCOPIC IM, P89; RIVIERE PJM, 1991, J PHARMACOL EXP THER, V256, P547; ROBERT A, 1976, PROSTAG OTH LIPID M, V11, P809, DOI 10.1016/0090-6980(76)90189-1; SAKURAI J, 1989, FEMS MICROBIOL LETT, V58, P269, DOI 10.1016/0378-1097(89)90051-7; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Tamai E, 2003, INFECT IMMUN, V71, P5371, DOI 10.1128/IAI.71.9.5371-5375.2003; UZAL FA, 1994, VET REC, V135, P279, DOI 10.1136/vr.135.12.279; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; Uzal FA, 1998, VET PATHOL, V35, P132, DOI 10.1177/030098589803500207	35	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7065	10.1371/journal.pone.0007065	http://dx.doi.org/10.1371/journal.pone.0007065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763257	Green Published, Green Accepted, gold			2022-12-25	WOS:000269970400007
J	Johnson, F; Kaplitt, MG				Johnson, Felicity; Kaplitt, Michael G.			Novel Mitochondrial Substrates of Omi Indicate a New Regulatory Role in Neurodegenerative Disorders	PLOS ONE			English	Article								The mitochondrial protease OMI (also known as HtrA2) has been implicated in Parkinson's Disease (PD) and deletion or protease domain point mutations have shown profound neuropathologies in mice. A beneficial role by OMI, in preserving cell viability, is assumed to occur via the avoidance of dysfunctional protein turnover. However relatively few substrates for mitochondrial Omi are known. Here we report our identification of three novel mitochondrial substrates that impact metabolism and ATP production. Using a dual proteomic approach we have identified three interactors based upon ability to bind to OMI, and/or to persist in the proteome after OMI activity has been selectively inhibited. One candidate, the chaperone HSPA8, was common to each independent study. Two others (PDHB subunit and IDH3A subunit) did not appear to bind to OMI, however persisted in the mito-proteome when OMI was inhibited. Pyruvate dehydrogenase (PDH) and isocitrate dehydrogenase (IDH) are two key Kreb's cycle enzymes that catalyse oxidative decarboxylation control points in mitochondrial respiration. We verified both PDHB and IDH3A co-immunoprecipitate with HSPA8 and after elution, were degraded by recombinant HtrA2 in vitro. Additionally our gene expression studies, using rotenone (an inhibitor of Complex I) showed Omi expression was silenced when pdhb and idh3a were increased when a sub-lethal dose was applied. However higher dose treatment caused increased Omi expression and decreased levels of pdhb and idh3a transcripts. This implicates mitochondrial OMI in a novel mechanism relating to metabolism.			Johnson, F (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA.	fej2001@med.cornell.edu						Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Jin SK, 2003, GENE DEV, V17, P359, DOI 10.1101/gad.1047003; JONES JM, 1993, GENOMICS, V16, P669, DOI 10.1006/geno.1993.1246; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kawamoto Y, 2008, J NEUROPATH EXP NEUR, V67, P984, DOI 10.1097/NEN.0b013e31818809f4; Kiang JG, 2006, AM J PHYSIOL-GASTR L, V291, pG117, DOI 10.1152/ajpgi.00397.2005; Klupsch K, 2006, CELL DEATH DIFFER, V13, P2157, DOI 10.1038/sj.cdd.4401955; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; MOISOI N, 2008, CELL DEATH DIFFER; Nam MK, 2006, EXP MOL MED, V38, P36, DOI 10.1038/emm.2006.5; Park HJ, 2006, J BIOL CHEM, V281, P34277, DOI 10.1074/jbc.M603443200; Plun-Favreau H, 2008, ANN NY ACAD SCI, V1147, P30, DOI 10.1196/annals.1427.032; PLUNFAVREAU H, 2007, NAT CELL BIOL; Ross OA, 2008, PARKINSONISM RELAT D, V14, P539, DOI 10.1016/j.parkreldis.2008.08.003; Savopoulos JW, 2000, PROTEIN EXPRES PURIF, V19, P227, DOI 10.1006/prep.2000.1240; Seong YM, 2004, J BIOL CHEM, V279, P37588, DOI 10.1074/jbc.M401408200; SIMONSANCHEZ J, 2008, HUM MOL GENET; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; TAIN LS, 2009, CELL DEATH DIFFER; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Vande Walle L, 2007, J PROTEOME RES, V6, P1006, DOI 10.1021/pr060510d; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Yang L, 2007, J BIOL CHEM, V282, P10981, DOI 10.1074/jbc.M700445200; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008; Zhang XF, 2004, BIOCHEMISTRY-MOSCOW+, V69, P687, DOI 10.1023/B:BIRY.0000033743.09806.1a; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207	41	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7100	10.1371/journal.pone.0007100	http://dx.doi.org/10.1371/journal.pone.0007100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763263	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970400021
J	Barabote, RD; Xie, G; Brettin, TS; Hinrichs, SH; Fey, PD; Jay, JJ; Engle, JL; Godbole, SD; Noronha, JM; Scheuermann, RH; Zhou, LW; Lion, C; Dempsey, MP				Barabote, Ravi D.; Xie, Gary; Brettin, Thomas S.; Hinrichs, Steven H.; Fey, Paul D.; Jay, Justin J.; Engle, Jennifer L.; Godbole, Shubhada D.; Noronha, Jyothi M.; Scheuermann, Richard H.; Zhou, Liwei W.; Lion, Christine; Dempsey, Michael P.			Complete Genome Sequence of Francisella tularensis Subspecies holarctica FTNF002-00	PLOS ONE			English	Article								Francisella tularensis subspecies holarctica FTNF002-00 strain was originally obtained from the first known clinical case of bacteremic F. tularensis pneumonia in Southern Europe isolated from an immunocompetent individual. The FTNF002-00 complete genome contains the RD23 deletion and represents a type strain for a clonal population from the first epidemic tularemia outbreak in Spain between 1997-1998. Here, we present the complete sequence analysis of the FTNF002-00 genome. The complete genome sequence of FTNF002-00 revealed several large as well as small genomic differences with respect to two other published complete genome sequences of F. tularensis subsp. holarctica strains, LVS and OSU18. The FTNF002-00 genome shares >99.9% sequence similarity with LVS and OSU18, and is also similar to 5 MB smaller by comparison. The overall organization of the FTNF002-00 genome is remarkably identical to those of LVS and OSU18, except for a single 3.9 kb inversion in FTNF002-00. Twelve regions of difference ranging from 0.1-1.5 kb and forty-two small insertions and deletions were identified in a comparative analysis of FTNF002-00, LVS, and OSU18 genomes. Two small deletions appear to inactivate two genes in FTNF002-00 causing them to become pseudogenes; the intact genes encode a protein of unknown function and a drug:H+ antiporter. In addition, we identified ninety-nine proteins in FTNF002-00 containing amino acid mutations compared to LVS and OSU18. Several non-conserved amino acid replacements were identified, one of which occurs in the virulence-associated intracellular growth locus subunit D protein. Many of these changes in FTNF002-00 are likely the consequence of direct selection that increases the fitness of this subsp. holarctica clone within its endemic population. Our complete genome sequence analyses lay the foundation for experimental testing of these possibilities.			Barabote, RD (corresponding author), Los Alamos Natl Lab, Biosci Div, M888, Los Alamos, NM 87545 USA.	dempseym@afip.osd.mil	Dempsey, Michael/GSM-7774-2022; Barabote, Ravi/B-8727-2011; Barabote, Ravi/C-1299-2017	Scheuermann, Richard H./0000-0003-1355-892X; Barabote, Ravi/0000-0002-0403-246X; xie, gary/0000-0002-9176-924X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bellido-Casado J, 2000, EUR J CLIN MICROBIOL, V19, P218, DOI 10.1007/s100960050462; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Brosch R, 2001, TRENDS MICROBIOL, V9, P452, DOI 10.1016/S0966-842X(01)02131-X; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; de la Puente-Redondo VA, 2000, J CLIN MICROBIOL, V38, P1016, DOI 10.1128/JCM.38.3.1016-1022.2000; del Blanco NG, 2004, VET REC, V154, P55, DOI 10.1136/vr.154.2.55; Del Blanco NG, 2002, J CLIN MICROBIOL, V40, P2964, DOI 10.1128/JCM.40.8.2964-2972.2002; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dempsey MP, 2007, APPL ENVIRON MICROB, V73, P7465, DOI 10.1128/AEM.00646-07; Dempsey MP, 2006, J BACTERIOL, V188, P5904, DOI 10.1128/JB.00437-06; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; EVANS ME, 1997, TXB MILITARY MED 1, P10; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Garcia Pena F.J, 1998, MED VET, V15, P418; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Haristoy X, 2003, J CLIN MICROBIOL, V41, P2774, DOI 10.1128/JCM.41.6.2774-2776.2003; HOPLA CE, 1994, TULAREMIA, P113; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lopatin DE, 2000, INFECT IMMUN, V68, P1980, DOI 10.1128/IAI.68.4.1980-1987.2000; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luque PB, 1998, REV CLIN ESP, V198, P789; McCoy G, 1912, J INFECT DIS, V10, P61, DOI 10.1093/infdis/10.1.61; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Perez-Castrillon JL, 2001, CLIN INFECT DIS, V33, P573, DOI 10.1086/322601; Petersen JM, 2005, VET RES, V36, P455, DOI 10.1051/vetres:2005006; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Puiu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003427; Samrakandi MM, 2004, FEMS MICROBIOL LETT, V237, P9, DOI [10.1111/j.1574-6968.2004.tb09672.x, 10.1016/j.femsle.2004.06.008]; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; *TIGR, 2006, MAN HOM PAG; *USDHHS, 1999, BIOS MICR BIOM LAB B; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Wilson K, 1997, CURRENT PROTOCOLS MO, p2 4 1	43	32	290	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7041	10.1371/journal.pone.0007041	http://dx.doi.org/10.1371/journal.pone.0007041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756146	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970000010
J	Ortigue, S; Thompson, JC; Parasuraman, R; Grafton, ST				Ortigue, Stephanie; Thompson, James C.; Parasuraman, Raja; Grafton, Scott T.			Spatio-Temporal Dynamics of Human Intention Understanding in Temporo-Parietal Cortex: A Combined EEG/fMRI Repetition Suppression Paradigm	PLOS ONE			English	Article								Inferring the intentions of other people from their actions recruits an inferior fronto-parietal action observation network as well as a putative social network that includes the posterior superior temporal sulcus (STS). However, the functional dynamics within and among these networks remains unclear. Here we used functional magnetic resonance imaging (fMRI) and high-density electroencephalogram (EEG), with a repetition suppression design, to assess the spatio-temporal dynamics of decoding intentions. Suppression of fMRI activity to the repetition of the same intention was observed in inferior frontal lobe, anterior intraparietal sulcus (aIPS), and right STS. EEG global field power was reduced with repeated intentions at an early (starting at 60 ms) and a later (similar to 330 ms) period after the onset of a hand-on-object encounter. Source localization during these two intervals involved right STS and aIPS regions highly consistent with RS effects observed with fMRI. These results reveal the dynamic involvement of temporal and parietal networks at multiple stages during the intention decoding and without a strict segregation of intention decoding between these networks.			Ortigue, S (corresponding author), UCSB Brain Imaging Ctr, Dept Psychol, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.	sortigue@syr.edu; grafton@psych.ucsb.edu	Thompson, James/E-7569-2010					Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; CROSS E, 2008, SENSITIVITY ACTION O; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Grafton ST, 2008, NAT NEUROSCI, V11, P248, DOI 10.1038/nn0308-248; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Guo C, 2007, NEUROSCIENCE, V149, P747, DOI 10.1016/j.neuroscience.2007.07.060; Hamilton AF, 2007, ATTENTION PERFORM, P381, DOI DOI 10.1093/ACPR0F:0S0/9780199231447.003.0018; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; HESSE MD, 2008, J COGN NEUROSCI; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Ishai A, 2006, BRAIN RES BULL, V70, P289, DOI 10.1016/j.brainresbull.2006.06.002; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kilner JM, 2008, CURR BIOL, V18, pR32, DOI 10.1016/j.cub.2007.11.008; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Materna S, 2008, NEUROPSYCHOLOGIA, V46, P2759, DOI 10.1016/j.neuropsychologia.2008.05.016; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Noppeney U, 2006, HUM BRAIN MAPP, V27, P411, DOI 10.1002/hbm.20242; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Pickering EC, 2003, J EXP PSYCHOL LEARN, V29, P1298, DOI 10.1037/0278-7393.29.6.1298; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; Rizzolatti Giacomo, 2008, MIRRORS BRAIN OUR MI; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shmuelof L, 2007, NEUROSCIENTIST, V13, P667, DOI 10.1177/1073858407302457; Sitnikova T, 2003, PSYCHOPHYSIOLOGY, V40, P160, DOI 10.1111/1469-8986.00016; Thompson JC, 2007, NEUROIMAGE, V37, P966, DOI 10.1016/j.neuroimage.2007.05.058; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; VANDERCRUYSSEN L, 2008, SOCIAL NEUROSCIENCE, V4, P165; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wong KF, 2008, FRONT NEUROSCI-SWITZ, V2, P245, DOI 10.3389/neuro.01.028.2008; Xu YD, 2007, J NEUROSCI, V27, P5981, DOI 10.1523/JNEUROSCI.5527-06.2007	48	50	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6962	10.1371/journal.pone.0006962	http://dx.doi.org/10.1371/journal.pone.0006962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750227	Green Published, Green Submitted, gold			2022-12-25	WOS:000269696600008
J	Song, SO; Varner, J				Song, Sang Ok; Varner, Jeffrey			Modeling and Analysis of the Molecular Basis of Pain in Sensory Neurons	PLOS ONE			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; METABOTROPIC P2Y RECEPTORS; ATP-GATED CHANNELS; SENSITIVITY-ANALYSIS; DORSAL-ROOT; ENDOPLASMIC-RETICULUM; PURINERGIC RECEPTORS; NEUROBLASTOMA-CELLS; NOCICEPTIVE NEURONS; SIGNALING PATHWAYS	Intracellular calcium dynamics are critical to cellular functions like pain transmission. Extracellular ATP plays an important role in modulating intracellular calcium levels by interacting with the P2 family of surface receptors. In this study, we developed a mechanistic mathematical model of ATP-induced P2 mediated calcium signaling in archetype sensory neurons. The model architecture, which described 90 species connected by 162 interactions, was formulated by aggregating disparate molecular modules from literature. Unlike previous models, only mass action kinetics were used to describe the rate of molecular interactions. Thus, the majority of the 252 unknown model parameters were either association, dissociation or catalytic rate constants. Model parameters were estimated from nine independent data sets taken from multiple laboratories. The training data consisted of both dynamic and steady-state measurements. However, because of the complexity of the calcium network, we were unable to estimate unique model parameters. Instead, we estimated a family or ensemble of probable parameter sets using a multi-objective thermal ensemble method. Each member of the ensemble met an error criterion and was located along or near the optimal trade-off surface between the individual training data sets. The model quantitatively reproduced experimental measurements from dorsal root ganglion neurons as a function of extracellular ATP forcing. Hypothesized architecture linking phosphoinositide regulation with P2X receptor activity explained the inhibition of P2X-mediated current flow by activated metabotropic P2Y receptors. Sensitivity analysis using individual and the whole system outputs suggested which molecular subsystems were most important following P2 activation. Taken together, modeling and analysis of ATP-induced P2 mediated calcium signaling generated qualitative insight into the critical interactions controlling ATP induced calcium dynamics. Understanding these critical interactions may prove useful for the design of the next generation of molecular pain management strategies.			Song, SO (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	jdv27@cornell.edu						ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Adkins CE, 1999, CURR BIOL, V9, P1115, DOI 10.1016/S0960-9822(99)80481-3; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; BEMIER LP, 2008, MOL PHARM, V74, P785; Bernier LP, 2008, J NEUROSCI, V28, P12938, DOI 10.1523/JNEUROSCI.3038-08.2008; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2000, BRIT J ANAESTH, V84, P476, DOI 10.1093/oxfordjournals.bja.a013473; Burnstock G, 1996, CURR OPIN NEUROBIOL, V6, P526, DOI 10.1016/S0959-4388(96)80060-2; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Cesare P, 1997, CURR OPIN NEUROBIOL, V7, P493, DOI 10.1016/S0959-4388(97)80028-1; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; Chizh BA, 2001, PHARMACOL REV, V53, P553; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cook SP, 1997, NEUROPHARMACOLOGY, V36, P1303, DOI 10.1016/S0028-3908(97)00132-9; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; DICKINSON RP, 1976, J COMPUT PHYS, V21, P123, DOI 10.1016/0021-9991(76)90007-3; Ding YN, 2000, J AUTONOM NERV SYST, V81, P289, DOI 10.1016/S0165-1838(00)00131-4; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Fedirko N, 2004, NEUROPHYSIOLOGY+, V36, P169, DOI 10.1023/B:NEPH.0000048339.09774.09; FONSECA CM, 1993, P INT C GEN ALG, V5, P416; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Gadkar KG, 2005, SYSTEMS BIOL, V2, P17, DOI 10.1049/sb:20045029; GEREVICH PI, 2005, EUR J PHARM, V521; Gerevich Z, 2007, BRIT J PHARMACOL, V151, P226, DOI 10.1038/sj.bjp.0707217; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; Gover TD, 2003, J NEUROSCI, V23, P4793; HAGENACKER T, 2007, CELL CALCIUM; Hamilton Sara G, 2002, Pain Pract, V2, P289, DOI 10.1046/j.1533-2500.2002.02041.x; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; HEARNE JW, 1985, APPL MATH MODEL, V9, P106, DOI 10.1016/0307-904X(85)90121-0; Hilliges M, 2002, PAIN, V98, P59, DOI 10.1016/S0304-3959(01)00469-9; Inoue K, 2003, DRUG DEVELOP RES, V59, P56, DOI 10.1002/ddr.10201; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; Jennings EA, 2007, DRUG DEVELOP RES, V68, P321, DOI 10.1002/ddr.20195; Kennedy C, 2005, NEUROSCIENTIST, V11, P345, DOI 10.1177/1073858404274063; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; KOLEN HS, 2006, PURINERG SIGNAL, V2, P451; Kress M, 1999, J NEUROPHYSIOL, V81, P2612, DOI 10.1152/jn.1999.81.6.2612; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Lakshmi S, 2005, CELL MOL NEUROBIOL, V25, P819, DOI 10.1007/s10571-005-4936-8; Lehotsky J, 2002, FRONT BIOSCI-LANDMRK, V7, pD53, DOI 10.2741/lehotsky; Lemon G, 2003, J THEOR BIOL, V223, P93, DOI 10.1016/S0022-5193(03)00079-1; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; LI YX, 1995, AM J PHYSIOL-CELL PH, V269, pC1079, DOI 10.1152/ajpcell.1995.269.5.C1079; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Mishra J, 2002, BIOPHYS J, V83, P1298, DOI 10.1016/S0006-3495(02)73901-5; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; Murthy KS, 1998, J BIOL CHEM, V273, P4695, DOI 10.1074/jbc.273.8.4695; Nakayama S, 2004, FASEB J, V18, P1562, DOI 10.1096/fj.04-1933fje; Nathanson NM, 2008, PHARMACOL THERAPEUT, V119, P33, DOI 10.1016/j.pharmthera.2008.04.006; Nayak S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002016; Nguyen HN, 2002, BRAIN RES, V924, P159, DOI 10.1016/S0006-8993(01)03229-2; North RA, 2004, J PHYSIOL-LONDON, V554, P301, DOI 10.1113/jphysiol.2003.048587; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Paukert M, 2001, J BIOL CHEM, V276, P21077, DOI 10.1074/jbc.M101465200; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; Prestwich GD, 2004, CHEM BIOL, V11, P619, DOI 10.1016/j.chembiol.2004.03.025; Purvis JE, 2008, BLOOD, V112, P4069, DOI 10.1182/blood-2008-05-157883; Purvis JE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000298; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Ruan HZ, 2005, J HISTOCHEM CYTOCHEM, V53, P1273, DOI 10.1369/jhc.4A6556.2005; Ruan HZ, 2003, HISTOCHEM CELL BIOL, V120, P415, DOI 10.1007/s00418-003-0579-3; Sanada M, 2002, NEUROSCIENCE, V111, P413, DOI 10.1016/S0306-4522(02)00005-2; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Sneyd J, 2004, PROG BIOPHYS MOL BIO, V85, P121, DOI 10.1016/j.pbiomolbio.2004.01.013; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Sokolova E, 2006, MOL PHARMACOL, V70, P373, DOI 10.1124/mol.106.023564; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stucky CL, 2004, PAIN, V109, P36, DOI 10.1016/j.pain.2004.01.007; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tang YH, 1996, BIOPHYS J, V70, P246, DOI 10.1016/S0006-3495(96)79567-X; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; Tsuda M, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0007.2000; Vial C, 2002, BRIT J PHARMACOL, V135, P363, DOI 10.1038/sj.bjp.0704486; WATRAS J, 1991, J NEUROSCI, V11, P3239; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Zhao Q, 2007, CHANNELS, V1, P46; Zhao Q, 2007, PFLUG ARCH EUR J PHY, V455, P181, DOI 10.1007/s00424-007-0271-x	97	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6758	10.1371/journal.pone.0006758	http://dx.doi.org/10.1371/journal.pone.0006758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750220	Green Published, gold			2022-12-25	WOS:000269696600001
J	Baltzer, C; Tiefenbock, SK; Marti, M; Frei, C				Baltzer, Claudia; Tiefenboeck, Stefanie K.; Marti, Mark; Frei, Christian			Nutrition Controls Mitochondrial Biogenesis in the Drosophila Adipose Tissue through Delg and Cyclin D/Cdk4	PLOS ONE			English	Article								Mitochondria are cellular organelles that perform critical metabolic functions: they generate energy from nutrients but also provide metabolites for de novo synthesis of fatty acids and several amino acids. Thus mitochondrial mass and activity must be coordinated with nutrient availability, yet this remains poorly understood. Here, we demonstrate that Drosophila larvae grown in low yeast food have strong defects in mitochondrial abundance and respiration activity in the larval fat body. This correlates with reduced expression of genes encoding mitochondrial proteins, particularly genes involved in oxidative phosphorylation. Second, genes involved in glutamine metabolism are also expressed in a nutrient-dependent manner, suggesting a coordination of amino acid synthesis with mitochondrial abundance and activity. Moreover, we show that Delg (CG6338), the Drosophila homologue to the alpha subunit of mammalian transcription factor NRF-2/GABP, is required for proper expression of most genes encoding mitochondrial proteins. Our data demonstrate that Delg is critical to adjust mitochondrial abundance in respect to Cyclin D/Cdk4, a growth-promoting complex and glutamine metabolism according to nutrient availability. However, in contrast to nutrients, Delg is not involved in the regulation of mitochondrial activity in the fat body. These findings are the first genetic evidence that the regulation of mitochondrial mass can be uncoupled from mitochondrial activity.			Baltzer, C (corresponding author), ETH, Dept Biol, Zurich, Switzerland.	Christian.frei@cell.biol.ethz.ch						Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Blesa JR, 2007, GENE, V391, P198, DOI 10.1016/j.gene.2006.12.024; Blesa JR, 2006, BIOCHEM CELL BIOL, V84, P813, DOI 10.1139/O06-064; Blesa JR, 2004, MITOCHONDRION, V3, P251, DOI 10.1016/j.mito.2004.02.001; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; CARTER RS, 1992, J BIOL CHEM, V267, P23418; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; CHEN T, 1992, DEV BIOL, V151, P176, DOI 10.1016/0012-1606(92)90225-6; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Datar SA, 2006, CELL CYCLE, V5, P647; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emmerich J, 2004, GENETICS, V168, P867, DOI 10.1534/genetics.104.027417; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; GAJEWSKI KM, 1995, ONCOGENE, V11, P1033; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; GREWAL SS, 2008, INT J BIOCH CELL BIO; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koushika SP, 1999, MOL CELL BIOL, V19, P3998; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; PRIBYL LJ, 1991, ONCOGENE, V6, P1175; Puig O, 2006, CELL CYCLE, V5, P503, DOI 10.4161/cc.5.5.2501; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235; SCHULZ RA, 1993, P NATL ACAD SCI USA, V90, P10076, DOI 10.1073/pnas.90.21.10076; SCHULZ RA, 1993, ONCOGENE, V8, P3369; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; THE SM, 1992, ONCOGENE, V7, P2471; Villena JA, 1998, BIOCHEM J, V331, P121, DOI 10.1042/bj3310121; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	59	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6935	10.1371/journal.pone.0006935	http://dx.doi.org/10.1371/journal.pone.0006935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742324	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622500013
J	Glitsch, MD				Glitsch, Maike D.			Activation of native TRPC3 cation channels by phospholipase D	FASEB JOURNAL			English	Article						slow EPSC; mGluR; Rho GTPase; Purkinje cell; dendritic tree development	METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN-KINASE-C; CEREBELLAR PURKINJE-CELLS; NEURITE OUTGROWTH; PLASMA-MEMBRANE; DIACYLGLYCEROL; RELEASE; LOCALIZATION; MECHANISMS; EXPRESSION	In the mammalian nervous system, stimulation of G-protein-coupled type I glutamate receptors triggers various forms of neuronal plasticity, including cerebellar long-term depression and hippocampal long-term potentiation. Activation of these receptors in the cerebellum also leads to a slow excitatory postsynaptic current mediated by nonselective TRPC3 cation channels. How TRPC3 channels are opened is unknown, although it is widely thought that channel gating requires phospholipase C activation. Using the patch-clamp technique and immunohistochemistry in rat cerebellar slices, we show that metabotropic glutamate receptors activate TRPC3 channels through the small GTP-binding protein Rho and subsequent phospholipase D stimulation. TRPC3 channel gating is independent of phospholipase C activity. These results reveal a new mechanism for the gating of the ubiquitous TRPC3 channel and identify a key role for phospholipase D in the generation of the slow excitatory postsynaptic current in cerebellar Purkinje cells.-Glitsch, M. D. Activation of native TRPC3 cation channels by phospholipase D. FASEB J. 24, 318-325 (2010). www.fasebj.org	Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3RH, England	University of Oxford	Glitsch, MD (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3RH, England.	maike.glitsch@dpag.ox.ac.uk		Glitsch, Maike/0000-0003-0723-3117				Adachi N, 2008, J BIOL CHEM, V283, P19854, DOI 10.1074/jbc.M801492200; Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Albert AP, 2005, J PHYSIOL-LONDON, V566, P769, DOI 10.1113/jphysiol.2005.090852; Albert AP, 2003, J PHYSIOL-LONDON, V549, P143, DOI 10.1113/jphysiol.2002.038190; ALGER BE, 1995, TRENDS NEUROSCI, V18, P333, DOI 10.1016/0166-2236(95)93923-L; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; BOSS V, 1992, J NEUROCHEM, V59, P2340; Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Glitsch MD, 2001, PFLUG ARCH EUR J PHY, V442, P404, DOI 10.1007/s004240100559; Hartmann J, 2005, CELL CALCIUM, V37, P459, DOI 10.1016/j.ceca.2005.01.014; Hartmann J, 2009, ACTA PHYSIOL, V195, P79, DOI 10.1111/j.1748-1716.2008.01923.x; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hashimotodani Y, 2007, CURR OPIN NEUROBIOL, V17, P360, DOI 10.1016/j.conb.2007.03.012; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Kim M, 2010, ACTA HISTOCHEM, V112, P81, DOI 10.1016/j.acthis.2008.09.004; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Kwan HY, 2009, EUR J PHARMACOL, V602, P181, DOI 10.1016/j.ejphar.2008.10.054; Lee MY, 2000, BRAIN RES, V864, P52, DOI 10.1016/S0006-8993(00)02134-X; Lessard CB, 2005, CELL SIGNAL, V17, P437, DOI 10.1016/j.cellsig.2004.09.005; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MARTY A, 1995, CURR OPIN NEUROBIOL, V5, P335, DOI 10.1016/0959-4388(95)80046-8; Oh DY, 2007, J CELL BIOCHEM, V101, P221, DOI 10.1002/jcb.21166; Okamoto Y, 2007, CHEM BIODIVERS, V4, P1842, DOI 10.1002/cbdv.200790155; Olenik C, 1997, MOL BRAIN RES, V52, P263, DOI 10.1016/S0169-328X(97)00270-2; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; PellegriniGiampietro DE, 1996, BRIT J PHARMACOL, V118, P1035, DOI 10.1111/j.1476-5381.1996.tb15503.x; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; RAYMOND SH, 1998, FEBS LETT, V422, P333; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Soboloff J., 2007, V179, P575; Sugiyama T, 1999, BIOCHEM BIOPH RES CO, V265, P473, DOI 10.1006/bbrc.1999.1628; Tai YL, 2009, PFLUG ARCH EUR J PHY, V458, P283, DOI 10.1007/s00424-008-0618-y; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; Weernink PAO, 2007, N-S ARCH PHARMACOL, V374, P399, DOI 10.1007/s00210-007-0131-4; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yamamoto S, 2007, BBA-MOL BASIS DIS, V1772, P958, DOI 10.1016/j.bbadis.2007.03.006; Yoon MS, 2006, BIOCHEM BIOPH RES CO, V347, P594, DOI 10.1016/j.bbrc.2006.06.111; Yoon MS, 2005, BIOCHEM BIOPH RES CO, V329, P804, DOI 10.1016/j.bbrc.2005.02.087; Zhang Y, 2005, J NEUROSCI, V25, P1797, DOI 10.1523/jneurosci.4850-04.2005; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	57	27	27	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					318	325		10.1096/fj.09-134973	http://dx.doi.org/10.1096/fj.09-134973			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19741172				2022-12-25	WOS:000273233600032
J	Del Vecchio, M; Pogni, R; Baratto, MC; Nobbs, A; Rappuoli, R; Pizza, M; Balducci, E				Del Vecchio, Mariangela; Pogni, Rebecca; Baratto, Maria Camilla; Nobbs, Angela; Rappuoli, Rino; Pizza, Mariagrazia; Balducci, Enrico			Identification of an Iron-Sulfur Cluster That Modulates the Enzymatic Activity in NarE, a Neisseria meningitidis ADP-ribosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-OLEOVORANS RUBREDOXIN; CRYSTAL-STRUCTURE; ADENYLATE-CYCLASE; PROTEIN-SYNTHESIS; RIBOSYLATION; TOXIN; ENTEROTOXIN; INHIBITION; CHOLERAGEN; MECHANISM	In prokaryotes, mono-ADP-ribose transfer enzymes represent a family of exotoxins that display activity in a variety of bacterial pathogens responsible for causing disease in plants and animals, including those affecting mankind, such as diphtheria, cholera, and whooping cough. We report here that NarE, a putative ADP-ribosylating toxin previously identified from Neisseria meningitidis, which shares structural homologies with Escherichia coli heat labile enterotoxin and toxin from Vibrio cholerae, possesses an iron-sulfur center. The recombinant protein was expressed in E. coli, and when purified at high concentration, NarE is a distinctive golden brown in color. Evidence from UV-visible spectrophotometry and EPR spectroscopy revealed characteristics consistent of an iron-binding protein. The presence of iron was determined by colorimetric method and by an atomic absorption spectrophotometer. To identify the amino acids involved in binding iron, a combination of site-directed mutagenesis and UV-visible and enzymatic assays were performed. All four cysteine residues were individually replaced by serine. Substitution of Cys(67) and Cys(128) into serine caused a drastic reduction in the E-420/E-280 ratio, suggesting that these two residues are essential for the formation of a stable coordination. This modification led to a consistent loss in ADP-ribosyltransferase activity, while decrease in NAD-glycohydrolase activity was less dramatic in these mutants, indicating that the correct assembly of the iron-binding site is essential for transferase but not hydrolase activity. This is the first observation suggesting that a member of the ADP-ribosyltransferase family contains an Fe-S cluster implicated in catalysis. This observation may unravel novel functions exerted by this class of enzymes.	[Del Vecchio, Mariangela; Nobbs, Angela; Rappuoli, Rino; Pizza, Mariagrazia] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Pogni, Rebecca; Baratto, Maria Camilla] Univ Siena, Dept Chem, I-53100 Siena, Italy; [Balducci, Enrico] Univ Camerino, Dept Comparat Morphol & Biochem, I-62032 Camerino, Italy; [Del Vecchio, Mariangela] Univ Piemonte Orientale, DiSCAFF, I-28100 Novara, Italy	Novartis; University of Siena; University of Camerino; University of Eastern Piedmont Amedeo Avogadro	Balducci, E (corresponding author), Ctr Ric, Via Fiorentina 1, I-53100 Siena, Italy.	enrico.balducci@novartis.com	Nobbs, Angela/AAS-3926-2020	Nobbs, Angela/0000-0003-3813-4410; Balducci, Enrico/0000-0001-6147-9033	Novartis Vaccines Diagnostics	Novartis Vaccines Diagnostics	This work was supported by Novartis Vaccines & Diagnostics.	AKTORIES K, 1989, J CELL BIOL, V109, P1385, DOI 10.1083/jcb.109.4.1385; AlaAldeen DAA, 1996, J MED MICROBIOL, V45, P419, DOI 10.1099/00222615-45-6-419; ANTOINE R, 1994, J BIOL CHEM, V269, P6450; BACHMAYE.H, 1967, P NATL ACAD SCI USA, V57, P122, DOI 10.1073/pnas.57.1.122; Balducci E, 2005, ANAL BIOCHEM, V344, P278, DOI 10.1016/j.ab.2005.06.024; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Chen CJ, 2006, BIOCHEM BIOPH RES CO, V349, P79, DOI 10.1016/j.bbrc.2006.07.205; DeHaan L, 1996, INFECT IMMUN, V64, P5413, DOI 10.1128/IAI.64.12.5413-5416.1996; Duelund L, 2000, SPECTROCHIM ACTA A, V56, P331, DOI 10.1016/S1386-1425(99)00243-7; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; GILL DM, 1985, CIBA F SYMP, V112, P57; HONJO T, 1968, J BIOL CHEM, V243, P3553; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; LODE ET, 1971, J BIOL CHEM, V246, P791; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; Masignani V, 2003, MOL MICROBIOL, V50, P1055, DOI 10.1046/j.1365-2958.2003.03770.x; MEYER J, 1995, BIOCHEM BIOPH RES CO, V212, P827, DOI 10.1006/bbrc.1995.2043; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; MOSS J, 1977, J BIOL CHEM, V252, P2455; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; PEISACH J, 1971, J BIOL CHEM, V246, P5877; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; PIZZA M, 1994, J EXP MED, V180, P2147, DOI 10.1084/jem.180.6.2147; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Wada K, 2005, FEBS LETT, V579, P6543, DOI 10.1016/j.febslet.2005.10.046; Yoo SJ, 2000, J BIOL INORG CHEM, V5, P475, DOI 10.1007/s007750050008	35	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33040	33047		10.1074/jbc.M109.057547	http://dx.doi.org/10.1074/jbc.M109.057547			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19744927	Green Published, hybrid			2022-12-25	WOS:000272028500006
J	Noguchi, Y; Young, JD; Aleman, JO; Hansen, ME; Kelleher, JK; Stephanopoulos, G				Noguchi, Yasushi; Young, Jamey D.; Aleman, Jose O.; Hansen, Michael E.; Kelleher, Joanne K.; Stephanopoulos, Gregory			Effect of Anaplerotic Fluxes and Amino Acid Availability on Hepatic Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS ISOTOPOMER DISTRIBUTIONS; ENDOPLASMIC-RETICULUM STRESS; BIDIRECTIONAL REACTION STEPS; FATTY LIVER-DISEASE; HEPATOCYTE LIPOAPOPTOSIS; METABOLIC NETWORKS; INDUCED APOPTOSIS; BETA-CELLS; RAT-LIVER; EXPRESSION	To identify metabolic pathways involved in hepatic lipoapoptosis, metabolic flux analysis using [U-C-13(5)]glutamine as an isotopic tracer was applied to quantify phenotypic changes in H4IIEC3 hepatoma cells treated with either palmitate alone (PA-cells) or both palmitate and oleate in combination (PA/OA-cells). Our results indicate that palmitate inhibited glycolysis and lactate dehydrogenase fluxes while activating citric acid cycle (CAC) flux and glutamine uptake. This decoupling of glycolysis and CAC fluxes occurred during the period following palmitate exposure but preceding the onset of apoptosis. Oleate co-treatment restored most fluxes to their control levels, resulting in steatotic lipid accumulation while preventing apoptosis. In addition, palmitate strongly increased the cytosolic NAD(+)/NADH ratio, whereas oleate co-treatment had the opposite effect on cellular redox. We next examined the influence of amino acids on these free fatty acid-induced phenotypic changes. Increased medium amino acids enhanced reactive oxygen species (ROS) generation and apoptosis in PA-cells but not in PA/OA-cells. Overloading the medium with non-essential amino acids induced apoptosis, but essential amino acid overloading partially ameliorated apoptosis. Glutamate was the most effective single amino acid in promoting ROS. Amino acid overloading also increased cellular palmitoyl-ceramide; however, ceramide synthesis inhibitors had no effect on measurable indicators of apoptosis. Our results indicate that free fatty acid-induced ROS generation and apoptosis are accompanied by the decoupling of glycolysis and CAC fluxes leading to abnormal cytosolic redox states. Amino acids play a modulatory role in these processes via a mechanism that does not involve ceramide accumulation.	[Noguchi, Yasushi; Young, Jamey D.; Aleman, Jose O.; Hansen, Michael E.; Kelleher, Joanne K.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kelleher, Joanne K.] Massachusetts Gen Hosp, Shriners Burn Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gregstep@mit.edu	Hansen, Michael Adsetts Edberg/C-9028-2011; Young, Jamey/A-5857-2012	Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Aleman, Jose/0000-0003-3753-6717	National Institutes of Health [DK075850, ES013925]; NATIONAL CANCER INSTITUTE [R01CA160458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK072856, R01DK075850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK075850 and ES013925.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; BLEMINGS KP, 1994, J NUTR, V124, P1215, DOI 10.1093/jn/124.8.1215; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; DUDEK SM, 1995, J BIOL CHEM, V270, P29323, DOI 10.1074/jbc.270.49.29323; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Hansson PK, 2004, BBA-MOL CELL BIOL L, V1684, P54, DOI 10.1016/j.bbalip.2004.06.005; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Jousse C, 1998, BIOCHEM J, V334, P147, DOI 10.1042/bj3340147; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Madsen K., 2004, METHODS NONLINEAR LE, V2nd; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; MORAND C, 1994, ARCH BIOCHEM BIOPHYS, V309, P254, DOI 10.1006/abbi.1994.1110; Okere IC, 2006, AM J PHYSIOL-HEART C, V291, pH38, DOI 10.1152/ajpheart.01295.2005; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; Srivastava S, 2008, BIOTECHNOL BIOENG, V99, P399, DOI 10.1002/bit.21568; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Swagell CD, 2006, NUTRITION, V22, P672, DOI 10.1016/j.nut.2006.03.005; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Vieu C, 2002, J LIPID RES, V43, P510; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P118, DOI 10.1002/(SICI)1097-0290(19970705)55:1<118::AID-BIT13>3.0.CO;2-I; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Wong MS, 2004, PHYSIOL GENOMICS, V16, P247, DOI 10.1152/physiolgenomics.00088.2003; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	45	52	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33425	33436		10.1074/jbc.M109.049478	http://dx.doi.org/10.1074/jbc.M109.049478			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19758988	Green Published, hybrid			2022-12-25	WOS:000272028500049
J	Zhang, GF; Kombu, RS; Kasumov, T; Han, Y; Sadhukhan, S; Zhang, JY; Sayre, LM; Ray, D; Gibson, KM; Anderson, VA; Tochtrop, GP; Brunengraber, H				Zhang, Guo-Fang; Kombu, Rajan S.; Kasumov, Takhar; Han, Yong; Sadhukhan, Sushabhan; Zhang, Jianye; Sayre, Lawrence M.; Ray, Dale; Gibson, K. Michael; Anderson, Vernon A.; Tochtrop, Gregory P.; Brunengraber, Henri			Catabolism of 4-Hydroxyacids and 4-Hydroxynonenal via 4-Hydroxy-4-phosphoacyl-CoAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; PERFUSED-RAT-LIVER; CHROMATOGRAPHY MASS-SPECTROMETRY; NADP+-DEPENDENT OXIDOREDUCTASE; GAMMA-HYDROXYBUTYRATE; STABLE-ISOTOPE; SEMIALDEHYDE DEHYDROGENASE; SUCCINIC SEMIALDEHYDE; 4-HYDROXYBUTYRIC ACID; LIPID-PEROXIDATION	4-Hydroxyacids are products of ubiquitously occurring lipid peroxidation (C-9, C-6) or drugs of abuse (C-4, C-5). We investigated the catabolism of these compounds using a combination of metabolomics and mass isotopomer analysis. Livers were perfused with various concentrations of unlabeled and labeled saturated 4-hydroxyacids (C-4 to C-11) or 4-hydroxynonenal. All the compounds tested form a new class of acyl-CoA esters, 4-hydroxy-4-phosphoacyl-CoAs, characterized by liquid chromatography-tandem mass spectrometry, accurate mass spectrometry, and P-31-NMR. All 4-hydroxyacids with five or more carbons are metabolized by two new pathways. The first and major pathway, which involves 4-hydroxy-4-phosphoacyl-CoAs, leads in six steps to the isomerization of 4-hydroxyacyl-CoA to 3-hydroxyacyl-CoAs. The latter are intermediates of physiological beta-oxidation. The second and minor pathway involves a sequence of beta-oxidation, alpha-oxidation, and beta-oxidation steps. In mice deficient in succinic semialdehyde dehydrogenase, high plasma concentrations of 4-hydroxybutyrate result in high concentrations of 4-hydroxy-4-phospho-butyryl-CoA in brain and liver. The high concentration of 4-hydroxy-4-phosphobutyryl-CoA may be related to the cerebral dysfunction of subjects ingesting 4-hydroxybutyrate and to the mental retardation of patients with 4-hydroxybutyric aciduria. Our data illustrate the potential of the combination of metabolomics and mass isotopomer analysis for pathway discovery.	[Brunengraber, Henri] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Han, Yong; Sadhukhan, Sushabhan; Zhang, Jianye; Sayre, Lawrence M.; Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Anderson, Vernon A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Ray, Dale] Case Western Reserve Univ, Cleveland Ctr Struct Biol, Cleveland, OH 44106 USA; [Gibson, K. Michael] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Michigan Technological University	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, WG48,10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu	Sadhukhan, Sushabhan/AAS-7136-2020	Sadhukhan, Sushabhan/0000-0002-3302-5875	National Institutes of Health [R33DK070291, R01ES013925]; Cleveland Mt. Sinai Health Care Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Mt. Sinai Health Care Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant R33DK070291 and Grant R01ES013925 (to H. B.). This work was also supported by a grant from the Cleveland Mt. Sinai Health Care Foundation.	Anderson IB, 2006, ANN EMERG MED, V47, P177, DOI 10.1016/j.annemergmed.2005.10.012; Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Bennaars-Eiden A, 2002, J BIOL CHEM, V277, P50693, DOI 10.1074/jbc.M209493200; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Brunengraber H, 1997, ANNU REV NUTR, V17, P559, DOI 10.1146/annurev.nutr.17.1.559; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CADENAS E, 1983, BIOCHEM J, V214, P479, DOI 10.1042/bj2140479; Choudhary S, 2003, INVEST OPHTH VIS SCI, V44, P2675, DOI 10.1167/iovs.02-0965; Coleman TM, 2005, TETRAHEDRON LETT, V46, P4307, DOI 10.1016/j.tetlet.2005.04.106; Dalluge JJ, 2002, ANAL BIOANAL CHEM, V374, P835, DOI 10.1007/s00216-002-1554-x; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Foulon V, 2005, J BIOL CHEM, V280, P9802, DOI 10.1074/jbc.M413362200; Gibson KM, 1998, NEUROPEDIATRICS, V29, P14, DOI 10.1055/s-2007-973527; GIBSON KM, 1990, BIOMED ENVIRON MASS, V19, P89, DOI 10.1002/bms.1200190207; Gioacchini AM, 1999, RAPID COMMUN MASS SP, V13, P1573, DOI 10.1002/(SICI)1097-0231(19990815)13:15<1573::AID-RCM675>3.0.CO;2-Z; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Grawert T, 2009, ANGEW CHEM INT EDIT, V48, P5756, DOI 10.1002/anie.200900548; Hecht S, 2001, P NATL ACAD SCI USA, V98, P14837, DOI 10.1073/pnas.201399298; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; ISHIKAWA T, 1986, J BIOL CHEM, V261, P1576; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; KAUFMAN EE, 1988, J NEUROCHEM, V51, P1079, DOI 10.1111/j.1471-4159.1988.tb03071.x; KAUFMAN EE, 1987, J NEUROCHEM, V48, P1935, DOI 10.1111/j.1471-4159.1987.tb05758.x; KAUFMAN EE, 1991, NEUROCHEM RES, V16, P965, DOI 10.1007/BF00965839; Koster J F, 1986, Free Radic Res Commun, V1, P273, DOI 10.3109/10715768609051637; KREBS HA, 1970, BIOCHEM J, V119, P525, DOI 10.1042/bj1190525; Luckey SW, 2001, ARCH BIOCHEM BIOPHYS, V389, P77, DOI 10.1006/abbi.2001.2307; Minkler PE, 2008, ANAL BIOCHEM, V376, P275, DOI 10.1016/j.ab.2008.02.022; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Pardi D, 2006, CNS DRUGS, V20, P993, DOI 10.2165/00023210-200620120-00004; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; POULOS A, 1993, BIOCHEM J, V292, P457, DOI 10.1042/bj2920457; POWERS L, 1995, J MASS SPECTROM, V30, P747, DOI 10.1002/jms.1190300514; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; SCHERF U, 1991, APPL ENVIRON MICROB, V57, P2699, DOI 10.1128/AEM.57.9.2699-2702.1991; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Siems Werner, 2003, Molecular Aspects of Medicine, V24, P167, DOI 10.1016/S0098-2997(03)00011-6; Siems WG, 1998, J BIOCHEM, V123, P534; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; SKORIN C, 1992, BIOCHEM J, V281, P561, DOI 10.1042/bj2810561; VAMECQ J, 1990, BIOCHEM CELL BIOL, V68, P846, DOI 10.1139/o90-125; Verhoeven NM, 1997, EUR J PEDIATR, V156, pS83, DOI 10.1007/PL00014279; Wong C Guin Ting, 2004, Toxicol Rev, V23, P3, DOI 10.2165/00139709-200423010-00002	47	50	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33521	33534		10.1074/jbc.M109.055665	http://dx.doi.org/10.1074/jbc.M109.055665			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19759021	Green Published, hybrid			2022-12-25	WOS:000272028500058
J	Dalmonte, ME; Forte, E; Genova, ML; Giuffre, A; Sarti, P; Lenaz, G				Dalmonte, Maria Elena; Forte, Elena; Genova, Maria Luisa; Giuffre, Alessandro; Sarti, Paolo; Lenaz, Giorgio			Control of Respiration by Cytochrome c Oxidase in Intact Cells ROLE OF THE MEMBRANE POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO CONTROL; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DISEASES; ELECTRON-TRANSFER; STEADY-STATE; GRADIENT; COMPLEX; CHAIN; FLUX; PH	Metabolic control analysis was applied to intact HepG2 cells. The effect on the control coefficient of cytochrome c oxidase (CcOX) over cell respiration of both the electrical (Delta psi) and chemical (Delta pH) component of the mitochondrial transmembrane proton electrochemical gradient (Delta mu(H+)) was investigated. The overall O-2 consumption and specific CcOX activity of actively phosphorylating cells were titrated with cyanide under conditions in which Delta psi and Delta pH were selectively modulated by addition of ionophores. In the absence of ionophores, CcOX displayed a high control coefficient (C-IV = 0.73), thus representing an important site of regulation of mitochondrial oxidative phosphorylation. A high control coefficient value (C-IV = 0.85) was also measured in the presence of nigericin, i.e. when Delta psi is maximal, and in the presence of nigericin and valinomycin (C-IV = 0.77), when Delta mu(H+) is abolished. In contrast, CcOX displayed a markedly lower control coefficient (C-IV = 0.30) upon addition of valinomycin, when Delta psi is converted into Delta pH. These results show that Delta psi is responsible for the tight control of CcOX over respiration in actively phosphorylating cells.	[Dalmonte, Maria Elena; Forte, Elena; Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Giuffre, Alessandro] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy; [Dalmonte, Maria Elena; Genova, Maria Luisa; Lenaz, Giorgio] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Bologna	Sarti, P (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.	paolo.sarti@uniroma1.it	Sarti, Paolo/D-2946-2009; Giuffrè, Alessandro/K-4341-2015; Genova, Maria Luisa/H-6921-2012; Lenaz, Giorgio/B-5751-2013; Forte, Elena/K-6015-2015	Giuffrè, Alessandro/0000-0001-5301-0681; Genova, Maria Luisa/0000-0002-9176-3630; Sarti, Paolo/0000-0002-8219-4827; FORTE, Elena/0000-0001-9049-6916	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (to P.S. and G.L.).	ANTONINI G, 1991, J BIOL CHEM, V266, P13193; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; BRAND MD, 1988, BIOCHEM J, V255, P535; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; BRUNORI M, 1985, EMBO J, V4, P2365, DOI 10.1002/j.1460-2075.1985.tb03940.x; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; CAPITANIO N, 1990, BIOCHEMISTRY-US, V29, P2939, DOI 10.1021/bi00464a008; CHANCE B, 1955, J BIOL CHEM, V217, P409; GREGORY L, 1989, BIOCHEMISTRY-US, V28, P2655, DOI 10.1021/bi00432a044; HEINRICH R, 1974, EUR J BIOCHEM, V42, P97, DOI 10.1111/j.1432-1033.1974.tb03319.x; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004; KHOLODENKO BN, 1993, FEBS LETT, V320, P71, DOI 10.1016/0014-5793(93)81660-R; Kunz WS, 2000, J BIOL CHEM, V275, P27741; LORUSSO M, 1995, J BIOENERG BIOMEMBR, V27, P101, DOI 10.1007/BF02110337; Mazat JP, 2001, BBA-BIOENERGETICS, V1504, P20, DOI 10.1016/S0005-2728(00)00236-X; Moreno-Sanchez R, 1999, EUR J BIOCHEM, V264, P427, DOI 10.1046/j.1432-1327.1999.00621.x; Namslauer I, 2009, P NATL ACAD SCI USA, V106, P3402, DOI 10.1073/pnas.0811450106; Nicholls D., 2002, BIOENERGETICS; NICHOLLS P, 1990, BIOCHEM CELL BIOL, V68, P1128, DOI 10.1139/o90-168; PAPA S, 1981, BIOCHEM J, V194, P395, DOI 10.1042/bj1940395; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; SARTI P, 1990, J BIOL CHEM, V265, P5554; Telford JE, 2009, J BIOL CHEM, V284, P9109, DOI 10.1074/jbc.M809101200; Verkhovsky MI, 2001, BIOCHEMISTRY-US, V40, P7077, DOI 10.1021/bi010030u; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Villani G, 2007, METHOD CELL BIOL, V80, P121, DOI 10.1016/S0091-679X(06)80005-1	32	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32331	32335		10.1074/jbc.M109.050146	http://dx.doi.org/10.1074/jbc.M109.050146			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776013	Green Published, hybrid			2022-12-25	WOS:000272028400015
J	Francois, IEJA; Bink, A; Vandercappellen, J; Ayscough, KR; Toulmay, A; Schneiter, R; van Gyseghem, E; Van den Mooter, G; Borgers, M; Vandenbosch, D; Coenye, T; Cammue, BPA; Thevissen, K				Francois, Isabelle E. J. A.; Bink, Anna; Vandercappellen, Jo; Ayscough, Kathryn R.; Toulmay, Alexandre; Schneiter, Roger; van Gyseghem, Elke; Van den Mooter, Guy; Borgers, Marcel; Vandenbosch, Davy; Coenye, Tom; Cammue, Bruno P. A.; Thevissen, Karin			Membrane Rafts Are Involved in Intracellular Miconazole Accumulation in Yeast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; ACTIN CYTOSKELETON; AZOLE ANTIFUNGALS; CANDIDA-ALBICANS; SURFACE; ATPASE; SPHINGOLIPIDS; RESISTANCE; ASSOCIATION; ERGOSTEROL	Azoles inhibit ergosterol biosynthesis, resulting in ergosterol depletion and accumulation of toxic 14 alpha-methylated sterols in membranes of susceptible yeast. We demonstrated previously that miconazole induces actin cytoskeleton stabilization in Saccharomyces cerevisiae prior to induction of reactive oxygen species, pointing to an ancillary mode of action. Using a genome-wide agar-based screening, we demonstrate in this study that S. cerevisiae mutants affected in sphingolipid and ergosterol biosynthesis, namely ipt1, sur1, skn1, and erg3 deletion mutants, are miconazole-resistant, suggesting an involvement of membrane rafts in its mode of action. This is supported by the antagonizing effect of membrane raft-disturbing compounds on miconazole antifungal activity as well as on miconazole-induced actin cytoskeleton stabilization and reactive oxygen species accumulation. These antagonizing effects point to a primary role for membrane rafts in miconazole antifungal activity. We further show that this primary role of membrane rafts in miconazole action consists of mediating intracellular accumulation of miconazole in yeast cells.	[Cammue, Bruno P. A.] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, B-3001 Heverlee, Belgium; [Ayscough, Kathryn R.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Toulmay, Alexandre; Schneiter, Roger] Univ Fribourg, Div Biochem, CH-1700 Fribourg, Switzerland; [van Gyseghem, Elke; Van den Mooter, Guy] Katholieke Univ Leuven, Lab Pharmaceut Technol & Biopharm, B-3000 Louvain, Belgium; [Borgers, Marcel] Barrier Therapeut NV, B-2440 Geel, Belgium; [Vandenbosch, Davy] Univ Ghent, Lab Farmaceut Microbiol, B-9000 Ghent, Belgium	KU Leuven; University of Sheffield; University of Fribourg; KU Leuven; Ghent University	Cammue, BPA (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20, B-3001 Heverlee, Belgium.	bruno.cammue@agr.kuleuven.ac.be	Coenye, Tom/A-6291-2014; Meis, Jacques F/A-9241-2010; Thevissen, Karin/B-7003-2015; Coenye, Tom/Z-1928-2019; Cammue, Bruno/M-9575-2013	Coenye, Tom/0000-0002-6407-0601; Meis, Jacques F/0000-0003-3253-6080; Thevissen, Karin/0000-0003-0275-9072; Coenye, Tom/0000-0002-6407-0601; Vandercappellen, Jo/0000-0001-8073-5493; Schneiter, Roger/0000-0002-9102-8396	IWT-Vlaanderen [030023]; Industrial Research Fund; Medical Research Council [G0601600] Funding Source: researchfish; MRC [G0601600] Funding Source: UKRI	IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Industrial Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant 030023 from IWT-Vlaanderen and by a postdoctoral fellowship from the Industrial Research Fund (Katholieke Universiteit Leuven; to K. T.).	Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; DENOLLIN S, 1977, ANTIMICROB AGENTS CH, V11, P500, DOI 10.1128/AAC.11.3.500; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Francois Isabelle E. J. A., 2006, Anti-Infective Agents in Medicinal Chemistry, V5, P3, DOI 10.2174/187152106774755554; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; Loffler J, 2000, FEMS MICROBIOL LETT, V185, P59, DOI 10.1016/S0378-1097(00)00071-9; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Thevissen K, 2007, J BIOL CHEM, V282, P21592, DOI 10.1074/jbc.M608505200; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; WATSON PF, 1989, BIOCHEM BIOPH RES CO, V164, P1170, DOI 10.1016/0006-291X(89)91792-0; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	23	25	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32680	32685		10.1074/jbc.M109.014571	http://dx.doi.org/10.1074/jbc.M109.014571			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783660	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000272028400051
J	Gallego-Sandin, S; Rodriguez-Garcia, A; Alonso, MT; Garcia-Sancho, J				Gallego-Sandin, Sonia; Rodriguez-Garcia, Arancha; Teresa Alonso, Maria; Garcia-Sancho, Javier			The Endoplasmic Reticulum of Dorsal Root Ganglion Neurons Contains Functional TRPV1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDUCED CA2+ RELEASE; VANILLOID RECEPTOR; CAPSAICIN RECEPTOR; CELL-DEATH; SENSORY NEURONS; ION CHANNELS; INTRACELLULAR CALCIUM; TARGETED AEQUORIN; CHROMAFFIN CELLS; PROTEIN-KINASE	Transient receptor potential vanilloid type 1 (TRPV1) is a plasma membrane Ca2+ channel involved in transduction of painful stimuli. Dorsal root ganglion (DRG) neurons express ectopic but functional TRPV1 channels in the endoplasmic reticulum (ER) (TRPV1(ER)). We have studied the properties of TRPV1(ER) in DRG neurons and HEK293T cells expressing TRPV1. Activation of TRPV1ER with capsaicin or other vanilloids produced an increase of cytosolic Ca2+ due to Ca2+ release from the ER. The decrease of [Ca2+](ER) was directly revealed by an ER-targeted aequorin Ca2+ probe, expressed in DRG neurons using a herpes amplicon virus. The sensitivity of TRPV1(ER) to capsaicin was smaller than the sensitivity of the plasma membrane TRPV1 channels. The low affinity of TRPV1(ER) was not related to protein kinase A- or C-mediated phosphorylations, but it was due to inactivation by cytosolic Ca2+ because the sensitivity to capsaicin was increased by loading the cells with the Ca2+ chelator BAPTA. Decreasing [Ca2+](ER) did not affect the sensitivity of TRPV1ER to capsaicin. Disruption of the TRPV1 calmodulin-binding domains at either the C terminus (Delta 35AA) or the N terminus (K155A) increased 10-fold the affinity of TRPV1(ER) for capsaicin, suggesting that calmodulin is involved in the inactivation. The lack of TRPV1 sensitizers, such as phosphatylinositol 4,5-bisphosphate, in the ER could contribute to decrease the affinity for capsaicin. The low sensitivity of TRPV1(ER) to agonists may be critical for neuron health, because otherwise Ca2+ depletion of ER could lead to ER stress, unfolding protein response, and cell death.	[Garcia-Sancho, Javier] Univ Valladolid, Inst Biol & Genet Mol, Valladolid 47003, Spain; CSIC, Valladolid 47003, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC)	Garcia-Sancho, J (corresponding author), Univ Valladolid, Inst Biol & Genet Mol, C Sanz & Fores S-N, Valladolid 47003, Spain.	jgsancho@ibgm.uva.es	Alonso Alonso, Maria Teresa/K-5003-2014; Garcia-Sancho, Javier/K-2975-2014	Garcia-Sancho, Javier/0000-0003-4573-7930	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFI2007-60157]; Instituto de Salud Carlos III [RD06/0010/0000]; Junta de Castilla y Leon [gr175]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported in part by Spanish Ministerio de Ciencia e Innovacion (MICINN) Grant BFI2007-60157, Instituto de Salud Carlos III Grant RD06/0010/0000, and Junta de Castilla y Leon Grant gr175.	Alonso MT, 1998, CELL CALCIUM, V24, P87, DOI 10.1016/S0143-4160(98)90076-8; Alonso MT, 1999, J CELL BIOL, V144, P241, DOI 10.1083/jcb.144.2.241; Alvarez J, 2002, CELL CALCIUM, V32, P251, DOI 10.1016/S0143416002001860; Appendino G, 1996, J MED CHEM, V39, P3123, DOI 10.1021/jm960063l; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; DRAY A, 1990, NEUROSCI LETT, V110, P52, DOI 10.1016/0304-3940(90)90786-9; Eun SY, 2001, BIOCHEM BIOPH RES CO, V285, P1114, DOI 10.1006/bbrc.2001.5272; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Gilabert R, 1997, J NEUROSCI METH, V71, P191, DOI 10.1016/S0165-0270(96)00144-6; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Karai LJ, 2004, J BIOL CHEM, V279, P16377, DOI 10.1074/jbc.M310891200; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lam PMW, 2007, J NEUROCHEM, V102, P801, DOI 10.1111/j.1471-4159.2007.04569.x; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu M, 2003, J BIOL CHEM, V278, P5462, DOI 10.1074/jbc.M209111200; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Manjarres IM, 2008, PFLUG ARCH EUR J PHY, V455, P961, DOI 10.1007/s00424-007-0349-5; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; Montell C, 2004, NAT CELL BIOL, V6, P690, DOI 10.1038/ncb0804-690; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Nunez L, 2007, J PHYSIOL-LONDON, V580, P385, DOI 10.1113/jphysiol.2006.126524; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Qin F., 2007, V179, P509; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Rosenbaum T, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-4; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Shin JS, 2001, NEUROSCI LETT, V299, P135, DOI 10.1016/S0304-3940(00)01777-8; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Thomas KC, 2007, J PHARMACOL EXP THER, V321, P830, DOI 10.1124/jpet.107.119412; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Turner H, 2003, BIOCHEM J, V371, P341, DOI 10.1042/BJ20021381; Villalobos C, 1996, FASEB J, V10, P654, DOI 10.1096/fasebj.10.5.8621065; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	59	69	72	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32591	32601		10.1074/jbc.M109.019687	http://dx.doi.org/10.1074/jbc.M109.019687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778904	hybrid, Green Published			2022-12-25	WOS:000272028400041
J	Hess, CN; Kou, RQ; Johnson, RP; Li, GK; Michel, T				Hess, Connie Ng; Kou, Ruqin; Johnson, Rosalyn P.; Li, Gordon K.; Michel, Thomas			ADP Signaling in Vascular Endothelial Cells ADP-DEPENDENT ACTIVATION OF THE ENDOTHELIAL ISOFORM OF NITRIC-OXIDE SYNTHASE REQUIRES THE EXPRESSION BUT NOT THE KINASE ACTIVITY OF AMP-ACTIVATED PROTEIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE AMPK; IN-VIVO; EXTRACELLULAR NUCLEOTIDES; ENOS PHOSPHORYLATION; GROWTH-FACTOR; P2 RECEPTORS; NO SYNTHESIS; PATHWAYS; MIGRATION; ROLES	ADP responses underlie therapeutic approaches to many cardiovascular diseases, and ADP receptor antagonists are in widespread clinical use. The role of ADP in platelet biology has been extensively studied, yet ADP signaling pathways in endothelial cells remain incompletely understood. We found that ADP promoted phosphorylation of the endothelial isoform of nitric-oxide synthase (eNOS) at Ser(1179) and Ser(635) and dephosphorylation at Ser(116) in cultured endothelial cells. Although eNOS activity was stimulated by both ADP and ATP, only ADP signaling was significantly inhibited by the P2Y(1) receptor antagonist MRS 2179 or by knockdown of P2Y(1) using small interfering RNA (siRNA). ADP activated the small GTPase Rac1 and promoted endothelial cell migration. siRNA-mediated knockdown of Rac1 blocked ADP-dependent eNOS Ser(1179) and Ser(635) phosphorylation, as well as eNOS activation. We analyzed pathways known to regulate eNOS, including phosphoinositide 3-kinase/Akt, ERK1/2, Src, and calcium/calmodulin-dependent kinase kinase-beta (CaMKK beta) using the inhibitors wortmannin, PD98059, PP2, and STO-609, respectively. None of these inhibitors altered ADP-modulated eNOS phosphorylation. In contrast, siRNA-mediated knockdown of AMP-activated protein kinase (AMPK) inhibited ADP-dependent eNOS Ser(635) phosphorylation and eNOS activity but did not affect eNOS Ser(1179) phosphorylation. Importantly, the AMPK enzyme inhibitor compound C had no effect on ADP-stimulated eNOS activity, despite completely blocking AMPK activity. CaMKK beta knockdown suppressed ADP-stimulated eNOS activity, yet inhibition of CaMKK beta kinase activity using STO-609 failed to affect eNOS activation by ADP. These data suggest that the expression, but not the kinase activity, of AMPK and CaMKK beta is necessary for ADP signaling to eNOS.	[Hess, Connie Ng; Kou, Ruqin; Johnson, Rosalyn P.; Li, Gordon K.; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St,Thorn Bldg,Rm 1210A, Boston, MA 02115 USA.	thomas_michel@harvard.edu			National Institutes of Health [HL46457, H48743, GM36259, 5T32HL07609-22]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046457, R29HL046457, T32HL007609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, H48743, and GM36259 (to T.M.) and 5T32HL07609-22 (to C.N.H.).	Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Baurand A, 2003, CARDIOVASC DRUG REV, V21, P67; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; BUSCONI L, 1993, J BIOL CHEM, V268, P8410; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Cale JM, 2006, BIOCHEM J, V398, P279, DOI 10.1042/BJ20060371; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; da Silva CG, 2009, CIRCULATION, V119, P871, DOI 10.1161/CIRCULATIONAHA.108.764571; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Guns PJDF, 2005, BRIT J PHARMACOL, V146, P288, DOI 10.1038/sj.bjp.0706326; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hirsch E, 2009, TRENDS BIOCHEM SCI, V34, P244, DOI 10.1016/j.tibs.2009.02.003; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Kou RQ, 2007, J BIOL CHEM, V282, P32719, DOI 10.1074/jbc.M706815200; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; LEROY EC, 1984, J CLIN INVEST, V74, P1003, DOI 10.1172/JCI111467; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li C, 2007, VASC PHARMACOL, V47, P257, DOI 10.1016/j.vph.2007.07.001; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; MILLS DCB, 1968, J PHYSIOL-LONDON, V195, P715, DOI 10.1113/jphysiol.1968.sp008484; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; SHIMOKAWA H, 1991, CIRCULATION, V83, P652, DOI 10.1161/01.CIR.83.2.652; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Sud N, 2008, AM J PHYSIOL-LUNG C, V294, pL582, DOI 10.1152/ajplung.00353.2007; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH704, DOI 10.1152/ajpheart.01076.2003; Wihlborg AK, 2004, ARTERIOSCL THROM VAS, V24, P1810, DOI 10.1161/01.ATV.0000142376.30582.ed; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Zhang H, 1997, J CARDIOVASC PHARM, V30, P767, DOI 10.1097/00005344-199712000-00011; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	58	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32209	32224		10.1074/jbc.M109.032656	http://dx.doi.org/10.1074/jbc.M109.032656			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783664	hybrid, Green Published			2022-12-25	WOS:000272028400002
J	Garrey, SM; Blech, M; Riffell, JL; Hankins, JS; Stickney, LM; Diver, M; Hsu, YHR; Kunanithy, V; Mackie, GA				Garrey, Stephen M.; Blech, Michaela; Riffell, Jenna L.; Hankins, Janet S.; Stickney, Leigh M.; Diver, Melinda; Hsu, Ying-Han Roger; Kunanithy, Vitharani; Mackie, George A.			Substrate Binding and Active Site Residues in RNases E and G ROLE OF THE 5 '-SENSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; RIBOSOMAL-RNA; CAFA PROTEIN; DEGRADATION; CLEAVAGE; DOMAIN; RIBONUCLEASE; MATURATION; DECAY	The paralogous endoribonucleases, RNase E and RNase G, play major roles in intracellular RNA metabolism in Escherichia coli and related organisms. To assay the relative importance of the principal RNA binding sites identified by crystallographic analysis, we introduced mutations into the 5'-sensor, the S1 domain, and the Mg+2/Mn+2 binding sites. The effect of such mutations has been measured by assays of activity on several substrates as well as by an assay of RNA binding. RNase E R169Q and the equivalent mutation in RNase G (R171Q) exhibit the strongest reductions in both activity (the k(cat) decrease similar to 40- to 100-fold) and RNA binding consistent with a key role for the 5'-sensor. Our analysis also supports a model in which the binding of substrate results in an increase in catalytic efficiency. Although the phosphate sensor plays a key role in vitro, it is unexpectedly dispensable in vivo. A strain expressing only RNase E R169Q as the sole source of RNase E activity is viable, exhibits a modest reduction in doubling time and colony size, and accumulates immature 5 S rRNA. Our results point to the importance of alternative RNA binding sites in RNase E and to alternative pathways of RNA recognition.	[Garrey, Stephen M.; Blech, Michaela; Riffell, Jenna L.; Hankins, Janet S.; Stickney, Leigh M.; Diver, Melinda; Hsu, Ying-Han Roger; Kunanithy, Vitharani; Mackie, George A.] Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Mackie, GA (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	gamackie@interchange.ubc.ca	Hankins, Jane/N-3362-2018	Diver, Melinda/0000-0001-5037-7322	Canadian Institutes of Health Research [MOP-5396]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-5396 from the Canadian Institutes of Health Research.	Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Briant DJ, 2003, MOL MICROBIOL, V50, P1381, DOI 10.1046/j.1365-2958.2003.03775.x; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Carpousis AJ, 2003, GENE DEV, V17, P2351, DOI 10.1101/gad.1147003; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; CORMACK RS, 1993, P NATL ACAD SCI USA, V90, P9006, DOI 10.1073/pnas.90.19.9006; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Diwa AA, 2002, MOL MICROBIOL, V46, P959, DOI 10.1046/j.1365-2958.2002.03231.x; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Joyce SA, 1998, J MOL BIOL, V282, P241, DOI 10.1006/jmbi.1998.2027; Kaberdin VR, 1998, P NATL ACAD SCI USA, V95, P11637, DOI 10.1073/pnas.95.20.11637; Kaberdin VR, 2000, J MOL BIOL, V301, P257, DOI 10.1006/jmbi.2000.3962; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Koslover DJ, 2008, STRUCTURE, V16, P1238, DOI 10.1016/j.str.2008.04.017; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Lin-Chao S, 1999, P NATL ACAD SCI USA, V96, P12406, DOI 10.1073/pnas.96.22.12406; MACKIE GA, 1992, J BIOL CHEM, V267, P1054; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; MISRA TK, 1979, J BIOL CHEM, V254, P1154; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Ow MC, 2000, MOL MICROBIOL, V38, P854, DOI 10.1046/j.1365-2958.2000.02186.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schubert M, 2004, J MOL BIOL, V341, P37, DOI 10.1016/j.jmb.2004.05.061; Spickler C, 2001, J BACTERIOL, V183, P1106, DOI 10.1128/JB.183.3.1106-1109.2001; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Wachi M, 2001, BIOCHEM BIOPH RES CO, V289, P1301, DOI 10.1006/bbrc.2001.6115; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Wicki J, 2007, BIOCHEMISTRY-US, V46, P6996, DOI 10.1021/bi700359e; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	42	44	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31843	31850		10.1074/jbc.M109.063263	http://dx.doi.org/10.1074/jbc.M109.063263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19778900	hybrid, Green Published			2022-12-25	WOS:000271572700039
J	Hou, TY; Ward, SM; Murad, JM; Watson, NP; Israel, MA; Duffield, GE				Hou, Tim Y.; Ward, Sarah M.; Murad, Joana M.; Watson, Nathan P.; Israel, Mark A.; Duffield, Giles E.			ID2 (Inhibitor of DNA Binding 2) Is a Rhythmically Expressed Transcriptional Repressor Required for Circadian Clock Output in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT MICE; ACYL-COA; GENE-EXPRESSION; INSULIN SENSITIVITY; RESPONSE ELEMENT; LIPID-METABOLISM; MOLECULAR CLOCK; ADIPOSE-TISSUE; FEEDBACK LOOPS; PROTEIN	Id2 is a helix-loop-helix transcription factor gene expressed in a circadian manner in multiple tissues with a phase-locked relationship with canonical clock genes (1). Our previous studies have identified circadian phenotypes in Id2 null mice, including enhanced photo-entrainment and disruption of activity rhythms, and have demonstrated a potent inhibitory effect of ID proteins upon CLOCK-BMAL1 transactivation of clock gene and clock-controlled gene activity (1). We have now begun to explore the potential role that ID2 may play in specifically regulating clock output. Here we show that ID2 protein is rhythmically expressed in mouse liver. Time-of-day-specific liver gene expression in Id2(+/+) and Id2(-/-) mice under circadian conditions was studied using DNA microarray analysis, identifying 651 differentially expressed genes, including a subset of 318 genes deemed rhythmically expressed in other studies. Examination of individual time courses reveals that these genes are dysregulated in a highly time-specific manner. A cohort of different functional groups were identified, including genes associated with glucose and lipid metabolism, e.g. serum protein Igfbp1 and lipoprotein lipase. We also reveal that the Id2(-/-) mice show a reduction in lipid storage in the liver and white adipose tissue, suggesting that disruption of normal circadian activity of components of lipid metabolism can result in overt physiological alterations. These data reveal a role for the transcriptional repressor ID2 as a circadian output regulator in the periphery.	[Hou, Tim Y.; Ward, Sarah M.; Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA; [Murad, Joana M.; Watson, Nathan P.; Israel, Mark A.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Murad, Joana M.; Watson, Nathan P.; Israel, Mark A.] Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03756 USA	University of Notre Dame; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Duffield, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA.	duffield.2@nd.edu		Watson, Nathan/0000-0002-9913-5575	University of Notre Dame; McDonald & Braco undergraduate research grant; Fisher graduate fellowship; Royal Society university research fellowship; Theodora B. Betz Foundation	University of Notre Dame; McDonald & Braco undergraduate research grant; Fisher graduate fellowship; Royal Society university research fellowship(Royal Society of London); Theodora B. Betz Foundation	This work was supported by a University of Notre Dame research grant ( to G. E. D.) a McDonald & Braco undergraduate research grant ( to T. Y. H.), a Fisher graduate fellowship ( to S. M. W.), a Royal Society university research fellowship ( to G. E. D.), and a Theodora B. Betz Foundation grant ( to M. A. I.).. S The on-line version of this article ( available at http://www.jbc.org) contains supplemental text, references, Fig. S1, and Tables S1-S7.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Garner B, 2002, J LIPID RES, V43, P205; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gunn TM, 2001, GENETICS, V158, P1683; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; HOGENESCH JB, 2000, DATABASE CIRCADIAN G; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ing NH, 2006, MOL REPROD DEV, V73, P967, DOI 10.1002/mrd.20510; Ishida N, 2007, NEUROSCI RES, V57, P483, DOI 10.1016/j.neures.2006.12.012; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kasuya F, 2006, PROTEIN EXPRES PURIF, V47, P405, DOI 10.1016/j.pep.2005.11.006; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; LEBOEUF RC, 1994, GENOMICS, V23, P296, DOI 10.1006/geno.1994.1501; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lehto M, 2001, J LIPID RES, V42, P1203; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; Lu YC, 2008, J LIPID RES, V49, P2582, DOI 10.1194/jlr.M800232-JLR200; Matsumoto K, 2006, BIOL PHARM BULL, V29, P539, DOI 10.1248/bpb.29.539; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nakaya Y, 2000, AM J CLIN NUTR, V71, P54; Norton JD, 2000, J CELL SCI, V113, P3897; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Ohgaki S, 2007, J ATHEROSCLER THROMB, V14, P179, DOI 10.5551/jat.E504; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PANDA S, 2006, CIRCA BIOINFORMATION; Park E, 2002, BBA-GENE STRUCT EXPR, V1574, P403, DOI 10.1016/S0167-4781(01)00364-5; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; PROKAZOVA NV, 1994, LIPIDS, V29, P1, DOI 10.1007/BF02537083; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; RAMSAY RR, 1993, ARCH BIOCHEM BIOPHYS, V302, P307, DOI 10.1006/abbi.1993.1216; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Walker JR, 2005, METHOD ENZYMOL, V393, P366, DOI 10.1016/S0076-6879(05)93016-4; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yanai H, 2006, J ATHEROSCLER THROMB, V13, P281, DOI 10.5551/jat.13.281; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636	75	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31735	31745		10.1074/jbc.M109.013961	http://dx.doi.org/10.1074/jbc.M109.013961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19740747	Green Published, hybrid			2022-12-25	WOS:000271572700028
J	Katre, UV; Mazumder, S; Prusti, RK; Mohanty, S				Katre, Uma V.; Mazumder, Suman; Prusti, Rabi K.; Mohanty, Smita			Ligand Binding Turns Moth Pheromone-binding Protein into a pH Sensor EFFECT ON THE ANTHERAEA POLYPHEMUS PBP1 CONFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHERAEA-POLYPHEMUS; BOMBYX-MORI; NMR STRUCTURE; RELEASE; FLUORESCENCE; SPECIFICITY; RECEPTORS; CHANNELS	In moths, pheromone-binding proteins (PBPs) are responsible for the transport of the hydrophobic pheromones to the membrane-bound receptors across the aqueous sensillar lymph. We report here that recombinant Antheraea polyphemus PBP1 (ApolPBP1) picks up hydrophobic molecule(s) endogenous to the Escherichia coli expression host that keeps the protein in the "open" (bound) conformation at high pH but switches to the "closed" (free) conformation at low pH. This finding has bearing on the solution structures of undelipidated lepidopteran moth PBPs determined thus far. Picking up a hydrophobic molecule from the host expression system could be a common feature for lipid-binding proteins. Thus, delipidation is critical for bacterially expressed lipid-binding proteins. We have shown for the first time that the delipidated ApolPBP1 exists primarily in the closed form at all pH levels. Thus, current views on the pH-induced conformational switch of PBPs hold true only for the ligand-bound open conformation of the protein. Binding of various ligands to delipidated ApolPBP1 studied by solution NMR revealed that the protein in the closed conformation switches to the open conformation only at or above pH 6.0 with a protein to ligand stoichiometry of similar to 1:1. Mutation of His(70) and His(95) to alanine drives the equilibrium toward the open conformation even at low pH for the ligand-bound protein by eliminating the histidine-dependent pH-induced conformational switch. Thus, the delipidated double mutant can bind ligand even at low pH in contrast to the wild type protein as revealed by fluorescence competitive displacement assay using 1-aminoanthracene and solution NMR.	[Katre, Uma V.; Mazumder, Suman; Prusti, Rabi K.; Mohanty, Smita] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	Auburn University System; Auburn University	Mohanty, S (corresponding author), Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.	mohansm@auburn.edu	Mohanty, Smita/AAP-2969-2021	Gabale, Uma/0000-0001-7919-8758	National Institutes of Health [DK082397]; United States Department of Agriculture Presidential Early Career Award for Scientists and Engineers [2003-35302-12930]; National Science Foundation [IBN-0628064]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Presidential Early Career Award for Scientists and Engineers(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK082397 (to S. M.). This work was also supported by United States Department of Agriculture Presidential Early Career Award for Scientists and Engineers Award 2003-35302-12930 and National Science Foundation Grant IBN-0628064.	Bette S, 2002, INSECT BIOCHEM MOLEC, V32, P241, DOI 10.1016/S0965-1748(01)00171-0; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Grolli S, 2006, FEBS J, V273, P5131, DOI 10.1111/j.1742-4658.2006.05510.x; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Mohanty S, 2003, J BIOMOL NMR, V27, P393, DOI 10.1023/A:1025880932197; Oldham NJ, 2001, CHEM SENSES, V26, P529, DOI 10.1093/chemse/26.5.529; PRESTWICH GD, 1993, PROTEIN SCI, V2, P420; RAMING K, 1989, FEBS LETT, V256, P215, DOI 10.1016/0014-5793(89)81751-X; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smita M., 2008, CURR CHEM BIOL, V2, P83, DOI DOI 10.2174/2212796810802010083; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	27	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32167	32177		10.1074/jbc.M109.013383	http://dx.doi.org/10.1074/jbc.M109.013383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758993	Green Published, hybrid			2022-12-25	WOS:000271572700071
J	Sun, QM; Zhou, H; Binmadi, NO; Basile, JR				Sun, Qiangming; Zhou, Hua; Binmadi, Nada O.; Basile, John R.			Hypoxia-inducible Factor-1-mediated Regulation of Semaphorin 4D Affects Tumor Growth and Vascularity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ANGIOGENESIS; FACTOR-I; ACTIVATION; TRANSCRIPTION; EXPRESSION; FACTOR-1; PATHWAY; PROTEIN	Tumor progression and metastasis depend on the ability of cancer cells to initiate angiogenesis to ensure delivery of oxygen, nutrients, and growth factors to tumor cells and provide access to the systemic circulation. Hypoxia-inducible factor-1 (HIF-1) can activate expression of a broad range of genes that mediate many of the adaptive responses to decreased oxygen concentration, such as enhanced glucose uptake and formation of new blood vessels. Acting through Plexin-B1 on endothelial cells, Semaphorin 4D (Sema4D) has been shown to promote angiogenesis and enhance invasive growth and proliferation in some tumors. Here we show that the gene for Sema4D, the product of which is elevated in head and neck squamous cell carcinoma (HNSCC) cells, contains upstream hypoxia response elements (HRE) and is strongly induced in hypoxia in a HIF-1-dependent manner. Knocking down Sema4D expression with short hairpin (sh) RNA reduces in vitro endothelial cell migration and growth and vascularity of HNSCC xenografts expressing a degradation resistant HIF-1 alpha subunit. We also demonstrate a correlation between HIF-1 activity and Sema4D expression in HNSCC specimens. These findings indicate that Sema4D is induced by hypoxia in a HIF-1-dependent manner and influences endothelial cell migration and tumor vascularity. Expression of Sema4D may be a strategy by which carcinomas promote angiogenesis and therefore could represent a therapeutic target for these malignancies.	[Basile, John R.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Basile, John R.] Marlene & Stuart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Basile, JR (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, 650 W Baltimore St, 7 North, Baltimore, MD 21201 USA.	jbasile@umaryland.edu	Binmadi, Nada O./O-5009-2016	Binmadi, Nada O./0000-0002-2200-6206				Amornphimoltham P, 2004, CLIN CANCER RES, V10, P4029, DOI 10.1158/1078-0432.CCR-03-0249; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; BISMUTH G, 2002, SCI STKE, pRE4; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Ch'ng E, 2007, CANCER-AM CANCER SOC, V110, P164, DOI 10.1002/cncr.22764; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kreuter M, 2002, ANN HEMATOL, V81, pS74; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Siebold C, 2005, P NATL ACAD SCI USA, V102, P16836, DOI 10.1073/pnas.0504997102; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; VANDEWOUDE GF, 1997, CIBA F SYMP, V212, P130; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; 1999, CELL, V97, P551	24	53	64	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32066	32074		10.1074/jbc.M109.057166	http://dx.doi.org/10.1074/jbc.M109.057166			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762474	hybrid, Green Published			2022-12-25	WOS:000271572700061
J	Wilkinson, IC; Hall, CJ; Veverka, V; Shi, JY; Muskett, FW; Stephens, PE; Taylor, RJ; Henry, AJ; Carr, MD				Wilkinson, Ian C.; Hall, Catherine J.; Veverka, Vaclav; Shi, Jiye Y.; Muskett, Frederick W.; Stephens, Paul E.; Taylor, Richard J.; Henry, Alistair J.; Carr, Mark D.			High Resolution NMR-based Model for the Structure of a scFv-IL-1 beta Complex POTENTIAL FOR NMR AS A KEY TOOL IN THERAPEUTIC ANTIBODY DESIGN AND DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE DETERMINATION; LIQUID-CRYSTALLINE PHASE; CHAIN FV FRAGMENT; CHEMICAL-SHIFT; ANGSTROM RESOLUTION; BINDING-SITE; FAB FRAGMENT; SPECTROSCOPY; NEUTRALIZATION; RESTRAINTS	Monoclonal antibodies have recently started to deliver on their promise as highly specific and active drugs; however, a more effective, knowledge-based approach to the selection, design, and optimization of potential therapeutic antibodies is currently limited by the surprising lack of detailed structural information for complexes formed with target proteins. Here we show that complexes formed with minimal antigen binding single chain variable fragments (scFv) reliably reflect all the features of the binding interface present in larger Fab fragments, which are commonly used as therapeutics, and report the development of a robust, reliable, and relatively rapid approach to the determination of high resolution models for scFv-target protein complexes. This NMR spectroscopy-based approach combines experimental determination of the interaction surfaces and relative orientations of the scFv and target protein, with NMR restraint-driven, semiflexible docking of the proteins to produce a reliable and highly informative model of the complex. Experience with scFvs and Fabs targeted at a number of secreted regulatory proteins suggests that the approach will be applicable to many therapeutic antibodies targeted at proteins, and its application is illustrated for a potential therapeutic antibody targeted at the cytokine IL-1 beta. The detailed structural information that can be obtained by this approach has the potential to have a major impact on the rational design and development of an increasingly important class of biological pharmaceuticals.	[Wilkinson, Ian C.; Hall, Catherine J.; Veverka, Vaclav; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Shi, Jiye Y.; Stephens, Paul E.; Taylor, Richard J.; Henry, Alistair J.] UCB Celltech, Slough SL1 3WE, Berks, England	University of Leicester; Celltech Group Ltd	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014; Shi, Jiye/G-2745-2012	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Shi, Jiye/0000-0002-9628-8680; Carr, Mark/0000-0002-3939-0996	UCB-Celltech; Wellcome Trust	UCB-Celltech(UCB Pharma SA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by UCB-Celltech and Wellcome Trust grants ( to M. D. C.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ay J, 2000, J MOL BIOL, V301, P239, DOI 10.1006/jmbi.2000.3971; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; CHARBONNIER JB, 1995, P NATL ACAD SCI USA, V92, P11721, DOI 10.1073/pnas.92.25.11721; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DESPLANCQ D, 1994, PROTEIN ENG, V7, P1027, DOI 10.1093/protein/7.8.1027; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P3542, DOI 10.1021/bi00466a018; Faelber K, 2001, J MOL BIOL, V313, P83, DOI 10.1006/jmbi.2001.5036; FREUND C, 1993, FEBS LETT, V320, P97, DOI 10.1016/0014-5793(93)80070-B; FREUND C, 1994, BIOCHEMISTRY-US, V33, P3296, DOI 10.1021/bi00177a021; GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x; Hubbard SJ., 1993, COMPUTER PROGRAM; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Josephson K, 2002, STRUCTURE, V10, P981, DOI 10.1016/S0969-2126(02)00791-8; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANE DP, 1993, CURR OPIN IMMUNOL, V5, P268, DOI 10.1016/0952-7915(93)90016-L; Lee YC, 2002, J MOL BIOL, V320, P107, DOI 10.1016/S0022-2836(02)00403-5; Lefranc MP, 1997, IMMUNOL TODAY, V18, P509, DOI 10.1016/S0167-5699(97)01163-8; Li S, 2008, STRUCTURE, V16, P216, DOI 10.1016/j.str.2007.11.009; Malby RL, 1998, J MOL BIOL, V279, P901, DOI 10.1006/jmbi.1998.1794; Meiler J, 2000, J BIOMOL NMR, V16, P245, DOI 10.1023/A:1008378624590; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Pavlou AK, 2005, EUR J PHARM BIOPHARM, V59, P389, DOI 10.1016/j.ejpb.2004.11.007; PRASAD L, 1993, J BIOL CHEM, V268, P10705; PRIESTLE JP, 1989, P NATL ACAD SCI USA, V86, P9667, DOI 10.1073/pnas.86.24.9667; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; VandeWater J, 1997, CLIN IMMUNOL IMMUNOP, V85, P229, DOI 10.1006/clin.1997.4434; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	45	33	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31928	31935		10.1074/jbc.M109.025304	http://dx.doi.org/10.1074/jbc.M109.025304			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776018	Green Published, hybrid			2022-12-25	WOS:000271572700048
J	Ganjam, GK; Dimova, EY; Unterman, TG; Kietzmann, T				Ganjam, Goutham Kumar; Dimova, Elitsa Y.; Unterman, Terry G.; Kietzmann, Thomas			FoxO1 and HNF-4 Are Involved in Regulation of Hepatic Glucokinase Gene Expression by Resveratrol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; PROTEIN-KINASE-B; FACTOR-BINDING PROTEIN-1; INSULIN-RESPONSE UNIT; CALORIE RESTRICTION; PROMOTER ACTIVITY; CELL-SURVIVAL; PEROXISOME PROLIFERATOR; DEPENDENT REGULATION; LENTIVIRUS VECTOR	Resveratrol, a polyphenol derived from grapes, exerts important effects on glucose and lipid metabolism, yet detailed mechanisms mediating these effects remain unknown. The liver plays a central role in energy homeostasis, and glucokinase (GK) is a key enzyme involved in glucose utilization. Resveratrol activates SIRT1 (sirtuin 1), which promotes deacetylation of the forkhead transcription factor FoxO1. Previously, we reported that FoxO1 can suppress and that HNF-4 can stimulate GK expression in the liver. Here, we examined the role of FoxO1 and HNF-4 in mediating resveratrol effects on liver GK expression. Resveratrol suppressed hepatic GK expression in vivo and in isolated hepatocytes, and knocking down FoxO1 with shRNAs disrupted this effect. Reporter gene, gel shift, supershift assay, and chromatin immunoprecipitation studies show that FoxO1 binds to the GK promoter and that the interplay between FoxO1 and HNF-4 within the GK promoter is essential for mediating the effects of resveratrol. Resveratrol promotes deacetylation of FoxO1 and enhances its recruitment to the FoxO-binding element. Conversely, resveratrol suppresses recruitment of HNF-4 to its binding site, and knockdown of FoxO1 blocks this effect of resveratrol. Coprecipitation and chromatin immunoprecipitation studies show that resveratrol enhances interaction between FoxO1 and HNF-4, reduces binding of HNF-4 to its own site, and promotes its recruitment to the FoxO site in a FoxO1-dependent manner. These results provide the first evidence that resveratrol represses GK expression via FoxO1 and that the interaction between FoxO1 and HNF-4 contributes to these effects of resveratrol.	[Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA; Univ Kaiserslautern, Fac Chem, Dept Biochem, D-67663 Kaiserslautern, Germany; [Ganjam, Goutham Kumar] Univ Marburg, Dept Nutrient Physiol, D-35043 Marburg, Germany; [Dimova, Elitsa Y.; Kietzmann, Thomas] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Unterman, Terry G.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Kaiserslautern; Philipps University Marburg; Finland National Institute for Health & Welfare; University of Oulu; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Unterman, TG (corresponding author), Univ Illinois, Coll Med, Dept Med, 820 S Damen Ave, Chicago, IL 60612 USA.	unterman@uic.edu; tkietzm@gwdg.de		Kietzmann, Thomas/0000-0003-0242-8636; Dimova, Elitsa/0000-0003-2745-8145	National Institutes of Health [DK41430]; Fonds der Chemischen Industrie; Deutsche Krebshilfe [106929]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041430, R01DK041430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK41430 (to T. G. U.). This work was also supported by the Department of Veterans Affairs Merit Review Program (to T. G. U.) as well as by grants from Fonds der Chemischen Industrie (to T. K.) and Deutsche Krebshilfe 106929 (to T. K.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; COLONNO RJ, 1978, CELL, V15, P93, DOI 10.1016/0092-8674(78)90085-5; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104; Dimova EY, 2005, THROMB HAEMOSTASIS, V93, P1176, DOI 10.1160/TH04-11-0761; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fukuoka M, 2003, INT J MOL MED, V12, P503; Fulda S, 2006, CANCER DETECT PREV, V30, P217, DOI 10.1016/j.cdp.2006.03.007; Ghosh AK, 2001, J BIOL CHEM, V276, P8507, DOI 10.1074/jbc.M008541200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Immenschuh S, 1998, BIOCHEM J, V334, P141, DOI 10.1042/bj3340141; Iynedjian PB, 1998, BIOCHEM J, V333, P705, DOI 10.1042/bj3330705; IYNEDJIAN PB, 1995, J CLIN INVEST, V95, P1966, DOI 10.1172/JCI117880; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kaestner KH, 2000, GENE DEV, V14, P142; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; Kietzmann T, 2004, METHOD ENZYMOL, V381, P357; Kietzmann T, 1997, BIOCHEM J, V321, P17, DOI 10.1042/bj3210017; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; KIM JJ, 2009, DIABETES IN PRESS; Kim S, 2004, DIABETES, V53, pS66, DOI 10.2337/diabetes.53.2007.S66; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kimura Y, 2000, J PHARM PHARMACOL, V52, P1287, DOI 10.1211/0022357001777270; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Klein A, 2008, MOL BIOL CELL, V19, P3667, DOI 10.1091/mbc.E08-01-0042; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kruger M, 1997, N-S ARCH PHARMACOL, V356, P433, DOI 10.1007/PL00005073; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; MAGNUSON MA, 1992, J CELL BIOCHEM, V48, P115, DOI 10.1002/jcb.240480202; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Roth U, 2004, BIOL CHEM, V385, P239, DOI 10.1515/BC.2004.018; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; SLADEK FM, 1993, RECEPTOR, V3, P223; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; VANDERCAMMEN A, 1991, EUR J BIOCHEM, V200, P545, DOI 10.1111/j.1432-1033.1991.tb16217.x; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Yeagley D, 2001, J BIOL CHEM, V276, P33705, DOI 10.1074/jbc.M101215200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshida K, 2007, ENDOCRINOLOGY, V148, P2904, DOI 10.1210/en.2006-1149; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	85	59	59	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30783	30797		10.1074/jbc.M109.045260	http://dx.doi.org/10.1074/jbc.M109.045260			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740748	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000271378400006
J	Morii, H; Kiyonari, S; Ishino, Y; Koga, Y				Morii, Hiroyuki; Kiyonari, Shinichi; Ishino, Yoshizumi; Koga, Yosuke			A Novel Biosynthetic Pathway of Archaetidyl-myo-inositol via Archaetidyl-myo-inositol Phosphate from CDP-archaeol and D-Glucose 6-Phosphate in Methanoarchaeon Methanothermobacter thermautotrophicus Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLAR ETHER LIPIDS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; INOSITOL-1-PHOSPHATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; 1-PHOSPHATE CYCLASE; TETRAETHER LIPIDS; COMPONENT PARTS; KEY ENZYME; IN-VITRO; METABOLISM	Ether-type inositol phospholipids are ubiquitously distributed in Archaea membranes. The present paper describes a novel biosynthetic pathway of the archaeal inositol phospholipid. To study the biosynthesis of archaetidylinositol in vitro, we prepared two possible substrates: CDP-archaeol, which was chemically synthesized, and myo-[14C] inositol 1-phosphate, which was enzymatically prepared from [14C] glucose 6-phosphate with the inositol 1-phosphate (IP) synthase of this organism. The complete structure of the IP synthase reaction product was determined to be 1L-myo-inositol 1-phosphate, based on gas liquid chromatography with a chiral column. When the two substrates were incubated with the Methanothermobacter thermautotrophicus membrane fraction, archaetidylinositol phosphate (AIP) was formed along with a small amount of archaetidylinositol (AI). The two products were identified by fast atom bombardment-mass spectrometry and chemical analyses. AI was formed from AIP by incubation with the membrane fraction, but AIP was not formed from AI. This finding indicates that archaeal AI was synthesized from CDP-archaeol and D-glucose 6-phosphate via myo-inositol 1-phosphate and AIP. Although the relevant enzymes were not isolated, three enzymes are implied: IP synthase, AIP synthase, and AIP phosphatase. AIP synthase was homologous to yeast phosphatidylinositol synthase, and we confirmed AIP synthase activity by cloning the encoding gene (MTH1691) and expressing it in Escherichia coli. AIP synthase is a newly found member of the enzyme superfamily CDP-alcohol phosphatidyltransferase, which includes a wide range of enzymes that attach polar head groups to ester-and ether-type phospholipids of bacterial and archaeal origin. This is the first report of the biosynthesis of ether-type inositol phospholipids in Archaea.	[Morii, Hiroyuki] Univ Occupat & Environm Hlth, Dept Chem, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Kiyonari, Shinichi; Ishino, Yoshizumi] Kyushu Univ, Lab Prot Chem & Engn, Dept Genet Resources Technol, Grad Sch Bioresource & Bioenvironm Sci,Fac Agr, Fukuoka 8128581, Japan	University of Occupational & Environmental Health - Japan; Kyushu University	Morii, H (corresponding author), Univ Occupat & Environm Hlth, Dept Chem, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	h-morii@health.uoeh-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Ishino, Yoshizumi/0000-0001-9419-0826	Japan Society for the Promotion of Science [C16580067]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research (KAKENHI) C16580067 from the Japan Society for the Promotion of Science.	Bachhawat N, 2000, TRENDS GENET, V16, P111, DOI 10.1016/S0168-9525(99)01966-6; BALLOU CE, 1960, J AM CHEM SOC, V82, P3333, DOI 10.1021/ja01498a026; BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; CHEN IW, 1965, BIOCHEM BIOPH RES CO, V19, P144, DOI 10.1016/0006-291X(65)90133-6; CHEN IW, 1966, ARCH BIOCHEM BIOPHYS, V117, P154, DOI 10.1016/0003-9861(66)90138-X; Daiyasu Hiromi, 2005, Archaea, V1, P399, DOI 10.1155/2005/452563; EISENBER.F, 1967, J BIOL CHEM, V242, P1375; Grochowski LL, 2006, J BACTERIOL, V188, P2836, DOI 10.1128/JB.188.8.2836-2844.2006; KANFER J, 1964, J BIOL CHEM, V239, P1720; KOGA Y, 1993, SYST APPL MICROBIOL, V16, P342, DOI 10.1016/S0723-2020(11)80264-X; Koga Y, 2008, SYST APPL MICROBIOL, V31, P169, DOI 10.1016/j.syapm.2008.02.005; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; LOEWUS MW, 1980, J BIOL CHEM, V255, P1710; MOLDOVEANU N, 1988, BIOCHIM BIOPHYS ACTA, V960, P164, DOI 10.1016/0005-2760(88)90062-8; Morii H, 2000, J BIOL CHEM, V275, P36568, DOI 10.1074/jbc.M005925200; MORII H, 1993, FEMS MICROBIOL LETT, V109, P283, DOI 10.1111/j.1574-6968.1993.tb06182.x; Morii H, 2003, J BACTERIOL, V185, P1181, DOI 10.1128/JB.185.4.1181-1189.2003; MORII H, 1988, AGR BIOL CHEM TOKYO, V52, P3149, DOI 10.1080/00021369.1988.10869195; Morii H, 2007, J BACTERIOL, V189, P4053, DOI 10.1128/JB.01875-06; Neelon K, 2005, J BIOL CHEM, V280, P11475, DOI 10.1074/jbc.M500469200; NISHIHARA M, 1995, J BIOCHEM-TOKYO, V117, P933, DOI 10.1093/oxfordjournals.jbchem.a124822; NISHIHARA M, 1989, BIOCHEMISTRY-US, V28, P95, DOI 10.1021/bi00427a014; NISHIHARA M, 1987, J BIOCHEM-TOKYO, V101, P1007, DOI 10.1093/oxfordjournals.jbchem.a121942; NISHIHARA M, 1987, J BIOCHEM-TOKYO, V101, P997, DOI 10.1093/oxfordjournals.jbchem.a121969; PIZER FL, 1959, J AM CHEM SOC, V81, P915, DOI 10.1021/ja01513a040; Rodrigues MV, 2007, J BACTERIOL, V189, P5405, DOI 10.1128/JB.00465-07; SHERMAN WR, 1969, J BIOL CHEM, V244, P5703; SHERMAN WR, 1981, J NEUROCHEM, V36, P1947, DOI 10.1111/j.1471-4159.1981.tb10819.x; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; ZHANG DL, 1990, J AM CHEM SOC, V112, P1264, DOI 10.1021/ja00159a067; ZHANG DL, 1993, J AM CHEM SOC, V115, P1270, DOI 10.1021/ja00057a008	37	25	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30766	30774		10.1074/jbc.M109.034652	http://dx.doi.org/10.1074/jbc.M109.034652			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740749	hybrid, Green Published			2022-12-25	WOS:000271378400004
J	Oki, T; Eto, K; Izawa, K; Yamanishi, Y; Inagaki, N; Frampton, J; Kitamura, T; Kitaura, J				Oki, Toshihiko; Eto, Koji; Izawa, Kumi; Yamanishi, Yoshinori; Inagaki, Naoki; Frampton, Jon; Kitamura, Toshio; Kitaura, Jiro			Evidence That Integrin alpha IIb beta 3-dependent Interaction of Mast Cells with Fibrinogen Exacerbates Chronic Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; CYTOKINE PRODUCTION; IN-VIVO; ACTIVATION; ADHESION; IGE; MICE; FIBRIN(OGEN); EXPRESSION; PLATELETS	Integrin alpha IIb beta 3 is expressed in mast cells as well as in megakaryocytes/platelets. A recent study has shown that surface expression levels of integrin alpha V beta 3 are elevated in integrin alpha IIb-deficient bone marrow-derived mast cells (BMMCs) as compared with wild-type (WT) counterparts, but the underlying mechanism remains obscure. Here we demonstrate by transducing integrin alpha IIb into integrin alpha IIb-deficient BMMCs that surface expression levels of integrin alpha V beta 3 are inversely related to those of integrin alpha IIb beta 3. Thus, competitive association of integrin beta 3 with integrin alpha IIb or integrin alpha V determines surface expression levels of integrin alpha IIb beta 3 or alpha V beta 3 in mast cells. We compared WT and integrin alpha IIb-deficient BMMCs as well as integrin alpha IIb-deficient BMMCs transduced with integrin alpha IIb(WT) or non-functional alpha IIb(D163A) mutant and found that enhancement of proliferation, degranulation, cytokine production, and migration of BMMCs through interaction with fibrinogen (FB) depended on integrin alpha IIb beta 3. In addition, elevated surface expression of integrin alpha V beta 3 failed to compensate for loss of FB-associated functions in integrin alpha IIb-deficient BMMCs while enhancing adhesion to vitronectin or von Willebrand factor. Importantly, integrin alpha IIb deficiency strongly suppressed chronic inflammation with the remarkable increase of mast cells induced by continuous intraperitoneal administration of FB, although it did not affect acute allergic responses or mast cell numbers in tissues in steady states. Interestingly, soluble FB promoted cytokine production of BMMCs in response to Staphylococcus aureus with FB-binding capacity, through integrin alpha IIb beta 3-dependent recognition of this pathogen. Collectively, integrin alpha IIb beta 3 in mast cells plays an important part in FB-associated, chronic inflammation and innate immune responses.	[Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo 1088639, Japan; [Eto, Koji] Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo 1088639, Japan; [Inagaki, Naoki] Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 5028585, Japan; [Frampton, Jon] Univ Birmingham, Div Immun & Infect, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Tokyo; University of Tokyo; Gifu Pharmaceutical University; University of Birmingham	Kitaura, J (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitaura-tky@umin.ac.jp	Kitamura, Toshio/AAA-2071-2021		Ministry of Education, Science, Technology, Sports and Culture; Ministry of Health and Welfare, Japan; Medical Research Council [G9818340B] Funding Source: researchfish	Ministry of Education, Science, Technology, Sports and Culture; Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Ministry of Education, Science, Technology, Sports and Culture and the Ministry of Health and Welfare, Japan.	Artis D, 2000, EUR J IMMUNOL, V30, P1656, DOI 10.1002/1521-4141(200006)30:6&lt;1656::AID-IMMU1656&gt;3.0.CO;2-Z; Berlanga O, 2005, EXP HEMATOL, V33, P403, DOI 10.1016/j.exphem.2005.01.011; BIANCHINE PJ, 1992, J IMMUNOL, V149, P3665; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; Edelson BT, 2004, BLOOD, V103, P2214, DOI 10.1182/blood-2003-08-2978; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Furumoto Y, 2004, J BIOL CHEM, V279, P49177, DOI 10.1074/jbc.M404730200; Gerber DJ, 1996, P NATL ACAD SCI USA, V93, P14698, DOI 10.1073/pnas.93.25.14698; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Honda S, 1998, J CLIN INVEST, V102, P1183, DOI 10.1172/JCI3206; INAGAKI N, 1986, INT ARCH ALLER A IMM, V81, P58, DOI 10.1159/000234108; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451; KINASHI T, 1994, BLOOD, V83, P1033; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2005, BLOOD, V105, P3222, DOI 10.1182/blood-2004-11-4205; Kitaura J, 2005, J IMMUNOL, V174, P4495, DOI 10.4049/jimmunol.174.8.4495; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Knight PA, 2002, AM J PATHOL, V161, P771, DOI 10.1016/S0002-9440(10)64236-8; Lengweiler S, 1999, BIOCHEM BIOPH RES CO, V262, P167, DOI 10.1006/bbrc.1999.1172; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; NAGAI H, 1995, BIOL PHARM BULL, V18, P239; Oki T, 2006, J IMMUNOL, V176, P52, DOI 10.4049/jimmunol.176.1.52; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Suehiro K, 1996, J BIOL CHEM, V271, P10365, DOI 10.1074/jbc.271.17.10365; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841; Wong MX, 2002, J IMMUNOL, V168, P6455, DOI 10.4049/jimmunol.168.12.6455	39	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31463	31472		10.1074/jbc.M109.030213	http://dx.doi.org/10.1074/jbc.M109.030213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19755424	Green Published, hybrid			2022-12-25	WOS:000271378400071
J	Kapralov, A; Vlasova, II; Feng, WH; Maeda, A; Walson, K; Tyurin, VA; Huang, ZT; Aneja, RK; Carcillo, J; Bayir, H; Kagan, VE				Kapralov, Alexandr; Vlasova, Irina I.; Feng, Weihong; Maeda, Akihiro; Walson, Karen; Tyurin, Vladimir A.; Huang, Zhentai; Aneja, Rajesh K.; Carcillo, Joseph; Bayir, Huelya; Kagan, Valerian E.			Peroxidase Activity of Hemoglobin.Haptoglobin Complexes COVALENT AGGREGATION AND OXIDATIVE STRESS IN PLASMA AND MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR; HAPTOGLOBIN GENOTYPE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; HUMAN HEMOGLOBIN; CARDIOLIPIN OXIDATION; CROSS-LINKING; CYTOCHROME-C; ANTIOXIDANT; MYOGLOBIN	As a hemoprotein, hemoglobin (Hb) can, in the presence of H2O2, act as a peroxidase. In red blood cells, this activity is regulated by the reducing environment. For stroma-free Hb this regulation is lost, and the potential for Hb to become a peroxidase is high and further increased by inflammatory cells generating superoxide. The latter can be converted into H2O2 and feed Hb peroxidase activity. Haptoglobins (Hp) bind with extracellular Hb and reportedly weaken Hb peroxidase activity. Here we demonstrate that: (i) Hb peroxidase activity is retained upon binding with Hp; (ii) in the presence of H2O2, Hb.Hp peroxidase complexes undergo covalent cross-linking; (iii) peroxidase activity of Hb.Hp complexes and aggregates consumes reductants such as ascorbate and nitric oxide; (iv) cross-linked Hb.Hp aggregates are taken up by macrophages at rates exceeding those for noncovalently cross-linked Hb.Hp complexes; (v) the engulfed Hb.Hp aggregates activate superoxide production and induce intracellular oxidative stress (deplete endogenous glutathione and stimulate lipid peroxidation); (vi) Hb.Hp aggregates cause cytotoxicity to macrophages; and (vii) Hb.Hp aggregates are present in septic plasma. Overall, our data suggest that under conditions of severe inflammation and oxidative stress, peroxidase activity of Hb.Hp covalent aggregates may cause macrophage dysfunction and microvascular vasoconstriction, which are commonly seen in severe sepsis and hemolytic diseases.	[Kapralov, Alexandr; Vlasova, Irina I.; Feng, Weihong; Maeda, Akihiro; Walson, Karen; Tyurin, Vladimir A.; Huang, Zhentai; Bayir, Huelya; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Kapralov, Alexandr; Vlasova, Irina I.; Feng, Weihong; Maeda, Akihiro; Tyurin, Vladimir A.; Huang, Zhentai; Bayir, Huelya; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Walson, Karen; Aneja, Rajesh K.; Carcillo, Joseph; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15219 USA; [Walson, Karen; Bayir, Huelya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15219 USA; [Vlasova, Irina I.] Res Inst Physicochem Med, Moscow 119992, Russia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency	Kagan, VE (corresponding author), 100 Technol Dr,Suite 350, Pittsburgh, PA 15219 USA.	kagan@pitt.edu	Maeda, Akihiro/K-5190-2015; Huang, Zhentai/C-6926-2012	Huang, Zhentai/0000-0002-8102-464X; Tyurin, Vladimir/0000-0002-3474-1697; Kagan, Valerian E./0000-0002-7245-1885; Kapralov, Oleksandr/0000-0002-3006-916X	National Institutes of Health [HL70755, HD057587, NS061817, AHA-0535365N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057587] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM076344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL70755, HD057587, NS061817, and AHA-0535365N.	Aird WC, 2003, MAYO CLIN PROC, V78, P869, DOI 10.4065/78.7.869; Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; Armour J, 2001, J APPL PHYSIOL, V90, P795, DOI 10.1152/jappl.2001.90.3.795; Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Asleh R, 2006, CIRC RES, V99, P1419, DOI 10.1161/01.RES.0000251741.65179.56; Atkinson SH, 2006, PLOS MED, V3, P652, DOI 10.1371/journal.pmed.0030172; Bachli EB, 2006, J LEUKOCYTE BIOL, V79, P312, DOI 10.1189/jlb.0605309; Berger MM, 2007, CRIT CARE MED, V35, pS584, DOI 10.1097/01.CCM.0000279189.81529.C4; Blum S, 2007, J AM COLL CARDIOL, V49, P82, DOI 10.1016/j.jacc.2006.08.044; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cepinskas G, 2008, J CLIN BIOCHEM NUTR, V42, P175, DOI 10.3164/jcbn.2008026; CERDA S, 1990, J IMMUNOL METHODS, V134, P51, DOI 10.1016/0022-1759(90)90111-8; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; COOPER GS, 1990, MEDICINE, V69, P114, DOI 10.1097/00005792-199069020-00005; DEMONTELLANO PRO, 1992, ANNU REV PHARMACOL, V32, P89, DOI 10.1146/annurev.pharmtox.32.1.89; EVERSE J, 1994, METHOD ENZYMOL, V231, P547; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; GOODE HF, 1993, CRIT CARE MED, V21, P1770, DOI 10.1097/00003246-199311000-00029; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; Han S, 2002, IMMUNOLOGY, V106, P53, DOI 10.1046/j.1365-2567.2002.01404.x; Hubel CA, 1997, FREE RADICAL BIO MED, V23, P597, DOI 10.1016/S0891-5849(97)00010-5; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Jeffers A, 2006, FREE RADICAL BIO MED, V41, P1557, DOI 10.1016/j.freeradbiomed.2006.08.017; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; KAYE D, 1963, J IMMUNOL, V91, P65; Keszler A, 2006, FREE RADICAL BIO MED, V40, P507, DOI 10.1016/j.freeradbiomed.2005.09.005; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois MR, 1996, CLIN CHEM, V42, P1589; LAVIALLE F, 1976, EUR J BIOCHEM, V64, P287, DOI 10.1111/j.1432-1033.1976.tb10299.x; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Long CL, 2003, J SURG RES, V109, P144, DOI 10.1016/S0022-4804(02)00083-5; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MARTIN WJ, 1984, AM REV RESPIR DIS, V130, P209; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; MCCORMICK DJ, 1990, J PROTEIN CHEM, V9, P735, DOI 10.1007/BF01024768; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; NIELSEN MJ, 2009, ANTIOXID RE IN PRESS; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Schaer DJ, 2007, ANTIOXID REDOX SIGN, V9, P991, DOI 10.1089/ars.2007.1576; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Strauss JG, 2002, BIOCHEM J, V368, P69, DOI 10.1042/BJ20020306; Su DH, 1997, INFECT IMMUN, V65, P1258, DOI 10.1128/IAI.65.4.1258-1266.1997; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Takeya R, 2006, ANTIOXID REDOX SIGN, V8, P1523, DOI 10.1089/ars.2006.8.1523; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Vallelian F, 2008, FREE RADICAL BIO MED, V45, P1150, DOI 10.1016/j.freeradbiomed.2008.07.013; Venkatesh B, 2005, BIOPOLYMERS, V80, P18, DOI 10.1002/bip.20194; Vlasova II, 2006, J BIOL CHEM, V281, P14554, DOI 10.1074/jbc.M509507200; WAKS M, 1963, BIOCHIM BIOPHYS ACTA, V67, P417	65	75	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30395	30407		10.1074/jbc.M109.045567	http://dx.doi.org/10.1074/jbc.M109.045567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740759	Green Published, hybrid			2022-12-25	WOS:000271090000042
J	Sarkar, A; Mitra, S; Mehta, S; Raices, R; Wewers, MD				Sarkar, Anasuya; Mitra, Srabani; Mehta, Sonya; Raices, Raquel; Wewers, Mark D.			Monocyte Derived Microvesicles Deliver a Cell Death Message via Encapsulated Caspase-1	PLOS ONE			English	Article								Apoptosis depends upon the activation of intracellular caspases which are classically induced by either an intrinsic (mitochondrial based) or extrinsic (cytokine) pathway. However, in the process of explaining how endotoxin activated monocytes are able to induce apoptosis of vascular smooth muscle cells when co-cultured, we uncovered a transcellular apoptosis inducing pathway that utilizes caspase-1 containing microvesicles. Endotoxin stimulated monocytes induce the cell death of VSMCs but this activity is found in 100,000 g pellets of cell free supernatants of these monocytes. This activity is not a direct effect of endotoxin, and is inhibited by the caspase-1 inhibitor YVADcmk but not by inhibitors of Fas-L, IL-1 beta and IL-18. Importantly, the apoptosis inducing activity co-purifies with 100 nm sized microvesicles as determined by TEM of the pellets. These microvesicles contain caspase-1 and caspase-1 encapsulation is required since disruption of microvesicular integrity destroys the apoptotic activity but not the caspase-1 enzymatic activity. Thus, monocytes are capable of delivering a cell death message which depends upon the release of microvesicles containing functional caspase-1. This transcellular apoptosis induction pathway describes a novel pathway for inflammation induced programmed cell death.			Sarkar, A (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040871, R01HL076278, R01HL040871] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40871, R01 HL040871, R01 HL076278, HL076278] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Elkon KB, 1999, J EXP MED, V190, P1725, DOI 10.1084/jem.190.12.1725; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GAVRILIN MA, 2009, J IMMUNOL IN PRESS; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Imanishi T, 2002, ATHEROSCLEROSIS, V161, P143, DOI 10.1016/S0021-9150(01)00631-1; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kim HJ, 2004, J IMMUNOL, V172, P4948, DOI 10.4049/jimmunol.172.8.4948; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Ludewig B, 2004, P NATL ACAD SCI USA, V101, P11529, DOI 10.1073/pnas.0404612101; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McKechnie NM, 2006, EXP EYE RES, V83, P304, DOI 10.1016/j.exer.2005.11.028; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Seshiah PN, 2002, CIRCULATION, V105, P174, DOI 10.1161/hc0202.102248; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; STELLER H, 1995, ICE LIKE PROTEASES A, P198; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Wang J, 2000, J CELL SCI, V113, P753; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Wewers MD, 1997, J IMMUNOL, V159, P5964; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	50	125	131	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7140	10.1371/journal.pone.0007140	http://dx.doi.org/10.1371/journal.pone.0007140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779610	Green Submitted, Green Published, gold			2022-12-25	WOS:000270176200002
J	Ramakrishnan, MA; Tu, ZJ; Singh, S; Chockalingam, AK; Gramer, MR; Wang, P; Goyal, SM; Yang, M; Halvorson, DA; Sreevatsan, S				Ramakrishnan, Muthannan A.; Tu, Zheng Jin; Singh, Sushmita; Chockalingam, Ashok K.; Gramer, Marie R.; Wang, Ping; Goyal, Sagar M.; Yang, My; Halvorson, David A.; Sreevatsan, Srinand			The Feasibility of Using High Resolution Genome Sequencing of Influenza A Viruses to Detect Mixed Infections and Quasispecies	PLOS ONE			English	Article								Background: The rapidly expanding availability of de novo sequencing technologies can greatly facilitate efforts to monitor the relatively high mutation rates of influenza A viruses and the detection of quasispecies. Both the mutation rates and the lineages of influenza A viruses are likely to play an important role in the natural history of these viruses and the emergence of phenotypically and antigenically distinct strains. Methodology and Principal Findings: We evaluated quasispecies and mixed infections by de novo sequencing the whole genomes of 10 virus isolates, including eight avian influenza viruses grown in embryonated chicken eggs (six waterfowl isolates - five H3N2 and one H4N6; an H7N3 turkey isolate; and a bald eagle isolate with H1N1/H2N1 mixed infection), and two tissue cultured H3N2 swine influenza viruses. Two waterfowl cloacal swabs were included in the analysis. Full-length sequences of all segments were obtained with 20 to 787-X coverage for the ten viruses and one cloacal swab. The second cloacal swab yielded 15 influenza reads of similar to 230 bases, sufficient for bioinformatic inference of mixed infections or quasispecies. Genomic subpopulations or quasispecies of viruses were identified in four egg grown avian influenza isolates and one cell cultured swine virus. A bald eagle isolate and the second cloacal swab showed evidence of mixed infections with two (H1 and H2) and three (H1, H3, and H4) HA subtypes, respectively. Multiple sequence differences were identified between cloacal swab and the virus recovered using embryonated chicken eggs. Conclusions: We describe a new approach to comprehensively identify mixed infections and quasispecies in low passage influenza A isolates and cloacal swabs and add to the understanding of the ecology of influenza A virus populations.			Ramakrishnan, MA (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	sreev001@umn.edu	Sreevatsan, Srinand/V-6808-2019; Ramakrishnan, Muthannan Andavar/Y-3338-2019; Culhane, Marie/H-3143-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Ramakrishnan, Muthannan Andavar/0000-0001-7789-328X	PHS HHS [HHSN266200700007C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cohen NJ, 2008, INFECTION, V36, P458, DOI 10.1007/s15010-008-7295-9; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Deyde VM, 2009, ANTIMICROB AGENTS CH, V53, P1039, DOI 10.1128/AAC.01446-08; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Domingo E, 1998, EMERG INFECT DIS, V4, P521, DOI 10.3201/eid0404.980402; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Higgins RR, 2009, J CLIN VIROL, V44, P91, DOI 10.1016/j.jcv.2008.10.001; Hoper D, 2009, J CLIN MICROBIOL, V47, P674, DOI 10.1128/JCM.01028-08; Katz JM, 2009, POULTRY SCI, V88, P872, DOI 10.3382/ps.2008-00465; Lackenby A, 2008, ANTIVIR THER, V13, P809; LAPLANTE JM, 2009, J CLIN MICROBIOL; Lee CW, 2009, COMP IMMUNOL MICROB, V32, P301, DOI 10.1016/j.cimid.2008.01.007; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Pourmand N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000095; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Stech J, 1999, J VIROL, V73, P1878, DOI 10.1128/JVI.73.3.1878-1884.1999; Wang RX, 2008, VIROLOGY, V375, P182, DOI 10.1016/j.virol.2008.01.041; Waybright N, 2008, J VIROL METHODS, V154, P200, DOI 10.1016/j.jviromet.2008.09.013	26	54	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7105	10.1371/journal.pone.0007105	http://dx.doi.org/10.1371/journal.pone.0007105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771155	Green Submitted, gold, Green Published			2022-12-25	WOS:000270154400005
J	Orelio, C; Verkuijlen, P; Geissler, J; van den Berg, TK; Kuijpers, TW				Orelio, Claudia; Verkuijlen, Paul; Geissler, Judy; van den Berg, Timo K.; Kuijpers, Taco W.			SBDS Expression and Localization at the Mitotic Spindle in Human Myeloid Progenitors	PLOS ONE			English	Article								Background: Shwachman-Diamond Syndrome (SDS) is a hereditary disease caused by mutations in the SBDS gene. SDS is clinically characterized by pancreatic insufficiency, skeletal abnormalities and bone marrow dysfunction. The hematologic abnormalities include neutropenia, neutrophil chemotaxis defects, and an increased risk of developing Acute Myeloid Leukemia (AML). Although several studies have suggested that SBDS as a protein plays a role in ribosome processing/maturation, its impact on human neutrophil development and function remains to be clarified. Methodology/Principal Findings: We observed that SBDS RNA and protein are expressed in the human myeloid leukemia PLB-985 cell line and in human hematopoietic progenitor cells by quantitative RT-PCR and Western blot analysis. SBDS expression is downregulated during neutrophil differentiation. Additionally, we observed that the differentiation and proliferation capacity of SDS-patient bone marrow hematopoietic progenitor cells in a liquid differentiation system was reduced as compared to control cultures. Immunofluorescence analysis showed that SBDS co-localizes with the mitotic spindle and in vitro binding studies reveal a direct interaction of SBDS with microtubules. In interphase cells a perinuclear enrichment of SBDS protein which co-localized with the microtubule organizing center ( MTOC) was observed. Also, we observed that transiently expressed SDS patient-derived SBDS-K62 or SBDS-C84 mutant proteins could co-localize with the MTOC and mitotic spindle. Conclusions/Significance: SBDS co-localizes with the mitotic spindle, suggesting a role for SBDS in the cell division process, which corresponds to the decreased proliferation capacity of SDS-patient bone marrow CD34(+) hematopoietic progenitor cells in our culture system and also to the neutropenia in SDS patients. A role in chromosome missegregation has not been clarified, since similar spatial and time-dependent localization is observed when patient-derived SBDS mutant proteins are studied. Thus, the increased risk of myeloid malignancy in SDS remains unexplained.			Orelio, C (corresponding author), Dept Blood Cell Res, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	orelio.c@hsleiden.nl	van den Berg, Timo K/AAC-2479-2022					Austin KM, 2008, J CLIN INVEST, V118, P1511, DOI 10.1172/JCI33764; Austin KM, 2005, BLOOD, V106, P1253, DOI 10.1182/blood-2005-02-0807; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; BODIAN M, 1964, ACTA PAEDIATR, V53, P282, DOI 10.1111/j.1651-2227.1964.tb07237.x; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Dror Y, 1999, BLOOD, V94, P3048, DOI 10.1182/blood.V94.9.3048.421k24_3048_3054; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Ganapathi KA, 2007, BLOOD, V110, P1458, DOI 10.1182/blood-2007-02-075184; Ginzberg H, 1999, J PEDIATR-US, V135, P81, DOI 10.1016/S0022-3476(99)70332-X; Goobie S, 2001, AM J HUM GENET, V68, P1048, DOI 10.1086/319505; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Kawakami T, 2005, TOHOKU J EXP MED, V206, P253, DOI 10.1620/tjem.206.253; Kuijpers TW, 2005, BLOOD, V106, P356, DOI 10.1182/blood-2004-11-4371; LIU JM, 2006, BLOOD; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Nicolis Elena, 2005, Hum Mutat, V25, P410, DOI 10.1002/humu.9324; Orelio C, 2007, INFLAMM RES, V56, P98, DOI 10.1007/s00011-006-6058-2; Rawls AS, 2007, BLOOD, V110, P2414, DOI 10.1182/blood-2006-03-007112; Savchenko A, 2005, J BIOL CHEM, V280, P19213, DOI 10.1074/jbc.M414421200; Shammas C, 2005, J BIOL CHEM, V280, P19221, DOI 10.1074/jbc.M414656200; Shimamura A, 2006, SEMIN HEMATOL, V43, P178, DOI 10.1053/j.seminhematol.2006.04.006; SHWACHMAN H, 1964, J PEDIATR, V65, P645; van Mirre E, 2006, BLOOD, V108, P584, DOI 10.1182/blood-2005-12-4997; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Willig TN, 2000, CURR OPIN HEMATOL, V7, P85, DOI 10.1097/00062752-200003000-00003; Woloszynek JR, 2004, BLOOD, V104, P3588, DOI 10.1182/blood-2004-04-1516; Yamaguchi M, 2007, EXP HEMATOL, V35, P579, DOI 10.1016/j.exphem.2006.12.010; Zhang SY, 2006, MOL CELL BIOL, V26, P6656, DOI 10.1128/MCB.00091-06	31	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7084	10.1371/journal.pone.0007084	http://dx.doi.org/10.1371/journal.pone.0007084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759903	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970200013
J	Zumsteg, A; Baeriswyl, V; Imaizumi, N; Schwendener, R; Ruegg, C; Christofori, G				Zumsteg, Adrian; Baeriswyl, Vanessa; Imaizumi, Natsuko; Schwendener, Reto; Rueegg, Curzio; Christofori, Gerhard			Myeloid Cells Contribute to Tumor Lymphangiogenesis	PLOS ONE			English	Article								The formation of new blood vessels (angiogenesis) and lymphatic vessels (lymphangiogenesis) promotes tumor outgrowth and metastasis. Previously, it has been demonstrated that bone marrow-derived cells (BMDC) can contribute to tumor angiogenesis. However, the role of BMDC in lymphangiogenesis has largely remained elusive. Here, we demonstrate by bone marrow transplantation/reconstitution and genetic lineage-tracing experiments that BMDC integrate into tumor-associated lymphatic vessels in the Rip1Tag2 mouse model of insulinoma and in the TRAMP-C1 prostate cancer transplantation model, and that the integrated BMDC originate from the myelomonocytic lineage. Conversely, pharmacological depletion of tumor-associated macrophages reduces lymphangiogenesis. No cell fusion events are detected by genetic tracing experiments. Rather, the phenotypical conversion of myeloid cells into lymphatic endothelial cells and their integration into lymphatic structures is recapitulated in two in vitro tube formation assays and is dependent on fibroblast growth factor-mediated signaling. Together, the results reveal that myeloid cells can contribute to tumor-associated lymphatic vessels, thus extending the findings on the previously reported role of hematopoietic cells in lymphatic vessel formation.			Zumsteg, A (corresponding author), Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland.	Gerhard.christofori@unibas.ch	Schwendener, Reto A/F-6373-2011	Schwendener, Reto/0000-0002-8114-6321				Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Benard A, 2006, EUR J IMMUNOL, V36, P2324, DOI 10.1002/eji.200636434; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Foster BA, 1997, CANCER RES, V57, P3325; Gannon G, 2002, CANCER RES, V62, P603; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gingrich JR, 1996, CANCER RES, V56, P4096; Gregory C. A., 2005, SCI STKE, ppe37; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hamrah P, 2003, AM J PATHOL, V163, P57, DOI 10.1016/S0002-9440(10)63630-9; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Jiang SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003812; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Loomans CJM, 2006, ARTERIOSCL THROM VAS, V26, P1760, DOI 10.1161/01.ATV.0000229243.49320.c9; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; McDonnell CO, 2003, BRIT J SURG, V90, P1373, DOI 10.1002/bjs.4338; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ozerdem U, 2006, PROSTATE, V66, P294, DOI 10.1002/pros.20346; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	50	92	93	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7067	10.1371/journal.pone.0007067	http://dx.doi.org/10.1371/journal.pone.0007067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759906	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970200005
J	Bosnakovski, D; Daughters, RS; Xu, ZHH; Slack, JMW; Kyba, M				Bosnakovski, Darko; Daughters, Randy S.; Xu, Zhaohui; Slack, Jonathan M. W.; Kyba, Michael			Biphasic Myopathic Phenotype of Mouse DUX, an ORF within Conserved FSHD-Related Repeats	PLOS ONE			English	Article								Facioscapulohumeral muscular dystrophy ( FSHD) is caused by contractions of D4Z4 repeats at 4q35.2 thought to induce misregulation of nearby genes, one of which, DUX4, is actually localized within each repeat. A conserved ORF (mDUX), embedded within D4Z4-like repeats, encoding a double-homeodomain protein, was recently identified on mouse chromosome 10. We show here that high level mDUX expression induces myoblast death, while low non-toxic levels block myogenic differentiation by down-regulating MyoD and Myf5. Toxicity and MyoD/Myf5 expression changes were competitively reversed by overexpression of Pax3 or Pax7, implying mechanistic similarities with the anti-myogenic activity of human DUX4. We tested the effect of mDUX expression on Xenopus development, and found that global overexpression led to abnormalities in gastrulation. When targeted unilaterally into blastomeres fated to become tail muscle in 16-cell embryos, mDUX caused markedly reduced tail myogenesis on the injected side. These novel cell and animal models highlight the myopathic nature of sequences within the FSHD-related repeat array.			Bosnakovski, D (corresponding author), Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA.	kyba@umn.edu	Bosnakovski, Darko/T-8292-2019	Slack, Jonathan/0000-0002-7154-6778; Xu, Zhaohui/0000-0003-0645-1737; Bosnakovski, Darko/0000-0002-7198-2019; Kyba, Michael/0000-0002-5579-7534	NHLBI NIH HHS [U01 HL100407] Funding Source: Medline; NIAMS NIH HHS [NIH T32 AR050938, T32 AR050938] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Barro M, 2008, J CELL MOL MED; BOSNAKOVSKI D, 2008, EXP NEUROL; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cheng L, 2006, BIOCHEM BIOPH RES CO, V344, P1290, DOI 10.1016/j.bbrc.2006.03.234; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; DALE L, 1987, DEVELOPMENT, V100, P279; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Doerner A, 1997, FEBS LETT, V414, P258, DOI 10.1016/S0014-5793(97)01000-4; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; IACOVINO M, 2008, STEM CELLS DEV; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Macaione V, 2007, ACTA NEUROL SCAND, V115, P115, DOI 10.1111/j.1600-0404.2006.00724.x; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; Morosetti R, 2007, STEM CELLS, V25, P3173, DOI 10.1634/stemcells.2007-0465; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SLACK JMW, 1980, J EMBRYOL EXP MORPH, V56, P283; SNIDER L, 2009, HUM MOL GENET; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; WRIGHT TJ, 1993, HUM MOL GENET, V2, P1673, DOI 10.1093/hmg/2.10.1673; Yip DJ, 2003, FEBS LETT, V537, P133, DOI 10.1016/S0014-5793(03)00110-8	35	47	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7003	10.1371/journal.pone.0007003	http://dx.doi.org/10.1371/journal.pone.0007003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756142	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000269970000007
J	Chatterjee, S; Mookerjee, A; Basu, JM; Chakraborty, P; Ganguly, A; Adhikary, A; Mukhopadhyay, D; Ganguli, S; Banerjee, R; Ashraf, M; Biswas, J; Das, PK; Sa, G; Chatterjee, M; Das, T; Choudhuri, SK				Chatterjee, Shilpak; Mookerjee, Ananda; Basu, Jayati Mookerjee; Chakraborty, Paramita; Ganguly, Avishek; Adhikary, Arghya; Mukhopadhyay, Debanjan; Ganguli, Sudipta; Banerjee, Rajdeep; Ashraf, Mohammad; Biswas, Jaydip; Das, Pradeep K.; Sa, Gourisankar; Chatterjee, Mitali; Das, Tanya; Choudhuri, Soumitra Kumar			A Novel Copper Chelate Modulates Tumor Associated Macrophages to Promote Anti-Tumor Response of T Cells	PLOS ONE			English	Article							IN-VITRO; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; INTERFERON-GAMMA; ACTIVATION; ANGIOGENESIS; APOPTOSIS; CD4(+); CANCER; TH1	Background: At the early stages of carcinogenesis, the induction of tumor specific T cell mediated immunity seems to block the tumor growth and give protective anti-tumor immune response. However, tumor associated macrophages (TAMs) might play an immunosuppressive role and subvert this anti tumor immunity leading to tumor progression and metastasis. Methodology/Principal Findings: The Cu (II) complex, (chelate), copper N-(2-hydroxy acetophenone) glycinate (CuNG), synthesized by us, has previously been shown to have a potential usefulness in immunotherapy of multiple drug resistant cancers. The current study demonstrates that CuNG treatment of TAMs modulates their status from immunosuppressive to proimmunogenic nature. Interestingly, these activated TAMs produced high levels of IL-12 along with low levels of IL-10 that not only allowed strong Th1 response marked by generation of high levels of IFN-gamma but also reduced activation induced T cell death. Similarly, CuNG treatment of peripheral blood monocytes from chemotherapy and/or radiotherapy refractory cancer patients also modulated their cytokine status. Most intriguingly, CuNG treated TAMs could influence reprogramming of TGF-beta producing CD4(+)CD25(+) T cells toward IFN-gamma producing T cells. Conclusion/Significance: Our results show the potential usefulness of CuNG in immunotherapy of drug-resistant cancers through reprogramming of TAMs that in turn reprogram the T cells and reeducate the T helper function to elicit proper anti-tumorogenic Th1 response leading to effective reduction in tumor growth.			Chatterjee, S (corresponding author), Chittaranjan Natl Canc Inst, Dept Vitro Carcinogenesis & Cellular Chemotherapy, Kolkata, India.	soumitra01@yahoo.com	Ganguly, Avishek/R-6138-2019; Chatterjee, Mitali/AAV-2129-2021; Ganguly, Sudipto/S-9152-2019; Mukhopadhyay, Debanjan/S-3347-2019; Chakraborty, Paramita/AAL-9606-2020	Ganguly, Sudipto/0000-0002-2662-8897; Mukhopadhyay, Debanjan/0000-0002-8921-4106; Chakraborty, Paramita/0000-0002-0320-8697				Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Bharhani MS, 2006, AM J PHYSIOL-GASTR L, V291, pG820, DOI 10.1152/ajpgi.00438.2005; BICKNELL R, 1991, EUR J CANCER, V27, P781, DOI 10.1016/0277-5379(91)90189-K; Bronte V, 2001, J IMMUNOTHER, V24, P431, DOI 10.1097/00002371-200111000-00001; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Choudhuri SK, 1998, ANTI-CANCER DRUG, V9, P825, DOI 10.1097/00001813-199810000-00013; DULUC D, 2009, INT J CANC      0227; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hagenbaugh A, 1997, J EXP MED, V185, P2101, DOI 10.1084/jem.185.12.2101; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; KIM J, 1995, J IMMUNOL, V155, P2240; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Leary SC, 2007, EMBO REP, V8, P224, DOI 10.1038/sj.embor.7400915; Leek RD, 1996, CANCER RES, V56, P4625; Lin Elaine Y, 2004, Novartis Found Symp, V256, P158; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Lu BF, 2006, IMMUNOL RES, V36, P275, DOI 10.1385/IR:36:1:275; Majumder S, 2003, EUR J MED CHEM, V38, P893, DOI 10.1016/j.ejmech.2003.08.002; Majumder S, 2009, BIOMETALS, V22, P377, DOI 10.1007/s10534-008-9174-3; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mookerjee A, 2006, CLIN CANCER RES, V12, P4339, DOI 10.1158/1078-0432.CCR-06-0001; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Percival SS, 1998, AM J CLIN NUTR, V67, p1064S, DOI 10.1093/ajcn/67.5.1064S; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wall L, 2003, CLIN CANCER RES, V9, P2487; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Whiteside TL, 2005, CANCER METAST REV, V24, P95, DOI 10.1007/s10555-005-5050-6; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	46	34	36	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7048	10.1371/journal.pone.0007048	http://dx.doi.org/10.1371/journal.pone.0007048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756150	Green Published, gold			2022-12-25	WOS:000269970000015
J	Ho, CK; Lam, AF; Symington, LS				Ho, Chu Kwen; Lam, Alicia F.; Symington, Lorraine S.			Identification of Nucleases and Phosphatases by Direct Biochemical Screen of the Saccharomyces cerevisiae Proteome	PLOS ONE			English	Article								The availability of yeast strain collections expressing individually tagged proteins to facilitate one-step purification provides a powerful approach to identify proteins with particular biochemical activities. To identify novel exo- and endo-nucleases that might function in DNA repair, we undertook a proteomic screen making use of the movable ORF (MORF) library of yeast expression plasmids. This library consists of 5,854 yeast strains each expressing a unique yeast ORF fused to a tripartite tag consisting of His(6), an HA epitope, a protease 3C cleavage site, and the IgG-binding domain (ZZ) from protein A, under the control of the GAL1 promoter for inducible expression. Pools of proteins were partially purified on IgG sepharose and tested for nuclease activity using three different radiolabeled DNA substrates. Several known nucleases and phosphatases were identified, as well as two new members of the histidine phosphatase superfamily, which includes phosphoglycerate mutases and phosphatases. Subsequent characterization revealed YDR051c/Det1 to be an acid phosphatase with broad substrate specificity, whereas YOR283w has a broad pH range and hydrolyzes hydrophilic phosphorylated substrates. Although no new nuclease activities were identified from this screen, we did find phosphatase activity associated with a protein of unknown function, YOR283w, and with the recently characterized protein Det1. This knowledge should guide further genetic and biochemical characterization of these proteins.			Ho, CK (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	lss5@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041784-22, R01 GM041784, GM041784] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; DAVIES AA, 1995, J BIOL CHEM, V270, P24638, DOI 10.1074/jbc.270.42.24638; Davies L, 2007, PROTEINS, V67, P720, DOI 10.1002/prot.21357; de los Santos T, 2003, GENETICS, V164, P81; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDQVIST Y, 1993, J BIOL CHEM, V268, P20744; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; Sullivan DP, 2009, EUKARYOT CELL, V8, P161, DOI 10.1128/EC.00135-08; SYMINGTON LS, 1985, P NATL ACAD SCI USA, V82, P7247, DOI 10.1073/pnas.82.21.7247; Toh E.A., 1976, BIOCHIM BIOPHYS ACTA, V428, P182; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	39	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e6993	10.1371/journal.pone.0006993	http://dx.doi.org/10.1371/journal.pone.0006993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753119	gold, Green Published, Green Submitted			2022-12-25	WOS:000269796500002
J	Karami, S; Brennan, P; Rosenberg, PS; Navratilova, M; Mates, D; Zaridze, D; Janout, V; Kollarova, H; Bencko, V; Matveev, V; Szeszenia-Dabrowska, N; Holcatova, I; Yeager, M; Chanock, S; Menashe, I; Rothman, N; Chow, WH; Boffetta, P; Moore, LE				Karami, Sara; Brennan, Paul; Rosenberg, Philip S.; Navratilova, Marie; Mates, Dana; Zaridze, David; Janout, Vladimir; Kollarova, Helena; Bencko, Vladimir; Matveev, Vsevolod; Szeszenia-Dabrowska, Neonila; Holcatova, Ivana; Yeager, Meredith; Chanock, Stephen; Menashe, Idan; Rothman, Nathaniel; Chow, Wong-Ho; Boffetta, Paolo; Moore, Lee E.			Analysis of SNPs and Haplotypes in Vitamin D Pathway Genes and Renal Cancer Risk	PLOS ONE			English	Article							D-RECEPTOR POLYMORPHISMS; CELL CARCINOMA; PROSTATE-CANCER; ASSOCIATION; EXPRESSION; VDR; CALCITRIOL; PROMOTER; EASTERN; BINDING	In the kidney vitamin D is converted to its active form. Since vitamin D exerts its activity through binding to the nuclear vitamin D receptor (VDR), most genetic studies have primarily focused on variation within this gene. Therefore, analysis of genetic variation in VDR and other vitamin D pathway genes may provide insight into the role of vitamin D in renal cell carcinoma (RCC) etiology. RCC cases (N = 777) and controls (N = 1,035) were genotyped to investigate the relationship between RCC risk and variation in eight target genes. Minimum-p-value permutation (Min-P) tests were used to identify genes associated with risk. A three single nucleotide polymorphism (SNP) sliding window was used to identify chromosomal regions with a False Discovery Rate of < 10%, where subsequently, haplotype relative risks were computed in Haplostats. Min-P values showed that VDR (p-value = 0.02) and retinoid-X-receptor-alpha (RXRA) (p-value = 0.10) were associated with RCC risk. Within VDR, three haplotypes across two chromosomal regions of interest were identified. The first region, located within intron 2, contained two haplotypes that increased RCC risk by approximately 25%. The second region included a haplotype (rs2239179, rs12717991) across intron 4 that increased risk among participants with the TC (OR = 1.31, 95% CI = 1.09-1.57) haplotype compared to participants with the common haplotype, TT. Across RXRA, one haplotype located 39 of the coding sequence (rs748964, rs3118523), increased RCC risk 35% among individuals with the variant haplotype compared to those with the most common haplotype. This study comprehensively evaluated genetic variation across eight vitamin D pathway genes in relation to RCC risk. We found increased risk associated with VDR and RXRA. Replication studies are warranted to confirm these findings.			Karami, S (corresponding author), NCI, Div Canc Epidemiol, NIH, DHHS, Bethesda, MD 20892 USA.	karamis@mail.nih.gov	Bencko, Vladimir/H-8598-2017; Zaridze, David/K-5605-2013; Szeszenia-Dabrowska, Neonila/F-7190-2010; Menashe, Idan/AAC-8670-2020; Menashe, Idan/W-6214-2019; Janout, Vladimir/M-5133-2014; Holcatova, Ivana/C-8327-2017; Matveev, Vsevolod B/O-7476-2017; Yeager, Meredith/AAA-5322-2020; Boffetta, Paolo/AAI-7767-2021	Bencko, Vladimir/0000-0003-1935-2228; Menashe, Idan/0000-0003-1961-1461; Holcatova, Ivana/0000-0002-1366-0337; Matveev, Vsevolod B/0000-0001-7748-9527; Boffetta, Paolo/0000-0002-3811-2791; Kollarova, Helena/0000-0001-6951-6716; mates, dana/0000-0002-6219-9807; Rosenberg, Philip/0000-0001-6349-9126	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIACP010120] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beer TM, 2003, J CLIN ONCOL, V21, P123, DOI 10.1200/jco.2003.05.117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Buentig N, 2004, CANCER BIOTHER RADIO, V19, P331, DOI 10.1089/1084978041425007; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; Dalhoff K, 2003, BRIT J CANCER, V89, P252, DOI 10.1038/sj.bjc.6601104; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fujioka T, 2000, WORLD J SURG, V24, P1205, DOI 10.1007/s002680010206; Fukazawa T, 1999, J NEUROL SCI, V166, P47, DOI 10.1016/S0022-510X(99)00112-4; Handoko H, 2006, AM J HUM BIOL, V18, P415, DOI 10.1002/ajhb.20504; Holick CN, 2007, CANCER EPIDEM BIOMAR, V16, P1990, DOI 10.1158/1055-9965.EPI-07-0487; Holick MF, 2006, PROG BIOPHYS MOL BIO, V92, P49, DOI 10.1016/j.pbiomolbio.2006.02.014; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Hung RJ, 2008, CANCER EPIDEM BIOMAR, V17, P3081, DOI 10.1158/1055-9965.EPI-08-0411; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Ikuyama T, 2002, ENDOCR J, V49, P433, DOI 10.1507/endocrj.49.433; *INT AG RES CANC, GLOBACAN; Karami S, 2008, J TOXICOL ENV HEAL A, V71, P367, DOI 10.1080/15287390701798685; Kong G, 2005, CANCER RES, V65, P3462, DOI 10.1158/0008-5472.CAN-03-2912; Lawrence JA, 1998, CANCER EPIDEM BIOMAR, V7, P29; Laws SM, 2003, J NEUROCHEM, V84, P1215, DOI 10.1046/j.1471-4159.2003.01615.x; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Ma J, 1998, CANCER EPIDEM BIOMAR, V7, P385; Maalej A, 2005, GENES IMMUN, V6, P707, DOI 10.1038/sj.gene.6364260; Madej A, 2003, NEPHRON EXP NEPHROL, V93, P150, DOI 10.1159/000070239; Martinet N, 2000, CANCER RES, V60, P2869; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Norman AW, 1998, AM J CLIN NUTR, V67, P1108, DOI 10.1093/ajcn/67.6.1108; Obara W, 2007, INT J UROL, V14, P483, DOI 10.1111/j.1442-2042.2007.01771.x; Ordonez-Moran P, 2005, FRONT BIOSCI-LANDMRK, V10, P2723, DOI 10.2741/1731; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Prufer K, 2002, MOL ENDOCRINOL, V16, P961, DOI 10.1210/me.16.5.961; Puzianowska-Kuznicka M, 2000, CANCER LETT, V155, P145, DOI 10.1016/S0304-3835(00)00416-X; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Sawada N, 2004, BIOCHEMISTRY-US, V43, P4530, DOI 10.1021/bi030207f; Slattery ML, 2007, NUTR REV, V65, pS102, DOI 10.1111/j.1753-4887.2007.tb00332.x; Tokar E, 2005, CLIN EXP METASTAS, V22, P275, DOI 10.1007/s10585-005-8393-z; Trump DL, 2004, J STEROID BIOCHEM, V89-90, P519, DOI 10.1016/j.jsbmb.2004.03.068; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; Verboven C, 2002, NAT STRUCT BIOL, V9, P131, DOI 10.1038/nsb754; Vidal M, 2002, MOL CELL BIOL, V22, P2777, DOI 10.1128/MCB.22.8.2777-2787.2002; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P885; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719	48	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7013	10.1371/journal.pone.0007013	http://dx.doi.org/10.1371/journal.pone.0007013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753122	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796500006
J	Kelly, TL; Wilson, KE; Heymsfield, SB				Kelly, Thomas L.; Wilson, Kevin E.; Heymsfield, Steven B.			Dual Energy X-Ray Absorptiometry Body Composition Reference Values from NHANES	PLOS ONE			English	Article								In 2008 the National Center for Health Statistics released a dual energy x-ray absorptiometry (DXA) whole body dataset from the NHANES population-based sample acquired with modern fan beam scanners in 15 counties across the United States from 1999 through 2004. The NHANES dataset was partitioned by gender and ethnicity and DXA whole body measures of %fat, fat mass/height(2), lean mass/height(2), appendicular lean mass/height(2), %fat trunk/%fat legs ratio, trunk/limb fat mass ratio of fat, bone mineral content (BMC) and bone mineral density (BMD) were analyzed to provide reference values for subjects 8 to 85 years old. DXA reference values for adults were normalized to age; reference values for children included total and sub-total whole body results and were normalized to age, height, or lean mass. We developed an obesity classification scheme by using estabbody mass index (BMI) classification thresholds and prevalences in young adults to generate matching classification thresholds for Fat Mass Index (FMI; fat mass/height(2)). These reference values should be helpful in the evaluation of a variety of adult and childhood abnormalities involving fat, lean, and bone, for establishing entry criteria into clinical trials, and for other medical, research, and epidemiological uses.			Kelly, TL (corresponding author), Hologic Inc, Bedford, MA USA.	tkelly@hologic.com	Heymsfield, Steven B/N-1968-2017	Heymsfield, Steven B/0000-0003-1127-9425				[Anonymous], WHO TECH REP SER, V854, P1; Baim S, 2008, J CLIN DENSITOM, V11, P6, DOI 10.1016/j.jocd.2007.12.002; Bishop N, 2008, J CLIN DENSITOM, V11, P29, DOI 10.1016/j.jocd.2007.12.004; Bonnet E, 2005, J CLIN DENSITOM, V8, P287, DOI 10.1385/JCD:8:3:287; Cavalcanti RB, 2005, J CLIN DENSITOM, V8, P293, DOI 10.1385/JCD:8:3:293; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gordon CM, 2008, J CLIN DENSITOM, V11, P43, DOI 10.1016/j.jocd.2007.12.005; Heymsfield SB, 2007, AM J CLIN NUTR, V86, P82, DOI 10.1093/ajcn/86.1.82; Hsu FC, 2005, OBES RES, V13, P312, DOI 10.1038/oby.2005.42; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Law M, 2006, ANTIVIR THER, V11, P179; Leonard CM, 2009, PEDIATR RADIOL, V39, P148, DOI 10.1007/s00247-008-1067-7; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; LOOKER AC, 2008, AGE GENDER RACE ETHN; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; Schoenau E, 2002, CALCIFIED TISSUE INT, V70, P405, DOI 10.1007/s00223-001-0048-8; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; WHO TECH REP SER, V894, pR1; WHO TECH REP SER, V894, P1	23	638	655	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7038	10.1371/journal.pone.0007038	http://dx.doi.org/10.1371/journal.pone.0007038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753111	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796500019
J	Medendorp, K; van Groningen, JJM; Vreede, L; Hetterschijt, L; van den Hurk, WH; de Bruijn, DRH; Brugmans, L; van Kessel, AG				Medendorp, Klaas; van Groningen, Jan J. M.; Vreede, Lilian; Hetterschijt, Lisette; van den Hurk, Wilhelmina H.; de Bruijn, Diederik R. H.; Brugmans, Linda; van Kessel, Ad Geurts			The Mitotic Arrest Deficient Protein MAD2B Interacts with the Small GTPase RAN throughout the Cell Cycle	PLOS ONE			English	Article								Background: Previously, we identified the mitotic arrest deficient protein MAD2B (MAD2L2) as a bona fide interactor of the renal cell carcinoma (RCC)-associated protein PRCC. In addition, we found that fusion of PRCC with the transcription factor TFE3 in t(X;1)(p11;q21)-positive RCCs results in an impairment of this interaction and, concomitantly, an abrogation of cell cycle progression. Although MAD2B is thought to inhibit the anaphase promoting complex (APC) by binding to CDC20 and/or CDH1(FZR1), its exact role in cell cycle control still remains to be established. Methodology/Principal Findings: Using a yeast two-hybrid interaction trap we identified the small GTPase RAN, a well-known cell cycle regulator, as a novel MAD2B binding protein. Endogenous interaction was established in mammalian cells via co-localization and co-immunoprecipitation of the respective proteins. The interaction domain of RAN could be assigned to a C-terminal moiety of 60 amino acids, whereas MAD2B had to be present in its full-length conformation. The MAD2B-RAN interaction was found to persist throughout the cell cycle. During mitosis, co-localization at the spindle was observed. Conclusions/Significance: The small GTPase RAN is a novel MAD2B binding protein. This novel protein-protein interaction may play a role in (i) the control over the spindle checkpoint during mitosis and (ii) the regulation of nucleocytoplasmic trafficking during interphase.			Medendorp, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	a.geurtsvankessel@antrg.umcn.nl	Vreede, Lilian/E-2557-2018; van Kessel, Ad Geurts/A-2810-2010; de Bruijn, D.R.H./L-4233-2015					Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; BRONS PPT, 1990, CYTOMETRY, V11, P837, DOI 10.1002/cyto.990110710; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; de Bruijn DRH, 2008, ONCOGENE, V27, P653, DOI 10.1038/sj.onc.1210688; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Hieda M, 1999, J CELL BIOL, V144, P645, DOI 10.1083/jcb.144.4.645; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Hoyt MA, 2000, CELL, V102, P267, DOI 10.1016/S0092-8674(00)00031-3; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kantardzhieva A, 2005, INVEST OPHTH VIS SCI, V46, P2192, DOI 10.1167/iovs.04-1417; Lavia P, 2003, ONCOGENE, V22, P6508, DOI 10.1038/sj.onc.1206861; Lenart P, 2006, CURR BIOL, V16, pR412, DOI 10.1016/j.cub.2006.05.008; Li L, 2007, MOL CELL BIOCHEM, V304, P297, DOI 10.1007/s11010-007-9512-8; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Medendorp K, 2009, EXP CELL RES, V315, P2399, DOI 10.1016/j.yexcr.2009.04.022; Murakumo Y, 2002, MUTAT RES-FUND MOL M, V510, P37, DOI 10.1016/S0027-5107(02)00250-6; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; van den Hurk WH, 2004, CYTOGENET GENOME RES, V106, P68, DOI 10.1159/000078562; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Ying BL, 2003, VIROLOGY, V313, P224, DOI 10.1016/S0042-6822(03)00287-3; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	39	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7020	10.1371/journal.pone.0007020	http://dx.doi.org/10.1371/journal.pone.0007020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753112	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796500010
J	McKinnon, LR; Mao, XJ; Kimani, J; Wachihi, C; Semeniuk, C; Mendoza, M; Liang, BH; Luo, M; Fowke, KR; Plummer, FA; Ball, TB				McKinnon, Lyle R.; Mao, Xiaojuan; Kimani, Joshua; Wachihi, Charles; Semeniuk, Christina; Mendoza, Mark; Liang, Binhua; Luo, Ma; Fowke, Keith R.; Plummer, Francis A.; Ball, T. Blake			Epitope Mapping of HIV-Specific CD8+T cells in a Cohort Dominated by Clade A1 Infection	PLOS ONE			English	Article								Background: CD8+ T cell responses are often detected at large magnitudes in HIV-infected subjects, and eliciting these responses is the central aim of many HIV-1 vaccine strategies. Population differences in CD8+ T cell epitope specificity will need to be understood if vaccines are to be effective in multiple geographic regions. Methodology/Principal Findings: In a large Kenyan cohort, we compared responsive CD8+ T cell HIV-1 Env overlapping peptides (OLPs) to Best Defined Epitopes (BDEs), many of which have been defined in clade B infection. While the majority of BDEs (69%) were recognized in this population, nearly half of responsive OLPs (47%) did not contain described epitopes. Recognition frequencies of BDEs were inversely correlated to epitopic sequence differences between clade A1 and BDE (P = 0.019), and positively selected residues were more frequent in "new'' OLPs ( without BDEs). We assessed the impact of HLA and TAP binding on epitope recognition frequencies, focusing on predicted and actual epitopes in the HLA B7 supertype. Conclusions/Significance: Although many previously described CD8 epitopes were recognized, several novel CD8 epitopes were defined in this population, implying that epitope mapping efforts have not been completely exhausted. Expansion of these studies will be critical to understand population differences in CD8 epitope recognition.			McKinnon, LR (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	sijuisijali@gmail.com	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407; McKinnon, Lyle/0000-0002-7157-0700; Fowke, Keith/0000-0001-8227-6649	NIAID NIH HHS [R01 AI56980 A1, R01 AI056980] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056980] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Bansal A, 2006, AIDS, V20, P353, DOI 10.1097/01.aids.0000206501.16783.67; Barugahare B, 2005, J VIROL, V79, P4132, DOI 10.1128/JVI.79.7.4132-4139.2005; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Chen Z, 2001, STUD FUZZ SOFT COMP, V62, P1; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; Currier JR, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-8; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; FRAHM N, 2005, HIV MOL IMMUNOLOGY, P3; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Geels MJ, 2005, J VIROL, V79, P11247, DOI 10.1128/JVI.79.17.11247-11258.2005; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Liang BH, 2008, CURR HIV RES, V6, P370, DOI 10.2174/157016208785132554; Luo M, 2002, TISSUE ANTIGENS, V59, P370, DOI 10.1034/j.1399-0039.2002.590503.x; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McKinnon LR, 2005, JAIDS-J ACQ IMM DEF, V40, P245, DOI 10.1097/01.qai.0000184858.16447.04; MCKINNON LR, 2008, J ACQUIR IMMUNE DEFI; McKinnon LR, 2007, J IMMUNOL, V178, P3750, DOI 10.4049/jimmunol.178.6.3750; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Peters HO, 2008, J VIROL, V82, P1980, DOI 10.1128/JVI.02742-06; Rutebemberwa A, 2005, AIDS, V19, P1165, DOI 10.1097/01.aids.0000176216.02743.98; Saavedra-Lozano J, 2006, PEDIATR INFECT DIS J, V25, P1142, DOI 10.1097/01.inf.0000246976.40494.af; Sabado RL, 2005, J IMMUNOL METHODS, V296, P1, DOI 10.1016/j.jim.2004.09.017; Schaubert KL, 2007, J IMMUNOL, V178, P7756, DOI 10.4049/jimmunol.178.12.7756; Scheliens IMM, 2008, AIDS, V22, P33, DOI 10.1097/QAD.0b013e3282f15622; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thakar MR, 2005, J INFECT DIS, V192, P749, DOI 10.1086/432547; Tsegaye A, 2007, JAIDS-J ACQ IMM DEF, V45, P389, DOI 10.1097/QAI.0b013e318059beaa; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yu XG, 2005, AIDS, V19, P1449, DOI 10.1097/01.aids.0000183126.32077.c8; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6965	10.1371/journal.pone.0006965	http://dx.doi.org/10.1371/journal.pone.0006965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750221	gold, Green Published, Green Submitted			2022-12-25	WOS:000269696600009
J	Arumugam, PI; Urbinati, F; Velu, CS; Higashimoto, T; Grimes, HL; Malik, P				Arumugam, Paritha I.; Urbinati, Fabrizia; Velu, Chinavenmeni S.; Higashimoto, Tomoyasu; Grimes, H. Leighton; Malik, Punam			The 3 ' Region of the Chicken Hypersensitive Site-4 Insulator Has Properties Similar to Its Core and Is Required for Full Insulator Activity	PLOS ONE			English	Article							HUMAN BETA-GLOBIN; RETROVIRAL VECTOR DESIGN; LOCUS-CONTROL REGION; CHROMATIN INSULATOR; CHS4 INSULATOR; GENE-THERAPY; HISTONE MODIFICATION; REGULATORY ELEMENTS; ENHANCER BLOCKING; CTCF-BINDING	Chromatin insulators separate active transcriptional domains and block the spread of heterochromatin in the genome. Studies on the chicken hypersensitive site-4 (cHS4) element, a prototypic insulator, have identified CTCF and USF-1/2 motifs in the proximal 250 bp of cHS4, termed the "core'', which provide enhancer blocking activity and reduce position effects. However, the core alone does not insulate viral vectors effectively. The full-length cHS4 has excellent insulating properties, but its large size severely compromises vector titers. We performed a structure-function analysis of cHS4 flanking lentivirus-vectors and analyzed transgene expression in the clonal progeny of hematopoietic stem cells and epigenetic changes in cHS4 and the transgene promoter. We found that the core only reduced the clonal variegation in expression. Unique insulator activity resided in the distal 400 bp cHS4 sequences, which when combined with the core, restored full insulator activity and open chromatin marks over the transgene promoter and the insulator. These data consolidate the known insulating activity of the canonical 59 core with a novel 39 400 bp element with properties similar to the core. Together, they have excellent insulating properties and viral titers. Our data have important implications in understanding the molecular basis of insulator function and design of gene therapy vectors.			Arumugam, PI (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	Punam.Malik@cchmc.org		Higashimoto, Tomoyasu/0000-0003-0435-065X; Grimes, H. Leighton/0000-0001-8162-6758	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070135, Z01HL006008, P01HL073104, R01HL079574, U54HL070595] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HL006008] Funding Source: Medline; NHLBI NIH HHS [U54 HL070595, R01 HL079574, R01-HL70135-01, U54-HL06-008, P01 HL073104, HL079574, R01 HL070135, U54-HL070595, P01-HL073104] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Bell A, 1998, COLD SPRING HARB SYM, V63, P509, DOI 10.1101/sqb.1998.63.509; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Carr JM, 2001, ARCH VIROL, V146, P2191, DOI 10.1007/s007050170029; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Elnitski L, 1997, J BIOL CHEM, V272, P369; Emery DW, 2002, BLOOD, V100, P2012, DOI 10.1182/blood-2002-01-0219; Evans-Galea MV, 2007, MOL THER, V15, P801, DOI 10.1038/sj.mt.6300103; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; JUNKER U, 1995, GENE THER, V2, P639; Kalberer CP, 2000, P NATL ACAD SCI USA, V97, P5411, DOI 10.1073/pnas.100082597; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kraunus J, 2004, GENE THER, V11, P1568, DOI 10.1038/sj.gt.3302309; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Li CL, 2008, GENE THER, V15, P49, DOI 10.1038/sj.gt.3303009; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Mohamedali A, 2004, MOL THER, V10, P249, DOI 10.1016/j.ymthe.2004.05.002; Moreau-Gaudry F, 2001, BLOOD, V98, P2664, DOI 10.1182/blood.V98.9.2664; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Neff T, 1997, STEM CELLS, V15, P265; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pannell D, 2000, EMBO J, V19, P5884, DOI 10.1093/emboj/19.21.5884; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024; PERUMBETI A, 2009, BLOOD; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Ryu BY, 2007, BLOOD CELL MOL DIS, V39, P221, DOI 10.1016/j.bcmd.2007.05.003; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STUMPH WE, 1984, P NATL ACAD SCI-BIOL, V81, P6667, DOI 10.1073/pnas.81.21.6667; URBINATI F, 2009, MOL THER; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Yao SY, 2003, NUCLEIC ACIDS RES, V31, P5317, DOI 10.1093/nar/gkg742; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	66	52	55	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6995	10.1371/journal.pone.0006995	http://dx.doi.org/10.1371/journal.pone.0006995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746166	Green Submitted, Green Published, gold			2022-12-25	WOS:000269696500008
J	Lapan, P; Zhang, J; Hill, A; Zhang, Y; Martinez, R; Haney, S				Lapan, Peter; Zhang, Jing; Hill, Andrew; Zhang, Ying; Martinez, Robert; Haney, Steven			Image-Based Assessment of Growth and Signaling Changes in Cancer Cells Mediated by Direct Cell-Cell Contact	PLOS ONE			English	Article								Background: Many important biological processes are controlled through cell-cell interactions, including the colonization of metastatic tumor cells and the control of differentiation of stem cells within their niche. Despite the crucial importance of the cellular environment in regulating cellular signaling, in vitro methods for the study of such interactions are difficult and/or indirect. Methodology/Principal Findings: We report on the development of an image-based method for distinguishing two cell types grown in coculture. Furthermore, cells of one type that are in direct contact with cells of a second type (adjacent cells) can be analyzed separately from cells that are not within a single well. Changes are evaluated using population statistics, which are useful in detecting subtle changes across two populations. We have used this system to characterize changes in the LNCaP prostate carcinoma cell line when grown in contact with human vascular endothelial cells (HUVECs). We find that the expression and phosphorylation of WWOX is reduced in LNCaP cells when grown in direct contact with HUVECs. Reduced WWOX signaling has been associated with reduced activation or expression of JNK and p73. We find that p73 levels are also reduced in LNCaP cells grown in contact with HUVECs, but we did not observe such a change in JNK levels. Conclusions/Significance: We find that the method described is statistically robust and can be adapted to a wide variety of studies where cell function or signaling are affected by heterotypic cell-cell contact. Ironically, a potential challenge to the method is its high level of sensitivity is capable of classifying events as statistically significant (due to the high number cells evaluated individually), when the biological effect may be less clear. The methodology would be best used in conjunction with additional methods to evaluate the biological role of potentially subtle differences between populations. However, many important events, such as the establishment of a metastatic tumor, occur through rare but important changes, and methods such as we describe here can be used to identify and characterize the contribution of the environment to these changes.			Lapan, P (corresponding author), Wyeth Res, Dept Biol Technol, Cambridge, MA USA.	Steven.Haney@pfizer.com	Hill, Andrew F./GZL-4124-2022	Hill, Andrew F./0000-0001-5581-2354				Ahmad SA, 2002, SEMIN CANCER BIOL, V12, P105, DOI 10.1006/scbi.2001.0418; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Bander NH, 2006, NAT CLIN PRACT UROL, V3, P216, DOI 10.1038/ncpuro0452; Bednarek AK, 2001, CANCER RES, V61, P8068; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHAKRAVARTY A, 2008, HIGH CONTENT SCREENI, P269; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; COMLEY J, 2005, DRUG DISC WORLD, V6, P31; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Elpek Gulsum Ozlem, 2002, Pathology & Oncology Research, V8, P175; Fromigue O, 2003, ONCOGENE, V22, P8487, DOI 10.1038/sj.onc.1206918; Gallagher PG, 2005, CANCER RES, V65, P4134, DOI 10.1158/0008-5472.CAN-04-0415; Gaudio E, 2006, CANCER RES, V66, P11585, DOI 10.1158/0008-5472.CAN-06-3376; Giuliano KA, 1997, J BIOMOL SCREEN, V2, P249, DOI 10.1177/108705719700200410; Gottfried E, 2006, CELL CYCLE, V5, P691, DOI 10.4161/cc.5.7.2624; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haney S.A., 2008, HIGH CONTENT SCREENI; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Huard C, 2007, GENOMICS, V89, P270, DOI 10.1016/j.ygeno.2006.10.006; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; KEPPLER OT, 1992, EUR J IMMUNOL, V22, P2777, DOI 10.1002/eji.1830221104; Kerr DJ, 2004, NAT CLIN PRACT ONCOL, V1, P39, DOI 10.1038/ncponc0026; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; MENDELSOHN J, 2001, MOL BASIS CANC; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Qin HR, 2007, MOL CANCER RES, V5, P957, DOI 10.1158/1541-7786.MCR-07-0211; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Scholz D, 1996, CELL TISSUE RES, V284, P415, DOI 10.1007/s004410050602; Shen L, 2004, WORLD J GASTROENTERO, V10, P1682, DOI 10.3748/wjg.v10.i11.1682; Taylor D Lansing, 2005, Drug Discov Today Technol, V2, P149, DOI 10.1016/j.ddtec.2005.05.023; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Wang J, 2006, INT J MOL MED, V17, P849; Watanabe A, 2003, CANCER RES, V63, P8629	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6822	10.1371/journal.pone.0006822	http://dx.doi.org/10.1371/journal.pone.0006822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19774227	gold, Green Submitted, Green Published			2022-12-25	WOS:000269415900003
J	Fossati, S; Cam, J; Meyerson, J; Mezhericher, E; Romero, IA; Couraud, PO; Weksler, BB; Ghiso, J; Rostagno, A				Fossati, S.; Cam, J.; Meyerson, J.; Mezhericher, E.; Romero, I. A.; Couraud, P. O.; Weksler, B. B.; Ghiso, J.; Rostagno, A.			Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls	FASEB JOURNAL			English	Article						cerebral amyloid angiopathy; Alzheimer's disease; endothelial cells; smooth muscle cells; oligomerization	ALZHEIMERS-DISEASE; MUTANT PEPTIDES; DUTCH; HEREDITARY; HEMORRHAGE; PROTEIN; MODEL; DYSFUNCTION; EXPRESSION; ANGIOPATHY	Cerebral amyloid angiopathy (CAA) is an age-associated condition and a common finding in Alzheimer's disease in which amyloid-beta (A beta) vascular deposits are featured in > 80% of the cases. Familial A beta variants bearing substitutions at positions 21-23 are primarily associated with CAA, although they manifest with strikingly different clinical phenotypes: cerebral hemorrhage or dementia. The recently reported Piedmont L34V A beta mutant, located outside the hot spot 21-23, shows a similar hemorrhagic phenotype, albeit less aggressive than the widely studied Dutch E22Q variant. We monitored the apoptotic events occurring after stimulation of human brain microvascular endothelial and smooth muscle cells with nonfibrillar structures of both variants and wild-type A beta 40. Induction of analogous caspase-mediated mitochondrial pathways was elicited by all peptides, although within different time frames and intensity. Activated pathways were susceptible to pharmacological modulation either through direct inhibition of mitochondrial cytochrome c release or by the action of pan- and pathway-specific caspase inhibitors, giving a clear indication of the independent or synergistic engagement of both extrinsic and intrinsic mechanisms. Structural analyses of the A beta peptides showed that apoptosis preceded fibril formation, correlating with the presence of oligomers and/or protofibrils. The data support the notion that rare genetic mutations constitute unique paradigms to understand the molecular pathogenesis of CAA.-Fossati, S., Cam, J., Meyerson, J., Mezhericher, E., Romero, I. A., Couraud, P. O., Weksler, B. B., Ghiso, J., Rostagno, A. Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls. FASEB J. 24, 229-241 (2010). www.fasebj.org	[Fossati, S.; Cam, J.; Meyerson, J.; Mezhericher, E.; Ghiso, J.; Rostagno, A.] New York Univ, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ghiso, J.] New York Univ, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Romero, I. A.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Couraud, P. O.] Univ Paris 05, Inst Cochin, Paris, France; [Weksler, B. B.] Cornell Univ, Div Hematol & Med Oncol, Weill Med Coll, New York, NY 10021 USA	New York University; New York University; Open University - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cornell University	Rostagno, A (corresponding author), New York Univ, Sch Med, Dept Pathol, 550 1st Ave TH-435, New York, NY 10016 USA.	agueda.rostagno@nyumc.org	Cam, Jorge Lora/U-4759-2018	Cam, Jorge Lora/0000-0001-8856-1053; Rostagno, Agueda/0000-0002-6817-2074; Fossati, Silvia/0000-0002-2047-222X; Romero, Ignacio/0000-0002-0322-9180	U. S. National Institutes of Health [NS-051715, AG-30539]; Alzheimer's Association; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030539, P30AG008051] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially funded by U. S. National Institutes of Health grants NS-051715 and AG-30539, the Alzheimer's Association, and the American Heart Association.	CAM J, 2006, ALZHEIMERS DIS NEW A, P397; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; Davis J, 1996, P NATL ACAD SCI USA, V93, P2996, DOI 10.1073/pnas.93.7.2996; Dobson CM, 2001, BIOCHEM SOC SYMP, V68, P1; Folin M, 2006, INT J MOL MED, V17, P431; Frangione B, 2001, AMYLOID, V8, P36; GALLAGHER SR, 1995, CURRENT PROTOCOLS PR; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Hames BD., 1990, GEL ELECTROPHORESIS, P1; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Krone MG, 2008, J MOL BIOL, V381, P221, DOI 10.1016/j.jmb.2008.05.069; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Maat-Schieman M, 2005, NEUROPATHOLOGY, V25, P288, DOI 10.1111/j.1440-1789.2005.00631.x; Maat-Schieman MLC, 2000, ACTA NEUROPATHOL, V99, P409, DOI 10.1007/s004010051143; Matsui T, 2006, J NEUROPATH EXP NEUR, V65, P508, DOI 10.1097/01.jnen.0000229238.05748.12; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Sajan Farrah D, 2007, Am J Alzheimers Dis Other Demen, V22, P319, DOI 10.1177/1533317507302447; Solito R, 2009, EXP CELL RES, V315, P385, DOI 10.1016/j.yexcr.2008.11.002; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takuma K, 2005, J PHARMACOL SCI, V97, P312, DOI 10.1254/jphs.CPJ04006X; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Viana RJS, 2009, CELL MOL LIFE SCI, V66, P1094, DOI 10.1007/s00018-009-8746-x; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang X, 2008, J NEUROSCI, V28, P9473, DOI 10.1523/JNEUROSCI.1867-08.2008; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Xu J, 2001, J CEREBR BLOOD F MET, V21, P702, DOI 10.1097/00004647-200106000-00008; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	40	57	67	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					229	241		10.1096/fj.09-139584	http://dx.doi.org/10.1096/fj.09-139584			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19770225	Green Published			2022-12-25	WOS:000273233600024
J	Kaur, M; Saxena, A; Rai, A; Bhatnagar, R				Kaur, Manpreet; Saxena, Ankur; Rai, Anant; Bhatnagar, Rakesh			Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice	FASEB JOURNAL			English	Article						encephalitis; intramuscular administration; rabies virus neutralizing antibodies; survival; prophylactic; therapeutic	MHC CLASS-I; CYTOTOXIC T-LYMPHOCYTES; B SURFACE-ANTIGEN; GENE-GUN; VIRUS; IMMUNOGENICITY; IMMUNIZATION; INJECTION; RESPONSES; IMMUNITY	The worldwide incidence of rabies and the inability of currently used vaccination strategies to provide highly potent and cost-effective therapy indicate the need for an improved rabies vaccine. Thus, DNA vaccine based on lysosome-targeted glycoprotein of the rabies virus was evaluated in BALB/c mice. It imparted partial protection (60%) against challenge with 20 LD50 of the challenge virus standard (CVS) strain of rabies virus. To improve the outcome of vaccination, to ultimately enhance the immune response, we investigated different routes for DNA vaccine delivery, varied doses of DNA, and the influence of adjuvant supplementation. The highest immune response pertaining to IgG antibody titer, with a predominantly IgG1/IgG2a subclass distribution, effective cellular immunity, and a high level of rabies virus neutralizing antibodies (RVNAs) was attained by the optimized DNA vaccine formulation comprising intramuscular administration of 100 mu g of DNA vaccine supplemented with Emulsigen (R)-D. In preexposure prophylaxis, a 3-dose regimen of this formulation generated a high RVNA titer (32 IU/ml) and conferred complete protection against challenge with 20 LD50 of CVS. For postexposure efficacy analysis, rabies was experimentally induced with 50 LD50 of CVS. Subsequent therapy with 5 doses of the formulation completely prevented rabies in BALB/c mice, which maintained protective RVNA titers of 4 IU/ml. The World Health Organization recommended rabies protective titer threshold is 0.5 IU/ml. Thus, this optimized DNA vaccine formulation provides an avenue for preventing and controlling rabies.-Kaur, M., Saxena, A., Rai, A., and Bhatnagar, R. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. FASEB J. 24, 173-183 ( 2010). www.fasebj.org	[Kaur, Manpreet; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, Delhi, India; [Saxena, Ankur; Rai, Anant] Indian Vet Res Inst, Natl Biotechnol Ctr, Izatnagar 243122, Uttar Pradesh, India	Jawaharlal Nehru University, New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Bhatnagar, R (corresponding author), Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, Delhi, India.	rakbhat01@yahoo.com	Rai, Anant/AAJ-9011-2020	Rai, Anant/0000-0003-3225-215X	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	We thank Dr. V. Srinivasan ( Indian Immunological Ltd., Hyderabad, India) for providing inactivated PV viral antigen and rabies reference antiserum. We also thank Anuj Kumar Sharma ( School of Biotechnology, Jawaharlal Nehru University) for critical suggestions in manuscript preparation. This study was supported by a grant from the Department of Biotechnology, Government of India. M. K is the recipient of a Senior Research Fellowship from the Council of Scientific and Industrial Research, Government of India. The results published in this work are covered under Indian Patent 1449/DEL/2008, filed June 17, 2008, and PCT/IN2008/000578/5598, filed September 9, 2008.	Alves AMB, 1998, VACCINE, V16, P9, DOI 10.1016/S0264-410X(97)00147-3; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P425; Bahloul C, 2006, VACCINE, V24, P1063, DOI 10.1016/j.vaccine.2005.09.016; Bahloul C, 2003, VACCINE, V22, P177, DOI 10.1016/S0264-410X(03)00568-1; Beran J, 2005, VACCINE, V23, P3902, DOI 10.1016/j.vaccine.2005.03.007; Chow YH, 1997, J VIROL, V71, P169, DOI 10.1128/JVI.71.1.169-178.1997; CONN A, 2726 BIOR LAB; Conry RM, 2002, CLIN CANCER RES, V8, P2782; Corr M, 1999, J IMMUNOL, V163, P4721; Dileo J, 2003, HUM GENE THER, V14, P79, DOI 10.1089/10430340360464732; Dobano C, 2007, IMMUNOL LETT, V111, P92, DOI 10.1016/j.imlet.2007.05.007; Dodet B, 2007, VACCINE, V25, P4123, DOI 10.1016/j.vaccine.2007.03.002; FELGNER P L, 1990, Advanced Drug Delivery Reviews, V5, P163, DOI 10.1016/0169-409X(90)90015-K; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fischer L, 2003, VACCINE, V21, P4593, DOI 10.1016/S0264-410X(03)00504-8; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120; Hanly W. Carey, 1995, ILAR J, V37, P93; Haynes JR, 2004, EXPERT OPIN BIOL TH, V4, P889, DOI 10.1517/14712598.4.6.889; Ito K, 2003, MOL IMMUNOL, V39, P847, DOI 10.1016/S0161-5890(03)00024-5; Kaur M, 2009, VACCINE, V27, P2128, DOI 10.1016/j.vaccine.2009.01.128; KIM N, 2006, CLIN MOL ALLERGY, V4, P1; Kirman JR, 2003, CURR OPIN IMMUNOL, V15, P471, DOI 10.1016/S0952-7915(03)00068-2; Klinman DM, 1997, J IMMUNOL, V158, P3635; Li WR, 2006, ACTA VIROL, V50, P251; LIN BC, 2006, 221228 AASV; Lin CC, 2004, MOL THER, V10, P290, DOI 10.1016/j.ymthe.2004.05.015; Lodmell DL, 1998, VACCINE, V16, P115, DOI 10.1016/S0264-410X(97)88325-9; Lodmell DL, 2003, VACCINE, V21, P3998, DOI 10.1016/S0264-410X(03)00297-4; Osorio JE, 1999, VACCINE, V17, P1109, DOI 10.1016/S0264-410X(98)00328-4; Patial S, 2007, VACCINE, V25, P4020, DOI 10.1016/j.vaccine.2007.02.051; Pavlenko M, 2004, BRIT J CANCER, V91, P688, DOI 10.1038/sj.bjc.6602019; Perrin P, 1999, VACCINE, V18, P479, DOI 10.1016/S0264-410X(99)00247-9; Schunk MK, 2005, ILAR J, V46, P241, DOI 10.1093/ilar.46.3.241; Smith J. S., 1996, P181; TESORO CE, 2006, DEV BIOL BASEL, V125, P221; Cruz ET, 2008, VACCINE, V26, P6936, DOI 10.1016/j.vaccine.2008.09.083; Timmerman JM, 2002, CANCER RES, V62, P5845; Torres CAT, 1997, J IMMUNOL, V158, P4529; Trimble C, 2003, VACCINE, V21, P4036, DOI 10.1016/S0264-410X(03)00275-5; TURING T, 1999, CURR OPIN MOL THER, V1, P216; Ulmer JB, 1999, VACCINE, V18, P18, DOI 10.1016/S0264-410X(99)00151-6; Ulmer JB, 1996, IMMUNOLOGY, V89, P59, DOI 10.1046/j.1365-2567.1996.d01-718.x; van Rooij EMA, 2002, J VIROL, V76, P10540, DOI 10.1128/JVI.76.20.10540-10545.2002; Vandermeer J, 2004, FOREST ECOL MANAG, V199, P125, DOI 10.1016/j.foreco.2004.05.033; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; XIANG ZQ, 1994, VIROLOGY, V199, P132, DOI 10.1006/viro.1994.1105	48	21	25	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					173	183		10.1096/fj.09-138644	http://dx.doi.org/10.1096/fj.09-138644			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19741168				2022-12-25	WOS:000273233600019
J	Kiel, C; Filchtinski, D; Spoerner, M; Schreiber, G; Kalbitzer, HR; Herrmann, C				Kiel, Christina; Filchtinski, Daniel; Spoerner, Michael; Schreiber, Gideon; Kalbitzer, Hans Robert; Herrmann, Christian			Improved Binding of Raf to Ras.GDP Is Correlated with Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; P-31 NMR-SPECTROSCOPY; DISSOCIATION STIMULATOR; EFFECTOR SPECIFICITY; BIOCHEMICAL-ANALYSIS; STRUCTURAL BASIS; H-RAS; R-RAS; COMPLEX; DOMAIN	The GTP-binding protein Ras plays a central role in the regulation of various cellular processes, acting as a molecular switch that triggers signaling cascades. Only Ras bound to GTP is able to interact strongly with effector proteins like Raf kinase, phosphatidylinositol 3-kinase, and RalGDS, whereas in the GDP-bound state, the stability of the complex is strongly decreased, and signaling is interrupted. To determine whether this process is only controlled by the stability of the complex, we used computer-aided protein design to improve the interaction between Ras and effector. We challenged the Ras.Raf complex in this study because Raf among all effectors shows the highest Ras affinity and the fastest association kinetics. The proposed mutations were characterized as to their changes in dynamics and binding strength. We demonstrate that Ras-Raf interaction can only be improved at the cost of a loss in specificity of Ras.GTP versus Ras.GDP. As shown by NMR spectroscopy, the Raf mutation A85K leads to a shift of Ras switch I in the GTP-bound as well as in the GDP-bound state, thereby increasing the complex stability. In a luciferase-based reporter gene assay, Raf A85K is associated with higher signaling activity, which appears to be a mere matter of Ras-Raf affinity.	[Filchtinski, Daniel; Herrmann, Christian] Ruhr Univ Bochum, Fak Chem & Biochem, D-44780 Bochum, Germany; [Kiel, Christina] Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany; [Spoerner, Michael; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kiel, Christina] Ctr Genom Regulat, Grp Design Biol Syst, Barcelona 08003, Spain	Ruhr University Bochum; Max Planck Society; University of Regensburg; Weizmann Institute of Science; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Herrmann, C (corresponding author), Ruhr Univ Bochum, Fak Chem & Biochem, Univ Str 150, D-44780 Bochum, Germany.	chr.herrmann@rub.de	Spörner, Michael/B-9018-2012; Spoerner, Michael/C-9035-2012	Kiel, Christina/0000-0001-8454-6008; Kalbitzer, Hans Robert/0000-0002-6514-2355	Deutsche Forschungsgemeinschaft [SFB 642]; German-Israeli Foundation for Scientific Research and Development; Gerhard C. Starck foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Gerhard C. Starck foundation	The work was supported by Deutsche Forschungsgemeinschaft Grant SFB 642, by the German-Israeli Foundation for Scientific Research and Development, and by a grant from the Gerhard C. Starck foundation ( to D. F.).	Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; EMERSON SD, 1995, BIOCHEMISTRY-US, V34, P6911, DOI 10.1021/bi00021a001; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAUSSER KH, 1991, NMR MED BIOL STRUCTU; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kiel C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000397; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Linnemann T, 2002, J BIOL CHEM, V277, P7831, DOI 10.1074/jbc.M110800200; Maurer T, 1996, J MAGN RESON SER B, V113, P177, DOI 10.1006/jmrb.1996.0172; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rohrer M, 2001, BIOCHEMISTRY-US, V40, P1884, DOI 10.1021/bi002164y; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Scheffzek K, 2001, STRUCTURE, V9, P1043, DOI 10.1016/S0969-2126(01)00674-8; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shaul Y, 2005, PROTEINS, V60, P341, DOI 10.1002/prot.20489; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1; Zhou HX, 1996, J CHEM PHYS, V105, P7235, DOI 10.1063/1.472530; Zhou HX, 1997, P NATL ACAD SCI USA, V94, P12372, DOI 10.1073/pnas.94.23.12372	56	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31893	31902		10.1074/jbc.M109.031153	http://dx.doi.org/10.1074/jbc.M109.031153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776012	hybrid, Green Published			2022-12-25	WOS:000271572700044
J	Rossi, MN; Carbone, M; Mostocotto, C; Mancone, C; Tripodi, M; Maione, R; Amati, P				Rossi, Marianna N.; Carbone, Mariarosaria; Mostocotto, Cassandra; Mancone, Carmine; Tripodi, Marco; Maione, Rossella; Amati, Paolo			Mitochondrial Localization of PARP-1 Requires Interaction with Mitofilin and Is Involved in the Maintenance of Mitochondrial DNA Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1; PROTEOMIC ANALYSIS; HYDROGEN-PEROXIDE; COILED-COIL; CELL-DEATH; NUCLEAR; PROTEIN; TRANSCRIPTION; DAMAGE; NAD(+)	Poly(ADP-ribose) polymerase-1 (PARP-1) is a predominantly nuclear enzyme that exerts numerous functions in cellular physiology and pathology, from maintenance of DNA stability to transcriptional regulation. Through a proteomic analysis of PARP-1 co-immunoprecipitation complexes, we identified Mitofilin, a mitochondrial protein, as a new PARP-1 interactor. This result prompted us to further investigate the presence and the role of the enzyme in mitochondria. Using laser confocal microscopy and Western blot analysis of purified mitochondria, we demonstrated the mitochondrial localization of a fraction of PARP-1. Further, the effects of overexpressing or down-regulating Mitofilin showed that this protein promotes and is required for PARP-1 mitochondrial localization. We also report several lines of evidence suggesting that intramitochondrial PARP-1 plays a role in mitochondrialDNA(mtDNA) damage signaling and/or repair. First, we show that PARP-1 binds to different regions throughout the mtDNA. Moreover, we demonstrated that the depletion of either PARP-1 or Mitofilin, which abrogates the mitochondrial localization of the enzyme, leads to the accumulation of mtDNA damage. Finally, we show that DNA ligase III, known to be required for mtDNA repair, participates in a PARP-1-containing complex bound to mtDNA. This work highlights a new environment for PARP-1, opening the possibility that at least some of the nuclear functions of the enzyme can be also extended to mtDNA metabolism.	[Rossi, Marianna N.; Carbone, Mariarosaria; Mostocotto, Cassandra; Tripodi, Marco; Maione, Rossella; Amati, Paolo] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy; [Mancone, Carmine; Tripodi, Marco] Ist Ricovero & Cura Carattere Sci, Natl Inst Infect Dis L Spallanzani, I-00149 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Lazzaro Spallanzani	Amati, P (corresponding author), Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Cellular Biotechnol & Hematol, Viale Regina Elena 324, I-00161 Rome, Italy.	amati@bce.uniroma1.it	Tripodi, Marco/ABO-1160-2022; Tripodi, Marco/F-1143-2011; Rossi, Marianna Nicoletta/S-5083-2019	Tripodi, Marco/0000-0001-6135-971X; Tripodi, Marco/0000-0001-6135-971X; Rossi, Marianna Nicoletta/0000-0003-4485-7738; Mancone, Carmine/0000-0002-9569-5030	Associazione Italiana per la Ricerca sul Cancro (AIRC) [4179]; Agenzia Spaziale Italiana	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was supported by Grant 4179 from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and the Agenzia Spaziale Italiana from Molecules to Man (ASI MOMA) project.	Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BURZIO LO, 1981, BIOCHEM BIOPH RES CO, V103, P369, DOI 10.1016/0006-291X(81)91702-2; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Dement GA, 2007, EXP CELL RES, V313, P77, DOI 10.1016/j.yexcr.2006.09.014; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Druzhyna N, 2000, DIABETES, V49, P1849, DOI 10.2337/diabetes.49.11.1849; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Jae-Kyung M, 2003, CELL MOL BIOL, V49, P739; Jarrett SG, 2007, OPHTHALMIC RES, V39, P213, DOI 10.1159/000104683; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mancone C, 2007, PROTEOMICS, V7, P143, DOI 10.1002/pmic.200600339; MASMOUDI A, 1988, J NEUROCHEM, V51, P188, DOI 10.1111/j.1471-4159.1988.tb04854.x; MASMOUDI A, 1987, BIOCHEMISTRY-US, V26, P1965, DOI 10.1021/bi00381a027; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Milano J, 2000, NUCLEIC ACIDS RES, V28, P968, DOI 10.1093/nar/28.4.968; Mosgoeller W, 1996, J CELL SCI, V109, P409; Odgren PR, 1996, J CELL SCI, V109, P2253; Poitras MF, 2007, NEUROSCIENCE, V148, P198, DOI 10.1016/j.neuroscience.2007.04.062; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; Rozen S, 2000, Methods Mol Biol, V132, P365; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; Strub A, 2000, BIOL CHEM, V381, P943, DOI 10.1515/BC.2000.115; Van Laar VS, 2008, NEUROBIOL DIS, V29, P477, DOI 10.1016/j.nbd.2007.11.007; Velsor LW, 2004, TOXICOL APPL PHARM, V199, P10, DOI 10.1016/j.taap.2004.03.005; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	46	123	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31616	31624		10.1074/jbc.M109.025882	http://dx.doi.org/10.1074/jbc.M109.025882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762472	hybrid, Green Published			2022-12-25	WOS:000271572700016
J	Sonobe, Y; Takeuchi, H; Kataoka, K; Li, H; Jin, S; Mimuro, M; Hashizume, Y; Sano, Y; Kanda, T; Mizuno, T; Suzumura, A				Sonobe, Yoshifumi; Takeuchi, Hideyuki; Kataoka, Kunio; Li, Hua; Jin, Shijie; Mimuro, Maya; Hashizume, Yoshio; Sano, Yasuteru; Kanda, Takashi; Mizuno, Tetsuya; Suzumura, Akio			Interleukin-25 Expressed by Brain Capillary Endothelial Cells Maintains Blood-Brain Barrier Function in a Protein Kinase C epsilon-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TIGHT-JUNCTION; P-GLYCOPROTEIN; MOUSE-BRAIN; IN-VITRO; MICROGLIA; PERMEABILITY; INFLAMMATION; LYMPHOCYTES; DISRUPTION	Interleukin (IL)-25, a member of the IL-17 family of cytokines, is expressed in the brains of normal mice. However, the cellular source of IL-25 and its function in the brain remain to be elucidated. Here, we show that IL-25 plays an important role in preventing infiltration of the inflammatory cells into the central nervous system. Brain capillary endothelial cells (BCECs) express IL-25. However, it is down-regulated by inflammatory cytokines, including tumor necrosis factor (TNF)-alpha, IL-17, interferon-gamma, IL-1 beta, and IL-6 in vitro, and is also reduced in active multiple sclerosis (MS) lesions and in the inflamed spinal cord of experimental autoimmune encephalomyelitis, an animal model of MS. Furthermore, IL-25 restores the reduced expression of tight junction proteins, occludin, junction adhesion molecule, and claudin-5, induced by TNF-alpha in BCECs and consequently repairs TNF-alpha-induced blood-brain barrier (BBB) permeability. IL-25 induces protein kinase C epsilon (PKC epsilon) phosphorylation, and up-regulation of claudin-5 is suppressed by PKC epsilon inhibitor peptide in the IL-25-stimulated BCECs. These results suggest that IL-25 is produced by BCECs and protects against inflammatory cytokine-induced excessive BBB collapse through a PKC epsilon-dependent pathway. These novel functions of IL-25 in maintaining BBB integrity may help us understand the pathophysiology of inflammatory brain diseases such as MS.	[Sonobe, Yoshifumi; Takeuchi, Hideyuki; Kataoka, Kunio; Li, Hua; Jin, Shijie; Mizuno, Tetsuya; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mimuro, Maya; Hashizume, Yoshio] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute, Aichi 4801195, Japan; [Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 7558505, Japan	Nagoya University; Aichi Medical University; Yamaguchi University	Sonobe, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	sonobe@riem.nagoya-u.ac.jp		Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grant-in-aid for Scientific Research Grant C, by the 21st Century COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by Health and Labour Science research grants for research on intractable diseases from the Ministry of Health, Labour, and Welfare of Japan.	Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P491, DOI 10.1023/B:CEMN.0000022776.47302.ce; Dohgu S, 2007, CELL MOL NEUROBIOL, V27, P889, DOI 10.1007/s10571-007-9209-2; Fabis MJ, 2007, P NATL ACAD SCI USA, V104, P5656, DOI 10.1073/pnas.0701252104; FABRY Z, 1995, J IMMUNOL, V155, P325; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fleegal MA, 2005, AM J PHYSIOL-HEART C, V289, pH2012, DOI 10.1152/ajpheart.00495.2005; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Ge SJ, 2008, J NEUROCHEM, V104, P1219, DOI 10.1111/j.1471-4159.2007.05056.x; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hirase T, 1997, J CELL SCI, V110, P1603; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC; Kassiotis G, 1999, EUR J IMMUNOL, V29, P774, DOI 10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kraus J, 2004, ANN NEUROL, V56, P192, DOI 10.1002/ana.20161; KRIZBAI I, 1995, J NEUROCHEM, V65, P459; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Lu TS, 2008, J IMMUNOL, V181, P6406, DOI 10.4049/jimmunol.181.9.6406; Minagar A, 2003, ENDOTHELIUM-J ENDOTH, V10, P299, DOI 10.1080/10623320390272299; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Pan GH, 2001, J IMMUNOL, V167, P6559, DOI 10.4049/jimmunol.167.11.6559; Park JH, 1999, AM J PHYSIOL-CELL PH, V277, pC1066, DOI 10.1152/ajpcell.1999.277.6.C1066; Qi X, 2008, J CLIN INVEST, V118, P173, DOI 10.1172/JCI32636; Ronaldson PT, 2009, J CEREBR BLOOD F MET, V29, P1084, DOI 10.1038/jcbfm.2009.32; SAWADA M, 1993, NEUROSCI LETT, V155, P175, DOI 10.1016/0304-3940(93)90701-L; Sonobe Y, 2008, BIOCHEM BIOPH RES CO, V370, P129, DOI 10.1016/j.bbrc.2008.03.059; Sonobe Y, 2007, TOHOKU J EXP MED, V213, P329, DOI 10.1620/tjem.213.329; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; SUZUMURA A, 1994, J NEUROIMMUNOL, V53, P209, DOI 10.1016/0165-5728(94)90031-0; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Weiler F, 2005, J CELL PHYSIOL, V204, P83, DOI 10.1002/jcp.20268; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Yoo J, 2003, AM J PHYSIOL-CELL PH, V285, pC300, DOI 10.1152/ajpcell.00267.2002; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	53	68	75	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31834	31842		10.1074/jbc.M109.025940	http://dx.doi.org/10.1074/jbc.M109.025940			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776017	Green Published, hybrid			2022-12-25	WOS:000271572700038
J	Sohy, D; Yano, H; de Nadai, P; Urizar, E; Guillabert, A; Javitch, JA; Parmentier, M; Springael, JY				Sohy, Denis; Yano, Hideaki; de Nadai, Patricia; Urizar, Eneko; Guillabert, Aude; Javitch, Jonathan A.; Parmentier, Marc; Springael, Jean-Yves			Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of "Selective" Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR GENE; COUPLED RECEPTORS; HIV-1 INFECTION; HETERODIMERIZATION; REVEALS; COOPERATIVITY; DIMERIZATION; ACTIVATION; EXPRESSION; MUTATION	Chemokine receptors constitute an attractive family of drug targets in the frame of inflammatory diseases. However, targeting specific chemokine receptors may be complicated by their ability to form dimers or higher order oligomers. Using a combination of luminescence complementation and bioluminescence resonance energy transfer assays, we demonstrate for the first time the existence of hetero-oligomeric complexes composed of at least three chemokine receptors (CCR2, CCR5, and CXCR4). We show in T cells and monocytes that negative binding cooperativity takes place between the binding pockets of these receptors, demonstrating their functional interaction in leukocytes. We also show that specific antagonists of one receptor (TAK-779 or AMD3100) lead to functional cross-inhibition of the others. Finally, using the air pouch model in mice, we show that the CCR2 and CCR5 antagonist TAK-779 inhibits cell recruitment promoted by the CXCR4 agonist SDF-1 alpha, demonstrating that cross-inhibition by antagonists also occurs in vivo. Thus, antagonists of the therapeutically important chemokine receptors regulate the functional properties of other receptors to which they do not bind directly with important implications for the use of these agents in vivo.	[Parmentier, Marc; Springael, Jean-Yves] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium; [Yano, Hideaki; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, Coll Phys & Surg, New York, NY 10128 USA; [Yano, Hideaki; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10128 USA; [Yano, Hideaki; Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10128 USA	Universite Libre de Bruxelles; Columbia University; Columbia University; Columbia University	Parmentier, M (corresponding author), Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	mparment@ulb.ac.be		de NADAI, Patricia/0000-0001-6084-7447; Javitch, Jonathan/0000-0001-7395-2967; Parmentier, Marc/0000-0001-8081-4685; Yano, Hideaki/0000-0001-9242-3884	National Institutes of Health [DA022413, MH54137]; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Belgian State, Belgian Science Policy; European Union [LSHB-CT-2005-518167/ INNOCHEM]; French Agence Nationale de Recherche sur le SIDA; Fonds de la Recherche Scientifique Medicale of Belgium; Fondation Medicale Reine Elisabeth;  [P6-14]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Actions de Recherche Concertees of the Communaute Francaise de Belgique; Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); European Union(European Commission); French Agence Nationale de Recherche sur le SIDA(ANRS); Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA022413 and MH54137 (to J. A. J.). This work was also supported by the Actions de Recherche Concertees of the Communaute Francaise de Belgique; the Interuniversity Attraction Poles Programme (P6-14), Belgian State, Belgian Science Policy, the Walloon region (Programme d'Excellence "CIBLES"); European Union Grant LSHB-CT-2005-518167/ INNOCHEM; the French Agence Nationale de Recherche sur le SIDA; the Fonds de la Recherche Scientifique Medicale of Belgium; and the Fondation Medicale Reine Elisabeth.	Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Blanpain C, 1999, BLOOD, V94, P1899; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Filizola M, 2005, FEBS J, V272, P2926, DOI 10.1111/j.1742-4658.2005.04730.x; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hamatake M, 2009, CANCER SCI, V100, P95, DOI 10.1111/j.1349-7006.2008.00997.x; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; LEVITZKI A, 1974, J THEOR BIOL, V44, P367, DOI 10.1016/0022-5193(74)90167-2; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Pease JE, 2006, BRIT J PHARMACOL, V147, pS212, DOI 10.1038/sj.bjp.0706475; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Reggio PH, 2006, AAPS J, V8, pE322; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	36	130	133	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31270	31279		10.1074/jbc.M109.054809	http://dx.doi.org/10.1074/jbc.M109.054809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758998	Green Published, hybrid			2022-12-25	WOS:000271378400054
J	Kim, JH; Jee, MK; Lee, SY; Han, TH; Kim, BS; Kang, KS; Kang, SK				Kim, Jung Hwan; Jee, Min Ki; Lee, So Young; Han, Tae Hee; Kim, Bong Sun; Kang, Kyung Sun; Kang, Soo Kyung			Regulation of Adipose Tissue Stromal Cells Behaviors by Endogenic Oct4 Expression Control	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; DIFFERENTIATION; IDENTIFICATION; IMPROVEMENT; INDUCTION; ENHANCER; OCT-3/4; GENES; SOX2	Background: To clarify the role of the POU domain transcription factor Oct4 in Adipose Tissue Stromal Cells (ATSCs), we investigated the regulation of Oct4 expression and other embryonic genes in fully differentiated cells, in addition to identifying expression at the gene and protein levels. The ATSCs and several immature cells were routinely expressing Oct4 protein before and after differentiating into specific lineages. Methodology/Principal Findings and Conclusions: Here, we demonstrated the role of Oct4 in ATSCs on cell proliferation and differentiation. Exogenous Oct4 improves adult ATSCs cell proliferation and differentiation potencies through epigenetic reprogramming of stemness genes such as Oct4, Nanog, Sox2, and Rex1. Oct4 directly or indirectly induces ATSCs reprogramming along with the activation of JAK/STAT3 and ERK1/2. Exogenic Oct4 introduced a transdifferentiation priority into the neural lineage than mesodermal lineage. Global gene expression analysis results showed that Oct4 regulated target genes which could be characterized as differentially regulated genes such as pluripotency markers NANOG, SOX2, and KLF4 and markers of undifferentiated stem cells FOXD1, CDC2, and EPHB1. The negatively regulated genes included FAS, TNFR, COL6A1, JAM2, FOXQ1, FOXO1, NESTIN, SMAD3, SLIT3, DKK1, WNT5A, BMP1, and GLIS3 which are implicated in differentiation processes as well as a number of novel genes. Finally we have demonstrated the therapeutic utility of Oct4/ATSCs were introduced into the mouse traumatic brain, engrafted cells was more effectively induces regeneration activity with high therapeutic modality than that of control ATSCs. Engrafted Oct4/ATSCs efficiently migrated and transdifferentiated into action potential carrying, functionally neurons in the hippocampus and promoting the amelioration of lesion cavities.			Kim, JH (corresponding author), Seoul Natl Univ, Dept Vet Biotechnol, Seoul, South Korea.	sookang@snu.ac.kr	Kang, Kyung-Sun/G-6205-2013	Kim, Jung Hwan/0000-0002-2975-4899				Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baal N, 2004, THROMB HAEMOSTASIS, V92, P767, DOI 10.1160/TH04-02-0079; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHRISTOPHER J, 2008, CELL CYCLE, V7, P725; Du ZW, 2001, BIOCHEM BIOPH RES CO, V282, P701, DOI 10.1006/bbrc.2001.4636; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Goodell MA, 2003, CURR OPIN HEMATOL, V10, P208, DOI 10.1097/00062752-200305000-00003; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kim JH, 2008, STEM CELLS, V26, P2724, DOI 10.1634/stemcells.2008-0184; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lennmyr F, 2002, ACTA NEUROL SCAND, V106, P333, DOI 10.1034/j.1600-0404.2002.01313.x; LINGYI C, 2008, HUM MOL GENET, V17, pR23; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; STEFANO Z, 2007, STEM CELLS, V25, P1675; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	29	42	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7166	10.1371/journal.pone.0007166	http://dx.doi.org/10.1371/journal.pone.0007166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777066	Green Submitted, Green Published, gold			2022-12-25	WOS:000270164600008
J	Snyder, CM; Shroff, EH; Liu, J; Chandel, NS				Snyder, Colleen M.; Shroff, Emelyn H.; Liu, Jing; Chandel, Navdeep S.			Nitric Oxide Induces Cell Death by Regulating Anti-Apoptotic BCL-2 Family Members	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; MITOCHONDRIAL RESPIRATORY-CHAIN; CYTOCHROME-C; MCL-1; JNK; BAX; INHIBITION; PHOSPHORYLATION; MEMBRANE; OXYGEN	Nitric oxide (NO) activates the intrinsic apoptotic pathway to induce cell death. However, the mechanism by which this pathway is activated in cells exposed to NO is not known. Here we report that BAX and BAK are activated by NO and that cytochrome c is released from the mitochondria. Cells deficient in Bax and Bak or Caspase-9 are completely protected from NO-induced cell death. The individual loss of the BH3-only proteins, Bim, Bid, Puma, Bad or Noxa, or Bid knockdown in Bim(-/-)/Puma(-/-) MEFs, does not prevent NO-induced cell death. Our data show that the anti-apoptotic protein MCL-1 undergoes ASK1-JNK1 mediated degradation upon exposure to NO, and that cells deficient in either Ask1 or Jnk1 are protected against NO-induced cell death. NO can inhibit the mitochondrial electron transport chain resulting in an increase in superoxide generation and peroxynitrite formation. However, scavengers of ROS or peroxynitrite do not prevent NO-induced cell death. Collectively, these data indicate that NO degrades MCL-1 through the ASK1-JNK1 axis to induce BAX/BAK-dependent cell death.			Snyder, CM (corresponding author), Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA.	nav@northwestern.edu			NCI NIH HHS [CA123067-03, R01 CA123067] Funding Source: Medline; NHLBI NIH HHS [P01 HL071643, 2T32HL076139-06, 1P01HL071643, T32 HL076139] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139, P01HL071643] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; Callsen D, 1999, BIOCHEMISTRY-US, V38, P2279, DOI 10.1021/bi982292a; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Clerk A, 1998, J BIOL CHEM, V273, P7228, DOI 10.1074/jbc.273.13.7228; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Go YM, 1999, AM J PHYSIOL-HEART C, V277, pH1647, DOI 10.1152/ajpheart.1999.277.4.H1647; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Harris CA, 2001, J BIOL CHEM, V276, P37754; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ing DJ, 1999, CIRC RES, V84, P21; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; Lee VY, 2002, J BIOL CHEM, V277, P16067, DOI 10.1074/jbc.M111177200; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mandic A, 2001, MOL CELL BIOL, V21, P3684, DOI 10.1128/MCB.21.11.3684-3691.2001; Mendelson KG, 1996, P NATL ACAD SCI USA, V93, P12908, DOI 10.1073/pnas.93.23.12908; Messmer UK, 1996, J BIOL CHEM, V271, P20192, DOI 10.1074/jbc.271.33.20192; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Okada S, 1998, J IMMUNOL, V160, P2590; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Pervin S, 2001, CANCER RES, V61, P4701; Pfeilschifter J, 1996, FEBS LETT, V396, P67, DOI 10.1016/0014-5793(96)01070-8; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sarker KP, 2003, J NEUROCHEM, V87, P1345, DOI 10.1046/j.1471-4159.2003.02096.x; Schieke SM, 1999, FEBS LETT, V448, P301, DOI 10.1016/S0014-5793(99)00372-5; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Song L, 2002, CHINESE MED J-PEKING, V115, P1241; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willison HJ, 2005, NAT CLIN PRACT NEURO, V1, P2, DOI 10.1038/ncpneuro0001; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	51	81	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7059	10.1371/journal.pone.0007059	http://dx.doi.org/10.1371/journal.pone.0007059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768117	Green Submitted, Green Published, gold			2022-12-25	WOS:000270154000002
J	Goyal, P; Behring, A; Kumar, A; Siess, W				Goyal, Pankaj; Behring, Antje; Kumar, Abhishek; Siess, Wolfgang			Identifying and Characterizing a Novel Protein Kinase STK35L1 and Deciphering Its Orthologs and Close-Homologs in Vertebrates	PLOS ONE			English	Article							GENOMIC ANALYSIS; STRESS FIBERS; GENE; SEQUENCE; IDENTIFICATION; TRANSLATION; EXPRESSION; EVOLUTION; CLUSTAL; POINT	Background: The human kinome containing 478 eukaryotic protein kinases has over 100 uncharacterized kinases with unknown substrates and biological functions. The Ser/Thr kinase 35 (STK35, Clik1) is a member of the NKF 4 (New Kinase Family 4) in the kinome with unknown substrates and biological functions. Various high throughput studies indicate that STK35 could be involved in various human diseases such as colorectal cancer and malaria. Methodology/Principal Findings: In this study, we found that the previously published coding sequence of the STK35 gene is incomplete. The newly identified sequence of the STK35 gene codes for a protein of 534 amino acids with a N-terminal elongation of 133 amino acids. It has been designated as STK35L (STK35 long). Since it is the first of further homologous kinases we termed it as STK35L1. The STK35L1 protein (58 kDa on SDS-PAGE), but not STK35 ( 44 kDa), was found to be expressed in all human cells studied ( endothelial cells, HeLa, and HEK cells) and was down-regulated after silencing with specific siRNA. EGFP-STK35L1 was localized in the nucleus and the nucleolus. By combining syntenic and gene structure pattern data and homology searches, two further STK35L1 homologs, STK35L2 (previously known as PDIK1L) and STK35L3, were found. All these protein kinase homologs were conserved throughout the vertebrates. The STK35L3 gene was specifically lost during placental mammalian evolution. Using comparative genomics, we have identified orthologous sets of these three protein kinases genes and their possible ancestor gene in two sea squirt genomes. Conclusions/Significance: We found the full-length coding sequence of the STK35 gene and termed it as STK35L1. We identified a new third STK35-like gene, STK35L3, in vertebrates and a possible ancestor gene in sea squirt genome. This study will provide a comprehensive platform to explore the role of STK35L kinases in cell functions and human diseases.			Goyal, P (corresponding author), Univ Munich, Inst Prevent Cardiovasc Dis, Munich, Germany.	pankaj.goyal@med.uni-muenchen.de	Siess, Wolfgang/A-6430-2009; Goyal, Pankaj/C-3567-2012; Kumar, Abhishek/A-8727-2012	Siess, Wolfgang/0000-0003-0698-6416; Kumar, Abhishek/0000-0003-4172-4059				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bauer K, 2000, BLOOD, V96, P4236; BERKS M, 1995, GENOME RES, V5, P99, DOI 10.1101/gr.5.2.99; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guo LC, 2003, J GENET, V82, P27, DOI 10.1007/BF02715878; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Karolchik Donna, 2007, V395, P17; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kostich M, 2002, GENOME BIOL, V3; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krupa A, 2002, GENOME BIOL, V3; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vallenius T, 2002, J CELL SCI, V115, P2067; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1	42	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e6981	10.1371/journal.pone.0006981	http://dx.doi.org/10.1371/journal.pone.0006981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756140	Green Submitted, gold, Green Published			2022-12-25	WOS:000269970000005
J	Matthijsen, RA; Derikx, JPM; Kuipers, D; van Dam, RM; Dejong, CHC; Buurman, WA				Matthijsen, Robert A.; Derikx, Joep P. M.; Kuipers, Dian; van Dam, Ronald M.; Dejong, Cornelis H. C.; Buurman, Wim A.			Enterocyte Shedding and Epithelial Lining Repair Following Ischemia of the Human Small Intestine Attenuate Inflammation	PLOS ONE			English	Article								Background: Recently, we observed that small-intestinal ischemia and reperfusion was found to entail a rapid loss of apoptotic and necrotic cells. This study was conducted to investigate whether the observed shedding of ischemically damaged epithelial cells affects IR induced inflammation in the human small gut. Methods and Findings: Using a newly developed IR model of the human small intestine, the inflammatory response was studied on cellular, protein and mRNA level. Thirty patients were consecutively included. Part of the jejunum was subjected to 30 minutes of ischemia and variable reperfusion periods (mean reperfusion time 120 (+/- 11) minutes). Ethical approval and informed consent were obtained. Increased plasma intestinal fatty acid binding protein (I-FABP) levels indicated loss in epithelial cell integrity in response to ischemia and reperfusion (p < 0.001 vs healthy). HIF-1 alpha gene expression doubled (p = 0.02) and C3 gene expression increased 4-fold (p = 0.01) over the course of IR. Gut barrier failure, assessed as LPS concentration in small bowel venous effluent blood, was not observed (p = 0.18). Additionally, mRNA expression of HO-1, IL-6, IL-8 did not alter. No increased expression of endothelial adhesion molecules, TNF alpha release, increased numbers of inflammatory cells (p = 0.71) or complement activation, assessed as activated C3 (p = 0.14), were detected in the reperfused tissue. Conclusions: In the human small intestine, thirty minutes of ischemia followed by up to 4 hours of reperfusion, does not seem to lead to an explicit inflammatory response. This may be explained by a unique mechanism of shedding of damaged enterocytes, reported for the first time by our group.			Matthijsen, RA (corresponding author), Spaarne Hosp, Hoofddorp, Netherlands.	w.buurman@ah.unimaas.nl		derikx, joep/0000-0003-0694-7679				Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Cuzzocrea S, 1999, J LEUKOCYTE BIOL, V66, P471, DOI 10.1002/jlb.66.3.471; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Daemen MARC, 1999, TRANSPLANTATION, V67, P792, DOI 10.1097/00007890-199903270-00003; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; de Vries B, 2003, J IMMUNOL, V170, P3883, DOI 10.4049/jimmunol.170.7.3883; De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003428; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; ENGELBERTS I, 1991, LANCET, V338, P515, DOI 10.1016/0140-6736(91)90591-C; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578; Laufer J, 2000, CLIN EXP IMMUNOL, V120, P30, DOI 10.1046/j.1365-2249.2000.01168.x; LIBBY P, 1973, J CLIN INVEST, V52, P599, DOI 10.1172/JCI107221; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; LUCCHESI BR, 1990, ANNU REV PHYSIOL, V52, P561, DOI 10.1146/annurev.ph.52.030190.003021; MA XL, 1991, J CLIN INVEST, V88, P1237, DOI 10.1172/JCI115427; MATTHIJSEN RA, 2009, MOL IMMUNOL; Matthijsen RA, 2007, AM J PATHOL, V171, P1743, DOI 10.2353/ajpath.2007.070184; Murohara T, 1996, J IMMUNOL, V156, P3550; Patel A, 2004, TRANSPLANTATION, V78, P1479, DOI 10.1097/01.TP.0000144182.27897.1E; Restifo NP, 2000, CURR OPIN IMMUNOL, V12, P597, DOI 10.1016/S0952-7915(00)00148-5; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304; SCHOENBERG MH, 1991, GUT, V32, P905, DOI 10.1136/gut.32.8.905; Takada M, 1997, J CLIN INVEST, V99, P2682, DOI 10.1172/JCI119457; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Tsuruma T, 1998, TRANSPLANT P, V30, P2644, DOI 10.1016/S0041-1345(98)00765-9; VEDDER NB, 1990, P NATL ACAD SCI USA, V87, P2643, DOI 10.1073/pnas.87.7.2643; Wada K, 2001, GASTROENTEROLOGY, V120, P126, DOI 10.1053/gast.2001.20873; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yaoita H, 1998, CIRCULATION, V97, P276, DOI 10.1161/01.CIR.97.3.276; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	42	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7045	10.1371/journal.pone.0007045	http://dx.doi.org/10.1371/journal.pone.0007045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753114	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796500021
J	Kenchington, EL; Hamilton, L; Cogswell, A; Zouros, E				Kenchington, Ellen L.; Hamilton, Lorraine; Cogswell, Andrew; Zouros, Eleftherios			Paternal mtDNA and Maleness Are Co-Inherited but Not Causally Linked in Mytilid Mussels	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; DEPENDENT SEX-RATIO; MITOCHONDRIAL-DNA; SPERM MITOCHONDRIA; CONTROL REGION; BLUE MUSSELS; EDULIS; GALLOPROVINCIALIS; GENOMES; SEGREGATION	Background: In marine mussels of the genus Mytilus there are two mitochondrial genomes. One is transmitted through the female parent, which is the normal transmission route in animals, and the other is transmitted through the male parent which is an unusual phenomenon. In males the germ cell line is dominated by the paternal mitochondrial genome and the somatic cell line by the maternal. Research to date has not allowed a clear answer to the question of whether inheritance of the paternal genome is causally related to maleness. Methodology/Principal Findings: Here we present results from hybrid crosses, from triploid mussels and from observations of sperm mitochondria in fertilized eggs which clearly show that maleness and presence of the paternal mitochondrial genome can be decoupled. These same results show that the female mussel has exclusive control of whether her progeny will inherit the mitochondrial genome of the male parent. Conclusions/Significance: These findings are important in our efforts to understand the mechanistic basis of this unusual mode of mitochondrial DNA inheritance that is common among bivalves.			Kenchington, EL (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	Kenchingtone@mar.dfo-mpo.gc.ca						AHMED M, 1970, BIOL BULL-US, V138, P1, DOI 10.2307/1540286; BEAUMONT AR, 1989, J EXP MAR BIOL ECOL, V132, P69, DOI 10.1016/0022-0981(89)90177-9; Burt A, 2006, GENES CONFLICT BIOL; Burzynski A, 2003, MOL BIOL EVOL, V20, P388, DOI 10.1093/molbev/msg058; Burzynski A, 2006, GENETICS, V174, P1081, DOI 10.1534/genetics.106.063180; Cao LQ, 2009, GENETICS, V181, P1045, DOI 10.1534/genetics.108.093229; Cao LQ, 2004, GENETICS, V166, P883, DOI 10.1534/genetics.166.2.883; Cao LQ, 2004, GENETICS, V167, P835, DOI 10.1534/genetics.103.026187; Cogswell AT, 2006, GENOME, V49, P799, DOI 10.1139/G06-036; COGSWELL AT, 2005, 2572 FISH AQ SCI; FISHER C, 1990, P ROY SOC B-BIOL SCI, V242, P149, DOI 10.1098/rspb.1990.0118; Garrido O, 1996, INVERTEBR REPROD DEV, V29, P95, DOI 10.1080/07924259.1996.9672501; Garrido-Ramos MA, 1998, GENOME, V41, P818, DOI 10.1139/gen-41-6-818; Heath DD, 1995, AQUACULTURE, V137, P51, DOI 10.1016/0044-8486(96)83524-1; HOWARD DW, 1983, NMFSFNEC25 NOAA, P1; HURST LD, 1994, NATURE, V368, P811, DOI 10.1038/368811a0; JACKSON DL, 2003, 2460 FISH AQ SCI; Kenchington E, 2002, GENETICS, V161, P1579; Kiyomoto M, 1996, ZOOL SCI, V13, P393, DOI 10.2108/zsj.13.393; Ladoukakis ED, 2002, MOL ECOL, V11, P755, DOI 10.1046/j.1365-294X.2002.01473.x; Mizi A, 2005, MOL BIOL EVOL, V22, P952, DOI 10.1093/molbev/msi079; Obata M, 2005, DEV GROWTH DIFFER, V47, P255; Obata Mayu, 2003, Zoological Science (Tokyo), V20, P1556; Quesada H, 1998, GENETICS, V149, P1511; Rawson PD, 1996, HEREDITY, V77, P599, DOI 10.1038/hdy.1996.187; Rawson PD, 1996, GENETICS, V144, P241; Saavedra C, 1996, GENETICS, V143, P1359; Saavedra C, 1997, GENETICS, V145, P1073; SHAW BARBARA L., 1957, CANADIAN JOUR ZOOL, V35, P325, DOI 10.1139/z57-026; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; SKIBINSKI DOF, 1994, GENETICS, V138, P801; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; Theologidis L, 2007, GENETICS, V176, P1367, DOI 10.1534/genetics.106.069930; Venetis C, 2007, GENE, V406, P79, DOI 10.1016/j.gene.2007.06.001; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Verdonk N.H., 1983, P91; Wood AR, 2003, HEREDITY, V91, P354, DOI 10.1038/sj.hdy.6800345; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0; Zouros E, 2000, GENES GENET SYST, V75, P313, DOI 10.1266/ggs.75.313	41	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6976	10.1371/journal.pone.0006976	http://dx.doi.org/10.1371/journal.pone.0006976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759895	Green Submitted, Green Published, gold			2022-12-25	WOS:000269696600013
J	Duan, ZF; Choy, E; Harmon, D; Yang, C; Ryu, K; Schwab, J; Mankin, H; Hornicek, FJ				Duan, Zhenfeng; Choy, Edwin; Harmon, David; Yang, Cao; Ryu, Keinosuke; Schwab, Joseph; Mankin, Henry; Hornicek, Francis J.			ZNF93 Increases Resistance to ET-743 (Trabectedin; Yondelis (R)) and PM00104 (Zalypsis (R)) in Human Cancer Cell Lines	PLOS ONE			English	Article								Background: ET-743 (trabectedin, Yondelis (R)) and PM00104 (Zalypsis (R)) are marine derived compounds that have antitumor activity. ET-743 and PM00104 exposure over sustained periods of treatment will result in the development of drug resistance, but the mechanisms which lead to resistance are not yet understood. Methodology/Principal Findings: Human chondrosarcoma cell lines resistant to ET-743 (CS-1/ER) or PM00104 (CS-1/PR) were established in this study. The CS-1/ER and CS-1/PR exhibited cross resistance to cisplatin and methotrexate but not to doxorubicin. Human Affymetrix Gene Chip arrays were used to examine relative gene expression in these cell lines. We found that a large number of genes have altered expression levels in CS-1/ER and CS-1/PR when compared to the parental cell line. 595 CS-1/ER and 498 CS-1/PR genes were identified as overexpressing; 856 CS-1/ER and 874 CS-1/PR transcripts were identified as underexpressing. Three zinc finger protein (ZNF) genes were on the top 10 overexpressed genes list. These genes have not been previously associated with drug resistance in tumor cells. Differential expressions of ZNF93 and ZNF43 genes were confirmed in both CS-1/ER and CS-1/PR resistant cell lines by real-time RT-PCR. ZNF93 was overexpressed in two ET-743 resistant Ewing sarcoma cell lines as well as in a cisplatin resistant ovarian cancer cell line, but was not overexpressed in paclitaxel resistant cell lines. ZNF93 knockdown by siRNA in CS-1/ER and CS-1/PR caused increased sensitivity for ET-743, PM00104, and cisplatin. Furthermore, ZNF93 transfected CS-1 cells are relatively resistant to ET-743, PM00104 and cisplatin. Conclusions/Significance: This study suggests that zinc finger proteins, and ZNF93 in particular, are involved in resistance to ET-743 and PM00104.			Duan, ZF (corresponding author), Massachusetts Gen Hosp, Sarcoma Biol Lab, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA.	zduan@partners.org		Choy, Edwin/0000-0001-9896-8084	NCI NIH HHS [R01-CA119617, R01 CA119617] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119617] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amador ML, 2003, ANN ONCOL, V14, P1607, DOI 10.1093/annonc/mdg443; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cuevas C, 2009, NAT PROD REP, V26, P322, DOI 10.1039/b808331m; Damia G, 2001, INT J CANCER, V92, P583, DOI 10.1002/ijc.1221; DUAN Z, 2008, CAN CHEMOTHER PHARM; Duan ZF, 1999, CLIN CANCER RES, V5, P3445; Duan ZF, 2005, CANCER CHEMOTH PHARM, V55, P277, DOI 10.1007/s00280-004-0878-y; Duan ZF, 1999, GENE, V229, P75, DOI 10.1016/S0378-1119(99)00042-6; Erba E, 2000, BRIT J CANCER, V82, P1732; Faircloth G, 2006, PROG MOLEC, V43, P363, DOI 10.1007/978-3-540-30880-5_16; Herrero AB, 2006, CANCER RES, V66, P8155, DOI 10.1158/0008-5472.CAN-06-0179; Ishiguchi H, 2004, INT J CANCER, V111, P900, DOI 10.1002/ijc.20358; Kanzaki A, 2002, MOL CANCER THER, V1, P1327; Lin XJ, 2006, MOL CANCER THER, V5, P1239, DOI 10.1158/1535-7163.MCT-05-0491; Manara MC, 2005, INT J ONCOL, V27, P1605; Marchini S, 2005, EUR J CANCER, V41, P323, DOI 10.1016/j.ejca.2004.10.021; Morioka H, 2003, CLIN CANCER RES, V9, P1211; Orth P, 2008, MOL BIOTECHNOL, V38, P137, DOI 10.1007/s12033-007-0071-8; RIEDEL RF, 2009, CURR TREAT OPTIONS O; Rinehart KL, 2000, MED RES REV, V20, P1; Shao L, 2003, BIOCHEM PHARMACOL, V66, P2381, DOI 10.1016/j.bcp.2003.08.033; Soares DG, 2007, P NATL ACAD SCI USA, V104, P13062, DOI 10.1073/pnas.0609877104; Susa M, 2009, ANTICANCER RES, V29, P1879; Torigoe Takayuki, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P15, DOI 10.2174/1568011053352587; Valoti G, 1998, CLIN CANCER RES, V4, P1977; Wakasugi T, 2007, ONCOGENE, V26, P5194, DOI 10.1038/sj.onc.1210326; Yin JM, 2005, RAPID COMMUN MASS SP, V19, P689, DOI 10.1002/rcm.1848	27	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6967	10.1371/journal.pone.0006967	http://dx.doi.org/10.1371/journal.pone.0006967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742314	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622500025
J	Temime-Smaali, N; Guittat, L; Sidibe, A; Shin-Ya, K; Trentesaux, C; Riou, JF				Temime-Smaali, Nassima; Guittat, Lionel; Sidibe, Assitan; Shin-ya, Kazuo; Trentesaux, Chantal; Riou, Jean-Francois			The G-Quadruplex Ligand Telomestatin Impairs Binding of Topoisomerase III alpha to G-Quadruplex-Forming Oligonucleotides and Uncaps Telomeres in ALT Cells	PLOS ONE			English	Article								In Alternative Lengthening of Telomeres (ALT) cell lines, specific nuclear bodies called APBs ( ALT-associated PML bodies) concentrate telomeric DNA, shelterin components and recombination factors associated with telomere recombination. Topoisomerase III alpha (Topo III) is an essential telomeric-associated factor in ALT cells. We show here that the binding of Topo III to telomeric G-overhang is modulated by G-quadruplex formation. Topo III binding to G-quadruplex-forming oligonucleotides was strongly inhibited by telomestatin, a potent and specific G-quadruplex ligand. In ALT cells, telomestatin treatment resulted in the depletion of the Topo III/BLM/TRF2 complex and the disruption of APBs and led to the segregation of PML, shelterin components and Topo III. Interestingly, a DNA damage response was observed at telomeres in telomestatin-treated cells. These data indicate the importance of G-quadruplex stabilization during telomere maintenance in ALT cells. The function of TRF2/TopoIII/BLM in the resolution of replication intermediates at telomeres is discussed.			Temime-Smaali, N (corresponding author), Univ Reims, UFR Pharm, Lab Oncopharmacol, JE 2428, Reims, France.	riou@mnhn.fr		riou, jean-francois/0000-0002-0055-6506; Guittat, Lionel/0000-0002-9971-7161				Ababou M, 2000, ONCOGENE, V19, P5955, DOI 10.1038/sj.onc.1204003; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Brassart B, 2007, MOL PHARMACOL, V72, P631, DOI 10.1124/mol.107.036574; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; De Cian A, 2007, P NATL ACAD SCI USA, V104, P17347, DOI 10.1073/pnas.0707365104; Douarre C, 2005, NUCLEIC ACIDS RES, V33, P2192, DOI 10.1093/nar/gki514; DRASKOVIC I, 2009, P NATL ACAD IN PRESS; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gomez D, 2004, J BIOL CHEM, V279, P41487, DOI 10.1074/jbc.M406123200; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gomez D, 2006, CANCER RES, V66, P6908, DOI 10.1158/0008-5472.CAN-06-1581; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Gowan SM, 2001, MOL PHARMACOL, V60, P981, DOI 10.1124/mol.60.5.981; Grobelny JV, 2000, J CELL SCI, V113, P4577; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; JIANG WQ, 2007, ONCOGENE; Kelland L, 2007, CLIN CANCER RES, V13, P4960, DOI 10.1158/1078-0432.CCR-07-0422; Kim MY, 2003, CANCER RES, V63, P3247; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Lavelle F, 2000, CRIT REV ONCOL HEMAT, V34, P111, DOI 10.1016/S1040-8428(00)00057-3; Lemarteleur T, 2004, BIOCHEM BIOPH RES CO, V323, P802, DOI 10.1016/j.bbrc.2004.08.150; Li JL, 2001, BIOCHEMISTRY-US, V40, P15194, DOI 10.1021/bi011067h; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pennarun G, 2005, ONCOGENE, V24, P2917, DOI 10.1038/sj.onc.1208468; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Riou Jean-Francois, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P439, DOI 10.2174/1568011043352740; Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099; RODRIGUEZ R, 2008, J AM CHEM SOC; Rosu F, 2003, CHEM COMMUN, P2702, DOI 10.1039/b309394h; Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Tsai HJ, 2006, J BIOL CHEM, V281, P13717, DOI 10.1074/jbc.M600649200; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang WS, 2000, EMBO J, V19, P3428, DOI 10.1093/emboj/19.13.3428; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yeager TR, 1999, CANCER RES, V59, P4175; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	57	54	56	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6919	10.1371/journal.pone.0006919	http://dx.doi.org/10.1371/journal.pone.0006919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742304	Green Submitted, Green Published, gold			2022-12-25	WOS:000269622500005
J	Lonn, M; Mehlig, K; Bengtsson, C; Lissner, L				Lonn, Malin; Mehlig, Kirsten; Bengtsson, Calle; Lissner, Lauren			Adipocyte size predicts incidence of type 2 diabetes in women	FASEB JOURNAL			English	Article						obesity; prospective study; anthropometry; abdominal; heredity	ADIPOSE-TISSUE CELLULARITY; FAT-CELL SIZE; PROSPECTIVE POPULATION; INSULIN SENSITIVITY; GOTEBORG 1974-1975; WEIGHT-REDUCTION; BODY-COMPOSITION; OBESITY; RISK; MELLITUS	Enlarged subcutaneous abdominal adipocytes have been shown to predict incidence of type 2 diabetes (T2D) in the Pima population of Arizona (USA). We investigated the role of subcutaneous abdominal adipocyte size (AAS), as well as femoral adipocyte size (FAS), as predictors of T2D in a population-based Swedish cohort. In 1974-1975, a sample of 1302 middle-aged women underwent a health examination, including anthropometry and evaluation of parental medical history. In addition, body composition (total body potassium and total body water), AAS and FAS (adipose tissue needle biopsy) were assessed in a sub-sample of 245 women. Incidence of T2D was followed until 2001, with 36 cases eligible for inclusion in this analysis. Women developing T2D had larger AAS at baseline vs. women remaining healthy (age/heredity-adjusted hazard ratio for increase of AAS by 1 SD [AAS-HR] 1.91; P<0.001). Further adjustment for both body fat percentage and waist-to-height ratio (WHtR) indicated a robust association. For FAS, the corresponding associations were consistently weaker. WHtR retained a strong predictive association independent of AAS and FAS (WHtR-HR 2.6 and 2.7, respectively; P<0.001). To conclude, in addition to the amount and distribution of body fat in women, subcutaneous adipocyte size, particularly in the abdominal region, predicts incidence of T2D in later life.-Lonn, M., Mehlig, K., Bengtsson, C., Lissner, L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J. 24, 326-331 (2010). www.fasebj.org	[Lonn, Malin] Univ Gothenburg, Dept Clin Chem, Gothenburg, Sweden; [Lonn, Malin] Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden; [Mehlig, Kirsten; Bengtsson, Calle; Lissner, Lauren] Univ Gothenburg, Sahlgrenska Acad, Publ Hlth Epidemiol Unit, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Lonn, M (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem, Bruna Straket 16, SE-41345 Gothenburg, Sweden.	malin.lonn@medic.gu.se	Mehlig, Kirsten/AAT-3468-2020		FAS Center EpiLife; FAS project WISH	FAS Center EpiLife; FAS project WISH	The authors thank professors Cecilia Bjorkelund, Leif Lapidus, and Lena Carlsson for valuable discussions. This work was supported by FAS Center EpiLife and FAS project WISH.	BENGTSSON C, 1978, SCAND J SOC MED, V6, P49, DOI 10.1177/140349487800600201; BENGTSSON C, 1973, ACTA MED SCAND, P311; Bjorkelund C, 2005, DIABETES CARE, V28, P2739, DOI 10.2337/diacare.28.11.2739; Bjorkelund C, 1996, INT J OBESITY, V20, P213; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; EVANS DJ, 1983, J CLIN ENDOCR METAB, V57, P304, DOI 10.1210/jcem-57-2-304; GOLDRICK RB, 1967, AM J PHYSIOL, V212, P777, DOI 10.1152/ajplegacy.1967.212.4.777; HIRSCH J, 1964, J CLIN INVEST, V43, P1776, DOI 10.1172/JCI105052; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KROTKIEWSKI M, 1977, INT J OBESITY, V1, P395; Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6; LUNDGREN H, 1989, INT J OBESITY, V13, P413; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Lundgren M, 2004, J CLIN ENDOCR METAB, V89, P2989, DOI 10.1210/jc.2003-031157; Maffeis C, 2007, J PEDIATR-US, V151, P647, DOI 10.1016/j.jpeds.2007.04.053; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; MOMBELLI G, 2009, METAB SYNDR RELAT DI; NOPPA H, 1980, INT J OBESITY, V4, P253; NOPPA H, 1979, ACTA MED SCAND, V206, P501; NOPPA H, 1979, AM J CLIN NUTR, V32, P1388, DOI 10.1093/ajcn/32.7.1388; OHLSON LO, 1985, DIABETES, V34, P1055, DOI 10.2337/diabetes.34.10.1055; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pasarica M, 2009, DIABETES CARE, V32, P900, DOI 10.2337/dc08-2240; Ridderstrale M, 2009, MOL CELL ENDOCRINOL, V297, P10, DOI 10.1016/j.mce.2008.10.002; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; SALANS LB, 1971, J CLIN INVEST, V50, P1399, DOI 10.1172/JCI106623; Shadid S, 2003, DIABETES CARE, V26, P3148, DOI 10.2337/diacare.26.11.3148; SJOSTROM L, 1971, J LIPID RES, V12, P521; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; SMITH U, 1970, Biochimica et Biophysica Acta, V218, P417, DOI 10.1016/0005-2760(70)90004-4; SMITH U, 1971, J LIPID RES, V12, P65; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SVENDSEN OL, 1995, METABOLISM, V44, P369, DOI 10.1016/0026-0495(95)90168-X; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; World Health Organization, 1985, WHO TECHN REP SER, V727	43	136	137	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					326	331		10.1096/fj.09-133058	http://dx.doi.org/10.1096/fj.09-133058			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19741173				2022-12-25	WOS:000273233600033
J	Barbash, O; Egan, E; Pontano, LL; Kosak, J; Diehl, JA				Barbash, O.; Egan, E.; Pontano, L. L.; Kosak, J.; Diehl, J. A.			Lysine 269 is essential for cyclin D1 ubiquitylation by the SCFFbx4/alpha B-crystallin ligase and subsequent proteasome-dependent degradation	ONCOGENE			English	Article						cyclin D1; Fbx4; ubiquitin; alpha B crystallin	MEDIATED DEGRADATION; UBIQUITIN LIGASE; PHOSPHORYLATION; PROTEOLYSIS; MUTATIONS; COMPLEX; CANCER; EXPRESSION; BINDING; PROTEIN	Protein ubiquitylation is a complex enzymatic process that results in the covalent attachment of ubiquitin, through Gly-76 of ubiquitin, to an epsilon NH2 group of an internal lysine residue in a given substrate. Although E3 ligases frequently use lysines adjacent to the degron within the substrate, many substrates can be targeted to the proteasome through the polyubiquitylation of any lysine. We have assessed the role of lysine residues proximal to the cyclin D1 phosphodegron for ubiquitylation by the SCFFbx4/alpha B-crystallin ubiquitin ligase and subsequent proteasome-dependent degradation of cyclin D1. The work described herein reveals a requisite role for Lys-269 (K269) for the rapid polyubiquitin-mediated degradation of cyclin D1. Mutation of Lys-269, which is proximal to the phosphodegron sequence surrounding Thr-286 in cyclin D1, not only stabilizes cyclin D1 but also triggers cyclin D1 accumulation within the nucleus, thereby promoting cell transformation. In addition, D1-K269R is resistant to genotoxic stress-induced degradation, similar to non-phosphorylatable D1-T286A, supporting the critical role for the post-translational regulation of cyclin D1 in response to DNA-damaging agents. Strikingly, although mutation of lysine 269 to arginine inhibits cyclin D1 degradation, it does not inhibit cyclin D1 ubiquitylation in vivo, showing that ubiquitylation of a specific lysine can influence substrate targeting to the 26S proteasome. Oncogene (2009) 28, 4317-4325; doi: 10.1038/onc.2009.287; published online 21 September 2009	[Barbash, O.; Egan, E.; Pontano, L. L.; Kosak, J.; Diehl, J. A.] Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Diehl, JA (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, 454 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu			NIH [CA93237]; NATIONAL CANCER INSTITUTE [P01CA098101, R01CA093237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank Serge Fuchs for the plasmids encoding the various ubiquitin lysine-arginine mutants, and Petia Zamfirova and Margarita Romero for their technical assistance. This work was supported by CA93237 (NIH) and a Leukemia & Lymphoma Scholar award (JAD).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Feng Q, 2007, ONCOGENE, V26, P5098, DOI 10.1038/sj.onc.1210309; Feng Q, 2008, MOL CANCER THER, V7, P3780, DOI 10.1158/1535-7163.MCT-08-0753; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Germain D, 2000, J BIOL CHEM, V275, P12074, DOI 10.1074/jbc.275.16.12074; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; KATO J, 1993, GENE DEV, V7, P331; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin J, 2004, SEMIN ONCOL, V31, P476, DOI 10.1053/j.seminoncol.2004.04.019; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Parry D, 1999, MOL CELL BIOL, V19, P1775; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; Sato Y, 1999, J GASTROENTEROL, V34, P486, DOI 10.1007/s005350050301; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Worsley SD, 1996, J CLIN PATHOL-CL MOL, V49, pM46; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	26	24	28	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4317	4325		10.1038/onc.2009.287	http://dx.doi.org/10.1038/onc.2009.287			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19767775	Green Accepted			2022-12-25	WOS:000272876400001
J	Shawgo, ME; Shelton, SN; Robertson, JD				Shawgo, Mary E.; Shelton, Shary N.; Robertson, John D.			Caspase-9 Activation by the Apoptosome Is Not Required for Fas-mediated Apoptosis in Type II Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; ETOPOSIDE-INDUCED APOPTOSIS; ALPHA-DEPENDENT APOPTOSIS; SMALL-MOLECULE INHIBITORS; STRESS-INDUCED APOPTOSIS; X-LINKED INHIBITOR; CD95 TYPE-I; STRUCTURAL BASIS; CANCER-CELLS; CD95-MEDIATED APOPTOSIS	Activation of executioner caspases during receptor-mediated apoptosis in type II cells requires the engagement of the mitochondrial apoptotic pathway. Although it is well established that recruitment of mitochondria in this context involves the cleavage of Bid to truncated Bid (tBid), the precise post-mitochondrial signaling responsible for executioner caspase activation is controversial. Here, we used distinct clones of type II Jurkat T-lymphocytes in which the mitochondrial apoptotic pathway had been inhibited to investigate the molecular requirements necessary for Fas-induced apoptosis. Cells over-expressing either Bcl-2 or Bcl-x(L) were protected from apoptosis induced by agonistic anti-Fas antibody. By comparison, Apaf-1-deficient Jurkat cells were sensitive to anti-Fas, exhibiting Bid cleavage, Bak activation, the release of cytochrome c and Smac, and activation of executioner caspase-3. Inhibiting downstream caspase activation with the pharmacological inhibitor Z-DEVD-fmk or by expressing the BIR1/BIR2 domains of X-linked inhibitor of apoptosis protein (XIAP) decreased all anti-Fas-induced apoptotic changes. Additionally, pretreatment of Bcl-x(L)-over-expressing cells with a Smac mimetic sensitized these cells to Fas-induced apoptosis. Combined, our findings strongly suggest that Fas-mediated activation of executioner caspases and induction of apoptosis do not depend on apoptosome-mediated caspase-9 activation in prototypical type II cells.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Kansas Univ Canc Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647]; National Center for Research Resources [P20 RR016475];  [T32 ES007079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647, T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 (to J. D. R.), P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources, and T32 ES007079.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen DJ, 2009, ANTI-CANCER DRUG, V20, P646, DOI 10.1097/CAD.0b013e32832ced78; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kandasamy K, 2003, CANCER RES, V63, P1712; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; Liu HT, 2005, J BIOL CHEM, V280, P11578, DOI 10.1074/jbc.M414385200; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Park CM, 2005, BIOORG MED CHEM LETT, V15, P771, DOI 10.1016/j.bmcl.2004.11.010; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Petrucci E, 2007, GYNECOL ONCOL, V105, P481, DOI 10.1016/j.ygyno.2007.01.011; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schmitz I, 1999, CELL DEATH DIFFER, V6, P821, DOI 10.1038/sj.cdd.4400569; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Sun HY, 2004, J MED CHEM, V47, P4147, DOI 10.1021/jm0499108; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Wu TYH, 2003, CHEM BIOL, V10, P759, DOI 10.1016/S1074-5521(03)00157-1; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	52	18	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33447	33455		10.1074/jbc.M109.032359	http://dx.doi.org/10.1074/jbc.M109.032359			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19758996	Green Published, hybrid			2022-12-25	WOS:000272028500051
J	Coleman, JA; Kwok, MCM; Molday, RS				Coleman, Jonathan A.; Kwok, Michael C. M.; Molday, Robert S.			Localization, Purification, and Functional Reconstitution of the P-4-ATPase Atp8a2, a Phosphatidylserine Flippase in Photoreceptor Disc Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; GLYCOPROTEIN MULTIDRUG TRANSPORTER; OUTER SEGMENT DISK; AMINOPHOSPHOLIPID TRANSLOCASE; LIPID ASYMMETRY; PLASMA-MEMBRANE; RIM PROTEIN; BOVINE; DRS2P; ABCR	P-4-ATPases comprise a relatively new subfamily of P-type ATPases implicated in the energy-dependent translocation of aminophospholipids across cell membranes. In this study, we report on the localization and functional properties of Atp8a2, a member of the P-4-ATPase subfamily that has not been studied previously. Reverse transcription-PCR revealed high expression of atp8a2 mRNA in the retina and testis. Within the retina, immunofluorescence microscopy and subcellular fractionation studies localized Atp8a2 to outer segment disc membranes of rod and cone photoreceptor cells. Atp8a2 purified from photoreceptor outer segments by immunoaffinity chromatography exhibited ATPase activity that was stimulated by phosphatidylserine and to a lesser degree phosphatidylethanolamine but not by phosphatidylcholine or other membrane lipids. Purified Atp8a2 was reconstituted into liposomes containing fluorescent-labeled phosphatidylserine to measure the ability of Atp8a2 to flip phosphatidylserine across the lipid bilayer. Fluorescence measurements showed that Atp8a2 flipped fluorescent-labeled phosphatidylserine from the inner leaflet of liposomes (equivalent to the exocytoplasmic leaflet of cell membranes) to the outer leaflet (equivalent to cytoplasmic leaflet) in an ATP-dependent manner. Our studies provide the first direct biochemical evidence that purified P-4-ATPases can translocate aminophospholipids across membranes and further implicates Atp8a2 in the generation and maintenance of phosphatidylserine asymmetry in photoreceptor disc membranes.	[Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Ophthalmol & Visual Sci, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca		Coleman, Jonathan/0000-0003-0001-6195	National Institutes of Health [EY 02422]; Canadian Institutes of Health Research [MT 5822]; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY 02422. This work was also supported by Canadian Institutes of Health Research Grant MT 5822.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; Grayson C, 2000, HUM MOL GENET, V9, P1873, DOI 10.1093/hmg/9.12.1873; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lev S, 2001, CELL MOL NEUROBIOL, V21, P575, DOI 10.1023/A:1015183500719; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; MILJANICH GP, 1981, J MEMBRANE BIOL, V60, P249, DOI 10.1007/BF01992562; MOLDAY LL, 1990, J BIOL CHEM, V265, P18690; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; MORIYAMA Y, 1988, J BIOL CHEM, V263, P8521; MORROT G, 1990, FEBS LETT, V266, P29, DOI 10.1016/0014-5793(90)81498-D; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Soupene E, 2006, BRIT J HAEMATOL, V133, P436, DOI 10.1111/j.1365-2141.2006.06051.x; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wetzel RK, 1999, J NEUROSCI, V19, P9878; WU G, 1993, BIOCHEMISTRY-US, V32, P879, DOI 10.1021/bi00054a020; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; ZIMMERMAN ML, 1993, BIOCHEMISTRY-US, V32, P12257, DOI 10.1021/bi00096a040	54	134	137	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32670	32679		10.1074/jbc.M109.047415	http://dx.doi.org/10.1074/jbc.M109.047415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778899	Green Published, hybrid			2022-12-25	WOS:000272028400050
J	Kim, SH; Ryan, TA				Kim, Sung Hyun; Ryan, Timothy A.			A Distributed Set of Interactions Controls mu 2 Functionality in the Role of AP-2 as a Sorting Adaptor in Synaptic Vesicle Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; AP2 COMPLEX; STRUCTURAL EXPLANATION; DILEUCINE MOTIF; RECOGNITION; SYNAPSES; SIGNALS; PROTEIN; PHOSPHORYLATION; SYNAPTOTAGMIN	The mechanisms of how, following exocytosis, the approximately nine types of synaptic vesicle (SV) transmembrane proteins are accurately resorted to form SVs are poorly understood. The time course of SV endocytosis is very sensitive to perturbations in clathrin and dynamin, supporting the model that SV endocytosis occurs through a clathrin-mediated pathway. We recently demonstrated that removal of the clathrin adaptor protein AP-2, the key protein thought to coordinate cargo selection into clathrin-coated pits, results in a significant impairment in endocytosis kinetics. Endocytosis, however, still proceeds in the absence of AP-2, bringing into question the role of AP-2 in cargo sorting in this process. Using quantitative endocytosis assays at nerve terminals, we examined how endocytosis depends on the integrity of mu 2 function. Our experiments indicate that no single perturbation in mu 2 prevents restoration of endocytic function when mutated mu 2 replaces native mu 2, whereas introduction of multiple distributed mutations significantly impairs endocytosis. We also examined whether the presence of AP-2 is important for the functionality of the previously identified endocytic motif in an SV cargo protein, the dileucine motif in vGlut-1. These data show that while mutations in the dileucine motif slow the retrieval of vGlut-1, they only do so in the presence of AP-2. These data thus indicate that AP-2 plays a role in cargo selection but that no single aspect of mu 2 function is critical, implying that a more distributed network of interactions supports AP-2 function in SV endocytosis.	[Kim, Sung Hyun; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020; Kim, Sung Hyun/AAI-8554-2020	Kim, Sung Hyun/0000-0002-3166-9941; Ryan, Timothy/0000-0003-2533-9548	National Institutes of Health [36942]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 36942 (to T. A. R.).	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007	33	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32803	32812		10.1074/jbc.M109.039149	http://dx.doi.org/10.1074/jbc.M109.039149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19762466	Green Published, hybrid			2022-12-25	WOS:000272028400065
J	Beard, WA; Shock, DD; Batra, VK; Pedersen, LC; Wilson, SH				Beard, William A.; Shock, David D.; Batra, Vinod K.; Pedersen, Lars C.; Wilson, Samuel H.			DNA Polymerase beta Substrate Specificity SIDE CHAIN MODULATION OF THE "A-RULE"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED-FIT MECHANISM; ABASIC SITE; STRUCTURAL BASIS; NUCLEOTIDE INCORPORATION; CRYSTAL-STRUCTURES; BASE SUBSTITUTION; TERNARY COMPLEXES; TEMPLATE-PRIMER; MINOR-GROOVE; T-OPPOSITE	Apurinic/apyrimidinic (AP) sites are continuously generated in genomic DNA. Left unrepaired, AP sites represent noninstructional premutagenic lesions that are impediments to DNA synthesis. When DNA polymerases encounter an AP site, they generally insert dAMP. This preferential insertion is referred to as the A-rule. Crystallographic structures of DNA polymerase (pol) beta, a family X polymerase, with active site mismatched nascent base pairs indicate that the templating (i.e. coding) base is repositioned outside of the template binding pocket thereby diminishing interactions with the incorrect incoming nucleotide. This effectively produces an abasic site because the template pocket is devoid of an instructional base. However, the template pocket is not empty; an arginine residue (Arg-283) occupies the space vacated by the templating nucleotide. In this study, we analyze the kinetics of pol beta insertion opposite an AP site and show that the preferential incorporation of dAMP is lost with the R283A mutant. The crystallographic structures of pol beta bound to gapped DNA with an AP site analog (tertrahydrofuran) in the gap (binary complex) and with an incoming nonhydrolyzable dATP analog (ternary complex) were solved. These structures reveal that binding of the dATP analog induces a closed polymerase conformation, an unstable primer terminus, and an upstream shift of the templating residue even in the absence of a template base. Thus, dATP insertion opposite an abasic site and dATP misinsertions have common features.	[Beard, William A.; Shock, David D.; Batra, Vinod K.; Pedersen, Lars C.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F3-01, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Pedersen, Lars/C-6173-2019; Wilson, Samuel H/E-6644-2019	Pedersen, Lars/0000-0002-4488-4077; Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health, NIEHS [Z01-ES0500158, Z01-ES050161]; National Institutes of Health [1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA105010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, ZIAES102645, Z01ES050161] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Research Projects Z01-ES0500158 and Z01-ES050161 (to S. H. W.) in the Intramural Research Program, National Institutes of Health, NIEHS, and was in association with National Institutes of Health Grant 1U19CA105010.	Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, P NATL ACAD SCI USA, V103, P17231, DOI 10.1073/pnas.0605069103; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; BEARD WA, 1995, PRACTICAL APPROACH, V2, P15; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Berdis AJ, 2001, BIOCHEMISTRY-US, V40, P7180, DOI 10.1021/bi0101594; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bose-Basu B, 2004, BIOCHEMISTRY-US, V43, P8911, DOI 10.1021/bi049641n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; CUNIASSE P, 1987, NUCLEIC ACIDS RES, V15, P8003, DOI 10.1093/nar/15.19.8003; CUNIASSE P, 1990, J MOL BIOL, V213, P303, DOI 10.1016/S0022-2836(05)80192-5; Efrati E, 1997, J BIOL CHEM, V272, P2559; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Guckian KM, 2000, J AM CHEM SOC, V122, P2213, DOI 10.1021/ja9934854; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kirby TW, 2005, BIOCHEMISTRY-US, V44, P15230, DOI 10.1021/bi0511742; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Nair DT, 2009, STRUCTURE, V17, P530, DOI 10.1016/j.str.2009.02.015; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nakamura J, 1999, CANCER RES, V59, P2522; Nakamura J, 1998, CANCER RES, V58, P222; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson TA, 2000, PROTEIN EXPRES PURIF, V18, P100, DOI 10.1006/prep.1999.1167; PazElizur T, 1997, BIOCHEMISTRY-US, V36, P1766, DOI 10.1021/bi9621324; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan R, 2006, BIOCHEMISTRY-US, V45, P15142, DOI 10.1021/bi061353z; Reineks EZ, 2004, BIOCHEMISTRY-US, V43, P393, DOI 10.1021/bi034948s; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Sheriff A, 2008, BIOCHEMISTRY-US, V47, P8527, DOI 10.1021/bi800324r; SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Sun LP, 2000, BIOCHEMISTRY-US, V39, P14603, DOI 10.1021/bi001446v; WILDE JA, 1989, J AM CHEM SOC, V111, P1894, DOI 10.1021/ja00187a062; Wolfle WT, 2003, GENE DEV, V17, P2191, DOI 10.1101/gad.1108603; Xiang Y, 2008, PROTEINS, V70, P231, DOI 10.1002/prot.21668; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807	62	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31680	31689		10.1074/jbc.M109.029843	http://dx.doi.org/10.1074/jbc.M109.029843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759017	Green Published, hybrid			2022-12-25	WOS:000271572700023
J	McGillicuddy, FC; Chiquoine, EH; Hinkle, CC; Kim, RJ; Shah, R; Roche, HM; Smyth, EM; Reilly, MP				McGillicuddy, Fiona C.; Chiquoine, Elise H.; Hinkle, Christine C.; Kim, Roy J.; Shah, Rachana; Roche, Helen M.; Smyth, Emer M.; Reilly, Muredach P.			Interferon gamma Attenuates Insulin Signaling, Lipid Storage, and Differentiation in Human Adipocytes via Activation of the JAK/STAT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADIPOSE-TISSUE; FACTOR-ALPHA; MACROPHAGE POLARIZATION; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; RECEPTOR-GAMMA; JAK KINASES; OBESITY	Recent reports demonstrate T-cell infiltration of adipose tissue in early obesity. We hypothesized that interferon (IFN) gamma, a major T-cell inflammatory cytokine, would attenuate human adipocyte functions and sought to establish signaling mechanisms. Differentiated human adipocytes were treated with IFN gamma +/- pharmacological inhibitors prior to insulin stimulation. [H-3]Glucose uptake and AKT phosphorylation were assessed as markers of insulin sensitivity. IFN gamma induced sustained loss of insulin-stimulated glucose uptake in human adipocytes, coincident with reduced Akt phosphorylation and down-regulation of the insulin receptor, insulin receptor substrate-1, and GLUT4. Loss of adipocyte triglyceride storage was observed with IFN gamma co-incident with reduced expression of peroxisome proliferator-activated receptor gamma, adiponectin, perilipin, fatty acid synthase, and lipoprotein lipase. Treatment with IFN gamma also blocked differentiation of pre-adipocytes to the mature phenotype. IFN gamma-induced robust STAT1 phosphorylation and SOCS1 mRNA expression, with modest, transient STAT3 phosphorylation and SOCS3 induction. Preincubation with a non-selective JAK inhibitor restored glucose uptake and Akt phosphorylation while completely reversing IFN gamma suppression of adipogenic mRNAs and adipocyte differentiation. Specific inhibition of JAK2 or JAK3 failed to block IFN gamma effects suggesting a predominant role for JAK1-STAT1. We demonstrate that IFN gamma attenuates insulin sensitivity and suppresses differentiation in human adipocytes, an effect most likely mediated via sustained JAK-STAT1 pathway activation.	[Reilly, Muredach P.] Univ Penn, Med Ctr, Cardiovasc Inst, Sch Med, Philadelphia, PA 19104 USA; [Kim, Roy J.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Smyth, Emer M.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Kim, Roy J.; Shah, Rachana] Childrens Hosp Philadelphia, Div Pediat Endocrinol, Philadelphia, PA 19104 USA; [McGillicuddy, Fiona C.; Roche, Helen M.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Nutrigenom Res Grp, Dublin 4, Ireland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University College Dublin	Reilly, MP (corresponding author), Univ Penn, Med Ctr, Cardiovasc Inst, Sch Med, 609 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	muredach@mail.med.upenn.edu	Roche, Helen M/AAF-4164-2019	Roche, Helen M/0000-0002-0628-3318; Reilly, Muredach/0000-0002-3035-9386; Shah, Rachana/0000-0001-7866-557X; McGillicuddy, Fiona/0000-0003-3623-3503	National Institutes of Health [RO1 HL-073278]; NHLBI [P50 HL-083799-SCCOR]; Science Foundation of Ireland PI Programme Grant [06/IM.1/B105]; National Center for Research Resources [RFA-RM-06-002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073278, P50HL083799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Science Foundation of Ireland PI Programme Grant(Science Foundation Ireland); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	* This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-073278 and P50 HL-083799-SCCOR ( to M. P. R.) from the NHLBI, Science Foundation of Ireland PI Programme Grant 06/IM.1/B105 ( to H. M. R.), and Clinical and Translational Science Award RFA-RM-06-002 from the National Center for Research Resources ( NCRR). Downloaded from www.jbc.org at unknown institution, on November 10, 2009	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bendinelli P, 2000, MOL CELL ENDOCRINOL, V168, P11, DOI 10.1016/S0303-7207(00)00313-0; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Caldenhoven E, 1999, J LEUKOCYTE BIOL, V65, P391, DOI 10.1002/jlb.65.3.391; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fenkci S, 2006, J INVEST MED, V54, P455, DOI 10.2310/6650.2006.06010; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Han YL, 1996, J BIOL CHEM, V271, P5947, DOI 10.1074/jbc.271.10.5947; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; HORVATH CM, 2004, SCI STKE, pTR9; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Li L, 2008, DIABETES OBES METAB, V10, P921, DOI 10.1111/j.1463-1326.2007.00832.x; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; SAKATSUME M, 1995, J BIOL CHEM, V270, P17528, DOI 10.1074/jbc.270.29.17528; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457	52	175	179	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31936	31944		10.1074/jbc.M109.061655	http://dx.doi.org/10.1074/jbc.M109.061655			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776010	Green Published, hybrid			2022-12-25	WOS:000271572700049
J	Hu, J; Winqvist, O; Flores-Morales, A; Wikstrom, AC; Norstedt, G				Hu, Jin; Winqvist, Ola; Flores-Morales, Amilcar; Wikstroem, Ann-Charlotte; Norstedt, Gunnar			SOCS2 Influences LPS Induced Human Monocyte-Derived Dendritic Cell Maturation	PLOS ONE			English	Article								Dendritic cells (DCs) are highly specific antigen presenting cells, which link innate and adaptive immune responses and participate in protecting hosts from invading pathogens. DCs can be generated in vitro by culturing human monocytes with GM-CSF and IL-4 followed by LPS induced DC maturation. We set out to study the suppressor of cytokine signaling (SOCS) proteins during maturation and activation of human monocyte-derived DCs from peripheral blood in vitro. We found that the expression of SOCS2 mRNA and protein is dramatically up-regulated during DC maturation. Silencing of SOCS2 using siRNA, inhibited DC maturation as evidenced by a decreased expression of maturation markers such as CD83, co-stimulatory molecules CD40, CD86 and HLA-DR. Furthermore, silencing of SOCS2 decreased LPS induced activation of MAP kinases (SAKP/JNK, p38, ERK), IRF3, decreased the translocation of the NF-kappa B transcription factor and reduced downstream gene mRNA expression. These results suggest a role for SOCS2 in the MyD88-dependent and -independent TLR4 signaling pathways. In conclusion, our results demonstrate that SOCS2 is required for appropriate TLR4 signaling in maturating human DCs via both the MyD88-dependent and -independent signaling pathway.			Hu, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	Gunnar.Norstedt@ki.se		winqvist, Ola/0000-0003-0842-4441; Norstedt, Gunnar/0000-0002-7759-3241				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2000, J ENDOTOXIN RES, V6, P383, DOI 10.1177/09680519000060050901; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bottcher I, 2008, IMMUNOLOGY, V123, P139, DOI 10.1111/j.1365-2567.2007.02754.x; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Machado FS, 2008, J EXP MED, V205, P1077, DOI 10.1084/jem.20072416; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; Piemonti L, 1995, EUR CYTOKINE NETW, V6, P245; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schnurr M, 2000, J IMMUNOL, V165, P4704, DOI 10.4049/jimmunol.165.8.4704; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Strengell M, 2006, J LEUKOCYTE BIOL, V79, P1279, DOI 10.1189/jlb.0905503; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	51	33	35	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7178	10.1371/journal.pone.0007178	http://dx.doi.org/10.1371/journal.pone.0007178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779605	Green Published, gold, Green Submitted			2022-12-25	WOS:000270176200015
J	Tromas, A; Braun, N; Muller, P; Khodus, T; Paponov, IA; Palme, K; Ljung, K; Lee, JY; Benfey, P; Murray, JAH; Scheres, B; Perrot-Rechenmann, C				Tromas, Alexandre; Braun, Nils; Muller, Philippe; Khodus, Tatyana; Paponov, Ivan A.; Palme, Klaus; Ljung, Karin; Lee, Ji-Young; Benfey, Philip; Murray, James A. H.; Scheres, Ben; Perrot-Rechenmann, Catherine			The AUXIN BINDING PROTEIN 1 Is Required for Differential Auxin Responses Mediating Root Growth	PLOS ONE			English	Article							ARABIDOPSIS ROOT; CELL-DIVISION; TRANSCRIPTION FACTOR; MODULATING AUXIN; TIR1; EXPRESSION; MECHANISM; MAINTENANCE; RECEPTORS; TRANSPORT	Background: In plants, the phytohormone auxin is a crucial regulator sustaining growth and development. At the cellular level, auxin is interpreted differentially in a tissue-and dose-dependent manner. Mechanisms of auxin signalling are partially unknown and the contribution of the AUXIN BINDING PROTEIN 1 (ABP1) as an auxin receptor is still a matter of debate. Methodology/Principal Findings: Here we took advantage of the present knowledge of the root biological system to demonstrate that ABP1 is required for auxin response. The use of conditional ABP1 defective plants reveals that the protein is essential for maintenance of the root meristem and acts at least on the D-type CYCLIN/RETINOBLASTOMA pathway to control entry into the cell cycle. ABP1 affects PLETHORA gradients and confers auxin sensitivity to root cells thus defining the competence of the cells to be maintained within the meristem or to elongate. ABP1 is also implicated in the regulation of gene expression in response to auxin. Conclusions/Significance: Our data support that ABP1 is a key regulator for root growth and is required for auxin-mediated responses. Differential effects of ABP1 on various auxin responses support a model in which ABP1 is the major regulator for auxin action on the cell cycle and regulates auxin-mediated gene expression and cell elongation in addition to the already well known TIR1-mediated ubiquitination pathway.			Tromas, A (corresponding author), Univ Paris Sud, CNRS, UPR2355, Inst Sci Vegetal, Gif Sur Yvette, France.	catherine.rechenmann@isv.cnrs-gif.fr	Paponov, Ivan A./H-9680-2016; Lee, Ji-Young/E-2196-2012; Ljung, Karin/AAE-8691-2019; Lee, Ji-Young/F-7455-2013; TROMAS, Alexandre/L-5767-2015; Murray, James AH/D-3399-2009; Palme, Klaus/A-9524-2013	Paponov, Ivan A./0000-0002-2138-0722; Ljung, Karin/0000-0003-2901-189X; TROMAS, Alexandre/0000-0002-9084-3874; Murray, James AH/0000-0002-2282-3839; Palme, Klaus/0000-0002-2728-3835; Scheres, Ben/0000-0001-5400-9578; Lee, Ji-Young/0000-0002-7631-5127	BBSRC [BB/E024858/2, BB/E024858/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024858/1, BB/E024858/2] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; del Pozo JC, 2002, PLANT CELL, V14, P3057, DOI 10.1105/tpc.006791; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dewitte W, 2003, PLANT CELL, V15, P79, DOI 10.1105/tpc.004838; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; EDLUND A, 1995, PLANT PHYSIOL, V108, P1043, DOI 10.1104/pp.108.3.1043; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Leyser O, 2005, CELL, V121, P819, DOI 10.1016/j.cell.2005.06.005; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Magyar Z, 2005, PLANT CELL, V17, P2527, DOI 10.1105/tpc.105.033761; Malamy JE, 1997, DEVELOPMENT, V124, P33; Menges M, 2006, PLANT CELL, V18, P893, DOI 10.1105/tpc.105.039636; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Nakajima K, 2002, PLANT CELL, V14, pS265, DOI 10.1105/tpc.010471; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Scherer GFE, 2002, PLANT MOL BIOL, V49, P357, DOI 10.1023/A:1015290510483; Scherer GFE, 2007, FEBS LETT, V581, P4205, DOI 10.1016/j.febslet.2007.07.059; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Tao LZ, 2005, PLANT CELL, V17, P2369, DOI 10.1105/tpc.105.032987; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Ueda M, 2004, DEVELOPMENT, V131, P2101, DOI 10.1242/dev.01096; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718	52	108	118	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e6648	10.1371/journal.pone.0006648	http://dx.doi.org/10.1371/journal.pone.0006648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777056	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000270164600001
J	Dace, DS; Khan, AA; Stark, JL; Kelly, J; Cross, AH; Apte, RS				Dace, Dru S.; Khan, Aslam A.; Stark, Jennifer L.; Kelly, Jennifer; Cross, Anne H.; Apte, Rajendra S.			Interleukin-10 Overexpression Promotes Fas-Ligand-Dependent Chronic Macrophage-Mediated Demyelinating Polyneuropathy	PLOS ONE			English	Article								Background: Demyelinating polyneuropathy is a debilitating, poorly understood disease that can exist in acute (Guillain-Barre syndrome) or chronic forms. Interleukin-10 (IL-10), although traditionally considered an anti-inflammatory cytokine, has also been implicated in promoting abnormal angiogenesis in the eye and in the pathobiology of autoimmune diseases such as lupus and encephalomyelitis. Principal Findings: Overexpression of IL-10 in a transgenic mouse model leads to macrophage-mediated demyelinating polyneuropathy. IL-10 upregulates ICAM-1 within neural tissues, promoting massive macrophage influx, inflammation-induced demyelination, and subsequent loss of neural tissue resulting in muscle weakness and paralysis. The primary insult is to perineural myelin followed by secondary axonal loss. Infiltrating macrophages within the peripheral nerves demonstrate a highly pro-inflammatory signature. Macrophages are central players in the pathophysiology, as in vivo depletion of macrophages using clodronate liposomes reverses the phenotype, including progressive nerve loss and paralysis. Macrophage-mediate demyelination is dependent on Fas-ligand (FasL)-mediated Schwann cell death. Significance: These findings mimic the human disease chronic idiopathic demyelinating polyneuropathy (CIDP) and may also promote further understanding of the pathobiology of related conditions such as acute idiopathic demyelinating polyneuropathy (AIDP) or Guillain-Barre syndrome.			Dace, DS (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	apte@vision.wustl.edu		Cross, Anne/0000-0003-0829-7569	NATIONAL EYE INSTITUTE [P30EY002687, K08EY016139] Funding Source: NIH RePORTER; NEI NIH HHS [K08 EY016139, P30 EY002687, P30 EY 02687, K08EY016139] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adorini L, 2003, CLIN EXP IMMUNOL, V132, P185, DOI 10.1046/j.1365-2249.2003.02144.x; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Cannella B, 1996, J NEUROSCI RES, V45, P735, DOI 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V; Croxford JL, 1998, J IMMUNOL, V160, P5181; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Ferguson Thomas A, 2002, Int Rev Immunol, V21, P153; FRASER CC, 1995, BLOOD, V86, P183, DOI 10.1182/blood.V86.1.183.bloodjournal861183; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Jadus MR, 1998, J IMMUNOL, V160, P361; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Lee MS, 1997, AUTOIMMUNITY, V26, P215, DOI 10.3109/08916939709008027; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Nagelkerken L, 1997, INT IMMUNOL, V9, P1243, DOI 10.1093/intimm/9.9.1243; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; PENNLINE KJ, 1994, CLIN IMMUNOL IMMUNOP, V71, P169, DOI 10.1006/clin.1994.1068; Persson S, 1996, SCAND J IMMUNOL, V44, P607, DOI 10.1046/j.1365-3083.1996.d01-355.x; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Stark JL, 2006, INT IMMUNOL, V18, P347, DOI 10.1093/intimm/dxh373; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; WOGENSEN L, 1993, J EXP MED, V178, P175, DOI 10.1084/jem.178.1.175	28	29	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7121	10.1371/journal.pone.0007121	http://dx.doi.org/10.1371/journal.pone.0007121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771172	Green Submitted, Green Published, gold			2022-12-25	WOS:000270154400014
J	Guo, YL; Liu, DQ; Bian, Z; Zhang, CY; Zen, K				Guo, Ya-Lan; Liu, Dan-Qing; Bian, Zhen; Zhang, Chen-Yu; Zen, Ke			Down-Regulation of Platelet Surface CD47 Expression in Escherichia coli O157:H7 Infection-Induced Thrombocytopenia	PLOS ONE			English	Article								Background: Platelet depletion is a key feature of hemolytic uremic syndrome (HUS) caused by Shiga toxin-producing Escherichia coli (STEC) infection. The mechanism underlying STEC-induced platelet depletion, however, is not completely understood. Methodology/Principal Findings: Here we demonstrated for the first time that platelet surface expression of CD47 was significantly decreased in C57BL6 mice treated with concentrated culture filtrates (CCF) from STEC O157:H7. STEC O157:H7 CCF treatment also led to a sharp drop of platelet counts. The reduction of cell surface CD47 was specific for platelets but not for neutrophil, monocytes and red blood cells. Down-regulation of platelet surface CD47 was also observed in isolated human platelets treated with O157:H7 CCF. Platelet surface CD47 reduction by O157:H7 CCF could be blocked by anti-TLR4 antibody but not anti-CD62 antibody. Down-regulation of platelet surface CD47 was positively correlated with platelet activation and phagocytosis by human monocyte-derived macrophages. Furthermore, the enhanced phagocytosis process of O157:H7 CCF-treated platelets was abolished by addition of soluble CD47 recombinants. Conclusions/Significance: Our results suggest that platelet CD47 down-regulation may be a novel mechanism underneath STEC-induced platelet depletion, and that the interactions between CD47 and its receptor, signal regulatory protein a (SIRPa), play an essential role in modulating platelet homeostasis.			Guo, YL (corresponding author), Nanjing Univ, Sch Life Sci, Inst Virol, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; kzen@nju.edu.cn						APPIANI AC, 1982, CLIN NEPHROL, V17, P195; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; COHEN A, 1987, J BIOL CHEM, V262, P17088; Cooling LLW, 1998, INFECT IMMUN, V66, P4355; Fernandez GC, 2000, CLIN IMMUNOL, V95, P227, DOI 10.1006/clim.2000.4862; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gu L, 2008, BIOCHEM BIOPH RES CO, V369, P1061, DOI 10.1016/j.bbrc.2008.02.160; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Ikeda M, 2004, PEDIATR NEPHROL, V19, P485, DOI 10.1007/s00467-003-1395-7; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Jung SM, 2000, TRENDS CARDIOVAS MED, V10, P285, DOI 10.1016/S1050-1738(01)00064-0; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Karpman D, 2001, BLOOD, V97, P3100, DOI 10.1182/blood.V97.10.3100; KATAYAMA M, 1993, BRIT J HAEMATOL, V84, P702, DOI 10.1111/j.1365-2141.1993.tb03149.x; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Nolasco LH, 2005, BLOOD, V106, P4199, DOI 10.1182/blood-2005-05-2111; OBRIG TG, 1988, INFECT IMMUN, V56, P2373, DOI 10.1128/IAI.56.9.2373-2378.1988; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Poole JA, 2008, J ALLERGY CLIN IMMUN, V122, P375, DOI 10.1016/j.jaci.2008.05.023; ROSE PE, 1985, J CLIN PATHOL, V38, P438, DOI 10.1136/jcp.38.4.438; Sauter KAD, 2008, INFECT IMMUN, V76, P4469, DOI 10.1128/IAI.00592-08; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Taylor FB, 1999, AM J PATHOL, V154, P1285, DOI 10.1016/S0002-9440(10)65380-1; te Loo DMWM, 2000, BLOOD, V95, P3396, DOI 10.1182/blood.V95.11.3396.011k19_3396_3402; TESH VL, 1991, J INFECT DIS, V164, P344, DOI 10.1093/infdis/164.2.344; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Uchida H, 1999, PEDIATR RES, V45, P133, DOI 10.1203/00006450-199901000-00022; Viisoreanu D, 2000, THROMB RES, V98, P403, DOI 10.1016/S0049-3848(00)00191-2; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438, DOI 10.1128/IAI.58.8.2438-2445.1990; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Yamazaki M, 2001, THROMB RES, V104, P197, DOI 10.1016/S0049-3848(01)00350-4; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhang WL, 2002, J CLIN MICROBIOL, V40, P1441, DOI 10.1128/JCM.40.4.1441-1446.2002	38	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7131	10.1371/journal.pone.0007131	http://dx.doi.org/10.1371/journal.pone.0007131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771158	Green Submitted, Green Published, gold			2022-12-25	WOS:000270154400019
J	Schule, S; Kloke, BP; Kaiser, JK; Heidmeier, S; Panitz, S; Wolfrum, N; Cichutek, K; Schweizer, M				Schuele, Silke; Kloke, Bjoern-Philipp; Kaiser, Julia K.; Heidmeier, Sabine; Panitz, Sylvia; Wolfrum, Nina; Cichutek, Klaus; Schweizer, Matthias			Restriction of HIV-1 Replication in Monocytes Is Abolished by Vpx of SIVsmmPBj	PLOS ONE			English	Article							VIRUS TYPE-2 VPX; VIRAL PREINTEGRATION COMPLEX; CELL-CYCLE ARREST; DENDRITIC CELLS; NUCLEAR-LOCALIZATION; REVERSE TRANSCRIPTION; STABLE TRANSDUCTION; EARLY STEPS; OLD-WORLD; INFECTION	Background: Human primary monocytes are refractory to infection with the human immunodeficiency virus 1 (HIV-1) or transduction with HIV-1-derived vectors. In contrast, efficient single round transduction of monocytes is mediated by vectors derived from simian immunodeficiency virus of sooty mangabeys (SIVsmmPBj), depending on the presence of the viral accessory protein Vpx. Methods and Findings: Here we analyzed whether Vpx of SIVsmmPBj is sufficient for transduction of primary monocytes by HIV-1-derived vectors. To enable incorporation of PBj Vpx into HIV-1 vector particles, a HA-Vpr/Vpx fusion protein was generated. Supplementation of HIV-1 vector particles with this fusion protein was not sufficient to facilitate transduction of human monocytes. However, monocyte transduction with HIV-1-derived vectors was significantly enhanced after delivery of Vpx proteins by virus-like particles (VLPs) derived from SIVsmmPBj. Moreover, pre-incubation with Vpx-containing VLPs restored replication capacity of infectious HIV-1 in human monocytes. In monocytes of non-human primates, single-round transduction with HIV-1 vectors was enabled. Conclusion: Vpx enhances transduction of primary human and even non-human monocytes with HIV-1-derived vectors, only if delivered in the background of SIVsmmPBj-derived virus-like particles. Thus, for accurate Vpx function the presence of SIVsmmPBj capsid proteins might be required. Vpx is essential to overcome a block of early infection steps in primary monocytes.			Schule, S (corresponding author), Paul Ehrlich Inst, Div Med Biotechnol, D-6070 Langen, Germany.	schmt@pei.de	Wolfrum, Nina/AAR-5772-2021	Wolfrum, Nina/0000-0001-6583-2658				Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Belshan M, 2006, VIROLOGY, V346, P118, DOI 10.1016/j.virol.2005.10.036; Berger G, 2009, GENE THER, V16, P159, DOI 10.1038/gt.2008.128; Brennan G, 2007, J VIROL, V81, P12210, DOI 10.1128/JVI.02499-06; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Jarrosson-Wuilleme L, 2006, J VIROL, V80, P1152, DOI 10.1128/JVI.80.3.1152-1159.2006; KAPPES JC, 1991, VIROLOGY, V184, P197, DOI 10.1016/0042-6822(91)90836-Z; Kino T, 2004, DNA CELL BIOL, V23, P193, DOI 10.1089/104454904773819789; LaBonte JA, 2002, J EXP MED, V196, P431, DOI 10.1084/jem.20020468; Lee K, 2004, P NATL ACAD SCI USA, V101, P10496, DOI 10.1073/pnas.0404066101; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Mahalingam S, 2001, J VIROL, V75, P362, DOI 10.1128/JVI.75.1.362-374.2001; Mahnke LA, 2006, VIROLOGY, V348, P165, DOI 10.1016/j.virol.2005.12.023; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Muhlebach MD, 2005, MOL THER, V12, P1206, DOI 10.1016/j.ymthe.2005.06.483; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pancio HA, 2000, J VIROL, V74, P6162, DOI 10.1128/JVI.74.13.6162-6167.2000; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; PENG G, 2007, BLOOD; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; POOLE JA, 2009, AM J PHYSL LUNG CELL; Sakuma R, 2007, GENE THER, V14, P185, DOI 10.1038/sj.gt.3302852; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; SCHUITEMAKER H, 1992, J CLIN INVEST, V89, P1154, DOI 10.1172/JCI115697; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Shi J, 2006, VIROLOGY, V350, P493, DOI 10.1016/j.virol.2006.03.013; Singhal PK, 2006, J VIROL, V80, P526, DOI 10.1128/JVI.80.1.526-536.2006; SINGHAL PK, 2006, J VIROL; Sleigh R, 1998, VIROLOGY, V245, P338, DOI 10.1006/viro.1998.9159; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Sonza S, 2001, AIDS, V15, P17, DOI 10.1097/00002030-200101050-00005; STRAPPE PM, 2005, RETROVIROLOGY, V55, P1; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Wolfrum N, 2007, VIROLOGY, V364, P330, DOI 10.1016/j.virol.2007.03.008	53	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7098	10.1371/journal.pone.0007098	http://dx.doi.org/10.1371/journal.pone.0007098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768115	gold, Green Published, Green Submitted			2022-12-25	WOS:000270154000006
J	Frisa, PS; Jacobberger, JW				Frisa, Phyllis S.; Jacobberger, James W.			Cell Cycle-Related Cyclin B1 Quantification	PLOS ONE			English	Article								Background: To obtain non-relative measures of cell proteins, purified preparations of the same proteins are used as standards in Western blots. We have previously quantified SV40 large T antigen expressed over a several fold range in different cell lines and correlated the average number of molecules to average fluorescence obtained by cytometry and determined cell cycle phase related expression by calculation from multi-parametric cytometry data. Using a modified approach, we report quantification of endogenous cyclin B1 and generation of the cell cycle time related expression profile. Methodology: Recombinant cyclin B1 was purified from a baculovirus lysate using an antibody affinity column and concentrated. We created fixed cell preparations from nocodazole-treated (high cyclin B1) and serum starved (low cyclin B1) PC3 cells that were either lyophilized (for preservation) or solubilized. The lysates and purified cyclin B1 were subjected to Western blotting; the cell preparations were subjected to cytometry, and fluorescence was correlated to molecules. Three untreated cell lines (K562, HeLa, and RKO) were prepared for cytometry without lyophilization and also prepared for Western blotting. These were quantified by Western blotting and by cytometry using the standard cell preparations. Results: The standard cell preparations had 1.5x10(5) to 2.5X10(6) molecules of cyclin B1 per cell on average (i.e., 16-fold range). The average coefficient of variation was 24%. Fluorescence varied 12-fold. The relationship between molecules/cell (Western blot) and immunofluorescence (cytometry) was linear (r(2) = 0.87). Average cyclin B1 levels for the three untreated cell lines determined by Western blotting and cytometry agreed within a factor of 2. The non-linear rise in cyclin B1 in S phase was quantified from correlated plots of cyclin B1 and DNA content. The peak levels achieved in G2 were similar despite differences in lineage, growth conditions, and rates of increase through the cell cycle (range: 1.6-2.2X10(6) molecules per cell). Conclusions: Net cyclin B1 expression begins in G1 in human somatic cells lines; increases non-linearly with variation in rates of accumulation, but peaks at similar peak values in different cell lines growing under different conditions. This suggests tight quantitative end point control.			Frisa, PS (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	jwj@case.edu	Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	NCI NIH HHS [P30CA43703, R01 CA073413, P30 CA043703, R01CA73413] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA073413] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Bagwell CB, 2005, CYTOM PART A, V64A, P34, DOI 10.1002/cyto.a.20114; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Chang P, 1999, MICROSC RES TECHNIQ, V44, P415, DOI 10.1002/(SICI)1097-0029(19990315)44:6<415::AID-JEMT3>3.0.CO;2-4; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Darzynkiewicz Zbigniew, 2003, Prog Cell Cycle Res, V5, P533; Frisa PS, 2000, CYTOMETRY, V39, P79, DOI 10.1002/(SICI)1097-0320(20000101)39:1<79::AID-CYTO11>3.0.CO;2-3; Frisa PS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-10; FRISA PS, 1994, J NEUROSCI RES, V39, P47, DOI 10.1002/jnr.490390107; GONG JP, 1995, CELL GROWTH DIFFER, V6, P1485; Hood Leroy, 2008, Briefings in Functional Genomics & Proteomics, V7, P239, DOI 10.1093/bfgp/eln027; Jacobberger JW, 1999, CYTOMETRY, V35, P284, DOI 10.1002/(SICI)1097-0320(19990301)35:3<284::AID-CYTO12>3.0.CO;2-K; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Kanatsu-Shinohara M, 2000, BIOL REPROD, V63, P1610, DOI 10.1095/biolreprod63.6.1610; KOBAYASHI H, 1991, J CELL BIOL, V114, P755, DOI 10.1083/jcb.114.4.755; LEHMAN JM, 1988, CYTOMETRY, V9, P52, DOI 10.1002/cyto.990090109; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SLADEK TL, 1994, CELL PROLIFERAT, V27, P711, DOI 10.1111/j.1365-2184.1994.tb01386.x; Soni DV, 2008, CELL CYCLE, V7, P1285, DOI 10.4161/cc.7.9.5711; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; Viallard JF, 1999, EXP CELL RES, V247, P208, DOI 10.1006/excr.1998.4352; Viallard JF, 2000, CYTOMETRY, V39, P117, DOI 10.1002/(SICI)1097-0320(20000201)39:2<117::AID-CYTO4>3.3.CO;2-R; Xu NH, 2007, CELL CYCLE, V6, P1639, DOI 10.4161/cc.6.13.4385; Yu AM, 2009, DRUG METAB DISPOS, V37, P170, DOI 10.1124/dmd.108.024166	24	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7064	10.1371/journal.pone.0007064	http://dx.doi.org/10.1371/journal.pone.0007064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763267	gold, Green Published, Green Submitted			2022-12-25	WOS:000269970400006
J	Jayaraman, S; Mabweijano, JR; Lipnick, MS; Caldwell, N; Miyamoto, J; Wangoda, R; Mijumbi, C; Hsia, R; Dicker, R; Ozgediz, D				Jayaraman, Sudha; Mabweijano, Jacqueline R.; Lipnick, Michael S.; Caldwell, Nolan; Miyamoto, Justin; Wangoda, Robert; Mijumbi, Cephas; Hsia, Renee; Dicker, Rochelle; Ozgediz, Doruk			First Things First: Effectiveness and Scalability of a Basic Prehospital Trauma Care Program for Lay First-Responders in Kampala, Uganda	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; COST-EFFECTIVENESS; MEDICAL-SERVICES; NORTH IRAQ; EXPERIENCE; MORTALITY; INJURIES; CAMBODIA; SYSTEMS; HEALTH	Background: We previously showed that in the absence of a formal emergency system, lay people face a heavy burden of injuries in Kampala, Uganda, and we demonstrated the feasibility of a basic prehospital trauma course for lay people. This study tests the effectiveness of this course and estimates the costs and cost-effectiveness of scaling up this training. Methods and Findings: For six months, we prospectively followed 307 trainees (police, taxi drivers, and community leaders) who completed a one-day basic prehospital trauma care program in 2008. Cross-sectional surveys and fund of knowledge tests were used to measure their frequency of skill and supply use, reasons for not providing aid, perceived utility of the course and kit, confidence in using skills, and knowledge of first-aid. We then estimated the cost-effectiveness of scaling up the program. At six months, 188 (62%) of the trainees were followed up. Their knowledge retention remained high or increased. The mean correct score on a basic fund of knowledge test was 92%, up from 86% after initial training (n = 146 pairs, p = 0.0016). 97% of participants had used at least one skill from the course: most commonly haemorrhage control, recovery position and lifting/moving and 96% had used at least one first-aid item. Lack of knowledge was less of a barrier and trainees were significantly more confident in providing first-aid. Based on cost estimates from the World Health Organization, local injury data, and modelling from previous studies, the projected cost of scaling up this program was $0.12 per capita or $25-75 per life year saved. Key limitations of the study include small sample size, possible reporter bias, preliminary local validation of study instruments, and an indirect estimate of mortality reduction. Conclusions: Lay first-responders effectively retained knowledge on prehospital trauma care and confidently used their first-aid skills and supplies for at least six months. The costs of scaling up this intervention to cover Kampala are very modest. This may be a cost-effective first step toward developing formal emergency services in Uganda other resource-constrained settings. Further research is needed in this critical area of trauma care in low-income countries.			Jayaraman, S (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	dozgediz@hotmail.com	Jayaraman, Sudha/AAH-3059-2019	Jayaraman, Sudha/0000-0003-1094-5836				Aboutanos MB, 2007, J TRAUMA, V62, P714, DOI 10.1097/TA.0b013e318031b56d; [Anonymous], 2000, STRAT PLAN 2000; AYYAZ M, 2008, AM COLL SURG 94 ANN; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Baker R, 1999, JAMA-J AM MED ASSOC, V281, P859, DOI 10.1001/jama.281.9.859; Bishai D, 2008, INJURY PREV, V14, P223, DOI 10.1136/ip.2008.018341; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; GAUTHAM S, 2008, AM COLL SURG 94 ANN; Husum H, 2003, MIL MED, V168, P934, DOI 10.1093/milmed/168.11.934; Husum H, 2003, J TRAUMA, V54, P1188, DOI 10.1097/01.TA.0000073609.12530.19; Husum H, 2003, MED TEACH, V25, P142, DOI 10.1080/0142159031000092526; JAYARAMAN S, 2009, WORLD J SUR IN PRESS; Kobusingye OC, 2000, J TRAUMA, V48, P498, DOI 10.1097/00005373-200003000-00022; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Kobusingye OC, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1261; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Mock C., 2004, GUIDELINES ESSENTIAL; Mock C, 2006, WORLD J SURG, V30, P946, DOI 10.1007/s00268-005-0768-4; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Mock CN, 1997, J TRAUMA, V42, P504, DOI 10.1097/00005373-199703000-00019; Mock CN, 2002, J TRAUMA, V53, P90, DOI 10.1097/00005373-200207000-00018; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P13, DOI 10.1076/icsp.10.1.13.14116; Peden M., 2004, WORLD REPORT ROAD TR; POGGETTI R, 2008, AM COLL SURG 94 ANN; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Roberts I, 2005, BRIT MED J, V331, P1094, DOI 10.1136/bmj.331.7525.1094; Sachs J., 2001, INVESTING HLTH REPOR; Tiska MA, 2004, EMERG MED J, V21, P237, DOI 10.1136/emj.2002.002097; *WHO, 2005, PREH TRAUM CAR SYST; WHO, 2008, WORLD HLTH STAT	31	98	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6955	10.1371/journal.pone.0006955	http://dx.doi.org/10.1371/journal.pone.0006955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759831	Green Published, gold, Green Submitted			2022-12-25	WOS:000269696600007
J	Muller, S; Gotz, M; Beier, D				Mueller, Stefanie; Goetz, Monika; Beier, Dagmar			Histidine Residue 94 Is Involved in pH Sensing by Histidine Kinase ArsS of Helicobacte pylori	PLOS ONE			English	Article								Background: The ArsRS two-component system is the master regulator of acid adaptation in the human gastric pathogen Helicobacter pylori. Low pH is supposed to trigger the autophosphorylation of the histidine kinase ArsS and the subsequent transfer of the phosphoryl group to its cognate response regulator ArsR which then acts as an activator or repressor of pH-responsive genes. Orthologs of the ArsRS two-component system are also present in H. pylori's close relatives H. hepaticus, Campylobacter jejuni and Wolinella succinogenes which are non-gastric colonizers. Methodology/Principal Findings: In order to investigate the mechanism of acid perception by ArsS, derivatives of H. pylori 26695 expressing ArsS proteins with substitutions of the histidine residues present in its periplasmic input domain were constructed. Analysis of pH-responsive transcription of selected ArsRS target genes in these mutants revealed that H94 is relevant for pH sensing, however, our data indicate that protonatable amino acids other than histidine contribute substantially to acid perception by ArsS. By the construction and analysis of H. pylori mutants carrying arsS allels from the related epsilon-proteobacteria we demonstrate that WS1818 of W. succinogenes efficiently responds to acidic pH. Conclusions/Significance: We show that H94 in the input domain of ArsS is crucial for acid perception in H. pylori 26695. In addition our data suggest that ArsS is able to adopt different conformations depending on the degree of protonation of acidic amino acids in the input domain. This might result in different activation states of the histidine kinase allowing a gradual transcriptional response to low pH conditions. Although retaining considerable similarity to ArsS the orthologous proteins of H. hepaticus and C. jejuni may have evolved to sensors of a different environmental stimulus in accordance with the non gastric habitat of these bacteria.			Muller, S (corresponding author), Tech Univ Munich, Lehrstuhl Mikrobiol Okol, D-8050 Freising Weihenstephan, Germany.	d.beier@biozentrum.uni-wuerzburg.de						Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Beier D, 2000, J BACTERIOL, V182, P2068, DOI 10.1128/JB.182.8.2068-2076.2000; Beier D, 1997, J BACTERIOL, V179, P4676, DOI 10.1128/jb.179.15.4676-4683.1997; Belzer C, 2005, MICROBIOL-SGM, V151, P3989, DOI 10.1099/mic.0.28188-0; Bijlsma JJE, 1998, FEMS MICROBIOL LETT, V167, P309, DOI 10.1111/j.1574-6968.1998.tb13244.x; Bijlsma JJE, 2000, J INFECT DIS, V182, P1566, DOI 10.1086/315855; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Contreras M, 2003, MOL MICROBIOL, V49, P947, DOI 10.1046/j.1365-2958.2003.03621.x; Dietz P, 2002, J BACTERIOL, V184, P350, DOI 10.1128/JB.184.2.350-362.2002; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Ge ZM, 2008, MICROB PATHOGENESIS, V45, P18, DOI 10.1016/j.micpath.2008.02.003; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Loh JT, 2006, INFECT IMMUN, V74, P3052, DOI 10.1128/IAI.74.5.3052-3059.2006; Marcus EA, 2005, J BACTERIOL, V187, P729, DOI 10.1128/JB.187.2.729-738.2005; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Mollenhauer-Rektorschek M, 2002, RES MICROBIOL, V153, P659, DOI 10.1016/S0923-2508(02)01380-3; Muller S, 2007, MICROBIOL RES, V162, P1, DOI 10.1016/j.micres.2006.01.003; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Panthel K, 2003, INFECT IMMUN, V71, P5381, DOI 10.1128/IAI.71.9.5381-5385.2003; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Pflock M, 2005, INFECT IMMUN, V73, P6437, DOI 10.1128/IAI.73.10.6437-6445.2005; Pflock M, 2004, FEMS MICROBIOL LETT, V234, P51, DOI 10.1016/j.femsle.2004.03.023; Pflock M, 2007, CURR MICROBIOL, V54, P320, DOI 10.1007/s00284-006-0520-9; Pflock M, 2006, J BACTERIOL, V188, P3449, DOI 10.1128/JB.188.10.3449-3462.2006; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Sachs G, 2005, PHYSIOLOGY, V20, P429, DOI 10.1152/physiol.00032.2005; Scott DR, 2000, INFECT IMMUN, V68, P470, DOI 10.1128/IAI.68.2.470-477.2000; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Suerbaum S, 2003, P NATL ACAD SCI USA, V100, P7901, DOI 10.1073/pnas.1332093100; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Waidner B, 2005, J BACTERIOL, V187, P4683, DOI 10.1128/JB.187.13.4683-4688.2005; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Weeks DL, 2001, MOL MICROBIOL, V40, P1249, DOI 10.1046/j.1365-2958.2001.02466.x; Wen Y, 2006, J BACTERIOL, V188, P1750, DOI 10.1128/JB.188.5.1750-1761.2006; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wen Y, 2007, J BACTERIOL, V189, P2426, DOI 10.1128/JB.01492-06; Wen Y, 2009, J BACTERIOL, V191, P449, DOI 10.1128/JB.01219-08; XIANG ZY, 1995, INFECT IMMUN, V63, P94, DOI 10.1128/IAI.63.1.94-98.1995	46	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6930	10.1371/journal.pone.0006930	http://dx.doi.org/10.1371/journal.pone.0006930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19759826	Green Submitted, Green Published, gold			2022-12-25	WOS:000269622300014
J	Ge, Z; Li, WJ; Wang, N; Liu, C; Zhu, QJ; Bjorkholm, M; Gruber, A; Xu, DW				Ge, Zheng; Li, Wenjuan; Wang, Na; Liu, Cheng; Zhu, Qingjun; Bjorkholm, Magnus; Gruber, Astrid; Xu, Dawei			Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase	FASEB JOURNAL			English	Article						HDM; MYC/MAX/MAD; hTERT; differentiation; E-box; immortalization	HTERT GENE; C-MYC; HUMAN CANCER; HUMAN-CELLS; DEACETYLASE INHIBITOR; MOLECULAR-MECHANISMS; DNA METHYLATION; HL60 CELLS; EXPRESSION; PROMOTER	The Myc/Max/Mad network transcription factors are known to govern target gene expression through recruiting histone acetyltransferases or deacetylases. In the present study, we show that Mad1 recruits the histone demethylase RBP2 to the Myc target telomerase reverse transcriptase (hTERT) gene promoter to repress transcription. With differentiation of leukemic HL60 cells, Mad1 and RBP2 were both up-regulated, interacted, and cooccupied the hTERT promoter accompanied by histone H3-K4 demethylation. In immortalized p493-6 B cells, shutting down c-Myc led to the accumulation of Mad1 and RBP2 at hTERT promoter and diminished hTERT mRNA expression. When RBP2 was depleted, hTERT expression was significantly enhanced, coupled with dissociation of RBP2 with and increased H3-K4 methylation at the hTERT promoter in p493-6 cells. Moreover, RBP2 and Mad1 were present on the hTERT promoter in human fibroblasts having a silent hTERT gene, and RBP2 depletion resulted in gene derepression. Taken together, Mad1 recruits RBP2 to the hTERT promoter that, in turn, demethylates H3-K4, thereby contributing to a stable repression of the hTERT gene in normal or differentiated malignant cells. Our findings reveal a novel mechanism through which the Myc/Max/Mad network proteins control their target gene transcription and provide insights into mechanisms underlying telomerase silencing and activation.-Ge, Z., Li, W., Wang, N., Liu, C., Zhu, Q., Bjorkholm, M., Gruber, A., Xu, D. Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. FASEB J. 24, 579-586 (2010). www.fasebj.org	[Ge, Zheng; Li, Wenjuan; Wang, Na; Liu, Cheng; Zhu, Qingjun; Bjorkholm, Magnus; Gruber, Astrid; Xu, Dawei] Karolinska Univ Hosp Solna, Ctr Hematol, Dept Med, Stockholm, Sweden; [Ge, Zheng; Li, Wenjuan; Wang, Na; Liu, Cheng; Zhu, Qingjun; Bjorkholm, Magnus; Gruber, Astrid; Xu, Dawei] Karolinska Inst, Stockholm, Sweden; [Li, Wenjuan] Shandong Univ, Sch Med, Dept Microbiol, Jinan 250100, Peoples R China; [Zhu, Qingjun] Shandong Univ Tradit Chinese Med, Coll Basic Med Sci, Jinan, Peoples R China	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Shandong University; Shandong University of Traditional Chinese Medicine	Xu, DW (corresponding author), Karolinska Univ Hosp, CMM, L8 00, S-17176 Stockholm, Sweden.	dawei.xu@ki.se		Xu, Dawei/0000-0003-3141-4524	Swedish Cancer Society; Swedish Research Council; Cancer Society in Stockholm; Swedish Society of Medicine; Sven & Ebba-Christina Hagbergs Foundation; Karolinska Institute	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Swedish Society of Medicine; Sven & Ebba-Christina Hagbergs Foundation; Karolinska Institute(Karolinska Institutet)	We thank Margareta Andersson and Yiteng Xu for technical assistance, Dr. D. Eick (GSF Research Centre, Munich, Germany) for the p493-6 cell line, Dr. S. Kyo ( Kanazawa University, Kanazawa, Japan) for the hTERT reporter plasmids, and Drs. P. A. Cloos and K. Helin ( University of Copenhagen, Copenhagen, Denmark) for the RBP2 plasmids. This work was supported by the grants from the Swedish Cancer Society, the Swedish Research Council, the Cancer Society in Stockholm, the Swedish Society of Medicine, the Sven & Ebba-Christina Hagbergs Foundation, and the Karolinska Institute.	Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cassar L, 2009, FASEB J, V23, P1880, DOI 10.1096/fj.08-119529; Cerezo A, 2002, J CELL SCI, V115, P1305; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cole MD, 2006, SEMIN CANCER BIOL, V16, P241, DOI 10.1016/j.semcancer.2006.08.003; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guilleret I, 2003, EXP CELL RES, V289, P326, DOI 10.1016/S0014-4827(03)00281-7; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Gunes C, 2000, CANCER RES, V60, P2116; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Hou M, 2002, EXP CELL RES, V274, P25, DOI 10.1006/excr.2001.5462; Jalink M, 2007, BIOCHEM BIOPH RES CO, V353, P999, DOI 10.1016/j.bbrc.2006.12.149; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kumakura S, 2005, CANCER RES, V65, P2778, DOI 10.1158/0008-5472.CAN-04-1819; Lai SR, 2005, FRONT BIOSCI-LANDMRK, V10, P1779, DOI 10.2741/1661; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Liu C, 2007, CANCER RES, V67, P2626, DOI 10.1158/0008-5472.CAN-06-4126; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; Ogretmen B, 2001, J BIOL CHEM, V276, P32506, DOI 10.1074/jbc.M101350200; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Sharma HW, 1995, P NATL ACAD SCI USA, V92, P12343, DOI 10.1073/pnas.92.26.12343; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xu D, 1996, LEUKEMIA, V10, P1354; Xu D, 1999, BRIT J CANCER, V80, P1156, DOI 10.1038/sj.bjc.6690480; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Xu DW, 1998, BRIT J HAEMATOL, V102, P1367, DOI 10.1046/j.1365-2141.1998.00969.x; Xu DW, 2001, P NATL ACAD SCI USA, V98, P3826, DOI 10.1073/pnas.071043198; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	54	42	43	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					579	586		10.1096/fj.09-140087	http://dx.doi.org/10.1096/fj.09-140087			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19762557				2022-12-25	WOS:000274045000025
J	Puklin-Faucher, E; Vogel, V				Puklin-Faucher, Eileen; Vogel, Viola			Integrin Activation Dynamics between the RGD-binding Site and the Headpiece Hinge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATCH BONDS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; A-DOMAIN; EXTRACELLULAR SEGMENT; LIGAND RECOGNITION; STRUCTURAL BASIS; HYBRID DOMAIN; FORCE; ALPHA(5)BETA(1)	Integrins form mechanical links between the extracellular matrix and the cytoskeleton. Although integrin activation is known to be regulated by an allosteric conformational change, which can be induced from the extracellular or intracellular end of the molecule, little is known regarding the sequence of structural events by which signals propagate between distant sites. Here, we reveal with molecular dynamics simulations of the FnIII(10)-bound alpha(V)beta(3) integrin headpiece how the binding pocket and interdomain beta A/hybrid domain hinge on the distal end of the beta A domain are allosterically linked via a hydrophobic T-junction between the middle of the alpha 1 helix and top of the alpha 7 helix. The key results of this study are: 1) that this T-junction is induced by ligand binding and hinge opening, and thus displays bidirectionality; 2) that formation of this junction can be accelerated by ligand-mediated force; and 3) how formation of this junction is inhibited by Ca2+ in place of Mg2+ at the site adjacent to the metal ion-dependent adhesion site ("ADMIDAS"). Together with recent experimental evidence that integrin complexes can form catch bonds (i.e. become strengthened under force), as well as earlier evidence that Ca2+ at the ADMIDAS results in lower binding affinity, these simulations provide a common structural model for the dynamic process by which integrins become activated.	[Puklin-Faucher, Eileen; Vogel, Viola] ETH, Lab Biologically Oriented Mat, Dept Mat, CH-8049 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Vogel, V (corresponding author), ETH, Lab Biologically Oriented Mat, Dept Mat, CH-8049 Zurich, Switzerland.	viola.vogel@mat.ethz.ch	Vogel, Viola/O-8025-2015	Vogel, Viola/0000-0003-2898-7671	ETH Zurich; Swiss National Supercomputing Center (CSCS, ALPS Project); National Institutes of Health Roadmap for Medical Research [PN2 EY016586]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Supercomputing Center (CSCS, ALPS Project); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by ETH Zurich, the Swiss National Supercomputing Center (CSCS, ALPS Project), and National Institutes of Health Roadmap for Medical Research Grant PN2 EY016586 to the Nanotechnology Center for Mechanics in Regenerative Medicine.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Luque I, 2000, PROTEINS, P63; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marinelli L, 2003, J MED CHEM, V46, P4393, DOI 10.1021/jm020577m; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wriggers W, 1997, PROTEINS, V29, P1; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	44	49	52	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36557	36568		10.1074/jbc.M109.041194	http://dx.doi.org/10.1074/jbc.M109.041194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19762919	Green Published, hybrid			2022-12-25	WOS:000272970500057
J	Yamada, H; Padilla-Parra, S; Park, SJ; Itoh, T; Chaineau, M; Monaldi, I; Cremona, O; Benfenati, F; De Camilli, P; Coppey-Moisan, M; Tramier, M; Galli, T; Takei, K				Yamada, Hiroshi; Padilla-Parra, Sergi; Park, Sun-Joo; Itoh, Toshiki; Chaineau, Mathilde; Monaldi, Ilaria; Cremona, Ottavio; Benfenati, Fabio; De Camilli, Pietro; Coppey-Moisan, Maite; Tramier, Marc; Galli, Thierry; Takei, Kohji			Dynamic Interaction of Amphiphysin with N-WASP Regulates Actin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; XENOPUS EGG EXTRACTS; MEMBRANE CURVATURE; ARP2/3 COMPLEX; PROTEIN AMPHIPHYSIN; WIP COMPLEX; LIVE CELLS; DOMAINS; CYTOSKELETON; CDC42	Amphiphysin 1, an endocytic adaptor concentrated at synapses that couples clathrin-mediated endocytosis to dynamin-dependent fission, was also shown to have a regulatory role in actin dynamics. Here, we report that amphiphysin 1 interacts with N-WASP and stimulates N-WASP- and Arp2/3-dependent actin polymerization. Both the Src homology 3 and the N-BAR domains are required for this stimulation. Acidicliposome-triggered, N-WASP dependent actin polymerization is strongly impaired in brain cytosol of amphiphysin 1 knock-out mice. FRET-FLIM analysis of Sertoli cells, where endogenously expressed amphiphysin 1 co-localizes with N-WASP in peripheral ruffles, confirmed the association between the two proteins in vivo. This association undergoes regulation and is enhanced by stimulating phosphatidylserine receptors on the cell surface with phosphatidylserine-containing liposomes that trigger ruffle formation. These results indicate that actin regulation is a key function of amphiphysin 1 and that such function cooperates with the endocytic adaptor role and membrane shaping/curvature sensing properties of the protein during the endocytic reaction.	[Yamada, Hiroshi; Takei, Kohji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Kita Ku, Okayama 7008558, Japan; [Padilla-Parra, Sergi; Chaineau, Mathilde; Coppey-Moisan, Maite; Tramier, Marc; Galli, Thierry] Univ Paris Diderot, Inst Jacques Monod, UMR 7592, CNRS, F-75205 Paris 13, France; [Padilla-Parra, Sergi; Chaineau, Mathilde; Coppey-Moisan, Maite; Tramier, Marc; Galli, Thierry] Univ Paris 06, F-75205 Paris 13, France; [Park, Sun-Joo] Kobe Univ, Grad Sch Med, Div Lipid Biochem, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Park, Sun-Joo] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea; [Itoh, Toshiki] Kobe Univ, Grad Sch Med, Div Membrane Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Chaineau, Mathilde; Galli, Thierry] Univ Paris 06, INSERM, U950, F-75013 Paris, France; [Monaldi, Ilaria; Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Monaldi, Ilaria; Benfenati, Fabio] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Monaldi, Ilaria; Benfenati, Fabio] Ist Nazl Neurosci, I-16132 Genoa, Italy; [Cremona, Ottavio] Univ Vita Salute San Raffaele, Cancro Inst Mol Oncol, Fdn Italiana Ric, I-20141 Milan, Italy; [Cremona, Ottavio] Ist Nazl Neurosci, I-20141 Milan, Italy; [De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol & Neurobiol, New Haven, CT 06510 USA	Okayama University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Kobe University; Pukyong National University; Kobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Istituto Italiano di Tecnologia - IIT; University of Genoa; Vita-Salute San Raffaele University; Howard Hughes Medical Institute; Yale University	Takei, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kohji@md.okayama-u.ac.jp	YAMADA, Hiroshi/B-2251-2011; Cremona, Ottavio/AAB-8793-2019; Yamada, Hiroshi/AGZ-4497-2022	YAMADA, Hiroshi/0000-0002-9328-3446; Cremona, Ottavio/0000-0001-9462-1040; Yamada, Hiroshi/0000-0002-9328-3446; Padilla-Parra, Sergi/0000-0002-8010-9481; Tramier, Marc/0000-0001-8200-6446; Coppey-Moisan, Maite/0000-0002-6246-4973; Galli, Thierry/0000-0001-8514-7455; Takei, Kohji/0000-0002-6555-9425	National Institutes of Health; Ministry of Education, Science, Sports, and Culture of Japan; United States-Japan Brain Research Collaborative; INSERM; INSERM-Japan Society for the Promotion of Science; Foundation pour la Recherche Medicale; CNRS; European Union-Marie-Curie [MRTN-CT-2005-019481]; Ministero dell'Istruzione, dell'Universita e della Ricerca (Italy); Compagnia di San Paolo, Torino, Italy; Ministry of Education, Science, and Technology [2009-0065739]; Fondazione Telethon Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); United States-Japan Brain Research Collaborative; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM-Japan Society for the Promotion of Science; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union-Marie-Curie(European Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca (Italy)(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Fondazione Telethon(Fondazione Telethon)	This work was supported, in whole or in part, by a National Institutes of Health grant (to P.D.C.). This work was also supported in part by grants from the Ministry of Education, Science, Sports, and Culture of Japan, a grant from the United States-Japan Brain Research Collaborative (to K. T.), grants from INSERM (to T.G.), an INSERM-Japan Society for the Promotion of Science grant (to K. T. and T. G.), grants from Foundation pour la Recherche Medicale and from CNRS ( to M. C. M.), European Union-Marie-Curie Fellowship MRTN-CT-2005-019481 (to S. P. P.), grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (Italy) (to F.B. and O.C.), grants from Compagnia di San Paolo, Torino, Italy (to F. B.), and by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant 2009-0065739 (to S.P.).	Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; DECAMILLI P, 1993, J EXP MED, V178, P2219, DOI 10.1084/jem.178.6.2219; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kamitani A, 2002, BIOCHEM BIOPH RES CO, V294, P261, DOI 10.1016/S0006-291X(02)00470-9; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kinuta M, 2002, P NATL ACAD SCI USA, V99, P2842, DOI 10.1073/pnas.261715599; Lebensohn AM, 2006, METHOD ENZYMOL, V406, P156, DOI 10.1016/S0076-6879(06)06013-7; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Ma L, 1998, J CELL BIOL, V140, P1125; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mundigl O, 1998, J NEUROSCI, V18, P93; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Otsuki M, 2003, J BIOL CHEM, V278, P6461, DOI 10.1074/jbc.M207433200; Padilla-Parra S, 2008, BIOPHYS J, V95, P2976, DOI 10.1529/biophysj.108.131276; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Park SJ, 2005, EMBO J, V24, P1557, DOI 10.1038/sj.emboj.7600586; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Watanabe M, 2001, BIOCHEM BIOPH RES CO, V287, P739, DOI 10.1006/bbrc.2001.5650; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Yamada H, 2007, MOL BIOL CELL, V18, P4669, DOI 10.1091/mbc.E07-04-0296; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	44	46	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34244	34256		10.1074/jbc.M109.064204	http://dx.doi.org/10.1074/jbc.M109.064204			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19759398	Green Published, hybrid			2022-12-25	WOS:000272165200056
J	Orgaz, JL; Ladhani, O; Hoek, KS; Fernandez-Barral, A; Mihic, D; Aguilera, O; Seftor, EA; Bernad, A; Rodriguez-Peralto, JL; Hendrix, MJC; Volpert, OV; Jimenez, B				Orgaz, J. L.; Ladhani, O.; Hoek, K. S.; Fernandez-Barral, A.; Mihic, D.; Aguilera, O.; Seftor, E. A.; Bernad, A.; Rodriguez-Peralto, J. L.; Hendrix, M. J. C.; Volpert, O. V.; Jimenez, B.			'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'	ONCOGENE			English	Article						PEDF; melanoma progression; vasculogenic mimicry; anti-angiogenic factors	CEREBELLAR GRANULE NEURONS; DOWN-REGULATION; FACTOR PEDF; NEUROTROPHIC ACTIVITY; RETINOBLASTOMA CELLS; ENDOTHELIAL-CELLS; MOTOR-NEURONS; ANGIOGENESIS; EXPRESSION; IDENTIFICATION	Pigment epithelium-derived factor (PEDF) is a multifunctional secreted glycoprotein that displays broad antitumor activity based on dual targeting of the tumor microenvironment (anti-angiogenic action) and the tumor cells (direct anti-tumor action). Here, we show that PEDF expression is high in melanocytes, but it is lost during malignant progression of human melanoma. Using a high-throughput analysis of the data from microarray studies of molecular profiling of human melanoma, we found that PEDF expression is lost in highly invasive melanomas. In paired cell lines established from the same lesion but representing the high and low extremes of malignant potential, abundant PEDF expression was restricted to the poorly aggressive counterparts. We used RNA interference to directly address the functional consequences of PEDF silencing. PEDF knockdown in poorly aggressive melanoma cell lines augmented migration, invasion and vasculogenic mimicry, which translated into an increased in vivo metastatic potential. PEDF interference also significantly enhanced the migratory and invasive capability of normal melanocytes and moderately increased their proliferative potential. Our results show that loss of PEDF enables melanoma cells to acquire an invasive phenotype and, therefore, modulation of this multifunctional factor could be critical for the malignant progression of human melanoma. Oncogene (2009) 28, 4147-4161; doi: 10.1038/onc.2009.284; published online 21 September 2009	[Orgaz, J. L.; Fernandez-Barral, A.; Aguilera, O.; Jimenez, B.] Univ Autonoma Madrid, Dept Biochem, Inst Invest Biomed, CSIC, Madrid 28029, Spain; [Ladhani, O.; Volpert, O. V.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hoek, K. S.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Mihic, D.] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Seftor, E. A.; Hendrix, M. J. C.] Northwestern Univ, Childrens Mem Res Ctr, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Bernad, A.] Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid, Spain; [Rodriguez-Peralto, J. L.] Hosp Univ 12 Octubre Madrid, Dept Pathol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Universitario 12 de Octubre	Jimenez, B (corresponding author), Univ Autonoma Madrid, Dept Biochem, Inst Invest Biomed, CSIC, Arturo Duperier 4, Madrid 28029, Spain.	bjimenez@iib.uam.es	Fernández-Barral, Asunión/O-8133-2015; Orgaz, Jose L./ABH-1835-2020; Cuenca, Benilde Jimenez/K-9959-2014	Fernández-Barral, Asunión/0000-0002-1278-4645; Orgaz, Jose L./0000-0002-9776-7544; Bernad, Antonio/0000-0003-0620-9668; Jimenez Cuenca, Benilde/0000-0002-1806-6636; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153	Ministerio de Educacion y Ciencia [SAF2007-62292]; Comunidad de Madrid [SAL-0311-2006]; NIH [RO1 HL68033, CA59702]; NIH/NCI [T32CA009560]; Fernandez-Barral by a Consejo Superior de Investigaciones Cientificas fellowship; NATIONAL CANCER INSTITUTE [T32CA009560, R01CA059702, R37CA059702] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068033, R01HL077471] Funding Source: NIH RePORTER	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fernandez-Barral by a Consejo Superior de Investigaciones Cientificas fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge with gratitude all researchers that contributed with cell lines: M Herlyn, PF Penas, F Vidal-Vanaclocha, GN Van Muijen, AM Valverde, M Garcia and M del Rio. We also thank P Fernandez for her technical assistance in lentivirus production. Supported by grants: Ministerio de Educacion y Ciencia grant SAF2007-62292 (BJ), Comunidad de Madrid SAL-0311-2006 (BJ), NIH grant RO1 HL68033 (OV), NIH merit grant CA59702 (MJCH). JL Orgaz has been supported by a Ministerio de Educacion y Ciencia fellowship, O Ladhani by an NIH/NCI training grant T32CA009560 and A Fernandez-Barral by a Consejo Superior de Investigaciones Cientificas fellowship.	Abramson LP, 2003, J PEDIATR SURG, V38, P336, DOI 10.1053/jpsu.2003.50104; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Becerra SP, 1997, ADV EXP MED BIOL, V425, P223; Beitzinger M, 2008, EMBO J, V27, P792, DOI 10.1038/emboj.2008.13; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; BOUCK N, 1990, CANCER CELL-MON REV, V2, P179; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Diaz R, 2008, INT J CANCER, V123, P1060, DOI 10.1002/ijc.23619; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; Fernandez-Garcia NI, 2007, J MOL MED-JMM, V85, P15, DOI 10.1007/s00109-006-0111; Fernandez-Garcia NI, 2005, ONCOGENE, V24, P6533, DOI 10.1038/sj.onc.1208801; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Garcia M, 2004, CANCER RES, V64, P5632, DOI 10.1158/0008-5472.CAN-04-0230; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277; Halin S, 2004, CANCER RES, V64, P5664, DOI 10.1158/0008-5472.CAN-04-0835; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Li G, 2001, CANCER RES, V61, P3819; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Notari L, 2005, INVEST OPHTH VIS SCI, V46, P2736, DOI 10.1167/iovs.04-1489; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Punzon I, 2004, BLOOD, V103, P580, DOI 10.1182/blood-2003-07-2298; Quan GMY, 2005, CALCIFIED TISSUE INT, V76, P146, DOI 10.1007/s00223-004-0068-2; Sasaki Y, 2005, ONCOGENE, V24, P5131, DOI 10.1038/sj.onc.1208695; Sato S, 2001, PIGM CELL RES, V14, P428, DOI 10.1034/j.1600-0749.2001.140602.x; Sawant S, 2004, BIOCHEM BIOPH RES CO, V325, P408, DOI 10.1016/j.bbrc.2004.10.041; Seftor EA, 2005, CANCER RES, V65, P10164, DOI 10.1158/0008-5472.CAN-05-2497; SEIGEL GM, 1994, GROWTH FACTORS, V10, P289, DOI 10.3109/08977199409010995; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Uehara H, 2004, CANCER RES, V64, P3533, DOI 10.1158/0008-5472.CAN-03-3725; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yamagishi SI, 2004, J MOL CELL CARDIOL, V37, P497, DOI 10.1016/j.yjmcc.2004.04.007; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474	48	59	61	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 26	2009	28	47					4147	4161		10.1038/onc.2009.284	http://dx.doi.org/10.1038/onc.2009.284			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DQ	19767774	Green Accepted			2022-12-25	WOS:000272876100002
J	Vembar, SS; Jin, Y; Brodsky, JL; Hendershot, LM				Vembar, Shruthi S.; Jin, Yi; Brodsky, Jeffrey L.; Hendershot, Linda M.			The Mammalian Hsp40 ERdj3 Requires Its Hsp70 Interaction and Substrate-binding Properties to Complement Various Yeast Hsp40-dependent Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; POSTTRANSLATIONAL PROTEIN TRANSLOCATION; CELL-WALL INTEGRITY; ER DNAJ HOMOLOG; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; MOLECULAR CHAPERONE; CO-CHAPERONE; PLASMODIUM-FALCIPARUM	Heat shock proteins of 70 kDa (Hsp70s) and their J domain-containing Hsp40 cofactors are highly conserved chaperone pairs that facilitate a large number of cellular processes. The observation that each Hsp70 partners with many J domain-containing proteins (JDPs) has led to the hypothesis that Hsp70 function is dictated by cognate JDPs. If this is true, one might expect highly divergent Hsp70-JDP pairs to be unable to function in vivo. However, we discovered that, when a yeast cytosolic JDP, Ydj1, was targeted to the mammalian endoplasmic reticulum (ER), it interacted with the ER-lumenal Hsp70, BiP, and bound to BiP substrates. Conversely, when a mammalian ER-lumenal JDP, ERdj3, was directed to the yeast cytosol, it rescued the temperature-sensitive growth phenotype of yeast-containing mutant alleles in two cytosolic JDPs, HLJ1 and YDJ1, and activated the ATP hydrolysis rate of Ssa1, the yeast cytosolic Hsp70 that partners with Hlj1 and Ydj1. Surprisingly, ERdj3 mutants that were compromised for substrate binding were unable to rescue the hlj1ydj1 growth defect even though they stimulated the ATPase activity of Ssa1. Yet, J domain mutants of ERdj3 that were defective for interaction with Ssa1 restored the growth of hlj1ydj1 yeast. Taken together, these data suggest that the substrate binding properties of certain JDPs, not simply the formation of unique Hsp70-JDP pairs, are critical to specify in vivo function.	[Jin, Yi; Hendershot, Linda M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Vembar, Shruthi S.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Jin, Yi; Hendershot, Linda M.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center	Hendershot, LM (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018; Vembar, Shruthi Sridhar/AAE-2479-2019	Hendershot, Linda/0000-0002-5473-0274; 	National Institutes of Health [GM75061, GM54068]; Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, R01GM054068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM75061 (to J. L. B.) and GM54068 (to L. M. H.). This work was supported by Cancer Center CORE Grant CA21765 and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital (to L. M. H.).	Becker J, 1996, MOL CELL BIOL, V16, P4378; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CAPLAN AJ, 1995, J BIOL CHEM, V270, P5251, DOI 10.1074/jbc.270.10.5251; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; CYR DM, 1992, J BIOL CHEM, V267, P20927; Fliss AE, 1999, J BIOL CHEM, V274, P34045, DOI 10.1074/jbc.274.48.34045; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; Marcus NY, 2007, ARCH BIOCHEM BIOPHYS, V468, P147, DOI 10.1016/j.abb.2007.10.001; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Nicoll WS, 2007, INT J BIOCHEM CELL B, V39, P736, DOI 10.1016/j.biocel.2006.11.006; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; Oka M, 1998, J BIOL CHEM, V273, P29727, DOI 10.1074/jbc.273.45.29727; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Shaner L, 2008, CURR GENET, V54, P1, DOI 10.1007/s00294-008-0193-y; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Wright CM, 2007, GENETICS, V175, P1649, DOI 10.1534/genetics.106.066274; Yang XX, 2006, FEMS YEAST RES, V6, P195, DOI 10.1111/j.1567-1364.2006.00026.x; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	66	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32462	32471		10.1074/jbc.M109.000729	http://dx.doi.org/10.1074/jbc.M109.000729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19748898	Green Published, hybrid			2022-12-25	WOS:000272028400029
J	Wen, DY; Vecchi, MM; Gu, S; Su, LH; Dolnikova, J; Huang, YM; Foley, SF; Garber, E; Pederson, N; Meier, W				Wen, Dingyi; Vecchi, Malgorzata M.; Gu, Sheng; Su, Lihe; Dolnikova, Jana; Huang, Yao-Ming; Foley, Susan F.; Garber, Ellen; Pederson, Nels; Meier, Werner			Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AMINO-ACIDS; CODON; MISTRANSLATION; GENE; STARVATION; BINDING	Misincorporation of amino acids in proteins expressed in Escherichia coli has been well documented but not in proteins expressed in mammalian cells under normal recombinant protein production conditions. Here we report for the first time that Ser can be incorporated at Asn positions in proteins expressed in Chinese hamster ovary cells. This misincorporation was discovered as a result of intact mass measurement, peptide mapping analysis, and tandem mass spectroscopy sequencing. Our analyses showed that the substitution was not related to specific protein molecules or DNA codons and was not site-specific. We believe that the incorporation of Ser at sites coded for Asn was due to mischarging of tRNA(Asn) rather than to codon misreading. The rationale for substitution of Asn by Ser and not by other amino acids is also discussed. Further investigation indicated that the substitution was due to the starvation for Asn in the cell culture medium and that the substitution could be limited by using the Asn-rich feed. These observations demonstrate that the quality of expressed proteins should be closely monitored when altering cell culture conditions.	[Wen, Dingyi; Vecchi, Malgorzata M.; Gu, Sheng; Su, Lihe; Dolnikova, Jana; Huang, Yao-Ming; Foley, Susan F.; Garber, Ellen; Pederson, Nels; Meier, Werner] Biogen Idec Inc, Cambridge, MA 02412 USA	Biogen	Wen, DY (corresponding author), Biogen Idec Inc, 14 Cambridge Ctr, Cambridge, MA 02412 USA.	dingyi.wen@biogenidec.com		Huang, Yao-ming/0000-0002-7895-0167				An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; ANDRULIS IL, 1979, J BIOL CHEM, V254, P629; Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; ARFIN SM, 1977, P NATL ACAD SCI USA, V74, P2367, DOI 10.1073/pnas.74.6.2367; BARKER DG, 1979, J MOL BIOL, V133, P217, DOI 10.1016/0022-2836(79)90531-X; Berthet-Colominas C, 1998, EMBO J, V17, P2947, DOI 10.1093/emboj/17.10.2947; Birch JR, 2006, ADV DRUG DELIVER REV, V58, P671, DOI 10.1016/j.addr.2005.12.006; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; George E, 1989, Med J Malaysia, V44, P259; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Jnaoui K, 2002, J VIROL, V76, P8138, DOI 10.1128/JVI.76.16.8138-8147.2002; JOHNSTON TC, 1984, MOL GEN GENET, V195, P459, DOI 10.1007/BF00341447; Kaye EM, 1997, J CHILD NEUROL, V12, P242, DOI 10.1177/088307389701200404; Klannemark M, 2000, DIABETIC MED, V17, P599, DOI 10.1046/j.1464-5491.2000.00343.x; LAGERKVIST U, 1978, P NATL ACAD SCI USA, V75, P1759, DOI 10.1073/pnas.75.4.1759; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Low D, 2007, J CHROMATOGR B, V848, P48, DOI 10.1016/j.jchromb.2006.10.033; LUSTIG F, 1981, J BIOL CHEM, V256, P2635; Mascarenhas A. P., 2009, V22, P155; McClendon CL, 2006, PROTEIN ENG DES SEL, V19, P195, DOI 10.1093/protein/gzl001; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; PARKER J, 1980, MOL GEN GENET, V177, P439, DOI 10.1007/BF00271482; PARKER J, 1983, J BIOL CHEM, V258, P7; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; PARKER J, 1978, P NATL ACAD SCI USA, V75, P1091, DOI 10.1073/pnas.75.3.1091; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; PRECUP J, 1987, J BIOL CHEM, V262, P11351; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; ROSENBERGER RF, 1991, MUTAT RES, V256, P255, DOI 10.1016/0921-8734(91)90016-5; ROSENBERGER RF, 1993, TRENDS BIOTECHNOL, V11, P498, DOI 10.1016/0167-7799(93)90027-7; ROSENBERGER RF, 1994, DEV BIOL STAND, V83, P21; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Sankaranarayanan R, 2001, ACTA BIOCHIM POL, V48, P323; SANTOS MAS, 1993, TRENDS BIOTECHNOL, V11, P500, DOI 10.1016/0167-7799(93)90028-8; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; SCORER CA, 1991, NUCLEIC ACIDS RES, V19, P3511, DOI 10.1093/nar/19.13.3511; SEETHARAM R, 1988, BIOCHEM BIOPH RES CO, V155, P518, DOI 10.1016/S0006-291X(88)81117-3; Seewoster T, 1995, APPL MICROBIOL BIOT, V44, P344; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; SPANJAARD RA, 1990, NUCLEIC ACIDS RES, V18, P5031, DOI 10.1093/nar/18.17.5031; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; STANNERS CP, 1978, J CELL PHYSIOL, V95, P125, DOI 10.1002/jcp.1040950202; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Walz R, 2004, NEUROLOGY, V63, P557, DOI 10.1212/01.WNL.0000133400.34423.AD; Wen DY, 2005, BIOCHEMISTRY-US, V44, P16491, DOI 10.1021/bi0517483; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	57	60	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32686	32694		10.1074/jbc.M109.059360	http://dx.doi.org/10.1074/jbc.M109.059360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783658	Green Published, hybrid			2022-12-25	WOS:000272028400052
J	Panja, D; Dagyte, G; Bidinosti, M; Wibrand, K; Kristiansen, AM; Sonenberg, N; Bramham, CR				Panja, Debabrata; Dagyte, Girstaute; Bidinosti, Michael; Wibrand, Karin; Kristiansen, Ase-Marit; Sonenberg, Nahum; Bramham, Clive R.			Novel Translational Control in Arc-dependent Long Term Potentiation Consolidation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; INITIATION-FACTOR 4E; TOP MESSENGER-RNAS; RAT DENTATE GYRUS; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; ACTIN POLYMERIZATION; KINASE; PHOSPHORYLATION	Regulation of translation factor activity plays a major role in protein synthesis-dependent forms of synaptic plasticity. We examined translational control across the critical period of Arc synthesis underlying consolidation of long term potentiation (LTP) in the dentate gyrus of intact, anesthetized rats. LTP induction by high frequency stimulation (HFS) evoked phosphorylation of the cap-binding protein eukaryotic initiation factor 4E (eIF4E) and dephosphorylation of eIF2 alpha on a protracted time course matching the time-window of Arc translation. Local infusion of the ERK inhibitor U0126 inhibited LTP maintenance and Arc protein expression, blocked changes in eIF4E and eIF2 alpha phosphorylation state, and prevented initiation complex (eIF4F) formation. Surprisingly, inhibition of the mTOR protein complex 1 (mTORC1) with rapamycin did not impair LTP maintenance or Arc synthesis nor did it inhibit eIF4F formation or phosphorylation of eIF4E. Rapamycin nonetheless blocked mTOR signaling to p70 S6 kinase and ribosomal protein S6 and inhibited synthesis of components of the translational machinery. Using immunohistochemistry and in situ hybridization, we show that Arc protein expression depends on dual, ERK-dependent transcription and translation. Arc translation is selectively blocked by pharmacological inhibition of mitogen-activated protein kinase-interacting kinase (MNK), the kinase coupling ERK to eIF4E phosphorylation. Furthermore, MNK signaling was required for eIF4F formation. These results support a dominant role for ERK-MNK signaling in control of translational initiation and Arc synthesis during LTP consolidation in the dentate gyrus. In contrast, mTORC1 signaling is activated but nonessential for Arc synthesis and LTP. The work, thus, identifies translational control mechanisms uniquely tuned to Arc-dependent LTP consolidation in live rats.	[Bramham, Clive R.] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Bramham, Clive R.] Univ Bergen, Bergen Mental Hlth Res Ctr, N-5009 Bergen, Norway; [Bidinosti, Michael; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	University of Bergen; University of Bergen; McGill University	Bramham, CR (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	clive.bramham@biomed.uib.no	Bramham, Clive/Q-1854-2018; Panja, Debabrata/E-8595-2010	Bramham, Clive/0000-0001-5958-7115; Panja, Debabrata/0000-0003-4774-1167	Norwegian Research Council; University of Bergen	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Bergen	This work was funded by the Norwegian Research Council and the University of Bergen.	Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Belelovsky K, 2005, EUR J NEUROSCI, V22, P2560, DOI 10.1111/j.1460-9568.2005.04428.x; Belelovsky K, 2009, J NEUROSCI, V29, P7424, DOI 10.1523/JNEUROSCI.3809-08.2009; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bliss TVP, 2007, HIPPOCAMPUS BOOK, P343; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kanhema T, 2006, J NEUROCHEM, V99, P1328, DOI 10.1111/j.1471-4159.2006.04158.x; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly MP, 2003, J NEUROSCI, V23, P6443; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kulla A, 2008, HIPPOCAMPUS, V18, P48, DOI 10.1002/hipo.20366; Larsen MH, 2005, BRAIN RES, V1064, P161, DOI 10.1016/j.brainres.2005.09.039; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Naie K, 2007, EUR J NEUROSCI, V25, P3264, DOI 10.1111/j.1460-9568.2007.05583.x; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; VAZDARJANOVA A, 2002, SOC NEUR ABSTR; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wu J, 2004, NEUROSCIENCE, V123, P507, DOI 10.1016/j.neuroscience.2003.09.013; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200	76	88	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31498	31511		10.1074/jbc.M109.056077	http://dx.doi.org/10.1074/jbc.M109.056077			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19755425	Green Published, hybrid			2022-12-25	WOS:000271572700003
J	Zhang, F; Wu, JX; Yu, XC				Zhang, Feng; Wu, Jiaxue; Yu, Xiaochun			Integrator3, a Partner of Single-stranded DNA-binding Protein 1, Participates in the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC STABILITY; HISTONE H2AX; REPAIR; CHECKPOINT; PHOSPHORYLATION; CHK1; ATR; COMPLEXES; PATHWAYS; RECOMBINATION	Single-stranded DNA-binding protein 1 (SSB1) plays an important role in the DNA damage response and maintenance of genomic stability. Here, by using protein affinity purification, we have identified Integrator3 (INT3) as a novel partner of SSB1. INT3 forms a complex with SSB1 by constitutively interacting with SSB1 regardless of DNA damage. However, following DNA damage, along with SSB1, INT3 relocates to the DNA damage sites and regulates the accumulation of TopBP1 and BRCA1 there. Moreover, INT3 controls DNA damage-induced Chk1 activation and G(2)/M checkpoint activation. In addition, INT3 is involved in homologous recombination repair by regulating Rad51 foci formation following DNA damage. Taken together, these results demonstrate that INT3 plays a key role in the DNA damage response.	[Zhang, Feng; Wu, Jiaxue; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yu, XC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, 109 Zina Pitcher Pl,BSRB 1520, Ann Arbor, MI 48109 USA.	xiayu@umich.edu			National Institutes of Health [CA132755, CA130899]; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	32	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30408	30415		10.1074/jbc.M109.039404	http://dx.doi.org/10.1074/jbc.M109.039404			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19759019	hybrid, Green Published			2022-12-25	WOS:000271090000043
J	Vercoulen, Y; Wehrens, EJ; van Teijlingen, NH; de Jager, W; Beekman, JM; Prakken, BJ				Vercoulen, Yvonne; Wehrens, Ellen J.; van Teijlingen, Nienke H.; de Jager, Wilco; Beekman, Jeffrey M.; Prakken, Berent J.			Human Regulatory T Cell Suppressive Function Is Independent of Apoptosis Induction in Activated Effector T Cells	PLOS ONE			English	Article							TGF-BETA; INTERLEUKIN (IL)-2; FOXP3 EXPRESSION; IL-2; EXPANSION; ARTHRITIS; ANTIBODY; MICE; TH17	Background: CD4(+)CD25(+)FOXP3(+) Regulatory T cells (Treg) play a central role in the immune balance to prevent autoimmune disease. One outstanding question is how Tregs suppress effector immune responses in human. Experiments in mice demonstrated that Treg restrict effector T cell (Teff) responses by deprivation of the growth factor IL-2 through Treg consumption, resulting in apoptosis of Teff. Principal Findings: In this study we investigated the relevance of Teff apoptosis induction to human Treg function. To this end, we studied naturally occurring Treg (nTreg) from peripheral blood of healthy donors, and, to investigate Treg function in inflammation in vivo, Treg from synovial fluid of Juvenile Idiopathic Arthritis (JIA) patients (SF-Treg). Both nTreg and SF-Treg suppress Teff proliferation and cytokine production efficiently as predicted. However, in contrast with murine Treg, neither nTreg nor SF-Treg induce apoptosis in Teff. Furthermore, exogenously supplied IL-2 and IL-7 reverse suppression, but do not influence apoptosis of Teff. Significance: Our functional data here support that Treg are excellent clinical targets to counteract autoimmune diseases. For optimal functional outcome in human clinical trials, future work should focus on the ability of Treg to suppress proliferation and cytokine production of Teff, rather than induction of Teff apoptosis.			Vercoulen, Y (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Dept Pediat Immunol, Utrecht, Netherlands.	y.vercoulen@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014	Beekman, Jeffrey M/0000-0003-4886-3756; de Jager, Wilco/0000-0002-0014-0682; Vercoulen, Yvonne/0000-0002-5060-2603				Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Brandenburg S, 2008, EUR J IMMUNOL, V38, P1643, DOI 10.1002/eji.200737791; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Koenen HJPM, 2003, J IMMUNOL, V171, P6431, DOI 10.4049/jimmunol.171.12.6431; Le Bras S, 2006, J CLIN INVEST, V116, P1473, DOI 10.1172/JCI28880; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Oberle N, 2007, J IMMUNOL, V179, P3578, DOI 10.4049/jimmunol.179.6.3578; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Qiao M, 2007, IMMUNOLOGY, V120, P447, DOI 10.1111/j.1365-2567.2007.02544.x; RAGHAVAN S, 2008, ANN RHEUM DIS; Rodriguez-Palmero M, 2006, J RHEUMATOL, V33, P110; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; Scheffold A, 2007, NAT IMMUNOL, V8, P1285, DOI 10.1038/ni1207-1285; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; van Amelsfort JMR, 2007, ARTHRITIS RHEUM, V56, P732, DOI 10.1002/art.22414; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	40	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7183	10.1371/journal.pone.0007183	http://dx.doi.org/10.1371/journal.pone.0007183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779623	Green Submitted, Green Published, gold			2022-12-25	WOS:000270176200016
J	Lui, G; Manches, O; Angel, J; Molens, JP; Chaperot, L; Plumas, J				Lui, Gabrielle; Manches, Olivier; Angel, Juliette; Molens, Jean-Paul; Chaperot, Laurence; Plumas, Joel			Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells	PLOS ONE			English	Article								Among the different subsets of dendritic cells (DC), plasmacytoid dendritic cells (PDC) play a unique role in secreting large amounts of type I interferons upon viral stimulation, but their efficiency as antigen-presenting cells has not been completely characterized. We show here, by flow cytometry, with human primary blood PDC and with a PDC cell line, that PDC display poor endocytic capacity for soluble or cellular antigens when compared to monocyte-derived myeloid DC. However, immature PDC efficiently take up cellular material from live influenza-exposed cells, subsequently mature and cross-present viral antigens very efficiently to specific CD8+ T cells. Therefore, during viral infection PDC not only secrete immunomodulatory cytokines, but also recognize infected cells and function as antigen cross-presenting cells to trigger the anti-viral immune response.			Lui, G (corresponding author), Univ Grenoble 1, Grenoble, France.	laurence.chaperot@efs.sante.fr	MANCHES, OLIVIER/F-5448-2019; Plumas, Joel/N-2516-2013; chaperot, laurence/N-2927-2013	MANCHES, OLIVIER/0000-0003-4509-2941; chaperot, laurence/0000-0002-1479-9410				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bendriss-Vermare N, 2005, J LEUKOCYTE BIOL, V78, P954, DOI 10.1189/jlb.0704383; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chaperot L, 2001, BLOOD, V97, P3210, DOI 10.1182/blood.V97.10.3210; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Chaperot L, 2004, EUR J IMMUNOL, V34, P418, DOI 10.1002/eji.200324531; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; DALGAARD J, 2005, J LEUKOC BIOL; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; FONTENEAU JF, 2003, BLOOD, V2, P2; Frleta D, 2009, J IMMUNOL, V182, P2766, DOI 10.4049/jimmunol.0801720; Fuchs A, 2005, BLOOD, V106, P2076, DOI 10.1182/blood-2004-12-4802; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jacob MC, 2003, HAEMATOLOGICA, V88, P941; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Kotelkin A, 2003, J VIROL, V77, P9156, DOI 10.1128/JVI.77.17.9156-9172.2003; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; LATZ E, 2004, NAT IMMUNOL; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lui G, 2004, CYTOTHERAPY, V6, P235, DOI 10.1080/14653240410006059; Manches O, 2008, CYTOTHERAPY, V10, P642, DOI 10.1080/14653240802317647; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Moutaftsi M, 2002, BLOOD, V99, P2913, DOI 10.1182/blood.V99.8.2913; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002	58	73	73	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7111	10.1371/journal.pone.0007111	http://dx.doi.org/10.1371/journal.pone.0007111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771163	Green Published, Green Submitted, gold			2022-12-25	WOS:000270154400009
J	Remes, K; Ortega, F; Fierro, I; Joger, U; Kosma, R; Ferrer, JMM; Ide, OA; Maga, A				Remes, Kristian; Ortega, Francisco; Fierro, Ignacio; Joger, Ulrich; Kosma, Ralf; Marin Ferrer, Jose Manuel; Ide, Oumarou Amadou; Maga, Abdoulaye		Project PALDES; Niger Project SNHM	A New Basal Sauropod Dinosaur from the Middle Jurassic of Niger and the Early Evolution of Sauropoda	PLOS ONE			English	Article							SUUWASSEA-EMILIEAE SAUROPODA; MORRISON FORMATION; PHYLOGENETIC-RELATIONSHIPS; MONTANA; ANATOMY; USA; FLAGELLICAUDATA; CETIOSAURUS; SAURISCHIA; OSTEOLOGY	Background: The early evolution of sauropod dinosaurs is poorly understood because of a highly incomplete fossil record. New discoveries of Early and Middle Jurassic sauropods have a great potential to lead to a better understanding of early sauropod evolution and to reevaluate the patterns of sauropod diversification. Principal Findings: A new sauropod from the Middle Jurassic of Niger, Spinophorosaurus nigerensis n. gen. et sp., is the most complete basal sauropod currently known. The taxon shares many anatomical characters with Middle Jurassic East Asian sauropods, while it is strongly dissimilar to Lower and Middle Jurassic South American and Indian forms. A possible explanation for this pattern is a separation of Laurasian and South Gondwanan Middle Jurassic sauropod faunas by geographic barriers. Integration of phylogenetic analyses and paleogeographic data reveals congruence between early sauropod evolution and hypotheses about Jurassic paleoclimate and phytogeography. Conclusions: Spinophorosaurus demonstrates that many putatively derived characters of Middle Jurassic East Asian sauropods are plesiomorphic for eusauropods, while South Gondwanan eusauropods may represent a specialized line. The anatomy of Spinophorosaurus indicates that key innovations in Jurassic sauropod evolution might have taken place in North Africa, an area close to the equator with summer-wet climate at that time. Jurassic climatic zones and phytogeography possibly controlled early sauropod diversification.			Remes, K (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Paleontol, D-5300 Bonn, Germany.	kristian.remes@uni-bonn.de	Tent-Manclus, Jose Enrique/I-1090-2015; Sanz, Jose Luis/O-1421-2019; Ortega, Francisco/K-3255-2015; Ortega, Francisco/B-5760-2009	Tent-Manclus, Jose Enrique/0000-0002-3393-741X; Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X; Chiappe, Luis/0000-0001-9661-0601; Sanz, Jose Luis/0000-0002-5214-5725; Maga, Abdoulaye/0000-0002-4684-217X				Allain R, 2008, GEODIVERSITAS, V30, P345; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Behrensmeyer A.K., 1992, TERRESTRIAL ECOSYSTE, P588; Berman D. S., 1978, B CARNEGIE MUS NAT H, V8, P1; BLAKEY RC, 2004, DETAILED GLOBAL PALE; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P247; CABRERA A, 1947, PALEONTOLOGIA, V12, P1; Casanovas Maria Lourdes, 2001, Paleontologia i Evolucio, V32-33, P99; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; COOPER M R, 1984, Palaeontologia Africana, V25, P203; DONG ZM, 1984, VERTEBRAT PALASIATIC, V22, P69; Galton PM, 2006, GEOL MAG, V143, P905, DOI 10.1017/S0016756806002561; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; HALLAM A, 1994, PALAEOCLIMATES THEIR, P79; Harris JD, 2006, J VERTEBR PALEONTOL, V26, P88, DOI 10.1671/0272-4634(2006)26[88:COOSES]2.0.CO;2; Harris JD, 2004, ACTA PALAEONTOL POL, V49, P197; Harris JD, 2007, GEOBIOS-LYON, V40, P501, DOI 10.1016/j.geobios.2006.02.002; Harris JD, 2006, PALAEONTOLOGY, V49, P1091, DOI 10.1111/j.1475-4983.2006.00577.x; Harris JD, 2006, J SYST PALAEONTOL, V4, P185, DOI 10.1017/S1477201906001805; Hatcher JB., 1903, MEM CARNEGIE MUS, V2, P1; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; HE XL, 1988, MIDDLE JURASSIC DINO, V2, P143; Hennig E., 1924, PALAEONTOGRAPHICA S, V7; Jain S. L., 1996, J PAL SOC INDIA, V41, P1; Janensch W., 1935, PALAEONTOGRAPHICA S7, V7, P147; Janensch W., 1950, PALAEONTOGRAPHICA, V3, P27; Janensch WJ., 1961, PALAEONTOGRAPHICA S, P177; Larson A., 1994, P371; MADDISON DR, 2003, MACCLADE 4 06; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Ouyang H, 1989, ZIGONG DINOSAUR MUSE, V2, P10; Ouyang H, 2002, 1 MAMENCHISAURIAN SK, P111; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; RAATH M A, 1972, Arnoldia (Rhodesia), V5, P1; Rauhut Oliver W.M., 2003, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V6, P173; Rauhut OWM, 2009, PALAEOGEOGR PALAEOCL, V271, P259, DOI 10.1016/j.palaeo.2008.10.019; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Rauhut OWM, 2003, AMEGHINIANA, V40, P425; Rees PM, 2004, J GEOL, V112, P643, DOI 10.1086/424577; Rees PM, 2000, WARM CLIMATES EARTH, P297, DOI [DOI 10.1017/CB09780511564512.011, 10.1017/CBO9780511564512.011]; REMES K, 2008, EVOLUTION PECTORAL G, P355; Remes K, 2006, J VERTEBR PALEONTOL, V26, P651, DOI 10.1671/0272-4634(2006)26[651:ROTTSD]2.0.CO;2; Remes K, 2008, J VERTEBR PALEONTOL, V28, p131A; Rich Thomas H., 1999, National Science Museum Monographs, V15, P61; Russell Dale E., 1995, Historical Biology, V10, P3; Salgado Leonardo, 1992, Ameghiniana, V29, P337; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sellwood BW, 2008, P GEOLOGIST ASSOC, V119, P5, DOI 10.1016/S0016-7878(59)80068-7; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; SERENO PC, 1994, SCIENCE, V266, P267, DOI 10.1126/science.266.5183.267; SERENO PC, 1999, P 2 GONDW DIN S, P249; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taquet P., 1976, GEOLOGIE PALEONTOLOG, P191; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Upchurch P, 1999, J VERTEBR PALEONTOL, V19, P106, DOI 10.1080/02724634.1999.10011127; Upchurch P, 2003, J VERTEBR PALEONTOL, V23, P208, DOI 10.1671/0272-4634(2003)23[208:TAATOC]2.0.CO;2; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; Upchurch P, 2002, PALAEONTOLOGY, V45, P1049, DOI 10.1111/1475-4983.00275; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; Upchurch P, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P104; Upchurch P, 2008, J VERTEBR PALEONTOL, V28, p155A; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; VONHUENE F, 1926, ABHANDLUNGEN GEOLOGI, V15, P1; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Yadagiri P., 1988, Records of the Geological Survey of India, V116, P102; Yadagiri P, 2001, J VERTEBR PALEONTOL, V21, P242, DOI 10.1671/0272-4634(2001)021[0242:TOOKYA]2.0.CO;2; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Zhang Y, 1988, MIDDLE JURASSIC DINO, V1, P89; Zheng Zhong, 1991, Vertebrata Palasiatica, V29, P108	75	80	83	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e6924	10.1371/journal.pone.0006924	http://dx.doi.org/10.1371/journal.pone.0006924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756139	gold, Green Published			2022-12-25	WOS:000269970000001
J	Manganelli, M; Malfatti, F; Samo, TJ; Mitchell, BG; Wang, H; Azam, F				Manganelli, Maura; Malfatti, Francesca; Samo, Ty J.; Mitchell, B. Greg; Wang, Haili; Azam, Farooq			Major Role of Microbes in Carbon Fluxes during Austral Winter in the Southern Drake Passage	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; BACTERIAL COMMUNITY COMPOSITION; NATURAL IRON FERTILIZATION; DISSOLVED ORGANIC-CARBON; PHYLOGENETIC COMPOSITION; GROWTH EFFICIENCY; BACTERIOPLANKTON BIOMASS; ARCHAEAL ASSEMBLAGES; PHYTOPLANKTON BLOOM; DEEP-SEA	Carbon cycling in Southern Ocean is a major issue in climate change, hence the need to understand the role of biota in the regulation of carbon fixation and cycling. Southern Ocean is a heterogeneous system, characterized by a strong seasonality, due to long dark winter. Yet, currently little is known about biogeochemical dynamics during this season, particularly in the deeper part of the ocean. We studied bacterial communities and processes in summer and winter cruises in the southern Drake Passage. Here we show that in winter, when the primary production is greatly reduced, Bacteria and Archaea become the major producers of biogenic particles, at the expense of dissolved organic carbon drawdown. Heterotrophic production and chemoautotrophic CO2 fixation rates were substantial, also in deep water, and bacterial populations were controlled by protists and viruses. A dynamic food web is also consistent with the observed temporal and spatial variations in archaeal and bacterial communities that might exploit various niches. Thus, Southern Ocean microbial loop may substantially maintain a wintertime food web and system respiration at the expense of summer produced DOC as well as regenerate nutrients and iron. Our findings have important implications for Southern Ocean ecosystem functioning and carbon cycle and its manipulation by iron enrichment to achieve net sequestration of atmospheric CO2.			Manganelli, M (corresponding author), ISPESL DIPIA, Monte Porzio Catone, RM, Italy.	maura.manganelli@ispesl.it; fmalfatt@ucsd.edu	Azam, Farooq/A-2306-2012; Manganelli, Maura/M-7103-2017	Manganelli, Maura/0000-0002-5650-8191; Samo, Ty/0000-0002-0548-4599; Mitchell, B. Greg/0000-0002-8550-4333				Abell GCJ, 2005, FEMS MICROBIOL ECOL, V51, P265, DOI 10.1016/j.femsec.2004.09.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AZAM F, 1991, POLAR RES, V10, P239, DOI 10.1111/j.1751-8369.1991.tb00649.x; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Bidle KD, 2003, LIMNOL OCEANOGR, V48, P1855, DOI 10.4319/lo.2003.48.5.1855; Bird DF, 1999, AQUAT MICROB ECOL, V19, P13, DOI 10.3354/ame019013; BJORNSEN PK, 1991, MAR ECOL PROG SER, V71, P185, DOI 10.3354/meps071185; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Bonilla-Findji O, 2008, DEEP-SEA RES PT II, V55, P790, DOI 10.1016/j.dsr2.2007.12.004; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; BUESSELER KO, 2008, MAR ECOL PROGR SER, V43, P1; Carlson CA, 1999, AQUAT MICROB ECOL, V19, P229, DOI 10.3354/ame019229; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Christaki U, 2008, DEEP-SEA RES PT II, V55, P706, DOI 10.1016/j.dsr2.2007.12.009; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; COTA GF, 1990, DEEP-SEA RES, V37, P1145, DOI 10.1016/0198-0149(90)90056-2; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DELONG EF, 1994, NATURE, V371, P695, DOI 10.1038/371695a0; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Doval MD, 2002, DEEP-SEA RES PT II, V49, P663, DOI 10.1016/S0967-0645(01)00117-5; Doval MD, 2001, MAR ECOL PROG SER, V223, P27, DOI 10.3354/meps223027; Duarte CM, 2005, LIMNOL OCEANOGR, V50, P1844, DOI 10.4319/lo.2005.50.6.1844; Ducklow HW, 1999, FEMS MICROBIOL ECOL, V30, P1, DOI 10.1111/j.1574-6941.1999.tb00630.x; Fandino LB, 2001, AQUAT MICROB ECOL, V23, P119, DOI 10.3354/ame023119; FERNANDEZ E, 1993, PCR METH APPL, V3, P122; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Grzymski JJ, 2006, APPL ENVIRON MICROB, V72, P1532, DOI 10.1128/AEM.72.2.1532-1541.2006; HANSON RB, 1983, APPL ENVIRON MICROB, V45, P1622, DOI 10.1128/AEM.45.5.1622-1632.1983; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Hopkinson BM, 2007, LIMNOL OCEANOGR, V52, P2540, DOI 10.4319/lo.2007.52.6.2540; HORRIGAN SG, 1981, LIMNOL OCEANOGR, V26, P378, DOI 10.4319/lo.1981.26.2.0378; Huber JA, 2006, ENVIRON MICROBIOL, V8, P88, DOI 10.1111/j.1462-2920.2005.00872.x; Huber JA, 2003, FEMS MICROBIOL ECOL, V43, P393, DOI 10.1111/j.1574-6941.2003.tb01080.x; KOTTMEIER ST, 1987, MAR ECOL PROG SER, V36, P287, DOI 10.3354/meps036287; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Lochte K, 1997, DEEP-SEA RES PT II, V44, P321, DOI 10.1016/S0967-0645(96)00081-1; Lopez-Garcia P, 2001, ENVIRON MICROBIOL, V3, P72, DOI 10.1046/j.1462-2920.2001.00162.x; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Malmstrom RR, 2007, AQUAT MICROB ECOL, V47, P45, DOI 10.3354/ame047045; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181; Mehta MP, 2005, ENVIRON MICROBIOL, V7, P1525, DOI 10.1111/j.1462-2920.2005.00836.x; Moran XAG, 2001, MAR ECOL PROG SER, V222, P25, DOI 10.3354/meps222025; MORDY CW, 1995, MAR ECOL PROG SER, V122, P9, DOI 10.3354/meps122009; Moreira D, 2006, MICROBIOL-SGM, V152, P505, DOI 10.1099/mic.0.28254-0; Moriarty DJW, 1997, DEEP-SEA RES PT II, V44, P1005, DOI 10.1016/S0967-0645(96)00110-5; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Murray AE, 2007, PHILOS T R SOC B, V362, P2259, DOI 10.1098/rstb.2006.1944; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Obernosterer I, 2008, DEEP-SEA RES PT II, V55, P777, DOI 10.1016/j.dsr2.2007.12.005; Patel A, 2007, NAT PROTOC, V2, P269, DOI 10.1038/nprot.2007.6; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Prabagaran SR, 2007, FEMS MICROBIOL ECOL, V59, P342, DOI 10.1111/j.1574-6941.2006.00213.x; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Riemann L, 1999, DEEP-SEA RES PT II, V46, P1791, DOI 10.1016/S0967-0645(99)00044-2; Rivkin RB, 2001, SCIENCE, V291, P2398, DOI 10.1126/science.291.5512.2398; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Sherr BF, 2003, DEEP-SEA RES PT I, V50, P529, DOI 10.1016/S0967-0637(03)00030-X; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Smith DC, 1992, ANTARCT J US, V27, P125; Smith MC, 2000, ANTARCT SCI, V12, P177, DOI 10.1017/S0954102000000237; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; Vaque D, 2002, DEEP-SEA RES PT II, V49, P847, DOI 10.1016/S0967-0645(01)00127-8; Vaque D, 2008, LIMNOL OCEANOGR, V53, P2427, DOI 10.4319/lo.2008.53.6.2427; Weinbauer MG, 2007, ENVIRON MICROBIOL, V9, P777, DOI 10.1111/j.1462-2920.2006.01200.x; West NJ, 2008, ENVIRON MICROBIOL, V10, P738, DOI 10.1111/j.1462-2920.2007.01497.x; Wiebinga CJ, 1998, MAR CHEM, V61, P185, DOI 10.1016/S0304-4203(98)00014-0	78	49	50	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6941	10.1371/journal.pone.0006941	http://dx.doi.org/10.1371/journal.pone.0006941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759822	Green Submitted, Green Published			2022-12-25	WOS:000269796300001
J	Simonetti, T; Lee, H; Bourke, M; Leamey, CA; Sawatari, A				Simonetti, Teresa; Lee, Hyunchul; Bourke, Michael; Leamey, Catherine A.; Sawatari, Atomu			Enrichment from Birth Accelerates the Functional and Cellular Development of a Motor Control Area in the Mouse	PLOS ONE			English	Article								Background: There is strong evidence that sensory experience in early life has a profound influence on the development of sensory circuits. Very little is known, however, about the role of experience in the early development of striatal networks which regulate both motor and cognitive function. To address this, we have investigated the influence of early environmental enrichment on motor development. Methodology/Principal Findings: Mice were raised in standard or enriched housing from birth. For animals assessed as adults, half of the mice had their rearing condition reversed at weaning to enable the examination of the effects of preversus post-weaning enrichment. We found that exclusively pre-weaning enrichment significantly improved performance on the Morris water maze compared to non-enriched mice. The effects of early enrichment on the emergence of motor programs were assessed by performing behavioural tests at postnatal day 10. Enriched mice traversed a significantly larger region of the test arena in an open-field test and had improved swimming ability compared to non-enriched cohorts. A potential cellular correlate of these changes was investigated using Wisteria-floribunda agglutinin (WFA) staining to mark chondroitin-sulfate proteoglycans (CSPGs). We found that the previously reported transition of CSPG staining from striosome-associated clouds to matrix-associated perineuronal nets (PNNs) is accelerated in enriched mice. Conclusions/Significance: This is the first demonstration that the early emergence of exploratory as well as coordinated movement is sensitive to experience. These behavioural changes are correlated with an acceleration of the emergence of striatal PNNs suggesting that they may consolidate the neural circuits underlying these behaviours. Finally, we confirm that pre-weaning experience can lead to life long changes in the learning ability of mice.			Simonetti, T (corresponding author), Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia.	atomu@medsci.usyd.edu.au		Bourke, Michael/0000-0001-8752-2941; Lee, Hyunchul/0000-0002-1427-6521; Leamey, Catherine/0000-0002-3390-4933				Allen JP, 2003, EUR J NEUROSCI, V17, P1881, DOI 10.1046/j.1460-9568.2003.02629.x; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Ariano MA, 1997, BRAIN RES, V752, P26, DOI 10.1016/S0006-8993(96)01422-9; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bezard E, 2003, J NEUROSCI, V23, P10999; Bolivar VJ, 1996, DEV PSYCHOBIOL, V29, P123, DOI 10.1002/(SICI)1098-2302(199603)29:2<123::AID-DEV3>3.0.CO;2-U; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Centonze D, 2003, J NEUROSCI, V23, P6245; CHESSELET MF, 1983, LIFE SCI, V33, P37, DOI 10.1016/0024-3205(83)90438-1; Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475; CUMMINS RA, 1982, DEV PSYCHOBIOL, V15, P187, DOI 10.1002/dev.420150302; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; FOX K, 1992, J NEUROSCI, V12, P1826; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; FRANCIS DD, 1995, PHYSIOL BEHAV, V58, P57, DOI 10.1016/0031-9384(95)00009-8; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; GLOBUS A, 1973, J COMP PHYSIOL PSYCH, V82, P175, DOI 10.1037/h0033910; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRAYBIEL AM, 1984, P NATL ACAD SCI-BIOL, V81, P7980, DOI 10.1073/pnas.81.24.7980; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Harburger LL, 2007, BEHAV BRAIN RES, V185, P43, DOI 10.1016/j.bbr.2007.07.009; HARTIG W, 1992, NEUROREPORT, V3, P869; Hebb DO., 1947, AM PSYCHOL, V2, P306; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ibarra GR, 1996, NEUROREPORT, V7, P2491, DOI 10.1097/00001756-199611040-00018; Ibarra GR, 1995, BRAIN RES, V705, P39, DOI 10.1016/0006-8993(95)01076-9; Iso H, 2007, BEHAV BRAIN RES, V179, P90, DOI 10.1016/j.bbr.2007.01.025; Iwata E, 2007, PHYSIOL BEHAV, V91, P318, DOI 10.1016/j.physbeh.2007.03.013; Jamon M, 2002, BEHAV NEUROSCI, V116, P1014, DOI 10.1037//0735-7044.116.6.1014; Jamon M, 1998, BEHAV NEUROSCI, V112, P1218, DOI 10.1037/0735-7044.112.5.1218; Kikusui T, 2009, J NEUROENDOCRINOL, V21, P427, DOI 10.1111/j.1365-2826.2009.01837.x; KRECH D, 1960, J COMP PHYSIOL PSYCH, V53, P509, DOI 10.1037/h0045402; KRECH D, 1962, J COMP PHYSIOL PSYCH, V55, P801, DOI 10.1037/h0044220; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; LEAMEY CA, 2009, CURR OPIN NEUROBIOL; Lee H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003020; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nisenbaum LK, 1998, DEV NEUROSCI-BASEL, V20, P113, DOI 10.1159/000017307; Pietropaolo S, 2006, BEHAV NEUROSCI, V120, P787, DOI 10.1037/0735-7044.120.4.787; Pistell PJ, 2009, BEHAV BRAIN RES, V197, P138, DOI 10.1016/j.bbr.2008.08.015; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2000, BEHAV BRAIN RES, V114, P11, DOI 10.1016/S0166-4328(00)00186-8; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; Rossi HL, 2008, BEHAV BRAIN RES, V187, P478, DOI 10.1016/j.bbr.2007.09.021; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; SCHAPIRO S, 1970, SCIENCE, V167, P292, DOI 10.1126/science.167.3916.292; SCHAPIRO S, 1970, SCIENCE, V168, P147, DOI 10.1126/science.168.3927.147; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Soiza-Reilly M, 2004, BRAIN RES, V1004, P217, DOI 10.1016/j.brainres.2004.01.050; STEHOUWER DJ, 1994, DEV BRAIN RES, V82, P143, DOI 10.1016/0165-3806(94)90157-0; STOMER VEV, 1987, NEUROPHARMACOLOGY, V26, P1351; STOMER VEV, 1990, NEUROTOXICOL TERATOL, V12, P85, DOI 10.1016/0892-0362(90)90117-U; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; SWANSON HH, 1983, BEHAV PROCESS, V8, P1, DOI 10.1016/0376-6357(83)90039-6; UYLINGS HBM, 1978, EXP NEUROL, V62, P658, DOI 10.1016/0014-4886(78)90276-5; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; WAINWRIGHT PE, 1993, NEUROTOXICOL TERATOL, V15, P11, DOI 10.1016/0892-0362(93)90040-U; WESTERGA J, 1990, DEV BRAIN RES, V57, P163, DOI 10.1016/0165-3806(90)90042-W; Whitaker J, 2007, LAB ANIMAL, V36, P32, DOI 10.1038/laban1107-32; WIDMAN DR, 1990, PHYSIOL BEHAV, V47, P57, DOI 10.1016/0031-9384(90)90042-3; WIDMAN DR, 1992, PHYSIOL BEHAV, V51, P309, DOI 10.1016/0031-9384(92)90146-S; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130; Zhu SW, 2006, BEHAV BRAIN RES, V169, P10, DOI 10.1016/j.bbr.2005.11.024	82	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6780	10.1371/journal.pone.0006780	http://dx.doi.org/10.1371/journal.pone.0006780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19756157	gold, Green Submitted, Green Published			2022-12-25	WOS:000269335000023
J	Hall, J; Karplus, PA; Barbar, E				Hall, Justin; Karplus, P. Andrew; Barbar, Elisar			Multivalency in the Assembly of Intrinsically Disordered Dynein Intermediate Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DYNEIN; LIGHT-CHAIN; FUNCTIONAL INTERACTION; DYNACTIN INTERACTION; BINDING; LC8; DIMERIZATION; PROCESSIVITY; COMPLEXES; PROTEINS	Dynein light chains are thought to increase binding efficiency of dynein intermediate chain to both dynein heavy chain and dynactin, but their exact role is not clear. Isothermal titration calorimetry and x-ray crystallography reported herein indicate that multivalency effects underlie efficient dynein assembly and regulation. For a ternary complex of a 60-amino acid segment of dynein intermediate chain (IC) bound to two homodimeric dynein light chains Tctex1 and LC8, there is a 50-fold affinity enhancement for the second light chain binding. For a designed IC construct containing two LC8 sites, observed the 1000-fold enhancement reflects a remarkably pure entropic chelate effect of a magnitude commensurate with theoretical predictions. The lower enhancement in wild-type IC is attributed to unfavorable free energy changes associated with incremental interactions of IC with Tctex1. Our results show assembled dynein IC as an elongated, flexible polybivalent duplex, and suggest that poly-bivalency is an important general mechanism for constructing stable yet reversible and functionally versatile complexes.	[Hall, Justin; Karplus, P. Andrew; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu		Barbar, Elisar/0000-0003-4892-5259; Karplus, Paul/0000-0001-8725-6292	National Science Foundation [MCB 0818896]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0818896.	Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; Boylan KLM, 2002, GENETICS, V162, P1211; Breslow R, 2000, PURE APPL CHEM, V72, P333, DOI 10.1351/pac200072030333; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; LESLIE A, 1992, JOINT CCP4 ESF EAMCB, V6; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murray CW, 2002, J COMPUT AID MOL DES, V16, P741, DOI 10.1023/A:1022446720849; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pappu RV, 2002, PROTEIN SCI, V11, P2437, DOI 10.1110/ps.0217402; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Talbott M, 2006, BIOCHEMISTRY-US, V45, P6793, DOI 10.1021/bi0600345; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wilkins MR, 1999, METH MOL B, V112, P531; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000	45	53	54	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33115	33121		10.1074/jbc.M109.048587	http://dx.doi.org/10.1074/jbc.M109.048587			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19759397	Green Published, hybrid			2022-12-25	WOS:000272028500015
J	Imai, H; Hakkaku, N; Iwamoto, R; Suzuki, J; Suzuki, T; Tajima, Y; Konishi, K; Minami, S; Ichinose, S; Ishizaka, K; Shioda, S; Arata, S; Nishimura, M; Naito, S; Nakagawa, Y				Imai, Hirotaka; Hakkaku, Nao; Iwamoto, Ryo; Suzuki, Jyunko; Suzuki, Toshiyuki; Tajima, Yoko; Konishi, Kumiko; Minami, Shintaro; Ichinose, Shizuko; Ishizaka, Kazuhiro; Shioda, Seiji; Arata, Satoru; Nishimura, Masuhiro; Naito, Shinsaku; Nakagawa, Yasuhito			Depletion of Selenoprotein GPx4 in Spermatocytes Causes Male Infertility in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; SPERM DEVELOPMENT; MAMMALIAN-CELLS; BINDING-PROTEIN; PHGPX GENE; EXPRESSION; IDENTIFICATION; FERTILITY; TRANSCRIPTION; MITOCHONDRIA	Phospholipid hydroperoxide glutathione peroxidase (GPx4) is an intracellular antioxidant enzyme that directly reduces peroxidized phospholipids. GPx4 is strongly expressed in the mitochondria of testis and spermatozoa. We previously found a significant decrease in the expression of GPx4 in spermatozoa from 30% of infertile human males diagnosed with oligoasthenozoospermia (Imai, H., Suzuki, K., Ishizaka, K., Ichinose, S., Oshima, H., Okayasu, I., Emoto, K., Umeda, M., and Nakagawa, Y. (2001) Biol. Reprod. 64, 674-683). To clarify whether defective GPx4 in spermatocytes causes male infertility, we established spermatocyte-specific GPx4 knock-out mice using a CreloxP system. All the spermatocyte-specific GPx4 knock-out male mice were found to be infertile despite normal plug formation after mating and displayed a significant decrease in the number of spermatozoa. Isolated epididymal GPx4-null spermatozoa could not fertilize oocytes in vitro. These spermatozoa showed significant reductions of forward motility and the mitochondrial membrane potential. These impairments were accompanied by the structural abnormality, such as a hairpin-like flagella bend at the midpiece and swelling of mitochondria in the spermatozoa. These results demonstrate that the depletion of GPx4 in spermatocytes causes severe abnormalities in spermatozoa. This may be one of the causes of male infertility in mice and humans.	[Imai, Hirotaka; Minami, Shintaro] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Imai, Hirotaka] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Sch Med, Instrumental Anal Res Ctr, Bunkyo Ku, Tokyo 1138510, Japan; [Ishizaka, Kazuhiro] Kanto Cent Hosp, Mutual Aid Assoc, Publ Sch Teachers, Dept Urol,Setagaya Ku, Tokyo 1588531, Japan; [Shioda, Seiji] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo 1428555, Japan; [Arata, Satoru] Showa Univ, Dept Anat, Shinagawa Ku, Sch Med, Tokyo 1428555, Japan; [Nishimura, Masuhiro; Naito, Shinsaku] Otsuka Amer Pharmaceut Inc, Div Pharmacol Drug Safety & Metab, Tokushima 7728601, Japan	Kitasato University; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Showa University; Showa University	Imai, H (corresponding author), Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	imaih@pharm.kitasato-u.ac.jp			Ministry of Education, Science and Culture of Japan [20590067]; Japan Science and Technology Agency; SHISEIDO	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); SHISEIDO	This work was supported by Grant-in-aid 20590067 from the Ministry of Education, Science and Culture of Japan, by PRESTO from the Japan Science and Technology Agency, and by a SHISEIDO grant for science research.	Andersen OM, 2003, J BIOL CHEM, V278, P23989, DOI 10.1074/jbc.M302157200; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Boschan C, 2002, GENOMICS, V79, P387, DOI 10.1006/geno.2001.6715; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Diaconu M, 2006, ANDROLOGIA, V38, P152, DOI 10.1111/j.1439-0272.2006.00729.x; Ferramosca A, 2008, INT J ANDROL, V31, P337, DOI 10.1111/j.1365-2605.2007.00775.x; Flohe L, 2007, BIOL CHEM, V388, P987, DOI 10.1515/BC.2007.112; Foresta C, 2002, BIOL REPROD, V67, P967, DOI 10.1095/biolreprod.102.003822; Hattori H, 2007, BIOCHEM J, V408, P277, DOI 10.1042/BJ20070245; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Imai H, 2003, BIOCHEM J, V371, P799, DOI 10.1042/BJ20021342; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Imai H, 2006, J BIOCHEM, V140, P573, DOI 10.1093/jb/mvj186; Jeyaraj D Antony, 2003, Reprod Biol Endocrinol, V1, P48, DOI 10.1186/1477-7827-1-48; Kido T, 2005, DEV GROWTH DIFFER, V47, P15, DOI 10.1111/j.1440-169x.2004.00775.x; Lipschultz L.Y., 1983, INFERTILITY MALE, P187; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Nakamura T, 2003, BIOCHEM BIOPH RES CO, V311, P139, DOI 10.1016/j.bbrc.2003.09.183; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; PUSHPAREKHA TR, 1995, J BIOL CHEM, V270, P26993, DOI 10.1074/jbc.270.45.26993; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5; Tramer F, 2004, BIOCHEM J, V383, P179, DOI 10.1042/BJ20040974; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103	37	126	134	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32522	32532		10.1074/jbc.M109.016139	http://dx.doi.org/10.1074/jbc.M109.016139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783653	hybrid, Green Published			2022-12-25	WOS:000272028400034
J	Levy, S; Beharier, O; Etzion, Y; Mor, M; Buzaglo, L; Shaltiel, L; Gheber, LA; Kahn, J; Muslin, AJ; Katz, A; Gitler, D; Moran, A				Levy, Shiri; Beharier, Ofer; Etzion, Yoram; Mor, Merav; Buzaglo, Liat; Shaltiel, Lior; Gheber, Levi A.; Kahn, Joy; Muslin, Anthony J.; Katz, Amos; Gitler, Daniel; Moran, Arie			Molecular Basis for Zinc Transporter 1 Action as an Endogenous Inhibitor of L-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INTERACTION DOMAIN; GATED CA2+ CHANNELS; BETA-SUBUNIT; TRANSCRIPTION FACTOR; FLUORESCENT PROTEIN; ZNT-1 EXPRESSION; FUNCTIONAL EXPRESSION; INTERNATIONAL-UNION; HEART-FAILURE; CELLS	The L-type calcium channel (LTCC) has a variety of physiological roles that are critical for the proper function of many cell types and organs. Recently, a member of the zinc-regulating family of proteins, ZnT-1, was recognized as an endogenous inhibitor of the LTCC, but its mechanism of action has not been elucidated. In the present study, using two-electrode voltage clamp recordings in Xenopus oocytes, we demonstrate that ZnT-1-mediated inhibition of the LTCC critically depends on the presence of the LTCC regulatory beta-subunit. Moreover, the ZnT-1-induced inhibition of the LTCC current is also abolished by excess levels of the beta-subunit. An interaction between ZnT-1 and the beta-subunit, as demonstrated by co-immunoprecipitation and by fluorescence resonance energy transfer, is consistent with this result. Using surface biotinylation and total internal reflection fluorescence microscopy in HEK293 cells, we show a ZnT-1-dependent decrease in the surface expression of the pore-forming alpha(1)-subunit of the LTCC. Similarly, a decrease in the surface expression of the alpha(1)-subunit is observed following up-regulation of the expression of endogenous ZnT-1 in rapidly paced cultured cardiomyocytes. We conclude that ZnT-1-mediated inhibition of the LTCC is mediated through a functional interaction of ZnT-1 with the LTCC beta-subunit and that it involves a decrease in the trafficking of the LTCC alpha(1)-subunit to the surface membrane.	[Gitler, Daniel; Moran, Arie] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84101 Beer Sheva, Israel; [Gheber, Levi A.] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84101 Beer Sheva, Israel; [Etzion, Yoram; Katz, Amos] Soroka Univ, Med Ctr, Cardiac Arrhythmia Res Lab, IL-84101 Beer Sheva, Israel; [Muslin, Anthony J.] Washington Univ, Sch Med, Cardiovasc Res Ctr, John Milliken Dept Med, St Louis, MO 63110 USA; [Katz, Amos] Barzilai Govt Hosp, Dept Cardiol, IL-78278 Ashqelon, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Washington University (WUSTL); Ben Gurion University; Barzilai Medical Center	Moran, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, POB 653, IL-84101 Beer Sheva, Israel.	arie@bgu.ac.il	MORAN, ARIE/F-1210-2012; ETZION, YORAM/F-2065-2012; Gitler, Daniel/F-1304-2012; Katz, Amos/E-6261-2011; Beharier, Ofer/AAC-8016-2021; Gheber, Levi/D-4383-2011	ETZION, YORAM/0000-0002-9930-1035; Gitler, Daniel/0000-0001-9544-3610; Gheber, Levi/0000-0002-7909-100X; Katz, Amos/0000-0003-0422-934X	German Israeli Foundation [I-850-263.2/2004]; Israel Science Foundation [992/07, 452/06]; Marc Rich Foundation for education, culture, and welfare; Chief Scientist Office of the Ministry of Health, Israel; Deutsche Forschungsgemeinschaft [MO 1932/1-1]	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Marc Rich Foundation for education, culture, and welfare; Chief Scientist Office of the Ministry of Health, Israel; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by German Israeli Foundation Grant I-850-263.2/2004 (to A. M., A. K., and Y.E.), by Israel Science Foundation Grants 992/07 (to A. M. and Y.E.) and 452/06 (to D. G.), by the Marc Rich Foundation for education, culture, and welfare (to D. G.), by the Chief Scientist Office of the Ministry of Health, Israel (to Y. E., A. K., and A. M.), and by Deutsche Forschungsgemeinschaft Grant MO 1932/1-1 (to A. M.).	Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Bannister RA, 2007, J MUSCLE RES CELL M, V28, P275, DOI 10.1007/s10974-007-9118-5; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beharier O, 2007, CELL CALCIUM, V42, P71, DOI 10.1016/j.ceca.2006.11.007; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; BRIK H, 1990, BASIC RES CARDIOL, V85, P237, DOI 10.1007/BF01907112; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Cousins RJ, 2003, J NUTR, V133, p1521S, DOI 10.1093/jn/133.5.1521S; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Dulhunty AF, 2006, CLIN EXP PHARMACOL P, V33, P763, DOI 10.1111/j.1440-1681.2006.04441.x; Felix R, 1997, J NEUROSCI, V17, P6884; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kerfant EG, 2006, TRENDS CARDIOVAS MED, V16, P250, DOI 10.1016/j.tcm.2006.04.006; Kim AH, 2000, BRAIN RES, V886, P99, DOI 10.1016/S0006-8993(00)02944-9; Kobayashi T, 2007, J PHARMACOL SCI, V103, P347, DOI 10.1254/jphs.CR0070012; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lavi Y, 2007, BIOPHYS J, V93, pL35, DOI 10.1529/biophysj.107.111567; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lee Tae-Seong, 2006, Journal of UOEH, V28, P277; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Majumder S, 2003, J BIOL CHEM, V278, P26216, DOI 10.1074/jbc.M302887200; McKeown L, 2006, ACTA PHARMACOL SIN, V27, P799, DOI 10.1111/j.1745-7254.2006.00394.x; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MOOSMANG S, 2007, HDB EXP PHARM, V178, P469; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Murata M, 2004, CIRC RES, V95, P398, DOI 10.1161/01.RES.0000138449.85324.c5; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Nitzan YB, 2002, DEV BRAIN RES, V137, P149, DOI 10.1016/S0165-3806(02)00437-6; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Ohana E, 2006, J MOL MED-JMM, V84, P753, DOI 10.1007/s00109-006-0062-4; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Segal D, 2004, BIOCHEM BIOPH RES CO, V323, P1145, DOI 10.1016/j.bbrc.2004.08.211; SINGERLAHAT D, 1992, FEBS LETT, V306, P113, DOI 10.1016/0014-5793(92)80980-U; Sonkusare S, 2006, VASC PHARMACOL, V44, P131, DOI 10.1016/j.vph.2005.10.005; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tsuda M, 1997, J NEUROSCI, V17, P6678; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888	68	47	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32434	32443		10.1074/jbc.M109.058842	http://dx.doi.org/10.1074/jbc.M109.058842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19767393	Green Published, hybrid			2022-12-25	WOS:000272028400026
J	Tai, CC; Chen, CY; Lee, HS; Wang, YC; Li, TK; Mersamm, HJ; Ding, ST; Wang, PH				Tai, Chen C.; Chen, Ching Y.; Lee, Hsuan S.; Wang, Ya C.; Li, Tsai K.; Mersamm, Harry J.; Ding, Shih T.; Wang, Pei H.			Docosahexaenoic Acid Enhances Hepatic Serum Amyloid A Expression via Protein Kinase A-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; EICOSAPENTAENOIC ACID; ADIPOCYTE DETERMINATION; GENE-TRANSCRIPTION; SIGNALING PATHWAY; LIPOGENIC GENES; N-3; PHOSPHORYLATION; ACTIVATION; CELLS	Serum amyloid A (SAA) reduces fat deposition in adipocytes and hepatoma cells. Human SAA1 mRNA is increased by docosahexaenoic acid (DHA) treatment in human cells. These studies asked whether DHA decreases fat deposition through SAA1 and explored the mechanisms involved. We demonstrated that DHA increased human SAA1 and C/EBP beta mRNA expression in human hepatoma cells, SK-HEP-1. Utilizing a promoter deletion assay, we found that a CCAAT/enhancer-binding protein beta (C/EBP beta)-binding site in the SAA1 promoter region between -242 and -102 bp was critical for DHA-mediated SAA1 expression. Mutation of the putative C/EBP beta-binding site suppressed the DHA-induced SAA1 promoter activity. The addition of the protein kinase A inhibitor H89 negated the DHA-induced increase in C/EBP beta protein expression. The up-regulation of SAA1 mRNA and protein by DHA was also inhibited by H89. We also demonstrated that DHA increased protein kinase A (PKA) activities. These data suggest that C/EBP beta is involved in the DHA-regulated increase in SAA1 expression via PKA-dependent mechanisms. Furthermore, the suppressive effect of DHA on triacylglycerol accumulation was abolished by H89 in SK-HEP-1 cells and adipocytes, indicating that DHA also reduces lipid accumulation via PKA. The observation of increased SAA1 expression coupled with reduced fat accumulation mediated by DHA via PKA suggests that SAA1 is involved in DHA-induced triacylglycerol breakdown. These findings provide new insights into the complicated regulatory network in DHA-mediated lipid metabolism and are useful in developing new approaches to reduce body fat deposition and fatty liver.	[Tai, Chen C.; Chen, Ching Y.; Wang, Ya C.; Mersamm, Harry J.; Ding, Shih T.; Wang, Pei H.] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 106, Taiwan; [Lee, Hsuan S.; Ding, Shih T.] Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan; [Li, Tsai K.] Natl Taiwan Univ, Inst Microbiol, Taipei 106, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 106, Taiwan.	sding@ntu.edu.tw; demonwang@ntu.edu.tw		LI, TSAI-KUN/0000-0003-0393-2340; Ding, Shih-Torng/0000-0002-9866-1776; LEE, HSUAN-SHU/0000-0002-8017-0434; Chen, Ching-Yi/0000-0002-5776-084X	National Science Council in Taiwan; National Taiwan University [97R0066-43]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported in part by the National Science Council in Taiwan and National Taiwan University (Grant 97R0066-43).	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; BETTS JC, 1993, J BIOL CHEM, V268, P25624; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Bousserouel S, 2003, J LIPID RES, V44, P601, DOI 10.1194/jlr.M200092-JLR200; BROWN ER, 1994, LIPIDS, V29, P825, DOI 10.1007/BF02536249; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Capanni M, 2006, ALIMENT PHARM THER, V23, P1143, DOI 10.1111/j.1365-2036.2006.02885.x; Chang WC, 2007, ASIAN AUSTRAL J ANIM, V20, P768, DOI 10.5713/ajas.2007.768; Chen CH, 2008, J NUTR, V138, P674, DOI 10.1093/jn/138.4.674; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Ding ST, 2002, IN VITRO CELL DEV-AN, V38, P352; DUBOIS M, 1993, J CARDIOVASC PHARM, V21, P522, DOI 10.1097/00005344-199304000-00003; Fickova M, 1998, J NUTR, V128, P512, DOI 10.1093/jn/128.3.512; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guo W, 2005, LIPIDS, V40, P815, DOI 10.1007/s11745-005-1443-8; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Jensen LE, 1997, J IMMUNOL, V158, P384; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kunesova M, 2006, PHYSIOL RES, V55, P63, DOI 10.33549/physiolres.930770; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Liu BH, 2005, J ANIM SCI, V83, P1516; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Mies F, 2004, AM J PHYSIOL-RENAL, V287, pF850, DOI 10.1152/ajprenal.00078.2004; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Osada S, 1996, J BIOL CHEM, V271, P3891; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picq M, 1996, J MOL CELL CARDIOL, V28, P2151, DOI 10.1006/jmcc.1996.0207; Ray A, 2003, J BIOL CHEM, V278, P22586, DOI 10.1074/jbc.M300705200; Ray A, 2002, DNA CELL BIOL, V21, P31, DOI 10.1089/10445490252810294; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Szentandrassy N, 2007, J PHYSIOL-LONDON, V582, P349, DOI 10.1113/jphysiol.2007.132753; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; WANG YC, 2009, J NUTR BIOC IN PRESS; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yang Y, 2004, EUR RESPIR J, V24, P360, DOI 10.1183/09031936.04.00089703	45	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32239	32247		10.1074/jbc.M109.024661	http://dx.doi.org/10.1074/jbc.M109.024661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19755416	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000272028400004
J	Careccia, S; Mainardi, S; Pelosi, A; Gurtner, A; Diverio, D; Riccioni, R; Testa, U; Pelosi, E; Piaggio, G; Sacchi, A; Lavorgna, S; Lo-Coco, F; Blandino, G; Levrero, M; Rizzo, MG				Careccia, S.; Mainardi, S.; Pelosi, A.; Gurtner, A.; Diverio, D.; Riccioni, R.; Testa, U.; Pelosi, E.; Piaggio, G.; Sacchi, A.; Lavorgna, S.; Lo-Coco, F.; Blandino, G.; Levrero, M.; Rizzo, M. G.			A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes	ONCOGENE			English	Article						microRNAs; acute promyelocytic leukemia; PML/RAR alpha	HEMATOPOIETIC STEM; RETINOIC ACID; RAR-ALPHA; LEUKEMIA; DIFFERENTIATION; MICRORNAS; EXPRESSION; CELLS; RECEPTORS; GENOMICS	MicroRNAs (miRNAs) are small non-coding RNAs involved in the regulation of critical cell processes such as apoptosis, cell proliferation and differentiation. A small set of miRNAs is differentially expressed in hematopoietic cells and seemingly has an important role in granulopoiesis and lineage differentiation. In this study, we analysed, using a quantitative real-time PCR approach, the expression of 12 granulocytic differentiation signature miRNAs in a cohort of acute promyelocytic leukemia (APL) patients. We found nine miRNAs overexpressed and three miRNAs (miR-107, -342 and let-7c) downregulated in APL blasts as compared with normal promyelocytes differentiated in vitro from CD34+ progenitors. Patients successfully treated with all-trans-retinoic acid (ATRA) and chemotherapy showed downregulation of miR-181b and upregulation of miR-15b, -16, -107, -223, -342 and let-7c. We further investigated whether the APL-associated oncogene, promyelocytic leukemia gene (PML)/retinoic acid receptor alpha (RAR alpha), might be involved in the transcriptional repression of miR-107, -342 and let-7c. We found that PML/RAR alpha binds the regulatory sequences of the intragenic miR-342 and let-7c. In addition, we observed, in response to ATRA, the release of PML/RAR alpha paralleled by their transcriptional activation, together with their host genes, EVL and C21orf34 alpha. In conclusion, we show that a small subset of miRNAs is differentially expressed in APL and modulated by ATRA-based treatment. Oncogene (2009) 28, 4034-4040; doi:10.1038/onc.2009.255; published online 14 September 2009	[Careccia, S.; Mainardi, S.; Pelosi, A.; Gurtner, A.; Piaggio, G.; Sacchi, A.; Blandino, G.; Rizzo, M. G.] Regina Elena Inst Canc Res, Dept Expt Oncol, Lab Mol Oncogenesis, I-00158 Rome, Italy; [Diverio, D.] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Riccioni, R.; Testa, U.; Pelosi, E.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Lavorgna, S.; Lo-Coco, F.] Univ Roma Tor Vergata, Dept Biopathol, Rome, Italy; [Lavorgna, S.; Lo-Coco, F.] Fdn Santa Lucia, Lab Neurooncoematol, Rome, Italy; [Blandino, G.; Levrero, M.] ROC, Rome, Italy; [Levrero, M.] Univ Roma La Sapienza, Dept Internal Med, Rome, Italy; [Levrero, M.] Fdn Andrea Cesalpino, Gene Express Lab, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; IRCCS Santa Lucia; Sapienza University Rome	Rizzo, MG (corresponding author), Regina Elena Inst Canc Res, Dept Expt Oncol, Lab Mol Oncogenesis, Via Messi dOro 156, I-00158 Rome, Italy.	massimo.levrero@uniroma1.it; rizzo@ifo.it	Piaggio, Giulia/AAD-7336-2022; Testa, Ugo/J-6472-2016; lavorgna, serena/O-8490-2016; Careccia, Silvia/K-6475-2016; pelosi, elvira/J-7298-2016; Piaggio, Giulia/J-7214-2018; Rizzo, Maria Giulia/B-2107-2018; gurtner, aymone/AAB-8843-2020; Gurtner, Aymone/J-7217-2018; Pelosi, Andrea/J-9690-2018; riccioni, roberta/AAC-5636-2021; Blandino, Giovanni/B-1137-2013; Levrero, Massimo/G-5680-2016	Testa, Ugo/0000-0001-7900-8942; lavorgna, serena/0000-0001-8812-2325; Careccia, Silvia/0000-0001-7221-8170; pelosi, elvira/0000-0002-3043-6249; Piaggio, Giulia/0000-0003-2114-1892; Rizzo, Maria Giulia/0000-0002-5009-2412; gurtner, aymone/0000-0002-7661-9059; Gurtner, Aymone/0000-0002-7661-9059; Pelosi, Andrea/0000-0003-2308-9215; riccioni, roberta/0000-0002-5766-7717; Blandino, Giovanni/0000-0002-6970-2241; Levrero, Massimo/0000-0002-4978-0875	Associazione Italiana per la Ricerca sul Cancro (AIRC); Ministero della Salute-Italy; European Community (Eu Active p53 Consortium)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute-Italy(Ministry of Health, Italy); European Community (Eu Active p53 Consortium)(European Commission)	We thank Dr WH Miller Jr for kindly providing the NB4 sub-clone MR2 and Dr I Sperduti for his help on statistical analysis. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Ministero della Salute-Italy and European Community (Eu Active p53 Consortium).	Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Fabbri M, 2008, LEUKEMIA, V22, P1095, DOI 10.1038/leu.2008.30; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kumar AR, 2009, BLOOD, V113, P1756, DOI 10.1182/blood-2008-06-163287; Mainardi S, 2007, CELL DEATH DIFFER, V14, P1968, DOI 10.1038/sj.cdd.4402210; Mallardo M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-19; Mandelli F, 1997, BLOOD, V90, P1014; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rosenauer A, 1996, BLOOD, V88, P2671, DOI 10.1182/blood.V88.7.2671.bloodjournal8872671; Saumet A, 2009, BLOOD, V113, P412, DOI 10.1182/blood-2008-05-158139; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Testa U, 1996, BLOOD, V88, P3391, DOI 10.1182/blood.V88.9.3391.bloodjournal8893391	26	64	67	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					4034	4040		10.1038/onc.2009.255	http://dx.doi.org/10.1038/onc.2009.255			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19749800				2022-12-25	WOS:000272560300008
J	Liu, HY; Han, JM; Cao, SY; Hong, T; Zhuo, DG; Shi, JB; Liu, ZQ; Cao, WH				Liu, Hui-Yu; Han, Jianmin; Cao, Sophia Y.; Hong, Tao; Zhuo, Degen; Shi, Jianbo; Liu, Zhenqi; Cao, Wenhong			Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia INHIBITION OF FoxO1-DEPENDENT EXPRESSION OF KEY AUTOPHAGY GENES BY INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; PRIMARY HEPATOCYTES; SIGNALING PATHWAY; OXIDATIVE STRESS; THERAPEUTIC IMPLICATIONS; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; MITOCHONDRIAL-DNA; CAPILLARY DENSITY	Autophagy is essential for maintaining both survival and health of cells. Autophagy is normally suppressed by amino acids and insulin. It is unclear what happens to the autophagy activity in the presence of insulin resistance and hyperinsulinemia. In this study, we examined the autophagy activity in the presence of insulin resistance and hyperinsulinemia and the associated mechanism. Insulin resistance and hyperinsulinemia were induced in mice by a high fat diet, followed by measurements of autophagy markers. Our results show that autophagy was suppressed in the livers of mice with insulin resistance and hyperinsulinemia. Transcript levels of some key autophagy genes were also suppressed in the presence of insulin resistance and hyperinsulinemia. Conversely, autophagy activity was increased in the livers of mice with streptozotocin-induced insulin deficiency. Levels of vps34, atg12, and gabarapl1 transcripts were elevated in the livers of mice with insulin deficiency. To study the mechanism, autophagy was induced by nutrient deprivation or glucagon in cultured hepatocytes in the presence or absence of insulin. Autophagy activity and transcript levels of vps34, atg12, and gabarapl1 genes were reduced by insulin. The effect of insulin was largely prevented by overexpression of the constitutive nuclear form of FoxO1. Importantly, autophagy of mitochondria (mitophagy) in cultured cells was suppressed by insulin in the presence of insulin resistance. Together, our results show that autophagy activity and expression of some key autophagy genes were suppressed in the presence of insulin resistance and hyperinsulinemia. Insulin suppression of autophagy involves FoxO1-mediated transcription of key autophagy genes.	[Liu, Hui-Yu; Han, Jianmin; Cao, Sophia Y.; Hong, Tao; Zhuo, Degen; Cao, Wenhong] Hamner Inst Hlth Sci, Durham, NC 27709 USA; [Han, Jianmin; Shi, Jianbo] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Otolaryngol & Head & Neck Surg, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med Endocrinol, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ Hlth Syst, Dept Internal Med Endocrinol, Durham, NC 27705 USA	The Hamner Institutes for Health Sciences; Sun Yat Sen University; University of Virginia; Duke University	Cao, WH (corresponding author), Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org			National Institutes of Health [R01DK076039]; The Hamner Institutes; American Heart Association [SDG-0530244N]; American Diabetes Association [7-09-BS-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hamner Institutes; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK076039 (to W. C.). This work was also supported by the Investigator Development Fund from The Hamner Institutes for Health Sciences (to W. C.), American Heart Association Grant SDG-0530244N (to W. C.), and American Diabetes Association Grant 7-09-BS-27 (to W. C.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Al-Shawwa BA, 2007, J ASTHMA, V44, P469, DOI 10.1080/02770900701423597; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Burns JM, 2007, NEUROLOGY, V69, P1094, DOI 10.1212/01.wnl.0000276952.91704.af; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Droge W, 2008, ANTIOXID REDOX SIGN, V10, P661, DOI 10.1089/ars.2007.1953; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; LENK SE, 1992, AM J PHYSIOL, V263, pE856, DOI 10.1152/ajpendo.1992.263.5.E856; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2009, J BIOL CHEM, V284, P27090, DOI 10.1074/jbc.M109.016675; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu HY, 2009, J BIOL CHEM, V284, P14087, DOI 10.1074/jbc.M807992200; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maassen JA, 2007, CURR OPIN CLIN NUTR, V10, P693, DOI 10.1097/MCO.0b013e3282f0b774; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Meijer AJ, 2007, AUTOPHAGY, V3, P523; Moreira PI, 2007, J NEUROL SCI, V257, P206, DOI 10.1016/j.jns.2007.01.017; Okazaki Ryo, 2008, Clin Calcium, V18, P638, DOI CliCa0805638643; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sterry W, 2007, BRIT J DERMATOL, V157, P649, DOI 10.1111/j.1365-2133.2007.08068.x; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Tsiotra PC, 2006, ANN NY ACAD SCI, V1083, P63, DOI 10.1196/annals.1367.007; van der Valk M, 2004, ANTIVIR THER, V9, P385; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	50	285	304	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31484	31492		10.1074/jbc.M109.033936	http://dx.doi.org/10.1074/jbc.M109.033936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19758991	hybrid, Green Published			2022-12-25	WOS:000271378400073
J	Muller, B; Prante, C; Kleesiek, K; Gotting, C				Mueller, Benjamin; Prante, Christian; Kleesiek, Knut; Goetting, Christian			Identification and Characterization of the Human Xylosyltransferase I Gene Promoter Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTORS; SP1 BINDING; EXTRACELLULAR-MATRIX; BIGLYCAN GENE; SP-FAMILY; XT-II; EXPRESSION; CELLS; PROTEOGLYCANS	Human xylosyltransferase I catalyzes the initial and rate-limiting step in the biosynthesis of glycosaminoglycans and proteoglycans. Furthermore, this enzyme has been shown to play a major role in the physiological development of bone and cartilage as well as in pathophysiological processes such as systemic sclerosis, dilated cardiomyopathy, or fibrosis. Here, we report for the first time the identification and characterization of the XYLT1 gene promoter region and important transcription factors involved in its regulation. Members of the activator protein 1 (AP-1) and specificity protein 1 (Sp1) family of transcription factors are necessary for the transcriptional regulation of the XYLT1 gene, which was proven by curcumin, tanshinone IIA, mithramycin A, and short interference RNA treatment. A stepwise 5' and 3' deletion of the predicted GC-rich promoter region, which lacks a TATA and/or CAAT box, revealed that a 531-bp core promoter element is able to drive the transcription on a basal level. A binding site for transcription factors of the AP-1 family, which is essential for full promoter activity, was identified by site-directed mutagenesis located 730 bp 5' of the translation initiation site. The ability of this site to bind members of the AP-1 family was further verified by electrophoretic mobility shift assays. A promoter element containing this binding site was able to drive the transcription to about 79-fold above control in SW1353 chondrosarcoma cells. Our findings provide a first insight into the regulation of the XYLT1 gene and may contribute to understanding the processes taking place during extracellular matrix formation and remodeling in health and disease.	[Mueller, Benjamin; Prante, Christian; Kleesiek, Knut; Goetting, Christian] Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabet Zentrum Nordrhein W Falen, Univ Klin, D-32545 Bad Oeynhausen, Germany	Ruhr University Bochum	Prante, C (corresponding author), Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabet Zentrum Nordrhein W Falen, Univ Klin, Georgstr 11, D-32545 Bad Oeynhausen, Germany.	cprante@hdz-nrw.de			Forschungsforderung an der Medizinischen Fakultat der Ruhr-Universitat Bochum (FoRUM) [F609-2007]	Forschungsforderung an der Medizinischen Fakultat der Ruhr-Universitat Bochum (FoRUM)	This work was supported by Forschungsforderung an der Medizinischen Fakultat der Ruhr-Universitat Bochum (FoRUM) Grant F609-2007.	BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bontemps Y, 2003, J BIOL CHEM, V278, P21566, DOI 10.1074/jbc.M209366200; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; FISHER LW, 1991, J BIOL CHEM, V266, P14371; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gotting C, 2007, CELL MOL LIFE SCI, V64, P1498, DOI 10.1007/s00018-007-7069-z; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Gotting C, 1999, J INVEST DERMATOL, V112, P919, DOI 10.1046/j.1523-1747.1999.00590.x; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Hergenhahn M, 2002, MOL CARCINOGEN, V33, P137, DOI 10.1002/mc.10029; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Huber R, 1998, GENE, V214, P35, DOI 10.1016/S0378-1119(98)00233-9; Hurtado A, 2008, BRAIN, V131, P2596, DOI 10.1093/brain/awn206; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jin UH, 2008, J CELL BIOCHEM, V104, P15, DOI 10.1002/jcb.21599; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Li HX, 2004, BBA-GENE STRUCT EXPR, V1679, P141, DOI 10.1016/j.bbaexp.2004.06.004; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Matsuo N, 2006, J BIOL CHEM, V281, P5445, DOI 10.1074/jbc.M509923200; Mauviel A, 1996, J BIOL CHEM, V271, P24824, DOI 10.1074/jbc.271.40.24824; Muller B, 2008, MATRIX BIOL, V27, P139, DOI 10.1016/j.matbio.2007.09.005; Park S, 1999, B KOR CHEM SOC, V20, P925; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PONTICOS M, 2009, NUCL ACIDS IN PRESS; Prante C, 2007, J BIOL CHEM, V282, P26441, DOI 10.1074/jbc.M702299200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Vatsyayan J, 2005, J BIOCHEM, V137, P703, DOI 10.1093/jb/mvi082; Venkatesan N, 2009, FASEB J, V23, P813, DOI 10.1096/fj.08-118166; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Weilke C, 1997, CLIN CHEM, V43, P45; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	39	18	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30775	30782		10.1074/jbc.M109.016592	http://dx.doi.org/10.1074/jbc.M109.016592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19762916	hybrid, Green Published			2022-12-25	WOS:000271378400005
J	Song, W; Ruder, AM; Hu, LY; Li, YF; Ni, R; Shao, WS; Kaslow, RA; Butler, M; Tang, JM				Song, Wei; Ruder, Avima M.; Hu, Liangyuan; Li, Yufeng; Ni, Rong; Shao, Wenshuo; Kaslow, Richard A.; Butler, MaryAnn; Tang, Jianming			Genetic Epidemiology of Glioblastoma Multiforme: Confirmatory and New Findings from Analyses of Human Leukocyte Antigen Alleles and Motifs	PLOS ONE			English	Article								Background: Human leukocyte antigen (HLA) class I genes mediate cytotoxic T-lymphocyte responses and natural killer cell function. In a previous study, several HLA-B and HLA-C alleles and haplotypes were positively or negatively associated with the occurrence and prognosis of glioblastoma multiforme (GBM). Methodology/Principal Findings: As an extension of the Upper Midwest Health Study, we have performed HLA genotyping for 149 GBM patients and 149 healthy control subjects from a non-metropolitan population consisting almost exclusively of European Americans. Conditional logistic regression models did not reproduce the association of HLA-B*07 or the B*07-Cw*07 haplotype with GBM. Nonetheless, HLA-A*32, which has previously been shown to predispose GBM patients to a favorable prognosis, was negatively associated with occurrence of GBM (odds ratio = 0.41, p = 0.04 by univariate analysis). Other alleles (A*29, A*30, A*31 and A*33) within the A19 serology group to which A*32 belongs showed inconsistent trends. Sequencing-based HLA-A genotyping established that A*3201 was the single A*32 allele underlying the observed association. Additional evaluation of HLA-A promoter and exon 1 sequences did not detect any unexpected single nucleotide polymorphisms that could suggest differential allelic expression. Further analyses restricted to female GBM cases and controls revealed a second association with a specific HLA-B sequence motif corresponding to Bw4-80Ile (odds ratio = 2.71, p = 0.02). Conclusions/Significance: HLA-A allelic product encoded by A*3201 is likely to be functionally important to GBM. The novel, sex-specific association will require further confirmation in other representative study populations.			Song, W (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.	jtang@uab.edu	Tang, Jianming "James"/O-4980-2019; Ruder, Avima/I-4155-2012	Tang, Jianming "James"/0000-0003-0137-7486; Ruder, Avima/0000-0003-0419-6664	NCI NIH HHS [CA097257, R03 CA128059, P50 CA097257, CA128059, CA097247, P50 CA097247] Funding Source: Medline; NIAID NIH HHS [K02 AI076123] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA128059, P50CA097257, P50CA097247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI076123] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aldape KD, 2003, CANCER J, V9, P99, DOI 10.1097/00130404-200303000-00005; APPLE RJ, 1994, NAT GENET, V6, P157, DOI 10.1038/ng0294-157; BASHIROVA AA, 2006, ANN REV GENOMICS HUM; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Brenner AV, 2007, CARCINOGENESIS, V28, P2543, DOI 10.1093/carcin/bgm210; Burt RD, 1996, CANCER EPIDEM BIOMAR, V5, P879; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; *CBTRUS, 2000, CBTRUS STAND STAT RE; Chen PC, 2001, CANCER RES, V61, P3949; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davis F G, 1999, Neuro Oncol, V1, P205, DOI 10.1093/neuonc/1.3.205; Debinski W, 2001, MOL MED, V7, P598, DOI 10.1007/BF03401866; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Frigerio S, 1999, CANCER GENET CYTOGEN, V109, P172, DOI 10.1016/S0165-4608(98)00161-7; Girdlestone J, 2000, BLOOD, V95, P3804; Goldsmith DB, 2002, CLIN OTOLARYNGOL, V27, P61, DOI 10.1046/j.0307-7772.2001.00529.x; Goymer P, 2008, NATURE, V454, P1047, DOI 10.1038/4541046a; Guerini FR, 2006, J NEURO-ONCOL, V77, P213, DOI 10.1007/s11060-005-9032-x; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hughes AL, 2002, IMMUNOL REV, V190, P161, DOI 10.1034/j.1600-065X.2002.19012.x; Jiang XB, 2007, ACTA BIOCH BIOPH SIN, V39, P641, DOI 10.1111/j.1745-7270.2007.00331.x; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; KULKARNI S, 2008, SEMIN IMMUNOL; LAMPSON LA, 1986, J IMMUNOL, V136, P4054; Lefebvre S, 1999, PLACENTA, V20, P293, DOI 10.1053/plac.1998.0380; LHaridon M, 1996, NUCLEIC ACIDS RES, V24, P1928, DOI 10.1093/nar/24.10.1928; Machulla HKG, 2001, J NEURO-ONCOL, V52, P253, DOI 10.1023/A:1010612327647; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Matsumoto K, 2003, INT J CANCER, V106, P919, DOI 10.1002/ijc.11332; McKenzie LM, 1999, GENES IMMUN, V1, P120, DOI 10.1038/sj.gene.6363648; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Mittelbronn M, 2007, J NEUROIMMUNOL, V189, P50, DOI 10.1016/j.jneuroim.2007.07.002; NITTA T, 1994, NEUROSURG REV, V17, P211, DOI 10.1007/BF00418435; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Okano F, 2002, CLIN CANCER RES, V8, P2851; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Ruder AM, 2006, J AGRIC SAF HEALTH, V12, P255, DOI 10.13031/2013.22013; Ruder AM, 2004, ARCH ENVIRON HEALTH, V59, P650, DOI 10.1080/00039890409602949; Schreuder GMT, 2005, HUM IMMUNOL, V66, P170, DOI 10.1016/j.humimm.2004.09.017; Shao W, 2004, TISSUE ANTIGENS, V64, P286, DOI 10.1111/j.0001-2815.2004.00295.x; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shimato S, 2008, J NEUROSURG, V109, P117, DOI 10.3171/JNS/2008/109/7/0117; Surawicz T S, 1999, Neuro Oncol, V1, P14, DOI 10.1093/neuonc/1.1.14; Tang J, 2005, CLIN CANCER RES, V11, P5292, DOI 10.1158/1078-0432.CCR-05-0545; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang JM, 2005, CANCER EPIDEM BIOMAR, V14, P2040, DOI 10.1158/1055-9965.EPI-05-0136; Ueda R, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-68; van der Burg SH, 2001, INT J CANCER, V91, P612, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1119>3.0.CO;2-C; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wiendl H, 2003, SEMIN CANCER BIOL, V13, P343, DOI 10.1016/S1044-579X(03)00025-7; Wischhusen J, 2005, J NEUROPATH EXP NEUR, V64, P523, DOI 10.1093/jnen/64.6.523; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zehbe I, 2003, HUM IMMUNOL, V64, P538, DOI 10.1016/S0198-8859(03)00033-8; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520	61	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7157	10.1371/journal.pone.0007157	http://dx.doi.org/10.1371/journal.pone.0007157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774073	Green Submitted, Green Published, gold			2022-12-25	WOS:000270160900022
J	Marchetto, MCN; Yeo, GW; Kainohana, O; Marsala, M; Gage, FH; Muotri, AR				Marchetto, Maria C. N.; Yeo, Gene W.; Kainohana, Osamu; Marsala, Martin; Gage, Fred H.; Muotri, Alysson R.			Transcriptional Signature and Memory Retention of Human-Induced Pluripotent Stem Cells	PLOS ONE			English	Article							EPISOMAL VECTORS; MOUSE; GENERATION; EXPRESSION; IDENTIFICATION; INDUCTION; SOX2; MYC	Genetic reprogramming of somatic cells to a pluripotent state (induced pluripotent stem cells or iPSCs) by over-expression of specific genes has been accomplished using mouse and human cells. However, it is still unclear how similar human iPSCs are to human Embryonic Stem Cells (hESCs). Here, we describe the transcriptional profile of human iPSCs generated without viral vectors or genomic insertions, revealing that these cells are in general similar to hESCs but with significant differences. For the generation of human iPSCs without viral vectors or genomic insertions, pluripotent factors Oct4 and Nanog were cloned in episomal vectors and transfected into human fetal neural progenitor cells. The transient expression of these two factors, or from Oct4 alone, resulted in efficient generation of human iPSCs. The reprogramming strategy described here revealed a potential transcriptional signature for human iPSCs yet retaining the gene expression of donor cells in human reprogrammed cells free of viral and transgene interference. Moreover, the episomal reprogramming strategy represents a safe way to generate human iPSCs for clinical purposes and basic research.			Marchetto, MCN (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	muotri@ucsd.edu	Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037				AASEN T, 2008, NAT BIOTECHNOL; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BELT PBGM, 1989, GENE, V84, P407, DOI 10.1016/0378-1119(89)90515-5; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Breier JM, 2008, TOXICOL SCI, V105, P119, DOI 10.1093/toxsci/kfn115; Cezar GG, 2007, STEM CELLS DEV, V16, P869, DOI 10.1089/scd.2007.0022; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; KAJI K, 2009, NATURE; Kameda T, 2006, BIOCHEM BIOPH RES CO, V349, P1269, DOI 10.1016/j.bbrc.2006.08.175; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Leight ER, 2001, MOL CELL BIOL, V21, P4149, DOI 10.1128/MCB.21.13.4149-4161.2001; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; MARGOLSKEE RF, 1992, CURR TOP MICROBIOL, V158, P67; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van Craenenbroeck K, 2000, EUR J BIOCHEM, V267, P5665, DOI 10.1046/j.1432-1327.2000.01645.x; Van Craenenbroeck K, 2000, GENE, V253, P293, DOI 10.1016/S0378-1119(00)00242-0; Varas F, 2008, STEM CELLS; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; WOLTJEN K, 2009, NATURE; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; YU J, 2009, SCIENCE; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	43	231	247	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7076	10.1371/journal.pone.0007076	http://dx.doi.org/10.1371/journal.pone.0007076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763270	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970400012
J	Andreasen, C; Powell, DA; Carbonetti, NH				Andreasen, Charlotte; Powell, Daniel A.; Carbonetti, Nicholas H.			Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; CELL-MEDIATED-IMMUNITY; RESPIRATORY-TRACT COLONIZATION; DENDRITIC CELLS; NEUTROPHIL RECRUITMENT; INFLAMMATORY CYTOKINE; INTERLEUKIN-17; TH1; LIPOPOLYSACCHARIDE; IDENTIFICATION	In a mouse model of respiratory tract infection by Bordetella pertussis, bacteria multiply in the airways over the first week and are then cleared over the next 3-4 weeks by the host immune response. Pertussis toxin ( PT), a virulence factor secreted exclusively by B. pertussis, promotes bacterial growth in the airways by suppression and modulation of host immune responses. By comparison of wild type and PT-deficient strains, we examined the role of PT in modulating airway cytokine and chemokine responses affecting neutrophil recruitment during B. pertussis infection in mice. We found that, despite early inhibition of neutrophil recruitment by PT, high numbers of neutrophils were recruited to the airways by 4 days post-infection with the wild type strain, but not with the PT-deficient strain, and that this correlated with upregulation of neutrophil-attracting chemokine gene expression. In addition, there was similar upregulation of genes expressing the cytokines IL-17A (IL-17), TNF-alpha and IFN-gamma, indicating a mixed Th1/Th17 response. Expression of IL-6, a cytokine involved in Th17 induction, was upregulated earlier than the IL-17 response. We showed that PT, rather than bacterial numbers, was important for induction of these responses. Flow cytometric analysis revealed that the IL-17-producing cells were macrophages and neutrophils as well as T cells, and were present predominantly in the airways rather than the lung tissue. Antibody neutralization of IL-17 significantly reduced chemokine gene expression and neutrophil recruitment to the airways, but only modestly increased peak bacterial loads. These data indicate that PT stimulates inflammatory responses by induction of Th1- and Th17-associated cytokines, including IL-17, during B. pertussis infection in mice, but a role for IL-17 in protection against the infection remains to be established.			Andreasen, C (corresponding author), Yale Univ, Sch Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA.	ncarbone@umaryland.edu		Powell, Daniel/0000-0003-0503-3330	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063080] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI063080] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Andreasen C, 2009, INFECT IMMUN, V77, P1182, DOI 10.1128/IAI.01150-08; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Aujla SJ, 2007, EXP LUNG RES, V33, P507, DOI 10.1080/01902140701756604; Ausiello CM, 1997, DEV BIOL STAND, V89, P315; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Banus S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-21; Barnard A, 1996, IMMUNOLOGY, V87, P372, DOI 10.1046/j.1365-2567.1996.497560.x; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Carbonetti NH, 2004, INFECT IMMUN, V72, P3350, DOI 10.1128/IAI.72.6.3350-3358.2004; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Castro MG, 2001, CELL MICROBIOL, V3, P45, DOI 10.1046/j.1462-5822.2001.00092.x; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Fedele G, 2005, INFECT IMMUN, V73, P1590, DOI 10.1128/IAI.73.3.1590-1597.2005; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Gaffen SL, 2004, ARTHRITIS RES THER, V6, P240, DOI 10.1186/ar1444; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Iwamoto S, 2007, J IMMUNOL, V179, P1449, DOI 10.4049/jimmunol.179.3.1449; Kramer JM, 2007, J PERIODONTOL, V78, P1083, DOI 10.1902/jop.2007.060392; Lentschat A, 2005, J IMMUNOL, V174, P4252, DOI 10.4049/jimmunol.174.7.4252; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; Linden A, 2000, EUR RESPIR J, V15, P973, DOI 10.1034/j.1399-3003.2000.15e28.x; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Perkins DJ, 2007, MOL MICROBIOL, V66, P1003, DOI 10.1111/j.1365-2958.2007.05972.x; PITTMAN M, 1980, J INFECT DIS, V142, P56, DOI 10.1093/infdis/142.1.56; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Skinner JA, 2004, J IMMUNOL, V173, P1934, DOI 10.4049/jimmunol.173.3.1934; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667; Zepp F, 1997, DEV BIOLOGICALS, V89, P307; ZHANG XK, 1993, J IMMUNOL, V150, P1011	42	84	87	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7079	10.1371/journal.pone.0007079	http://dx.doi.org/10.1371/journal.pone.0007079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759900	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970200009
J	Elbers, CC; de Kovel, CGF; van der Schouw, YT; Meijboom, JR; Bauer, F; Grobbee, DE; Trynka, G; van Vliet-Ostaptchouk, JV; Wijmenga, C; Onland-Moret, NC				Elbers, Clara C.; de Kovel, Carolien G. F.; van der Schouw, Yvonne T.; Meijboom, Juliaan R.; Bauer, Florianne; Grobbee, Diederick E.; Trynka, Gosia; van Vliet-Ostaptchouk, Jana V.; Wijmenga, Cisca; Onland-Moret, N. Charlotte			Variants in Neuropeptide Y Receptor 1 and 5 Are Associated with Nutrient-Specific Food Intake and Are Under Recent Selection in Europeans	PLOS ONE			English	Article								There is a large variation in caloric intake and macronutrient preference between individuals and between ethnic groups, and these food intake patterns show a strong heritability. The transition to new food sources during the agriculture revolution around 11,000 years ago probably created selective pressure and shaped the genome of modern humans. One major player in energy homeostasis is the appetite-stimulating hormone neuropeptide Y, in which the stimulatory capacity may be mediated by the neuropeptide Y receptors 1, 2 and 5 (NPY1R, NPY2R and NPY5R). We assess association between variants in the NPY1R, NPY2R and NPY5R genes and nutrient intake in a cross-sectional, single-center study of 400 men aged 40 to 80 years, and we examine whether genomic regions containing these genes show signatures of recent selection in 270 HapMap individuals (90 Africans, 90 Asians, and 90 Caucasians) and in 846 Dutch bloodbank controls. Our results show that derived alleles in NPY1R and NPY5R are associated with lower carbohydrate intake, mainly because of a lower consumption of mono- and disaccharides. We also show that carriers of these derived alleles, on average, consume meals with a lower glycemic index and glycemic load and have higher alcohol consumption. One of these variants shows the hallmark of recent selection in Europe. Our data suggest that lower carbohydrate intake, consuming meals with a low glycemic index and glycemic load, and/or higher alcohol consumption, gave a survival advantage in Europeans since the agricultural revolution. This advantage could lie in overall health benefits, because lower carbohydrate intake, consuming meals with a low GI and GL, and/or higher alcohol consumption, are known to be associated with a lower risk of chronic diseases.			Elbers, CC (corresponding author), Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, Utrecht, Netherlands.	Y.T.vanderSchouw@UMCUtrecht.nl	Wijmenga, Cisca/D-2173-2009; van der Schouw, Yvonne T./F-8327-2014; Grobbee, Diederick/C-7651-2014; de Kovel, Carolien/AAI-3531-2021; Onland-Moret, N. Charlotte/G-9185-2011; Wijmenga, Cisca/AAE-7719-2019	van der Schouw, Yvonne T./0000-0002-4605-435X; Grobbee, Diederick/0000-0003-4472-4468; de Kovel, Carolien/0000-0002-7818-1396; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Wijmenga, Cisca/0000-0002-5635-1614; Trynka, Gosia/0000-0002-6955-9529; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beulens JWJ, 2005, DIABETES CARE, V28, P2933, DOI 10.2337/diacare.28.12.2933; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Kleijn MJJ, 2001, J NUTR, V131, P1826; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DOWSE GK, 1991, AM J EPIDEMIOL, V133, P1093, DOI 10.1093/oxfordjournals.aje.a115822; Elbers CC, 2007, TRENDS ENDOCRIN MET, V18, P19, DOI 10.1016/j.tem.2006.11.003; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Inui A, 1999, TRENDS PHARMACOL SCI, V20, P43, DOI 10.1016/S0165-6147(99)01303-6; JOBLING M, 2004, HUMAN EVOLUTIONARY G, V20; Kagawa Y, 2002, BIOCHEM BIOPH RES CO, V295, P207, DOI 10.1016/S0006-291X(02)00680-0; KALRA SP, 2004, TRENDS PHARMACOL SCI, V20, P43; Kenneth F, 2000, CAMBRIDGE WORLD HIST; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Loos RJF, 2005, AM J CLIN NUTR, V82, P1097, DOI 10.1093/ajcn/82.5.1097; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; MCDONALD RB, 1994, P SOC EXP BIOL MED, V207, P102, DOI 10.3181/00379727-207-43798; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Rankinen T, 2006, ANNU REV NUTR, V26, P413, DOI 10.1146/annurev.nutr.26.061505.111218; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459; STANLEY BG, 1985, PEPTIDES, V6, P1205, DOI 10.1016/0196-9781(85)90452-8; STEPHEN AM, 1995, AM J CLIN NUTR, V62, p851S, DOI 10.1093/ajcn/62.4.851S; Thiele TE, 2003, PHYSIOL BEHAV, V79, P95, DOI 10.1016/S0031-9384(03)00109-4; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; van Vliet-Ostaptchouk JV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001405; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	40	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7070	10.1371/journal.pone.0007070	http://dx.doi.org/10.1371/journal.pone.0007070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759915	Green Published, gold, Green Submitted			2022-12-25	WOS:000269970200006
J	Metzgar, D; Skochko, G; Gibbins, C; Hudson, N; Lott, L; Jones, MS				Metzgar, David; Skochko, Greg; Gibbins, Carl; Hudson, Nolan; Lott, Lisa; Jones, Morris S.			Evaluation and Validation of a Real-Time PCR Assay for Detection and Quantitation of Human Adenovirus 14 from Clinical Samples	PLOS ONE			English	Article							IDENTIFICATION	In 2007, the Centers for Disease Control and Prevention (CDC) reported that Human adenovirus type 14 (HAdV-14) infected 106 military personnel and was responsible for the death of one U. S. soldier at Lackland Air Force Base in Texas. Identification of the responsible adenovirus, which had not previously been seen in North America and for which rapid diagnostic tools were unavailable, required retrospective analysis at reference laboratories. Initial quarantine measures were also reliant on relatively slow traditional PCR analysis at other locations. To address this problem, we developed a real-time PCR assay that detects a 225 base pair sequence in the HAdV-14a hexon gene. Fifty-one oropharyngeal swab specimens from the Naval Health Research Center, San Diego, CA and Advanced Diagnostic Laboratory, Lackland AFB, TX were used to validate the new assay. The described assay detected eight of eight and 19 of 19 confirmed HAdV-14a clinical isolates in two separate cohorts from respiratory disease outbreaks. The real-time PCR assay had a wide dynamic range, detecting from 10 2 to 10 7 copies of genomic DNA per reaction. The assay did not cross-react with other adenoviruses, influenza, respiratory syncytial virus, or common respiratory tract bacteria. The described assay is easy to use, sensitive and specific for HAdV-14a in clinical throat swab specimens, and very rapid since turnaround time is less than four hours to obtain an answer.			Metzgar, D (corresponding author), Naval Hlth Res Ctr, Dept Resp Dis Res, San Diego, CA USA.	drmorrisj@yahoo.com						Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1181; Benko M., 2005, VIRUS TAXONOMY 8 REP, P213; Chmielewicz B, 2005, J MED VIROL, V77, P232, DOI 10.1002/jmv.20441; DINGLE JH, 1968, AM REV RESPIR DIS, V97, P1; Ebner K, 2006, J CLIN MICROBIOL, V44, P2808, DOI 10.1128/JCM.00048-06; Ginsberg HS, 1955, AM J PUBLIC HEALTH N, V45, P915, DOI 10.2105/AJPH.45.7.915; Gu Z, 2003, J CLIN MICROBIOL, V41, P4636, DOI 10.1128/JCM.41.10.4636-4641.2003; HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825; Huang ML, 2008, DIAGN MICR INFEC DIS, V62, P263, DOI 10.1016/j.diagmicrobio.2008.06.009; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kim HS, 2008, J CLIN MICROBIOL, V46, P2992, DOI 10.1128/JCM.00027-08; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Madisch I, 2006, J MED VIROL, V78, P1210, DOI 10.1002/jmv.20683; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Pang XL, 2004, J CLIN MICROBIOL, V42, P4679, DOI 10.1128/JCM.42.10.4679-4685.2004; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; TATE JE, 2009, J INFECT DIS    0406; WALSH MP, 2009, PLOS ONE IN PRESS; Wong S, 2008, J MED VIROL, V80, P856, DOI 10.1002/jmv.21136; Xu WH, 2001, J MED VIROL, V64, P537, DOI 10.1002/jmv.1083; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	22	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7081	10.1371/journal.pone.0007081	http://dx.doi.org/10.1371/journal.pone.0007081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759905	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970200011
J	Nishizawa, D; Nagashima, M; Katoh, R; Satoh, Y; Tagami, M; Kasai, S; Ogai, Y; Han, WH; Hasegawa, J; Shimoyama, N; Sora, I; Hayashida, M; Ikeda, K				Nishizawa, Daisuke; Nagashima, Makoto; Katoh, Ryoji; Satoh, Yasuo; Tagami, Megumi; Kasai, Shinya; Ogai, Yasukazu; Han, Wenhua; Hasegawa, Junko; Shimoyama, Naohito; Sora, Ichiro; Hayashida, Masakazu; Ikeda, Kazutaka			Association between KCNJ6 (GIRK2) Gene Polymorphisms and Postoperative Analgesic Requirements after Major Abdominal Surgery	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; POTASSIUM CHANNELS; MORPHINE; SUBUNIT; LOCALIZATION; CONTRIBUTE; MUTATIONS; OPIOIDS; ETHANOL; POWER	Opioids are commonly used as effective analgesics for the treatment of acute and chronic pain. However, considerable individual differences have been widely observed in sensitivity to opioid analgesics. We focused on a G-protein-activated inwardly rectifying potassium (GIRK) channel subunit, GIRK2, that is an important molecule in opioid transmission. In our initial polymorphism search, a total of nine single-nucleotide polymorphisms (SNPs) were identified in the whole exon, 5'-flanking, and exon-intron boundary regions of the KCNJ6 gene encoding GIRK2. Among them, G-1250A and A1032G were selected as representative SNPs for further association studies. In an association study of 129 subjects who underwent major open abdominal surgery, the A/A genotype in the A1032G SNP and -1250G/1032A haplotype were significantly associated with increased postoperative analgesic requirements compared with other genotypes and haplotypes. The total dose (mean +/- SEM) of rescue analgesics converted to equivalent oral morphine doses was 20.45 +/- 9.27 mg, 10.84 +/- 2.24 mg, and 13.07 +/- 2.39 mg for the A/A, A/G, and G/G genotypes in the A1032G SNP, respectively. Additionally, KCNJ6 gene expression levels in the 1032A/A subjects were significantly decreased compared with the 1032A/G and 1032G/G subjects in a real-time quantitative PCR analysis using human brain tissues, suggesting that the 1032A/A subjects required more analgesics because of lower KCNJ6 gene expression levels and consequently insufficient analgesic effects. The results indicate that the A1032G SNP and G-1250A/A1032G haplotype could serve as markers that predict increased analgesic requirements. Our findings will provide valuable information for achieving satisfactory pain control and open new avenues for personalized pain treatment.			Nishizawa, D (corresponding author), Tokyo Inst Psychiat, Div Psychobiol, Tokyo, Japan.	Ikedak@prit.go.jp	Nishizawa, Daisuke/G-6933-2013; Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278				BAHAR M, 1985, ANAESTHESIA, V40, P529; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basar H, 2003, J ENDOUROL, V17, P3, DOI 10.1089/089277903321196706; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; BUCHANAN WW, 1986, AM J MED, V80, P145, DOI 10.1016/0002-9343(86)90134-8; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Coulbault L, 2006, CLIN PHARMACOL THER, V79, P316, DOI 10.1016/j.clpt.2006.01.007; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hayashida M, 2008, PHARMACOGENOMICS, V9, P1605, DOI 10.2217/14622416.9.11.1605; HOSKIN PJ, 1991, DRUGS, V41, P326, DOI 10.2165/00003495-199141030-00002; Ikeda K, 2000, NEUROSCI RES, V38, P113, DOI 10.1016/S0168-0102(00)00144-9; Ikeda K, 2005, TRENDS PHARMACOL SCI, V26, P311, DOI 10.1016/j.tips.2005.04.001; Ikeda K, 2002, NEUROSCI RES, V44, P121, DOI 10.1016/S0168-0102(02)00094-9; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; KALSO E, 1990, CLIN PHARMACOL THER, V47, P639, DOI 10.1038/clpt.1990.85; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KLINCK JR, 1982, ANAESTHESIA, V37, P907, DOI 10.1111/j.1365-2044.1982.tb01852.x; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Marker CL, 2004, J NEUROSCI, V24, P2806, DOI 10.1523/JNEUROSCI.5251-03.2004; Marker CL, 2002, NEUROREPORT, V13, P2509, DOI 10.1097/00001756-200212200-00026; Mitrovic I, 2003, P NATL ACAD SCI USA, V100, P271, DOI 10.1073/pnas.0136822100; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; Ozcan S, 2002, SCAND J UROL NEPHROL, V36, P281, DOI 10.1080/003655902320248254; PATHAK KS, 1983, ANESTH ANALG, V62, P841; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; SAKURA H, 1995, FEBS LETT, V367, P193, DOI 10.1016/0014-5793(95)00498-X; Smith SB, 2008, PHARMACOGENET GENOM, V18, P231, DOI 10.1097/FPC.0b013e3282f55ab2; STOFFEL M, 1994, GENOMICS, V21, P254, DOI 10.1006/geno.1994.1253; SUNSHINE S, 1994, TXB PAIN, P923; Tong YH, 1996, FEBS LETT, V390, P63, DOI 10.1016/0014-5793(96)00632-1; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; YASUDA K, 1995, BIOCHEM BIOPH RES CO, V211, P1036, DOI 10.1006/bbrc.1995.1915; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	49	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7060	10.1371/journal.pone.0007060	http://dx.doi.org/10.1371/journal.pone.0007060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756153	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970000022
J	Wu, CY; Steffen, J; Eide, DJ				Wu, Chang-Yi; Steffen, Janet; Eide, David J.			Cytosolic Superoxide Dismutase (SOD1) Is Critical for Tolerating the Oxidative Stress of Zinc Deficiency in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; COPPER CHAPERONE; NITRIC-OXIDE; DIETARY ZINC; CELL-DEATH; CU; AGGREGATION; ACTIVATION; RESISTANCE	Zinc deficiency causes oxidative stress in many organisms including the yeast Saccharomyces cerevisiae. Previous studies of this yeast indicated that the Tsa1 peroxiredoxin is required for optimal growth in low zinc because of its role in degrading H2O2. In this report, we assessed the importance of other antioxidant genes to zinc-limited growth. Our results indicated that the cytosolic superoxide dismutase Sod1 is also critical for growth under zinc-limiting conditions. We also found that Ccs1, the copper-delivering chaperone required for Sod1 activity is essential for optimal zinc-limited growth. To our knowledge, this is the first demonstration of the important roles these proteins play under this condition. It has been proposed previously that a loss of Sod1 activity due to inefficient metallation is one source of reactive oxygen species (ROS) under zinc-limiting conditions. Consistent with this hypothesis, we found that both the level and activity of Sod1 is diminished in zinc-deficient cells. However, under conditions in which Sod1 was overexpressed in zinc-limited cells and activity was restored, we observed no decrease in ROS levels. Thus, these data indicate that while Sod1 activity is critical for low zinc growth, diminished Sod1 activity is not a major source of the elevated ROS observed under these conditions.			Wu, CY (corresponding author), Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.	deide@wisc.edu			NIGMS NIH HHS [R01-GM56285, R01 GM056285] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE JP, 1985, P SOC EXP BIOL MED, V179, P187; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; CHANG EC, 1989, J BIOL CHEM, V264, P12172; Crow JP, 1997, J NEUROCHEM, V69, P1936; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Ermilova IP, 2005, NEUROSCI LETT, V379, P42, DOI 10.1016/j.neulet.2004.12.045; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Garay-Arroyo A, 2003, FEBS LETT, V539, P68, DOI 10.1016/S0014-5793(03)00199-6; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; GRALLA EB, 1992, ADV GENET, V30, P251, DOI 10.1016/S0065-2660(08)60322-3; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hao Q, 2005, J ALZHEIMERS DIS, V8, P161; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005; Ho E, 2003, J NUTR, V133, P2543, DOI 10.1093/jn/133.8.2543; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Hoffman EK, 1996, J NEUROL SCI, V139, P15, DOI 10.1016/S0022-510X(96)00031-7; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; OTEIZA PI, 1995, J NUTR, V125, P823; Park JI, 1998, J BIOL CHEM, V273, P22921, DOI 10.1074/jbc.273.36.22921; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sun JY, 2005, BIOL TRACE ELEM RES, V107, P153, DOI 10.1385/BTER:107:2:153; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Taysi S, 2008, BIOL TRACE ELEM RES, V123, P161, DOI 10.1007/s12011-008-8095-x; TRUMBULL KA, 2009, ANTIOXID RE IN PRESS; Wei JPJ, 2001, J BIOL CHEM, V276, P44798, DOI 10.1074/jbc.M104708200; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370	49	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7061	10.1371/journal.pone.0007061	http://dx.doi.org/10.1371/journal.pone.0007061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756144	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970000023
J	Spangler, R; Goddard, NL; Thaler, DS				Spangler, Rudolph; Goddard, Noel L.; Thaler, David S.			Optimizing Taq Polymerase Concentration for Improved Signal-to-Noise in the Broad Range Detection of Low Abundance Bacteria	PLOS ONE			English	Article							CHAIN-REACTION REAGENTS; REAL-TIME PCR; CONTAMINATING DNA; ONE-CELL; ELIMINATION; DECONTAMINATION; IDENTIFICATION; ASSAY	Background: PCR in principle can detect a single target molecule in a reaction mixture. Contaminating bacterial DNA in reagents creates a practical limit on the use of PCR to detect dilute bacterial DNA in environmental or public health samples. The most pernicious source of contamination is microbial DNA in DNA polymerase preparations. Importantly, all commercial Taq polymerase preparations inevitably contain contaminating microbial DNA. Removal of DNA from an enzyme preparation is problematical. Methodology/Principal Findings: This report demonstrates that the background of contaminating DNA detected by quantitative PCR with broad host range primers can be decreased greater than 10-fold through the simple expedient of Taq enzyme dilution, without altering detection of target microbes in samples. The general method is: For any thermostable polymerase used for high-sensitivity detection, do a dilution series of the polymerase crossed with a dilution series of DNA or bacteria that work well with the test primers. For further work use the concentration of polymerase that gave the least signal in its negative control (H2O) while also not changing the threshold cycle for dilutions of spiked DNA or bacteria compared to higher concentrations of Taq polymerase. Conclusions/Significance: It is clear from the studies shown in this report that a straightforward procedure of optimizing the Taq polymerase concentration achieved "treatment-free" attenuation of interference by contaminating bacterial DNA in Taq polymerase preparations. This procedure should facilitate detection and quantification with broad host range primers of a small number of bona fide bacteria (as few as one) in a sample.			Spangler, R (corresponding author), Rockefeller Univ, Sackler Lab Mol Genet & Informat, 1230 York Ave, New York, NY 10021 USA.	rspangle@hunter.cuny.edu						BOTTGER EC, 1990, CLIN CHEM, V36, P1258; Carroll NM, 1999, J CLIN MICROBIOL, V37, P3402, DOI 10.1128/JCM.37.10.3402-3404.1999; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; FURRER B, 1990, NATURE, V346, P324, DOI 10.1038/346324b0; GOLDENBERGER D, 1995, J MICROBIOL METH, V21, P27, DOI 10.1016/0167-7012(94)00024-2; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Heininger A, 2003, J CLIN MICROBIOL, V41, P1763, DOI 10.1128/JCM.41.4.1763-1765.2003; Hilali F, 1997, MOL BIOTECHNOL, V7, P207, DOI 10.1007/BF02740812; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Iversen Bjorn G, 2007, Ann Clin Microbiol Antimicrob, V6, P3, DOI 10.1186/1476-0711-6-3; JINNO Y, 1990, NUCLEIC ACIDS RES, V18, P6739, DOI 10.1093/nar/18.22.6739; Klaschik S, 2002, MOL BIOTECHNOL, V22, P231, DOI 10.1385/MB:22:3:231; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; MEIER A, 1993, J CLIN MICROBIOL, V31, P646, DOI 10.1128/JCM.31.3.646-652.1993; Mohammadi T, 2003, J CLIN MICROBIOL, V41, P4796, DOI 10.1128/JCM.41.10.4796-4798.2003; OU CY, 1991, BIOTECHNIQUES, V10, P442; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; ROCHELLE PA, 1992, BIOTECHNIQUES, V13, P520; Sambrook J, 2001, MOL CLONING LAB MANU; SCHMIDT TM, 1991, BIOTECHNIQUES, V11, P176; SHARMA JK, 1992, NUCLEIC ACIDS RES, V20, P6117, DOI 10.1093/nar/20.22.6117; Silkie SS, 2008, J MICROBIOL METH, V72, P275, DOI 10.1016/j.mimet.2007.12.011; Spangler R, 2009, J MOL BIOL, V392, P283, DOI 10.1016/j.jmb.2009.07.012; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002	27	34	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7010	10.1371/journal.pone.0007010	http://dx.doi.org/10.1371/journal.pone.0007010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753123	gold, Green Published			2022-12-25	WOS:000269796500005
J	Estrada-Gelonch, A; Aramburu, J; Lopez-Rodriguez, C				Estrada-Gelonch, Anais; Aramburu, Jose; Lopez-Rodriguez, Cristina			Exclusion of NFAT5 from Mitotic Chromatin Resets Its Nucleo-Cytoplasmic Distribution in Interphase	PLOS ONE			English	Article								Background: The transcription factor NFAT5 is a major inducer of osmoprotective genes and is required to maintain the proliferative capacity of cells exposed to hypertonic stress. In response to hypertonicity, NFAT5 translocates to the nucleus, binds to regulatory regions of osmoprotective genes and activates their transcription. Besides stimulus-specific regulatory mechanisms, the activity of transcription factors in cycling cells is also regulated by the passage through mitosis, when most transcriptional processes are downregulated. It was not known whether mitosis could be a point of control for NFAT5. Methodology/Principal Findings: Using confocal microscopy we observed that NFAT5 was excluded from chromatin during mitosis in both isotonic and hypertonic conditions. Analysis of NFAT5 deletions showed that exclusion was mediated by the carboxy-terminal domain (CTD). NFAT5 mutants lacking this domain showed constitutive binding to mitotic chromatin independent of tonicity, which caused them to localize in the nucleus and remain bound to chromatin in the subsequent interphase without hypertonic stimulation. We analyzed the contribution of the CTD, DNA binding, and nuclear import and export signals to the subcellular localization of this factor. Our results indicated that cytoplasmic localization of NFAT5 in isotonic conditions required both the exclusion from mitotic DNA and active nuclear export in interphase. Finally, we identified several regions within the CTD of NFAT5, some of them overlapping with transactivation domains, which were separately capable of causing its exclusion from mitotic chromatin. Conclusions/Significance: Our results reveal a multipart mechanism regulating the subcellular localization of NFAT5. The transactivating module of NFAT5 switches its function from an stimulus-specific activator of transcription in interphase to an stimulus-independent repressor of binding to DNA in mitosis. This mechanism, together with export signals acting in interphase, resets the cytoplasmic localization of NFAT5 and prevents its nuclear accumulation and association with DNA in the absence of hypertonic stress.			Estrada-Gelonch, A (corresponding author), UPF, Dept Expt & Hlth Sci DCEXS, Immunol Unit, Parc Recerca Biomed Barcelona PRBB, Barcelona, Spain.	jose.aramburu@upf.edu; cristina.lopez-rodriguez@upf.edu	Lopez-Rodriguez, C/G-4482-2014; Aramburu, J/G-8991-2014	Lopez-Rodriguez, C/0000-0002-2311-2406; Aramburu, J/0000-0001-9279-9523				Aramburu J, 2006, BIOCHEM PHARMACOL, V72, P1597, DOI 10.1016/j.bcp.2006.07.002; Batonnet-Pichon S, 2006, EXP CELL RES, V312, P3999, DOI 10.1016/j.yexcr.2006.09.001; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; CAELLES C, 1995, MOL CELL BIOL, V15, P6694; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Drews-Elger K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005245; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jiang ZR, 2000, INVEST OPHTH VIS SCI, V41, P1467; Kwon MS, 2008, J BIOL CHEM, V283, P22400, DOI 10.1074/jbc.M710550200; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; LIOU HC, 1992, EMBO J, V11, P3003, DOI 10.1002/j.1460-2075.1992.tb05370.x; Lopez-Rodriguez C, 1999, COLD SPRING HARB SYM, V64, P517, DOI 10.1101/sqb.1999.64.517; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Miyakawa H, 1999, BBA-GENE STRUCT EXPR, V1446, P359, DOI 10.1016/S0167-4781(99)00122-0; Morancho B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-13; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Rodriguez A, 1999, ANAL BIOCHEM, V272, P171, DOI 10.1006/abio.1999.4156; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Xu SX, 2008, J BIOL CHEM, V283, P17624, DOI 10.1074/jbc.M800281200	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7036	10.1371/journal.pone.0007036	http://dx.doi.org/10.1371/journal.pone.0007036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750013	Green Published, gold			2022-12-25	WOS:000269796300021
J	Heath, L; Fox, A; McClure, J; Diem, K; Van ' t, AB; Zhao, H; Park, DR; Schouten, JT; Twigg, HL; Corey, L; Mullins, JI; Mittler, JE				Heath, Laura; Fox, Alan; McClure, Jan; Diem, Kurt; Van ' t Wout, Angelique B.; Zhao, Hong; Park, David R.; Schouten, Jeffrey T.; Twigg, Homer L., III; Corey, Lawrence; Mullins, James I.; Mittler, John E.			Evidence for Limited Genetic Compartmentalization of HIV-1 between Lung and Blood	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; ALVEOLAR MACROPHAGES; INFECTED INDIVIDUALS; PERIPHERAL-BLOOD; T-LYMPHOCYTES; PROVIRAL DNA; COPY NUMBER; V3 LOOP; CELLS	Background: HIV-1 is frequently detected in the lungs of infected individuals and is likely important in the development of pulmonary opportunistic infections. The unique environment of the lung, rich in alveolar macrophages and with specialized local immune responses, may contribute to differential evolution or selection of HIV-1. Methodology and Findings: We characterized HIV-1 in the lung in relation to contemporaneous viral populations in the blood. The C2-V5 region of HIV-1 env was sequenced from paired lung (induced sputum or bronchoalveolar lavage) and blood (plasma RNA and proviral DNA from sorted or unsorted PBMC) from 18 subjects. Compartmentalization between tissue pairs was assessed using 5 established tree or distance-based methods, including permutation tests to determine statistical significance. We found statistical evidence of compartmentalization between lung and blood in 10/18 subjects, although lung and blood sequences were intermingled on phylogenetic trees in all subjects. The subject showing the greatest compartmentalization contained many nearly identical sequences in BAL sample, suggesting clonal expansion may contribute to reduced viral diversity in the lung in some cases. However, HIV-1 sequences in lung were not more homogeneous overall, nor were we able to find a lung-specific genotype associated with macrophage tropism in V3. In all four subjects in whom predicted X4 genotypes were found in blood, predicted X4 genotypes were also found in lung. Conclusions: Our results support a picture of continuous migration of HIV-1 between circulating blood and lung tissue, with perhaps a very limited degree of localized evolution or clonal replication.			Mittler, JE (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmittler@u.washington.edu	Fox, Alan/GPS-5041-2022; Corey, Lawrence/AAE-1796-2020	Fox, Alan/0000-0002-9047-1986; Corey, Lawrence/0000-0002-2179-2436	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL072631] Funding Source: Medline; NIAID NIH HHS [P30 AI027757, P01 AI057005, P30-AI027757, P01-AI057005] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini C, 1996, IMMUNOL TODAY, V17, P359, DOI 10.1016/0167-5699(96)30022-4; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P49, DOI 10.1038/mi.2007.5; Clark JG, 2004, AM J RESP CELL MOL, V30, P220, DOI 10.1165/rcmb.2003-0208OC; CLARKE JR, 1995, THORAX, V50, P567, DOI 10.1136/thx.50.5.567; CLARKE JR, 1994, CLIN EXP IMMUNOL, V96, P182; Collins KR, 2000, J ACQ IMMUN DEF SYND, V24, P408, DOI 10.1097/00126334-200008150-00002; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; Critchlow DE, 2000, MATH COMPUT MODEL, V32, P69, DOI 10.1016/S0895-7177(00)00120-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Diem K, 2008, AIDS RES HUM RETROV, V24, P561, DOI 10.1089/aid.2007.0115; FELS AOS, 1986, J APPL PHYSIOL, V60, P353, DOI 10.1152/jappl.1986.60.2.353; Gilbert PB, 2005, BIOMETRICS, V61, P106, DOI 10.1111/j.0006-341X.2005.020719.x; Grabar S, 2008, HIV MED, V9, P246, DOI 10.1111/j.1468-1293.2008.00554.x; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hudson RR, 2000, GENETICS, V155, P2011; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; ITESCU S, 1994, P NATL ACAD SCI USA, V91, P11378, DOI 10.1073/pnas.91.24.11378; JEFFREY AA, 1991, CLIN EXP IMMUNOL, V84, P488; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kruger K, 2008, BRAIN BEHAV IMMUN, V22, P324, DOI 10.1016/j.bbi.2007.08.008; Liu SL, 1997, J VIROL, V71, P4284, DOI 10.1128/JVI.71.6.4284-4295.1997; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; MADDISON WP, 2001, MACCLADE ANAL PHYLOG, P503; McClure J, 2007, JAIDS-J ACQ IMM DEF, V44, P254, DOI 10.1097/QAI.0b013e318030f5c5; MITCHELL DM, 1995, THORAX, V50, P294, DOI 10.1136/thx.50.3.294; Moreno P, 1996, AIDS, V10, P682, DOI 10.1097/00002030-199606000-00019; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; NAKATA K, 1995, MOL MED, V1, P744, DOI 10.1007/BF03401889; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Park DR, 1996, J IMMUNOL, V157, P2528; Pillai SK, 2006, BRAIN, V129, P1872, DOI 10.1093/brain/awl136; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; PLATA F, 1987, NATURE, V328, P348, DOI 10.1038/328348a0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RODRIGO AG, 1998, QUALITY ENDPOINT DIL; Rogan MP, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-29; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SEMENSATO G, 1995, BLOOD, V85, P2308, DOI 10.1182/blood.V85.9.2308.bloodjournal8592308; Singh A, 1999, J VIROL, V73, P6680, DOI 10.1128/JVI.73.8.6680-6690.1999; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Twigg HL, 2008, J INFECT DIS, V197, P109, DOI 10.1086/523766; vantWout AB, 1998, J VIROL, V72, P488; WAGNER TA, 2009, AIDS; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	58	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6949	10.1371/journal.pone.0006949	http://dx.doi.org/10.1371/journal.pone.0006949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759830	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796300006
J	Lindstrom, S; Eriksson, M; Vazin, T; Sandberg, J; Lundeberg, J; Frisen, J; Andersson-Svahn, H				Lindstrom, Sara; Eriksson, Malin; Vazin, Tandis; Sandberg, Julia; Lundeberg, Joakim; Frisen, Jonas; Andersson-Svahn, Helene			High-Density Microwell Chip for Culture and Analysis of Stem Cells	PLOS ONE			English	Article								With recent findings on the role of reprogramming factors on stem cells, in vitro screening assays for studying (de)differentiation is of great interest. We developed a miniaturized stem cell screening chip that is easily accessible and provides means of rapidly studying thousands of individual stem/progenitor cell samples, using low reagent volumes. For example, screening of 700,000 substances would take less than two days, using this platform combined with a conventional bio-imaging system. The microwell chip has standard slide format and consists of 672 wells in total. Each well holds 500 nl, a volume small enough to drastically decrease reagent costs but large enough to allow utilization of standard laboratory equipment. Results presented here include weeklong culturing and differentiation assays of mouse embryonic stem cells, mouse adult neural stem cells, and human embryonic stem cells. The possibility to either maintain the cells as stem/progenitor cells or to study cell differentiation of stem/progenitor cells over time is demonstrated. Clonality is critical for stem cell research, and was accomplished in the microwell chips by isolation and clonal analysis of single mouse embryonic stem cells using flow cytometric cell-sorting. Protocols for practical handling of the microwell chips are presented, describing a rapid and user-friendly method for the simultaneous study of thousands of stem cell cultures in small microwells. This microwell chip has high potential for a wide range of applications, for example directed differentiation assays and screening of reprogramming factors, opening up considerable opportunities in the stem cell field.			Lindstrom, S (corresponding author), Royal Inst Technol, AlbaNova Univ Ctr, Div Nanobiotechnol, Stockholm, Sweden.	helene.andersson-svahn@biotech.kth.se	Rockberg, Julia/HGB-6917-2022		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ashton RS, 2007, STEM CELLS, V25, P2928, DOI 10.1634/stemcells.2007-0468; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254; Chu VT, 2001, P NATL ACAD SCI USA, V98, P7652, DOI 10.1073/pnas.141244198; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Cimetta E, 2009, METHODS, V47, P81, DOI 10.1016/j.ymeth.2008.10.015; COLE R, 1964, EXP CELL RES, V37, P501; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Gottwald E, 2007, LAB CHIP, V7, P777, DOI 10.1039/b618488j; Jessberger S, 2007, STEM CELLS, V25, P871, DOI 10.1634/stemcells.2006-0620; Jin A., 2009, NAT MED; Kamei KI, 2009, LAB CHIP, V9, P555, DOI 10.1039/b809105f; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035; Kim MS, 2007, LAB CHIP, V7, P513, DOI 10.1039/b617760n; Lii J, 2008, ANAL CHEM, V80, P3640, DOI 10.1021/ac8000034; Lindstrom S, 2008, ELECTROPHORESIS, V29, P1219, DOI 10.1002/elps.200700536; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030; Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012; MOREAU JF, 1988, NATURE, V336, P690, DOI 10.1038/336690a0; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Orfao A, 1996, CLIN BIOCHEM, V29, P5, DOI 10.1016/0009-9120(95)02017-9; Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sim WY, 2007, LAB CHIP, V7, P1775, DOI 10.1039/b712361m; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Underhill GH, 2007, CURR OPIN CHEM BIOL, V11, P357, DOI 10.1016/j.cbpa.2007.05.036; Vazin T, 2008, RESTOR NEUROL NEUROS, V26, P447; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035	46	48	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6997	10.1371/journal.pone.0006997	http://dx.doi.org/10.1371/journal.pone.0006997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750008	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796300013
J	Rao, L; Zhao, XB; Pan, F; Li, Y; Xue, YF; Ma, YH; Lu, JR				Rao, Lang; Zhao, Xiubo; Pan, Fang; Li, Yin; Xue, Yanfen; Ma, Yanhe; Lu, Jian R.			Solution Behavior and Activity of a Halophilic Esterase under High Salt Concentration	PLOS ONE			English	Article								Background: Halophiles are extremophiles that thrive in environments with very high concentrations of salt. Although the salt reliance and physiology of these extremophiles have been widely investigated, the molecular working mechanisms of their enzymes under salty conditions have been little explored. Methodology/Principal Findings: A halophilic esterolytic enzyme LipC derived from archeaon Haloarcula marismortui was overexpressed from Escherichia coli BL21. The purified enzyme showed a range of hydrolytic activity towards the substrates of p-nitrophenyl esters with different alkyl chains (n = 2 - 16), with the highest activity being observed for p-nitrophenyl acetate, consistent with the basic character of an esterase. The optimal esterase activities were found to be at pH 9.5 and [NaCl] = 3.4 M or [KCl] = 3.0 M and at around 45 degrees C. Interestingly, the hydrolysis activity showed a clear reversibility against changes in salt concentration. At the ambient temperature of 22 degrees C, enzyme systems working under the optimal salt concentrations were very stable against time. Increase in temperature increased the activity but reduced its stability. Circular dichroism (CD), dynamic light scattering (DLS) and small angle neutron scattering (SANS) were deployed to determine the physical states of LipC in solution. As the salt concentration increased, DLS revealed substantial increase in aggregate sizes, but CD measurements revealed the maximal retention of the alpha-helical structure at the salt concentration matching the optimal activity. These observations were supported by SANS analysis that revealed the highest proportion of unimers and dimers around the optimal salt concentration, although the coexistent larger aggregates showed a trend of increasing size with salt concentration, consistent with the DLS data. Conclusions/Significance: The solution alpha-helical structure and activity relation also matched the highest proportion of enzyme unimers and dimers. Given that all the solutions studied were structurally inhomogeneous, it is important for future work to understand how the LipC's solution aggregation affected its activity.			Rao, L (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	mayanhe@im.ac.cn; j.lu@manchester.ac.uk	MA, YAN/HHN-2912-2022; Zhao, Xiubo/A-1690-2011; Li, Yin/C-6644-2009; Lu, Jian/GRY-4556-2022; Zhao, Xiubo/AAZ-9058-2021	Zhao, Xiubo/0000-0002-4620-2893; Li, Yin/0000-0003-0995-3070; Zhao, Xiubo/0000-0002-4620-2893; Yu, Hai/0000-0002-6386-9761				Amoozegar MA, 2008, J BASIC MICROB, V48, P160, DOI 10.1002/jobm.200700361; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bhatnagar T, 2005, FEMS MICROBIOL LETT, V248, P133, DOI 10.1016/j.femsle.2005.05.044; Boutaiba S, 2006, J MOL CATAL B-ENZYM, V41, P21, DOI 10.1016/j.molcatb.2006.03.010; BREUIL C, 1975, CAN J MICROBIOL, V21, P423, DOI 10.1139/m75-061; Cho AR, 2000, FEMS MICROBIOL LETT, V186, P235, DOI 10.1016/S0378-1097(00)00150-6; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Follmer C, 2004, BIOPHYS CHEM, V111, P79, DOI 10.1016/j.bpc.2004.03.009; GONZALEZ C, 1970, Canadian Journal of Microbiology, V16, P1165; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; HERBERT RA, 1992, TRENDS BIOTECHNOL, V10, P395, DOI 10.1016/0167-7799(92)90282-Z; Imamura S, 2000, J BIOCHEM-TOKYO, V127, P419, DOI 10.1093/oxfordjournals.jbchem.a022623; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jinwal UK, 2003, BIOORGAN MED CHEM, V11, P1041, DOI 10.1016/S0968-0896(02)00516-3; Kim J, 1997, BIOTECHNOL BIOENG, V55, P471, DOI 10.1002/(SICI)1097-0290(19970805)55:3<471::AID-BIT2>3.3.CO;2-D; King S.M., 1999, MODERN TECHNIQUES PO, P171; KOJIMA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1564, DOI 10.1271/bbb.58.1564; Li HB, 2005, PROTEIN EXPRES PURIF, V42, P153, DOI 10.1016/j.pep.2005.03.011; Lu JR, 2005, LANGMUIR, V21, P3354, DOI 10.1021/la047162j; Luo Y, 2006, APPL MICROBIOL BIOT, V73, P349, DOI 10.1007/s00253-006-0478-3; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; MONSTADT GM, 1991, BIOCHEM J, V273, P739, DOI 10.1042/bj2730739; MULLERSANTOS M, 2009, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/J.BBALIP.2009.1003.1006; NORBERG P, 1969, J GEN MICROBIOL, V55, P251, DOI 10.1099/00221287-55-2-251; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; OREN A, 1990, INT J SYST BACTERIOL, V40, P209, DOI 10.1099/00207713-40-2-209; Panda T, 2005, APPL MICROBIOL BIOT, V67, P160, DOI 10.1007/s00253-004-1840-y; Pratuangdejkul J, 2000, MICROBIOL RES, V155, P95, DOI 10.1016/S0944-5013(00)80043-9; Reis P, 2009, ADV COLLOID INTERFAC, V147-48, P237, DOI 10.1016/j.cis.2008.06.001; Sana B, 2007, PROCESS BIOCHEM, V42, P1571, DOI 10.1016/j.procbio.2007.05.026; SchmidtDannert C, 1996, BBA-LIPID LIPID MET, V1301, P105, DOI 10.1016/0005-2760(96)00027-6; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; TONIOLO C, 1979, MACROMOLECULES, V12, P620, DOI 10.1021/ma60070a014; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2	37	43	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6980	10.1371/journal.pone.0006980	http://dx.doi.org/10.1371/journal.pone.0006980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759821	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000269796300009
J	Gaidarenko, O; Xu, Y				Gaidarenko, O.; Xu, Y.			Transcription activity is required for p53-dependent tumor suppression	ONCOGENE			English	Article						p53; transcription activity; tumor suppression; metastasis	EMBRYONIC STEM-CELLS; LI-FRAUMENI-SYNDROME; MOUSE MODEL; DNA-DAMAGE; P53 GAIN; APOPTOSIS; CANCER; MICE; PHOSPHORYLATION; ACTIVATION	As a transcription factor, the critical tumor suppressor, p53, directly regulates the transcription of hundreds of genes, leading to cell-cycle arrest, apoptosis, cellular senescence and differentiation. Although it has been assumed that p53 transcription activity is critical for tumor suppression, this assumption has been increasingly contested by recent findings of transcription-independent roles of p53 in apoptosis as well as findings that none of the mutant mice lacking important p53 transcription targets are cancer prone. On the basis of previous findings that p53 transcription activity is abolished in p53(QS) (Leu25Trp26 to Gln25Ser26) knock-in mouse cells after DNA damage, to determine the importance of transcription activity of p53 in tumor suppression, we generated knock-in mice that can conditionally express p53QS protein in a Cre-dependent manner. By breeding the knock-in mice with Lck-Cre transgenic mice that specifically express Cre in thymocytes, we show that p53-dependent suppression of thymic lymphomas is abolished in thymocytes expressing high levels of p53QS protein. In addition, p53QS protein is accumulated in some of the thymic tumors. Therefore, p53 transcription activity induced by DNA damage is required for tumor suppression. Together with the findings that the disruption of various p53-dependent functions individually fails to promote cancer, our findings indicate that various transcription-dependent functions of p53 must collaborate to efficiently suppress tumorigenesis. Oncogene (2009) 28, 4397-4401; doi: 10.1038/onc.2009.290; published online 21 September 2009	[Gaidarenko, O.; Xu, Y.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.du		Xu, Yang/0000-0001-5574-921X; Gaidarenko, Olga/0000-0002-3259-3352	NIH [R01 CA94254]; NATIONAL CANCER INSTITUTE [R01CA094254] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T Lin and C Chao for their help in constructing the p53QS mice. This work was supported by a NIH grant (R01 CA94254) to YX.	BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Schuler M, 2005, TRENDS GENET, V21, P182, DOI 10.1016/j.tig.2005.01.001; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xu Y, 2005, CELL CYCLE, V4, P363, DOI 10.4161/cc.4.3.1529	28	13	13	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4397	4401		10.1038/onc.2009.290	http://dx.doi.org/10.1038/onc.2009.290			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19767771	Green Accepted			2022-12-25	WOS:000272876400008
J	Chan, IH; Privalsky, ML				Chan, I. H.; Privalsky, M. L.			Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire	ONCOGENE			English	Article						hepatocellular carcinoma; thyroid hormone receptors; gene expression; mutant; dominant negative	AVIAN ERYTHROBLASTOSIS VIRUS; V-ERBA; NUCLEAR RECEPTORS; MOLECULAR-BASIS; RETINOIC ACID; HIGH-AFFINITY; HUMAN CANCER; HEPG2 CELLS; C-ERBA; RESISTANCE	Thyroid hormone receptors (TRs) are hormone-regulated transcription factors that control multiple aspects of normal physiology and development. Mutations in TRs have been identified at high frequency in certain cancers, including human hepatocellular carcinomas (HCCs). The majority of HCC-TR mutants bear lesions within their DNA recognition domains, and we have hypothesized that these lesions change the mutant receptors' target gene repertoire in a way crucial to their function as oncoproteins. Using stable cell transformants and expression array analysis, we determined that mutant TRs isolated from two different HCCs do, as hypothesized, display a target gene repertoire distinct from that of their normal TR progenitors. Only a subset of genes regulated by wild-type TRs was regulated by the corresponding HCC-TR mutants. More surprisingly, the HCC-TR mutants also gained the ability to regulate additional target genes not recognized by the wild-type receptors, and were not simply restricted to repression, but could also activate a subset of their target genes. We conclude that the TR mutants isolated from HCC have sustained multiple alterations from their normal progenitors that include not only changes in their transcriptional outputs, but also changes in the genes they target; both are likely to contribute to neoplasia. Oncogene (2009) 28, 4162-4174; doi: 10.1038/onc.2009.265; published online 14 September 2009	[Chan, I. H.; Privalsky, M. L.] Univ Calif Davis, Dept Microbiol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Privalsky, ML (corresponding author), Univ Calif Davis, Dept Microbiol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	mlprivalsky@ucdavis.edu	Chan, Ivan/B-7922-2010	Chan, Ivan/0000-0003-2834-2574	Public Health Service/National Cancer Institute [R37-CA53394]; UC Davis Cancer Center Gene Expression Resource [NCI P30-CA93373]; National Institute of General Medical Sciences [T32-GM007377]; NATIONAL CANCER INSTITUTE [P30CA093373, R37CA053394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	Public Health Service/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); UC Davis Cancer Center Gene Expression Resource; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are extremely grateful to Liming Liu for excellent technical assistance, Michael L Goodson for expert assistance in analysis of the array data, and Elsie L Campbell for helpful discussions. This work was supported by the Public Health Service/National Cancer Institute award R37-CA53394 and by the UC Davis Cancer Center Gene Expression Resource (NCI P30-CA93373). IHC was supported in part by a PHS predoctoral training award, T32-GM007377, from the National Institute of General Medical Sciences.	BARLOW C, 1994, EMBO J, V13, P4241, DOI 10.1002/j.1460-2075.1994.tb06744.x; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; BONDE BG, 1990, J VIROL, V64, P1314, DOI 10.1128/JVI.64.3.1314-1320.1990; Brent G A, 2000, Rev Endocr Metab Disord, V1, P27, DOI 10.1023/A:1010056202122; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Chamba A, 1996, J CLIN ENDOCR METAB, V81, P360, DOI 10.1210/jc.81.1.360; Chan IH, 2006, ONCOGENE, V25, P3576, DOI 10.1038/sj.onc.1209389; CHEN HW, 1993, MOL CELL BIOL, V13, P2366, DOI 10.1128/MCB.13.4.2366; Cheng S Y, 2000, Rev Endocr Metab Disord, V1, P9, DOI 10.1023/A:1010052101214; Cheng SY, 2005, TRENDS ENDOCRIN MET, V16, P176, DOI 10.1016/j.tem.2005.03.008; Cheng SY, 2003, MOL CELL ENDOCRINOL, V213, P23, DOI 10.1016/j.mce.2003.10.051; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DARBY IA, 1991, IN VITRO CELL DEV B, V27, P21, DOI 10.1007/BF02630890; DeGroot LJ, 1996, ANN INTERN MED, V125, P623, DOI 10.7326/0003-4819-125-7-199610010-00022; DESBOIS C, 1991, CELL, V67, P731, DOI 10.1016/0092-8674(91)90068-A; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamiya Y, 2002, CARCINOGENESIS, V23, P25, DOI 10.1093/carcin/23.1.25; KATZ RW, 1993, J BIOL CHEM, V268, P19392; Kopp P, 1996, P SOC EXP BIOL MED, V211, P49; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lee AY, 2004, BIOCHEM BIOPH RES CO, V323, P1246, DOI 10.1016/j.bbrc.2004.09.001; Lin KH, 1997, ENDOCRINOLOGY, V138, P5308, DOI 10.1210/en.138.12.5308; Lin KH, 1996, ENDOCRINOLOGY, V137, P4073, DOI 10.1210/en.137.10.4073; Lin KH, 1999, MOL CARCINOGEN, V26, P53, DOI 10.1002/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Meyer T, 1997, J BIOL CHEM, V272, P21090, DOI 10.1074/jbc.272.34.21090; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Murata Y, 1998, Nagoya J Med Sci, V61, P103; Nygard M, 2003, MOL ENDOCRINOL, V17, P79, DOI 10.1210/me.2002-0107; PRIVALSKY ML, 1992, BIOCHIM BIOPHYS ACTA, V1114, P51, DOI 10.1016/0304-419X(92)90006-K; PRIVALSKY ML, 2008, THRYOID HORMONE RECE; Puzianowska-Kuznicka M, 2002, J CLIN ENDOCR METAB, V87, P1120, DOI 10.1210/jc.87.3.1120; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; REFETOFF S, 1993, CLIN LAB MED, V13, P563, DOI 10.1016/S0272-2712(18)30426-8; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Rietveld LEG, 2001, ONCOGENE, V20, P3100, DOI 10.1038/sj.onc.1204335; Rosen MD, 2009, MOL ENDOCRINOL, V23, P1183, DOI 10.1210/me.2009-0126; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SHARIF M, 1991, CELL, V66, P885, DOI 10.1016/0092-8674(91)90435-2; SHARIF M, 1992, ONCOGENE, V7, P953; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Starr DB, 1996, GENE DEV, V10, P1271, DOI 10.1101/gad.10.10.1271; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; THERIAULT A, 1992, BIOCHEM BIOPH RES CO, V186, P617, DOI 10.1016/0006-291X(92)90791-I; Tsai CC, 2004, VITAM HORM, V68, P93; Uht Rosalie M, 2004, Nucl Recept, V2, P2, DOI 10.1186/1478-1336-2-2; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Ventura-Holman T, 2008, GENE, V425, P23, DOI 10.1016/j.gene.2008.08.006; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, J ENDOCRINOL INVEST, V26, P780, DOI 10.1007/BF03347365; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang LP, 2005, CANCER RES, V65, P457	69	31	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 26	2009	28	47					4162	4174		10.1038/onc.2009.265	http://dx.doi.org/10.1038/onc.2009.265			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DQ	19749797	Green Accepted			2022-12-25	WOS:000272876100003
J	Bunpo, P; Dudley, A; Cundiff, JK; Cavener, DR; Wek, RC; Anthony, TG				Bunpo, Piyawan; Dudley, Allison; Cundiff, Judy K.; Cavener, Douglas R.; Wek, Ronald C.; Anthony, Tracy G.			GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent L-Asparaginase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EIF2-ALPHA KINASE; MAMMALIAN TARGET; STRESS RESPONSES; RAPAMYCIN; INDUCTION; LEUKEMIA; GROWTH; PHOSPHORYLATION; TRANSLATION	Asparaginase depletes circulating asparagine and glutamine, activating amino acid deprivation responses (AADR) such as phosphorylation of eukaryotic initiation factor 2 (p-eIF2) leading to increased mRNA levels of asparagine synthetase and CCAAT/enhancer-binding protein beta homologous protein (CHOP) and decreased mammalian target of rapamycin complex 1 (mTORC1) signaling. The objectives of this study were to assess the role of the eIF2 kinases and protein kinase R-like endoplasmic reticulum resident kinase (PERK) in controlling AADR to asparaginase and to compare the effects of asparaginase on mTORC1 to that of rapamycin. In experiment 1, asparaginase increased hepatic p-eIF2 in wild-type mice and mice with a liver-specific PERK deletion but not in GCN2 null mice nor in GCN2-PERK double null livers. In experiment 2, wild-type and GCN2 null mice were treated with asparaginase (3 IU per g of body weight), rapamycin (2 mg per kg of body weight), or both. In wild-type mice, asparaginase but not rapamycin increased p-eIF2, p-ERK1/2, p-Akt, and mRNA levels of asparagine synthetase and CHOP in liver. Asparaginase and rapamycin each inhibited mTORC1 signaling in liver and pancreas but maximally together. In GCN2 null livers, all responses to asparaginase were precluded except CHOP mRNA expression, which remained partially elevated. Interestingly, rapamycin blocked CHOP induction by asparaginase in both wild-type and GCN2 null livers. These results indicate that GCN2 is required for activation of AADR to asparaginase in liver. Rapamycin modifies the hepatic AADR to asparaginase by preventing CHOP induction while maximizing inhibition of mTORC1.	[Bunpo, Piyawan; Dudley, Allison; Cundiff, Judy K.; Anthony, Tracy G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Evansville, IN 47712 USA; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Indiana University System; Indiana University-Purdue University Indianapolis	Anthony, TG (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 8600 Univ Blvd, Evansville, IN 47712 USA.	tganthon@iupui.edu	Cavener, Douglas R/E-3524-2010; Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884; Lyle, Allison/0000-0002-5169-5792	National Institutes of Health [GM49164]; American Institute for Cancer Research; Indiana University School of Medicine; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; Indiana University School of Medicine; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49164 (to R. C. W.), the American Institute for Cancer Research (to T. G. A.), a research enhancement grant from the Indiana University School of Medicine (to T. G. A.), and an American Cancer Society institutional grant (to T. G. A.).	Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Bunpo P, 2008, J NUTR, V138, P338, DOI 10.1093/jn/138.2.338; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; DISTASIO JA, 1976, J BIOL CHEM, V251, P6929; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Entingh AJ, 2001, ENDOCRINOLOGY, V142, P221, DOI 10.1210/en.142.1.221; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; HILL JM, 1967, J AMER MED ASSOC, V202, P882, DOI 10.1001/jama.202.9.882; Holcenberg J, 2004, J PEDIAT HEMATOL ONC, V26, P273, DOI 10.1097/00043426-200405000-00001; Huang QH, 1999, BIOCHEM J, V341, P225, DOI 10.1042/0264-6021:3410225; Janus A, 2009, ANTI-CANCER DRUG, V20, P693, DOI 10.1097/CAD.0b013e32832e89b4; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kimball Sr, 2004, TOP CURR GENET, V7, P113; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Smolewski P, 2006, EXPERT OPIN INV DRUG, V15, P1201, DOI 10.1517/13543784.15.10.1201; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Su N, 2008, PEDIATR BLOOD CANCER, V50, P274, DOI 10.1002/pbc.21213; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	36	88	90	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32742	32749		10.1074/jbc.M109.047910	http://dx.doi.org/10.1074/jbc.M109.047910			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783659	hybrid, Green Published			2022-12-25	WOS:000272028400059
J	Fujita, N; Saitoh, T; Kageyama, S; Akira, S; Noda, T; Yoshimori, T				Fujita, Naonobu; Saitoh, Tatsuya; Kageyama, Shun; Akira, Shizuo; Noda, Takeshi; Yoshimori, Tamotsu			Differential Involvement of Atg16L1 in Crohn Disease and Canonical Autophagy ANALYSIS OF THE ORGANIZATION OF THE Atg16L1 COMPLEX IN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; MEMBRANE BIOGENESIS; PROTEIN; LC3; LIPIDATION; MOUSE; CELLS; PATHOGENESIS; CONJUGATE; VARIANT	A single nucleotide polymorphism in Atg16L1, an autophagy-related gene (ATG), is a risk factor for Crohn disease, a major form of chronic inflammatory bowel disease. However, it is still unknown how the Atg16L1 variant contributes to disease development. The Atg16L1 protein possesses a C-terminal WD repeat domain whose function is entirely unknown, and the Crohn disease-associated mutation (T300A) is within this domain. To elucidate the function of the WD repeat domain, we established an experimental system in which a WD repeat domain mutant of Atg16L1 is stably expressed in Atg16L1-deficient mouse embryonic fibroblasts. Using the system, we show that the Atg16L1 complex forms a dimeric complex and that the total Atg16L1 protein level is strictly maintained, possibly by the ubiquitin proteasome system. Furthermore, we show that an Atg16L1 WD repeat domain deletion and the T300A mutant have little impact on canonical autophagy and autophagy against Salmonella enterica serovar Typhimurium. Therefore, we propose that Atg16L1 T300A is differentially involved in Crohn disease and canonical autophagy.	[Fujita, Naonobu; Kageyama, Shun; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Yoshimori, T (corresponding author), Osaka Univ, Dept Cellular Regulat, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tamyoshi@biken.osaka-u.ac.jp	Fujita, Naonobu/A-1218-2010; Akira, Shizuo/C-3134-2009; Noda, Takeshi/B-7240-2008	Noda, Takeshi/0000-0003-3581-7961; Fujita, Naonobu/0000-0003-1914-8438	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology (to T. Y. and T. N.), the Japan Society for the Promotion of Science (to N. F.), and the Takeda Science Foundation (to T. Y.).	Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hosokawa N, 2007, FEBS LETT, V581, P2623, DOI 10.1016/j.febslet.2006.04.008; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010	27	95	97	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32602	32609		10.1074/jbc.M109.037671	http://dx.doi.org/10.1074/jbc.M109.037671			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783656	hybrid, Green Published			2022-12-25	WOS:000272028400042
J	Domazet, I; Martin, SS; Holleran, BJ; Morin, ME; Lacasse, P; Lavigne, P; Escher, E; Leduc, R; Guillemette, G				Domazet, Ivana; Martin, Stephane S.; Holleran, Brian J.; Morin, Marie-Eve; Lacasse, Patrick; Lavigne, Pierre; Escher, Emanuel; Leduc, Richard; Guillemette, Gaetan			The Fifth Transmembrane Domain of Angiotensin II Type 1 Receptor Participates in the Formation of the Ligand-binding Pocket and Undergoes a Counterclockwise Rotation upon Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CYSTEINE ACCESSIBILITY METHOD; MEMBRANE-SPANNING SEGMENT; HUMAN AT(1) RECEPTOR; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVATION; CONFORMATIONAL-CHANGES; CONTACT POINTS; SITE CREVICE; RHODOPSIN	The octapeptide hormone angiotensin II exerts a wide variety of cardiovascular effects through the activation of the angiotensin II Type 1 (AT(1)) receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT(1) receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand-binding pocket. The role of the fifth transmembrane domain (TMD5) was investigated using the substituted cysteine accessibility method. All of the residues within Thr-190 to Leu-217 region were mutated one at a time to cysteine, and after expression in COS-7 cells, the mutant receptors were treated with the sulfhydryl-specific alkylating agent methanethiosulfonate-ethylammonium (MTSEA). MTSEA reacts selectively with water-accessible, free sulfhydryl groups of endogenous or introduced point mutation cysteines. If a cysteine is found in the binding pocket, the covalent modification will affect the binding kinetics of the ligand. MTSEA substantially decreased the binding affinity of L197C-AT(1), N200C-AT(1), I201C-AT(1), G203C-AT(1), and F204C-AT(1) mutant receptors, which suggests that these residues orient themselves within the water-accessible binding pocket of the AT(1) receptor. Interestingly, this pattern of acquired MTSEA sensitivity was altered for TMD5 reporter cysteines engineered in a constitutively active N111G-AT(1) receptor background. Indeed, mutant I201C-N111G-AT(1) became more sensitive to MTSEA, whereas mutant G203C-N111G-AT(1) lost some sensitivity. Our results suggest that constitutive activation of AT(1) receptor causes an apparent counterclockwise rotation of TMD5 as viewed from the extracellular side.	[Domazet, Ivana; Martin, Stephane S.; Holleran, Brian J.; Morin, Marie-Eve; Lacasse, Patrick; Lavigne, Pierre; Escher, Emanuel; Leduc, Richard; Guillemette, Gaetan] Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Guillemette, G (corresponding author), Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Gaetan.Guillemette@USherbrooke.ca	Lacasse, Pierre/B-5084-2013	Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Javitch JA, 1995, BIOCHEMISTRY-US, V34, P16433, DOI 10.1021/bi00050a026; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; KOJIMA I, 1984, J BIOL CHEM, V259, P4448; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	45	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31953	31961		10.1074/jbc.M109.051839	http://dx.doi.org/10.1074/jbc.M109.051839			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773549	Green Published, hybrid			2022-12-25	WOS:000271572700051
J	Zhao, M; Wan, ZL; Whittaker, L; Xu, B; Phillips, NB; Katsoyannis, PG; Ismail-Beigi, F; Whittaker, J; Weiss, MA				Zhao, Ming; Wan, Zhu-li; Whittaker, Linda; Xu, Bin; Phillips, Nelson B.; Katsoyannis, Panayotis G.; Ismail-Beigi, Faramarz; Whittaker, Jonathan; Weiss, Michael A.			Design of an Insulin Analog with Enhanced Receptor Binding Selectivity RATIONALE, STRUCTURE, AND THERAPEUTIC IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; TYPE-2 DIABETES-MELLITUS; PHOTO-CROSS-LINKING; ALANINE SCANNING MUTAGENESIS; CANCER-RELATED MORTALITY; COLORECTAL-CANCER; CRYSTAL-STRUCTURE; A-CHAIN; RISK; PROTEIN	Insulin binds with high affinity to the insulin receptor (IR) and with low affinity to the type 1 insulin-like growth factor (IGF) receptor (IGFR). Such cross-binding, which reflects homologies within the insulin-IGF signaling system, is of clinical interest in relation to the association between hyperinsulinemia and colorectal cancer. Here, we employ nonstandard mutagenesis to design an insulin analog with enhanced affinity for the IR but reduced affinity for the IGFR. Unnatural amino acids were introduced by chemical synthesis at the N- and C-capping positions of a recognition alpha-helix (residues A1 and A8). These sites adjoin the hormone-receptor interface as indicated by photocross-linking studies. Specificity is enhanced more than 3-fold on the following: (i) substitution of Gly(A1) by D-Ala or D-Leu, and (ii) substitution of Thr(A8) by diaminobutyric acid (Dab). The crystal structure of [D-Ala(A1), Dab(A8)] insulin, as determined within a T-6 zinc hexamer to a resolution of 1.35 angstrom, is essentially identical to that of human insulin. The nonstandard side chains project into solvent at the edge of a conserved receptor-binding surface shared by insulin and IGF-I. Our results demonstrate that modifications at this edge discriminate between IR and IGFR. Because hyperinsulinemia is typically characterized by a 3-fold increase in integrated postprandial insulin concentrations, we envisage that such insulin analogs may facilitate studies of the initiation and progression of cancer in animal models. Future development of clinical analogs lacking significant IGFR cross-binding may enhance the safety of insulin replacement therapy in patients with type 2 diabetes mellitus at increased risk of colorectal cancer.	[Zhao, Ming; Wan, Zhu-li; Whittaker, Linda; Xu, Bin; Phillips, Nelson B.; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Katsoyannis, Panayotis G.] NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Case Western Reserve University; Case Western Reserve University; Icahn School of Medicine at Mount Sinai; New York University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu		Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK065890, DK40949, DK074176]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK065890, R01DK074176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK065890 (to J.W.) and DK40949 and DK074176 (to M. A. W.). This article is a contribution from the Cleveland Center for Structural Biology.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Berster Jutta M., 2008, Archives of Physiology and Biochemistry, V114, P84, DOI [10.1080/13813450802008455, 10.1080/13813450802008455 ]; Berti L, 1998, HORM METAB RES, V30, P123, DOI 10.1055/s-2007-978849; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chung YW, 2008, DIS COLON RECTUM, V51, P593, DOI 10.1007/s10350-007-9184-1; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; COSMATOS A, 1978, J BIOL CHEM, V253, P6586; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Donovan EA, 2008, CRIT REV ONCOL HEMAT, V66, P91, DOI 10.1016/j.critrevonc.2007.09.003; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GEIGER R, 1975, H-S Z PHYSIOL CHEM, V356, P1635, DOI 10.1515/bchm2.1975.356.2.1635; GEIGER R, 1982, H-S Z PHYSIOL CHEM, V363, P1231, DOI 10.1515/bchm2.1982.363.2.1231; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Heald A, 2006, DIABETIC MED, V23, P19, DOI 10.1111/j.1464-5491.2006.01833f.x; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; HUANG Z, 1994, J CLIN INVEST, V94, P1289, DOI 10.1172/JCI117447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYAN.PG, 1972, BIOCHEMISTRY-US, V11, P1128, DOI 10.1021/bi00757a002; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Kochendoerfer GG, 1999, CURR OPIN CHEM BIOL, V3, P665, DOI 10.1016/S1367-5931(99)00024-1; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; KRAIL G, 1975, H-S Z PHYSIOL CHEM, V356, P981, DOI 10.1515/bchm2.1975.356.s1.981; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; Monami M, 2008, EXP CLIN ENDOCR DIAB, V116, P184, DOI 10.1055/s-2007-992157; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Nanjo K, 1986, Trans Assoc Am Physicians, V99, P132; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Sun J, 2008, CELL SIGNAL, V20, P219, DOI 10.1016/j.cellsig.2007.10.010; Tran TT, 2006, ENDOCRINOLOGY, V147, P1830, DOI 10.1210/en.2005-1012; WAN Z, 1988, SCI CHINA SER B, V31, P1426; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Weiss MA, 2002, J MOL BIOL, V315, P103, DOI 10.1006/jmbi.2001.5224; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	72	8	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32178	32187		10.1074/jbc.M109.028399	http://dx.doi.org/10.1074/jbc.M109.028399			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773552	hybrid, Green Published			2022-12-25	WOS:000271572700072
J	Lung, M; Shulga, YV; Ivanova, PT; Myers, DS; Milne, SB; Brown, HA; Topham, MK; Epand, RM				Lung, Michael; Shulga, Yulia V.; Ivanova, Pavlina T.; Myers, David S.; Milne, Stephen B.; Brown, H. Alex; Topham, Matthew K.; Epand, Richard M.			Diacylglycerol Kinase epsilon Is Selective for Both Acyl Chains of Phosphatidic Acid or Diacylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; DICTYOSTELIUM-DISCOIDEUM; ARABIDOPSIS-THALIANA; HYDROPHOBIC SEGMENT; GENE-EXPRESSION; BINDING DOMAINS; NERVOUS-SYSTEM; IN-VITRO; PROTEIN; ISOFORMS	The phosphatidylinositol ( PI) cycle mediates many cellular events by controlling the metabolism of many lipid second messengers. Diacylglycerol kinase epsilon (DGK epsilon) has an important role in this cycle. DGK epsilon is the only DGK isoform to show inhibition by its product phosphatidic acid (PA) as well as substrate specificity for sn-2 arachidonoyl-diacylglycerol (DAG). Here, we show that this inhibition and substrate specificity are both determined by selectivity for a combination of the sn-1 and sn-2 acyl chains of PA or DAG, respectively, preferring the most prevalent acyl chain composition of lipids involved specifically in the PI cycle, 1-stearoyl-2-arachidonoyl. Although the difference in rate for closely related lipid species is small, there is a significant enrichment of 1-stearoyl-2-arachidonoyl PI because of the cyclical nature of PI turnover. Wealso show that the inhibition of DGK epsilon by PA is competitive and that the deletion of the hydrophobic segment and cationic cluster of DGK epsilon does not affect its selectivity for the acyl chains of PA or DAG. Thus, this active site not only recognizes the lipid headgroup but also a combination of the two acyl chains in PA or DAG. We propose a mechanism of DGK epsilon regulation where its dual acyl chain selectivity is used to negatively regulate its enzymatic activity in a manner that ensures DGK epsilon remains committed to the PI turnover cycle. This novel mechanism of enzyme regulation within a signaling pathway could serve as a template for the regulation of enzymes in other pathways in the cell.	[Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Ivanova, Pavlina T.; Myers, David S.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	McMaster University; Vanderbilt University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Epand, RM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	epand@mcmaster.ca	, Richard/R-2316-2019; Ivanova, Pavlina/K-8307-2012	, Richard/0000-0002-9602-9558; 	National Institutes of Health [R01-CA95463, U54 GM069338]; Natural Sciences and Engineering Research Council of Canada [9848]; NATIONAL CANCER INSTITUTE [R01CA095463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA95463 (to M.K.T.) and by National Institutes of Health Large Scale Collaborative Initiative LIPID MAPS Grant U54 GM069338 (to H.A.B.). This work was also supported by Natural Sciences and Engineering Research Council of Canada Grant 9848 (to R.M.E.).	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cipres A, 2003, J BIOL CHEM, V278, P35629, DOI 10.1074/jbc.M305635200; de la Roche MA, 2002, BIOCHEM J, V368, P809, DOI 10.1042/BJ20021027; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Deems RA, 2000, ANAL BIOCHEM, V287, P1, DOI 10.1006/abio.2000.4766; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Dicu AO, 2007, BIOCHEMISTRY-US, V46, P6109, DOI 10.1021/bi6024726; Epand RM, 2007, BIOCHEMISTRY-US, V46, P14225, DOI 10.1021/bi701584v; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Gomez-Merino FC, 2005, J BIOL CHEM, V280, P34888, DOI 10.1074/jbc.M506859200; Gomez-Merino FC, 2004, J BIOL CHEM, V279, P8230, DOI 10.1074/jbc.M312187200; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Gotoh A, 2008, ARTHROPOD STRUCT DEV, V37, P199, DOI 10.1016/j.asd.2007.11.001; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; HARDEN N, 1993, BIOCHEM J, V289, P439, DOI 10.1042/bj2890439; Holub B J, 1978, Adv Lipid Res, V16, P1; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; JONES GA, 1993, J BIOL CHEM, V268, P20845; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; KAI M, 1994, J BIOL CHEM, V269, P18492; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Katagiri T, 1996, PLANT MOL BIOL, V30, P647, DOI 10.1007/BF00049339; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; MASAI I, 1992, P NATL ACAD SCI USA, V89, P6030, DOI 10.1073/pnas.89.13.6030; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Milne SB, 2008, BIOCHEMISTRY-US, V47, P9372, DOI 10.1021/bi800492c; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Ostroski M, 2005, BIOCHEMISTRY-US, V44, P10199, DOI 10.1021/bi0507276; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pettitt TR, 1999, J BIOL CHEM, V274, P36181, DOI 10.1074/jbc.274.51.36181; Postle AD, 2004, BIOCHEM SOC T, V32, P1057, DOI 10.1042/BST0321057; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SAKANE F, 1991, J BIOL CHEM, V266, P7096; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; TANG Q, 1996, J BIOL CHEM, V271, P10237; Thirugnanam S, 2001, BIOCHEMISTRY-US, V40, P10607, DOI 10.1021/bi010609s; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Tu-Sekine B, 2007, BIOCHEMISTRY-US, V46, P924, DOI 10.1021/bi061170c; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; WALSH JP, 1994, J BIOL CHEM, V269, P21155; WALSH JP, 1995, J BIOL CHEM, V270, P28647, DOI 10.1074/jbc.270.48.28647	58	50	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31062	31073		10.1074/jbc.M109.050617	http://dx.doi.org/10.1074/jbc.M109.050617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744926	Green Published, hybrid			2022-12-25	WOS:000271378400035
J	Faa, V; Incani, F; Meloni, A; Corda, D; Masala, M; Baffico, AM; Seia, M; Cao, A; Rosatelli, MC				Faa, Valeria; Incani, Federica; Meloni, Alessandra; Corda, Denise; Masala, Maddalena; Baffico, A. Maria; Seia, Manuela; Cao, Antonio; Rosatelli, M. Cristina			Characterization of a Disease-associated Mutation Affecting a Putative Splicing Regulatory Element in Intron 6b of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MESSENGER-RNA; VAS-DEFERENS; DISSEMINATED BRONCHIECTASIS; CONGENITAL ABSENCE; EXON; PROTEINS; COMPLEX; PANCREATITIS; SPLICEOSOME	Cystic fibrosis (CF) is a common recessive disorder caused by > 1600 mutations in the CF transmembrane conductance regulator (CFTR) gene. About 13% of CFTR mutations are classified as "splicing mutations," but for almost 40% of these, their role in affecting the pre-mRNA splicing of the gene is not yet defined. In this work, we describe a new splicing mutation detected in three unrelated Italian CF patients. By DNA analyses and mRNA studies, we identified the c.1002-1110_1113delTAAG mutation localized in intron 6b of the CFTR gene. At the mRNA level, this mutation creates an aberrant inclusion of a sequence of 101 nucleotides between exons 6b and 7. This sequence corresponds to a portion of intron 6b and resembles a cryptic exon because it is characterized by an upstream ag and a downstream gt sequence, which are most probably recognized as 5'- and 3'-splice sites by the spliceosome. Through functional analysis of this splicing defect, we show that this mutation abolishes the interaction of the splicing regulatory protein heterogeneous nuclear ribonucleoprotein A2/B1 with an intronic splicing regulatory element and creates a new recognition motif for the SRp75 splicing factor, causing activation of the cryptic exon. Our results show that the c.1002-1110_1113delTAAG mutation creates a new intronic splicing regulatory element in intron 6b of the CFTR gene exclusively recognized by SRp75.	[Incani, Federica; Corda, Denise; Masala, Maddalena; Rosatelli, M. Cristina] Univ Cagliari, Dipt Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; [Faa, Valeria; Meloni, Alessandra; Cao, Antonio] CNR, Ist Neurogenet & Neurofarmacol, I-09042 Cagliari, Italy; [Baffico, A. Maria] Ente Osped Galliera, I-16128 Genoa, Italy; [Seia, Manuela] Fdn Policlin Mangiagalli & Regina Elena, I-20122 Milan, Italy	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Ente Ospedaliero Ospedali Galliera; IRCCS Ca Granda Ospedale Maggiore Policlinico	Rosatelli, MC (corresponding author), Univ Cagliari, Dipt Sci Biomed & Biotecnol, Via Jenner, I-09121 Cagliari, Italy.	rosatelli@mcweb.unica.it		MASALA, MADDALENA/0000-0003-1222-2885; Faa, Valeria/0000-0001-9783-7904; ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190; incani, federica/0000-0003-2699-8035	Italian Cystic Fibrosis Research Foundation [FFC24/2006]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This work was supported by an Italian Cystic Fibrosis Research Foundation grant (to M. C. R.), Project FFC24/2006, adopted by Silvana Ratti (Pesaro, Italy).	AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chiba-Falek O, 1998, GENOMICS, V53, P276, DOI 10.1006/geno.1998.5517; Chiba-Falek O, 1999, AM J RESP CRIT CARE, V159, P1998, DOI 10.1164/ajrccm.159.6.9808012; CHILLON M, 1995, AM J HUM GENET, V56, P623; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; COSTES B, 1995, EUR J HUM GENET, V3, P285; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; Faa V, 2006, J MOL DIAGN, V8, P499, DOI 10.2353/jmoldx.2006.050146; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Girodon E, 1997, EUR J HUM GENET, V5, P149, DOI 10.1159/000484750; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Groman JD, 2002, NEW ENGL J MED, V347, P401, DOI 10.1056/NEJMoa011899; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Ishii S, 2002, AM J HUM GENET, V70, P994, DOI 10.1086/339431; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nissim-Rafinia M, 2000, HUM MOL GENET, V9, P1771, DOI 10.1093/hmg/9.12.1771; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; PIGNATTI PF, 1995, HUM MOL GENET, V4, P635, DOI 10.1093/hmg/4.4.635; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Vervoort R, 1998, HUM GENET, V103, P686, DOI 10.1007/PL00008709; Wang M, 1997, BREAST CANCER RES TR, V44, P145, DOI 10.1023/A:1005753117205; Welsh MJ, 1995, CYSTIC FIBROSIS META, P3799; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; ZIELENSKI J, 1995, AM J HUM GENET, V57, P958	36	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30024	30031		10.1074/jbc.M109.032623	http://dx.doi.org/10.1074/jbc.M109.032623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19759008	Green Published, hybrid			2022-12-25	WOS:000271090000004
J	Sette, M; Spurio, R; Trotta, E; Brandizi, C; Brandi, A; Pon, CL; Barbato, G; Boelens, R; Gualerzi, CO				Sette, Marco; Spurio, Roberto; Trotta, Edoardo; Brandizi, Cinzia; Brandi, Anna; Pon, Cynthia L.; Barbato, Gaetano; Boelens, Rolf; Gualerzi, Claudio O.			Sequence-specific Recognition of DNA by the C-terminal Domain of Nucleoid-associated Protein H-NS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CURVED DNA; TRANSCRIPTIONAL CONTROL; STRUCTURAL BASIS; BINDING PROTEIN; VIRF PROMOTER; GENE; SHIGELLA; EXPRESSION; OLIGOMERIZATION	The molecular determinants necessary and sufficient for recognition of its specific DNA target are contained in the C-terminal domain (H-NSctd) of nucleoid-associated protein H-NS. H-NSctd protects from DNaseI cleavage a few short DNA segments of the H-NS-sensitive hns promoter whose sequences closely match the recently identified H-NS consensus motif (tCG(t/a)T(a/t)AATT) and, alone or fused to the protein oligomerization domain of phage lambda CI repressor, inhibits transcription from the hns promoter in vitro and in vivo. The importance of H-NS oligomerization is indicated by the fact that with an extended hns promoter construct (400 bp), which allows protein oligomerization, DNA binding and transcriptional repression are highly and almost equally efficient with native H-NS and H-NSctd::lambda CI and much less effective with the monomeric H-NSctd. With a shorter (110 bp) construct, which does not sustain extensive protein oligomerization, transcriptional repression is less effective, but native H-NS, H-NSctd::lambda CI, and monomeric H-NSctd have comparable activity on this construct. The specific H-NS-DNA interaction was investigated by NMR spectroscopy using monomeric H-NSctd and short DNA duplexes encompassing the H-NS target sequence of hns (TCCTTACATT) with the best fit (8 of 10 residues) to the H-NS-binding motif. H-NSctd binds specifically and with high affinity to the chosen duplexes via an overall electropositive surface involving four residues (Thr(109), Arg(113), Thr(114), and Ala(116)) belonging to the same protein loop and Glu(101). The DNA target is recognized by virtue of its sequence and of a TpA step that confers a structural irregularity to the B-DNA duplex.	[Spurio, Roberto; Brandizi, Cinzia; Brandi, Anna; Pon, Cynthia L.; Gualerzi, Claudio O.] Univ Camerino, Genet Lab, Dept Biol, I-62032 Camerino, MC, Italy; [Trotta, Edoardo] CNR, Inst Neurobiol & Mol Med, I-00133 Rome, Italy; [Sette, Marco] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Barbato, Gaetano] Merck Ist Ric Biol Mol P Angeletti, I-00040 Pomezia, Italy; [Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Camerino; Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata; Merck & Company; Utrecht University	Gualerzi, CO (corresponding author), Univ Camerino, Genet Lab, Dept Biol MCA, I-62032 Camerino, MC, Italy.	claudio.gualerzi@unicam.it	Trotta, Edoardo/AAW-4697-2020; Barbato, Gaetano/G-4904-2011; Boelens, Rolf/B-4702-2009	Trotta, Edoardo/0000-0002-1417-9238; Barbato, Gaetano/0000-0001-9840-6858; Boelens, Rolf/0000-0002-6939-8913; Spurio, Roberto/0000-0002-7611-4341	Programmi di Ricerca di Rilevante Interesse Nazionale [PRIN 2003, PRIN 2005]; Ministero dell'Istruzione; dell'Universita e della Ricerca; European Commission [RII3-026145]	Programmi di Ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Programmi di Ricerca di Rilevante Interesse Nazionale Grants PRIN 2003 (to C. L. P. and M. S.) and PRIN 2005 ( to C. L. P. and R. S.) from the Ministero dell'Istruzione, dell'Universita e della Ricerca and by Contract RII3-026145 from the European Commission 6th Framework for Access to Research Infrastructures.	Badaut C, 2002, J BIOL CHEM, V277, P41657, DOI 10.1074/jbc.M206037200; BAIN DL, 1994, BIOCHEMISTRY-US, V33, P14679, DOI 10.1021/bi00253a005; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Dame RT, 2001, BIOCHIMIE, V83, P231; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DERSCH P, 1993, MOL MICROBIOL, V8, P875, DOI 10.1111/j.1365-2958.1993.tb01634.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; FALCONI M, 1993, MOL MICROBIOL, V10, P273, DOI 10.1111/j.1365-2958.1993.tb01953.x; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Goldenberg D, 1997, MOL GEN GENET, V256, P282, DOI 10.1007/s004380050571; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; LATEANA A, 1991, P NATL ACAD SCI USA, V88, P10907, DOI 10.1073/pnas.88.23.10907; Leonard PG, 2009, MOL MICROBIOL, V73, P165, DOI 10.1111/j.1365-2958.2009.06754.x; Lingbeck J, 1996, BIOCHEMISTRY-US, V35, P719, DOI 10.1021/bi951364k; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Madrid C, 2002, J BACTERIOL, V184, P5058, DOI 10.1128/JB.184.18.5058-5066.2002; Pon CL, 2005, MOL B INT U, P52; Prosseda G, 2004, MOL MICROBIOL, V51, P523, DOI 10.1046/j.1365-2958.2003.03848.x; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; RIMSKY S, 1990, BIOCHEMISTRY-US, V29, P3765, DOI 10.1021/bi00467a024; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Rimsky S, 2001, MOL MICROBIOL, V42, P1311, DOI 10.1046/j.1365-2958.2001.02706.x; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; TIPPNER D, 1995, J BIOL CHEM, V270, P22243, DOI 10.1074/jbc.270.38.22243; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; USSERY DW, 1994, BIOCHIMIE, V76, P968, DOI 10.1016/0300-9084(94)90022-1; WIJMENGA SS, 1993, NMR MACROMOLECULES P, P216; YAMADA H, 1990, J BIOCHEM-TOKYO, V108, P420, DOI 10.1093/oxfordjournals.jbchem.a123216; YAMADA H, 1991, MOL GEN GENET, V230, P332, DOI 10.1007/BF00290685; YASUZAWA K, 1992, GENE, V122, P9; ZUBER F, 1994, MOL MICROBIOL, V12, P231, DOI 10.1111/j.1365-2958.1994.tb01012.x	44	36	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30453	30462		10.1074/jbc.M109.044313	http://dx.doi.org/10.1074/jbc.M109.044313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740756	Green Published, hybrid			2022-12-25	WOS:000271090000048
J	Bull, M; Learn, G; Genowati, I; McKernan, J; Hitti, J; Lockhart, D; Tapia, K; Holte, S; Dragavon, J; Coombs, R; Mullins, J; Frenkel, L				Bull, Marta; Learn, Gerald; Genowati, Indira; McKernan, Jennifer; Hitti, Jane; Lockhart, David; Tapia, Kenneth; Holte, Sarah; Dragavon, Joan; Coombs, Robert; Mullins, James; Frenkel, Lisa			Compartmentalization of HIV-1 within the Female Genital Tract Is Due to Monotypic and Low-Diversity Variants Not Distinct Viral Populations	PLOS ONE			English	Article								Background: Compartmentalization of HIV-1 between the genital tract and blood was noted in half of 57 women included in 12 studies primarily using cell-free virus. To further understand differences between genital tract and blood viruses of women with chronic HIV-1 infection cell-free and cell-associated virus populations were sequenced from these tissues, reasoning that integrated viral DNA includes variants archived from earlier in infection, and provides a greater array of genotypes for comparisons. Methodology/Principal Findings: Multiple sequences from single-genome-amplification of HIV-1 RNA and DNA from the genital tract and blood of each woman were compared in a cross-sectional study. Maximum likelihood phylogenies were evaluated for evidence of compartmentalization using four statistical tests. Genital tract and blood HIV-1 appears compartmentalized in 7/13 women by >= 2 statistical analyses. These subjects' phylograms were characterized by low diversity genital-specific viral clades interspersed between clades containing both genital and blood sequences. Many of the genital-specific clades contained monotypic HIV-1 sequences. In 2/7 women, HIV-1 populations were significantly compartmentalized across all four statistical tests; both had low diversity genital tract-only clades. Collapsing monotypic variants into a single sequence diminished the prevalence and extent of compartmentalization. Viral sequences did not demonstrate tissue-specific signature amino acid residues, differential immune selection, or co-receptor usage. Conclusions/Significance: In women with chronic HIV-1 infection multiple identical sequences suggest proliferation of HIV-1-infected cells, and low diversity tissue-specific phylogenetic clades are consistent with bursts of viral replication. These monotypic and tissue-specific viruses provide statistical support for compartmentalization of HIV-1 between the female genital tract and blood. However, the intermingling of these clades with clades comprised of both genital and blood sequences and the absence of tissue-specific genetic features suggests compartmentalization between blood and genital tract may be due to viral replication and proliferation of infected cells, and questions whether HIV-1 in the female genital tract is distinct from blood.			Bull, M (corresponding author), Seattle Childrens Hosp, Res Inst, Seattle, WA USA.	lfrenkel@u.washington.edu	Learn, Gerald H/B-6934-2011; Learn, Jerry/E-3356-2012	Learn, Gerald H/0000-0003-0434-7733; 	NIAID NIH HHS [AI07140, P30 AI27757, T32 AI007140, P30 AI027757] Funding Source: Medline; NICHD NIH HHS [P01 HD040540, 1 P01 HD40540] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, P30AI027757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adal M, 2005, AIDS RES HUM RETROV, V21, P649, DOI 10.1089/aid.2005.21.649; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Andreoletti L, 2007, J CLIN MICROBIOL, V45, P1838, DOI 10.1128/JCM.00113-07; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; BEERLI P, 2001, COMPUTATIONAL EVOLUT, P217; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; BULL ME, 2009, J VIROL; Chomont N, 2007, AIDS, V21, P153, DOI 10.1097/QAD.0b013e328011f94b; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Critchlow DE, 2000, MATH COMPUT MODEL, V32, P69, DOI 10.1016/S0895-7177(00)00120-5; De Pasquale MP, 2003, JAIDS-J ACQ IMM DEF, V34, P37, DOI 10.1097/00126334-200309010-00005; DELASSUS S, 1992, J VIROL, V66, P5642, DOI 10.1128/JVI.66.9.5642-5645.1992; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Delwart EL, 1997, J VIROL, V71, P7498, DOI 10.1128/JVI.71.10.7498-7508.1997; Diem K, 2008, AIDS RES HUM RETROV, V24, P561, DOI 10.1089/aid.2007.0115; Ellerbrock TV, 2001, J INFECT DIS, V184, P28, DOI 10.1086/321000; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frenkel LM, 2006, AIDS RES HUM RETROV, V22, P870, DOI 10.1089/aid.2006.22.870; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hudson RR, 2000, GENETICS, V155, P2011; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; JENSEN MA, 2003, BIOINFORMATIC PREDIC; Kemal KS, 2007, J INFECT DIS, V195, P535, DOI 10.1086/510855; Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Kovacs A, 2001, LANCET, V358, P1593, DOI 10.1016/S0140-6736(01)06653-3; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Min SS, 2004, JAIDS-J ACQ IMM DEF, V37, P1577, DOI 10.1097/00126334-200412150-00008; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Philpott S, 2005, J VIROL, V79, P353, DOI 10.1128/JVI.79.1.353-363.2005; POSS M, 1995, J VIROL, V69, P8118, DOI 10.1128/JVI.69.12.8118-8122.1995; Poss M, 1998, J VIROL, V72, P8240, DOI 10.1128/JVI.72.10.8240-8251.1998; Reichelderfer PS, 2000, AIDS, V14, P2101, DOI 10.1097/00002030-200009290-00005; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Si-Mohamed A, 2000, J INFECT DIS, V182, P112, DOI 10.1086/315679; SLATKIN M, 1989, GENETICS, V123, P603; Sullivan ST, 2005, J VIROL, V79, P9799, DOI 10.1128/JVI.79.15.9799-9809.2005; Tirado G, 2005, VIROLOGY, V334, P299, DOI 10.1016/j.virol.2005.01.030; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Wright TC, 2001, AM J OBSTET GYNECOL, V184, P279, DOI 10.1067/mob.2001.108999; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; ZARATE S, 2007, J VIROL; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	54	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7122	10.1371/journal.pone.0007122	http://dx.doi.org/10.1371/journal.pone.0007122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771165	gold, Green Submitted, Green Published			2022-12-25	WOS:000270154400015
J	James, AW; Theologis, AA; Brugmann, SA; Xu, Y; Carre, AL; Leucht, P; Hamilton, K; Korach, KS; Longaker, MT				James, Aaron W.; Theologis, Alexander A.; Brugmann, Samantha A.; Xu, Yue; Carre, Antoine L.; Leucht, Philipp; Hamilton, Katherine; Korach, Kenneth S.; Longaker, Michael T.			Estrogen/Estrogen Receptor Alpha Signaling in Mouse Posterofrontal Cranial Suture Fusion	PLOS ONE			English	Article								Background: While premature suture fusion, or craniosynostosis, is a relatively common condition, the cause is often unknown. Estrogens are associated with growth plate fusion of endochondral bones. In the following study, we explore the previously unknown significance of estrogen/estrogen receptor signaling in cranial suture biology. Methodology/Principal Findings: Firstly, estrogen receptor (ER) expression was examined in physiologically fusing (posterofrontal) and patent (sagittal) mouse cranial sutures by quantitative RT-PCR. Next, the cranial suture phenotype of ER alpha and ER beta knockout (alpha ERKO, beta ERKO) mice was studied. Subsequently, mouse suture-derived mesenchymal cells (SMCs) were isolated; the effects of 17-beta estradiol or the estrogen antagonist Fulvestrant on gene expression, osteogenic and chondrogenic differentiation were examined in vitro. Finally, in vivo experiments were performed in which Fulvestrant was administered subcutaneously to the mouse calvaria. Results showed that increased ER alpha but not ER beta transcript abundance temporally coincided with posterofrontal suture fusion. The alpha ERKO but not beta ERKO mouse exhibited delayed posterofrontal suture fusion. In vitro, addition of 17-beta estradiol enhanced both osteogenic and chondrogenic differentiation in suture-derived mesenchymal cells, effects reversible by Fulvestrant. Finally, in vivo application of Fulvestrant significantly diminished calvarial osteogenesis, inhibiting suture fusion. Conclusions/Significance: Estrogen signaling through ER alpha but not ER beta is associated with and necessary for normal mouse posterofrontal suture fusion. In vitro studies suggest that estrogens may play a role in osteoblast and/or chondrocyte differentiation within the cranial suture complex.			James, AW (corresponding author), Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Pediat Regenerat Res Lab,Dept Surg, Stanford, CA 94305 USA.	Longaker@stanford.edu	Leucht, Philipp/H-7238-2019	Leucht, Philipp/0000-0002-8409-8513; Korach, Kenneth/0000-0002-7765-418X	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013194, R01DE014526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDCR NIH HHS [R01 DE013194, R01 DE-13194, R01 DE014526, R01 DE-14526] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Albrecht U, 1997, MOL CELLULAR METHODS, P23; Bradley JP, 1997, PLAST RECONSTR SURG, V100, P1091, DOI 10.1097/00006534-199710000-00001; Bradley JP, 1999, PLAST RECONSTR SURG, V104, P129, DOI 10.1097/00006534-199907000-00019; Carani C, 1997, NEW ENGL J MED, V337, P91, DOI 10.1056/NEJM199707103370204; Chagin AS, 2007, ACTA PAEDIATR, V96, P1275, DOI 10.1111/j.1651-2227.2007.00415.x; Chagin AS, 2006, J ENDOCRINOL, V188, P193, DOI 10.1677/joe.1.06364; Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; CHOW JWM, 1992, ENDOCRINOLOGY, V130, P3025, DOI 10.1210/en.130.5.3025; D'Angelo M, 2001, J BONE MINER RES, V16, P2339, DOI 10.1359/jbmr.2001.16.12.2339; Egerbacher M, 2002, HORM RES, V58, P99, DOI 10.1159/000064661; Emmen JMA, 2005, ENDOCRINOLOGY, V146, P2817, DOI 10.1210/en.2004-1108; Farkas LG, 1999, J CRANIOFAC SURG, V10, P18, DOI 10.1097/00001665-199901000-00005; Foo C, 2007, GYNECOL ENDOCRINOL, V23, P535, DOI 10.1080/09513590701556483; Gaissmaier C, 2008, INJURY, V39, pS88, DOI 10.1016/j.injury.2008.01.035; GALLAGHER A, 1993, ENDOCRINOLOGY, V133, P2787, DOI 10.1210/en.133.6.2787; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Greenwald JA, 2001, AM J PATHOL, V158, P441, DOI 10.1016/S0002-9440(10)63987-9; Greenwald JA, 2000, J BONE MINER RES, V15, P2413, DOI 10.1359/jbmr.2000.15.12.2413; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Grumbach MM, 2004, ANN NY ACAD SCI, V1038, P7, DOI 10.1196/annals.1315.008; Hernandez JL, 2008, ARTHRITIS RHEUM, V58, P1696, DOI 10.1002/art.23500; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hirukawa K, 2005, ARCH ORAL BIOL, V50, P367, DOI 10.1016/j.archoralbio.2004.07.003; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Hong L, 2006, TISSUE ENG, V12, P2747, DOI 10.1089/ten.2006.12.2747; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; JACQUES B, 1999, GENE DEV, V13, P2072; James AW, 2008, PLAST RECONSTR SURG, V122, P53, DOI 10.1097/PRS.0b013e31817747b5; James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19; Jemtland R, 2003, BONE, V32, P611, DOI 10.1016/S8756-3282(03)00092-9; Kharode Yogendra P., 2008, V455, P111, DOI 10.1007/978-1-59745-104-8_8; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Koga K, 2008, ANTICANCER RES, V28, P731; KOKICH V G, 1986, P81; Kousteni S, 2007, MOL CELL BIOL, V27, P1516, DOI 10.1128/MCB.01550-06; Lea CK, 1999, J ENDOCRINOL, V160, P111, DOI 10.1677/joe.0.1600111; Lenton KA, 2005, CURR TOP DEV BIOL, V66, P287, DOI 10.1016/S0070-2153(05)66009-7; Lin IC, 2004, J CRANIOFAC SURG, V15, P922, DOI 10.1097/00001665-200411000-00006; Lin IC, 2007, PLAST RECONSTR SURG, V120, P1137, DOI 10.1097/01.prs.0000279527.99734.bf; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Maneix L, 2008, RHEUMATOLOGY, V47, P281, DOI 10.1093/rheumatology/kem323; MANZANARES MC, 1988, J ANAT, V161, P203; McCauley LK, 2003, CONNECT TISSUE RES, V44, P250, DOI 10.1080/03008200390181744; McCauley LK, 2002, CRIT REV EUKAR GENE, V12, P89, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.10; Mehrara BJ, 2002, PLAST RECONSTR SURG, V110, P506, DOI 10.1097/00006534-200208000-00022; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Nilsson O, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730407; Okazaki R, 2002, ENDOCRINOLOGY, V143, P2349, DOI 10.1210/en.143.6.2349; Ong DB, 2004, J BONE MINER RES, V19, P447, DOI 10.1359/JBMR.0301249; Opperman LA, 1997, J BONE MINER RES, V12, P301, DOI 10.1359/jbmr.1997.12.3.301; Panchal J, 2003, PLAST RECONSTR SURG, V111, P2032, DOI 10.1097/01.PRS.0000056839.94034.47; Parikka V, 2005, EUR J ENDOCRINOL, V152, P301, DOI 10.1530/eje.1.01832; Plant A, 2001, J CELL BIOCHEM, V82, P683, DOI 10.1002/jcb.1201; Plant A, 2002, J CELL BIOCHEM, V84, P285, DOI 10.1002/jcb.10021; Qu Q, 1999, J CELL BIOCHEM, V73, P500, DOI 10.1002/(SICI)1097-4644(19990615)73:4<500::AID-JCB8>3.0.CO;2-E; Rao L G, 2001, Drug Metabol Drug Interact, V18, P149; Roth DA, 1997, PLAST RECONSTR SURG, V99, P300, DOI 10.1097/00006534-199702000-00002; Roth DA, 1997, PLAST RECONSTR SURG, V99, P310; Sahar DE, 2005, DEV BIOL, V280, P344, DOI 10.1016/j.ydbio.2005.01.022; Sibonga JD, 1998, ENDOCRINOLOGY, V139, P3736, DOI 10.1210/en.139.9.3736; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Smith EP, 2008, J CLIN ENDOCR METAB, V93, P3088, DOI 10.1210/jc.2007-2397; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Talwar RM, 2006, J ORAL MAXIL SURG, V64, P600, DOI 10.1016/j.joms.2005.12.006; Tang X, 2008, J PERIODONTAL RES, V43, P311, DOI 10.1111/j.1600-0765.2007.01031.x; Tanko LB, 2008, CLIMACTERIC, V11, P4, DOI 10.1080/13697130701857639; van der Eerden BCJ, 2004, J ENDOCRINOL, V180, P457, DOI 10.1677/joe.0.1800457; Van Der Eerden BCJ, 2002, BONE, V30, P478, DOI 10.1016/S8756-3282(01)00703-7; van der Horst G, 2003, BONE, V33, P899, DOI 10.1016/j.bone.2003.07.004; Vanderschueren D, 2006, J CLIN ENDOCR METAB, V91, P378, DOI 10.1210/jc.2005-1766; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Vidal O, 1999, BIOCHEM BIOPH RES CO, V265, P569, DOI 10.1006/bbrc.1999.1711; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; WESTERLIND KC, 1995, STEROIDS, V60, P484, DOI 10.1016/0039-128X(95)00056-V; Xu Y, 2007, PLAST RECONSTR SURG, V119, P819, DOI 10.1097/01.prs.0000255540.91987.a0; Xu Y, 2008, PLAST RECONSTR SURG, V122, P1649, DOI 10.1097/PRS.0b013e31818cbf44; Yamamoto T, 2002, ENDOCRINOLOGY, V143, P2635, DOI 10.1210/en.143.7.2635; Yao XF, 2006, MED MOL MORPHOL, V39, P193, DOI 10.1007/s00795-006-0336-5; Yuasa T, 2002, J CELL PHYSIOL, V193, P225, DOI 10.1002/jcp.10166; ZHANG B, 2005, COMPUTER ENG APPL, V6, P7; Zhou SH, 2003, MOL ENDOCRINOL, V17, P56, DOI 10.1210/me.2002-0210; Zofkova I, 2003, PHYSIOL RES, V52, P657	84	47	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7120	10.1371/journal.pone.0007120	http://dx.doi.org/10.1371/journal.pone.0007120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771170	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154400013
J	Moniaux, N; Nemos, C; Deb, S; Zhu, B; Dornreiter, I; Hollingsworth, MA; Batra, SK				Moniaux, Nicolas; Nemos, Christophe; Deb, Shonali; Zhu, Bing; Dornreiter, Irena; Hollingsworth, Michael A.; Batra, Surinder K.			The Human RNA Polymerase II-Associated Factor 1 (hPaf1): A New Regulator of Cell-Cycle Progression	PLOS ONE			English	Article								Background: The human PAF (hPAF) complex is part of the RNA polymerase II transcription apparatus and regulates multiple steps in gene expression. Further, the yeast homolog of hPaf1 has a role in regulating the expression of a subset of genes involved in the cell-cycle. We therefore investigated the role of hPaf1 during progression of the cell-cycle. Methodology/Findings: Herein, we report that the expression of hPaf1, a subunit of the hPAF complex, increases with cell-cycle progression and is regulated in a cell-cycle dependant manner. hPaf1 specifically regulates a subclass of genes directly implicated in cell-cycle progression during G1/S, S/G2, and G2/M. In prophase, hPaf1 aligns in filament-like structures, whereas in metaphase it is present within the pole forming a crown-like structure, surrounding the centrosomes. Moreover, hPaf1 is degraded during the metaphase to anaphase transition. In the nucleus, hPaf1 regulates the expression of cyclins A1, A2, D1, E1, B1, and Cdk1. In addition, expression of hPaf1 delays DNA replication but favors the G2/M transition, in part through microtubule assembly and mitotic spindle formation. Conclusion/Significance: Our results identify hPaf1 and the hPAF complex as key regulators of cell-cycle progression. Mutation or loss of stoichiometry of at least one of the members may potentially lead to cancer development.			Moniaux, N (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.	sbatra@unmc.edu	Moniaux, Nicolas/Y-3243-2018	Moniaux, Nicolas/0000-0001-9718-1386	NATIONAL CANCER INSTITUTE [P50CA072712] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA72712, P50 CA072712] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Moniaux N, 2006, ONCOGENE, V25, P3247, DOI 10.1038/sj.onc.1209353; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Sherr C J, 2000, Harvey Lect, V96, P73; Shi XM, 1996, MOL CELL BIOL, V16, P669; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; SZABO J, 1995, AM J HUM GENET, V56, P944; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105; ZHU FG, 1987, HISTOPATHOLOGY, V11, P631, DOI 10.1111/j.1365-2559.1987.tb02673.x; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	37	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7077	10.1371/journal.pone.0007077	http://dx.doi.org/10.1371/journal.pone.0007077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771162	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154400003
J	Carlson, PE; Carr, KA; Janes, BK; Anderson, EC; Hanna, PC				Carlson, Paul E., Jr.; Carr, Katherine A.; Janes, Brian K.; Anderson, Erica C.; Hanna, Philip C.			Transcriptional Profiling of Bacillus anthracis Sterne (34F(2)) during Iron Starvation	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; IDENTIFICATION; INFECTION; VIRULENCE; PROTEINS; FAMILY; GROWTH; MODEL	Lack of available iron is one of many environmental challenges that a bacterium encounters during infection and adaptation to iron starvation is important for the pathogen to efficiently replicate within the host. Here we define the transcriptional response of B. anthracis Sterne (34F(2)) to iron depleted conditions. Genome-wide transcript analysis showed that B. anthracis undergoes considerable changes in gene expression during growth in iron-depleted media, including the regulation of known and candidate virulence factors. Two genes encoding putative internalin proteins were chosen for further study. Deletion of either gene (GBAA0552 or GBAA1340) resulted in attenuation in a murine model of infection. This attenuation was amplified in a double mutant strain. These data define the transcriptional changes induced during growth in low iron conditions and illustrate the potential of this dataset in the identification of putative virulence determinants for future study.			Carlson, PE (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	pchanna@umich.edu			NIAID NIH HHS [T32 AI007528, T32-AI-07528, 1-U54-AI-057053, N266200400059C-N01-AI-40059, N01AI40059] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007528] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacon J, 2007, MICROBIOL-SGM, V153, P1435, DOI 10.1099/mic.0.2006/004317-0; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heffernan BJ, 2007, FEMS MICROBIOL LETT, V271, P98, DOI 10.1111/j.1574-6968.2007.00713.x; Hoffmaster AR, 1997, INFECT IMMUN, V65, P3091, DOI 10.1128/IAI.65.8.3091-3099.1997; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kim CC, 2003, INFECT IMMUN, V71, P3196, DOI 10.1128/IAI.71.6.3196-3205.2003; KIM HU, 1974, J APPL BACTERIOL, V37, P265, DOI 10.1111/j.1365-2672.1974.tb00438.x; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Nanduri B, 2008, PROTEOMICS, V8, P2104, DOI 10.1002/pmic.200701048; Nguyen CC, 1995, FEBS LETT, V377, P98, DOI 10.1016/0014-5793(95)01344-X; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Passalacqua KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004904; Patel Satish, 2004, Appl Bioinformatics, V3, P49; Pfleger BF, 2008, P NATL ACAD SCI USA, V105, P17133, DOI 10.1073/pnas.0808118105; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruthel G, 2004, J INFECT DIS, V189, P1313, DOI 10.1086/382656; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Seveau S, 2007, MICROBES INFECT, V9, P1167, DOI 10.1016/j.micinf.2007.05.004; Tong SX, 1996, J BACTERIOL, V178, P3260, DOI 10.1128/jb.178.11.3260-3269.1996; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Yu GX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S3; ZAWADZKA A, 2009, BIOCHEMISTRY	39	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e6988	10.1371/journal.pone.0006988	http://dx.doi.org/10.1371/journal.pone.0006988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768119	Green Published, gold, Green Submitted			2022-12-25	WOS:000270154000001
J	Kilroy, G; Burk, DH; Floyd, ZE				Kilroy, Gail; Burk, David H.; Floyd, Z. Elizabeth			High Efficiency Lipid-Based siRNA Transfection of Adipocytes in Suspension	PLOS ONE			English	Article							PPAR-GAMMA	Background: Fully differentiated adipocytes are considered to be refractory to introduction of siRNA via lipid-based transfection. However, large scale siRNA-based loss-of-function screening of adipocytes using either electroporation or virally-mediated transfection approaches can be prohibitively complex and expensive. Methodology/Principal Findings: We present a method for introducing small interfering RNA ( siRNA) into differentiated 3T3-L1 adipocytes and primary human adipocytes using an approach based on forming the siRNA/cell complex with the adipocytes in suspension rather than as an adherent monolayer, a variation of "reverse transfection''. Conclusions/Significance: Transfection of adipocytes with siRNA by this method is economical, highly efficient, has a simple workflow, and allows standardization of the ratio of siRNA/cell number, making this approach well-suited for high-throughput screening of fully differentiated adipocytes.			Kilroy, G (corresponding author), Pennington Biomed Res Ctr, Ubiquitin Biol Lab, Baton Rouge, LA USA.	Elizabeth.Floyd@pbrc.edu	Floyd, Elizabeth/W-2758-2019; Burk, David/D-2056-2009; Floyd, Elizabeth/N-1962-2017	Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186	NCRR NIH HHS [P20-RR021945, P20 RR02195, P20 RR021945] Funding Source: Medline; NIDDK NIH HHS [P30 DK072476, 1 P30-DK072476] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amarzguioui M, 2004, BIOTECHNIQUES, V36, P766, DOI 10.2144/04365BM03; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kilroy GE, 2009, OBESITY, V17, P665, DOI 10.1038/oby.2008.616; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Orlicky DJ, 2001, J LIPID RES, V42, P460; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Puri V, 2007, J LIPID RES, V48, P465, DOI 10.1194/jlr.D600033-JLR200; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829	14	49	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6940	10.1371/journal.pone.0006940	http://dx.doi.org/10.1371/journal.pone.0006940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759827	Green Published, Green Submitted, gold			2022-12-25	WOS:000269696600003
J	Melekhin, VV; Shepherd, BE; Stinnette, SE; Rebeiro, PF; Barkanic, G; Raffanti, SP; Sterling, TR				Melekhin, Vlada V.; Shepherd, Bryan E.; Stinnette, Samuel E.; Rebeiro, Peter F.; Barkanic, Gema; Raffanti, Stephen P.; Sterling, Timothy R.			Antiretroviral Therapy Initiation Before, During, or After Pregnancy in HIV-1-Infected Women: Maternal Virologic, Immunologic, and Clinical Response	PLOS ONE			English	Article								Background: Pregnancy has been associated with a decreased risk of HIV disease progression in the highly active antiretroviral therapy (HAART) era. The effect of timing of HAART initiation relative to pregnancy on maternal virologic, immunologic and clinical outcomes has not been assessed. Methods: We conducted a retrospective cohort study from 1997-2005 among 112 pregnant HIV-infected women who started HAART before (N=12), during (N=70) or after pregnancy (N=30). Results: Women initiating HAART before pregnancy had lower CD4+ nadir and higher baseline HIV-1 RNA. Women initiating HAART after pregnancy were more likely to receive triple-nucleoside reverse transcriptase inhibitors. Multivariable analyses adjusted for baseline CD4+ lymphocytes, baseline HIV-1 RNA, age, race, CD4+ lymphocyte count nadir, history of ADE, prior use of non-HAART ART, type of HAART regimen, prior pregnancies, and date of HAART start. In these models, women initiating HAART during pregnancy had better 6-month HIV-1 RNA and CD4+ changes than those initiating HAART after pregnancy (-0.35 vs. 0.10 log(10) copies/mL, P=0.03 and 183.8 vs. -70.8 cells/mm(3), P=0.03, respectively) but similar to those initiating HAART before pregnancy (-0.32 log(10) copies/mL, P=0.96 and 155.8 cells/mm(3), P=0.81, respectively). There were 3 (25%) AIDS-defining events or deaths in women initiating HAART before pregnancy, 3 (4%) in those initiating HAART during pregnancy, and 5 (17%) in those initiating after pregnancy (P=0.01). There were no statistical differences in rates of HIV disease progression between groups. Conclusions: HAART initiation during pregnancy was associated with better immunologic and virologic responses than initiation after pregnancy.			Melekhin, VV (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.	vlada.melekhin@vanderbilt.edu		Rebeiro, Peter/0000-0003-1951-9104	NIAID NIH HHS [P30 AI054999, P30 AI54999, T32 AI07474-10, T32 AI007474] Funding Source: Medline; PHS HHS [K24 A1065298] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007474, P30AI054999] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alliegro MB, 1997, ARCH INTERN MED, V157, P2585, DOI 10.1001/archinte.157.22.2585; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bardeguez AD, 2003, JAIDS-J ACQ IMM DEF, V32, P170, DOI 10.1097/00126334-200302010-00009; Bardeguez AD, 2008, JAIDS-J ACQ IMM DEF, V48, P408, DOI 10.1097/QAI.0b013e31817bbe80; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Bessinger R, 1998, AM J EPIDEMIOL, V147, P434, DOI 10.1093/oxfordjournals.aje.a009468; BIGGAR RJ, 1989, AM J OBSTET GYNECOL, V161, P1239, DOI 10.1016/0002-9378(89)90674-1; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966; Cheng DM, 2007, ALCOHOL CLIN EXP RES, V31, P829, DOI 10.1111/j.1530-0277.2007.00381.x; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; DESCHAMPS MM, 1993, J ACQ IMMUN DEF SYND, V6, P446; Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x; Dronda F, 2004, AIDS, V18, P2210, DOI 10.1097/00002030-200411050-00018; Eastman PS, 1998, J INFECT DIS, V177, P557, DOI 10.1086/514228; Ebrahim SH, 2000, JAMA-J AM MED ASSOC, V283, P361, DOI 10.1001/jama.283.3.361; Effros RB, 2003, CURR HIV RES, V1, P153, DOI 10.2174/1570162033485348; Ekpini RA, 2002, AIDS, V16, P625, DOI 10.1097/00002030-200203080-00015; FINGERHUT LA, 1990, AM J PUBLIC HEALTH, V80, P541, DOI 10.2105/AJPH.80.5.541; Giuliano M, 2003, AIDS, V17, P1570, DOI 10.1097/00002030-200307040-00022; Golub ET, 2008, CLIN INFECT DIS, V46, P305, DOI 10.1086/524752; HOCKE C, 1995, OBSTET GYNECOL, V86, P886, DOI 10.1016/0029-7844(95)00257-R; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Kakehasi FM, 2007, AIDS RES HUM RETROV, V23, P1515, DOI 10.1089/aid.2007.0025; Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kully C, 1999, J INFECT DIS, V179, P705, DOI 10.1086/314615; KUMAR RM, 1995, INT J GYNECOL OBSTET, V49, P137, DOI 10.1016/0020-7292(95)02356-H; Kuritzkes DR, 2007, J INFECT DIS, V195, P1169, DOI 10.1086/512619; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lucas GM, 2002, AIDS, V16, P767, DOI 10.1097/00002030-200203290-00012; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; MINKOFF H, 1987, OBSTET GYNECOL, V69, P285; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Mofenson L., 2006, Morbidity and Mortality Weekly Report, V55, P592; *PAN ANT GUID ADU, 2008, GUID US ANT AG HIV 1; *PER HIV GUID GROU, 2008, PUBL HLTH SERV TASK; Perez-Elias MJ, 2005, HIV CLIN TRIALS, V6, P312, DOI 10.1310/B3NK-V5XQ-6VX9-5DEK; Polanczyk MJ, 2004, J IMMUNOL, V173, P2227, DOI 10.4049/jimmunol.173.4.2227; Vaz MJR, 2007, INT J STD AIDS, V18, P28, DOI 10.1258/095646207779949808; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017; Sanchez-Ramon S, 2005, IMMUNOL LETT, V96, P195, DOI 10.1016/j.imlet.2004.09.004; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; SCOTT GB, 1985, JAMA-J AM MED ASSOC, V253, P363, DOI 10.1001/jama.253.3.363; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Tai JH, 2007, J INFECT DIS, V196, P1044, DOI 10.1086/520814; Thea DM, 1997, AIDS, V11, P437, DOI 10.1097/00002030-199704000-00006; *UN JOINT PROGR HI, 2008, 2007 AIDS EP UPD; Waller DK, 2000, PAEDIATR PERINAT EP, V14, P263, DOI 10.1046/j.1365-3016.2000.00275.x; Weisser M, 1998, J ACQ IMMUN DEF SYND, V17, P404, DOI 10.1097/00042560-199804150-00004; Welles SL, 2000, AIDS, V14, P263, DOI 10.1097/00002030-200002180-00008	56	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6961	10.1371/journal.pone.0006961	http://dx.doi.org/10.1371/journal.pone.0006961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742315	gold, Green Published, Green Submitted			2022-12-25	WOS:000269622500022
J	Xie, YY; Zhou, CJ; Zhou, ZR; Hong, J; Che, MX; Fu, QS; Song, AX; Lin, DH; Hu, HY				Xie, Yuan-Yuan; Zhou, Chen-Jie; Zhou, Zi-Ren; Hong, Jing; Che, Mei-Xia; Fu, Qing-Shan; Song, Ai-Xin; Lin, Dong-Hai; Hu, Hong-Yu			Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication	FASEB JOURNAL			English	Article						coiled coil; solution structure; Parkinson's disease; Lewy body; dimerization; N-terminal stretch	PARKINSONS-DISEASE; LEWY BODIES; NEUROBLASTOMA-CELLS; AGGRESOME FORMATION; CHEMICAL-SHIFT; WILD-TYPE; PROTEIN; AGGREGATION; NMR; MUTATION	alpha-Synuclein (alpha-Syn) is the major component of Lewy bodies (LBs) deposited in the brains of patients with Parkinson's disease. Synphilin-1 (Sph1) is a novel alpha-Syn-interacting protein also present in the LBs. However, the roles of alpha-Syn-Sph1 interaction in LB formation and in the related pathogenesis are still unclear. We have studied the interaction between alpha-Syn and Sph1 by biochemical and structural approaches and found that the central coiled-coil domain of Sph1 specifically interacts with the N-terminal stretch of alpha-Syn. When overexpressed in HEK 293T cells, Sph1 forms inclusions together with alpha-Syn, but the Sph1positive inclusions cannot recruit the N-terminally truncated alpha-Syn. The central portion of Sph1 can also recruit alpha-Syn and induce inclusion formation through its coiled-coil domain. These observations demonstrate that the alpha-Syn-Sph1 interaction significantly promotes the formation of cytoplasmic alpha-Syn inclusions, which may have implications for LB formation in neural cells. We have also elucidated solution structure of the coiled-coil domain of Sph1 and its interaction with the N-terminal peptide of alpha-Syn. The specific interaction between alpha-Syn and Sph1 provides mechanistic insights into the inclusion-body formation in cells and pathological implication in Parkinson's disease. Xie, Y.-Y., Zhou, C.-J., Zhou, Z.-R., Hong, J., Che, M.-X., Fu, Q.-S., Song, A.-X., Lin, D.-H., and Hu, H.-Y. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication. FASEB J. 24, 196-205 (2010). www.fasebj.org	[Xie, Yuan-Yuan; Zhou, Chen-Jie; Zhou, Zi-Ren; Che, Mei-Xia; Fu, Qing-Shan; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Hong, Jing; Lin, Dong-Hai] Shanghai Inst Biol Sci, Inst Mat Med, Shanghai, Peoples R China; [Xie, Yuan-Yuan; Zhou, Zi-Ren; Hong, Jing; Che, Mei-Xia; Fu, Qing-Shan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Che, Meixia/Q-2119-2019; Hu, Hong-Yu/AAQ-2633-2020; Xie, Yuanyuan/F-1974-2017; Chou, Steven Ziren/M-1995-2014; Fu, Qingshan/E-1405-2015; Fu, Qingshan/E-8083-2015	Che, Meixia/0000-0002-4515-1414; Fu, Qingshan/0000-0002-7445-2355; 	National Basic Research Program of China [2006CB910305, 2006CB806508]; National Natural Science Foundation of China [30570377, 30600103, 30870485]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. C. W. Jin and Ms. F. Yang ( Beijing NMR Center, Peking University, Beijing, China) for providing the NMR facilities and technical assistance. We thank Drs. L. N. Ji, J. W. Zhou, and X. Y. Luo for valuable discussions, and Mr. T. Y. Zhang, Mr. M. Xu, and Mr. H. C. Gao for technical help. We also thank Dr. M. M. Mouradian ( National Institutes of Health, Bethesda, MD, USA) for providing the synphilin-1 cDNA. This work was supported by grants from the National Basic Research Program of China (2006CB910305, 2006CB806508), and the National Natural Science Foundation of China (30570377, 30600103, 30870485). The coordinates and structure factors for the coiled-coil domain (Sph1CC) and the alpha-Syn12 peptide bound with Sph1M have been deposited in the Protein Data Bank with accession codes 2KES and 2JN5, respectively.	Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eyal A, 2006, P NATL ACAD SCI USA, V103, P5917, DOI 10.1073/pnas.0509707103; Gao YG, 2006, STRUCTURE, V14, P1755, DOI 10.1016/j.str.2006.09.014; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Goddard T. D., 2004, SPARKY, V3; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Hasegawa T, 2004, BRAIN RES, V1013, P51, DOI 10.1016/j.brainres.2004.04.018; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawamata H, 2001, J NEUROCHEM, V77, P929, DOI 10.1046/j.1471-4159.2001.00301.x; KINCAID RL, 1982, J BIOL CHEM, V257, P638; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krenz A, 2009, J NEUROCHEM, V108, P139, DOI 10.1111/j.1471-4159.2008.05755.x; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee G, 2002, J NEUROCHEM, V83, P346, DOI 10.1046/j.1471-4159.2002.01136.x; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Megy S, 2005, J BIOL CHEM, V280, P29107, DOI 10.1074/jbc.M501628200; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Neystat M, 2002, NEUROSCI LETT, V325, P119, DOI 10.1016/S0304-3940(02)00253-7; O'Farrell C, 2002, NEUROSCI LETT, V322, P9, DOI 10.1016/S0304-3940(02)00068-X; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WISHART DS, 1994, J BIOMOL NMR, V4, P171; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108	49	27	30	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					196	205		10.1096/fj.09-133082	http://dx.doi.org/10.1096/fj.09-133082			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19762560	Bronze			2022-12-25	WOS:000273233600021
J	Shimabe, M; Goyama, S; Watanabe-Okochi, N; Yoshimi, A; Ichikawa, M; Imai, Y; Kurokawa, M				Shimabe, M.; Goyama, S.; Watanabe-Okochi, N.; Yoshimi, A.; Ichikawa, M.; Imai, Y.; Kurokawa, M.			Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells	ONCOGENE			English	Article						Evi-1; Pbx1; leukemogenesis; target gene	MYELOID-TRANSFORMING GENE; DNA-BINDING; STEM-CELLS; PRE-B; TRANSCRIPTION FACTOR-1; TRANSLOCATION PROTEIN; ZINC FINGERS; SELF-RENEWAL; IDENTIFICATION; SEQUENCE	Ecotropic viral integration site-1 (Evi-1) is a nuclear transcription factor, which is essential for the proliferation/maintenance of hematopoietic stem cells (HSCs). Aberrant expression of Evi-1 has been frequently found in myeloid leukemia, and is associated with a poor patient survival. Recently, we reported candidate target genes of Evi-1 shared in HSCs and leukemic cells using gene expression profiling analysis. In this study, we identified Pbx1, a proto-oncogene in hematopoietic malignancy, as a target gene of Evi-1. Overexpression of Evi-1 increased Pbx1 expression in hematopoietic stem/progenitor cells. An analysis of the Pbx1 promoter region revealed that Evi-1 upregulates Pbx1 transcription. Furthermore, reduction of Pbx1 levels through RNAi-mediated knockdown significantly inhibited Evi-1-induced transformation. In contrast, knockdown of Pbx1 did not impair bone marrow transformation by E2A/HLF or AML1/ETO, suggesting that Pbx1 is specifically required for the maintenance of bone marrow transformation mediated by Evi-1. These results indicate that Pbx1 is a target gene of Evi-1 involved in Evi-1-mediated leukemogenesis. Oncogene (2009) 28, 4364-4374; doi: 10.1038/onc.2009.288; published online 21 September 2009	[Kurokawa, M.] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo	Kurokawa, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp	Yoshimi, Akihide/I-3792-2019	Yoshimi, Akihide/0000-0002-0664-7281; Imai, Yoichi/0000-0002-2938-6133	Japan Society for the Promotion of Science; Health and Labour Sciences Research; Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [19679004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T Kitamura for Plat-E packaging cells and pMYs-IG retrovirus vector, H Nakauchi and M Onodera for pGCDNsameGFP retroviral vector, T Inaba for E2A/HLF cDNA, SW Hiebert for AML1/ETO cDNA, D Bohmann for c-Jun cDNA, Y Shimamura for expert technical assistance, and KYOWA KIRIN for cytokines. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, and by Health and Labour Sciences Research grants from Ministry of Health, Labour and Welfare.	DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Goyama S, 2009, CANCER SCI, V100, P990, DOI 10.1111/j.1349-7006.2009.01152.x; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Knoepfler PS, 2001, ONCOGENE, V20, P5440, DOI 10.1038/sj.onc.1204710; Krosl J, 1998, ONCOGENE, V16, P3403, DOI 10.1038/sj.onc.1201883; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Laricchia-Robbio L, 2008, BLOOD CELL MOL DIS, V40, P141, DOI 10.1016/j.bcmd.2007.07.012; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Lawrence HJ, 1996, STEM CELLS, V14, P281, DOI 10.1002/stem.140281; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lim JH, 2005, HUM MOL GENET, V14, P2027, DOI 10.1093/hmg/ddi207; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Manley NR, 2004, DEV BIOL, V276, P301, DOI 10.1016/j.ydbio.2004.08.030; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Nitta E, 2005, ONCOGENE, V24, P6165, DOI 10.1038/sj.onc.1208754; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; Ogawa S, 1996, ONCOGENE, V13, P183; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; PINTADO T, 1985, CANCER, V55, P535, DOI 10.1002/1097-0142(19850201)55:3<535::AID-CNCR2820550311>3.0.CO;2-4; Qiu Y, 2007, AM J PATHOL, V170, P152, DOI 10.2353/ajpath.2007.060722; Sato T, 2008, CANCER SCI, V99, P1407, DOI 10.1111/j.1349-7006.2008.00842.x; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; Schnabel CA, 2003, DEV BIOL, V254, P262, DOI 10.1016/S0012-1606(02)00038-6; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shiraishi K, 2007, ONCOGENE, V26, P339, DOI 10.1038/sj.onc.1209800; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; SUZUKAWA K, 1994, BLOOD, V84, P2681; Takeshita M, 2008, LEUKEMIA, V22, P1241, DOI 10.1038/leu.2008.53; TANAKA T, 1994, J BIOL CHEM, V269, P24020; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Yaron Y, 2001, J IMMUNOL, V166, P5058, DOI 10.4049/jimmunol.166.8.5058; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679	48	47	53	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4364	4374		10.1038/onc.2009.288	http://dx.doi.org/10.1038/onc.2009.288			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19767769				2022-12-25	WOS:000272876400005
J	Anquetil, V; Le Sommer, C; Mereau, A; Hamon, S; Lerivray, H; Hardy, S				Anquetil, Vincent; Le Sommer, Caroline; Mereau, Agnes; Hamon, Sandra; Lerivray, Hubert; Hardy, Serge			Polypyrimidine Tract Binding Protein Prevents Activity of an Intronic Regulatory Element That Promotes Usage of a Composite 3 '-Terminal Exon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ALTERNATIVE POLYADENYLATION; SR FAMILY; IMMUNOGLOBULIN; XENOPUS; RECOGNITION; EFFICIENCY; CONTRIBUTE; MOUSE; GENE	Alternative splicing of 3'-terminal exons plays a critical role in gene expression by producing mRNA with distinct 3'-untranslated regions that regulate their fate and their expression. The Xenopus alpha-tropomyosin pre-mRNA possesses a composite internal/3'-terminal exon (exon 9A9') that is differentially processed depending on the embryonic tissue. Exon 9A9' is repressed in non-muscle tissue by the polypyrimidine tract binding protein, whereas it is selected as a 3'-terminal or internal exon in myotomal cells and adult striated muscles, respectively. We report here the identification of an intronic regulatory element, designated the upstream terminal exon enhancer (UTE), that is required for the specific usage of exon 9A9' as a 3'-terminal exon in the myotome. We demonstrate that polypyrimidine tract binding protein prevents the activity of UTE in non-muscle cells, whereas a subclass of serine/arginine rich (SR) proteins promotes the selection of exon 9A9' in a UTE-dependent way. Morpholino-targeted blocking of UTE in the embryo strongly reduced the inclusion of exon 9A9' as a 3'-terminal exon in the endogenous mRNA, demonstrating the function of UTE under physiological circumstances. This strategy allowed us to reveal a splicing pathway that generates a mRNA with no in frame stop codon and whose steady-state level is translation-dependent. This result suggests that a non-stop decay mechanism participates in the strict control of the 3'- end processing of the alpha-tropomyosin pre-mRNA.	[Anquetil, Vincent; Le Sommer, Caroline; Mereau, Agnes; Hamon, Sandra; Lerivray, Hubert; Hardy, Serge] Univ Rennes 1, CNRS, Inst Genet & Dev Rennes, Fac Med,UMR 6061,IFR 140,CS 34317, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Hardy, S (corresponding author), Univ Rennes 1, CNRS, Inst Genet & Dev Rennes, Fac Med,UMR 6061,IFR 140,CS 34317, F-35043 Rennes, France.	serge.hardy@univ-rennes1.fr	anquetil, vincent/K-9865-2019	anquetil, vincent/0000-0002-6912-9908; MEREAU, AGNES/0000-0002-5603-757X	Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by grants from the Association Francaise contre les Myopathies (to S. H.).	Awasthi S, 2003, RNA, V9, P1400, DOI 10.1261/rna.5104603; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bruno IG, 2004, HUM MOL GENET, V13, P2409, DOI 10.1093/hmg/ddh272; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; EDWALDSGILBERT G, 1995, MOL CELL BIOL, V15, P6420; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Hamon S, 2004, J BIOL CHEM, V279, P22166, DOI 10.1074/jbc.M313809200; Hardy S, 1999, MECH DEVELOP, V87, P199, DOI 10.1016/S0925-4773(99)00148-3; HARDY S, 1991, EUR J BIOCHEM, V202, P431, DOI 10.1111/j.1432-1033.1991.tb16392.x; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kole R, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P451; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; LEESMILLER JP, 1990, MOL CELL BIOL, V10, P1729, DOI 10.1128/MCB.10.4.1729; Longman D, 2001, CURR BIOL, V11, P1923, DOI 10.1016/S0960-9822(01)00589-9; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; Maciolek NL, 2007, J VIROL, V81, P11208, DOI 10.1128/JVI.00919-07; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mereau A, 2007, BIOL CELL, V99, P55, DOI 10.1042/BC20060073; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363; NIEUWKOOP P, 1956, NORMAL TABLE X LAEVI; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; Peterson ML, 2007, IMMUNOL RES, V37, P33, DOI 10.1007/BF02686094; Peterson ML, 2006, MOL CELL BIOL, V26, P6762, DOI 10.1128/MCB.00889-06; PETERSON ML, 1994, MOL CELL BIOL, V14, P7891, DOI 10.1128/MCB.14.12.7891; PETERSON ML, 1991, MOL CELL BIOL, V11, P2324, DOI 10.1128/MCB.11.4.2324; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Seipelt RL, 1998, MOL CELL BIOL, V18, P1042, DOI 10.1128/MCB.18.2.1042; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605	46	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32370	32383		10.1074/jbc.M109.029314	http://dx.doi.org/10.1074/jbc.M109.029314			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19762469	Green Published, hybrid			2022-12-25	WOS:000272028400020
J	Clayton, CC; Xu, M; Chavkin, C				Clayton, Cecilea C.; Xu, Mei; Chavkin, Charles			Tyrosine Phosphorylation of K(ir)3 following kappa-Opioid Receptor Activation of p38 MAPK Causes Heterologous Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; CHRONIC NEUROPATHIC PAIN; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; SPINAL-CORD; BETA-ARRESTINS; NERVE INJURY; K+ CHANNELS; STRESS; INHIBITION	Prior studies showed that tyrosine 12 phosphorylation in the N-terminal, cytoplasmic domain of the G-protein-gated inwardly rectifying potassium channel, K(ir)3.1 facilitates channel deactivation by increasing intrinsic GTPase activity of the channel. Using a phosphoselective antibody directed against this residue (pY12), we now report that partial sciatic nerve ligation increased pY12-K(ir)3.1-immunoreactivity (ir) in the ipsilateral dorsal horn of wildtype mice, but not in mice lacking the kappa-opioid receptor (KOR) or lacking the G-protein receptor kinase 3 (GRK3) genes. Treatment of AtT-20 cells stably expressing KOR-GFP with the selective KOR agonist U50,488 increased both phospho-p38-ir and pY12-K(ir)3.1-ir. The U50,488-induced increase in pY12-K(ir)3.1-ir was blocked by the p38 inhibitor SB203580. Cells expressing KOR(S369A)-GFP did not increase either phospho-p38-ir or pY12-K(ir)3.1-ir following U50,488 treatment. Whole cell voltage clamp of AtT-20 cells expressing KOR-GFP demonstrated that p38 activation by U50,488 reduced somatostatin-evoked K(ir)3 currents. This heterologous desensitization was blocked by SB203580 and was not evident in cells expressing KOR(S369A)-GFP. Tyrosine phosphorylation of K(ir)3.1 was likely mediated by p38 MAPK activation of Src kinase. U50,488 also increased (pY418)Src-ir; this increase was blocked by SB203580 and not evident in KOR(S369A)-GFP expressing AtT20 cells; the Src inhibitor PP2 blocked the U50,488-induced increase in pY12-K(ir)3.1-ir; and the heterologous desensitization of K(ir)3 currents was blocked by PP2. These results suggest that KOR causes phosphorylation of Y12-K(ir)3.1 and channel inhibition through a GRK3-, p38 MAPK- and Src-dependent mechanism. Reduced inward potassium current following nerve ligation would increase dorsal horn neuronal excitability and may contribute to the neuropathic pain response.	[Clayton, Cecilea C.; Xu, Mei; Chavkin, Charles] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chavkin, C (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 Pacific Ave NE, Seattle, WA 98195 USA.	cchavkin@u.washington.edu	Chavkin, Charles/G-2797-2010		National Institutes of Health USPHS [R37-DA11672]; NIDA [K05 DA20570]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA011672, K05DA020570] Funding Source: NIH RePORTER	National Institutes of Health USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health USPHS Grants R37-DA11672 and K05 DA20570 from NIDA.	Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bruchas MR, 2008, NEUROREPORT, V19, P1417, DOI 10.1097/WNR.0b013e32830dd655; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Carr GV, 2008, J NEUROSCI, V28, P2299, DOI 10.1523/JNEUROSCI.5679-07.2008; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gallagher TF, 1997, BIOORGAN MED CHEM, V5, P49, DOI 10.1016/S0968-0896(96)00212-X; Gardell LR, 2004, NEUROSCIENCE, V123, P43, DOI 10.1016/j.neuroscience.2003.08.021; Ippolito DL, 2005, J BIOL CHEM, V280, P41683, DOI 10.1074/jbc.M507069200; Ippolito DL, 2002, J BIOL CHEM, V277, P32692, DOI 10.1074/jbc.M204407200; Kam AYF, 2004, J PHARMACOL EXP THER, V310, P301, DOI 10.1124/jpet.104.065078; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kuzhikandathil EV, 1998, MOL CELL NEUROSCI, V12, P390, DOI 10.1006/mcne.1998.0722; Lai J, 2001, Mol Interv, V1, P160; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Luttrell LM, 2002, J CELL SCI, V115, P455; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mao JZ, 2004, P NATL ACAD SCI USA, V101, P1087, DOI 10.1073/pnas.0304827101; Marker CL, 2006, J NEUROSCI, V26, P12251, DOI 10.1523/JNEUROSCI.3693-06.2006; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Marker CL, 2004, J NEUROSCI, V24, P2806, DOI 10.1523/JNEUROSCI.5251-03.2004; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; Mora SI, 2005, FEBS LETT, V579, P3019, DOI 10.1016/j.febslet.2005.04.056; PATEL YC, 1994, J BIOL CHEM, V269, P1506; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pravetoni M, 2008, GENES BRAIN BEHAV, V7, P523, DOI 10.1111/j.1601-183X.2008.00388.x; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Rogalski SL, 2000, J BIOL CHEM, V275, P25082, DOI 10.1074/jbc.M000183200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Thakali K, 2007, J PHARMACOL EXP THER, V320, P236, DOI 10.1124/jpet.106.110650; Vit JP, 2008, J NEUROSCI, V28, P4161, DOI 10.1523/JNEUROSCI.5053-07.2008; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Wittmann W, 2009, NEUROPSYCHOPHARMACOL, V34, P775, DOI 10.1038/npp.2008.142; Xu M, 2004, J NEUROSCI, V24, P4576, DOI 10.1523/JNEUROSCI.5552-03.2004; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200	48	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31872	31881		10.1074/jbc.M109.053793	http://dx.doi.org/10.1074/jbc.M109.053793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773548	hybrid, Green Published			2022-12-25	WOS:000271572700042
J	Musayev, FN; Di Salvo, ML; Saavedra, MA; Contestabile, R; Ghatge, MS; Haynes, A; Schirch, V; Safo, MK				Musayev, Faik N.; Di Salvo, Martino L.; Saavedra, Mario A.; Contestabile, Roberto; Ghatge, Mohini S.; Haynes, Alexina; Schirch, Verne; Safo, Martin K.			Molecular Basis of Reduced Pyridoxine 5 '-Phosphate Oxidase Catalytic Activity in Neonatal Epileptic Encephalopathy Disorder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI PYRIDOXINE-5'-PHOSPHATE OXIDASE; X-RAY-STRUCTURE; PYRIDOXINE-5-PHOSPHATE OXIDASE; ANGSTROM RESOLUTION; PNPO DEFICIENCY; PHOSPHATE; KINASE; SCHIZOPHRENIA; CHILDREN; ENZYMES	Mutations in pyridoxine 5'-phosphate oxidase are known to cause neonatal epileptic encephalopathy. This disorder has no cure or effective treatment and is often fatal. Pyridoxine 5'-phosphate oxidase catalyzes the oxidation of pyridoxine 5'-phosphate to pyridoxal 5'-phosphate, the active cofactor form of vitamin B-6 required by more than 140 different catalytic activities, including enzymes involved in amino acid metabolism and biosynthesis of neurotransmitters. Our aim is to elucidate the mechanism by which a homozygous missense mutation (R229W) in the oxidase, linked to neonatal epileptic encephalopathy, leads to reduced oxidase activity. The R229W variant is similar to 850-fold less efficient than the wild-type enzyme due to an similar to 192-fold decrease in pyridoxine 5'-phosphate affinity and an similar to 4.5-fold decrease in catalytic activity. There is also an similar to 50-fold reduction in the affinity of the R229W variant for the FMN cofactor. A 2.5 angstrom crystal structure of the R229W variant shows that the substitution of Arg-229 at the FMN binding site has led to a loss of hydrogen-bond and/or salt-bridge interactions between FMN and Arg-229 and Ser-175. Additionally, the mutation has led to an alteration of the configuration of a beta-strand-loop-beta-strand structure at the active site, resulting in loss of two critical hydrogen-bond interactions involving residues His-227 and Arg-225, which are important for substrate binding and orientation for catalysis. These results provide a molecular basis for the phenotype associated with the R229W mutation, as well as providing a foundation for understanding the pathophysiological consequences of pyridoxine 5'-phosphate oxidase mutations.	[Musayev, Faik N.; Saavedra, Mario A.; Ghatge, Mohini S.; Schirch, Verne; Safo, Martin K.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23219 USA; [Musayev, Faik N.; Saavedra, Mario A.; Ghatge, Mohini S.; Schirch, Verne; Safo, Martin K.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23219 USA; [Di Salvo, Martino L.; Contestabile, Roberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Haynes, Alexina] Virginia Union Univ, Dept Nat Sci, Richmond, VA 23220 USA	Virginia Commonwealth University; Virginia Commonwealth University; Fondazione Cenci Bolognetti; Sapienza University Rome; Virginia Union University	Safo, MK (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, 800 E Leigh St,Ste 212, Richmond, VA 23219 USA.	msafo@vcu.edu	Safo, Martin/AAJ-9833-2020; Ghatge, Mohini/AAY-3381-2020; Musayev, Faik/AAY-2010-2020; Contestabile, Roberto/J-3467-2019	Contestabile, Roberto/0000-0002-5235-9993; di Salvo, Martino Luigi/0000-0003-1233-9338	Jeffress Research; Istituto Pasteur - Fondazione Cenci Bolognetti [PRIN2007]	Jeffress Research; Istituto Pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	The work was supported by a grant from the AD Williams Fund (to M. K. S.), the Jeffress Research Grant Award (to M. K. S.) and grants from PRIN2007 and Istituto Pasteur - Fondazione Cenci Bolognetti (to M. L. D. S. and R. C.).	AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; Adams JB, 2006, J ALTERN COMPLEM MED, V12, P59, DOI 10.1089/acm.2006.12.59; Adams JB, 2004, J ALTERN COMPLEM MED, V10, P1033, DOI 10.1089/acm.2004.10.1033; Bagci S, 2008, ARCH DIS CHILD-FETAL, V93, pF151, DOI 10.1136/adc.2006.115162; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHOI SY, 1987, J BIOL CHEM, V262, P12013; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; Clayton PT, 2003, LANCET, V361, P1614, DOI 10.1016/S0140-6736(03)13312-0; COBURN SP, 1991, J MENT DEFIC RES, V35, P543; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELPORT R, 1993, RES COMMUN CHEM PATH, V79, P325; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hoffmann GF, 2007, J INHERIT METAB DIS, V30, P96, DOI 10.1007/s10545-006-0508-4; HORIIKE K, 1979, J BIOL CHEM, V254, P6638; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; KAZARINOFF MN, 1973, BIOCHEM BIOPH RES CO, V52, P440, DOI 10.1016/0006-291X(73)90731-6; Khayat M, 2008, MOL GENET METAB, V94, P431, DOI 10.1016/j.ymgme.2008.04.008; Kuwahara Hiroya, 2008, Rinsho Shinkeigaku, V48, P125; KWON O, 1991, J BIOL CHEM, V266, P22136; LaineCessac P, 1997, BIOCHEM PHARMACOL, V54, P863, DOI 10.1016/S0006-2952(97)00252-9; Leklem J.E., 1991, HDB VITAMINS, P341; McCormick Donald B., 1996, P396; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Miodownik C, 2007, CLIN NEUROPHARMACOL, V30, P13, DOI 10.1097/01.WNF.0000236770.38903.AF; Mousain-Bosc M, 2006, MAGNESIUM RES, V19, P53; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Nakagawa E, 1997, NEUROLOGY, V48, P1468, DOI 10.1212/WNL.48.5.1468; Nogovitsina O. R., 2006, Eksperimental'naya i Klinicheskaya Farmakologiya, V69, P74; Pedelacq JD, 2006, PROTEINS, V62, P563, DOI 10.1002/prot.20824; Rajesh R, 2003, Indian Pediatr, V40, P633; Reif A, 2003, J NEURAL TRANSM, V110, P1401, DOI 10.1007/s00702-003-0061-3; Ruiz A, 2008, MOL GENET METAB, V93, P216, DOI 10.1016/j.ymgme.2007.10.003; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Safo MK, 2005, ACTA CRYSTALLOGR D, V61, P599, DOI 10.1107/S0907444905005512; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; SANDYK R, 1990, INT J NEUROSCI, V52, P225, DOI 10.3109/00207459009000524; SETO T, 2000, TO HATTATSU, V32, P295; Song H, 2007, SCHIZOPHR RES, V97, P264, DOI 10.1016/j.schres.2007.08.004; Steichen O, 2006, REV MAL RESPIR, V23, P157, DOI 10.1016/S0761-8425(06)71480-2; Takuma Y, 1998, EPILEPSIA, V39, P42, DOI 10.1111/j.1528-1157.1998.tb05149.x; UBBINK JB, 1990, J NUTR, V120, P1352, DOI 10.1093/jn/120.11.1352; Yang ES, 2000, ARCH BIOCHEM BIOPHYS, V377, P109, DOI 10.1006/abbi.2000.1737	45	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30949	30956		10.1074/jbc.M109.038372	http://dx.doi.org/10.1074/jbc.M109.038372			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759001	Green Published, hybrid			2022-12-25	WOS:000271378400024
J	Patsouris, D; Neels, JG; Fan, WQ; Li, PP; Nguyen, MTA; Olefsky, JM				Patsouris, David; Neels, Jaap G.; Fan, WuQiang; Li, Ping-Ping; Nguyen, M. T. Audrey; Olefsky, Jerrold M.			Glucocorticoids and Thiazolidinediones Interfere with Adipocyte-mediated Macrophage Chemotaxis and Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; DEHYDROGENASE TYPE-1 EXPRESSION; INDUCED INSULIN-RESISTANCE; ADIPOSE-TISSUE; UP-REGULATION; PPAR-DELTA; T-CELLS; KAPPA-B; OBESITY; FAT	The link between intra-abdominal adiposity and type II diabetes has been known for decades, and adipose tissue macrophage (ATM)-associated inflammation has recently been linked to insulin resistance. However, the mechanisms associated with ATM recruitment remain ill defined. Herein, we describe in vitro chemotaxis studies, in which adipocyte conditioned medium was used to stimulate macrophage migration. We demonstrate that tumor necrosis factor alpha and free fatty acids, key inflammatory stimuli involved in obesity-associated autocrine/paracrine inflammatory signaling, stimulate adipocyte expression and secretion of macrophage chemoattractants. Pharmacological studies showed that peroxisome proliferator-activated receptor gamma agonists and glucocorticoids potently inhibit adipocyte- induced recruitment of macrophages. This latter effect was mediated by the glucocorticoid receptor, which led to decreased chemokine secretion and expression. In vivo results were quite comparable; treatment of high fat diet-fed mice with dexamethasone prevented ATM accumulation in epididymal fat. This decrease in ATM was most pronounced for the proinflammatory F4/80(+), CD11b(+), CD11c(+) M-1-like ATM subset. Overall, our results elucidate a beneficial function of peroxisome proliferator-activated receptor gamma activation and glucocorticoid receptor/glucocorticoids in adipose tissue and indicate that pharmacologic prevention of ATM accumulation could be beneficial.	[Patsouris, David; Neels, Jaap G.; Fan, WuQiang; Li, Ping-Ping; Nguyen, M. T. Audrey; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med 0673, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Neels, Jaap G/F-5534-2010; Li, Pingping/F-1109-2019	Neels, Jaap G/0000-0002-5900-8395; Li, Pingping/0000-0003-0679-270X	National Institutes of Health [DK033651, DK074868, T32 DK007494]; Eunice Kennedy Shriver NICHD/National Institutes of Health [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, T32DK007494, R37DK033651, R01DK033651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK033651, DK074868, and T32 DK007494 and by the Eunice Kennedy Shriver NICHD/National Institutes of Health through cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Berger J, 2001, J BIOL CHEM, V276, P12629, DOI 10.1074/jbc.M003592200; Bujalska IJ, 2008, ENDOCRINOLOGY, V149, P2584, DOI 10.1210/en.2007-1705; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gunin AG, 2003, EUR J OBSTET GYN R B, V107, P62, DOI 10.1016/S0301-2115(02)00375-5; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kharroubi I, 2006, DIABETOLOGIA, V49, P2350, DOI 10.1007/s00125-006-0366-5; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lehrke M, 2005, GENE DEV, V19, P1737, DOI 10.1101/gad.1341005; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Reynolds RM, 2003, DIABETES OBES METAB, V5, P5, DOI 10.1046/j.1463-1326.2003.00221.x; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Stulnig TM, 2002, DIABETES, V51, P2426, DOI 10.2337/diabetes.51.8.2426; Syed AA, 2005, OBES RES, V13, P1131, DOI 10.1038/oby.2005.132; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Takaishi H, 2003, BIOCHEM BIOPH RES CO, V305, P122, DOI 10.1016/S0006-291X(03)00712-5; Wallerath T, 2004, NITRIC OXIDE-BIOL CH, V10, P36, DOI 10.1016/j.niox.2004.01.008; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153; Zhang BG, 2009, EUR J IMMUNOL, V39, P894, DOI 10.1002/eji.200838809	50	65	65	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31223	31235		10.1074/jbc.M109.041665	http://dx.doi.org/10.1074/jbc.M109.041665			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740750	Green Published, hybrid			2022-12-25	WOS:000271378400050
J	Snyder, RL; Frederick-Hudson, KH; Schul, J				Snyder, Robert L.; Frederick-Hudson, Katy H.; Schul, Johannes			Molecular Phylogenetics of the Genus Neoconocephalus (Orthoptera, Tettigoniidae) and the Evolution of Temperate Life Histories	PLOS ONE			English	Article								Background: The katydid genus Neoconocephalus (25+ species) has a prominent acoustic communication system and occurs in large parts of the Neotropics and Nearctic. This group has been subject of numerous behavioral, physiological, and evolutionary studies of its acoustic communication system. Two distinct life histories occur in this group: The tropical life history incorporates multiple generations/year and direct egg development without environmental triggers. Temperate life history is characterized by overwintering in the egg stage, cold trigger of egg development, and one generation/year. This study reconstructs the phylogenetic relationships within the genus to (1) determine the evolutionary history of the temperate life history, and (2) to support comparative studies of evolutionary and physiological problems in this genus. Methodology/Principal Findings: We used Amplified Fragment Length Polymorphisms (AFLP), and sequences of two nuclear loci and one mitochondrial locus to reconstruct phylogenetic relationships. The analysis included 17 ingroup and two outgroup species. AFLP and mitochondrial data provided resolution at the species level while the two nuclear loci revealed only deeper nodes. The data sets were combined in a super-matrix to estimate a total evidence tree. Seven of the temperate species form a monophyletic group; however, three more temperate species were placed as siblings of tropical species. Conclusions/Significance: Our analyses support the reliability of the current taxonomic treatment of the Neoconocephalus fauna of Caribbean, Central, and North America. Ancestral state reconstruction of life history traits was not conclusive, however at least four transitions between life histories occurred among our sample of species. The proposed phylogeny will strengthen conclusions from comparative work in this group.			Snyder, RL (corresponding author), SUNY Coll Potsdam, Dept Biol, Potsdam, NY 13676 USA.	schulj@missouri.edu		Frederick, Katy/0000-0001-9651-3502; Schul, Johannes/0000-0003-4059-7123				Alexander R.D., 1956, THESIS OHIO STATE U, V2; BAILEY WJ, 1978, J NAT HIST, V12, P259, DOI 10.1080/00222937800770151; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Beckers OM, 2008, P ROY SOC B-BIOL SCI, V275, P1243, DOI 10.1098/rspb.2007.1765; BRUSH JS, 1985, PHYSIOL ENTOMOL, V10, P23, DOI 10.1111/j.1365-3032.1985.tb00015.x; Bush SL, 2009, J EXP BIOL, V212, P648, DOI 10.1242/jeb.024786; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Deily JA, 2006, J EXP BIOL, V209, P1757, DOI 10.1242/jeb.02189; Deily JA, 2004, J EXP BIOL, V207, P3523, DOI 10.1242/jeb.01179; Deily JA, 2009, J COMP PHYSIOL A, V195, P31, DOI 10.1007/s00359-008-0379-2; Dobzhansky T., 1937; Eades D. C., 2008, ORTHOPTERA SPECIES F; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Greenfield MD, 1997, P ROY SOC B-BIOL SCI, V264, P1355, DOI 10.1098/rspb.1997.0188; GREENFIELD MD, 1983, ANIM BEHAV, V31, P102, DOI 10.1016/S0003-3472(83)80178-X; GREENFIELD MD, 1993, NATURE, V364, P618, DOI 10.1038/364618a0; GREENFIELD MD, 1990, TETTIGONIIDAE BIOL S, P171; HEATH JE, 1970, BIOL BULL-US, V138, P272, DOI 10.2307/1540212; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; JOSEPHSON RK, 1985, J EXP BIOL, V117, P357; JOSEPHSON RK, 1984, J EXP BIOL, V108, P77; Koopman WJM, 2008, AM J BOT, V95, P353, DOI 10.3732/ajb.95.3.353; Lin CP, 2002, ANN ENTOMOL SOC AM, V95, P162, DOI 10.1603/0013-8746(2002)095[0162:MPOTNA]2.0.CO;2; MADDISON D, 2005, MACCLADE 4; Meade A., 2007, BAYESTRAITS; MEIXNER AJ, 1979, ANN ENTOMOL SOC AM, V72, P602, DOI 10.1093/aesa/72.5.602; MEIXNER AJ, 1986, ANN ENTOMOL SOC AM, V79, P554, DOI 10.1093/aesa/79.4.554; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; NASRECKI P, 2000, KATYDIDS COSTA RICA, V1; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nylander JAA, 2004, MRMODELTEST V2 0; REDTENBACHER J, 1891, VERH ZOOL BOT GES WI, V41, P315; Rehn J. A. G., 1915, Transactions of the American Entomological Society Philadelphia, V40; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schul J, 2003, J EXP BIOL, V206, P141, DOI 10.1242/jeb.00070; SWOFFORD DL, 2003, PAUP PHYLOGENETIC AN; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker T.J., 1983, Transactions of the American Entomological Society (Philadelphia), V109, P357; WALKER T J, 1973, Ohio Journal of Science, V73, P321; WALKER TJ, 1975, J INSECT PHYSIOL, V21, P595, DOI 10.1016/0022-1910(75)90163-8; WALKER TJ, 1978, ENTOMOL NEWS, V89, P27; WALKER TJ, 1978, FLA ENTOMOL, V61, P1, DOI 10.2307/3494421; WALKER TJ, 2008, SINGING INSECTS N AM; WHITESELL JJ, 1978, NATURE, V274, P887, DOI 10.1038/274887a0; WHITESELL JJ, 1969, THESIS U FLORIDA; Whitesell JJ, 1974, THESIS U FLORIDA FLO	47	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7203	10.1371/journal.pone.0007203	http://dx.doi.org/10.1371/journal.pone.0007203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779617	gold, Green Submitted, Green Published			2022-12-25	WOS:000270176200023
J	Cohen, DJ; Morfino, RC; Maharbiz, MM				Cohen, Daniel J.; Morfino, Roberto C.; Maharbiz, Michel M.			A Modified Consumer Inkjet for Spatiotemporal Control of Gene Expression	PLOS ONE			English	Article							GRADIENTS; CHEMOTAXIS; HYDROGELS; PATTERN; CELLS	This paper presents a low-cost inkjet dosing system capable of continuous, two-dimensional spatiotemporal regulation of gene expression via delivery of diffusible regulators to a custom-mounted gel culture of E. coli. A consumer-grade, inkjet printer was adapted for chemical printing; E. coli cultures were grown on 750 mm thick agar embedded in micro-wells machined into commercial compact discs. Spatio-temporal regulation of the lac operon was demonstrated via the printing of patterns of lactose and glucose directly into the cultures; X-Gal blue patterns were used for visual feedback. We demonstrate how the bistable nature of the lac operon's feedback, when perturbed by patterning lactose (inducer) and glucose (inhibitor), can lead to coordination of cell expression patterns across a field in ways that mimic motifs seen in developmental biology. Examples of this include sharp boundaries and the generation of traveling waves of mRNA expression. To our knowledge, this is the first demonstration of reaction-diffusion effects in the well-studied lac operon. A finite element reaction-diffusion model of the lac operon is also presented which predicts pattern formation with good fidelity.			Cohen, DJ (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	dancohen@berkeley.edu						AHMADZADEH A, 2005, ANAL LACTOSE METABOL, P879; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; BANSAL T, 2009, IEEE BIOMEDICAL MICR, V11; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Boland T, 2007, MAT SCI ENG C-BIO S, V27, P372, DOI 10.1016/j.msec.2006.05.047; Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081; Bonner JT., 2000, 1 SIGNALS EVOLUTION; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BROWN T, 2007, IET SYNTHETIC BIOL, V1, P21; Campbell PG, 2005, BIOMATERIALS, V26, P6762, DOI 10.1016/j.biomaterials.2005.04.032; Chambers JJ, 2006, J NEUROPHYSIOL, V96, P2792, DOI 10.1152/jn.00318.2006; Chen D, 2008, P NATL ACAD SCI USA, V105, P16843, DOI 10.1073/pnas.0807916105; Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; Dunlop M. J., 2008, NATURE GENETICS, V40; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Engelmann TW, 1881, PFLUGERS ARCH GESAMM, P285, DOI [10.1007/BF01661982, DOI 10.1007/BF01661982]; Fujikawa H, 2005, APPL ENVIRON MICROB, V71, P7920, DOI 10.1128/AEM.71.12.7920-7926.2005; Gu W, 2004, P NATL ACAD SCI USA, V101, P15861, DOI 10.1073/pnas.0404353101; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018; Ismagilov RF, 2007, CURR OPIN CHEM BIOL, V11, P604, DOI 10.1016/j.cbpa.2007.10.003; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Lausted C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r58; LEHNINGER A, 2004, PRINCIPLES BIOCH; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Madou M, 2006, ANNU REV BIOMED ENG, V8, P601, DOI 10.1146/annurev.bioeng.8.061505.095758; Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387; Merrin J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000663; MURRAY JD, 1993, MATH BIOL, V2; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Park J, 2006, LAB CHIP, V6, P611, DOI 10.1039/b516483d; Peterman MC, 2004, P NATL ACAD SCI USA, V101, P9951, DOI 10.1073/pnas.0402089101; Rosoff WJ, 2005, BIOTECHNOL BIOENG, V91, P754, DOI 10.1002/bit.20564; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomaterials.2007.09.032; Shestopalov IA, 2008, CHEM SOC REV, V37, P1294, DOI 10.1039/b703023c; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; WONG P, MATH MODEL LAC OPERO, P132; Yildirim N, 2003, BIOPHYS J, V84, P2841, DOI 10.1016/S0006-3495(03)70013-7; ZICHA D, 1991, J CELL SCI, V99, P769	43	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7086	10.1371/journal.pone.0007086	http://dx.doi.org/10.1371/journal.pone.0007086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763256	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970400014
J	Varani, K; Vincenzi, F; Tosi, A; Gessi, S; Casetta, I; Granieri, G; Fazio, P; Leung, E; MacLennan, S; Granieri, E; Borea, PA				Varani, Katia; Vincenzi, Fabrizio; Tosi, Alice; Gessi, Stefania; Casetta, Ilaria; Granieri, Gino; Fazio, Patrik; Leung, Edward; MacLennan, Stephen; Granieri, Enrico; Borea, Pier Andrea			A(2A) adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease	FASEB JOURNAL			English	Article						D-2 dopamine receptors; human putamen; human lymphocytes and neutrophils	PERIPHERAL-BLOOD CELLS; INFLAMMATORY CYTOKINES; BINDING; EXPRESSION; CAFFEINE; DOPAMINE; ISTRADEFYLLINE; ASSOCIATION; ANTAGONISTS; MEMBRANE	The antagonistic interaction between adenosine and dopamine receptors could have important pathophysiological and therapeutic implications in Parkinson's disease (PD). The primary aim of this study was to investigate the expression, affinity, and density of A(1), A(2A), A(2B), and A(3) adenosine receptors (ARs) and D-2 dopamine receptors (D(2)Rs) in PD. An increase in A(2A)AR density in putamen was found. The presence and functionality of ARs in human lymphocyte and neutrophil membranes from patients with PD revealed a specific A(2A)AR alteration compared with healthy subjects. A statistically significant linear correlation among the A(2A)AR density, functionality, or tumor necrosis factor-alpha (TNF-alpha) levels and Unified Parkinson's Disease Rating Scale (UPDRS) motor score was reported. Adenosine concentration and TNF-alpha levels were increased in plasma of patients with PD. In rat adrenal pheochromocytoma (PC12) cells, a widely useful model, adenosine antagonists decreased dopamine uptake, and an opposite effect was mediated by A(2A) agonists. This is the first report showing the presence of an A(2A)AR alteration in putamen in PD that mirrors a similar up-regulation in human peripheral blood cells. Moreover, the correlation found between A(2A)AR density or A(2A) agonist potency and UPDRS motor score highlights the central role of A(2A)ARs in the pharmacological treatment of PD.-Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., Borea, P. A. A(2A) adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. FASEB J. 24, 587-598 (2010). www.fasebj.org	[Borea, Pier Andrea] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Unit, Pharmacol Sect, I-44100 Ferrara, Italy; [Granieri, Gino] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy; [Casetta, Ilaria; Fazio, Patrik; Granieri, Enrico] Univ Hosp Ferrara, Neurol Clin, Ferrara, Italy; [Leung, Edward; MacLennan, Stephen] King Pharmaceut Inc, Res & Dev, Cary, NC USA	University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; Pfizer	Borea, PA (corresponding author), Univ Ferrara, Dept Clin & Expt Med, Pharmacol Unit, Pharmacol Sect, Via Fossato Mortara 17-19, I-44100 Ferrara, Italy.	bpa@unife.it	Gessi, Stefania/AAS-3844-2020; Vincenzi, Fabrizio/E-7925-2013; Casetta, Ilaria/K-5289-2016	Casetta, Ilaria/0000-0003-4099-8875; Granieri, Enrico/0000-0003-4038-3192; Vincenzi, Fabrizio/0000-0002-5027-1699; Fazio, Patrik/0000-0002-1863-1922; Gessi, Stefania/0000-0002-2197-5611	King Pharmaceuticals; Cassa di Risparmio di Ferrara (Ferrara, Italy)	King Pharmaceuticals; Cassa di Risparmio di Ferrara (Ferrara, Italy)	This study was supported by King Pharmaceuticals and Cassa di Risparmio di Ferrara (Ferrara, Italy).	Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODDE OE, 1987, TRENDS PHARMACOL SCI, V8, P403, DOI 10.1016/0165-6147(87)90108-8; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Calon F, 2004, BRAIN, V127, P1075, DOI 10.1093/brain/awh128; Capecchi PL, 2005, J CARD FAIL, V11, P67, DOI 10.1016/j.cardfail.2004.04.005; CAPECCHI PL, 2005, J CARD FAIL, V67, pA2; Cieslak M, 2008, PURINERG SIGNAL, V4, P305, DOI 10.1007/s11302-008-9100-8; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; Forrest CM, 2005, CLIN EXP RHEUMATOL, V23, P89; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Fuxe K, 2007, MOVEMENT DISORD, V22, P1990, DOI 10.1002/mds.21440; Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gessi S, 2004, CLIN CANCER RES, V10, P5895, DOI 10.1158/1078-0432.CCR-1134-03; GESSI S, 2005, MOL PHARM, V67, P1; Golembiowska K, 2008, PHARMACOL REP, V60, P319; Hashimoto W, 2005, LIFE SCI, V76, P1603, DOI 10.1016/j.lfs.2004.08.029; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; HAUSER RA, 2007, MOV DIS, V3, P359; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUTCHISON KA, 1990, BIOCHEMISTRY-US, V29, P5138, DOI 10.1021/bi00473a020; Jankovic J, 2008, ANN NEUROL, V63, P267, DOI 10.1002/ana.21348; Jenner P, 2005, EXPERT OPIN INV DRUG, V14, P729, DOI 10.1517/13543784.14.6.729; KADOWAKI K, 1990, NEUROENDOCRINOLOGY, V52, P256, DOI 10.1159/000125595; Khoa ND, 2006, MOL PHARMACOL, V69, P1311, DOI 10.1124/mol.105.016857; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; MARTINEZMIR MI, 1991, NEUROSCIENCE, V42, P697, DOI 10.1016/0306-4522(91)90038-P; Merighi S, 2002, J INVEST DERMATOL, V119, P923, DOI 10.1046/j.1523-1747.2002.00111.x; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nagatsu T, 2006, CELL MOL NEUROBIOL, V26, P781, DOI 10.1007/s10571-006-9061-9; NQUYEN DK, 2003, J IMMUNOL, V171, P3991; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Pahwa Rajesh, 2006, J Am Med Dir Assoc, V7, P4; Pearson T, 2001, J NEUROSCI, V21, P2298, DOI 10.1523/JNEUROSCI.21-07-02298.2001; Petzer JP, 2009, NEUROTHERAPEUTICS, V6, P141, DOI 10.1016/j.nurt.2008.10.035; Pinna A, 2007, SYNAPSE, V61, P606, DOI 10.1002/syn.20410; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Saint-Hilaire Marie-Helene, 2008, Med Health R I, V91, P136; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Stoessl AJ, 2008, EXPERT OPIN THER TAR, V12, P425, DOI [10.1517/14728222.12.4.425 , 10.1517/14728222.12.4.425]; TRAMPUS M, 1991, EUR J PHARMACOL, V194, P17, DOI 10.1016/0014-2999(91)90118-A; vanderPloeg I, 1996, N-S ARCH PHARMACOL, V353, P250, DOI 10.1007/BF00168626; Varani K, 2000, MOL PHARMACOL, V57, P968; Varani K, 2003, FASEB J, V17, P2148, DOI 10.1096/fj.03-0079fje; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167	49	92	97	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					587	598		10.1096/fj.09-141044	http://dx.doi.org/10.1096/fj.09-141044			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19776336				2022-12-25	WOS:000274045000026
J	Lai, CPK; Bechberger, JF; Naus, CC				Lai, C. P. K.; Bechberger, J. F.; Naus, C. C.			Pannexin2 as a novel growth regulator in C6 glioma cells	ONCOGENE			English	Article						Panx2; pannexins; gap junction; intercellular communication; C6 glioma	GAP-JUNCTIONS; INTERLEUKIN-1-BETA RELEASE; EXPRESSION; HEMICHANNELS; DEGRADATION; COMMUNICATION; CONNEXIN-43; DELETION; FAMILY; BRAIN	Connexins (Cxs), the gap junction proteins, have been found to be downregulated in many types of cancers including gliomas. By restoring gap junctional communication in cancer cell models, the neoplastic phenotype can be reversed, suggesting Cxs are tumor suppressors. Pannexin2 (Panx2) is a member of the novel gap junction protein family, Panxs, and it has been proposed as a brain-specific protein. Recently, gene array analysis showed an overall reduction of Panx2 in gliomas, and a direct correlation was observed between Panx2 expression and post-diagnosis survival in patients. In this study, we explored the potential inverse correlation between Panx2 and glioma oncogenicity. A decrease or absence of Panx2 expression in a panel of human glioma cell lines was found, whereas an appreciable amount of Panx2 was detected in both human brain and astrocytes. Stable Panx2 expression revealed a flattened morphology and increased cell-cell contacts in rat C6 glioma cells similar to Panx1. However, in contrast to Panx1 and Panx3, Panx2 was predominately detected in the cytoplasm in vesicle-like patterns but not at the plasma membrane. Coexpression of Panx2 and Panx1 did not show colocalization of both Panxs. Strikingly, restoration of Panx2 expression significantly reduced in vitro oncogenicity parameters, including monolayer saturation density and anchorage-independent growth, as well as in vivo tumor growth. This study suggests a role of aberrant Panx2 expression during gliomagenesis, and that Panx2 independently functions as a negative growth regulator without Panx1. Oncogene (2009) 28, 4402-4408; doi: 10.1038/onc.2009.283; published online 14 September 2009	[Lai, C. P. K.; Bechberger, J. F.; Naus, C. C.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Naus, CC (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cnaus@interchange.ubc.ca	Lai, Charles Pin-Kuang/D-5442-2017	Lai, Charles Pin-Kuang/0000-0001-8050-7060	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The research was supported by the Canadian Institutes of Health Research. The authors thank Dr WC Sin for the critical review of the paper, Dr L Matsuuchi for the insightful data discussions, as well as Lynne Bechberger for proofreading the paper. CCN is a recipient of a Canada Research Chair.	Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Das Sarma J, 2005, CELL COMMUN ADHES, V12, P237, DOI 10.1080/15419060500511875; Hu J, 2004, CHINESE MED J-PEKING, V117, P456; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Ino Y, 1999, J NEUROPATH EXP NEUR, V58, P881, DOI 10.1097/00005072-199908000-00010; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li H, 2002, AM J PHYSIOL-HEART C, V282, pH2124, DOI 10.1152/ajpheart.01028.2001; Litvin O, 2006, J CELL MOL MED, V10, P613, DOI 10.1111/j.1582-4934.2006.tb00424.x; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; LOEWENSTEIN WR, 1987, CELL, V48, P725, DOI 10.1016/0092-8674(87)90067-5; Mesnil M, 2002, BIOL CELL, V94, P493, DOI 10.1016/S0248-4900(02)00025-4; Naus CC, 2005, GAP JUNCTIONS IN DEVELOPMENT AND DISEASE, P253, DOI 10.1007/3-540-28621-7_12; Naus CCG, 2002, CAN J PHYSIOL PHARM, V80, P136, DOI 10.1139/Y02-009; NAUS CCG, 1991, NEUROSCI LETT, V126, P33, DOI 10.1016/0304-3940(91)90364-Y; Oskam NT, 2000, INT J CANCER, V85, P336, DOI 10.1002/(SICI)1097-0215(20000201)85:3<336::AID-IJC7>3.0.CO;2-9; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Schulz R, 2007, HEART FAIL REV, V12, P261, DOI 10.1007/s10741-007-9032-3; Skerrett IM, 2004, FASEB J, V18, P860, DOI 10.1096/fj.03-0763fje; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Trosko JE, 2002, CURR DRUG TARGETS, V3, P465, DOI 10.2174/1389450023347371; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang XH, 2009, J COMP NEUROL, V512, P336, DOI 10.1002/cne.21898; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028; Zheng L, 2007, INT J INF SECUR, V6, P67, DOI 10.1007/s10207-007-0019-9	38	53	57	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4402	4408		10.1038/onc.2009.283	http://dx.doi.org/10.1038/onc.2009.283			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19749789				2022-12-25	WOS:000272876400009
J	Walerych, D; Olszewski, MB; Gutkowska, M; Helwak, A; Zylicz, M; Zylicz, A				Walerych, D.; Olszewski, M. B.; Gutkowska, M.; Helwak, A.; Zylicz, M.; Zylicz, A.			Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions	ONCOGENE			English	Article						p53; molecular chaperones; Hsp70; Hsp90; protein folding	WILD-TYPE P53; HEAT-SHOCK PROTEINS; DNA-BINDING ACTIVITY; MUTANT P53; CORE DOMAIN; HSP90 INHIBITORS; CANCER-THERAPY; IN-VIVO; STABILIZATION; DEGRADATION	p53 as an unstable protein in vitro likely requires stabilizing factors to act as a tumor suppressor in vivo. Here, we show that in human cells transfected with wildtype (WT) p53, Hsp90 and Hsp70 molecular chaperones maintain the p53 native conformation under heat-shock conditions (42 degrees C) as well as assist p53 refolding at 37 degrees C, during the recovery from heat shock. We also show that the interaction of WT p53 with WAF1 promoter in cells is sensitive to Hsp70 and Hsp90 inhibition already at 37 degrees C and further decreased on heat shock. The influence of chaperones on p53 binding to the WAF1 promoter sequence has been confirmed in vitro, using highly purified proteins. Hsp90 stabilizes the binding of p53 to the promoter sequence at 37 degrees C, whereas under heat-shock conditions the requirement for the Hsp70-Hsp40 system and its cooperation with Hsp90 increases. Hop co-chaperone additionally stimulates these reactions. Interestingly, the combined Hsp90 and Hsp70-Hsp40 allow for a limited in vitro restoration of the DNA-binding activity by the p53 oncogenic variant R249S and affect its conformation in cells. Our results indicate for the first time that, especially under stress conditions, not only Hsp90 but also Hsp70 is required for the chaperoning of WT and R249S p53. Oncogene (2009) 28, 4284-4294; doi: 10.1038/onc.2009.281; published online 14 September 2009	[Walerych, D.; Olszewski, M. B.; Gutkowska, M.; Helwak, A.; Zylicz, M.; Zylicz, A.] Int Inst Mol & Cell Biol Warsaw, Dept Mol Biol, PL-02109 Warsaw, Poland; [Gutkowska, M.] Nencki Inst Expt Biol PAS, Warsaw, Poland; [Helwak, A.] Inst Biochem & Biophys PAS, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol Warsaw, Dept Mol Biol, 4 Ksiecia Trojdena St, PL-02109 Warsaw, Poland.	mzylicz@iimcb.gov.pl; alicja.zylicz@iimcb.gov.pl	Olszewski, Maciej/C-2021-2015; Walerych, Dawid/I-2517-2016; Olszewski, Maciej/G-8396-2016	Olszewski, Maciej/0000-0003-0961-0801; Olszewski, Maciej/0000-0003-0961-0801; Walerych, Dawid/0000-0002-8440-1375; Zylicz, Alicja/0000-0003-4174-3073; Gutkowska, Malgorzata/0000-0001-6584-7964	Postgraduate School of Molecular Medicine affiliated with the Medical University of Warsaw; Polish Ministry of Science and Higher Education	Postgraduate School of Molecular Medicine affiliated with the Medical University of Warsaw; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We thank Dr Marcin Klejman for sharing purified Hsp90b proteins; Professor Peter Csermely for the plasmid encoding human Hsp90a; Professor Ted Hupp for plasmid for p53 overexpression; Professor Richard Morimoto for plasmids encoding human Hsp70, Hdj1 and Hop; and Professor Kazutoyo Terada for construct for the Hdj2 overexpression. Dawid Walerych is the recipient of a scholarship from the Postgraduate School of Molecular Medicine affiliated with the Medical University of Warsaw. This work was supported by a grant from the Polish Ministry of Science and Higher Education.	Agashe VR, 2000, SEMIN CELL DEV BIOL, V11, P15, DOI 10.1006/scdb.1999.0347; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Butler JS, 2006, PROTEIN SCI, V15, P2457, DOI 10.1110/ps.062324206; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Fourie AM, 1997, J BIOL CHEM, V272, P19471, DOI 10.1074/jbc.272.31.19471; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Friedler A, 2004, J MOL BIOL, V336, P187, DOI 10.1016/j.jmb.2003.12.005; Hansen S, 1996, J BIOL CHEM, V271, P3917; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lee DW, 2005, J CELL SCI, V118, P4311, DOI 10.1242/jcs.02548; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; MILNER J, 1990, J MOL BIOL, V216, P481, DOI 10.1016/0022-2836(90)90371-R; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller P, 2005, J BIOL CHEM, V280, P6682, DOI 10.1074/jbc.M412767200; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Pacey S, 2006, HANDB EXP PHARM, V172, P331; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Sepehrnia B, 1996, J BIOL CHEM, V271, P15084, DOI 10.1074/jbc.271.25.15084; Sreedhar AS, 2004, FEBS LETT, V562, P11; SUGITO K, 1995, FEBS LETT, V358, P161, DOI 10.1016/0014-5793(94)01417-Y; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	47	58	59	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4284	4294		10.1038/onc.2009.281	http://dx.doi.org/10.1038/onc.2009.281			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19749793				2022-12-25	WOS:000272876300006
J	Westrop, GD; Georg, I; Coombs, GH				Westrop, Gareth D.; Georg, Ina; Coombs, Graham H.			The Mercaptopyruvate Sulfurtransferase of Trichomonas vaginalis Links Cysteine Catabolism to the Production of Thioredoxin Persulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AMINO-ACID-METABOLISM; SULFANE SULFUR; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; INTRACELLULAR CYSTEINE; ENTAMOEBA-HISTOLYTICA; ENZYMATIC ACTIVATION; PROTOZOAN PARASITES; CRYSTAL-STRUCTURE; HYDROGEN-SULFIDE	Trichomonas vaginalis is a protozoan parasite of humans that is able to synthesize cysteine de novo using cysteine synthase but does not produce glutathione. In this study, high pressure liquid chromatography analysis confirmed that cysteine is the major intracellular redox buffer by showing that T. vaginalis contains high levels of cysteine (similar to 600 mu M) comprising more than 70% of the total thiols detected. To investigate possible mechanisms for the regulation of cysteine levels in T. vaginalis, we have characterized enzymes of the mercaptopyruvate pathway. This consists of an aspartate aminotransferase (TvAspAT1), which transaminates cysteine to form 3-mercaptopyruvate (3-MP), and mercaptopyruvate sulfurtransferase (TvMST), which transfers the sulfur of 3-MP to a nucleophilic acceptor, generating pyruvate. TvMST has high activity with 3-MP as a sulfur donor and can use several thiol compounds as sulfur acceptor substrates. Our analysis indicated that TvMST has a k(cat)/K-m for reduced thioredoxin of 6.2 x 10(7) M-1 s(-1), more than 100-fold higher than that observed for beta-mercaptoethanol and cysteine, suggesting that thioredoxin is a preferred substrate for TvMST. Thiol trapping and mass spectrometry provided direct evidence for the formation of thioredoxin persulfide as a product of this reaction. The thioredoxin persulfide could serve a biological function such as the transfer of the persulfide to a target protein or the sequestered release of sulfide for biosynthesis. Changes in MST activity of T. vaginalis in response to variation in the supply of exogenous cysteine are suggestive of a role for the mercaptopyruvate pathway in the removal of excess intracellular cysteine, redox homeostasis, and antioxidant defense.	[Westrop, Gareth D.; Georg, Ina; Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	University of Strathclyde	Westrop, GD (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland.	gareth.westrop@strath.ac.uk	Georg, Ina/L-5018-2014	Georg, Ina/0000-0002-1256-5805; Westrop, Gareth/0000-0002-8011-6219	Medical Research Council [G9722968] Funding Source: Medline; MRC [G9722968] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AKAGI R, 1982, ACTA MED OKAYAMA, V36, P187; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Alphey MS, 2003, J BIOL CHEM, V278, P48219, DOI 10.1074/jbc.M307187200; Ariyanayagam MR, 1999, MOL BIOCHEM PARASIT, V103, P61, DOI 10.1016/S0166-6851(99)00118-8; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Billaut-Laden I, 2006, TOXICOL LETT, V165, P101, DOI 10.1016/j.toxlet.2006.02.002; BROWN DM, 1993, MOL BIOCHEM PARASIT, V61, P155, DOI 10.1016/0166-6851(93)90169-X; Coombs GH, 2004, J BIOL CHEM, V279, P5249, DOI 10.1074/jbc.M304359200; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Dominy JE, 2007, AM J PHYSIOL-ENDOC M, V293, pE62, DOI 10.1152/ajpendo.00053.2007; DRAKE MR, 1987, BIOCHEM J, V244, P279, DOI 10.1042/bj2440279; Dunne RL, 2003, CELL RES, V13, P239, DOI 10.1038/sj.cr.7290169; ELLIS JE, 1994, MICROBIOL-SGM, V140, P2489, DOI 10.1099/13500872-140-9-2489; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Iciek M, 2001, POL J PHARMACOL, V53, P215; Iciek M, 2007, EUR J PHARMACOL, V569, P1, DOI 10.1016/j.ejphar.2007.04.055; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kissinger P, 2009, SEX TRANSM DIS, V36, P11, DOI 10.1097/OLQ.0b013e318186decf; KNODLER LA, 1994, EXP PARASITOL, V79, P117, DOI 10.1006/expr.1994.1071; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; LINSTEAD DJ, 1988, MOL BIOCHEM PARASIT, V27, P125, DOI 10.1016/0166-6851(88)90032-1; LOWE PN, 1986, MOL BIOCHEM PARASIT, V21, P65, DOI 10.1016/0166-6851(86)90080-0; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McKie AE, 1998, J BIOL CHEM, V273, P5549, DOI 10.1074/jbc.273.10.5549; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; MIKAMI H, 1984, ACTA MED OKAYAMA, V38, P415; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Shafir SC, 2009, CLIN MICROBIOL REV, V22, P37, DOI 10.1128/CMR.00002-08; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sorvillo F, 2001, EMERG INFECT DIS, V7, P927, DOI 10.3201/eid0706.010603; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; TERKUILE BH, 1993, FEMS MICROBIOL LETT, V110, P27, DOI 10.1111/j.1574-6968.1993.tb06290.x; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; VINA J, 1983, BIOCHEM J, V212, P39, DOI 10.1042/bj2120039; Walker J, 1997, INT J PARASITOL, V27, P883, DOI 10.1016/S0020-7519(97)00039-8; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c	52	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33485	33494		10.1074/jbc.M109.054320	http://dx.doi.org/10.1074/jbc.M109.054320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19762467	Green Published, hybrid			2022-12-25	WOS:000272028500055
J	Saliba, RS; Gu, ZL; Yan, Z; Moss, SJ				Saliba, Richard S.; Gu, Zhenglin; Yan, Zhen; Moss, Stephen J.			Blocking L-type Voltage-gated Ca2+ Channels with Dihydropyridines Reduces gamma-Aminobutyric Acid Type A Receptor Expression and Synaptic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; NMDA RECEPTORS; PROTEIN-KINASE; TRAFFICKING; SYNAPSES; PHOSPHORYLATION; MODULATION; AMPLITUDE	gamma-Aminobutyric acid type A receptors (GABA(A)Rs) are the major sites of fast inhibitory neurotransmission in the brain, and the numbers of these receptors at the cell surface can determine the strength of GABAergic neurotransmission. Chronic changes in neuronal activity lead to an adaptive modulation in the efficacy of GABAergic synaptic inhibition, brought about in part by changes in the number of synaptic GABA(A)Rs, a mechanism known as homeostatic synaptic plasticity. Reduction in the number of GABA(A) Rs in response to prolonged neuronal activity blockade is dependent on the ubiquitin-proteasome system. The underlying biochemical pathways linking chronic activity blockade to proteasome-dependent degradation of GABA(A)Rs are unknown. Here, we show that chronic blockade of L-type voltage-gated calcium channels (VGCCs) with nifedipine decreases the number of GABA(A) Rs at synaptic sites but not the overall number of inhibitory synapses. In parallel, blockade of L-type VGCCs decreases the amplitude but not the frequency of miniature inhibitory postsynaptic currents or expression of the glutamic acid decarboxylase GAD65. We further reveal that the activation of L-type VGCCs regulates the turnover of newly translated GABA(A)R subunits in a mechanism dependent upon the activity of the proteasome and thus regulates GABA(A)R insertion into the plasma membrane. Together, these observations suggest that activation of L-type VGCCs can regulate the abundance of synaptic GABA(A)Rs and the efficacy of synaptic inhibition, revealing a potential mechanism underlying the homeostatic adaptation of fast GABAergic inhibition to prolonged changes in activity.	[Saliba, Richard S.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Gu, Zhenglin; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Moss, Stephen J.] UCL, Dept Neurosci, London WC1E 6BT, England; [Moss, Stephen J.] UCL, Dept Physiol, London WC1E 6BT, England; [Moss, Stephen J.] UCL, Dept Pharmacol, London WC1E 6BT, England	Tufts University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of London; University College London; University of London; University College London; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	stephen.moss@tufts.edu			National Institutes of Health [NS047478, NS048045, NS051195, NS056359, NS054900]; NINDS; American Society for Epilepsy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS056359, R01NS048045, P01NS054900, R01NS047478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Society for Epilepsy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047478, NS048045, NS051195, NS056359, and NS054900 from NINDS ( to S. J. M.) and by a fellowship from the American Society for Epilepsy (to R. S. S.).	Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Saliba RS, 2008, J BIOL CHEM, V283, P18538, DOI 10.1074/jbc.M802077200; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	39	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32544	32550		10.1074/jbc.M109.040071	http://dx.doi.org/10.1074/jbc.M109.040071			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19778903	hybrid, Green Published			2022-12-25	WOS:000272028400036
J	Choi, HJ; Gross, JC; Pokutta, S; Weis, WI				Choi, Hee-Jung; Gross, Julia C.; Pokutta, Sabine; Weis, William I.			Interactions of Plakoglobin and beta-Catenin with Desmosomal Cadherins BASIS OF SELECTIVE EXCLUSION OF alpha-AND beta-CATENIN FROM DESMOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT ANCHORAGE; CELL-CELL ADHESION; ADHERENS JUNCTIONS; INTERCELLULAR-ADHESION; CLASSICAL CADHERINS; CYTOPLASMIC DOMAIN; CRYSTAL-STRUCTURE; TERMINAL TAILS; BINDING-SITES; FULL-LENGTH	Plakoglobin and beta-catenin are homologous armadillo repeat proteins found in adherens junctions, where they interact with the cytoplasmic domain of classical cadherins and with beta-catenin. Plakoglobin, but normally not beta-catenin, is also a structural constituent of desmosomes, where it binds to the cytoplasmic domains of the desmosomal cadherins, desmogleins and desmocollins. Here, we report structural, biophysical, and biochemical studies aimed at understanding the molecular basis of selective exclusion of beta-catenin and beta-catenin from desmosomes. The crystal structure of the plakoglobin armadillo domain bound to phosphorylated E-cadherin shows virtually identical interactions to those observed between beta-catenin and E-cadherin. Trypsin sensitivity experiments indicate that the plakoglobin arm domain by itself is more flexible than that of beta-catenin. Binding of plakoglobin and beta-catenin to the intracellular regions of E-cadherin, desmoglein1, and desmocollin1 was measured by isothermal titration calorimetry. Plakoglobin and beta-catenin bind strongly and with similar thermodynamic parameters to E-cadherin. In contrast, beta-catenin binds to desmoglein-1 more weakly than does plakoglobin. beta-Catenin and plakoglobin bind with similar weak affinities to desmocollin-1. Full affinity binding of desmoglein-1 requires sequences C-terminal to the region homologous to the catenin-binding domain of classical cadherins. Although pulldown assays suggest that the presence of N- and C-terminal beta-catenin "tails" that flank the armadillo repeat region reduces the affinity for desmosomal cadherins, calorimetric measurements show no significant effects of the tails on binding to the cadherins. Using purified proteins, we show that desmosomal cadherins and beta-catenin compete directly for binding to plakoglobin, consistent with the absence of beta-catenin in desmosomes.	[Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011; Gross, Julia Christina/AAN-5730-2020	Weis, William I/0000-0002-5583-6150; Gross, Julia Christina/0000-0002-8939-5664; Choi, Hee-Jung/0000-0002-1167-1526	National Institutes of Health [R01 GM56169]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM56169.	Acehan D, 2008, J INVEST DERMATOL, V128, P2665, DOI 10.1038/jid.2008.141; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Bierkamp C, 1999, DEVELOPMENT, V126, P371; Chitaev NA, 1996, J CELL BIOL, V133, P359, DOI 10.1083/jcb.133.2.359; Chitaev NA, 1998, J CELL SCI, V111, P1941; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kami K, 2009, J MOL BIOL, V386, P531, DOI 10.1016/j.jmb.2008.12.054; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; MATHUR M, 1994, J BIOL CHEM, V269, P14075; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Norvell SM, 1998, J CELL SCI, V111, P1305; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; PLOTT RT, 1994, J INVEST DERMATOL, V103, P168, DOI 10.1111/1523-1747.ep12392642; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Solanas G, 2004, J BIOL CHEM, V279, P49849, DOI 10.1074/jbc.M408685200; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tago K, 2000, GENE DEV, V14, P1741; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; TROYANOVSKY SM, 1994, J CELL BIOL, V127, P151, DOI 10.1083/jcb.127.1.151; TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2; TROYANOVSKY SM, 1994, P NATL ACAD SCI USA, V91, P10790, DOI 10.1073/pnas.91.23.10790; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wahl JK, 2000, J CELL SCI, V113, P1737; Wahl JK, 1996, J CELL SCI, V109, P1143; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	49	51	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31776	31788		10.1074/jbc.M109.047928	http://dx.doi.org/10.1074/jbc.M109.047928			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759396	hybrid, Green Published			2022-12-25	WOS:000271572700032
J	Jung, SY; Kim, JM; Kang, HK; Jang, DH; Min, BM				Jung, Sung Youn; Kim, Jin-Man; Kang, Hyun Ki; Jang, Da Hyun; Min, Byung-Moo			A Biologically Active Sequence of the Laminin alpha 2 Large Globular 1 Domain Promotes Cell Adhesion through Syndecan-1 by Inducing Phosphorylation and Membrane Localization of Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC PEPTIDE; HEPARAN-SULFATE; BINDING-SITE; A-CHAIN; PERIPHERAL-NERVE; SCHWANN-CELLS; LG4 MODULE; PKC-ALPHA; IDENTIFICATION; DYSTROGLYCAN	Laminin-2 promotes basement membrane assembly and peripheral myelinogenesis; however, a receptor-binding motif within laminin-2 and the downstream signaling pathways for motif-mediated cell adhesion have not been fully established. The human laminin-2 alpha 2 chain cDNAs cloned from human keratinocytes and fibroblasts correspond to the laminin alpha 2 chain variant sequence from the human brain. Individually expressed recombinant large globular (LG) 1 protein promotes cell adhesion and has heparin binding activities. Studies with synthetic peptides delineate the DLTIDDSYWYRI motif (Ln2-P3) within the LG1 as a major site for both heparin and cell binding. Cell adhesion to LG1 and Ln2-P3 is inhibited by treatment of heparitinase I and chondroitinase ABC. Syndecan-1 from PC12 cells binds to LG1 and Ln2-P3 and colocalizes with both molecules. Suppression of syndecan-1 with RNA interference inhibits cell adhesion to LG1 and Ln2-P3. The binding of syndecan-1 with LG1 and Ln2-P3 induces the recruitment of protein kinase C delta (PKC delta) into the membrane and stimulates its tyrosine phosphorylation. A decrease in PKC delta activity significantly reduces cell adhesion to LG1 and Ln2-P3. Taken together, these results indicate that the Ln2-P3 motif and LG1 domain, containing the motif, within the human laminin-2 alpha 2 chain are major ligands for syndecan-1, which mediates cell adhesion through the PKC delta signaling pathway.	Intellectual Biointerface Engn Ctr, Dent Res Inst, Dept Oral Biochem, Seoul 110749, South Korea; Intellectual Biointerface Engn Ctr, Dent Res Inst, Program Craniomaxillofacial Reconstruct Sci, Seoul 110749, South Korea; Seoul Natl Univ, Sch Dent, CLS BK21, Seoul 110749, South Korea	Seoul National University (SNU)	Min, BM (corresponding author), 28 Yeonkun Dong, Seoul 110749, South Korea.	bmmin@snu.ac.kr	Min, Byung-Moo/F-2854-2012		Korea Science and Engineering Foundation through the Intellectual Biointerface Engineering Center at Seoul National University	Korea Science and Engineering Foundation through the Intellectual Biointerface Engineering Center at Seoul National University(Korea Science and Engineering Foundation)	This work was supported by grants from the Korea Science and Engineering Foundation through the Intellectual Biointerface Engineering Center at Seoul National University ( to B.- M. M.).	Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Carey DJ, 1997, BIOCHEM J, V327, P1; CHARONIS AS, 1988, J CELL BIOL, V107, P1253, DOI 10.1083/jcb.107.3.1253; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Couchman JR, 1999, J CELL SCI, V112, P3415; Edwards JP, 1998, BRAIN RES, V788, P262, DOI 10.1016/S0006-8993(98)00010-9; Ekblom M, 1998, ANN NY ACAD SCI, V857, P194, DOI 10.1111/j.1749-6632.1998.tb10117.x; Feltri ML, 2005, J PERIPHER NERV SYST, V10, P128, DOI 10.1111/j.1085-9489.2005.0010204.x; GEHLSEN KR, 1992, J CELL BIOL, V117, P449, DOI 10.1083/jcb.117.2.449; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Lyon M, 2000, J BIOL CHEM, V275, P4599, DOI 10.1074/jbc.275.7.4599; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Malave C, 2003, BRAIN RES, V983, P74, DOI 10.1016/S0006-8993(03)03031-2; Masaki T, 2000, ACTA NEUROPATHOL, V99, P289, DOI 10.1007/PL00007440; Matsumura K, 1997, NEUROMUSCULAR DISORD, V7, P7, DOI 10.1016/S0960-8966(96)00402-6; Nielsen PK, 2000, J BIOL CHEM, V275, P14517, DOI 10.1074/jbc.275.19.14517; Nomizu M, 1996, FEBS LETT, V396, P37, DOI 10.1016/0014-5793(96)01060-5; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Quittau-Prevostel C, 2004, J CELL SCI, V117, P63, DOI 10.1242/jcs.00832; Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sewry CA, 1997, NEUROPEDIATRICS, V28, P217, DOI 10.1055/s-2007-973703; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Talts JF, 1999, FEBS LETT, V458, P319, DOI 10.1016/S0014-5793(99)01180-1; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; TASHIRO K, 1994, BIOCHEM J, V302, P73, DOI 10.1042/bj3020073; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vossmeyer D, 2002, J BIOL CHEM, V277, P4636, DOI 10.1074/jbc.M105415200; VUOLTEENAHO R, 1994, J CELL BIOL, V124, P381, DOI 10.1083/jcb.124.3.381; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; Yamashita H, 2004, BIOCHEM J, V382, P933, DOI 10.1042/BJ20040558; Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a; Yoshida I, 1999, J CELL PHYSIOL, V179, P18, DOI 10.1002/(SICI)1097-4652(199904)179:1<18::AID-JCP3>3.0.CO;2-K	49	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31764	31775		10.1074/jbc.M109.038547	http://dx.doi.org/10.1074/jbc.M109.038547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19762914	Green Published, hybrid			2022-12-25	WOS:000271572700031
J	Zhao, Q; Wang, QE; Ray, A; Wani, G; Han, CH; Milum, K; Wani, AA				Zhao, Qun; Wang, Qi-En; Ray, Alo; Wani, Gulzar; Han, Chunhua; Milum, Keisha; Wani, Altaf A.			Modulation of Nucleotide Excision Repair by Mammalian SWI/SNF Chromatin-remodeling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-BINDING-PROTEIN; GROUP-C PROTEIN; DAMAGED-DNA; HUMAN-CELLS; PYRIMIDINE DIMERS; HUMAN-FIBROBLASTS; UV-IRRADIATION; XPC; RECRUITMENT	Accessibility within chromatin is an important factor in the prompt removal of UV-induced DNA damage by nucleotide excision repair (NER). Chromatin remodeling by the SWI/SNF complex has been shown to play an important modulating role in NER in vitro and yeast in vivo. Nevertheless, the molecular basis of cross-talk between SWI/SNF and NER in mammalian cells is not fully understood. Here, we show that knockdown of Brg1, the ATPase subunit of SWI/SNF, negatively affects the elimination of cyclobutane pyrimidine dimers (CPD), but not of pyrimidine (6, 4) pyrimidone photoproducts (6-4PP) following UV irradiation of mammalian cells. Brg1-deficient cells exhibit a lower chromatin relaxation as well as impaired recruitment of downstream NER factors, XPG and PCNA, to UV lesions. However, the assembly of upstream NER factors, DDB2 and XPC, at the damage site was unaffected by Brg1 knockdown. Interestingly, Brg1 interacts with XPC within chromatin and is recruited to UV-damaged sites in a DDB2- and XPC-dependent manner. Also, postirradiation decrease of XPC levels occurred more rapidly in Brg1-deficient than normal cells. Conversely, XPC transcription remained unaltered upon Brg1 knockdown indicating that Brg1 affects the stability of XPC protein following irradiation. Thus, Brg1 facilitates different stages of NER by initially modulating UV-induced chromatin relaxation and stabilizing XPC at the damage sites, and subsequently stimulating the recruitment of XPG and PCNA to successfully culminate the repair.	[Zhao, Qun; Wang, Qi-En; Ray, Alo; Wani, Gulzar; Han, Chunhua; Milum, Keisha; Wani, Altaf A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wang, QE (corresponding author), Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA.	wang.771@osu.edu; wani.2@osu.edu			National Institutes of Health [ES2388, ES12991, CA93413]; NATIONAL CANCER INSTITUTE [R01CA093413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012991, R01ES002388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Public Health Service National Institutes of Health Grants ES2388, ES12991, and CA93413 (to A. A. W.).	ABOUSSEKHRA A, 1995, EXP CELL RES, V221, P326, DOI 10.1006/excr.1995.1382; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Baxter BK, 1998, J BIOL CHEM, V273, P17517, DOI 10.1074/jbc.273.28.17517; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; Hara R, 2002, MOL CELL BIOL, V22, P6779, DOI 10.1128/MCB.22.19.6779-6787.2002; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Nakanishi S, 2007, NUCLEIC ACIDS RES, V35, P4313, DOI 10.1093/nar/gkm436; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2006, J MOL HISTOL, V37, P189, DOI 10.1007/s10735-006-9044-7; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VENKATACHALAM S, 1995, CARCINOGENESIS, V16, P2029, DOI 10.1093/carcin/16.9.2029; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; Wang QE, 2007, NUCLEIC ACIDS RES, V35, P5338, DOI 10.1093/nar/gkm550; WANG ZG, 1991, J BIOL CHEM, V266, P22472; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Zhang L, 2009, BIOCHEM CELL BIOL, V87, P265, DOI 10.1139/O08-101; Zhao Q, 2008, J BIOL CHEM, V283, P32553, DOI 10.1074/jbc.M803963200	46	76	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30424	30432		10.1074/jbc.M109.044982	http://dx.doi.org/10.1074/jbc.M109.044982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740755	Green Published, hybrid			2022-12-25	WOS:000271090000045
J	Molloy, SA; Kaplan, JH				Molloy, Shannon A.; Kaplan, Jack H.			Copper-dependent Recycling of hCTR1, the Human High Affinity Copper Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; MUTATIONAL ANALYSIS; HUMAN CTR1; YEAST; GENE; COMPLEMENTATION; TRAFFICKING; MECHANISMS	Copper is an essential co-factor in many important physiological processes, but at elevated levels it is toxic to cells. Thus at both the organism and cellular level mechanisms have evolved to finely tune copper homeostasis. The protein responsible for copper entry from the circulation in most human cells is hCTR1, a small protein (190 amino acid residues) that functions as a trimer in the plasma membrane. In the present work we employ cell surface biotinylation and isotopic copper uptake studies of overexpressed hCTR1 in HEK293 cells to examine the acute (minutes) response of hCTR1 to changes in extracellular copper. We show that within 10 min of exposure to copper at 2.5 mu M or higher, plasma membrane hCTR1 levels are reduced (by similar to 40%), with a concomitant reduction in copper uptake rates. We are unable to detect any degradation of internalized hCTR1 in the presence of cycloheximide after up to 2 h of exposure to 0-100 mu M copper. Using a reversible biotinylation assay, we quantified internalized hCTR1, which increased upon the addition of copper and corresponded to the hCTR1 lost from the surface. In addition, when extracellular copper is then removed, internalized hCTR1 is promptly (within 30 min) recycled to the plasma membrane. We have shown that in the absence of added extracellular copper, there is a small but detectable amount of internalized hCTR1 that is increased in the presence of copper. Similar studies on endogenous hCTR1 show a cell-specific response to elevated extracellular copper. Copper-dependent internalization and recycling of hCTR1 provides an acute and reversible mechanism for the regulation of cellular copper entry.	[Molloy, Shannon A.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [PO1 GM 067166]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 GM 067166, Project 1 (to J. H. K.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Dumay QC, 2006, J MOL MICROB BIOTECH, V11, P10, DOI 10.1159/000092815; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Ford ES, 2000, AM J EPIDEMIOL, V151, P1182, DOI 10.1093/oxfordjournals.aje.a010168; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Harris ED, 2000, ANNU REV NUTR, V20, P291, DOI 10.1146/annurev.nutr.20.1.291; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200	32	73	76	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29704	29713		10.1074/jbc.M109.000166	http://dx.doi.org/10.1074/jbc.M109.000166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19740744	hybrid, Green Published			2022-12-25	WOS:000270896800052
J	Hammond, R; Blaess, S; Abeliovich, A				Hammond, Rachel; Blaess, Sandra; Abeliovich, Asa			Sonic Hedgehog Is a Chemoattractant for Midbrain Dopaminergic Axons	PLOS ONE			English	Article								Midbrain dopaminergic axons project from the substantia nigra (SN) and the ventral tegmental area (VTA) to rostral target tissues, including the striatum, pallidum, and hypothalamus. The axons from the medially located VTA project primarily to more medial target tissues in the forebrain, whereas the more lateral SN axons project to lateral targets including the dorsolateral striatum. This structural diversity underlies the distinct functions of these pathways. Although a number of guidance cues have been implicated in the formation of the distinct axonal projections of the SN and VTA, the molecular basis of their diversity remains unclear. Here we investigate the molecular basis of structural diversity in mDN axonal projections. We find that Sonic Hedgehog (Shh) is expressed at a choice point in the course of the rostral dopaminergic projections. Furthermore, in midbrain explants, dopaminergic projections are attracted to a Shh source. Finally, in mice in which Shh signaling is inactivated during late neuronal development, the most medial dopaminergic projections are deficient. In addition to the role of Shh in the induction of mDN precursors, Shh plays an important role in dopaminergic axon pathfinding to rostral target tissues. Furthermore, Shh signaling is involved in determining the structural diversity of these dopaminergic projections.			Hammond, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol, Ctr Neurobiol, New York, NY 10027 USA.	aa900@columbia.edu	Blaess, Sandra/K-8503-2015	Blaess, Sandra/0000-0002-1898-4891	NINDS NIH HHS [R01 NS064433, R01 NS060832] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Barresi MJF, 2005, DEVELOPMENT, V132, P3643, DOI 10.1242/dev.01929; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Lin L, 2005, MOL CELL NEUROSCI, V28, P547, DOI 10.1016/j.mcn.2004.11.009; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; VarelaEchavarria A, 1997, GENE DEV, V11, P545, DOI 10.1101/gad.11.5.545; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yamauchi K, 2009, J NEUROSCI, V29, P4044, DOI 10.1523/JNEUROSCI.4794-08.2009; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	19	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7007	10.1371/journal.pone.0007007	http://dx.doi.org/10.1371/journal.pone.0007007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774071	Green Submitted, Green Published, gold			2022-12-25	WOS:000270160900002
J	Morales-Corraliza, J; Mazzella, MJ; Berger, JD; Diaz, NS; Choi, JHK; Levy, E; Matsuoka, Y; Planel, E; Mathews, PM				Morales-Corraliza, Jose; Mazzella, Matthew J.; Berger, Jason D.; Diaz, Nicole S.; Choi, Jennifer H. K.; Levy, Efrat; Matsuoka, Yasuji; Planel, Emmanuel; Mathews, Paul M.			In Vivo Turnover of Tau and APP Metabolites in the Brains of Wild-Type and Tg2576 Mice: Greater Stability of sAPP in the beta-Amyloid Depositing Mice	PLOS ONE			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; A-BETA; SECRETED FORMS; HYPERPHOSPHORYLATION; INHIBITION; NEURONS; SUPPRESSION; ACTIVATION; CLEARANCE	The metabolism of the amyloid precursor protein (APP) and tau are central to the pathobiology of Alzheimer's disease (AD). We have examined the in vivo turnover of APP, secreted APP (sAPP), Ab and tau in the wild-type and Tg2576 mouse brain using cycloheximide to block protein synthesis. In spite of overexpression of APP in the Tg2576 mouse, APP is rapidly degraded, similar to the rapid turnover of the endogenous protein in the wild-type mouse. sAPP is cleared from the brain more slowly, particularly in the Tg2576 model where the half-life of both the endogenous murine and transgene-derived human sAPP is nearly doubled compared to wild-type mice. The important Ab degrading enzymes neprilysin and IDE were found to be highly stable in the brain, and soluble A beta 40 and A beta 42 levels in both wild-type and Tg2576 mice rapidly declined following the depletion of APP. The cytoskeletal-associated protein tau was found to be highly stable in both wild-type and Tg2576 mice. Our findings unexpectedly show that of these various AD-relevant protein metabolites, sAPP turnover in the brain is the most different when comparing a wild-type mouse and a beta-amyloid depositing, APP overexpressing transgenic model. Given the neurotrophic roles attributed to sAPP, the enhanced stability of sAPP in the beta-amyloid depositing Tg2576 mice may represent a neuroprotective response.			Morales-Corraliza, J (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.	jmorales-corraliza@nki.rfmh.org; mathews@nki.rfmh.org	Tudor, Jennifer/L-2104-2013; Tudor, Jennifer/Q-2151-2019	Tudor, Jennifer/0000-0002-3826-3012; Tudor, Jennifer/0000-0002-3826-3012; Mathews, Paul/0000-0003-1742-7687; Morales-Corraliza, Jose/0000-0003-3287-9382; Planel, Emmanuel/0000-0001-5128-0565	NIA NIH HHS [AG017617, P01 AG017617, F31 AG029787, AG022455, K01 AG022455] Funding Source: Medline; NINDS NIH HHS [NS045205, R01 NS045205] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617, F31AG029787, K01AG022455] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; BARNEY CC, 1979, BRAIN RES BULL, V4, P355, DOI 10.1016/S0361-9230(79)80013-1; BASS NH, 1973, BRAIN RES, V52, P323, DOI 10.1016/0006-8993(73)90668-9; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cirrito JR, 2003, J NEUROSCI, V23, P8844; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; De Strooper B, 2000, J CELL SCI, V113, P1857; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; GARNER JA, 1988, BRAIN RES, V458, P309, DOI 10.1016/0006-8993(88)90473-8; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLD PE, 1978, SCIENCE, V201, P367, DOI 10.1126/science.208153; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LeBlanc AC, 1996, J NEUROCHEM, V66, P2300; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; MATTSON MP, 1994, J NEUROBIOL, V25, P439, DOI 10.1002/neu.480250409; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mercken M, 1995, J NEUROSCI, V15, P8259; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Rozmahel R, 2002, NEUROBIOL AGING, V23, P187, DOI 10.1016/S0197-4580(01)00267-6; RUDICK RA, 1982, J NEUROSCI METH, V6, P253, DOI 10.1016/0165-0270(82)90088-7; Savage MJ, 2002, J NEUROSCI, V22, P3376; Savage MJ, 1998, J NEUROSCI, V18, P1743; Schmidt Stephen D., 2004, V299, P279; Schmidt Stephen D., 2004, V299, P267; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200	52	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7134	10.1371/journal.pone.0007134	http://dx.doi.org/10.1371/journal.pone.0007134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771166	Green Submitted, Green Published, gold			2022-12-25	WOS:000270154400022
J	Toujani, S; Dessen, P; Ithzar, N; Danglot, G; Richon, C; Vassetzky, Y; Robert, T; Lazar, V; Bosq, J; Da Costa, L; Perot, C; Ribrag, V; Patte, C; Wiels, J; Bernheim, A				Toujani, Saloua; Dessen, Philippe; Ithzar, Nathalie; Danglot, Gisele; Richon, Catherine; Vassetzky, Yegor; Robert, Thomas; Lazar, Vladimir; Bosq, Jacques; Da Costa, Lydie; Perot, Christine; Ribrag, Vincent; Patte, Catherine; Wiels, Joeelle; Bernheim, Alain			High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; COPY NUMBER VARIATION; CELL-LINES; CANCER; EXPRESSION; HYBRIDIZATION; GENE; AMPLIFICATION; ABNORMALITIES	Additional chromosomal abnormalities are currently detected in Burkitt's lymphoma. They play major roles in the progression of BL and in prognosis. The genes involved remain elusive. A whole-genome oligonucleotide array CGH analysis correlated with karyotype and FISH was performed in a set of 27 Burkitt's lymphoma-derived cell lines and primary tumors. More than half of the 145 CNAs<2 Mb were mapped to Mendelian CNVs, including GSTT1, glutathione s-transferase and BIRC6, an anti-apoptotic protein, possibly predisposing to some cancers. Somatic cell line-specific CNVs localized to the IG locus were consistently observed with the 244 K aCGH platform. Among 136 CNAs>2 Mb, gains were found in 1q (12/27), 13q (7/27), 7q (6/27), 8q(4/27), 2p (3/27), 11q (2/27) and 15q (2/27). Losses were found in 3p (5/27), 4p (4/27), 4q (4/27), 9p (4/27), 13q (4/27), 6p (3/27), 17p (3/27), 6q (2/27), 11pterp13 (2/27) and 14q12q21.3 (2/27). Twenty one minimal critical regions (MCR), (range 0.04-71.36 Mb), were delineated in tumors and cell lines. Three MCRs were localized to 1q. The proximal one was mapped to 1q21.1q25.2 with a 6.3 Mb amplicon (1q21.1q21.3) harboring BCA2 and PIAS3. In the other 2 MCRs, 1q32.1 and 1q44, MDM4 and AKT3 appeared as possible drivers of these gains respectively. The 13q31.3q32.1 < 89.58-96.81 > MCR contained an amplicon and ABCC4 might be the driver of this amplicon. The 40 Kb 2p16.1 < 60.96-61 > MCR was the smallest gained MCR and specifically encompassed the REL oncogene which is already implicated in B cell lymphomas. The most frequently deleted MCR was 3p14.1 < 60.43-60.53 > that removed the fifth exon of FHIT. Further investigations which combined gene expression and functional studies are essential to understand the lymphomagenesis mechanism and for the development of more effective, targeted therapeutic strategies.			Toujani, S (corresponding author), Inst Gustave Roussy, CNRS, FRE2939, Villejuif, France.	bernheim@igr.fr	AMSELLEM, Sophie/B-3645-2012; Vassetzky, Yegor/M-3383-2019; Wiels, Joëlle/AGL-2319-2022; Lazar, Vladimir/AAV-2087-2020; Vassetzky, Yegor S/C-6447-2008; Lazar, Vladimir/AAQ-2086-2020	Vassetzky, Yegor/0000-0003-3101-7043; Wiels, Joëlle/0000-0002-3313-2937; Vassetzky, Yegor S/0000-0003-3101-7043; RICHON, Catherine/0000-0002-3556-3941				Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; Berger R, 1985, IARC Sci Publ, P65; Bernheim A, 2008, LAB INVEST, V88, P464, DOI 10.1038/labinvest.2008.18; Bernheim A, 2007, CANCER GENET CYTOGEN, V176, P89, DOI 10.1016/j.cancergencyto.2007.03.008; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Burger AM, 2005, CANCER RES, V65, P10401, DOI 10.1158/0008-5472.CAN-05-2103; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Clapper M L, 2000, Curr Oncol Rep, V2, P251, DOI 10.1007/s11912-000-0075-z; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davidsson J, 2007, HUM MOL GENET, V16, P2215, DOI 10.1093/hmg/ddm173; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Greshock J, 2007, CANCER RES, V67, P3594, DOI 10.1158/0008-5472.CAN-06-3674; Harris NL, 2006, NEW ENGL J MED, V354, P2495, DOI 10.1056/NEJMe068075; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heerema Nyla A, 2005, Pediatr Blood Cancer, V45, P616, DOI 10.1002/pbc.20552; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karpova MB, 2006, INT J ONCOL, V28, P605; Kawamata N, 2002, ONCOGENE, V21, P4983, DOI 10.1038/sj.onc.1205628; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; LENOIR GM, 1982, NATURE, V298, P474, DOI 10.1038/298474a0; Lones MA, 2004, J PEDIAT HEMATOL ONC, V26, P169, DOI 10.1097/00043426-200403000-00006; Lucito R, 2007, CANCER BIOL THER, V6, P1592, DOI 10.4161/cbt.6.10.4725; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Morari EC, 2002, CANCER EPIDEM BIOMAR, V11, P1485; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Neat MJ, 2001, GENE CHROMOSOME CANC, V32, P236, DOI 10.1002/gcc.1187; Nielaender I, 2006, LEUKEMIA, V20, P904, DOI 10.1038/sj.leu.2404173; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Salaverria I, 2008, HAEMATOL-HEMATOL J, V93, P1327, DOI 10.3324/haematol.13071; Sebat J, 2007, NAT GENET, V39, pS3, DOI 10.1038/ng2095; Shaffer LG., 2005, INT SYSTEM HUMAN CYT; Sobol H, 2002, GENE CHROMOSOME CANC, V33, P217, DOI 10.1002/gcc.10022; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Terzian T, 2007, MOL CELL BIOL, V27, P5479, DOI 10.1128/MCB.00555-06; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Tresnasari K, 2007, CANCER SCI, V98, P978, DOI 10.1111/j.1349-7006.2007.00482.x; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weniger MA, 2007, GENE CHROMOSOME CANC, V46, P406, DOI 10.1002/gcc.20420; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650; WIMAN KG, 1991, ONCOGENE, V6, P1633; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zhao C, 2008, ONCOGENE, V27, P63, DOI 10.1038/sj.onc.1210637	55	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7089	10.1371/journal.pone.0007089	http://dx.doi.org/10.1371/journal.pone.0007089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759907	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970200015
J	Raso, G; Li, YS; Zhao, ZY; Balen, J; Williams, GM; McManus, DP				Raso, Giovanna; Li, Yuesheng; Zhao, Zhengyuan; Balen, Julie; Williams, Gail M.; McManus, Donald P.			Spatial Distribution of Human Schistosoma japonicum Infections in the Dongting Lake Region, China	PLOS ONE			English	Article								Background: The aim of this study was to spatially model the effect of demographic, reservoir hosts and environmental factors on human Schistosoma japonicum infection prevalence in the Dongting Lake area of Hunan Province, China and to determine the potential of each indicator in targeting schistosomiasis control. Methodology/Principal Findings: Cross-sectional serological, coprological and demographic data were obtained from the 2004 nationwide periodic epidemiologic survey for Hunan Province. Environmental data were downloaded from the USGS EROS data centre. Bayesian geostatistical models were employed for spatial analysis of the infection prevalence among study participants. A total of 47,139 participants from 47 administrative villages were selected. Age, sex and occupation of residents and the presence of infected buffaloes and environmental factors, i.e. NDVI, distance to the lake and endemic type of setting, were significantly associated with S. japonicum infection prevalence. After taking into account spatial correlation, however, only demographic factors (age, sex and occupation) and the presence of infected buffaloes remained significant indicators. Conclusions/Significance: Long established demographic factors, as well presence of host reservoirs rather than environmental factors are driving human transmission. Findings of this work can be used for epidemiologic surveillance and for the future planning of interventions in the Dongting Lake area of Hunan Province.	[Raso, Giovanna] Ctr Suisse Rech Sci, Dept Environm & Sante, Abidjan, Cote Ivoire; [Balen, Julie] Nanyang Technol Univ, Ctr Non Trad Security Stud, S Rajaratnam Sch Int Relat, Singapore, Singapore; [Raso, Giovanna; Li, Yuesheng; Balen, Julie] Queensland Inst Med Res, Mol Parasitol Lab, Brisbane, Qld, Australia; [Balen, Julie; Williams, Gail M.; McManus, Donald P.] Univ Queensland, Sch Popul Hlth, Brisbane, Qld, Australia; [Zhao, Zhengyuan] WHO Collab Ctr Res & Control Schistosomiasis, Hunan Inst Parasit Dis, Yueyang, Hunan, Peoples R China; [Zhao, Zhengyuan] Cent S Univ, Sch Publ Hlth, Changsha, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; QIMR Berghofer Medical Research Institute; University of Queensland; Central South University	Raso, G (corresponding author), Ctr Suisse Rech Sci, Dept Environm & Sante, Abidjan, Cote Ivoire.	Giovanna.Raso@gmail.com	LI, Yue/GRS-8071-2022; McManus, Donald P./G-2678-2013; McManus, Don/AAC-5394-2020; Williams, Gail/S-8833-2019	McManus, Don/0000-0001-6443-1449; Williams, Gail/0000-0002-4822-5263; Balen, Julie/0000-0002-4736-8465	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; BIAN Y, 2004, INT J HLTH PLANN S1, V19, P79; Booth M, 2004, PARASITE IMMUNOL, V26, P499, DOI 10.1111/j.0141-9838.2004.00735.x; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Brooker S, 2007, GEOSPATIAL HEALTH, V1, P141, DOI 10.4081/gh.2007.262; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Engels D, 1996, AM J TROP MED HYG, V54, P319, DOI 10.4269/ajtmh.1996.54.319; Gelfand AE, 2003, BIOSTATISTICS, V4, P11, DOI 10.1093/biostatistics/4.1.11; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Li SZ, 2009, GEOSPATIAL HEALTH, V3, P221, DOI 10.4081/gh.2009.222; Li YS, 2007, EMERG INFECT DIS, V13, P973, DOI 10.3201/eid1307.060848; MALONE JB, 1994, AM J TROP MED HYG, V50, P714, DOI 10.4269/ajtmh.1994.50.714; McManus DP, 2009, EXPERT REV ANTI-INFE, V7, P473, DOI [10.1586/eri.09.17, 10.1586/ERI.09.17]; *MIN PUB HLTH PEOP, 2000, AN TREATM SCH HDB SC, P230; Paolino L, 2005, Parassitologia, V47, P171; Rinaldi L, 2006, GEOSPATIAL HEALTH, V1, P33, DOI 10.4081/gh.2006.279; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Spear RC, 2004, AM J TROP MED HYG, V70, P48, DOI 10.4269/ajtmh.2004.70.48; Steinmann P, 2007, GEOSPATIAL HEALTH, V2, P59, DOI 10.4081/gh.2007.255; Steinmann P, 2007, ACTA TROP, V104, P38, DOI 10.1016/j.actatropica.2007.07.003; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Wang XH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000250; WU ZW, 1993, ACTA TROP, V54, P83, DOI 10.1016/0001-706X(93)90053-E; Yang GJ, 2005, INT J PARASITOL, V35, P155, DOI 10.1016/j.ijpara.2004.11.002; Yang J, 2009, INT J INFECT DIS; YU DB, 1992, CHIN J SCHISTO CONTR, V4, P260; ZHENG QS, 1996, CHIN J SCHISTO CONTR, V8, P344; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	35	20	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6947	10.1371/journal.pone.0006947	http://dx.doi.org/10.1371/journal.pone.0006947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19759819	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000269796300004
J	Doyle, PJ; Saeed, H; Hermans, A; Gleddie, SC; Hussack, G; Arbabi-Ghahroudi, M; Seguin, C; Savard, ME; MacKenzie, CR; Hall, JC				Doyle, Patrick J.; Saeed, Hanaa; Hermans, Anne; Gleddie, Steve C.; Hussack, Greg; Arbabi-Ghahroudi, Mehdi; Seguin, Charles; Savard, Marc E.; MacKenzie, C. Roger; Hall, J. Christopher			Intracellular Expression of a Single Domain Antibody Reduces Cytotoxicity of 15-Acetyldeoxynivalenol in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSARIUM-GRAMINEARUM; MYCOTOXIN DEOXYNIVALENOL; TRICHOTHECENE MYCOTOXINS; ARABIDOPSIS-THALIANA; RESISTANCE; GROWTH; GENE; TOXIN; CELLS; WHEAT	15-Acetyldeoxynivalenol (15-AcDON) is a low molecular weight sesquiterpenoid trichothecene mycotoxin associated with Fusarium ear rot of maize and Fusarium head blight of small grain cereals. The accumulation of mycotoxins such as deoxynivalenol (DON) and 15-AcDON within harvested grain is subject to stringent regulation as both toxins pose dietary health risks to humans and animals. These toxins inhibit peptidyltransferase activity, which in turn limits eukaryotic protein synthesis. To assess the ability of intracellular antibodies (intrabodies) to modulate mycotoxin-specific cytotoxocity, a gene encoding a camelid single domain antibody fragment (VHH) with specificity and affinity for 15-AcDON was expressed in the methylotropic yeast Pichia pastoris. Cytotoxicity and VHH immunomodulation were assessed by continuous measurement of cellular growth. At equivalent doses, 15-AcDON was significantly more toxic to wild-type P. pastoris than was DON. In turn, DON was orders of magnitude more toxic than 3-acetyldeoxynivalenol. Intracellular expression of a mycotoxin-specific VHH within P. pastoris conveyed significant (p = 0.01) resistance to 15-AcDON cytotoxicity at doses ranging from 20 to 100 mu g.ml(-1). We also documented a biochemical transformation of DON to 15-AcDON to account for the attenuation of DON cytotoxicity at 100 and 200 mu g.ml(-1). The proof of concept established within this eukaryotic system suggests that in planta VHH expression may lead to enhanced tolerance to mycotoxins and thereby limit Fusarium infection of commercial agricultural crops.	[Doyle, Patrick J.; Hall, J. Christopher] Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada; [Saeed, Hanaa; Hermans, Anne; Gleddie, Steve C.; Seguin, Charles; Savard, Marc E.] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON K1A 0C6, Canada; [Hussack, Greg; Arbabi-Ghahroudi, Mehdi; MacKenzie, C. Roger] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; Agriculture & Agri Food Canada; National Research Council Canada	Hall, JC (corresponding author), Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada.	jchall@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Ontario Ministry of Agriculture, Food, and Rural Affairs	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Agriculture, Food, and Rural Affairs	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, and the Ontario Ministry of Agriculture, Food, and Rural Affairs (to J.C.H.).	Abolinaal S, 2008, J MICROBIOL METH, V72, P306, DOI 10.1016/j.mimet.2007.12.013; Alexander NJ, 2008, WORLD MYCOTOXIN J, V1, P31, DOI 10.3920/WMJ2008.x004; Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; Almquist KC, 2004, PLANT BIOTECHNOL J, V2, P189, DOI 10.1111/j.1467-7652.2004.00060.x; BETINA V, 1989, CHEM-BIOL INTERACT, V71, P105, DOI 10.1016/0009-2797(89)90030-6; Binder J, 1999, NAT TOXINS, V7, P401, DOI 10.1002/1522-7189(199911/12)7:6<401::AID-NT77>3.0.CO;2-A; Binder J, 1997, CEREAL RES COMMUN, V25, P343; Biswas SK, 2003, J ELECTRON MICROSC, V52, P133, DOI 10.1093/jmicro/52.2.133; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CHRISTOPHER J, 1977, BIOCHEM J, V166, P399; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; D'Mello JPF, 1999, ANIM FEED SCI TECH, V80, P183, DOI 10.1016/S0377-8401(99)00059-0; Del Ponte EM, 2007, J PHYTOPATHOL, V155, P577, DOI 10.1111/j.1439-0434.2007.01281.x; Desjardins, 2006, FUSARIUM MYCOTOXINS, P13; Desjardins AE, 2007, J AGR FOOD CHEM, V55, P6487, DOI 10.1021/jf0709193; Doyle PJ, 2008, MOL IMMUNOL, V45, P3703, DOI 10.1016/j.molimm.2008.06.005; EHRLICH KC, 1987, BIOCHIM BIOPHYS ACTA, V923, P206, DOI 10.1016/0304-4165(87)90005-5; Ellgaard L, 2004, BIOCHEM SOC T, V32, P663, DOI 10.1042/BST0320663; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gurkan C, 2004, BIOTECHNOL APPL BIOC, V39, P115, DOI 10.1042/BA20030096; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Harris LJ, 2001, PHYSIOL MOL PLANT P, V58, P173, DOI 10.1006/pmpp.2001.0326; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Johnson DD, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P461; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Kimura M, 2006, PESTIC BIOCHEM PHYS, V86, P117, DOI 10.1016/j.pestbp.2006.02.008; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; McCormick SP, 1996, APPL ENVIRON MICROB, V62, P353, DOI 10.1128/AEM.62.2.353-359.1996; Mesterhazy A, 2002, EUR J PLANT PATHOL, V108, P675, DOI 10.1023/A:1020631114063; Mitterbauer R, 2004, PLANT BIOTECHNOL J, V2, P329, DOI 10.1111/j.1467-7652.2004.00075.x; Mitterbauer R, 2002, EUR J PLANT PATHOL, V108, P699, DOI 10.1023/A:1020666627267; Moss MO, 2004, TOXICOL LETT, V153, P23, DOI 10.1016/j.toxlet.2004.04.021; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Omidfar K, 2007, BIOTECHNOL APPL BIOC, V46, P41, DOI 10.1042/BA20060104; Pestka JJ, 2008, FOOD ADDIT CONTAM A, V25, P1128, DOI 10.1080/02652030802056626; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rahbarizadeh F, 2006, MOL IMMUNOL, V43, P426, DOI 10.1016/j.molimm.2005.03.003; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; SCHWADORF K, 1991, CHROMATOGRAPHIA, V32, P137, DOI 10.1007/BF02325016; SHERMAN F, 2000, METHOD ENZYMOL, V350, P3; Snijders CHA, 2004, TOXICOL LETT, V153, P37, DOI 10.1016/j.toxlet.2004.04.044; Tamaki H, 2005, GENES CELLS, V10, P193, DOI 10.1111/j.1365-2443.2005.00828.x; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; UENO Y, 1984, FUND APPL TOXICOL, V4, pS124, DOI 10.1016/0272-0590(84)90144-1	48	14	17	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35029	35039		10.1074/jbc.M109.045047	http://dx.doi.org/10.1074/jbc.M109.045047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19783651	Green Published, hybrid			2022-12-25	WOS:000272439600057
J	Olaussen, KA; Commo, F; Tailler, M; Lacroix, L; Vitale, I; Raza, SQ; Richon, C; Dessen, P; Lazar, V; Soria, JC; Kroemer, G				Olaussen, K. A.; Commo, F.; Tailler, M.; Lacroix, L.; Vitale, I.; Raza, S. Q.; Richon, C.; Dessen, P.; Lazar, V.; Soria, J-C; Kroemer, G.			Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines	ONCOGENE			English	Article						pazopanib; lapatinib; TKIs; apoptosis; kinome; transcriptome	EPIDERMAL-GROWTH-FACTOR; TUMOR-CELLS; FACTOR RECEPTOR-1; DUAL INHIBITION; MESSENGER-RNA; RIBOSOMAL-RNA; DRUG INSIGHT; C-MET; CANCER; EXPRESSION	Pazopanib and lapatinib are two tyrosine kinase inhibitors that have been designed to inhibit the VEGF tyrosine kinase receptors 1, 2 and 3 (pazopanib), and the HER1 and HER2 receptors in a dual manner (lapatinib). Pazopanib has also been reported to mediate inhibitory effect on a selected panel of additional tyrosine kinases such as PDGFR and c-kit. Here, we report that pazopanib and lapatinib act synergistically to induce apoptosis of A549 non-small-cell lung cancer cells. Systematic assessment of the kinome revealed that both pazopanib and lapatinib inhibited dozens of different tyrosine kinases and that their combination could suppress the activity of some tyrosine kinases (such as c-Met) that were not or only partially affected by either of the two agents alone. We also found that pazopanib and lapatinib induced selective changes in the transcriptome of A549 cells, some of which were specific for the combination of both agents. Analysis of a panel of unrelated human carcinoma cell lines revealed a signature of 52 genes whose up- or downregulation reflected the combined action of pazopanib and lapatinib. Indeed, pazopanib and lapatinib exerted synergistic cytotoxic effects on several distinct non-small-cell lung cancer cells as well as on unrelated carcinomas. Altogether, these results support the contention that combinations of tyrosine kinase inhibitors should be evaluated for synergistic antitumor effects. Such combinations may lead to a 'collapse' of pro-survival signal transduction pathways that leads to apoptotic cell death. Oncogene (2009) 28, 4249-4260; doi: 10.1038/onc.2009.277; published online 14 September 2009	[Kroemer, G.] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Olaussen, K. A.; Commo, F.; Lacroix, L.; Soria, J-C] Inst Gustave Roussy, Lab Rech Translat, F-94805 Villejuif, France; [Olaussen, K. A.; Tailler, M.; Vitale, I.; Raza, S. Q.; Soria, J-C; Kroemer, G.] Univ Paris 11, Paris, France; [Richon, C.; Dessen, P.; Lazar, V.] Inst Gustave Roussy, Unite Genom Fonct & Bioinformat, F-94805 Villejuif, France; [Soria, J-C] Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Kroemer, G (corresponding author), Inst Gustave Roussy, INSERM, U848, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	kroemer@igr.fr	Lazar, Vladimir/AAV-2087-2020; Kroemer, Guido/AAY-9859-2020; Raza, Syed/G-3158-2016; Vitale, Ilio/M-3960-2017; Soria, Jean-Charles/F-3619-2014; KROEMER, Guido/B-4263-2013; Lazar, Vladimir/AAQ-2086-2020	Raza, Syed/0000-0003-3536-6611; Vitale, Ilio/0000-0002-5918-1841; KROEMER, Guido/0000-0002-9334-4405; RICHON, Catherine/0000-0002-3556-3941; Olaussen, Ken/0000-0002-3115-8914	Ligue Nationale contre le Cancer; Agence Nationale de Recherche; Institut National contre le Cancer; Canceropole Ile-de France; European Union; Fondation pour la Recherche Medicale	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de Recherche(French National Research Agency (ANR)); Institut National contre le Cancer; Canceropole Ile-de France(Region Ile-de-France); European Union(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	GK received grants from Ligue Nationale contre le Cancer (equipe labellisee), Agence Nationale de Recherche, Institut National contre le Cancer, Canceropole Ile-de France, European Union (Active p53, ApoSys, ChemoRes, DeathTrain, RIGHT, TransDeath) and Fondation pour la Recherche Medicale.	Barnes CJ, 2003, CANCER METAST REV, V22, P301, DOI 10.1023/A:1023726827771; Bianco R, 2008, CLIN CANCER RES, V14, P5069, DOI 10.1158/1078-0432.CCR-07-4905; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bozec A, 2007, BRIT J CANCER, V97, P65, DOI 10.1038/sj.bjc.6603791; Calandrella N, 2007, J EXP CLIN CANC RES, V26, P405; Cameron DA, 2008, NAT CLIN PRACT ONCOL, V5, P512, DOI 10.1038/ncponc1156; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Chien AJ, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3595; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Danilov AV, 2005, BRIT J HAEMATOL, V128, P472, DOI 10.1111/j.1365-2141.2004.05346.x; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Golubovskaya V, 2002, J BIOL CHEM, V277, P38978, DOI 10.1074/jbc.M205002200; Harris PA, 2008, J MED CHEM, V51, P4632, DOI 10.1021/jm800566m; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Hegde PS, 2007, MOL CANCER THER, V6, P1629, DOI 10.1158/1535-7163.MCT-05-0399; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; HOUGE G, 1995, MOL CELL BIOL, V15, P2051; Hulit J, 2002, BIOCHEM PHARMACOL, V64, P827, DOI 10.1016/S0006-2952(02)01145-0; Hurwitz HI, 2009, CLIN CANCER RES, V15, P4220, DOI 10.1158/1078-0432.CCR-08-2740; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Joo JH, 2007, CANCER RES, V67, P7929, DOI 10.1158/0008-5472.CAN-07-0931; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KLAWITTER J, 2009, BIOMED CHROMATOGR; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kumar R, 2007, MOL CANCER THER, V6, P2012, DOI 10.1158/1535-7163.MCT-07-0193; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Mourali J, 2006, MOL CELL BIOL, V26, P6209, DOI 10.1128/MCB.01515-05; Nadano D, 2000, J BIOL CHEM, V275, P13967, DOI 10.1074/jbc.275.18.13967; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Oberst MD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-189; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Petit AMV, 1997, AM J PATHOL, V151, P1523; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Podar K, 2006, P NATL ACAD SCI USA, V103, P19478, DOI 10.1073/pnas.0609329103; Press MF, 2008, CLIN CANCER RES, V14, P7861, DOI 10.1158/1078-0432.CCR-08-1056; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Puri Neelu, 2008, J Carcinog, V7, P9; Riely GJ, 2009, J CLIN ONCOL, V27, P264, DOI 10.1200/JCO.2008.17.4656; Rouge TD, 2007, CANCER RES, V67, P6253, DOI 10.1158/0008-5472.CAN-07-0538; Simiantonaki N, 2008, INT J ONCOL, V32, P585; Sini P, 2008, CANCER RES, V68, P1581, DOI 10.1158/0008-5472.CAN-06-4685; Sleijfer S, 2008, NAT CLIN PRACT ONCOL, V5, P102, DOI 10.1038/ncponc1037; Sloan B, 2008, CURR OPIN INVEST DR, V9, P1324; Sonpavde G, 2008, EXPERT OPIN INV DRUG, V17, P253, DOI 10.1517/13543784.17.2.253; Storey John D, 2003, Methods Mol Biol, V224, P149; Storniolo AM, 2008, J CLIN ONCOL, V26, P3317, DOI 10.1200/JCO.2007.13.5202; Thompson HJ, 2004, CANCER RES, V64, P1541, DOI 10.1158/0008-5472.CAN-03-3108; Vitale I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001337; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wu BL, 2006, BIOINFORMATICS, V22, P472, DOI 10.1093/bioinformatics/bti827; ZAMZAMI N, 2003, METH MOL B, V282, P103	64	53	55	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4249	4260		10.1038/onc.2009.277	http://dx.doi.org/10.1038/onc.2009.277			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19749798				2022-12-25	WOS:000272876300003
J	Duterme, C; Mertens-Strijthagen, J; Tammi, M; Flamion, B				Duterme, Cecile; Mertens-Strijthagen, Jeannine; Tammi, Markku; Flamion, Bruno			Two Novel Functions of Hyaluronidase-2 (Hyal2) Are Formation of the Glycocalyx and Control of CD44-ERM Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH PERICELLULAR MATRIX; JAAGSIEKTE SHEEP RETROVIRUS; MARROW ENDOTHELIAL-CELLS; ERM PROTEINS; HYALURONAN-BINDING; MUCOPOLYSACCHARIDOSIS-IX; EPITHELIAL-CELLS; BREAST-CANCER; TUMOR-CELLS; IN-VITRO	It has long been predicted that the members of the hyaluronidase enzyme family have important non-enzymatic functions. However, their nature remains a mystery. The metabolism of hyaluronan (HA), their major enzymatic substrate, is also enigmatic. To examine the function of Hyal2, a glycosylphosphatidylinositol-anchored hyaluronidase with intrinsically weak enzymatic activity, we have compared stably transfected rat fibroblastic BB16 cell lines with various levels of expression of Hyal2. These cell lines continue to express exclusively the standard form (CD44s) of the main HA receptor, CD44. Hyal2, CD44, and one of its main intracellular partners, ezrin-radixin-moesin (ERM), were found to co-immunoprecipitate. Functionally, Hyal2 overexpression was linked to loss of the glycocalyx, the HA-rich pericellular coat. This effect could be mimicked by exposure of BB16 cells either to Streptomyces hyaluronidase, to HA synthesis inhibitors, or to HA oligosaccharides. This led to shedding of CD44, separation of CD44 from ERM, reduction in baseline level of ERM activation, and markedly decreased cell motility (50% reduction in a wound healing assay). The effects of Hyal2 on the pericellular coat and on CD44-ERM interactions were inhibited by treatment with the Na+/H+ exchanger-1 inhibitor ethyl-N-isopropylamiloride. We surmise that Hyal2, through direct interactions with CD44 and possibly some pericellular hyaluronidase activity requiring acidic foci, suppresses the formation or the stability of the glycocalyx, modulates ERM-related cytoskeletal interactions, and diminishes cell motility. These effects may be relevant to the purported in vivo tumor-suppressive activity of Hyal2.	[Duterme, Cecile; Mertens-Strijthagen, Jeannine; Flamion, Bruno] Univ Namur, URPhyM, B-5000 Namur, Belgium; [Tammi, Markku] Univ Kuopio, Dept Anat, Inst Biomed, FIN-70211 Kuopio, Finland	University of Namur; University of Eastern Finland	Flamion, B (corresponding author), Univ Namur, URPhyM, 61 Rue Bruxelles, B-5000 Namur, Belgium.	Bruno.Flamion@fundp.ac.be	Tammi, Markku/AAQ-7878-2021		Academy of Finland; Sigrid Juselius Foundation; Kuopio University Hospital	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio University Hospital	This work was supported by The Academy of Finland, the Sigrid Juselius Foundation, and the EVO Funds of Kuopio University Hospital.	Andre F, 1999, GASTROENTEROLOGY, V116, P64, DOI 10.1016/S0016-5085(99)70230-1; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Chang NS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-8; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P849, DOI 10.1016/j.joca.2006.02.009; Cichy J, 2000, J BIOL CHEM, V275, P18061, DOI 10.1074/jbc.M907962199; CLARRIS BJ, 1968, EXP CELL RES, V49, P181, DOI 10.1016/0014-4827(68)90530-2; Conn EM, 2008, J BIOL CHEM, V283, P26518, DOI 10.1074/jbc.M803337200; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; GOLDBERG RL, 1984, EXP CELL RES, V151, P258, DOI 10.1016/0014-4827(84)90374-4; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hosono K, 2007, AM J PATHOL, V171, P274, DOI 10.2353/ajpath.2007.060828; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; Liu Dacai, 1998, Frontiers in Bioscience, V3, pD631; Lokeshwar VB, 2002, J BIOL CHEM, V277, P33654, DOI 10.1074/jbc.M203821200; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Monz K, 2008, J CELL BIOCHEM, V105, P1260, DOI 10.1002/jcb.21925; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Novak U, 1999, CANCER RES, V59, P6246; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Platek A, 2004, J CELL SCI, V117, P4849, DOI 10.1242/jcs.01359; QIN Y, 1992, DEV DYNAM, V193, P145, DOI 10.1002/aja.1001930206; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shi M, 2001, J IMMUNOL, V167, P123, DOI 10.4049/jimmunol.167.1.123; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Tsuda M, 2004, J BIOL CHEM, V279, P46843, DOI 10.1074/jbc.M401476200; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; UNDERHILL CB, 1983, J BIOL CHEM, V258, P8086; Veithen A, 1996, J CELL SCI, V109, P2005; Vigdorovich V, 2007, J VIROL, V81, P3124, DOI 10.1128/JVI.02177-06; Wang FL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003031; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	62	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33495	33508		10.1074/jbc.M109.044362	http://dx.doi.org/10.1074/jbc.M109.044362			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19783662	hybrid, Green Published			2022-12-25	WOS:000272028500056
J	Marechal, A; Kido, Y; Kita, K; Moore, AL; Rich, PR				Marechal, Amandine; Kido, Yasutoshi; Kita, Kiyoshi; Moore, Anthony L.; Rich, Peter R.			Three Redox States of Trypanosoma brucei Alternative Oxidase Identified by Infrared Spectroscopy and Electrochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE CRYPTOSPORIDIUM-PARVUM; CYTOCHROME BC(1) COMPLEX; ACTIVE-SITE; RIBONUCLEOTIDE REDUCTASE; PARTIAL-PURIFICATION; ARUM-MACULATUM; PHOTOSYSTEM-II; IRON; PROTEIN; RESPIRATION	Electrochemistry coupled with Fourier transform infrared (IR) spectroscopy was used to investigate the redox properties of recombinant alternative ubiquinol oxidase from Trypanosoma brucei, the organism responsible for African sleeping sickness. Stepwise reduction of the fully oxidized resting state of recombinant alternative ubiquinol oxidase revealed two distinct IR redox difference spectra. The first of these, signal 1, titrates in the reductive direction as an n = 2 Nernstian component with an apparent midpoint potential of 80 mV at pH 7.0. However, reoxidation of signal 1 in the same potential range under anaerobic conditions did not occur and only began with potentials in excess of 500 mV. Reoxidation by introduction of oxygen was also unsuccessful. Signal 1 contained clear features that can be assigned to protonation of at least one carboxylate group, further perturbations of carboxylic and histidine residues, bound ubiquinone, and a negative band at 1554 cm(-1) that might arise from a radical in the fully oxidized protein. A second distinct IR redox difference spectrum, signal 2, appeared more slowly once signal 1 had been reduced. This component could be reoxidized with potentials above 100 mV. In addition, when both signals 1 and 2 were reduced, introduction of oxygen caused rapid oxidation of both components. These data are interpreted in terms of the possible active site structure and mechanism of oxygen reduction to water.	[Marechal, Amandine; Rich, Peter R.] UCL, Inst Struct & Mol Biol, Glynn Lab Bioenerget, London WC1E 6BT, England; [Kido, Yasutoshi; Kita, Kiyoshi] Univ Tokyo, Dept Biomed Chem, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Moore, Anthony L.] Univ Sussex, Sch Life Sci, Dept Biochem & Biomed Sci, Brighton BN1 9QG, E Sussex, England	University of London; Birkbeck University London; University College London; University of Tokyo; University of Sussex	Rich, PR (corresponding author), UCL, Inst Struct & Mol Biol, Glynn Lab Bioenerget, Gower St, London WC1E 6BT, England.	prr@ucl.ac.uk	MARECHAL, Amandine/AAF-7931-2020; Kido, Yasutoshi/AAW-3688-2021	MARECHAL, Amandine/0000-0003-3460-3806; Kido, Yasutoshi/0000-0003-3615-2631; Kita, Kiyoshi/0000-0002-0426-4308	Wellcome Trust; Japanese Society for the Promotion of Science [18GS0314, 18073004]; Japanese Ministry of Education, Science, Culture, Sports and Technology; Biotechnology and Biological Sciences Research Council; Prime Minister's Initiative 2 ( Connect) fund for collaborative twinning with KK; Biotechnology and Biological Sciences Research Council Research [BB/H000097/1];  [21790402]; Biotechnology and Biological Sciences Research Council [BB/H000097/1, BB/C50747X/1, BB/E015328/1] Funding Source: researchfish; BBSRC [BB/H000097/1, BB/E015328/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Science, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prime Minister's Initiative 2 ( Connect) fund for collaborative twinning with KK; Biotechnology and Biological Sciences Research Council Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a Wellcome Trust ViP award.; 2 Supported in part by Grant-in-aid for Young Scientists ( B) 21790402.; 3 Supported by Creative Scientific Research Grant 18GS0314, Grant-in-aid for Scientific Research on Priority Areas 18073004 from the Japanese Society for the Promotion of Science, and a Targeted Proteins Research Program from the Japanese Ministry of Education, Science, Culture, Sports and Technology.; 4 Supported by the Biotechnology and Biological Sciences Research Council and the Prime Minister's Initiative 2 ( Connect) fund for collaborative twinning with KK.; 5 Supported by Biotechnology and Biological Sciences Research Council Research Grant BB/H000097/1. To whom correspondence should be addressed. Tel.: 44-20-7679-7746; Fax: 44-20-7679-7096; E-mail: prr@ucl.ac.uk.	Affourtit C, 2004, BBA-BIOENERGETICS, V1608, P181, DOI 10.1016/j.bbabio.2003.12.002; Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Ajayi WU, 2002, J BIOL CHEM, V277, P8187, DOI 10.1074/jbc.M111477200; Albury MS, 2002, J BIOL CHEM, V277, P1190, DOI 10.1074/jbc.M109853200; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; BERTHOLD DA, 1993, PLANT PHYSIOL, V101, P113, DOI 10.1104/pp.101.1.113; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; Berthold DA, 2002, J BIOL CHEM, V277, P43608, DOI 10.1074/jbc.M206724200; Berthomieu C, 1998, BBA-BIOENERGETICS, V1365, P112, DOI 10.1016/S0005-2728(98)00056-5; Berthomieu C, 2005, BBA-BIOENERGETICS, V1707, P51, DOI 10.1016/j.bbabio.2004.03.011; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; Breton J, 1996, BBA-BIOENERGETICS, V1275, P84, DOI 10.1016/0005-2728(96)00054-0; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; CLARKSON AB, 1989, J BIOL CHEM, V264, P17770; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; Frisch MJ., 2005, GAUSSIAN 03; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Heimburg T, 1996, BIOCHEMISTRY-US, V35, P1375, DOI 10.1021/bi9515883; Iwaki M, 2005, BIOCHEMISTRY-US, V44, P4230, DOI 10.1021/bi047533v; Iwaki M, 2004, J AM CHEM SOC, V126, P2386, DOI 10.1021/ja039320j; Iwaki M, 2003, BIOCHEMISTRY-US, V42, P11109, DOI 10.1021/bi0343020; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4243, DOI 10.1021/bi000192a; McDonald AE, 2004, IUBMB LIFE, V56, P333, DOI 10.1080/1521-6540400000876; McDonald AE, 2006, COMP BIOCHEM PHYS D, V1, P357, DOI 10.1016/j.cbd.2006.08.001; MINAGAWA N, 1990, FEBS LETT, V267, P114, DOI 10.1016/0014-5793(90)80302-Y; Minagawa N, 1997, MOL BIOCHEM PARASIT, V84, P271, DOI 10.1016/S0166-6851(96)02797-1; Moore AL, 2002, TRENDS PLANT SCI, V7, P478, DOI 10.1016/S1360-1385(02)02366-X; Moore AL, 2008, BIOCHEM SOC T, V36, P1022, DOI 10.1042/BST0361022; Moore AL, 2008, BBA-BIOENERGETICS, V1777, P327, DOI 10.1016/j.bbabio.2008.01.004; Nakamura K, 2005, BIOCHEM BIOPH RES CO, V334, P593, DOI 10.1016/j.bbrc.2005.06.131; Nihei C, 2003, FEBS LETT, V538, P35, DOI 10.1016/S0014-5793(03)00120-0; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; Noguchi T, 1999, BIOCHEMISTRY-US, V38, P10187, DOI 10.1021/bi990631+; Reisdorf WC, 1996, BIOCHEMISTRY-US, V35, P1383, DOI 10.1021/bi951589v; Rich PR, 2007, MOL BIOSYST, V3, P398, DOI 10.1039/b702328f; Rich PR, 2005, RSC BIOMOLEC SCI, P314; RICH PR, 1978, FEBS LETT, V96, P252, DOI 10.1016/0014-5793(78)80412-8; Rich PR, 2004, BBA-BIOENERGETICS, V1658, P165, DOI 10.1016/j.bbabio.2004.04.021; Roberts CW, 2004, INT J PARASITOL, V34, P297, DOI 10.1016/j.ijpara.2003.11.002; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Suzuki T, 2004, BIOCHEM BIOPH RES CO, V313, P1044, DOI 10.1016/j.bbrc.2003.12.038; Voevodskaya N, 2006, P NATL ACAD SCI USA, V103, P9850, DOI 10.1073/pnas.0600603103; Walden SE, 1996, J CHEM SOC PERK T 2, P2663, DOI 10.1039/p29960002663; Yabu Y, 2003, PARASITOL INT, V52, P155, DOI 10.1016/S1383-5769(03)00012-6	49	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31827	31833		10.1074/jbc.M109.059980	http://dx.doi.org/10.1074/jbc.M109.059980			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19767647	Green Published, hybrid			2022-12-25	WOS:000271572700037
J	Zou, K; Maeda, T; Watanabe, A; Liu, JJ; Liu, SY; Oba, R; Satoh, Y; Komano, H; Michikawa, M				Zou, Kun; Maeda, Tomoji; Watanabe, Atsushi; Liu, Junjun; Liu, Shuyu; Oba, Ryutaro; Satoh, Yoh-ichi; Komano, Hiroto; Michikawa, Makoto			A beta 42-to-A beta 40-and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID BETA-PROTEIN; TERMINAL CATALYTIC DOMAIN; ALZHEIMERS-DISEASE; A-BETA; ACE; INHIBITION; DEPOSITION; PEPTIDE; MICE; A-BETA(1-42)	Amyloid beta-protein 1-42 (A beta 42) is believed to play a causative role in the development of Alzheimer disease (AD), although it is a minor part of A beta. In contrast, A beta 40 is the predominant secreted form of A beta and recent studies have suggested that A beta 40 has neuroprotective effects and inhibits amyloid deposition. We have reported that angiotensin-converting enzyme (ACE) converts A beta 42 to A beta 40, and its inhibition enhances brain A beta 42 deposition (Zou, K., Yamaguchi, H., Akatsu, H., Sakamoto, T., Ko, M., Mizoguchi, K., Gong, J. S., Yu, W., Yamamoto, T., Kosaka, K., Yanagisawa, K., and Michikawa, M. (2007) J. Neurosci. 27, 8628-8635). ACE has two homologous domains, each having a functional active site. In the present study, we identified the domain of ACE, which is responsible for converting A beta 42 to A beta 40. Interestingly, A beta 42-to-A beta 40-converting activity is solely found in the N-domain of ACE and the angiotensin-converting activity is found predominantly in the C-domain of ACE. We also found that the N-linked glycosylation is essential for both A beta 42-to-A beta 40- and angiotensin-converting activities and that unglycosylated ACE rapidly degraded. The domain-specific converting activity of ACE suggests that ACE inhibitors could be designed to specifically target the angiotensin-converting C-domain, without inhibiting the A beta 42-to-A beta 40-converting activity of ACE or increasing neurotoxic A beta 42.	[Komano, Hiroto] Iwate Med Univ, Sch Pharm, Dept Neurosci, Yahaba, Iwate 0283694, Japan; [Satoh, Yoh-ichi] Iwate Med Univ, Sch Med, Dept Anat, Yahaba, Iwate 0283694, Japan; [Oba, Ryutaro] BML Inc, Dept Adv Med & Dev, Kawagoe, Saitama 3501101, Japan; [Watanabe, Atsushi] Natl Ctr Geriatr & Gerontol, Dept Vasc Dementia Res, Natl Inst Longev Sci, Aichi 4748522, Japan; [Michikawa, Makoto] Natl Ctr Geriatr & Gerontol, Dept Alzheimer Dis Res, Natl Inst Longev Sci, Aichi 4748522, Japan	Iwate Medical University; Iwate Medical University; BML, Inc.; National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology		kunzou@iwate-med.ac.jp; hkomano@iwate-med.ac.jp; michi@nils.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19800040, 19300138]; Ministry of Health, Labor and Welfare of Japan ( Comprehensive Research on Aging and Health) [H20-007]; National Institute of Biomedical Innovation ( NIBIO); Takeda Science Foundation; Kato Memorial Bioscience Foundation; The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan ( Comprehensive Research on Aging and Health)(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation ( NIBIO)(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Bioscience Foundation; The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for Young Scientists ( Start-up) ( 19800040), and Scientific Research ( B) ( 19300138), the Ministry of Health, Labor and Welfare of Japan ( Comprehensive Research on Aging and Health) (H20-007), the Program for Promotion of Fundamental Studies in Health of the National Institute of Biomedical Innovation ( NIBIO), Takeda Science Foundation, Kato Memorial Bioscience Foundation, and The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care.	Elkins JS, 2004, NEUROLOGY, V62, P363, DOI 10.1212/01.WNL.0000106823.72493.FF; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Sadhukhan R, 1996, J BIOL CHEM, V271, P6429, DOI 10.1074/jbc.271.11.6429; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007; Zou K, 2008, REV NEUROSCIENCE, V19, P203	24	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31914	31920		10.1074/jbc.M109.011437	http://dx.doi.org/10.1074/jbc.M109.011437			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19773553	Green Published, hybrid			2022-12-25	WOS:000271572700046
J	Hanlon, K; Rudin, CE; Harries, LW				Hanlon, Katy; Rudin, Claudius E.; Harries, Lorna W.			Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL)	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CHROMOSOME 13Q14; MICRORNAS; GENES; CLONING; REGION; RAS; EXPRESSION; SEQUENCE; DELETION	Background: MicroRNAs (miRNAs) are short, noncoding RNAs that regulate the expression of multiple target genes. Deregulation of miRNAs is common in human tumorigenesis. The miRNAs, MIR-15a/16-1, at chromosome band 13q14 are down-regulated in the majority of patients with chronic lymphocytic leukaemia (CLL). Methodology/Principal Findings: We have measured the expression of MIR-15a/16-1, and 92 computationally-predicted MIR-15a/16-1 target genes in CLL patients and in normal controls. We identified 35 genes that are deregulated in CLL patients, 5 of which appear to be specific targets of the MIR-15a/16-1 cluster. These targets included 2 genes (BAZ2A and RNF41) that were significantly up-regulated (p < 0.05) and 3 genes (RASSF5, MKK3 and LRIG1) that were significantly downregulated (p < 0.05) in CLL patients with down-regulated MIR-15a/16-1 expression. Significance: The genes identified here as being subject to MIR-15a/16-1 regulation could represent direct or indirect targets of these miRNAs. Many of these are good biological candidates for involvement in tumorigenesis and as such, may be important in the aetiology of CLL.			Hanlon, K (corresponding author), Royal Devon & Exeter NHS Fdn Trust, Dept Haematol, Exeter, Devon, England.	L.W.Harries@exeter.ac.uk	Harries, Lorna/D-2241-2014; Lunnon, Katie/C-4638-2012	Harries, Lorna/0000-0001-7791-8061; Lunnon, Katie/0000-0001-7570-6065				Abdullah JM, 2001, BLOOD CELL MOL DIS, V27, P320, DOI 10.1006/bcmd.2001.0390; Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; *APPL BIOS, 1997, US B APPL BIOS, V2, P11; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bullrich F, 2001, CANCER RES, V61, P6640; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2007, METHOD ENZYMOL, V427, P193, DOI 10.1016/S0076-6879(07)27011-9; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2008, LEUKEMIA, V22, P1095, DOI 10.1038/leu.2008.30; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Facon T, 2001, BLOOD, V97, P1566, DOI 10.1182/blood.V97.6.1566; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Geli J, 2007, ENDOCR-RELAT CANCER, V14, P125, DOI 10.1677/ERC-06-0031; Guil S, 2009, INT J BIOCHEM CELL B, V41, P87, DOI 10.1016/j.biocel.2008.09.005; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Jing X, 2008, EXP HEMATOL, V36, P1110, DOI 10.1016/j.exphem.2008.04.001; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; La Starza R, 1998, BLOOD, V91, P231, DOI 10.1182/blood.V91.1.231.231_231_237; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu Y, 1997, ONCOGENE, V15, P2463, DOI 10.1038/sj.onc.1201643; Mabuchi H, 2001, CANCER RES, V61, P2870; MATUTES E, 1994, LEUKEMIA, V8, P1640; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Molica S, 2003, EUR J HAEMATOL, V70, P373, DOI 10.1034/j.1600-0609.2003.00064.x; MULLERHERMELINK HK, 2001, WHO CLASSIFICATION T, P127; Nilsson J, 2001, BIOCHEM BIOPH RES CO, V284, P1155, DOI 10.1006/bbrc.2001.5092; Panagopoulos I, 2006, BRIT J HAEMATOL, V133, P270, DOI 10.1111/j.1365-2141.2006.06020.x; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Ringshausen I, 2004, LEUKEMIA, V18, P1964, DOI 10.1038/sj.leu.2403544; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Schlade-Bartusiak Kamilla, 2005, Journal of Applied Genetics, V46, P407; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Zojer N, 2000, BLOOD, V95, P1925, DOI 10.1182/blood.V95.6.1925	46	50	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7169	10.1371/journal.pone.0007169	http://dx.doi.org/10.1371/journal.pone.0007169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779621	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200011
J	Pyka, M; Beckmann, CF; Schoning, S; Hauke, S; Heider, D; Kugel, H; Arolt, V; Konrad, C				Pyka, Martin; Beckmann, Christian F.; Schoening, Sonja; Hauke, Sascha; Heider, Dominik; Kugel, Harald; Arolt, Volker; Konrad, Carsten			Impact of Working Memory Load on fMRI Resting State Pattern in Subsequent Resting Phases	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; TASK-INDUCED DEACTIVATION; STREAM-OF-CONSCIOUSNESS; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; BRAIN ACTIVITY; AGE; FLUCTUATIONS	Background: The default-mode network (DMN) is a functional network with increasing relevance for psychiatric research, characterized by increased activation at rest and decreased activation during task performance. The degree of DMN deactivation during a cognitively demanding task depends on its difficulty. However, the relation of hemodynamic responses in the resting phase after a preceding cognitive challenge remains relatively unexplored. We test the hypothesis that the degree of activation of the DMN following cognitive challenge is influenced by the cognitive load of a preceding working-memory task. Methodology/Principal Findings: Twenty-five healthy subjects were investigated with functional MRI at 3 Tesla while performing a working-memory task with embedded short resting phases. Data were decomposed into statistically independent spatio-temporal components using Tensor Independent Component Analysis (TICA). The DMN was selected using a template-matching procedure. The spatial map contained rest-related activations in the medial frontal cortex, ventral anterior and posterior cingulate cortex. The time course of the DMN revealed increased activation at rest after 1-back and 2-back blocks compared to the activation after a 0-back block. Conclusion/Significance: We present evidence that a cognitively challenging working-memory task is followed by greater activation of the DMN than a simple letter-matching task. This might be interpreted as a functional correlate of self-evaluation and reflection of the preceding task or as relocation of cerebral resources representing recovery from high cognitive demands. This finding is highly relevant for neuroimaging studies which include resting phases in cognitive tasks as stable baseline conditions. Further studies investigating the DMN should take possible interactions of tasks and subsequent resting phases into account.			Pyka, M (corresponding author), Univ Munster, Dept Psychiat, Munster, Germany.	carsten.konrad@med.uni-marburg.de	Heider, Dominik/F-8545-2010; Beckmann, Christian F./E-6374-2012; Kugel, Harald/A-4963-2013	Heider, Dominik/0000-0002-3108-8311; Beckmann, Christian F./0000-0002-3373-3193; Kugel, Harald/0000-0002-4349-1984; Lauwereyns, Jan/0000-0003-0551-2550				ANTROBUS JS, 1966, PERCEPT MOTOR SKILL, V23, P399, DOI 10.2466/pms.1966.23.2.399; Bailey A, 2007, MULT SCLER J, V13, P73, DOI 10.1177/1352458506071162; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; CALHOUN VD, 2003, P INT WORKSH IND COM, P281; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GIAMBRA LM, 1995, CONSCIOUS COGN, V4, P1, DOI 10.1006/ccog.1995.1001; Gould RL, 2006, NEUROIMAGE, V31, P818, DOI 10.1016/j.neuroimage.2005.12.045; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Harshman R. A., 1970, FDN PARAFAC PROCEDUR, P1; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jansma JM, 2007, HUM BRAIN MAPP, V28, P431, DOI 10.1002/hbm.20297; KIM DI, 2009, HUM BRAIN M IN PRESS; Kineses ZT, 2008, NEUROIMAGE, V39, P1950, DOI 10.1016/j.neuroimage.2007.09.070; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McGuire PK, 1996, NEUROREPORT, V7, P2095; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; POPE KS, 1976, CONSCIOUSNESS SELF R, P101; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; SAMBATARO F, 2008, NEUROBIOLOG IN PRESS; SCHONING S, 2009, HUMAN BRAIN IN PRESS; SHEHZAD Z, 2009, CEREB CORTE IN PRESS; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; VANDENHEUVEL MP, 2009, HUMAN BRAIN IN PRESS; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wig GS, 2008, P NATL ACAD SCI USA, V105, P18555, DOI 10.1073/pnas.0804546105; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; YAN H, 2009, NEUROIMAGE IN PRESS	59	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7198	10.1371/journal.pone.0007198	http://dx.doi.org/10.1371/journal.pone.0007198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779619	gold, Green Published, Green Submitted			2022-12-25	WOS:000270176200021
J	Quan, FS; Kim, YC; Yoo, DG; Compans, RW; Prausnitz, MR; Kang, SM				Quan, Fu-Shi; Kim, Yeu-Chun; Yoo, Dae-Goon; Compans, Richard W.; Prausnitz, Mark R.; Kang, Sang-Moo			Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin	PLOS ONE			English	Article								Background: Simple and effective vaccine administration is particularly important for annually recommended influenza vaccination. We hypothesized that vaccine delivery to the skin using a patch containing vaccine-coated microneedles could be an attractive approach to improve influenza vaccination compliance and efficacy. Methodology/Principal Findings: Solid microneedle arrays coated with inactivated influenza vaccine were prepared for simple vaccine delivery to the skin. However, the stability of the influenza vaccine, as measured by hemagglutination activity, was found to be significantly damaged during microneedle coating. The addition of trehalose to the microneedle coating formulation retained hemagglutination activity, indicating stabilization of the coated influenza vaccine. For both intramuscular and microneedle skin immunization, delivery of un-stabilized vaccine yielded weaker protective immune responses including viral neutralizing antibodies, protective efficacies, and recall immune responses to influenza virus. Immunization using un-stabilized vaccine also shifted the pattern of antibody isotypes compared to the stabilized vaccine. Importantly, a single microneedle-based vaccination using stabilized influenza vaccine was found to be superior to intramuscular immunization in controlling virus replication as well as in inducing rapid recall immune responses post challenge. Conclusions/Significance: The functional integrity of hemagglutinin is associated with inducing improved protective immunity against influenza. Simple microneedle influenza vaccination in the skin produced superior protection compared to conventional intramuscular immunization. This approach is likely to be applicable to other vaccines too.			Quan, FS (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	Compans@microbio.emory.edu; prausnitz@gatech.edu; skang2@emory.edu	Kim, Yeu Chun/B-3389-2012; Quan, Fu-Shi/V-1826-2019; Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X; Prausnitz, Mark/0000-0002-9076-8448	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579, R01AI068003, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI074579-04, U01 AI074579-01, R01 AI068003-03, R01 AI068003-01, R01 AI068003-04, AI057157, R01 AI068003-02, R01 AI068003-05, U01 AI074579-03, U01 AI074579, R01 AI068003, U01 AI074579-02, AI0680003, U54 AI057157] Funding Source: Medline; NIBIB NIH HHS [R01 EB006369-01A1, R01 EB006369, R01 EB006369-02S1, EB006369] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alarcon JB, 2007, CLIN VACCINE IMMUNOL, V14, P375, DOI 10.1128/CVI.00387-06; Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Auewarakul P, 2007, VACCINE, V25, P659, DOI 10.1016/j.vaccine.2006.08.026; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Belshe RB, 2007, VACCINE, V25, P6755, DOI 10.1016/j.vaccine.2007.06.066; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Beran J, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-13; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Chen DX, 2000, NAT MED, V6, P1187, DOI 10.1038/80538; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; COMPANS RW, 1970, VIROLOGY, V42, P880, DOI 10.1016/0042-6822(70)90337-5; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; DEBECKER G, 1994, EUR J IMMUNOL, V24, P1523, DOI 10.1002/eji.1830240710; Deng YP, 1997, J IMMUNOL, V158, P1507; FAZEKAS G, 1994, EUR J IMMUNOL, V24, P3063, DOI 10.1002/eji.1830241222; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gill HS, 2007, PHARM RES, V24, P1369, DOI 10.1007/s11095-007-9286-4; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Glenn G M, 1999, Expert Opin Investig Drugs, V8, P797, DOI 10.1517/13543784.8.6.797; Glenn GM, 2000, NAT MED, V6, P1403, DOI 10.1038/82225; Guebre-Xabier M, 2003, J VIROL, V77, P5218, DOI 10.1128/JVI.77.9.5218-5225.2003; HEUSSER CH, 1977, J EXP MED, V145, P1316, DOI 10.1084/jem.145.5.1316; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Hon H, 2004, IMMUNOL RES, V29, P69, DOI 10.1385/IR:29:1-3:069; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Khanlou H, 2006, ARCH INTERN MED, V166, P1417, DOI 10.1001/archinte.166.13.1417; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; La Montagne JR, 2004, NEW ENGL J MED, V351, P2330, DOI 10.1056/NEJMe048314; Markine-Goriaynoff D, 2000, INT IMMUNOL, V12, P223, DOI 10.1093/intimm/12.2.223; Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040; Mitsui H, 2004, J INVEST DERMATOL, V122, P95, DOI 10.1046/j.0022-202X.2003.22116.x; Mozdzanowska K, 2006, VIROLOGY, V352, P418, DOI 10.1016/j.virol.2006.05.008; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; NOVAK M, 1993, VACCINE, V11, P55, DOI 10.1016/0264-410X(93)90339-Y; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Rappuoli R, 2007, NAT BIOTECHNOL, V25, P1361, DOI 10.1038/nbt1207-1361; SCHULZE IT, 1970, VIROLOGY, V42, P890, DOI 10.1016/0042-6822(70)90338-7; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Sugimura T, 2008, VACCINE, V26, P2700, DOI 10.1016/j.vaccine.2008.03.016; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; Van Reeth K, 2002, VIRAL IMMUNOL, V15, P583, DOI 10.1089/088282402320914520; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	57	84	90	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7152	10.1371/journal.pone.0007152	http://dx.doi.org/10.1371/journal.pone.0007152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779615	Green Submitted, Green Published, gold			2022-12-25	WOS:000270176200007
J	Ladroue, C; Guo, SX; Kendrick, K; Feng, JF				Ladroue, Christophe; Guo, Shuixia; Kendrick, Keith; Feng, Jianfeng			Beyond Element-Wise Interactions: Identifying Complex Interactions in Biological Processes	PLOS ONE			English	Article							LINEAR-DEPENDENCE; CAUSALITY; FEEDBACK; DATABASE; TOOLS	Background: Biological processes typically involve the interactions of a number of elements (genes, cells) acting on each others. Such processes are often modelled as networks whose nodes are the elements in question and edges pairwise relations between them (transcription, inhibition). But more often than not, elements actually work cooperatively or competitively to achieve a task. Or an element can act on the interaction between two others, as in the case of an enzyme controlling a reaction rate. We call "complex'' these types of interaction and propose ways to identify them from time-series observations. Methodology: We use Granger Causality, a measure of the interaction between two signals, to characterize the influence of an enzyme on a reaction rate. We extend its traditional formulation to the case of multi-dimensional signals in order to capture group interactions, and not only element interactions. Our method is extensively tested on simulated data and applied to three biological datasets: microarray data of the Saccharomyces cerevisiae yeast, local field potential recordings of two brain areas and a metabolic reaction. Conclusions: Our results demonstrate that complex Granger causality can reveal new types of relation between signals and is particularly suited to biological data. Our approach raises some fundamental issues of the systems biology approach since finding all complex causalities (interactions) is an NP hard problem.			Ladroue, C (corresponding author), Univ Warwick, Dept Math & Comp Sci, Coventry CV4 7AL, W Midlands, England.	Jianfeng.Feng@warwick.ac.uk		feng, jianfeng/0000-0002-9328-5732; Kendrick, Keith/0000-0002-0371-5904	EPSRC [EP/E002331/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E002331/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aebersold R, 2000, NAT BIOTECHNOL, V18, P359, DOI 10.1038/74325; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Ding M, 2006, HDB TIME SERIES ANAL, DOI [DOI 10.1002/9783527609970, 10.1002/9783527609970]; Fletcher M, 2008, NEURAL NETWORKS, V21, P1076, DOI 10.1016/j.neunet.2008.06.009; Friston K., 2009, PLOS BIOL, V7; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Gourevitch B, 2006, BIOL CYBERN, V95, P349, DOI 10.1007/s00422-006-0098-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Horn R.A., 2013, MATRIX ANAL, P321; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Klamt S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000385; KOSSLYN SM, 1998, FUNDAMENTAL NEUROSCI, P1521; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mukherjee S, 2008, P NATL ACAD SCI USA, V105, P14313, DOI 10.1073/pnas.0802272105; NEEDHAM CJ, 2007, PLOS COMPUTATIONAL B, V3; PARKINSON H, 2008, NUCLEIC ACIDS RES; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tate AJ, 2006, PHILOS T R SOC B, V361, P2155, DOI 10.1098/rstb.2006.1937; TEIXEIRA MC, 2006, NUCL ACIDS RES, V34; Timmer, 2006, HDB TIME SERIES ANAL, P335, DOI [10.1002/9783527609970.ch14, DOI 10.1002/9783527609970.CH14]; Wang RS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-391; Wiener N, 1956, MODERN MATH ENG; Wu JH, 2008, J NEUROSCI METH, V167, P367, DOI 10.1016/j.jneumeth.2007.08.022; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; ZOU CL, 2009, BMC BIOINFORMATICS, V10	35	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e6899	10.1371/journal.pone.0006899	http://dx.doi.org/10.1371/journal.pone.0006899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774090	Green Submitted, Green Published, gold			2022-12-25	WOS:000270160900001
J	Wodarczyk, C; Rowe, I; Chiaravalli, M; Pema, M; Qian, F; Boletta, A				Wodarczyk, Claas; Rowe, Isaline; Chiaravalli, Marco; Pema, Monika; Qian, Feng; Boletta, Alessandra			A Novel Mouse Model Reveals that Polycystin-1 Deficiency in Ependyma and Choroid Plexus Results in Dysfunctional Cilia and Hydrocephalus	PLOS ONE			English	Article							KIDNEY-DISEASE; CYST FORMATION; PKD1; GENE; EXPRESSION; DEFECTS; RECEPTOR; CLEAVAGE; MICE; MECHANOSENSATION	Polycystin-1 (PC-1), the product of the PKD1 gene, mutated in the majority of cases of Autosomal Dominant Polycystic Kidney Disease (ADPKD), is a very large (similar to 520 kDa) plasma membrane receptor localized in several subcellular compartments including cell-cell/matrix junctions as well as cilia. While heterologous over-expression systems have allowed identification of several of the potential biological roles of this receptor, its precise function remains largely elusive. Studying PC-1 in vivo has been a challenging task due to its complexity and low expression levels. To overcome these limitations and facilitate the study of endogenous PC-1, we have inserted HA-or Myc-tag sequences into the Pkd1 locus by homologous recombination. Here, we show that our approach was successful in generating a fully functional and easily detectable endogenous PC-1. Characterization of PC-1 distribution in vivo showed that it is expressed ubiquitously and is developmentally-regulated in most tissues. Furthermore, our novel tool allowed us to investigate the role of PC-1 in brain, where the protein is abundantly expressed. Subcellular localization of PC-1 revealed strong and specific staining in ciliated ependymal and choroid plexus cells. Consistent with this distribution, we observed hydrocephalus formation both in the ubiquitous knock-out embryos and in newborn mice with conditional inactivation of the Pkd1 gene in the brain. Both choroid plexus and ependymal cilia were morphologically normal in these mice, suggesting a role for PC-1 in ciliary function or signalling in this compartment, rather than in ciliogenesis. We propose that the role of PC-1 in the brain cilia might be to prevent hydrocephalus, a previously unrecognized role for this receptor and one that might have important implications for other genetic or sporadic diseases.			Wodarczyk, C (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst DTI Dibit, I-20132 Milan, Italy.	boletta.alessandra@hsr.it	rowe, isaline/AAN-1985-2020	rowe, isaline/0000-0002-5398-1776; chiaravalli, marco/0000-0003-0369-1989	NIDDK NIH HHS [R01 DK062199, DK062199] Funding Source: Medline; Telethon [GTF07004, TCR07005] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen E, 2006, HUM MOL GENET, V15, P11, DOI 10.1093/hmg/ddi421; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Banizs B, 2007, AM J PHYSIOL-CELL PH, V292, pC1409, DOI 10.1152/ajpcell.00408.2006; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Boca M, 2006, J AM SOC NEPHROL, V17, P637, DOI 10.1681/ASN.2005050534; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Driscoll JA, 2008, CHEST, V133, P1181, DOI 10.1378/chest.07-2147; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Geng L, 1997, AM J PHYSIOL-RENAL, V272, pF451, DOI 10.1152/ajprenal.1997.272.4.F451; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Lantinga-van Leeuwen IS, 2007, HUM MOL GENET, V16, P3188, DOI 10.1093/hmg/ddm299; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Scheffers MS, 2000, HUM MOL GENET, V9, P2743, DOI 10.1093/hmg/9.18.2743; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; STURROCK RR, 1979, J ANAT, V129, P777; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Town T, 2008, P NATL ACAD SCI USA, V105, P2853, DOI 10.1073/pnas.0712385105; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104	48	66	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7137	10.1371/journal.pone.0007137	http://dx.doi.org/10.1371/journal.pone.0007137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774080	gold, Green Published			2022-12-25	WOS:000270160900015
J	Cho, JS; Kim, YC; Morrison, SL				Cho, John S.; Kim, Yun C.; Morrison, Sherie L.			Inhibitors of MyD88-Dependent Proinflammatory Cytokine Production Identified Utilizing a Novel RNA Interference Screening Approach	PLOS ONE			English	Article								Background: The events required to initiate host defenses against invading pathogens involve complex signaling cascades comprised of numerous adaptor molecules, kinases, and transcriptional elements, ultimately leading to the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-alpha). How these signaling cascades are regulated, and the proteins and regulatory elements participating are still poorly understood. Results: We report here the development a completely random short-hairpin RNA (shRNA) library coupled with a novel forward genetic screening strategy to identify inhibitors of Toll-like receptor (TLR) dependent proinflammatory responses. We developed a murine macrophage reporter cell line stably transfected with a construct expressing diphtheria toxin-A (DT-A) under the control of the TNF-alpha-promoter. Stimulation of the reporter cell line with the TLR ligand lipopolysaccharide (LPS) resulted in DT-A induced cell death, which could be prevented by the addition of an shRNA targeting the TLR adaptor molecule MyD88. Utilizing this cell line, we screened a completely random lentiviral short hairpin RNA (shRNA) library for sequences that inhibited TLR-mediated TNF-alpha production. Recovery of shRNA sequences from surviving cells led to the identification of unique shRNA sequences that significantly inhibited TLR4-dependent TNF-alpha gene expression. Furthermore, these shRNA sequences specifically blocked TLR2 but not TLR3-dependent TNF-alpha production. Conclusions: Thus, we describe the generation of novel tools to facilitate large-scale forward genetic screens in mammalian cells and the identification of potent shRNA inhibitors of TLR2 and TLR4-dependent proinflammatory responses.			Cho, JS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	johncho@ucla.edu			NCI NIH HHS [T32 CA009120, 5 T32 CA009120: 32] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi H, 2005, MOL BIOSYST, V1, P382, DOI 10.1039/b510159j; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Diederichs S, 2008, P NATL ACAD SCI USA, V105, P9284, DOI 10.1073/pnas.0800803105; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Du C, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-28; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Li Y, 2002, CANCER RES, V62, P2576; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7029	10.1371/journal.pone.0007029	http://dx.doi.org/10.1371/journal.pone.0007029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753301	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796500014
J	Das, A; Bellofatto, V				Das, Anish; Bellofatto, Vivian			The Non-Canonical CTD of RNAP-II Is Essential for Productive RNA Synthesis in Trypanosoma brucei	PLOS ONE			English	Article								The carboxy-terminal domain (CTD) of the largest subunit (RPB1) of RNA polymerase II (RNAP-II) is essential for gene expression in metazoa and yeast. The canonical CTD is characterized by heptapeptide repeats. Differential phosphorylation of canonical CTD orchestrates transcriptional and co-transcriptional maturation of mRNA and snRNA. Many organisms, including trypanosomes, lack a canonical CTD. In these organisms, the CTD is called a non-canonical CTD or pseudo-CTD (Psi CTD. In the African trypanosome, Trypanosoma brucei, the Psi CTD is similar to 285 amino acids long, rich in serines and prolines, and phosphorylated. We report that T. brucei RNAP-II lacking the entire Psi CTD or containing only a 95-amino-acid-long Psi CTD failed to support cell viability. In contrast, RNAP-II with a 186-amino-acid-long Psi CTD maintained cellular growth. RNAP-II with Psi CTD truncations resulted in abortive initiation of transcription. These data establish that non-canonical CTDs play an important role in gene expression.			Das, A (corresponding author), Univ Med & Dent New Jersey, Sch Dent, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA.	A.Das-dasak@umdnj.edu; bellofat@umdnj.edu			NIAID NIH HHS [R01 AI029478, AI535835, AI29478] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029478] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BANGS JD, 1992, J BIOL CHEM, V267, P9805; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; CHAPMAN AB, 1994, J BIOL CHEM, V269, P4754; Chapman RD, 2005, MOL CELL BIOL, V25, P7665, DOI 10.1128/MCB.25.17.7665-7674.2005; Chapman RD, 2004, NUCLEIC ACIDS RES, V32, P35, DOI 10.1093/nar/gkh172; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Das A, 2006, MOL BIOCHEM PARASIT, V150, P201, DOI 10.1016/j.molbiopara.2006.08.002; Devaux S, 2006, MOL BIOCHEM PARASIT, V148, P60, DOI 10.1016/j.molbiopara.2006.02.020; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; GRONDAL EJM, 1989, EMBO J, V8, P3383, DOI 10.1002/j.1460-2075.1989.tb08502.x; Guo ZH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-69; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patrick KL, 2008, MOL MICROBIOL, V67, P435, DOI 10.1111/j.1365-2958.2007.06057.x; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Sambrook J., 2001, MOL CLONING; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schumacher MA, 2003, CELL, V115, P413, DOI 10.1016/S0092-8674(03)00887-0; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; SMITH JL, 1989, CELL, V56, P815, DOI 10.1016/0092-8674(89)90686-7; Stiller JW, 1998, P NATL ACAD SCI USA, V95, P11769, DOI 10.1073/pnas.95.20.11769; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ULLU E, 1990, NUCLEIC ACIDS RES, V18, P3319, DOI 10.1093/nar/18.11.3319; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yurchenko VY, 2006, PARASITOLOGY, V133, P537, DOI 10.1017/S0031182006000746	35	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6959	10.1371/journal.pone.0006959	http://dx.doi.org/10.1371/journal.pone.0006959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742309	Green Submitted, gold, Green Published			2022-12-25	WOS:000269622500020
J	Gravlee, CC; Non, AL; Mulligan, CJ				Gravlee, Clarence C.; Non, Amy L.; Mulligan, Connie J.			Genetic Ancestry, Social Classification, and Racial Inequalities in Blood Pressure in Southeastern Puerto Rico	PLOS ONE			English	Article							SKIN COLOR; POPULATION-STRUCTURE; AFRICAN-AMERICANS; RACE; HEALTH; ADMIXTURE; ETHNICITY; DISPARITIES; HYPERTENSION; ENVIRONMENT	Background: The role of race in human genetics and biomedical research is among the most contested issues in science. Much debate centers on the relative importance of genetic versus sociocultural factors in explaining racial inequalities in health. However, few studies integrate genetic and sociocultural data to test competing explanations directly. Methodology/Principal Findings: We draw on ethnographic, epidemiologic, and genetic data collected in southeastern Puerto Rico to isolate two distinct variables for which race is often used as a proxy: genetic ancestry versus social classification. We show that color, an aspect of social classification based on the culturally defined meaning of race in Puerto Rico, better predicts blood pressure than does a genetic-based estimate of continental ancestry. We also find that incorporating sociocultural variables reveals a new and significant association between a candidate gene polymorphism for hypertension (alpha(2C) adrenergic receptor deletion) and blood pressure. Conclusions/Significance: This study addresses the recognized need to measure both genetic and sociocultural factors in research on racial inequalities in health. Our preliminary results provide the most direct evidence to date that previously reported associations between genetic ancestry and health may be attributable to sociocultural factors related to race and racism, rather than to functional genetic differences between racially defined groups. Our results also imply that including sociocultural variables in future research may improve our ability to detect significant allele-phenotype associations. Thus, measuring sociocultural factors related to race may both empower future genetic association studies and help to clarify the biological consequences of social inequalities.			Gravlee, CC (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	cgravlee@ufl.edu	Non, Amy/AAW-7116-2021; Gravlee, Clarence C/A-2249-2009	Gravlee, Clarence C/0000-0002-0913-2320				*AM J PUBL HLTH, 2005, AM J PUBLIC HLTH, V95; *AM PSYCH, 2005, AM PSYCHOL, V60; Anwar, 1998, Blood Press Monit, V3, P261; Boks MPM, 2007, INT J EPIDEMIOL, V36, P1363, DOI 10.1093/ije/dym215; Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7; BOYLE E, 1970, J AMER MED ASSOC, V213, P1637, DOI 10.1001/jama.213.10.1637; Braun L, 2006, INT J HEALTH SERV, V36, P557, DOI 10.2190/8JAF-D8ED-8WPD-J9WH; Braveman P, 2001, PUBLIC HEALTH REP, V116, P449, DOI 10.1093/phr/116.5.449; Brondolo E, 2003, ANN BEHAV MED, V25, P55, DOI 10.1207/S15324796ABM2501_08; Brondolo E, 2008, PSYCHOSOM MED, V70, P49, DOI 10.1097/PSY.0b013e31815ff3bd; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Choudhry S, 2006, AM J RESP CRIT CARE, V174, P1086, DOI [10.1164/RCCM.200605-596OC, 10.1164/rccm.200605-596OC]; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cooper RS, 2003, ANN INTERN MED, V139, P437, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00011; COSTAS R, 1981, AM J PUBLIC HEALTH, V71, P614, DOI 10.2105/AJPH.71.6.614; Deo RC, 2007, PLOS GENET, V3, P2200, DOI 10.1371/journal.pgen.0030196; DRESSLER W W, 1991, Ethnicity and Disease, V1, P60; Dressler WW, 2005, ANNU REV ANTHROPOL, V34, P231, DOI 10.1146/annurev.anthro.34.081804.120505; Farmer MM, 2005, SOC SCI MED, V60, P191, DOI 10.1016/j.socscimed.2004.04.026; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Frisancho AR, 1999, AM J HUM BIOL, V11, P489, DOI 10.1002/(SICI)1520-6300(1999)11:4<489::AID-AJHB8>3.0.CO;2-S; Fyr CLW, 2007, HUM GENET, V121, P615, DOI 10.1007/s00439-007-0353-z; GLEIBERMAN L, 1999, NATIVITY RACE RESPON, V34, pE7; Glover M. J., 2005, Morbidity and Mortality Weekly Report, V54, P7; Godreau IP, 2008, CENTRO J, V20; Goodman E, 2005, J ADOLESCENT HEALTH, V37, P484, DOI 10.1016/j.jadohealth.2004.11.126; Gower BA, 2003, DIABETES, V52, P1047, DOI 10.2337/diabetes.52.4.1047; Gravlee CC, 2005, AM J PUBLIC HEALTH, V95, P2191, DOI 10.2105/AJPH.2005.065615; Gravlee CC, 2005, AM J HUM BIOL, V17, P195, DOI 10.1002/ajhb.20111; Gravlee CC, 2005, SOC FORCES, V83, P949, DOI 10.1353/sof.2005.0033; Gravlee CC, 2008, MED ANTHROPOL Q, V22, P27, DOI 10.1111/j.1548-1387.2008.00002.x; Gravlee CC, 2009, AM J PHYS ANTHROPOL, V139, P47, DOI 10.1002/ajpa.20983; Halberstein RA, 1999, HUM BIOL, V71, P659; HARBURG E, 1978, AM J PUBLIC HEALTH, V68, P1177, DOI 10.2105/AJPH.68.12.1177; Harrell JP, 2003, AM J PUBLIC HEALTH, V93, P243, DOI 10.2105/AJPH.93.2.243; HERRING C, 2004, SKIN DEEP RACE COMPL, P248; JAMES S A, 1991, Ethnicity and Disease, V1, P91; Jones CP, 2008, ETHNIC DIS, V18, P496; Kaufman JS, 2008, ANN EPIDEMIOL, V18, P119, DOI 10.1016/j.annepidem.2007.09.002; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P2155, DOI 10.2105/AJPH.2005.067108; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P194, DOI 10.2105/AJPH.93.2.194; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li JL, 2006, HYPERTENSION, V47, P1140, DOI 10.1161/01.HYP.0000217972.80731.ef; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; MINTZ SW, 1974, CARIBBEAN TRANSFORMA, P355; *NAT GEN, 2004, NAT GENET, V36; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; Pan American Health Organization, 2007, HLTH AM; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Penner AM, 2008, P NATL ACAD SCI USA, V105, P19628, DOI 10.1073/pnas.0805762105; Peralta CA, 2006, J AM SOC NEPHROL, V17, P3491, DOI 10.1681/ASN.2006050493; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Pritchard JK, 2000, GENETICS, V155, P945; RACE E, 2005, AM J HUM GENET, V77, P519; Rebbeck TR, 2005, CANCER EPIDEM BIOMAR, V14, P2467, DOI 10.1158/1055-9965.EPI-05-0649; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Risch N., 2002, GENOME BIOL, V3; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Sankar P, 2007, AM J MED GENET A, V143A, P961, DOI 10.1002/ajmg.a.31575; SCARANO FA, 1984, SUGAR SLAVERY PUERTO, P1800; Sweet E, 2007, AM J PUBLIC HEALTH, V97, P2253, DOI 10.2105/AJPH.2006.088799; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; TYROLER HA, 1978, AM J PUBLIC HEALTH, V68, P1170, DOI 10.2105/AJPH.68.12.1170; *US BUR CENS, 2001, PROF GEN DEM CHAR CE, P320; VAZQUEZ MM, 1999, DISCRIMEN RAZON RAZA; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams DR, 1997, ANN EPIDEMIOL, V7, P322, DOI 10.1016/S1047-2797(97)00051-3; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	79	61	61	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6821	10.1371/journal.pone.0006821	http://dx.doi.org/10.1371/journal.pone.0006821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	491ZI	19742303	Green Published, gold			2022-12-25	WOS:000269622500001
J	Kuroda, A; Rauch, TA; Todorov, I; Ku, HT; Al-Abdullah, IH; Kandeel, F; Mullen, Y; Pfeifer, GP; Ferreri, K				Kuroda, Akio; Rauch, Tibor A.; Todorov, Ivan; Ku, Hsun Teresa; Al-Abdullah, Ismail H.; Kandeel, Fouad; Mullen, Yoko; Pfeifer, Gerd P.; Ferreri, Kevin			Insulin Gene Expression Is Regulated by DNA Methylation	PLOS ONE			English	Article							PROINSULIN BIOSYNTHESIS; BETA-CELLS; BINDING PROTEIN; INS2 LOCUS; CHROMATIN; TRANSCRIPTION; ACTIVATION; PROMOTER; GLUCOSE; 5-METHYLCYTOSINE	Background: Insulin is a critical component of metabolic control, and as such, insulin gene expression has been the focus of extensive study. DNA sequences that regulate transcription of the insulin gene and the majority of regulatory factors have already been identified. However, only recently have other components of insulin gene expression been investigated, and in this study we examine the role of DNA methylation in the regulation of mouse and human insulin gene expression. Methodology/Principal Findings: Genomic DNA samples from several tissues were bisulfite-treated and sequenced which revealed that cytosine-guanosine dinucleotide (CpG) sites in both the mouse Ins2 and human INS promoters are uniquely demethylated in insulin-producing pancreatic beta cells. Methylation of these CpG sites suppressed insulin promoter-driven reporter gene activity by almost 90% and specific methylation of the CpG site in the cAMP responsive element (CRE) in the promoter alone suppressed insulin promoter activity by 50%. Methylation did not directly inhibit factor binding to the CRE in vitro, but inhibited ATF2 and CREB binding in vivo and conversely increased the binding of methyl CpG binding protein 2 (MeCP2). Examination of the Ins2 gene in mouse embryonic stem cell cultures revealed that it is fully methylated and becomes demethylated as the cells differentiate into insulin-expressing cells in vitro. Conclusions/Significance: Our findings suggest that insulin promoter CpG demethylation may play a crucial role in beta cell maturation and tissue-specific insulin gene expression.			Kuroda, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka, Japan.	kferreri@coh.org		Ku, Hsun/0000-0001-5662-9893; Ferreri, Kevin/0000-0003-0379-0389	NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081587, R01DK056952] Funding Source: NIH RePORTER; NCRR NIH HHS [U42 RR16607, U42 RR016607] Funding Source: Medline; NIDDK NIH HHS [R01 DK081587, R01 DK056952, DK056952, 5R01DK081587-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dell G, 2001, Methods Mol Biol, V181, P251; DELTOUR L, 1995, DEV BIOL, V168, P686, DOI 10.1006/dbio.1995.1114; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Faideau B, 2005, DIABETES, V54, pS87, DOI 10.2337/diabetes.54.suppl_2.S87; FEIL R, 1994, DEVELOPMENT, V120, P2933; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Gu GQ, 2002, DEVELOPMENT, V129, P2447; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Hay CW, 2007, BBA-GENE STRUCT EXPR, V1769, P79, DOI 10.1016/j.bbaexp.2007.01.005; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Iannello RC, 2000, J BIOL CHEM, V275, P19603, DOI 10.1074/jbc.M001867200; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Ku HT, 2007, DIABETES, V56, P921, DOI 10.2337/db06-0468; Lamotte L, 2004, TRANSGENIC RES, V13, P463, DOI 10.1007/s11248-004-9587-x; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lorenzo M, 2008, J Anim Sci, V86, pE94; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Palumbo MO, 2006, DIABETES, V55, P2595, DOI 10.2337/db05-1651; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sharma RP, 2005, J PSYCHIATR NEUROSCI, V30, P257; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Todorov I, 2006, PANCREAS, V32, P130, DOI 10.1097/01.mpa.0000202945.78331.93; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Uchizono Y, 2007, DIABETES OBES METAB, V9, P56, DOI 10.1111/j.1463-1326.2007.00774.x; Vu TH, 2000, GENOMICS, V64, P132, DOI 10.1006/geno.1999.6094; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; WU C, 1981, P NATL ACAD SCI-BIOL, V78, P1577, DOI 10.1073/pnas.78.3.1577; Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	51	212	234	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6953	10.1371/journal.pone.0006953	http://dx.doi.org/10.1371/journal.pone.0006953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742322	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622500016
J	de Alba, E				de Alba, Eva			Structure and Interdomain Dynamics of Apoptosis-associated Speck-like Protein Containing a CARD (ASC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE RECRUITMENT DOMAIN; N-15 NMR RELAXATION; PYRIN DOMAIN; CHEMICAL-SHIFTS; ROTATIONAL DIFFUSION; ACTIVATING ADAPTER; BACKBONE DYNAMICS; ONLY PROTEIN; CELL-DEATH; KAPPA-B	The human protein ASC is a key mediator in apoptosis and inflammation. Through its two death domains (pyrin and CARD) ASC interacts with cell death executioners, acts as an essential adapter for inflammasome integrity, and oligomerizes into functional supramolecular assemblies. However, these functions are not understood at the structural-dynamic level. This study reports the solution structure and interdomain dynamics of full-length ASC. The pyrin and CARD domains are structurally independent six-helix bundle motifs connected by a 23-residue linker. The CARD structure reveals two distinctive characteristics; helix 1 is not fragmented as in all other known CARDs, and its electrostatic surface shows a uniform distribution of positive and negative charges, whereas these are commonly separated into two areas in other death domains. The linker adopts residual structure resulting in a back-to-back orientation of the domains, which avoids steric interference of each domain with the binding site of the other. NMR relaxation experiments show that the linker is flexible despite the residual structure. This flexibility could help expand the relative volume occupied by each domain, thus increasing the capture radius for effectors. Based on the ASC structure, a tentative model is proposed to illustrate how ASC oligomerizes via CARD and pyrin homophilic interactions. Moreover, ASC oligomers have been analyzed by atomic force microscopy, showing a predominant species of disk-like particles of similar to 12-nm diameter and similar to 1-nm height. Taken together, these results provide structural insight into the behavior of ASC as an adapter molecule.	CSIC, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de Alba, E (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	dealbae@cib.csic.es			European Commission Marie Curie International Reintegration [IRG-046412]; Spanish Ministerio de Ciencia e Innovacion through the Programa Ramo n y Cajal; Plan Nacional I+D+I [BFU2008-03278]; Comunidad de Madrid and Agencia CSIC [CCG08CSIC/SAL-3777]	European Commission Marie Curie International Reintegration(European Commission); Spanish Ministerio de Ciencia e Innovacion through the Programa Ramo n y Cajal(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Nacional I+D+I; Comunidad de Madrid and Agencia CSIC	This work was supported by the European Commission Marie Curie International Reintegration Grant IRG-046412 (to E.d.A.), by the Spanish Ministerio de Ciencia e Innovacion through the Programa Ramo n y Cajal (to E.d.A.), by Plan Nacional I+D+I Grant BFU2008-03278 (to E.d.A.), and by Comunidad de Madrid and Agencia CSIC through the IV PRICIT CCG08CSIC/SAL-3777 (to E.d.A.).	Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Conway KE, 2000, CANCER RES, V60, P6236; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; de Alba E, 2007, BIOMOL NMR ASSIGM, V1, P135, DOI 10.1007/s12104-007-9036-x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fushman D, 2004, PROG NUCL MAG RES SP, V44, P189, DOI 10.1016/j.pnmrs.2004.02.001; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McConnell BB, 2000, CANCER RES, V60, P6243; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Palmer AG, 1996, J PHYS CHEM-US, V100, P13293, DOI 10.1021/jp9606117; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Petrilli V, 2007, JOINT BONE SPINE, V74, P571, DOI 10.1016/j.jbspin.2007.04.004; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; WAGNER G, 1993, J BIOMOL NMR, V3, P375; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	68	98	100	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32932	32941		10.1074/jbc.M109.024273	http://dx.doi.org/10.1074/jbc.M109.024273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759015	Green Published, hybrid			2022-12-25	WOS:000272028400076
J	Wittrup, A; Zhang, SH; ten Dam, GB; van Kuppevelt, TH; Bengtson, P; Johansson, M; Welch, J; Morgelin, M; Belting, M				Wittrup, Anders; Zhang, Si-He; ten Dam, Gerdy B.; van Kuppevelt, Toin H.; Bengtson, Per; Johansson, Maria; Welch, Johanna; Morgelin, Matthias; Belting, Mattias			ScFv Antibody-induced Translocation of Cell-surface Heparan Sulfate Proteoglycan to Endocytic Vesicles EVIDENCE FOR HEPARAN SULFATE EPITOPE SPECIFICITY AND ROLE OF BOTH SYNDECAN AND GLYPICAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR DEGRADATIVE PATHWAYS; PHAGE DISPLAY ANTIBODIES; ARGININE-RICH PEPTIDES; MEDIATED GENE-TRANSFER; MAMMALIAN-CELLS; MACROPINOCYTOSIS; INTERNALIZATION; 2-O-SULFATION; PROTEINS; DOMAINS	Cellular uptake of several viruses and polybasic macromolecules requires the expression of cell-surface heparan sulfate proteoglycan (HSPG) through as yet ill defined mechanisms. We unexpectedly found that among several cell-surface-binding single chain variable fragment (scFv) anti-HS antibody (alpha HS) clones, only one, AO4B08, efficiently translocated macromolecular cargo to intracellular vesicles through induction of HSPG endocytosis. Interestingly, AO4B08-induced PG internalization was strictly dependent on HS 2-O-sulfation and appeared independent of intact N-sulfation. AO4B08 and human immunodeficiency virus (HIV)-Tat, i.e. a well known cell-penetrating peptide, were shown to compete for the internalizing PG population. To obtain a more detailed characterization of this pathway, we have developed a procedure for the isolation of endocytic vesicles by conjugating AO4B08 with superparamagnetic nanoparticles. [S-35] sulfate-labeled HSPG was found to accumulate in isolated, AO4B08-containing vesicles, providing the first biochemical evidence for intact HSPG co-internalization with its ligand. Further analysis revealed the existence of both syndecan, i.e. a transmembrane HSPG, and glycosyl-phosphatidyl-inositol-anchored glypican in purified vesicles. Importantly, internalized syndecan and glypican were found to colocalize in AO4B08-containing vesicles. Our data establish HSPGs as true internalizing receptors of macromolecular cargo and indicate that the sorting of cell-surface HSPG to endocytic vesicles is determined by a specific HS epitope that can be carried by both syndecan and glypican core protein.	[Wittrup, Anders; Zhang, Si-He; Bengtson, Per; Johansson, Maria; Welch, Johanna; Belting, Mattias] Lund Univ, Sect Oncol, Dept Clin Sci, SE-22185 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Sect Clin & Expt Infect Med, Dept Clin Sci, SE-22185 Lund, Sweden; [ten Dam, Gerdy B.; van Kuppevelt, Toin H.] Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Lund University; Lund University; Radboud University Nijmegen	Wittrup, A (corresponding author), Lund Univ, Sect Oncol, Dept Clin Sci, Barngatan 2-1, SE-22185 Lund, Sweden.	anders.wittrup@med.lu.se; mattias.belting@med.lu.se	Zhang, Si-he/AAV-9442-2021; van Kuppevelt, A.H.M.S.M./L-4463-2015	Zhang, Si-he/0000-0002-8923-1993; Belting, Mattias/0000-0003-1585-5434; Wittrup, Anders/0000-0003-4918-0500	Swedish Cancer Fund; Swedish Research Council; Swedish Foundation for Strategic Research (FLAK); Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska, Gunnar Nilsson, and Kamprad Foundations; Lund University Hospital (ALF)	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research (FLAK)(Swedish Foundation for Strategic Research); Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska, Gunnar Nilsson, and Kamprad Foundations; Lund University Hospital (ALF)	This work was supported by grants from the Swedish Cancer Fund; the Swedish Research Council; the Swedish Foundation for Strategic Research (FLAK); the Swedish Society of Medicine; the Physiographic Society, Lund; the Crafoordska, Gunnar Nilsson, and Kamprad Foundations; and the Lund University Hospital (ALF).	Bai X, 2001, Methods Mol Biol, V171, P309; Bai XM, 1997, J BIOL CHEM, V272, P23172, DOI 10.1074/jbc.272.37.23172; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BAME KJ, 1994, BIOCHEM J, V303, P81, DOI 10.1042/bj3030081; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Belting M, 1999, BIOCHEM J, V338, P317, DOI 10.1042/0264-6021:3380317; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Belting M, 1999, J BIOL CHEM, V274, P19375, DOI 10.1074/jbc.274.27.19375; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Duenas-Gonzalez A, 1998, J CELL BIOL, V141, P1407, DOI 10.1083/jcb.141.6.1407; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Payne CK, 2007, TRAFFIC, V8, P389, DOI 10.1111/j.1600-0854.2007.00540.x; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Wittrup A, 2007, J BIOL CHEM, V282, P27897, DOI 10.1074/jbc.M701611200; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9505; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270	36	50	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32959	32967		10.1074/jbc.M109.036129	http://dx.doi.org/10.1074/jbc.M109.036129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19783663	Green Published, hybrid			2022-12-25	WOS:000272028400079
J	Sabouri, N; Johansson, E				Sabouri, Nasim; Johansson, Erik			Translesion Synthesis of Abasic Sites by Yeast DNA Polymerase epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; REPLICATION FORK; SULFOLOBUS-SOLFATARICUS; LESION BYPASS; SPECIFICITY; ETA; EXONUCLEASE; MECHANISMS; EFFICIENCY; PROTEINS	Studies of replicative DNA polymerases have led to the generalization that abasic sites are strong blocks to DNA replication. Here we show that yeast replicative DNA polymerase epsilon bypasses a model abasic site with comparable efficiency to Pol eta and Dpo4, two translesion polymerases. DNA polymerase epsilon also exhibited high bypass efficiency with a natural abasic site on the template. Translesion synthesis primarily resulted in deletions. In cases where only a single nucleotide was inserted, dATP was the preferred nucleotide opposite the natural abasic site. In contrast to translesion polymerases, DNA polymerase epsilon with 3'-5' proofreading exonuclease activity bypasses only the model abasic site during processive synthesis and cannot reinitiate DNA synthesis. This characteristic may allow other pathways to rescue leading strand synthesis when stalled at an abasic site.	[Sabouri, Nasim; Johansson, Erik] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Umea University	Johansson, E (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	erik.johansson@medchem.umu.se	Sabouri, Nasim/AFP-6927-2022	Sabouri, Nasim/0000-0002-4541-7702; Johansson, Erik/0000-0002-8526-6224	Swedish Research Council; The Swedish Cancer Society; Fund for Basic Science-oriented Biotechnology; Medical Faculty at Umea University; Smartafonden; Ake Wibergs stiftelse; Magnus Bergwalls stiftelse; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); The Swedish Cancer Society(Swedish Cancer Society); Fund for Basic Science-oriented Biotechnology; Medical Faculty at Umea University; Smartafonden; Ake Wibergs stiftelse; Magnus Bergwalls stiftelse; Kempe Foundation	This work was supported by the Swedish Research Council, The Swedish Cancer Society, the Fund for Basic Science-oriented Biotechnology, and the Medical Faculty at Umea University, Smartafonden, Ake Wibergs stiftelse, and Magnus Bergwalls stiftelse (to E. J.) and in part by a grant from the Kempe Foundation (to N. S.).	Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Auerbach P, 2005, P NATL ACAD SCI USA, V102, P17711, DOI 10.1073/pnas.0504643102; Blanca G, 2007, BIOCHEM J, V402, P321, DOI 10.1042/BJ20060898; BONNER CA, 1988, J BIOL CHEM, V263, P18946; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Eckert KA, 1999, MUTAT RES-FUND MOL M, V424, P221, DOI 10.1016/S0027-5107(99)00021-4; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Gruz P, 2003, NUCLEIC ACIDS RES, V31, P4024, DOI 10.1093/nar/gkg447; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Le Gac NT, 2004, J MOL BIOL, V336, P1023, DOI 10.1016/j.jmb.2004.01.005; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; McCulloch SD, 2004, NUCLEIC ACIDS RES, V32, P4665, DOI 10.1093/nar/gkh777; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MEZZINA M, 1988, J VIROL, V62, P4249, DOI 10.1128/JVI.62.11.4249-4258.1988; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1	33	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31555	31563		10.1074/jbc.M109.043927	http://dx.doi.org/10.1074/jbc.M109.043927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776424	Green Published, hybrid			2022-12-25	WOS:000271572700009
J	Horler, RSP; Muller, A; Williamson, DC; Potts, JR; Wilson, KS; Thomas, GH				Horler, Richard S. P.; Mueller, Axel; Williamson, David C.; Potts, Jennifer R.; Wilson, Keith S.; Thomas, Gavin H.			Furanose-specific Sugar Transport CHARACTERIZATION OF A BACTERIAL GALACTOFURANOSE-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; SALMONELLA-TYPHIMURIUM; LIGAND SPECIFICITY; ACTIVE-TRANSPORT; GALACTOSE; GLUCOSE; CHEMOTAXIS; RECEPTOR	The widespread utilization of sugars by microbes is reflected in the diversity and multiplicity of cellular transporters used to acquire these compounds from the environment. The model bacterium Escherichia coli has numerous transporters that allow it to take up hexoses and pentoses, which recognize the more abundant pyranose forms of these sugars. Here we report the biochemical and structural characterization of a transporter protein YtfQ from E. coli that forms part of an uncharacterized ABC transporter system. Remarkably the crystal structure of this protein, solved to 1.2 angstrom using x-ray crystallography, revealed that YtfQ binds a single molecule of galactofuranose in its ligand binding pocket. Selective binding of galactofuranose over galactopyranose was also observed using NMR methods that determined the form of the sugar released from the protein. The pattern of expression of the ytfQRTyjfF operon encoding this transporter mirrors that of the high affinity galactopyranose transporter of E. coli, suggesting that this bacterium has evolved complementary transporters that enable it to use all the available galactose present during carbon limiting conditions.	[Horler, Richard S. P.; Mueller, Axel; Potts, Jennifer R.; Thomas, Gavin H.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Mueller, Axel; Wilson, Keith S.] Univ York, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Williamson, David C.; Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Thomas, GH (corresponding author), Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England.	ght2@york.ac.uk	Thomas, Gavin H/E-5753-2011	Thomas, Gavin H/0000-0002-9763-1313; Horler, Richard/0000-0002-9908-2469; Wilson, Keith/0000-0002-3581-2194	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (to G.H.T.) and a BBSRC quota studentship (to R.S.P.H.).	Barlow JN, 2000, CARBOHYD RES, V328, P473, DOI 10.1016/S0008-6215(00)00135-X; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; Bulyk ML, 2004, GENOME RES, V14, P201, DOI 10.1101/gr.1448004; Chaudhuri BN, 1999, J MOL BIOL, V286, P1519, DOI 10.1006/jmbi.1999.2571; Collins P. C., 1995, MONOSACCHARIDES THEI; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Franchini AG, 2006, MICROBIOL-SGM, V152, P2111, DOI 10.1099/mic.0.28939-0; FRANKS F, 1987, PURE APPL CHEM, V59, P1189, DOI 10.1351/pac198759091189; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HENDERSON PJF, 1977, BIOCHEM J, V162, P309, DOI 10.1042/bj1620309; Hobley P, 1996, MAGN RESON CHEM, V34, P755; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ingraham JL., 1987, Escherichia coli and Salmonella typhimurium: cellular and molecular biology; Jahreis K, 2008, FEMS MICROBIOL REV, V32, P891, DOI 10.1111/j.1574-6976.2008.00125.x; JASEJA M, 1990, MAGN RESON CHEM, V28, P283, DOI 10.1002/mrc.1260280402; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MILLER DM, 1980, J BIOL CHEM, V255, P2465; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; Muller A, 2005, MOL MICROBIOL, V57, P143, DOI 10.1111/j.1365-2958.2005.04691.x; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; QUIOCHO FA, 1977, J SUPRAMOL STR CELL, V6, P502; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Raman B, 2005, BIOTECHNOL BIOENG, V92, P384, DOI 10.1002/bit.20570; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Wilkinson T., 2003, ABC PROTEINS BACTERI, P187; WILSON DB, 1974, J BIOL CHEM, V249, P553; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549; ZUKIN RS, 1977, BIOCHEMISTRY-US, V16, P381, DOI 10.1021/bi00622a007	52	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31156	31163		10.1074/jbc.M109.054296	http://dx.doi.org/10.1074/jbc.M109.054296			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744923	hybrid, Green Published			2022-12-25	WOS:000271378400043
J	Spaulding, M; O'Leary, MA; Gatesy, J				Spaulding, Michelle; O'Leary, Maureen A.; Gatesy, John			Relationships of Cetacea (Artiodactyla) Among Mammals: Increased Taxon Sampling Alters Interpretations of Key Fossils and Character Evolution	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; NORTHWEST PAKISTAN; BRANCH SUPPORT; WHALES; EOCENE; HIPPOPOTAMUS; POSITION; INCLUSION; DENTITION; ORIGINS	Background: Integration of diverse data (molecules, fossils) provides the most robust test of the phylogeny of cetaceans. Positioning key fossils is critical for reconstructing the character change from life on land to life in the water. Methodology/Principal Findings: We reexamine relationships of critical extinct taxa that impact our understanding of the origin of Cetacea. We do this in the context of the largest total evidence analysis of morphological and molecular information for Artiodactyla (661 phenotypic characters and 46,587 molecular characters, coded for 33 extant and 48 extinct taxa). We score morphological data for Carnivoramorpha, dagger Creodonta, Lipotyphla, and the dagger raoellid artiodactylan dagger Indohyus and concentrate on determining which fossils are positioned along stem lineages to major artiodactylan crown clades. Shortest trees place Cetacea within Artiodactyla and close to dagger Indohyus, with dagger Mesonychia outside of Artiodactyla. The relationships of dagger Mesonychia and dagger Indohyus are highly unstable, however - in trees only two steps longer than minimum length, dagger Mesonychia falls inside Artiodactyla and displaces dagger Indohyus from a position close to Cetacea. Trees based only on data that fossilize continue to show the classic arrangement of relationships within Artiodactyla with Cetacea grouping outside the clade, a signal incongruent with the molecular data that dominate the total evidence result. Conclusions/Significance: Integration of new fossil material of Indohyus impacts placement of another extinct clade Mesonychia, pushing it much farther down the tree. The phylogenetic position of Indohyus suggests that the cetacean stem lineage included herbivorous and carnivorous aquatic species. We also conclude that extinct members of Cetancodonta (whales + hippopotamids) shared a derived ability to hear underwater sounds, even though several cetancodontans lack a pachyostotic auditory bulla. We revise the taxonomy of living and extinct artiodactylans and propose explicit node and stem-based definitions for the ingroup.			Spaulding, M (corresponding author), Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA.	mspaulding@amnh.org		O'Leary, Maureen A./0000-0001-7837-5708				Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; AX P, 1985, Cladistics, V1, P279, DOI 10.1111/j.1096-0031.1985.tb00428.x; Ayoub NA, 2009, MOL PHYLOGENET EVOL, V52, P550, DOI 10.1016/j.ympev.2009.03.008; Barklow WE, 2004, ANIM BEHAV, V68, P1125, DOI 10.1016/j.anbehav.2003.10.034; BORENSTEIN S, 2007, WHALES MAY BE RELATE; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; BROCHU C, SYSTEMATIC IN PRESS; Bryant HN, 1996, SYST BIOL, V45, P174, DOI 10.2307/2413614; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Cole R, 1996, PROCEEDINGS OF THE SEVENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P323; COOMBS MC, 1977, J MAMMAL, V58, P291, DOI 10.2307/1379328; Cope E. D., 1875, P ACADEMY NATURAL SC, V27, P444; De Queiroz K, 2007, SYST BIOL, V56, P956, DOI 10.1080/10635150701656378; Delgado S, 2005, J MOL EVOL, V60, P12, DOI 10.1007/s00239-003-0070-8; DEQUEIROZ K, 1990, SYST ZOOL, V39, P307, DOI 10.2307/2992353; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; DEQUEIROZ K, COMPANION VOLU UNPUB; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Flynn JJ, 2005, RISE PLACENTAL MAMMA; Gatesy J, 2000, SYST BIOL, V49, P800, DOI 10.1080/106351500750049842; Gatesy J, 1996, MOL BIOL EVOL, V13, P954, DOI 10.1093/oxfordjournals.molbev.a025663; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; Geisler JH, 2003, J VERTEBR PALEONTOL, V23, P991, DOI 10.1671/32; Geisler JH, 1998, ADV VERT PALEOBIOL, P163; Geisler Jonathan H., 2005, Journal of Mammalian Evolution, V12, P145, DOI 10.1007/s10914-005-4963-8; Geisler Jonathan H., 2001, American Museum Novitates, V3344, P1, DOI 10.1206/0003-0082(2001)344<0001:NMEFTP>2.0.CO;2; Geisler Jonathan H., 2007, P19; Geisler JH, 2009, NATURE, V458, pE1, DOI 10.1038/nature07776; GILBERT D, 1992, SEQAPP VERSION 1 9A; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GRAUR D, 1994, MOL BIOL EVOL, V11, P357; GUNNELL GF, 1998, EVOLUTION TERTIARY M, V1, P91; Hiiemae K.M., 1985, P262; Irwin David M., 1994, Journal of Mammalian Evolution, V2, P37, DOI 10.1007/BF01464349; Kleineidam RG, 1999, J MOL EVOL, V48, P360, DOI 10.1007/PL00006480; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Novacek M, 2008, J VERTEBR PALEONTOL, V28, p121A; NOVACEK MJ, 1985, NATURE, V315, P140, DOI 10.1038/315140a0; O'Leary M.A., 2007, MORPHOBANK 2 5 WEB A; O'Leary MA, 2004, ASSEMBLING THE TREE OF LIFE, P490; O'Leary MA, 1999, SYST BIOL, V48, P455, DOI 10.1080/106351599260102; O'Leary MA, 1998, ADV VERT PALEOBIOL, P133; O'Leary MA, 2001, AM ZOOL, V41, P487, DOI 10.1668/0003-1569(2001)041[0487:TPPOCF]2.0.CO;2; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; O'Leary MA, 2008, CLADISTICS, V24, P397, DOI 10.1111/j.1096-0031.2007.00187.x; OLeary MA, 2009, J MAMM EVOL, V16, P65, DOI DOI 10.1007/S10914-008-9088-4; Osborn H. F., 1924, American Museum Novitates, Vno. 146, P1; Polly PD, 1996, J VERTEBR PALEONTOL, V16, P303, DOI 10.1080/02724634.1996.10011318; RADINSKY LB, 1987, EVOLUTION VERTEBRATE; RUSSELL DE, 1983, P K NED AKAD B PHYS, V86, P285; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Stucky Richard K., 1998, P358; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Theodor Jessica M., 2005, Journal of Mammalian Evolution, V12, P161, DOI 10.1007/s10914-005-5706-6; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Thewissen JGM, 2009, NATURE, V458, pE5, DOI 10.1038/nature07775; THEWISSEN JGM, 1983, P K NED AKAD B PHYS, V86, P153; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VAN VALEN LEIGH, 1966, BULL AMER MUS NATUR HIST, V132, P1; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WYSS AR, 1993, MAMMAL PHYLOGENY : PLACENTALS, P32	71	144	151	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7062	10.1371/journal.pone.0007062	http://dx.doi.org/10.1371/journal.pone.0007062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774069	gold, Green Published, Green Submitted			2022-12-25	WOS:000270160900005
J	Dard, N; Le, T; Maro, B; Louvet-Vallee, S				Dard, Nicolas; Le, Tran; Maro, Bernard; Louvet-Vallee, Sophie			Inactivation of aPKC lambda Reveals a Context Dependent Allocation of Cell Lineages in Preimplantation Mouse Embryos	PLOS ONE			English	Article								Background: During mammalian preimplantation development, lineage divergence seems to be controlled by the interplay between asymmetric cell division (once cells are polarized) and positional information. In the mouse embryo, two distinct cell populations are first observed at the 16-cell stage and can be distinguished by both their position (outside or inside) and their phenotype (polarized or non-polarized). Many efforts have been made during the last decade to characterize the molecular mechanisms driving lineage divergence. Methodology/Principal Findings: In order to evaluate the importance of cell polarity in the determination of cell fate we have disturbed the activity of the apical complex aPKC/PAR6 using siRNA to down-regulate aPKC lambda expression. Here we show that depletion of aPKCl results in an absence of tight junctions and in severe polarity defects at the 16-cell stage. Importantly, we found that, in absence of aPKC lambda, cell fate depends on the cellular context: depletion of aPKC lambda in all cells results in a strong reduction of inner cells at the 16-cell stage, while inhibition of aPKC lambda in only half of the embryo biases the progeny of aPKC lambda defective blastomeres towards the inner cell mass. Finally, our study points to a role of cell shape in controlling cell position and thus lineage allocation. Conclusion: Our data show that aPKC lambda is dispensable for the establishment of polarity at the 8-cell stage but is essential for the stabilization of cell polarity at the 16-cell stage and for cell positioning. Moreover, this study reveals that in addition to positional information and asymmetric cell divisions, cell shape plays an important role for the control of lineage divergence during mouse preimplantation development. Cell shape is able to influence both the type of division (symmetric or asymmetric) and the position of the blastomeres within the embryo.			Dard, N (corresponding author), CNRS, Lab Biol Cellulaire Dev, UMR7622, 9 Quai St Bernard,Batiment C, Paris, France.	nicolas.dard@upmc.fr	Maro, Bernard/AAL-2220-2020	DARD, Nicolas/0000-0001-7036-2275				ALLEGRI L, 1986, AM J PATHOL, V125, P1; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Cui S, 2007, MOL CELL NEUROSCI, V34, P431, DOI 10.1016/j.mcn.2006.11.016; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Dard N, 2001, DEV BIOL, V233, P161, DOI 10.1006/dbio.2001.0192; Dard N, 2008, MOL CELL ENDOCRINOL, V282, P70, DOI 10.1016/j.mce.2007.11.004; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Eckert JJ, 2008, BBA-BIOMEMBRANES, V1778, P717, DOI 10.1016/j.bbamem.2007.09.031; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; FLEMING TP, 1993, DEVELOPMENT, V117, P1135; GOODALL H, 1986, J CELL BIOL, V102, P568, DOI 10.1083/jcb.102.2.568; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Hipfner DR, 2004, GENE DEV, V18, P2243, DOI 10.1101/gad.303304; HOULISTON E, 1989, DEV BIOL, V134, P342, DOI 10.1016/0012-1606(89)90106-1; HYAFIL F, 1981, CELL, V26, P447, DOI 10.1016/0092-8674(81)90214-2; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Johnson M.H., 1986, EXPT APPROACHES MAMM, P35; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; JOHNSON MH, 1985, CELL CONTACT ADHESIO, P27; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Louvet S, 1996, DEV BIOL, V177, P568, DOI 10.1006/dbio.1996.0186; MARO B, 1991, CELL POLARITY MICROT, P17; MINTZ B, 1965, PREIMPLANTATION STAG, P194; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ninomiya H, 2008, NAT CELL BIOL, V10, P61, DOI 10.1038/ncb1669; PAPAIOANNOU VE, 1995, DEV DYNAM, V203, P393, DOI 10.1002/aja.1002030402; PICKERING SJ, 1988, DEVELOPMENT, V103, P353; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Sheth B, 1997, DEVELOPMENT, V124, P2027; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Thomas FC, 2004, J CELL SCI, V117, P5599, DOI 10.1242/jcs.01424; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844	45	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7117	10.1371/journal.pone.0007117	http://dx.doi.org/10.1371/journal.pone.0007117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768116	Green Published, Green Submitted, gold			2022-12-25	WOS:000270154000010
J	DeWard, AD; Leali, K; West, RA; Prendergast, GC; Alberts, AS				DeWard, Aaron D.; Leali, Kellie; West, Richard A.; Prendergast, George C.; Alberts, Arthur S.			Loss of RhoB Expression Enhances the Myelodysplastic Phenotype of Mammalian Diaphanous-Related Formin mDia1 Knockout Mice	PLOS ONE			English	Article								Myelodysplastic syndrome (MDS) is characterized by ineffective hematopoiesis and hyperplastic bone marrow. Complete loss or interstitial deletions of the long arm of chromosome 5 occur frequently in MDS. One candidate tumor suppressor on 5q is the mammalian Diaphanous (mDia)-related formin mDia1, encoded by DIAPH1 (5q31.3). mDia-family formins act as effectors for Rho-family small GTP-binding proteins including RhoB, which has also been shown to possess tumor suppressor activity. Mice lacking the Drf1 gene that encodes mDia1 develop age-dependent myelodysplastic features. We crossed mDia1 and RhoB knockout mice to test whether the additional loss of RhoB expression would compound the myelodysplastic phenotype. Drf1(-/-)RhoB(-/-) mice are fertile and develop normally. Relative to age-matched Drf1(-/-)RhoB(+/-) mice, the age of myelodysplasia onset was earlier in Drf1(-/-)RhoB(-/-) animals-including abnormally shaped erythrocytes, splenomegaly, and extramedullary hematopoiesis. In addition, we observed a statistically significant increase in the number of activated monocytes/macrophages in both the spleen and bone marrow of Drf1(-/-)RhoB(+/-) mice relative to Drf1(-/-)RhoB(+/-) mice. These data suggest a role for RhoB-regulated mDia1 in the regulation of hematopoietic progenitor cells.			DeWard, AD (corresponding author), Van Andel Res Inst, Lab Cell Struct & Signal Integrat, Grand Rapids, MI USA.	Art.Alberts@vai.org		West, Richard/0000-0003-1459-0825	NATIONAL CANCER INSTITUTE [R01CA100123] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100123] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Couderc B, 2008, CANCER GENE THER, V15, P456, DOI 10.1038/cgt.2008.12; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; EISENMANN KM, 2009, 5Q MYELODYS IN PRESS, V5, P5; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kamasani U, 2005, CANCER BIOL THER, V4, P282, DOI 10.4161/cbt.4.3.1498; KENT DG, 2009, BLOOD; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Morgan MA, 2003, LEUKEMIA, V17, P1482, DOI 10.1038/sj.leu.2403024; Nimer Stephen D, 2008, Hematology Am Soc Hematol Educ Program, P43, DOI 10.1182/asheducation-2008.1.43; Nolte F, 2008, ANN HEMATOL, V87, P777, DOI 10.1007/s00277-008-0502-z; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Sato N, 2007, INT J CANCER, V120, P543, DOI 10.1002/ijc.22328; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033	22	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7102	10.1371/journal.pone.0007102	http://dx.doi.org/10.1371/journal.pone.0007102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768111	Green Published, Green Submitted, gold			2022-12-25	WOS:000270154000007
J	Dinnage, R				Dinnage, Russell			Disturbance Alters the Phylogenetic Composition and Structure of Plant Communities in an Old Field System	PLOS ONE			English	Article							TAXONOMIC DISTINCTNESS; SPECIES-DIVERSITY; EVOLUTION; COMPETITION; SPACE; BIODIVERSITY; ORGANIZATION; DIVERGENCE; SUCCESSION; PREDATION	The changes in phylogenetic composition and structure of communities during succession following disturbance can give us insights into the forces that are shaping communities over time. In abandoned agricultural fields, community composition changes rapidly when a field is plowed, and is thought to reflect a relaxation of competition due to the elimination of dominant species which take time to re-establish. Competition can drive phylogenetic overdispersion, due to phylogenetic conservation of 'niche' traits that allow species to partition resources. Therefore, undisturbed old field communities should exhibit higher phylogenetic dispersion than recently disturbed systems, which should be relatively 'clustered' with respect to phylogenetic relationships. Several measures of phylogenetic structure between plant communities were measured in recently plowed areas and nearby 'undisturbed' sites. There was no difference in the absolute values of these measures between disturbed and 'undisturbed' sites. However, there was a difference in the 'expected' phylogenetic structure between habitats, leading to significantly lower than expected phylogenetic diversity in disturbed plots, and no difference from random expectation in 'undisturbed' plots. This suggests that plant species characteristic of each habitat are fairly evenly distributed on the shared species pool phylogeny, but that once the initial sorting of species into the two habitat types has occurred, the processes operating on them affect each habitat differently. These results were consistent with an analysis of correlation between phylogenetic distance and co-occurrence indices of species pairs in the two habitat types. This study supports the notion that disturbed plots are more clustered than expected, rather than 'undisturbed' plots being more overdispersed, suggesting that disturbed plant communities are being more strongly influenced by environmental filtering of conserved niche traits.			Dinnage, R (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	russell.dinnage@utoronto.ca	Dinnage, Russell/L-9892-2013; Dinnage, Russell/H-9023-2019	Dinnage, Russell/0000-0003-0846-2819; Dinnage, Russell/0000-0003-0846-2819				Abellan P, 2006, FRESHWATER BIOL, V51, P1744, DOI 10.1111/j.1365-2427.2006.01613.x; ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; BENSON DA, 2005, NUCLEIC ACIDS RES, P33; BILLINGS W. D., 1938, ECOL MONOGR, V8, P437, DOI 10.2307/1943541; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; CARSON WP, 1990, ECOLOGY, V71, P226, DOI 10.2307/1940262; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; GOLDBERG DE, 1987, B TORREY BOT CLUB, V114, P139, DOI 10.2307/2996123; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KEMBEL SW, 2009, PICANTE R TOOLS INTE; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Knapp S, 2008, ECOL LETT, V11, P1054, DOI 10.1111/j.1461-0248.2008.01217.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Oosting H. J., 1942, American Midland Naturalist, V28, P1, DOI 10.2307/2420696; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; R Core Team, 2022, R LANG ENV STAT COMP; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; Terlizzi A, 2005, MAR BIOL, V148, P293, DOI 10.1007/s00227-005-0080-8; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2007, PHYLOCOM SOFTWARE AN; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	52	71	74	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7071	10.1371/journal.pone.0007071	http://dx.doi.org/10.1371/journal.pone.0007071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763265	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970400009
J	McCormick, MI				McCormick, Mark I.			Behaviourally Mediated Phenotypic Selection in a Disturbed Coral Reef Environment	PLOS ONE			English	Article							CLIMATE-CHANGE; EVOLUTIONARY CONSEQUENCES; HABITAT LOSS; FISH LARVAE; MARINE FISH; PREDATION; SURVIVAL; LIFE; SIZE; POMACENTRIDAE	Natural and anthropogenic disturbances are leading to changes in the nature of many habitats globally, and the magnitude and frequency of these perturbations are predicted to increase under climate change. Globally coral reefs are one of the most vulnerable ecosystems to climate change. Fishes often show relatively rapid declines in abundance when corals become stressed and die, but the processes responsible are largely unknown. This study explored the mechanism by which coral bleaching may influence the levels and selective nature of mortality on a juvenile damselfish, Pomacentrus amboinensis, which associates with hard coral. Recently settled fish had a low propensity to migrate small distances (40 cm) between habitat patches, even when densities were elevated to their natural maximum. Intraspecific interactions and space use differ among three habitats: live hard coral, bleached coral and dead algal-covered coral. Large fish pushed smaller fish further from the shelter of bleached and dead coral thereby exposing smaller fish to higher mortality than experienced on healthy coral. Small recruits suffered higher mortality than large recruits on bleached and dead coral. Mortality was not size selective on live coral. Survival was 3 times as high on live coral as on either bleached or dead coral. Subtle behavioural interactions between fish and their habitats influence the fundamental link between life history stages, the distribution of phenotypic traits in the local population and potentially the evolution of life history strategies.			McCormick, MI (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	mark.mccormick@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645				Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Arvedlund M, 1999, MAR ECOL PROG SER, V188, P207, DOI 10.3354/meps188207; BERKELMANS R, 2009, BLEACHING MORTALITY, P103; Beukers JS, 1997, OECOLOGIA, V111, P50, DOI DOI 10.1007/S004420050419); Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brown DR, 2008, BEHAV ECOL, V19, P1314, DOI 10.1093/beheco/arn073; Clark R, 2009, B MAR SCI, V84, P167; COATES D, 1980, J ANIM ECOL, V49, P335, DOI 10.2307/4292; Dixson DL, 2008, P ROY SOC B-BIOL SCI, V275, P2831, DOI 10.1098/rspb.2008.0876; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Evans KL, 2009, OIKOS, V118, P251, DOI 10.1111/j.1600-0706.2008.17092.x; FEARY DA, 2009, J EXP MAR B IN PRESS; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Gagliano M, 2007, OIKOS, V116, P111, DOI 10.1111/j.2006.0030-1299.15418.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gende SM, 2004, OIKOS, V104, P518, DOI 10.1111/j.0030-1299.2004.12762.x; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Hamilton SL, 2008, P NATL ACAD SCI USA, V105, P1561, DOI 10.1073/pnas.0707676105; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoey A. S., 2006, P 10 INT COR REEFS S, P420; Hoey AS, 2004, OECOLOGIA, V139, P23, DOI 10.1007/s00442-004-1489-3; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2009, OECOLOGIA, V159, P401, DOI 10.1007/s00442-008-1220-x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; JONES GP, 1987, ECOLOGY, V68, P1534, DOI 10.2307/1939237; Kokko H, 2001, EVOL ECOL RES, V3, P537; Lee JSF, 2009, ENVIRON BIOL FISH, V84, P411, DOI 10.1007/s10641-009-9450-2; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Long RA, 2008, J WILDLIFE MANAGE, V72, P1133, DOI 10.2193/2007-337; LYTHGOE JN, 1988, SENSORY BIOL AQUATIC, P75; Marshall NJ, 2003, COPEIA, P467, DOI 10.1643/01-056; Marshall NJ, 2000, PHILOS T ROY SOC B, V355, P1243, DOI 10.1098/rstb.2000.0676; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClure MM, 2008, EVOL APPL, V1, P300, DOI 10.1111/j.1752-4571.2008.00030.x; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; McCormick MI, 2002, MAR BIOL, V141, P841, DOI 10.1007/s00227-002-0883-9; MCCORMICK MI, P 11 INT CO IN PRESS; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; MEEKAN MG, ANIM BEHAV IN PRESS; MOORE JAY, 2007, INFLUENCE CORAL BLEA; Munday P. L., 2007, CLIMATE CHANGE GREAT, P357; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Ohman MC, 1998, J EXP MAR BIOL ECOL, V225, P219, DOI 10.1016/S0022-0981(97)00224-4; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; Pechenik JA, 1998, BIOSCIENCE, V48, P901, DOI 10.2307/1313294; Podolsky RD, 2006, INTEGR COMP BIOL, V46, P577, DOI 10.1093/icb/icl026; Pratchett M. S., 2009, V205, P139; Rasner CA, 2004, MOL ECOL, V13, P671, DOI 10.1046/j.1365-294X.2004.02104.x; Rincon PA, 2001, J FISH BIOL, V59, P968, DOI 10.1006/jfbi.2001.1711; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Sale P.F., 1978, P313; SORENSEN PW, 1986, ENVIRON BIOL FISH, V17, P185, DOI 10.1007/BF00698197; Sponaugle S, 2006, INTEGR COMP BIOL, V46, P623, DOI 10.1093/icb/icl014; Strychar KB, 2009, J EXP MAR BIOL ECOL, V369, P31, DOI 10.1016/j.jembe.2008.10.021; Svanback R, 2009, AM NAT, V173, P507, DOI 10.1086/597223; SWEATMAN H, 1988, J EXP MAR BIOL ECOL, V124, P163, DOI 10.1016/0022-0981(88)90170-0; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Vonesh JR, 2005, OECOLOGIA, V143, P280, DOI 10.1007/s00442-004-1806-x; Walker SPW, 2007, J FISH BIOL, V71, P1347, DOI 10.1111/j.1095-8649.2007.01595.x; WALLACE B, 1975, EVOLUTION, V29, P465, DOI [10.2307/2407259, 10.1111/j.1558-5646.1975.tb00836.x]; Webster MS, 2004, ECOLOGY, V85, P986, DOI 10.1890/02-0576; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z	69	58	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e7096	10.1371/journal.pone.0007096	http://dx.doi.org/10.1371/journal.pone.0007096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763262	Green Published, Green Accepted, gold			2022-12-25	WOS:000269970400020
J	De Roo, M; Klauser, P; Briner, A; Nikonenko, I; Mendez, P; Dayer, A; Kiss, JZ; Muller, D; Vutskits, L				De Roo, Mathias; Klauser, Paul; Briner, Adrian; Nikonenko, Irina; Mendez, Pablo; Dayer, Alexandre; Kiss, Jozsef Z.; Muller, Dominique; Vutskits, Laszlo			Anesthetics Rapidly Promote Synaptogenesis during a Critical Period of Brain Development	PLOS ONE			English	Article								Experience-driven activity plays an essential role in the development of brain circuitry during critical periods of early postnatal life, a process that depends upon a dynamic balance between excitatory and inhibitory signals. Since general anesthetics are powerful pharmacological modulators of neuronal activity, an important question is whether and how these drugs can affect the development of synaptic networks. To address this issue, we examined here the impact of anesthetics on synapse growth and dynamics. We show that exposure of young rodents to anesthetics that either enhance GABAergic inhibition or block NMDA receptors rapidly induce a significant increase in dendritic spine density in the somatosensory cortex and hippocampus. This effect is developmentally regulated; it is transient but lasts for several days and is also reproduced by selective antagonists of excitatory receptors. Analyses of spine dynamics in hippocampal slice cultures reveals that this effect is mediated through an increased rate of protrusions formation, a better stabilization of newly formed spines, and leads to the formation of functional synapses. Altogether, these findings point to anesthesia as an important modulator of spine dynamics in the developing brain and suggest the existence of a homeostatic process regulating spine formation as a function of neural activity. Importantly, they also raise concern about the potential impact of these drugs on human practice, when applied during critical periods of development in infants.			De Roo, M (corresponding author), Univ Geneva, Fac Med, Dept Neurosci, Geneva, Switzerland.	laszlo.vutskits@unige.ch	Mendez, Pablo/J-7552-2017	Mendez, Pablo/0000-0001-9862-6818; Klauser, Paul/0000-0003-0284-4947; De Roo, Mathias/0000-0001-9912-6954; Dayer, Alexandre/0000-0002-4490-9780				Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Chacko J, 1999, PEDIATR SURG INT, V15, P496, DOI 10.1007/s003830050648; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Kabra NS, 2007, J PEDIATR-US, V150, P229, DOI 10.1016/j.jpeds.2006.11.039; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Ludman L, 2001, J PEDIATR SURG, V36, P858, DOI 10.1053/jpsu.2001.23954; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mateos JM, 2007, J PHYSIOL-LONDON, V581, P129, DOI 10.1113/jphysiol.2006.120550; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; PETIT TL, 1988, DEV BRAIN RES, V41, P209, DOI 10.1016/0165-3806(88)90183-6; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Zha XM, 2005, MOL CELL NEUROSCI, V29, P494, DOI 10.1016/j.mcn.2005.04.007; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	38	117	117	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7043	10.1371/journal.pone.0007043	http://dx.doi.org/10.1371/journal.pone.0007043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19756154	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970000012
J	Bednarski, BK; Baldwin, AS; Kim, HJ				Bednarski, Brian K.; Baldwin, Albert S., Jr.; Kim, Hong Jin			Addressing Reported Pro-Apoptotic Functions of NF-kappa B: Targeted Inhibition of Canonical NF-kappa B Enhances the Apoptotic Effects of Doxorubicin	PLOS ONE			English	Article							GENE-EXPRESSION; ACTIVATION; BETA; IKK; ALPHA; CHEMORESISTANCE; TRANSCRIPTION; MANAGEMENT; CPT-11; CELLS	The ability of the transcription factor NF-kappa B to upregulate anti-apoptotic proteins has been linked to the chemoresistance of solid tumors to standard chemotherapy. In contrast, recent studies have proposed that, in response to doxorubicin, NF-kappa B can be pro-apoptotic through repression of anti-apoptotic target genes. However, there is little evidence analyzing the outcome of NF-kappa B inhibition on the cytotoxicity of doxorubicin in studies describing pro-apoptotic NF-kappa B activity. In this study, we further characterize the activation of NF-kappa B in response to doxorubicin and evaluate its role in chemotherapy-induced cell death in sarcoma cells where NF-kappa B is reported to be pro-apoptotic. Doxorubicin treatment in U2OS cells induced canonical NF-kappa B activity as evidenced by increased nuclear accumulation of phosphorylated p65 at serine 536 and increased DNA-binding activity. Co-treatment with a small molecule IKK beta inhibitor, Compound A, abrogated this response. RT-PCR evaluation of anti-apoptotic gene expression revealed that doxorubicin-induced transcription of cIAP2 was inhibited by Compound A, while doxorubicin-induced repression of other anti-apoptotic genes was unaffected by Compound A or siRNA to p65. Furthermore, the combination of doxorubicin and canonical NF-kappa B inhibition with Compound A or siRNA to p65 resulted in decreased cell viability measured by trypan blue staining and MTS assay and increased apoptosis measured by cleaved poly (ADP-ribose) polymerase and cleaved caspase 3 when compared to doxorubicin alone. Our results demonstrate that doxorubicin-induced canonical NF-kappa B activity associated with phosphorylated p65 is anti-apoptotic in its function and that doxorubicin-induced repression of anti-apoptotic genes occurs independent of p65. Therefore, combination therapies incorporating NF-kappa B inhibitors together with standard chemotherapies remains a viable method to improve the clinical outcomes in patients with advanced stage malignancies.			Bednarski, BK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	hongjin_kim@med.unc.edu			NCI NIH HHS [K08 CA098240, T32 CA 009688, GI SPORE P50 CA10699, R01 CA 73756, K08 CA 098240, R01 CA073756, T32 CA009688] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA098240, T32CA009688, R01CA073756] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashikawa K, 2004, BIOCHEM PHARMACOL, V67, P353, DOI 10.1016/j.bcp.2003.08.039; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bednarski BK, 2008, MOL CANCER THER, V7, P1827, DOI 10.1158/1535-7163.MCT-08-0321; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chen WS, 2008, J CELL BIOCHEM, V105, P554, DOI 10.1002/jcb.21856; Cusack JC, 2001, CANCER RES, V61, P3535; Cusack JC, 2000, CANCER RES, V60, P2323; GANGADHARAN C, 2009, J CELL BIOCH; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; Hueman MT, 2008, SURG CLIN N AM, V88, P583, DOI 10.1016/j.suc.2008.03.002; Hueman MT, 2008, SURG CLIN N AM, V88, pXIII, DOI 10.1016/j.suc.2008.04.009; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Nadiminty N, 2008, PROSTATE, V68, P1725, DOI 10.1002/pros.20839; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; THORNTON K, 2008, SURG CLIN N AM, V88, pR8; Thornton K, 2008, SURG CLIN N AM, V88, P647, DOI 10.1016/j.suc.2008.03.004; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	24	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6992	10.1371/journal.pone.0006992	http://dx.doi.org/10.1371/journal.pone.0006992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XR	19746155	Green Submitted, Green Published, gold			2022-12-25	WOS:000269696500006
J	Rickman, C; Duncan, RR				Rickman, Colin; Duncan, Rory R.			Munc18/Syntaxin Interaction Kinetics Control Secretory Vesicle Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NEURONAL SNARE COMPLEX; PROTEIN-KINASE-C; MEMBRANE-FUSION; SEC1/MUNC18 PROTEINS; DISTINCT MODES; BINDING MODE; MUNC18-1; SYNTAXIN; EXOCYTOSIS	In neuronal and hormonal release, regulated exocytosis requires an essential set of proteins: the soluble N-ethylmaleimide sensitive-factor attachment receptor proteins (SNAREs) syntaxin 1, SNAP-25, VAMP, and their regulator, Munc18. Recently, it was found that Munc18-1 can interact with syntaxin 1 through distinct mechanisms: an inhibitory mode enveloping syntaxin (mode 1), sequestering it from SNARE protein interactions, and direct binding to an evolutionarily conserved N-terminal peptide of syntaxin (mode 2/3). The latter interaction has been proposed to control "priming" of the fusion reaction, defined using electrophysiology, but it is unknown how this interaction is regulated, and any dynamic effect at the molecular or vesicular level in cells remains undiscovered. We now show that a phosphorylation site in syntaxin 1 (Ser14) regulates the N-terminal interaction with Munc18-1. Probing syntaxin 1 association with Munc18-1, in real-time and in living cells, we found that modification of Ser14 modulated the dynamics of this interaction, specifically at the plasma membrane. Destabilization of this dynamic interaction enhanced vesicle immobilization at the plasma membrane with a resulting inhibition of exocytosis.	[Rickman, Colin; Duncan, Rory R.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Duncan, RR (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	rory.duncan@ed.ac.uk		Rickman, Colin/0000-0001-8938-524X; Duncan, Rory/0000-0003-0693-910X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a project grant from the Wellcome Trust (to R. R. D.).	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; BENNETT MK, 1993, J NEUROSCI, V13, P1701; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; QIAN H, 1990, P NATL ACAD SCI USA, V87, P5479, DOI 10.1073/pnas.87.14.5479; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	46	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3965	3972		10.1074/jbc.M109.040402	http://dx.doi.org/10.1074/jbc.M109.040402			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19748891	Green Published, hybrid			2022-12-25	WOS:000275254000050
J	Shao, R; Hamel, K; Petersen, L; Cao, QJ; Arenas, RB; Bigelow, C; Bentley, B; Yan, W				Shao, R.; Hamel, K.; Petersen, L.; Cao, Q. J.; Arenas, R. B.; Bigelow, C.; Bentley, B.; Yan, W.			YKL-40, a secreted glycoprotein, promotes tumor angiogenesis	ONCOGENE			English	Article						tumor angiogenesis; vascular endothelial cells; YKL-40 (human cartilage-glycoprotein 39 or Chitinase 3-like 1); signal transduction; heparin-binding protein; breast cancer	HUMAN CARTILAGE GLYCOPROTEIN-39; CHITINASE PROTEIN FAMILY; GROWTH-FACTOR; SERUM YKL-40; INTEGRIN ACTIVITY; CARCINOMA CELLS; SYNOVIAL-CELLS; SHORT SURVIVAL; BREAST-CANCER; IN-VIVO	Tumor angiogenesis is of paramount importance in solid tumor development. Elevated serum levels of YKL-40, which is a secreted heparin-binding glycoprotein, have been associated with a worse prognosis from various advanced human cancers. Yet the role of YKL-40 activity in these cancers is still missing. In this study, we showed that ectopic expression of YKL-40 in MDA-MB-231 breast cancer cells and in HCT-116 colon cancer cells led to larger tumor formation with an extensive angiogenic phenotype than did control cancer cells in mice. Affinity-purified recombinant YKL-40 protein promoted vascular endothelial cell angiogenesis in vitro, the effects of which are similar to the activities observed using MDA-MB-231 and HCT-116 cell-conditioned medium after transfection with YKL-40. Furthermore, YKL-40 was found to induce coordination of membrane-bound receptor syndecan-1 and integrin alpha(v)beta(3) and to activate an intracellular signaling cascade, including focal adhesion kinase and mitogen-activated protein kinase extracellular signal-related kinase1/2 in endothelial cells. Moreover, blockade of YKL-40 using small-interfering RNA gene knockdown suppressed tumor angiogenesis in vitro and in vivo. Immunohistochemical analysis of human breast cancer showed a correlation between YKL-40 expression and blood vessel density. These findings provide novel insights into angiogenic activities and molecular mechanisms of YKL-40 in cancer development. Oncogene (2009) 28, 4456-4468; doi:10.1038/onc.2009.292; published online 21 September 2009	[Shao, R.] Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Baystate Med Ctr, Springfield, MA 01199 USA; [Shao, R.; Hamel, K.; Petersen, L.] Univ Massachusetts, Mol & Cellular Biol Program, Morrill Sci Ctr, Amherst, MA 01003 USA; [Shao, R.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Cao, Q. J.] Baystate Med Ctr, Dept Pathol, Springfield, MA USA; [Arenas, R. B.] Baystate Med Ctr, Dept Surg, Springfield, MA 01107 USA; [Bigelow, C.] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA	Baystate Medical Center; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Baystate Medical Center; Baystate Medical Center; University of Massachusetts System; University of Massachusetts Amherst	Shao, R (corresponding author), Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Baystate Med Ctr, 3601 Main St, Springfield, MA 01199 USA.	rong.shao@bhs.org			NCI [R01 CA120659]; DOD [W81XWH-06-1-0563]; Collaborative Biomedical Research Program; Baystate Medical Center/University of Massachusetts at Amherst; Rays of Hope, Baystate Medical Center; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); Collaborative Biomedical Research Program; Baystate Medical Center/University of Massachusetts at Amherst; Rays of Hope, Baystate Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs A Schneyer, S Schneider and S Scully for their critical comments. This work was supported by NCI R01 CA120659 and DOD W81XWH-06-1-0563 (RS), Collaborative Biomedical Research Program, Baystate Medical Center/University of Massachusetts at Amherst (RS, QJC and RBA) and Rays of Hope, Baystate Medical Center (QJC and RS).	Albini A, 1996, ONCOGENE, V12, P289; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bergmann OJ, 2005, CLIN CANCER RES, V11, P8644, DOI 10.1158/1078-0432.CCR-05-1317; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brasso K, 2006, PROSTATE, V66, P503, DOI 10.1002/pros.20311; Cintin C, 2002, CANCER-AM CANCER SOC, V95, P267, DOI 10.1002/cncr.10644; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Jendraschak E, 1996, SEMIN CANCER BIOL, V7, P139, DOI 10.1006/scbi.1996.0019; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2004, LUNG CANCER-J IASLC, V46, P333, DOI 10.1016/j.lungcan.2004.05.010; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Kim H, 2007, J KOREAN ASTRON SOC, V40, P17, DOI 10.5303/JKAS.2007.40.1.017; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Lal A, 1999, CANCER RES, V59, P5403; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; MAGLIONE D, 1993, ONCOGENE, V8, P925; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Millauer B, 1996, CANCER RES, V56, P1615; Naruse T, 2006, CARCINOGENESIS, V27, P584, DOI 10.1093/carcin/bgi240; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Polnaszek N, 2003, CANCER RES, V63, P5754; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Roslind A, 2008, BREAST CANCER RES TR, V112, P275, DOI 10.1007/s10549-007-9870-7; Schmidt H, 2006, CANCER-AM CANCER SOC, V106, P1130, DOI 10.1002/cncr.21678; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Sharif M, 2006, RHEUMATOLOGY, V45, P522, DOI 10.1093/rheumatology/kei216; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	43	201	217	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC 17	2009	28	50					4456	4468		10.1038/onc.2009.292	http://dx.doi.org/10.1038/onc.2009.292			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DU	19767768	Green Accepted			2022-12-25	WOS:000272876500005
J	Najdi, R; Syed, A; Arce, L; Theisen, H; Ting, JHT; Atcha, F; Nguyen, AV; Martinez, M; Holcombe, RF; Edwards, RA; Marsh, JL; Waterman, ML				Najdi, R.; Syed, A.; Arce, L.; Theisen, H.; Ting, J-H T.; Atcha, F.; Nguyen, A. V.; Martinez, M.; Holcombe, R. F.; Edwards, R. A.; Marsh, J. L.; Waterman, M. L.			A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer	ONCOGENE			English	Article						CaMKII; colon cancer; export; TCF-1; Wnt	COLORECTAL-CANCER; BETA-CATENIN; TRANSCRIPTION FACTORS; CELLS; PATHWAY; DISEASE; EXPORT; PHOSPHORYLATION; PROTEINS; ISOFORMS	Constitutive activation of the Wnt/beta-catenin pathway has been implicated as the primary cause of colon cancer. However, the major transducers of Wnt signaling in the intestine, T-cell factor 1 (TCF-1) and TCF-4, have opposing functions. Knockout of TCF-4 suppresses growth and maintenance of crypt stem cells, whereas knockout of TCF-1 leads to adenomas. These phenotypes suggest that TCF-4 is Wnt-promoting, whereas TCF-1 acts like a tumor suppressor. Our study of TCF expression in human colon crypts reveals a mechanistic basis for this paradox. In normal colon cells, a dominant-negative isoform of TCF-1 (dnTCF-1) is expressed that is equally distributed between nuclear and cytoplasmic compartments. In colon cancer cells, TCF-1 is predominantly cytoplasmic. Localization is because of active nuclear export and is directed by an autocrine-acting Wnt ligand that requires Ca2+/calmodulin-dependent kinase II (CaMKII) activity for secretion and a downstream step in the export pathway. TCF-4 remains nuclear; its unopposed activity is accompanied by downregulation of dnTCF-1 and increased expression of full-length isoforms. Thus, the dnTCF-1 and TCF-4 balance is corrupted in cancer by two mechanisms, a Wnt/CaMKII kinase signal for nuclear export and decreased dnTCF-1 expression. We propose that dnTCF-1 provides homeostatic regulation of Wnt signaling and growth in normal colon, and the alterations in nuclear export and promoter usage contribute to aberrant Wnt activity in colon cancer. Oncogene (2009) 28, 4133-4146; doi: 10.1038/onc.2009.271; published online 14 September 2009	[Syed, A.; Theisen, H.; Marsh, J. L.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Najdi, R.; Arce, L.; Ting, J-H T.; Atcha, F.; Waterman, M. L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Syed, A.; Theisen, H.; Marsh, J. L.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; [Nguyen, A. V.; Martinez, M.; Holcombe, R. F.] Univ Calif Irvine, Div Hematol Oncol, Dept Med, Irvine, CA 92697 USA; [Edwards, R. A.; Marsh, J. L.] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Marsh, JL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	jlmarsh@uci.edu; mlwaterm@uci.edu			NIH [RO1 HD36081, RO1 HD36049, T32 CA113265, CA096878, CA108697, R21 DK071591, CA-82450]; Cancer Center Support Grant at the University of California, Irvine [CA-62203]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036049, R01HD036081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K24CA082450, R01CA096878, T32CA113265, P30CA062203, R01CA108697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071591] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant at the University of California, Irvine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We specially thank Didi Mwengela, Amanda Chamberlain, Candice Solomon and David Hernandez for help in cloning and sequencing TCF-1 cDNA. We also thank Eric J Stanbridge for critical reading of the manuscript, Michelle Digman for help with confocal imaging, Tohru Ishitani, Bang Hoang and Randall T Moon for reagents and advice. This work was supported by NIH grants RO1 HD36081 and RO1 HD36049 to JLM, NIH T32 CA113265, CA096878 and CA108697 to MLW, R21 DK071591 to RAE and NIH grant CA-82450 to RFH. This work was made possible, in part, through access to the confocal facility of the Optical Biology Shared Resource of the Cancer Center Support Grant (CA-62203) at the University of California, Irvine.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chang MV, 2008, CURR BIOL, V18, P1877, DOI 10.1016/j.cub.2008.10.047; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Griffith LC, 2008, CELL, V133, P397, DOI 10.1016/j.cell.2008.04.018; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sievers S, 2006, BIOMARKERS, V11, P270, DOI 10.1080/13547500600633954; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200	30	41	41	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 26	2009	28	47					4133	4146		10.1038/onc.2009.271	http://dx.doi.org/10.1038/onc.2009.271			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DQ	19749792	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000272876100001
J	Han, XB; Kitamoto, S; Lian, QY; Boisvert, WA				Han, Xinbing; Kitamoto, Shiro; Lian, Qingyu; Boisvert, William A.			Interleukin-10 Facilitates Both Cholesterol Uptake and Efflux in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIINFLAMMATORY CYTOKINE INTERLEUKIN-10; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; SCAVENGER RECEPTOR; FOAM CELL; INHIBITS ATHEROSCLEROSIS; TANGIER-DISEASE; TRANSGENIC MICE; SERUM-LEVELS; EXPRESSION	Foam cell formation is a hallmark event during atherosclerosis. The current paradigm is that lipid uptake by scavenger receptor in macrophages initiates the chronic proinflammatory cascade and necrosis core formation that characterize atherosclerosis. We report here that a cytokine considered to be antiatherogenic, interleukin-10 (IL10), promotes cholesterol uptake from modified lipoproteins in macrophages and its transformation into foam cells by increasing the expression of scavenger receptor CD36 and scavenger receptor A. Although uptake of modified lipoproteins is considered proatherogenic, we found that IL10 also increases cholesterol efflux from macrophages to protect against toxicity of free cholesterol accumulation in the cell. This process was PPAR gamma-dependent and was mediated through up-regulation of ABCA1 (ATP-binding cassette transporter A1) protein expression. Importantly, expression of inflammatory molecules, such as tumor necrosis factor-alpha, intercellular adhesion molecule-1, and MMP9 as well as apoptosis were dramatically suppressed in lipid-laden foam cells treated with IL10. The notion that IL10 can mediate both the uptake of cholesterol from modified lipoproteins and the efflux of stored cholesterol suggests that the process of foam cell formation is not necessarily detrimental as long as mechanisms of cholesterol efflux and transfer to an exogenous acceptor are functioning robustly. Our results present a comprehensive antiatherogenic role of IL10 in macrophages, including enhanced disposal of harmful lipoproteins, inhibition of inflammatory molecules, and reduced apoptosis.	[Han, Xinbing; Kitamoto, Shiro; Lian, Qingyu; Boisvert, William A.] Harvard Univ, Sch Med, Brigham Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital	Boisvert, WA (corresponding author), Harvard Univ, Sch Med, Brigham Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02139 USA.	wab@hawaii.edu			National Institutes of Health [HL075677]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075677 (to W.A.B.).	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Anguera I, 2002, AM HEART J, V144, P811, DOI 10.1067/mhj.2002.124831; Attie AD, 2001, J LIPID RES, V42, P1717; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Costet P, 2000, J BIOL CHEM, V275, P28240; de Winther MPJ, 2000, J CLIN INVEST, V105, P1039, DOI 10.1172/JCI9919; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Halvorsen B, 2005, J LIPID RES, V46, P211, DOI 10.1194/jlr.M400324-JLR200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Kolodgie FD, 2000, AM J PATHOL, V157, P1259, DOI 10.1016/S0002-9440(10)64641-X; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Liao HS, 2000, ARTERIOSCL THROM VAS, V20, P1968, DOI 10.1161/01.ATV.20.8.1968; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 1999, ARTERIOSCL THROM VAS, V19, P611, DOI 10.1161/01.ATV.19.3.611; Mei CL, 2007, CELL BIOL INT, V31, P1456, DOI 10.1016/j.cellbi.2007.06.009; Mitchinson MJ, 1996, CURR OPIN LIPIDOL, V7, P324, DOI 10.1097/00041433-199610000-00011; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Pinderski LJ, 2002, CIRC RES, V90, P1064, DOI 10.1161/01.RES.0000018941.10726.FA; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161/hc3201.094973; Tabas I, 1996, J BIOL CHEM, V271, P22773, DOI 10.1074/jbc.271.37.22773; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; Teupser D, 1999, ARTERIOSCL THROM VAS, V19, P1299, DOI 10.1161/01.ATV.19.5.1299; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, P2600, DOI 10.1161/01.ATV.20.12.2600; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Whitman SC, 2002, J LIPID RES, V43, P1201, DOI 10.1194/jlr.M200116-JLR200; Yoshioka T, 2004, GENE THER, V11, P1772, DOI 10.1038/sj.gt.3302348	46	63	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32950	32958		10.1074/jbc.M109.040899	http://dx.doi.org/10.1074/jbc.M109.040899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19776020	Green Published, hybrid			2022-12-25	WOS:000272028400078
J	Yellaturu, CR; Deng, X; Park, EA; Raghow, R; Elam, MB				Yellaturu, Chandrahasa R.; Deng, Xiong; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.			Insulin Enhances the Biogenesis of Nuclear Sterol Regulatory Element-binding Protein (SREBP)-1c by Posttranscriptional Down-regulation of Insig-2A and Its Dissociation from SREBP Cleavage-activating Protein (SCAP).SREBP-1c Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; TRANSCRIPTION FACTORS; LIPID HOMEOSTASIS; RAT HEPATOCYTES; COPII VESICLES; MESSENGER-RNA; SCAP; CHOLESTEROL; TRANSPORT	The regulation of lipid homeostasis by insulin is mediated in part by the enhanced transcription of the gene encoding sterol regulatory element-binding protein-1c (SREBP-1c). The nascent SREBP-1c is embedded in the endoplasmic reticulum (ER) and must be transported to the Golgi where two sequential cleavages generate its NH2-terminal fragment, nSREBP-1c. We have shown recently that in primary cultures of rat hepatocytes, insulin rapidly and selectively stimulates proteolytic processing of the nascent SREBP-1c by enhancing the affinity of the SREBP cleavage-activating protein (SCAP).SREBP-1c complex for coatomer protein complex II (COPII) vesicles. The SCAP.SREBP complex is retained in the ER by Insig proteins. We report here that insulin persistently stimulates controlled proteolysis of the nascent SREBP-1c by selectively reducing the level of Insig-2a protein via accelerated degradation of its cognate mRNA. Insulin enhanced the rate of turnover of Insig-2a mRNA via its 3'-untranslated region. Insulin-induced depletion of Insig-2a promotes association of the SCAP.SREBP-1c complex with COPII vesicles and subsequent migration to the Golgi where site-1 and site-2 proteases process the nascent SREBP-1c. Consistent with this mechanism, experimental knockdown of Insig-2a expression with small interfering RNA mimicked insulin-induced proteolysis of the nascent SREBP-1c, whereas exogenous expression of Insig-2a in hepatocytes led to reduced intramembrane proteolysis of the newly synthesized SREBP-1c. The action of insulin on the processing of the nascent SREBP-1c via Insig-2a was highly selective, as proteolysis of the newly synthesized SREBP-2 remained unchanged under identical conditions. On the basis of these data, we propose that the stimulation of SREBP-1c processing by insulin is mediated by a selective depletion of Insig-2a protein by promoting decay of its cognate mRNA. Thus, insulin-induced reduction in Insig-2a protein leads to an enhanced export of the SCAP.SREBP-1c complex from ER to the Golgi.	[Yellaturu, Chandrahasa R.; Deng, Xiong; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Deng, Xiong; Raghow, Rajendra; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Yellaturu, CR (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	cyellatu@utmem.edu			National Institutes of Health [RO1 DK075504]; NIDDK [RO1 DK059368]; American Heart Association; American Heart Association, Southeastern Affiliate; Office of Research and Development, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059368, R01DK075504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); American Heart Association, Southeastern Affiliate(American Heart Association); Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK075504 ( to M. B. E., R. R., and C. R. Y.) and RO1 DK059368 ( to E. A. P.) from the NIDDK. This work was also supported by a postdoctoral fellowship grant from the American Heart Association ( to C. R. Y.), a grantin- aid from the American Heart Association, Southeastern Affiliate ( to M. B. E. and C. R. Y.), and the Office of Research and Development, Department of Veterans Affairs ( to M. B. E.).	Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; THORNGATE FE, 1994, P NATL ACAD SCI USA, V91, P5392, DOI 10.1073/pnas.91.12.5392; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Yellaturu CR, 2005, BIOCHEM BIOPH RES CO, V332, P174, DOI 10.1016/j.bbrc.2005.04.112	31	79	82	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31726	31734		10.1074/jbc.M109.050914	http://dx.doi.org/10.1074/jbc.M109.050914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759400	Green Published, hybrid			2022-12-25	WOS:000271572700027
J	Bremer, J; Heikenwalder, M; Haybaeck, J; Tiberi, C; Krautler, NJ; Kurrer, MO; Aguzzi, A				Bremer, Juliane; Heikenwalder, Mathias; Haybaeck, Johannes; Tiberi, Cinzia; Krautler, Nike Julia; Kurrer, Michael O.; Aguzzi, Adriano			Repetitive Immunization Enhances the Susceptibility of Mice to Peripherally Administered Prions	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; SCRAPIE AGENT; SPONGIFORM ENCEPHALOPATHIES; VARIANT; PROTEIN; NEUROINVASION; IMMUNE; SPLEEN; BSE	The susceptibility of humans and animals to prion infections is determined by the virulence of the infectious agent, by genetic modifiers, and by hitherto unknown host and environmental risk factors. While little is known about the latter two, the activation state of the immune system was surmised to influence prion susceptibility. Here we administered prions to mice that were repeatedly immunized by two initial injections of CpG oligodeoxynucleotides followed by repeated injections of bovine serum albumin/alum. Immunization greatly reduced the required dosage of peripherally administered prion inoculum necessary to induce scrapie in 50% of mice. No difference in susceptibility was observed following intracerebral prion challenge. Due to its profound impact onto scrapie susceptibility, the host immune status may determine disease penetrance after low-dose prion exposure, including those that may give rise to iatrogenic and variant Creutzfeldt-Jakob disease.			Bremer, J (corresponding author), Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Bremer, Juliane/AAH-9487-2020; Heikenwalder, Mathias/AAA-2269-2020; Bremer, Juliane/E-2298-2012; Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2004, NAT REV IMMUNOL, V4, P725, DOI 10.1038/nri1437; Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Aguzzi A, 1996, NATURE, V381, P734, DOI 10.1038/381734a0; Aguzzi A, 1996, NATURE, V383, P666, DOI 10.1038/383666a0; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; Boelle PY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-26; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Collinge J, 1996, LANCET, V347, P916, DOI 10.1016/S0140-6736(96)91407-5; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Cordier-Dirikoc S, 2008, J VIROL, V82, P8933, DOI 10.1128/JVI.02440-07; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dore G, 2008, J NEUROIMMUNOL, V197, P74, DOI 10.1016/j.jneuroim.2008.03.016; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Friedman-Levi Y, 2007, J VIROL, V81, P9942, DOI 10.1128/JVI.00780-07; Frigg R, 1999, J VIROL, V73, P9584, DOI 10.1128/JVI.73.11.9584-9588.1999; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Heikenwalder M, 2007, J NEUROIMMUNOL, V192, P113, DOI 10.1016/j.jneuroim.2007.09.022; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Ierna M, 2006, J VIROL, V80, P474, DOI 10.1128/JVI.80.1.474-482.2006; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kovacs GG, 2008, AM J PATHOL, V172, P555, DOI 10.2353/ajpath.2008.070442; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Levavasseur E, 2007, J GEN VIROL, V88, P2353, DOI 10.1099/vir.0.82816-0; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott NA, 2000, J VIROL, V74, P3338, DOI 10.1128/JVI.74.7.3338-3344.2000; Matthews L, 2001, ARCH VIROL, V146, P1173, DOI 10.1007/s007050170113; Mohan J, 2005, J VIROL, V79, P1888, DOI 10.1128/JVI.79.3.1888-1897.2005; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Oehen S, 2002, J IMMUNOL, V169, P1453, DOI 10.4049/jimmunol.169.3.1453; OUTRAM GW, 1973, NATURE, V241, P536, DOI 10.1038/241536a0; OUTRAM GW, 1974, NATURE, V249, P855, DOI 10.1038/249855a0; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Raeber A J, 2001, Dev Immunol, V8, P291, DOI 10.1155/2001/95404; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Raeber AJ, 1999, EMBO J, V18, P2702, DOI 10.1093/emboj/18.10.2702; Raymond CR, 2007, J IMMUNOL, V179, P7758, DOI 10.4049/jimmunol.179.11.7758; Raymond CR, 2007, J NEUROIMMUNOL, V187, P114, DOI 10.1016/j.jneuroim.2007.05.006; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Tal Y, 2003, J NEUROSCI RES, V71, P286, DOI 10.1002/jnr.10474; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Yang H, 1998, NEUROIMMUNOMODULAT, V5, P53, DOI 10.1159/000026326; Zeidler M, 1997, LANCET, V350, P903, DOI 10.1016/S0140-6736(97)07472-2	66	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7160	10.1371/journal.pone.0007160	http://dx.doi.org/10.1371/journal.pone.0007160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779609	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200008
J	Lea, WA; Xi, J; Jadhav, A; Lu, L; Austin, CP; Simeonov, A; Eckenhoff, RG				Lea, Wendy A.; Xi, Jin; Jadhav, Ajit; Lu, Louis; Austin, Christopher P.; Simeonov, Anton; Eckenhoff, Roderic G.			A High-Throughput Approach for Identification of Novel General Anesthetics	PLOS ONE			English	Article								Anesthetic development has been a largely empirical process. Recently, we described a GABAergic mimetic model system for anesthetic binding, based on apoferritin and an environment-sensitive fluorescent probe. Here, a competition assay based on 1-aminoanthracene and apoferritin has been taken to a high throughput screening level, and validated using the LOPAC(1280) library of drug-like compounds. A raw hit rate of similar to 15% was reduced through the use of computational filters to yield an overall hit rate of similar to 1%. These hits were validated using isothermal titration calorimetry. The success of this initial screen and computational triage provides feasibility to undergo a large scale campaign to discover novel general anesthetics.			Lea, WA (corresponding author), NHGRI, NIH Chem Genom Ctr, Bethesda, MD 20892 USA.	asimeono@mail.nih.gov; roderic.eckenhoff@uphs.upenn.edu		Eckenhoff, Roderic/0000-0002-5581-746X; Jadhav, Ajit/0000-0001-7955-1451	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084836] Funding Source: NIH RePORTER; NIGMS NIH HHS [NIH P-01 GM55876, P01 GM055876] Funding Source: Medline; NIMH NIH HHS [R-03 MH84836, R03 MH084836] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Eckenhoff RG, 1999, MOL PHARMACOL, V56, P414, DOI 10.1124/mol.56.2.414; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KOBLIN DD, 1994, ANESTH ANALG, V79, P1043; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; VEDULA LS, 2009, J BIOL CHEM; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	12	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7150	10.1371/journal.pone.0007150	http://dx.doi.org/10.1371/journal.pone.0007150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777064	Green Submitted, Green Published, gold			2022-12-25	WOS:000270164600004
J	Mauris, J; Evans, TC				Mauris, Jerome; Evans, Thomas C., Jr.			Adenosine Triphosphate Stimulates Aquifex aeolicus MutL Endonuclease Activity	PLOS ONE			English	Article								Background: Human PMS2 (hPMS2) homologues act to nick 59 and 39 to misincorporated nucleotides during mismatch repair in organisms that lack MutH. Mn(++) was previously found to stimulate the endonuclease activity of these homologues. ATP was required for the nicking activity of hPMS2 and yPMS1, but was reported to inhibit bacterial MutL proteins from Thermus thermophilus and Aquifex aeolicus that displayed homology to hPMS2. Mutational analysis has identified the DQHA(X)(2)E(X)(4)E motif present in the C-terminus of PMS2 homologues as important for endonuclease activity. Methodologies/Principal Findings: We examined the effect ATP had on the Mn(++) induced nicking of supercoiled pBR322 by full-length and mutant A. aeolicus MutL (Aae MutL) proteins. Assays were single time point, enzyme titration experiments or reaction time courses. The maximum velocity for MutL nicking was determined to be 1.6+/-0.08x10(-5) s(-1) and 4.2(+/-)0.3x10(-5) s(-1) in the absence and presence of ATP, respectively. AMPPNP stimulated the nicking activity to a similar extent as ATP. A truncated Aae MutL protein composed of only the C-terminal 123 amino acid residues was found to nick supercoiled DNA. Furthermore, mutations in the conserved C-terminal DQHA(X)(2)E(X)(4)E and CPHGRP motifs were shown to abolish Aae MutL endonuclease activity. Conclusions: ATP stimulated the Mn(++) induced endonuclease activity of Aae MutL. Experiments utilizing AMPPNP implied that the stimulation did not require ATP hydrolysis. A mutation in the DQHA(X)(2)E(X)(4)E motif of Aae MutL further supported the role of this region in endonclease activity. For the first time, to our knowledge, we demonstrate that changing the histidine residue in the conserved CPHGRP motif abolishes endonucleolytic activity of a hPMS2 homologue. Finally, the C-terminal 123 amino acid residues of Aae MutL were sufficient to display Mn(++) induced nicking activity.			Mauris, J (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	evans@neb.com						Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Ahrends R, 2006, NUCLEIC ACIDS RES, V34, P3169, DOI 10.1093/nar/gkl407; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Duppatla V., 2009, BIOCH J; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Evans TC, 1999, J BIOL CHEM, V274, P3923, DOI 10.1074/jbc.274.7.3923; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, CELL, V126, P239, DOI 10.1016/j.cell.2006.07.003; Joseph N, 2004, DNA REPAIR, V3, P1561, DOI 10.1016/j.dnarep.2004.06.014; Junop MS, 2003, DNA REPAIR, V2, P387, DOI 10.1016/S1568-7864(02)00245-8; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kim TG, 2009, J BIOCHEM, V145, P199, DOI 10.1093/jb/mvn157; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Plotz G, 2006, BIOCHEM BIOPH RES CO, V340, P852, DOI 10.1016/j.bbrc.2005.12.096; Robertson AB, 2006, J BIOL CHEM, V281, P19949, DOI 10.1074/jbc.M601604200; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021	36	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7175	10.1371/journal.pone.0007175	http://dx.doi.org/10.1371/journal.pone.0007175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777055	Green Published, gold, Green Submitted			2022-12-25	WOS:000270164600011
J	Milo, M; Cacciabue-Rivolta, D; Kneebone, A; Van Doorninck, H; Johnson, C; Lawoko-Kerali, G; Niranjan, M; Rivolta, M; Holley, M				Milo, Marta; Cacciabue-Rivolta, Daniela; Kneebone, Adam; Van Doorninck, Hikke; Johnson, Claire; Lawoko-Kerali, Grace; Niranjan, Mahesan; Rivolta, Marcelo; Holley, Matthew			Genomic Analysis of the Function of the Transcription Factor gata3 during Development of the Mammalian Inner Ear	PLOS ONE			English	Article								We have studied the function of the zinc finger transcription factor gata3 in auditory system development by analysing temporal profiles of gene expression during differentiation of conditionally immortal cell lines derived to model specific auditory cell types and developmental stages. We tested and applied a novel probabilistic method called the gamma Model for Oligonucleotide Signals to analyse hybridization signals from Affymetrix oligonucleotide arrays. Expression levels estimated by this method correlated closely (p<0.0001) across a 10-fold range with those measured by quantitative RT-PCR for a sample of 61 different genes. In an unbiased list of 26 genes whose temporal profiles clustered most closely with that of gata3 in all cell lines, 10 were linked to Insulin-like Growth Factor signalling, including the serine/threonine kinase Akt/PKB. Knock-down of gata3 in vitro was associated with a decrease in expression of genes linked to IGF-signalling, including IGF1, IGF2 and several IGF-binding proteins. It also led to a small decrease in protein levels of the serine-threonine kinase Akt2/PKB beta, a dramatic increase in Akt1/PKB alpha protein and relocation of Akt1/PKB alpha from the nucleus to the cytoplasm. The cyclin-dependent kinase inhibitor p27(kip1), a known target of PKB/Akt, simultaneously decreased. In heterozygous gata3 null mice the expression of gata3 correlated with high levels of activated Akt/PKB. This functional relationship could explain the diverse function of gata3 during development, the hearing loss associated with gata3 heterozygous null mice and the broader symptoms of human patients with Hearing-Deafness-Renal anomaly syndrome.			Milo, M (corresponding author), Univ Sheffield, Dept Biomed Sci, Addison Bldg,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	m.c.holley@sheffield.ac.uk		Holley, Matthew/0000-0001-9547-1953; Johnson, Claire/0000-0003-4428-3594; Niranjan, Mahesan/0000-0001-7021-140X	Wellcome Trust [042065/Z96/D, 074556/Z/04/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; ALESSI DR, 1993, ONCOGENE, V8, P2015; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aoki N, 2000, J INVEST DERMATOL, V115, P402, DOI 10.1046/j.1523-1747.2000.00070.x; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Chen J, 2003, GENE, V302, P103, DOI 10.1016/S0378-1119(02)01095-8; Chen P, 1999, DEVELOPMENT, V126, P1581; CHILOECHES A, 2008, MOL ENDOCRINOL; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Davies D, 2002, J COMP NEUROL, V445, P122, DOI 10.1002/cne.10161; Diaz RC, 2007, JARO-J ASSOC RES OTO, V8, P422, DOI 10.1007/s10162-007-0089-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Endo T, 2002, NEUROSCI LETT, V334, P173, DOI 10.1016/S0304-3940(02)01115-1; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Fromigue O, 2003, INT J CANCER, V106, P355, DOI 10.1002/ijc.11232; Fujimoto S, 2004, NEUROSCI RES, V50, P179, DOI 10.1016/j.neures.2004.06.013; Helyer R, 2007, EUR J NEUROSCI, V25, P957, DOI 10.1111/j.1460-9568.2007.05338.x; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Ikeda K, 2003, J NEUROSCI, V23, P4667; Isenovic ER, 2004, INT J MOL MED, V13, P915; Janzen V, 2006, NATURE, V441, P418, DOI 10.1038/441418b; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; KORNHAUSER JM, 1994, MOL BRAIN RES, V23, P100, DOI 10.1016/0169-328X(94)90216-X; Kurek D, 2007, DEVELOPMENT, V134, P261, DOI 10.1242/dev.02721; Lawoko-Kerali G, 2004, DEV DYNAM, V231, P801, DOI 10.1002/dvdy.20187; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; Lawoko-Kerali G, 2002, J COMP NEUROL, V442, P378, DOI 10.1002/cne.10088; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Lillevali K, 2004, DEV DYNAM, V231, P775, DOI 10.1002/dvdy.20185; Lillevali K, 2006, MECH DEVELOP, V123, P415, DOI 10.1016/j.mod.2006.04.007; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; MACKAY DJC, 1998, ERICE, P175; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Marelli MM, 2006, INT J ONCOL, V28, P723; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Milo M, 2003, BIOCHEM SOC T, V31, P1510; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Nicholl AJ, 2005, EUR J NEUROSCI, V22, P343, DOI 10.1111/j.1460-9568.2005.04213.x; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Ohuchi H, 2005, DEV DYNAM, V233, P177, DOI 10.1002/dvdy.20319; Oshima A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034397; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Rattray M, 2006, BRIEF BIOINFORM, V7, P37, DOI 10.1093/bib/bbk003; Rivolta MN, 2002, GENOME RES, V12, P1091, DOI 10.1101/gr.225602; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Rivolta MN, 1998, J NEUROCYTOL, V27, P637, DOI 10.1023/A:1006951813063; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Shen XL, 2006, EXP CELL RES, V312, P3822, DOI 10.1016/j.yexcr.2006.08.011; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tachibana I, 1997, J BIOL CHEM, V272, P29181, DOI 10.1074/jbc.272.46.29181; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van der Wees J, 2004, NEUROBIOL DIS, V16, P169, DOI 10.1016/j.nbd.2004.02.004; Van Esch H, 2001, CELL MOL LIFE SCI, V58, P1296, DOI 10.1007/PL00000940; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Varela-Nieto I, 2004, HEARING RES, V196, P19, DOI 10.1016/j.heares.2003.12.022; Verri A, 2004, ANN GENET-PARIS, V47, P281, DOI 10.1016/j.anngen.2004.03.001; Wang XQ, 2005, J NEUROCHEM, V93, P1515, DOI 10.1111/j.1471-4159.2005.03147.x; Williams CKI, 2005, NEURAL COMPUT, V17, P1, DOI 10.1162/0899766052530884; Wirtz KWA, 2006, ADV ENZYME REGUL, V46, P301, DOI 10.1016/j.advenzreg.2006.01.020; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Zhou XM, 2001, BIOCHEM BIOPH RES CO, V285, P46, DOI 10.1006/bbrc.2001.5126	87	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7144	10.1371/journal.pone.0007144	http://dx.doi.org/10.1371/journal.pone.0007144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774072	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000270160900018
J	Nishizawa, H; Suzuki, T; Shioya, T; Nakazato, Y; Daida, H; Kurebayashi, N				Nishizawa, Hiroto; Suzuki, Takeshi; Shioya, Takao; Nakazato, Yuji; Daida, Hiroyuki; Kurebayashi, Nagomi			Causes of Abnormal Ca2+ Transients in Guinea Pig Pathophysiological Ventricular Muscle Revealed by Ca2+ and Action Potential Imaging at Cellular Level	PLOS ONE			English	Article								Background: Abnormal Ca2+ transients are often observed in heart muscles under a variety of pathophysiological conditions including ventricular tachycardia. To clarify whether these abnormal Ca2+ transients can be attributed to abnormal action potential generation or abnormal Ca2+ handling/excitation-contraction (EC) coupling, we developed a procedure to determine Ca2+ and action potential signals at the cellular level in isolated heart tissues. Methodology/Principal Findings: After loading ventricular papillary muscle with rhod-2 and di-4-ANEPPS, mono-wavelength fluorescence images from rhod-2 and ratiometric images of two wavelengths of emission from di-4-ANEPPS were sequentially obtained. To mimic the ventricular tachycardia, the ventricular muscles were field-stimulated in nonflowing Krebs solution which elicited abnormal Ca2+ transients. For the failed and alternating Ca2+ transient generation, there were two types of causes, i.e., failed or abnormal action potential generation and abnormal EC coupling. In cells showing delayed initiation of Ca2+ transients with field stimulation, action potential onset was delayed and the rate of rise was slower than in healthy cells. Similar delayed onset was also observed in the presence of heptanol, an inhibitor of gap junction channels but having a non-specific channel blocking effect. A Na+ channel blocker, on the other hand, reduced the rate of rise of the action potentials but did not result in desynchronization of the action potentials. The delayed onset of action potentials can be explained primarily by impaired gap junctions and partly by Na+ channel inactivation. Conclusions/Significance: Our results indicate that there are multiple patterns for the causes of abnormal Ca2+ signals and that our methods are useful for investigating the physiology and pathophysiology of heart muscle.			Nishizawa, H (corresponding author), Juntendo Univ, Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan.	nagomik@juntendo.ac.jp						Aistrup GL, 2006, CIRC RES, V99, pE65, DOI 10.1161/01.RES.0000244087.36230.bf; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; BRIDGE JHB, 1990, SCIENCE, V248, P376, DOI 10.1126/science.2158147; Choi BR, 2000, J PHYSIOL-LONDON, V529, P171, DOI 10.1111/j.1469-7793.2000.00171.x; Clusin WT, 2008, AM J PHYSIOL-HEART C, V294, pH1, DOI 10.1152/ajpheart.00802.2007; Clusin WT, 2003, CRIT REV CL LAB SCI, V40, P337, DOI 10.1080/713609356; Eisner DA, 2000, CIRC RES, V87, P1087, DOI 10.1161/01.RES.87.12.1087; Fujiwara K, 2008, CIRC RES, V103, P509, DOI 10.1161/CIRCRESAHA.108.176677; HATTORI Y, 1986, J CARDIOVASC PHARM, V8, P998, DOI 10.1097/00005344-198609000-00017; Horishita T, 2008, J PHARMACOL EXP THER, V326, P270, DOI 10.1124/jpet.108.138370; Kapur S, 2009, AM J PHYSIOL-HEART C, V296, pH1491, DOI 10.1152/ajpheart.00539.2008; Knisley SB, 2000, AM J PHYSIOL-HEART C, V279, pH1421, DOI 10.1152/ajpheart.2000.279.3.H1421; Kurebayashi N, 2004, AM J PHYSIOL-CELL PH, V287, pC1646, DOI 10.1152/ajpcell.00200.2004; Kurebayashi N, 2008, AM J PHYSIOL-CELL PH, V294, pC1419, DOI 10.1152/ajpcell.00413.2007; Lakireddy V, 2005, AM J PHYSIOL-HEART C, V288, pH400, DOI 10.1152/ajpheart.00502.2004; Laurita KR, 2001, AM J PHYSIOL-HEART C, V280, pH2053, DOI 10.1152/ajpheart.2001.280.5.H2053; LEE HC, 1988, CIRCULATION, V78, P1047, DOI 10.1161/01.CIR.78.4.1047; MONTANA V, 1989, BIOCHEMISTRY-US, V28, P4536, DOI 10.1021/bi00437a003; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Ohara M, 1983, Nihon Seirigaku Zasshi, V45, P629; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Pruvot EJ, 2004, CIRC RES, V94, P1083, DOI 10.1161/01.RES.0000125629.72053.95; Sato D, 2007, BIOPHYS J, V92, pL33, DOI 10.1529/biophysj.106.100982; Sato D, 2006, CIRC RES, V99, P520, DOI 10.1161/01.RES.0000240542.03986.e7; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Sipido KR, 2004, CIRC RES, V94, P570, DOI 10.1161/01.RES.0000124606.14903.6F; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Yamashita T, 1998, JPN HEART J, V39, P389	31	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2009	4	9							e7069	10.1371/journal.pone.0007069	http://dx.doi.org/10.1371/journal.pone.0007069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PJ	19768114	Green Published, Green Submitted, gold			2022-12-25	WOS:000270154000003
J	Fragoso, CM; Burkard, GS; Oberle, M; Renggli, CK; Hilzinger, K; Roditi, I				Fragoso, Cristina M.; Burkard, Gabriela Schumann; Oberle, Michael; Renggli, Christina Kunz; Hilzinger, Karen; Roditi, Isabel			PSSA-2, a Membrane-Spanning Phosphoprotein of Trypanosoma brucei, Is Required for Efficient Maturation of Infection	PLOS ONE			English	Article								The coat of Trypanosoma brucei consists mainly of glycosylphosphatidylinositol-anchored proteins that are present in several million copies and are characteristic of defined stages of the life cycle. While these major components of the coats of bloodstream forms and procyclic (insect midgut) forms are well characterised, very little is known about less abundant stage-regulated surface proteins and their roles in infection and transmission. By creating epitope-tagged versions of procyclic-specific surface antigen 2 (PSSA-2) we demonstrated that it is a membrane-spanning protein that is expressed by several different life cycle stages in tsetse flies, but not by parasites in the mammalian bloodstream. In common with other membrane-spanning proteins in T. brucei, PSSA-2 requires its cytoplasmic domain in order to exit the endoplasmic reticulum. Correct localisation of PSSA-2 requires phosphorylation of a cytoplasmic threonine residue (T-305), a modification that depends on the presence of TbMAPK4. Mutation of T-305 to alanine (T(305)A) has no effect on the localisation of the protein in cells that express wild type PSSA-2. In contrast, this protein is largely intracellular when expressed in a null mutant background. A variant with a T305D mutation gives strong surface expression in both the wild type and null mutant, but slows growth of the cells, suggesting that it may function as a dominant negative mutant. The PSSA-2 null mutant exhibits no perceptible phenotype in culture and is fully competent at establishing midgut infections in tsetse, but is defective in colonising the salivary glands and the production of infectious metacyclic forms. Given the protein's structure and the effects of mutation of T-305 on proliferation and localisation, we postulate that PSSA-2 might sense and transmit signals that contribute to the parasite's decision to divide, differentiate or migrate.			Fragoso, CM (corresponding author), Ist Cantonale Microbiol, Bellinzona, Switzerland.	isabel.roditi@izb.unibe.ch		Roditi, Isabel/0000-0003-2812-6513	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BAYNE RAL, 1993, MOL BIOCHEM PARASIT, V61, P295, DOI 10.1016/0166-6851(93)90075-9; BEECROFT RP, 1993, MOL BIOCHEM PARASIT, V61, P285, DOI 10.1016/0166-6851(93)90074-8; BRUN R, 1979, ACTA TROP, V36, P289; BRUN R, 1981, Z PARASITENKD, V66, P17, DOI 10.1007/BF00941941; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Butikofer P, 1999, J CELL SCI, V112, P1785; Butikofer P, 2002, MOL BIOCHEM PARASIT, V119, P7, DOI 10.1016/S0166-6851(01)00382-6; Chung WL, 2004, J BIOL CHEM, V279, P54887, DOI 10.1074/jbc.M409311200; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; DELAUW MF, 1985, EMBO J, V4, P989, DOI 10.1002/j.1460-2075.1985.tb03728.x; ENGSTLER M, 1993, MOL BIOCHEM PARASIT, V61, P1, DOI 10.1016/0166-6851(93)90153-O; FAIRBAIRN H, 1946, ANN TROP MED PARASIT, V40, P270, DOI 10.1080/00034983.1946.11685286; Grandgenett PM, 2007, PLOS PATHOG, V3, P1432, DOI 10.1371/journal.ppat.0030150; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Guttinger A, 2007, MOL BIOCHEM PARASIT, V153, P203, DOI 10.1016/j.molbiopara.2007.02.001; Haenni S, 2006, MOL BIOCHEM PARASIT, V150, P144, DOI 10.1016/j.molbiopara.2006.07.005; HAJDUK SL, 1984, J PROTOZOOL, V31, P41, DOI 10.1111/j.1550-7408.1984.tb04287.x; JACKSON DG, 1993, J BIOL CHEM, V268, P1894; KOENIGMARTIN E, 1992, MOL BIOCHEM PARASIT, V55, P135, DOI 10.1016/0166-6851(92)90134-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; Liniger M, 2001, MOL MICROBIOL, V40, P869, DOI 10.1046/j.1365-2958.2001.02426.x; Pfister DD, 2006, EUKARYOT CELL, V5, P1126, DOI 10.1128/EC.00094-06; Qiao XG, 2006, EUKARYOT CELL, V5, P1229, DOI 10.1128/EC.00064-06; RICHARDSON JP, 1986, J IMMUNOL, V136, P2259; RICHARDSON JP, 1988, MOL BIOCHEM PARASIT, V31, P203, DOI 10.1016/0166-6851(88)90150-8; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Sakurai T, 2008, MOL BIOCHEM PARASIT, V161, P1, DOI 10.1016/j.molbiopara.2008.05.003; Schlaeppi AC, 2003, J BIOL CHEM, V278, P49980, DOI 10.1074/jbc.M309548200; Thuita JK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000238; Urwyler S, 2007, MOL MICROBIOL, V63, P218, DOI 10.1111/j.1365-2958.2006.05492.x; Urwyler S, 2005, PLOS PATHOG, V1, P225, DOI 10.1371/journal.ppat.0010022; Utz S, 2006, EUKARYOT CELL, V5, P1430, DOI 10.1128/EC.00067-06; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10797	40	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7074	10.1371/journal.pone.0007074	http://dx.doi.org/10.1371/journal.pone.0007074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759911	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970200008
J	Bromberg-White, JL; Boguslawski, E; Duesbery, NS				Bromberg-White, Jennifer L.; Boguslawski, Elissa; Duesbery, Nicholas S.			Perturbation of Mouse Retinal Vascular Morphogenesis by Anthrax Lethal Toxin	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHORYLATION; KINASE-KINASE; PROTEOLYTIC INHIBITOR; FACTOR CLEAVES; TUMOR-GROWTH; ANGIOGENESIS; INACTIVATION; ACTIVATION; CELLS	Lethal factor, the enzymatic moiety of anthrax lethal toxin (LeTx) is a protease that inactivates mitogen activated protein kinase kinases (MEK or MKK). In vitro and in vivo studies demonstrate LeTx targets endothelial cells. However, the effects of LeTx on endothelial cells are incompletely characterized. To gain insight into this process we used a developmental model of vascularization in the murine retina. We hypothesized that application of LeTx would disrupt normal retinal vascularization, specifically during the angiogenic phase of vascular development. By immunoblotting and immunofluorescence microscopy we observed that MAPK activation occurs in a spatially and temporally regulated manner during retinal vascular development. Intravitreal administration of LeTx caused an early delay (4 d post injection) in retinal vascular development that was marked by reduced penetration of vessels into distal regions of the retina as well as failure of sprouting vessels to form the deep and intermediate plexuses within the inner retina. In contrast, later stages (8 d post injection) were characterized by the formation of abnormal vascular tufts that co-stained with phosphorylated MAPK in the outer retinal region. We also observed a significant increase in the levels of secreted VEGF in the vitreous 4 d and 8 d after LeTx injection. In contrast, the levels of over 50 cytokines other cytokines, including bFGF, EGF, MCP-1, and MMP-9, remained unchanged. Finally, co-injection of VEGF-neutralizing antibodies significantly decreased LeTx-induced neovascular growth. Our studies not only reveal that MAPK signaling plays a key role in retinal angiogenesis but also that perturbation of MAPK signaling by LeTx can profoundly alter vascular morphogenesis.			Bromberg-White, JL (corresponding author), Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI 49503 USA.	duesbery@vai.org		DUESBERY, NICK/0000-0002-4258-5655; Duesbery, Nicholas/0000-0002-5708-4984	NCI NIH HHS [R01 CA109308, CA109308] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109308] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Alfano RW, 2009, MOL CANCER RES, V7, P452, DOI 10.1158/1541-7786.MCR-08-0451; ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bromberg-White JL, 2008, METHOD ENZYMOL, V438, P355, DOI 10.1016/S0076-6879(07)38025-7; Bullard LE, 2003, INVEST OPHTH VIS SCI, V44, P1722, DOI 10.1167/iovs.01-1193; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; Depeille P, 2007, CLIN CANCER RES, V13, P5926, DOI 10.1158/1078-0432.CCR-07-0732; Ding Y, 2008, MOL CANCER THER, V7, P648, DOI 10.1158/1535-7163.MCT-07-2229; Dorrell M.I., 2007, RETINAL VASCULAR DIS, P24; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Ennis BW, 2005, J PHARMACOL EXP THER, V313, P325, DOI 10.1124/jpet.104.078873; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; GUMA M, 2009, P NATL ACAD SCI US; Hayashi A, 1996, INVEST OPHTH VIS SCI, V37, P2146; Hayashi A, 1997, INVEST OPHTH VIS SCI, V38, P372; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Pang JJ, 2006, MOL VIS, V12, P756; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Qiao H, 2007, J LEUKOCYTE BIOL, V81, P1012, DOI 10.1189/jlb.0506342; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Sherer K, 2007, AM J RESP CRIT CARE, V175, P211, DOI 10.1164/rccm.200608-1239CP; SINGH Y, 1989, J BIOL CHEM, V264, P11099; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Su XJ, 2003, MOL VIS, V9, P171; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Yafai Y, 2007, GLIA, V55, P642, DOI 10.1002/glia.20495; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	52	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e6956	10.1371/journal.pone.0006956	http://dx.doi.org/10.1371/journal.pone.0006956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750016	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796300007
J	Senechal, P; Arseneault, G; Leroux, A; Lindquist, S; Rokeach, LA				Senechal, Patrick; Arseneault, Genevieve; Leroux, Alexandre; Lindquist, Susan; Rokeach, Luis A.			The Schizosaccharomyces pombe Hsp104 Disaggregase Is Unable to Propagate the [PSI+] Prion	PLOS ONE			English	Article								The molecular chaperone Hsp104 is a crucial factor in the acquisition of thermotolerance in yeast. Under stress conditions, the disaggregase activity of Hsp104 facilitates the reactivation of misfolded proteins. Hsp104 is also involved in the propagation of fungal prions. For instance, the well-characterized [PSI+] prion of Saccharomyces cerevisiae does not propagate in Delta hsp104 cells or in cells overexpressing Hsp104. In this study, we characterized the functional homolog of Hsp104 from Schizosaccharomyces pombe (Sp_Hsp104). As its S. cerevisiae counterpart, Sp_hsp104(+) is heat-inducible and required for thermotolerance in S. pombe. Sp_Hsp104 displays low disaggregase activity and cannot propagate the [PSI+] prion in S. cerevisiae. When overexpressed in S. cerevisiae, Sp_Hsp104 confers thermotolerance to Delta hsp104 cells and reactivates heat-aggregated proteins. However, overexpression of Sp_Hsp104 does not propagate nor eliminate [PSI+]. Strikingly, [PSI+] was cured by overexpression of a chimeric chaperone bearing the C- terminal domain (CTD) of the S. cerevisiae Hsp104 protein. Our study demonstrates that the ability to untangle aggregated proteins is conserved between the S. pombe and S. cerevisiae Hsp104 homologs, and points to a role of the CTD in the propagation of the S. cerevisiae [PSI+] prion.			Senechal, P (corresponding author), Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ, Canada.	luis.rokeach@umontreal.ca						Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BEAUREGARD PB, 2009, J CELL SCI; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Collin P, 2004, J CELL SCI, V117, P907, DOI 10.1242/jcs.00943; DEVIRGILIO C, 1990, FEBS LETT, V273, P107, DOI 10.1016/0014-5793(90)81062-S; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Elagoz A, 1999, J CELL SCI, V112, P4449; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Elliott B, 1996, GENETICS, V144, P923; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Grably MR, 2002, MOL MICROBIOL, V44, P21, DOI 10.1046/j.1365-2958.2002.02860.x; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Iwahashi H, 1998, APPL ENVIRON MICROB, V64, P4614; Jones GW, 2005, BIOESSAYS, V27, P823, DOI 10.1002/bies.20267; Kim KI, 1998, BIOCHEM J, V333, P671, DOI 10.1042/bj3330671; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Marechal A, 2004, BIOCHEM J, V380, P441, DOI 10.1042/BJ20031546; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; PETKO L, 1986, CELL, V45, P885, DOI 10.1016/0092-8674(86)90563-5; Ribeiro MJS, 1997, MOL MICROBIOL, V25, P571, DOI 10.1046/j.1365-2958.1997.4961856.x; Ronicke V, 1997, METHOD ENZYMOL, V283, P313; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sambrook J., 1989, MOL CLONING LAB MANU, p3 v; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Seppa L, 2004, MOL MICROBIOL, V52, P217, DOI 10.1111/j.1365-2958.2003.03959.x; Sherman F., 1981, METHODS YEAST GENETI; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Strub C, 2003, FEBS LETT, V553, P125, DOI 10.1016/S0014-5793(03)00985-2; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yoshida J, 2005, CELL STRUCT FUNCT, V29, P125, DOI 10.1247/csf.29.125; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	71	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6939	10.1371/journal.pone.0006939	http://dx.doi.org/10.1371/journal.pone.0006939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759825	gold, Green Submitted, Green Published			2022-12-25	WOS:000269696600002
J	Mury, FB; da Silva, JR; Ferreira, LS; Ferreira, BD; de Souza, GA; de Souza-Neto, JA; Ribolla, PEM; Silva, CP; do Nascimento, VV; Machado, OLT; Berbert-Molina, MA; Dansa-Petretski, M				Mury, Flavia Borges; da Silva, Jose Roberto; Ferreira, Ligia Souza; Ferreira, Beatriz dos Santos; de Souza-Filho, Goncalo Apolinario; de Souza-Neto, Jayme Augusto; Martins Ribolla, Paulo Eduardo; Silva, Carlos Peres; do Nascimento, Viviane Veiga; Tavares Machado, Olga Lima; Berbert-Molina, Marilia Amorim; Dansa-Petretski, Marilvia			Alpha-Glucosidase Promotes Hemozoin Formation in a Blood-Sucking Bug: An Evolutionary History	PLOS ONE			English	Article							DYSDERCUS-PERUVIANUS HEMIPTERA; PERIMICROVILLAR MEMBRANES; PLASMODIUM HEMOZOIN; HEME DETOXIFICATION; MALARIA PARASITE; MIDGUT; BINDING; PURIFICATION; HAEMOZOIN; POLYMERIZATION	Background: Hematophagous insects digest large amounts of host hemoglobin and release heme inside their guts. In Rhodnius prolixus, hemoglobin-derived heme is detoxified by biomineralization, forming hemozoin (Hz). Recently, the involvement of the R. prolixus perimicrovillar membranes in Hz formation was demonstrated. Methodology/Principal Findings: Hz formation activity of an alpha-glucosidase was investigated. Hz formation was inhibited by specific alpha-glucosidase inhibitors. Moreover, Hz formation was sensitive to inhibition by Diethypyrocarbonate, suggesting a critical role of histidine residues in enzyme activity. Additionally, a polyclonal antibody raised against a phytophagous insect alpha-glucosidase was able to inhibit Hz formation. The alpha-glucosidase inhibitors have had no effects when used 10 h after the start of reaction, suggesting that alpha-glucosidase should act in the nucleation step of Hz formation. Hz formation was seen to be dependent on the substrate-binding site of enzyme, in a way that maltose, an enzyme substrate, blocks such activity. dsRNA, constructed using the sequence of alpha-glucosidase gene, was injected into R. prolixus females' hemocoel. Gene silencing was accomplished by reduction of both alpha-glucosidase and Hz formation activities. Insects were fed on plasma or hemin-enriched plasma and gene expression and activity of alpha-glucosidase were higher in the plasma plus hemin-fed insects. The deduced amino acid sequence of alpha-glucosidase shows a high similarity to the insect alpha-glucosidases, with critical histidine and aspartic residues conserved among the enzymes. Conclusions/Significance: Herein the Hz formation is shown to be associated to an alpha-glucosidase, the biochemical marker from Hemipteran perimicrovillar membranes. Usually, these enzymes catalyze the hydrolysis of glycosidic bond. The results strongly suggest that alpha-glucosidase is responsible for Hz nucleation in the R. prolixus midgut, indicating that the plasticity of this enzyme may play an important role in conferring fitness to hemipteran hematophagy, for instance.			Mury, FB (corresponding author), Univ Estadual Norte Fluminense, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil.	marilvia@uenf.br	Silva, Carlos P/N-8746-2014; Machado, Olga/P-1944-2019; Silva, José Roberto/F-2931-2017; Ribolla, Paulo/AAH-3354-2020; Souza-Neto, Jayme A/E-7841-2010; Ribolla, Paulo EM/B-9122-2012; Machado, Olga LT/G-7461-2012; de Souza Filho, Goncalo/S-7251-2017	Souza-Neto, Jayme A/0000-0001-9281-894X; Ribolla, Paulo EM/0000-0001-8735-6090; de Souza Filho, Goncalo/0000-0003-1028-4425; Silva, Carlos/0000-0001-5112-7050; Machado, Olga/0000-0003-0647-1762				BILLINGSLEY PF, 1983, CAN J ZOOL, V61, P2574, DOI 10.1139/z83-339; Brandt SM, 2008, GENETICS, V180, P1671, DOI 10.1534/genetics.108.089748; Bravo-Torres JC, 2004, INT J PARASITOL, V34, P455, DOI 10.1016/j.ijpara.2003.11.015; Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0; Choi CYH, 1999, BIOCHEMISTRY-US, V38, P16916, DOI 10.1021/bi991665k; DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537; Dhanawansa R, 2002, GLYCOBIOLOGY, V12, P229, DOI 10.1093/glycob/12.3.229; Dillon RJ, 1997, COMP BIOCHEM PHYS B, V116, P35, DOI 10.1016/S0305-0491(96)00195-2; Dixon M., 1979, ENZYMES, Vthird; Egan TJ, 2008, J INORG BIOCHEM, V102, P1288, DOI 10.1016/j.jinorgbio.2007.12.004; Egan TJ, 2006, FEBS LETT, V580, P5105, DOI 10.1016/j.febslet.2006.08.043; Ferrer M, 2005, BIOCHEM J, V391, P269, DOI 10.1042/BJ20050346; Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Jacobson RL, 2001, ACTA TROP, V78, P41, DOI 10.1016/S0001-706X(00)00164-9; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; Lehane MJ., 2005, BIOL BLOODS INS 2 ED, DOI 10.1017/CBO9780511610493; Lynn A, 1999, FEBS LETT, V459, P267, DOI 10.1016/S0014-5793(99)01260-0; MORGAN MRJ, 1975, J INSECT PHYSIOL, V21, P1045, DOI 10.1016/0022-1910(75)90114-6; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; Oliveira MF, 2005, FEBS LETT, V579, P6010, DOI 10.1016/j.febslet.2005.09.035; Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910; Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1; Oliveira PL, 2002, FEBS LETT, V525, P3, DOI 10.1016/S0014-5793(02)03026-0; Pandey AV, 2003, BIOCHEM BIOPH RES CO, V308, P736, DOI 10.1016/S0006-291X(03)01465-7; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Pisciotta JM, 2005, INT J PARASITOL, V35, P1037, DOI 10.1016/j.ijpara.2005.03.020; Pisciotta JM, 2008, PARASITOL INT, V57, P89, DOI 10.1016/j.parint.2007.09.009; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P61, DOI 10.1016/j.ibmb.2003.09.004; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Romaniouk A, 1997, GLYCOBIOLOGY, V7, P399, DOI 10.1093/glycob/7.3.399; Schneider EL, 2005, BIOCHEMISTRY-US, V44, P979, DOI 10.1021/bi048570p; Shirai T, 2008, PROTEINS, V73, P126, DOI 10.1002/prot.22044; Silva CP, 2004, ARTHROPOD STRUCT DEV, V33, P139, DOI 10.1016/j.asd.2003.12.002; SILVA CP, 1994, INSECT BIOCHEM MOLEC, V24, P493, DOI 10.1016/0965-1748(94)90044-2; SILVA CP, 1995, J INSECT PHYSIOL, V41, P1093, DOI 10.1016/0022-1910(95)00066-4; Silva JR, 2007, INSECT BIOCHEM MOLEC, V37, P523, DOI 10.1016/j.ibmb.2007.01.001; SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; TAINER J A, 1992, Current Opinion in Biotechnology, V3, P378, DOI 10.1016/0958-1669(92)90166-G; TERRA WR, 1979, BIOCHIM BIOPHYS ACTA, V571, P79, DOI 10.1016/0005-2744(79)90227-4; TERRA WR, 1988, BRAZ J MED BIOL RES, V21, P675; Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005; Zeng YC, 1998, ARCH BIOCHEM BIOPHYS, V355, P26, DOI 10.1006/abbi.1998.0717	52	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6966	10.1371/journal.pone.0006966	http://dx.doi.org/10.1371/journal.pone.0006966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742319	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622500024
J	Patwardhan, GA; Zhang, QJ; Yin, DM; Gupta, V; Bao, JX; Senkal, CE; Ogretmen, B; Cabot, MC; Shah, GV; Sylvester, PW; Jazwinski, SM; Liu, YY				Patwardhan, Gauri A.; Zhang, Qian-Jin; Yin, Dongmei; Gupta, Vineet; Bao, Jianxiong; Senkal, Can E.; Ogretmen, Besim; Cabot, Myles C.; Shah, Girish V.; Sylvester, Paul W.; Jazwinski, S. Michal; Liu, Yong-Yu			A New Mixed-Backbone Oligonucleotide against Glucosylceramide Synthase Sensitizes Multidrug-Resistant Tumors to Apoptosis	PLOS ONE			English	Article							PROTEIN-KINASE-A; LONGEVITY ASSURANCE GENE-1; INDUCED CELL-DEATH; CERAMIDE GLYCOSYLATION; P-GLYCOPROTEIN; CANCER-CELLS; TELOMERASE ACTIVITY; HUMAN HEAD; IN-VITRO; EXPRESSION	Enhanced ceramide glycosylation catalyzed by glucosylceramide synthase (GCS) limits therapeutic efficiencies of antineoplastic agents including doxorubicin in drug-resistant cancer cells. Aimed to determine the role of GCS in tumor response to chemotherapy, a new mixed-backbone oligonucleotide (MBO-asGCS) with higher stability and efficiency has been generated to silence human GCS gene. MBO-asGCS was taken up efficiently in both drug-sensitive and drug-resistant cells, but it selectively suppressed GCS overexpression, and sensitized drug-resistant cells. MBO-asGCS increased doxorubicin sensitivity by 83-fold in human NCI/ADR-RES, and 43-fold in murine EMT6/AR1 breast cancer cells, respectively. In tumor-bearing mice, MBO-asGCS treatment dramatically inhibited the growth of multidrug-resistant NCI/ADR-RE tumors, decreasing tumor volume to 37%, as compared with scrambled control. Furthermore, MBO-asGCS sensitized multidrug-resistant tumors to chemotherapy, increasing doxorubicin efficiency greater than 2-fold. The sensitization effects of MBO-asGCS relied on the decreases of gene expression and enzyme activity of GCS, and on the increases of C-18-ceramide and of caspase-executed apoptosis. MBO-asGCS was accumulation in tumor xenografts was greater in other tissues, excepting liver and kidneys; but MBO-asGCS did not exert significant toxic effects on liver and kidneys. This study, for the first time in vivo, has demonstrated that GCS is a promising therapeutic target for cancer drug resistance, and MBO-asGCS has the potential to be developed as an antineoplastic agent.			Patwardhan, GA (corresponding author), Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, Monroe, LA USA.	yliu@ulm.edu	Liu, Yong-Yu/H-8593-2014	Liu, Yong-Yu/0000-0002-7968-0162	NCI NIH HHS [R01 CA096534, P01 CA097132, CA097132, R01 CA088932, CA088932] Funding Source: Medline; NCRR NIH HHS [P20 RR016456, P20 RR16456] Funding Source: Medline; NIDCR NIH HHS [DE016572, R01 DE016572] Funding Source: Medline; NIGMS NIH HHS [GM77391, R01 GM077391] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096534, P01CA097132, R01CA088932] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077391] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal S, 1997, P NATL ACAD SCI USA, V94, P2620, DOI 10.1073/pnas.94.6.2620; Bogin L, 2002, CANCER RES, V62, P1948; De Larco JE, 2001, CANCER RES, V61, P2857; Delpy E, 1999, CARDIOVASC RES, V43, P398, DOI 10.1016/S0008-6363(99)00142-X; Diaz-Montero CM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-39; Dijkhuis AJ, 2006, MOL CANCER THER, V5, P593, DOI 10.1158/1535-7163.MCT-05-0457; FAIRCHILD CR, 1987, CANCER RES, V47, P5141; Goel S, 2003, CLIN CANCER RES, V9, P4069; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gouaze V, 2005, CANCER RES, V65, P3861, DOI 10.1158/0008-5472.CAN-04-2329; Gouaze V, 2004, MOL CANCER THER, V3, P633; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Itoh M, 2003, CLIN CANCER RES, V9, P415; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Kolesnick R, 2007, CANCER CELL, V11, P473, DOI 10.1016/j.ccr.2007.05.003; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Lavie Y, 1997, J BIOL CHEM, V272, P1682, DOI 10.1074/jbc.272.3.1682; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu Yong-Yu, 2004, Methods Mol Biol, V249, P177; Liu YY, 2000, J BIOL CHEM, V275, P7138, DOI 10.1074/jbc.275.10.7138; Liu YY, 1999, EXP CELL RES, V252, P464, DOI 10.1006/excr.1999.4649; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Lucci A, 1998, ANTICANCER RES, V18, P475; Marks DL, 2001, J BIOL CHEM, V276, P26492, DOI 10.1074/jbc.M102612200; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mehta K, 2002, J NATL CANCER I, V94, P1652; Mistry P, 2001, CANCER RES, V61, P749; Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2001, DRUG RESIST UPDATE, V4, P368, DOI 10.1054/drup.2001.0225; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; Olshefski RS, 2001, INT J CANCER, V93, P131, DOI 10.1002/ijc.1301; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Rath G, 2009, INT J BIOCHEM CELL B, V41, P1165, DOI 10.1016/j.biocel.2008.10.021; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Ruckhaberle E, 2009, J CANCER RES CLIN, V135, P81, DOI 10.1007/s00432-008-0436-9; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Sun YL, 2006, NEOPLASMA, V53, P1; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tepel J, 2004, PANCREAS, V28, P1, DOI 10.1097/00006676-200401000-00001; Tortora G, 2000, CLIN CANCER RES, V6, P2506; Wang H, 1999, P NATL ACAD SCI USA, V96, P13989, DOI 10.1073/pnas.96.24.13989; Watanabe R, 1998, J BIOL CHEM, V273, P9651, DOI 10.1074/jbc.273.16.9651; Weiss M, 2003, CANCER RES, V63, P3654; Wu KJ, 1999, BIOCHEM J, V341, P395, DOI 10.1042/0264-6021:3410395; Xie P, 2008, LEUKEMIA RES, V32, P475, DOI 10.1016/j.leukres.2007.07.006; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100	55	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6938	10.1371/journal.pone.0006938	http://dx.doi.org/10.1371/journal.pone.0006938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742320	gold, Green Published, Green Submitted			2022-12-25	WOS:000269622500014
J	Sakuma, T; Sakurai, A; Yasuda, J				Sakuma, Toshie; Sakurai, Akira; Yasuda, Jiro			Dimerization of Tetherin Is Not Essential for Its Antiviral Activity against Lassa and Marburg Viruses	PLOS ONE			English	Article								Tetherin (also known as BST2, CD317 or HM1.24) has recently been reported to inhibit a wide range of viruses. However, the antiviral mechanism of action of tetherin has not been determined. Both ends of the tetherin molecule are associated with the plasma membrane and it forms a homodimer. Therefore, a model in which progeny virions are retained on the cell surface by dimer formation between tetherin molecules on the viral envelope and plasma membrane has been proposed as the antiviral mechanism of action of this molecule. To investigate this possibility, we examined the correlation between dimerization and antiviral activity of tetherin in Lassa and Marburg virus-like particle production systems using tetherin mutants deficient in dimer formation. However, the tetherin mutant with complete loss of dimerization activity still showed apparent antiviral activity, indicating that dimerization of tetherin is not essential for its antiviral activity. This suggests that tetherin retains progeny virions on the cell surface by a mechanism other than dimerization.			Sakuma, T (corresponding author), Natl Res Inst Police Sci, Dept Forens Sci 1, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	yasuda@nrips.go.jp		Yasuda, Jiro/0000-0001-9928-5621				Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Gottlinger HG, 2008, NATURE, V451, P406, DOI 10.1038/nature06364; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Urata S, 2006, J VIROL, V80, P4191, DOI 10.1128/JVI.80.8.4191-4195.2006; Urata S, 2007, J VIROL, V81, P4895, DOI 10.1128/JVI.02829-06; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132	15	41	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6934	10.1371/journal.pone.0006934	http://dx.doi.org/10.1371/journal.pone.0006934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742323	Green Submitted, gold, Green Published			2022-12-25	WOS:000269622500012
J	Reddy, MCM; Palaninathan, SK; Bruning, JB; Thurman, C; Smith, D; Sacchettini, JC				Reddy, Manchi C. M.; Palaninathan, Satheesh K.; Bruning, John B.; Thurman, Cory; Smith, Danielle; Sacchettini, James C.			Structural Insights into the Mechanism of the Allosteric Transitions of Mycobacterium tuberculosis cAMP Receptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE ACTIVATOR PROTEIN; CYCLIC-NUCLEOTIDE BINDING; CAP-DNA COMPLEX; ESCHERICHIA-COLI; TRANSCRIPTION REGULATORS; STRUCTURE VALIDATION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ELECTRON-DENSITY; GENE-EXPRESSION	The cAMP receptor protein (CRP) from Mycobacterium tuberculosis is a cAMP-responsive global transcriptional regulator, responsible for the regulation of a multitude of diverse proteins. We have determined the crystal structures of the CRP.cAMP and CRP.N-6-cAMP derivative-bound forms of the enzyme to 2.2- and 2.3 angstrom-resolution, respectively, to investigate cAMP-mediated conformational and structural changes. The allosteric switch from the open, inactive conformation to the closed, active conformation begins with a number of changes in the ligand-binding cavity upon cAMP binding. These subtle structural changes and numerous non-bonding interactions between cAMP, the N-domain residues, and the C-domain helices demonstrate that the N-domain hairpin loop acts as a structural mediator of the allosteric switch. Based on the CRP.N-6-cAMP crystal structure, binding of N-6-cAMP with a bulkier methylphenylethyl extension from the N6 atom stabilizes the cAMP-binding domain, N-domain hairpin, and C-terminal domain in a similar manner as that of the CRP.cAMP structure, maintaining structural integrity within the subunits. However, the bulkier N6 extension of N-6-cAMP (in R conformation) is accommodated only in subunit A with minor changes, whereas in subunit B, the N-6 extension is in the S conformation hindering the hinge region of the central helix. As a result, the entire N-domain and the C-domain of subunit B integrated by the cAMP portion of this ligand, together tilt away (similar to 7 degrees tilt) from central helix C, positioning the helix-turn-helix motif in an unfavorable position for the DNA substrate, asymmetrically. Together, these crystal structures demonstrate the mechanism of action of the cAMP molecule and its role in integrating the active CRP structure.	[Reddy, Manchi C. M.; Palaninathan, Satheesh K.; Bruning, John B.; Thurman, Cory; Smith, Danielle; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 103 Biochem Biophys Bldg, College Stn, TX 77843 USA.	sacchett@tamu.edu	Bruning, John/AAW-8567-2020	Bruning, John/0000-0002-6919-1824	Structural Genomics of Persistence Targets from Mycobacterium tuberculosis [PO1AI068135]; Wolfe-Welch Foundation Chair in Science [8-0015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	Structural Genomics of Persistence Targets from Mycobacterium tuberculosis; Wolfe-Welch Foundation Chair in Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Structural Genomics of Persistence Targets from Mycobacterium tuberculosis (Grant PO1AI068135) and by the R. J. Wolfe-Welch Foundation Chair in Science (Grant 8-0015).	Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; ANDERSON WB, 1972, J BIOL CHEM, V247, P2717; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Chen R, 2003, J BIOL CHEM, V278, P13235, DOI 10.1074/jbc.M211551200; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; EBRIGHT RH, 1985, J MOL BIOL, V182, P91, DOI 10.1016/0022-2836(85)90030-0; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; GARGES S, 1985, CELL, V41, P745, DOI 10.1016/S0092-8674(85)80055-6; Gorshkova EV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1180, DOI 10.1007/s10541-005-0244-7; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Green J, 2001, ADV MICROB PHYSIOL, V44, P1, DOI 10.1016/S0065-2911(01)44010-0; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Hobson RJ, 2002, MICROBIOL-SGM, V148, P1571, DOI 10.1099/00221287-148-5-1571; KOLB A, 1993, NUCLEIC ACIDS RES, V21, P319, DOI 10.1093/nar/21.2.319; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lee TW, 2001, J BIOCHEM-TOKYO, V130, P57, DOI 10.1093/oxfordjournals.jbchem.a002962; Malecki J, 2000, J BIOL CHEM, V275, P8480, DOI 10.1074/jbc.275.12.8480; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Spreadbury CL, 2005, MICROBIOL-SGM, V151, P547, DOI 10.1099/mic.0.27444-0; Tutar Y, 2008, CELL BIOCHEM FUNCT, V26, P399, DOI 10.1002/cbf.1462; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; WEBER IT, 1982, P NATL ACAD SCI-BIOL, V79, P7679, DOI 10.1073/pnas.79.24.7679; Won HS, 2002, J BIOL CHEM, V277, P11450, DOI 10.1074/jbc.M112411200; Won HS, 2008, J BIOCHEM, V143, P163, DOI 10.1093/jb/mvm238; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166	41	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36581	36591		10.1074/jbc.M109.041343	http://dx.doi.org/10.1074/jbc.M109.041343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19740754	Green Published, hybrid			2022-12-25	WOS:000272970500059
J	Cesaro, E; De Cegli, R; Medugno, L; Florio, F; Grosso, M; Lupo, A; Izzo, P; Costanzo, P				Cesaro, Elena; De Cegli, Rossella; Medugno, Lina; Florio, Francesca; Grosso, Michela; Lupo, Angelo; Izzo, Paola; Costanzo, Paola			The Kruppel-like Zinc Finger Protein ZNF224 Recruits the Arginine Methyltransferase PRMT5 on the Transcriptional Repressor Complex of the Aldolase A Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; SM PROTEINS; METHYLATION; EXPRESSION; COREPRESSOR; BINDING; FAMILY; DOMAIN; KAP-1; INTERACTS	Gene transcription in eukaryotes is modulated by the coordinated recruitment of specific transcription factors and chromatin-modulating proteins. Indeed, gene activation and/or repression is/are regulated by histone methylation status at specific arginine or lysine residues. In this work, by co-immunoprecipitation experiments, we demonstrate that PRMT5, a type II protein arginine methyltransferase that monomethylates and symmetrically dimethylates arginine residues, is physically associated with the Kruppel-like associated box-zinc finger protein ZNF224, the aldolase A gene repressor. Moreover, chromatin immunoprecipitation assays show that PRMT5 is recruited to the L-type aldolase A promoter and that methylation of the nucleosomes that surround the L-type promoter region occurs in vivo on the arginine 3 of histone H4. Consistent with its association to the ZNF224 repressor complex, the decrease of PRMT5 expression produced by RNA interference positively affects L-type aldolase A promoter transcription. Finally, the alternating occupancy of the L-type aldolase A promoter by the ZNF224-PRMT5 repression complex in proliferating and growth-arrested cells suggests that these regulatory proteins play a significant role during the cell cycle modulation of human aldolase A gene expression. Our data represent the first experimental evidence that protein arginine methylation plays a role in ZNF224-mediated transcriptional repression and provide novel insight into the chromatin modifications required for repression of gene transcription by Kruppel-like associated box-zinc finger proteins.	[Cesaro, Elena; De Cegli, Rossella; Medugno, Lina; Florio, Francesca; Grosso, Michela; Lupo, Angelo; Izzo, Paola; Costanzo, Paola] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; [Lupo, Angelo] Univ Sannio, Fac Sci, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy	University of Naples Federico II; University of Sannio	Costanzo, P (corresponding author), Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	costanzo@dbbm.unina.it	De Cegli, Rossella/ABA-4372-2020; Florio, Francesca/K-6509-2018	Florio, Francesca/0000-0001-6687-9183; CESARO, Elena/0000-0003-3931-7956; COSTANZO, Paola/0000-0002-0267-379X; De Cegli, Rossella/0000-0002-8526-8692; Izzo, Paola/0000-0003-1549-0615; Grosso, Michela/0000-0003-1664-1657	Ministero dell'Istruzione dell'Universita e della Ricerca [PRIN2004, PRIN2007]; Regione Campania	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Regione Campania(Regione Campania)	This work was supported by the Ministero dell'Istruzione dell'Universita e della Ricerca (Grants PRIN2004 and PRIN2007) and by Regione Campania.	Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Costanzo P, 1999, FEBS LETT, V454, P61, DOI 10.1016/S0014-5793(99)00775-9; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Krebs CJ, 2005, GENOMICS, V85, P752, DOI 10.1016/j.ygeno.2005.03.004; LE DB, 1996, EMBO J, V15, P6701; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lupo A, 1997, J BIOL CHEM, V272, P31641, DOI 10.1074/jbc.272.50.31641; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Medugno L, 2005, GENE, V359, P35, DOI 10.1016/j.gene.2005.06.021; Medugno L, 2003, FEBS LETT, V534, P93, DOI 10.1016/S0014-5793(02)03783-3; Medugno L, 2007, GENE, V403, P125, DOI 10.1016/j.gene.2007.07.036; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	37	29	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32321	32330		10.1074/jbc.M109.043349	http://dx.doi.org/10.1074/jbc.M109.043349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19741270	Green Published, hybrid			2022-12-25	WOS:000272028400014
J	Damsma, GE; Cramer, P				Damsma, Gerke E.; Cramer, Patrick			Molecular Basis of Transcriptional Mutagenesis at 8-Oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FIDELITY DNA-POLYMERASE; STRUCTURAL BASIS; DAMAGED DNA; ELONGATION; BYPASS; LESION; TRANSLOCATION; REPLICATION; COMPLEXES	Structure-function analysis has revealed the mechanism of yeast RNA polymerase II transcription at 8-oxoguanine (8-oxoG), the major DNA lesion resulting from oxidative stress. When polymerase II encounters 8-oxoG in the DNA template strand, it can misincorporate adenine, which forms a Hoogsteen bp with 8-oxoG at the active center. This requires rotation of the 8-oxoG base from the standard anti- to an uncommon syn-conformation, which likely occurs during 8-oxoG loading into the active site. The misincorporated adenine escapes intrinsic proofreading, resulting in transcriptional mutagenesis that is observed directly by mass spectrometric RNA analysis.	[Cramer, Patrick] Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Dept Chem & Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de			Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB646]; Transregio 5	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Transregio 5	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich SFB646, and Transregio 5. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut (Villigen, Switzerland).	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; CHEN YH, 1993, J BIOL CHEM, V268, P5849; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; Dengl S, 2009, J BIOL CHEM, V284, P21270, DOI 10.1074/jbc.M109.013847; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; Yamaguchi Y, 2007, GENES CELLS, V12, P863, DOI 10.1111/j.1365-2443.2007.01094.x	35	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31658	31663		10.1074/jbc.M109.022764	http://dx.doi.org/10.1074/jbc.M109.022764			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758983	Green Published, hybrid			2022-12-25	WOS:000271572700020
J	Rajavel, M; Mitra, A; Gopal, B				Rajavel, Malligarjunan; Mitra, Ashima; Gopal, Balasubramanian			Role of Bacillus subtilis BacB in the Synthesis of Bacilysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; DIFFRACTION; ENZYME; ACID	Bacilysin is a non-ribosomally synthesized dipeptide antibiotic that is active against a wide range of bacteria and some fungi. Synthesis of bacilysin (L-alanine-[2,3-epoxycyclohexano-4]-L-alanine) is achieved by proteins in the bac operon, also referred to as the bacABCDE (ywfBCDEF) gene cluster in B. subtilis. Extensive genetic analysis from several strains of B. subtilis suggests that the bacABC gene cluster encodes all the proteins that synthesize the epoxyhexanone ring of L-anticapsin. These data, however, were not consistent with the putative functional annotation for these proteins whereby BacA, a prephenate dehydratase along with a potential isomerase/guanylyl transferase, BacB and an oxidoreductase, BacC, could synthesize L-anticapsin. Here we demonstrate that BacA is a decarboxylase that acts on prephenate. Further, based on the biochemical characterization and the crystal structure of BacB, we show that BacB is an oxidase that catalyzes the synthesis of 2-oxo-3-(4-oxocyclohexa-2,5-dienyl)propanoic acid, a precursor to L-anticapsin. This protein is a bi-cupin, with two putative active sites each containing a bound metal ion. Additional electron density at the active site of the C-terminal domain of BacB could be interpreted as a bound phenylpyruvic acid. A significant decrease in the catalytic activity of a point variant of BacB with a mutation at the N-terminal domain suggests that the N-terminal cupin domain is involved in catalysis.	[Rajavel, Malligarjunan; Mitra, Ashima; Gopal, Balasubramanian] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gopal, B (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	bgopal@mbu.iisc.ernet.in	Gopal, Balasubramanian/ABG-3754-2021; Gopal, Balasubramanian/K-4566-2012		Department of Science and Technology; Department of Biotechnology; Council for Scientific and Industrial Research, India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Department of Science and Technology, Department of Biotechnology, and the Council for Scientific and Industrial Research, India.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; ANNATHARAMAN V, 2003, CURR OPIN CHEM BIOL, V7, P12; Anthon GE, 2003, J SCI FOOD AGR, V83, P1210, DOI 10.1002/jsfa.1525; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Dimitropoulos D., 2006, CURRENT PROTOCOLS BI, P141311; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gopal B, 2005, BIOCHEMISTRY-US, V44, P193, DOI 10.1021/bi0484421; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Inaoka T, 2003, J BIOL CHEM, V278, P2169, DOI 10.1074/jbc.M208722200; KENIG M, 1976, J GEN MICROBIOL, V94, P37, DOI 10.1099/00221287-94-1-37; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Rajavel M, 2006, ACTA CRYSTALLOGR F, V62, P1259, DOI 10.1107/S1744309106047087; ROSCOE J, 1966, BIOCHEM J, V99, P793, DOI 10.1042/bj0990793; SAKAJOH M, 1987, J IND MICROBIOL, V2, P201, DOI 10.1007/BF01569541; Steinborn G, 2005, ARCH MICROBIOL, V183, P71, DOI 10.1007/s00203-004-0743-8; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Williams A, 2003, PROTEIN ENG, V16, P913, DOI 10.1093/protein/gzg116	23	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31882	31892		10.1074/jbc.M109.014522	http://dx.doi.org/10.1074/jbc.M109.014522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19776011	Green Published, hybrid			2022-12-25	WOS:000271572700043
J	Yuan, JS; Chen, JJ				Yuan, Jingsong; Chen, Junjie			N Terminus of CtIP Is Critical for Homologous Recombination-mediated Double-strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DNA-DAMAGE RESPONSE; S-PHASE CHECKPOINT; MRE11 COMPLEX; MEIOTIC RECOMBINATION; END RESECTION; BRCA1; PHOSPHORYLATION; BINDING; PATHWAY	DNA double-strand breaks (DSBs) represent one of the most lethal types of DNA damage cells encounter. CtIP (also known as RBBP8) acts together with the MRN (MRE11-RAD50-NBS1) complex to promote DNA end resection and the generation of single-stranded DNA, which is critically important for homologous recombination repair. However, it is not yet clear exactly how CtIP participates in this process. Here, we demonstrate that besides the known conserved C terminus, the N terminus of CtIP protein is also required in DSB end resection and DNA damage-induced G(2)/M checkpoint control. We further show that both termini of CtIP can interact with the MRN complex and that the N terminus of CtIP, especially residues 22-45, binds to MRN and plays a critical role in targeting CtIP to sites of DNA breaks. Collectively, our results highlight the importance of the N terminus of CtIP in directing its localization and function in DSB repair.	[Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org	Yuan, Jingsong/G-4527-2011		National Institutes of Health [CA089239, CA092312, CA100109]; United States Department of Defense; NATIONAL CANCER INSTITUTE [R01CA100109, R01CA092312, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar Award from the United States Department of Defense and member of the Mayo Clinic Breast SPORE Program.	Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lavin MF, 2004, DNA REPAIR, V3, P1515, DOI 10.1016/j.dnarep.2004.07.001; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	54	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31746	31752		10.1074/jbc.M109.023424	http://dx.doi.org/10.1074/jbc.M109.023424			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759395	Green Published, hybrid			2022-12-25	WOS:000271572700029
J	Skinner, JR; Shew, TM; Schwartz, DM; Tzekov, A; Lepus, CM; Abumrad, NA; Wolins, NE				Skinner, James R.; Shew, Trevor M.; Schwartz, Danielle M.; Tzekov, Anatoly; Lepus, Christin M.; Abumrad, Nada A.; Wolins, Nathan E.			Diacylglycerol Enrichment of Endoplasmic Reticulum or Lipid Droplets Recruits Perilipin 3/TIP47 during Lipid Storage and Mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ACYL-COA; ADIPOCYTE LIPOLYSIS; PROTEIN-KINASE; MEMBRANE; CELL; DROSOPHILA; BINDING; TRIACYLGLYCEROL; STABILIZATION; BIOSYNTHESIS	Fatty acid-induced triacylglycerol synthesis produces triacylglycerol droplets with a protein coat that includes perilipin 3/TIP47 and perilipin 4/S3-12. This study addresses the following two questions. Where do lipid droplets emerge, and how are their coat proteins recruited? We show that perilipin 3- and perilipin 4-coated lipid droplets emerge along the endoplasmic reticulum (ER). Blocking membrane trafficking with AlF4- during fatty acid-induced triacylglycerol synthesis drove perilipin 3 to the tubular ER. Forskolin, which like AlF4- activates adenylate cyclase, did not redistribute perilipin 3, but when added together with AlF4- perilipin 3 was recruited to lipid droplets rather than the ER. Thus inhibiting trafficking with AlF4- redistributed perilipin 3 differently under conditions of triacylglycerol synthesis (fatty acid addition) versus hydrolysis (forskolin) suggesting a shared acylglycerol-mediated mechanism. We tested whether diacylglycerol (DG), the immediate precursor of triacylglycerol and its first hydrolytic product, affects the distribution of perilipin 3. Stabilizing DG with the DG lipase inhibitor RHC80267 enhanced the perilipin 3 recruited to lipid droplets and raised DG levels in this fraction. Treating cells with a membrane-permeable DG recruited perilipin 3 to the ER. Stabilizing DG, by blocking its hydrolysis with RHC80267 or its acylation with triacsin C, enhanced recruitment of perilipin 3 to the ER. Expressing the ER enzyme DGAT1, which removes DG by converting it to triacylglycerol, attenuated perilipin 3 DG-induced ER recruitment. Membrane-permeable DG also drove perilipin 4 and 5 onto the ER. Together the data suggest that these lipid droplet proteins are recruited to DG-enriched membranes thereby linking lipid coat proteins to the metabolic state of the cell.	[Wolins, Nathan E.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Tzekov, Anatoly] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wolins, NE (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, Campus Box 8031, St Louis, MO 63110 USA.	nwolins@wustl.edu			National Institutes of Health [R01DK 33301]; American Diabetes Association [7-06-JF-69]; Clinical Nutrition Research Unit [DK56351]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Clinical Nutrition Research Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK 33301 (to N.A.A.). This work was supported by American Diabetes Association Grant 7-06-JF-69 (to N.E.W.) and by Clinical Nutrition Research Unit Grant DK56351 through a pilot and feasibility grant (to N.E.W.) for use of the Adipocyte Biology Core facility.	Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Carey GB, 1998, ADV EXP MED BIOL, V441, P157; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; CUSHMAN SW, 1970, J CELL BIOL, V46, P326, DOI 10.1083/jcb.46.2.326; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; KIMMEL AR, 2009, J LIPID RES IN PRESS; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nakamura N, 2004, BIOCHEM BIOPH RES CO, V322, P957, DOI 10.1016/j.bbrc.2004.08.010; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; ROBENEK H, 2008, BIOCH BIOPH IN PRESS; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; SUTHERLAND CA, 1982, J BIOL CHEM, V257, P4006; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Wang RX, 1998, J IMMUNOL, V161, P2201; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200	50	102	106	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30941	30948		10.1074/jbc.M109.013995	http://dx.doi.org/10.1074/jbc.M109.013995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748893	hybrid, Green Published			2022-12-25	WOS:000271378400023
J	Balabanova, Y; Drobniewski, F; Nikolayevskyy, V; Kruuner, A; Malomanova, N; Simak, T; Ilyina, N; Zakharova, S; Lebedeva, N; Alexander, HL; O'Brien, R; Sohn, H; Shakhmistova, A; Fedorin, I				Balabanova, Yanina; Drobniewski, Francis; Nikolayevskyy, Vladyslav; Kruuner, Annika; Malomanova, Nadezhda; Simak, Tatyana; Ilyina, Nailya; Zakharova, Svetlana; Lebedeva, Natalya; Alexander, Heather L.; O'Brien, Rick; Sohn, Hojoon; Shakhmistova, Anastasia; Fedorin, Ivan			An Integrated Approach to Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using Liquid Culture and Molecular Methods in Russia	PLOS ONE			English	Article								Objective: To analyse the feasibility, cost and performance of rapid tuberculosis (TB) molecular and culture systems, in a high multidrug-resistant TB (MDR TB) middle-income region (Samara, Russia) and provide evidence for WHO policy change. Methods: Performance and cost evaluation was conducted to compare the BACTEC (TM) MGIT (TM) 960 system for culture and drug susceptibility testing (DST) and molecular systems for TB diagnosis, resistance to isoniazid and rifampin, and MDR TB identification compared to conventional Lowenstein-Jensen culture assays. Findings: 698 consecutive patients (2487 sputum samples) with risk factors for drug-resistant tuberculosis were recruited. Overall M. tuberculosis complex culture positivity rates were 31.6% (787/2487) in MGIT and 27.1% (675/2487) in LJ (90.5% and 83.2% for smear-positive specimens). In total, 809 cultures of M. tuberculosis complex were isolated by any method. Median time to detection was 14 days for MGIT and 36 days for LJ (10 and 33 days for smear positive specimens) and indirect DST in MGIT took 9 days compared to 21 days on LJ. There was good concordance between DST on LJ and MGIT (96.8% for rifampin and 95.6% for isoniazid). Both molecular hybridization assay results correlated well with MGIT DST results, although molecular assays generally yielded higher rates of resistance (by approximately 3% for both isoniazid and rifampin). Conclusion: With effective planning and logistics, the MGIT 960 and molecular based methodologies can be successfully introduced into a reference laboratory setting in a middle incidence country. High rates of MDR TB in the Russian Federation make the introduction of such assays particularly useful.			Balabanova, Y (corresponding author), Univ London, Barts & London Sch Med, Queen Mary Coll,Inst Cell & Mol Sci, Natl Mycobacterium Reference Lab, London, England.	y.balabanova@qmul.ac.uk	Sohn, Hojoon/AAL-2856-2020; Nikolayevskyy, Vladyslav/HFZ-7738-2022	Sohn, Hojoon/0000-0001-5837-3844; Nikolayevskyy, Vladyslav/0000-0002-9502-0332				Balabanova Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-44; Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Bardarov S, 2003, DIAGN MICR INFEC DIS, V45, P53, DOI 10.1016/S0732-8893(02)00478-9; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Bergmann JS, 2000, ARCH PATHOL LAB MED, V124, P82; Chien HP, 2000, INT J TUBERC LUNG D, V4, P866; Coninx R, 1998, BRIT MED J, V316, P1423, DOI 10.1136/bmj.316.7142.1423; Dewan P, 2005, INT J TUBERC LUNG D, V9, P170; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; Drobniewski FA, 2000, J MED MICROBIOL, V49, P271, DOI 10.1099/0022-1317-49-3-271; DROBNIEWSKI FA, 2006, EUROPE EUR RESP J; Drummond MF, 2015, METHODS EC EVALUATIO; Edejer T, 2003, MAKING CHOICES HLTH; Giampaglia CMS, 2007, INT J TUBERC LUNG D, V11, P986; Goloubeva V, 2001, J CLIN MICROBIOL, V39, P1501, DOI 10.1128/JCM.39.4.1501-1505.2001; Hanna BA, 1999, J CLIN MICROBIOL, V37, P748, DOI 10.1128/JCM.37.3.748-752.1999; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hillemann D, 2006, J CLIN MICROBIOL, V44, P4014, DOI 10.1128/JCM.00829-06; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Migliori GB, 2008, CLIN INFECT DIS, V46, P958, DOI 10.1086/528875; Mokrousov I, 2004, J MICROBIOL METH, V57, P323, DOI 10.1016/j.mimet.2004.02.006; Nikolayevsky V, 2004, J CLIN MICROBIOL, V42, P4498, DOI 10.1128/JCM.42.10.4498-4502.2004; Nikolayevskyy V, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-2; Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P364, DOI 10.1128/JCM.35.2.364-368.1997; *PRIK MIN HLTH RUS, 2003, 109 PRIK MIN HLTH RU; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Rusch-Gerdes S, 1999, J CLIN MICROBIOL, V37, P45; Seagar AL, 2008, J MED MICROBIOL, V57, P605, DOI 10.1099/jmm.0.47484-0; Skenders G, 2005, EMERG INFECT DIS, V11, P1461, DOI 10.3201/eid1109.041236; Somoskovi A, 2003, J CLIN MICROBIOL, V41, P2822, DOI 10.1128/JCM.41.7.2822-2826.2003; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P2314, DOI 10.1128/JCM.00712-06; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P4459, DOI 10.1128/JCM.01506-06; Srisuwanvilai LO, 2008, DIAGN MICR INFEC DIS, V61, P402, DOI 10.1016/j.diagmicrobio.2008.02.015; Tortoli E, 2002, J CLIN MICROBIOL, V40, P607, DOI 10.1128/JCM.40.2.607-610.2002; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; *WHO, 2008, NEW WHO POL; *WHO INT UN TUB LU, 2008, 4WHOHTMTB2008394 INT; World Health Organization, 2008, MOL LIN PROB ASS RAP	45	41	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7129	10.1371/journal.pone.0007129	http://dx.doi.org/10.1371/journal.pone.0007129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774085	Green Submitted, gold, Green Published			2022-12-25	WOS:000270160900013
J	Solomon, LA; Li, JR; Berube, NG; Beier, F				Solomon, Lauren A.; Li, Jennifer R.; Berube, Nathalie G.; Beier, Frank			Loss of ATRX in Chondrocytes Has Minimal Effects on Skeletal Development	PLOS ONE			English	Article							MENTAL-RETARDATION; CRE RECOMBINASE; PROTEIN ATRX; MICE LACKING; SNF2 FAMILY; MUTATIONS; DIFFERENTIATION; EXPRESSION; PROLIFERATION; OSTEOBLAST	Background: Mutations in the human ATRX gene cause developmental defects, including skeletal deformities and dwarfism. ATRX encodes a chromatin remodeling protein, however the role of ATRX in skeletal development is currently unknown. Methodology/Principal Findings: We induced Atrx deletion in mouse cartilage using the Cre-loxP system, with Cre expression driven by the collagen II (Col2a1) promoter. Growth rate, body size and weight, and long bone length did not differ in Atrx(Col2cre) mice compared to control littermates. Histological analyses of the growth plate did not reveal any differences between control and mutant mice. Expression patterns of Sox9, a transcription factor required for cartilage morphogenesis, and p57, a marker of cell cycle arrest and hypertrophic chondrocyte differentiation, was unaffected. However, loss of ATRX in cartilage led to a delay in the ossification of the hips in some mice. We also observed hindlimb polydactily in one out of 61 mutants. Conclusions/Significance: These findings indicate that ATRX is not directly required for development or growth of cartilage in the mouse, suggesting that the short stature in ATR-X patients is caused by defects in cartilage-extrinsic mechanisms.			Solomon, LA (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	nberube@uwo.ca; fbeier@uwo.ca	Beier, Frank/G-4595-2013; Berube, Nathalie G/E-3885-2015; Beier, Frank/T-4734-2019	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Badens C, 2006, CLIN GENET, V70, P57, DOI 10.1111/j.1399-0004.2006.00641.x; Ballock R. Tracy, 2003, Birth Defects Research, V69, P123, DOI 10.1002/bdrc.10014; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; Bobick Brent E., 2008, Birth Defects Research, V84, P131, DOI 10.1002/bdrc.20126; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Garrick D, 2004, GENE, V326, P23, DOI 10.1016/j.gene.2003.10.026; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Hoffman UM, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300002-00017; James CG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-205; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Maestroni GJM, 2000, ANN NY ACAD SCI, V917, P29; Medina CF, 2009, HUM MOL GENET, V18, P966, DOI 10.1093/hmg/ddn424; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008; Takeda S, 2005, BIOCHEM BIOPH RES CO, V328, P697, DOI 10.1016/j.bbrc.2004.11.071; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	33	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7106	10.1371/journal.pone.0007106	http://dx.doi.org/10.1371/journal.pone.0007106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774083	Green Submitted, gold, Green Published			2022-12-25	WOS:000270160900008
J	Chen, LW; Tredget, EE; Liu, CX; Wu, YJ				Chen, Liwen; Tredget, Edward E.; Liu, Chenxiong; Wu, Yaojiong			Analysis of Allogenicity of Mesenchymal Stem Cells in Engraftment and Wound Healing in Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN BONE-MARROW; T-CELLS; DIFFERENTIATION; RESPONSES; INHIBIT; REPAIR; FIBROBLASTS; DISEASE; HOST	Studies have shown that allogeneic (allo-) bone marrow derived mesenchymal stem cells (BM-MSCs) may enhance tissue repair/regeneration. However, recent studies suggest that immune rejection may occur to allo- MSCsleading to reduced engraftment. In this study, we compared allo- BM-MSCs with syngeneic BM-MSCs or allo- fibroblasts in engraftment and effect in wound healing. Equal numbers of GFP-expressing allo- BM-MSCs, syngeneic BM-MSCs or allo- fibroblasts were implanted into excisional wounds in GFP-negative mice. Quantification of GFP-expressing cells in wounds at 7, 14 and 28 days indicated similar amounts of allogeneic or syngeneic BM-MSCs but significantly reduced amounts of allo- fibroblasts. With healing progression, decreasing amounts of allogeneic and syngeneic BM-MSCs were found in the wound; however, the reduction was more evident (2 fold) in allo- fibroblasts. Similar effects in enhancing wound closure were found in allogeneic and syngeneic BM-MSCs but not in allo- fibroblasts. Histological analysis showed that allo- fibroblasts were largely confined to the injection sites while allo- BM-MSCs had migrated into the entire wound. Quantification of inflammatory cells in wounds showed that allo-fibroblast- but not allo- BM-MSC-treated wounds had significantly increased CD45(+) leukocytes, CD3(+) lymphocytes and CD8(+) T cells. Our study suggests that allogeneic BM-MSCs exhibit ignorable immunogenicity and are equally efficient as syngeneic BM-MSCs in engraftment and in enhancing wound healing.			Chen, LW (corresponding author), S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	wu.yaojiong@sz.tsinghua.edu.cn						Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; El-Badri NS, 2004, STEM CELLS DEV, V13, P463, DOI 10.1089/scd.2004.13.463; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Kern A, 2001, J INVEST DERMATOL, V117, P112, DOI 10.1046/j.0022-202x.2001.01386.x; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lamme EN, 2002, WOUND REPAIR REGEN, V10, P152, DOI 10.1046/j.1524-475X.2002.10901.x; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liu H, 2006, J IMMUNOL, V176, P2864, DOI 10.4049/jimmunol.176.5.2864; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; McFarlin K, 2006, WOUND REPAIR REGEN, V14, P471, DOI 10.1111/j.1743-6109.2006.00153.x; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Smythe JA, 1999, J IMMUNOL, V163, P3239; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	34	127	135	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7119	10.1371/journal.pone.0007119	http://dx.doi.org/10.1371/journal.pone.0007119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771171	Green Submitted, gold, Green Published			2022-12-25	WOS:000270154400012
J	Danovaro, R; Umani, SF; Pusceddu, A				Danovaro, Roberto; Umani, Serena Fonda; Pusceddu, Antonio			Climate Change and the Potential Spreading of Marine Mucilage and Microbial Pathogens in the Mediterranean Sea	PLOS ONE			English	Article								Background: Marine snow (small amorphous aggregates with colloidal properties) is present in all oceans of the world. Surface water warming and the consequent increase of water column stability can favour the coalescence of marine snow into marine mucilage, large marine aggregates representing an ephemeral and extreme habitat. Marine mucilage characterize aquatic systems with altered environmental conditions. Methodology/Principal Findings: We investigated, by means of molecular techniques, viruses and prokaryotes within the mucilage and in surrounding seawater to examine the potential of mucilage to host new microbial diversity and/or spread marine diseases. We found that marine mucilage contained a large and unexpectedly exclusive microbial biodiversity and hosted pathogenic species that were absent in surrounding seawater. We also investigated the relationship between climate change and the frequency of mucilage in the Mediterranean Sea over the last 200 years and found that the number of mucilage outbreaks increased almost exponentially in the last 20 years. The increasing frequency of mucilage outbreaks is closely associated with the temperature anomalies. Conclusions/Significance: We conclude that the spreading of mucilage in the Mediterranean Sea is linked to climate-driven sea surface warming. The mucilage can act as a controlling factor of microbial diversity across wide oceanic regions and could have the potential to act as a carrier of specific microorganisms, thereby increasing the spread of pathogenic bacteria.			Danovaro, R (corresponding author), Polytech Univ Marche, Dept Marine Sci, Ancona, Italy.	r.danovaro@univpm.it	Fonda, Serena/H-6753-2012					Aktan Y., 2008, Harmful Algae News, V36, P1; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Azam F, 1999, Ann Ist Super Sanita, V35, P411; Baldi F, 1997, MAR ECOL PROG SER, V153, P45, DOI 10.3354/meps153045; Beaumont NJ, 2007, MAR POLLUT BULL, V54, P253, DOI 10.1016/j.marpolbul.2006.12.003; Bongiorni L, 2007, AQUAT MICROB ECOL, V49, P15, DOI 10.3354/ame01126; Carlton JT, 1998, CONSERV BIOL, V12, P1165, DOI 10.1046/j.1523-1739.1998.0120061165.x; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Corinaldesi C, 2003, APPL ENVIRON MICROB, V69, P2664, DOI 10.1128/AEM.69.5.2664-2673.2003; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Danovaro R, 2005, SCI TOTAL ENVIRON, V353, P189, DOI 10.1016/j.scitotenv.2005.09.029; Danovaro R, 2003, MAR POLLUT BULL, V46, P301, DOI 10.1016/S0025-326X(02)00461-7; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Danovaro R, 2008, ENVIRON HEALTH PERSP, V116, P441, DOI 10.1289/ehp.10966; DEGOBBIS D, 1995, SCI TOTAL ENVIRON, V165, P43, DOI 10.1016/0048-9697(95)04542-9; Del Negro P, 2005, SCI TOTAL ENVIRON, V353, P258, DOI 10.1016/j.scitotenv.2005.09.018; Flander-Putrle V, 2008, HARMFUL ALGAE, V7, P752, DOI 10.1016/j.hal.2008.02.009; FOGG GE, 1995, SCI TOTAL ENVIRON, V165, P59, DOI 10.1016/0048-9697(95)04543-A; Fonda Umani S., 1989, EPISODI MARE SPORCO, P178; GIANI M, 1992, SCIENCE OF THE TOTAL ENVIRONMENT, SUPPLEMENT 1992, P539; Heissenberger A, 1996, MAR ECOL PROG SER, V135, P299, DOI 10.3354/meps135299; HEISSENBERGER A, 1994, MARINE ECOLOGY PROGR, V111, P128; Herndl Gerhard J., 1992, Marine Microbial Food Webs, V6, P149; HERNDL GJ, 1988, PSZNI MAR ECOL, V9, P79; KALTENBOCK E, 1992, MAR ECOL PROG SER, V87, P147, DOI 10.3354/meps087147; KOKELJ F, 1994, CONTACT DERMATITIS, V31, P257, DOI 10.1111/j.1600-0536.1994.tb01999.x; LEPPARD GG, 1995, SCI TOTAL ENVIRON, V165, P103, DOI 10.1016/0048-9697(95)04546-D; Luna GM, 2007, ENVIRON MICROBIOL, V9, P1851, DOI 10.1111/j.1462-2920.2007.01287.x; MacKenzie L, 2002, HARMFUL ALGAE, V1, P295, DOI 10.1016/S1568-9883(02)00006-9; MALEJ A, 1993, MAR ECOL PROG SER, V96, P33, DOI 10.3354/meps096033; MONTI M, 1995, SCI TOTAL ENVIRON, V165, P145, DOI 10.1016/0048-9697(95)04548-F; MULLERNIKLAS G, 1994, LIMNOL OCEANOGR, V39, P58; MYKLESTAD S, 1977, J EXP MAR BIOL ECOL, V29, P161, DOI 10.1016/0022-0981(77)90046-6; OBERNOSTERER I, 1995, MAR ECOL PROG SER, V116, P247, DOI 10.3354/meps116247; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Pajdak-Stos A, 2001, AQUAT MICROB ECOL, V23, P237, DOI 10.3354/ame023237; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PEDUZZI P, 1993, LIMNOL OCEANOGR, V38, P1562, DOI 10.4319/lo.1993.38.7.1562; POSEDEL N, 1991, MAR ECOL PROG SER, V77, P135, DOI 10.3354/meps077135; Precali R, 2005, SCI TOTAL ENVIRON, V353, P10, DOI 10.1016/j.scitotenv.2005.09.066; Pusceddu A, 2005, CONT SHELF RES, V25, P2491, DOI 10.1016/j.csr.2005.08.013; Rath J, 1998, AQUAT MICROB ECOL, V14, P261, DOI 10.3354/ame014261; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; RINALDI A, 1995, SCI TOTAL ENVIRON, V165, P165, DOI 10.1016/0048-9697(95)04550-K; Roether W, 1996, SCIENCE, V271, P333, DOI 10.1126/science.271.5247.333; SCHUSTER S, 1995, MAR ECOL PROG SER, V124, P227, DOI 10.3354/meps124227; Sellner KG, 1999, COAST ESTUAR STUD, V55, P173; SHIBATA A, 2007, MARINE ECOLOGY PROGR, V155, P303; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Umani SF, 2007, AQUAT MICROB ECOL, V46, P163; Umani SF, 2005, SCI TOTAL ENVIRON, V353, P218, DOI 10.1016/j.scitotenv.2005.09.016; WEINBAUER MG, 1995, J PLANKTON RES, V17, P1851, DOI 10.1093/plankt/17.9.1851; WEINBAUER MG, 1995, MICROBIAL ECOL, V30, P25, DOI 10.1007/BF00184511; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	58	87	100	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2009	4	9							e7006	10.1371/journal.pone.0007006	http://dx.doi.org/10.1371/journal.pone.0007006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KE	19759910	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970000008
J	Stahl, AL; Sartz, L; Nelsson, A; Bekassy, ZD; Karpman, D				Stahl, Anne-lie; Sartz, Lisa; Nelsson, Anders; Bekassy, Zivile D.; Karpman, Diana			Shiga Toxin and Lipopolysaccharide Induce Platelet-Leukocyte Aggregates and Tissue Factor Release, a Thrombotic Mechanism in Hemolytic Uremic Syndrome	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; POLYMORPHONUCLEAR LEUKOCYTES; FACTOR EXPRESSION; UP-REGULATION; COAGULATION; ACTIVATION; DIARRHEA; VEROCYTOTOXIN; MONOCYTES	Background: Aggregates formed between leukocytes and platelets in the circulation lead to release of tissue factor (TF)-bearing microparticles contributing to a prothrombotic state. As enterohemorrhagic Escherichia coli (EHEC) may cause hemolytic uremic syndrome (HUS), in which microthrombi cause tissue damage, this study investigated whether the interaction between blood cells and EHEC virulence factors Shiga toxin (Stx) and lipopolysaccharide (LPS) led to release of TF. Methodology/Principal Findings: The interaction between Stx or LPS and blood cells induced platelet-leukocyte aggregate formation and tissue factor (TF) release, as detected by flow cytometry in whole blood. O157LPS was more potent than other LPS serotypes. Aggregates formed mainly between monocytes and platelets and less so between neutrophils and platelets. Stimulated blood cells in complex expressed activation markers, and microparticles were released. Microparticles originated mainly from platelets and monocytes and expressed TF. TF-expressing microparticles, and functional TF in plasma, increased when blood cells were simultaneously exposed to the EHEC virulence factors and high shear stress. Stx and LPS in combination had a more pronounced effect on platelet-monocyte aggregate formation, and TF expression on these aggregates, than each virulence factor alone. Whole blood and plasma from HUS patients (n = 4) were analyzed. All patients had an increase in leukocyte-platelet aggregates, mainly between monocytes and platelets, on which TF was expressed during the acute phase of disease. Patients also exhibited an increase in microparticles, mainly originating from platelets and monocytes, bearing surface-bound TF, and functional TF was detected in their plasma. Blood cell aggregates, microparticles, and TF decreased upon recovery. Conclusions/Significance: By triggering TF release in the circulation, Stx and LPS can induce a prothrombotic state contributing to the pathogenesis of HUS.			Stahl, AL (corresponding author), Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden.	diana.karpman@med.lu.se		Aradottir, Sigridur Sunna/0000-0002-6898-3256; Karpman, Diana/0000-0001-7220-7658				Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; BACH RR, 1988, CRC CR REV BIOCH MOL, V23, P339, DOI 10.3109/10409238809082548; Bancsi MJLMF, 1996, INFECT IMMUN, V64, P448, DOI 10.1128/IAI.64.2.448-451.1996; Brambilla M, 2008, ARTERIOSCL THROM VAS, V28, P947, DOI 10.1161/ATVBAHA.107.161471; Cambien B, 2004, TRENDS MOL MED, V10, P179, DOI 10.1016/j.molmed.2004.02.007; Chandler WL, 2002, NEW ENGL J MED, V346, P23, DOI 10.1056/NEJMoa011033; DAVEY MG, 1966, THROMB DIATH HAEMOST, VS, P283; EDGINGTON TS, 1992, NOUV REV FR HEMATOL, V34, pS15; Etalamy I, 2008, THROMB RES, V121, P843, DOI 10.1016/j.thromres.2007.07.016; Galli M, 1996, THROMB HAEMOSTASIS, V75, P427; Geelen JM, 2007, NEPHROL DIAL TRANSPL, V22, P749, DOI 10.1093/ndt/gfl688; Ghosh SA, 2004, J THROMB HAEMOST, V2, P499, DOI 10.1111/j.1538-7933.2004.00638.x; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; HILLER E, 1977, HAEMOSTASIS, V6, P347; Inward CD, 1997, PEDIATR NEPHROL, V11, P556, DOI 10.1007/s004670050337; INZANA TJ, 1983, J INFECT DIS, V148, P492, DOI 10.1093/infdis/148.3.492; Kalsch T, 2007, BASIC RES CARDIOL, V102, P460, DOI 10.1007/s00395-007-0667-y; Kamitsuji H, 2000, CLIN NEPHROL, V53, P319; Karpman D, 1995, PEDIATR NEPHROL, V9, P694, DOI 10.1007/BF00868714; Karpman D, 2001, BLOOD, V97, P3100, DOI 10.1182/blood.V97.10.3100; Karpman D, 2002, CURR PAEDIAT, V12, P569, DOI DOI 10.1054/CUPE.2002.0346; Leguyader Alexandre, 2006, Interact Cardiovasc Thorac Surg, V5, P60; LOUISE CB, 1992, INFECT IMMUN, V60, P1536, DOI 10.1128/IAI.60.4.1536-1543.1992; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Maugeri N, 2006, J THROMB HAEMOST, V4, P1323, DOI 10.1111/j.1538-7836.2006.01968.x; May AE, 2007, SEMIN THROMB HEMOST, V33, P123, DOI 10.1055/s-2007-969023; MESZAROS K, 1994, BLOOD, V83, P2516; MILFORD DV, 1991, NEPHROL DIAL TRANSPL, V6, P232, DOI 10.1093/ndt/6.4.232; MOORE KL, 1987, J CLIN INVEST, V79, P124, DOI 10.1172/JCI112772; Morigi M, 2001, BLOOD, V98, P1828, DOI 10.1182/blood.V98.6.1828; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; Murata K, 2006, BBA-MOL BASIS DIS, V1762, P835, DOI 10.1016/j.bbadis.2006.07.004; Nestoridi E, 2008, PEDIATR NEPHROL, V23, P221, DOI 10.1007/s00467-007-0636-6; Nevard CHF, 1997, THROMB HAEMOSTASIS, V78, P1450; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Osterud B, 2003, DM-DIS MON, V49, P7, DOI 10.1016/S0011-5029(03)90010-1; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Siddiqui FA, 2002, PLATELETS, V13, P247, DOI 10.1080/09537100220146398; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Sugatani J, 2000, THROMB RES, V100, P61, DOI 10.1016/S0049-3848(00)00305-4; Svenungsson B, 2000, CLIN INFECT DIS, V30, P770, DOI 10.1086/313770; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tazzari PL, 2004, CYTOM PART B-CLIN CY, V61B, P40, DOI 10.1002/cyto.b.20022; te Loo DMWM, 2001, J AM SOC NEPHROL, V12, P800, DOI 10.1681/ASN.V124800; Tefferi A, 2007, SEMIN THROMB HEMOST, V33, P313, DOI 10.1055/s-2007-976165; Tremoli E, 1999, ATHEROSCLEROSIS, V144, P273, DOI 10.1016/S0021-9150(99)00063-5; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; VANDEKAR NCAJ, 1992, BLOOD, V80, P2755; vanSetten PA, 1996, BLOOD, V88, P174, DOI 10.1182/blood.V88.1.174.bloodjournal881174; Wakita Y, 1999, CLIN APPL THROMB-HEM, V5, P10, DOI 10.1177/107602969900500103; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; Yamani MH, 2002, J HEART LUNG TRANSPL, V21, P983, DOI 10.1016/S1053-2498(02)00408-4	54	97	99	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6990	10.1371/journal.pone.0006990	http://dx.doi.org/10.1371/journal.pone.0006990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750223	Green Submitted, Green Published, gold			2022-12-25	WOS:000269696600016
J	Petkova, VI; Ehrsson, HH				Petkova, Valeria I.; Ehrsson, H. Henrik			When Right Feels Left: Referral of Touch and Ownership between the Hands	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; PRIMARY SOMATOSENSORY CORTEX; RUBBER HAND; RECEPTIVE-FIELDS; PARIETAL CORTEX; MULTISENSORY INTEGRATION; CALLOSAL CONNECTIONS; CUTANEOUS RABBIT; INFERIOR AREA-6; BODY	Feeling touch on a body part is paradigmatically considered to require stimulation of tactile afferents from the body part in question, at least in healthy non-synaesthetic individuals. In contrast to this view, we report a perceptual illusion where people experience "phantom touches" on a right rubber hand when they see it brushed simultaneously with brushes applied to their left hand. Such illusory duplication and transfer of touch from the left to the right hand was only elicited when a homologous (i.e., left and right) pair of hands was brushed in synchrony for an extended period of time. This stimulation caused the majority of our participants to perceive the right rubber hand as their own and to sense two distinct touches - one located on the right rubber hand and the other on their left (stimulated) hand. This effect was supported by quantitative subjective reports in the form of questionnaires, behavioral data from a task in which participants pointed to the felt location of their right hand, and physiological evidence obtained by skin conductance responses when threatening the model hand. Our findings suggest that visual information augments subthreshold somatosensory responses in the ipsilateral hemisphere, thus producing a tactile experience from the non-stimulated body part. This finding is important because it reveals a new bilateral multisensory mechanism for tactile perception and limb ownership.			Petkova, VI (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	Valeria.Petkova@ki.se						Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; COLBY CL, 1991, NEUROPSYCHOLOGIA, V29, P517, DOI 10.1016/0028-3932(91)90008-V; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2009, PERCEPTION, V38, P310, DOI 10.1068/p6304; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fabri M, 1999, EUR J NEUROSCI, V11, P3983, DOI 10.1046/j.1460-9568.1999.00829.x; GARDNER EP, 1980, J NEUROPHYSIOL, V43, P420, DOI 10.1152/jn.1980.43.2.420; GELDARD FA, 1972, SCIENCE, V178, P178, DOI 10.1126/science.178.4057.178; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; GODSCHALK M, 1984, EXP BRAIN RES, V56, P410; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Haggard P, 2007, EXP BRAIN RES, V180, P187, DOI 10.1007/s00221-007-0971-7; Halligan PW, 1996, NEUROCASE, V2, P21; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Iriki A, 1996, NEUROREPORT, V7, P2325; Iwamura Y, 2002, BEHAV BRAIN RES, V135, P185, DOI 10.1016/S0166-4328(02)00164-X; Iwamura Y, 2001, NEUROSCIENTIST, V7, P419, DOI 10.1177/107385840100700511; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Johnson MJ, 1996, J NEUROPHYSIOL, V75, P1444, DOI 10.1152/jn.1996.75.4.1444; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LEDBERG A, 1995, EUR J NEUROSCI, V7, P1934, DOI 10.1111/j.1460-9568.1995.tb00716.x; LEDERMAN SJ, 1981, J EXP PSYCHOL HUMAN, V7, P902, DOI 10.1037/0096-1523.7.4.902; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; NEAL JW, 1987, BRAIN RES, V419, P341, DOI 10.1016/0006-8993(87)90605-6; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Press C, 2004, EXP BRAIN RES, V154, P238, DOI 10.1007/s00221-003-1651-x; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; ROBINSON CJ, 1980, J COMP NEUROL, V192, P43, DOI 10.1002/cne.901920104; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; ROSEN B, 2009, SCAND J PLA IN PRESS; Ruben J, 2001, CEREB CORTEX, V11, P463, DOI 10.1093/cercor/11.5.463; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; Sathian K, 2000, NEUROLOGY, V54, P1866, DOI 10.1212/WNL.54.9.1866; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; SHERRICK CE, 1964, AM J PSYCHOL, V77, P42, DOI 10.2307/1419270; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Simoes C, 1999, NEUROIMAGE, V10, P408, DOI 10.1006/nimg.1999.0476; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Tipper SP, 2001, EXP BRAIN RES, V139, P160, DOI 10.1007/s002210100743; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; von Bekesy G, 1967, SENSORY INHIBITION; Wozny DR, 2008, J VISION, V8, DOI 10.1167/8.3.24	72	71	73	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6933	10.1371/journal.pone.0006933	http://dx.doi.org/10.1371/journal.pone.0006933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	491ZI	19742313	Green Published, gold			2022-12-25	WOS:000269622500011
J	Huart, AS; MacLaine, NJ; Meek, DW; Hupp, TR				Huart, Anne-Sophie; MacLaine, Nicola J.; Meek, David W.; Hupp, Ted R.			CK1 alpha Plays a Central Role in Mediating MDM2 Control of p53 and E2F-1 Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; IN-VITRO; PHOSPHORYLATION; DOMAIN; CASEIN-KINASE-1; UBIQUITINATION; STABILIZATION; INHIBITION; PATHWAY; BINDING	The ubiquitin ligase murine double minute clone 2 (MDM2) mediates ubiquitination and degradation of the tumor suppressor p53. The activation and stabilization of p53 by contrast is maintained by enzymes catalyzing p53 phosphorylation and acetylation. Casein kinase 1 (CK1) is one such enzyme; it stimulates p53 after transforming growth factor-beta treatment, irradiation, or DNA virus infection. We analyzed whether CK1 regulates p53 protein stability in unstressed conditions. Depletion of CK1 using small interfering RNA or inhibition of CK1 using the kinase inhibitor (D4476) activated p53 and destabilized E2F-1, indicating that steady-state levels of these proteins are controlled by CK1. Co-immunoprecipitation of endogenous CK1 with MDM2 occurred in undamaged cells, indicating the existence of a stable multiprotein complex, and as such, we evaluated whether the MDM2 Nutlin had similar pharmacological properties to the CK1 inhibitor D4476. Indeed, D4476 or Nutlin treatments resulted in the same p53 and E2F-1 steady-state protein level changes, indicating that the MDM2 center dot CK1 complex is both a negative regulator of p53 and a positive regulator of E2F-1 in undamaged cells. Although the treatment of cells with D4476 resulted in a partial p53-dependent growth arrest, the induction of p53-independent apoptosis by D4476 suggested a critical role for the MDM2 center dot CK1 complex in maintaining E2F-1 anti-apoptotic signaling. These data highlighting a pharmacological similarity between MDM2 and CK1 small molecule inhibitors and the fact that CK1 and MDM2 form a stable complex suggest that the MDM2 center dot CK1 complex is a component of a genetic pathway that co-regulates the stability of the p53 and E2F-1 transcription factors.	[Huart, Anne-Sophie; MacLaine, Nicola J.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Div Canc Biol, CRUK Signal Transduct Grp P53, Edinburgh EH4 2XR, Midlothian, Scotland; [Meek, David W.] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland; [Meek, David W.] Ninewells Hosp, Biomed Res Ctr, Dundee DD1 9SY, Scotland	University of Edinburgh; University of Dundee; University of Dundee	Hupp, TR (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Div Canc Biol, CRUK Signal Transduct Grp P53, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk		Huart, Anne-Sophie/0000-0003-0913-1501	Cancer Research UK [C483/A10706]	Cancer Research UK(Cancer Research UK)	Supported by a Ph.D. studentship from the Cancer Research UK (C483/A10706).	Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Stevens C, 2008, FEBS J, V275, P4875, DOI 10.1111/j.1742-4658.2008.06627.x; Tabe Y, 2009, CLIN CANCER RES, V15, P933, DOI 10.1158/1078-0432.CCR-08-0399; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Worrall Erin G, 2009, J Chem Biol, V2, P113, DOI 10.1007/s12154-009-0019-5; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814	26	69	79	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32384	32394		10.1074/jbc.M109.052647	http://dx.doi.org/10.1074/jbc.M109.052647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19759023	Green Published, hybrid			2022-12-25	WOS:000272028400021
J	Shim, MS; Kim, JY; Jung, HK; Lee, KH; Xu, XM; Carlson, BA; Kim, KW; Kim, IY; Hatfield, DL; Lee, BJ				Shim, Myoung Sup; Kim, Jin Young; Jung, Hee Kyoung; Lee, Kwang Hee; Xu, Xue-Ming; Carlson, Bradley A.; Kim, Ki Woo; Kim, Ick Young; Hatfield, Dolph L.; Lee, Byeong Jae			Elevation of Glutamine Level by Selenophosphate Synthetase 1 Knockdown Induces Megamitochondrial Formation in Drosophila Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN SYNTHESIS; SELENOCYSTEINE TRANSFER; INDUCED APOPTOSIS; ESCHERICHIA-COLI; IN-VITRO; SELENIUM; GENE; HOMOLOG; VIVO; IDENTIFICATION	Although selenophosphate synthetase 1 (SPS1/SelD) is an essential gene in Drosophila, its function has not been determined. To elucidate its intracellular role, we targeted the removal of SPS1/SelD mRNA in Drosophila SL2 cells using RNA interference technology that led to the formation of vacuole-like globular structures. Surprisingly, these structures were identified as megamitochondria, and only depolarized mitochondria developed into megamitochondria. The mRNA levels of l(2) 01810 and glutamine synthetase 1 (GS1) were increased by SPS1/SelD knockdown. Blocking the expression of GS1 and l(2) 01810 completely inhibited the formation of megamitochondria induced by loss of SPS1/SelD activity and decreased the intracellular levels of glutamine to those of control cells suggesting that the elevated level of glutamine is responsible for megamitochondrial formation. Overexpression of GS1 and l(2) 01810 had a synergistic effect on the induction of megamitochondrial formation and on the synthesis of glutamine suggesting that l(2) 01810 is involved in glutamine synthesis presumably by activating GS1. Our results indicate that, in Drosophila, SPS1/SelD regulates the intracellular glutamine by inhibiting GS1 and l(2) 01810 expression and that elevated levels of glutamine lead to a nutritional stress that provides a signal for megamitochondrial formation.	[Shim, Myoung Sup; Kim, Jin Young; Jung, Hee Kyoung; Lee, Kwang Hee; Lee, Byeong Jae] Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Lab Mol Genet & Genom, Seoul 151742, South Korea; [Xu, Xue-Ming; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Lab Canc Prevent, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kim, Ki Woo] Seoul Natl Univ, Coll Agr & Life Sci, Natl Instrumentat Ctr Environm Management, Seoul 151742, South Korea; [Kim, Ick Young] Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, Seoul 136701, South Korea	Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Korea University	Lee, BJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Lab Mol Genet & Genom, Bldg 504,Rm 523, Seoul 151742, South Korea.	imbglmg@snu.ac.kr	Kim, Ki Woo/AAC-5623-2022	Kim, Ki Woo/0000-0002-7010-0336	Korean Government [KRF-2005-070-C00086, KRF-2008-005-J00201]; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010767, ZIABC005317] Funding Source: NIH RePORTER	Korean Government(Korean Government); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Korea Research Foundation Grants KRF-2005-070-C00086 and KRF-2008-005-J00201 funded by the Korean Government (Ministry of Education, Science, and Technology) (to B. J. L.). This work was also supported in part by a National Institutes of Health Intramural Research Program grant from NCI, Center for Cancer Research.	ALBERTS B, 2001, MOL BIOL CELL, P769; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Alsina B, 1998, MOL GEN GENET, V257, P113, DOI 10.1007/s004380050630; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Boosalis MG, 2008, NUTR CLIN PRACT, V23, P152, DOI 10.1177/0884533608314532; Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; CAIZZI R, 1990, J MOL BIOL, V212, P17, DOI 10.1016/0022-2836(90)90301-2; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; CLAUDE A, 1946, J EXP MED, V84, P61, DOI 10.1084/jem.84.1.61; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; EHRENREICH A, 1992, EUR J BIOCHEM, V206, P767, DOI 10.1111/j.1432-1033.1992.tb16983.x; Flohe L, 2007, BIOL CHEM, V388, P987, DOI 10.1515/BC.2007.112; Gao WH, 2001, J CELL SCI, V114, P2855; GLASS RS, 1993, BIOCHEMISTRY-US, V32, P12555, DOI 10.1021/bi00210a001; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330; Jin JS, 2004, NUCLEIC ACIDS RES, V32, P2482, DOI 10.1093/nar/gkh569; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Karbowski M, 1999, FREE RADICAL BIO MED, V26, P396, DOI 10.1016/S0891-5849(98)00209-3; Kim M, 2003, BIOCHEM BIOPH RES CO, V306, P1106, DOI 10.1016/S0006-291X(03)01069-6; Kim SK, 2003, PEPTIDES, V24, P945, DOI 10.1016/S0196-9781(03)00194-3; LAMAR C, 1965, BIOCHEM PHARMACOL, V14, P489, DOI 10.1016/0006-2952(65)90222-4; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; LEE BJ, 1989, J BIOL CHEM, V264, P9724; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LEINFELDER W, 1989, J BIOL CHEM, V264, P9720; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; Lobanov AV, 2008, PROTEIN SCI, V17, P176, DOI 10.1110/ps.073261508; Longtin R, 2004, J NATL CANCER I, V96, P504, DOI 10.1093/jnci/96.7.504; LOW SC, 1995, J BIOL CHEM, V270, P21659, DOI 10.1074/jbc.270.37.21659; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Lund P, 1986, METHOD ENZYMAT AN, P357; Morey M, 2003, J CELL SCI, V116, P4597, DOI 10.1242/jcs.00783; Morey M, 2001, DEV BIOL, V238, P145, DOI 10.1006/dbio.2001.0389; PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304; Peng TI, 2004, ANN NY ACAD SCI, V1011, P112, DOI 10.1196/annals.1293.012; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rao KVR, 2003, NEUROCHEM INT, V43, P517, DOI 10.1016/S0197-0186(03)00042-1; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Squires JE, 2008, IUBMB LIFE, V60, P232, DOI 10.1002/iub.38; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; TANDLER B, 1986, ANN NY ACAD SCI, V488, P65; TANDLER B, 1968, AM J PATHOL, V52, P69; Teranishi M, 1999, J ELECTRON MICROSC, V48, P637, DOI 10.1093/oxfordjournals.jmicro.a023730; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; ZARAGOZA R, 1987, ARCH BIOCHEM BIOPHYS, V258, P426, DOI 10.1016/0003-9861(87)90364-X	57	26	28	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32881	32894		10.1074/jbc.M109.026492	http://dx.doi.org/10.1074/jbc.M109.026492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19755423	Green Published, hybrid			2022-12-25	WOS:000272028400072
J	Cekic, C; Casella, CR; Eaves, CA; Matsuzawa, A; Ichijo, H; Mitchell, TC				Cekic, Caglar; Casella, Carolyn R.; Eaves, Chelsea A.; Matsuzawa, Atsushi; Ichijo, Hidenori; Mitchell, Thomas C.			Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-REGULATORY FACTOR-3; PROTEIN-KINASES; GENE-EXPRESSION; HELICOBACTER-PYLORI; SIGNALING PATHWAYS; ADAPTIVE IMMUNITY; DENDRITIC CELLS; CUTTING EDGE; LIPOPOLYSACCHARIDE; ADJUVANT	TLR4 stimulation by lipopolysaccharide can cause both MAL/MyD88- and TRAM/TRIF (Toll IL-1 receptor domain-containing adaptor-inducing IFN beta)-dependent signaling events. Monophosphoryl lipid A (MPLA), a low toxicity derivative of endotoxic lipopolysaccharide, enhances antibody responses, T cell expansion, and recall responses against antigens without causing excessive inflammatory side effects. Previously, we proposed that TRIF-biased activation of TLR4 by MPLA is responsible for its reduced toxicity while retaining potent adjuvant effects. However, some TRIF-associated genes, such as MCP-1, are only weakly expressed, and some MyD88-associated inflammatory and anti-inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-10, are strongly activated after MPLA stimulation despite weak NF-kappa B but strong IRF3 activation. We now report that synthetic derivatives of MPLA retained TRIF bias as compared with synthetic diphosphoryl lipid A, indicating a change in a single phosphoryl group is sufficient for TRIF-biased TLR4 stimulation. We extend our previous observations by showing that sMLA induces strong p38 MAPK but weak JNK activation, resulting in high IP-10 (interferon-inducible protein 10), tumor necrosis factor alpha, and interleukin-10 but low MCP-1 transcript levels. Results of this study identify a novel biochemical mechanism for regulation of sMLA-induced gene expression.	[Cekic, Caglar; Casella, Carolyn R.; Eaves, Chelsea A.; Mitchell, Thomas C.] Univ Louisville, Inst Cellular Therapeut, Sch Med, Donald Baxter Res Bldg,570 S Preston St,Rm 410, Louisville, KY 40202 USA; Univ Louisville, Dept Microbiol & Immunol, Sch Med, Louisville, KY 40202 USA; [Matsuzawa, Atsushi; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo 1130033, Japan	University of Louisville; University of Louisville; University of Tokyo	Mitchell, TC (corresponding author), Univ Louisville, Inst Cellular Therapeut, Sch Med, Donald Baxter Res Bldg,570 S Preston St,Rm 410, Louisville, KY 40202 USA.	tom.mitchell@louisville.edu	Mitchell, Thomas C/B-4193-2013; Matsuzawa, Atsushi/GLU-1387-2022	Matsuzawa, Atsushi/0000-0001-8303-3905; Cekic, Caglar/0000-0001-8081-508X; Ichijo, Hidenori/0000-0002-5005-6438	National Institutes of Health [AI071047, AI059023]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071047, K02AI059023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071047 and AI059023 (to T. C. M.). This work was also supported by an American Heart Association Predoctoral fellowship (to C. C.).	Alderson MR, 2006, J ENDOTOXIN RES, V12, P313, DOI 10.1179/096805106X118753; Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Dang O, 2004, J IMMUNOL, V172, P747, DOI 10.4049/jimmunol.172.2.747; Del Corno M, 2009, BLOOD, V114, P796, DOI 10.1182/blood-2009-01-199406; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Foey AD, 1998, J IMMUNOL, V160, P920; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Okemoto K, 2006, J IMMUNOL, V176, P1203, DOI 10.4049/jimmunol.176.2.1203; Park SM, 2008, J IMMUNOL, V181, P6447, DOI 10.4049/jimmunol.181.9.6447; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Salkowski CA, 1997, INFECT IMMUN, V65, P3239, DOI 10.1128/IAI.65.8.3239-3247.1997; Salmon RA, 2001, EUR J IMMUNOL, V31, P3218, DOI 10.1002/1521-4141(200111)31:11<3218::AID-IMMU3218>3.0.CO;2-9; Spiller S, 2007, J BIOL CHEM, V282, P13190, DOI 10.1074/jbc.M610340200; Sukhumavasi W, 2008, J IMMUNOL, V181, P3464, DOI 10.4049/jimmunol.181.5.3464; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tran AX, 2006, J BACTERIOL, V188, P4531, DOI 10.1128/JB.00146-06; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wheeler AW, 2001, INT ARCH ALLERGY IMM, V126, P135, DOI 10.1159/000049504; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	40	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31982	31991		10.1074/jbc.M109.046383	http://dx.doi.org/10.1074/jbc.M109.046383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19759006	hybrid, Green Published			2022-12-25	WOS:000271572700054
J	Yuan, Q; McHenry, CS				Yuan, Quan; McHenry, Charles S.			Strand Displacement by DNA Polymerase III Occurs through a tau-psi-chi Link to Single-stranded DNA-binding Protein Coating the Lagging Strand Template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI REPLICATION PROTEINS; CLAMP-LOADER COMPLEX; ESCHERICHIA-COLI; DISTINCT DOMAINS; BETA-SUBUNIT; GAMMA-SUBUNIT; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; DELTA-DELTA'; SSB PROTEIN	In addition to the well characterized processive replication reaction catalyzed by the DNA polymerase III holoenzyme on single-stranded DNA templates, the enzyme possesses an intrinsic strand displacement activity on flapped templates. The strand displacement activity is distinguished from the single-stranded DNA-templated reaction by a high dependence upon single-stranded DNA binding protein and an inability of gamma-complex to support the reaction in the absence of tau. However, if gamma-complex is present to load beta(2), a truncated tau protein containing only domains III-V will suffice. This truncated protein is sufficient to bind both the alpha subunit of DNA polymerase (Pol) III and chi psi. This is reminiscent of the minimal requirements for Pol III to replicate short single-stranded DNA-binding protein (SSB)-coated templates where tau is only required to serve as a scaffold to hold Pol III and chi in the same complex (Glover, B., and McHenry, C. (1998) J. Biol. Chem. 273, 23476-23484). We propose a model in which strand displacement by DNA polymerase III holoenzyme depends upon a Pol III-tau-psi-chi-SSB binding network, where SSB is bound to the displaced strand, stabilizing the Pol III-template interaction. The same interaction network is probably important for stabilizing the leading strand polymerase interactions with authentic replication forks. The specificity constant (k(cat)/K-m) for the strand displacement reaction is similar to 300-fold less favorable than reactions on single-stranded templates and proceeds with a slower rate (150 nucleotides/s) and only moderate processivity (similar to 300 nucleotides). PriA, the initiator of replication restart on collapsed or misassembled replication forks, blocks the strand displacement reaction, even if added to an ongoing reaction.	[Yuan, Quan; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	charles.mchenry@colorado.edu	yuan, quan/GZM-5597-2022		National Institutes of Health [R01 GM035695, T32 GM-065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, R01GM035695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM035695 and T32 GM-065103 (Molecular Biophysics Training Grant to Q. Y.).	BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Canceill D, 1996, P NATL ACAD SCI USA, V93, P6647, DOI 10.1073/pnas.93.13.6647; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Gao DX, 2001, J BIOL CHEM, V276, P4447, DOI 10.1074/jbc.M009827200; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Gao DX, 2001, J BIOL CHEM, V276, P4433, DOI 10.1074/jbc.M009828200; Glover BP, 2000, J BIOL CHEM, V275, P3017, DOI 10.1074/jbc.275.5.3017; Glover BP, 2001, J BIOL CHEM, V276, P35842, DOI 10.1074/jbc.M103719200; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Gulbis JM, 2004, EUR J BIOCHEM, V271, P439, DOI 10.1046/j.1432-1033.2003.03944.x; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Jones CE, 2004, J BIOL CHEM, V279, P25721, DOI 10.1074/jbc.M402128200; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim DR, 1996, J BIOL CHEM, V271, P20690, DOI 10.1074/jbc.271.34.20690; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LADUCA RJ, 1986, J BIOL CHEM, V261, P7550; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Pritchard AE, 2001, J BIOL CHEM, V276, P35217, DOI 10.1074/jbc.M102735200; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Stephens KM, 1997, J BIOL CHEM, V272, P28800, DOI 10.1074/jbc.272.45.28800; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421	43	35	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31672	31679		10.1074/jbc.M109.050740	http://dx.doi.org/10.1074/jbc.M109.050740			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19749191	hybrid, Green Published			2022-12-25	WOS:000271572700022
J	Lee, JH; Wang, F; Schnell, DJ				Lee, Jeonghwa; Wang, Fei; Schnell, Danny J.			Toc Receptor Dimerization Participates in the Initiation of Membrane Translocation during Protein Import into Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; ATTOC159 PREPROTEIN RECEPTOR; PRECURSOR PROTEINS; GTP-BINDING; OUTER ENVELOPE; FLORAL-DIP; RECOGNITION; APPARATUS; COMPONENT; MUTANT	The post-translational import of nucleus-encoded preproteins into chloroplasts occurs through multimeric translocons in the outer (Toc) and inner (Tic) membranes. The high fidelity of the protein import process is maintained by specific recognition of the transit peptide of preproteins by the coordinate activities of two homologous GTPase Toc receptors, Toc34 and Toc159. Structural and biochemical studies suggest that dimerization of the Toc receptors functions as a component of the mechanism to control access of preproteins to the membrane translocation channel of the translocon. We show that specific mutations that disrupted receptor dimerization in vitro reduced the rate of protein import in transgenic Arabidopsis compared with the wild type receptor. The mutations did not affect the GTPase activities of the receptors. Interestingly, these mutations did not decrease the initial preprotein binding at the receptors, but they reduced the efficiency of the transition from preprotein binding to membrane translocation. These data indicate that dimerization of receptors has a direct role in protein import and support a hypothesis in which receptor-receptor interactions participate in the initiation of membrane translocation of chloroplast preproteins as part of the molecular mechanism of GTP-regulated protein import.	[Lee, Jeonghwa; Schnell, Danny J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Lee, Jeonghwa; Schnell, Danny J.] Univ Massachusetts, Program Plant Biol, Amherst, MA 01003 USA; [Wang, Fei] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Harvard University	Schnell, DJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St,913 Lederle GRC, Amherst, MA 01003 USA.	dschnell@biochem.umass.edu			National Institutes of Health [GM61893]; Gilgut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilgut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61893 (to D.J.S.). This work was also supported by a Gilgut Fellowship in Plant Biology (to J.L.).	Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen DD, 1997, J BIOL CHEM, V272, P6614, DOI 10.1074/jbc.272.10.6614; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Dabney-Smith C, 1999, J BIOL CHEM, V274, P32351, DOI 10.1074/jbc.274.45.32351; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gutensohn M, 2000, PLANT J, V23, P771, DOI 10.1046/j.1365-313x.2000.00849.x; Gutensohn M, 2004, MOL GENET GENOMICS, V272, P379, DOI 10.1007/s00438-004-1068-7; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Inaba T, 2008, BIOCHEM J, V413, P15, DOI 10.1042/BJ20080490; INOUE H, 2008, PLANT PHYSIOL BIOCH, V72, P2926; Inoue H, 2008, J BIOL CHEM, V283, P7491, DOI 10.1074/jbc.M709571200; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jelic M, 2003, BIOCHEMISTRY-US, V42, P5906, DOI 10.1021/bi034001q; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Kessler F, 2002, NAT STRUCT BIOL, V9, P81, DOI 10.1038/nsb0202-81; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Koenig P, 2008, J BIOL CHEM, V283, P23104, DOI 10.1074/jbc.M710576200; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Li HM, 2007, J BIOMED SCI, V14, P505, DOI 10.1007/s11373-007-9166-2; Ma YK, 1996, J CELL BIOL, V134, P315, DOI 10.1083/jcb.134.2.315; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; OLSEN LJ, 1989, J BIOL CHEM, V264, P6724; Rahim G, 2009, J EXP BOT, V60, P257, DOI 10.1093/jxb/ern283; Reddick LE, 2007, J BIOL CHEM, V282, P11410, DOI 10.1074/jbc.M609491200; ROUNDS C, 2007, ENZYMES MOL MACHINES, V25, P407; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schleiff E, 2002, BIOCHEMISTRY-US, V41, P1934, DOI 10.1021/bi011361+; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Sun YJ, 2002, NAT STRUCT BIOL, V9, P95, DOI 10.1038/nsb744; THEG SM, 1989, J BIOL CHEM, V264, P6730; Wallas TR, 2003, J BIOL CHEM, V278, P44289, DOI 10.1074/jbc.M307873200; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Weibel P, 2003, J BIOL CHEM, V278, P37321, DOI 10.1074/jbc.M305946200; Wittinghofer A, 2000, BIOL CHEM, V381, P355, DOI 10.1515/BC.2000.047; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200; Young ME, 1999, PLANT PHYSIOL, V121, P237, DOI 10.1104/pp.121.1.237	53	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31130	31141		10.1074/jbc.M109.053751	http://dx.doi.org/10.1074/jbc.M109.053751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744928	Green Published, hybrid			2022-12-25	WOS:000271378400041
J	Liang, HY; Yoo, SE; Na, R; Walter, CA; Richardson, A; Ran, QT				Liang, Hanyu; Yoo, Si-Eun; Na, Ren; Walter, Christi A.; Richardson, Arlan; Ran, Qitao			Short Form Glutathione Peroxidase 4 Is the Essential Isoform Required for Survival and Somatic Mitochondrial Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DAMAGE; LIPID-PEROXIDATION; CELLS; EXPRESSION; PHGPX; GPX4; GLUTATHIONE-PEROXIDASE-4; APOPTOSIS; PROTECTS; SEQUENCE	Glutathione peroxidase 4 (Gpx4) is an essential antioxidant enzyme having multiple functions. A long form Gpx4 protein and a short form Gpx4 protein, which are distinguishable by the presence or lack of a mitochondrial signal peptide at the N terminus, are generated from the Gpx4 gene. In this study, we generated transgenic mice using mutated GPX4 genes encoding either the long form Gpx4 (lPX4 gene) or the short form Gpx4 (sGPX4 gene). Our results showed that transgenic mice with the sGPX4 gene had increased Gpx4 protein in all tissues and were protected against diquat-induced apoptosis in liver. Moreover, the sGPX4 gene was able to rescue the lethal phenotype of the mouse Gpx4-null mutation. In contrast, transgenic mice with the lGPX4 gene had increased Gpx4 protein only in the testes, and the lGPX4 gene failed to rescue the lethal phenotype of the mouse Gpx4-null mutation. In Gpx4-null mice rescued by the sGPX4 gene, the Gpx4 protein was present in mitochondria isolated from somatic tissues, and the submitochondrial distribution pattern of the Gpx4 protein in these mice was identical to that in wild-type mice. Interestingly, the male Gpx4-null mice rescued by the sGPX4 gene were infertile and exhibited sperm malformation. Together, our results demonstrated for the first time that the short form Gpx4 protein is present in somatic tissue mitochondria and is essential for survival and protection against apoptosis in mice, whereas the long form Gpx4 protein is important for male fertility.	Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Yoo, Si-Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Walter, Christi A.; Richardson, Arlan; Ran, Qitao] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Walter, Christi A.; Richardson, Arlan; Ran, Qitao] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Ran, QT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, 15355 Lambda Dr, San Antonio, TX 78245 USA.	ran@uthscsa.edu	Liang, Hanyu/A-1066-2010		National Institutes of Health [P01AG19316, R37 AG026557, AG021163]; San Antonio Nathan Shock Aging Center [1P30-AG13319]; Veterans Affairs Merit; NATIONAL INSTITUTE ON AGING [P01AG019316, P30AG013319, R37AG026557, R01AG021163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Antonio Nathan Shock Aging Center; Veterans Affairs Merit(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AG19316, R37 AG026557, and AG021163, San Antonio Nathan Shock Aging Center Grant 1P30-AG13319, and Veterans Affairs Merit grants (to A. R. and Q. R.).	Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Aral F, 2008, RES VET SCI, V84, P95, DOI 10.1016/j.rvsc.2007.04.007; Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Chen LJ, 2008, J NEUROCHEM, V107, P197, DOI 10.1111/j.1471-4159.2008.05603.x; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Flohe L, 2007, BIOL CHEM, V388, P987, DOI 10.1515/BC.2007.112; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Knopp EA, 1999, MAMM GENOME, V10, P601, DOI 10.1007/s003359901053; Legault J, 2000, BIOCHEM BIOPH RES CO, V272, P416, DOI 10.1006/bbrc.2000.2800; Liang HY, 2007, BIOCHEM BIOPH RES CO, V356, P893, DOI 10.1016/j.bbrc.2007.03.045; Liang HY, 2009, FREE RADICAL BIO MED, V47, P312, DOI 10.1016/j.freeradbiomed.2009.05.012; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; PUSHPAREKHA TR, 1995, J BIOL CHEM, V270, P26993, DOI 10.1074/jbc.270.45.26993; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Schneider M, 2006, GENE EXPR PATTERNS, V6, P489, DOI 10.1016/j.modgep.2005.11.002; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Tanaka M, 2004, BLOOD, V104, P3789, DOI 10.1182/blood-2004-02-0666; THOMAS JP, 1990, J BIOL CHEM, V265, P454; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	26	93	95	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30836	30844		10.1074/jbc.M109.032839	http://dx.doi.org/10.1074/jbc.M109.032839			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19744930	hybrid, Green Published			2022-12-25	WOS:000271378400011
J	Zhang, YL; Reynolds, JM; Chang, SH; Martin-Orozco, N; Chung, Y; Nurieva, RI; Dong, C				Zhang, Yongliang; Reynolds, Joseph M.; Chang, Seon Hee; Martin-Orozco, Natalia; Chung, Yeonseok; Nurieva, Roza I.; Dong, Chen			MKP-1 Is Necessary for T Cell Activation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; PROTEIN-TYROSINE-PHOSPHATASE; MAP KINASE PHOSPHATASE-1; IMMEDIATE-EARLY GENE; VIRUS-INFECTION; SHOCK; DIFFERENTIATION; INFLAMMATION; STRESS; GROWTH	MAPKs are evolutionarily conserved immune regulators. MAPK phosphatases (MKPs) that negatively regulate MAPK activities have recently emerged as critical players in both innate and adaptive immune responses. MKP-1, also known as DUSP1, was previously shown to negatively regulate innate immunity by inhibiting pro-inflammatory cytokine production. Here, we found that MKP-1 is necessary in T cell activation and function. MKP-1 deficiency in T cells impaired the activation, proliferation, and function of T cells in vitro, associated with enhanced activation of JNK and reduced NFATc1 translocation into the nucleus. Consistently, MKP-1(-/-) mice were defective in anti-influenza immunity in vivo and resistant to experimental autoimmune encephalomyelitis. Our results thus demonstrate that MKP-1 is a critical positive regulator of T cell activation and function and may be targeted in treatment of autoimmune diseases.	[Zhang, Yongliang; Reynolds, Joseph M.; Chang, Seon Hee; Martin-Orozco, Natalia; Chung, Yeonseok; Nurieva, Roza I.; Dong, Chen] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin,Unit 902, Houston, TX 77030 USA.	cdong@mdanderson.org	Chang, Seon Hee/AAQ-9521-2020; Martin Orozco, Natalia/E-4794-2010; dong, chen/B-3181-2009	Chang, Seon Hee/0000-0002-9389-508X; dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841	National Institutes of Health [AI050761]; Center for Targeted Therapy of the M. D. Anderson Cancer Center; NCI training; American Heart Association scientist developmen; Leukemia and Lymphoma Society scholar; Trust fellowship; Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761, R56AI050761, R01AI050761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Targeted Therapy of the M. D. Anderson Cancer Center; NCI training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association scientist developmen(American Heart Association); Leukemia and Lymphoma Society scholar(Leukemia and Lymphoma Society); Trust fellowship; Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI050761 (to C. D. and R.I.N.). This work was also supported by grants from the Center for Targeted Therapy of the M. D. Anderson Cancer Center (to C. D.), an NCI training grant (to J.R.), an American Heart Association scientist development grant (to R.I.N.), and a Leukemia and Lymphoma Society scholar award and a Trust fellowship from the M. D. Anderson Cancer Center (to C. D.).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147; CHARLES CH, 1992, ONCOGENE, V7, P187; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dorfman K, 1996, ONCOGENE, V13, P925; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hussell T, 1996, J GEN VIROL, V77, P2447, DOI 10.1099/0022-1317-77-10-2447; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; Willoughby EA, 2003, J BIOL CHEM, V278, P10731, DOI 10.1074/jbc.M207324200; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	35	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30815	30824		10.1074/jbc.M109.052472	http://dx.doi.org/10.1074/jbc.M109.052472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19748894	Green Published, hybrid			2022-12-25	WOS:000271378400009
J	Belin, S; Beghin, A; Solano-Gonzalez, E; Bezin, L; Brunet-Manquat, S; Textoris, J; Prats, AC; Mertani, HC; Dumontet, C; Diaz, JJ				Belin, Stephane; Beghin, Anne; Solano-Gonzalez, Eduardo; Bezin, Laurent; Brunet-Manquat, Stephanie; Textoris, Julien; Prats, Anne-Catherine; Mertani, Hichem C.; Dumontet, Charles; Diaz, Jean-Jacques			Dysregulation of Ribosome Biogenesis and Translational Capacity Is Associated with Tumor Progression of Human Breast Cancer Cells	PLOS ONE			English	Article							RNA-POLYMERASE-I; C-MYC; PROTEIN SYNTHESIS; HELA-CELLS; ENTRY SITE; EXPRESSION; PERSISTENCE; EFFICIENCY; INITIATION; INFECTION	Protein synthesis is a fundamental cell process and ribosomes - particularly through the ribosomal RNA that display ribozyme activity - are the main effectors of this process. Ribosome biogenesis is a very complex process involving transcriptional as well as many post-transcriptional steps to produce functional ribosomes. It is now well demonstrated that ribosome production is enhanced in cancer cells and that ribosome biogenesis plays a crucial role in tumor progression. However, at present there is an important lack of data to determine whether the entire process of ribosome biogenesis and ribosome assembly is modified during tumor progression and what could be the potential impact on the dysregulation of translational control that is observed in cancer cells. In breast cancer cells displaying enhanced aggressivity, both in vitro and in vivo, we have analyzed the major steps of ribosome biogenesis and the translational capacity of the resulting ribosome. We show that increased tumorigenicity was associated with modifications of nucleolar morphology and profound quantitative and qualitative alterations in ribosomal biogenesis and function. Specifically cells with enhanced tumor aggressivity displayed increased synthesis of 45S pre-rRNA, with activation of an alternative preRNA synthetic pathway containing a 43S precursor and enhanced post-transcriptional methylation of specifc sites located in the 28S rRNA. While the global translational activity was not modified, IRES-initiated translation, notably that of p53 mRNA, was less efficient and the control of translational fidelity was importantly reduced in cells with increased aggressivity. These results suggest that acquisition of enhanced tumor aggressivity can be associated with profound qualitative alterations in ribosomal control, leading to reduced quality control of translation in cancer cells.	[Beghin, Anne; Brunet-Manquat, Stephanie; Dumontet, Charles] INSERM, U590, Lyon, France; [Beghin, Anne; Brunet-Manquat, Stephanie; Dumontet, Charles] Univ Lyon 1, ISPB, Lyon, France; [Belin, Stephane; Textoris, Julien; Diaz, Jean-Jacques] Univ Lyon 1, CNRS, UMR 5534, Ctr Leon Berard, Lyon, France; [Bezin, Laurent; Mertani, Hichem C.] Univ Lyon 1, CNRS, UMR 5123, Ctr Leon Berard, Lyon, France; [Solano-Gonzalez, Eduardo; Prats, Anne-Catherine] INSERM, U858, Toulouse, France; [Solano-Gonzalez, Eduardo; Prats, Anne-Catherine] Univ Toulouse, UPS, Inst Med Mol Rangueil, IFR150, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Diaz, JJ (corresponding author), Univ Lyon 1, CNRS, UMR 5534, Ctr Leon Berard, Lyon, France.	diazjj@lyon.fnclcc.fr	MERTANI, Hichem-Claude/AAR-6415-2020; DIAZ, Jean-Jacques/H-3018-2014; DIAZ, Jean-Jacques/AAT-3846-2021; Prats, Anne-Catherine/E-5051-2016; Textoris, Julien/H-3317-2019	DIAZ, Jean-Jacques/0000-0002-7914-4319; DIAZ, Jean-Jacques/0000-0002-7914-4319; Prats, Anne-Catherine/0000-0002-5282-3776; Textoris, Julien/0000-0002-3821-9337; Belin, Stephane/0000-0001-7074-6885; Dumontet, Charles/0000-0003-1875-134X				Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Baxter-Roshek JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000174; Beghin A, 2008, CELL CYCLE, V7, P3074, DOI 10.4161/cc.7.19.6777; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; BOISVERT FM, 2007, NAT REV MOL CELL BIO; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Coute Y, 2006, MASS SPECTROM REV, V25, P215, DOI 10.1002/mas.20067; COUTE Y, 2007, MOL CELL PROTEOMICS; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Derenzini M, 1998, AM J PATHOL, V152, P1291; Derenzini M, 2000, MICRON, V31, P117, DOI 10.1016/S0968-4328(99)00067-0; Diaz JJ, 2002, J CHROMATOGR B, V771, P237, DOI 10.1016/S1570-0232(02)00038-7; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Greco A, 1997, MOL GEN GENET, V256, P320, DOI 10.1007/s004380050575; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liu B, 2008, RNA BIOL, V5, P249, DOI 10.4161/rna.6916; Maden BEH, 2001, METHODS, V25, P374, DOI 10.1006/meth.2001.1250; MADJAR JJ, 1979, MOL GEN GENET, V171, P121, DOI 10.1007/BF00269998; MADJAR JJ, 1977, MOL BIOL REP, V3, P289, DOI 10.1007/BF00368299; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Navarro FP, 2008, J NEUROCHEM, V105, P34, DOI 10.1111/j.1471-4159.2007.05116.x; Ofner D, 2000, MICRON, V31, P161, DOI 10.1016/S0968-4328(99)00073-6; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Pich A, 2000, MICRON, V31, P133, DOI 10.1016/S0968-4328(99)00070-0; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Simonin D, 1997, J GEN VIROL, V78, P435, DOI 10.1099/0022-1317-78-2-435; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tinton SA, 2005, BIOCHEM J, V385, P155, DOI 10.1042/BJ20040963; Trere D, 2004, J HISTOCHEM CYTOCHEM, V52, P1601, DOI 10.1369/jhc.4A6454.2004; Wang SI, 2002, INT J ONCOL, V20, P1269; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	47	158	163	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7147	10.1371/journal.pone.0007147	http://dx.doi.org/10.1371/journal.pone.0007147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779612	gold, Green Published, Green Submitted			2022-12-25	WOS:000270176200005
J	Shaham, S				Shaham, Shai			galign: A Tool for Rapid Genome Polymorphism Discovery	PLOS ONE			English	Article								Background: Highly parallel sequencing technologies have become important tools in the analysis of sequence polymorphisms on a genomic scale. However, the development of customized software to analyze data produced by these methods has lagged behind. Methods/Principal Findings: Here I describe a tool, 'galign', designed to identify polymorphisms between sequence reads obtained using Illumina/Solexa technology and a reference genome. The 'galign' alignment tool does not use Smith-Waterman matrices for sequence comparisons. Instead, a simple algorithm comparing parsed sequence reads to parsed reference genome sequences is used. 'galign' output is geared towards immediate user application, displaying polymorphism locations, nucleotide changes, and relevant predicted amino-acid changes for ease of information processing. To do so, 'galign' requires several accessory files easily derived from an annotated reference genome. Direct sequencing as well as in silico studies demonstrate that 'galign' provides lesion predictions comparable in accuracy to available prediction programs, accompanied by greater processing speed and more user-friendly output. We demonstrate the use of 'galign' to identify mutations leading to phenotypic consequences in C. elegans. Conclusion/Significance: Our studies suggest that 'galign' is a useful tool for polymorphism discovery, and is of immediate utility for sequence mining in C. elegans.			Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA.	shaham@rockefeller.edu			NICHD NIH HHS [R01 HD042680, R01 HD052677] Funding Source: Medline; NINDS NIH HHS [R01 NS064273] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042680, R01HD052677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064273] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5	7	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2009	4	9							e7188	10.1371/journal.pone.0007188	http://dx.doi.org/10.1371/journal.pone.0007188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WL	19779626	Green Published, Green Submitted, gold			2022-12-25	WOS:000270176200019
J	Stahl, HF; Fauti, T; Ullrich, N; Bopp, T; Kubach, J; Rust, W; Labhart, P; Alexiadis, V; Becker, C; Hafner, M; Weith, A; Lenter, MC; Jonuleit, H; Schmitt, E; Mennerich, D				Stahl, Heiko F.; Fauti, Tanja; Ullrich, Nina; Bopp, Tobias; Kubach, Jan; Rust, Werner; Labhart, Paul; Alexiadis, Vassili; Becker, Christian; Hafner, Mathias; Weith, Andreas; Lenter, Martin C.; Jonuleit, Helmut; Schmitt, Edgar; Mennerich, Detlev			miR-155 Inhibition Sensitizes CD4+Th Cells for TREG Mediated Suppression	PLOS ONE			English	Article								Background: In humans and mice naturally occurring CD4(+)CD25(+) regulatory T cells (nTregs) are a thymus-derived subset of T cells, crucial for the maintenance of peripheral tolerance by controlling not only potentially autoreactive T cells but virtually all cells of the adaptive and innate immune system. Recent work using Dicer-deficient mice irrevocably demonstrated the importance of miRNAs for nTreg cell-mediated tolerance. Principal Findings: DNA-Microarray analyses of human as well as murine conventional CD4(+) Th cells and nTregs revealed a strong up-regulation of mature miR-155 (microRNA-155) upon activation in both populations. Studying miR-155 expression in FoxP3-deficient scurfy mice and performing FoxP3 ChIP-Seq experiments using activated human T lymphocytes, we show that the expression and maturation of miR-155 seem to be not necessarily regulated by FoxP3. In order to address the functional relevance of elevated miR-155 levels, we transfected miR-155 inhibitors or mature miR-155 RNAs into freshly-isolated human and mouse primary CD4(+) Th cells and nTregs and investigated the resulting phenotype in nTreg suppression assays. Whereas miR-155 inhibition in conventional CD4(+) Th cells strengthened nTreg cell-mediated suppression, overexpression of mature miR-155 rendered these cells unresponsive to nTreg cell-mediated suppression. Conclusion: Investigation of FoxP3 downstream targets, certainly of bound and regulated miRNAs revealed the associated function between the master regulator FoxP3 and miRNAs as regulators itself. miR-155 is shown to be crucially involved in nTreg cell mediated tolerance by regulating the susceptibility of conventional human as well as murine CD4(+) Th cells to nTreg cell-mediated suppression.			Stahl, HF (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Genom Grp, Resp Dis Res, Biberach, Germany.	detlev.mennerich@boehringer-ingelheim.com	Becker, Christian/GLS-0862-2022; Jonuleit, Helmut/D-8059-2011; Becker, Christian/AAD-4549-2020; Bopp, Tobias/A-4328-2018; Becker, Christian/F-5384-2010	Becker, Christian/0000-0002-1716-7208; Jonuleit, Helmut/0000-0002-5672-9365; Becker, Christian/0000-0002-1716-7208; Bopp, Tobias/0000-0002-3232-8065; Becker, Christian/0000-0002-1716-7208				Becker C, 2007, EUR J IMMUNOL, V37, P1217, DOI 10.1002/eji.200636480; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Harada M, 2007, AM J RESP CELL MOL, V36, P491, DOI 10.1165/rcmb.2006-0090OC; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Turner M, 2008, BIOCHEM SOC T, V36, P531, DOI 10.1042/BST0360531; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	30	72	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2009	4	9							e7158	10.1371/journal.pone.0007158	http://dx.doi.org/10.1371/journal.pone.0007158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498SW	19777054	gold, Green Submitted, Green Published			2022-12-25	WOS:000270164600006
J	Byrne, JA; Nguyen, HN; Pera, RAR				Byrne, James A.; Nguyen, Ha Nam; Pera, Renee A. Reijo			Enhanced Generation of Induced Pluripotent Stem Cells from a Subpopulation of Human Fibroblasts	PLOS ONE			English	Article							SOMATIC-CELLS; INDUCTION; FUSION	Background: The derivation of induced pluripotent stem cells (iPSCs) provides new possibilities for basic research and novel cell-based therapies. Limitations, however, include our current lack of understanding regarding the underlying mechanisms and the inefficiency of reprogramming. Methodology/Principal Findings: Here, we report identification and isolation of a subpopulation of human dermal fibroblasts that express the pluripotency marker stage specific embryonic antigen 3 (SSEA3). Fibroblasts that expressed SSEA3 demonstrated an enhanced iPSC generation efficiency, while no iPSC derivation was obtained from the fibroblasts that did not express SSEA3. Transcriptional analysis revealed NANOG expression was significantly increased in the SSEA3 expressing fibroblasts, suggesting a possible mechanistic explanation for the differential reprogramming. Conclusions/Significance: To our knowledge, this study is the first to identify a pluripotency marker in a heterogeneous population of human dermal fibroblasts, to isolate a subpopulation of cells that have a significantly increased propensity to reprogram to pluripotency and to identify a possible mechanism to explain this differential reprogramming. This discovery provides a method to significantly increase the efficiency of reprogramming, enhancing the feasibility of the potential applications based on this technology, and a tool for basic research studies to understand the underlying reprogramming mechanisms.			Byrne, JA (corresponding author), Stanford Univ, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94304 USA.	reneer@stanford.edu		Byrne, James/0000-0002-2232-292X; Reijo Pera, Renee/0000-0002-6487-1329				Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Byrne JA, 2008, HUM MOL GENET, V17, pR37, DOI 10.1093/hmg/ddn053; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; NGUYEN HN, 2008, COLD SPRING HARB PRO, V5047; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wong CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001955; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	23	61	65	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7118	10.1371/journal.pone.0007118	http://dx.doi.org/10.1371/journal.pone.0007118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774082	Green Published, gold, Green Submitted			2022-12-25	WOS:000270160900009
J	Mereghetti, L; Sitkiewicz, I; Green, NM; Musser, JM				Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.			Identification of an Unusual Pattern of Global Gene Expression in Group B Streptococcus Grown in Human Blood	PLOS ONE			English	Article								Because passage of the bacterium to blood is a crucial step in the pathogenesis of many group B Streptococcus (GBS) invasive infections, we recently conducted a whole-genome transcriptome analysis during GBS incubation ex vivo with human blood. In the current work, we sought to analyze in detail the difference in GBS gene expression that occurred in one blood sample (donor A) relative to other blood samples. We incubated GBS strain NEM316 with fresh heparinized human blood obtained from healthy volunteers, and analyzed GBS genome expression and cytokine production. Principal component analysis identified extensive clustering of the transcriptome data among all samples at time 0. In striking contrast, the whole bacterial gene expression in the donor A blood sample was significantly different from the gene expression in all other blood samples studied, both after 30 and 90 min of incubation. More genes were up-regulated in donor A blood relative to the other samples, at 30 min and 90 min. Furthermore, there was significant variation in transcript levels between donor A blood and other blood samples. Notably, genes with the highest transcript levels in donor A blood were those involved in carbohydrate metabolism. We also discovered an unusual production of proinflammatory and immunomodulatory cytokines: MIF, tPAI-1 and IL-1 beta were produced at higher levels in donor A blood relative to the other blood samples, whereas GM-CSF, TNF-alpha, IFN-gamma, IL-7 and IL-10 remained at lower levels in donor A blood. Potential reasons for our observations are that the immune response of donor A significantly influenced the bacterial transcriptome, or both GBS gene expression and immune response were influenced by the metabolic status of donor A.			Mereghetti, L (corresponding author), Methodist Hosp Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX USA.	JMMusser@tmhs.org	Sitkiewicz, Izabela/G-5058-2011	Sitkiewicz, Izabela/0000-0001-8228-9917				Alessi MC, 2007, CURR OPIN LIPIDOL, V18, P240, DOI 10.1097/MOL.0b013e32814e6d29; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Bohnsack JF, 2001, J INFECT DIS, V183, P1694, DOI 10.1086/320717; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, SCAND J INFECT DIS, V35, P573, DOI 10.1080/00365540310016277; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Herbert MA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-31; Hery-Arnaud G, 2005, J BACTERIOL, V187, P6248, DOI 10.1128/JB.187.17.6248-6252.2005; Hery-Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4668, DOI 10.1128/AEM.02604-06; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Katial RK, 1998, CLIN DIAGN LAB IMMUN, V5, P78, DOI 10.1128/CDLI.5.1.78-81.1998; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Kotb M, 2003, SCAND J INFECT DIS, V35, P665, DOI 10.1080/00365540310015962; Leurs PB, 2002, DIABETES CARE, V25, P1340, DOI 10.2337/diacare.25.8.1340; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Rolland K, 2002, MICROBIOL-SGM, V148, P1493, DOI 10.1099/00221287-148-5-1493; Sendi P, 2009, EMERG INFECT DIS, V15, P223, DOI 10.3201/eid1502.080990; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Sigge A, 2008, J CLIN MICROBIOL, V46, P807, DOI 10.1128/JCM.01963-07; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wang SM, 2008, DIAGN MICR INFEC DIS, V61, P165, DOI 10.1016/j.diagmicrobio.2008.01.008; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7145	10.1371/journal.pone.0007145	http://dx.doi.org/10.1371/journal.pone.0007145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774088	Green Published, Green Submitted, gold			2022-12-25	WOS:000270160900019
J	Rzadzinska, AK; Nevalainen, EM; Prosser, HM; Lappalainen, P; Steel, KP				Rzadzinska, Agnieszka K.; Nevalainen, Elisa M.; Prosser, Haydn M.; Lappalainen, Pekka; Steel, Karen P.			MyosinVIIa Interacts with Twinfilin-2 at the Tips of Mechanosensory Stereocilia in the Inner Ear	PLOS ONE			English	Article								In vertebrates hearing is dependent upon the microvilli-like mechanosensory stereocilia and their length gradation. The staircase-like organization of the stereocilia bundle is dynamically maintained by variable actin turnover rates. Two unconventional myosins were previously implicated in stereocilia length regulation but the mechanisms of their action remain unknown. MyosinXVa is expressed in stereocilia tips at levels proportional to stereocilia length and its absence produces staircase-like bundles of very short stereocilia. MyosinVIIa localizes to the tips of the shorter stereocilia within bundles, and when absent, the stereocilia are abnormally long. We show here that myosinVIIa interacts with twinfilin-2, an actin binding protein, which inhibits actin polymerization at the barbed end of the filament, and that twinfilin localization in stereocilia overlaps with myosinVIIa. Exogenous expression of myosinVIIa in fibroblasts results in a reduced number of filopodia and promotes accumulation of twinfilin-2 at the filopodia tips. We hypothesize that the newly described interaction between myosinVIIa and twinfilin-2 is responsible for the establishment and maintenance of slower rates of actin turnover in shorter stereocilia, and that interplay between complexes of myosinVIIa/twinfilin-2 and myosinXVa/whirlin is responsible for stereocilia length gradation within the bundle staircase.			Rzadzinska, AK (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge, England.	akr@sanger.ac.uk		Lappalainen, Pekka/0000-0001-6227-0354	MRC [MC_qA137918, G0300212] Funding Source: UKRI; Medical Research Council [MC_qA137918] Funding Source: researchfish; Medical Research Council [G0300212] Funding Source: Medline; Wellcome Trust [79643] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Holme RH, 2002, J COMP NEUROL, V450, P94, DOI 10.1002/cne.10301; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; HUG C, 1992, J CELL BIOL, V116, P923, DOI 10.1083/jcb.116.4.923; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Karolyi IJ, 2003, HUM MOL GENET, V12, P2797, DOI 10.1093/hmg/ddg308; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mogensen MM, 2007, CELL MOTIL CYTOSKEL, V64, P496, DOI 10.1002/cm.20199; Nevalainen EM, 2009, BIOCHEM J, V417, P593, DOI 10.1042/BJ20080608; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Paavilainen VO, 2002, J BIOL CHEM, V277, P43089, DOI 10.1074/jbc.M208225200; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022	29	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2009	4	9							e7097	10.1371/journal.pone.0007097	http://dx.doi.org/10.1371/journal.pone.0007097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498RP	19774077	Green Published, gold, Green Submitted			2022-12-25	WOS:000270160900006
J	Cooke, GS; Little, KE; Bland, RM; Thulare, H; Newell, ML				Cooke, Graham S.; Little, Kirsty E.; Bland, Ruth M.; Thulare, Hilary; Newell, Marie-Louise			Need for Timely Paediatric HIV Treatment within Primary Health Care in Rural South Africa	PLOS ONE			English	Article								Background: In areas where adult HIV prevalence has reached hyperendemic levels, many infants remain at risk of acquiring HIV infection. Timely access to care and treatment for HIV-infected infants and young children remains an important challenge. We explore the extent to which public sector roll-out has met the estimated need for paediatric treatment in a rural South African setting. Methods: Local facility and population-based data were used to compare the number of HIV infected children accessing HAART before 2008, with estimates of those in need of treatment from a deterministic modeling approach. The impact of programmatic improvements on estimated numbers of children in need of treatment was assessed in sensitivity analyses. Findings: In the primary health care programme of HIV treatment 346 children <16 years of age initiated HAART by 2008; 245(70.8%) were aged 10 years or younger, and only 2(<1%) under one year of age. Deterministic modeling predicted 2,561 HIV infected children aged 10 or younger to be alive within the area, of whom at least 521(20.3%) would have required immediate treatment. Were extended PMTCT uptake to reach 100% coverage, the annual number of infected infants could be reduced by 49.2%. Conclusion: Despite progress in delivering decentralized HIV services to a rural sub-district in South Africa, substantial unmet need for treatment remains. In a local setting, very few children were initiated on treatment under 1 year of age and steps have now been taken to successfully improve early diagnosis and referral of infected infants.			Cooke, GS (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa.	gcooke@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Cooke, Graham/0000-0001-6475-5056; Bland, Ruth/0000-0003-1675-9268	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARNIGHAUSEN T, 2007, PLOS MED, pE298, DOI DOI 10.1371/JOURNAL.PMED.0040298; Bland RM, 2007, B WORLD HEALTH ORGAN, V85, P289, DOI 10.2471/BLT.06.032441; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; *DEP HLTH HUM SERV, 2008, PAN ANT GUID AD AD G, P1; *DEP HLTH SA, 2008, PROGR REP DECL COMM; *DEP HLTH SA, 2004, HLTH STAT B 2003 4; Department of Health SA, 2004, NAT ANT TREATM GUID; Little K, 2007, INT J EPIDEMIOL, V36, P679, DOI 10.1093/ije/dym019; MCKERROW NH, 2008, STEP BY STEP GUIDE M; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Moultrie TA, 2008, STUD FAMILY PLANN, V39, P39, DOI 10.1111/j.1728-4465.2008.00149.x; National Department of Health (South Africa), 2008, NAT HIV SYPH PREV SU; NATIONS U, 2008, MILLENIUM DEV GOALS; ROCHAT T, 2006, 16 INT AIDS C TOR CA; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; UNAIDS, 2008, REP GLOB AIDS EP; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2008, ANT THER INF CHILDR	22	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7101	10.1371/journal.pone.0007101	http://dx.doi.org/10.1371/journal.pone.0007101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771168	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000270154400004
J	van der Wath, RC; Wilson, A; Laurenti, E; Trumpp, A; Lio, P				van der Wath, Richard C.; Wilson, Anne; Laurenti, Elisa; Trumpp, Andreas; Lio, Pietro			Estimating Dormant and Active Hematopoietic Stem Cell Kinetics through Extensive Modeling of Bromodeoxyuridine Label-Retaining Cell Dynamics	PLOS ONE			English	Article							TURNOVER; 5-BROMO-2'-DEOXYURIDINE; PROLIFERATION; SEGREGATION; STRANDS; CANCER; CYCLE; BRDU; DNA	Bone marrow hematopoietic stem cells (HSCs) are responsible for both lifelong daily maintenance of all blood cells and for repair after cell loss. Until recently the cellular mechanisms by which HSCs accomplish these two very different tasks remained an open question. Biological evidence has now been found for the existence of two related mouse HSC populations. First, a dormant HSC (d-HSC) population which harbors the highest self-renewal potential of all blood cells but is only induced into active self-renewal in response to hematopoietic stress. And second, an active HSC (a-HSC) subset that by and large produces the progenitors and mature cells required for maintenance of day-to-day hematopoiesis. Here we present computational analyses further supporting the d-HSC concept through extensive modeling of experimental DNA label-retaining cell (LRC) data. Our conclusion that the presence of a slowly dividing subpopulation of HSCs is the most likely explanation (amongst the various possible causes including stochastic cellular variation) of the observed long term Bromodeoxyuridine (BrdU) retention, is confirmed by the deterministic and stochastic models presented here. Moreover, modeling both HSC BrdU uptake and dilution in three stages and careful treatment of the BrdU detection sensitivity permitted improved estimates of HSC turnover rates. This analysis predicts that d-HSCs cycle about once every 149-193 days and a-HSCs about once every 28-36 days. We further predict that, using LRC assays, a 75%-92.5% purification of d-HSCs can be achieved after 59-130 days of chase. Interestingly, the d-HSC proportion is now estimated to be around 30-45% of total HSCs - more than twice that of our previous estimate.			van der Wath, RC (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	rvanderwath@gmail.com	P. Lió, Pietro Lio/AAV-3358-2021; Trumpp, Andreas/Z-2141-2019	P. Lió, Pietro Lio/0000-0002-0540-5053; Trumpp, Andreas/0000-0002-6212-3466; Laurenti, Elisa/0000-0002-9917-9092				Allen L.J.S., 2010, INTRO STOCHASTIC PRO; Bonhoeffer S, 2000, J IMMUNOL, V164, P5049, DOI 10.4049/jimmunol.164.10.5049; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; De Boer RJ, 2003, P ROY SOC B-BIOL SCI, V270, P849, DOI 10.1098/rspb.2002.2316; ESSERS MAG, 2009, NATURE; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; STOCKDALE F, 1964, SCIENCE, V146, P533, DOI 10.1126/science.146.3643.533; VANDERWATCH RC, 2008, LECT NOTES COMPUTER, P387; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Viale A, 2009, EMBO MOL MED, V1, P88, DOI 10.1002/emmm.200900019; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; YEN A, 1990, CANCER RES, V50, P1411	26	59	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e6972	10.1371/journal.pone.0006972	http://dx.doi.org/10.1371/journal.pone.0006972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771180	Green Submitted, Green Published, gold			2022-12-25	WOS:000270154400002
J	Dridi, B; Henry, M; El Khechine, A; Raoult, D; Drancourt, M				Dridi, Bedis; Henry, Mireille; El Khechine, Amel; Raoult, Didier; Drancourt, Michel			High Prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae Detected in the Human Gut Using an Improved DNA Detection Protocol	PLOS ONE			English	Article								Background: The low and variable prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae DNA in human stool contrasts with the paramount role of these methanogenic Archaea in digestion processes. We hypothesized that this contrast is a consequence of the inefficiencies of current protocols for archaeon DNA extraction. We developed a new protocol for the extraction and PCR-based detection of M. smithii and M. stadtmanae DNA in human stool. Methodology/Principal Findings: Stool specimens collected from 700 individuals were filtered, mechanically lysed twice, and incubated overnight with proteinase K prior to DNA extraction using a commercial DNA extraction kit. Total DNA was used as a template for quantitative real-time PCR targeting M. smithii and M. stadtmanae 16S rRNA and rpoB genes. Amplification of 16S rRNA and rpoB yielded positive detection of M. smithii in 95.7% and M. stadtmanae in 29.4% of specimens. Sequencing of 16S rRNA gene PCR products from 30 randomly selected specimens ( 15 for M. smithii and 15 for M. stadtmanae) yielded a sequence similarity of 99-100% using the reference M. smithii ATCC 35061 and M. stadtmanae DSM 3091 sequences. Conclusions/Significance: In contrast to previous reports, these data indicate a high prevalence of the methanogens M. smithii and M. stadtmanae in the human gut, with the former being an almost ubiquitous inhabitant of the intestinal microbiome.			Dridi, B (corresponding author), Univ Aix Marseille 2, CNRS, UMR 6236, IRD 3R198,IFR 48,Fac Med,Unite Rech Malad Infect, Marseille, France.	Michel.Drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; BELAY N, 1988, APPL ENVIRON MICROB, V54, P600, DOI 10.1128/AEM.54.2.600-603.1988; BELAY N, 1990, J CLIN MICROBIOL, V28, P1666, DOI 10.1128/JCM.28.7.1666-1668.1990; Carcopino X, 2006, J MED VIROL, V78, P1131, DOI 10.1002/jmv.20673; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Khechine A, 2009, MICROBIOL-SGM, V155, P2384, DOI 10.1099/mic.0.026484-0; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; KLENK HP, 1994, J MOL EVOL, V38, P420, DOI 10.1007/BF00163158; Kubota K, 2008, J MICROBIOL METH, V72, P54, DOI 10.1016/j.mimet.2007.10.006; Levitt MD, 2006, CLIN GASTROENTEROL H, V4, P123, DOI 10.1016/j.cgh.2005.11.006; MACY JM, 1972, AM J CLIN NUTR, V25, P1318; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Mihajlovski A, 2008, RES MICROBIOL, V159, P516, DOI 10.1016/j.resmic.2008.06.007; MILLER TL, 1984, APPL ENVIRON MICROB, V48, P449, DOI 10.1128/AEM.48.2.449-450.1984; MILLER TL, 1982, ARCH MICROBIOL, V131, P14, DOI 10.1007/BF00451492; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; MISAWA H, 1986, APPL ENVIRON MICROB, V51, P429, DOI 10.1128/AEM.51.2.429-431.1986; Nicholson MJ, 2007, MICROB ECOL, V54, P141, DOI 10.1007/s00248-006-9182-1; OVCHINNIKOV YA, 1982, NUCLEIC ACIDS RES, V10, P4035, DOI 10.1093/nar/10.13.4035; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PUHLER G, 1989, NUCLEIC ACIDS RES, V17, P4517, DOI 10.1093/nar/17.12.4517; Saengkerdsub S, 2007, LETT APPL MICROBIOL, V45, P629, DOI 10.1111/j.1472-765X.2007.02243.x; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79; Stewart JA, 2006, LETT APPL MICROBIOL, V43, P58, DOI 10.1111/j.1472-765X.2006.01906.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	28	235	246	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2009	4	9							e7063	10.1371/journal.pone.0007063	http://dx.doi.org/10.1371/journal.pone.0007063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KG	19759898	Green Published, Green Submitted, gold			2022-12-25	WOS:000269970200003
J	Boyd, WA; Smith, MV; Kissling, GE; Rice, JR; Snyder, DW; Portier, CJ; Freedman, JH				Boyd, Windy A.; Smith, Marjolein V.; Kissling, Grace E.; Rice, Julie R.; Snyder, Daniel W.; Portier, Christopher J.; Freedman, Jonathan H.			Application of a Mathematical Model to Describe the Effects of Chlorpyrifos on Caenorhabditis elegans Development	PLOS ONE			English	Article							C-ELEGANS; NEMATODE; TOXICOLOGY; NEURODEVELOPMENT; SYSTEM; GROWTH; ASSAY	Background: The nematode Caenorhabditis elegans is being assessed as an alternative model organism as part of an interagency effort to develop better means to test potentially toxic substances. As part of this effort, assays that use the COPAS Biosort flow sorting technology to record optical measurements (time of flight (TOF) and extinction (EXT)) of individual nematodes under various chemical exposure conditions are being developed. A mathematical model has been created that uses Biosort data to quantitatively and qualitatively describe C. elegans growth, and link changes in growth rates to biological events. Chlorpyrifos, an organophosphate pesticide known to cause developmental delays and malformations in mammals, was used as a model toxicant to test the applicability of the growth model for in vivo toxicological testing. Methodology/Principal Findings: L1 larval nematodes were exposed to a range of sub-lethal chlorpyrifos concentrations (0-75 mu M) and measured every 12 h. In the absence of toxicant, C. elegans matured from L1s to gravid adults by 60 h. A mathematical model was used to estimate nematode size distributions at various times. Mathematical modeling of the distributions allowed the number of measured nematodes and log(EXT) and log(TOF) growth rates to be estimated. The model revealed three distinct growth phases. The points at which estimated growth rates changed (change points) were constant across the ten chlorpyrifos concentrations. Concentration response curves with respect to several model-estimated quantities (numbers of measured nematodes, mean log(TOF) and log(EXT), growth rates, and time to reach change points) showed a significant decrease in C. elegans growth with increasing chlorpyrifos concentration. Conclusions: Effects of chlorpyrifos on C. elegans growth and development were mathematically modeled. Statistical tests confirmed a significant concentration effect on several model endpoints. This confirmed that chlorpyrifos affects C. elegans development in a concentration dependent manner. The most noticeable effect on growth occurred during early larval stages: L2 and L3. This study supports the utility of the C. elegans growth assay and mathematical modeling in determining the effects of potentially toxic substances in an alternative model organism using high-throughput technologies.			Boyd, WA (corresponding author), NIEHS, Natl Toxicol Program, Biomol Screening Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	freedma1@niehs.nih.gov	Portier, Christopher J/A-3160-2010	Portier, Christopher J/0000-0002-0954-0279; Boyd, Windy/0000-0003-3803-3716	Intramural NIH HHS [Z01 ES102046] Funding Source: Medline; PHS HHS [GS-00F-0003L] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES045004, ZIAES102046, Z01ES102046] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*AG TOX SUBST DIS, 1997, TOX PROF CHLORP, P217; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Boyd W.A., 2009, NEUROTOXICOL TERATOL; Boyd WA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001259; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Connors SL, 2008, PEDIATR NEUROL, V38, P163, DOI 10.1016/j.pediatrneurol.2007.10.009; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dong J, 2008, J MOL BIOL, V376, P621, DOI 10.1016/j.jmb.2007.11.094; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Hollander M, 1973, NONPARAMETRIC STAT M, Vxviii; Jameson RR, 2006, ENVIRON HEALTH PERSP, V114, P667, DOI 10.1289/ehp.8750; KLEINBAUM DG, 1988, APPL REGRESSION ANAL, pR18; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; NGUYEN M, 1995, GENETICS, V140, P527; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; Pulak Rock, 2006, V351, P275; Rand JB., 2007, ACETYLCHOLINE, V1, DOI [10.1895/wormbook.1.131.1, DOI 10.1895/WORMBOOK.1.131.1]; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Ruaud AF, 2006, DEVELOPMENT, V133, P2211, DOI 10.1242/dev.02392; Sherman JD, 1996, ARCH ENVIRON HEALTH, V51, P5, DOI 10.1080/00039896.1996.9935986; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; SMITH MV, 2009, PLOS ONE, pR30; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; *US NAT RES COUNC, 2000, APP C SIGN PATHW SCI, P296; USEPA, 2000, CHLORPYRIFOS REVISED; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406	37	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2009	4	9							e7024	10.1371/journal.pone.0007024	http://dx.doi.org/10.1371/journal.pone.0007024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FO	19753116	Green Submitted, Green Published, gold			2022-12-25	WOS:000269796500012
J	Chen, HG; Han, WJ; Deng, M; Qin, JC; Yuan, D; Liu, JP; Xiao, L; Gong, LL; Liang, SP; Zhang, J; Liu, Y; Li, DWC				Chen, He-Ge; Han, Wen-Jun; Deng, Mi; Qin, Jichao; Yuan, Dan; Liu, Jin-Ping; Xiao, Ling; Gong, Lili; Liang, Songping; Zhang, Jian; Liu, Yun; Li, David Wan-Cheng			Transcriptional Regulation of PP2A-A alpha Is Mediated by Multiple Factors Including AP-2 alpha, CREB, ETS-1, and SP-1	PLOS ONE			English	Article								Protein phosphatases-2A (PP-2A) is a major serine/threonine phosphatase and accounts for more than 50% serine/threonine phosphatase activity in eukaryotes. The holoenzyme of PP-2A consists of the scaffold A subunit, the catalytic C subunit and the regulatory B subunit. The scaffold subunits, PP2A-A alpha/beta, provide a platform for both C and B subunits to bind, thus playing a crucial role in providing specific PP-2A activity. Mutation of the two genes encoding PP2A-A alpha/beta leads to carcinogenesis and likely other human diseases. Regulation of these genes by various factors, both extracellular and intracellular, remains largely unknown. In the present study, we have conducted functional dissection of the promoter of the mouse PP2A-A alpha gene. Our results demonstrate that the proximal promoter of the mouse PP2A-A alpha gene contains numerous cis-elements for the binding of CREB, ETS-1, AP-2 alpha, SP-1 besides the putative TFIIB binding site (BRE) and the downstream promoter element (DPE). Gel mobility shifting assays revealed that CREB, ETS-1, AP-2 alpha, and SP-1 all bind to PP2A-A alpha gene promoter. In vitro mutagenesis and reporter gene activity assays reveal that while SP-1 displays negative regulation, CREB, ETS-1 and AP-2A alpha all positively regulate the promoter of the PP2A-A alpha gene. ChIP assays further confirm that all the above transcription factors participate the regulation of PP2A-A alpha gene promoter. Together, our results reveal that multiple transcription factors regulate the PP2A-A alpha gene.			Chen, HG (corresponding author), Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	dwli1688@hotmail.com	chen, hege/GYV-5810-2022; Li, David/AAN-9205-2021; Deng, Mi/K-8699-2012; Gong, Lili/F-8452-2014	Deng, Mi/0000-0003-4291-0144; Gong, Lili/0000-0002-6533-5333; Qin, Jichao/0000-0002-2961-7624	NATIONAL EYE INSTITUTE [R01EY015765, R01EY018380] Funding Source: NIH RePORTER; NEI NIH HHS [1R01EY015765, 1R01EY018380, R01 EY018380, R01 EY015765] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Cowley DO, 2000, GENE DEV, V14, P366; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; FLEISCHMAN LF, 1995, MOL CELL BIOL, V15, P925; FU H, 2009, SCI CHINA SER C, V52, P1; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kantorow M, 1998, INVEST OPHTH VIS SCI, V39, P2344; Kitange G, 1999, MODERN PATHOL, V12, P618; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; LI WC, 1992, EUR J BIOCHEM, V205, P491, DOI 10.1111/j.1432-1033.1992.tb16805.x; Liu WB, 2008, MOL VIS, V14, P762; Ma HL, 2009, GENE REGUL SYST BIO, V3, P115; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PALCZEWSKI K, 1991, EXP EYE RES, V53, P101, DOI 10.1016/0014-4835(91)90151-4; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Qin JC, 2008, CANCER RES, V68, P4150, DOI 10.1158/0008-5472.CAN-08-0839; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Suzuki K, 2003, INT J ONCOL, V23, P1263; Takagi Y, 2000, GUT, V47, P268, DOI 10.1136/gut.47.2.268; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; WALTER G, 1993, BIOCHIM BIOPHYS ACTA, V1155, P207, DOI 10.1016/0304-419X(93)90005-W; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; YAN Q, 2009, ENCY NEUROSCIENCE, P3325; Yan Q, 2007, J BIOL CHEM, V282, P13954, DOI 10.1074/jbc.M611476200; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Zhou TY, 2001, J BIOL CHEM, V276, P25503, DOI 10.1074/jbc.M102875200; 郑春兵, 2009, [自然科学进展, Progress in Natural Science], V19, P272	56	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2009	4	9							e7019	10.1371/journal.pone.0007019	http://dx.doi.org/10.1371/journal.pone.0007019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FN	19750005	Green Published, gold, Green Submitted			2022-12-25	WOS:000269796300016
J	Diaz-Ruiz, O; Zapata, A; Shan, LF; Zhang, YJ; Tomac, AC; Malik, N; de la Cruz, F; Backman, CM				Diaz-Ruiz, Oscar; Zapata, Agustin; Shan, Lufei; Zhang, YaJun; Tomac, Andreas C.; Malik, Nasir; de la Cruz, Fidel; Backman, Cristina M.			Selective Deletion of PTEN in Dopamine Neurons Leads to Trophic Effects and Adaptation of Striatal Medium Spiny Projecting Neurons	PLOS ONE			English	Article								The widespread distribution of the tumor suppressor PTEN in the nervous system suggests a role in a broad range of brain functions. PTEN negatively regulates the signaling pathways initiated by protein kinase B (Akt) thereby regulating signals for growth, proliferation and cell survival. Pten deletion in the mouse brain has revealed its role in controlling cell size and number. In this study, we used Cre-loxP technology to specifically inactivate Pten in dopamine (DA) neurons (Pten KO mice). The resulting mutant mice showed neuronal hypertrophy, and an increased number of dopaminergic neurons and fibers in the ventral mesencephalon. Interestingly, quantitative microdialysis studies in Pten KO mice revealed no alterations in basal DA extracellular levels or evoked DA release in the dorsal striatum, despite a significant increase in total DA tissue levels. Striatal dopamine receptor D1 (DRD1) and prodynorphin (PDyn) mRNA levels were significantly elevated in KO animals, suggesting an enhancement in neuronal activity associated with the striatonigral projection pathway, while dopamine receptor D2 (DRD2) and preproenkephalin (PPE) mRNA levels remained unchanged. In addition, PTEN inactivation protected DA neurons and significantly enhanced DA-dependent behavioral functions in KO mice after a progressive 6OHDA lesion. These results provide further evidence about the role of PTEN in the brain and suggest that manipulation of the PTEN/Akt signaling pathway during development may alter the basal state of dopaminergic neurotransmission and could provide a therapeutic strategy for the treatment of Parkinson's disease, and other neurodegenerative disorders.			Diaz-Ruiz, O (corresponding author), NIDA, Cellular Neurobiol Branch, Natl Inst Hlth, Baltimore, MD USA.	cbackman@mail.nih.gov	backman, cristina/C-1276-2013; Diaz-Ruiz, Oscar/F-3162-2010		Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000560, Z01DA000515, ZIADA000515] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BURKE RE, 1990, J NEUROSCI METH, V35, P63, DOI 10.1016/0165-0270(90)90095-W; BURKE RE, 1992, NEUROSCIENCE, V50, P559, DOI 10.1016/0306-4522(92)90447-A; Calhoun ME, 2000, J CHEM NEUROANAT, V20, P61, DOI 10.1016/S0891-0618(00)00074-0; Chang N, 2007, TRENDS NEUROSCI, V30, P581, DOI 10.1016/j.tins.2007.08.006; Chefer VI, 2006, J NEUROSCI METH, V155, P187, DOI 10.1016/j.jneumeth.2005.12.018; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; HATTORI T, 1973, EXP NEUROL, V38, P70, DOI 10.1016/0014-4886(73)90008-3; He Y, 2000, BRAIN RES, V858, P163, DOI 10.1016/S0006-8993(99)02459-2; Jackson-Lewis V, 2000, J COMP NEUROL, V424, P476, DOI 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Kalueff AV, 2006, BEHAV PROCESS, V72, P104, DOI 10.1016/j.beproc.2005.12.011; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li L, 2003, J CELL BIOCHEM, V88, P24, DOI 10.1002/jcb.10312; Li Q, 2007, EXP NEUROL, V204, P840, DOI 10.1016/j.expneurol.2007.01.005; LINDEN R, 1994, NEUROSCIENCE, V58, P671, DOI 10.1016/0306-4522(94)90447-2; LUNDBERG C, 1994, BRAIN RES, V644, P205, DOI 10.1016/0006-8993(94)91681-0; Marti MJ, 1997, J NEUROSCI, V17, P2030; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; O'Neill MF, 1999, PSYCHOPHARMACOLOGY, V145, P237, DOI 10.1007/s002130051055; Ram, 2004, BIOPHOTONICS INT, V11, P46; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Sano T, 1999, CANCER RES, V59, P1820; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SEIGER A, 1973, Z ANAT ENTWICKLUNGS, V140, P281, DOI 10.1007/BF00525058; SMITH AD, 1994, J NEUROSCI METH, V54, P75, DOI 10.1016/0165-0270(94)90161-9; Smits SM, 2006, J NEURAL TRANSM-SUPP, P57; SWERDLOW NR, 1991, J PHARMACOL EXP THER, V256, P530; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5	46	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e7027	10.1371/journal.pone.0007027	http://dx.doi.org/10.1371/journal.pone.0007027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19750226	Green Published, Green Submitted, gold			2022-12-25	WOS:000269696600019
J	Gram, GJ; Karlsson, I; Agger, EM; Andersen, P; Fomsgaard, A				Gram, Gregers Jacob; Karlsson, Ingrid; Agger, Else Marie; Andersen, Peter; Fomsgaard, Anders			A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8(+) Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice	PLOS ONE			English	Article								Background: Specific cellular cytotoxic immune responses (CTL) are important in combating viral diseases and a highly desirable feature in the development of targeted HIV vaccines. Adjuvants are key components in vaccines and may assist the HIV immunogens in inducing the desired CTL responses. In search for appropriate adjuvants for CD8(+) T cells it is important to measure the necessary immunological features e. g. functional cell killing/lysis in addition to immunological markers that can be monitored by simple immunological laboratory methods. Methodology/Principal Findings: We tested the ability of a novel two component adjuvant, CAF01, consisting of the immune stimulating synthetic glycolipid TDB (Trehalose-Dibehenate) incorporated into cationic DDA (Dimethyldioctadecylammonium bromide) liposomes to induce CD8(+) T-cell restricted cellular immune responses towards subdominant minimal HLA-A0201-restricted CTL epitopes from HIV-1 proteins in HLA-A*0201 transgenic HHD mice. CAF01 has an acceptable safety profile and is used in preclinical development of vaccines against HIV-1, malaria and tuberculosis. Conclusions/Significance: We found that CAF01 induced cellular immune responses against HIV-1 minimal CTL epitopes in HLA-A*0201 transgenic mice to levels comparable with that of incomplete Freund's adjuvant.			Gram, GJ (corresponding author), Statens Serum Inst, Dept Virol, DK-2300 Copenhagen, Denmark.	afo@ssi.dk		Andersen, Peter/0000-0002-5869-2551; Fomsgaard, Anders/0000-0003-4304-0603				ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Christensen D, 2007, EXPERT REV VACCINES, V6, P785, DOI 10.1586/14760584.6.5.785; Corbet S, 2003, J GEN VIROL, V84, P2409, DOI 10.1099/vir.0.19152-0; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kloverpris H, 2009, AIDS, V23, P1329, DOI 10.1097/QAD.0b013e32832d9b00; Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Malhotra U, 2003, J VIROL, V77, P2663, DOI 10.1128/JVI.77.4.2663-2674.2003; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Thorn M, 2007, APMIS, V115, P757, DOI 10.1111/j.1600-0463.2007.apm_595.x; Vangala A, 2006, J PHARM PHARMACOL, V58, P787, DOI 10.1211/jpp.58.6.0009; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001	15	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2009	4	9							e6950	10.1371/journal.pone.0006950	http://dx.doi.org/10.1371/journal.pone.0006950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492XS	19759892	gold, Green Published, Green Submitted			2022-12-25	WOS:000269696600005
J	Guruharsha, KG; Ruiz-Gomez, M; Ranganath, HA; Siddharthan, R; VijayRaghavan, K				Guruharsha, K. G.; Ruiz-Gomez, Mar; Ranganath, H. A.; Siddharthan, Rahul; VijayRaghavan, K.			The Complex Spatio-Temporal Regulation of the Drosophila Myoblast Attractant Gene duf/kirre	PLOS ONE			English	Article							INDIRECT FLIGHT MUSCLES; ROLLING-PEBBLES; BINDING-SITE; MESODERM DEVELOPMENT; WIDE PREDICTION; TRANSCRIPTION; SEQUENCE; EXPRESSION; MEF2; DNA	A key early player in the regulation of myoblast fusion is the gene dumbfounded (duf, also known as kirre). Duf must be expressed, and function, in founder cells (FCs). A fixed number of FCs are chosen from a pool of equivalent myoblasts and serve to attract fusion-competent myoblasts (FCMs) to fuse with them to form a multinucleate muscle-fibre. The spatial and temporal regulation of duf expression and function are important and play a deciding role in choice of fibre number, location and perhaps size. We have used a combination of bioinformatics and functional enhancer deletion approaches to understand the regulation of duf. By transgenic enhancer-reporter deletion analysis of the duf regulatory region, we found that several distinct enhancer modules regulate duf expression in specific muscle founders of the embryo and the adult. In addition to existing bioinformatics tools, we used a new program for analysis of regulatory sequence, PhyloGibbs-MP, whose development was largely motivated by the requirements of this work. The results complement our deletion analysis by identifying transcription factors whose predicted binding regions match with our deletion constructs. Experimental evidence for the relevance of some of these TF binding sites comes from available ChIP-on-chip from the literature, and from our analysis of localization of myogenic transcription factors with duf enhancer reporter gene expression. Our results demonstrate the complex regulation in each founder cell of a gene that is expressed in all founder cells. They provide evidence for transcriptional control-both activation and repression-as an important player in the regulation of myoblast fusion. The set of enhancer constructs generated will be valuable in identifying novel trans-acting factor-binding sites and chromatin regulation during myoblast fusion in Drosophila. Our results and the bioinformatics tools developed provide a basis for the study of the transcriptional regulation of other complex genes.	[Guruharsha, K. G.; VijayRaghavan, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Guruharsha, K. G.; Ranganath, H. A.] Univ Mysore, Dept Studies Zool, Mysore, Karnataka, India; [Ruiz-Gomez, Mar] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Ruiz-Gomez, Mar] UAM, Madrid, Spain; [Siddharthan, Rahul] Inst Math Sci, Chennai, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Mysore; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Institute of Mathematical Sciences (IMSc) India	Guruharsha, KG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	vijay@ncbs.res.in	Kuthethur, Guruharsha/Z-2605-2019; Ruiz-Gómez, Mar/K-9266-2014	Kuthethur, Guruharsha/0000-0001-7292-4868; Ruiz-Gómez, Mar/0000-0002-9024-1400	Wellcome Trust [NLO- 056727/Z/99/B] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anant S, 1998, DEVELOPMENT, V125, P1361; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Bagni C, 2002, MECH DEVELOP, V117, P265, DOI 10.1016/S0925-4773(02)00176-4; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Blanchette M, 2002, J COMPUT BIOL, V9, P211, DOI 10.1089/10665270252935421; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Bour BA, 2000, GENE DEV, V14, P1498; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CURRIE DA, 1991, DEVELOPMENT, V113, P91; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; Dutta D, 2005, PLOS BIOL, V3, P1789, DOI 10.1371/journal.pbio.0030337; Dutta D, 2004, DEVELOPMENT, V131, P3761, DOI 10.1242/dev.01249; Elgar SJ, 2008, P NATL ACAD SCI USA, V105, P918, DOI 10.1073/pnas.0711255105; Estrada B, 2006, PLOS GENET, V2, P160, DOI 10.1371/journal.pgen.0020016; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Furlong EE, 2004, CURR OPIN GENET DEV, V14, P343, DOI 10.1016/j.gde.2004.06.011; Gajewski K, 1998, DEV GENES EVOL, V208, P382, DOI 10.1007/s004270050194; Georgias C, 1997, MECH DEVELOP, V69, P115, DOI 10.1016/S0925-4773(97)00169-X; Ghazi A, 2000, DEVELOPMENT, V127, P5309; Gogos JA, 1996, P NATL ACAD SCI USA, V93, P2159, DOI 10.1073/pnas.93.5.2159; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; HARTENSTEIN V, 1993, ATLAS DROSOPHILA DEV, V5, P57; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; Klapper R, 2002, MECH DEVELOP, V110, P85, DOI 10.1016/S0925-4773(01)00567-6; LAWRENCE PA, 1982, CELL, V29, P493, DOI 10.1016/0092-8674(82)90166-0; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; MAGGERT K, 1995, DEVELOPMENT, V121, P2107; Maqbool T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000122; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Nose A, 1998, DEVELOPMENT, V125, P215; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rau A, 2001, DEVELOPMENT, V128, P5061; Reddy KL, 2000, DEV BIOL, V224, P401, DOI 10.1006/dbio.2000.9797; Riechmann V, 1998, DEVELOPMENT, V125, P713; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Saller E, 2001, EMBO REP, V2, P298, DOI 10.1093/embo-reports/kve068; San Martin B, 2001, DEVELOPMENT, V128, P3331; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; SIDDHARTHAN R, 2008, PLOS COMP B IN PRESS; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393; Sudarsan V, 2001, DEV CELL, V1, P829, DOI 10.1016/S1534-5807(01)00089-2; Taylor MV, 2000, CURR BIOL, V10, pR646, DOI 10.1016/S0960-9822(00)00664-3; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; VonOhlen T, 1997, P NATL ACAD SCI USA, V94, P2404, DOI 10.1073/pnas.94.6.2404; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zaffran S, 2001, GENE DEV, V15, P2900; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	75	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2009	4	9							e6960	10.1371/journal.pone.0006960	http://dx.doi.org/10.1371/journal.pone.0006960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZI	19742310	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622500021
J	Jean, L; Lee, CF; Lee, C; Shaw, M; Vaux, DJ				Jean, Letitia; Lee, Chiu Fan; Lee, Chongsoo; Shaw, Michael; Vaux, David J.			Competing discrete interfacial effects are critical for amyloidogenesis	FASEB JOURNAL			English	Article						islet amyloid polypeptide; surface tension; hydrophobic-hydrophilic interfaces	ISLET AMYLOID POLYPEPTIDE; PHOSPHOLIPID MONOLAYERS; BETA-PROTEIN; FIBRILLOGENESIS; AGGREGATION; MEMBRANE; DISEASE; FIBRIL; MECHANISM; PEPTIDES	Amyloid accumulation is associated with pathological conditions, including type II diabetes and Alzheimer's disease. Lipids influence amyloidogenesis and are themselves targets for amyloid-mediated cell membrane disruption. Amyloid precursors are surface-active, accumulating at hydrophobic-hydrophilic interfaces (e. g., air-water), where their biophysical and kinetic behaviors differ from those in the bulk solution with significant and underappreciated consequences. Biophysical modeling predicted the probability and rate of beta-sheet amyloid dimer formation to be higher and faster at the air-water interface (AWI) than in the bulk (by 14 and similar to 1500 times, respectively). Time-course staining experiments with a typical amyloid dye verified our predictions by demonstrating that without AWI, islet amyloid polypeptide (IAPP) fibrilization was abolished or slowed, depending on the conditions. Our controls included undisturbed IAPP reactions, and we ascertained that the AWI removal process (technical or material) did not itself affect the reaction. Furthermore, we showed that the role of membranes in amyloidogenesis has been previously underestimated; in an in vivo-like situation (with no AWI), anionic liposomes (containing dioleoylphosphatidylglycerol) enhanced IAPP fibrilogenesis far more than described previously in conventional assay conditions (in the presence of an AWI). These findings have implications for the protein misfolding field and in assay design to target toxic protein aggregation.-Jean, L., Lee, C. F., Lee, C., Shaw, M., Vaux, D. J. Competing discrete interfacial effects are critical for amyloidogenesis. FASEB J. 24, 309-317 (2010). www.fasebj.org	[Jean, Letitia; Shaw, Michael; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lee, Chiu Fan; Lee, Chongsoo] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Lee, Chiu Fan/0000-0003-4363-9050; Jean, Letitia/0000-0002-6450-7148; Vaux, David/0000-0002-4901-9795	Synaptica Ltd. (Didcot, Oxfordshire, UK); Glasstone Trust (Oxford, UK); MRC [G0801917] Funding Source: UKRI; Medical Research Council [G0801917] Funding Source: researchfish	Synaptica Ltd. (Didcot, Oxfordshire, UK); Glasstone Trust (Oxford, UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Helen Mather for technical contribution. This work was supported by a research grant from Synaptica Ltd. (Didcot, Oxfordshire, UK). C. F. L. was supported by the Glasstone Trust (Oxford, UK).	Chi EY, 2008, PROTEINS, V72, P1, DOI 10.1002/prot.21887; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jackson M. B., 2006, MOL CELLULAR BIOPHYS; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Larson JL, 2000, PROTEIN SCI, V9, P427; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; Maltseva E, 2005, CHEMBIOCHEM, V6, P1817, DOI 10.1002/cbic.200500116; MATSUYAMA A, 1995, MACROMOLECULES, V28, P131, DOI 10.1021/ma00105a017; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; RUSTENBECK I, 1994, LIPIDS, V29, P685, DOI 10.1007/BF02538912; Sabate R, 2005, J PHYS CHEM B, V109, P11027, DOI 10.1021/jp050716m; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Szymczyk K, 2006, J COLLOID INTERF SCI, V293, P172, DOI 10.1016/j.jcis.2005.06.038; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604	30	43	44	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					309	317		10.1096/fj.09-137653	http://dx.doi.org/10.1096/fj.09-137653			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19741169				2022-12-25	WOS:000273233600031
J	Hassan, S; Biswas, MHU; Zhang, C; Du, C; Balaji, KC				Hassan, S.; Biswas, M. H. U.; Zhang, C.; Du, C.; Balaji, K. C.			Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cells	ONCOGENE			English	Article						PKD1; Hsp27; AR; p38; prostate cancer	BETA-CATENIN; MAPKAP KINASE-2; SERINE-82 PHOSPHORYLATION; SUBCELLULAR-LOCALIZATION; E-CADHERIN; C-MU; HSP27; NEUROTENSIN; ACTIVATION; GROWTH	We have previously shown that protein kinase D1 (PKD1), charter member of PKD protein family, is downregulated in advanced prostate cancer ( PC) and influences androgen receptor (AR) function in PC cells. Other independent studies showed that serine 82 residue in heat shock protein 27 (Hsp27) undergoes substrate phosphorylation by PKD1 and is associated with nuclear transport of AR resulting in increased AR transcriptional activity. In this study, we show that PKD1 interacts and phosphorylates Hsp27 at Ser82 in PC cells, which is mediated by p38-dependent mitogen-activated protein kinase pathway and is necessary for PKD1 repression of AR transcriptional activity and androgen-dependent proliferation of PC cells. The study provides first in vivo evidence that Hsp27 is a mediator of repression of AR function by PKD1 in PC cells, thereby linking the data in the published literature. Oncogene (2009) 28, 4386-4396; doi: 10.1038/onc.2009.291; published online 21 September 2009	[Hassan, S.; Biswas, M. H. U.; Zhang, C.; Du, C.; Balaji, K. C.] Univ Massachusetts, Sch Med, Dept Surg, Div Urol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Balaji, KC (corresponding author), Univ Massachusetts, Sch Med, Dept Surg, Div Urol, 55 Lake Ave N,Room S4-868, Worcester, MA 01655 USA.	Balajik@ummhc.org	Du, Cheng/F-1569-2013	Du, Cheng/0000-0002-8882-2513	Department of Surgery, University of Massachusetts Medical School	Department of Surgery, University of Massachusetts Medical School	We thank Dr FJ Johannes, Fraunhofer Institute for Interfacial Engineering, Stuttgart, Germany for providing the PKD1 expression vector. This study was supported by an institutional grant from the Department of Surgery, University of Massachusetts Medical School.	BELKA C, 1995, LEUKEMIA, V9, P288; CARRAWAY R, 1976, J BIOL CHEM, V251, P7045; Carraway RE, 2007, REGUL PEPTIDES, V141, P140, DOI 10.1016/j.regpep.2006.12.027; Cornford PA, 2000, CANCER RES, V60, P7099; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Du C, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-28; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; DUDICH IV, 1995, BBA-PROTEIN STRUCT M, V1253, P163, DOI 10.1016/0167-4838(95)00135-X; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Fanelli MA, 2008, CELL STRESS CHAPERON, V13, P207, DOI 10.1007/s12192-007-0007-z; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; Gomase VS, 2008, CURR DRUG METAB, V9, P255, DOI 10.2174/138920008783884803; Haslbeck Martin, 2002, Prog Mol Subcell Biol, V28, P37; Jaggi M, 2005, CANCER RES, V65, P483; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Ku GY, 2008, CANCER CHEMOTH PHARM, V62, P875, DOI 10.1007/s00280-008-0677-y; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Maizels ET, 1998, BIOCHEM J, V332, P703, DOI 10.1042/bj3320703; Mak P, 2008, BIOCHEM BIOPH RES CO, V373, P618, DOI 10.1016/j.bbrc.2008.06.097; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinez V, 2000, PEPTIDES, V21, P1617, DOI 10.1016/S0196-9781(00)00293-X; Moody TW, 2003, CURR PHARM DESIGN, V9, P495, DOI 10.2174/1381612033391621; Mosca A, 2005, J Endocrinol Invest, V28, P141; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Roberts JD, 2006, CLIN CANCER RES, V12, P5809, DOI 10.1158/1078-0432.CCR-05-2730; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Rocchi P, 2004, CANCER RES, V64, P6595, DOI 10.1158/0008-5472.CAN-03-3998; Rocchi P, 2006, BJU INT, V98, P1082, DOI 10.1111/j.1464-410X.2006.06425.x; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; So A, 2007, CURR GENOMICS, V8, P252; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Syed V, 2008, J CELL BIOCHEM, V104, P82, DOI 10.1002/jcb.21603; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	46	29	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4386	4396		10.1038/onc.2009.291	http://dx.doi.org/10.1038/onc.2009.291			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19767773				2022-12-25	WOS:000272876400007
J	Liu, YT; Matte, SL; Corbin, JD; Francis, SH; Cote, RH				Liu, Yu-Ting; Matte, Suzanne L.; Corbin, Jackie D.; Francis, Sharron H.; Cote, Rick H.			Probing the Catalytic Sites and Activation Mechanism of Photoreceptor Phosphodiesterase Using Radiolabeled Phosphodiesterase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; ROD CGMP PHOSPHODIESTERASE; DEPENDENT CONFORMATIONAL-CHANGE; GAMMA-SUBUNIT; BINDING-SITES; OUTER SEGMENTS; G-PROTEIN; GAF DOMAINS; TRANSDUCIN; BOVINE	Retinal photoreceptor phosphodiesterase (PDE6) is unique among the phosphodiesterase enzyme family not only for its catalytic heterodimer but also for its regulatory gamma-subunits (P gamma) whose inhibitory action is released upon binding to the G-protein transducin. It is generally assumed that during visual excitation both catalytic sites are relieved of P gamma inhibition upon binding of two activated transducin molecules. Because PDE6 shares structural and pharmacological similarities with PDE5, we utilized radiolabeled PDE5 inhibitors to probe the catalytic sites of PDE6. The membrane filtration assay we used to quantify [H-3] vardenafil binding to PDE6 required histone II-AS to stabilize drug binding to the active site. Under these conditions, [H-3] vardenafil binds stoichiometrically to both the alpha- and beta-subunits of the activated PDE6 heterodimer. [H-3] vardenafil fails to bind to either the PDE6 holoenzyme or the PDE6 catalytic dimer reconstituted with P gamma, consistent with P gamma blocking access to the drug-binding sites. Following transducin activation of membrane-associated PDE6 holoenzyme, [H-3] vardenafil binding increases in proportion to the extent of PDE6 activation. Both [H-3] vardenafil binding and hydrolytic activity of transducin-activated PDE6 fail to exceed 50% of the value for the PDE6 catalytic dimer. However, adding a 1000-fold excess of activated transducin can stimulate the hydrolytic activity of PDE6 to its maximum extent. These results demonstrate that both subunits of the PDE6 heterodimer are able to bind ligands to the enzyme active site. Furthermore, transducin relieves P gamma inhibition of PDE6 in a biphasic manner, with only one-half of the maximum PDE6 activity efficiently attained during visual excitation.	[Liu, Yu-Ting; Matte, Suzanne L.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Corbin, Jackie D.; Francis, Sharron H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University System Of New Hampshire; University of New Hampshire; Vanderbilt University	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798, DK-40029]; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY-05798 and DK-40029. This is Scientific Contribution Number 2392 from the New Hampshire Agricultural Experiment Station.	ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; BEAVO JA, 2006, CYCLIC NUCL PHOSPHOD; BELTMAN J, 1995, MOL PHARMACOL, V47, P330; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; BOWNDS D, 1971, J GEN PHYSIOL, V58, P225, DOI 10.1085/jgp.58.3.225; BRUCKERT F, 1994, BIOCHEMISTRY-US, V33, P12625, DOI 10.1021/bi00208a013; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Cote RH, 2000, METHOD ENZYMOL, V315, P646; COTE RH, 2006, CYCLIC NUCL PHOSPHOD; COTE RH, 2008, VISUAL TRANSDUCTION; Cote Rick H., 2005, V307, P141; D'Amours MR, 1999, MOL PHARMACOL, V55, P508; Fink TL, 1999, J BIOL CHEM, V274, P34613, DOI 10.1074/jbc.274.49.34613; FRANCIS SH, 2006, CYCLIC NUCL PHOSPHOD; FUNG BKK, 1989, BIOCHEMISTRY-US, V28, P3133, DOI 10.1021/bi00434a003; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; GILLESPIE PG, 1990, CYCLIC NUCL PHOSPHOD; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; MCALLISTERLUCAS LM, 1993, J BIOL CHEM, V268, P22863; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; MIKI N, 1975, J BIOL CHEM, V250, P6320; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; Pentia Dana C., 2005, V307, P125; PLEISS U, 2007, SYNTHESIS 3H VARDENA; PUGH EN, 2000, MOL MECH VISUAL TRAN; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; WENSEL TG, 1988, ENZYME DYNAMICS REGU; Wensel Theodore G., 2005, V307, P289; WHALEN MM, 1990, BIOCHEM J, V265, P655, DOI 10.1042/bj2650655; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	56	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31541	31547		10.1074/jbc.M109.018606	http://dx.doi.org/10.1074/jbc.M109.018606			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19758990	Green Published, hybrid			2022-12-25	WOS:000271572700007
J	Park, MS; O'Donnell, M				Park, Mee Sook; O'Donnell, Mike			The Clamp Loader Assembles the beta Clamp onto Either a 3 ' or 5 ' Primer Terminus THE UNDERLYING BASIS FAVORING 3 ' LOADING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; ESCHERICHIA-COLI; SLIDING CLAMP; GAMMA COMPLEX; ATP HYDROLYSIS; DELTA-SUBUNIT; RECA PROTEIN; MECHANISM	Clamp loaders assemble sliding clamps onto 3' primed sites for DNA polymerases. Clamp loaders are thought to be specific for a 3' primed site, and unable to bind a 5' site. We demonstrate here that the Escherichia coli gamma complex clamp loader can load the beta clamp onto a 5' primed site, although with at least 20-fold reduced efficiency relative to loading at a 3' primed site. Preferential clamp loading at a 3' site does not appear to be due to DNA binding, as the clamp loader forms an avid complex with beta at a 5' site. Preferential loading at a 3' versus a 5' site occurs at the ATP hydrolysis step, needed to close the ring around DNA. We also address DNA structural features that are recognized for preferential loading at a 3' site. Although the single-stranded template strand extends in opposite directions from 3' and 5' primed sites, thus making it a favorite candidate for distinguishing between 3' and 5' sites, the single-strand polarity at a primed template junction does not determine 3' site selection for clamp loading. Instead, we find that clamp loader recognition of a 3' site lies in the duplex portion of the primed site, not the single-strand portion. We present evidence that the beta clamp facilitates its own loading specificity for a 3' primed site. Implications to eukaryotic clamp loader complexes are proposed.	[Park, Mee Sook; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), 1230 York Ave,Box 228, New York, NY 10065 USA.	odonnel@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM3883]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM3883.	Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; de Saro FJL, 2003, EMBO J, V22, P6408, DOI 10.1093/emboj/cdg603; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440	35	12	12	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31473	31483		10.1074/jbc.M109.050310	http://dx.doi.org/10.1074/jbc.M109.050310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19759020	Green Published, hybrid			2022-12-25	WOS:000271378400072
J	Veesler, D; Dreier, B; Blangy, S; Lichiere, J; Tremblay, D; Moineau, S; Spinelli, S; Tegoni, M; Pluckthun, A; Campanacci, V; Cambillau, C				Veesler, David; Dreier, Birgit; Blangy, Stephanie; Lichiere, Julie; Tremblay, Denise; Moineau, Sylvain; Spinelli, Silvia; Tegoni, Mariella; Plueckthun, Andreas; Campanacci, Valerie; Cambillau, Christian			Crystal Structure and Function of a DARPin Neutralizing Inhibitor of Lactococcal Phage TP901-1 COMPARISON OF DARPin AND CAMELID VHH BINDING MODE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT PROTEIN; CHAIN ANTIBODY FRAGMENT; IN-VITRO; RIBOSOME DISPLAY; LACTIS PHAGES; IDENTIFICATION; DOMAIN; LLAMA; CRYSTALLIZATION; BACTERIOPHAGES	Combinatorial libraries of designed ankyrin repeat proteins (DARPins) have been proven to be a valuable source of specific binding proteins, as they can be expressed at very high levels and are very stable. We report here the selection of DARPins directed against a macromolecular multiprotein complex, the baseplate BppU.BppL complex of the lactococcal phage TP901-1. Using ribosome display, we selected several DARPins that bound specifically to the tip of the receptor-binding protein (RBP, the BppL trimer). The three selected DARPins display high specificity and affinity in the low nanomolar range and bind with a stoichiometry of one DARPin per BppL trimer. The crystal structure of a DARPin complexed with the RBP was solved at 2.1 angstrom resolution. The DARPin.RBP interface is of the concave (DARPin)-convex (RBP) type, typical of other DARPin protein complexes and different from what is observed with a camelid VHH domain, which penetrates the phage p2 RBP inter-monomer interface. Finally, phage infection assays demonstrated that TP901-1 infection of Lactococcus lactis cells was inhibited by each of the three selected DARPins. This study provides proof of concept for the possible use of DARPins to circumvent viral infection. It also provides support for the use of DARPins in co-crystallization, due to their rigidity and their ability to provide multiple crystal contacts.	[Veesler, David; Blangy, Stephanie; Lichiere, Julie; Spinelli, Silvia; Tegoni, Mariella; Campanacci, Valerie; Cambillau, Christian] AFMB, CNRS, UMR 6098, F-13288 Marseille 09, France; [Veesler, David; Blangy, Stephanie; Lichiere, Julie; Spinelli, Silvia; Tegoni, Mariella; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Veesler, David; Blangy, Stephanie; Lichiere, Julie; Spinelli, Silvia; Tegoni, Mariella; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [Dreier, Birgit; Plueckthun, Andreas] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Tremblay, Denise] Univ Laval, Grp Rech Ecol Buccale, Felix Herelle Reference Ctr Bacterial Viruses, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada; [Moineau, Sylvain] Univ Laval, Dept Biochim & Microbiol, Fac Sci & Genie, Quebec City, PQ G1V 0A6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Zurich; Laval University; Laval University	Campanacci, V (corresponding author), AFMB, CNRS, UMR 6098, 163 Av Luminy,Case 932,Campus Luminy, F-13288 Marseille 09, France.	valerie.campanacci@afmb.univ-mrs.fr; cambillau@afmb.univ-mrs.fr	Veesler, David/HCH-3986-2022; Moineau, Sylvain/I-7231-2019; Moineau, Sylvain/N-3578-2013; Plückthun, Andreas/C-2746-2009	Moineau, Sylvain/0000-0002-2832-5101; Plückthun, Andreas/0000-0003-4191-5306; Campanacci, Valerie/0000-0001-6407-6395	Marseille-Nice Geno-pole; CNRS; Natural Sciences and Engineering Research Council of Canada through its strategic grogram; Agence Nationale de la Recherche [ANR-07-BLAN-0095]	Marseille-Nice Geno-pole; CNRS(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada through its strategic grogram(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported, in part, by grants from the Marseille-Nice Geno-pole ( to J.L.), the CNRS, the Natural Sciences and Engineering Research Council of Canada through its strategic grogram ( to S. M.), and by Agence Nationale de la Recherche (ANR-07-BLAN-0095).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bandeiras TM, 2008, ACTA CRYSTALLOGR D, V64, P339, DOI 10.1107/S0907444907068217; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bissonnette F, 2000, J DAIRY SCI, V83, P620, DOI 10.3168/jds.S0022-0302(00)74921-6; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; De Haard HJW, 2005, J BACTERIOL, V187, P4531, DOI 10.1128/JB.187.13.4531-4541.2005; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Geller BL, 2005, J DAIRY SCI, V88, P900, DOI 10.3168/jds.S0022-0302(05)72756-9; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hultberg A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-58; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kohl A, 2005, STRUCTURE, V13, P1131, DOI 10.1016/j.str.2005.04.020; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labrie SJ, 2008, APPL ENVIRON MICROB, V74, P4636, DOI 10.1128/AEM.00118-08; Labrie SJ, 2007, J BACTERIOL, V189, P1482, DOI 10.1128/JB.01111-06; Ledeboer AM, 2002, J DAIRY SCI, V85, P1376, DOI 10.3168/jds.S0022-0302(02)74204-5; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P197, DOI 10.1128/AEM.59.1.197-202.1993; Moineau S, 1999, ANTON LEEUW INT J G, V76, P377, DOI 10.1023/A:1002045701064; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	44	53	57	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30718	30726		10.1074/jbc.M109.037812	http://dx.doi.org/10.1074/jbc.M109.037812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740746	Green Published, hybrid			2022-12-25	WOS:000271090000073
J	Garza-Garcia, A; Harris, R; Esposito, D; Gates, PB; Driscoll, PC				Garza-Garcia, Acely; Harris, Richard; Esposito, Diego; Gates, Phillip B.; Driscoll, Paul C.			Solution Structure and Phylogenetics of Prod1, a Member of the Three-Finger Protein Superfamily Implicated in Salamander Limb Regeneration	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NMR STRUCTURE; QUALITY; VENOM; BUNGAROTOXIN; DIVERGENCE; SIMILARITY; ALGORITHM; EVOLUTION; ACCURACY	Background: Following the amputation of a limb, newts and salamanders have the capability to regenerate the lost tissues via a complex process that takes place at the site of injury. Initially these cells undergo dedifferentiation to a state competent to regenerate the missing limb structures. Crucially, dedifferentiated cells have memory of their level of origin along the proximodistal (PD) axis of the limb, a property known as positional identity. Notophthalmus viridescens Prod1 is a cell-surface molecule of the three-finger protein (TFP) superfamily involved in the specification of newt limb PD identity. The TFP superfamily is a highly diverse group of metazoan proteins that includes snake venom toxins, mammalian transmembrane receptors and miscellaneous signaling molecules. Methodology/Principal Findings: With the aim of identifying potential orthologs of Prod1, we have solved its 3D structure and compared it to other known TFPs using phylogenetic techniques. The analysis shows that TFP 3D structures group in different categories according to function. Prod1 clusters with other cell surface protein TFP domains including the complement regulator CD59 and the C-terminal domain of urokinase-type plasminogen activator. To infer orthology, a structure-based multiple sequence alignment of representative TFP family members was built and analyzed by phylogenetic methods. Prod1 has been proposed to be the salamander CD59 but our analysis fails to support this association. Prod1 is not a good match for any of the TFP families present in mammals and this result was further supported by the identification of the putative orthologs of both CD59 and N. viridescens Prod1 in sequence data for the salamander Ambystoma tigrinum. Conclusions/Significance: The available data suggest that Prod1, and thereby its role in encoding PD identity, is restricted to salamanders. The lack of comparable limb-regenerative capability in other adult vertebrates could be correlated with the absence of the Prod1 gene.			Garza-Garcia, A (corresponding author), Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England.	pdrisco@nimr.mrc.ac.uk	Driscoll, Paul C/B-8007-2010	Driscoll, Paul C/0000-0002-4124-6950; Garza-Garcia, Acely/0000-0003-0307-0138; Harris, Richard/0000-0001-7459-1745	Medical Research Council [MC_U117574559, MC_U117533887, G0600229] Funding Source: Medline; MRC [G0600229, MC_U117533887] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Breitling R, 2001, MOL BIOL EVOL, V18, P2154, DOI 10.1093/oxfordjournals.molbev.a003761; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bujnicki JM, 2000, J MOL EVOL, V50, P39, DOI 10.1007/s002399910005; Carlson B.M, 2007, PRINCIPLES REGENERAT, P379; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Csaba G, 2008, BIOINFORMATICS, V24, pI98, DOI 10.1093/bioinformatics/btn271; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fitch WM, 1997, J MOL EVOL, V44, pS65, DOI 10.1007/PL00000059; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JOHNSON MS, 1990, METHOD ENZYMOL, V183, P670; Junqueira-de-Azevedo ILM, 2006, GENETICS, V173, P877, DOI 10.1534/genetics.106.056515; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Moreira D, 2000, MOL MICROBIOL, V35, P1, DOI 10.1046/j.1365-2958.2000.01692.x; NARDI JB, 1983, DIFFERENTIATION, V25, P27; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shiu JH, 2004, PROTEINS, V57, P839, DOI 10.1002/prot.20269; Standley DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-116; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres AM, 2001, BIOCHEM J, V360, P539, DOI 10.1042/0264-6021:3600539; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	60	49	52	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2009	4	9							e7123	10.1371/journal.pone.0007123	http://dx.doi.org/10.1371/journal.pone.0007123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498PN	19771161	gold, Green Published, Green Submitted			2022-12-25	WOS:000270154400016
J	Zhao, CY; Xu, ZW; Wang, F; Chen, JH; Ng, SK; Wong, PW; Yu, ZL; Pun, FW; Ren, LH; Lo, WS; Tsang, SY; Xue, H				Zhao, Cunyou; Xu, Zhiwen; Wang, Feng; Chen, Jianhuan; Ng, Siu-Kin; Wong, Pak-Wing; Yu, Zhiliang; Pun, Frank W.; Ren, Lihuan; Lo, Wing-Sze; Tsang, Shui-Ying; Xue, Hong			Alternative-Splicing in the Exon-10 Region of GABA(A) Receptor beta(2) Subunit Gene: Relationships between Novel Isoforms and Psychotic Disorders	PLOS ONE			English	Article							2 FORMS; SCHIZOPHRENIA; ASSOCIATION; EXPRESSION; HAPLOTYPES; SUBTYPES; TARGETS; UPDATE; FAMILY; CELL	Methods and Findings: Non-coding single nucleotide polymorphisms ( SNPs) in GABRB2, the gene for beta(2)-subunit of gamma-aminobutyric acid type A (GABA(A)) receptor, have been associated with schizophrenia (SCZ) and quantitatively correlated to mRNA expression and alternative splicing. Methods and Findings: Expression of the Exon 10 region of GABRB2 from minigene constructs revealed this region to be an "alternative splicing hotspot'' that readily gave rise to differently spliced isoforms depending on intron sequences. This led to a search in human brain cDNA libraries, and the discovery of two novel isoforms, beta(2S1) and beta(2S2), bearing variations in the neighborhood of Exon-10. Quantitative real-time PCR analysis of postmortem brain samples showed increased beta(2S1) expression and decreased beta(2S2) expression in both SCZ and bipolar disorder (BPD) compared to controls. Disease-control differences were significantly correlated with SNP rs187269 in BPD males for both beta(2S1) and beta(2S2) expressions, and significantly correlated with SNPs rs2546620 and rs187269 in SCZ males for beta(2S2) expression. Moreover, site-directed mutagenesis indicated that Thr(365), a potential phosphorylation site in Exon-10, played a key role in determining the time profile of the ATP-dependent electrophysiological current run-down. Conclusion: This study therefore provided experimental evidence for the importance of non-coding sequences in the Exon-10 region in GABRB2 with respect to beta(2)-subunit splicing diversity and the etiologies of SCZ and BPD.			Zhao, CY (corresponding author), Hong Kong Univ Sci & Technol, Fok Ying Tung Grad Sch, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	hxue@ust.hk	ZHAO, Cunyou/Q-5076-2016; Chen, Jian-Huan/ABB-9660-2021; Chen, Jian-Huan/L-7188-2017; Lo, Cario Wing Sze/DGZ-8810-2022	ZHAO, Cunyou/0000-0001-6116-4584; Chen, Jian-Huan/0000-0001-8714-2543; Chen, Jian-Huan/0000-0001-8714-2543; Xue, Hong/0000-0002-8133-9828				CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; HARVEY RJ, 1994, J NEUROCHEM, V62, P10; Harvey RJ, 1997, NEUROSCIENCE, V77, P361, DOI 10.1016/S0306-4522(96)00467-8; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Korpi ER, 2006, PHARMACOL THERAPEUT, V109, P12, DOI 10.1016/j.pharmthera.2005.05.009; Liu JX, 2005, BIOCHEM BIOPH RES CO, V334, P817, DOI 10.1016/j.bbrc.2005.06.167; Lo WS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000462; Lo WS, 2007, BIOL PSYCHIAT, V61, P653, DOI 10.1016/j.biopsych.2006.05.003; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; MCKINLEY DD, 1995, MOL BRAIN RES, V28, P175, DOI 10.1016/0169-328X(94)00228-7; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; NAGATA K, 1994, BRAIN RES, V645, P19, DOI 10.1016/0006-8993(94)91633-0; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whiting PJ, 1999, NEUROCHEM INT, V34, P387, DOI 10.1016/S0197-0186(99)00048-0; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Zhao C, 2006, MOL PSYCHIATR, V11, P1092, DOI 10.1038/sj.mp.4001899	20	25	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2009	4	9							e6977	10.1371/journal.pone.0006977	http://dx.doi.org/10.1371/journal.pone.0006977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496KI	19763268	Green Submitted, Green Published, gold			2022-12-25	WOS:000269970400003
J	Chen, GJ; Han, GC; Feng, JN; Wang, JA; Wang, RX; Xu, RN; Shen, BF; Qian, JH; Li, Y				Chen, Guojiang; Han, Gencheng; Feng, Jiannan; Wang, Jianan; Wang, Renxi; Xu, Ruonan; Shen, Beifen; Qian, Jiahua; Li, Yan			Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells	PLOS ONE			English	Article								Background: CD4(+)CD25(+) regulatory T cell (Treg)-based immunotherapy is considered a promising regimen for controlling the progression of autoimmune diabetes. In this study, we tested the hypothesis that the therapeutic effects of Tregs in response to the antigenic epitope stimulation depend on the structural properties of the epitopes used. Methodology/Principal Findings: Splenic lymphocytes from nonobese diabetic (NOD) mice were stimulated with different glutamic acid decarboxylase (GAD)-derived epitopes for 7-10 days and the frequency and function of Tregs was analyzed. We found that, although all expanded Tregs showed suppressive functions in vitro, only p524 (GAD524-538)-expanded CD4(+)CD25(+) T cells inhibited diabetes development in the co-transfer models, while p509 (GAD509-528)- or p530 (GAD530-543)-expanded CD4(+)CD25(+) T cells had no such effects. Using computer-guided molecular modeling and docking methods, the differences in structural characteristics of these epitopes and the interaction mode (including binding energy and identified domains in the epitopes) between the above-mentioned epitopes and MHC class II I-A(g7) were analyzed. The theoretical results showed that the epitope p524, which induced protective Tregs, possessed negative surface-electrostatic potential and bound two chains of MHC class II I-A(g7), while the epitopes p509 and p530 which had no such ability exhibited positive surface-electrostatic potential and bound one chain of I-A(g7). Furthermore, p524 bound to I-A(g7) more stably than p509 and p530. Of importance, we hypothesized and subsequently confirmed experimentally that the epitope (GAD570-585, p570), which displayed similar characteristics to p524, was a protective epitope by showing that p570-expanded CD4(+)CD25(+) T cells suppressed the onset of diabetes in NOD mice. Conclusions/Significance: These data suggest that molecular modeling-based structural analysis of epitopes may be an instrumental tool for prediction of protective epitopes to expand functional Tregs.			Chen, GJ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China.	liyan62033@yahoo.com.cn	Wang, Renxi/AAM-1326-2020	Wang, Renxi/0000-0003-4130-3334; Han, George/0000-0003-3302-5098; Friedman, Adam/0000-0001-8925-1620				Arneson LS, 2000, J IMMUNOL, V165, P2059, DOI 10.4049/jimmunol.165.4.2059; ATKINSON MA, 1992, LANCET, V339, P458, DOI 10.1016/0140-6736(92)91061-C; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Chen C, 2003, J IMMUNOL, V171, P733, DOI 10.4049/jimmunol.171.2.733; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Dai YD, 2008, EUR J IMMUNOL, V38, P968, DOI 10.1002/eji.200737703; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Ellis TM, 1996, NAT MED, V2, P148, DOI 10.1038/nm0296-148; Fanelli F, 1998, METHODS, V14, P302, DOI 10.1006/meth.1998.0586; Fisson S, 2006, EUR J IMMUNOL, V36, P817, DOI 10.1002/eji.200535445; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Geng LP, 1998, P NATL ACAD SCI USA, V95, P10055, DOI 10.1073/pnas.95.17.10055; Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Nicholson MJ, 2005, IMMUNITY, V23, P351, DOI 10.1016/j.immuni.2005.09.009; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Ortiz AR, 1999, PROTEINS, P177; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Quinn A, 2001, J IMMUNOL, V166, P2982, DOI 10.4049/jimmunol.166.5.2982; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Severe S, 2007, MOL IMMUNOL, V44, P2950, DOI 10.1016/j.molimm.2007.01.008; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Song L, 2004, GENE THER, V11, P1487, DOI 10.1038/sj.gt.3302327; Stockinger B, 2001, NAT IMMUNOL, V2, P757, DOI 10.1038/ni0901-757; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tarbell KV, 2002, J EXP MED, V196, P481, DOI 10.1084/jem.20011845; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878; Zhao YL, 2008, BIOCHEM BIOPH RES CO, V372, P346, DOI 10.1016/j.bbrc.2008.05.046; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	51	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2009	4	9							e7034	10.1371/journal.pone.0007034	http://dx.doi.org/10.1371/journal.pone.0007034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494FM	19759824	Green Published, Green Submitted, gold			2022-12-25	WOS:000269796100001
